Citrus Sinensis ID: 013793

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430------
Protein Sequence
MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN
Secondary Structure (PSIPRED)
cccccEEEcccccccccccHHccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEcccccccHHHHHHHHHccccccEEEEccccEEEEEEcccccEEEEEEEcccccHHHHHHHHHHHHHHHHHcccccccccccEEEEcccccEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccHHHcccccccEEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHccccccccccHHHHHccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHHHEEccccccEEEEcHcHHHHccccccEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHHccccHHEEccHHcccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccccccccccccccccccc
Coil and Loop (DISEMBL)
mknltwldisnnkiegsipgeltdlsrldylnlswnklsgpvpfsneqlssmsrvrlspnkglcgnfitlpscdatkpaTLFVEIFLPLAIVPSVIVFACLLVVKrkykkpkvkaratnsidvfsiwnydgrifYEDLIEATEDFHIKYcigtggygsvykaqlpngkvfaLKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYlhhdcspsiihrdissnnillNSKLEAFVADfgtarrlhadssnrtllagtygyiapeLAYTMVMTEKCDVYSFGVVTLEVLmgkhprdllsslssssdpkimlidvldqrlpppvdqKVIQDILLASTISFAclqsnpksrptmqyvsqgflitrktplvkhaaiqdisISELRN
Flexible Loop (DISEMBL)
mknltwldisnnkiegsipgelTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKrkykkpkvkaratnsidvfsiwnyDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARrlhadssnrtllagTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFlitrktplvkhaaiqdisiselrn
Low Complexity Region (SEG)
MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLvvkrkykkpkvkARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDllsslssssDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN
Disordered region (IsUnstruct)
****TWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG*******************NKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH***************IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQS******TMQYVSQGFLITRKTPLVKHAAIQDI*******
Disordered Region (DISOPRED)
MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLC*********************FLPLAIVPSVIVFACLLVVK*********************WNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHT***********FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ********************IS****
Disordered Region (DISEMBL)
MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN
Disordered Region (DISPRO)
*KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPS****KPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKK*********SIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ*F************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	436	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.938	0.391	0.442	1e-100
Q9LP24	1120	Probable leucine-rich rep	no	no	0.938	0.365	0.431	2e-93
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.917	0.363	0.358	3e-66
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.880	0.348	0.376	5e-66
O49318	1124	Probable leucine-rich rep	no	no	0.915	0.354	0.360	3e-64
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.942	0.410	0.349	3e-61
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.917	0.394	0.368	5e-61
C0LGF4	591	LRR receptor-like serine/	no	no	0.905	0.668	0.366	2e-60
O49545	1003	Leucine-rich repeat recep	no	no	0.903	0.392	0.355	2e-59
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.915	0.319	0.326	2e-59

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  367 bits (941), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 189/427 (44%), Positives = 279/427 (65%), Gaps = 18/427 (4%)

Query: 1    MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            ++NL  LD+S+N + G IP    D+  L ++++S N L GP+P  N    +        N
Sbjct: 621  LQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIP-DNAAFRNAPPDAFEGN 679

Query: 61   KGLCGNFIT---LPSCDAT------KPATLFVEIFLPL--AIVPSVIVFACLLVVKRKYK 109
            K LCG+  T   L  C  T      K   L + I +P+  AI+   +     +  +++ K
Sbjct: 680  KDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTK 739

Query: 110  KPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKV 169
            + +    + +  +  SI+++DG++ Y+++I+AT +F  KY IGTGG+G VYKA+LPN  +
Sbjct: 740  QIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-I 798

Query: 170  FALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER 226
             A+KKL+ +    ++     + F NE + L+++ HR++VKL+GFC H++  FL+YEYMER
Sbjct: 799  MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMER 858

Query: 227  GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE 286
            GSL  +L NDDEA +LDW KR+N+VK +AHAL+Y+HHD SP+I+HRDISS NILL    E
Sbjct: 859  GSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYE 918

Query: 287  AFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 346
            A ++DFGTA+ L  DSSN + +AGTYGY+APELAY M +TEKCDVYSFGV+TLEV+ G+H
Sbjct: 919  AKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEH 978

Query: 347  PRDLLSSLSSS-SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTM 405
            P DL+S+LSSS  D  + L  + D RLP P  + + +++L    ++  CL S+P++RPTM
Sbjct: 979  PGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE-IKEEVLEILKVALLCLHSDPQARPTM 1037

Query: 406  QYVSQGF 412
              +S  F
Sbjct: 1038 LSISTAF 1044

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  343 bits (880), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 193/447 (43%), Positives = 279/447 (62%), Gaps = 38/447 (8%)

Query: 1    MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            +  LT LD+S+N+++G IP +L+ L  LD L+LS N LSG +P + E + +++ V +S N
Sbjct: 676  LTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNN 735

Query: 61   K-----------------------GLCGNFITL---PSCDATKP---ATLFVEIFLPLAI 91
            K                       GLC N       P  +  KP     L V I +P+  
Sbjct: 736  KLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILG 795

Query: 92   VPSVIVFACLLVVKRKYKKPKVK-ARATN--SIDVFSIWNYDGRIFYEDLIEATEDFHIK 148
            V  VI+  C        +K K++  R T+  + +  SI++ DG+  Y+D+IE+T +F   
Sbjct: 796  V-LVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPT 854

Query: 149  YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRSIV 205
            + IGTGGY  VY+A L +  + A+K+LH +  EE++     + F NE + L+++ HR++V
Sbjct: 855  HLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVV 913

Query: 206  KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
            KL+GFC H++  FLIYEYME+GSL  +L ND+EA  L W KR+N+VK +AHAL+Y+HHD 
Sbjct: 914  KLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDR 973

Query: 266  SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
               I+HRDISS NILL++   A ++DFGTA+ L  DSSN + +AGTYGY+APE AYTM +
Sbjct: 974  ITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKV 1033

Query: 326  TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL 385
            TEKCDVYSFGV+ LE+++GKHP DL+SSLSSS    + L  + D+R+  P  Q   + +L
Sbjct: 1034 TEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQNR-EKLL 1092

Query: 386  LASTISFACLQSNPKSRPTMQYVSQGF 412
                ++  CLQ+NP+SRPTM  +S  F
Sbjct: 1093 KMVEMALLCLQANPESRPTMLSISTTF 1119

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  252 bits (644), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 160/446 (35%), Positives = 234/446 (52%), Gaps = 46/446 (10%)

Query: 7    LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSS--------------- 51
            L+IS+N + G+IP  L +L  L+ L L+ NKLSG +P S   L S               
Sbjct: 625  LNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTV 684

Query: 52   --------MSRVRLSPNKGLCGNFIT-----LPSCDATKPATLFVEIFLPLAIVPSVIVF 98
                    M     + N GLC +  +     +P  D+     +       +  +  +++ 
Sbjct: 685  PDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIG 744

Query: 99   ACLLVV------KRKYKKPK-VKARATNSIDVFSIWNYDGRIF-YEDLIEATEDFHIKYC 150
            +  L+         K ++P  V        DV   + +  + F Y+ L++AT +F     
Sbjct: 745  SVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVV 804

Query: 151  IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
            +G G  G+VYKA++  G+V A+KKL+ S  E  +   SFR E   L ++ HR+IVKLYGF
Sbjct: 805  LGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGF 863

Query: 211  CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            C H+    L+YEYM +GSL   L   ++   LDW  R  I    A  L YLHHDC P I+
Sbjct: 864  CYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIV 923

Query: 271  HRDISSNNILLNSKLEAFVADFGTARRLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKC 329
            HRDI SNNILL+ + +A V DFG A+ +    S + + +AG+YGYIAPE AYTM +TEKC
Sbjct: 924  HRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKC 983

Query: 330  DVYSFGVVTLEVLMGKHP-------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ 382
            D+YSFGVV LE++ GK P        DL++ +  S    I  I++ D RL    D++ + 
Sbjct: 984  DIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVH 1042

Query: 383  DILLASTISFACLQSNPKSRPTMQYV 408
            ++ L   I+  C  ++P SRPTM+ V
Sbjct: 1043 EMSLVLKIALFCTSNSPASRPTMREV 1068

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  252 bits (643), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 158/420 (37%), Positives = 224/420 (53%), Gaps = 36/420 (8%)

Query: 16   GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFIT------ 69
            G IP    +LS L   N S+N L+GP+P     L ++S      N+GLCG  +       
Sbjct: 664  GEIPSSFANLSSLLGYNFSYNSLTGPIPL----LRNISMSSFIGNEGLCGPPLNQCIQTQ 719

Query: 70   --LPSCDATKPATLFVE--IFLPLAIVPSVIVFACLLVVKRKYKKPKVKARATN------ 119
               PS    KP  +     I +  A++  V +    L+V    +  +  A +        
Sbjct: 720  PFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSE 779

Query: 120  -SIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTS 178
             S+D++  +       ++DL+ AT++F   + +G G  G+VYKA LP G   A+KKL ++
Sbjct: 780  MSLDIY--FPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASN 837

Query: 179  ET--EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND 236
                       SFR E   L  + HR+IVKL+GFC H+    L+YEYM +GSL  ILH  
Sbjct: 838  HEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH-- 895

Query: 237  DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
            D +  LDW+KR  I    A  LAYLHHDC P I HRDI SNNILL+ K EA V DFG A+
Sbjct: 896  DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 955

Query: 297  RLH-ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------R 348
             +    S + + +AG+YGYIAPE AYTM +TEK D+YS+GVV LE+L GK P        
Sbjct: 956  VIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG 1015

Query: 349  DLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            D+++ + S      +   VLD RL    D++++  +L    I+  C   +P +RP+M+ V
Sbjct: 1016 DVVNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  246 bits (627), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 158/438 (36%), Positives = 228/438 (52%), Gaps = 39/438 (8%)

Query: 4    LTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGL 63
            L +L ++NN + G IP    +LS L   N S+N L+G +P + +   +M+      NKGL
Sbjct: 664  LMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHT-QIFQNMTLTSFLGNKGL 722

Query: 64   CGNFITLPSCDATKPATLFVEIF--------------LPLAIVPSVIVFACLLVVKRKYK 109
            CG    L SCD +  +   +                   +    S+++ A ++   R   
Sbjct: 723  CGGH--LRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPV 780

Query: 110  KPKV-----KARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQL 164
            +P       K       D++ +     R   +D++EAT+ FH  Y +G G  G+VYKA +
Sbjct: 781  EPTAPYVHDKEPFFQESDIYFV--PKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVM 838

Query: 165  PNGKVFALKKLH----TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMF 218
            P+GK  A+KKL      +         SFR E   L ++ HR+IV+LY FC H+      
Sbjct: 839  PSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNL 898

Query: 219  LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN 278
            L+YEYM RGSL  +LH   ++  +DW  R  I    A  LAYLHHDC P IIHRDI SNN
Sbjct: 899  LLYEYMSRGSLGELLH-GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNN 957

Query: 279  ILLNSKLEAFVADFGTARRLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 337
            IL++   EA V DFG A+ +    S + + +AG+YGYIAPE AYTM +TEKCD+YSFGVV
Sbjct: 958  ILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 1017

Query: 338  TLEVLMGKHP-------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTI 390
             LE+L GK P        DL +   +      +  ++LD  L    D  ++  ++  + I
Sbjct: 1018 LLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKI 1077

Query: 391  SFACLQSNPKSRPTMQYV 408
            +  C +S+P  RPTM+ V
Sbjct: 1078 AVLCTKSSPSDRPTMREV 1095

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  236 bits (602), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 162/464 (34%), Positives = 244/464 (52%), Gaps = 53/464 (11%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS--- 58
           K LT++D+S N++ G IP ELT +  L+YLNLS N L G +P +   + S++ V  S   
Sbjct: 528 KLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNN 587

Query: 59  -----PNKG---------------LCGNFITLPSCDAT-----KPATLFVEIFLPLAIVP 93
                P+ G               LCG ++  P    T     KP +   ++ L L ++ 
Sbjct: 588 LSGLVPSTGQFSYFNYTSFVGNSHLCGPYLG-PCGKGTHQSHVKPLSATTKLLLVLGLLF 646

Query: 94  SVIVFACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGT 153
             +VFA + ++K +  +   +A+A   +  F   ++      +D++++ ++ +I   IG 
Sbjct: 647 CSMVFAIVAIIKARSLRNASEAKAWR-LTAFQRLDFT----CDDVLDSLKEDNI---IGK 698

Query: 154 GGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH 213
           GG G VYK  +P G + A+K+L T  +   +    F  E Q L ++ HR IV+L GFC +
Sbjct: 699 GGAGIVYKGTMPKGDLVAVKRLATM-SHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN 757

Query: 214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 273
            +   L+YEYM  GSL  +LH   +   L W  R  I    A  L YLHHDCSP I+HRD
Sbjct: 758 HETNLLVYEYMPNGSLGEVLHGK-KGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRD 816

Query: 274 ISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDV 331
           + SNNILL+S  EA VADFG A+ L    ++  +  +AG+YGYIAPE AYT+ + EK DV
Sbjct: 817 VKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDV 876

Query: 332 YSFGVVTLEVLMGKHP-------RDLLSSLSSSSDP-KIMLIDVLDQRLPPPVDQKVIQD 383
           YSFGVV LE++ GK P        D++  + S +D  K  ++ V+D RL        + +
Sbjct: 877 YSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRL----SSVPVHE 932

Query: 384 ILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQ 427
           +     ++  C++     RPTM+ V Q      K PL K  A +
Sbjct: 933 VTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAE 976

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  235 bits (599), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 160/434 (36%), Positives = 229/434 (52%), Gaps = 34/434 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M  L  LD+SNN + G +P  +     L+ LN+S+NKL+GPVP  N  L +++   L  N
Sbjct: 547 MSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPI-NGFLKTINPDDLRGN 605

Query: 61  KGLCGNFITLPSCDATKPAT-----LFVEIFLP--LAIVPSVIVFACLLVVKRK-YKKPK 112
            GLCG    LP C   + AT     L  +  +   L  + SV+    L +V R  YKK  
Sbjct: 606 SGLCGG--VLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWY 663

Query: 113 VKARATNSIDVFSIWNYDGRIFYE------DLIEATEDFHIKYCIGTGGYGSVYKAQLP- 165
                 +       W +    F+       D++   ++ ++   IG G  G VYKA++  
Sbjct: 664 SNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNM---IGMGATGIVYKAEMSR 720

Query: 166 NGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM 224
           +  V A+KKL  S  + E      F  E  +L ++ HR+IV+L GF  + K M ++YE+M
Sbjct: 721 SSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFM 780

Query: 225 ERGSLFCILHNDDEAVEL--DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN 282
             G+L   +H  + A  L  DW  R NI   +AH LAYLHHDC P +IHRDI SNNILL+
Sbjct: 781 LNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLD 840

Query: 283 SKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           + L+A +ADFG AR +       +++AG+YGYIAPE  YT+ + EK D+YS+GVV LE+L
Sbjct: 841 ANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELL 900

Query: 343 MGKHPRDLLSSLSSSSD------PKIMLIDVLDQRLPPPVD--QKVIQDILLASTISFAC 394
            G+ P  L      S D       KI     L++ L P V   + V +++LL   I+  C
Sbjct: 901 TGRRP--LEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLC 958

Query: 395 LQSNPKSRPTMQYV 408
               PK RP+M+ V
Sbjct: 959 TTKLPKDRPSMRDV 972

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  233 bits (594), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 162/442 (36%), Positives = 232/442 (52%), Gaps = 47/442 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  LD+S+N + G IP  L  L +L   N+S N L G +P S+  LS  S+     N
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIP-SDGVLSGFSKNSFIGN 203

Query: 61  KGLCGNFITLPSCDATKPATLFVEIFL-------PLAIVPSVIVFACLLV---------V 104
             LCG  + +   D +   +   +           L I  S  V A LLV         +
Sbjct: 204 LNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALMCFWGCFL 263

Query: 105 KRKYKKPKVKARATNSIDVFSIWNYDGRIFY--EDLIEATEDFHIKYCIGTGGYGSVYKA 162
            +K  K ++K+ A +     SI  + G + Y  +D+I+  E  + ++ IG GG+G+VYK 
Sbjct: 264 YKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTVYKL 323

Query: 163 QLPNGKVFALKK-LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY 221
            + +GKVFALK+ L  +E     F + F  E ++L  + HR +V L G+C       L+Y
Sbjct: 324 AMDDGKVFALKRILKLNE----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379

Query: 222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 281
           +Y+  GSL   LH   E  +LDW  RVNI+   A  L+YLHHDCSP IIHRDI S+NILL
Sbjct: 380 DYLPGGSLDEALHERGE--QLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILL 437

Query: 282 NSKLEAFVADFGTARRLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLE 340
           +  LEA V+DFG A+ L  + S+  T++AGT+GY+APE   +   TEK DVYSFGV+ LE
Sbjct: 438 DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLE 497

Query: 341 VLMGKHPRDL------------LSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           VL GK P D             L  L S   P+    D++D    P  +   ++ +    
Sbjct: 498 VLSGKRPTDASFIEKGLNVVGWLKFLISEKRPR----DIVD----PNCEGMQMESLDALL 549

Query: 389 TISFACLQSNPKSRPTMQYVSQ 410
           +I+  C+  +P+ RPTM  V Q
Sbjct: 550 SIATQCVSPSPEERPTMHRVVQ 571

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  230 bits (586), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 153/430 (35%), Positives = 231/430 (53%), Gaps = 36/430 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           MK L +L++S N + GSIPG ++ +  L  L+ S+N LSG VP +  Q S  +      N
Sbjct: 550 MKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTG-QFSYFNYTSFLGN 608

Query: 61  KGLCGNFITLPSCDAT----------KPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKK 110
             LCG ++  P  D             P +  +++ L L ++   I FA + ++K +  K
Sbjct: 609 PDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLK 667

Query: 111 PKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVF 170
              ++RA   +  F   ++      +D++++ ++ +I   IG GG G VYK  +PNG + 
Sbjct: 668 KASESRAWR-LTAFQRLDFT----CDDVLDSLKEDNI---IGKGGAGIVYKGVMPNGDLV 719

Query: 171 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF 230
           A+K+L  + +   +    F  E Q L ++ HR IV+L GFC + +   L+YEYM  GSL 
Sbjct: 720 AVKRL-AAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLG 778

Query: 231 CILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA 290
            +LH   +   L W  R  I    A  L YLHHDCSP I+HRD+ SNNILL+S  EA VA
Sbjct: 779 EVLHGK-KGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVA 837

Query: 291 DFGTARRLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP- 347
           DFG A+ L    ++  +  +AG+YGYIAPE AYT+ + EK DVYSFGVV LE++ G+ P 
Sbjct: 838 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV 897

Query: 348 ------RDLLSSLSSSSDP-KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPK 400
                  D++  +   +D  K  ++ VLD RL        I ++     ++  C++    
Sbjct: 898 GEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRL----SSIPIHEVTHVFYVAMLCVEEQAV 953

Query: 401 SRPTMQYVSQ 410
            RPTM+ V Q
Sbjct: 954 ERPTMREVVQ 963

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  230 bits (586), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 150/460 (32%), Positives = 233/460 (50%), Gaps = 61/460 (13%)

Query: 1    MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            +  L  LD+S+N++ G +PG + D+  L YLN+S+N L G +    +Q S         N
Sbjct: 791  LSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL---KKQFSRWPADSFLGN 847

Query: 61   KGLCGNFITLPSCDATKP----------ATLFVEIFLPLAIVPSVIVFACLLVVKR---- 106
             GLCG+   L  C+  +           + + +     L  +  +I+   L   +R    
Sbjct: 848  TGLCGS--PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFF 905

Query: 107  --------KYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGS 158
                     Y      ++AT+   +F        I +ED++EAT +   ++ IG+GG G 
Sbjct: 906  KKVGHGSTAYTSSSSSSQATHK-PLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGK 964

Query: 159  VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK--C 216
            VYKA+L NG+  A+KK+   +  +L   KSF  E + L ++ HR +VKL G+C  K    
Sbjct: 965  VYKAELENGETVAVKKILWKD--DLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGL 1022

Query: 217  MFLIYEYMERGSLFCILHNDDEAVE-----LDWAKRVNIVKAMAHALAYLHHDCSPSIIH 271
              LIYEYM+ GS++  LH D   +E     LDW  R+ I   +A  + YLHHDC P I+H
Sbjct: 1023 NLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVH 1082

Query: 272  RDISSNNILLNSKLEAFVADFGTARRL----HADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            RDI S+N+LL+S +EA + DFG A+ L      ++ + T  A +YGYIAPE AY++  TE
Sbjct: 1083 RDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATE 1142

Query: 328  KCDVYSFGVVTLEVLMGKHPRDLL------------SSLSSSSDPKIMLIDVLDQRLPP- 374
            K DVYS G+V +E++ GK P D +            + L  +   +  LI   D +L P 
Sbjct: 1143 KSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLI---DPKLKPL 1199

Query: 375  -PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
             P ++     +L    I+  C +++P+ RP+ +      L
Sbjct: 1200 LPFEEDAACQVL---EIALQCTKTSPQERPSSRQACDSLL 1236

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
296085303	789	unnamed protein product [Vitis vinifera]	0.933	0.515	0.576	1e-140
359484066	843	PREDICTED: probable LRR receptor-like se	0.933	0.482	0.576	1e-140
359484068	868	PREDICTED: probable leucine-rich repeat	0.940	0.472	0.565	1e-139
296085307	874	unnamed protein product [Vitis vinifera]	0.954	0.475	0.557	1e-139
225465647	820	PREDICTED: probable LRR receptor-like se	0.892	0.474	0.556	1e-137
359484063	1003	PREDICTED: probable LRR receptor-like se	0.944	0.410	0.561	1e-134
359488983	758	PREDICTED: probable LRR receptor-like se	0.990	0.569	0.529	1e-133
225466223	736	PREDICTED: probable leucine-rich repeat	0.954	0.565	0.563	1e-132
359488981	757	PREDICTED: probable LRR receptor-like se	0.990	0.570	0.530	1e-132
224093626	1039	predicted protein [Populus trichocarpa]	0.961	0.403	0.531	1e-131

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  506 bits (1302), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 248/430 (57%), Positives = 310/430 (72%), Gaps = 23/430 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-------------FSNE 47
           + NLT LD+S N I G IP ++ +L RL YLNLS NKLSG +P              S+ 
Sbjct: 334 LNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHN 393

Query: 48  QL---------SSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVF 98
            L         S  S+     NKGLCG+   LP C      T  + I L   +    +V 
Sbjct: 394 DLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVL 453

Query: 99  ACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGS 158
             LL+  RK +K + K   T + D+FS+WNYDG+I YED+I+ATEDF IKYCIGTGGYGS
Sbjct: 454 GFLLL-SRKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGS 512

Query: 159 VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF 218
           VYKAQLP G V ALKKLH  E +E  ++KSF+NE Q+LS++ HR+IVKL G+CLHK+CMF
Sbjct: 513 VYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMF 572

Query: 219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN 278
           LIY YM RGSL+C+L N+ EA+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNN
Sbjct: 573 LIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNN 632

Query: 279 ILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
           ILL+SKL+AF++DFGTAR LH DSSN+TLLAGTYGYIAPELAYTMV+TEKCDVYSFGVV 
Sbjct: 633 ILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVA 692

Query: 339 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSN 398
           LE +MGKHP +L + LSSSS   IML ++LD RLP P DQ+V +D++L   ++  C+ SN
Sbjct: 693 LETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSN 752

Query: 399 PKSRPTMQYV 408
           P+SRPTMQ++
Sbjct: 753 PRSRPTMQHI 762

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 248/430 (57%), Positives = 310/430 (72%), Gaps = 23/430 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-------------FSNE 47
           + NLT LD+S N I G IP ++ +L RL YLNLS NKLSG +P              S+ 
Sbjct: 388 LNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHN 447

Query: 48  QL---------SSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVF 98
            L         S  S+     NKGLCG+   LP C      T  + I L   +    +V 
Sbjct: 448 DLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVL 507

Query: 99  ACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGS 158
             LL+  RK +K + K   T + D+FS+WNYDG+I YED+I+ATEDF IKYCIGTGGYGS
Sbjct: 508 GFLLL-SRKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGS 566

Query: 159 VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF 218
           VYKAQLP G V ALKKLH  E +E  ++KSF+NE Q+LS++ HR+IVKL G+CLHK+CMF
Sbjct: 567 VYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMF 626

Query: 219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN 278
           LIY YM RGSL+C+L N+ EA+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNN
Sbjct: 627 LIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNN 686

Query: 279 ILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
           ILL+SKL+AF++DFGTAR LH DSSN+TLLAGTYGYIAPELAYTMV+TEKCDVYSFGVV 
Sbjct: 687 ILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVA 746

Query: 339 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSN 398
           LE +MGKHP +L + LSSSS   IML ++LD RLP P DQ+V +D++L   ++  C+ SN
Sbjct: 747 LETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSN 806

Query: 399 PKSRPTMQYV 408
           P+SRPTMQ++
Sbjct: 807 PRSRPTMQHI 816

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  502 bits (1293), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 247/437 (56%), Positives = 316/437 (72%), Gaps = 27/437 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-------------FSNE 47
           + NLT LD+S+N I+G IP +L +L  L+ LNLS NKLSG +P             FS+ 
Sbjct: 415 LNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSHN 474

Query: 48  ----------QLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIV 97
                     Q     RV    NKGLCG    LP C       L + +     I+    V
Sbjct: 475 DFEGHIPHELQFVYPPRV-FGHNKGLCGEREGLPHCKRGHKTILIISLS---TILFLSFV 530

Query: 98  FACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYG 157
              +L++ RK ++ + KA +T + D+FS+WNYDG+I YED+IEATEDF IKYCIGTGGYG
Sbjct: 531 ALGILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYG 590

Query: 158 SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM 217
           SVYKAQLP G V ALKKLH  E +E  ++KSF+NE QVLS++ HR+I+KL+G+CLHK+CM
Sbjct: 591 SVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCM 650

Query: 218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 277
           FLIY+YMERGSL+C+L N+ EA+ELDW KRVN++K++ HAL Y+HHD +P IIHRD+SSN
Sbjct: 651 FLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSN 710

Query: 278 NILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 337
           NILL+ KL+AF++DFGTAR LH DSSN+TLLAGTYGYIAPELAYTM +TEKCDVYSFGVV
Sbjct: 711 NILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVV 770

Query: 338 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQS 397
            LE +MG+HPR+L + LSSSS   IML D+LD RLP P D++V +D++L   ++  C+ S
Sbjct: 771 ALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALKCIHS 830

Query: 398 NPKSRPTMQYVSQGFLI 414
           NP+SRPTMQ++S   LI
Sbjct: 831 NPRSRPTMQHISSKLLI 847

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  502 bits (1292), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 248/445 (55%), Positives = 321/445 (72%), Gaps = 29/445 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-------------FSNE 47
           + NLT LD+S+N I+G IP +L +L  L+ LNLS NKLSG +P             FS+ 
Sbjct: 421 LNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSHN 480

Query: 48  ----------QLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIV 97
                     Q     RV    NKGLCG    LP C       L + +     I+    V
Sbjct: 481 DFEGHIPHELQFVYPPRV-FGHNKGLCGEREGLPHCKRGHKTILIISLS---TILFLSFV 536

Query: 98  FACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYG 157
              +L++ RK ++ + KA +T + D+FS+WNYDG+I YED+IEATEDF IKYCIGTGGYG
Sbjct: 537 ALGILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYG 596

Query: 158 SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM 217
           SVYKAQLP G V ALKKLH  E +E  ++KSF+NE QVLS++ HR+I+KL+G+CLHK+CM
Sbjct: 597 SVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCM 656

Query: 218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 277
           FLIY+YMERGSL+C+L N+ EA+ELDW KRVN++K++ HAL Y+HHD +P IIHRD+SSN
Sbjct: 657 FLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSN 716

Query: 278 NILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 337
           NILL+ KL+AF++DFGTAR LH DSSN+TLLAGTYGYIAPELAYTM +TEKCDVYSFGVV
Sbjct: 717 NILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVV 776

Query: 338 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQS 397
            LE +MG+HPR+L + LSSSS   IML D+LD RLP P D++V +D++L   ++  C+ S
Sbjct: 777 ALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALKCIHS 836

Query: 398 NPKSRPTMQYVSQGFLITRKTPLVK 422
           NP+SRPTMQ++S   LI  ++P ++
Sbjct: 837 NPRSRPTMQHISSKLLI--QSPFLE 859

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  493 bits (1269), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 242/435 (55%), Positives = 302/435 (69%), Gaps = 46/435 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP----------------- 43
           + NLT LD+S+N I G IP ++ +L RL YLNLS NKLSG +P                 
Sbjct: 388 LNNLTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKLSGSIPTLLIYDHIRPSLDLSYN 447

Query: 44  -----FSNEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVF 98
                   E  S  S+     NKGLCG+   LP C      T  +               
Sbjct: 448 DLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIT-------------- 493

Query: 99  ACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGS 158
                     +K + K   T + D+FS+WNYDG+I YED+I+ATEDF IKYCIGTGGYGS
Sbjct: 494 ----------RKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGS 543

Query: 159 VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF 218
           VYKAQLP G V ALKKLH  ET+E  ++KSF+NE Q+LS++ HR+IVKL G+CLHK+CMF
Sbjct: 544 VYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMF 603

Query: 219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN 278
           LIY YM RGSL+C+L N+ EA+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNN
Sbjct: 604 LIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNN 663

Query: 279 ILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
           ILL+SKL+AF++DFGT+R LH DSSN+TLL+GTYGYIAPELAYTMV+TEKCDVYSFGVV 
Sbjct: 664 ILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVA 723

Query: 339 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSN 398
           LE +MGKHP +L + LSSSS   IML D+LD RLP P DQ+V +D++L   ++  C+ SN
Sbjct: 724 LETMMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQQVARDVVLVVWLALKCIHSN 783

Query: 399 PKSRPTMQYVSQGFL 413
           P+SRPTMQ++S   L
Sbjct: 784 PRSRPTMQHISSKLL 798

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  485 bits (1249), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 245/436 (56%), Positives = 306/436 (70%), Gaps = 24/436 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-----------FSNEQL 49
           +KN+  LD+S+N I   IP +L +L  L+ LNLS NKLSG +P            S   L
Sbjct: 547 LKNMASLDLSDNLINVKIPSQLQNLESLENLNLSHNKLSGHIPTLPKYGWLSIDLSYNDL 606

Query: 50  SSMSRVRL---------SPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFAC 100
                + L         S NKGLCG     P C       L   I +   +     VF  
Sbjct: 607 EGHIPIELQLEHSPEVFSYNKGLCGEIKGWPHCKRGHKTMLITTIAISTILFLLFAVFGF 666

Query: 101 LLVVKRKYKKPKVKA---RATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYG 157
           LL+  RK ++ + K    +   + D+FSIWNYDG+I YED+IEATEDF IKYCIGTGGYG
Sbjct: 667 LLL-SRKMRQNQTKTPLKKNEKNGDIFSIWNYDGKIAYEDIIEATEDFDIKYCIGTGGYG 725

Query: 158 SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM 217
           +VYKAQLP G V ALKKLH  E +E  + KSF+NE QVLS++ HR+I+KL+G+CLHK+CM
Sbjct: 726 TVYKAQLPTGNVVALKKLHGWERDEATYFKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCM 785

Query: 218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 277
           FLIY+YMERGSLF +L N+ EA+ELDW KRVN+VK++ HAL Y+HHD +  IIHRDISS+
Sbjct: 786 FLIYKYMERGSLFGVLSNEVEALELDWIKRVNVVKSIVHALCYMHHDYTLPIIHRDISSS 845

Query: 278 NILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 337
           NILL+SKL+AF++DFGTAR LH DSSN+T+LAGTYGYIAPELAYTMV+TEKCDVYSFGVV
Sbjct: 846 NILLDSKLDAFLSDFGTARLLHHDSSNQTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVV 905

Query: 338 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQS 397
            LE +MGKHPR+L + LSSSS   IML D+LD RLP P DQ+V +D++L   ++  C+ S
Sbjct: 906 ALETMMGKHPRELFTLLSSSSAQSIMLTDILDSRLPSPQDQQVARDVVLVVWLALKCIHS 965

Query: 398 NPKSRPTMQYVSQGFL 413
           NP+SRPTMQ +S   L
Sbjct: 966 NPRSRPTMQLISSRLL 981

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  482 bits (1240), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 240/453 (52%), Positives = 312/453 (68%), Gaps = 21/453 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS--------------N 46
           +K L+ LD+SNN I G IP +L +L  + Y NLS N LSG +P+S              N
Sbjct: 307 LKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYNKWTLIDLSN 366

Query: 47  EQLSSMSRVRLSP---NKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLV 103
            +L   +R  +     NKGLCG     P C      TL + + L   ++ S+ +   L  
Sbjct: 367 NRLEGQTRAPVEAFGHNKGLCGEIKGRPRCKKRHQITLIIVVSLSTTLLLSIAILGFLFH 426

Query: 104 VKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ 163
            +R  K   ++     + D+FSIW+YDG I Y+D+I+ATEDF IKYCIGTGGYGSVY+AQ
Sbjct: 427 KRRIRKNQLLETTKVKNGDLFSIWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQ 486

Query: 164 LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY 223
           LP+GKV ALKKLH  E  +  ++KSF NE Q+L+++ HR+IVKL+GFCLHK+CMFL+Y+Y
Sbjct: 487 LPSGKVVALKKLHGWERGDPTYLKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKY 546

Query: 224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS 283
           ME+GSL+C+L ++ EAVELDW KRVN+VK++A+AL+Y+HHDC   IIHRDISSNNILL+S
Sbjct: 547 MEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDS 606

Query: 284 KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 343
           KLEAFV+DFGTAR L  DSSNRTLL GTYGYIAPELAYTMV+TEKCD+YSFG+V LE +M
Sbjct: 607 KLEAFVSDFGTARLLDNDSSNRTLLVGTYGYIAPELAYTMVVTEKCDIYSFGMVALETMM 666

Query: 344 GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRP 403
           G HP + ++SLSSSS     L DVLD RL  P   +V  +I L  +++  CL SNP+ RP
Sbjct: 667 GMHPGEFVTSLSSSSTQNTTLKDVLDSRLSSPKSTQVANNIALIVSLALKCLHSNPQFRP 726

Query: 404 TMQYVSQGFLITRKTPLVKHAAIQDISISELRN 436
           +MQ VS   + TR  P      I  IS+ +L++
Sbjct: 727 SMQEVSSKLVSTRSFP----QPISTISLLQLKD 755

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera]

 Score =  478 bits (1231), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 238/422 (56%), Positives = 317/422 (75%), Gaps = 6/422 (1%)

Query: 7   LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGN 66
           LD+S N I G+IP +  + + L+YL+LS+N L G VPF    L S+ R     NKGLCG+
Sbjct: 306 LDLSVNNISGTIPLQFQNFNSLEYLDLSYNYLEGYVPFE-LHLPSLFRA-FEHNKGLCGD 363

Query: 67  F-ITLPSCDATKPATLFVEIFLPL--AIVPSVIVFACLLVVKRKYKKPK-VKARATNSID 122
               +P C      T+ + + + L  A++ S I+F  LL+ +RK +K +  +A  T + D
Sbjct: 364 TKFGIPPCRKRNRITIIIIVVICLCSALLISSIIFGVLLIWRRKTRKLQPEEATTTQNGD 423

Query: 123 VFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE 182
           +FSIW+YDG+I YED+IEATEDF IKYCIGTGGYGSVY+A+L NGK  ALKKLHT E++ 
Sbjct: 424 IFSIWDYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYRAKLTNGKEVALKKLHTLESQN 483

Query: 183 LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVEL 242
             ++KSF NE +VLS++ HR+IVKLYGFCLHK+CMFL+YEYMERGSL C+L ++ EA+E 
Sbjct: 484 PTYMKSFTNEVRVLSKIRHRNIVKLYGFCLHKRCMFLVYEYMERGSLHCVLSDEIEALEF 543

Query: 243 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS 302
           DW KRVN+VK++A+AL+Y+H+DC P ++HRDISS NILL+S+  A V+DFGTAR L  DS
Sbjct: 544 DWIKRVNVVKSIANALSYMHNDCIPPLLHRDISSGNILLDSEFRAVVSDFGTARLLDPDS 603

Query: 303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI 362
           SN+TLLAGTYGY+APELAYTMV+TEKCDVYSFGV+TLE++MGKHPR+L++ LS+SS   I
Sbjct: 604 SNQTLLAGTYGYVAPELAYTMVVTEKCDVYSFGVLTLEIMMGKHPRELVTILSTSSSQNI 663

Query: 363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK 422
           ML+D+LD RL P +D +VI +++L   ++  C+  NP SRPTMQ+V + F      P+  
Sbjct: 664 MLVDILDPRLAPHIDPEVIDNVVLIIRLALKCINLNPTSRPTMQHVCKEFETCTPFPIPF 723

Query: 423 HA 424
           HA
Sbjct: 724 HA 725

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  477 bits (1228), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 240/452 (53%), Positives = 311/452 (68%), Gaps = 20/452 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-------------NE 47
           +K L+ LD+SNN I G IP +L +L  + Y NLS N LSG +P+S             N 
Sbjct: 307 LKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYRWTLIDLSNN 366

Query: 48  QLSSMSRVRLSP---NKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVV 104
           +L   +R  +     NKGLCG       C      TL + + L   ++ SV +   L   
Sbjct: 367 RLEGQARAPVEAFGHNKGLCGEIKGWARCKKRHQITLIIVVSLSTTLLLSVAILGFLFHK 426

Query: 105 KRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQL 164
           +R  K   ++     + D+FSIW++DG I Y+D+I+ATEDF IKYCIGTGGYGSVY+AQL
Sbjct: 427 RRIRKNQLLETTKVKNGDLFSIWDFDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQL 486

Query: 165 PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM 224
           P+GKV ALKKLH  E E+  ++KSF NE Q+L+++ HR+IVKL+GFCLHK+CMFL+Y+YM
Sbjct: 487 PSGKVVALKKLHGWEREDPTYLKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYM 546

Query: 225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
           E+GSL+C+L ++ EAVELDW KRVN+VK++A+AL+Y+HHDC   IIHRDISSNNILL+SK
Sbjct: 547 EKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSK 606

Query: 285 LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 344
           LEAFV+DFGTAR L  DSSNRTLLAGTYGYIAPELAYTMV+TEKCDVYSFG+V LE +MG
Sbjct: 607 LEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGMVALETMMG 666

Query: 345 KHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
            HP + ++SLSSSS     L DVLD RL  P   +V  +I L  +++  CL  NP+  P+
Sbjct: 667 MHPGEFITSLSSSSTQNTTLKDVLDSRLSSPKSTRVANNIALIVSLALKCLHFNPQFCPS 726

Query: 405 MQYVSQGFLITRKTPLVKHAAIQDISISELRN 436
           MQ VS   + TR  P      I  IS+ +L++
Sbjct: 727 MQEVSSKLVSTRSFP----QPISAISLLQLKD 754

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093626|ref|XP_002334827.1| predicted protein [Populus trichocarpa] gi|222875006|gb|EEF12137.1| predicted protein [Populus trichocarpa]

 Score =  473 bits (1217), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 243/457 (53%), Positives = 318/457 (69%), Gaps = 38/457 (8%)

Query: 7    LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPF---------------------S 45
            L +S+N+I GSIP E+ +L+ L+ LN S+N  SGPVP                      S
Sbjct: 580  LFLSHNQINGSIPLEIQNLTNLEELNFSYNNFSGPVPLALRSPFNFYFTCDFVRGQNSTS 639

Query: 46   NEQLSSMSRVRLSPNKGLCGNFITLPSCDATKPA-----TLFVEIFLPLAIVP-SVIVFA 99
             E  +      L PN   C +F   PS     P+        ++IFLP+  +   ++V  
Sbjct: 640  FEATAFEGNKDLHPNFSYCSSFYDPPSKTYLLPSKDNRMIHSIKIFLPITTISLCLLVLG 699

Query: 100  CLLVVKRKYKKPKVKARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSV 159
            C  + + K  +P+  A ++ + D+FSIWNYDGRI YED+I ATE+F ++YCIGTGGYGSV
Sbjct: 700  CCSLSRCKATQPE--ATSSKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCIGTGGYGSV 757

Query: 160  YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL 219
            Y+AQLP+GK+ ALKKLH  E EE AF KSF+NE ++L+Q+ HRSIVKLYGFCLH++CMFL
Sbjct: 758  YRAQLPSGKLVALKKLHRREAEEPAFDKSFKNEVELLTQIRHRSIVKLYGFCLHQRCMFL 817

Query: 220  IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI 279
            +YEYME+GSLFC L ND  AVEL W KR +I+K +AHAL+YLHH+C+P I+HRDISS+N+
Sbjct: 818  VYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHECNPPIVHRDISSSNV 877

Query: 280  LLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 339
            LLNS+ ++FVADFG AR L  DSSN T+LAGTYGYIAPELAYTMV+TEKCDVYSFGVV L
Sbjct: 878  LLNSESKSFVADFGVARLLDPDSSNNTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 937

Query: 340  EVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNP 399
            E LMG+HP D+L    SSS   I L +VLD RLPPP ++ VIQ+I + ++++F+CL SNP
Sbjct: 938  ETLMGRHPGDIL----SSSARAITLKEVLDPRLPPPTNEIVIQNICIIASLAFSCLHSNP 993

Query: 400  KSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN 436
            K RP+M++VS  FL  ++          +IS+ +LRN
Sbjct: 994  KYRPSMKFVSLEFLSPKRL-----LGGLEISLLDLRN 1025

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.931	0.388	0.430	6.9e-94
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.938	0.365	0.413	3.1e-83
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.949	0.413	0.352	2.5e-63
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.974	0.439	0.335	6.9e-63
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.633	0.245	0.426	9.3e-63
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.915	0.397	0.355	6.9e-62
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.908	0.359	0.375	1.6e-60
TAIR|locus:2005507	976	ER "ERECTA" [Arabidopsis thali	0.949	0.424	0.331	1.9e-60
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.933	0.421	0.349	2.9e-59
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.924	0.366	0.362	3.1e-59

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 889 (318.0 bits), Expect = 6.9e-94, Sum P(2) = 6.9e-94
 Identities = 185/430 (43%), Positives = 265/430 (61%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             ++NL  LD+S+N + G IP    D+  L ++++S N L GP+P  N    +        N
Sbjct:   621 LQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIP-DNAAFRNAPPDAFEGN 679

Query:    61 KGLCGNFIT---LPSCDAT------KPATLFVEIFLPLA---IVPSVI--VFACLLXXXX 106
             K LCG+  T   L  C  T      K   L + I +P+    I+ SV   +F C      
Sbjct:   680 KDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTK 739

Query:   107 XXXXXXXXARATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPN 166
                          ++ +FS   +DG++ Y+++I+AT +F  KY IGTGG+G VYKA+LPN
Sbjct:   740 QIEEHTDSESGGETLSIFS---FDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN 796

Query:   167 GKVFALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY 223
               + A+KKL+ +    ++     + F NE + L+++ HR++VKL+GFC H++  FL+YEY
Sbjct:   797 A-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEY 855

Query:   224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS 283
             MERGSL  +L NDDEA +LDW KR+N+VK +AHAL+Y+HHD SP+I+HRDISS NILL  
Sbjct:   856 MERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGE 915

Query:   284 KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 343
               EA ++DFGTA+ L  DSSN + +AGTYGY+APELAY M +TEKCDVYSFGV+TLEV+ 
Sbjct:   916 DYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIK 975

Query:   344 GKHPRDXXXXXXXXX-DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSR 402
             G+HP D          D  + L  + D RLP P  + + +++L    ++  CL S+P++R
Sbjct:   976 GEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE-IKEEVLEILKVALLCLHSDPQAR 1034

Query:   403 PTMQYVSQGF 412
             PTM  +S  F
Sbjct:  1035 PTMLSISTAF 1044

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 803 (287.7 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
 Identities = 175/423 (41%), Positives = 254/423 (60%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             +++L  LD+S+N + G IP     +  L  +++S NKL GP+P         +   L  N
Sbjct:   700 LQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLP-DTPTFRKATADALEEN 758

Query:    61 KGLCGNFIT--LPSC-DATKP---ATLFVEIFLPLAIVPSVIVFACLLXXXXXXXXXXXX 114
              GLC N     L  C +  KP     L V I +P+  V  ++                  
Sbjct:   759 IGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQN 818

Query:   115 ARATN--SIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFAL 172
              R T+  + +  SI++ DG+  Y+D+IE+T +F   + IGTGGY  VY+A L +  + A+
Sbjct:   819 GRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAV 877

Query:   173 KKLHTSETEELA--FIKS-FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL 229
             K+LH +  EE++   +K  F NE + L+++ HR++VKL+GFC H++  FLIYEYME+GSL
Sbjct:   878 KRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSL 937

Query:   230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 289
               +L ND+EA  L W KR+N+VK +AHAL+Y+HHD    I+HRDISS NILL++   A +
Sbjct:   938 NKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKI 997

Query:   290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
             +DFGTA+ L  DSSN + +AGTYGY+APE AYTM +TEKCDVYSFGV+ LE+++GKHP D
Sbjct:   998 SDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGD 1057

Query:   350 XXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVS 409
                         + L  + D+R+  P  Q   + +L    ++  CLQ+NP+SRPTM  +S
Sbjct:  1058 LVSSLSSSPGEALSLRSISDERVLEPRGQNR-EKLLKMVEMALLCLQANPESRPTMLSIS 1116

Query:   410 QGF 412
               F
Sbjct:  1117 TTF 1119

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 588 (212.0 bits), Expect = 2.5e-63, Sum P(2) = 2.5e-63
 Identities = 157/446 (35%), Positives = 228/446 (51%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             MK L +L++S N + GSIP  +  +  L  ++ S+N LSG VP S  Q S  +      N
Sbjct:   551 MKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVP-STGQFSYFNYTSFVGN 609

Query:    61 KGLCGNFITLPSCDAT-----KPATLFVEIFLPLAIVPSVIVFACLLXXXXXXXXXXXXA 115
               LCG ++  P    T     KP +   ++ L L ++   +VFA +             A
Sbjct:   610 SHLCGPYLG-PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEA 668

Query:   116 RATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKL 175
             +A   +  F   ++      +D++++ ++ +I   IG GG G VYK  +P G + A+K+L
Sbjct:   669 KAWR-LTAFQRLDFT----CDDVLDSLKEDNI---IGKGGAGIVYKGTMPKGDLVAVKRL 720

Query:   176 HTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN 235
              T  +   +    F  E Q L ++ HR IV+L GFC + +   L+YEYM  GSL  +LH 
Sbjct:   721 ATM-SHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG 779

Query:   236 DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 295
               +   L W  R  I    A  L YLHHDCSP I+HRD+ SNNILL+S  EA VADFG A
Sbjct:   780 K-KGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLA 838

Query:   296 RRLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR----- 348
             + L    ++  +  +AG+YGYIAPE AYT+ + EK DVYSFGVV LE++ GK P      
Sbjct:   839 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGD 898

Query:   349 --DXXXXXXXXXDP-KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTM 405
               D         D  K  ++ V+D RL        + ++     ++  C++     RPTM
Sbjct:   899 GVDIVQWVRSMTDSNKDCVLKVIDLRL----SSVPVHEVTHVFYVALLCVEEQAVERPTM 954

Query:   406 QYVSQGFLITRKTPLVKH-AAIQDIS 430
             + V Q      K PL K  AA  D++
Sbjct:   955 REVVQILTEIPKIPLSKQQAAESDVT 980

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 592 (213.5 bits), Expect = 6.9e-63, Sum P(2) = 6.9e-63
 Identities = 153/456 (33%), Positives = 231/456 (50%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             ++NL  L ++NNK+ G IP +LT+   L  LN+S+N LSG VP   +  S  +      N
Sbjct:   501 LQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVP-PMKNFSRFAPASFVGN 559

Query:    61 KGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLXXXXXXXXXXX-----XA 115
               LCGN++    C     + +F    L + IV  VI   C++                 +
Sbjct:   560 PYLCGNWVG-SICGPLPKSRVFSRGAL-ICIVLGVITLLCMIFLAVYKSMQQKKILQGSS 617

Query:   116 RATNSIDVFSIWNYDGRIF-YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKK 174
             +    +    I + D  I  ++D++  TE+ + K+ IG G   +VYK  L + +  A+K+
Sbjct:   618 KQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKR 677

Query:   175 LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH 234
             L+      L   + F  E + +  + HR+IV L+G+ L      L Y+YME GSL+ +LH
Sbjct:   678 LYNQYPHNL---REFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLH 734

Query:   235 NDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 294
                + V+LDW  R+ I    A  LAYLHHDC+P IIHRDI S+NILL+   EA ++DFG 
Sbjct:   735 GSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGI 794

Query:   295 ARRLHADSSNR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXX 353
             A+ + A  ++  T + GT GYI PE A T  + EK D+YSFG+V LE+L GK   D    
Sbjct:   795 AKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEAN 854

Query:   354 XXXXXDPKIMLIDVLDQRLPPPVDQKVIQDIL----LASTISFA--CLQSNPKSRPTMQY 407
                    +++L    D  +   VD +V    +    +  T   A  C + NP  RPTM  
Sbjct:   855 LH-----QLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQLALLCTKRNPLERPTMLE 909

Query:   408 VSQGFL-------ITRKTPLVKHAAIQDISISELRN 436
             VS+  L       + +K P + H+  +    +E+RN
Sbjct:   910 VSRVLLSLVPSLQVAKKLPSLDHSTKKLQQENEVRN 945

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 571 (206.1 bits), Expect = 9.3e-63, Sum P(2) = 9.3e-63
 Identities = 124/291 (42%), Positives = 168/291 (57%)

Query:   132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE----TEELAFIK 187
             R   +D++EAT+ FH  Y +G G  G+VYKA +P+GK  A+KKL ++             
Sbjct:   806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865

Query:   188 SFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWA 245
             SFR E   L ++ HR+IV+LY FC H+      L+YEYM RGSL  +LH   ++  +DW 
Sbjct:   866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSHSMDWP 924

Query:   246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD-SSN 304
              R  I    A  LAYLHHDC P IIHRDI SNNIL++   EA V DFG A+ +    S +
Sbjct:   925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984

Query:   305 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------RDXXXXXXXX 357
              + +AG+YGYIAPE AYTM +TEKCD+YSFGVV LE+L GK P        D        
Sbjct:   985 VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNH 1044

Query:   358 XDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                  +  ++LD  L    D  ++  ++  + I+  C +S+P  RPTM+ V
Sbjct:  1045 IRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 576 (207.8 bits), Expect = 6.9e-62, Sum P(2) = 6.9e-62
 Identities = 151/425 (35%), Positives = 217/425 (51%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             MK L +L++S N + GSIPG ++ +  L  L+ S+N LSG VP +  Q S  +      N
Sbjct:   550 MKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTG-QFSYFNYTSFLGN 608

Query:    61 KGLCGNFITLPSCDATKPATLFVEIFLPL-AIVPSVIVFACLLXXXXXXXXXXXXARATN 119
               LCG ++  P  D             PL A +  ++V   L+            AR+  
Sbjct:   609 PDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLK 667

Query:   120 SIDVFSIWNYDG--RIFY--EDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKL 175
                    W      R+ +  +D++++ ++ +I   IG GG G VYK  +PNG + A+K+L
Sbjct:   668 KASESRAWRLTAFQRLDFTCDDVLDSLKEDNI---IGKGGAGIVYKGVMPNGDLVAVKRL 724

Query:   176 HTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN 235
               + +   +    F  E Q L ++ HR IV+L GFC + +   L+YEYM  GSL  +LH 
Sbjct:   725 -AAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG 783

Query:   236 DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 295
               +   L W  R  I    A  L YLHHDCSP I+HRD+ SNNILL+S  EA VADFG A
Sbjct:   784 K-KGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLA 842

Query:   296 RRLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR----- 348
             + L    ++  +  +AG+YGYIAPE AYT+ + EK DVYSFGVV LE++ G+ P      
Sbjct:   843 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGD 902

Query:   349 --DXXXXXXXXXDP-KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTM 405
               D         D  K  ++ VLD RL        I ++     ++  C++     RPTM
Sbjct:   903 GVDIVQWVRKMTDSNKDSVLKVLDPRL----SSIPIHEVTHVFYVAMLCVEEQAVERPTM 958

Query:   406 QYVSQ 410
             + V Q
Sbjct:   959 REVVQ 963

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 1.6e-60, P = 1.6e-60
 Identities = 162/432 (37%), Positives = 227/432 (52%)

Query:     4 LTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGL 63
             L +L ++NN + G IP    +LS L   N S+N L+GP+P     L ++S      N+GL
Sbjct:   652 LEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL----LRNISMSSFIGNEGL 707

Query:    64 CGNFIT--------LPSCDATKPATLFVE--IFLPLAIVPSV-IVFACLLXXXXXXXXXX 112
             CG  +          PS    KP  +     I +  A++  V ++   L+          
Sbjct:   708 CGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRT 767

Query:   113 XXARATN------SIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPN 166
               + A +      S+D++     +G  F +DL+ AT++F   + +G G  G+VYKA LP 
Sbjct:   768 VASSAQDGQPSEMSLDIY-FPPKEGFTF-QDLVAATDNFDESFVVGRGACGTVYKAVLPA 825

Query:   167 GKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM 224
             G   A+KKL ++           SFR E   L  + HR+IVKL+GFC H+    L+YEYM
Sbjct:   826 GYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYM 885

Query:   225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
              +GSL  ILH  D +  LDW+KR  I    A  LAYLHHDC P I HRDI SNNILL+ K
Sbjct:   886 PKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDK 943

Query:   285 LEAFVADFGTARRLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 343
              EA V DFG A+ +    S + + +AG+YGYIAPE AYTM +TEK D+YS+GVV LE+L 
Sbjct:   944 FEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLT 1003

Query:   344 GKHP-------RDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQ 396
             GK P        D             +   VLD RL    D++++  +L    I+  C  
Sbjct:  1004 GKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIALLCTS 1062

Query:   397 SNPKSRPTMQYV 408
              +P +RP+M+ V
Sbjct:  1063 VSPVARPSMRQV 1074

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 1.9e-60, Sum P(2) = 1.9e-60
 Identities = 143/432 (33%), Positives = 215/432 (49%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             ++N+  L + NN + G++ G L +   L  LN+S N L G +P  N   S  S      N
Sbjct:   498 LQNIILLRLENNNLTGNV-GSLANCLSLTVLNVSHNNLVGDIP-KNNNFSRFSPDSFIGN 555

Query:    61 KGLCGNFITLPSCDATKPATLFVE--IFLPLAI-----VPSVIVFACLLXXXXXXXXXXX 113
              GLCG+++  P  D+ +   + +     L +AI     +  V++ AC             
Sbjct:   556 PGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPPPFLDGSL 615

Query:   114 XARATNSIDVFSIWNYDGRIF-YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFAL 172
                 T S     I + +  +  YED++  TE+   KY IG G   +VYK  L N K  A+
Sbjct:   616 DKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAI 675

Query:   173 KKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCI 232
             K+L++   + +   K F  E ++LS + HR++V L  + L      L Y+Y+E GSL+ +
Sbjct:   676 KRLYSHNPQSM---KQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDL 732

Query:   233 LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF 292
             LH   +   LDW  R+ I    A  LAYLHHDCSP IIHRD+ S+NILL+  LEA + DF
Sbjct:   733 LHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDF 792

Query:   293 GTARRLHADSSNR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXX 351
             G A+ L    S+  T + GT GYI PE A T  +TEK DVYS+G+V LE+L  +   D  
Sbjct:   793 GIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDE 852

Query:   352 XXXXXXXDPKIMLIDVLDQRLPPPVDQ-KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                      K    +V++   P      K +  +     ++  C +  P  RPTM  V++
Sbjct:   853 SNLHHLIMSKTGNNEVMEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPTMHQVTR 912

Query:   411 ---GFLITRKTP 419
                 F+++ + P
Sbjct:   913 VLGSFMLSEQPP 924

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048281 "inflorescence morphogenesis" evidence=IMP

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005739 "mitochondrion" evidence=IDA

GO:0050832 "defense response to fungus" evidence=IMP

GO:0010103 "stomatal complex morphogenesis" evidence=RCA;IMP

GO:0001558 "regulation of cell growth" evidence=IGI;IMP

GO:0009965 "leaf morphogenesis" evidence=RCA;IMP

GO:0010148 "transpiration" evidence=IMP

GO:0030155 "regulation of cell adhesion" evidence=IMP

GO:0051302 "regulation of cell division" evidence=IGI;IMP

GO:0009664 "plant-type cell wall organization" evidence=IMP

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0031540 "regulation of anthocyanin biosynthetic process" evidence=RCA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:2000027 "regulation of organ morphogenesis" evidence=IMP

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 569 (205.4 bits), Expect = 2.9e-59, Sum P(2) = 2.9e-59
 Identities = 155/444 (34%), Positives = 218/444 (49%)

Query:     1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN------EQLSSMSR 54
             +K+L  LD+S+N + G IP  L++L     +N S N+LSGP+P S       E  S    
Sbjct:   507 LKSLNVLDLSSNLLTGRIPENLSELLPTS-INFSSNRLSGPIPVSLIRGGLVESFSDNPN 565

Query:    55 VRLSPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSVIVFACLLXXXXXXXXXXXX 114
             + + P  G   + +  P C           I+  L  V  ++V   ++            
Sbjct:   566 LCIPPTAG--SSDLKFPMCQEPHGKKKLSSIWAILVSV-FILVLGVIMFYLRQRMSKNRA 622

Query:   115 ARATNSIDVFSIWNYDGRIFYE---DLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFA 171
                 +     S ++YD + F+    D  E  E    K  +G GG G+VY+ +L +G+V A
Sbjct:   623 VIEQDETLASSFFSYDVKSFHRISFDQREILESLVDKNIVGHGGSGTVYRVELKSGEVVA 682

Query:   172 LKKLHTSETEELA------FIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYME 225
             +KKL +   ++ A        K  + E + L  + H++IVKL+ +     C  L+YEYM 
Sbjct:   683 VKKLWSQSNKDSASEDKMHLNKELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMP 742

Query:   226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL 285
              G+L+  LH     V L+W  R  I   +A  LAYLHHD SP IIHRDI S NILL+   
Sbjct:   743 NGNLWDALHKG--FVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNY 800

Query:   286 EAFVADFGTARRLHA--DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 343
             +  VADFG A+ L A    S  T++AGTYGY+APE AY+   T KCDVYSFGVV +E++ 
Sbjct:   801 QPKVADFGIAKVLQARGKDSTTTVMAGTYGYLAPEYAYSSKATIKCDVYSFGVVLMELIT 860

Query:   344 GKHPRDXXXXX--------XXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACL 395
             GK P D                 D K  LI+ LD+RL      K   D++ A  ++  C 
Sbjct:   861 GKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSE--SSKA--DMINALRVAIRCT 916

Query:   396 QSNPKSRPTMQYVSQGFLITRKTP 419
                P  RPTM  V Q  L+   TP
Sbjct:   917 SRTPTIRPTMNEVVQ--LLIDATP 938

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 3.1e-59, P = 3.1e-59
 Identities = 156/430 (36%), Positives = 221/430 (51%)

Query:     3 NLTWLDI---SNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
             NL  L+I   ++NK+ G IP  + +L  L   N+S N L G VP        M     + 
Sbjct:   642 NLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVP-DTAVFQRMDSSNFAG 700

Query:    60 NKGLCGNFIT-----LPSCDATKPATLFVE-----IFLPLAIVPSV--IVFACLLXXXXX 107
             N GLC +  +     +P  D+     +        + +   ++ SV  I F  L      
Sbjct:   701 NHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKR 760

Query:   108 XXXXXXXARATNSIDVFSIWNYDGRIF-YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPN 166
                           DV   + +  + F Y+ L++AT +F     +G G  G+VYKA++  
Sbjct:   761 REPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSG 820

Query:   167 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER 226
             G+V A+KKL+ S  E  +   SFR E   L ++ HR+IVKLYGFC H+    L+YEYM +
Sbjct:   821 GEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSK 879

Query:   227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE 286
             GSL   L   ++   LDW  R  I    A  L YLHHDC P I+HRDI SNNILL+ + +
Sbjct:   880 GSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQ 939

Query:   287 AFVADFGTARRLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
             A V DFG A+ +    S + + +AG+YGYIAPE AYTM +TEKCD+YSFGVV LE++ GK
Sbjct:   940 AHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGK 999

Query:   346 HP-------RDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSN 398
              P        D            I  I++ D RL    D++ + ++ L   I+  C  ++
Sbjct:  1000 PPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNS 1058

Query:   399 PKSRPTMQYV 408
             P SRPTM+ V
Sbjct:  1059 PASRPTMREV 1068

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00031862001 SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (722 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	436
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-39
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-35
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-33
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-30
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-28
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-25
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-25
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-21
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-14
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-14
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-12
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-05
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	7e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.004
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (424), Expect = 5e-49
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 18/261 (6%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + I   +G G +G VY A+    GK+ A+K +   + ++    +    E ++L ++ H +
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IV+LY     +  ++L+ EY E G LF +L      +  D A+    ++ +  AL YLH 
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLH- 114

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  I+HRD+   NILL+      +ADFG AR+L       T   GT  Y+APE+    
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGK 171

Query: 324 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD 383
              +  D++S GV+  E+L GK P               +   +   + P P  +  I  
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP------FPGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 384 ILLASTISFACLQSNPKSRPT 404
                 I    L  +P+ R T
Sbjct: 226 -EAKDLIR-KLLVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (419), Expect = 3e-48
 Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 22/272 (8%)

Query: 145 FHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + +   +G+G +G+VYKA+    GK+ A+K L     +      + R E ++L ++ H +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IV+L      K  ++L+ EY E G LF  L        L   +   I   +   L YLH 
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH- 115

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE--LAY 321
             S  IIHRD+   NILL+      +ADFG A++L   SS+ T   GT  Y+APE  L  
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI 381
                 K DV+S GV+  E+L GK P         S +  +  + ++ + L PP++    
Sbjct: 174 NGY-GPKVDVWSLGVILYELLTGKPP--------FSGENILDQLQLIRRILGPPLEFDEP 224

Query: 382 QDILLAST-ISFA--CLQSNPKSRPTMQYVSQ 410
           +    +         CL  +P  RPT + + Q
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  152 bits (387), Expect = 4e-44
 Identities = 66/193 (34%), Positives = 106/193 (54%), Gaps = 10/193 (5%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+G+VY A+    GK  A+K +   ++     ++    E ++L ++ H +IVKLYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               +  ++L+ EY E GSL  +L  ++   +L   + + I+  +   L YLH   S  I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLH---SNGI 113

Query: 270 IHRDISSNNILLNSK-LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTE 327
           IHRD+   NILL+S   +  +ADFG ++ L +D S    + GT  Y+APE L      +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 328 KCDVYSFGVVTLE 340
           K D++S GV+  E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (375), Expect = 9e-42
 Identities = 86/269 (31%), Positives = 124/269 (46%), Gaps = 33/269 (12%)

Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            F I   IG GG+G VYKA     GK  A+K +     E+   I    NE Q+L +  H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---NEIQILKKCKHP 57

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDW-AKRVNIVKAMAHALAYL 261
           +IVK YG  L K  ++++ E+   GSL  +L + ++ +     A    + K +   L YL
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYL 114

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRDI + NILL S  E  + DFG + +L +D+  R  + GT  ++APE+  
Sbjct: 115 H---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPEVIN 170

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ--- 378
                 K D++S G+  +E+  GK P          S+   M          PP  +   
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPY---------SELPPMKALFKIATNGPPGLRNPE 221

Query: 379 ---KVIQDILLASTISFACLQSNPKSRPT 404
                 +D L        CLQ NP+ RPT
Sbjct: 222 KWSDEFKDFLK------KCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  144 bits (365), Expect = 3e-40
 Identities = 78/266 (29%), Positives = 121/266 (45%), Gaps = 33/266 (12%)

Query: 150 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +G G +GSVY A     G++ A+K +  S   E   +++   E ++LS + H +IV+ Y
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHPNIVRYY 65

Query: 209 GFCLHK-KCMFLIY-EYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYLHH 263
           G    + K    I+ EY+  GSL  +L       E V   + +++         LAYLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYLH- 118

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH--ADSSNRTLLAGTYGYIAPELAY 321
             S  I+HRDI   NIL++S     +ADFG A+RL           + GT  ++APE+  
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV- 380
                   D++S G   +E+  GK P       S   +P   L  +     PP + + + 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP------WSELGNPMAALYKIGSSGEPPEIPEHLS 230

Query: 381 --IQDILLASTISFACLQSNPKSRPT 404
              +D L        CL+ +PK RPT
Sbjct: 231 EEAKDFLR------KCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (365), Expect = 3e-40
 Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 44/275 (16%)

Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           +G G +G VYK  L         KV A+K L    +EE    + F  EA ++ ++ H +I
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEE--REEFLEEASIMKKLSHPNI 63

Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V+L G C   + ++++ EYM  G L   L    E + L     + +   +A  + YL   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----APEL 319
            S + +HRD+++ N L+   L   ++DFG +R ++ D   R       G +     APE 
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPES 175

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPP 374
                 T K DV+SFGV+  E+           +L     P +   +VL+      RLP 
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIF----------TLGEQPYPGMSNEEVLELLEDGYRLPR 225

Query: 375 PVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           P +    + +++L       C   +P+ RPT   +
Sbjct: 226 PENCPDELYELML------QCWAYDPEDRPTFSEL 254

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  142 bits (360), Expect = 2e-39
 Identities = 76/275 (27%), Positives = 129/275 (46%), Gaps = 37/275 (13%)

Query: 151 IGTGGYGSVYKAQLPNGKVF-----ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G G +G VYK +L           A+K L    +E+   I+ F  EA+++ ++ H ++V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           KL G C  ++ ++++ EYME G L   L  +    +L  +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYLE--- 119

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIAPELAYTMV 324
           S + IHRD+++ N L+   L   ++DFG +R L+ D   R         ++APE      
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 325 MTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP-PPVD 377
            T K DV+SFGV+  E+  +G+ P            P +   +VL+      RLP PP  
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPY-----------PGMSNEEVLEYLKNGYRLPQPPNC 228

Query: 378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
              + D++L       C   +P+ RPT   + +  
Sbjct: 229 PPELYDLML------QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (359), Expect = 2e-39
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 36/275 (13%)

Query: 151 IGTGGYGSVYKAQL----PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G G +G VYK  L       +V  A+K L    +E+   I+ F  EA+++ ++ H +IV
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           KL G C  ++ + ++ EYM  G L   L  +    EL  +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE--- 120

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIAPELAYTMV 324
           S + IHRD+++ N L+   L   ++DFG +R L+ D   +         ++APE      
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 325 MTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVD- 377
            T K DV+SFGV+  E+  +G+ P            P +   +VL+      RLP P + 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPY-----------PGMSNAEVLEYLKKGYRLPKPPNC 229

Query: 378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
              +  ++L       C   +P+ RPT   + +  
Sbjct: 230 PPELYKLML------QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  139 bits (353), Expect = 2e-38
 Identities = 82/271 (30%), Positives = 120/271 (44%), Gaps = 31/271 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            D      +G G  G VYK +  P GK++ALKK+H    EE  F K    E + L     
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE--FRKQLLRELKTLRSCES 58

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +VK YG    +  + ++ EYM+ GSL  +L    +  E   A    I + +   L YL
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYL 115

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL-- 319
           H      IIHRDI  +N+L+NSK E  +ADFG ++ L           GT  Y++PE   
Sbjct: 116 HTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173

Query: 320 --AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI--MLIDVLDQRLPPP 375
             +Y+       D++S G+  LE  +GK P            P    ++  + D   P  
Sbjct: 174 GESYSY----AADIWSLGLTLLECALGKFP------FLPPGQPSFFELMQAICDGPPPSL 223

Query: 376 VDQKVIQDILLASTISF--ACLQSNPKSRPT 404
             ++   +        F  ACLQ +PK RP+
Sbjct: 224 PAEEFSPE-----FRDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  133 bits (335), Expect = 5e-35
 Identities = 81/274 (29%), Positives = 125/274 (45%), Gaps = 17/274 (6%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
            + I   +G G +G VY A+    K+ ALK L      +   ++ F  E Q+L+ + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 204 -IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            IVKLY F   +  ++L+ EY++ GSL  +L        L  ++ + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFV-ADFGTARRLHADSSNRTLLA------GTYGYI 315
              S  IIHRDI   NILL+         DFG A+ L    S  ++ A      GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 316 APELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD-PKIMLIDVLDQR 371
           APE+   +     +   D++S G+   E+L G  P +   + S++S   KI+L       
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTM 405
             P            AS +    L  +PK+R + 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  130 bits (329), Expect = 6e-35
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 51/286 (17%)

Query: 151 IGTGGYGSVYKAQL---PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VYK +L          A+K L    +EE    K F  EA+V+ ++ H ++V+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60

Query: 207 LYGFCLHKKCMFLIYEYMERGSL------FCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           L G C  ++ ++L+ EYME G L         +    E   L     ++    +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI----- 315
           L    S   +HRD+++ N L+   L   ++DFG +R ++ D   R     T G +     
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRWM 174

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSSDPKIMLIDVL 368
           APE     + T K DV+SFGV+  E+  +G  P       ++L  L              
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK------------ 222

Query: 369 DQRLPPP--VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
             RLP P     + + +++L      +C Q +P+ RPT   + +  
Sbjct: 223 GYRLPKPEYCPDE-LYELML------SCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (320), Expect = 8e-34
 Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 22/261 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G  G V K    P GK+ A+K +     E +   K    E  +L +     IV  YG
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI--QKQILRELDILHKCNSPYIVGFYG 66

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
              +   + +  EYM+ GSL  IL      +      ++ +  A+   L YLH      I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--I 122

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRD+  +NIL+NS+ +  + DFG + +L  +S  +T   GT  Y+APE       + K 
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAPERIQGNDYSVKS 180

Query: 330 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDQKVIQDILLA 387
           D++S G+  +E+  G+ P          +DP   + ++L   +  PPP   ++       
Sbjct: 181 DIWSLGLSLIELATGRFP------YPPENDPPDGIFELLQYIVNEPPP---RLPSGKFSP 231

Query: 388 STISF--ACLQSNPKSRPTMQ 406
               F   CL  +P+ RP+ +
Sbjct: 232 DFQDFVNLCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 1e-33
 Identities = 77/263 (29%), Positives = 118/263 (44%), Gaps = 21/263 (7%)

Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +G VYK   L  G   A+K++   + +E   +KS   E  +L  + H 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHP 59

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVK  G       +++I EY E GSL  I+       E   A     V  +   LAYLH
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQGLAYLH 116

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 +IHRDI + NIL        +ADFG A +L+  S +   + GT  ++APE+   
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVI 381
              +   D++S G   +E+L G  P   L+ ++       +   V D   P P      +
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIVQDDHPPLPEGISPEL 227

Query: 382 QDILLASTISFACLQSNPKSRPT 404
           +D L+       C Q +P  RPT
Sbjct: 228 KDFLM------QCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  131 bits (332), Expect = 5e-33
 Identities = 117/452 (25%), Positives = 201/452 (44%), Gaps = 71/452 (15%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP-- 59
           K L  LD+S+N++ G IP   +++  L  L+LS N+LSG +P +   + S+ +V +S   
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582

Query: 60  ---------------------NKGLCGNFIT--LPSC---DATKPATLFVEIFLPLAIVP 93
                                N  LCG   T  LP C     T     ++   L   +V 
Sbjct: 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVL 642

Query: 94  SVIVFACLLVVKRKYKKPKVKARATNSIDVFSIWNYDGR----IFYEDLIEATEDFHIKY 149
           +++ F    V  R     ++K R  N    + +  +D +    I   D++ + ++ ++  
Sbjct: 643 ALVAFG--FVFIRGRNNLELK-RVENEDGTWELQFFDSKVSKSITINDILSSLKEENV-- 697

Query: 150 CIGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            I  G  G+ YK +     + F +K+++   +   + I           ++ H +IVKL 
Sbjct: 698 -ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVKLI 749

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +K  +LI+EY+E  +L  +L N      L W +R  I   +A AL +LH  CSP+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           ++  ++S   I+++ K E  +        L  D+      A    Y+APE   T  +TEK
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEK 858

Query: 329 CDVYSFGVVTLEVLMGKHPRDLLSSLSSS---------SDPKI-MLIDVLDQRLPPPVDQ 378
            D+Y FG++ +E+L GK P D    +  S         SD  + M ID    R    V+Q
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS-IRGDVSVNQ 917

Query: 379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             I +++    ++  C  ++P +RP    V +
Sbjct: 918 NEIVEVM---NLALHCTATDPTARPCANDVLK 946

Length = 968

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  121 bits (305), Expect = 1e-31
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 37/279 (13%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            + I   IG G +G VY  +   +GK++ LK++  S   E    +   NE ++L ++ H 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE-------LDWAKRVNIVKAMA 255
           +I+K Y     K  + ++ EY + G L   +    +  +       LDW   V +     
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL--- 114

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
            AL YLH   S  I+HRDI   NI L S     + DFG ++ L +       + GT  Y+
Sbjct: 115 -ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170

Query: 316 APEL----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 371
           +PEL     Y      K D++S G V  E+   KHP +         +  + L   + + 
Sbjct: 171 SPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFE--------GENLLELALKILKG 218

Query: 372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             PP+  +   ++     +  + LQ +P+ RP++  + Q
Sbjct: 219 QYPPIPSQYSSEL---RNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  121 bits (306), Expect = 2e-31
 Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 33/281 (11%)

Query: 130 DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLH-TSETEELAFIK 187
           D R  Y++L +          IG G  G VYKA     GK  A+KK+    + +EL    
Sbjct: 16  DPRELYKNLEK----------IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-- 63

Query: 188 SFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-HNDDEAVELDWAK 246
              NE  ++    H +IV  Y   L    ++++ EYM+ GSL  I+  N     E   A 
Sbjct: 64  ---NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY 120

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
              + + +   L YLH   S ++IHRDI S+NILL+      +ADFG A +L  + S R 
Sbjct: 121 ---VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174

Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 366
            + GT  ++APE+        K D++S G++ +E+  G+ P           +P +  + 
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY--------LREPPLRALF 226

Query: 367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQY 407
           ++  +  PP+             ++  CL  +P+ RP+ + 
Sbjct: 227 LITTKGIPPLKNPEKWSPEFKDFLNK-CLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  120 bits (303), Expect = 2e-31
 Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 33/269 (12%)

Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLS 197
           DF I   IG G +G V+K  +  + +V+A+K     K++  E EE        +EA+VL+
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI------DEARVLA 54

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDE---AVELDWAKRVNIVKAM 254
           ++    I++ Y   L K  + ++ EY E G L  +L          +  W   + I+   
Sbjct: 55  KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG- 113

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
              LA+LH   S  I+HRDI S N+ L++     + D G A+ L  +++    + GT  Y
Sbjct: 114 ---LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY 167

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           ++PEL       EK DV++ GVV  E   GKHP D        ++ +  LI  + + + P
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFP 219

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRP 403
           PV Q   Q +   + +   CL  + + RP
Sbjct: 220 PVSQMYSQQL---AQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  116 bits (293), Expect = 6e-30
 Identities = 90/276 (32%), Positives = 126/276 (45%), Gaps = 51/276 (18%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G VY A  L  G++ A+K++   +  +   IK   +E +VL  + H ++VK YG
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHN---DDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
             +H++ +++  EY   G+L  +L +    DE V      RV     +   LAYLH   S
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRV-YTLQLLEGLAYLH---S 117

Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTL-------LAGTYGYI 315
             I+HRDI   NI L+     KL     DFG A +L    +N T        LAGT  Y+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYM 170

Query: 316 APELAYTMVMTEK---CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 372
           APE+             D++S G V LE+  GK P   L +        IM    +    
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMF--HVGAGH 223

Query: 373 PPPVDQKVIQDILLAST--ISF--ACLQSNPKSRPT 404
            PP     I D L  S     F   CL+S+PK RPT
Sbjct: 224 KPP-----IPDSLQLSPEGKDFLDRCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 3e-29
 Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 53/283 (18%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ +   IG+G YG VYKA+ +  G++ A+K +     ++   I   + E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII---QQEISMLKECRH 59

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH----- 256
            +IV  +G  L +  ++++ EY   GSL  I       +             +A+     
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---------QIAYVCRET 110

Query: 257 --ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
              LAYLH       IHRDI   NILL    +  +ADFG + +L A  + R    GT  +
Sbjct: 111 LKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167

Query: 315 IAPELA-------YTMVMTEKCDVYSFGVVTLEVLMGK------HPRDLLSSLSSSSDPK 361
           +APE+A       Y      KCD+++ G+  +E+   +      HP   L  +S S+ P 
Sbjct: 168 MAPEVAAVERKGGY----DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP- 222

Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
                      PP +  K     +    I   CL  +PK RPT
Sbjct: 223 -----------PPKLKDKEKWSPVFHDFIK-KCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 2e-28
 Identities = 75/263 (28%), Positives = 119/263 (45%), Gaps = 39/263 (14%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-Y 208
           +G G +G V   +  + GK++A+K L   +  +   ++    E  +LS++ H  IVKL Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYLHHDC 265
            F   +K ++L+ EY   G LF  L  +    E    + A+       +  AL YLH   
Sbjct: 61  AFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSE----ERARF--YAAEIVLALEYLH--- 110

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL----AY 321
           S  II+RD+   NILL++     + DFG A+ L ++ S      GT  Y+APE+     Y
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDQK 379
                   D +S GV+  E+L GK P         + D K +   +L   L  P  +  +
Sbjct: 171 GKA----VDWWSLGVLLYEMLTGKPPFY-------AEDRKEIYEKILKDPLRFPEFLSPE 219

Query: 380 VIQDILLASTISFACLQSNPKSR 402
             +D++         LQ +P  R
Sbjct: 220 A-RDLIS------GLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  110 bits (278), Expect = 7e-28
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 18/219 (8%)

Query: 145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           F +   IG G +G V   Q     K+FA+K ++  +  E   +++  NE ++L ++ H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 204 IVKL-YGFCLHKKCMFLIYEYMERGSL-FCILHN---DDEAVELDWAKRVNIVKAMAHAL 258
           +V L Y F   +  M+L+ + +  G L + +       +E V+         +  +  AL
Sbjct: 62  LVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLAL 113

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            YLH   S  IIHRDI  +NILL+ +    + DF  A ++  D +  T  +GT GY+APE
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPE 169

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS 357
           +      +   D +S GV   E L GK P    S     
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 1e-27
 Identities = 84/276 (30%), Positives = 120/276 (43%), Gaps = 46/276 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVL 200
           E F +  CIG G +G VYKA      +V A+K +   E E E+  I+    E Q LSQ  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ---QEIQFLSQCR 57

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLF-----CILHNDDEAVELDWAKRVNIVKAMA 255
              I K YG  L    +++I EY   GS         L     A          I++ + 
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------ILREVL 108

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             L YLH +     IHRDI + NILL+ + +  +ADFG + +L +  S R    GT  ++
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
           APE+       EK D++S G+  +E+  G+ P        S   P  M +  L  +  PP
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPL-------SDLHP--MRVLFLIPKNNPP 216

Query: 376 VDQKVIQDILLASTIS-----F--ACLQSNPKSRPT 404
                    L  +  S     F   CL  +PK RP+
Sbjct: 217 S--------LEGNKFSKPFKDFVSLCLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  109 bits (275), Expect = 2e-27
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 21/217 (9%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQV 199
           D+ +   IG G +G+V K +   +GK+   K++     +E E+   +    +E  +L ++
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILREL 56

Query: 200 LHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHN---DDEAVELD--WAKRVNIVK 252
            H +IV+ Y   + +  + ++++ EY E G L  ++     + + +E +  W     I+ 
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILT 112

Query: 253 AMAHALAYLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
            +  AL   H+  D   +++HRD+   NI L++     + DFG A+ L  DSS      G
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  Y++PE    M   EK D++S G +  E+     P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 81/267 (30%), Positives = 128/267 (47%), Gaps = 33/267 (12%)

Query: 151 IGTGGYGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V +   +LP  K    A+K L    +++      F  EA ++ Q  H +I++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L G     + + +I EYME GSL   L  +D   +    + V +++ +A  + YL     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG--YIAPE-LAYTM 323
              +HRD+++ NIL+NS L   V+DFG +RRL    +  T   G     + APE +AY  
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR- 183

Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVD-QK 379
             T   DV+SFG+V  EV+  G+ P   +S+          +I  ++   RLPPP+D   
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLPPPMDCPS 235

Query: 380 VIQDILLASTISFACLQSNPKSRPTMQ 406
            +  ++L       C Q +   RPT  
Sbjct: 236 ALYQLML------DCWQKDRNERPTFS 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (263), Expect = 8e-26
 Identities = 80/270 (29%), Positives = 119/270 (44%), Gaps = 34/270 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E F I   +G G YGSVYKA     G+V A+K +   E      ++    E  +L Q   
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDS 57

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKAMAHALA 259
             IVK YG       ++++ EY   GS+  I+    +     L   +   I+      L 
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLE 113

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YLH   S   IHRDI + NILLN + +A +ADFG + +L    + R  + GT  ++APE+
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP---V 376
              +    K D++S G+  +E+  GK P          SD   M    +    PPP    
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPY---------SDIHPMRAIFMIPNKPPPTLSD 221

Query: 377 DQKVIQDILLASTISF--ACLQSNPKSRPT 404
            +K   +        F   CL  +P+ RP+
Sbjct: 222 PEKWSPEF-----NDFVKKCLVKDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  104 bits (262), Expect = 1e-25
 Identities = 78/275 (28%), Positives = 121/275 (44%), Gaps = 31/275 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +D+ +   IG G    VY A  LPN +  A+K++   + +    +   R E Q +SQ  H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNH 58

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            ++VK Y   +    ++L+  Y+  GSL  I+ +      LD A    ++K +   L YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN----RTLLAGTYGYIAP 317
           H   S   IHRDI + NILL       +ADFG +  L          R    GT  ++AP
Sbjct: 119 H---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 318 ELAYTMVMTE------KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 371
           E     VM +      K D++SFG+  +E+  G  P      +      K++++ +  Q 
Sbjct: 176 E-----VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTL--QN 222

Query: 372 LPPPVDQKVIQDILLASTISF--ACLQSNPKSRPT 404
            PP ++          S       CLQ +P  RPT
Sbjct: 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAF-IKSFRNEAQVLSQVLHRSIVKLY 208
           IG G YG VYKA+    G++ ALKK+   E E+  F I + R E ++L ++ H +IV+L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIR-EIKLLQKLRHPNIVRLK 64

Query: 209 GFCLHKKC--MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
                K    +++++EYM+   L  +L + +        K    +K +   L YLH +  
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC--YMKQLLEGLQYLHSN-- 119

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-TLLAGTYGYIAPEL-----A 320
             I+HRDI  +NIL+N+     +ADFG AR     +S   T    T  Y  PEL      
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGK 345
           Y      + D++S G +  E+ +GK
Sbjct: 179 Y----GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 50/276 (18%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  +   IG G +G V        KV A+K L     ++    ++F  EA V++ + H 
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYRGQKV-AVKCLK----DDSTAAQAFLAEASVMTTLRHP 60

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++V+L G  L    ++++ EYM +GSL   L +   AV +  A+++     +   + YL 
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPELA 320
                + +HRD+++ N+L++  L A V+DFG A+      +++   +G     + APE  
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171

Query: 321 YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RL-- 372
                + K DV+SFG++  E+   G+ P            P+I L DV+       R+  
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVVPHVEKGYRMEA 220

Query: 373 ----PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
               PP V + +             C + +P  RPT
Sbjct: 221 PEGCPPEVYKVMKD-----------CWELDPAKRPT 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (259), Expect = 3e-25
 Identities = 83/270 (30%), Positives = 135/270 (50%), Gaps = 34/270 (12%)

Query: 147 IKYCIGTGGYGSVYKAQL-PNGK---VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           I+  IG G +G V + +L   GK     A+K L +  TE+    + F +EA ++ Q  H 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +I+ L G     + + +I E+ME G+L   L  +D   +    + V +++ +A  + YL 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYL- 122

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----AP 317
                + +HRD+++ NIL+NS L   V+DFG +R L  D+S+ T  +   G I     AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPR-DLLSSLSSSSDPKIMLIDVLDQ--RLP 373
           E       T   DV+S+G+V  EV+  G+ P  D+     S+ D    +I+ ++Q  RLP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQD----VINAIEQDYRLP 231

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRP 403
           PP+D       L+       C Q +  +RP
Sbjct: 232 PPMDCPTALHQLM-----LDCWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 8e-25
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 22/262 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +GTG + S Y+A+ +  G + A+K++     + +E+   +++ R E ++++++ H  I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           + G         L  E+M  GS+  +L       E   A  +N  + +   L+YLH +  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 267 PSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTL----LAGTYGYIAPELAY 321
             IIHRD+   N+L++S  +   +ADFG A RL A  +        L GT  ++APE+  
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI 381
                  CDV+S G V +E+   K P +        S+   ++  +      P + + + 
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWN----AEKHSNHLALIFKIASATTAPSIPEHLS 237

Query: 382 QDILLASTISFACLQSNPKSRP 403
             +     ++  CL+  P+ RP
Sbjct: 238 PGL---RDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 8e-25
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 38/264 (14%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLH---RSIV 205
           IG G YG+VY+   +P G+V ALK ++  +  ++++ I+    E  +LSQ+      +I 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQSQPPNIT 65

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           K YG  L    +++I EY E GS+  ++    +A  +       I++ +  AL Y+H   
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKV- 120

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
              +IHRDI + NIL+ +     + DFG A  L+ +SS R+   GT  ++APE     V+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----VI 173

Query: 326 TE------KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI-DVLDQRLPPPVDQ 378
           TE      K D++S G+   E+  G  P   + +  +     +MLI      RL      
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPKSKPPRLEDNGYS 228

Query: 379 KVIQDILLASTISFACLQSNPKSR 402
           K++++ +       ACL   PK R
Sbjct: 229 KLLREFVA------ACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 27/262 (10%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V++    N    A+K L     +   F+     EAQ++ ++ H  +++LY  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAV 69

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ ++++ E M+ GSL   L        L   + +++   +A  +AYL    + + I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N+L+       VADFG AR +  D    R        + APE A     + K 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 330 DVYSFGVVTLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVD-QKVIQDIL 385
           DV+SFG++  E V  G+ P   +++          ++  +DQ  R+P P    K + DI+
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMPCPPGCPKELYDIM 237

Query: 386 LASTISFACLQSNPKSRPTMQY 407
           L       C + +P  RPT + 
Sbjct: 238 L------DCWKEDPDDRPTFET 253

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 83/281 (29%), Positives = 136/281 (48%), Gaps = 38/281 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQ++ ++ H 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHD 61

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY  C  ++ ++++ EYM +GSL   L    E  +L   + V++   +A  +AYL 
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI---APEL 319
              S + IHRD+++ NIL+   L   +ADFG AR +  D    T   G    I   APE 
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEA 175

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP 373
           A     T K DV+SFG++  E++  G+ P            P +   +VL+Q     R+P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPY-----------PGMTNREVLEQVERGYRMP 224

Query: 374 PPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
            P +  + + D++L       C   +P+ RPT +Y+ Q FL
Sbjct: 225 RPPNCPEELYDLML------QCWDKDPEERPTFEYL-QSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  100 bits (251), Expect = 5e-24
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           I  G YG V+ A+  + G ++A+K +  ++      +     E  +LSQ     +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               KK ++L+ EY+  G L  +L N   +++ D A+    +  +  AL YLH   S  I
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVAR--IYIAEIVLALEYLH---SNGI 114

Query: 270 IHRDISSNNILLNS----KLEAFVADFG---------TARRLHADSSNRTLLAGTYGYIA 316
           IHRD+  +NIL++S    KL     DFG                +  ++ ++ GT  YIA
Sbjct: 115 IHRDLKPDNILIDSNGHLKL----TDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIA 169

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE+      ++  D +S G +  E L+G  P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 48/290 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-L 200
           +DF     IG G + +V  A+     K +A+K L   +  +   +K  + E +VL+++  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  I+KLY     ++ ++ + EY   G L   +        LD          +  AL Y
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEY 117

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA----------- 309
           LH   S  IIHRD+   NILL+  +   + DFGTA+ L  +SS  +              
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 310 ---------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP 360
                    GT  Y++PEL       +  D+++ G +  ++L GK P         S++ 
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP------FRGSNEY 228

Query: 361 ----KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
               KI+ ++       PP  + +I+ +L+           +P+ R  + 
Sbjct: 229 LTFQKILKLEYSFPPNFPPDAKDLIEKLLVL----------DPQDRLGVN 268

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 9e-23
 Identities = 74/235 (31%), Positives = 115/235 (48%), Gaps = 21/235 (8%)

Query: 151 IGTGGYGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V++   ++P  K    A+K L    TE+    + F +EA ++ Q  H +I++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L G     K   +I EYME G+L   L + D   E    + V +++ +A  + YL     
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYL---SD 125

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG---TYGYIAPELAYTM 323
            + +HRD+++ NIL+NS LE  V+DFG +R L  D       +G      + APE     
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
             T   DV+SFG+V  EV+  G+ P          S+ ++M       RLP P+D
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP------YWDMSNHEVMKAINDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G GG+G V   ++    + FALK   K H  ET +   I    +E ++L +  H  IVK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           LY     KK ++++ EY   G L+ IL    +    D       +  +  A  YLH+   
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR-- 112

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMVM 325
             II+RD+   N+LL+S     + DFG A++L   S  +T    GT  Y+APE+      
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGY 169

Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
               D +S G++  E+L G+ P
Sbjct: 170 DFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 21/267 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       KV A+K +   E E+   I+  + E  VLSQ     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH   S   
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 122

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+   E  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 330 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P   L  +      K++ +  + +  PP ++    + +     
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPM------KVLFL--IPKNNPPTLEGNYSKPL---KE 231

Query: 390 ISFACLQSNPKSRPTMQYVSQGFLITR 416
              ACL   P  RPT + + +   I R
Sbjct: 232 FVEACLNKEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 48/290 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVL 196
           +   +K  +G G +G V+  +  + +      + A+K L  + + +    K F  EA++L
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELL 62

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----------HNDDEAVELDWA 245
           +   H +IVK YG C       +++EYME G L   L             D    EL  +
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR 305
           + + I   +A  + YL    S   +HRD+++ N L+   L   + DFG +R ++     R
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 306 ----TLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSD 359
               T+L     ++ PE + Y    TE  DV+SFGVV  E+   GK P   LS+      
Sbjct: 180 VGGHTMLP--IRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEE---- 232

Query: 360 PKIMLIDVLDQRL---PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
               +I+ + Q      P      + DI+L       C + +P+ R  ++
Sbjct: 233 ----VIECITQGRLLQRPRTCPSEVYDIML------GCWKRDPQQRINIK 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 46/279 (16%)

Query: 151 IGTGGYGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +GSV K    + +GK    A+K L   +    A  K F  EA V++Q+ H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHH 263
           L G C  +  M L+ E    G L   L    E    D    A +V      A  +AYL  
Sbjct: 61  LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE- 112

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPE 318
             S   +HRD+++ N+LL ++ +A ++DFG +R L A S      A T G     + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPE 168

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDLLSSLSSSSDPKIMLIDVLDQ--RLP- 373
                  + K DV+S+GV   E    G  P  ++          +++   +L+   RLP 
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVI--AMLESGERLPR 219

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           P    + I  I+L      +C +  P+ RPT   +   F
Sbjct: 220 PEECPQEIYSIML------SCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 82/306 (26%), Positives = 131/306 (42%), Gaps = 43/306 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED      +G G  GSV K + +P G V A K +H      +   K    E Q++ +   
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRS 62

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             IV  YG  L++  + +  E+M+ GSL  I       + ++   +  I  A+   L YL
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGK--IAVAVVEGLTYL 119

Query: 262 ---HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
              H      I+HRDI  +NIL+NS+ +  + DFG +  L  +S   T + GT  Y++PE
Sbjct: 120 YNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV-GTSTYMSPE 172

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-------R 371
                  T K DV+S G+  +E+ +GK P    +      D  + ++D+L Q       R
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232

Query: 372 LP----PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQ 427
           LP    P   +  +           ACL  +P  RPT Q       +    P ++     
Sbjct: 233 LPSSDFPEDLRDFVD----------ACLLKDPTERPTPQ------QLCAMPPFIQALRAS 276

Query: 428 DISISE 433
           ++ +  
Sbjct: 277 NVDLQA 282

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 82/301 (27%), Positives = 132/301 (43%), Gaps = 65/301 (21%)

Query: 151 IGTGGYGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G VYKAQ     +F A K +     EEL   + F  E  +LS+  H +IV LY 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKHPNIVGLYE 69

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN------IVKAMAHALAYLHH 263
              ++  ++++ E+ + G+L      D   +EL+  + +       + + M  AL +LH 
Sbjct: 70  AYFYENKLWILIEFCDGGAL------DSIMLELE--RGLTEPQIRYVCRQMLEALNFLH- 120

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  +IHRD+ + NILL    +  +ADFG + +  +    R    GT  ++APE+    
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV---- 174

Query: 324 VMTE---------KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           V  E         K D++S G+  +E+   + P   L+       P  +L+ +L    PP
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-------PMRVLLKILKSE-PP 226

Query: 375 PVDQ-----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDI 429
            +DQ         D L       +CL  +P  RPT               L+KH  + D 
Sbjct: 227 TLDQPSKWSSSFNDFLK------SCLVKDPDDRPTA------------AELLKHPFVSDQ 268

Query: 430 S 430
           S
Sbjct: 269 S 269

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 2e-22
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 40/206 (19%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +     +G G YG VYKA+    G++ ALKK+     EE     + R E  +L ++ H +
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IVKL      ++ ++L++EY +   L   L      +  +  K   I+  +   LAY H 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCH- 115

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  I+HRD+   NIL+N      +ADFG AR               +G   P   YT 
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLAR--------------AFGI--PLRTYTH 157

Query: 324 VMTEKCDVYSFGVVTL-----EVLMG 344
                       VVTL     E+L+G
Sbjct: 158 E-----------VVTLWYRAPEILLG 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.1 bits (236), Expect = 3e-22
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 33/278 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 119

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP-PP 375
               T K DV+SFG++  E          L++      P ++  +VLDQ     R+P PP
Sbjct: 177 YGRFTIKSDVWSFGILLTE----------LTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
              + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 227 ECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 95.5 bits (237), Expect = 4e-22
 Identities = 81/273 (29%), Positives = 126/273 (46%), Gaps = 29/273 (10%)

Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G VYK      K V A+K +   E E+   I+  + E  VLSQ     I + YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L    +   L+      I++ +   L YLH   S   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH---SERK 122

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+ + +  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 330 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ----KVIQDIL 385
           D++S G+  +E+  G+ P         +SD   M +  L  +  PP  +    K  ++ +
Sbjct: 183 DIWSLGITAIELAKGEPP---------NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFV 233

Query: 386 LASTISFACLQSNPKSRPTMQYVSQGFLITRKT 418
                  ACL  +P+ RPT + + +   ITR T
Sbjct: 234 E------ACLNKDPRFRPTAKELLKHKFITRYT 260

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 35/271 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E+F ++  +G+G +G V++    N    A+K L + +  +    + F+ E Q L ++ H+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHK 62

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            ++ L+  C   + +++I E ME+GSL   L + +  V L  A  +++   +A  +AYL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE 121

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPEL 319
                + IHRD+++ NIL+   L   VADFG AR +  D   SS++ +    Y + APE 
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEA 175

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP 373
           A     + K DV+SFG++  E+   G+ P            P +   +V DQ     R+P
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPY-----------PGMNNHEVYDQITAGYRMP 224

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPT 404
            P   K  Q+I     I   C  + P+ RP+
Sbjct: 225 CPA--KCPQEIY---KIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 48/286 (16%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G  G+VYK    P G+++ALK ++ +  +     +    E ++L  V H ++VK + 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHD 139

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
              H   + ++ E+M+ GSL    H  DE    D A+++         +AYLH      I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT-HIADEQFLADVARQI------LSGIAYLH---RRHI 189

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHA--DSSNRTLLAGTYGYIAPELAYTMVMTE 327
           +HRDI  +N+L+NS     +ADFG +R L    D  N ++  GT  Y++PE   T +   
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHG 247

Query: 328 KC-----DVYSFGVVTLEVLMGKHP---------RDLLSSLSSSSDPKIMLIDVLDQRLP 373
                  D++S GV  LE  +G+ P           L+ ++  S  P+            
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE-----------A 296

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
           P    +  +       IS  CLQ  P  R +   + Q   I R  P
Sbjct: 297 PATASREFRHF-----ISC-CLQREPAKRWSAMQLLQHPFILRAQP 336

Length = 353

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 9/197 (4%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG VYKA+    G++ A+KK+      E     + R E ++L ++ H +I+KL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
              HK  ++L++E+M+   L+ ++   D    L  +   + +  +   LA+ H   S  I
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM-TEK 328
           +HRD+   N+L+N++    +ADFG AR   +     T    T  Y APEL       +  
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 329 CDVYSFGVVTLEVLMGK 345
            D++S G +  E+L  +
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.0 bits (234), Expect = 7e-22
 Identities = 76/270 (28%), Positives = 115/270 (42%), Gaps = 41/270 (15%)

Query: 151 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G V + +     GKV   A+K L + +  ++  +  F  EA ++  + H ++++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEA-----VELDWAKRVNIVKAMAHALAYL 261
           LYG  L    M ++ E    GSL   L  D           D+A  V I   M     YL
Sbjct: 61  LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYA--VQIANGMR----YL 113

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL------HADSSNRTLLAGTYGYI 315
               S   IHRD+++ NILL S  +  + DFG  R L      +    +  +    + + 
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWC 167

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM-LIDVLDQRLPP 374
           APE   T   +   DV+ FGV   E  M  +  +  + LS S   +I+  ID   +RL  
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWE--MFTYGEEPWAGLSGS---QILKKIDKEGERLER 222

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P      QDI     +   C   NP  RPT
Sbjct: 223 PEACP--QDIY---NVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.0 bits (233), Expect = 1e-21
 Identities = 76/262 (29%), Positives = 118/262 (45%), Gaps = 31/262 (11%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       +V A+K +   E E+   I+  + E  VLSQ     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L     A   D  +   ++K +   L YLH   S   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLH---SEKK 122

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+ + +  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 330 DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P         +SD   M +  L  +  PP    +  +     +
Sbjct: 183 DIWSLGITAIELAKGEPP---------NSDMHPMRVLFLIPKNNPPT---LTGEF----S 226

Query: 390 ISF-----ACLQSNPKSRPTMQ 406
             F     ACL  +P  RPT +
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 78/271 (28%), Positives = 130/271 (47%), Gaps = 35/271 (12%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+          A+K L        +F++    EAQ++ ++ H  +V+LY  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLYA- 68

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            + ++ ++++ EYM +GSL   L  D E   L     V++   +A  +AY+      + I
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ S NIL+   L   +ADFG AR +  +  + R        + APE A     T K 
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 330 DVYSFGVVTLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDQKV-IQ 382
           DV+SFG++  E V  G+ P            P +   +VL+Q     R+P P D  + + 
Sbjct: 185 DVWSFGILLTELVTKGRVPY-----------PGMNNREVLEQVERGYRMPCPQDCPISLH 233

Query: 383 DILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           +++L       C + +P+ RPT +Y+ Q FL
Sbjct: 234 ELML------QCWKKDPEERPTFEYL-QSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 19/210 (9%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHT------SETEELAFIKSFRNEAQVLSQVLHRS 203
           IG+G +GSVY      +G++ A+K++        S+  + + + +   E  +L ++ H +
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IV+  G  L    + +  EY+  GS+  +L+N   A E    +  N V+ +   L YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVR--NFVRQILKGLNYLH- 123

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS------SNRTLLAGTYGYIAP 317
             +  IIHRDI   NIL+++K    ++DFG +++L A+S        R  L G+  ++AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+      T K D++S G + +E+L GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 73/241 (30%), Positives = 102/241 (42%), Gaps = 37/241 (15%)

Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G  GSV K +L N   +FALK + T    +L   K    E ++        IVK YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66

Query: 210 FCLHKK-CMFLI-YEYMERGSLFCILHNDDEAVELDWAKRVN------IVKAMAHALAYL 261
             L +      I  EY E GSL  I              R+       I +++   L+YL
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE--- 318
           H   S  IIHRDI  +NILL  K +  + DFG +  L   +S      GT  Y+APE   
Sbjct: 122 H---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFTGTSFYMAPERIQ 176

Query: 319 -LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPP 375
              Y++      DV+S G+  LEV   + P           +P +  I++L     +P P
Sbjct: 177 GKPYSI----TSDVWSLGLTLLEVAQNRFP------FPPEGEPPLGPIELLSYIVNMPNP 226

Query: 376 V 376
            
Sbjct: 227 E 227

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +D      +GTG +G V+  +   +   +ALK +   E   L   +   NE +VL +V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH----- 256
             I++L+     ++ ++++ EY+  G LF  L N         + R +    + +     
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIV 111

Query: 257 -ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGY 314
            AL YLH   S  I++RD+   NILL+ +    + DFG A++L     +RT  L GT  Y
Sbjct: 112 CALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEY 164

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +APE+  +    +  D ++ G++  E+L+G  P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 83/284 (29%), Positives = 125/284 (44%), Gaps = 44/284 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V K +    G++ A+KK   SE +E     + R E +VL Q+ H +IV L  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKE 67

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               K  ++L++EY+ER +L  +L      +  D  +    +  +  A+AY H   S +I
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---SHNI 121

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-TLLAGTYGYIAPELAYTMVMTEK 328
           IHRDI   NIL++      + DFG AR L A  ++  T    T  Y APEL        K
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 329 -CDVYSFGVVTLEVLMGK-------------HPRDLLSSLSSS------SDPK------- 361
             DV++ G +  E+L G+               +  L  L  S      S+P+       
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241

Query: 362 -IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
                + L++R P  V    +    L      ACL+ +PK R T
Sbjct: 242 EPSQPESLERRYPGKVSSPALD--FLK-----ACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 91.6 bits (227), Expect = 5e-21
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 40/278 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            D+ +   +G+G YG VYKA+ L  G++ A+K +     ++ + I+    E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKH 65

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IV  +G  L ++ +++  EY   GSL  I H      EL  A    + +     LAYL
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYL 122

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S   +HRDI   NILL    +  +ADFG A ++ A  + R    GT  ++APE+A 
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA- 178

Query: 322 TMVMTEK-------CDVYSFGVVTLEV------LMGKHPRDLLSSLSSSSDPKIMLIDVL 368
                EK       CD+++ G+  +E+      +   HP   L  +S S+          
Sbjct: 179 ---AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-------- 227

Query: 369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
               PP +  K        + +  + L  NPK RPT +
Sbjct: 228 ----PPKLKDKTKWSSTFHNFVKIS-LTKNPKKRPTAE 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.1 bits (226), Expect = 8e-21
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           D  +K+ +G G YG VY+          A+K L     E+   ++ F  EA V+ ++ H 
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL 
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 121

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE- 318
                + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE 
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 176

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV---LDQ--RL- 372
           LAY      K DV++FGV+  E+          ++   S  P I L  V   L++  R+ 
Sbjct: 177 LAYNKFSI-KSDVWAFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKGYRME 225

Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P     KV + +        AC Q NP  RP+   + Q F
Sbjct: 226 RPEGCPPKVYELMR-------ACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 42/301 (13%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           D  +K  +G G +G V+ A+  N    K   L  +   +   LA  K F+ EA++L+ + 
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV-----------ELDWAKR 247
           H  IVK YG C     + +++EYM+ G L  F   H  D  +           EL  ++ 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-- 305
           ++I   +A  + YL    S   +HRD+++ N L+ + L   + DFG +R +++    R  
Sbjct: 126 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 306 --TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKI 362
             T+L     ++ PE       T + DV+SFGV+  E+   GK P   LS          
Sbjct: 183 GHTMLP--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTE 233

Query: 363 MLIDVLDQRL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQG-FLITRKTP 419
           ++  +   R+   P V  K + DI+L       C Q  P+ R  ++ + +    + + TP
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIML------GCWQREPQQRLNIKEIYKILHALGKATP 287

Query: 420 L 420
           +
Sbjct: 288 I 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 30/267 (11%)

Query: 147 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           I+  IG G +G V   + +LP  +    A+K L    TE+    + F +EA ++ Q  H 
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +I+ L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL- 122

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG---TYGYIAPEL 319
                  +HRD+++ NIL+NS L   V+DFG +R L  D        G      + APE 
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 320 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV 376
                 T   DV+S+G+V  EV+  G+ P   +S+          +I  +++  RLP P+
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRLPAPM 232

Query: 377 DQKVIQDILLASTISFACLQSNPKSRP 403
           D       L+       C Q +   RP
Sbjct: 233 DCPAALHQLM-----LDCWQKDRNERP 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 70/267 (26%), Positives = 114/267 (42%), Gaps = 33/267 (12%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YGSVYK    P G   A+K++   E +E  F      E  +L + +   IV  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKF-NQIIMELDILHKAVSPYIVDFYG 66

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               +  +++  EYM+ GSL  +         +       I  A+   L +L  +   +I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE-- 327
           IHRD+   N+L+N   +  + DFG +  L A  +   +  G   Y+APE   +    +  
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQNP 182

Query: 328 ----KCDVYSFGVVTLEVLMGKHP------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
               + DV+S G+  LE+ +G++P       ++ + LS+       ++D     LP    
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-------IVDGDPPTLPSGYS 235

Query: 378 QKVIQDILLASTISFACLQSNPKSRPT 404
               QD +        CL   P  RPT
Sbjct: 236 DDA-QDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +GTG +G V   +   +GK +ALK L  ++  +L  ++   NE ++L  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK--RVNIVKAMAHALA 259
             +V LYG       ++L+ EY+  G LF  L           A+     +V     AL 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVL----ALE 115

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGYIAPE 318
           YLH      I++RD+   N+LL+S     + DFG A+R+      RT  L GT  Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPE 168

Query: 319 LAYTMVMTEKC----DVYSFGVVTLEVLMGKHP 347
               +++++      D ++ G++  E+L G  P
Sbjct: 169 ----IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 44/267 (16%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G+G +G V+  +       A+K +      E  FI+    EA+V+ ++ H ++V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F++ EYM  G L   L      +  +W   +++   +  A+ YL  +     I
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPELAYTMVMTE 327
           HRD+++ N L+       V+DFG AR +  D    T   GT     +  PE+      + 
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 328 KCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDQKVI 381
           K DV+SFGV+  EV   GK P +  S+            +V++      RL  P      
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNS-----------EVVESVSAGYRLYRPK----- 224

Query: 382 QDILLAS----TISFACLQSNPKSRPT 404
               LA     TI ++C    P+ RP 
Sbjct: 225 ----LAPTEVYTIMYSCWHEKPEDRPA 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 81/293 (27%), Positives = 119/293 (40%), Gaps = 50/293 (17%)

Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           L + T  F +   IG G YG VYKA     G++ A+K +   E EE    +  + E  +L
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNIL 56

Query: 197 ---SQVLHRSIVKLYGFCLHKKC------MFLIYEYMERGS---LFCILHNDDEAVELDW 244
              S   H +I   YG  + K        ++L+ E    GS   L   L    + ++ +W
Sbjct: 57  RKYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114

Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
                I++     LAYLH      +IHRDI   NILL    E  + DFG + +L +    
Sbjct: 115 IAY--ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 305 RTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK------HPRDLLSS 353
           R    GT  ++APE+             + DV+S G+  +E+  GK      HP   L  
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229

Query: 354 LSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           +  +  P +           P    K   D      IS  CL  N + RP M+
Sbjct: 230 IPRNPPPTLK---------SPENWSKKFNDF-----IS-ECLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 31/276 (11%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN---EAQVLSQVLHRSIVKL 207
           +G G YG+VY      G++ A+K++    +  LA  K +     E  +L  + H +IV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            G CL    + +  E++  GS+  IL+      E  + K     K +   +AYLH++C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT------LLAGTYGYIAPELAY 321
            ++HRDI  NN++L       + DFG ARRL     + T       + GT  ++APE+  
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDQKV 380
                 K D++S G    E+  GK P        +S D    +  +   R   P +    
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL-------ASMDRLAAMFYIGAHRGLMPRLP--- 231

Query: 381 IQDILLASTISF--ACLQSNPKSRPT-MQYVSQGFL 413
             D   A+ I F  +CL  +   RP+ +Q +   FL
Sbjct: 232 --DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 32/278 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF +   IG+G YG VYKA+ +  G++ A+K +     E+ A ++    E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IV  +G  L +  +++  E+   GSL  I H      E   A    + +     L YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYL 122

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S   +HRDI   NILL       +ADFG + ++ A  + R    GT  ++APE+A 
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Query: 322 TMV---MTEKCDVYSFGVVTLEV------LMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 372
                   + CD+++ G+  +E+      +   HP   L  ++ S+              
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ------------ 227

Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           PP +  K+         +  A L  NPK RPT + + Q
Sbjct: 228 PPKLKDKMKWSNSFHHFVKMA-LTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 69/272 (25%), Positives = 136/272 (50%), Gaps = 36/272 (13%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETE-------ELAFIKSFRNEAQVLSQVLHR 202
           IG G YG VY A  +  G++ A+K++    T        +   +K+ R+E + L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  GF   ++ + +  EY+  GS+   L      +++ V           + +   L
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-------FFTEQVLEGL 121

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR---LHADSSNRTLLAGTYGYI 315
           AYLH   S  I+HRD+ ++N+L+++     ++DFG +++   ++ +  N + + G+  ++
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWM 177

Query: 316 APEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 373
           APE+  +Y+   + K D++S G V LE+  G+ P     ++++       +  + ++R  
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-------MFKLGNKRSA 230

Query: 374 PPVDQKVIQDIL-LASTISFACLQSNPKSRPT 404
           PP+   V  ++  +A     AC   NP +RPT
Sbjct: 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 66/244 (27%), Positives = 109/244 (44%), Gaps = 44/244 (18%)

Query: 151 IGTGGYGSVYKAQ-LPNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G+G +G+VYK   +P G+      A+K L    + +    K   +EA V++ V H  +V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMASVDHPHVV 72

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIVKAMAHALAYL 261
           +L G CL  +   LI + M  G L   + N  + +     L+W   V I K M+    YL
Sbjct: 73  RLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGMS----YL 125

Query: 262 --HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAP 317
                    ++HRD+++ N+L+ +     + DFG A+ L  D        G     ++A 
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD-----QR 371
           E     + T K DV+S+GV   E++  G  P +            I  +++ D     +R
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-----------GIPAVEIPDLLEKGER 229

Query: 372 LPPP 375
           LP P
Sbjct: 230 LPQP 233

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 72/265 (27%), Positives = 128/265 (48%), Gaps = 32/265 (12%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+          A+K L        AF+     EA ++ Q+ H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            + ++ +++I EYME GSL   L    E ++L   K +++   +A  +A++      + I
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPELAYTMVMTE 327
           HRD+ + NIL++  L   +ADFG AR +  + +  T   G      + APE       T 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 328 KCDVYSFGVVTLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVD-QKVIQD 383
           K DV+SFG++  E V  G+ P          ++P++  I  L++  R+P P +  + + +
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP------YPGMTNPEV--IQNLERGYRMPRPDNCPEELYE 234

Query: 384 ILLASTISFACLQSNPKSRPTMQYV 408
           ++        C +  P+ RPT +Y+
Sbjct: 235 LMR------LCWKEKPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 23/261 (8%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+     N    A+K L          +++F  EA ++  + H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
              ++ +++I EYM +GSL   L + DE  ++   K ++    +A  +AY+      + I
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ + N+L++  L   +ADFG AR +  +  + R        + APE       T K 
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 330 DVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV-IQDILLA 387
           DV+SFG++  E++  GK P          S+  +M       R+P   +    + DI+  
Sbjct: 186 DVWSFGILLYEIVTYGKIP------YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK- 238

Query: 388 STISFACLQSNPKSRPTMQYV 408
                 C +   + RPT  Y+
Sbjct: 239 -----TCWKEKAEERPTFDYL 254

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   IG G +G V   ++ N G+V+A+K L+  E  + A    FR E  VL     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 202 RSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK--RVNIVKAM--AH 256
           R I  L Y F   +  ++L+ +Y   G L  +L   ++ +  D A+     +V A+   H
Sbjct: 61  RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYI 315
            L Y         +HRDI  +N+LL+      +ADFG+  RL AD + ++ +A GT  YI
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170

Query: 316 APELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 347
           +PE+   M         +CD +S GV   E+L G+ P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 22/258 (8%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ ++++ EYM  G L   L    +  +   ++ + + K +   +AYL    S   I
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L++ +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 330 DVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           DV++FGV+  EV  +GK P +      ++S+    +   L    P    +KV        
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERF----NNSETVEKVSQGLRLYRPHLASEKVYA------ 232

Query: 389 TISFACLQSNPKSRPTMQ 406
            I ++C     + RPT Q
Sbjct: 233 -IMYSCWHEKAEERPTFQ 249

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG VY+A+   +G++ ALKK+      +   I S R E  +L  + H +IV+L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73

Query: 210 FCL--HKKCMFLIYEYMER--GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
             +  H   +FL+ EY E+   SL      D+       ++   ++  +   L YLH + 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-V 324
              IIHRD+  +N+LL  K    +ADFG AR     +   T    T  Y APEL      
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185

Query: 325 MTEKCDVYSFGVVTLEVLMGK 345
            T   D+++ G +  E+L  K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 24/259 (9%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A     G+  A+KK  L   +  EL F     NE  ++    H +IV++
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHPNIVEM 81

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+        ++  +   +  A+  AL++LH   + 
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLH---AQ 134

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL S     ++DFG   ++  +   R  L GT  ++APE+   +    
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 328 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLA 387
           + D++S G++ +E++ G+ P          ++P +  +  +   LPP +         L 
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPY--------FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLR 246

Query: 388 STISFACLQSNPKSRPTMQ 406
           S +    L  +P  R T  
Sbjct: 247 SFLD-RMLVRDPAQRATAA 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.1 bits (210), Expect = 9e-19
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 33/278 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   +   +G G +G V+          A+K L        AF++    EAQ++ ++ H 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLRHD 61

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V LY   + ++ ++++ E+M +GSL   L   D    L   + V++   +A  +AY+ 
Sbjct: 62  KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE 119

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + IHRD+ + NIL+   L   +ADFG AR +  +  + R        + APE A 
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 322 TMVMTEKCDVYSFGVVTLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPP 375
               T K DV+SFG++  E V  G+ P            P ++  +VL+Q     R+P P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPY-----------PGMVNREVLEQVERGYRMPCP 225

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
             Q   + +     +   C + +P  RPT +Y+ Q FL
Sbjct: 226 --QGCPESL---HELMKLCWKKDPDERPTFEYI-QSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 77/294 (26%), Positives = 130/294 (44%), Gaps = 56/294 (19%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ----LPNGK--VFALKKLHTSETEELAFIKSFRNEAQVL 196
            D  +K+ +G G +G V+ A+    LP     + A+K L   E  E A  + F+ EA++L
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELL 61

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV----------ELDW 244
           + + H+ IV+ YG C   + + +++EYM  G L  F   H  D  +          +L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-- 302
            + + I   +A  + YL    S   +HRD+++ N L+   L   + DFG +R +++    
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178

Query: 303 --SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD 359
               RT+L     ++ PE       T + D++SFGVV  E+   GK P   LS+  +   
Sbjct: 179 RVGGRTMLP--IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--- 233

Query: 360 PKIMLIDVLDQ-------RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
                I+ + Q       R  PP    ++Q           C Q  P+ R  ++
Sbjct: 234 -----IECITQGRELERPRTCPPEVYAIMQ----------GCWQREPQQRMVIK 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 24/257 (9%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G+G +G V+  +       A+K ++     E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  +K ++++ E+ME G L   L      +  D    +++ + +   + YL  +   S I
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L++S     V+DFG  R +  D    +  A     +  PE+      + K 
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 330 DVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRL-PPPVDQKVIQDILLA 387
           DV+SFGV+  EV   GK P          S+ +++ +     RL  P +    + +++  
Sbjct: 183 DVWSFGVLMWEVFTEGKMP------FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM-- 234

Query: 388 STISFACLQSNPKSRPT 404
               ++C    P+ RPT
Sbjct: 235 ----YSCWHEKPEGRPT 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 10/197 (5%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+KA+    G+  ALKK+     E          E + L    H  +VKL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
              H     L+ EYM    L  +L +++  +     K    ++ +   +AY+H   +  I
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMH---ANGI 120

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-TLLAGTYGYIAPELAY-TMVMTE 327
           +HRD+   N+L+++     +ADFG AR    +     +    T  Y APEL Y       
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 328 KCDVYSFGVVTLEVLMG 344
             D+++ G +  E+L G
Sbjct: 181 GVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 42/220 (19%)

Query: 151 IGTGGYGSVYKAQL--PNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +G G +G VYK +L  PN +       +  LK+    + ++      FR EA+++S + H
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-----EFRQEAELMSDLQH 67

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE-----------LDWAKRV 248
            +IV L G C  ++   +++EY+  G L  F + ++    V            LD +  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 249 NIVKAMAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS---- 302
           +I   +A  + YL  HH      +HRD+++ N L+   L   ++DFG +R +++      
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182

Query: 303 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 341
            S   L      ++ PE       T + D++SFGVV  E+
Sbjct: 183 QSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 33/269 (12%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G VYK  L      A+K   ++   +L   + F  EA++L Q  H +IVKL G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C+ K+ ++++ E +  GSL   L    +   L   K + +    A  + YL    S + I
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT----YGYIAPELAYTMVMT 326
           HRD+++ N L+       ++DFG +R    +    T+  G       + APE       T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 327 EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDQKVI 381
            + DV+S+G++  E            SL  +  P +      ++     R+P P  Q   
Sbjct: 174 SESDVWSYGILLWETF----------SLGDTPYPGMSNQQTRERIESGYRMPAP--QLCP 221

Query: 382 QDILLASTISFACLQSNPKSRPTMQYVSQ 410
           ++I     +   C   +P++RP+   +  
Sbjct: 222 EEI---YRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 22/191 (11%)

Query: 145 FHIKYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + I+ CIG G YG VYKA+  N   GK +A+KK    + +     +S   E  +L ++ H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 202 RSIVKLYGFCLHK--KCMFLIYEYMERGSLFCIL--HNDDEAVELDWAKRVNIVKAMAHA 257
            ++V L    L    K ++L+++Y E   L+ I+  H   + V +  +   +++  + + 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLAG--- 310
           + YLH   S  ++HRD+   NIL+  +        + D G AR  +A    + L      
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL--KPLADLDPV 175

Query: 311 --TYGYIAPEL 319
             T  Y APEL
Sbjct: 176 VVTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 40/268 (14%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G+V + +    KV A+K +    T +     +F  E  V++++ H+++V+L G 
Sbjct: 14  IGEGEFGAVLQGEYTGQKV-AVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGV 67

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            LH   ++++ E M +G+L   L     A+ +   + +     +A  + YL    S  ++
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 271 HRDISSNNILLNSKLEAFVADFGTAR--RLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           HRD+++ NIL++    A V+DFG AR   +  D+S   +      + APE       + K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSK 177

Query: 329 CDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDQKVIQ 382
            DV+S+GV+  EV   G+ P            PK+ L +V +      R+ PP       
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY-----------PKMSLKEVKECVEKGYRMEPPEGCPADV 226

Query: 383 DILLASTISFACLQSNPKSRPTMQYVSQ 410
            +L+ S     C ++ PK RP+   + +
Sbjct: 227 YVLMTS-----CWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 21/258 (8%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELA--FIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G +GSVY+   L +G  FA+K++  ++  +     +K    E  +LS++ H +IV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            G    +  +++  E +  GSL  +L                  + +   L YLH     
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLH---DR 121

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMT 326
           + +HRDI   NIL+++     +ADFG A+++   S  ++   G+  ++APE +A      
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGGYG 180

Query: 327 EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL 386
              D++S G   LE+  GK P        S  +    +  +   +  PP+   +  +   
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-------WSQLEGVAAVFKIGRSKELPPIPDHLSDE--- 230

Query: 387 ASTISFACLQSNPKSRPT 404
           A      CLQ +P  RPT
Sbjct: 231 AKDFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 29/228 (12%)

Query: 147 IKYCIGTGGYGSVYKAQLPN-----GKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           +K  +G G +G V+ A+  N      K+  A+K L  +        K F  EA++L+ + 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 65

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV--------ELDWAKRVNI 250
           H  IVK YG C+    + +++EYM+ G L  F   H  D  +        EL  ++ ++I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----T 306
            + +A  + YL    S   +HRD+++ N L+   L   + DFG +R +++    R    T
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS 353
           +L     ++ PE       T + DV+S GVV  E+   GK P   LS+
Sbjct: 183 MLP--IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 47/292 (16%)

Query: 143 EDFHIKYC--IGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E  H+K+   +G G +G V   +        G+  A+K L+ S  E       F  E ++
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEI 59

Query: 196 LSQVLHRSIVKLYGFC--LHKKCMFLIYEYMERGSLFCIL--HNDDEAVELDWAKRVNIV 251
           L  + H +IVK  G C     + + LI EY+  GSL   L  H D    +++  + +   
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFS 115

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS------SNR 305
             +   + YL    S   IHRD+++ NIL+ S+    ++DFG A+ L  D          
Sbjct: 116 SQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM----GKHPRDLLSSLSSSSDPK 361
                 Y   APE   T   +   DV+SFGV   E+       + P      +   +  +
Sbjct: 173 ESPIFWY---APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229

Query: 362 IMLIDVLD-----QRLPPP--VDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           +++  +L+     +RLP P     +V   + L       C ++ P+ RP+  
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFA 274

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 23/260 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G VYKA+    G + A K + T   EEL   + +  E ++L+   H  IVKL G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                  ++++ E+   G++  I+   D  +     +   I + M  AL YLH   S  I
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLH---SMKI 131

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE-- 327
           IHRD+ + N+LL    +  +ADFG + +       R    GT  ++APE+     M +  
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 328 ---KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI 384
              K D++S G+  +E+   + P   L       +P  +L+ +     PP + Q     +
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSE-PPTLSQPSKWSM 243

Query: 385 LLASTISFACLQSNPKSRPT 404
                +  A L  +P++RP+
Sbjct: 244 EFRDFLKTA-LDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 84.0 bits (207), Expect = 8e-18
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 20/216 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   IG G +G V   +L N  KVFA+K L+  E  + A    FR E  VL    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK----RVNIVKAMAHA 257
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  D A+     + I     H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIA 316
           L Y         +HRDI  +NIL++      +ADFG+  +L  D + ++ +A GT  YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 317 PELAYTMV-----MTEKCDVYSFGVVTLEVLMGKHP 347
           PE+   M         +CD +S GV   E+L G+ P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 150 CIGTGGYGSVYKA-QLPNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
            +G G +G VY    +  G+  A+K++       E    + +   E Q+L  + H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 207 LYGFCLHKKCMFLIY-EYMERGSLFCILHNDDEAVELDWAKRVNIVKA----MAHALAYL 261
            YG CL       I+ EYM  GS+        + ++   A    + +     +   + YL
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSV-------KDQLKAYGALTETVTRKYTRQILEGVEYL 120

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPE 318
           H   S  I+HRDI   NIL +S     + DFG ++RL    S+ T +    GT  +++PE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +        K DV+S G   +E+L  K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 36/230 (15%)

Query: 141 ATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
              D+ I   +G G +G VYKA Q+  G+V ALKK+     ++   I + R E ++L ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 200 LHRSIVKLYGFCLH--------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
            H ++V L    +         +  ++++  YM+   L  +L N    +     K    +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK--CYM 121

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN------- 304
             +   + YLH      I+HRDI + NIL++++    +ADFG AR       N       
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 305 ----RTLLAGTYGYIAPELAYTMVMTEK-----CDVYSFGVVTLEVLMGK 345
                T L  T  Y  PEL    ++ E+      D++  G V  E+   +
Sbjct: 179 GTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+       +  A+K +      E  FI+    EAQV+ ++ H  +V+LYG 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYGV 67

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  +  + L++E+ME G L   L    +  +      + +   +   +AYL       +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPELAYTMVMTE 327
           HRD+++ N L+       V+DFG  R +  D   SS  T     +   +PE+      + 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFSKYSS 180

Query: 328 KCDVYSFGVVTLEVLM-GKHPRD 349
           K DV+SFGV+  EV   GK P +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 143 EDFHIKYCIGTGGYGSVY----KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +DF +K  +G G +G V     KA    G ++A+K +  S       +  F  E  +LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 199 VLHRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK--RVNIVKAM- 254
                I +L Y F   K  ++L+ EY   G L  +L+  ++  + D A+     +V A+ 
Sbjct: 58  SNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 255 -AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS-NRTLLAGTY 312
             H + Y         +HRDI   N+L++      +ADFG+A RL A+   N  L  GT 
Sbjct: 117 SVHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 313 GYIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGKHP 347
            YIAPE+  TM    K      CD +S GV+  E++ G+ P
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 69/270 (25%), Positives = 127/270 (47%), Gaps = 24/270 (8%)

Query: 151 IGTGGYGSVYKAQLPNG--KVFALKKLH-------TSETEELAFIKSFRNEAQVLSQVL- 200
           +G+G +G VYK +  N    + ALK+++         + E    I    +E  ++ + L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV-NIVKAMAHALA 259
           H +IV+ Y   L    ++++ + +E   L    ++  E  +    +R+ NI   M  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YLH +    I+HRD++ NNI+L    +  + DFG A++     S  T + GT  Y  PE+
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTILYSCPEI 184

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK 379
                  EK DV++FG +  ++   + P    S+   S   KI+      + +  P+ + 
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIV------EAVYEPLPEG 236

Query: 380 VIQDILLASTISFACLQSNPKSRPTMQYVS 409
           +  +  +   I+ +CL  + ++RP +  VS
Sbjct: 237 MYSE-DVTDVIT-SCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 68/260 (26%), Positives = 128/260 (49%), Gaps = 22/260 (8%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+ A        A+K +          +++F  EA V+  + H  +VKL+  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHA- 68

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            + K+ +++I E+M +GSL   L +D E  +    K ++    +A  +A++      + I
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ + NIL+++ L   +ADFG AR +  +  + R        + APE       T K 
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 330 DVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           DV+SFG++ +E++  G+ P   +S+      P++  I  L++    P  +   +++    
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSN------PEV--IRALERGYRMPRPENCPEELY--- 233

Query: 389 TISFACLQSNPKSRPTMQYV 408
            I   C ++ P+ RPT +Y+
Sbjct: 234 NIMMRCWKNRPEERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 67/253 (26%), Positives = 123/253 (48%), Gaps = 30/253 (11%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +G+  A+K   L   +  EL F     NE  ++    H+++V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L  + ++++ E+++ G+L  I+        L+  +   + +++  AL YLH   S 
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQ 136

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  D   R  L GT  ++APE+        
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 328 KCDVYSFGVVTLEVLMGK------HPRDLLSSLSSSSDPKI--------MLIDVLDQRLP 373
           + D++S G++ +E++ G+       P   +  L  S  PK+        +L D L++ L 
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 374 -PPVDQKVIQDIL 385
             P ++   Q++L
Sbjct: 257 REPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 80/285 (28%), Positives = 121/285 (42%), Gaps = 37/285 (12%)

Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIEI 58

Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + L+ EY+  GSL   L    E   LD  K +     
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQ 116

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    S   +HRD+++ NIL+ S+    + DFG  + L  D     +      
Sbjct: 117 ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173

Query: 314 YI---APELAYTMVMTEKCDVYSFGVVTLEVL----MGKHPRDLLSSLSSSSDPKIM--- 363
            I   APE       +   DV+SFGVV  E+         P      +  +     M   
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233

Query: 364 -LIDVL--DQRLPPPVDQKV-IQDILLASTISFACLQSNPKSRPT 404
            LI++L  + RLP P      I  I+        C  ++P  RP+
Sbjct: 234 HLIELLKNNGRLPAPPGCPAEIYAIMK------ECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 25/234 (10%)

Query: 144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVL 200
           D  IK  IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    
Sbjct: 23  DNFIK--IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQ 75

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H ++V++Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ 
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSV 131

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   +  +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL 
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
             +    + D++S G++ +E++ G+ P          ++P +  + ++   LPP
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+K+++  +  +   I    NE  V+ +  H +IV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII---NEILVMRENKHPNIVNYLD 83

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKAMAHALAYLHHDCSP 267
             L    ++++ EY+  GSL       D   E  +D  +   + +    AL +LH   S 
Sbjct: 84  SYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLH---SN 134

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
           K D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRSIV 205
           +G G Y  VYKA     G++ A+KK+   E +E    + F  + R E ++L ++ H +I+
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALR-EIKLLQELKHPNII 65

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH--------- 256
            L     HK  + L++E+ME          D E V     K  +IV   A          
Sbjct: 66  GLLDVFGHKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYMLMTL 112

Query: 257 -ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             L YLH   S  I+HRD+  NN+L+ S     +ADFG AR   + +   T    T  Y 
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 316 APELAYTMVM-TEKCDVYSFGVVTLEVLMGK 345
           APEL +         D++S G +  E+L+  
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY- 208
           IG G YG VYKA+    G++ ALKK+     +E   I + R E ++L Q+ HR+IV L  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLKE 73

Query: 209 ---------GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
                     F   K   +L++EYM+   L  +L  +   V        + +K +   L 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS----NRTLLAGTYGYI 315
           Y H     + +HRDI  +NILLN+K +  +ADFG AR  +++ S    N+ +   T  Y 
Sbjct: 131 YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI---TLWYR 184

Query: 316 APELAYTMVM-TEKCDVYSFGVVTLEVLMGK 345
            PEL           DV+S G +  E+   K
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 51/288 (17%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRSIVK 206
           IG G YG+VYKA+ L  G+  ALKK+    +EE   + + R E  +L Q+    H +IV+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65

Query: 207 LYGFCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           L   C       +  + L++E++++  L   L    +   L      ++++ +   + +L
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFL 123

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  I+HRD+   NIL+ S  +  +ADFG AR    + +  T +  T  Y APE+  
Sbjct: 124 H---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLL 179

Query: 322 TMVMTEKCDVYSFGVVTLEV---------------------LMGKHPRD---LLSSLSSS 357
                   D++S G +  E+                     ++G    +      SL  S
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239

Query: 358 SDPKIMLIDVLDQRLPPPVDQKVIQDI-LLASTISFACLQSNPKSRPT 404
           S P            P    +  + +I      +    L  NP  R +
Sbjct: 240 SFP---------SYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +++     I  G YG VY+A+    G++ ALKKL   + +E   I S R E  +L ++ H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 202 RSIVKL----YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
            +IV +     G  L K  ++++ EY+E   L  ++    +      ++   ++  +   
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQ--SEVKCLMLQLLSG 118

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           +A+LH +    I+HRD+ ++N+LLN++    + DFG AR   +     T L  T  Y AP
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAP 175

Query: 318 ELAY-TMVMTEKCDVYSFGVVTLEVLMGK 345
           EL       +   D++S G +  E+L  K
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 30/268 (11%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+  +L  +    A+K    +   +L     F  EA++L Q  H +IV+L G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
            C  K+ ++++ E ++ G     L    E   L   + + +V+  A  + YL        
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPE-LAYTMVM 325
           IHRD+++ N L+  K    ++DFG +R    D   +S   +      + APE L Y    
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 326 TEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQ 382
           +E  DV+SFG++  E   +G  P   LS+  +         + ++Q  RLP P  +    
Sbjct: 175 SES-DVWSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGVRLPCP--ELCPD 223

Query: 383 DILLASTISFACLQSNPKSRPTMQYVSQ 410
            +     +   C + +P  RP+   V Q
Sbjct: 224 AVY---RLMERCWEYDPGQRPSFSTVHQ 248

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 18/202 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNE-AQVLSQVLHRSIVKLY 208
           I  G +GSVY A+    G  FA+K L  S+      + + + E A ++ Q     + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 209 GFCLHKKCMFLIYEYMERG---SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
                K  ++L+ EY+  G   SL   L    E    DWAK    +  +   +  LH   
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE----DWAK--QYIAEVVLGVEDLHQR- 116

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
              IIHRDI   N+L++      + DFG +R       N+  + GT  Y+APE    +  
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENKKFV-GTPDYLAPETILGVGD 170

Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D +S G V  E L G  P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 72/272 (26%), Positives = 123/272 (45%), Gaps = 36/272 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +D   +  +G G  G+VYKA  L   ++ A+K +    T EL   K   +E ++L +   
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV------NIVKAMA 255
             I+  YG    +  + +  E+M+ GSL             D  +++       I  A+ 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL-------------DVYRKIPEHVLGRIAVAVV 105

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             L YL    S  I+HRD+  +N+L+N++ +  + DFG + +L  +S  +T + GT  Y+
Sbjct: 106 KGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV-GTNAYM 160

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP- 374
           APE           DV+S G+  +E+ +G+ P   +     S  P  +L  ++D+  P  
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220

Query: 375 PVDQKVIQDILLASTISF--ACLQSNPKSRPT 404
           PV Q           + F   C++  PK RP 
Sbjct: 221 PVGQ------FSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 79/308 (25%), Positives = 126/308 (40%), Gaps = 50/308 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V K    P+G + A K +H      L    + RN+     +VLH
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH------LEIKPAIRNQIIRELKVLH 54

Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K   I  A+   
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK---ISIAVLRG 111

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 112 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 167

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------------------RDLLS 352
           E       T + D++S G+  +E+ +G++P                            +S
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227

Query: 353 SLSSSSDPKIMLIDVLDQRL--PPPVDQKVIQDILLASTISF--ACLQSNPKSRPTMQYV 408
                S   + + ++LD  +  PPP   K+           F   CL+ NPK R  ++ +
Sbjct: 228 GHPPDSPRPMAIFELLDYIVNEPPP---KLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284

Query: 409 SQGFLITR 416
           ++   I R
Sbjct: 285 TKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+V+ A  +  G+  A+K+++  +  +   I    NE  V+ ++ + +IV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII---NEILVMKELKNPNIVNFLD 83

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKAMAHALAYLHHDCSP 267
             L    +F++ EY+  GSL       D   E  +D A+   + +    AL +LH +   
Sbjct: 84  SFLVGDELFVVMEYLAGGSL------TDVVTETCMDEAQIAAVCRECLQALEFLHAN--- 134

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S+N+LL       + DFG   ++  + S R+ + GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
           K D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   IG G +G V   ++ +  +++A+K L+  E  + A    FR E  VL     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA-HALAY 260
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  D A+       +A H++  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIAPEL 319
           LH+      +HRDI  +N+LL+      +ADFG+  +++ D + ++ +A GT  YI+PE+
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 320 AYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 347
              M         +CD +S GV   E+L G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 23/231 (9%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +   GK  A+KK  L   +  EL F     NE  ++    H ++V +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDM 84

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  ++  AL+YLH   + 
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQ 137

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL S     ++DFG   ++  +   R  L GT  ++APE+   +    
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 328 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ 378
           + D++S G++ +E++ G+ P          ++P +  +  +   LPP V  
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP--------YFNEPPLQAMRRIRDNLPPRVKD 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.5 bits (190), Expect = 7e-16
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+K+++  +  +   I    NE  V+ +  + +IV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 83

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKAMAHALAYLHHDCSP 267
             L    ++++ EY+  GSL       D   E  +D  +   + +    AL +LH   S 
Sbjct: 84  SYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALDFLH---SN 134

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
           K D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF +   +GTG +G V  A+    G+ +A+K L   E  ++  ++    E  +L ++ H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA---LA 259
            IV +      +  ++ + E++  G LF  L            +  N V    HA   LA
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLA 130

Query: 260 --YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIA 316
             YLH   S  II+RD+   N+LL++K    V DFG A+++     +RT  L GT  Y+A
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLA 183

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE+  +    +  D ++ GV+  E + G  P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 44/284 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYK---AQLPNGKVF---ALKKLHTSETEELAFIKSFRNEAQVL 196
           E   +   +G G +G VY+     +  G+     A+K ++  E   +     F NEA V+
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVM 63

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN---DDEAVEL----DWAKRVN 249
            +     +V+L G     +   ++ E M +G L   L +   + E           K + 
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           +   +A  +AYL    +   +HRD+++ N ++   L   + DFG  R ++     R    
Sbjct: 124 MAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK--- 177

Query: 310 GTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSS---LSSSSDP 360
           G  G     ++APE     V T K DV+SFGVV  E+  + + P   LS+   L    D 
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237

Query: 361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
             +        LP     K+  +++        C Q NPK RPT
Sbjct: 238 GHL-------DLPENCPDKL-LELMR------MCWQYNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 38/286 (13%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 202
           F +   +G G YG VYK + +  G++ A+K +  +E EE    +  + E  +L +  H R
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73

Query: 203 SIVKLYGFCL------HKKCMFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMA 255
           +I   YG  +      H   ++L+ E+   GS+  ++ N    A++ DW     I + + 
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREIL 131

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             LA+LH   +  +IHRDI   N+LL    E  + DFG + +L      R    GT  ++
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 316 APELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
           APE+             + D++S G+  +E+  G  P           D   M    L  
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---------CDMHPMRALFLIP 239

Query: 371 RLPPPVDQKVIQDILLASTISF--ACLQSNPKSRP-TMQYVSQGFL 413
           R PPP   K+         I F   CL  N  SRP T Q +   F+
Sbjct: 240 RNPPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.7 bits (188), Expect = 1e-15
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + +IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKAMAHALAYLHHDCSP 267
             L    ++++ EY+  GSL       D   E  +D  +   + +    AL +LH   S 
Sbjct: 85  SYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLH---SN 135

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
           K D++S G++ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 61/267 (22%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQ 198
           +DF     IG G +G V   Q  + G ++A+KKL  S   E E++A +++ R+   +L++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERD---ILAE 57

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDD----EAVELDWAKRVNIVKAM 254
             +  +VKLY     +  ++LI EY+  G +  +L   D    E      A+ +  + ++
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG--------------------- 293
            H L Y         IHRDI  +N+LL++K    ++DFG                     
Sbjct: 118 -HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 294 -------------TARRLHADSSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGV 336
                        + R+      NR  LA    GT  YIAPE+       ++CD +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 337 VTLEVLMGKHPRDLLSSLSSSSDPKIM 363
           +  E+L+G  P    S     +  KI+
Sbjct: 228 IMYEMLVGYPP--FCSDNPQETYRKII 252

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 70/239 (29%), Positives = 109/239 (45%), Gaps = 28/239 (11%)

Query: 125 SIWNYDGRIFYEDLIEA-------TEDFHIKYCIGTGGYGSVYKAQL----PNGKVFALK 173
           +I N+  R  YE   E         EDF +   IG G +G V   QL     + +V+A+K
Sbjct: 20  NIDNFLSR--YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMK 74

Query: 174 KLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL 233
            L   E  + +    F  E  +++      IV+L+      K ++++ EYM  G L  ++
Sbjct: 75  LLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM 134

Query: 234 HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG 293
            N D  +   WA+       +  AL  +H   S   IHRD+  +N+LL+      +ADFG
Sbjct: 135 SNYD--IPEKWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Query: 294 TARRLHADSSNRTLLA-GTYGYIAPEL----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++ A+   R   A GT  YI+PE+            +CD +S GV   E+L+G  P
Sbjct: 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 33/276 (11%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT---SETEELAFIKSFRNEAQVLSQV 199
           DF +   +G G YGSVYK + L + + +ALK++     S+ E    +    NE ++L+ V
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASV 56

Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV-----ELDWAKRVNIVKAM 254
            H +I+      L    + ++ EY   G L   +    +       +  W     I   +
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQL 112

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
              L  LH      I+HRD+ S NILL +     + D G ++ L  + +   +  GT  Y
Sbjct: 113 LRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTPHY 167

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           +APE+      + K D++S G +  E+     P +      S  D +  +       +PP
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE----ARSMQDLRYKVQRGKYPPIPP 223

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
              Q +   I        + LQ  PK RP    +  
Sbjct: 224 IYSQDLQNFIR-------SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 38/251 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF +   IG G +G V+  +    G+V+A+K L  S+  +   I   R E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             IVKLY     ++ ++L+ EYM  G L  +L   D   E + A+    +  +  AL  +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARF--YIAELVLALDSV 117

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH---------------------- 299
           H       IHRDI  +NIL+++     +ADFG  ++++                      
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 300 ---ADSSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS 352
               D   R + A    GT  YIAPE+        +CD +S GV+  E+L G  P    S
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP--FYS 232

Query: 353 SLSSSSDPKIM 363
                +  KI+
Sbjct: 233 DTLQETYNKII 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 14/200 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  +   IG G +G V        KV A+K +    T + AF+     EA V++Q+ H 
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLA----EASVMTQLRHS 59

Query: 203 SIVKLYGFCLHKK-CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++V+L G  + +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 118

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
               + + +HRD+++ N+L++    A V+DFG  +   +      L      + APE   
Sbjct: 119 E---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR 172

Query: 322 TMVMTEKCDVYSFGVVTLEV 341
               + K DV+SFG++  E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 19/152 (12%)

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           + + +KLY      K   LI +Y++ G LF +L  +    +L  A+   I++ +  AL  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALND 124

Query: 261 LHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           LH     +IIH DI   N+L + +K   ++ D+G  + +   S       GT  Y +PE 
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEK 177

Query: 319 ---LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                Y +      D ++ GV+T E+L GKHP
Sbjct: 178 IKGHNYDVSF----DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 74/279 (26%), Positives = 114/279 (40%), Gaps = 50/279 (17%)

Query: 151 IGTGGYGSVYKAQ---LPNGKV---FALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+          V    A+K L    SE +E  F+     EA ++S+  H+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL----MEALIMSKFNHQ 69

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILH----NDDEAVELDWAKRVNIVKAMAHAL 258
           +IV+L G    +   F++ E M  G L   L       +    L     +   + +A   
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARRLHADS----SNRTLLAGT 311
            YL        IHRDI++ N LL  K     A +ADFG AR ++  S      R +L   
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP-- 184

Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
             ++ PE     + T K DV+SFGV+  E+  +G  P          ++ ++M       
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP------YPGRTNQEVMEFVTGGG 238

Query: 371 RLPPPVD-----QKVIQDILLASTISFACLQSNPKSRPT 404
           RL PP        +++ D          C Q  P+ RP 
Sbjct: 239 RLDPPKGCPGPVYRIMTD----------CWQHTPEDRPN 267

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 40/296 (13%)

Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 193
           +++ TE   +K  +G+G +G+VYK   +P G+   +    K+    T   A ++ F +EA
Sbjct: 3   ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 60

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVN 249
            +++ + H  +V+L G CL    + L+ + M  G L   +H   + +     L+W   V 
Sbjct: 61  LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQ 117

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           I K M     YL       ++HRD+++ N+L+ S     + DFG AR L  D        
Sbjct: 118 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170

Query: 310 GTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLID 366
           G     ++A E  +    T + DV+S+GV   E++  G  P D +        P   + D
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPD 222

Query: 367 VLD--QRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
           +L+  +RLP PP+      D+ +   +   C   +  SRP  + ++  F    + P
Sbjct: 223 LLEKGERLPQPPI---CTIDVYM---VMVKCWMIDADSRPKFKELAAEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 28/275 (10%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G+VY A+ +   +V A+KK+  S  +     +    E + L ++ H + ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 210 FCLHKKCMFLIYEY-MERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
             L +   +L+ EY +   S    +H    + VE+       I       LAYLH   S 
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLH---SH 144

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           ++IHRDI + NILL    +  +ADFG+A      +S      GT  ++APE+   M   +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200

Query: 328 ---KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI 384
              K DV+S G+  +E+   K P   ++++S+        +  + Q   P +      D 
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQSNEWSDY 252

Query: 385 LLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
                   +CLQ  P+ RPT + + +   + R+ P
Sbjct: 253 F--RNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 151 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G   KA L     +GK + +K+++ S+       +S R E  VLS + H +IV+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFC-------ILHNDDEAVELDWAKRVNIVKAMAHALA 259
                     ++++ +Y E G L+        +L  +D+   LDW   V I  A+ H   
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWF--VQICLALKHV-- 117

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
              HD    I+HRDI S NI L       + DFG AR L++         GT  Y++PE+
Sbjct: 118 ---HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKH 346
                   K D+++ G V  E+   KH
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 27/267 (10%)

Query: 151 IGTGGYGSVYKAQLPNG------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           +G G +G V+ A+           +  +K L  ++ E L     FR E  +  ++ H+++
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKNV 70

Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK--AMAHALAY-L 261
           V+L G C   +  ++I EY + G L   L       E      ++  +  A+   +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYIAPEL 319
            H  +   +HRD+++ N L++S+ E  V+    ++ ++       R  L     ++APE 
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEA 189

Query: 320 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD- 377
                 + K DV+SFGV+  EV   G+ P   L     S +  +  +      LP P   
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-----SDEEVLNRLQAGKLELPVPEGC 244

Query: 378 QKVIQDILLASTISFACLQSNPKSRPT 404
              +  ++        C   NPK RP+
Sbjct: 245 PSRLYKLMT------RCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 145 FHIKYCIGTGGYGSVY--KAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           + I   IG G +G +Y  KA+  +     K   L K+   E E      + + E  +L++
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE------ASKKEVILLAK 55

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-------CILHNDDEAVELDWAKRVNIV 251
           + H +IV  +        +F++ EY + G L         +L ++D+   L W   V I 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSWF--VQIS 111

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHADSSNRTLLAG 310
             + H      HD    I+HRDI S NI L+   + A + DFG AR+L+          G
Sbjct: 112 LGLKHI-----HD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  Y++PE+        K D++S G V  E+   KHP
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 34/262 (12%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+K  L +    A+K       +EL     F +EA++L Q  H +IVKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ ++++ E +  G     L    +  EL   + V      A  +AYL    S + I
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 271 HRDISSNNILLNSKLEAFVADFGTARR----LHADSSNRTLLAGTYGYIAPELAYTMVMT 326
           HRD+++ N L+       ++DFG +R+    +++ S  + +      + APE       +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI---PIKWTAPEALNYGRYS 172

Query: 327 EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPVDQKVI 381
            + DV+S+G++  E            SL     P +      +Q     R+  P  QK  
Sbjct: 173 SESDVWSYGILLWETF----------SLGVCPYPGMTNQQAREQVEKGYRMSCP--QKCP 220

Query: 382 QDILLASTISFACLQSNPKSRP 403
            D+     +   C    P++RP
Sbjct: 221 DDV---YKVMQRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 43/231 (18%)

Query: 151 IGTGGYGSVYKAQ------LPNGKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G V KA              A+K L  + S +E    +  F     +L QV H 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF----NLLKQVNHP 63

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----------------------HNDDEA 239
            ++KLYG C     + LI EY + GSL   L                       + D+ A
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 240 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
           + +     ++    ++  + YL       ++HRD+++ N+L+    +  ++DFG +R ++
Sbjct: 124 LTM--GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 300 ADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            + S   R+       ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V K Q  P+G + A K +H      L    + RN+     QVLH
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58

Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E +   +V+I  A+   
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI--AVLRG 115

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           LAYL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 171

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 36/269 (13%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G YG V   +   +GK + +KKL   + S  E     K+   EAQ+LSQ+ H +IV 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER----KAAEQEAQLLSQLKHPNIVA 63

Query: 207 LYGFCLHKKCM-FLIYEYMERGSLFCILHNDD-----EAVELDWAKRVNIVKAMAHALAY 260
                  +  + +++  + E G L+  L         E   ++W  ++      A AL Y
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQY 117

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH      I+HRD+ + N+ L       V D G AR L       + L GT  Y++PEL 
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVDQK 379
                  K DV++ G    E+   KH  +       + D   ++  +++ +LPP P D  
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFN-------AKDMNSLVYRIIEGKLPPMPKD-- 225

Query: 380 VIQDILLASTISFACLQSNPKSRPTMQYV 408
                 L   I+   L   P+ RP+++ +
Sbjct: 226 --YSPELGELIA-TMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 28/229 (12%)

Query: 136 EDLIEATEDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLH-TSETEELAFIKSFRNEA 193
           E L + T+ + I   IG G YG VYK     +G + A+K L   S+ +E   I++  N  
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE--IEAEYNIL 72

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH--NDDEAVEL-----DWAK 246
           Q L    H ++VK YG       MF   + +  G L+ +L   N     EL        +
Sbjct: 73  QSLPN--HPNVVKFYG-------MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 247 RVN---IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
           R++   I   +  AL  L H  +  IIHRD+  NNILL ++    + DFG + +L +   
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 304 NRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            R    GT  ++APE+      Y      +CDV+S G+  +E+  G  P
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 8/199 (4%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-Y 208
           +G GG+G V   Q+   GK++A KKL     ++    +   NE ++L +V  R IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K  + L+   M  G L   ++N  E      A+ +     +   L +LH      
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---R 115

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           I++RD+   N+LL+      ++D G A  L          AGT GY+APE+    V    
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ G    E++ G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 47/283 (16%)

Query: 151 IGTGGYGSVYKAQLPN------GKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +G+G +G VY+    +      G +  A+K L    T++    K F  EA ++S   H +
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIVKAMAHALA 259
           IVKL G CL  +  ++I E ME G L   L +          L   + ++I   +A    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAF-----VADFGTARRLHADSSNRTLLAGTYG- 313
           YL        IHRD+++ N L++ K         + DFG AR ++     R    G    
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 314 -YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ- 370
            ++APE       T + DV+SFGV+  E+L +G+ P   L++            +VL   
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------QEVLQHV 226

Query: 371 ----RL-PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
               RL  P      I  ++        C   +P  RPT   +
Sbjct: 227 TAGGRLQKPENCPDKIYQLMT------NCWAQDPSERPTFDRI 263

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 17/215 (7%)

Query: 191 NEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVN 249
           NE  +LS + H +I+  Y   +    + +  EY   G+L+  I+    +  E +    + 
Sbjct: 48  NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV--LW 105

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
            +  +  A++Y+H      I+HRDI + NI L       + DFG ++ L ++ S    + 
Sbjct: 106 YLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162

Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD 369
           GT  Y++PEL   +    K D+++ G V  E+L  K   D       +++P  +++ ++ 
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-------ATNPLNLVVKIVQ 215

Query: 370 QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
               P V     + I L      + LQ +P+ RPT
Sbjct: 216 GNYTPVVSVYSSELISLVH----SLLQQDPEKRPT 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 67/238 (28%), Positives = 108/238 (45%), Gaps = 13/238 (5%)

Query: 116 RATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKK 174
           R   +ID F     D      DL    ED+ +   IG G +G V   +     KV+A+K 
Sbjct: 16  RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 75

Query: 175 LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH 234
           L   E  + +    F  E  +++      +V+L+      + ++++ EYM  G L  ++ 
Sbjct: 76  LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 135

Query: 235 NDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 294
           N D  V   WA+       +  AL  +H   S   IHRD+  +N+LL+      +ADFGT
Sbjct: 136 NYD--VPEKWARFYT--AEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188

Query: 295 ARRLHADSSNRTLLA-GTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 347
             +++ +   R   A GT  YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 67/235 (28%)

Query: 145 FHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETE------ELAFIKSFRNEAQ 194
           + I   +G G YG V+KA      +V ALKK+  +    T+      E+ F++   +   
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--- 65

Query: 195 VLSQVLHRSIVKLYGFCLHK----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI 250
                 H +IVKL    + K    K ++L++EYME       LH            R NI
Sbjct: 66  ------HPNIVKLLN--VIKAENDKDIYLVFEYMETD-----LHA---------VIRANI 103

Query: 251 VKAMAH---------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           ++ +           AL Y+H   S ++IHRD+  +NILLNS     +ADFG AR L   
Sbjct: 104 LEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Query: 302 SSNRTLLAGTYGYIA------PEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
             N      T  Y+A      PE+      YT  +    D++S G +  E+L+GK
Sbjct: 161 EENPENPVLTD-YVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 202
           F +   +G G YG VYK + +  G++ A+K +  +  EE    +  + E  +L +  H R
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 203 SIVKLYGFCLHKKC------MFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMA 255
           +I   YG  + K        ++L+ E+   GS+  ++ N     ++ +W     I + + 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             L++LH      +IHRDI   N+LL    E  + DFG + +L      R    GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 316 APELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHP 347
           APE+             K D++S G+  +E+  G  P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 14/197 (7%)

Query: 151 IGTGGYGSVYKAQLPNG-KVFALKKLHT---SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G V+  +     K+  +K++     ++ E L    + +NE QVL  + H +I++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL----AAQNECQVLKLLSHPNIIE 63

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            Y   L  K + ++ EY   G+L   +     ++ LD      I+      L  LHH  +
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LD---EDTILHFFVQILLALHHVHT 119

Query: 267 PSIIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
             I+HRD+ + NILL+  K+   + DFG ++ L + S   T++ GT  YI+PEL      
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGKPY 178

Query: 326 TEKCDVYSFGVVTLEVL 342
            +K D+++ G V  E+ 
Sbjct: 179 NQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           ED  +  CIG G +G VY+     P  +    A+K      +  +   + F  EA ++ Q
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQ 63

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             H  IVKL G       ++++ E    G L   L  +     LD A  +     ++ AL
Sbjct: 64  FDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTAL 120

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS---SNRTLLAGTYGYI 315
           AYL    S   +HRDI++ N+L++S     + DFG +R L  +S   +++  L     ++
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWM 175

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
           APE       T   DV+ FGV   E+LM G  P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 19/186 (10%)

Query: 170 FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL 229
            A+K L    ++     + F  E ++LS++   +I +L G C     + +I EYME G L
Sbjct: 49  VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 230 -----FCILHNDDEAVE---LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 281
                  +      A     L ++  + +   +A  + YL    S + +HRD+++ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 282 NSKLEAFVADFGTARRLHA----DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 337
                  +ADFG +R L++        R  L     ++A E       T K DV++FGV 
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP--IRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 338 TLEVLM 343
             E+L 
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 22/211 (10%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF I   +G GGYG V+ A+  + G++ ALK++  S   +L  ++    E  +L+     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
            +VKL       + ++L  EY+  G    +L+N     ++      A+    V A+ H L
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HEL 120

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL--HADSSNRTLLAGTYGYIA 316
            Y+H D  P          N L+++     + DFG ++ +  +A+S     + G+  Y+A
Sbjct: 121 GYIHRDLKPE---------NFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMA 166

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE+          D +S G +  E L G  P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 50/282 (17%)

Query: 151 IGTGGYGSVYKAQL-------PNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQV 199
           +G G +G V +A            KV A+K L    H+SE E L       +E +++S +
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSSEREALM------SELKIMSHL 95

Query: 200 -LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             H +IV L G C     + +I EY   G L   L    E+  L     ++    +A  +
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGM 154

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY---GYI 315
           A+L    S + IHRD+++ N+LL       + DFG AR +  D SN  +         ++
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWM 210

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM-------LIDVL 368
           APE  +  V T + DV+S+G++  E+           SL S+  P +        LI   
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIF----------SLGSNPYPGMPVDSKFYKLIKEG 260

Query: 369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            +   P      I DI+        C  ++P  RPT + + Q
Sbjct: 261 YRMAQPEHAPAEIYDIMK------TCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 79/296 (26%), Positives = 129/296 (43%), Gaps = 34/296 (11%)

Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRN 191
           +FY+D  +  E F   + IG G +G+VY A      +V A+KK+  S  +     +    
Sbjct: 13  LFYKD--DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK 70

Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY-MERGSLFCILHNDD-EAVELDWAKRVN 249
           E + L Q+ H + ++  G  L +   +L+ EY +   S    +H    + VE+       
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AA 125

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           I       LAYLH      +IHRDI + NILL    +  +ADFG+A +    +S      
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FV 178

Query: 310 GTYGYIAPELAYTMVMTE---KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 366
           GT  ++APE+   M   +   K DV+S G+  +E+   K P   ++++S+        + 
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LY 230

Query: 367 VLDQRLPPPVDQKVIQDILLASTISFA--CLQSNPKSRPTMQYVSQGFLITRKTPL 420
            + Q   P +      D    S   F   CLQ  P+ RP    + +   + R  P 
Sbjct: 231 HIAQNDSPTLQSNEWTD----SFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V K +    G++ A+KK   SE +++    + R E ++L Q+ H ++V L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIE 67

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKAMAHALAYLHHDCSP 267
               KK ++L++E+++   L     +D E     LD ++    +  +   + + H   S 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCH---SH 119

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           +IIHRDI   NIL++      + DFG AR L A     T    T  Y APEL   +V   
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---LVGDT 176

Query: 328 K----CDVYSFGVVTLEVLMG 344
           K     D+++ G +  E+L G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 25/224 (11%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H +IVKL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 70

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
             ++  ++++ E+   G++  ++   +  +     + V   K    AL YLH +    II
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEALNYLHEN---KII 125

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE--- 327
           HRD+ + NIL     +  +ADFG + +       R    GT  ++APE+    VM E   
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV----VMCETSK 181

Query: 328 ------KCDVYSFGVVTLEVLMGKHPRDLLSSLS-----SSSDP 360
                 K DV+S G+  +E+   + P   L+ +      + S+P
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 225

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 64/290 (22%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     IG G +G V   Q  + G V+A+K L  ++  E   +   R E  +L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDD----EAVELDWAKRVNIVKAMAHA 257
             +VK++     K  ++LI E++  G +  +L   D    E  +   A+ V  + ++ H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG------------------------ 293
           L +         IHRDI  +N+LL+SK    ++DFG                        
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 294 -------TARRLHADSSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
                  + R+      NR  LA    GT  YIAPE+       + CD +S GV+  E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 343 MGKHPRDLLSSLSSSSDPKIMLIDVLDQR----LPP--PVDQKVIQDILL 386
           +G  P         S  P+     V++ +     PP  P+ +K  +D++L
Sbjct: 231 IGYPP-------FCSETPQETYKKVMNWKETLIFPPEVPISEKA-KDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 50/245 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     IG G +G V   Q  + G ++A+K L  ++  E   +   R E  +L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDD----EAVELDWAKRVNIVKAMAHA 257
             +VK++     K+ ++LI E++  G +  +L   D    EA +   A+ V  + A+ H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG------------------------ 293
           L +         IHRDI  +N+LL++K    ++DFG                        
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 294 -------TARRLHADSSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
                  + R+      NR  LA    GT  YIAPE+       + CD +S GV+  E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 343 MGKHP 347
           +G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 38/275 (13%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAF-----IKSFRNEAQVLSQVLHRSIV 205
           +G G +GSV + QL N     LK     +T ++A      ++ F +EA  + +  H +++
Sbjct: 7   LGEGEFGSVMEGQL-NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 206 KLYGFCLHKK------CMFLIYEYMERGSLFCIL---HNDDEAVELDWAKRVNIVKAMAH 256
           +L G CL            +I  +M+ G L   L      D    L     V  +  +A 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT--LLAGTYGY 314
            + YL    S S IHRD+++ N +LN  +   VADFG +++++     R   +      +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--R 371
           IA E     V T K DV+SFGV   E+   G+ P      + +S      + D L Q  R
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPGVENSE-----IYDYLRQGNR 232

Query: 372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           L  P D     D L +  +  +C   NPK RP+ +
Sbjct: 233 LKQPPD---CLDGLYS--LMSSCWLLNPKDRPSFE 262

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 143 EDFHIKYCIGTGGYGSV----YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           ED+ +   IG G +G V    +K+   + KV+A+K L   E  + +    F  E  +++ 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
                +V+L+      K ++++ EYM  G L  ++ N D  V   WAK       +  AL
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLAL 155

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIAP 317
             +H   S  +IHRD+  +N+LL+      +ADFGT  ++      R   A GT  YI+P
Sbjct: 156 DAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212

Query: 318 ELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 347
           E+  +         +CD +S GV   E+L+G  P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIK--SFRNEAQVLSQVLHRSIVKL 207
           IG G YG V+K +    G++ A+KK    E+E+   IK  + R E ++L Q+ H ++V L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALR-EIRMLKQLKHPNLVNL 65

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE-LDWAKRVNIVKAMAHALAYLH-HDC 265
                 K+ + L++EY +      +L+  ++    +       I+     A+ + H H+C
Sbjct: 66  IEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY-TMV 324
               IHRD+   NIL+  + +  + DFG AR L     + T    T  Y APEL      
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 325 MTEKCDVYSFGVVTLEVLMG 344
                DV++ G V  E+L G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 27/210 (12%)

Query: 151 IGTGGYGSVYKAQL----PNGKVFALKKLHTS----ETEELAFIKSFRNEAQVLSQVLHR 202
           +G GGYG V++ +       GK+FA+K L  +      ++ A  K+ RN   +L  V H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVKHP 60

Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVEL-DWAK--RVNIVKAMAHAL 258
            IV L Y F    K ++LI EY+  G LF  +H + E + + D A      I  A+ H  
Sbjct: 61  FIVDLIYAFQTGGK-LYLILEYLSGGELF--MHLEREGIFMEDTACFYLSEISLALEH-- 115

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR-LHADSSNRTLLAGTYGYIAP 317
             LH      II+RD+   NILL+++    + DFG  +  +H  +   T   GT  Y+AP
Sbjct: 116 --LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAP 169

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+       +  D +S G +  ++L G  P
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 82/305 (26%), Positives = 135/305 (44%), Gaps = 42/305 (13%)

Query: 122 DVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSET 180
           ++FS    D    + DL E          IG G +G+VY A+ +   +V A+KK+  S  
Sbjct: 6   ELFS--KDDPEKLFTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 53

Query: 181 EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV 240
           +     +    E + L Q+ H + ++  G  L +   +L+ EY   GS   IL    + +
Sbjct: 54  QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPL 112

Query: 241 -ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
            E++ A    I       LAYLH   S   IHRDI + NILL       +ADFG+A  + 
Sbjct: 113 QEVEIAA---ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166

Query: 300 ADSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS 356
             +S      GT  ++APE+   M       K DV+S G+  +E+   K P   ++++S+
Sbjct: 167 PANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

Query: 357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISF--ACLQSNPKSRPTMQYVSQGFLI 414
                   +  + Q   P +      D       +F  +CLQ  P+ RP+ + + +   +
Sbjct: 223 --------LYHIAQNDSPTLSSNDWSD----YFRNFVDSCLQKIPQDRPSSEELLKHRFV 270

Query: 415 TRKTP 419
            R+ P
Sbjct: 271 LRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 70/275 (25%), Positives = 127/275 (46%), Gaps = 26/275 (9%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAV-ELDWAKRVNIVKAMAHALAYLHHDCSPS 268
             L +   +L+ EY   GS   +L    + + E++ A    +       LAYLH   S +
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLH---SHN 135

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE- 327
           +IHRD+ + NILL+      + DFG+A  +   +       GT  ++APE+   M   + 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQY 191

Query: 328 --KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL 385
             K DV+S G+  +E+   K P   ++++S+        +  + Q   P +      +  
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPALQSGHWSEYF 243

Query: 386 LASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL 420
                  +CLQ  P+ RPT + + +   + R+ P 
Sbjct: 244 --RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 10/201 (4%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG VY A+ L      A+K++   ++     ++    E  + S + HR+IV+  G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLG 72

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                    +  E +  GSL  +L +    ++ +    +   K +   L YLH +    I
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129

Query: 270 IHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV--MT 326
           +HRDI  +N+L+N+      ++DFGT++RL   +       GT  Y+APE+         
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 327 EKCDVYSFGVVTLEVLMGKHP 347
              D++S G   +E+  GK P
Sbjct: 190 APADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 38/221 (17%)

Query: 151 IGTGGYGSVYKAQLPN---GKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           IG G +G V++A+ P     + F   A+K L   E         F+ EA ++++  H +I
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDHPNI 70

Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCIL------------HNDDEAV-------ELDWA 245
           VKL G C   K M L++EYM  G L   L            H+   A         L   
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---- 301
           +++ I K +A  +AYL        +HRD+++ N L+   +   +ADFG +R +++     
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 302 -SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 341
            S N  +      ++ PE  +    T + DV+++GVV  E+
Sbjct: 188 ASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 31/272 (11%)

Query: 144 DFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELA-FIKSFRNEAQVLSQ 198
           +F +   +GTG YG V+  +      +GK++A+K L  +   + A   +  R E QVL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 199 VLHRS-IVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI-VKAMA 255
           +     +V L Y F    K + LI +Y+  G LF  L   +   E    + V I    + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGY 314
            AL +LH      II+RDI   NILL+S     + DFG ++  H D   R     GT  Y
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 315 IAPELAY--TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD--PKIMLIDVLDQ 370
           +AP++         +  D +S GV+  E+L G  P  +    +S ++   +I+  +    
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---- 228

Query: 371 RLPPPVDQKVIQDILLASTISFACLQSNPKSR 402
              PP  Q++     LA  I    L  +PK R
Sbjct: 229 ---PPYPQEMSA---LAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 71/254 (27%), Positives = 115/254 (45%), Gaps = 20/254 (7%)

Query: 144 DFHIKYCIGTGGYGSVY---KAQLPN-GKVFALKKLHTSE-TEELAFIKSFRNEAQVLSQ 198
           +F +   +GTG YG V+   K    + GK++A+K L  +   ++   ++  R E  VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 199 VLHRS-IVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           V     +V L Y F    K + LI +Y+  G +F  L+  D   E     R      +  
Sbjct: 61  VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSED--EVRF-YSGEIIL 116

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYI 315
           AL +LH      I++RDI   NILL+S+    + DFG ++   ++   RT    GT  Y+
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 316 APELAYTMVMTEKC-DVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           APE+        K  D +S G++  E+L G  P  L    ++ S+    ++   D   P 
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPS 232

Query: 375 ---PVDQKVIQDIL 385
              P  Q ++  +L
Sbjct: 233 FIGPEAQDLLHKLL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG VYKA+     +  ALKK+   + +E     + R E  +L ++ H +IV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA----MAHALAYLHHDC 265
               +K ++L++EY++   L    H D      D+AK   ++K     +   +AY H   
Sbjct: 69  VVHSEKRLYLVFEYLD---LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH--- 119

Query: 266 SPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTM 323
           S  ++HRD+   N+L++ +  A  +ADFG AR         T    T  Y APE L  + 
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 324 VMTEKCDVYSFGVVTLEVLMGK 345
             +   D++S G +  E++  K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 151 IGTGGYGSVY---KAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G V+   K   P+ G+++A+K L  +  +    +++ + E  +L++V H  IVK
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62

Query: 207 L-YGFCLHKKCMFLIYEYMERGSLFCILHND----DEAVELDWAKRVNIVKAMAHALAYL 261
           L Y F    K ++LI +++  G LF  L  +    +E V+   A+       +A AL +L
Sbjct: 63  LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE+  
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
               T+  D +SFGV+  E+L G  P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 37/212 (17%)

Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKL-----HTSETEELAFIKSFR--NEAQVLSQVLH 201
            +G G +GSVY A+    G++ A+KK+        E   L  +KS R  NE        H
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE--------H 57

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL         ++ ++EYME G+L+  L  D +      +   +I+  +   LA++
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR---TLLAGTYGYIAPE 318
           H        HRD+   N+L++      +ADFG AR +     +R   T    T  Y APE
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR----SRPPYTDYVSTRWYRAPE 168

Query: 319 L-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
           +     +Y    +   D+++ G +  E+   +
Sbjct: 169 ILLRSTSY----SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 68/280 (24%), Positives = 118/280 (42%), Gaps = 41/280 (14%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG GG G VY A  P   +  ALKK+    +E     K F  EA++ + ++H  IV +Y 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHN--DDEAVELDWAKR------VNIVKAMAHALAYL 261
            C     ++    Y+E  +L  +L +    E++  + A++      ++I   +   + Y+
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---------------SSNRT 306
           H   S  ++HRD+  +NILL    E  + D+G A     +                S+ T
Sbjct: 130 H---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 307 L---LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 363
           +   + GT  Y+APE    +  +E  D+Y+ GV+  ++L    P             KI 
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP------YRRKKGRKIS 240

Query: 364 LIDVLDQRLPPPVDQKVIQDI-LLASTISFACLQSNPKSR 402
                   +  P++    ++I    S I+   L  +P  R
Sbjct: 241 ----YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276

Length = 932

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 65/280 (23%), Positives = 115/280 (41%), Gaps = 29/280 (10%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
             +F I+  IG G +  VYKA  L +G+V ALKK+   E  +    +    E  +L Q+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV-NIVKAMAHALA 259
           H +++K     +    + ++ E  + G L  ++ +  +   L   + +      +  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           ++H   S  I+HRDI   N+ + +     + D G  R   + ++    L GT  Y++PE 
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP--------RDLLSSLSSSSDPKIMLIDVLDQR 371
            +      K D++S G +  E+   + P          L   +     P           
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP----------- 226

Query: 372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQG 411
            P P D    +   L   +S  C+  +P+ RP + YV Q 
Sbjct: 227 -PLPADHYSEE---LRDLVS-RCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 7/200 (3%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-Y 208
           +G GG+G V   Q+   GK++A KKL+    ++    +    E ++L++V  R IV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 209 GFCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            F   K  + L+   M  G L + I + D+E       +       +   L +LH     
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            II+RD+   N+LL++     ++D G A  L    S     AGT G++APEL        
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D ++ GV   E++  + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G + A K +H      L    + RN+     QVLH
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58

Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 115

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 171

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 51/283 (18%)

Query: 151 IGTGGYGSVYKAQL-----PNGKV-FALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHR 202
           +G G +G V KA+      PN     A+K L    TE +L+ + S   E +++  +  H+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS---EMEMMKMIGKHK 76

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA--------- 253
           +I+ L G C  +  ++++ EY   G+L   L           +                 
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 254 -----MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
                +A  + +L    S   IHRD+++ N+L+       +ADFG AR +H     R   
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 309 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI---M 363
            G     ++APE  +  V T + DV+SFGV+  E+           +L  S  P I    
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----------TLGGSPYPGIPVEE 242

Query: 364 LIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           L  +L +  R+  P  Q   Q++     +   C    P  RPT
Sbjct: 243 LFKLLKEGYRMEKP--QNCTQELY---HLMRDCWHEVPSQRPT 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           +G G +G V+ A+L    + FA+K L          ++    E +VLS    H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                K+ +F + EY+  G L   + +     + D  +       +   L +LH   S  
Sbjct: 63  CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKG 116

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           I++RD+  +NILL++     +ADFG  +      +      GT  YIAPE+         
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D +SFGV+  E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 78/301 (25%), Positives = 121/301 (40%), Gaps = 68/301 (22%)

Query: 130 DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKS 188
           DG+ +  DL     D      IG+G  G VYK +    G V A+K++  +  +E      
Sbjct: 6   DGQKYPADL----NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE------ 55

Query: 189 FRNEAQVLS--QVLHRS-----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
                ++L    V+ +S     IVK YG+ +    +F+  E M   +    L        
Sbjct: 56  --ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKL-------- 103

Query: 242 LDWAKRVN----------IVKAMAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFV 289
               KR+           +  A+  AL YL   H     +IHRD+  +NILL++     +
Sbjct: 104 ---LKRIQGPIPEDILGKMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKL 156

Query: 290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK----CDVYSFGVVTLEVLMGK 345
            DFG + RL  DS  +T  AG   Y+APE         K     DV+S G+  +E+  G+
Sbjct: 157 CDFGISGRL-VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Query: 346 HPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDQKVIQDILLASTISFA--CLQSNPKSR 402
            P     +         +L  +L +  P  P ++    D       SF   CL  + + R
Sbjct: 216 FPYKNCKTEFE------VLTKILQEEPPSLPPNEGFSPDF-----CSFVDLCLTKDHRKR 264

Query: 403 P 403
           P
Sbjct: 265 P 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.0 bits (166), Expect = 8e-13
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 31/276 (11%)

Query: 151 IGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +GSV +AQL     + +  A+K L   +    + I+ F  EA  + +  H +++K
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 207 LYGFCLHKKCM------FLIYEYMERGSLFCIL---HNDDEAVELDWAKRVNIVKAMAHA 257
           L G  L  +         +I  +M+ G L   L      +E   L     V  +  +A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYI 315
           + YL    S + IHRD+++ N +LN  +   VADFG ++++++    R   A      ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           A E     V T   DV++FGV   E++  G+ P       +   + +I    +   RL  
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP------YAGVENSEIYNYLIKGNRLKQ 236

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           P D   ++D+     +   C    PK RP+ Q++  
Sbjct: 237 PPD--CLEDVY---ELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 54/294 (18%)

Query: 145 FHIKYC-----IGTGGYGSV--YKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQ 194
           FH +Y      +G G +G V  Y     N   G++ A+K L     ++      ++ E  
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEIN 58

Query: 195 VLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCIL--HNDDEAVELDWAKRVNI 250
           +L  + H +IVK  G C  +  K + LI EY+  GSL   L  H  + A  L +A+++  
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQI-- 116

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR---------RLHAD 301
                  +AYLH   S   IHRD+++ N+LL++     + DFG A+         R+  D
Sbjct: 117 ----CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169

Query: 302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM----GKHPRDLLSSL--- 354
             +         + A E       +   DV+SFGV   E+L      + P      +   
Sbjct: 170 GDSPVF------WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP 223

Query: 355 SSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
                  + LI++L+   RLP P +      IL+ +     C ++  K RPT +
Sbjct: 224 KQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKN-----CWETEAKFRPTFR 272

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 210 FCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
               K  + L+   M  G L F I H  +     +  + V     +   L  LH +    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQE---R 122

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           I++RD+   NILL+      ++D G A  +    + +  + GT GY+APE+      T  
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ G +  E++ G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 42/297 (14%)

Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGK----VFALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 3   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 59

Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L   +    + +     L+W   V
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 116

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L AD       
Sbjct: 117 QIAKGMN----YLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLI 365
            G     ++A E     + T + DV+S+GV   E++  G  P D +        P   + 
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEIS 221

Query: 366 DVLD--QRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
            +L+  +RLP PP+    +  I++       C   +  SRP  + +   F    + P
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMV------KCWMIDADSRPKFRELIIEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 16/203 (7%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V  A+   +GK +A+K L        +E   I + RN   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVG 60

Query: 207 L-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHD 264
           L Y F   +K ++ + +++  G LF  L  +    E     R     A +A AL YLH  
Sbjct: 61  LHYSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH-- 113

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
            S +I++RD+   NILL+S+    + DFG  +   A S   T   GT  Y+APE+     
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
                D +  G V  E+L G  P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 43/302 (14%)

Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKL---HTSETEELAFIKS 188
           I ++   + ++ + I   IG G YG V+K     NG   A+K L   H  + E    I++
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEA 63

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELD 243
             N  + LS   H ++VK YG    K       ++L+ E    GS+      D     L 
Sbjct: 64  EYNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLK 116

Query: 244 WAKRVN--IVKAMAH-ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
             +R+   I+  + H AL  L H      IHRD+  NNILL ++    + DFG + +L +
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176

Query: 301 DSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS 355
               R    GT  ++APE+             +CDV+S G+  +E+  G  P   L+ L 
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP---LADLH 233

Query: 356 SSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTIS---FACLQSNPKSRPTMQYVSQGF 412
               P   L  +   R PPP    + Q  L ++  +     CL  + + RPT+  + Q  
Sbjct: 234 ----PMRALFKI--PRNPPP---TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284

Query: 413 LI 414
            I
Sbjct: 285 FI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 80/276 (28%), Positives = 123/276 (44%), Gaps = 39/276 (14%)

Query: 144 DFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQ 198
           +F +   +GTG YG V+  +       GK++A+K L   +  ++    +  R E QVL  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 199 VLHRS---IVKL-YGFCLHKKCMFLIYEYMERGSLFCIL----HNDDEAVELDWAKRVNI 250
           V  R    +V L Y F    K + LI +Y+  G LF  L    H  +  V +  A+   I
Sbjct: 61  V--RRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEVRVYIAE---I 114

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LA 309
           V A+ H    LH      II+RDI   NILL+S+    + DFG ++   A+   R     
Sbjct: 115 VLALDH----LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167

Query: 310 GTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV 367
           GT  Y+APE+         +  D +S GV+T E+L G  P  +    +S S+   +   +
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE---ISRRI 224

Query: 368 LDQRLP-PPVDQKVIQDILLASTISFACLQSNPKSR 402
           L  + P P       +D +         L+ +PK R
Sbjct: 225 LKSKPPFPKTMSAEARDFIQ------KLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 14/203 (6%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLSQVLHRSIVKL 207
           IG G YG+VYKA+ P+ G   ALK +     E+   + + R  A  + L    H +IV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 208 YGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
              C   +      + L++E++++     +       +  +  K  ++++     L +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFLH 125

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
            +C   I+HRD+   NIL+ S  +  +ADFG A R+++     T +  T  Y APE+   
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 323 MVMTEKCDVYSFGVVTLEVLMGK 345
                  D++S G +  E+   K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 24/202 (11%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H +IVKL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK----RVNIVKA----MAHALAYL 261
               +  ++L++E++          + D    +D +      + ++K+    +   LA+ 
Sbjct: 67  VIHTENKLYLVFEFL----------HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173

Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G G +G VY    +  G+  A K++       E    + +   E Q+L  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 208 YGFCLH---KKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYL 261
           YG CL    +K + +  EYM  GS+   L       E+V   + +++         ++YL
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYL 122

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT---LLAGTYGYIAPE 318
           H   S  I+HRDI   NIL +S     + DFG ++RL     + T    + GT  +++PE
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +        K DV+S G   +E+L  K P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 73/269 (27%), Positives = 109/269 (40%), Gaps = 52/269 (19%)

Query: 135 YEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLH--TSETEELAFIKSFRN 191
            EDL +  E       IG G +G+V K    P+G + A+K++     E E+    K    
Sbjct: 3   AEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ----KRLLM 51

Query: 192 EAQVLSQVLHRS-----IVKLYGFCLHKK----CMFLIYEYMERGSLFCILHNDDEAVEL 242
           +  V+     RS     IVK YG    +     CM L+   +++   +          E 
Sbjct: 52  DLDVVM----RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEE 107

Query: 243 DWAK-RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
              K  V  VKA+ +    L       IIHRD+  +NILL+      + DFG + +L  D
Sbjct: 108 ILGKIAVATVKALNYLKEELK------IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VD 160

Query: 302 SSNRTLLAGTYGYIAPEL-------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRD----L 350
           S  +T  AG   Y+APE         Y +    + DV+S G+   EV  GK P      +
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFPYPKWNSV 216

Query: 351 LSSLSS--SSDPKIMLIDVLDQRLPPPVD 377
              L+     DP I+      +  P  V+
Sbjct: 217 FDQLTQVVKGDPPILSNSEEREFSPSFVN 245

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 65/203 (32%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V  A+   +GK +A+K   K    + +E   I + RN   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERN--VLLKNVKHPFLVG 60

Query: 207 L-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHD 264
           L Y F    K  F++ +Y+  G LF  L  +    E     R     A +A AL YLH  
Sbjct: 61  LHYSFQTADKLYFVL-DYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH-- 113

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
            S +II+RD+   NILL+S+    + DFG  +     S   +   GT  Y+APE+     
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
                D +  G V  E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G G +G VY       G+  A+K++       E    + +   E Q+L  +LH  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 208 YGFCLH---KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           YG CL    ++ + +  E+M  GS+   L +     E +  ++    + +   ++YLH  
Sbjct: 70  YG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLH-- 123

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA---DSSNRTLLAGTYGYIAPELAY 321
            S  I+HRDI   NIL +S     + DFG ++RL       +    + GT  +++PE+  
Sbjct: 124 -SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
                 K D++S G   +E+L  K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 52/157 (33%), Positives = 73/157 (46%), Gaps = 29/157 (18%)

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA---DSSNRTLLAGTYGY 314
           L  +HH  S  +IHRDI S NILL S     + DFG ++   A   D   RT   GT  Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYY 211

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD-------LLSSLSSSSDPKIMLIDV 367
           +APE+      ++K D++S GV+  E+L  K P D       +  +L+   DP       
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP------- 264

Query: 368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
               LPP +  ++         I  A L S+PK RP+
Sbjct: 265 ----LPPSISPEM-------QEIVTALLSSDPKRRPS 290

Length = 496

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 44/285 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRSIV 205
           IG G YG V+KA+ L NG  F ALK++     EE   + + R E  VL  +    H ++V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67

Query: 206 KLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           +L+  C   +      + L++E++++     +    +  V  +  K  +++  +   L +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  ++HRD+   NIL+ S  +  +ADFG A R+++     T +  T  Y APE+ 
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVL 181

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD--- 377
                    D++S G +  E+      R  L   SS  D    ++DV+   LP   D   
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR----RKPLFRGSSDVDQLGKILDVIG--LPGEEDWPR 235

Query: 378 -----------------QKVIQDI-LLASTISFACLQSNPKSRPT 404
                            +K + DI  L   +   CL  NP  R +
Sbjct: 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YGSV  A     G+  A+KKL      E+   +++R E  +L  + H +++ L  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 210 FCLHKKCM------FLIYEYMERGSLFCI--LHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                         +L+  YM +  L  I      ++ V+        +V  M   L Y+
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQY-------LVYQMLCGLKYI 133

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+   N+ +N   E  + DFG AR  HAD+   T    T  Y APE+  
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAE-MTGYVVTRWYRAPEVIL 187

Query: 322 T-MVMTEKCDVYSFGVVTLEVLMGK 345
             M   +  D++S G +  E+L GK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 44/278 (15%)

Query: 147 IKYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           I+  +GTG +G + +   +LP+ +    A+  L    +++    + F  EA  L Q  H 
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHS 66

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IV+L G       M ++ EYM  G+L   L   +   +L   + + ++  +A  + YL 
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYL- 123

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR--TLLAGTYG--YIAPE 318
                  +H+ ++++ +L+NS L   ++ F   RRL  D S    T ++G     + APE
Sbjct: 124 --SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPE 178

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSSDPKIMLIDVLDQR 371
                  +   DV+SFG+V  EV+  G+ P      +D++ ++                R
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------------R 226

Query: 372 LPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           LP P +   ++  ++L       C Q     RP    +
Sbjct: 227 LPAPRNCPNLLHQLML------DCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 70/259 (27%), Positives = 105/259 (40%), Gaps = 66/259 (25%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQ 198
           EDFH    IG G +G V   Q    GK++A+K L  SE    ++LA +K+ R+   VL++
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERD---VLAE 57

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDD---EAVELDWAKRVNIVKAMA 255
                +V LY      + ++LI E++  G L  +L   D   E V   +     +     
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA--DSS---------- 303
           H L +         IHRDI  +NIL++      ++DFG +   H   DS+          
Sbjct: 118 HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 304 -------------------------------NRTLLA----GTYGYIAPELAYTMVMTEK 328
                                          NR L+A    GT  YIAPE+       ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228

Query: 329 CDVYSFGVVTLEVLMGKHP 347
           CD +S G +  E L+G  P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 14/202 (6%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLY 208
           +G G +G V  A+L    +++A+K L      +   ++    E +VL+    H  + +L+
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYLHHDC 265
                K  +F + EY+  G L   +      DE     +A  + +       L +LH   
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL------GLQFLH--- 113

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
              II+RD+  +N+LL+S+    +ADFG  +         +   GT  YIAPE+      
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173

Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
               D ++ GV+  E+L G+ P
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 13/170 (7%)

Query: 192 EAQVLSQVLHRSIVKLYGFCLHKK--CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           EA +L  V H S++++    +     CM L +       L+  L      + +D A  + 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSRPLPIDQA--LI 161

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           I K +   L YLH   +  IIHRD+ + NI +N   +  + D G A +    +     LA
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLGLA 217

Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD 359
           GT    APE+        K D++S G+V  E+L   +P  +     S+ +
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPSTPE 265

Length = 357

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 39/259 (15%)

Query: 144 DFHIKY----CIGTGGYGSVYKA-QLPNGKVFALKKL-HTSETEELAFIKSFRNEAQVLS 197
           D   +Y     IG+G YG V  A    +GK  A+KK+ H  +   LA  ++ R E ++L 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA-KRTLR-ELKILR 59

Query: 198 QVLHRSIVKLYGFCLHK----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
              H +I+ +           K ++++ + ME   L  I+H+D + +  +  +    +  
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRY--FLYQ 115

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLA 309
           +   L Y+H   S ++IHRD+  +N+L+N   E  + DFG AR L +  +      T   
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 310 GTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKH--P-RDLLSSLSSSSDPKIMLI 365
            T  Y APEL  ++   T   D++S G +  E+L  +   P ++ +  L        +++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK-------LIL 225

Query: 366 DVLDQRLPPPVDQKVIQDI 384
            VL    P    ++V+  I
Sbjct: 226 SVLGS--PS---EEVLNRI 239

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 14/202 (6%)

Query: 151 IGTGGYGSVYKAQLPNGKVF----ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V  A+    + F     L+K    + +E   I S RN   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNVKHPFLVG 60

Query: 207 L-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           L + F    K ++ + +Y+  G LF   H   E   L+   R    + +A AL YLH   
Sbjct: 61  LHFSFQTADK-LYFVLDYINGGELF--YHLQRERCFLEPRARFYAAE-IASALGYLH--- 113

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S +I++RD+   NILL+S+    + DFG  +     +   +   GT  Y+APE+ +    
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
               D +  G V  E+L G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 51/198 (25%), Positives = 100/198 (50%), Gaps = 10/198 (5%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +VYK +    G++ ALK++H  + EE     + R E  ++ ++ H +IV+L+ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIR-EISLMKELKHENIVRLHD 65

Query: 210 FCLHKKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
               +  + L++EYM++    +   H    A++ +  K  +    +   +A+ H +    
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN---R 120

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTE 327
           ++HRD+   N+L+N + E  +ADFG AR      +  +    T  Y AP+ L  +   + 
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 328 KCDVYSFGVVTLEVLMGK 345
             D++S G +  E++ G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 22/183 (12%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           IG G +G V+KA+     ++ ALKK L  +E E    I + R E ++L  + H ++V L 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-ITALR-EIKILQLLKHENVVNLI 77

Query: 209 GFCLHKKCM--------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
             C  K           +L++E+ E   L  +L N +    L   K+V  +K + + L Y
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNGLYY 134

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH---ADSSNR-TLLAGTYGYIA 316
           +H      I+HRD+ + NIL+       +ADFG AR          NR T    T  Y  
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 317 PEL 319
           PEL
Sbjct: 192 PEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 40/227 (17%)

Query: 151 IGTGGYGSVYKA-------QLPNGKV-FALKKLHTSETE-ELAFIKSFRNEAQVLSQVLH 201
           +G G +G V +A         P+  V  A+K L  + T+ +LA + S     +++ +  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCILHNDDEAVELDWAK 246
           ++I+ L G C  +  +++I EY  +G+L               F I    +E  +L +  
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE--QLSFKD 135

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-----AD 301
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H       
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           +SN  L      ++APE  +  V T + DV+SFG++  E+  +G  P
Sbjct: 193 TSNGRL---PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 38/292 (13%)

Query: 145 FHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + I+  IG G YG V  A     G+  A+KK++    E ++       E ++L  + H  
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPD 60

Query: 204 IVKLYGFCLHK-----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           IV++    L       K +++++E ME      I  NDD   E         +  +  AL
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRAL 116

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL---LAGTYGYI 315
            Y+H   + ++ HRD+   NIL N+  +  + DFG AR    D+           T  Y 
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 316 APEL--AYTMVMTEKCDVYSFGVVTLEVLMGK---------HPRDLLSSLSSSSDPKIM- 363
           APEL  ++    T   D++S G +  EVL GK         H  DL++ L  +  P+ + 
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 364 ---------LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
                     +  + ++ P P  QK      LA  +    L  +PK RPT +
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 36/218 (16%)

Query: 151 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G   +G VYK  L    P  +  A+      +  E    + F++EA + S++ H +IV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 207 LYGFCLHKKCMFLIYEYMERGSL--FCILH---------NDDEAVE--LDWAKRVNIVKA 253
           L G    ++ + +I+ Y     L  F ++          +DD+ V+  L+ A  V+IV  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 254 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           +A  + +L  HH     ++H+D+++ N+L+  KL   ++D G  R ++A +    L+  +
Sbjct: 133 IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYA-ADYYKLMGNS 186

Query: 312 Y---GYIAPELAYTMVMTEKC----DVYSFGVVTLEVL 342
                +++PE     +M  K     D++S+GVV  EV 
Sbjct: 187 LLPIRWMSPE----AIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 76/292 (26%), Positives = 116/292 (39%), Gaps = 53/292 (18%)

Query: 151 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G G +G V    Y  +  N G+  A+K L          I   + E ++L  + H +IV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 69

Query: 206 KLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKR--VNIVKAMAHALAYL 261
           K  G C       + LI E++  GSL   L  +   + L    +  V I K M     YL
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD----YL 125

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL---LAGTYGYIAPE 318
               S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+   L     + APE
Sbjct: 126 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM--------------- 363
                      DV+SFGV   E         LL+   S S P  +               
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYE---------LLTYCDSESSPMTLFLKMIGPTHGQMTVT 233

Query: 364 -LIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            L+ VL++  RLP P +       L+       C +  P  R T Q + +GF
Sbjct: 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRK-----CWEFQPSKRTTFQNLIEGF 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 18/198 (9%)

Query: 151 IGTGGYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G +G+V K       + K  A+K L  ++  + A       EA V+ Q+ +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            G C  +  M L+ E  E G L   L  +    E +      +V  ++  + YL      
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMGMKYLEET--- 114

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYT 322
           + +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE    
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNY 172

Query: 323 MVMTEKCDVYSFGVVTLE 340
              + K DV+SFGV+  E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 21/230 (9%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V  A+   +G  +A+K L      + +E   I + RN   +L  + H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVG 60

Query: 207 L-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           L Y F   +K ++ + +Y+  G LF   H   E   L+   R    + +A A+ YLH   
Sbjct: 61  LHYSFQTAEK-LYFVLDYVNGGELF--FHLQRERCFLEPRARFYAAE-VASAIGYLH--- 113

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S +II+RD+   NILL+S+    + DFG  +         +   GT  Y+APE+      
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 326 TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
               D +  G V  E+L G  P         S D   M  ++L + L  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP-------FYSRDVSQMYDNILHKPLQLP 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-IVKLY 208
           +G G +G V  A+L   G+ FA+K L          ++    E +VL+       +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA------LAYLH 262
                K+ +F + E++  G L  + H  D+        R ++ +A  +A      L +LH
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL--MFHIQDKG-------RFDLYRATFYAAEIVCGLQFLH 113

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
              S  II+RD+  +N++L+      +ADFG  +      +  +   GT  YIAPE+   
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
           +  T   D +SFGV+  E+L+G+ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 47/278 (16%)

Query: 151 IGTGGYGSVYKAQLPN-----GKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +G G +GSV + QL        KV A+K  KL      E   I+ F +EA  +    H +
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPN 62

Query: 204 IVKLYGFCLHKKCM------FLIYEYMERGSLFCIL---HNDDEAVELDWAKRVNIVKAM 254
           ++KL G C     +       +I  +M+ G L   L          +L     +  +  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY-- 312
           A  + YL    + + IHRD+++ N +L   +   VADFG ++++++    R         
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD-- 369
            +IA E     V T K DV++FGV   E+   G+ P            P +   ++ D  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-----------PGVENHEIYDYL 228

Query: 370 ---QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
               RL  P D     D L     S  C +++PK RPT
Sbjct: 229 RHGNRLKQPED---CLDELYDLMYS--CWRADPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-Y 208
           +G GG+G V   Q+ N GK++A KKL     ++ +  K    E ++L +V    IV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 209 GFCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            F   K  + L+   M  G L + I +  +  +E++  + ++    +   + +LH   S 
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME--RVIHYSAQITCGILHLH---SM 114

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            I++RD+   N+LL+ +    ++D G A  L  D    T  AGT GY+APE+      + 
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D ++ G    E++ G+ P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 32/223 (14%)

Query: 151 IGTGGYGSVYKAQL-------PN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-L 200
           +G G +G V  A+        PN   KV A+K L +  TE+   +    +E +++  +  
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKV-AVKMLKSDATEK--DLSDLISEMEMMKMIGK 82

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDEAVELDWAKR 247
           H++I+ L G C     +++I EY  +G+L             +C         +L +   
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
           V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +  
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 308 LAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
             G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 42/277 (15%)

Query: 151 IGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G   +G +YK  L      + ++ A+K L      +      F+ EA +++++ H +IV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ--QWGEFQQEASLMAELHHPNIV 70

Query: 206 KLYGFCLHKKCMFLIYEYMERGSL--FCIL---HND-------DEAVE--LDWAKRVNIV 251
            L G    ++ + +++EY+ +G L  F I+   H+D       D  V+  LD    ++I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TL 307
             +A  + YL    S   +H+D+++ NIL+  +L   ++D G +R +++    R    +L
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLID 366
           L     ++ PE       +   D++SFGVV  E+   G  P          S+ +++ + 
Sbjct: 188 LP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP------YYGFSNQEVIEMV 239

Query: 367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRP 403
              Q LP   D       L+       C Q  P  RP
Sbjct: 240 RKRQLLPCSEDCPPRMYSLMTE-----CWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 34/224 (15%)

Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 80

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCILHNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L               + I    DE  ++ +  
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE--QMTFKD 138

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     + 
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 307 LLAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 29/216 (13%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            +++   +G G +G     Q  N  + +A+K++   ++   + ++  R EA +L+++ H 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHP 58

Query: 203 SIVKLYGFCLHKKCMFLIYEY-----------MERGSLFCILHNDDEAVELDWAKRVNIV 251
           +IV           ++++ EY           ++RG LF       E   L W  +    
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF------PEDTILQWFVQ---- 108

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             M   + ++H      ++HRDI S NI L    +  + DFG+AR L +  +      GT
Sbjct: 109 --MCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163

Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             Y+ PE+   M    K D++S G +  E+   KHP
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 46/228 (20%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN-------------EAQVL 196
           +G G YG V KA     GK+ A+KK+   E      +   R              E +++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS--NDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           +++ H +I+ L    +    + L+ + M    L  ++   D  + L  ++   I+  + +
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILN 130

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG--- 313
            L  LH       +HRD+S  NI +NSK    +ADFG ARR      + TL         
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 314 -----------YIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
                      Y APEL      Y        D++S G +  E+L GK
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 41/284 (14%)

Query: 151 IGTGGYGSVYKA-QLPNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G+G +G+VYK   +P+G+      A+K L  + + +    K   +EA V++ V    + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVC 72

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIVKAMAHALAYL 261
           +L G CL      L+ + M  G L   +  + + +     L+W   V I K M+    YL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGMS----YL 125

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPEL 319
                  ++HRD+++ N+L+ S     + DFG AR L  D +      G     ++A E 
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 320 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLP-PP 375
                 T + DV+S+GV   E++  G  P D          P   + D+L+  +RLP PP
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD--------GIPAREIPDLLEKGERLPQPP 234

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
           +    +  I++       C   + + RP  + +   F    + P
Sbjct: 235 ICTIDVYMIMV------KCWMIDSECRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)

Query: 151 IGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YG+V        G   A+KKL+     EL F K    E ++L  + H +++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHENVIGLLD 81

Query: 210 FCLHKKCM------FLIYEYM--ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                  +      +L+  +M  + G L       ++ ++        +V  M   L Y+
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   +  IIHRD+   N+ +N   E  + DFG AR    DS   T    T  Y APE+  
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSE-MTGYVVTRWYRAPEVIL 188

Query: 322 T-MVMTEKCDVYSFGVVTLEVLMGK 345
             M  T+  D++S G +  E+L GK
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKV--FALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           EDF+    +GTG +G V  A   N      A+K+   S+  +   +    +E ++L+ + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDE---AVELDWAKRVNIVKAMAHA 257
           H   V LYG    +  ++L+ E++  G  F  L  +      V   +A ++ ++      
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI------ 143

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
             YL    S +I++RD+   N+LL+      + DFG A+ +  D+   TL  GT  YIAP
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTL-CGTPEYIAP 197

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+   +   +  D ++ G+   E+L+G  P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 8/199 (4%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+G V   Q+   GK++A K+L     ++        NE Q+L +V  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 210 FCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
               K  + L+   M  G L F I +  +   E +       +   A  L  L      +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE-----RALFYAAEILCGLEDLHREN 122

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
            ++RD+   NILL+      ++D G A ++    S R  + GT GY+APE+      T  
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D +  G +  E++ G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 36/229 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           ED   +  IG G +G V +A +       N  +  LK+   SE +     + F  E +VL
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDH----RDFAGELEVL 56

Query: 197 SQV-LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWA---------- 245
            ++  H +I+ L G C ++  +++  EY   G+L   L      +E D A          
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTAST 115

Query: 246 -KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
                +++  +     + +      IHRD+++ N+L+   L + +ADFG +R        
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GE 169

Query: 305 RTLLAGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              +  T G     ++A E     V T K DV+SFGV+  E++ +G  P
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 50/222 (22%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKL-HTSETE--------ELAFIKSFRNEAQVLSQVL 200
           IG+G YG V  A     G+  A+KK+ +  +          E+  ++  R          
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR---------- 57

Query: 201 HRSIVKLYGFCLHKKCM-----FLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIV 251
           H +I+ L               +++ E ME   L  ++ +     D+ ++         +
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQY-------FL 109

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG- 310
             +   L YLH   S ++IHRD+  +NIL+NS  +  + DFG AR +  D   +  L   
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 311 --TYGYIAPELAYTMVMTEKC----DVYSFGVVTLEVLMGKH 346
             T  Y APEL   ++ + +     D++S G +  E+L  K 
Sbjct: 167 VVTRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 38/273 (13%)

Query: 151 IGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLH 201
           +G G +G VY+          P  +V A+K ++ + +  E + F+    NEA V+ +   
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----NEASVMKEFNC 68

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------WAKRVNIVKAM 254
             +V+L G     +   +I E M RG L   L +    +E +         K + +   +
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG- 313
           A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R    G    
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 314 -YIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 371
            +++PE     V T   DV+SFGVV  E+  + + P   +S+       + +L  V++  
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFVMEGG 238

Query: 372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           L    D     D+L    +   C Q NPK RP+
Sbjct: 239 LLDKPDN--CPDMLF--ELMRMCWQYNPKMRPS 267

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 151 IGTGGYGSVY----KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G+VY    K  +   ++  LK++   E      +++   EAQ+LS++ H +IVK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV----NIVKAMAHALAYLH 262
            +   L +    +I EY E   L      D +  EL    +      + +     L  +H
Sbjct: 67  FHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
           +     I+HRD+ + NI L + L   + DFG +R L       T   GT  Y++PE    
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 323 MVMTEKCDVYSFGVVTLEVLMGKH 346
                K D++S G +  E+    H
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAH 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 65/262 (24%), Positives = 111/262 (42%), Gaps = 27/262 (10%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   H  +V L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 267
                +  +F + EY+  G L   +    +  E    +      A ++ AL YLH     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALNYLHER--- 115

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAPE+        
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 328 KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-------RLPPPVDQKV 380
             D ++ GV+  E++ G+ P D+   + SS +P     D L Q       R+P  +  K 
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI---VGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK- 231

Query: 381 IQDILLASTISFACLQSNPKSR 402
                 A+++  + L  +PK R
Sbjct: 232 ------AASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 20/218 (9%)

Query: 158 SVYKAQLPNGKVFALKKLHTSETEELAFIKSFR-----NEAQVLSQVLHRSIVKLYG-FC 211
           S+ +   P  + FA   +  ++T E   IK+ +      EA +L  + H SI++L G F 
Sbjct: 95  SILETFTPGAEGFAFACID-NKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFT 153

Query: 212 LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 271
            +K    ++  Y  +  L+C L         D    + I +++  A+ YLH +    IIH
Sbjct: 154 YNKFTCLILPRY--KTDLYCYLAAKRNIAICDI---LAIERSVLRAIQYLHEN---RIIH 205

Query: 272 RDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMVMTEKCD 330
           RDI + NI +N   +  + DFG A      ++N+    AGT    APEL          D
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVD 265

Query: 331 VYSFGVVTLEVLMGKHP---RDLLSSLSSSSDPKIMLI 365
           ++S G+V  E+         +D L      SD +I LI
Sbjct: 266 IWSAGIVLFEMATCHDSLFEKDGLDG-DCDSDRQIKLI 302

Length = 391

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 10/148 (6%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H++IV+LY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 210 FCLHKKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                K + L++EY ++    +     D    ++D     + +  +   LA+ H   S +
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYF----DSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTAR 296
           ++HRD+   N+L+N   E  +ADFG AR
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 38/229 (16%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQV- 199
           D   +  IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65

Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCILHNDDEAVELDW 244
            H +I+ L G C H+  ++L  EY   G+L               F I ++   A  L  
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS--TASTLSS 123

Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
            + ++    +A  + YL        IHRD+++ NIL+     A +ADFG +R        
Sbjct: 124 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQ 174

Query: 305 RTLLAGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              +  T G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           +G G +G V  A+L    + FA+K L      E   ++    E +VL+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                K+ +F + EY+  G L   + +   +   D A+       +   L +LH      
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH---KKG 116

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           II+RD+  +N+LL+      +ADFG  +         +   GT  YIAPE+       E 
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D +SFGV+  E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 25/275 (9%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F I+  IG G +  VY+A  L + K  ALKK+   E  +    +    E  +L Q+ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-----WAKRVNIVKAMAHA 257
           +++K     +    + ++ E  + G L  ++    +   L      W   V +  A+ H 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH- 121

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
              +H   S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++P
Sbjct: 122 ---MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--RDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
           E  +      K D++S G +  E+   + P   D ++  S        L   ++Q   PP
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--------LCQKIEQCDYPP 227

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           +  +   + L    +   C+  +P  RP + YV Q
Sbjct: 228 LPTEHYSEKL--RELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 35/161 (21%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG VYKA+    G++ ALKK+     +E     + R E  +L ++ H +IV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN----------IVKA----MA 255
               +  ++L++E+                ++LD  K ++          ++K+    + 
Sbjct: 66  VVHSENKLYLVFEF----------------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
             +AY H   S  ++HRD+   N+L++ +    +ADFG AR
Sbjct: 110 QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHT-------SETEELAFIKSFRNEAQVLSQVLHRS 203
           +G+G +G V K       V+ ++K              E +       EA+++ Q+ +  
Sbjct: 3   LGSGNFGCVKKG------VYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM---AHALAY 260
           IV++ G C  +  M L+ E    G L   L    + + +      N+V+ M   +  + Y
Sbjct: 57  IVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKY 110

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YI 315
           L      + +HRD+++ N+LL ++  A ++DFG ++ L AD S     A + G     + 
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWY 165

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           APE       + + DV+S+G+   E    G+ P
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 42/271 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLSQVLH-RSIVKL 207
           +G G YG V K + +P G + A+K++  +  ++E    K    +  +  + +     V  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDLDISMRSVDCPYTVTF 65

Query: 208 YGFCLHKKCMFLIYEYMERG--SLFCILHNDDEAVELDWAKR--VNIVKAMAHALAYLHH 263
           YG    +  +++  E M+      +  +++    +  D   +  V+IVKA    L YLH 
Sbjct: 66  YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA----LEYLHS 121

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL---- 319
             S  +IHRD+  +N+L+N   +  + DFG +  L  DS  +T+ AG   Y+APE     
Sbjct: 122 KLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPE 178

Query: 320 ----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
                Y +    K DV+S G+  +E+  G+ P D      S   P   L  V+++  P P
Sbjct: 179 LNQKGYDV----KSDVWSLGITMIELATGRFPYD------SWKTPFQQLKQVVEE--PSP 226

Query: 376 VDQKVIQDILLASTISFA--CLQSNPKSRPT 404
              ++  +        F   CL+ N K RP 
Sbjct: 227 ---QLPAEKFSPEFQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 25/175 (14%)

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---HNDDEAVE---- 241
           F  E ++LS++   +I++L G C+ +  + +I EYME G L   L   H DD+       
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 242 ---------LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF 292
                    + ++  +++   +A  + YL    S + +HRD+++ N L+   L   +ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 293 GTARRLHADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 343
           G +R L+A        R +L     ++A E       T   DV++FGV   E+LM
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 40/223 (17%)

Query: 151 IGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-S 203
           IG G +G V KA++       +  +  +K+ + S+ +     + F  E +VL ++ H  +
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDH----RDFAGELEVLCKLGHHPN 57

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHND-------------DEAVELDWAKRVNI 250
           I+ L G C H+  ++L  EY   G+L   L                  A  L   + ++ 
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
              +A  + YL        IHRD+++ NIL+     A +ADFG +R           +  
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKK 168

Query: 311 TYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           T G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 10/196 (5%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +VYK +   NGK+ ALK +   E E   F      EA +L  + H +IV L+ 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               K+ + L++EY+    L   +      +  +  K    +  +   L+Y+H      I
Sbjct: 71  IIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--FLFQLLRGLSYIHQR---YI 124

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           +HRD+   N+L++   E  +ADFG AR     S   +    T  Y  P++         C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184

Query: 330 -DVYSFGVVTLEVLMG 344
            D++  G + +E++ G
Sbjct: 185 LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 6/198 (3%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+G V   Q+   GK++A KKL     ++        NE ++L +V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               K  + L+   M  G L   ++N       D  + +     +   L  L  +    I
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRE---RI 123

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           ++RD+   NILL+ +    ++D G A ++    + R  + GT GY+APE+      T   
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFSP 182

Query: 330 DVYSFGVVTLEVLMGKHP 347
           D +  G +  E++ G+ P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 49/152 (32%), Positives = 69/152 (45%), Gaps = 33/152 (21%)

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD------SSNRTLLAGTYGYIAPEL 319
           S   IHRD+++ NILL+      + DFG AR ++ D       S R  L     ++APE 
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK----WMAPES 247

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL------- 372
            +  V T + DV+SFGV+  E+           SL +S  P + + +   QRL       
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
            P      I  I+L      AC Q +PK RPT
Sbjct: 298 APENATPEIYRIML------ACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 15/268 (5%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F I+  IG G +  VY+A  L +G   ALKK+   +  +         E  +L Q+ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +++K Y   +    + ++ E  + G L  ++ +  +   L   K V   K      + L 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSALE 120

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
           H  S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++PE  + 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP--RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
                K D++S G +  E+   + P   D ++  S        L   ++Q   PP+    
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------LCKKIEQCDYPPLPSDH 232

Query: 381 IQDILLASTISFACLQSNPKSRPTMQYV 408
             + L    +   C+  +P+ RP + YV
Sbjct: 233 YSEEL--RQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G G +G VY       G+  A+K++       E    + +   E Q+L  + H  IV+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 208 YGFCLH---KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           YG CL    +K + +  EYM  GS+   L       E +  +R    + +   ++YLH  
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVSYLH-- 123

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT---LLAGTYGYIAPELAY 321
            S  I+HRDI   NIL +S     + DFG ++R+     + T    + GT  +++PE+  
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
                 K DV+S     +E+L  K P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 10/200 (5%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           +G G +G V  A+L  +G+++A+K L      +   ++    E ++LS    H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 209 GFCLHK-KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
             C      +F + E++  G L   + +  ++   D A+       +  AL +LH     
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH---DK 115

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            II+RD+  +N+LL+ +    +ADFG  +    +    +   GT  YIAPE+   M+   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D ++ GV+  E+L G  P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRSI 204
           +G GG+G V   Q+   GK++A KKL        + E +A      NE Q+L +V  R +
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSRFV 62

Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHND-----DEAVELDWAKRVNIVKAMAHALA 259
           V L      K  + L+   M  G L   ++N      DE   + +A  +         L 
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLE 116

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
            LH      I++RD+   NILL+      ++D G A  +    + R  + GT GY+APE+
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEV 172

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                 T   D +  G +  E++ GK P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 29/192 (15%)

Query: 171 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY--GFCLHKKCMFLIYEYMERGS 228
           A+K L T   EE      FR E  + +++ H +IV L   G       +F ++EY+   +
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRT 65

Query: 229 LFCILHND-----DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS 283
           L  +L  D      E   L     + ++ A+A A     H+    I+HRD+   NI+++ 
Sbjct: 66  LREVLAADGALPAGETGRL----MLQVLDALACA-----HN--QGIVHRDLKPQNIMVSQ 114

Query: 284 ---KLEAFVADFGTARRL----HADSSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYS 333
              +  A V DFG    L     AD +  T    + GT  Y APE      +T   D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 334 FGVVTLEVLMGK 345
           +G++ LE L G+
Sbjct: 175 WGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 27/167 (16%)

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSL-----------------FCILHNDDEAVELD 243
           H++I+ L G C     ++++ EY  +G+L                  C L  +    +L 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE----QLT 132

Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
           +   V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H    
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 304 NRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            +    G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 9/203 (4%)

Query: 145 FHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           F +   +G G YG V K +    K + A+KK   SE  E     + R E ++L  +   +
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IV+L      +  ++L++EY+E+ ++  +L      V  +  +  + +  +  A+ + H 
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR--SYIYQLIKAIHWCHK 118

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL-HADSSNRTLLAGTYGYIAPELAYT 322
           +    I+HRDI   N+L++      + DFG AR L    ++N T    T  Y +PEL   
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175

Query: 323 MVMTEKCDVYSFGVVTLEVLMGK 345
               +  D++S G +  E+  G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 29/211 (13%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSE---TEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G VY+ +  +  +++A+K L   E    +E+A     RN       +L R+++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERN-------ILVRTLLD 53

Query: 207 LYGFCLHKKCMF-------LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHAL 258
              F +  K  F       L+ +YM  G LF  L  +    E     R     A +  AL
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLAL 109

Query: 259 AYLH-HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
            +LH +D    I++RD+   NILL++     + DFG ++    D+       GT  Y+AP
Sbjct: 110 EHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165

Query: 318 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E L      T+  D +S GV+  E+  G  P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 15/203 (7%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRSIVK 206
           +G G +G V  A+    G+++A+K L   +      ++S   E ++    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHND--DEAVELDWAKRVNIVKAMAHALAYLHHD 264
           L+     +  +  + EY   G L   +H D   E   + +A  V +       L YLH +
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL------GLQYLHEN 120

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               I++RD+  +N+LL+++    +ADFG  +         +   GT  ++APE+     
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177

Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            T   D +  GV+  E+L+G+ P
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 14/176 (7%)

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDD------EAVEL 242
           F  E +++S++ + +I++L G C+    + +I EYME G L   L   +       A  +
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 243 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS 302
                 N++       + + +  S + +HRD+++ N L+ +     +ADFG +R L++  
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 303 ----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV--LMGKHPRDLLS 352
                 R +L     ++A E       T   DV++FGV   E+  L  + P  LLS
Sbjct: 184 YYRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 7/198 (3%)

Query: 151 IGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V + +  +  +++ALK +  +     + +     E  VL+QV    IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                + ++L+  ++  G LF   H+       D ++       +  AL  LH     ++
Sbjct: 61  SFQSPEKLYLVLAFINGGELF---HHLQREGRFDLSRARFYTAELLCALENLH---KFNV 114

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           I+RD+   NILL+ +    + DFG  +    D        GT  Y+APEL      T+  
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174

Query: 330 DVYSFGVVTLEVLMGKHP 347
           D ++ GV+  E+L G  P
Sbjct: 175 DWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 39/279 (13%)

Query: 151 IGTGGYGSVYKAQLPNGKVFA---LKKLHTSET--EELAFIKSFRNEAQVLSQVLHRSIV 205
           IG G +G V   +   G   A   +K+L  S T  E+L F++    E Q   ++ H +++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ----EVQPYRELNHPNVL 58

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH----ALAYL 261
           +  G C+      L+ E+   G L   L ++   V     K V  ++ MA      L +L
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT--LLAGTYGYIAPEL 319
           H       IH D++  N  L + L   + D+G A   + +    T    A    ++APEL
Sbjct: 117 HQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173

Query: 320 A-------YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQ- 370
                        T+K +++S GV   E+      P          SD +++   V +Q 
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP------YPDLSDEQVLKQVVREQD 227

Query: 371 -RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            +LP P       D      + F  L   P++RPT + V
Sbjct: 228 IKLPKPQLDLKYSDRWY-EVMQFCWLD--PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 63/269 (23%), Positives = 109/269 (40%), Gaps = 24/269 (8%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G Y  V   +L  N +++A+K +      +   I   + E  V  Q      +    
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 210 FCLHKKC-MFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
            C      +FL+ EY+  G L   +    +  E     +A  + I      AL +LH   
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER- 115

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
              II+RD+  +N+LL++     + D+G  +         +   GT  YIAPE+      
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 326 TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQD 383
               D ++ GV+  E++ G+ P D+++     +    +   +L++  R+P  +  K    
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK---- 229

Query: 384 ILLASTISFACLQSNPKSRPTMQYVSQGF 412
              AS +    L  +PK R   Q    GF
Sbjct: 230 ---ASHVLKGFLNKDPKERLGCQ-PQTGF 254

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +V+K +      + ALK++   E EE A   + R E  +L  + H +IV L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 210 FCLHKKCMFLIYEYMER---------GSLFCILHNDDEAVELDWAKRVNIVK-AMAHALA 259
               ++C+ L++EY++          G+L   +HN            V I    +   L+
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHN------------VKIFMFQLLRGLS 117

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           Y H      I+HRD+   N+L+N K E  +ADFG AR     +   +    T  Y  P+ 
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
           L  +   +   D++  G +  E+  G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 39/241 (16%)

Query: 151 IGTGGYGSVYKA-QLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +G+V+K   +P G   K+    K     +    F +   +    +  + H  IV+
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF-QEITDHMLAMGSLDHAYIVR 73

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIVKAMAHALAYLH 262
           L G C     + L+ +    GSL   +    ++++    L+W   V I K M     YL 
Sbjct: 74  LLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGMY----YLE 126

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD------SSNRTLLAGTYGYIA 316
                 ++HR++++ NILL S     +ADFG A  L+ D      S ++T +     ++A
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMA 179

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLM-------GKHPR---DLLSSLSSSSDPKIMLID 366
            E       T + DV+S+GV   E++        G  P    DLL      + P+I  ID
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239

Query: 367 V 367
           V
Sbjct: 240 V 240

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 141 ATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           AT   +++  +G G Y +VYK     NG++ ALK +   +TEE     + R EA +L  +
Sbjct: 4   ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIR-EASLLKGL 60

Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAM---A 255
            H +IV L+     K+ +  ++EYM    + + I H              N+   M    
Sbjct: 61  KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-------LHPYNVRLFMFQLL 113

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             LAY+H      I+HRD+   N+L++   E  +ADFG AR     S   +    T  Y 
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170

Query: 316 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            P+ L      +   D++  G + +E+L G+
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 9/199 (4%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-Y 208
           +G G +G V    +  +GK +A+K L          +     E++VL    H  +  L Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F    +  F++ EY+  G LF   H   E V  +   R    + ++ AL YLH   S  
Sbjct: 63  SFQTKDRLCFVM-EYVNGGELF--FHLSRERVFSEDRTRFYGAEIVS-ALDYLH---SGK 115

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           I++RD+   N++L+      + DFG  +    D++      GT  Y+APE+         
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D +  GVV  E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 55/234 (23%), Positives = 87/234 (37%), Gaps = 34/234 (14%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            F     +G G  G V+  +L   GK+FALK L   E  +   +K    E ++L+ + H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +  LY     +  + L+ +Y   G LF +L         +   R    + +  AL YLH
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLH 120

Query: 263 HDCSPSIIHRDISSNNILLN-------------------SKLEAFVADFGTARRLHADSS 303
                 I++RD+   NILL+                       +     G+ R       
Sbjct: 121 ---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 304 NRTLLA----------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           + T             GT  YIAPE+          D ++ G++  E+L G  P
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 23/154 (14%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +VYK +    G++ ALK++   E EE A   + R EA +L  + H +IV L+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV---NIVK----AMAHALAYLH 262
               KK + L++EY++           D    +D        + V+     +   LAY H
Sbjct: 71  IIHTKKTLTLVFEYLDT----------DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
                 ++HRD+   N+L++ + E  +ADFG AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 56/244 (22%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G V    ++    ++A+K L  ++     + A +K+ R+   +L++  +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERD---ILAEADNEWVVK 65

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           LY     K  ++ + +Y+  G +  +L       E D A R  I + +  A+  +H    
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLA-RFYIAE-LTCAIESVH---K 119

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFG--------------------------------- 293
              IHRDI  +NIL++      + DFG                                 
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 294 -------TARRLHADSSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 343
                     R       R L   L GT  YIAPE+      T+ CD +S GV+  E+L+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239

Query: 344 GKHP 347
           G+ P
Sbjct: 240 GQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 25/171 (14%)

Query: 187 KSFRNEAQVLSQVLHRSIVKLYGFCLHKK--CMFL------IYEYMERGSLFCILHNDDE 238
           K+   E  +L  + HR+I+ L      K   CM +      ++ Y++R            
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG---------- 180

Query: 239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL 298
              L   + + I + +  ALAYLH      IIHRD+ + NI L+    A + DFG A +L
Sbjct: 181 --PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235

Query: 299 --HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             H D+      +GT    +PEL        K D++S G+V  E+ +    
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 22/208 (10%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEA--QVLSQVLHRSIVKL 207
           IG G YG VYKA+    GK+ ALKK      EE     + R  +  Q+LS+ ++  IV+L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY--IVRL 66

Query: 208 YGFCLH-------KKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
               +        K  ++L++EY++     F   +       L      + +  +   +A
Sbjct: 67  --LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           + H      ++HRD+   N+L++ +     +AD G  R       + T    T  Y APE
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 319 --LAYTMVMTEKCDVYSFGVVTLEVLMG 344
             L  T   T   D++S G +  E+   
Sbjct: 182 VLLGSTHYST-PVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 30/208 (14%)

Query: 151 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G +G VY   L          A+K L  +   +L  ++ F  E  ++    H +++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 207 LYGFCLHKKCMFLI-YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM-------AHAL 258
           L G CL  +   L+   YM+ G L   + ++              VK +       A  +
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGM 111

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR----RLHADSSNRTLLAGTYGY 314
            YL    S   +HRD+++ N +L+      VADFG AR    + +    N T       +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           +A E   T   T K DV+SFGV+  E++
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 21/162 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F I   I  G +G VY  +   N K++A+K +  ++      +   + E   L+  L 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA--LS 61

Query: 202 RS--IVKLYGFCLHKKCMFLIYEYMERGSLFCILH-----NDDEAVELDWAKRVNIVKAM 254
           +S  IV LY        ++L+ EY+  G +  +LH     +++ AV+         +  +
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEV 113

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
           A AL YLH      IIHRD+  +N+L++++    + DFG ++
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G V    +   G+ +A+K L        +E+A   +   E++VL    H  +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTRHPFLTA 59

Query: 207 L-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHD 264
           L Y F  H +  F++ EY   G LF   H   E V  +  +R     A +  AL YLH  
Sbjct: 60  LKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTE--ERARFYGAEIVSALEYLH-- 112

Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
            S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+     
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
                D +  GVV  E++ G+ P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 37/208 (17%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS----QVL----- 200
           IG G +  V KAQ    GK +A+K +           K F++  QV +    Q L     
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----------KKHFKSLEQVNNLREIQALRRLSP 56

Query: 201 HRSIVKLYGFCLHKK--CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           H +I++L      +K   + L++E M+  +L+ ++        L   +  + +  +  +L
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRP--LPEKRVKSYMYQLLKSL 113

Query: 259 AYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
            ++H +    I HRDI   NIL+     KL    ADFG+ R ++      T    T  Y 
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKDDILKL----ADFGSCRGIY-SKPPYTEYISTRWYR 165

Query: 316 APELAYTM-VMTEKCDVYSFGVVTLEVL 342
           APE   T      K D+++ G V  E+L
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 8/208 (3%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF+    +G G +G V  A+     +++A+K L      +   ++    E +VL+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 203 SIVKLYGFCLHK-KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +     C      ++ + EY+  G L   +++  +  +    + V     ++  L +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H      II+RD+  +N++L+S+    +ADFG  +    D        GT  YIAPE+  
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                +  D +++GV+  E+L G+ P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 22/153 (14%)

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFC----ILHNDDEAVELDWAKRVNIVKAMAHALA 259
           +V L+ + + +  +FL+ ++ E G L+      L+  +E V+  WA        M  AL 
Sbjct: 47  MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAE------MVVALD 99

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
            LH +    I+ RD++ NNILL+ +    +  F     +  DS +   +   Y   APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-EDSCDGEAVENMY--CAPEV 153

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGK-----HP 347
                 TE CD +S G +  E+L GK     HP
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 14/202 (6%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRSIVKLY 208
           +G G +G V  A+L    +V+A+K L      +   +     E ++L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYLHHDC 265
                K  +F + EY+  G L   +      DE     +A  V +      AL +LH   
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL------ALMFLHRH- 115

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
              +I+RD+  +NILL+++    +ADFG  +    +    T   GT  YIAPE+   +  
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
               D ++ GV+  E++ G+ P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 40/278 (14%)

Query: 151 IGTGGYGSVYKAQL-------PNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLH 201
           +G G +G VY+             +V A+K ++ S +  E + F+    NEA V+     
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFL----NEASVMKGFTC 68

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM------- 254
             +V+L G     +   ++ E M  G L   L +     E +  +    ++ M       
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY-- 312
           A  +AYL+   +   +HRD+++ N ++       + DFG  R ++     R    G    
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDLLSSLSSSSDPK-IMLIDVLDQ 370
            ++APE     V T   D++SFGVV  E+  + + P      LS+    K +M    LDQ
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVMDGGYLDQ 242

Query: 371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             P    ++V       + +   C Q NPK RPT   +
Sbjct: 243 --PDNCPERV-------TDLMRMCWQFNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.5 bits (137), Expect = 8e-09
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 30/208 (14%)

Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTS-ETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G YG V  A         A+KKL    ++   A  +++R E ++L  + H +++ L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA-KRTYR-ELRLLKHMDHENVIGLL 80

Query: 209 G-FCLHKKCM-----FLIYEYMERGSLFCILH----NDDEAVELDWAKRVNIVKAMAHAL 258
             F            +L+   M    L  I+     +DD    L        V  +   L
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFL--------VYQILRGL 131

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            Y+H   S  IIHRD+  +NI +N   E  + DFG AR  H D    T    T  Y APE
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTD-DEMTGYVATRWYRAPE 185

Query: 319 LAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           +    M   +  D++S G +  E+L GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 18/177 (10%)

Query: 172 LKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF 230
           LK L  S  +  LAF ++    A ++ QV H+ IV LYG C+      ++ E++E G L 
Sbjct: 37  LKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 231 CILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA 290
             +H   + +   W  +  + K +A AL+YL       ++H ++ + NILL    E    
Sbjct: 93  LFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAR--EGIDG 145

Query: 291 DFGTARRLHADSSNRTLLA-----GTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEV 341
           + G   +L       T+L+         +IAPE +  +  ++   D +SFG    E+
Sbjct: 146 ECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 14/128 (10%)

Query: 154 GGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH 213
           G YG ++K ++   KV  L K H + +E      SF   A ++SQ+ H+ +V  YG C+ 
Sbjct: 20  GDYGELHKTEVLL-KV--LDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGVCVC 70

Query: 214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 273
                ++ EY++ GSL   L  +   + + W  ++ + K +A AL +L       + H +
Sbjct: 71  GDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGN 125

Query: 274 ISSNNILL 281
           + + N+LL
Sbjct: 126 VCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 33/152 (21%)

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD------SSNRTLLAGTYGYIAPEL 319
           S   IHRD+++ NILL+      + DFG AR ++ D         R  L     ++APE 
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPES 246

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL------- 372
            +  V T + DV+SFGV+  E+           SL +S  P + + +   +RL       
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQIDEEFCRRLKEGTRMR 296

Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
            P      I  I+L       C  +NP+ RPT
Sbjct: 297 APEYATPEIYSIML------DCWHNNPEDRPT 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR-LHADSSNRTLLAGTY 312
           +A  L +LH   S  II+RD+  +N++L+++    +ADFG  +  +    + RT   GT 
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            YIAPE+       +  D ++FGV+  E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 34/212 (16%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKL------HTSETE---ELAFIKSFRNEAQVLS--Q 198
           IG G +G V+    P +GK  ALKK+        S      EL  +  F+++  VLS   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHD-NVLSALD 66

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN---DDEAVELDWAKRVNIVKAMA 255
           +L    +  +      + ++++ E M+       LH      + +  D  K    +  + 
Sbjct: 67  ILQPPHIDPF------EEIYVVTELMQ-----SDLHKIIVSPQPLSSDHVKV--FLYQIL 113

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS-NRTLLAGTYGY 314
             L YLH   S  I+HRDI   N+L+NS     + DFG AR    D S + T    T  Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 315 IAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            APE L  +   T   D++S G +  E+L  +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 10/200 (5%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-Y 208
           +G G +G V    +   G+ +A+K L          +     E +VL    H  +  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHDCSP 267
            F  H +  F++ EY   G LF  L  +    E     R     A +  AL YLH +   
Sbjct: 63  SFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE--K 115

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+        
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D +  GVV  E++ G+ P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 22/221 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     I  G YG+VY  +    +  FA+KK++         I+    E  +L+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +V ++     K+ + ++ EY+E G    +L N   A+ +D A R+   + +  AL YL
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMA-RMYFAETVL-ALEYL 117

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR--------RL---HADSSNRTLL-- 308
           H   +  I+HRD+  +N+L+ S     + DFG ++         L   H +   R  L  
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 309 --AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              GT  YIAPE+       +  D ++ G++  E L+G  P
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 48/206 (23%)

Query: 223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN 282
           Y+++     IL  D+ A  LD    ++    +A  +++L    S + IHRD+++ NILL 
Sbjct: 194 YIDQDVTSEILEEDELA--LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLT 248

Query: 283 SKLEAFVADFGTARRLHADSS-----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVV 337
                 + DFG AR +  DS+     N  L      ++APE  +  V T + DV+S+G++
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARL---PVKWMAPESIFNCVYTFESDVWSYGIL 305

Query: 338 TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ---KVIQDILLASTISFA- 393
             E+           SL SS  P +            PVD    K+I++     +   A 
Sbjct: 306 LWEIF----------SLGSSPYPGM------------PVDSKFYKMIKEGYRMLSPECAP 343

Query: 394 ---------CLQSNPKSRPTMQYVSQ 410
                    C  ++P  RPT + + Q
Sbjct: 344 SEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 36/205 (17%)

Query: 191 NEAQVLSQVLHRSIVKL--------YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVEL 242
           NE   L ++ H +I+K+          + + +K  F +Y +M   +       D +   L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265

Query: 243 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS 302
               R  I+K +  A+ Y+H      +IHRDI   NI LN   +  + DFGTA     + 
Sbjct: 266 LKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 303 SNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-------------GKHPR 348
                   GT    +PE+       E  D++S G++ L++L              GK   
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381

Query: 349 DLLSSLSSSS----DPKIMLIDVLD 369
            ++ SLS       DP   L D +D
Sbjct: 382 KIIDSLSVCDEEFPDPPCKLFDYID 406

Length = 501

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 14/151 (9%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG VYK +    G++ A+KK+   E+EE     +   E  +L ++ H +IV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL-ESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA----MAHALAYLHHDC 265
             + +  ++LI+E+     L   L    +++         +VK+    +   + + H   
Sbjct: 67  VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
           S  ++HRD+   N+L+++K    +ADFG AR
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 10/110 (9%)

Query: 172 LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFC 231
           LK L +   + LAF ++    A ++SQ+ H+ +VKLYG C+  + + ++ EY++ G L  
Sbjct: 35  LKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDV 89

Query: 232 ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 281
            LH +   V L W  ++++ K +A AL YL       ++H ++   NIL+
Sbjct: 90  FLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G  G V  A     G   A+KKL      +    +++R E  +L  V H++I+ L  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 210 FCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
               +K +      +L+ E M+  +L  ++H     +ELD  +   ++  M   + +LH 
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 140

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  IIHRD+  +NI++ S     + DFG AR    +      +   Y Y APE+   M
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGM 197

Query: 324 VMTEKCDVYSFGVVTLEVLMG 344
              E  D++S G +  E++ G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 8/208 (3%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF+    +G G +G V  A+     +++A+K L      +   ++    E +VL+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 203 SIVKLYGFCLHK-KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +     C      ++ + EY+  G L   ++   +         V     +A  L +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  II+RD+  +N++L+S+    +ADFG  +    D        GT  YIAPE+  
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                +  D ++FGV+  E+L G+ P +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 10/197 (5%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +VYK +      + ALK++   E EE A   + R E  +L  + H +IV L+ 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               +K + L++EY+++  L   L +   ++ +   K    +  +   L Y H      +
Sbjct: 72  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL--FLFQLLRGLNYCHRR---KV 125

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEK 328
           +HRD+   N+L+N + E  +ADFG AR     +   +    T  Y  P+ L  +   + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185

Query: 329 CDVYSFGVVTLEVLMGK 345
            D++  G +  E+  G+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 36/231 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             +     IG G YG V  A   P G   A+KK+   E +     ++ R E ++L +  H
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC-QRTLR-EIKILRRFKH 62

Query: 202 RSIVKLY------GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
            +I+ +        F      ++++ E ME       L+   +   L        +  + 
Sbjct: 63  ENIIGILDIIRPPSFESFND-VYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL 116

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR---RLHADSSNRTLLAGTY 312
             L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR     H  +   T    T 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 313 GYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLM------GKHPRDLLS 352
            Y APE+      YT  +    D++S G +  E+L       GK     L+
Sbjct: 174 WYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLSNRPLFPGKDYLHQLN 220

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 27/234 (11%)

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHN------DDEAV 240
           F  E +++S++   +I++L   C+    + +I EYME G L  F   H         + V
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            + ++  + +   +A  + YL    S + +HRD+++ N L+       +ADFG +R L++
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 301 DS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSSL 354
                   R +L     +++ E       T   DV++FGV   E+L    + P   LS  
Sbjct: 183 GDYYRIQGRAVLP--IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Query: 355 SSSSDPKIMLIDVLDQ-RLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
               +      D   Q  LP P +    +  ++L      +C + N K RP+ Q
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLML------SCWRRNAKERPSFQ 288

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +V+K +      + ALK++   E EE A   + R E  +L  + H +IV L+ 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI-VKAMAHALAYLHHDCSPS 268
                K + L++EY+++     +    D+   +     V I +  +   LAY H      
Sbjct: 72  IVHTDKSLTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTE 327
           ++HRD+   N+L+N + E  +ADFG AR     +   +    T  Y  P+ L  +   + 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 328 KCDVYSFGVVTLEVLMGK 345
           + D++  G +  E+  G+
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 45/148 (30%), Positives = 63/148 (42%), Gaps = 18/148 (12%)

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  ++HRD+  +NIL+N   +  + DFG AR         T    T  Y AP
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAP 174

Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 376
           E+  T      + D++S G +  E+L GK        L    D       + D    PP 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK-------PLFPGKDHVNQFSIITDLLGTPP- 226

Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
              VI  I   +T+ F  +QS PK  P 
Sbjct: 227 -DDVINTICSENTLRF--VQSLPKREPV 251

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 27/208 (12%)

Query: 151 IGTGGYGSVY----KAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRS 203
           +G G +G V     KA    GK +A+K L        +E+A   +   E++VL    H  
Sbjct: 3   LGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLQNTRHPF 56

Query: 204 IVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR---VNIVKAMAHALA 259
           +  L Y F  H +  F++ EY   G LF   H   E V  +   R     IV A    L 
Sbjct: 57  LTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVSA----LG 109

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YLH   S  +++RD+   N++L+      + DFG  +   +D +      GT  Y+APE+
Sbjct: 110 YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                     D +  GVV  E++ G+ P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 49/239 (20%)

Query: 188 SFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
           +F   A ++SQV H  +  ++G C+      ++ E++E G L   L  +   V + W  +
Sbjct: 62  AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
           + + + +A AL+YL      +++H ++ + NILL             AR   A+ ++  +
Sbjct: 120 ITVAQQLASALSYLE---DKNLVHGNVCAKNILL-------------ARLGLAEGTSPFI 163

Query: 308 LAGTYG----------------YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRD 349
                G                +IAPE +     ++   D +SFG   LE+   G+ P  
Sbjct: 164 KLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP-- 221

Query: 350 LLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
               L   +  +         RLP P  ++      LA+ IS  CL   P  RP+ + +
Sbjct: 222 ----LKERTPSEKERFYEKKHRLPEPSCKE------LATLIS-QCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 35/153 (22%)

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD------SSNRTLLAGTYGYIAPEL 319
           S   IHRD+++ NILL+      + DFG AR ++ D         R  L     ++APE 
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPET 252

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL------- 372
            +  V T + DV+SFGV+  E+           SL +S  P + + +   +RL       
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIF----------SLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
            P     ++ Q +L        C    P  RPT
Sbjct: 303 APDYTTPEMYQTML-------DCWHGEPSQRPT 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 42/178 (23%)

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS-----NRTLL 308
           +A  + +L    S + IHRD+++ N+LL     A + DFG AR +  DS+     N  L 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL 368
                ++APE  +  V T + DV+S+G++  E+           SL  S  P I+    +
Sbjct: 277 --PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----------SLGKSPYPGIL----V 320

Query: 369 DQRLPPPVDQKVIQDILLASTISFA----------CLQSNPKSRPTMQYVSQGFLITR 416
           + +       K+++     S   FA          C    P  RPT   +SQ  LI R
Sbjct: 321 NSKF-----YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ--LIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 54/245 (22%), Positives = 108/245 (44%), Gaps = 39/245 (15%)

Query: 135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVF------ALKKLHTSETEELAFIKS 188
           Y+D      ++ +   IG G +G V+  +    + F      + + L   E  +L     
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--- 61

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAV-ELDWA 245
              E  V+ ++ H++IV+     L+K  + ++++ E+ + G L   +    +   +++  
Sbjct: 62  ---EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 246 KRVNIVKAMAHALAYLHH----DCSPSIIHRDISSNNILLNSKLE--------------- 286
             V+I + + HALAY H+         ++HRD+   NI L++ +                
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 287 --AFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY--TMVMTEKCDVYSFGVVTLEVL 342
             A + DFG ++ +  +S   + + GT  Y +PEL    T    +K D+++ G +  E+ 
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 343 MGKHP 347
            GK P
Sbjct: 238 SGKTP 242

Length = 1021

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 31/264 (11%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           IG G Y  V   +L    +++A+K +      +   I   + E  V      H  +V L+
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                +  +F + E++  G L   +    +  E     ++  +++      AL +LH   
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLH--- 113

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
              II+RD+  +N+LL+++    + D+G  +         +   GT  YIAPE+      
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 326 TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-------RLPPPVDQ 378
               D ++ GV+  E++ G+ P D+   +  S +P     D L Q       R+P  +  
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI---VGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV 230

Query: 379 KVIQDILLASTISFACLQSNPKSR 402
           K       AS++    L  +PK R
Sbjct: 231 K-------ASSVLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 135

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 191

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 36/211 (17%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H +++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA--------------MA 255
                +         E   ++ + H       L  A   NIVK               + 
Sbjct: 84  VFTPAR------SLEEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 130

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y 
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYR 184

Query: 316 APELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           APE+    M   +  D++S G +  E+L G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 37/159 (23%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRL--- 57
           +++L  +++S N I G+IP  L  ++ L+ L+LS+N  +G +P S  QL+S+  + L   
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 58  ----------------------SPNKGLCGNFITLPSCDATKPATLFVEIFLPLAIVPSV 95
                                 + N GLCG    L +C         + I   +++    
Sbjct: 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACGPHLSVGAKIGIAFGVSVAFLF 559

Query: 96  IVFACLLVVKRKY-----------KKPKVKARATNSIDV 123
           +V   +   KR+            + P  KAR   S DV
Sbjct: 560 LVICAMCWWKRRQNILRAQRIAAREAPYAKARTHFSRDV 598

Length = 623

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 61/301 (20%), Positives = 112/301 (37%), Gaps = 69/301 (22%)

Query: 150 CIGTGGYGSVYKAQLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           C        + K + P   + A+KK  L +   E+L  ++    E     Q+ H +I+  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ---QEIITSRQLQHPNILPY 64

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCIL--HNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
               +    ++++   M  GS   +L  H  +   EL  A    I+K + +AL Y+H   
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA---FILKDVLNALDYIHSK- 120

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRL------------HADSSNRTLLAGTYG 313
               IHR + +++ILL+   +  ++    +  +               SS + L      
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL-----P 173

Query: 314 YIAPELAYTMVM--TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR 371
           +++PE+    +    EK D+YS G+   E+  G  P               ML++ +   
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP-------FKDMPATQMLLEKVRGT 226

Query: 372 LPPPVDQKVI---QDILLASTISFA--------------------------CLQSNPKSR 402
           +P  +D+      +D +  S  S                            CLQ +P+SR
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286

Query: 403 P 403
           P
Sbjct: 287 P 287

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 57/248 (22%), Positives = 98/248 (39%), Gaps = 60/248 (24%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G V  A ++    ++A+K L   +      +   + E  +L++  +  +VKLY 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDD---EAVELDWAKRVNIVKAMAHALAYLHHDCS 266
               K  ++ + +Y+  G +  +L   +   E +   +   + +     H + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFG--TARR-----------------------LHAD 301
              IHRDI  +NIL++      + DFG  T  R                       L  D
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 302 SSN-------RTL---------------LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 339
            SN       +TL               L GT  YIAPE+      T+ CD +S GV+  
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 340 EVLMGKHP 347
           E+L+G+ P
Sbjct: 240 EMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 36/234 (15%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRS- 203
           IG GG+G VY  +  + GK++A+K     ++   + E LA      NE  +LS V     
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-----NERIMLSLVSTGDC 56

Query: 204 --IVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
             IV + Y F    K  F I + M  G L   L       E +      +    A  +  
Sbjct: 57  PFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAE------MRFYAAEIILG 109

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA-----RRLHADSSNRTLLAGTYGYI 315
           L H  +  +++RD+   NILL+      ++D G A     ++ HA         GT+GY+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VGTHGYM 162

Query: 316 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIMLIDV 367
           APE L   +      D +S G +  ++L G  P R   +      D   + + V
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 23/61 (37%), Positives = 38/61 (62%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           MK+L W+ +  N + G IP E+  L+ L++L+L +N L+GP+P S   L ++  + L  N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270

Query: 61  K 61
           K
Sbjct: 271 K 271

Length = 968

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 198

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++ G 
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 22/151 (14%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV---KL 207
           +  G    VY     +   + LK   + E            E  +L Q+L R  +   K+
Sbjct: 6   LKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-----REREVAIL-QLLARKGLPVPKV 58

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
                     +L+ E++E           +   E+   ++ +I + +A  LA LH     
Sbjct: 59  LASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 268 SIIHRDISSNNILL-NSKLEAFVADFGTARR 297
            + H D+   NIL+ + K+   + D+  A  
Sbjct: 109 VLCHGDLHPGNILVDDGKILGII-DWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)

Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G YGSV   Y  +L   KV A+KKL       +   +++R E ++L  + H +++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ-KV-AVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79

Query: 208 YGFCLHKKCMFLIYE-YMERGSLFCILHN-------DDEAVELDWAKRVNIVKAMAHALA 259
                    +    E Y+    +   L+N        DE V+        ++  +   L 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLK 132

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y+H   S  IIHRD+  +N+ +N   E  + DFG AR+  AD      +A T  Y APE+
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVA-TRWYRAPEI 186

Query: 320 AYT-MVMTEKCDVYSFGVVTLEVLMGK 345
               M   +  D++S G +  E+L GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 38/216 (17%)

Query: 150 CIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
            IG G YG V  A     N KV A+KK+  +    +   ++ R E ++L  + H +++ +
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKV-AIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 208 YGFCLHKKCM-----------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
                 K  M           +++YE M+   L  I+ +  + +  D  +    +  +  
Sbjct: 70  ------KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSS-QTLSDDHCQY--FLYQLLR 119

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
            L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR         T    T  Y A
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176

Query: 317 PEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PEL      YT  +    DV+S G +  E L+G+ P
Sbjct: 177 PELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 25/208 (12%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  S+V   G
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLSLVST-G 54

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM----AHALAYLHHDC 265
            C    CM   +   ++      L N  +         V   K M       +  L H  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTA-----RRLHADSSNRTLLAGTYGYIAPE-L 319
           +  +++RD+   NILL+      ++D G A     ++ HA         GT+GY+APE L
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VGTHGYMAPEVL 167

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                     D +S G +  ++L G  P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 39/223 (17%)

Query: 145 FHIKYCIGTGGYGSVYKAQ--------------LPNGKVFALKKLHTSETEELAFIKSFR 190
           + +   +G G YG V  A+              + N  VF+ K L      EL  ++ FR
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN--VFSKKILAKRALRELKLLRHFR 59

Query: 191 NEAQVLSQVLHRSIVKLYGFCLHKKCMF-LIYEYME--RGSLFCILHNDDEAVELDWAKR 247
                     H++I  LY   +     F  +Y Y E     L  I+ +      L  A  
Sbjct: 60  G---------HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG---QPLTDAHF 107

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD----SS 303
            + +  +   L Y+H   S +++HRD+   N+L+N+  E  + DFG AR    +    + 
Sbjct: 108 QSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164

Query: 304 NRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 345
             T    T  Y APE+  +    T+  DV+S G +  E+L  K
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 68/252 (26%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G V  A ++    ++A+K L   +     ++A +K+ R+   +L++  +  +V+
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERD---ILAEADNEWVVR 65

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHALAYLH 262
           LY     K  ++ + +Y+  G +  +L       ++      A+    V+++ H + +  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV-HKMGF-- 122

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTA---RRLH-------------------- 299
                  IHRDI  +NIL++      + DFG     R  H                    
Sbjct: 123 -------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 300 --ADSSN-------------------RTL---LAGTYGYIAPELAYTMVMTEKCDVYSFG 335
              D +N                   R L   L GT  YIAPE+      T+ CD +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 336 VVTLEVLMGKHP 347
           V+  E+L+G+ P
Sbjct: 236 VILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 65/281 (23%), Positives = 120/281 (42%), Gaps = 48/281 (17%)

Query: 154 GGYGSVYKAQLPNGKVFALK-------KLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           G +G ++   L + K    +       K H SE +    +     E+ +L  + H++I+ 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ----VTLLLQESCLLYGLSHQNILP 72

Query: 207 LYGFC--LHKKCMFLIYEYMERGSL-----FCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           +   C    +   F++Y YM  G+L      C L   +    L   + V++   +A  ++
Sbjct: 73  ILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL-----H--ADSSNRTLLAGTY 312
           YLH      +IH+DI++ N +++ +L+  + D   +R L     H   D+ NR +     
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV----- 183

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLE-VLMGKHPRDLLSSLSSSSDPKIMLIDVLD-Q 370
            ++A E       +   DV+SFGV+  E + +G+ P   +       DP  M   + D  
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-------DPFEMAAYLKDGY 236

Query: 371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQG 411
           RL  P++     D L    +   C   +P+ RP+   + Q 
Sbjct: 237 RLAQPIN---CPDELF--AVMACCWALDPEERPSFSQLVQC 272

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 68/255 (26%), Positives = 103/255 (40%), Gaps = 46/255 (18%)

Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRV 248
           R+E   L+   H  IVK +        + LI EY   G L   I     E +     +  
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL- 307
            +   +  AL  +H      ++HRD+ S NI L       + DFG +++ ++DS +  + 
Sbjct: 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVA 228

Query: 308 --LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP------RDLLSS-LSSSS 358
               GT  Y+APEL      ++K D++S GV+  E+L    P      R+++   L    
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288

Query: 359 DPKIMLIDVLDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR 416
           DP            P PV    K + D LL+          NP  RPT Q +        
Sbjct: 289 DP-----------FPCPVSSGMKALLDPLLS---------KNPALRPTTQQLLH------ 322

Query: 417 KTPLVKHAA--IQDI 429
            T  +K+ A   QDI
Sbjct: 323 -TEFLKYVANLFQDI 336

Length = 478

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G  G V  A     G+  A+KKL           +++R E  ++  V H++I+ L  
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82

Query: 210 -FCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
            F   K       ++L+ E M+  +L  ++      ++LD  +   ++  M   + +LH 
Sbjct: 83  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLH- 135

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   M
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 192

Query: 324 VMTEKCDVYSFGVVTLEVLMGK 345
              E  D++S G +  E++ G 
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 151 IGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G G YG VYKA+  +G   + +ALK++     E      S   E  +L ++ H +++ L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVISL 63

Query: 208 YGFCLH--KKCMFLIYEYMERGSLFCI-LHNDDEAVELDWAKRVNIVKAMAHALAY---- 260
               L    + ++L+++Y E      I  H   +A +    K V + + M  +L Y    
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK----KPVQLPRGMVKSLLYQILD 119

Query: 261 -LHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTARRLHA---DSSNRTLLAGTY 312
            +H+  +  ++HRD+   NIL+      +    +AD G AR  ++     ++   +  T+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 313 GYIAPELAY-TMVMTEKCDVYSFGVVTLEVL 342
            Y APEL       T+  D+++ G +  E+L
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 2e-05
 Identities = 14/38 (36%), Positives = 19/38 (50%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKL 38
          + NL  LD+S N +    P   + L  L  L+LS N L
Sbjct: 23 LPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 28/211 (13%)

Query: 151 IGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G G YG VYKA+  +G   K +ALK++     E      S   E  +L ++ H +++ L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIAL 63

Query: 208 YG-FCLHK-KCMFLIYEYMERGSLFCI-LHNDDEAVELDWAKRVNIVKAMAHALAY---- 260
              F  H  + ++L+++Y E      I  H   +A +    K + + ++M  +L Y    
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANK----KPMQLPRSMVKSLLYQILD 119

Query: 261 -LHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTARRLHA---DSSNRTLLAGTY 312
            +H+  +  ++HRD+   NIL+      +    +AD G AR  ++     ++   +  T+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 313 GYIAPELAY-TMVMTEKCDVYSFGVVTLEVL 342
            Y APEL       T+  D+++ G +  E+L
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 23/59 (38%), Positives = 34/59 (57%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           NL  LD+SNN + G IP ++   S L  L+L  N L G +P S   L+S+  + L+ N+
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 32/83 (38%), Positives = 38/83 (45%), Gaps = 4/83 (4%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG 62
           NLT LD+S N + G IP  L     L  L L  N L G +P S     S+ RVRL  N  
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN-S 415

Query: 63  LCGNFITLPSCDATKPATLFVEI 85
             G    LPS     P   F++I
Sbjct: 416 FSGE---LPSEFTKLPLVYFLDI 435

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 25/60 (41%), Positives = 33/60 (55%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  LD+  N + G IP  L +L  L YL L  NKLSGP+P S   L  +  + LS N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 6/63 (9%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSR---VRLS 58
           K L  LD+S N+  G++P +L  LS L  L LS NKLSG +P   ++LSS  +   + LS
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP---DELSSCKKLVSLDLS 531

Query: 59  PNK 61
            N+
Sbjct: 532 HNQ 534

Length = 968

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 5/101 (4%)

Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           L  A+   + + +  A+ Y+H +    IIHRDI + N+L+N   +  + DFG A      
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 302 SSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLE 340
            S      +AGT    APE+      T   D++S G+V  E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 21/205 (10%)

Query: 158 SVYKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF----C 211
           S+YK    N +V     KK H         I    NE + L ++   +I+K+YGF     
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHK---VLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91

Query: 212 LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH-HDCSPSII 270
                + LI EY  RG L  +L  +    +L +  ++++       L  L+ +   P   
Sbjct: 92  DDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKP--- 145

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV--MTEK 328
           +++++S + L+    +  +   G  + L +             Y + ++   +    T K
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV---NFMVYFSYKMLNDIFSEYTIK 202

Query: 329 CDVYSFGVVTLEVLMGKHPRDLLSS 353
            D+YS GVV  E+  GK P + L++
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTT 227

Length = 283

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 39.8 bits (94), Expect = 7e-05
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 2/45 (4%)

Query: 2  KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN 46
           NL  LD+SNN+I   +P  L++L  L+ L+LS NK++   P SN
Sbjct: 1  TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKITDLSPLSN 43

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 27/155 (17%)

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY---GYIAPELAYT 322
           S + +HRD+++ N+LL       + DFG AR +  D SN      T+    ++APE  + 
Sbjct: 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFD 313

Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-------PPP 375
            + T   DV+S+G++  E+           SL  +  P +++      ++        P 
Sbjct: 314 NLYTTLSDVWSYGILLWEIF----------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
              + + DI++       C  S P+ RP+  ++S 
Sbjct: 364 HATQEVYDIMV------KCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 149 YCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
             +G G  G V+ A      K  A+KK+  ++ + +   K    E +++ ++ H +IVK+
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKV 67

Query: 208 Y--------------GFCLHKKCMFLIYEYMERGSLFCILHN--DDEAVELDWAKRVNIV 251
           Y              G       ++++ EYME      +      +E   L        +
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-------FM 120

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHADSSNRTLLA- 309
             +   L Y+H   S +++HRD+   N+ +N++ L   + DFG AR +    S++  L+ 
Sbjct: 121 YQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 310 --GTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 345
              T  Y +P L  +    T+  D+++ G +  E+L GK
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 21/58 (36%), Positives = 34/58 (58%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +L  LD+  N + G IP  LT+L+ L++L L+ N+L G +P    Q+ S+  + L  N
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222

Length = 968

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 43/281 (15%)

Query: 151 IGTGGYGSVYKAQLPNGKVFA---LKKLHTSET--EELAFIKSFRNEAQVLSQVLHRSIV 205
           IG G +G V   ++ +G   A   +K+L  S +  E++ F++    EAQ    + H +++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA----YL 261
           +  G C       L+ E+   G L   L +  +A  +        ++ MA  +A    +L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHL 116

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD----SSNRTLLAGTYGYIAP 317
           H +   + IH D++  N LL + L   + D+G +   + +    + ++  +     +IAP
Sbjct: 117 HKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP--LRWIAP 171

Query: 318 ELA-------YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD 369
           EL          +  T++ +V+S GV   E+  +G  P   L      SD +++   V +
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL------SDEQVLTYTVRE 225

Query: 370 Q--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           Q  +LP P  +  + D      + F  LQ  P+ RP+ + V
Sbjct: 226 QQLKLPKPRLKLPLSDRWY-EVMQFCWLQ--PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 5/86 (5%)

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY---GYIAPELAYT 322
           S + +HRD+++ N+L+       + DFG AR +  D SN      T+    ++APE  + 
Sbjct: 257 SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFN 315

Query: 323 MVMTEKCDVYSFGVVTLEVL-MGKHP 347
            + T   DV+SFG++  E+  +G  P
Sbjct: 316 NLYTTLSDVWSFGILLWEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 7e-04
 Identities = 21/59 (35%), Positives = 29/59 (49%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          NL  LD+SNN++     G    L  L  L+LS N L+   P +   L S+  + LS N 
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Length = 60

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 8e-04
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 9/79 (11%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           ++NL  L + +N   G IP  LT L RL  L L  NK SG +P +  + ++++ + LS N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 61  -------KGLC--GNFITL 70
                  +GLC  GN   L
Sbjct: 367 NLTGEIPEGLCSSGNLFKL 385

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 19/55 (34%), Positives = 32/55 (58%), Gaps = 3/55 (5%)

Query: 7   LDISNNKIEGSIPGELTDLS-RLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +++SNN++ G IP ++   S  L YLNLS N  +G +P     + ++  + LS N
Sbjct: 98  INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP--RGSIPNLETLDLSNN 150

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 23/61 (37%), Positives = 34/61 (55%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNL +L +  NK+ G IP  +  L +L  L+LS N LSG +P    QL ++  + L  N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318

Query: 61  K 61
            
Sbjct: 319 N 319

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 19/60 (31%), Positives = 37/60 (61%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L +L +++N++ G IP EL  +  L ++ L +N LSG +P+    L+S++ + L  N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	436
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
smart00090	237	RIO RIO-like kinase.	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
KOG1243	690	consensus Protein kinase [General function predict	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
PLN03150	623	hypothetical protein; Provisional	99.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
PLN03150	623	hypothetical protein; Provisional	98.94
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.94
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.82
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.72
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.67
PRK09902	216	hypothetical protein; Provisional	98.66
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.62
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	98.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.41
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.27
PLN02876	822	acyl-CoA dehydrogenase	98.23
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.17
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.14
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.14
PRK10593	297	hypothetical protein; Provisional	98.11
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.08
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.07
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.99
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	97.92
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.89
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.78
PRK05231	319	homoserine kinase; Provisional	97.76
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.74
KOG0472	565	consensus Leucine-rich repeat protein [Function un	97.73
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.68
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.61
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.53
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	97.52
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.49
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.45
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.44
KOG0472	565	consensus Leucine-rich repeat protein [Function un	97.42
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.41
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.4
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.38
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.36
KOG2270	520	consensus Serine/threonine protein kinase involved	97.33
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.28

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-58  Score=439.03  Aligned_cols=278  Identities=38%  Similarity=0.646  Sum_probs=235.5

Q ss_pred             CcccHHHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeE
Q 013793          131 GRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF  210 (436)
Q Consensus       131 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  210 (436)
                      ..+++.++..||++|...+.||+|+||.||+|.+.+|..||||++.......   ..+|.+|++++++++|||+|+++||
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4578999999999999999999999999999999999999999888765532   2569999999999999999999999


Q ss_pred             EeeCC-EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          211 CLHKK-CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       211 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                      |.+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+.+.++|+||||||+|||+|+++++||
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            99999 599999999999999999987655 8999999999999999999999998889999999999999999999999


Q ss_pred             eecccccccCCCCCCcccc-ccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc--------CCCCc
Q 013793          290 ADFGTARRLHADSSNRTLL-AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS--------SSSDP  360 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--------~~~~~  360 (436)
                      +|||+|+............ .||.+|+|||+...+..+.|+|||||||+|+||+||+.|.+......        .....
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999997654312222222 79999999999999999999999999999999999998877432100        01111


Q ss_pred             ccchhhhhcCCCCC-CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          361 KIMLIDVLDQRLPP-PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       361 ~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +....+++|+++.. ....  ...+..+..++.+|++.+|.+||+|.||++.+..
T Consensus       299 ~~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             CcchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            22466777887763 2221  1566668899999999999999999999998833

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-53  Score=463.01  Aligned_cols=395  Identities=27%  Similarity=0.447  Sum_probs=268.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC--------------------
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN--------------------   60 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n--------------------   60 (436)
                      |++|++|+|++|+++|.+|..+++|++|+.|||++|+++|.+|..+..+++|+.+++++|                    
T Consensus       522 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~  601 (968)
T PLN00113        522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAV  601 (968)
T ss_pred             ccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhh
Confidence            467888888888888888888888888888888888888888887777777766666554                    


Q ss_pred             ---CCCCCCcc--cCCCCCCCCCc-cchhhhhhhHhHHHHHHHHHHHHHhhhccCCccccccccCCccc-eeeec--CCC
Q 013793           61 ---KGLCGNFI--TLPSCDATKPA-TLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKVKARATNSIDV-FSIWN--YDG  131 (436)
Q Consensus        61 ---~~lcg~~~--~~~~c~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~  131 (436)
                         +++||...  ..++|...... .....+++.++++++++++++++++++++++.+.+......... ...+.  ...
T Consensus       602 ~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (968)
T PLN00113        602 AGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSK  681 (968)
T ss_pred             cCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccch
Confidence               45565432  23445322111 11111222222222222222222333322221111111110000 00000  011


Q ss_pred             cccHHHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeE
Q 013793          132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF  210 (436)
Q Consensus       132 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  210 (436)
                      .+.++++   ...|...+.||+|+||.||+|.. .++..||||++......       ...|++.+++++|||||+++|+
T Consensus       682 ~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~  751 (968)
T PLN00113        682 SITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGL  751 (968)
T ss_pred             hhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEE
Confidence            2334443   34577788999999999999976 58899999998754322       1245888999999999999999


Q ss_pred             EeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       211 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      |.+.+..++||||+++|+|.++++      .++|.++.+|+.|+|+||+|||+.++++|+||||||+||+++.++.+++.
T Consensus       752 ~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~  825 (968)
T PLN00113        752 CRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR  825 (968)
T ss_pred             EEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence            999999999999999999999995      38999999999999999999998878899999999999999999988875


Q ss_pred             ecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCC-------CCcccc
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS-------SDPKIM  363 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~  363 (436)
                       ||.+......    ....+++.|+|||++.+..++.++|||||||++|||+||+.||+........       ......
T Consensus       826 -~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  900 (968)
T PLN00113        826 -LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH  900 (968)
T ss_pred             -eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc
Confidence             6655433221    2236789999999999999999999999999999999999998632111000       000111


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ...++++.+...... ...+...+.+++.+||+.||++||||.||++.+.....
T Consensus       901 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 LDMWIDPSIRGDVSV-NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhheeCccccCCCCc-cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            222334443322221 23445567899999999999999999999999976533

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-52  Score=375.53  Aligned_cols=258  Identities=28%  Similarity=0.406  Sum_probs=213.2

Q ss_pred             cceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-EEEEEEeecc
Q 013793          148 KYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-CMFLIYEYME  225 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  225 (436)
                      .+.||+|..|+|||+.++ +++.+|+|.+......  ...+++.+|++++++.+||+||.++|.|.... +..|+||||.
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~--~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP--ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH--HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            567999999999999765 7899999999655433  33589999999999999999999999999998 5999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR  305 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  305 (436)
                      +|||.+++...+   .+++...-+|+.++++||.|||+  ..+||||||||+|+|++..|++||||||.++.+...  ..
T Consensus       162 gGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a  234 (364)
T KOG0581|consen  162 GGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IA  234 (364)
T ss_pred             CCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hc
Confidence            999999998654   68999999999999999999996  489999999999999999999999999999887543  44


Q ss_pred             cccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHH
Q 013793          306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL  385 (436)
Q Consensus       306 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  385 (436)
                      .+++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....  ........+..+++...+ .....  ....
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll~~Iv~~ppP-~lP~~--~fS~  309 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELLCAIVDEPPP-RLPEG--EFSP  309 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHHHHHhcCCCC-CCCcc--cCCH
Confidence            668899999999999999999999999999999999999999874310  011111122333332222 12111  2334


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          386 LASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ++..++..||++||.+||++.|+++|+|+++...
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            4778999999999999999999999999986644

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=385.45  Aligned_cols=255  Identities=34%  Similarity=0.543  Sum_probs=210.5

Q ss_pred             cccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-EEEEEEeec
Q 013793          146 HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-CMFLIYEYM  224 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  224 (436)
                      ...+.+|+|+||+||+|.+.+...||||++......... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            345559999999999999976666999999887655443 689999999999999999999999999988 799999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceeecCCC-CeEEeecccccccCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS-IIHRDISSNNILLNSKL-EAFVADFGTARRLHADS  302 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  302 (436)
                      ++|+|..+++.. ....+++..+++++.+||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999875 3347999999999999999999999   666 99999999999999997 99999999998765443


Q ss_pred             CCccccccccccccccccc--cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SNRTLLAGTYGYIAPELAY--TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      ...+...||+.|||||++.  ...++.|+||||||+++|||+||+.||.....       ......+......+..... 
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p~~-  270 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIPKE-  270 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCcc-
Confidence            4444578999999999999  56999999999999999999999999974322       1222333323333322221 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                        ....+..++.+||+.||+.||++.+++..+...
T Consensus       271 --~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  271 --CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             --CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence              223366788889999999999999999988643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-51  Score=391.00  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=222.4

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ..|...+.||+|||+.+|.++. .+|+.||+|++...........+.+.+|+++.++++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5689999999999999999976 899999999998866555555688999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |+|++++|..++....   ++++.+++.++.||+.||.|||   +.+|+|||||..|+|+++++++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998443   8999999999999999999999   889999999999999999999999999999999877


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .....+.+|||.|+|||++.....+..+||||+|||+|-|++|++||+.-.     ..+........+..+|...     
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~~Y~~P~~l-----  241 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLNEYSMPSHL-----  241 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhcCccccccc-----
Confidence            777788999999999999999999999999999999999999999997311     1111111122233333322     


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                        ...+.+|+.++|++||.+|||+++|+.|.|+++.
T Consensus       242 --s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  242 --SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             --CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence              2236689999999999999999999999999443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-52  Score=378.05  Aligned_cols=265  Identities=26%  Similarity=0.328  Sum_probs=217.2

Q ss_pred             HhhcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhH----HHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEEL----AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      ..+.|.+.+.||+|+||.|-+| ..++|+.||||+++.......    .....+.+|+++|++++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3456778899999999999999 556899999999976543321    11234679999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeec
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADF  292 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df  292 (436)
                      ..|+||||++||+|.+.+-.++   .+.+.....++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999997665   6777888999999999999999   8999999999999999766   77999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCc---cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      |+|+... ..+...+.+||+.|.|||++.++.   +..++|+||+|||||-+++|.+||...      ........++..
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~------~~~~sl~eQI~~  396 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE------YTDPSLKEQILK  396 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc------cCCccHHHHHhc
Confidence            9999876 445567789999999999998764   334889999999999999999999621      111223344444


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          370 QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       370 ~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .+... .+..+.....+..+|+.+||..||++|||+.|+++|+|++..+.
T Consensus       397 G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  397 GRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             Ccccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            44332 22234555666889999999999999999999999999986653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=360.10  Aligned_cols=265  Identities=28%  Similarity=0.438  Sum_probs=222.7

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.++||+|+||+||.++. .+++.+|+|+++....-+....+....|..+|..++||.||++...|++.+..++|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            56799999999999999999954 57899999999988776655568889999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+.||.|..+|.+.+   .+++..+.-++..|+.||.|||   +.+||||||||+|||+|.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999998765   7899999999999999999999   89999999999999999999999999999997666


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .+....+++||+.|||||++.+..++..+|.||+|+++|||++|.+||..       .+...+...+...+++.+...  
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-------~~~~~~~~~I~~~k~~~~p~~--  248 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-------EDVKKMYDKILKGKLPLPPGY--  248 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-------ccHHHHHHHHhcCcCCCCCcc--
Confidence            66666778999999999999999999999999999999999999999973       222233444444442211110  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC----HHHHHHHHhhcCCCCCccccccccchhhhhh
Q 013793          381 IQDILLASTISFACLQSNPKSRPT----MQYVSQGFLITRKTPLVKHAAIQDISISELR  435 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt----~~ev~~~l~~~~~~~~~~~~~~~~~~~~~~~  435 (436)
                        ......+++.+.+..||++|..    +.+            +..||++.+++|+.+.
T Consensus       249 --ls~~ardll~~LL~rdp~~RLg~~~d~~~------------ik~HpfF~~inW~~l~  293 (357)
T KOG0598|consen  249 --LSEEARDLLKKLLKRDPRQRLGGPGDAEE------------IKRHPFFKGINWEKLL  293 (357)
T ss_pred             --CCHHHHHHHHHHhccCHHHhcCCCCChHH------------hhcCcccccCCHHHHH
Confidence              1122567888999999999974    444            5566677777777654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=356.33  Aligned_cols=264  Identities=26%  Similarity=0.401  Sum_probs=207.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+....... .-.+.+..|+.+|+.++|||||++++++..++..++|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            467888888999999999999765 68999999998775322 2246788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC------CCeEEeeccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK------LEAFVADFGT  294 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~  294 (436)
                      ||||.||+|.++++..+   .+++..++.++.|+|.||++||   +++||||||||.|||++..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999999776   7999999999999999999999   8999999999999999865      4589999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      |+.+.. .....+.+|++.|||||++..++|+.|+|+||+|+|+|+|++|+.||+.....      +....-..+....+
T Consensus       162 AR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~------eL~~~~~k~~~~~~  234 (429)
T KOG0595|consen  162 ARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK------ELLLYIKKGNEIVP  234 (429)
T ss_pred             hhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHhccccccC
Confidence            998864 34456688999999999999999999999999999999999999999732210      00000000111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK  422 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~  422 (436)
                      ...   ......+.++....++.+|.+|-+..+-..+......+....
T Consensus       235 ~~~---~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~~  279 (429)
T KOG0595|consen  235 VLP---AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDRA  279 (429)
T ss_pred             chh---hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCccccc
Confidence            110   011111335666677777888888777777776665554333

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-48  Score=364.01  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=217.7

Q ss_pred             HHhhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      ....+|.+.+.||.|+|++|++|+ ..+++.||||++.....-.+...+-+..|-++|.+| .||.|++|+..|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345789999999999999999995 457999999999877665555557788999999999 899999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      |+|+||+++|+|.+++++.+   .+++..++.++.+|+.||+|||   +.|||||||||+|||+|+||+++|+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999876   7999999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCCC-------------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccch
Q 013793          298 LHADSSN-------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       298 ~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~  364 (436)
                      +.+....             ...++||..|.+||++.....+..+|+|+||||||+|+.|++||...+       +...+
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-------eyliF  296 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-------EYLIF  296 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-------HHHHH
Confidence            8542211             145789999999999999999999999999999999999999997433       22334


Q ss_pred             hhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          365 IDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       365 ~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +.+++  ..+++..+       ..+.+|+.+.|..||.+|+|.+|+.+|++|
T Consensus       297 qkI~~l~y~fp~~fp-------~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  297 QKIQALDYEFPEGFP-------EDARDLIKKLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             HHHHHhcccCCCCCC-------HHHHHHHHHHHccCccccccHHHHhhCccc
Confidence            44443  33444333       236689999999999999999999887744

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-49  Score=342.47  Aligned_cols=260  Identities=24%  Similarity=0.321  Sum_probs=210.4

Q ss_pred             hcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeee-EEeeCCE-EEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG-FCLHKKC-MFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~l  219 (436)
                      .+|++.++||+|.||+||++ ...+|..+|.|.++-...+.. ..+....|+.+|++++|||||++++ -+.+..+ ..|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k-~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAK-ARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHH-HHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            45888899999999999999 567999999999986554433 3578889999999999999999998 4444444 899


Q ss_pred             EEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          220 IYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      |||||.+|+|..++.... ....+++..+++++.|++.||.++|+.... -|+||||||.||+++.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999987543 345789999999999999999999954322 388999999999999999999999999999


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      +..........+|||.||+||.+.+..|+.||||||+||++|||+.-++||...        .-..+...+.+.-.++.+
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcCCCCCCc
Confidence            887766677789999999999999999999999999999999999999999732        111233333333222333


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..  -....+..++..|+.+||+.||+....++.+.
T Consensus       250 ~~--~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  250 DE--HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HH--HhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            22  22334668899999999999999655555443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=363.95  Aligned_cols=249  Identities=28%  Similarity=0.477  Sum_probs=206.6

Q ss_pred             ccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      +...+.||+|-||.||.|.+.+...||+|.++......    ..|.+|+.+|.+++|+|||+++|+|...+.++||||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            34467799999999999999888899999999876543    67889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      +.|+|.++|... ....+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||+|+....+...
T Consensus       284 ~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             ccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            999999999873 3447899999999999999999999   889999999999999999999999999999965443332


Q ss_pred             -ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh--cCCCCCCCChhH
Q 013793          305 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDQKV  380 (436)
Q Consensus       305 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~  380 (436)
                       .....-...|.|||.+..++++.|||||||||+||||+| |+.|+..+..        ....+.+  ..+++.|..   
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRlp~P~~---  428 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRLPRPEG---  428 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcCCCCCC---
Confidence             222223568999999999999999999999999999998 8888763221        1122223  244554443   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        +...+.+++..||+.+|++|||++.+...+..
T Consensus       429 --CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  429 --CPDEVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             --CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence              23347789999999999999999987766643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=331.19  Aligned_cols=265  Identities=25%  Similarity=0.328  Sum_probs=208.9

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|+...++|+|+||+|||++.+ +|+.||||++.....+. ...+-..+|+++|++++|+|+|.++++|..+...++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~-~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP-VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH-HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            35777888999999999999876 69999999998765432 23466789999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++..-|.++ ....  ..++.....+++.|++.|+.|+|   +++++||||||+|||++.++.+||||||+|+.+...
T Consensus        81 E~~dhTvL~eL-e~~p--~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDHTVLHEL-ERYP--NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecchHHHHHH-Hhcc--CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99988555444 3332  25888999999999999999999   889999999999999999999999999999999877


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCC-------cccchhhhhcC---
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD-------PKIMLIDVLDQ---  370 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~---  370 (436)
                      +...+..+.|.+|+|||.+.+ .+|+..+|||++||++.||++|.+.|...++.+.-..       -....+.++..   
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            777788899999999999887 6899999999999999999999988754332110000       00001111111   


Q ss_pred             ----CCCC-----CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          371 ----RLPP-----PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       371 ----~l~~-----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                          ++|.     +...........+.+++..|++.||.+|++-+|++.|..|
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence                1111     1111122223347799999999999999999999998876

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=343.26  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=207.6

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC--EEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK--CMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  219 (436)
                      .++...+.||+|+||+||++... +|...|||.+.......   .+.+.+|+.+|++++|||||+.+|.....+  ..++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            34666888999999999999765 49999999987764332   477899999999999999999999865555  6899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeeccccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARRL  298 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~  298 (436)
                      .|||+++|+|.+++.+.+.  .+++..++.++.||++||+|||   ++||+||||||+|||++. ++.+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999987654  6999999999999999999999   899999999999999999 799999999999877


Q ss_pred             CCC---CCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HAD---SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ...   ........||+.|||||+...+ ....++||||+||++.||+||+.||...      .........+......+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P  242 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP  242 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC
Confidence            531   1223457799999999999854 3446999999999999999999998732      11111111222111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....   ......+++.+|++.||++|||+.++++|+|.....+
T Consensus       243 ~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  243 EIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            22111   2223678999999999999999999999999977654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-45  Score=345.53  Aligned_cols=275  Identities=27%  Similarity=0.353  Sum_probs=213.1

Q ss_pred             hhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  218 (436)
                      .+.|+..++||+|+||.||+|+ ..+|+.||+|++........ ...-..+|+.+|++++||||++|.+...+.  ..+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4567778889999999999994 56899999999987654322 235567899999999999999999999887  6899


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +|+|||++ +|.-++....  ..++..++..++.|++.||.|||   +.+|+|||||.+|||||.+|.+||+|||+|+++
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence            99999988 7887776543  47999999999999999999999   899999999999999999999999999999988


Q ss_pred             CCCCCC-ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccc---------cCCCCcccchhhh
Q 013793          299 HADSSN-RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL---------SSSSDPKIMLIDV  367 (436)
Q Consensus       299 ~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---------~~~~~~~~~~~~~  367 (436)
                      ...... .+..+-|.+|+|||++.|. .|+.+.|+||.||||.||++|++.+..-..+         -+...++.|....
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            665543 6777889999999998876 7999999999999999999999888633211         1111112221100


Q ss_pred             hc----CCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccc
Q 013793          368 LD----QRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKH  423 (436)
Q Consensus       368 ~~----~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~  423 (436)
                      +.    .+...++...    ...-....++|+..+|..||.+|.|+.+++++.||+..+.....
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p  412 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDP  412 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCc
Confidence            00    0000111100    11112235678899999999999999999999999555444433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=351.20  Aligned_cols=259  Identities=22%  Similarity=0.345  Sum_probs=214.0

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh-h-HHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE-E-LAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKC  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  216 (436)
                      ....|.+.+.||+|+||+|+.|.. .+++.||+|.+...... . ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456789999999999999999954 57899999977654211 0 122356778999999998 9999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTA  295 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a  295 (436)
                      .++||||+.||+|.+++...+   ++.+.++..++.|++.|++|||   +.+|+||||||+|+|+|.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998743   6888999999999999999999   8999999999999999999 99999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCc-cC-cchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTMV-MT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .............+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..       ........+......
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~ki~~~~~~  241 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYRKIRKGEFK  241 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcCCcc
Confidence            97743444566788999999999999877 75 7899999999999999999999831       111222233333333


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      -+....    ...+..|+.+|+..||.+|+|+.+++++.|++.
T Consensus       242 ~p~~~~----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 IPSYLL----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCcC----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            222110    334678999999999999999999999999997

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-46  Score=352.38  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=218.4

Q ss_pred             hhcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ...|..-.+||+|..|.||.+ +..+++.||||++........   +-+.+|+.+|+..+|+|||++++.|..+++.|+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            455777788999999999999 556889999999987765542   5678999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||||+||+|.+.+...    .+++.++..|++++++||+|||   ..+|+|||||.+|||++.++.+||+|||++..+..
T Consensus       349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            9999999999999765    4899999999999999999999   89999999999999999999999999999998877


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      ........+||+.|||||+.....|++|.||||||++++||+-|.+||--..       +-..+.-+.+ ...+.. ...
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAlyLIa~-ng~P~l-k~~  492 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYLIAT-NGTPKL-KNP  492 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHHHHhh-cCCCCc-CCc
Confidence            7767778899999999999999999999999999999999999999985211       1111122222 111111 112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ......+.+++.+||+.|+++||++.|+++|+++....+
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            333445789999999999999999999999999955443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-45  Score=335.81  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=214.5

Q ss_pred             hhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|++.+.||.|..++||+|+ .+.+..||||++...+....  .+.+.+|+..++.++||||++++..|..+.+.|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            4678999999999999999995 56789999999987765543  58899999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |.||.+||+.+++...-. ..+++..+..|.+++++||.|||   .+|.||||||+.||||+++|.+||+|||.+-.+..
T Consensus       103 mpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999986532 25899999999999999999999   88999999999999999999999999998765544


Q ss_pred             CCCC---c-ccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          301 DSSN---R-TLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       301 ~~~~---~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ....   . ..+.||+.|||||++..  ..|+.|+||||||+...||.+|+.||....       +..++...+....+.
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-------PmkvLl~tLqn~pp~  251 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-------PMKVLLLTLQNDPPT  251 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-------hHHHHHHHhcCCCCC
Confidence            3322   1 44689999999999543  369999999999999999999999996321       112222222222221


Q ss_pred             CC----C-hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          375 PV----D-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       375 ~~----~-~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      +.    + .........+.+++..||+.||++|||+++++++.||+..+.
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            00    0 111112224778999999999999999999999999977654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.8e-45  Score=317.02  Aligned_cols=270  Identities=26%  Similarity=0.336  Sum_probs=213.5

Q ss_pred             hcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+|...+.+|+|.||.||+|+ .++|+.||||+++..+..+. ......+|++.|+.++|+||+.++++|...+...||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            357778899999999999995 56899999999987754321 2256778999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |||+. +|+..++...  ..++..++..++.++++|++|||   ...|+||||||.|+|++++|.+||+|||+|+.+.+.
T Consensus        81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99986 8999997653  47899999999999999999999   889999999999999999999999999999999877


Q ss_pred             CCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccc-------------cCCCCcccc-hhh
Q 013793          302 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------SSSSDPKIM-LID  366 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------------~~~~~~~~~-~~~  366 (436)
                      ....+..+-|.+|+|||.+.|. .|+...|+||.|||+.||+-|.+-|...++.             .....++.. +-+
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            7666666789999999988875 7999999999999999999998766432221             011111000 000


Q ss_pred             h--hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          367 V--LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       367 ~--~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .  +.....++...-.......+.+|+.+++..||.+|+|++|+++|.+|+..+.
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            0  1111111111112223334678999999999999999999999999986443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=345.74  Aligned_cols=273  Identities=22%  Similarity=0.304  Sum_probs=218.2

Q ss_pred             HhhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCC-EE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKK-CM  217 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~  217 (436)
                      ..++|.+.++||.|+||+||+|+ ..+|..||||+++.....-.+  -.-.+|+..|++++ |||||++.+++.+.+ ..
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            35678899999999999999995 557999999999876544322  23357999999998 999999999999988 99


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|||||+. +|++++..+  ...+++.+++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+|+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence            999999976 999999876  458999999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCCCccccccccccccccccc-cCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCC----c-cc
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSD----P-KI  362 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~----~-~~  362 (436)
                      +... ...+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|...+..+         +...    . ..
T Consensus       160 v~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  160 VRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            7543 3356678999999999876 5679999999999999999999998876443211         1111    1 12


Q ss_pred             chhhhhcCCCCCCCC----hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 013793          363 MLIDVLDQRLPPPVD----QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK  422 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~  422 (436)
                      .+...+..+++.-..    .-.......+.+++.+|+..||.+|||+.|++++++++-..+...
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~  302 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS  302 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence            233444444432211    111224455788999999999999999999999999977655433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-45  Score=320.15  Aligned_cols=253  Identities=27%  Similarity=0.398  Sum_probs=215.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++.....-.....+...+|..+|+.+.||+++++.+.|.+....++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            356888899999999999999765 6889999999887776666667788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||.+||.|.+++++.+   +++...++.++.+|+.||+|||   +.+|++|||||+|||+|.+|.+||+|||.|+....
T Consensus       123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999998766   7999999999999999999999   89999999999999999999999999999998753


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .   .-+.+|||.|+|||.+.++.+..++|.|+|||++|||+.|.+||..       ..+......++...+..|...  
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-------~~~~~iY~KI~~~~v~fP~~f--  264 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-------DNPIQIYEKILEGKVKFPSYF--  264 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-------CChHHHHHHHHhCcccCCccc--
Confidence            3   4567899999999999999999999999999999999999999962       222334455555554433221  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCC-----CCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSR-----PTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~R-----Pt~~ev~~~l~~~  415 (436)
                         ...+.+|+.+.++.|-.+|     +...+|..|+||.
T Consensus       265 ---s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  265 ---SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             ---CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence               1125678888999999988     4566777777765

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-44  Score=340.06  Aligned_cols=261  Identities=24%  Similarity=0.278  Sum_probs=206.4

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .|+..+.||+|+||.||++.. .+|+.||+|.+.............+.+|+.++.+++|+|++++.+++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999965 5799999999876544333333567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999998876432 235899999999999999999999   8899999999999999999999999999998753322


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||......   ................  ...   .
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~--~~~---~  227 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER---VKREEVDRRVKEDQEE--YSE---K  227 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHHhhccccc--CCc---c
Confidence             223456899999999999999999999999999999999999998632110   0000001111111111  111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcCC
Q 013793          383 DILLASTISFACLQSNPKSRPT-----MQYVSQGFLITRK  417 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~~  417 (436)
                      ....+.+|+.+||+.||++||+     ++++++|+|+..-
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            1223678999999999999997     9999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.7e-45  Score=343.84  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=215.3

Q ss_pred             HhhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++...||+|+||.||+|+ ..+|..+|+|+++....-.....+-+..|-.+|...++|+||+++..|.+.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999995 45799999999999888777777889999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+|||++..+|...+   .|++..+..++.+++-|+..+|   ..|+|||||||+|+|||..|++||+|||+++.+.
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999998765   7999999999999999999999   8999999999999999999999999999986442


Q ss_pred             C----C-------------------CC----Cc--------------------cccccccccccccccccCccCcchhhH
Q 013793          300 A----D-------------------SS----NR--------------------TLLAGTYGYIAPELAYTMVMTEKCDVY  332 (436)
Q Consensus       300 ~----~-------------------~~----~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~  332 (436)
                      .    +                   ..    ..                    ...+|||.|+|||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1    0                   00    00                    123699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC---HHH
Q 013793          333 SFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQKVIQDILLASTISFACLQSNPKSRPT---MQY  407 (436)
Q Consensus       333 s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~e  407 (436)
                      |+|||+|||+.|.+||..       ..+......++..+  +..+......   .++.+|+.+|+. ||++|..   ++|
T Consensus       373 SLG~ImyEmLvGyPPF~s-------~tp~~T~rkI~nwr~~l~fP~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCS-------ETPQETYRKIVNWRETLKFPEEVDLS---DEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHHHhhhccCCCcCccc---HHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            999999999999999962       22233333333322  3222222111   346789999999 9999985   888


Q ss_pred             HHHHHhhcC
Q 013793          408 VSQGFLITR  416 (436)
Q Consensus       408 v~~~l~~~~  416 (436)
                      |.+|+||+.
T Consensus       442 IK~HPfF~~  450 (550)
T KOG0605|consen  442 IKKHPFFKG  450 (550)
T ss_pred             HhcCCcccc
Confidence            888887754

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-45  Score=313.38  Aligned_cols=257  Identities=30%  Similarity=0.443  Sum_probs=219.9

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      +.++|++.+.||+|.||.||.|+. +++-.||+|++...+........++.+|+++-+.++||||++++++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            356799999999999999999965 5788999999988877666666899999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ++||.++|++...|.... ...++......++.|+|.||.|+|   .++++||||||+|+|++.++..||+|||.+..- 
T Consensus       100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-  174 (281)
T ss_pred             EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence            999999999999998543 336888999999999999999999   899999999999999999999999999998543 


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh--cCCCCCCCC
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVD  377 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~  377 (436)
                       +.....+.+||..|.|||...+...+..+|+|++|++.||++.|.+||+...       ......++.  +-.++....
T Consensus       175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~~~~~p~~is  246 (281)
T KOG0580|consen  175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKVDLKFPSTIS  246 (281)
T ss_pred             -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHccccCCcccC
Confidence             3445667899999999999999999999999999999999999999997322       122233333  333333222


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                             ..+.+++.+|+..+|.+|.+..||+.|+|....
T Consensus       247 -------~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  247 -------GGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------hhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                   236789999999999999999999999998653

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.9e-45  Score=346.69  Aligned_cols=257  Identities=28%  Similarity=0.402  Sum_probs=217.1

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+....+. ..+.+.+|+++++.++|||||.++++|+...+.++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            57888899999999999999655 788999999977655443 3588999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+.| +|..++...+   .++++.+..++.+++.||.|||   +.+|.|||+||.|||++..+.+|+||||+|+.+..+
T Consensus        81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99988 9999998765   7999999999999999999999   899999999999999999999999999999998877


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ....+...|||.|||||...+..|+..+|.||+|||+||+.+|++||-..+-.       .....+......++.     
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d~v~~p~-----  221 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKDPVKPPS-----  221 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcCCCCCcc-----
Confidence            76677788999999999999999999999999999999999999998521100       001111111111111     


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....+..++...+..||.+|.|-.+++.|++.+..-.
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence            22334677888999999999999999999998765533

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=339.83  Aligned_cols=253  Identities=26%  Similarity=0.366  Sum_probs=208.3

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.||+|++.............+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999765 78999999997654333333467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999997654   6889999999999999999999   889999999999999999999999999999865432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                         .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+...   
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~---  221 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-------PFGIYEKILAGKLEFPRHL---  221 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCcCCCccC---
Confidence               223568999999999998889999999999999999999999986321       1111222222222211111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                        ...+.+++.+||+.||.+||+     +.|+++|+|+..
T Consensus       222 --~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         222 --DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             --CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence              223678999999999999995     999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-44  Score=343.90  Aligned_cols=248  Identities=22%  Similarity=0.310  Sum_probs=203.9

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      +.||+|+||.||++.. .+|+.||+|++.............+.+|++++.+++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 478999999997654333333467788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccc
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      +|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9999987644   6899999999999999999999   889999999999999999999999999999764333333445


Q ss_pred             cccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCChhHHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQKVIQDIL  385 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~  385 (436)
                      ..||+.|+|||.+.+..++.++|||||||++|||+||+.||....       .......+....  ++...       ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~-------~~  220 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRTL-------SP  220 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCC-------CH
Confidence            679999999999999999999999999999999999999985211       111111122111  12211       22


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          386 LASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      .+.+++.+||+.||++||     ++.++++|.|+..
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            366899999999999999     8999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=349.16  Aligned_cols=246  Identities=24%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|...++||+|.||+|+++..+ +++.+|||++++...-.....+..+.|.+++... +||.+++++..|.++++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999765 6889999999988776666678889999998888 5999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+.||++..+.+..    .+++..+.-++..|+.||+|||   +++||+||||.+|||+|.+|.+||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999955554432    6999999999999999999999   899999999999999999999999999999976


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ........+++||+.|+|||++.+..|+.++|.|||||+||||+.|..||.       ..+++.....++......|...
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~-------gddEee~FdsI~~d~~~yP~~l  591 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP-------GDDEEEVFDSIVNDEVRYPRFL  591 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHhcCCCCCCCcc
Confidence            655556778999999999999999999999999999999999999999997       2334444455554444433322


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCH
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTM  405 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~  405 (436)
                           ..+...++.+++..+|++|..+
T Consensus       592 -----s~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  592 -----SKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----cHHHHHHHHHHhccCcccccCC
Confidence                 2335678899999999999976

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=348.78  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=214.8

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      -|++.+.||.|+.|.|-.|++ .+|+.+|||++.....-.......+.+|+.+|+-+.|||++++++++++..+.|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            467788899999999999965 5899999999987643333334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|-|.+++-..+   ++++.++.+++.||..|+.|+|   ..+|+||||||+|+|+|..+++||+|||+|..- .++
T Consensus        93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~g  165 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPG  165 (786)
T ss_pred             ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc-cCC
Confidence            999999999998766   7999999999999999999999   889999999999999999999999999999753 455


Q ss_pred             CCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ....+.+|++.|.|||+..|.+| +.++||||.|||||.|+||+.||+..+       -...+..+....+..+..    
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f~MPs~----  234 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVFEMPSN----  234 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcccCCCc----
Confidence            56677899999999999999987 579999999999999999999998211       111122222222222211    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                       ....+.+|+.+|+..||+.|.|++||++|+|...-+..
T Consensus       235 -Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  235 -ISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             -CCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence             12236789999999999999999999999998765443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=344.82  Aligned_cols=268  Identities=25%  Similarity=0.417  Sum_probs=215.5

Q ss_pred             cHHHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          134 FYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       134 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      +.+++....+++.+.+.||+|+||+||+|.+.+  .||||+++....... ..+.|++|+..+++-||.||+-+.|||..
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            345555556667788899999999999999843  479999988765544 56999999999999999999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      ++. .||+-+|+|.+|+.++|..+  ..++..+.+.|+.|||+|+.|||   ..+|||||||+.||++.+++++||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence            887 99999999999999999765  46899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCC--CCCCccccccccccccccccccC---ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh
Q 013793          294 TARRLHA--DSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       294 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      ++..-..  ........-|...|||||++...   .|+..+||||||+|+|||+||..||.. +      ..+..+..+=
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~------~~dqIifmVG  606 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-Q------NRDQIIFMVG  606 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-C------ChhheEEEec
Confidence            9975432  22223344578899999988743   689999999999999999999999872 1      1122222222


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +..+.+............+.+|+..||..++++||.+.+++..+....+
T Consensus       607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            2323333333233344457789999999999999999999997665554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-43  Score=341.89  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             hhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||.||+|..      .+++.||||++.......  ....+.+|++++..+ +||||++++++|...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS--EHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH--HHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            46789999999999999999963      245689999997643322  236788999999999 899999999998764


Q ss_pred             C-EEEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 013793          215 K-CMFLIYEYMERGSLFCILHNDDE-------------------------------------------------------  238 (436)
Q Consensus       215 ~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  238 (436)
                      + ..++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 58899999999999999875321                                                       


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC--cccccccc
Q 013793          239 ----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTY  312 (436)
Q Consensus       239 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~  312 (436)
                          ...+++.++..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++........  .....++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                135888899999999999999999   789999999999999999999999999999865432221  12234567


Q ss_pred             ccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHH
Q 013793          313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTIS  391 (436)
Q Consensus       313 ~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~  391 (436)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||.....      .........+..... ...   .....+.+++
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~~~-~~~---~~~~~l~~li  310 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------NEEFCQRLKDGTRMR-APE---NATPEIYRIM  310 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHhcCCCCC-CCC---CCCHHHHHHH
Confidence            8999999999999999999999999999997 9999863211      011111111111111 000   1122367899


Q ss_pred             hhccCCCCCCCCCHHHHHHHHhh
Q 013793          392 FACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       392 ~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+||+.||++|||+.|+++.+..
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHH
Confidence            99999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.2e-44  Score=342.38  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=209.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999765 68999999997654333334467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999997654   6888999999999999999999   889999999999999999999999999999866432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                         .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....       .......+....+..+..    
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~p~~----  237 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYEKILAGRLKFPNW----  237 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcCCcCCCCC----
Confidence               223568999999999999999999999999999999999999986321       111122222222221111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                       ....+.+++.+||+.||.+||+     +.++++|+|+..
T Consensus       238 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        238 -FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             -CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence             1123668999999999999997     899999999865

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-44  Score=359.30  Aligned_cols=256  Identities=26%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      ..+....+.||+|.||.||+|+..      +...||||.++.......  ..+|++|++++..++|||||+++|.|.+++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~--~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQA--RQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHH--HHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            344556778999999999999653      345799999998766533  489999999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          216 CMFLIYEYMERGSLFCILHNDDE-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      ..++|+|||..|+|.++|.....           ..+|+..+.+.|+.|||.||.||-   +..+|||||..+|+|+.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence            99999999999999999964321           234889999999999999999999   8899999999999999999


Q ss_pred             CCeEEeecccccccCCCCCCc--cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcc
Q 013793          285 LEAFVADFGTARRLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPK  361 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~  361 (436)
                      ..+||+|||+++..-..+...  ....-..+|||||.+..+++|++||||||||+|||+++ |+.|+...+.       +
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~  712 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------Q  712 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------H
Confidence            999999999998664332221  11223568999999999999999999999999999997 9999864321       2


Q ss_pred             cchhhhhcCCC-CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          362 IMLIDVLDQRL-PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       362 ~~~~~~~~~~l-~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..+..+....+ +-+.     .....+..|+..||+.+|++||++.||-..|..
T Consensus       713 EVIe~i~~g~lL~~Pe-----~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  713 EVIECIRAGQLLSCPE-----NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             HHHHHHHcCCcccCCC-----CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence            22333333332 2222     334557889999999999999999999888754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=328.29  Aligned_cols=256  Identities=22%  Similarity=0.367  Sum_probs=218.9

Q ss_pred             hhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..+|++.+.||+|+||.|-+|. ...|+.||||.++.....++...-.+.+|+++|+.++||||++++++|++.+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3467888899999999999994 578999999999988887777777889999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||..+|.|++++...+   .|++.+++.+++||..|+.|+|   .++++|||||.+|||+|.++++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999998776   7999999999999999999999   88999999999999999999999999999987753


Q ss_pred             CCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                       .....+++|++-|.+||...+..| .+.+|-||+||+||-|+.|..||+..       +-.....++-......+... 
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~lvrQIs~GaYrEP~~P-  276 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRLVRQISRGAYREPETP-  276 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-------hHHHHHHHhhcccccCCCCC-
Confidence             445677899999999999999987 57899999999999999999999832       22222333333222221111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                           ....-|+++||..+|++|-|+.+|..|.|....
T Consensus       277 -----SdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  277 -----SDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             -----chHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence                 113458899999999999999999999997654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=338.15  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=202.7

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||+|+||.||++... +++.||+|.+.............+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999764 6889999998754433333346788899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA  309 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  309 (436)
                      .+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99997643   6899999999999999999999   88999999999999999999999999999986543333344567


Q ss_pred             cccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHH
Q 013793          310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST  389 (436)
Q Consensus       310 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  389 (436)
                      ||+.|+|||.+.+..++.++|||||||++|||+||+.||....       ...............+..     ....+.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~~  222 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEPLRFPDG-----FDRDAKD  222 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCCCCCc-----CCHHHHH
Confidence            9999999999999999999999999999999999999986321       111122222222211111     1123668


Q ss_pred             HHhhccCCCCCCCC---CHHHHHHHHhhcCC
Q 013793          390 ISFACLQSNPKSRP---TMQYVSQGFLITRK  417 (436)
Q Consensus       390 l~~~cl~~dP~~RP---t~~ev~~~l~~~~~  417 (436)
                      ++.+||+.||++||   ++.|++.|+|+...
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            89999999999997   58999999998763

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-44  Score=342.64  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=209.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.||+|++.............+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999765 68999999997654333334567889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997544   6889999999999999999999   78999999999999999999999999999976543 


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc--CCCCCCCCh-
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQ-  378 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~-  378 (436)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+..  ..+..+... 
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~  224 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-------NETWENLKYWKETLQRPVYDD  224 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-------HHHHHHHHhccccccCCCCCc
Confidence              22345689999999999999999999999999999999999999863211       000111110  011111000 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ........+.+++.+||..+|++||++.++++|+|+...
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            001112346788999999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-43  Score=337.89  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=203.1

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      +.||+|+||.||++.. .+|+.||+|++.............+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999965 478999999997654333333467788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccc
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      +|..++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9998887543   6899999999999999999999   789999999999999999999999999998764333333344


Q ss_pred             cccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCChhHHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQKVIQDIL  385 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~  385 (436)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||....       ............  ++...       ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~-------~~  220 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRTL-------SP  220 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCCCCCCCC-------CH
Confidence            679999999999999999999999999999999999999986221       111112222222  22212       12


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          386 LASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      .+.+++.+||+.||++||     ++.++++|.|+..
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            356899999999999998     9999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.2e-43  Score=329.24  Aligned_cols=247  Identities=21%  Similarity=0.292  Sum_probs=199.1

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCEEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKCMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  224 (436)
                      ..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 788999999987655444445788899999999999999999999877    34689999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      ++|+|.+++....   .+++....+++.+++.||+|||+  ..+++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999997653   68999999999999999999994  2488899999999999999999999999998654322  


Q ss_pred             cccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          305 RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       305 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                       ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||....       .......+.......+.+.   .
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~---~  246 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDLIINKNNSLKLPL---D  246 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcCCCCCCCC---c
Confidence             23457889999999876  688999999999999999999999997321       1111122221111111111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+.+++.+||+.||++|||+.|+++.+..
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            12347789999999999999999999998754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-43  Score=341.22  Aligned_cols=254  Identities=23%  Similarity=0.323  Sum_probs=207.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC--CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|...  ++..||+|.+.............+.+|++++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            356889999999999999999654  346899999875443333334678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997654   6899999999999999999999   8899999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.......+... 
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~-  251 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-------PLLIYQKILEGIIYFPKFL-  251 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-------HHHHHHHHhcCCCCCCCCC-
Confidence            32   234568999999999998889999999999999999999999986321       1111222332222111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          380 VIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                          ...+.+++.+|++.||++|+     +++++++|+|+..
T Consensus       252 ----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        252 ----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             ----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence                12256899999999999995     9999999999865

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.7e-43  Score=338.19  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=202.8

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      +.||+|+||.||++.. .+++.||+|++.............+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3599999999999965 478999999997654333333467888999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccc
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      +|..++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9998887543   6899999999999999999999   889999999999999999999999999998764333333344


Q ss_pred             cccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--CCCCCCChhHHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQDIL  385 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~  385 (436)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ......+...  .++...       ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~p~~~-------~~  220 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEDIKFPRTL-------SA  220 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccCCccCCCCC-------CH
Confidence            5799999999999988999999999999999999999999863211       1111111111  122222       12


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          386 LASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      .+.+++.+||+.||++||     ++.|+++|+|+..
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            366889999999999997     8999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=353.34  Aligned_cols=265  Identities=31%  Similarity=0.494  Sum_probs=221.0

Q ss_pred             CcccHHHHHHHhhcc---------cccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHh
Q 013793          131 GRIFYEDLIEATEDF---------HIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLS  197 (436)
Q Consensus       131 ~~~~~~~l~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~  197 (436)
                      ...+|||-.+|...|         .+.++||.|.||.||+|+++-    ...||||.++....+..  ..+|..|..+|.
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq--rrdFL~EAsIMG  685 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ--RRDFLSEASIMG  685 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH--Hhhhhhhhhhcc
Confidence            356677766555444         467899999999999997752    34699999998876543  488999999999


Q ss_pred             hccCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 013793          198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  277 (436)
Q Consensus       198 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~  277 (436)
                      +++||||++|.|+.......+||.|||+||+|..+|+.++.  .+++.+...+.++||.|+.||.   +.++|||||.++
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAAR  760 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAAR  760 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhh
Confidence            99999999999999999999999999999999999998764  5999999999999999999999   889999999999


Q ss_pred             ceeecCCCCeEEeecccccccCCCCCC-cccccc--ccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccccc
Q 013793          278 NILLNSKLEAFVADFGTARRLHADSSN-RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS  353 (436)
Q Consensus       278 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  353 (436)
                      |||++.+..+|++|||+++.+.++... .+...|  ..+|.|||.+..++++.+|||||||+|+||.++ |.+||..++ 
T Consensus       761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-  839 (996)
T KOG0196|consen  761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-  839 (996)
T ss_pred             heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-
Confidence            999999999999999999988655432 222223  468999999999999999999999999999985 999986332 


Q ss_pred             ccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          354 LSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                           ..+....-.-+.+++++.+.     ...+.+|++.||++|-.+||++.|++..+-
T Consensus       840 -----NQdVIkaIe~gyRLPpPmDC-----P~aL~qLMldCWqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  840 -----NQDVIKAIEQGYRLPPPMDC-----PAALYQLMLDCWQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             -----hHHHHHHHHhccCCCCCCCC-----cHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence                 12222222235678887765     334788999999999999999999998873

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-42  Score=334.18  Aligned_cols=266  Identities=25%  Similarity=0.350  Sum_probs=207.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||++... ++..+|+|.+......  .....+.+|++++.+++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            367899999999999999999765 6889999998765322  2246789999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999997644   58899999999999999999994  24699999999999999999999999999976533


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc------cCC----CCc----------
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL------SSS----SDP----------  360 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~------~~~----~~~----------  360 (436)
                      .  ......|++.|+|||.+.+..++.++|||||||++|||+||+.||......      ...    ...          
T Consensus       157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            2  223456899999999999999999999999999999999999998532110      000    000          


Q ss_pred             ---------------ccch---hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          361 ---------------KIML---IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       361 ---------------~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                                     ....   .+.+.....+....  ......+.+|+.+||+.||++|||+.|+++|+|+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN--GVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCC--ccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                           0000   00000000000000  01123477899999999999999999999999997653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-43  Score=339.18  Aligned_cols=274  Identities=26%  Similarity=0.350  Sum_probs=203.9

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----CEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----KCM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  217 (436)
                      +|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+++++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            478889999999999999965 478999999987532221 1235688999999999999999999988643     247


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+. ++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999995 68988887543   6899999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCC---Ccccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCccccccccC--------CCCcccc-
Q 013793          298 LHADSS---NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIM-  363 (436)
Q Consensus       298 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~~~~-  363 (436)
                      ......   ......||+.|+|||.+.+  ..++.++|||||||++|||+||+.||........        ....... 
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            532221   1234568999999999865  5789999999999999999999999863221000        0000000 


Q ss_pred             ----------hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccc
Q 013793          364 ----------LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAA  425 (436)
Q Consensus       364 ----------~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~  425 (436)
                                ....+....+.+...........+.+++.+||+.||++|||+.|+++|+|+.........+.
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~  304 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS  304 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccc
Confidence                      00001111111110000011233578999999999999999999999999977655444333

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-43  Score=339.89  Aligned_cols=257  Identities=27%  Similarity=0.386  Sum_probs=199.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|+..+.||+|+||.||+|... +++.||||++......  .....+.+|+++++.++|+||+++++++...+..++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            34566788999999999999754 7899999999655432  22467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|....       ..++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986432       3566778899999999999999   789999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ........||..|+|||.+..     ...+.++|||||||++|||++|+.||.....    .+.......... ......
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~-~~~~~~  296 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWASLMCAICM-SQPPEA  296 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhc-cCCCCC
Confidence            333344578999999998743     2345689999999999999999999862110    000000001100 001111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ..   .....+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       297 ~~---~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        297 PA---TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             CC---ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            10   11223678999999999999999999999999988744

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.2e-43  Score=335.89  Aligned_cols=257  Identities=21%  Similarity=0.350  Sum_probs=204.6

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||++... +++.||+|+++..........+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999654 6889999999865443333446788899999988 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99998886543   6899999999999999999999   88999999999999999999999999999875333333334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCC--CcccchhhhhcCCCCCCCChhHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS--DPKIMLIDVLDQRLPPPVDQKVIQDI  384 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~  384 (436)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.||+.........  ........+.......+..     ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~  229 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS-----LS  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC-----CC
Confidence            5679999999999999999999999999999999999999997432211000  0111112222222221111     12


Q ss_pred             HHHHHHHhhccCCCCCCCCC------HHHHHHHHhhcC
Q 013793          385 LLASTISFACLQSNPKSRPT------MQYVSQGFLITR  416 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt------~~ev~~~l~~~~  416 (436)
                      ..+.+++.+||+.||.+||+      +.++++|+|+..
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            23678999999999999997      899999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=316.27  Aligned_cols=275  Identities=23%  Similarity=0.284  Sum_probs=213.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCM  217 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  217 (436)
                      ..++|+..+.|++|+||.||+|+.+ +++.||+|+++...... ..--...+|+.+|.+++|||||.+-.+...  -+.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            3567888899999999999999664 78999999998765322 122345689999999999999999887764  4579


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|||||+. +|...++.-.  .++...++.-++.|+++|++|||   ...|+|||||++|+|++..|.+||+|||+|+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence            999999987 8999988755  47899999999999999999999   88999999999999999999999999999999


Q ss_pred             cCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccc-------------cCCCCcccc
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------SSSSDPKIM  363 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------------~~~~~~~~~  363 (436)
                      +.......+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|...+.+             .....+...
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            98887778888899999999998876 6999999999999999999999877532211             001111100


Q ss_pred             hhhhhc-CCCC-CCCC---hhH--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 013793          364 LIDVLD-QRLP-PPVD---QKV--IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK  422 (436)
Q Consensus       364 ~~~~~~-~~l~-~~~~---~~~--~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~  422 (436)
                      ...... ..++ .+..   ...  ......-.+|+..++..||.+|.|+.|.++|-||...+....
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~  372 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID  372 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence            000000 0000 0000   000  001133567889999999999999999999999988655433

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.2e-43  Score=327.95  Aligned_cols=256  Identities=25%  Similarity=0.308  Sum_probs=203.4

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||+|+||+||++... +++.||+|.+...........+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999654 7899999998765444333346678899999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcccc
Q 013793          230 FCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL  308 (436)
Q Consensus       230 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  308 (436)
                      ..++.... ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            88875422 2346899999999999999999999   7899999999999999999999999999998765443334445


Q ss_pred             ccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHH
Q 013793          309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAS  388 (436)
Q Consensus       309 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  388 (436)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......   .................+     ......+.
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~  229 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILNDSVTYP-----DKFSPASK  229 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHhhcccCCCCc-----ccCCHHHH
Confidence            7899999999999999999999999999999999999998632110   000001111111111100     11223367


Q ss_pred             HHHhhccCCCCCCCC-----CHHHHHHHHhhcCC
Q 013793          389 TISFACLQSNPKSRP-----TMQYVSQGFLITRK  417 (436)
Q Consensus       389 ~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~  417 (436)
                      +++.+||+.||++||     +++++++|+|+..-
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            899999999999999     88999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=343.78  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||+||+|... +++.||+|++.............+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999765 78999999997654333233467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999997653   6899999999999999999999   789999999999999999999999999999876543


Q ss_pred             C-----------------------------CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          302 S-----------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       302 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                      .                             .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            3                             12234568999999999999999999999999999999999999986322


Q ss_pred             cccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhhcC
Q 013793          353 SLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT-MQYVSQGFLITR  416 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~ev~~~l~~~~  416 (436)
                      .       ......+..  ..+..+....   ....+.+++.+|+. ||.+||+ +.++++|+|+..
T Consensus       235 ~-------~~~~~~i~~~~~~~~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         235 L-------QETYNKIINWKESLRFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             H-------HHHHHHHhccCCcccCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            1       111112222  1111111110   12236678889997 9999999 999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.8e-43  Score=330.48  Aligned_cols=264  Identities=20%  Similarity=0.259  Sum_probs=200.6

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||+||+|... +++.||+|.+........  ...+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc--chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            56888999999999999999654 789999999875432211  246678999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99985 8988886543  25788999999999999999999   889999999999999999999999999999765433


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc--------c
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI--------M  363 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~--------~  363 (436)
                      ........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||.......         .......        .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            333344568999999998865 568999999999999999999999985321100         0000000        0


Q ss_pred             hhhhhcCCCCC-CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          364 LIDVLDQRLPP-PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       364 ~~~~~~~~l~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ......+.... +.............+++.+||+.||.+|||++|+++|+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            00000000000 0000000112236789999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=328.13  Aligned_cols=271  Identities=24%  Similarity=0.323  Sum_probs=211.5

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH-----------HHHHHHHHHHHHHhhccCCCceeee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL-----------AFIKSFRNEAQVLSQVLHRSIVKLY  208 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~  208 (436)
                      ..++|++...||+|.||.|-+|+. .+++.||||++........           ...+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            457899999999999999999965 4799999999976533211           1135788999999999999999999


Q ss_pred             eEEeeC--CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC
Q 013793          209 GFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  286 (436)
Q Consensus       209 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  286 (436)
                      ++..+.  +.+|||+|||..|.+...=..   ...++..++++++.++..||.|||   .+|||||||||+|+|++++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            999875  579999999998877543322   223999999999999999999999   889999999999999999999


Q ss_pred             eEEeecccccccCCCC-----CCccccccccccccccccccC----ccCcchhhHHHHHHHHHHHhCCCCccccccccCC
Q 013793          287 AFVADFGTARRLHADS-----SNRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS  357 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  357 (436)
                      +||+|||.+.......     .......|||.|+|||...++    ..+.+.||||+||+||.|+.|+.||-...     
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-----  323 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-----  323 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence            9999999987653221     112346799999999988774    24678999999999999999999985211     


Q ss_pred             CCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccccc
Q 013793          358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQ  427 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~~  427 (436)
                        .......++...+..+...   +....+.+|+.++|.+||++|.+..+|..|+|..+.-....+....
T Consensus       324 --~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~  388 (576)
T KOG0585|consen  324 --ELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPS  388 (576)
T ss_pred             --HHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcc
Confidence              1112334444444433322   2233477899999999999999999999999999885444433333

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.9e-43  Score=331.09  Aligned_cols=269  Identities=22%  Similarity=0.287  Sum_probs=203.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +++.||+|++........  ...+.+|+.+++.++||||+++.+++.+....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            467999999999999999999765 789999999875432221  24567899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 57877776532  35888999999999999999999   88999999999999999999999999999976543


Q ss_pred             CCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC----------CCCcccch--h--
Q 013793          301 DSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS----------SSDPKIML--I--  365 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------~~~~~~~~--~--  365 (436)
                      .........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........          ......+.  .  
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            3333344568999999998765 4578999999999999999999999964321100          00000000  0  


Q ss_pred             -hhhcCCCCCCCChhHHH------HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          366 -DVLDQRLPPPVDQKVIQ------DILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       366 -~~~~~~l~~~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       .................      ....+.+++.+|++.||++|||+.|+++|+|+...+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence             00000000000000000      012366899999999999999999999999997653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.3e-43  Score=335.29  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||++... +++.||+|.+.............+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999754 6889999999865433333346678888888877 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99998886543   6899999999999999999999   78999999999999999999999999999976433333334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc--ccchhhhhcCCCCCCCChhHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIMLIDVLDQRLPPPVDQKVIQDI  384 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~  384 (436)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||............  ..............+..     ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-----~~  229 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-----LS  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC-----CC
Confidence            567899999999999999999999999999999999999999643211111000  01111122222211111     12


Q ss_pred             HHHHHHHhhccCCCCCCCCC------HHHHHHHHhhcC
Q 013793          385 LLASTISFACLQSNPKSRPT------MQYVSQGFLITR  416 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt------~~ev~~~l~~~~  416 (436)
                      ..+.+++.+||+.||++||+      +.++++|+|+..
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            23668999999999999998      689999998854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-42  Score=333.34  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHH---hhccCCCceeeeeEEeeCCEEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      |++.+.||+|+||.||+|.. .+++.||||++...........+.+.+|.+++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56788999999999999965 47899999999765432222335566666554   567899999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|..+++..    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999999888643    5899999999999999999999   88999999999999999999999999999875433


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........|++.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..   
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~---  223 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-------EEEVFDSIVNDEVRYPRF---  223 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCC---
Confidence            3333445679999999999999999999999999999999999999986321       111122222222111111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                        ....+.+++.+||+.||.+||     ++.++++++|+..
T Consensus       224 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         224 --LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             --CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence              112356799999999999999     7999999998765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.9e-43  Score=334.24  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=201.8

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||+||+|... +++.||+|++.............+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 6889999998764332223346677888888877 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999887654   6899999999999999999999   88999999999999999999999999999876433333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILNDEVVYPTW-----LSQD  222 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHH
Confidence            5679999999999998899999999999999999999999986321       111122222222211111     1123


Q ss_pred             HHHHHhhccCCCCCCCCCH------HHHHHHHhhcC
Q 013793          387 ASTISFACLQSNPKSRPTM------QYVSQGFLITR  416 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~------~ev~~~l~~~~  416 (436)
                      +.+++.+||+.||++||++      +++++|+|+..
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            6689999999999999998      99999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-42  Score=337.88  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||++... +++.||+|++.............+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999654 68999999997654433344567889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999997653   6899999999999999999999   889999999999999999999999999998754321


Q ss_pred             CC-----------------------------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCC
Q 013793          302 SS-----------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH  346 (436)
Q Consensus       302 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~  346 (436)
                      ..                                   ......||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                   0123469999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCcccchhhhhc--C--CCCCCCChhHHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          347 PRDLLSSLSSSSDPKIMLIDVLD--Q--RLPPPVDQKVIQDILLASTISFA--CLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       347 p~~~~~~~~~~~~~~~~~~~~~~--~--~l~~~~~~~~~~~~~~~~~l~~~--cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ||....       .......+..  .  .+++...  ..   ..+.+++.+  |...++..||+++|+++|+|+...
T Consensus       235 Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~~--~s---~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         235 PFCSET-------PQETYKKVMNWKETLIFPPEVP--IS---EKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCCC-------HHHHHHHHHcCcCcccCCCcCC--CC---HHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            996321       1111122221  1  1121111  11   123344444  333344567999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.1e-43  Score=336.70  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=202.0

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      +.||+|+||.||++.. .+|+.||+|.+.............+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 578999999997654333333467788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccc
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      +|..++....   .+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            9999887543   68999999999999999999993  269999999999999999999999999998764333333344


Q ss_pred             cccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCChhHHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQKVIQDIL  385 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~  385 (436)
                      ..||+.|+|||++.+..++.++|||||||++|||+||+.||....       .......+....  ++...       ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~-------~~  221 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRTL-------SP  221 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-------HHHHHHHHhcCCCCCCCCC-------CH
Confidence            569999999999999999999999999999999999999985211       111111111111  12212       12


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          386 LASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      .+.+++.+||+.||++|+     ++.++++|+|+..
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            366889999999999996     9999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-44  Score=337.29  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=203.8

Q ss_pred             cccHHHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEE
Q 013793          132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFC  211 (436)
Q Consensus       132 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  211 (436)
                      .+.|+++.+       .+-||.|+.|.||+|++. ++.||||+++.-+.          .+++-|++++||||+.+.|+|
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE----------TdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE----------TDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhhh----------hhHHHHHhccCcceeeEeeee
Confidence            345555544       355999999999999985 57789998765432          478889999999999999999


Q ss_pred             eeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          212 LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       212 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                      .....++||||||+.|-|...|+..+   .+.......+..+||.|+.|||   ...|||||||+-||||..+..+||+|
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecc
Confidence            99999999999999999999998665   6788888899999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      ||.++..... +....++||..|||||++....+++|+||||||||||||+||..||......       ..+..+=...
T Consensus       256 FGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwGVGsNs  327 (904)
T KOG4721|consen  256 FGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWGVGSNS  327 (904)
T ss_pred             ccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------eeEEeccCCc
Confidence            9999876543 5566789999999999999999999999999999999999999998743221       1111111222


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +.-+...   .+..-+.-|+..||+..|..||+++++++|+....+
T Consensus       328 L~LpvPs---tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  328 LHLPVPS---TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             ccccCcc---cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            2222221   112224457789999999999999999999865443

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-42  Score=333.12  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=202.4

Q ss_pred             ceeeecCceEEEEEEc----CCCCEEEEEEecCcchh-hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          149 YCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      +.||+|+||.||++..    .+++.||+|.+...... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    36789999999764322 112235678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999997644   5788899999999999999999   78999999999999999999999999999875443333


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.......+..     .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~~~~~~~~~-----~  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILKGKLNLPPY-----L  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----C
Confidence            3344579999999999998889999999999999999999999986321       111122222222221111     1


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          384 ILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      ...+.+++.+||+.||++||     ++.++++|+|+..
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            12366899999999999999     8999999999865

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-42  Score=333.06  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC-CCceeeeeEEeeCCEEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  221 (436)
                      +|++.+.||+|+||.||+|... +++.||+|++.............+..|.+++..++| ++|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788999999999999999655 678999999976533222334677889999999976 56888899999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999987544   6889999999999999999999   789999999999999999999999999998754333


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||....       .......+.......+..    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~~~~~~~~----  223 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQSIMEHNVSYPKS----  223 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC----
Confidence            333344578999999999999999999999999999999999999986321       111122222222211111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCH-----HHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPTM-----QYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~-----~ev~~~l~~~~  416 (436)
                       ....+.+++.+||+.||.+||+.     +++.+|+|+.+
T Consensus       224 -~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         224 -LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             -CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence             11236688999999999999976     89999998765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.6e-43  Score=341.26  Aligned_cols=257  Identities=22%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .|+..+.||+|+||+||+|.. .+++.||+|++.............+.+|++++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578899999999999999965 5788999999976544333445778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999997654   6888999999999999999999   8899999999999999999999999999976431100


Q ss_pred             C-----------------------------------------------CccccccccccccccccccCccCcchhhHHHH
Q 013793          303 S-----------------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG  335 (436)
Q Consensus       303 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G  335 (436)
                      .                                               ......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                               01234699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 013793          336 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFA--CLQSNPKSRPTMQYVSQG  411 (436)
Q Consensus       336 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~--cl~~dP~~RPt~~ev~~~  411 (436)
                      |++|||+||+.||....       .......+..  ..+..+...   .....+.+++.+  |+..+|..||++.|+++|
T Consensus       236 ~il~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~---~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         236 VILFEMLVGQPPFLAPT-------PTETQLKVINWENTLHIPPQV---KLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             hHHHHHHhCCCCCcCCC-------HHHHHHHHHccccccCCCCCC---CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999999996321       1111111211  111111110   011224456655  667777789999999999


Q ss_pred             HhhcC
Q 013793          412 FLITR  416 (436)
Q Consensus       412 l~~~~  416 (436)
                      +|+..
T Consensus       306 p~f~~  310 (381)
T cd05626         306 PFFSE  310 (381)
T ss_pred             cccCC
Confidence            99865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-42  Score=327.18  Aligned_cols=265  Identities=23%  Similarity=0.278  Sum_probs=202.9

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||++... +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            36889999999999999999765 68899999987653322 22367788999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++++.+..+....   ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999998776554432   26889999999999999999999   889999999999999999999999999999876432


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC--------CCCcccchhhh-hc--
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIMLIDV-LD--  369 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~-~~--  369 (436)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|+.||........        ...+....... .+  
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            22 22335689999999999988899999999999999999999999864221000        00000000000 00  


Q ss_pred             ---CCCCCCCC-hh-----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          370 ---QRLPPPVD-QK-----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       370 ---~~l~~~~~-~~-----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ...+.... ..     .......+.+++.+||+.||++|||++|+++|+|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               00000000 00     00112347899999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=341.35  Aligned_cols=258  Identities=25%  Similarity=0.359  Sum_probs=205.7

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|... +++.||||++.............+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999764 68999999997654333334467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999997654   6899999999999999999999   889999999999999999999999999998764321


Q ss_pred             CC--------------------------------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHh
Q 013793          302 SS--------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM  343 (436)
Q Consensus       302 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt  343 (436)
                      ..                                      ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                      0012358999999999999899999999999999999999


Q ss_pred             CCCCccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHHhhcCC
Q 013793          344 GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT---MQYVSQGFLITRK  417 (436)
Q Consensus       344 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~ev~~~l~~~~~  417 (436)
                      |+.||.....       ......+..  ..+..+....   ....+.+++.+|+. +|.+|++   +.|+++|+|+...
T Consensus       235 G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~---~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         235 GYPPFCSDNP-------QETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCCCH-------HHHHHHHHcCCCccCCCCCCC---CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999863221       111111211  1111111111   11235678888886 9999998   9999999998653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-42  Score=337.40  Aligned_cols=261  Identities=22%  Similarity=0.261  Sum_probs=202.1

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+|++.+.||+|+||.||++.. .+++.||+|....         ..+.+|++++++++||||+++++++......++|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            5799999999999999999965 5789999996432         34568999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |++. ++|..++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus       163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            9995 68888886543   6889999999999999999999   789999999999999999999999999999754322


Q ss_pred             C-CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccc-----------------
Q 013793          302 S-SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM-----------------  363 (436)
Q Consensus       302 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~-----------------  363 (436)
                      . .......||+.|+|||++.+..++.++|||||||++|||+||+.|+-..............                 
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            1 2233457999999999999989999999999999999999999886422111110000000                 


Q ss_pred             -----hhhhh----cCCC--C--CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          364 -----LIDVL----DQRL--P--PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       364 -----~~~~~----~~~l--~--~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                           .....    ....  +  .+...........+.+++.+||+.||++|||+.|+++|+|+...+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                 00000    0000  0  0011111122345778999999999999999999999999977543

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-42  Score=333.04  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||+|... +++.||+|++.............+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35999999999999765 5789999999765433333345677888888876 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99999887543   6889999999999999999999   78999999999999999999999999999876543333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||+||+.||....       .......+.......+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-----~~~~  222 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-------EDDLFESILHDDVLYPVW-----LSKE  222 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----CCHH
Confidence            5678999999999999899999999999999999999999996321       111222222222211111     1123


Q ss_pred             HHHHHhhccCCCCCCCC-------CHHHHHHHHhhcC
Q 013793          387 ASTISFACLQSNPKSRP-------TMQYVSQGFLITR  416 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RP-------t~~ev~~~l~~~~  416 (436)
                      +.+++.+||+.||++||       ++.++++|+|+..
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            66889999999999999       9999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-42  Score=331.14  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=204.8

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +|++.+.||+|+||.||+|... +++.||+|.+.............+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999999665 6789999999765433333345567788888777 5899999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999887543   6889999999999999999999   789999999999999999999999999999764433


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........||+.|+|||++.+..++.++|||||||++|||+||+.||....       .......+.......+..    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~p~~----  223 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKS----  223 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCc----
Confidence            333445679999999999999999999999999999999999999986321       112222233322221111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                       ....+.+++.+|++.||++|++     ..++.+|.|+..
T Consensus       224 -~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         224 -MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             -CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence             1223668999999999999998     488999888753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.8e-42  Score=331.05  Aligned_cols=257  Identities=22%  Similarity=0.347  Sum_probs=203.5

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||++.. .+++.||+|++...........+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999965 46789999999876544444456788999999888 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99998886543   6899999999999999999999   78999999999999999999999999999975433333334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||+||+.||+.........................+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~~~  229 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF-----LSVK  229 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC-----CCHH
Confidence            56799999999999999999999999999999999999999963221111111111112222222211111     1123


Q ss_pred             HHHHHhhccCCCCCCCCC------HHHHHHHHhhcC
Q 013793          387 ASTISFACLQSNPKSRPT------MQYVSQGFLITR  416 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt------~~ev~~~l~~~~  416 (436)
                      +.+++.+||+.||++||+      +.++.+|+|+..
T Consensus       230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            568899999999999998      579999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=328.18  Aligned_cols=257  Identities=31%  Similarity=0.458  Sum_probs=215.6

Q ss_pred             hcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ..|...+.||+|.||.||+|. ...++.||+|++.......  ....+.+|+.++.+++++||.+++|.+..+...+++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            456667889999999999995 4589999999998765543  2478899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |||.||++.+.+....   .+++.++.-|++++..||.|||   ..+.+|||||+.|||+..+|.+|++|||.+-.+...
T Consensus        91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999997654   4577788889999999999999   889999999999999999999999999999888766


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .....+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.....+        ...-.+.+..++....   
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlflIpk~~PP~L~~---  233 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFLIPKSAPPRLDG---  233 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEeccCCCCCcccc---
Confidence            66567789999999999999889999999999999999999999998633221        1112222223333322   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .....+.+++..||+.||+.||++.++++|-+.++.+
T Consensus       234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            2233367899999999999999999999999887744

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=338.00  Aligned_cols=263  Identities=28%  Similarity=0.423  Sum_probs=207.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC--CC--CE-EEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--NG--KV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++-...++||+|+||.||+|.+.  ++  .. ||||..+...........++.+|.++|++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            344555689999999999999654  33  23 89999987544445557899999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++|||+|+||+|.++|.....  .++..+++.++.+.|+||+|||   +.+++||||.++|+|++.++.+||+|||+++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999988754  5899999999999999999999   8899999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .-...........-...|+|||.+....++.++|||||||++||+++ |..||.....       ......+.....+.+
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------YEVKAKIVKNGYRMP  383 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------HHHHHHHHhcCccCC
Confidence            64311111111224568999999999999999999999999999998 8889874322       112222322222222


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .+...   ...+..++.+||..+|++||+|.++.+.+.......
T Consensus       384 ~~~~~---p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  384 IPSKT---PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             CCCCC---HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence            22211   223556777999999999999999999886655543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3e-42  Score=336.70  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=202.1

Q ss_pred             HhhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      ..++|++.+.||+|+||.||+|..      .++..||||+++......  ..+.+.+|+.++..+ +||||++++++|..
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            345788999999999999999953      246689999997554322  236788999999999 89999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDE-------------------------------------------------------  238 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  238 (436)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999998864321                                                       


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          239 -----------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       239 -----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                                       ...+++..+++++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             125789999999999999999999   789999999999999999999999999999866433


Q ss_pred             CCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          302 SSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       302 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .......+..........
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIKEGYRMLSPE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHHhCccCCCCC
Confidence            221  112335667999999999999999999999999999998 8888753211       111112222211111110


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .....+.+++.+||+.||++||++.||++.++.
T Consensus       341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               011236789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.8e-42  Score=329.43  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=197.3

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||+|... +++.||+|.++..........+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 6889999999765432222335556677777654 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99999987543   6889999999999999999999   78999999999999999999999999999986543333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-------EDELFDSILNDRPHFPRW-----ISKE  222 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----CCHH
Confidence            5679999999999999899999999999999999999999986321       111111222111111111     1123


Q ss_pred             HHHHHhhccCCCCCCCCCHH-HHHHHHhhcC
Q 013793          387 ASTISFACLQSNPKSRPTMQ-YVSQGFLITR  416 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~~-ev~~~l~~~~  416 (436)
                      +.+++.+||+.||++||++. ++++|+|+..
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence            56788999999999999875 7888888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6e-42  Score=329.49  Aligned_cols=266  Identities=24%  Similarity=0.349  Sum_probs=206.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||++... ++..+|+|.+......  .....+.+|+++++.++||||++++++|.+.+..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            367999999999999999999765 6888999988765322  2236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..+..++.+++.||.|||+  ..+|+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999997643   58889999999999999999994  34799999999999999999999999999976532


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc----------cCCCCcc---------
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSDPK---------  361 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------~~~~~~~---------  361 (436)
                      .  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......          .......         
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            2  223356899999999999888999999999999999999999998632110          0000000         


Q ss_pred             --------------cch---hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          362 --------------IML---IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       362 --------------~~~---~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                                    ...   .+.+.....+.....  .....+.+++.+||+.||++|||+.|+++|+|++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSG--VFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCC--CcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                          000   000000000000000  0112367899999999999999999999999997664

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-42  Score=338.08  Aligned_cols=259  Identities=26%  Similarity=0.353  Sum_probs=206.9

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||.||++... +++.||+|.+.............+.+|+++++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999664 688999999975433222233567889999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++|+|.+++...    .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999998653    4788889999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccccccccC----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--C
Q 013793          300 ADSS-NRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--L  372 (436)
Q Consensus       300 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l  372 (436)
                      .... ......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....       ......+....  +
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~  266 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKNSL  266 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCcC
Confidence            3322 22345699999999988653    478999999999999999999999863211       11122222221  1


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHhhcC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKS--RPTMQYVSQGFLITR  416 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~ev~~~l~~~~  416 (436)
                      ..+..   ......+.+++.+|++.+|++  ||++.|+++|+|++.
T Consensus       267 ~~~~~---~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         267 TFPDD---IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             CCCCc---CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            11111   011234678999999999988  999999999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-42  Score=327.34  Aligned_cols=262  Identities=22%  Similarity=0.325  Sum_probs=197.2

Q ss_pred             hcccccceeeecCceEEEEEEcCC-----------------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCce
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN-----------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV  205 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  205 (436)
                      ++|.+.+.||+|+||.||++...+                 +..||+|.+.......  ....+.+|++++.+++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH--HHHHHHHHHHHHhhcCCCCee
Confidence            568889999999999999996532                 3469999987654322  246789999999999999999


Q ss_pred             eeeeEEeeCCEEEEEEeeccCCChhhhhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 013793          206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDD----------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  269 (436)
Q Consensus       206 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  269 (436)
                      ++++++.+.+..++||||+++|+|.+++....                ....+++..+++++.|++.||+|||   +.+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            99999999999999999999999999886431                1135788999999999999999999   7899


Q ss_pred             EecCCCCCceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh--CC
Q 013793          270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GK  345 (436)
Q Consensus       270 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~  345 (436)
                      +||||||+|||+++++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999999865432211  122345778999999988899999999999999999997  45


Q ss_pred             CCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          346 HPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       346 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .||.......    ...........................+.+++.+||+.||++|||+.||.+.+.
T Consensus       240 ~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDEQ----VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHHH----HHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6665221100    000000111100000000000011123678999999999999999999988763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=324.63  Aligned_cols=261  Identities=24%  Similarity=0.273  Sum_probs=206.8

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|+||+||++.. .+++.||+|++.............+.+|+.+++.++||||+++.+.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999975 4789999999976544333333567789999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998886542 236899999999999999999999   7899999999999999999999999999998754322


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                       ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.....    ..........+.... .....   .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~-~~~~~---~  227 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKEDQ-EEYSE---K  227 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhcc-cccCc---c
Confidence             22334689999999999988999999999999999999999999863111    000000111111111 11111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCC
Q 013793          383 DILLASTISFACLQSNPKSRP-----TMQYVSQGFLITRK  417 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~  417 (436)
                      ....+.+++.+||+.||++||     ++.++++++|+...
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            122367899999999999999     89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-42  Score=329.30  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||+||++... +++.||+|++.............+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 6789999999865433333346677888888888 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99999887653   6899999999999999999999   88999999999999999999999999999875433333334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..     ....
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILEDEVRYPRW-----LSKE  222 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCc-----CCHH
Confidence            4568999999999999999999999999999999999999986321       111111222222111111     1123


Q ss_pred             HHHHHhhccCCCCCCCCCH-----HHHHHHHhhcC
Q 013793          387 ASTISFACLQSNPKSRPTM-----QYVSQGFLITR  416 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~-----~ev~~~l~~~~  416 (436)
                      +.+++.+||+.||++||++     .++++++|+..
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            6789999999999999999     99999999866

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=339.95  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++.. .+++.||||++...........+.+.+|++++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999965 578999999987654333344577889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999997543   6889999999999999999999   889999999999999999999999999998643210


Q ss_pred             CC-----------------------------------------------CccccccccccccccccccCccCcchhhHHH
Q 013793          302 SS-----------------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSF  334 (436)
Q Consensus       302 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~  334 (436)
                      ..                                               ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                               0012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCC---CCHHHHH
Q 013793          335 GVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSR---PTMQYVS  409 (436)
Q Consensus       335 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Pt~~ev~  409 (436)
                      ||++|||+||+.||.....       ......+..  ..+..+...   .....+.+++.+|+. +|.+|   +++.|++
T Consensus       235 Gvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~---~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS-------HETYRKIINWRETLYFPDDI---HLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH-------HHHHHHHHccCCccCCCCCC---CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999999863211       111111111  111111110   112236678889997 66665   6999999


Q ss_pred             HHHhhcC
Q 013793          410 QGFLITR  416 (436)
Q Consensus       410 ~~l~~~~  416 (436)
                      +|+|+..
T Consensus       304 ~hp~~~~  310 (377)
T cd05629         304 SHPFFRG  310 (377)
T ss_pred             cCCCcCC
Confidence            9999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-42  Score=319.42  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=202.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......   ...+.+|+.++.+++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            35789999999999999999975 578899999997654322   25677899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+++++|.++++...   .+++..+..++.|++.||+|||   +.+|+||||+|+||++++++.++|+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999987543   6889999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .........|+..|+|||.+.   ...++.++||||||+++|||++|+.|+........       ........+..+..
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~  231 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMSKSNFQPPKL  231 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------heeeecCCCCCCCC
Confidence            333333456889999999874   34578899999999999999999999853221100       00001111111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .........+.+++.+||+.+|++|||++++++++|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            101112234778999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.7e-42  Score=327.81  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=197.7

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||+|... +++.||||.++............+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999765 5789999999765322222235566777888765 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999997543   6889999999999999999999   78999999999999999999999999999875433333334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDI  384 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~  384 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+..  ...+...       .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~~~~~~~~-------~  220 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-------EEELFQSIRMDNPCYPRWL-------T  220 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccC-------C
Confidence            4568999999999999899999999999999999999999986321       1111111111  1111111       1


Q ss_pred             HHHHHHHhhccCCCCCCCCCHH-HHHHHHhhcC
Q 013793          385 LLASTISFACLQSNPKSRPTMQ-YVSQGFLITR  416 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt~~-ev~~~l~~~~  416 (436)
                      ..+.+++.+||+.||++||++. ++.+|+|+..
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            2366889999999999999997 8989988755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4e-42  Score=328.39  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=198.3

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||+|... +|+.||+|.++...............|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999765 6889999999764322222235566788887765 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99999987543   6889999999999999999999   88999999999999999999999999999875433333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--CCCCCCChhHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQDI  384 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~  384 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+...  .++...       .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~-------~  220 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFESIRVDTPHYPRWI-------T  220 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCC-------C
Confidence            5679999999999999999999999999999999999999986321       11111111111  111111       1


Q ss_pred             HHHHHHHhhccCCCCCCCCCH-HHHHHHHhhcCC
Q 013793          385 LLASTISFACLQSNPKSRPTM-QYVSQGFLITRK  417 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt~-~ev~~~l~~~~~  417 (436)
                      ..+.+++.+||+.||++||++ +++.+|+|+...
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            236689999999999999998 578889988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-42  Score=325.31  Aligned_cols=265  Identities=24%  Similarity=0.326  Sum_probs=195.4

Q ss_pred             hcccccceeeecCceEEEEEEc--CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc---cCCCceeeeeEEee----
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRSIVKLYGFCLH----  213 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  213 (436)
                      .+|++.+.||+|+||.||+|..  .+++.||+|.+........ ....+.+|+.++..+   +||||++++++|..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            3688899999999999999975  3578899999875432221 113455677666655   69999999999863    


Q ss_pred             -CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          214 -KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       214 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                       ....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence             346899999997 589888875432 35899999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccc
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM  363 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~  363 (436)
                      |+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......         ....+...
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999865433 22334568999999999988899999999999999999999999986432110         00000000


Q ss_pred             hh------hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          364 LI------DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       364 ~~------~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..      .........+...........+.+++.+|++.||++|||+.|+++|+|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            00      0000000000000000112335689999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-42  Score=334.89  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=201.9

Q ss_pred             HhhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      ..++|++.+.||+|+||.||+|..      .++..||+|.+.......  ....+.+|+++++.+ +|+||++++++|..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            456799999999999999999863      234579999997654332  236788999999999 89999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCC--------------------------------------------------------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDD--------------------------------------------------------  237 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  237 (436)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999885421                                                        


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC--
Q 013793          238 -----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--  304 (436)
Q Consensus       238 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  304 (436)
                                 ....+++.++++++.||+.||+|||   +.+|+||||||+|||+++++.++|+|||+++........  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       1125788999999999999999999   789999999999999999999999999999765432211  


Q ss_pred             ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          305 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       305 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....       ...................   .
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~---~  340 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQMSRPDF---A  340 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccCccCCCC---C
Confidence            112335668999999998899999999999999999997 9999863211       1111122222111111110   1


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ...+.+++.+||+.||++|||+.+|++.+..
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            2336789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-42  Score=330.29  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=198.0

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHH-HHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||+||+|... +|+.||+|++.............+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999764 78999999997653322222344555554 56788999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999987543   6889999999999999999999   78999999999999999999999999999876433333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC--CCCCChhHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPVDQKVIQDI  384 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~  384 (436)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.....  ++..       .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~-------~  220 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNILNKPLRLKPNI-------S  220 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCC-------C
Confidence            5679999999999999999999999999999999999999986321       1111222222221  1111       2


Q ss_pred             HHHHHHHhhccCCCCCCCCCH----HHHHHHHhhcC
Q 013793          385 LLASTISFACLQSNPKSRPTM----QYVSQGFLITR  416 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt~----~ev~~~l~~~~  416 (436)
                      ..+.+++.+|++.||.+||++    .++++++|+..
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            236689999999999999987    69999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-42  Score=338.65  Aligned_cols=256  Identities=22%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .|+..+.||+|+||+||+|.. .+++.||+|++.............+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578899999999999999965 4788999999976544333445778899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999997643   5888999999999999999999   7899999999999999999999999999975321000


Q ss_pred             -----------------------------------------------CCccccccccccccccccccCccCcchhhHHHH
Q 013793          303 -----------------------------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG  335 (436)
Q Consensus       303 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G  335 (436)
                                                                     .......||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 013793          336 VVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT---MQYVSQ  410 (436)
Q Consensus       336 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~ev~~  410 (436)
                      |++|||++|+.||.....       ......+..  ..+..+.....   ...+.+++.+|+ .+|.+|++   +.++++
T Consensus       236 vil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~---s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP-------LETQMKVINWQTSLHIPPQAKL---SPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH-------HHHHHHHHccCCCcCCCCcccC---CHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999963211       111111211  11111111111   122445565654 49999997   999999


Q ss_pred             HHhhcC
Q 013793          411 GFLITR  416 (436)
Q Consensus       411 ~l~~~~  416 (436)
                      |+|+..
T Consensus       305 hp~f~~  310 (382)
T cd05625         305 HPFFKT  310 (382)
T ss_pred             CCCcCC
Confidence            999865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-42  Score=333.34  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=203.3

Q ss_pred             cccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchh-hHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      +|++.+.||+|+||.||++..    .+++.||+|++...... .....+.+..|+.++..+ +|+||+++.+++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999864    36889999998754322 122235678899999999 589999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999987543   6899999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc--CCCC
Q 013793          298 LHADSS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLP  373 (436)
Q Consensus       298 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~  373 (436)
                      ...... ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||......   ............  ..++
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER---NTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC---CCHHHHHHHHhcCCCCCC
Confidence            543322 22345699999999998765 4788999999999999999999998632110   000011111111  1112


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      ...       ...+.+++.+||+.||++||     +++++++|+|+..
T Consensus       232 ~~~-------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         232 SFI-------GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCC-------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            111       12356889999999999999     8999999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-42  Score=337.12  Aligned_cols=261  Identities=25%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ...++|++.+.||+|+||.||++... +++.+|+|.+.............+.+|+.+++.++||||+++++++.+....+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999765 68899999986543322223456788999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999999653    4788899999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCC-CccccccccccccccccccC----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--
Q 013793          299 HADSS-NRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--  371 (436)
Q Consensus       299 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  371 (436)
                      ..... ......||+.|+|||.+.+.    .++.++||||+||++|||++|+.||.....       ......+.+..  
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~  265 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKNS  265 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcc
Confidence            43322 22345699999999998754    378899999999999999999999963211       11122222221  


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHhhcCC
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKS--RPTMQYVSQGFLITRK  417 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~ev~~~l~~~~~  417 (436)
                      +..+...   .....+.+++..|+..+|.+  ||++.|+++|+|+...
T Consensus       266 ~~~p~~~---~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         266 LNFPEDV---EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cCCCCcc---cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            1111111   11223557778888755543  8999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.4e-42  Score=327.98  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +|+..+.||+|+||+||+|.. .+|+.||+|++...........+.+..|.+++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467788999999999999965 478999999997653333333466778888888885 577888999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999987543   6899999999999999999999   789999999999999999999999999998764433


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||....       .......+.......+..    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~~~~~p~~----  223 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-------EDELFQSIMEHNVSYPKS----  223 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCcc----
Confidence            333344568999999999998899999999999999999999999986321       112222333322221111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                       ....+.+++.+|++.+|.+|++     ..++.+|+|+..
T Consensus       224 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         224 -LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             -CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence             1123567899999999999997     578888888765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-42  Score=339.60  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=201.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++.. .+++.||||++.............+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688999999999999999965 468999999987654333333467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999997653   5788899999999999999999   789999999999999999999999999997532100


Q ss_pred             C-------------------------------------------CCccccccccccccccccccCccCcchhhHHHHHHH
Q 013793          302 S-------------------------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT  338 (436)
Q Consensus       302 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il  338 (436)
                      .                                           .......||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                           001124699999999999999999999999999999


Q ss_pred             HHHHhCCCCccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHHHh
Q 013793          339 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRP---TMQYVSQGFL  413 (436)
Q Consensus       339 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---t~~ev~~~l~  413 (436)
                      |||++|+.||.....       ......+..  .....+...   .....+.+++.+|+ .+|.+|+   ++.++++|+|
T Consensus       235 yell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         235 YEMLVGQPPFLADTP-------AETQLKVINWETTLHIPSQA---KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             eehhhCCCCCCCCCH-------HHHHHHHhccCccccCCCCC---CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            999999999963221       111111111  111111100   01122455666665 4999999   9999999999


Q ss_pred             hcC
Q 013793          414 ITR  416 (436)
Q Consensus       414 ~~~  416 (436)
                      +..
T Consensus       304 ~~~  306 (376)
T cd05598         304 FKG  306 (376)
T ss_pred             cCC
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=327.91  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=219.8

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  218 (436)
                      ..+.|++.+.||+|.||.||++..+ +|+.+|+|.+.............+.+|+.+|+++. |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457888899999999999999766 49999999998766544333478999999999998 999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CCeEEeeccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGT  294 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~  294 (436)
                      +|||++.||.|.+.+...    .+++.++..++.|++.++.|||   +.||+||||||+|+|+...    +.++++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999765    3899999999999999999999   8999999999999999643    4799999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC--
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--  372 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l--  372 (436)
                      +..... .......+||++|+|||.+....++..+||||+|+++|.|++|..||...+.       ......+....+  
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEIFLAILRGDFDF  257 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHHHHHHHcCCCCC
Confidence            998766 5556678899999999999999999999999999999999999999974321       122233433333  


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ..+.   +......+.+++..|+..||.+|+|+.++++|+|.......
T Consensus       258 ~~~~---w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  258 TSEP---WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             CCCC---ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence            2222   22234447789999999999999999999999998875333

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-41  Score=322.14  Aligned_cols=274  Identities=23%  Similarity=0.339  Sum_probs=220.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..+|.+.+.||+|++|.||++.. .+++.||+|.+.......   .+.+.+|+.+++.++|+|++++++++...+..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            46788999999999999999975 579999999997654332   25678899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++...    .+++.++..++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999998643    5788999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........+++.|+|||...+..++.++||||||+++|+|++|+.||.......       ..........+...  ..
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~~~~--~~  238 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPELQ--NP  238 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------heeeeccCCCCCCC--Cc
Confidence            4333344568899999999998889999999999999999999999986322110       00011111110000  01


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccccccchhhhh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISEL  434 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~~~~~~~~~  434 (436)
                      ......+.+++.+||+.+|++||++.++++++|+....+..+-....+++.+-+
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~  292 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAI  292 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccCHHHHHHHHHH
Confidence            111233668899999999999999999999999998888877776666665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-43  Score=305.41  Aligned_cols=262  Identities=25%  Similarity=0.352  Sum_probs=213.0

Q ss_pred             HHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh-----hHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      ..-..|...+.||+|..++|-++.. ++|..+|+|++......     ..+..+.-.+|+.+|+++ .||+|+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3446678888999999999999854 57889999998543221     223345667899999999 6999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                      .+...++|+|.|+.|.|.++|...-   .+++.+.++|++|+.+|+.|||   ...|+||||||+|||+|++.+++|+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999997654   7999999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      |.++.+.+. ......+|||+|+|||.+.-      ..|+...|.|+.|||+|.++.|.+||..-.+       -.++.-
T Consensus       168 GFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~  239 (411)
T KOG0599|consen  168 GFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRM  239 (411)
T ss_pred             ceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHH
Confidence            999988654 34566889999999998753      3578899999999999999999999973221       122223


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ++.....-. +..+.+......+|+.+||+.||++|.|++|+++|+|+..
T Consensus       240 ImeGkyqF~-speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  240 IMEGKYQFR-SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHhcccccC-CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            333332211 1224445555789999999999999999999999999943

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-42  Score=330.95  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=201.0

Q ss_pred             ceeeecCceEEEEEEc----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      +.||+|+||.||++..    .+|+.||+|++....... .....+.+|++++.+++||||+++++++...+..++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5699999999999864    368899999997643322 12356778999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      ++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++........
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            9999999987543   6899999999999999999999   789999999999999999999999999999865444333


Q ss_pred             ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHH
Q 013793          305 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI  384 (436)
Q Consensus       305 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  384 (436)
                      .....|++.|+|||.+.+..++.++|||||||++|||+||+.||....       .......+.......+..     ..
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-------~~~~~~~i~~~~~~~p~~-----~~  222 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-------RKETMTMILKAKLGMPQF-----LS  222 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----CC
Confidence            445678999999999998889999999999999999999999986321       111122222222211111     11


Q ss_pred             HHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          385 LLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                      ..+.+++.+||+.||++||+     +.++++++|+..
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            23567899999999999999     778999988754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-42  Score=343.20  Aligned_cols=255  Identities=23%  Similarity=0.252  Sum_probs=203.1

Q ss_pred             cccccceeeecCceEEEEEEcC-C-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-N-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+......   ....+.+|+++++.++|||||++++++...+..++||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER---QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4888999999999999999543 4 677888877554332   2356778999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++|+|.+++... .....+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999988643 22346889999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          301 DSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       301 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...  ......||++|+|||++.+..++.++|||||||++|||+||+.||....       ..............+ ...
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~-~~~  293 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVLYGKYDP-FPC  293 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCC-CCc
Confidence            322  1234569999999999999999999999999999999999999986321       111122222222111 111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         .....+.+++.+||+.||++||++.+++++.|..
T Consensus       294 ---~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        294 ---PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             ---cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence               1122367899999999999999999999876653

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-41  Score=321.05  Aligned_cols=269  Identities=23%  Similarity=0.340  Sum_probs=215.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|.+.......   ...+.+|+++++.++|+|++++++.+......++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            35788889999999999999964 578999999987654432   26688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++...    .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999998643    4789999999999999999999   78999999999999999999999999999886544


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh-cCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL-DQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~  379 (436)
                      .........+++.|+|||.+.+..++.++|||||||++|||++|+.||......       ....... ........   
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~---  238 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQN---  238 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcCCCCCCCC---
Confidence            333334456889999999999888999999999999999999999998632210       0011111 11111001   


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccccccch
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDIS  430 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~~~~~  430 (436)
                      .......+.+++.+||..+|++||++.+++++.|+....+..........+
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~~~  289 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA  289 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCccccHHHHHHH
Confidence            111223367899999999999999999999999998877666554444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.3e-42  Score=319.88  Aligned_cols=254  Identities=23%  Similarity=0.285  Sum_probs=197.5

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||+|+||.||++..+ +|+.||+|.+.............+..|++++.+++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999654 6899999999754332222234566799999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA  309 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  309 (436)
                      .+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            98886543 235889999999999999999999   8899999999999999999999999999997664322 223356


Q ss_pred             cccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHH
Q 013793          310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST  389 (436)
Q Consensus       310 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  389 (436)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||.....   .....................    .....+.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  228 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE---KVAKEELKRRTLEDEVKFEHQ----NFTEESKD  228 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc---hhhHHHHHHHhhccccccccc----cCCHHHHH
Confidence            89999999999988899999999999999999999999863211   000011111111111111110    11223678


Q ss_pred             HHhhccCCCCCCCCCH----HHHHHHHhhcC
Q 013793          390 ISFACLQSNPKSRPTM----QYVSQGFLITR  416 (436)
Q Consensus       390 l~~~cl~~dP~~RPt~----~ev~~~l~~~~  416 (436)
                      ++.+||+.||++||++    ++++.|.|+..
T Consensus       229 li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             HHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence            9999999999999999    66778888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-41  Score=313.85  Aligned_cols=255  Identities=28%  Similarity=0.423  Sum_probs=207.8

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|++|.||++... +++.|++|.+....... .....+.+|+++++.++|||++++++++.+.+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4777889999999999999764 78999999987543222 234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.++++... ...+++..++.++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999998652 246899999999999999999999   7899999999999999999999999999998765544


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......|++.|+|||+..+..++.++||||||+++|||++|+.||....       .............+. ...   .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~---~  224 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-------QGALILKIIRGVFPP-VSQ---M  224 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCC-Ccc---c
Confidence            33344568899999999999889999999999999999999999986322       111112222222211 111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+.+++.+||+.+|++||++.++++++|.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            22346789999999999999999999998763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.8e-41  Score=314.69  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=208.1

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.||||.+.............+.+|+++++.++|||++++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999754 78999999886543333333467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++|+|.+++.... ....+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998886432 2235788999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........+++.|+|||.+.+..++.++|+||||+++|||++|+.||....     . ........+.....++...  
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~-~~~~~~~~~~~~~~~~~~~--  230 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----M-NLFSLCQKIEQCDYPPLPT--  230 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-----c-cHHHHHHHHhcCCCCCCCh--
Confidence            3333334568889999999988889999999999999999999999975211     0 0011112222211111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ......+.+++.+||+.+|++||++.+|++.+...
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11223477899999999999999999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-42  Score=333.32  Aligned_cols=258  Identities=25%  Similarity=0.350  Sum_probs=206.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||++... +++.||+|+++..........+.+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999654 78999999998654433334567889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999997652  26899999999999999999999   889999999999999999999999999999876443


Q ss_pred             CCC-ccccccccccccccccc------cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--C
Q 013793          302 SSN-RTLLAGTYGYIAPELAY------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--L  372 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l  372 (436)
                      ... .....||+.|+|||++.      ...++.++|||||||++|||++|+.||.....       ......++...  +
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~  228 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQRFL  228 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCCcc
Confidence            322 23346899999999986      45678999999999999999999999863211       11111221111  1


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ..+...   .....+.+++.+|++ +|.+||++.++++|+|+..
T Consensus       229 ~~~~~~---~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         229 KFPEDP---KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CCCCCC---CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            111110   112235678889998 9999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=312.43  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=218.5

Q ss_pred             hcccccceeeecCceEEEEEEcCC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|+..+.||+|.-|+||+++..+ +..+|+|++................|-++|+.++||.++.|++.++..+..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            446667889999999999998764 5899999999887776666788889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC-
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA-  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~-  300 (436)
                      |||+||+|...++.+. ...+++..++.++..++-||+|||   -.|||+|||||+|||+.++|++-|+||.++..... 
T Consensus       157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999998765 447999999999999999999999   88999999999999999999999999998754311 


Q ss_pred             --------------------------------CCC-----------------------CccccccccccccccccccCcc
Q 013793          301 --------------------------------DSS-----------------------NRTLLAGTYGYIAPELAYTMVM  325 (436)
Q Consensus       301 --------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~  325 (436)
                                                      ...                       ....++||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                       0112468999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC-
Q 013793          326 TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT-  404 (436)
Q Consensus       326 ~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-  404 (436)
                      +.++|+|+|||++|||+.|+.||..       ......+..++.+.+.-+...   .....+.+|+++.|.+||++|.. 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG-------~~~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKG-------SNNKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCC-------CCchhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhcc
Confidence            9999999999999999999999973       333455666766665544332   33445789999999999999998 


Q ss_pred             ---HHHHHHHHhhcC
Q 013793          405 ---MQYVSQGFLITR  416 (436)
Q Consensus       405 ---~~ev~~~l~~~~  416 (436)
                         +.||.+|++|..
T Consensus       383 ~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  383 KRGAAEIKRHPFFEG  397 (459)
T ss_pred             ccchHHhhcCccccC
Confidence               888888776543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-41  Score=313.02  Aligned_cols=249  Identities=25%  Similarity=0.422  Sum_probs=200.7

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||.||++...++..+|+|.+......    ...+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            468888999999999999999888889999998755433    2568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.++++...  ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999999987543  25899999999999999999999   7899999999999999999999999999987653322


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC-CCCCCCChh
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDQK  379 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~  379 (436)
                      .. .....++..|+|||...+..++.++||||||+++|||++ |+.||.....       ......+... ....+..  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~~~~~~--  225 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRLYRPKL--  225 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCCCCCCC--
Confidence            11 122335568999999988889999999999999999999 8999863211       1111111111 1111111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                         ....+.+++.+||+.+|++||++.++++.+
T Consensus       226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               122367899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-41  Score=315.13  Aligned_cols=253  Identities=22%  Similarity=0.366  Sum_probs=199.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++......  ....+.+|+..+.+++||||+++++++..++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            356888999999999999999653    45689999998754332  236788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999999997643  36899999999999999999999   78999999999999999999999999998765


Q ss_pred             cCCCCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          298 LHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       298 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ....... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||.....       .. ..+.+......+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~-~~~~~~~~~~~~  228 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QD-VIKAVEDGFRLP  228 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HH-HHHHHHCCCCCC
Confidence            4222111 112335678999999999999999999999999999875 9999863221       11 111111111111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      ...   .....+.+++.+||+.+|++||++.++.+.+
T Consensus       229 ~~~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l  262 (266)
T cd05064         229 APR---NCPNLLHQLMLDCWQKERGERPRFSQIHSIL  262 (266)
T ss_pred             CCC---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence            111   1223367899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=307.46  Aligned_cols=261  Identities=25%  Similarity=0.354  Sum_probs=213.4

Q ss_pred             hhcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      +++|++.+.||+|.|+.||++ ..++|+.+|+|.+........ ..+++.+|+.+-+.++|||||++.+.+.+....++|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            567888889999999999998 556899999998876554433 347889999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~  297 (436)
                      +|+|+|++|..-+-.+   ...++..+-..+.||+++|.|+|   .++|+|||+||+|+++...   --+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999996544332   25788889999999999999999   8999999999999999543   3589999999998


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPP  375 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~  375 (436)
                      +. +.......+|||+|||||+....+++..+|||+-|||||-++.|..||...+       .......++...  ++++
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-------~~rlye~I~~g~yd~~~~  234 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYEQIKAGAYDYPSP  234 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHhccccCCCCc
Confidence            87 5566677899999999999999999999999999999999999999996321       111222333222  2232


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ...   .......+|+.+||..||.+|.|+.|.++|+|.......
T Consensus       235 ~w~---~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~  276 (355)
T KOG0033|consen  235 EWD---TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV  276 (355)
T ss_pred             ccC---cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence            222   233346789999999999999999999999999766443

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.5e-42  Score=317.70  Aligned_cols=249  Identities=34%  Similarity=0.527  Sum_probs=190.2

Q ss_pred             ccceeeecCceEEEEEEcC-----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          147 IKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.....+  ..+.+.+|++.+.+++||||++++|+|...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE--EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH--HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc--cceeeeecccccccccccccccccccccccccccccc
Confidence            4578999999999999765     35679999996643332  2478999999999999999999999999888899999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++.... ...+++.++..|+.|+++||+|||   +.+++||||+++||++++++.+||+|||++......
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999998762 236899999999999999999999   778999999999999999999999999999876322


Q ss_pred             CCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          302 SSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       302 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...  .........|+|||.+....++.++||||||+++|||+| |+.|+...       ........+.+..... ...
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~~~~~~~~~~-~~~  228 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIEKLKQGQRLP-IPD  228 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHHHHHTTEETT-SBT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccccce-ecc
Confidence            211  222346778999999999999999999999999999999 67887521       1111122222221111 111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .   ....+.+++..||+.||++|||+.++++.|
T Consensus       229 ~---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 N---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             T---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1   122266789999999999999999999865

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=353.13  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=205.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC--CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++.+..+.||+|.||.||.|...  +|.    .||||.+.......  ...+|.+|..+|++++|||||+++|+|.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~--~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ--EVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            344556778999999999999654  343    48999988765443  3589999999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          216 CMFLIYEYMERGSLFCILHNDDE----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                      ..+|++|||++|+|..+|++.+.    ...++..+.+.++.|||+|+.||+   +.++|||||.++|+|++....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999987632    346899999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCCcc-cc-ccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchh-hh
Q 013793          292 FGTARRLHADSSNRT-LL-AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI-DV  367 (436)
Q Consensus       292 fg~a~~~~~~~~~~~-~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~-~~  367 (436)
                      ||+|+.+........ .. .-...|||||.+..+.++.|+|||||||+|||++| |..||...+.       ..... -.
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~  918 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVL  918 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHH
Confidence            999995433322211 11 22458999999999999999999999999999998 8888863221       11222 22


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ...+++.+...     ...+.+++..||+.+|++||++..++..+.
T Consensus       919 ~ggRL~~P~~C-----P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  919 EGGRLDPPSYC-----PEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             hCCccCCCCCC-----ChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            23466555433     334668999999999999999999998653

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.3e-41  Score=315.68  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=203.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.......  ....+.+|++++.+++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            3677889999999999999965 578999999986543222  2367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|..+.       .+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999996542       4678889999999999999999   889999999999999999999999999999765432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                        ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....................+.. +.....  .
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~  223 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVLPV--G  223 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCCCCC--C
Confidence              22345689999999999988999999999999999999999999864221111111111111111111 111100  0


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .....+.+++.+|++.+|++||+++|+++++|+...
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            112236789999999999999999999999999665

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=329.97  Aligned_cols=257  Identities=22%  Similarity=0.350  Sum_probs=216.7

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE-EEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC-MFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv  220 (436)
                      ++|...+.+|+|+||.++.++++ +++.+++|.+......+.. .....+|+.++++++|||||.+.+.+.+++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            56888999999999999999765 6788999999876654433 2477899999999999999999999999988 9999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |+|++||++.+.+...+ ...+++..+..++.|++.|+.|||   +..|+|||||+.||+++.+..++|+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998765 457899999999999999999999   88999999999999999999999999999999987


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      +........||+.|+.||.+.+..|..|+||||+||++|||++-+++|+..+       .......+.... ..+.+.. 
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------m~~Li~ki~~~~-~~Plp~~-  229 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------MSELILKINRGL-YSPLPSM-  229 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------hHHHHHHHhhcc-CCCCCcc-
Confidence            7766677899999999999999999999999999999999999999997322       112222222222 2222222 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                        ....+..++..|+..+|+.||++.+++.++...
T Consensus       230 --ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  230 --YSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             --ccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence              223366788999999999999999999987554

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=312.64  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=205.1

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh--hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ++|++.+.||+|++|.||++.. .+++.+|+|.+......  .....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999965 47899999998754322  12234678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |+||+++++|.+++....   .+++..+..++.+++.||+|||   +.+++||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999987653   5888999999999999999999   8899999999999999999999999999997654


Q ss_pred             CCCCCc---cccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          300 ADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       300 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ......   ....++..|+|||.+.+..++.++||||+|+++|||++|+.||......       ...............
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~  228 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQL  228 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCCC
Confidence            322111   2345788999999999988999999999999999999999998632111       111111111111111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..   .....+.+++.+||..+|++|||+.|+++++|+
T Consensus       229 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         229 PS---HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             Cc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            11   112236689999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-42  Score=344.22  Aligned_cols=262  Identities=27%  Similarity=0.294  Sum_probs=206.2

Q ss_pred             HHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC--
Q 013793          139 IEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK--  215 (436)
Q Consensus       139 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  215 (436)
                      ....++|.+.+.||+|+||+||++.. .+|+.||||.+....... .....+.+|+..+..++|+|++++.+.+....  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            33457899999999999999999964 579999999987654332 22467889999999999999999987765432  


Q ss_pred             ------EEEEEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeE
Q 013793          216 ------CMFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  288 (436)
Q Consensus       216 ------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  288 (436)
                            ..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence                  3689999999999999987532 2346899999999999999999999   88999999999999999999999


Q ss_pred             EeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          289 VADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      |+|||+++.+.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~  256 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHK  256 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHH
Confidence            999999987643221  2234569999999999999999999999999999999999999986321       1111112


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .......+ ...   .....+.+++.+||+.||.+||++.++++++|..
T Consensus       257 ~~~~~~~~-~~~---~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~  301 (496)
T PTZ00283        257 TLAGRYDP-LPP---SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK  301 (496)
T ss_pred             HhcCCCCC-CCC---CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence            22211111 111   1122367899999999999999999999998754

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-41  Score=317.17  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=202.3

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC---
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK---  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---  214 (436)
                      .+++.|++.+.||+|+||.||+|... +++.||+|.+......    ...+.+|+.++.++ +|+|++++.+++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            45678888999999999999999654 6889999998765432    25677899999998 799999999998753   


Q ss_pred             ---CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          215 ---KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       215 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                         ...++||||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence               46899999999999999987643 236899999999999999999999   78999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      ||++..............|+..|+|||++.     +..++.++|||||||++|||++|+.||......       .....
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~~  227 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFL  227 (272)
T ss_pred             CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHHH
Confidence            999986644333344567899999999886     335788999999999999999999998632211       00111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ............   .....+.+++.+||..+|.+|||+.+++.++|+
T Consensus       228 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         228 IPRNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HhcCCCCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            111111110111   111236789999999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6e-42  Score=328.60  Aligned_cols=250  Identities=26%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHH-HHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||+||+|.. .+|+.||+|++.............+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3599999999999965 478999999997653322222345555554 46778999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99998887543   6899999999999999999999   88999999999999999999999999999875433333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       ............+.....     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~  222 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHKPLVLRPG-----ASLT  222 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcCCccCCCC-----CCHH
Confidence            5679999999999999999999999999999999999999986321       111122222222211111     1123


Q ss_pred             HHHHHhhccCCCCCCCCCH----HHHHHHHhhcC
Q 013793          387 ASTISFACLQSNPKSRPTM----QYVSQGFLITR  416 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~----~ev~~~l~~~~  416 (436)
                      +.+++.+|++.+|.+||++    .++++|+|+..
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            5678899999999999977    58999988864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-41  Score=326.47  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=196.2

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHH-HHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||.||+|... +++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 68899999997654333222344555554 57888999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99998886543   6888899999999999999999   78999999999999999999999999999875433333334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHKPLQLPGG-----KTVA  222 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHH
Confidence            4578999999999998899999999999999999999999986321       111122222222221111     1223


Q ss_pred             HHHHHhhccCCCCCCCCCH----HHHHHHHhhc
Q 013793          387 ASTISFACLQSNPKSRPTM----QYVSQGFLIT  415 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~----~ev~~~l~~~  415 (436)
                      +.+++.+||+.||.+||+.    .++++++|+.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~  255 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS  255 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence            6688999999999999865    5888888875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=312.97  Aligned_cols=269  Identities=24%  Similarity=0.297  Sum_probs=207.4

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-----C
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-----K  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~  214 (436)
                      ....|...+.||+|+||.|+.+.. .+|+.||||++......... .+.-.+|+.+|+.++|+||+.+.+.+..     -
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~-akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID-AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH-HHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            445666678899999999999954 57899999999855443332 3677889999999999999999998875     3


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      +..++|+|+| +.+|...++...   .++......++.|+++||.|+|   +.+|+||||||+|+|++.+...||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence            4689999999 458999998654   5899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCC--CCCccccccccccccccccc-cCccCcchhhHHHHHHHHHHHhCCCCccccccc---------cCCCCccc
Q 013793          295 ARRLHAD--SSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL---------SSSSDPKI  362 (436)
Q Consensus       295 a~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---------~~~~~~~~  362 (436)
                      |+.....  ....+..+.|.+|.|||.+. ...|+.+.||||.|||+.||++|+.-|...+.+         .+...++.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9987542  23346678899999999875 458999999999999999999999888532211         11111100


Q ss_pred             -------chhhhhc---CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          363 -------MLIDVLD---QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       363 -------~~~~~~~---~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                             .....+.   ...+.+............++|+.+||..||.+|+|++|.++|+.+..-
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                   0111111   111111111122233447789999999999999999999999987544

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-41  Score=332.19  Aligned_cols=265  Identities=24%  Similarity=0.350  Sum_probs=207.5

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      .++....++|++.+.||+|+||.||++... +++.+|+|.+.............+.+|+.++..++||||+++++.+.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            345556789999999999999999999765 6889999998754333333345678899999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++||||+++|+|.+++...    .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999998653    4788889999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCC-CccccccccccccccccccC----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          295 ARRLHADSS-NRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       295 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      ++....... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....       ......+..
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~  261 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMN  261 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHc
Confidence            987643322 22345699999999998754    378899999999999999999999963211       111222222


Q ss_pred             CC--CCCCCChhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHhhcCC
Q 013793          370 QR--LPPPVDQKVIQDILLASTISFACLQSNPKS--RPTMQYVSQGFLITRK  417 (436)
Q Consensus       370 ~~--l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~ev~~~l~~~~~  417 (436)
                      ..  +..+...   .....+.+++..|+..++.+  ||++.|+++|+|+...
T Consensus       262 ~~~~~~~~~~~---~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         262 HKNSLTFPDDN---DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCcccCCCcC---CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            11  1111111   11223567888999844443  7899999999998653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-42  Score=333.97  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=203.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|+..+.||+|+||+||++... +++.||+|++.............+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999664 68999999997654333334567889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999997644   6899999999999999999999   889999999999999999999999999998754321


Q ss_pred             CC-----------------------------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCC
Q 013793          302 SS-----------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH  346 (436)
Q Consensus       302 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~  346 (436)
                      ..                                   ......||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                   0113469999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHHHhhcCC
Q 013793          347 PRDLLSSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRP---TMQYVSQGFLITRK  417 (436)
Q Consensus       347 p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---t~~ev~~~l~~~~~  417 (436)
                      ||....       .......+..  ..+..+....   ....+.+++.+|+ .||.+|+   ++.|+++|+|+...
T Consensus       235 Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~~---~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         235 PFCSET-------PQETYRKVMNWKETLVFPPEVP---ISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCCC-------HHHHHHHHHcCCCceecCCCCC---CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            986321       1111122221  1111111000   1122456666665 4999998   58999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-41  Score=315.58  Aligned_cols=255  Identities=25%  Similarity=0.436  Sum_probs=202.6

Q ss_pred             hcccccceeeecCceEEEEEEcCC------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.......  ....+.+|++.+..++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~--~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH--HHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468888999999999999996542      2579999987654322  24678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          217 MFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      .+++|||+++|+|.+++.....             ...+++.+++.++.|++.||+|||   +.+++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcC
Confidence            9999999999999999875421             145889999999999999999999   789999999999999999


Q ss_pred             CCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCc
Q 013793          284 KLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  360 (436)
                      ++.++|+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....       .
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-------~  232 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-------N  232 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-------H
Confidence            99999999999976533221  1223446788999999988899999999999999999998 999986321       1


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      . .....+.........   ......+.+++.+||+.||.+||+++||++++.
T Consensus       233 ~-~~~~~i~~~~~~~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         233 Q-EVIEMIRSRQLLPCP---EDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             H-HHHHHHHcCCcCCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence            1 122222222111111   112234778999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.8e-41  Score=321.70  Aligned_cols=268  Identities=19%  Similarity=0.241  Sum_probs=202.9

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||+||+|..+ +++.||+|.+........  ...+.+|++++++++||||+++++++...+..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            56888999999999999999764 678899999875432221  245678999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            99985 7888776543  25788999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccc-----hhh
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM-----LID  366 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~-----~~~  366 (436)
                      ........+++.|+|||.+.+ ..++.++||||||+++|||+||+.||.......         .......+     ...
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            333334567899999998865 468899999999999999999999986322100         00000000     000


Q ss_pred             hhcCCCCCCCCh----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          367 VLDQRLPPPVDQ----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       367 ~~~~~l~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..+...+.....    ........+.+++.+|++.||.+|||+.|+++|+|+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            000000000000    0001123367899999999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-41  Score=315.31  Aligned_cols=256  Identities=28%  Similarity=0.414  Sum_probs=202.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.++......   ...+.+|+.++..++||||+++++.+...+..++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            35788889999999999999965 478999999987654322   25678899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999987544   6899999999999999999999   78999999999999999999999999999876644


Q ss_pred             CCCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .........|+..|+|||.+.   ...++.++|||||||++|||++|+.||......       ............++..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~  231 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFLMTKSNFQPPKL  231 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hhHHhhhccCCCCCcc
Confidence            333334457899999999874   456889999999999999999999997522110       0001111111111110


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .........+.+++.+|++.+|++||+++++++++|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            000011123668999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-41  Score=315.71  Aligned_cols=258  Identities=30%  Similarity=0.471  Sum_probs=205.8

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |++.+.||+|+||+||++... +++.+|+|.+......... .....+|+.++.+++||||+++++++......++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            567889999999999999765 5668999999888665433 23445699999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++++|.+++...   ..+++..+..++.|+++||++||   +.+++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             ccccccccccccc---ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999832   36899999999999999999999   78999999999999999999999999999976533334


Q ss_pred             Cccccccccccccccccc-cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          304 NRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      ......++..|+|||.+. +...+.++||||+|+++|+|++|+.||.....    ..................... ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~  228 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS----DDQLEIIEKILKRPLPSSSQQ-SRE  228 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH----HHHHHHHHHHHHTHHHHHTTS-HTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc----hhhhhhhhhcccccccccccc-cch
Confidence            445567899999999998 88899999999999999999999999873200    000111111111111100000 000


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+.+++.+||+.||++||++.++++++|+
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            01457889999999999999999999999996

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-41  Score=318.17  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=204.6

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |+..+.||+|+||.||++.. .+++.||+|.+.............+.+|+.++.+++|+|++++.+.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778899999999999965 47899999998765433333335677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            99999999886543 235899999999999999999999   8899999999999999999999999999987654322 


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc---CCCCCCCChhH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD---QRLPPPVDQKV  380 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~~  380 (436)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......    ...........   ...+...    
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~----  228 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEVQEEYSEKF----  228 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHHHHhhhhhhhhhcCccC----
Confidence            223346899999999999989999999999999999999999998632110    00000111111   1111111    


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                         ...+.+++.+||+.||++|||     +.|+++|+|+.+
T Consensus       229 ---~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         229 ---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             ---CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence               123668999999999999999     999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.6e-41  Score=311.65  Aligned_cols=253  Identities=26%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||.||+|...++..||+|.+......    .+.+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            3578899999999999999999888889999998764432    367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++.... ...+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999997543 236889999999999999999999   789999999999999999999999999999876432


Q ss_pred             CCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... .....++..|+|||+..+..++.++||||||+++|||+| |+.||....       .. .....+......+... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~-  227 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-------NS-DVMSALQRGYRMPRME-  227 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-------HH-HHHHHHHcCCCCCCCC-
Confidence            211 122335678999999988889999999999999999998 999985211       10 1111111111111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                        .....+.+++.+|++.+|++||+++++.+.+.
T Consensus       228 --~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         228 --NCPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             --CCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence              11223678999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.8e-41  Score=328.93  Aligned_cols=259  Identities=22%  Similarity=0.351  Sum_probs=202.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  213 (436)
                      ..++|.+.+.||+|+||.||+|...      .+..||||++.......  ..+.+.+|++++.++. ||||++++++|.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS--EKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3567888999999999999999642      23479999997654332  2367899999999996 9999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDE-------------------------------------------------------  238 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  238 (436)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999998864310                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 013793          239 --------------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  280 (436)
Q Consensus       239 --------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nil  280 (436)
                                                            ...+++.++..++.|++.||+|||   +.+|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEE
Confidence                                                  124788899999999999999999   789999999999999


Q ss_pred             ecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCC
Q 013793          281 LNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSS  357 (436)
Q Consensus       281 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~  357 (436)
                      +++++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....    
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~----  345 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV----  345 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence            999999999999999865432221  222346778999999998899999999999999999997 9999863210    


Q ss_pred             CCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .......+......+...   .....+.+++.+||+.||++||++.+|.+.+..
T Consensus       346 ---~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         346 ---DSTFYNKIKSGYRMAKPD---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             ---hHHHHHHHhcCCCCCCCc---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence               111111111111111111   112346789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=338.20  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=208.9

Q ss_pred             hcccccceeeecCceEEEEEEcCCC-CEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeE-Eee------
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGF-CLH------  213 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------  213 (436)
                      .++++.+.|.+|||+.||.|....+ ..||+|++...+.   ...+.+.+|+++|+.|+ |+|||.+++. ...      
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            4566788999999999999987665 9999999987743   34688999999999996 9999999993 222      


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      .-+.+|.||||.||+|-+++..+... .|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            23688999999999999999866544 499999999999999999999965 7889999999999999999999999999


Q ss_pred             cccccCCCCCC---------cccccccccccccccc---ccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc
Q 013793          294 TARRLHADSSN---------RTLLAGTYGYIAPELA---YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK  361 (436)
Q Consensus       294 ~a~~~~~~~~~---------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  361 (436)
                      .|+-.......         ......|+.|+|||++   .+..+++|+|||+|||+||-|+....||+..+.        
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------  263 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------  263 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence            99754333211         1123578999999976   466899999999999999999999999984322        


Q ss_pred             cchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       362 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                         ..++......+...   .....+.+|+..||++||++||++-||+.++.....++..
T Consensus       264 ---laIlng~Y~~P~~p---~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  264 ---LAILNGNYSFPPFP---NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             ---eeEEeccccCCCCc---cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence               23333333222222   2333477899999999999999999999999887766543

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-40  Score=310.07  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=208.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|.||+|... +|+.||+|.++..........+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999766 89999999987543333333477889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++|+|.+++.... ....+++.+++.++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886532 2346899999999999999999999   88999999999999999999999999999876644


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........++..|+|||.+.+..++.++||||||+++|+|++|+.||....      .......+........+...  
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~--  230 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEKCDYPPLPA--  230 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhcCCCCCCCh--
Confidence            3333344568889999999988889999999999999999999999985211      00000111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ......+.+++.+||..+|++|||+.+|++.+...
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11223467899999999999999999999988643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.1e-41  Score=316.17  Aligned_cols=260  Identities=23%  Similarity=0.267  Sum_probs=204.8

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |+..+.||+|+||+||++.. .+++.+|+|.+.............+.+|+++++.++|+|++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999999999965 47899999998765443333335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998886543 236999999999999999999999   8899999999999999999999999999997654322 


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......   ...............  ...   ..
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~~~--~~~---~~  228 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETEEV--YSA---KF  228 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccccc--cCc---cC
Confidence            2234568999999999988899999999999999999999999986321100   000000111111100  111   11


Q ss_pred             HHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcCC
Q 013793          384 ILLASTISFACLQSNPKSRPT-----MQYVSQGFLITRK  417 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~~  417 (436)
                      ...+.+++.+|++.||++||+     +.+++++.|+...
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            223568899999999999999     8899999988654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-40  Score=310.88  Aligned_cols=260  Identities=21%  Similarity=0.294  Sum_probs=207.0

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|.||++.. .+++.+|||.+.............+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999975 588999999887654433344578889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++++|.+++.... ....+++..++.++.+++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2346899999999999999999999   88999999999999999999999999999887654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........++..|+|||...+..++.++||||||+++|||++|..||.....     ..............++...   
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~---  230 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPS---  230 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCCCCCc---
Confidence            33333345688999999999888899999999999999999999999852110     0001111111111111111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ......+.+++.+||+.||++||||.+|++.+.
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence            112234778999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.2e-41  Score=312.21  Aligned_cols=262  Identities=23%  Similarity=0.353  Sum_probs=203.2

Q ss_pred             HHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          138 LIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       138 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++.+++++.....||+|+||.||+|... ++..||+|.+.......   .+.+.+|+++++.++|+||+++++++..++.
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH---HHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            3445666777788999999999999754 67889999987664332   3678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeecccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTA  295 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a  295 (436)
                      .++|+||+++++|.+++.........++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.++|+|||.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            9999999999999999976432212278888999999999999999   789999999999999986 678999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ..............++..|+|||.+.+.  .++.++||||||+++|+|++|+.||......      .............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~  230 (268)
T cd06624         157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVGMFKIH  230 (268)
T ss_pred             eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh------hhhHhhhhhhccC
Confidence            7664433333345688999999998654  3788999999999999999999998632110      0000000000011


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +....   .....+.+++.+||+.+|++|||+.|+++++|+
T Consensus       231 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         231 PEIPE---SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCCCc---ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            11111   112236688999999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9e-41  Score=309.50  Aligned_cols=250  Identities=24%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|...++..+|+|.+......    ...+.+|+.++.+++||||+++++++......++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            467888999999999999998877778999998765432    2568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999976432  6899999999999999999999   8899999999999999999999999999987654332


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....++..|+|||...+..++.++||||||+++|||++ |+.||.....       ............. ..... 
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~-  225 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRL-YRPHL-  225 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCC-CCCCC-
Confidence            21 112335678999999988889999999999999999998 9999863221       1111111111111 11110 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                        ....+.+++.+||+.+|.+||++.++++.+
T Consensus       226 --~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         226 --ASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             --CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence              123467899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-41  Score=312.45  Aligned_cols=259  Identities=31%  Similarity=0.466  Sum_probs=210.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||.|++|.||+|... +++.||+|.+......  .....+.+|+++++.++|+|++++.+++.+....++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36788889999999999999754 6889999998765322  12367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++...    .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999999754    6899999999999999999999   789999999999999999999999999999877544


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........++..|+|||.+.+..++.++||||||+++|||+||+.||.....       ...... +.....+.....  
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~~-~~~~~~~~~~~~--  221 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLFL-IPKNNPPSLEGN--  221 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHHH-hhhcCCCCCccc--
Confidence            3333445688899999999988899999999999999999999999863221       111111 111111111111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      .....+.+++.+||..+|++|||+++++++.|+.+....
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            012236688999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.4e-41  Score=312.30  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=207.2

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ...+|++.+.||.|+||.||+|...++..+|+|.+.......   ...+.+|+.+++.++|+||+++++++......++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh---HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            456788999999999999999998889999999987665422   35788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++..++.++.+++.||+|||   +.+++||||+|+||++++++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999998653 346899999999999999999999   78999999999999999999999999999987644


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .........++..|+|||...+..++.++||||||+++|+|++ |+.||....       ......... .....+... 
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~-~~~~~~~~~-  227 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQIT-AGYRMPCPA-  227 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHH-hCCcCCCCC-
Confidence            3332333446678999999988889999999999999999998 899986322       111111111 111111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                        .....+.+++.+||+.||++|||+.++++.+.
T Consensus       228 --~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         228 --KCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             --CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              11233678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-41  Score=311.78  Aligned_cols=253  Identities=30%  Similarity=0.455  Sum_probs=202.0

Q ss_pred             hhcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||+||+|.+..    ...||||.+.......  ....+.+|+.++..++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            3578899999999999999997642    4579999987654332  236788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||++++++.++|+|||+++.
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            999999999999999976432  6899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC-CCC
Q 013793          298 LHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP  373 (436)
Q Consensus       298 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~  373 (436)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....       ........... ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~  228 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDVIKAVEDGYRLP  228 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-------HHHHHHHHHcCCCCC
Confidence            7422221  112334678999999998899999999999999999998 999985211       01111111111 111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .+.     .....+.+++.+||+.+|++||++.||++++.
T Consensus       229 ~~~-----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         229 PPM-----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111     11233678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-41  Score=306.56  Aligned_cols=273  Identities=23%  Similarity=0.274  Sum_probs=209.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC-ceeeeeEEeeCC----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-IVKLYGFCLHKK----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----  215 (436)
                      ...|...++||+|+||+||+|+. .+|+.||+|++......+. .-....+|+.++++++|+| ||++.+++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            34566677899999999999964 5789999999987654211 1245578999999999999 999999999877    


Q ss_pred             --EEEEEEeeccCCChhhhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          216 --CMFLIYEYMERGSLFCILHNDDEA-VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       216 --~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                        ..++|+||+.. +|..++...... ..++...+..++.||++||+|||   +.+|+||||||.|+|++++|.+||+||
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence              78899999966 899999876532 35677889999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccc-------------cCCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------SSSS  358 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------------~~~~  358 (436)
                      |+|+...-+....+.-.+|.+|+|||++.+. .|+...||||+|||+.||++++.-|...+..             ....
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9999776555556667899999999999887 7999999999999999999999887643221             0111


Q ss_pred             CcccchhhhhcCCCCCC---CC--hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          359 DPKIMLIDVLDQRLPPP---VD--QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       359 ~~~~~~~~~~~~~l~~~---~~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .+........+...+..   ..  ...........+++.+|++.+|.+|.|+..++.|++|.....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            11100000000011100   00  000111134678999999999999999999999998866533

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=309.01  Aligned_cols=253  Identities=26%  Similarity=0.435  Sum_probs=203.6

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|++|.||+|...+++.||+|.++.....    .+.+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            4568889999999999999998878889999998765432    256888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++..+..++.+++.||.|||   +.+++||||||+||++++++.++|+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999997643 346899999999999999999999   789999999999999999999999999999876532


Q ss_pred             CCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... ......+..|+|||...+..++.++||||||+++|||+| |+.||....       ... ....+......+... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~~-  227 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-------NAE-VLQQVDQGYRMPCPP-  227 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-------HHH-HHHHHHcCCCCCCCC-
Confidence            211 111223457999999998899999999999999999999 999986321       111 111111111111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                        .....+.+++.+|++.+|++||++.++.+.+.
T Consensus       228 --~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         228 --GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             --cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence              11234678999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.1e-41  Score=316.90  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+|++.+.||.|++|.||+|.. .+++.||+|.+.......   .+.+.+|+++++.++|||++++++++...+..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4688899999999999999964 578999999987654332   367788999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|..++...    .+++.++..++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999988643    5899999999999999999999   889999999999999999999999999998876544


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........++..|+|||.+.+..++.++|||||||++|+|++|+.||......       ...........+. . ....
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~-~-~~~~  239 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNGTPE-L-QNPE  239 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCcc-c-CCcc
Confidence            33334456888999999999888999999999999999999999998632211       0111111111100 0 0011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....+.+++.+||..||++||++.+++++.|+....+
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            11223667899999999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=323.67  Aligned_cols=258  Identities=27%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999754 68999999997543333333467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999997532  25889999999999999999999   889999999999999999999999999998765433


Q ss_pred             CCC-cccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC----C
Q 013793          302 SSN-RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ----R  371 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~  371 (436)
                      ... .....||+.|+|||++..     ..++.++|||||||++|||++|+.||.....       ......+...    .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~  228 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHFQ  228 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCccc
Confidence            322 223468999999999863     4578899999999999999999999863211       0011111111    1


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHhhcC
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQS--NPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPt~~ev~~~l~~~~  416 (436)
                      ++....    .....+.+++.+|+..  ++..||++.++++|+|+..
T Consensus       229 ~~~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         229 FPPDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CCCccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            111110    0112245666666644  4444899999999999864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=309.07  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=206.7

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.+++|.+......   ..+.+.+|++++++++|||++++++++......+++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            57888999999999999999764 6788999999765433   2478889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....  ..+++.++..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.+......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999999987642  36889999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccC---ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          302 SSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ........++..|+|||...+.   .++.++||||||+++|||+||+.||.....       ...........+.+....
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~  227 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-------MRALFLISKSNFPPPKLK  227 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCcccc
Confidence            3333445688899999998877   889999999999999999999999863221       111111111111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ........+.+++.+||..+|.+|||+.+|+.+.|
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            12223345778999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-41  Score=316.79  Aligned_cols=265  Identities=28%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||++.. .+|+.||+|++......  ...+.+.+|++++..++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            5678889999999999999965 46889999988754332  22477889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++...+   .+++..+..++.+++.||.|||+  ..+++||||+|+||++++++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999987643   68999999999999999999994  358999999999999999999999999998654222


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCccc----chhhhhcCCCCCCCC
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI----MLIDVLDQRLPPPVD  377 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~l~~~~~  377 (436)
                      .  .....|+..|+|||.+.+..++.++|||||||++|||+||+.||..............    ..........+. ..
T Consensus       158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  234 (284)
T cd06620         158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR-LP  234 (284)
T ss_pred             c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC-CC
Confidence            1  2235689999999999888899999999999999999999999874322110000001    111111111111 11


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .  ......+.+++.+|++.||++|||+.|+++++|+.+...
T Consensus       235 ~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         235 S--SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             c--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            1  112234678999999999999999999999998877543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-40  Score=312.85  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=202.8

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++|.+.+.||+|+||.||+|...      +++.||+|.+......+  ..+.+.+|++++..++|+|++++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH--HHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            46788899999999999999753      34789999987654432  23788999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          217 MFLIYEYMERGSLFCILHNDD-----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      .++||||+++++|.+++...+           ....+++.++..++.|++.|++|||   +.+++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCC
Confidence            999999999999999997542           1245889999999999999999999   88999999999999999999


Q ss_pred             CeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCccc
Q 013793          286 EAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKI  362 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  362 (436)
                      .++|+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       ..
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-------~~  232 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-------EE  232 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HH
Confidence            999999999976533221  1223345778999999999999999999999999999998 9999852211       11


Q ss_pred             chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ...............    .....+.+++.+||+.||++||++.||++.+.
T Consensus       233 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 VIECITQGRLLQRPR----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111112122111111    11233678999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.1e-41  Score=309.44  Aligned_cols=253  Identities=30%  Similarity=0.455  Sum_probs=206.1

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.+++|.+.....     .+.+.+|++++++++|+|++++++++......++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            57888999999999999999776 488999999875432     378899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999986543  36899999999999999999999   789999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|+.||.......       .... ........... ..
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~~~-~~  223 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFM-IPNKPPPTLSD-PE  223 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhhh-hccCCCCCCCc-hh
Confidence            333344558889999999998899999999999999999999999986322110       0000 00111111110 11


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....+.+++.+||+.||++|||+.|+++++|+
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            112346789999999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-40  Score=312.53  Aligned_cols=257  Identities=24%  Similarity=0.340  Sum_probs=200.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      ++++|++.+.||+|+||.||+|...      ++..||+|.+.......  ....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4678999999999999999998643      35679999986543222  236788999999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCe
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  287 (436)
                      ...++||||+++|+|.+++.....       ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence            999999999999999999865321       234688899999999999999999   7899999999999999999999


Q ss_pred             EEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccch
Q 013793          288 FVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  364 (436)
                      +|+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....       .....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~  231 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVL  231 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHH
Confidence            99999998765332221  112345778999999998889999999999999999999 788875221       11111


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .......... ...   .....+.+++.+|++.||++|||+.|+++.+.
T Consensus       232 ~~~~~~~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGLLD-KPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCcCC-CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111211111 111   11223678999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-41  Score=323.63  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=194.6

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHH-HHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEA-QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||+||++... +++.||+|++.............+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 6788999999764432222223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999997643   5788889999999999999999   88999999999999999999999999999976543333344


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+..........     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNKPLQLKPN-----ITNS  222 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCCcCCCCC-----CCHH
Confidence            5679999999999999999999999999999999999999986321       111122222222211110     1123


Q ss_pred             HHHHHhhccCCCCCCCCCHH----HHHHHHhhc
Q 013793          387 ASTISFACLQSNPKSRPTMQ----YVSQGFLIT  415 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~~----ev~~~l~~~  415 (436)
                      +.+++.+|++.||.+||++.    ++.+++|+.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~  255 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS  255 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccC
Confidence            66788999999999999866    777777763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-41  Score=324.35  Aligned_cols=262  Identities=26%  Similarity=0.318  Sum_probs=201.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+.............+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999765 57889999987543333333456888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999997632  25889999999999999999999   889999999999999999999999999999765433


Q ss_pred             CCC-ccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          302 SSN-RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.....       ......+........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERFQ  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCcccc
Confidence            222 23356999999999886     34678999999999999999999999863211       111112222111100


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCC--CCCCCHHHHHHHHhhcC
Q 013793          376 VDQKVIQDILLASTISFACLQSNP--KSRPTMQYVSQGFLITR  416 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP--~~RPt~~ev~~~l~~~~  416 (436)
                      ...........+.+++.+|+..++  ..|+++.|+++|+|+..
T Consensus       229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            110011112235667777775544  44789999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-40  Score=318.85  Aligned_cols=256  Identities=24%  Similarity=0.388  Sum_probs=199.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.......  ....+.+|+.+++.++||||++++|+|... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46888999999999999999753 343    38999987543322  236788999999999999999999999865 46


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|+||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence            79999999999999997643  25889999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCCc--cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+....        ......+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  230 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhCCCCC
Confidence            65433221  12234668999999999999999999999999999998 9999863211        1112222221111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +...   .....+.+++.+||+.+|++||++.+++..+.....
T Consensus       231 ~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 PQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            1111   112236688999999999999999999998765443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.5e-41  Score=315.77  Aligned_cols=266  Identities=22%  Similarity=0.265  Sum_probs=200.9

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|++|.||+|... ++..||+|.+....... .....+.+|+.++..++|||++++++++..++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4778899999999999999764 78999999986543221 123567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |++ ++|.+++........+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 688888876544457899999999999999999999   8899999999999999999999999999997654333


Q ss_pred             CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCccc--chh--hhh
Q 013793          303 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKI--MLI--DVL  368 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~--~~~--~~~  368 (436)
                      .......+++.|+|||.+.+. .++.++||||||+++|||+||+.||........         ......  ...  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            333334578899999987654 578999999999999999999999863211000         000000  000  000


Q ss_pred             cCCCCCC----CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 DQRLPPP----VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ~~~l~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+..    ...........+.+++.+||+.||++|||+.+++.++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0000000    000000012335689999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-40  Score=316.47  Aligned_cols=264  Identities=26%  Similarity=0.352  Sum_probs=205.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++... ++..+|+|.+......  .....+.+|++++.+++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36888999999999999999654 6888999998754322  22467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+  ..+++|+||||+||++++++.++|+|||++......
T Consensus        79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999997653   68899999999999999999994  258999999999999999999999999998765322


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc------CCC----Ccc----------
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------SSS----DPK----------  361 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~------~~~----~~~----------  361 (436)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......      ...    ...          
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              1234568899999999988889999999999999999999999985321100      000    000          


Q ss_pred             -----cchhhhhcC---CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          362 -----IMLIDVLDQ---RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       362 -----~~~~~~~~~---~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                           ....+..+.   ..++....  ......+.+++.+||+.+|++|||+.|+++++|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                 000000000   00000000  0012346789999999999999999999999999654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.9e-41  Score=324.52  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=203.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++... +++.||+|.+.............+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999764 68899999987643333333466888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999997632  26889999999999999999999   889999999999999999999999999999876443


Q ss_pred             CCC-cccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          302 SSN-RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ... .....||+.|+|||++.+     ..++.++||||||+++|||++|+.||.....       ......+.......+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~  228 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHEERFQ  228 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHHHHHHcCCCccc
Confidence            322 223569999999998875     4678899999999999999999999863211       111112221111101


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHhhcC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKS--RPTMQYVSQGFLITR  416 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~ev~~~l~~~~  416 (436)
                      ...........+.+++.+|+..++.+  |++++++++|+|+..
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            11101111234667888888766544  579999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.6e-41  Score=326.22  Aligned_cols=265  Identities=24%  Similarity=0.264  Sum_probs=200.3

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----EE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----CM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  217 (436)
                      +|++.+.||+|+||.||++.. .+++.||+|++....... ...+.+.+|++++..++|+||+++++++....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch-HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            477889999999999999975 478999999986543221 12367889999999999999999999998776     78


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|+||+. ++|.+.+....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999997 57877775443   6899999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc----
Q 013793          298 LHADSS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI----  362 (436)
Q Consensus       298 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~----  362 (436)
                      ...... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.......         .......    
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            543222 22334578899999998774 57899999999999999999999986322110         0000000    


Q ss_pred             --chh-hhhcCCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          363 --MLI-DVLDQRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       363 --~~~-~~~~~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                        ... .+......++....    .......+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence              000 00000000000000    0001234678999999999999999999999999876

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=320.93  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.......  ..+.+..|++++.++ +|+||++++++|...
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS--EYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH--HHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            357899999999999999999532      35789999997654322  236778899999999 899999999988754


Q ss_pred             -CEEEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 013793          215 -KCMFLIYEYMERGSLFCILHNDDE-------------------------------------------------------  238 (436)
Q Consensus       215 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  238 (436)
                       ...++++||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             568899999999999998854221                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC--ccccccccc
Q 013793          239 ---AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYG  313 (436)
Q Consensus       239 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~  313 (436)
                         ...++|..+..++.||+.||+|||   +.+|+||||||+||++++++.++|+|||+++.+......  .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               126899999999999999999999   889999999999999999999999999999876433221  223345678


Q ss_pred             cccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHh
Q 013793          314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISF  392 (436)
Q Consensus       314 y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~  392 (436)
                      |+|||++.+..++.++|||||||++|||++ |+.||.....       .......+..........   .....+.+++.
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~  310 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------DEEFCRRLKEGTRMRAPE---YATPEIYSIML  310 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-------cHHHHHHHhccCCCCCCc---cCCHHHHHHHH
Confidence            999999999999999999999999999998 9999853110       011111111111111111   11233678999


Q ss_pred             hccCCCCCCCCCHHHHHHHHhh
Q 013793          393 ACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       393 ~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +||+.+|++||++.|+++++..
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=325.92  Aligned_cols=249  Identities=23%  Similarity=0.320  Sum_probs=195.4

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc---cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      ||+|+||+||+|... +++.||||++.............+..|..++...   +||||+++.+.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999654 6899999998754433322334555666776655   699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99999887543   6899999999999999999999   78999999999999999999999999999976443333344


Q ss_pred             ccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL  385 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  385 (436)
                      ...||+.|+|||.+.+. .++.++|||||||++|||+||+.||....       .......+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~----~~~  223 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQMYRNIAFGKVRFPKNV----LSD  223 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCcc----CCH
Confidence            56799999999998765 47999999999999999999999986321       1111112221111111110    112


Q ss_pred             HHHHHHhhccCCCCCCCC----CHHHHHHHHhhcC
Q 013793          386 LASTISFACLQSNPKSRP----TMQYVSQGFLITR  416 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RP----t~~ev~~~l~~~~  416 (436)
                      .+.+++.+||+.||.+||    ++.++++|+|+..
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            356789999999999998    7999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-40  Score=312.73  Aligned_cols=260  Identities=25%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |++.+.||+|+||.||++... ++..+++|.+......   ..+.+.+|+++++.++|||++++++++...+..++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            567788999999999999765 5788899998665432   236788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++++|..++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999998876532  36899999999999999999999   78999999999999999999999999999876543333


Q ss_pred             Cccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC-CCC
Q 013793          304 NRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP-PVD  377 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~  377 (436)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.||.....       ............+. ...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~  231 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLAQP  231 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCCCCCCCc
Confidence            333456889999999874     44578899999999999999999999863221       11111111111100 001


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK  422 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~  422 (436)
                      .   .....+.+++.+||+.||++||++.++++++|+........
T Consensus       232 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  273 (282)
T cd06643         232 S---RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI  273 (282)
T ss_pred             c---ccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCCCH
Confidence            0   11234678999999999999999999999999987655443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-40  Score=311.81  Aligned_cols=255  Identities=22%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             hcccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      ++|++.+.||+|+||+||+|..     .++..+|+|.+......  .....+.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4678889999999999999963     35678999999754432  2236788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          218 FLIYEYMERGSLFCILHNDD--------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      ++||||+++++|.+++....              ....+++.+.+.++.+++.||+|||   +.+++||||||+||++++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcC
Confidence            99999999999999985321              1235889999999999999999999   789999999999999999


Q ss_pred             CCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCc
Q 013793          284 KLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  360 (436)
                      ++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||....       .
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-------~  232 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-------N  232 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-------H
Confidence            99999999999986543221  1222345678999999988889999999999999999998 988875211       1


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                       ....+........+...   .....+.+++.+||+.||++||++.++.+++.
T Consensus       233 -~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         233 -QEVIEMVRKRQLLPCSE---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             -HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence             11122222221111111   11233677899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=308.10  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=199.4

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .+|++.+.||+|+||.||++...++..+|+|.+.......    ..+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            3577888999999999999988888889999987544322    467789999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++.....  .+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999975432  6899999999999999999999   7899999999999999999999999999997653322


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....++..|+|||...+..++.++||||||+++|||++ |+.||.....        ......+..........  
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  224 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVSAGYRLYRPK--  224 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHHcCCcCCCCC--
Confidence            11 111223457999999998899999999999999999999 8999863211        11111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                       .....+.+++.+||+.+|++|||+.|+++.+
T Consensus       225 -~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 -LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             1123477899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-40  Score=306.84  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=204.2

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CCEEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKCMFLIY  221 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  221 (436)
                      +|++.+.||+|++|.||++... +++.+|+|.+....... ...+.+.+|++++++++|+|++++.+.+.. ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4788999999999999999654 67899999986543322 223678899999999999999999988764 44678999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++.+++.++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999997642 235899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........+++.|+|||...+..++.++||||||++++||++|+.||+...       ............++. ...   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~-~~~---  224 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYRIIEGKLPP-MPK---  224 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcCCCC-Ccc---
Confidence            333344568899999999999999999999999999999999999986211       111112222222211 111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....+.+++.+|++.+|++||++.++++++|+
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         225 DYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            122346789999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-40  Score=323.96  Aligned_cols=265  Identities=25%  Similarity=0.299  Sum_probs=199.1

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----  215 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  215 (436)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++....... .....+.+|+.++..++||||+++++++....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            457899999999999999999965 468999999997543222 22367778999999999999999999886543    


Q ss_pred             --EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          216 --CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       216 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                        ..++||||+++ +|...++.     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCC
Confidence              47999999976 56555532     4788899999999999999999   8899999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC-------CCCccc----
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKI----  362 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------~~~~~~----  362 (436)
                      +++..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........       ...+..    
T Consensus       169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            99764332 223345689999999999999999999999999999999999999963221000       000000    


Q ss_pred             ----chhhhhcCC--CCC-------------CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          363 ----MLIDVLDQR--LPP-------------PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       363 ----~~~~~~~~~--l~~-------------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                          .........  .+.             ............+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                000000000  000             000000011234678999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.3e-41  Score=309.53  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=205.4

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|+||.+|++.. .+|+.||+|.+....... ...+++.+|++++++++||||+++.+++...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            478889999999999999965 478999999987543222 223678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++.... ...+++.+++.++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999999987543 235789999999999999999999   7899999999999999999999999999998764433


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......|++.|+|||...+...+.++||||||+++++|++|+.||....       .............+. ...   .
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~-~~~---~  224 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLVLKIIRGSYPP-VSS---H  224 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-------HHHHHHHHhcCCCCC-Ccc---c
Confidence            33334458889999999998889999999999999999999999986211       111122222222211 111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+.+++.+||+.+|++||++.+|++++|+
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            12236789999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-40  Score=308.33  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=203.8

Q ss_pred             cccccceeeecCceEEEEEEcCCCCEEEEEEecCcch---hhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....   ........+.+|+++++.++|+||+++.+++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999888899999999875432   1223346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997543   5789999999999999999999   78999999999999999999999999999876532


Q ss_pred             CC------CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC-CCC
Q 013793          301 DS------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP  373 (436)
Q Consensus       301 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~  373 (436)
                      ..      .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......       ......... ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~  227 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------AAMFYIGAHRGLM  227 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------HHHHHhhhccCCC
Confidence            11      1122345888999999999888999999999999999999999998632211       001111111 011


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +....   .....+.+++.+||+.+|++||++.|+++++|+
T Consensus       228 ~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 PRLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCC---CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11111   112236789999999999999999999999885

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.9e-41  Score=333.10  Aligned_cols=264  Identities=20%  Similarity=0.269  Sum_probs=194.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  214 (436)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++....       ....+|+.+++.++||||+++.+++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            46799999999999999999976 468899999886542       2234699999999999999999877532      


Q ss_pred             --CEEEEEEeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEe
Q 013793          215 --KCMFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVA  290 (436)
Q Consensus       215 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~  290 (436)
                        ...++||||+++ +|.+++... .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence              246799999986 676665432 22346899999999999999999999   88999999999999999664 79999


Q ss_pred             ecccccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC-------CCCccc
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKI  362 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------~~~~~~  362 (436)
                      |||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||........       ...+..
T Consensus       214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9999987643322 2345689999999988664 689999999999999999999999863221000       000000


Q ss_pred             chhhhhc-----CCCCCCCChhHH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          363 MLIDVLD-----QRLPPPVDQKVI-----QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       363 ~~~~~~~-----~~l~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .......     ..++........     .....+.+|+.+||+.||.+|||+.|+++|+|+...
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            0000000     001100000000     012347789999999999999999999999998643

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.3e-41  Score=335.54  Aligned_cols=272  Identities=19%  Similarity=0.267  Sum_probs=198.8

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC------CCceeeee
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH------RSIVKLYG  209 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~  209 (436)
                      ++...+++|++.+.||+|+||+||+|.. .+++.||||+++.....    ......|++++..++|      .+++++.+
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY----TRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh----HHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            3444578899999999999999999965 46788999999653221    2345556666666654      45888888


Q ss_pred             EEeeC-CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---
Q 013793          210 FCLHK-KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---  285 (436)
Q Consensus       210 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---  285 (436)
                      ++... ...++|||++ +++|.+++....   .+++..+..|+.||+.||+|||+  ..+|+||||||+|||++.++   
T Consensus       199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        199 YFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccc
Confidence            88764 4688999988 678888886543   68999999999999999999993  25999999999999998765   


Q ss_pred             -------------CeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          286 -------------EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       286 -------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                                   .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                         49999999886432   22344679999999999999999999999999999999999999996422


Q ss_pred             cccC--------CCCcccc--------hhhhhcC--CCCCCCCh------------hHHHHHHHHHHHHhhccCCCCCCC
Q 013793          353 SLSS--------SSDPKIM--------LIDVLDQ--RLPPPVDQ------------KVIQDILLASTISFACLQSNPKSR  402 (436)
Q Consensus       353 ~~~~--------~~~~~~~--------~~~~~~~--~l~~~~~~------------~~~~~~~~~~~l~~~cl~~dP~~R  402 (436)
                      ....        ...+..+        ..+..+.  .+.+....            ........+.+|+.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            1000        0000000        0000000  00000000            000112346789999999999999


Q ss_pred             CCHHHHHHHHhhcCCCCCc
Q 013793          403 PTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       403 Pt~~ev~~~l~~~~~~~~~  421 (436)
                      ||+.|+++|+|+....+..
T Consensus       430 ~ta~e~L~Hp~~~~~~~~~  448 (467)
T PTZ00284        430 LNARQMTTHPYVLKYYPEC  448 (467)
T ss_pred             CCHHHHhcCccccccCCcc
Confidence            9999999999998876644

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=311.39  Aligned_cols=263  Identities=27%  Similarity=0.423  Sum_probs=201.8

Q ss_pred             cccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc--cCCCceeeeeEEeeCC----EE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRSIVKLYGFCLHKK----CM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~  217 (436)
                      ..+..+++|+|+||.||||.+.+ +.||||++.....      ++|.+|-++.+..  +|+||++++++-....    +.
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~k------qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEK------QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC-ceeEEEecCHHHH------HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            34456779999999999999854 8999999976543      6788888877654  7999999999877655    89


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceeecCCCCeEEee
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC------SPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                      +||+||.+.|+|.++|..+    .++|.+..+|+..+++||+|||++.      .++|+|||||++|||+..|+++.|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            9999999999999999866    6999999999999999999999753      57899999999999999999999999


Q ss_pred             cccccccCCCCC--CccccccccccccccccccCcc-C-----cchhhHHHHHHHHHHHhCCCCccc--cccc-------
Q 013793          292 FGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVM-T-----EKCDVYSFGVVTLEVLMGKHPRDL--LSSL-------  354 (436)
Q Consensus       292 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~-----~~~Dv~s~G~il~elltg~~p~~~--~~~~-------  354 (436)
                      ||+|..+.+...  .....+||.+|||||++.+... .     .+.||||+|.|||||+++..-.+.  ...+       
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            999988765433  2344689999999999987532 2     368999999999999997654421  1111       


Q ss_pred             -cCCCCcccchhhhhcCCCCCCCChhHH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          355 -SSSSDPKIMLIDVLDQRLPPPVDQKVI--QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       355 -~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                       .....-+.+..-++..+..+.....+.  ..+..+.+.+..||..||+.|.|+.=|.+.++....
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence             111111122222333333333322221  345557889999999999999999999888776544

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.7e-41  Score=313.60  Aligned_cols=254  Identities=31%  Similarity=0.464  Sum_probs=204.5

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.......  ..+.+.+|++++++++||||+++++++......++|+|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            355677899999999999965 467899999987544322  24678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++...    .+++..+..++.++++|++|||   +.+++|+||+|+||++++++.++++|||++.......
T Consensus        83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999999988642    5889999999999999999999   7899999999999999999999999999998765433


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......++..|+|||.+.+..++.++||||||+++|||+||+.|+.....       ..... .......+....   .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------~~~~~-~~~~~~~~~~~~---~  224 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-------MRVLF-LIPKNSPPTLEG---Q  224 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-------hhHHh-hhhcCCCCCCCc---c
Confidence            333345688899999999988899999999999999999999999752211       00111 111111111111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ....+.+++.+||+.+|++||++.++++++|+..-
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            22346789999999999999999999999998653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-40  Score=308.89  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=208.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ..|+..+.||.|+||.||+|... ++..||+|.+.......  ....+.+|+.+++.++|||++++++++.+....++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35667888999999999999764 68899999987554322  2478889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++...    .+++.+...++.+++.||+|||   +.+++|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999998643    5888999999999999999999   789999999999999999999999999999776543


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........++..|+|||.+.+..++.++||||||+++|||+||+.||......       . .........++...   .
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~-~~~~~~~~~~~~~~---~  223 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------R-VLFLIPKNNPPTLT---G  223 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------h-HhhhhhcCCCCCCc---h
Confidence            33333456788999999998888999999999999999999999998632210       0 01111111111111   1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....+.+++.+||+.+|++||++.+++++.|+.....
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            23344778999999999999999999999999866643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-40  Score=307.09  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+|.+.+.||+|++|.||+|... .++.||+|.+......    ...+.+|++++..++|+|++++++++...+..++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            45778899999999999999654 5889999998754332    367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++..++.++.|+++||+|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999987543 236899999999999999999999   789999999999999999999999999999876433


Q ss_pred             CCCc-cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SSNR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .... ....++..|+|||...+..++.++||||||+++|||++ |..|+....       .. .....+...........
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~  229 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LS-QVYELLEKGYRMERPEG  229 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HH-HHHHHHHCCCCCCCCCC
Confidence            2211 11224568999999998899999999999999999998 899975211       00 11111222111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                         ....+.+++.+||+.+|++||++.++++.+.
T Consensus       230 ---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         230 ---CPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             ---CCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence               1233678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-40  Score=313.16  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=206.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++... ++..||+|.+.......  ....+.+|++++.+++|+||+++++.+...+..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH--HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36788899999999999999765 78999999887543221  2367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|..++........+++..+..++.+++.||.|||+  ..+|+||||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            999999999998765334478999999999999999999994  358999999999999999999999999998765322


Q ss_pred             CCCccccccccccccccccccCc------cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                        ......++..|+|||.+.+..      ++.++|||||||++|||++|+.||.....    .............. +..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~-~~~  229 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGD-PPT  229 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcC-CCC
Confidence              223345788999999886543      47899999999999999999999863210    00000111111111 111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...   .....+.+++.+||+.+|++||++.++++++|+.....
T Consensus       230 ~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         230 LPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CCc---ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            111   12333668999999999999999999999999866543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-40  Score=307.57  Aligned_cols=259  Identities=28%  Similarity=0.448  Sum_probs=207.6

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||.|+||+||+|.. .++..+|+|++.......  ..+.+.+|++.++.++|+|++++++.+...+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            4688999999999999999975 468899999987654333  3478899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++........+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            99999999999976543346899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCC----ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          302 SSN----RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       302 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...    .....|+..|+|||.+... .++.++||||||+++|||++|+.||......       ....+...... +..
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~  227 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLTLQNDP-PSL  227 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHHhcCCC-CCc
Confidence            322    1334588999999998777 7899999999999999999999998632211       11111111111 111


Q ss_pred             Chh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          377 DQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       377 ~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ...  .......+.+++.+||+.||++||++.++++|+|+
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            100  01122346789999999999999999999999885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3e-40  Score=315.72  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=189.2

Q ss_pred             cceeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEEEEEEe
Q 013793          148 KYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCMFLIYE  222 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  222 (436)
                      ...||+|+||+||+|...   +++.||+|.+......     ..+.+|++++++++||||+++++++..  ....++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            457999999999999754   5678999998765432     456789999999999999999998864  456899999


Q ss_pred             eccCCChhhhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCCeEEeec
Q 013793          223 YMERGSLFCILHNDD------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADF  292 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Df  292 (436)
                      |+.+ +|.+++....      ....+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9865 7877765321      2235889999999999999999999   8899999999999999    45678999999


Q ss_pred             ccccccCCCCC---CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc--cchhh
Q 013793          293 GTARRLHADSS---NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK--IMLID  366 (436)
Q Consensus       293 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--~~~~~  366 (436)
                      |+++.......   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....-.....+.  .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99987643322   22345689999999998764 58999999999999999999999986322110000000  00000


Q ss_pred             hhc---------------------------C-CCCCCCChhHH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          367 VLD---------------------------Q-RLPPPVDQKVI-----QDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       367 ~~~---------------------------~-~l~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      +..                           . ...........     .....+.+++.+||+.||.+|||++|+++|+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            000                           0 00000000000     00123668999999999999999999999998


Q ss_pred             h
Q 013793          414 I  414 (436)
Q Consensus       414 ~  414 (436)
                      +
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-40  Score=304.80  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=206.8

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|+..+.||+|+||.||.++. .+++.+++|.+........ ....+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            478889999999999999854 5688999999876543322 23678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++.... ...+++.++..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999997653 336899999999999999999999   7899999999999999999999999999998765444


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......+++.|+|||...+...+.++||||||+++|||++|+.||+...       .......+.........    ..
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~----~~  224 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIVQGNYTPVV----SV  224 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCc----cc
Confidence            33344568999999999988889999999999999999999999986311       11112222222222111    11


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+.+++.+||+.+|++||++.++++++|+
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            12336789999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-40  Score=317.80  Aligned_cols=271  Identities=16%  Similarity=0.260  Sum_probs=199.9

Q ss_pred             ccceeeec--CceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          147 IKYCIGTG--GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       147 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      +.++||+|  +|++||++.. .+|+.||+|.+....... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            35679999  7899999965 578999999997654322 2236778899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++++||+..........
T Consensus        81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999986542 225899999999999999999999   78999999999999999999999999986544321111


Q ss_pred             -------Ccccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCcccccccc-------CCC----Ccccc
Q 013793          304 -------NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSS----DPKIM  363 (436)
Q Consensus       304 -------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------~~~----~~~~~  363 (436)
                             ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......       ...    +....
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112346778999999876  458899999999999999999999986322100       000    00000


Q ss_pred             hhhh---------hcCCC---------CC-----CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          364 LIDV---------LDQRL---------PP-----PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       364 ~~~~---------~~~~l---------~~-----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ..+.         .+...         .+     ............+.+++.+||+.||++|||++|+++++|+.+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~  316 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR  316 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence            0000         00000         00     0000001122347789999999999999999999999999775544


Q ss_pred             cc
Q 013793          421 VK  422 (436)
Q Consensus       421 ~~  422 (436)
                      ..
T Consensus       317 ~~  318 (327)
T cd08227         317 AS  318 (327)
T ss_pred             hh
Confidence            33

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-40  Score=313.28  Aligned_cols=266  Identities=26%  Similarity=0.351  Sum_probs=206.9

Q ss_pred             cHHHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEE
Q 013793          134 FYEDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFC  211 (436)
Q Consensus       134 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  211 (436)
                      .++++..++++|++.+.||+|+||.||++.. .+++.+|+|.+......    ...+.+|+.++.++ +|||++++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            3456667789999999999999999999966 47889999998764322    25677889999998 899999999998


Q ss_pred             eeC-----CEEEEEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          212 LHK-----KCMFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       212 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      ...     +..++|+||+++|+|.++++... ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence            754     35899999999999999886421 2346899999999999999999999   78999999999999999999


Q ss_pred             CeEEeecccccccCCCCCCccccccccccccccccccC-----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc
Q 013793          286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  360 (436)
                      .++|+|||++..............|+..|+|||.+...     .++.++|||||||++|||++|+.||.....       
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------  238 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------  238 (291)
T ss_pred             CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------
Confidence            99999999998765433333345688899999987543     368899999999999999999999863211       


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .....+......+ .... .......+.+++.+||+.+|++||++.|+++|+|++
T Consensus       239 ~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         239 VKTLFKIPRNPPP-TLLH-PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHhcCCCC-CCCc-ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            1111111111111 0000 111123477899999999999999999999999873

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.1e-40  Score=309.86  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             hcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .+|.+.+.||+|+||.||++..      .++..+|+|.+......   ..+.+.+|++++.+++||||+++.+++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH---HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            5688899999999999999964      23456899988765432   23678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC
Q 013793          217 MFLIYEYMERGSLFCILHNDD----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  286 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  286 (436)
                      .++||||+++++|.+++....          ....+++.+++.++.|++.||+|||   +.+++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999999987432          1235899999999999999999999   789999999999999999999


Q ss_pred             eEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccc
Q 013793          287 AFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  363 (436)
                      ++|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       ...
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~  231 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEV  231 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence            999999999865432211  122335778999999998899999999999999999998 8999853211       111


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ...+....... ...   .....+.+++.+||+.||.+|||+.+|.+.+...
T Consensus       232 ~~~i~~~~~~~-~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         232 IECITQGRVLQ-RPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             HHHHHcCCcCC-CCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11111111111 110   0112377899999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.5e-40  Score=310.82  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=205.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|++.+.||+|+||.||+|... +++.+++|.+......   ....+.+|+++++.++|||++++.+.+...+..++|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            366888999999999999999765 5889999998765432   246788899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|..++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999988876433  25899999999999999999999   88999999999999999999999999999876433


Q ss_pred             CCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .........+++.|+|||++.     ...++.++|||||||++|||++|+.||.....       ............+. 
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~-  234 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPT-  234 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCCcc-
Confidence            333334456888999999885     34568899999999999999999999853211       11111111111110 


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ... .......+.+++.+||+.+|++||++.++++++|+..-..
T Consensus       235 ~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         235 LSQ-PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             CCC-CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            000 0111223678899999999999999999999999865433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.2e-40  Score=305.67  Aligned_cols=252  Identities=26%  Similarity=0.443  Sum_probs=202.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||.||+|..++++.||+|.+.......    ..+.+|++++++++|+|++++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH----HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            35788899999999999999998899999999998655432    57888999999999999999999874 45689999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999987543 336899999999999999999999   889999999999999999999999999999776522


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ......+......+....
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  227 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLERGYRMPRPDN  227 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHcCCCCCCCCC
Confidence            22 1223345678999999998889999999999999999999 9999863211        111111111111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                         ....+.+++.+|++.+|++||+++++.+.+.
T Consensus       228 ---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         228 ---CPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ---CCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence               1224778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-40  Score=312.31  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=203.6

Q ss_pred             hcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .+|.+.+.||+|+||.||++..      .++..+++|.+.......   .+.+.+|++++++++|+||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4577889999999999999964      245668999987654332   3678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          217 MFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      .++||||+++++|.+++.....             ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence            9999999999999999875421             235899999999999999999999   889999999999999999


Q ss_pred             CCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCc
Q 013793          284 KLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  360 (436)
                      ++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------  231 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------  231 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence            99999999999976543221  1223446788999999999999999999999999999999 9999853211       


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .............. ...   .....+.+++.+||+.+|++||++.+|++.+....+
T Consensus       232 ~~~~~~~~~~~~~~-~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         232 TEVIECITQGRVLE-RPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHHHHhCCCCCC-CCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11111111111111 100   112346789999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-40  Score=312.23  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.......  ....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4678999999999999999999543      24579999887554322  235678899999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCe
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  287 (436)
                      ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||   +++|+||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence            999999999999999999975321       234677888999999999999999   8899999999999999999999


Q ss_pred             EEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccch
Q 013793          288 FVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  364 (436)
                      +|+|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||....       .....
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-------~~~~~  231 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVL  231 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHH
Confidence            99999999865432221  112235678999999998899999999999999999998 788875321       11111


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ....+..... ...   .....+.+++.+|++.||++|||+.++++.+...
T Consensus       232 ~~~~~~~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGGYLD-QPD---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCCCCC-CCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1122221111 100   1123477899999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-40  Score=313.12  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=205.1

Q ss_pred             ccHHHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeE
Q 013793          133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGF  210 (436)
Q Consensus       133 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  210 (436)
                      +.++++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+......    ...+.+|+.++..+ +||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            33456667889999999999999999999965 46889999988654322    25677899999999 69999999998


Q ss_pred             Ee-----eCCEEEEEEeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          211 CL-----HKKCMFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       211 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      +.     .++..++||||+++++|.++++.. .....+++..+..++.|++.||.|||   +.+++||||||+||+++++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCC
Confidence            85     345689999999999999987642 22346889999999999999999999   7899999999999999999


Q ss_pred             CCeEEeecccccccCCCCCCcccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCC
Q 013793          285 LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD  359 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~  359 (436)
                      +.++|+|||+++.............|++.|+|||.+..     ..++.++||||+||++|||++|+.|+.......    
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----  236 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----  236 (286)
T ss_pred             CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----
Confidence            99999999999876443333334568999999998753     457889999999999999999999986322110    


Q ss_pred             cccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       360 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ........ ....... .......+.+++.+||+.||++|||+.|+++++|+
T Consensus       237 ---~~~~~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         237 ---ALFKIPRN-PPPTLHQ-PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ---HHhhcccc-CCCcccC-CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence               01111000 0000000 00011236689999999999999999999999885

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.6e-40  Score=305.44  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=199.3

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcch--hhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  217 (436)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.....  ........+.+|+.+++.++||||+++.+++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999965 4689999998864421  122234678899999999999999999998875  3578


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++++||+++++|.+++....   .+++...+.++.|++.||+|||   +.+|+||||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999997643   5889999999999999999999   88999999999999999999999999999876


Q ss_pred             cCCCC---CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADS---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....       .............+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~  228 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTNP  228 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCCCCC
Confidence            53321   112234578899999999988899999999999999999999999863211       11111111111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ....   .....+.+++ .||..+|++||+++||++|+|+.
T Consensus       229 ~~~~---~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         229 QLPS---HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCch---hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            1111   1112244455 68889999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-40  Score=328.03  Aligned_cols=259  Identities=22%  Similarity=0.266  Sum_probs=197.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+|.+.+.||+|+||.||++... .++.||||....         ..+.+|++++++++|+|||++++++...+..++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46889999999999999999765 578899996322         34567999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |++. ++|.+++....  ..++|.+++.|+.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus       240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            9995 68888876532  26999999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC---------
Q 013793          302 SSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ---------  370 (436)
Q Consensus       302 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  370 (436)
                      ...  .....||..|+|||++.+..++.++|||||||++|||++|..|+-..............+..++..         
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            221  223569999999999999999999999999999999999886642111000000000000000000         


Q ss_pred             ------------------CCC---CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          371 ------------------RLP---PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       371 ------------------~l~---~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                                        ..+   ...+.........+.+|+.+||+.||.+|||+.|+++|+||..
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                              000   0000001111224678999999999999999999999999964

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6e-40  Score=303.10  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=194.5

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      +.||+|+||.||+|... +++.+|+|.+......+  ....+.+|+++++.++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            35999999999999764 78999999876543222  2367889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc--
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR--  305 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  305 (436)
                      +|.+++....  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++..........  
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999997543  35889999999999999999999   8899999999999999999999999999987643221111  


Q ss_pred             cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHH
Q 013793          306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI  384 (436)
Q Consensus       306 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  384 (436)
                      .....+..|+|||.+.+..++.++||||||+++|||++ |..||.....        ......+..........   ...
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~  222 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRLPCPE---LCP  222 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCCCcc---cCC
Confidence            11123457999999998889999999999999999998 8888863211        11112222211111111   112


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          385 LLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..+.+++.+|++.+|++|||+.++.+.+.
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            34678999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=311.23  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=207.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||.|++|.||++... ++..+|+|.+......   ..+.+.+|++++++++|||++++++++......++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            467888999999999999999764 6889999998765432   236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            99999999999987643  25899999999999999999999   78999999999999999999999999999876544


Q ss_pred             CCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .........+++.|+|||.+.     +..++.++||||||+++|||++|+.||.....       ............+ .
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~  227 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKSEPP-T  227 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcCCCC-C
Confidence            433344456899999999874     34577899999999999999999999863211       1111111111111 0


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ... .......+.+++.+||+.+|++||++.+++++.|+...
T Consensus       228 ~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         228 LDQ-PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             cCC-cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            000 00112236688999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.6e-40  Score=304.83  Aligned_cols=251  Identities=27%  Similarity=0.467  Sum_probs=201.0

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||.||+|..+++..+|+|.+.......    ..+.+|+.++++++|+|++++++++.. ...+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            5688899999999999999988888899999998654432    568899999999999999999998754 56789999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++.... ...+++..++.++.+++.||+|||   +.+++||||||+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          81 YMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999997643 235899999999999999999999   7899999999999999999999999999998764332


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....++..|+|||...+..++.++||||||+++|||++ |+.||....       . ....+.+......+...  
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~--  226 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-------N-REVLEQVERGYRMPCPQ--  226 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-------H-HHHHHHHHcCCCCCCCC--
Confidence            21 122335668999999988889999999999999999999 888885321       1 11122222222211111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                       .....+.+++.+|++.+|++|||+.++.+.+.
T Consensus       227 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         227 -DCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             -cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence             11234778999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-40  Score=314.91  Aligned_cols=267  Identities=19%  Similarity=0.237  Sum_probs=202.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+........  ...+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            56888999999999999999764 688999999875432221  245678999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            9997 58888886543  25889999999999999999999   889999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccchhhhh---
Q 013793          302 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLIDVL---  368 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~---  368 (436)
                      ........+++.|+|||.+.+. .++.++||||||+++|||+||+.||.......         ....... .....   
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET-WPGILSNE  236 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh-chhhhccc
Confidence            3333344578899999987654 57889999999999999999999986322100         0000000 00000   


Q ss_pred             ---cCCCCCCCC----hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          369 ---DQRLPPPVD----QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       369 ---~~~l~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                         ....+....    .........+.+++.+|++.||.+|||+.|+++|+|++.-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence               000000000    00001122367899999999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.9e-40  Score=310.94  Aligned_cols=265  Identities=25%  Similarity=0.322  Sum_probs=202.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|+....||+|++|.||+|... +|+.||+|++....... ...+.+.+|++++..++|+|++++++++......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            46888899999999999999765 68999999986543211 11256788999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|..+.....   .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999998888775433   5899999999999999999999   789999999999999999999999999999876544


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCC------Cc-ccchhhhhc----
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS------DP-KIMLIDVLD----  369 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~------~~-~~~~~~~~~----  369 (436)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........      .. .....+..+    
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            333334567889999998876 467899999999999999999999986322110000      00 000000000    


Q ss_pred             ---CCCCCCCC-----hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          370 ---QRLPPPVD-----QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       370 ---~~l~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ...+.+..     .........+.+++.+||+.+|++||++.|++.|+|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               00000000     0001112346789999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=313.44  Aligned_cols=261  Identities=23%  Similarity=0.327  Sum_probs=211.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|+..+.||+|++|+||++... +++.||+|.+...........+.+.+|++++..++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999765 58999999998765443334577899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+.+++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987542 346899999999999999999999   889999999999999999999999999998755322


Q ss_pred             CC-----------------------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          302 SS-----------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       302 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                      ..                             ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                             0112357889999999998889999999999999999999999986321


Q ss_pred             cccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHHHhhcCC
Q 013793          353 SLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT----MQYVSQGFLITRK  417 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt----~~ev~~~l~~~~~  417 (436)
                             ...............+...   .....+.+++.+||+.||++||+    +.|++++.|+...
T Consensus       237 -------~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         237 -------RDETFSNILKKEVTFPGSP---PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             -------hHHHHHHHhcCCccCCCcc---ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence                   1112222333322221111   12334778999999999999999    9999999998653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.7e-40  Score=305.07  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=202.1

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|+||.||++... +++.+|+|.+......  ...+.+.+|+.+++.++|+|++++.+.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4778899999999999999654 7889999998654322  224678889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++.... ...+++..++.++.|++.||.|||   +.+|+|+||||+||++++++.++++|||.+.......
T Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999999886532 235789999999999999999999   8899999999999999999999999999998765443


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....       ..............+ ...   .
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~---~  223 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKVCQGSYKP-LPS---H  223 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHHhcCCCCC-CCc---c
Confidence            33344568899999999998889999999999999999999999986321       111111111111111 111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQG  411 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~  411 (436)
                      ....+.+++.+||+.||++||++.+++..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            12236689999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.1e-40  Score=304.83  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=202.7

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh------hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE------ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      +|.+...||+|++|.||+|.. .+++.+|+|.+......      .....+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366788999999999999965 46889999988654322      12234678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++|+||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997653   6888999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC
Q 013793          297 RLHADSS------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       297 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      .......      ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......       .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGEN  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhcc
Confidence            7653221      112245788999999999888999999999999999999999998632211       111111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       ..+....   .....+.+++.+||+.||.+||++.|++++.|+
T Consensus       228 -~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 -ASPEIPS---NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -CCCcCCc---ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence             1111111   112336688999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.3e-40  Score=312.81  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=203.5

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |.....||+|+||.||++.. .++..||||.+......   ..+.+.+|+..++.++|+|++++++.+...+..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            33346699999999999965 46889999998654332   236788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++++|.+++...    .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999988543    5889999999999999999999   78999999999999999999999999999876544333


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      ......|+..|+|||...+..++.++||||||+++|||++|+.||......       ... ..+...++..... ....
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~-~~~~~~~~~~~~~-~~~~  244 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAM-RRIRDNLPPRVKD-SHKV  244 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHHHhcCCCcccc-cccc
Confidence            334456889999999998888999999999999999999999998632110       001 1111111111100 0111


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...+.+++.+|+..||++|||+.|+++++|+....+
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            223667889999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.3e-40  Score=309.39  Aligned_cols=257  Identities=25%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      .+++|.+.+.||+|++|.||+|...      .+..||+|.+.......  ....+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3567889999999999999999765      35678999886543322  236788899999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---Ce
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDE----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EA  287 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~  287 (436)
                      ...++||||+++++|.+++.....    ...+++..++.++.||+.||+|||   +.+++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcce
Confidence            999999999999999999876432    235899999999999999999999   78999999999999998754   58


Q ss_pred             EEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccch
Q 013793          288 FVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  364 (436)
                      ||+|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||+....        ...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~  230 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEV  230 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence            99999999876322111  112223568999999998899999999999999999997 9999863211        011


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .+.+..........   .....+.+++.+|++.+|++||++.+|++++.
T Consensus       231 ~~~~~~~~~~~~~~---~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 MEFVTGGGRLDPPK---GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111111111100   11224678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-41  Score=287.67  Aligned_cols=260  Identities=23%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             hhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      .++|.+.+.||+|||+-||.++ ..++..||+|++.....++   .+..++|++..++++|||++++++++..+.     
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            4679999999999999999996 5688999999998776433   477889999999999999999998876543     


Q ss_pred             EEEEEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      +.|++++|...|+|.+.+.... +...+++.+.+.|+.++++||.+||.. .++++||||||.|||+.+.+.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            5899999999999999987653 334799999999999999999999944 34599999999999999999999999999


Q ss_pred             ccccCCCCCC---------ccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCccc
Q 013793          295 ARRLHADSSN---------RTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI  362 (436)
Q Consensus       295 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~  362 (436)
                      ++...-.-..         ...-..|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-.-.     ..
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-----gS  250 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-----GS  250 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----Ce
Confidence            9865321111         12234788999999876   4567899999999999999999999998543211     11


Q ss_pred             chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ....+....+.-+....   ....+.+++.+|++.||.+||++.+++.++.
T Consensus       251 laLAv~n~q~s~P~~~~---yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSR---YSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             EEEeeeccccccCCCCC---ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            12222222222222221   2234778999999999999999999998764

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-40  Score=318.52  Aligned_cols=269  Identities=23%  Similarity=0.283  Sum_probs=201.9

Q ss_pred             HHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--
Q 013793          138 LIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--  214 (436)
Q Consensus       138 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  214 (436)
                      ..+..++|.+.+.||+|+||+||+|.. .+++.||||++....... .....+.+|+++++.++||||+++++++...  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            345678899999999999999999965 578899999987643322 2235677899999999999999999887543  


Q ss_pred             ----CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          215 ----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       215 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                          ...++++|++ +++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEc
Confidence                3578999988 77898887542    5899999999999999999999   8899999999999999999999999


Q ss_pred             ecccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP  360 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~  360 (436)
                      |||+++.....   .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......         .....
T Consensus       161 Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         161 DFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             CCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999865432   234568999999999876 568999999999999999999999986321100         00000


Q ss_pred             cc------chhhhhcCCCCCCCChhH----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          361 KI------MLIDVLDQRLPPPVDQKV----IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       361 ~~------~~~~~~~~~l~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..      .........++.......    ......+.+++.+|++.||++|||+.|+++|+|+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            00      000000000000000000    00112356899999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-40  Score=340.45  Aligned_cols=258  Identities=26%  Similarity=0.388  Sum_probs=198.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999764 68999999997654333333467899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          222 EYMERGSLFCILHNDD--------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      ||++||+|.+++....        ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421        1234677888999999999999999   7899999999999999999999999999


Q ss_pred             cccccCCCCC------------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc
Q 013793          294 TARRLHADSS------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS  355 (436)
Q Consensus       294 ~a~~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~  355 (436)
                      +++.......                  ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....  
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~--  236 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG--  236 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence            9986521110                  01124689999999999999999999999999999999999999863111  


Q ss_pred             CCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHH
Q 013793          356 SSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT-MQYVSQGF  412 (436)
Q Consensus       356 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~ev~~~l  412 (436)
                          ..............   ..........+.+++.+|++.||++||+ ++++.+.+
T Consensus       237 ----~ki~~~~~i~~P~~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        237 ----RKISYRDVILSPIE---VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             ----hhhhhhhhccChhh---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                00000111100000   0000111233668899999999999975 44455443

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.2e-40  Score=308.20  Aligned_cols=260  Identities=26%  Similarity=0.363  Sum_probs=207.3

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|+..+.||+|++|.||++... +++.+|+|.+......  .....+.+|+++++.++||||+++++.+......++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            35777889999999999999765 6899999998766433  22367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++++|.+++....  ..+++.....++.|++.||+|||   + .+++|+||+|+||++++++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999997653  36888999999999999999999   6 8999999999999999999999999999876533


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      ...  ....++..|+|||...+..++.++||||||+++|+|++|+.||.......  ............... +..... 
T Consensus       154 ~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~-  227 (265)
T cd06605         154 SLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFELLQYIVNEPP-PRLPSG-  227 (265)
T ss_pred             HHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHHHhcCCC-CCCChh-
Confidence            221  12568889999999998899999999999999999999999986321100  000011111122111 111111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                       .....+.+++.+||..||++|||+.+++.++|+++
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         228 -KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             -hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence             12333678999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.1e-40  Score=309.47  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=206.0

Q ss_pred             cHHHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEE
Q 013793          134 FYEDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFC  211 (436)
Q Consensus       134 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  211 (436)
                      .+.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+......    ...+..|+.++.++ +|+|++++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH----HHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            4556667788999999999999999999966 46889999998654322    25678899999998 799999999998


Q ss_pred             ee------CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          212 LH------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       212 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      ..      ....+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+|+||+|+||++++++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~  158 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence            63      457899999999999999987543 235788889999999999999999   78999999999999999999


Q ss_pred             CeEEeecccccccCCCCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc
Q 013793          286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  360 (436)
                      .++|+|||++..............|+..|+|||.+.     ...++.++||||||+++|||++|+.||......      
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------  232 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------  232 (282)
T ss_pred             CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------
Confidence            999999999876543333334456889999999875     346788999999999999999999998632211      


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       ................   ......+.+++.+||+.||.+|||+.|+++++|+
T Consensus       233 -~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         233 -RALFLIPRNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -hhhhhHhhCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             0011111111111000   1122347789999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.9e-40  Score=309.28  Aligned_cols=255  Identities=26%  Similarity=0.378  Sum_probs=209.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|.||++... +++.+|+|.+...........+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999654 68999999987654433334577889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999997653   6899999999999999999999   789999999999999999999999999999876433


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....       ...............+..    
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~----  220 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-------PIQIYEKILEGKVRFPSF----  220 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCccCCcc----
Confidence               233468899999999988888999999999999999999999986322       111122222222211111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCCC
Q 013793          382 QDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITRKT  418 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~~  418 (436)
                       ....+.+++.+||..||.+||     +++|+++++|+..-.
T Consensus       221 -~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         221 -FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             -CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence             123366889999999999999     999999999875543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.8e-40  Score=310.46  Aligned_cols=272  Identities=25%  Similarity=0.297  Sum_probs=206.9

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchh--hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      +|+..+.||+|++|.||+|... +++.||+|.+......  .......+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999754 6899999999765433  112235677899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+ +|+|.+++....  ..+++..++.++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999997643  36899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc-----chh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI-----MLI  365 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~-----~~~  365 (436)
                      .........++..|+|||.+.+ ..++.++|||||||++|||++|..||.......         .......     ...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4333333456788999998865 467899999999999999999987775322100         0000000     000


Q ss_pred             hhhcCCCCCCC--ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          366 DVLDQRLPPPV--DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       366 ~~~~~~l~~~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                      ...........  ..........+.+++.+||+.||++|||+.|++++.|+.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            00000000000  000111234477899999999999999999999999998875544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.8e-40  Score=320.80  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=202.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  213 (436)
                      ..++|.+.+.||+|+||.||+|.+.      .++.||+|+++.......  ...+.+|++++.++. ||||++++++|..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE--KQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH--HHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            4456788899999999999999753      346899999986543322  357889999999997 9999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDE-------------------------------------------------------  238 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  238 (436)
                      .+..++|+||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999865321                                                       


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 013793          239 ----------------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  278 (436)
Q Consensus       239 ----------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~N  278 (436)
                                                              ...+++...+.++.|++.||+|||   +.+++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence                                                    124778889999999999999999   8899999999999


Q ss_pred             eeecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccccccc
Q 013793          279 ILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLS  355 (436)
Q Consensus       279 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~  355 (436)
                      ||+++++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....   
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~---  346 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP---  346 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC---
Confidence            9999999999999999986533221  1222356788999999998889999999999999999998 888975321   


Q ss_pred             CCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          356 SSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       356 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                          ........+..........   .....+.+++.+||+.+|.+||+++|+++.+..
T Consensus       347 ----~~~~~~~~~~~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         347 ----MNEQFYNAIKRGYRMAKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             ----chHHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                1111112222211111111   112346789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-40  Score=320.16  Aligned_cols=266  Identities=24%  Similarity=0.270  Sum_probs=199.9

Q ss_pred             HHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC----
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK----  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  214 (436)
                      ...++|++.+.||+|+||.||++.. ..++.||||++....... .....+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            3467899999999999999999965 468899999997643322 2236677899999999999999999988643    


Q ss_pred             --CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          215 --KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       215 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                        ...++||||+++ ++.+.+..     .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeC
Confidence              357999999976 56666542     4788999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcc--
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPK--  361 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~--  361 (436)
                      |+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||........         ...+.  
T Consensus       164 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999865332 222345689999999999998999999999999999999999999863221000         00000  


Q ss_pred             ----cchhhhhcCC---------------CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          362 ----IMLIDVLDQR---------------LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       362 ----~~~~~~~~~~---------------l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                          .......+..               ..+............+.+++.+|++.||++|||+.|+++|+|+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                0000000000               000000000011234678999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-39  Score=309.51  Aligned_cols=257  Identities=24%  Similarity=0.369  Sum_probs=202.7

Q ss_pred             HhhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      ..++|.+.+.||+|+||.||++..      .++..+|+|.+.......  ..+.+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS--EREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH--HHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            346789999999999999999963      234579999987654322  236788999999999 79999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      .+..++||||+++|+|.++++.... ..+++.++..++.+++.||+|||   +.+|+|+||||+||+++.++.++++|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999975432 24899999999999999999999   7899999999999999999999999999


Q ss_pred             cccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC
Q 013793          294 TARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       294 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      +++........  .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       ..........
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~~~~  259 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKLIKE  259 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHHHHc
Confidence            99866433221  122345678999999998899999999999999999998 9999863211       1111222222


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ........   .....+.+++.+|++.+|++|||+.|+++.+.
T Consensus       260 ~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         260 GYRMAQPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             CCcCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            21111111   11224778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-39  Score=308.17  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=200.0

Q ss_pred             cccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      +|++.+.||+|+||.||+|...      ....+++|.+.......  ....+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS--ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH--HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4677889999999999999642      23578999887654332  236788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 013793          218 FLIYEYMERGSLFCILHNDD---------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  276 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~  276 (436)
                      ++|+||+++|+|.+++....                     ....+++..++.++.|++.||+|||   +.+++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhh
Confidence            99999999999999886421                     1235889999999999999999999   78999999999


Q ss_pred             CceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccccc
Q 013793          277 NNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS  353 (436)
Q Consensus       277 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  353 (436)
                      +||++++++.++|+|||+++........  .....++..|+|||...+..++.++||||||+++|||+| |+.||.... 
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-  234 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-  234 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence            9999999999999999999765332221  122345678999999988889999999999999999998 999985221 


Q ss_pred             ccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          354 LSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                             .....+........+...   .....+.+++.+||+.+|++||++.++++.+..
T Consensus       235 -------~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         235 -------PERLFNLLKTGYRMERPE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             -------HHHHHHHHhCCCCCCCCC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                   111222222222111111   112246789999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.1e-40  Score=311.21  Aligned_cols=264  Identities=25%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc---cCCCceeeeeEEee-----C
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRSIVKLYGFCLH-----K  214 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~  214 (436)
                      +|++.+.||+|+||+||+|... +++.||+|.+........ ....+.+|++++..+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4788899999999999999654 789999999875422111 113445566666555   79999999998865     2


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++||||+++ +|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence            457999999985 8888887543 235899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccchh
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLI  365 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~~~  365 (436)
                      ++...... ......|+..|+|||.+.+..++.++||||+||++|||++|+.||.......         .......+..
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            98664322 2234568899999999998899999999999999999999999985321100         0000000000


Q ss_pred             ------hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          366 ------DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       366 ------~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                            .....................+.+++.+|++.||++|||+.|+++|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  0000000000000001112336789999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.5e-40  Score=311.13  Aligned_cols=255  Identities=23%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .+|.+.+.||+|+||.||+|...      +++.||+|++.......  ....+.+|+.++..++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            34677888999999999999753      35789999998654322  23678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          217 MFLIYEYMERGSLFCILHNDD-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      .++++||+++++|.+++....             ....+++..+..++.|++.||+|||   +.+|+||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecC
Confidence            999999999999999985321             1235888999999999999999999   889999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCc
Q 013793          284 KLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  360 (436)
                      ++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....       .
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~  232 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------N  232 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------H
Confidence            999999999998865432211  123345778999999988889999999999999999998 888875211       1


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ......+.+.... +...   .....+.+++..||+.+|.+||++.+|++.+.
T Consensus       233 ~~~~~~i~~~~~~-~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         233 QDVIEMIRNRQVL-PCPD---DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHHHHHHcCCcC-CCCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            1112222222211 1111   11223668999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-39  Score=302.44  Aligned_cols=245  Identities=24%  Similarity=0.371  Sum_probs=193.3

Q ss_pred             eeeecCceEEEEEEc---CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          150 CIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .||+|+||.||+|.+   .++..+|+|++...... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999954   36788999998755432 233478899999999999999999999885 4567899999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC--
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--  304 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  304 (436)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||+++........  
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999997543   6899999999999999999999   789999999999999999999999999999876443321  


Q ss_pred             -ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          305 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       305 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.||.....        ....+.+......+...   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~---~  222 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMIESGERMECPQ---R  222 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCCCC---C
Confidence             122234578999999988889999999999999999998 9999863211        11122222221111111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ....+.+++.+||+.||++||++.+|.+.+.
T Consensus       223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             CCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence            1233678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.9e-40  Score=304.67  Aligned_cols=251  Identities=26%  Similarity=0.439  Sum_probs=199.2

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||.||+|...++..||+|.+......    .+.+.+|+++++.++||||+++++.+.+ ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            568899999999999999998877778999999864432    2568889999999999999999998754 55789999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++.... ...+++..+..++.+++.||+|||   +.+++||||||+||++++++.++|+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          81 YMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             cCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999997542 235799999999999999999999   7899999999999999999999999999998664332


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....++..|+|||...+..++.++||||||+++|||+| |+.||....       ... ..+........+..   
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~---  225 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NRE-VLDQVERGYRMPCP---  225 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------hHH-HHHHHhcCCCCCCc---
Confidence            21 122346678999999988899999999999999999999 888875221       111 11111111111111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ......+.+++.+|++.+|++||++.++++.+.
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            112334678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.3e-40  Score=319.09  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=199.3

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  214 (436)
                      ..++|.+.+.||+|+||.||++.. ..++.||||++....... .....+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            457899999999999999999965 468899999997643222 1236678899999999999999999987643     


Q ss_pred             -CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          215 -KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       215 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                       ...++||||+++ +|...+..     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999975 67666642     4788999999999999999999   8899999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc--
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI--  362 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~--  362 (436)
                      +++...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||.......         ....+..  
T Consensus       172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             CccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            998653322 2234568999999999999999999999999999999999999986322100         0000000  


Q ss_pred             ----chhhhhcCCC--------------CCCCC-hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          363 ----MLIDVLDQRL--------------PPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       363 ----~~~~~~~~~l--------------~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                          ........+.              ..+.. .........+.+++.+|++.||++|||+.|+++|+|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                0000000000              00000 000011234678999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.6e-40  Score=309.06  Aligned_cols=264  Identities=25%  Similarity=0.375  Sum_probs=211.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||.||++.. .+++.||+|.+.......   .+.+.+|+.+++.++|||++++.+++...+..++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH---HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            36788899999999999999964 478899999986543322   36788899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+++++|.+++...    .+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999998653    4789999999999999999999   88999999999999999999999999999876654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........+++.|+|||.+.+..++.++||||||+++|++++|+.||........       .........+ .. ...
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~-~~-~~~  238 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTP-EL-QNP  238 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-------eeehhcCCCC-CC-CCc
Confidence            44333445688899999999888899999999999999999999999863221100       0001000000 00 001


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHA  424 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~  424 (436)
                      ......+.+++.+||+.+|++||++.+++.|.|+...++..+-+
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~  282 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT  282 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence            11223466899999999999999999999999999887655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-41  Score=307.75  Aligned_cols=262  Identities=24%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----EE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----CM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  217 (436)
                      .|...+++|+|+||.||+|... +++.||||+........       .+|+++|+.++|||||+++.+|....     ..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            4556789999999999999654 57899999987765432       36999999999999999999887543     34


Q ss_pred             EEEEeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecccc
Q 013793          218 FLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTA  295 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a  295 (436)
                      .+||||||. +|...++.. .....++...+.-+..||++||+|||   +.+|+||||||.|+|+|.+ |.+||||||.|
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            689999998 888888742 12346788888999999999999999   8999999999999999976 99999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccc----------cCCCCccc--
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSDPKI--  362 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------~~~~~~~~--  362 (436)
                      +.+..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...+..          ....+++.  
T Consensus       174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            988765544 455678999999998876 7999999999999999999999888642210          00000000  


Q ss_pred             ---chhhhhcCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          363 ---MLIDVLDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       363 ---~~~~~~~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                         ...+...+.+......  ..........+|+.++++.+|.+|.++.|+++|++|...
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence               0000000111111000  011122346789999999999999999999999987543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-40  Score=325.22  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=201.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ..+|.+.+.||+|+||.||++...   .++.||+|.+....        ...+|+++++.++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999643   46789999886542        3457999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +|||++. ++|.+++...   ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999996 5888888433   36899999999999999999999   789999999999999999999999999999766


Q ss_pred             CCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC------------------CC
Q 013793          299 HADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS------------------SS  358 (436)
Q Consensus       299 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~------------------~~  358 (436)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||........                  ..
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            433221  2345699999999999999999999999999999999999999853211000                  00


Q ss_pred             Ccccchhhh---hcCCCCCCCC--h--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          359 DPKIMLIDV---LDQRLPPPVD--Q--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       359 ~~~~~~~~~---~~~~l~~~~~--~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      .........   ......++..  .  ........+.+++.+||..||++|||+.|+++++|+...++.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence            000000000   0000000000  0  000112336678999999999999999999999999776543

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.5e-40  Score=312.69  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=202.6

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      ..++|++.+.||+|+||.||++...      +...+|+|.+.......  ....+.+|++++.++ +|+||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            4567888999999999999999753      33679999987654322  236688999999999 89999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 013793          214 KKCMFLIYEYMERGSLFCILHND-------------DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  280 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nil  280 (436)
                      .+..+++|||+++|+|.++++..             .....+++..++.++.|++.||+|||   +.+|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence            99999999999999999998643             12346899999999999999999999   789999999999999


Q ss_pred             ecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCC
Q 013793          281 LNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSS  357 (436)
Q Consensus       281 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~  357 (436)
                      +++++.++|+|||+++.+......  .....++..|+|||...+..++.++|||||||++|||++ |..||.....    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            999999999999999876443221  122235678999999988899999999999999999997 8888752110    


Q ss_pred             CCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         . ...+.+..........   .....+.+++.+||+.||++|||+.|+++.+..
T Consensus       241 ---~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         241 ---E-ELFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             ---H-HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence               0 1111111111111111   112346789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-39  Score=301.49  Aligned_cols=251  Identities=26%  Similarity=0.443  Sum_probs=199.4

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|.+.+.||+|++|.||++...++..+|+|.+......    ...+.+|+++++.++|+|++++++++. .+..++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            468888999999999999998877778999988765432    256788999999999999999998875 456789999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++.... ...+++..+..++.+++.||+|||   +.+++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999997643 235899999999999999999999   7899999999999999999999999999997654322


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....++..|+|||...+..++.++||||||+++|||+| |+.||....       ... ..+........+...  
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~~--  226 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-------NRE-VLEQVERGYRMPCPQ--  226 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHH-HHHHHHcCCCCCCCc--
Confidence            21 122345678999999988899999999999999999999 899986321       111 111111121111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                       .....+.+++.+||+.||++||++++|.+.+.
T Consensus       227 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         227 -GCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             -ccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence             12234778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-39  Score=305.38  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=196.1

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+......  .....+..|+..+++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch--HHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            46788899999999999999753 444    4788887543322  223677888889999999999999998764 457


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++++||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            88999999999999997543  36899999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ......  ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....        ....+.+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERL  230 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcC
Confidence            643322  1223456778999999998899999999999999999998 9999863211        1111222211111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +....   ....+.+++.+||..||++|||+.|+++.+..
T Consensus       231 ~~~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         231 AQPQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            11110   11235678889999999999999999998755

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.8e-40  Score=311.13  Aligned_cols=265  Identities=25%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46888999999999999999775 58999999986543332 22367888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|..+.....   .+++.+++.++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999999988776443   5899999999999999999999   789999999999999999999999999999876544


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCC-------CCcccchhhhhc----
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS-------SDPKIMLIDVLD----  369 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~----  369 (436)
                      ........++..|+|||+..+ ..++.++||||||+++|||++|+.||.........       ...........+    
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            433344567889999998875 45788999999999999999999988532210000       000000000000    


Q ss_pred             --CCCCCCCC--h----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          370 --QRLPPPVD--Q----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       370 --~~l~~~~~--~----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        ....+...  .    ........+.+++.+||+.+|++||++.+++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              00000000  0    000112347789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-39  Score=303.61  Aligned_cols=255  Identities=30%  Similarity=0.457  Sum_probs=206.0

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      -|+..+.||+|+||.||+|.. .++..+|+|.+.......  ..+.+.+|++.+.+++||||+++++++..+...++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH--HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            366788899999999999965 478899999986544322  23678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++...    .+++..+..++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999998643    5889999999999999999999   8899999999999999999999999999987664433


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......++..|+|||.+.+...+.++||||||+++|+|++|+.|+.....       .. ....+.....+....   .
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~---~  224 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MK-VLFLIPKNNPPTLEG---N  224 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HH-HHHHHhcCCCCCCCc---c
Confidence            333345678899999999888899999999999999999999999863211       01 111111111111111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ....+.+++.+||+.+|++||++.++++++|+.+..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            123366889999999999999999999999997753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-39  Score=311.53  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=187.8

Q ss_pred             ceeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEEEEEEee
Q 013793          149 YCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCMFLIYEY  223 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  223 (436)
                      ..||+|+||+||+|...   ++..||+|.+......     ..+.+|+++++.++||||+++++++..  ....++|+||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            57999999999999764   4578999998765432     456789999999999999999998854  5578999999


Q ss_pred             ccCCChhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCCeEEeecc
Q 013793          224 MERGSLFCILHND------DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFG  293 (436)
Q Consensus       224 ~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg  293 (436)
                      +++ +|.+++...      .....+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            875 777666422      12235889999999999999999999   7899999999999999    566789999999


Q ss_pred             cccccCCCCC---CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc--ccch---
Q 013793          294 TARRLHADSS---NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIML---  364 (436)
Q Consensus       294 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--~~~~---  364 (436)
                      +++.......   ......+|+.|+|||.+.+. .++.++|||||||++|||+||+.||............  ....   
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            9987643322   12335689999999988764 5899999999999999999999998632210000000  0000   


Q ss_pred             ------------hh------------hhc-CCCCCCCChh-----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          365 ------------ID------------VLD-QRLPPPVDQK-----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       365 ------------~~------------~~~-~~l~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                                  ..            ... ..........     .......+.+++.+|++.||.+|||+.|+++|+|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                        00            000 0000000000     00011236679999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-39  Score=300.94  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=195.1

Q ss_pred             eeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      +||+|+||.||+|...+++.+|+|.+.......  ....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            589999999999998889999999987654332  235688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC-cccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN-RTLL  308 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  308 (436)
                      .+++....  ..+++..++.++.+++.||.|||   +.+++||||||+||++++++.++|+|||++......... ....
T Consensus        80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            99986543  25889999999999999999999   889999999999999999999999999998754322211 1122


Q ss_pred             ccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHH
Q 013793          309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLA  387 (436)
Q Consensus       309 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  387 (436)
                      .++..|+|||+..+..++.++||||||+++||+++ |..||.....       .. ...............   .....+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~---~~~~~~  223 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-------QQ-AREQVEKGYRMSCPQ---KCPDDV  223 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-------HH-HHHHHHcCCCCCCCC---CCCHHH
Confidence            34567999999998899999999999999999998 9999863211       00 111111111111111   112347


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          388 STISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       388 ~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .+++.+|++.+|++||++.|+++.+
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHh
Confidence            7899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.4e-40  Score=310.15  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=197.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++......  ..+.+.+|++++.++ +||||+++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH--HHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            57888999999999999999765 333  47888887433222  236788999999999 7999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          219 LIYEYMERGSLFCILHNDD-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      +|+||+++|+|.+++....             ....+++..++.++.|++.||+|||   +.+|+||||||+||++++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCC
Confidence            9999999999999996532             1135889999999999999999999   78999999999999999999


Q ss_pred             CeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccch
Q 013793          286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  364 (436)
                      .+||+|||++....... .......+..|+|||...+..++.++|||||||++|||++ |+.||.....       .. .
T Consensus       157 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~-~  227 (297)
T cd05089         157 ASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AE-L  227 (297)
T ss_pred             eEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HH-H
Confidence            99999999986432111 1111223557999999988889999999999999999997 9999863211       11 1


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .+............   .....+.+++.+||+.+|.+||++.++++.+...
T Consensus       228 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         228 YEKLPQGYRMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111111111111   1122367899999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-39  Score=305.08  Aligned_cols=258  Identities=24%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             ccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCM  217 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  217 (436)
                      |+..+.||+|+||+||++..     .++..||+|.+.......  ....+.+|+++++.++||||+++.+++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            37789999999999988642     367889999987654321  236788999999999999999999988763  468


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++...    .+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.++|+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            8999999999999999753    5899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc-cc---CC---CCcccchhhh
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-LS---SS---SDPKIMLIDV  367 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-~~---~~---~~~~~~~~~~  367 (436)
                      .......   .....++..|+|||...+..++.++||||||+++|||+||+.|+..... +.   ..   ........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            6432221   1223456679999999888899999999999999999999999753211 00   00   0000011111


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+.....+...   .....+.+++..||+.+|++|||++++++.+..
T Consensus       237 ~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         237 LERGMRLPCPK---NCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hhcCCCCCCCC---CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            11111111111   112347789999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-39  Score=309.87  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=201.1

Q ss_pred             hhcccccceeeecCceEEEEEEcC--------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.......  ....+.+|++++..+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH--HHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            357899999999999999999642        23579999997653222  236788899999999 7999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      ..+..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||   +.+++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence            99999999999999999999976432             135899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      ++++++.++|+|||.++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....    
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----  247 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----  247 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence            9999999999999998765432211  111224568999999998889999999999999999998 888875211    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         . ......+..........   .....+.+++.+||+.+|++|||+.+|++.+...
T Consensus       248 ---~-~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         248 ---V-EELFKLLKEGHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---H-HHHHHHHHcCCCCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               1 11111222211111111   1123466899999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-39  Score=303.15  Aligned_cols=259  Identities=24%  Similarity=0.360  Sum_probs=206.1

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCMFLI  220 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  220 (436)
                      +|++.+.||.|+||.||++.. .+++.+|+|.+....... ...+.+.+|+++++.++|+|++++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            477889999999999999964 578899999987654322 224678899999999999999999998764  4567999


Q ss_pred             EeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      |||+++++|.+++... .....+++..++.++.+++.||+|||..+  +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999998653 22347899999999999999999999554  67899999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++|+.||....       ... ..+.+.....+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~  231 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-------QLQ-LASKIKEGKFRRIP  231 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-------HHH-HHHHHhcCCCCCCc
Confidence            7554432344568999999999998889999999999999999999999986321       111 11112211111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .   .....+.+++.+|++.+|++||++.+|++++|.
T Consensus       232 ~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         232 Y---RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             c---ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            1   122346789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-39  Score=302.65  Aligned_cols=259  Identities=30%  Similarity=0.434  Sum_probs=211.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|.||++... +++.|++|++......  .....+.+|++.+.+++|+|++++++++...+..++|+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            36888999999999999999766 5999999998776542  22478899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++++|.+++...   ..+++..++.++.|+++|++|||   + .+++||||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999765   36899999999999999999999   7 9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........++..|+|||...+..++.++||||||+++|+|+||+.||.....    .........+.....+ ..... 
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~-~~~~~-  226 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPP-SLPAE-  226 (264)
T ss_pred             CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCCCC-CCCcc-
Confidence            44433345688899999999988999999999999999999999999864321    0001111122211111 11111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                       .....+.+++.+||+.+|++||++.|+++++|+..
T Consensus       227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         227 -EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             -cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence             02234778999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-39  Score=303.98  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=200.4

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++|++.+.||+|+||+||+|.+ .+++    .||+|.+.......  ....+.+|+.++..++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH--HHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            35788899999999999999964 3454    48999987654332  236788999999999999999999999754 4


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++++||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence            679999999999999997643  26899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ........  .....++..|+|||...+..++.++||||||+++|||++ |..||+....        ......+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~  229 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEKGER  229 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCc
Confidence            76433221  112234678999999998899999999999999999998 8999863211        111122222111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .+...   .....+.+++.+||+.||++||++.++++.+......
T Consensus       230 ~~~~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         230 LPQPP---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CCCCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            11111   1123467899999999999999999999887654443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-39  Score=305.21  Aligned_cols=258  Identities=19%  Similarity=0.309  Sum_probs=203.6

Q ss_pred             hhcccccceeeecCceEEEEEEcCC-----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  215 (436)
                      .++|.+.+.||+|+||.||+|...+     +..|++|.+......  .....+.+|+.++..++|+|++++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            5678899999999999999997755     788999998754332  224778899999999999999999998876 46


Q ss_pred             EEEEEEeeccCCChhhhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEA-----VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      ..++++||+++|+|.+++......     ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998764322     46899999999999999999999   7899999999999999999999999


Q ss_pred             ecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhh
Q 013793          291 DFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       291 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      |||+++.+......  .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....        ......
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~  231 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAY  231 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHH
Confidence            99999866433221  122345678999999988889999999999999999999 9999863211        111111


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +..........   .....+.+++.+||+.||++|||+.++++.+...
T Consensus       232 ~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         232 LKDGYRLAQPI---NCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             HHcCCCCCCCC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111111111   1122367899999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-39  Score=302.06  Aligned_cols=256  Identities=30%  Similarity=0.464  Sum_probs=204.6

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|+||.||+|.. .+++.|++|.++..... ....+.+.+|+++++.++|+||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            477889999999999999975 47899999998766543 2345889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++....   .+++..+..++.++++||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999997643   5788999999999999999999   7899999999999999999999999999998765433


Q ss_pred             CCcc----ccccccccccccccccCc---cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          303 SNRT----LLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       303 ~~~~----~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ....    ...++..|+|||.+.+..   .+.++||||||+++||+++|+.||....      ........... ...+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~------~~~~~~~~~~~-~~~~~  226 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD------NEFQIMFHVGA-GHKPP  226 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc------chHHHHHHHhc-CCCCC
Confidence            2211    245788999999988766   8899999999999999999999986321      00000111111 11111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ... .......+.+++.+||+.+|++||++.|++.++|+
T Consensus       227 ~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 IPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            111 11112335689999999999999999999999884

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=304.57  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=197.3

Q ss_pred             ccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE----
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC----  216 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  216 (436)
                      |++.+.||+|+||.||+|....    +..||+|.++...... .....+.+|++.++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            5677889999999999997542    3679999987643322 234678999999999999999999999876554    


Q ss_pred             --EEEEEeeccCCChhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          217 --MFLIYEYMERGSLFCILHNDD---EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       217 --~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                        .++++||+++|+|..++....   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence              799999999999999885432   2346899999999999999999999   78999999999999999999999999


Q ss_pred             cccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh
Q 013793          292 FGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       292 fg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      ||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....       ........
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~  229 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLR  229 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence            9999876433221  112235678999999988889999999999999999999 8888753211       11111111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..... ....   .....+.+++.+||+.||++|||+.|+++.+.
T Consensus       230 ~~~~~-~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         230 HGNRL-KQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             cCCCC-CCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111 1111   12234778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-39  Score=314.49  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             hhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||.||+|..      .+++.||||.++......  ....+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH--HHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            45789999999999999999963      357899999997654322  236788999999999 689999999988754


Q ss_pred             -CEEEEEEeeccCCChhhhhccCCC-------------------------------------------------------
Q 013793          215 -KCMFLIYEYMERGSLFCILHNDDE-------------------------------------------------------  238 (436)
Q Consensus       215 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  238 (436)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467899999999999999864321                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC--ccc
Q 013793          239 ---------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTL  307 (436)
Q Consensus       239 ---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~  307 (436)
                               ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++.........  ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     124788899999999999999999   889999999999999999999999999999765332221  122


Q ss_pred             cccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .......+...........   ....
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~  310 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDY---TTPE  310 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHHHhccCCCCCCCC---CCHH
Confidence            335678999999988899999999999999999997 8989853211       0011111111111111100   1123


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          387 ASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +.+++..||+.||++|||+.|+++++..
T Consensus       311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         311 MYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            6788899999999999999999999854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=301.85  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=218.8

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      -|.+..+||+|+||.||++.+ .+|..+|||.+.....     ++++.+|+.++++++.|++|+++|.|......|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            366788899999999999955 5899999999877643     4788899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      ||..|+..+.++-++  .++++.++..+.+..+.||+|||   ...-+|||||+.|||++-+|.+||+|||.|..+...-
T Consensus       109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            999999999998654  47999999999999999999999   6778999999999999999999999999998775544


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......||+.|||||++..-.|+.++||||+|+...||.-|++||.....++         .-.+-+.-+++....+..
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIPT~PPPTF~KPE~  254 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIPTKPPPTFKKPEE  254 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEeccCCCCCCCCChHh
Confidence            44556789999999999999999999999999999999999999986332211         111223334444444555


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ....+.+++.+||..+|++|-|+.++.+|.+.+..+.
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            6666889999999999999999999999998876654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=317.80  Aligned_cols=262  Identities=25%  Similarity=0.347  Sum_probs=207.9

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +...+.++||+|-||.|..+...++..||||.++.......  .++|.+|+++|.+++|||||+++|+|..++..++|+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~--r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA--RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH--HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            44567889999999999999998889999999998876543  4899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      ||++|+|..++....... +.-....+|+.|||.||+||.   +.++|||||.++|+|+|.++++||+|||+++.+-...
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999998775332 455667789999999999999   8999999999999999999999999999999664443


Q ss_pred             CCc--cccccccccccccccccCccCcchhhHHHHHHHHHHHh--CCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          303 SNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       303 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...  ...+-...|||||.+..++++.++|||+||+++||+++  ...||..+.+...    .....+.++..-......
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhhhhhcCCCCcceecc
Confidence            322  22345679999999999999999999999999999975  7788864332110    001122222111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+.-....+.+++.+||..+-++||+++++..++..
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            111122236689999999999999999999888754

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.1e-39  Score=301.74  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=193.2

Q ss_pred             cccceeeecCceEEEEEEcCC-CC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------CE
Q 013793          146 HIKYCIGTGGYGSVYKAQLPN-GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------KC  216 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  216 (436)
                      .+.+.||+|+||.||+|...+ +.  .+|+|.++...... ...+.+.+|++++..++|+||+++++++...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            457789999999999997654 33  58999887653222 2247788999999999999999999987542      24


Q ss_pred             EEEEEeeccCCChhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          217 MFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      .++++||+++|+|.+++...   .....+++.....++.|++.||+|||   +.+|+||||||+|||+++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432   12335899999999999999999999   7899999999999999999999999999


Q ss_pred             cccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC
Q 013793          294 TARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       294 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      +++........  .....+++.|+|||...+..++.++||||||+++|||++ |+.||.....       ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence            99876433221  122345678999999999999999999999999999999 7888863211       1111111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .... ...   .....+.+++.+||+.||++|||+.++++.+.
T Consensus       231 ~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         231 NRLK-QPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             CCCC-CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1111 000   11223678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=300.81  Aligned_cols=253  Identities=28%  Similarity=0.482  Sum_probs=203.5

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|.+.+.||+|+||.||+|...+++.+|||.+......    .+.+.+|++++++++|+|++++++++......++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            4678899999999999999998888889999999865443    267889999999999999999999999989999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++..+..++.+++.|++|||   +.+++|+||||+||++++++.++|+|||.++.....
T Consensus        81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999997643 236899999999999999999999   789999999999999999999999999999876432


Q ss_pred             CCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... .....++..|+|||.+.+..++.++||||||+++||++| |+.||....       ........ ......+....
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~-~~~~~~~~~~~  228 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQV-ERGYRMPRPPN  228 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH-HcCCCCCCCCC
Confidence            111 112234568999999998889999999999999999998 999985221       11111111 11111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                         ....+.+++.+|++.+|++||++.++.+.+.
T Consensus       229 ---~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         229 ---CPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ---CCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence               1234678999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=307.13  Aligned_cols=264  Identities=22%  Similarity=0.299  Sum_probs=198.7

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|.||+|... +++.||+|.+........  ...+.+|++++++++|+||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            57888999999999999999765 789999999875432211  144668999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ +|.+++.....  .+++.....++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus        83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            99985 89998875432  6889999999999999999999   789999999999999999999999999998754332


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCCcccch-----h
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSDPKIML-----I  365 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~~~~~~-----~  365 (436)
                      ........++..|+|||...+ ..++.++||||+|+++|||++|+.||.......          ....+....     .
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            222223346788999998875 457899999999999999999999985322100          000000000     0


Q ss_pred             hhhcCCCCCCCChh------HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          366 DVLDQRLPPPVDQK------VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       366 ~~~~~~l~~~~~~~------~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..............      .......+.+++.+|++.+|++|||+.++++++||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000000000000      00011346789999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-40  Score=309.88  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             hcccccceeeecCceEEEEEEcCC---------------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceee
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN---------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL  207 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  207 (436)
                      ++|++.+.||+|+||.||++...+               ...||+|.++......  ....+.+|++++.+++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT--ARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH--HHHHHHHHHHHHHhCCCCCcCeE
Confidence            578899999999999999986532               2358999987653322  23678999999999999999999


Q ss_pred             eeEEeeCCEEEEEEeeccCCChhhhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 013793          208 YGFCLHKKCMFLIYEYMERGSLFCILHNDD---------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  278 (436)
Q Consensus       208 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~N  278 (436)
                      ++++...+..++||||+++++|.+++....         ....+++..++.++.+++.||+|||   +.+++||||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhh
Confidence            999999999999999999999999986432         1124788999999999999999999   7899999999999


Q ss_pred             eeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh--CCCCccccccc
Q 013793          279 ILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSSL  354 (436)
Q Consensus       279 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~  354 (436)
                      |++++++.+||+|||++.........  .....++..|+|||...+..++.++||||||+++|||++  |..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            99999999999999999765332211  122335678999999988889999999999999999998  56676532110


Q ss_pred             cCCCCcccchhhhhc---CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          355 SSSSDPKIMLIDVLD---QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       355 ~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..    .....+..+   .........   .....+.+++.+||+.||++||++.+|++.+.
T Consensus       240 ~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QV----IENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HH----HHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            00    000000000   000000000   01234778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-39  Score=303.92  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=200.7

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh-------hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE-------ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.+......       .....+.+.+|++++..++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            466788999999999999965 47899999988643211       1122457888999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++|+||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999997653   6899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC--CccccccccccccccccccCc--cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          296 RRLHADSS--NRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       296 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      +.......  ......++..|+|||.+....  ++.++||||||+++||+++|+.||......       ....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence            76543211  123345788999999987654  789999999999999999999998522110       0011111111


Q ss_pred             CCCCCChh-HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          372 LPPPVDQK-VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       372 l~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ........ .......+.+++.+||+.+|++||++.+|++|+|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            11111000 01112346789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9e-40  Score=339.86  Aligned_cols=267  Identities=22%  Similarity=0.340  Sum_probs=204.4

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCE
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKC  216 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  216 (436)
                      ...++|.+.+.||+|+||+||++... ++..+|+|.+....... .....+..|+.++..++|||||++++++..  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34578999999999999999999654 67789999987654332 224678899999999999999999998864  456


Q ss_pred             EEEEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCceeecCC-------
Q 013793          217 MFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDC----SPSIIHRDISSNNILLNSK-------  284 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~dlk~~Nill~~~-------  284 (436)
                      .++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+..    ..+|+||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999987532 2236999999999999999999999532    1469999999999999642       


Q ss_pred             ----------CCeEEeecccccccCCCCCCcccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          285 ----------LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       285 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                                ..+||+|||++..+.... ......||+.|+|||++.+  ..++.++||||||||||||+||+.||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      348999999998764332 2234568999999998854  458899999999999999999999986321


Q ss_pred             cccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          353 SLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ..       ......+......+...    ....+.+|+..||+.+|.+||++.|++++.|+....+
T Consensus       248 ~~-------~qli~~lk~~p~lpi~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 NF-------SQLISELKRGPDLPIKG----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cH-------HHHHHHHhcCCCCCcCC----CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            11       11111111111111110    1223678999999999999999999999999875433

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-39  Score=301.24  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=199.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcc--hhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--TEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  217 (436)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+....  .......+.+.+|+.++.+++||||+++.+++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788899999999999999975 468999999886432  11222346788999999999999999999988764  467


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++++|.+++....   .+++...+.++.+++.||+|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999987543   5788899999999999999999   78999999999999999999999999999876


Q ss_pred             cCCCC---CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADS---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....       .....+.......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNP  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHHHHHhcCCCCC
Confidence            53211   112334588899999999888899999999999999999999999863211       11111111111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ...   ......+.+++.+|+. +|++||+++|+++++|.
T Consensus       229 ~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         229 VLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             CCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            111   1222346678888885 99999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-39  Score=305.15  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=197.7

Q ss_pred             hcccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CC
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KK  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  215 (436)
                      .+|++.+.||+|+||+||++..     .++..||+|.+......   ..+.+.+|+++++.++||||+++.+++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4678889999999999999964     35789999998765432   23678899999999999999999998754  34


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++|+||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence            6889999999999999997543  25899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc-ccCCCCcc-------cch
Q 013793          296 RRLHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-LSSSSDPK-------IML  364 (436)
Q Consensus       296 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-~~~~~~~~-------~~~  364 (436)
                      .........   .....++..|+|||...+..++.++||||||+++|||++|..|+..... +.......       ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            876443221   1112234569999999888899999999999999999998776532111 00000000       001


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+.+......+...   .....+.+++.+||+.+|++|||+.||++.+..
T Consensus       236 ~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         236 IELLKNNGRLPAPP---GCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHHhcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            11111111111111   112247789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-39  Score=306.14  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=198.9

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .+|...+.||+|+||.||++...      ++..+|+|.+......   ....+.+|+++++.++|+||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46777889999999999999532      4567899988765432   23678999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          217 MFLIYEYMERGSLFCILHNDDE------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      .+++|||+++|+|.+++.....            ...+++..++.++.|++.|++|||   +.+++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCC
Confidence            9999999999999999875431            135889999999999999999999   8899999999999999999


Q ss_pred             CCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcc
Q 013793          285 LEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPK  361 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~  361 (436)
                      +.++|+|||++.........  .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....       .
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~  231 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------T  231 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-------H
Confidence            99999999999765332211  122335678999999999999999999999999999998 8999853211       0


Q ss_pred             cchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       362 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      . ...............   .....+.+++.+||+.||++||++.||.+.+.
T Consensus       232 ~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 E-AIECITQGRELERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-HHHHHHcCccCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0 111111111111111   11223668999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.6e-40  Score=310.94  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=197.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||.||+|... ++.  .+|+|.+......  .....+.+|++++.++ +|+||+++++++...+..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            357888999999999999999754 454  4577777653322  2236788999999999 899999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          218 FLIYEYMERGSLFCILHNDD-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      ++|+||+++|+|.++++...             ....+++.+++.++.|++.||+|||   +.+++||||||+|||++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCC
Confidence            99999999999999997542             1235889999999999999999999   8899999999999999999


Q ss_pred             CCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccc
Q 013793          285 LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  363 (436)
                      +.++|+|||++....... ......++..|+|||...+..++.++||||||+++|||+| |..||.....       .. 
T Consensus       161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~-  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-  231 (303)
T ss_pred             CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-------HH-
Confidence            999999999986432111 1112234667999999988889999999999999999998 9999853211       01 


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..+............   .....+.+++.+||+.+|++||++.++++.+..
T Consensus       232 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         232 LYEKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HHHHHhcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111111111111111   112236789999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-39  Score=308.17  Aligned_cols=259  Identities=24%  Similarity=0.301  Sum_probs=204.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++... +++.||+|.+.............+.+|++++..++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999764 67899999987664433333467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....   .+++..+..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997653   6899999999999999999999   789999999999999999999999999998642110


Q ss_pred             CC---------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          302 SS---------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       302 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      ..               ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...       ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-------~~~~~~~~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQ  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence            00               011235788999999998888999999999999999999999998521       11111222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHHhhcC
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT---MQYVSQGFLITR  416 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~ev~~~l~~~~  416 (436)
                      ........+....  .....+.+++.+||+.||++||+   +.++++++|+..
T Consensus       228 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         228 VISDDIEWPEGDE--ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             HHhcccCCCCccc--cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            2222211111110  11223678999999999999998   789999998744

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-39  Score=299.11  Aligned_cols=244  Identities=22%  Similarity=0.368  Sum_probs=190.9

Q ss_pred             eeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          151 IGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      ||+|+||.||+|.+.   ++..||+|.+......  ...+.+.+|+.++++++||||+++++++. ....++||||+++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            899999999999653   4557999998765432  23467899999999999999999999885 45689999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC---
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---  304 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~---  304 (436)
                      +|.+++....  ..+++..+++++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.........   
T Consensus        80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9999987533  36899999999999999999999   789999999999999999999999999999865433221   


Q ss_pred             ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          305 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       305 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....        ......+........+.   ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~  223 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKRLDCPA---EC  223 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCCCC---CC
Confidence            111223568999999988889999999999999999996 9999863211        11111121111111111   11


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ...+.+++.+||..+|++||++.+|.+.+.
T Consensus       224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         224 PPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            234668999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=303.58  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.......  ....+.+|+.++..++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            357888999999999999999654      24689999987554322  2367889999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeE
Q 013793          216 CMFLIYEYMERGSLFCILHNDDE-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  288 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  288 (436)
                      ..++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence            99999999999999999865321       234789999999999999999999   88999999999999999999999


Q ss_pred             EeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchh
Q 013793          289 VADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  365 (436)
                      |+|||+++.......  ......++..|+|||.+.+..++.++||||||+++||++| |+.||....       ......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~~~~~  232 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------NEEVLK  232 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-------HHHHHH
Confidence            999999976543321  1223346788999999988889999999999999999998 898875211       111111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ........ .....   ....+.+++.+||+.+|++|||+.++++.+.
T Consensus       233 ~~~~~~~~-~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGGHL-DLPEN---CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCCCC-CCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111111 11111   1234678999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.6e-39  Score=300.72  Aligned_cols=254  Identities=28%  Similarity=0.429  Sum_probs=199.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CC---CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|+..+.||+|+||.||+|..+ ++   ..+|+|.+.......  ..+.+.+|++++.+++|||++++.+++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            356888899999999999999764 33   379999987653322  236788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++++|.+++....  ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          82 MIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence            99999999999999997543  36899999999999999999999   78999999999999999999999999999976


Q ss_pred             cCCCCCCc---cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ........   .....+..|+|||++.+..++.++||||||+++|||++ |+.||.....       .. ....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~-~~~~i~~~~~  228 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HE-VMKAINDGFR  228 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH-HHHHHhcCCC
Confidence            64322211   11123457999999988889999999999999999997 9999853211       11 1111111111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .+...   .....+.+++.+||+.+|++||++.+|++.+.
T Consensus       229 ~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         229 LPAPM---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             CCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111   11233678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=304.97  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCC---
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKK---  215 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---  215 (436)
                      ++++|++.+.||+|++|.||+|... +++.+++|.+......    ...+.+|+++++++ .|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            5688999999999999999999764 6789999998765432    26788999999999 7999999999997644   


Q ss_pred             ---EEEEEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          216 ---CMFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       216 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                         ..++||||+++++|.+++.... ....+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999999886532 2346899999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCCcccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      ||++..............|+..|+|||.+..     ..++.++||||||+++|+|++|+.||.....       ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~  229 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRALFK  229 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHHHH
Confidence            9998765443333344568899999998753     3467899999999999999999999863211       111112


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ......+ .... .......+.+++.+||..||++|||+.|+++++|.
T Consensus       230 ~~~~~~~-~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         230 IPRNPPP-TLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhccCCC-CCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            2111111 1111 11122346789999999999999999999999884

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=302.60  Aligned_cols=256  Identities=28%  Similarity=0.468  Sum_probs=204.8

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc---CCCceeeeeEEeeCCEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  219 (436)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.......  ....+.+|+.+++.++   |||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            467788899999999999975 578999999987543222  2367788999999996   9999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++++|.+++...    .+++...+.++.+++.||.|||   +.+|+||||+|+||++++++.++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999998653    6899999999999999999999   7899999999999999999999999999998775


Q ss_pred             CCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ..........|+..|+|||.+.++ .++.++||||||+++|+|++|+.||.......       .. .......++....
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~~  224 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRLED  224 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCCCCCCCc
Confidence            544434445688999999988654 57899999999999999999999986322110       00 0111111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .  .....+.+++.+||+.||++||++.|++.+.|+++..
T Consensus       225 ~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         225 N--GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             c--cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            0  0123467899999999999999999999999996653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=300.33  Aligned_cols=248  Identities=29%  Similarity=0.457  Sum_probs=200.6

Q ss_pred             ceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      +.||+|+||.||+|....    +..|++|.+.......  ..+.+.+|++.+..++|+|++++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            369999999999997653    7889999998765543  3478899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          225 ERGSLFCILHNDDE------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       225 ~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      ++++|.+++.....      ...+++.++..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987521      247899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCC--CCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          299 HADS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       299 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ....  .......++..|+|||.+.+..++.++||||+|+++|||++ |+.||....       ............ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~-~~~  227 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEVLEYLRKGY-RLP  227 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCC-CCC
Confidence            5433  12233457889999999988889999999999999999999 699986321       111111111111 111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      ...   .....+.+++.+||+.+|++|||+.|+++++
T Consensus       228 ~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         228 KPE---YCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             CCc---cCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            111   1123467899999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-39  Score=305.31  Aligned_cols=268  Identities=28%  Similarity=0.332  Sum_probs=206.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  219 (436)
                      ++|+..+.||.|++|.||++... +++.+|+|.+......  .....+.+|+++++.++||||++++++|...  +..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            36788899999999999999764 6889999998765432  2236788999999999999999999998653  46899


Q ss_pred             EEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          220 IYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      ||||+++++|.+++.... ....+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999998875421 2346888999999999999999999   789999999999999999999999999998765


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC---CCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR---LPPP  375 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---l~~~  375 (436)
                      ....  .....++..|+|||...+..++.++||||+|+++|||++|+.||+.....  ...............   +...
T Consensus       156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd06621         156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMPNPELKDE  231 (287)
T ss_pred             cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCCchhhccC
Confidence            3222  12345788999999999889999999999999999999999998743220  001111111111111   1111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ... .......+.+++.+||+.+|++|||+.|++++.|++.....
T Consensus       232 ~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         232 PGN-GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CCC-CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            100 00112346789999999999999999999999999665443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-39  Score=299.74  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=202.6

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcch--hhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      +|+..+.||+|++|.||+|... +++.|++|.+.....  ......+.+.+|+++++.++|+|++++.+++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667788999999999999765 789999999865432  1122347788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997643   5889999999999999999999   78999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccccccCc-cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....       .............+.... 
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~-  225 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPD-  225 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCCcCC-
Confidence            32 223456888999999987766 89999999999999999999999863221       011111111000111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        .....+.+++.+||+.+|++||++.++++++|+
T Consensus       226 --~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         226 --HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             --CcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence              112336678999999999999999999998874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-39  Score=308.63  Aligned_cols=257  Identities=24%  Similarity=0.374  Sum_probs=200.6

Q ss_pred             hhcccccceeeecCceEEEEEEc--------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|.+.+.||+|+||.||++..        .++..||+|.+......  .....+.+|+.++..+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            46788899999999999999963        13457999998754322  2236788999999999 8999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      .....++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||   +.+++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence            99999999999999999999875421             235889999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      ++++++.++|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....    
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence            9999999999999999876432221  122345678999999988889999999999999999998 778875211    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .. ...+.+..........   .....+.+++.+||+.+|++|||+.|+++.+..
T Consensus       245 ---~~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         245 ---VE-ELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             ---HH-HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence               01 1111111111111111   122346789999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-39  Score=308.26  Aligned_cols=257  Identities=22%  Similarity=0.360  Sum_probs=200.3

Q ss_pred             hhcccccceeeecCceEEEEEEcCC-----------------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN-----------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  204 (436)
                      ..+|++.+.||+|+||.||++...+                 +..||+|.+......  ...+.+.+|++++.+++|||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            4578899999999999999986542                 346899998765433  234788999999999999999


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDE--------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  276 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~  276 (436)
                      +++++++...+..++|+||+++++|.+++.....        ...+++..++.++.|++.||+|||   +.+++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccch
Confidence            9999999999999999999999999999875431        235899999999999999999999   78999999999


Q ss_pred             CceeecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh--CCCCccccc
Q 013793          277 NNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLS  352 (436)
Q Consensus       277 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~  352 (436)
                      +||+++.++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999876533221  1223446778999999988889999999999999999998  667765321


Q ss_pred             cccCCCCcccchhhhhc------CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          353 SLSSSSDPKIMLIDVLD------QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~------~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .       .........      .....+..   ......+.+++.+||+.||++|||+.|+++.|.
T Consensus       239 ~-------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 D-------QQVIENAGHFFRDDGRQIYLPRP---PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             h-------HHHHHHHHhccccccccccCCCc---cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1       000010000      00000000   011134778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-39  Score=302.43  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=199.3

Q ss_pred             hcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.+.......  ..+.+.+|+.++.+++||||+++.+++...+..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            57888999999999999999653    23479999987644322  2367889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++++|.+++....  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++++|||++...
T Consensus        82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999997643  35899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCCc---cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .......   ....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....       ......+.+ ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~-~~~~  228 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-------QDVIKAIEE-GYRL  228 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-------HHHHHHHhC-CCcC
Confidence            4432211   11223567999999998899999999999999999886 9999863211       001111111 1111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      +...   .....+.+++.+|++.+|++||+|.++++.+.
T Consensus       229 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         229 PAPM---DCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CCCC---CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            1111   11223678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-39  Score=297.67  Aligned_cols=249  Identities=23%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|++|.||+|... |+.||+|.+.....    ..+.+.+|+.++..++|+|++++++++......++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            357888999999999999999874 78899999977654    2377889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999976532 36899999999999999999999   889999999999999999999999999999876322


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      ..   ....+..|+|||.+.+..++.++||||||+++||+++ |+.||.....        ......+..........  
T Consensus       156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  222 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRMEAPE--  222 (256)
T ss_pred             cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCcc--
Confidence            11   2334568999999988889999999999999999997 9999852211        11111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                       .....+.+++.+||..+|++|||+.++++.+.
T Consensus       223 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         223 -GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             -CCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence             11234678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-40  Score=307.68  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|+..+.||.|++|.||+|... +++.||||++....... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999764 78999999987543221 122568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |++ ++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 58888886543 236899999999999999999999   7899999999999999999999999999987664433


Q ss_pred             CCccccccccccccccccccCc-cCcchhhHHHHHHHHHHHhCCCCccccccccCC-------CCcccc----hhhhh--
Q 013793          303 SNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS-------SDPKIM----LIDVL--  368 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~----~~~~~--  368 (436)
                      .......++..|+|||...+.. ++.++||||||+++|||+||+.||.........       ..+...    .....  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            3333345788999999887654 688999999999999999999998532110000       000000    00000  


Q ss_pred             cCCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 DQRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ~~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+......    .......+.+++.+|++.||++|||+.++++++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00000000000    00012235689999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-39  Score=301.21  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=204.2

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcch---hhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+.....   ......+.+.+|+.++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999964 5789999999875432   122235788999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeeccccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARRL  298 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~  298 (436)
                      |+||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999997543   6889999999999999999999   78999999999999998776 5999999999776


Q ss_pred             CCCCC----CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSS----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .....    ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....    ........+.......+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  230 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATTAP  230 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCCCC
Confidence            54321    11234578899999999888899999999999999999999999852211    00011111111111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ....   .....+.+++.+|+..+|++||++.++++++|++
T Consensus       231 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         231 SIPE---HLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCch---hhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            1111   1223467899999999999999999999999873

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.6e-39  Score=306.20  Aligned_cols=258  Identities=28%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ...|...+.||+|+||+||+|... +++.||+|.+...........+.+.+|+++++.++|||++++.++|...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            345888899999999999999764 6899999998654433333346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||++ |++.+++....  ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 57777665432  25899999999999999999999   78999999999999999999999999999876532


Q ss_pred             CCCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .    ....++..|+|||.+.   ...++.++||||||+++|||+||+.||......       ...........+ ...
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~-~~~  235 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSP-TLS  235 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcCCCC-CCC
Confidence            2    2345788999999874   456889999999999999999999998532110       001111111111 111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                        .......+.+++.+||+.+|++||++.++++++|+.+..+
T Consensus       236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence              0112234778999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-39  Score=308.49  Aligned_cols=252  Identities=24%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             cceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          148 KYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      ...||+|+||.||++.. .+++.||+|.+.......   .+.+.+|+.++..++|||++++++++..++..++|+||+++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            45699999999999965 478999999986543322   35678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      ++|..++...    .+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++...........
T Consensus       103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659         103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            9999887542    5899999999999999999999   88999999999999999999999999999876544433334


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||......       . ....+....... ..........
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~-~~~~~~~~~~~~-~~~~~~~~~~  246 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------Q-AMKRLRDSPPPK-LKNAHKISPV  246 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhccCCCC-ccccCCCCHH
Confidence            456899999999999888999999999999999999999998632110       0 011111111100 0000111223


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          387 ASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      +.+++.+|++.+|++||++.++++++|+....
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            66889999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.6e-39  Score=298.74  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=196.7

Q ss_pred             ceeeecCceEEEEEEcCC--CC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQLPN--GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~--~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      +.||+|++|.||+|.+.+  ++  .||+|.+......  ...+.+.+|+..+++++||||+++++++.. ...++|+||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            358999999999997643  33  6899999877653  335789999999999999999999999988 8899999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      ++|+|.+++..... ..+++...+.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999987543 46899999999999999999999   889999999999999999999999999999876443221


Q ss_pred             ---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          305 ---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       305 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                         .....++..|+|||++.+..++.++||||||+++|||++ |+.||.....       ..................  
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~--  224 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKIDKEGERLERPE--  224 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCcCCCCc--
Confidence               122456789999999998899999999999999999998 9999853211       001111111110010110  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                       .....+.+++.+|++.+|++||++.++++.+
T Consensus       225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence             1123467899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-39  Score=306.76  Aligned_cols=257  Identities=23%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             hcccccceeeecCceEEEEEEcC-----------------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCce
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-----------------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV  205 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  205 (436)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+......  .....+.+|++++..++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcc
Confidence            56889999999999999998532                 2446899998765332  2236788999999999999999


Q ss_pred             eeeeEEeeCCEEEEEEeeccCCChhhhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 013793          206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDE--------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  277 (436)
Q Consensus       206 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~  277 (436)
                      ++++++...+..++||||+++|+|.+++.....        ...+++.++..++.|++.||+|||   +.+++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChh
Confidence            999999999999999999999999999875421        134788899999999999999999   789999999999


Q ss_pred             ceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh--CCCCcccccc
Q 013793          278 NILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDLLSS  353 (436)
Q Consensus       278 Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~  353 (436)
                      ||++++++.++|+|||+++.+......  .....++..|+|||...++.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999999865432211  112234678999999888889999999999999999998  6778753211


Q ss_pred             ccCCCCcccchhhhhc-----CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          354 LSSSSDPKIMLIDVLD-----QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       354 ~~~~~~~~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ....    ........     ...+.+.     .....+.+++.+||+.||++||++.+|.+.+.
T Consensus       240 ~~~~----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQVI----ENTGEFFRDQGRQVYLPKPA-----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHH----HHHHHHHhhccccccCCCCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0000    00000000     0111111     11234678999999999999999999998774

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.3e-39  Score=297.86  Aligned_cols=254  Identities=22%  Similarity=0.371  Sum_probs=203.0

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+....... .....+.+|+++++.++|||++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            478889999999999999965 478899999987654332 224788899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecccccccCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHAD  301 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~  301 (436)
                      |+++++|.+++.... ...+++..+..++.+++.||+|||   +.+++||||+|+||+++++ +.++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999997643 235899999999999999999999   7899999999999999865 45899999999876433


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+...       ............... ...   
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~---  223 (256)
T cd08220         156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSGTFAP-ISD---  223 (256)
T ss_pred             c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhcCCCC-CCC---
Confidence            2 2233568889999999998889999999999999999999999986321       111112222211111 111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....+.+++.+||+.+|++|||+.|+++++|+
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            112236789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-39  Score=300.84  Aligned_cols=255  Identities=22%  Similarity=0.355  Sum_probs=203.6

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|+||.||++... +|..+|+|.+....... ...+.+.+|+++++.++|+|++++++.+......++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4778899999999999999765 68899999986643221 123677899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeecccccccCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARRLHAD  301 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  301 (436)
                      |+++++|.+++.... ...+++..+..++.+++.||+|||   +.+++|+||+|+||++++++ .++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999987543 235799999999999999999999   78999999999999999885 4699999999876543


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........|++.|+|||...+..++.++||||||+++|||++|+.||....       ..................    
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~----  224 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGYFAPISP----  224 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcccCCCCCC----
Confidence            333334568899999999988889999999999999999999999986321       111122222222211111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....+.+++.+|++.+|++|||+.|+++++|+
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            011236688999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-39  Score=298.13  Aligned_cols=250  Identities=25%  Similarity=0.421  Sum_probs=199.5

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .+|++.+.||+|+||.||++...++..+|+|.+.......    ..+.+|++++++++|||++++++++......++|+|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            4678889999999999999988778899999987654432    568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++....  ..+++..++.++.+++.|++|||   +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999999987543  25789999999999999999999   7899999999999999999999999999987653322


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....++.+|+|||.+.+..++.++||||||+++|||++ |+.||....       ... ..+.+........... 
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~-~~~~~~~~~~~~~~~~-  225 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-------NSE-VVETINAGFRLYKPRL-  225 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-------HHH-HHHHHhCCCCCCCCCC-
Confidence            11 122335678999999998889999999999999999998 999985211       011 1111111101000000 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                        ....+.+++.+||+.+|++|||+.++++++
T Consensus       226 --~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              123477899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=319.64  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             eeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCC
Q 013793          150 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGS  228 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  228 (436)
                      +||+|+||+||.|+.. +...+|||.+.......   .+-+..|+.+-++++|.|||+++|.|.+++.+-|.||.+|||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~---~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE---VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchh---hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            6999999999999765 45679999998765432   3678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeecccccccCCCCCCccc
Q 013793          229 LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       229 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      |.++++..=+.-.=.+..+-.+.+||++||.|||   .+.|||||||..|||++- .|.+||+|||-++.+..-.....+
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            9999986532222266778889999999999999   889999999999999964 689999999999988766666777


Q ss_pred             cccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHH
Q 013793          308 LAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL  385 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  385 (436)
                      +.||..|||||++..+  .|+.++|||||||.+.||.||++||-.++......     + .+=-.+..++.+   .+...
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----F-kVGmyKvHP~iP---eelsa  806 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----F-KVGMYKVHPPIP---EELSA  806 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----h-hhcceecCCCCc---HHHHH
Confidence            8899999999999866  58899999999999999999999996443221111     1 110111123332   23344


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          386 LASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ++..++.+|+.+||.+||++.++++.++.+..
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            57789999999999999999999999988765

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.1e-39  Score=301.39  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=187.5

Q ss_pred             eeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          150 CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .||+|+||.||+|...   ++..+|+|.+.......  ....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            5899999999999754   34579999987654332  235788899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          227 GSLFCILHNDDE--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       227 g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      |+|.+++.....  ....++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999975432  235677888899999999999999   789999999999999999999999999999754332211


Q ss_pred             --ccccccccccccccccccC-------ccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhc--CCC
Q 013793          305 --RTLLAGTYGYIAPELAYTM-------VMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRL  372 (436)
Q Consensus       305 --~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~l  372 (436)
                        .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||.....      .......+..  ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~  230 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD------EQVLTYTVREQQLKL  230 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHhhcccCCC
Confidence              1234567889999987642       35789999999999999996 9999863211      0000000111  111


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      +.+...  ......+.+++..|+ .+|++|||++||++.+.
T Consensus       231 ~~~~~~--~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK--LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC--CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111100  001122556888898 58999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.5e-39  Score=297.43  Aligned_cols=247  Identities=22%  Similarity=0.384  Sum_probs=195.8

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEe-eCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCL-HKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||++... |..+|+|.+.....     .+.+.+|+.++++++|+|++++++++. ..+..++|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            46888999999999999999764 77889999865432     257889999999999999999999765 456789999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++..... ..+++..++.++.+++.||+|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999876432 35889999999999999999999   889999999999999999999999999998764332


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .   ....++..|+|||+..+..++.++||||||+++|||++ |+.||.....        ......+..........  
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  222 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPD--  222 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCCC--
Confidence            2   22334568999999988889999999999999999997 9999752110        00111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                       .....+.+++.+|++.+|++|||+.++++.+.
T Consensus       223 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         223 -GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence             11234678999999999999999999998774

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.8e-39  Score=303.17  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=200.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++|++.+.||+|+||.||++..+      ++..||+|.+.......  ....+.+|+.++++++|||++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            467888999999999999999753      46789999987654322  2367889999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 013793          216 CMFLIYEYMERGSLFCILHNDD-------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  276 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~  276 (436)
                      ..++|+||+++|+|.+++....                   ....+++..++.++.|++.||+|||   +.+++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence            9999999999999999986421                   1235788999999999999999999   78999999999


Q ss_pred             CceeecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccccc
Q 013793          277 NNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS  353 (436)
Q Consensus       277 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  353 (436)
                      +||++++++.++|+|||++........  .......+..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876533221  1122234667999999988899999999999999999997 8888752211


Q ss_pred             ccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          354 LSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                             ........+....+ ...   .....+.+++.+||+.+|++|||+.|+++.+.
T Consensus       239 -------~~~~~~~~~~~~~~-~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 -------EEVIYYVRDGNVLS-CPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             -------HHHHHHHhcCCCCC-CCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                   11111111222111 000   11234778999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=304.90  Aligned_cols=265  Identities=29%  Similarity=0.364  Sum_probs=203.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|.||+|... +++.||+|+++...... ...+.+.+|+++++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc-cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            36888999999999999999765 68899999987643322 22367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++++.+..+.....   .+++.++..++.+++.||+|||   ..+++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9999877776665432   5899999999999999999999   789999999999999999999999999999876544


Q ss_pred             CC-CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccc----hhh
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM----LID  366 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~----~~~  366 (436)
                      .. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.......         ....+...    ...
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            32 23345678899999999888 88999999999999999999999986321100         00000000    000


Q ss_pred             hh-cCCCCCCCChhHH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          367 VL-DQRLPPPVDQKVI------QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       367 ~~-~~~l~~~~~~~~~------~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .. ....+........      .....+.+++.+||..+|++||++++++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00 0000000000000      013447789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.5e-40  Score=317.59  Aligned_cols=261  Identities=22%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             cccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-C-----CCceeeeeEEeeCCE
Q 013793          144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-H-----RSIVKLYGFCLHKKC  216 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~  216 (436)
                      +|++.+.||+|+||.|-+| ..++++.||||+++....-    ..+...|+.+|..++ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            8899999999999999999 5668999999999887543    467778999999997 4     489999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CCeEEeeccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--LEAFVADFGT  294 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~  294 (436)
                      .+||+|.+.. +|++++..+... .++...++.++.||+.||.+||   ..+|||+||||+||||.+-  ..+||+|||.
T Consensus       263 lciVfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999865 999999887543 6999999999999999999999   8999999999999999653  4799999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc---------------------
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS---------------------  353 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~---------------------  353 (436)
                      ++.....   ......+..|+|||++.+.+|+.+.||||||||+.||+||.+.|...+.                     
T Consensus       338 Sc~~~q~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  338 SCFESQR---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             ccccCCc---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9875332   2256678899999999999999999999999999999999766642111                     


Q ss_pred             -------ccC-CCCc-----cc-----------c-hhhhhcC-CCCCC---CChhHH-HHHHHHHHHHhhccCCCCCCCC
Q 013793          354 -------LSS-SSDP-----KI-----------M-LIDVLDQ-RLPPP---VDQKVI-QDILLASTISFACLQSNPKSRP  403 (436)
Q Consensus       354 -------~~~-~~~~-----~~-----------~-~~~~~~~-~l~~~---~~~~~~-~~~~~~~~l~~~cl~~dP~~RP  403 (436)
                             +.. ....     ..           . .....+. +.++.   ...... .....+.+++.+|+..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                   000 0000     00           0 0000111 11101   111111 3344578999999999999999


Q ss_pred             CHHHHHHHHhhcC
Q 013793          404 TMQYVSQGFLITR  416 (436)
Q Consensus       404 t~~ev~~~l~~~~  416 (436)
                      |..|+++|+|++.
T Consensus       495 tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  495 TPAQALNHPFLTG  507 (586)
T ss_pred             CHHHHhcCccccc
Confidence            9999999999983

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.3e-40  Score=307.64  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=198.0

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|+||.||+|... +|+.+|+|.+....... .....+.+|++++++++|||++++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4778899999999999999764 78999999987543221 112567789999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++ +|.+++....  ..+++..++.++.||++||.|||   +.+|+||||||+||+++.++.++|+|||+++......
T Consensus        80 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            9974 7877776432  35899999999999999999999   7899999999999999999999999999998664433


Q ss_pred             CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCCcccc--hhhhhc
Q 013793          303 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSDPKIM--LIDVLD  369 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~~~~~--~~~~~~  369 (436)
                      .......++..|+|||.+.+. .++.++||||||+++|||+||+.|+.......          ........  .....+
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            333345678899999988765 46899999999999999999998863211100          00000000  000000


Q ss_pred             CCCCCCCC--hh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          370 QRLPPPVD--QK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       370 ~~l~~~~~--~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ........  ..    .......+.+++.+||+.||.+|||+.++++|+|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00000000  00    00112346789999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-39  Score=314.03  Aligned_cols=260  Identities=21%  Similarity=0.279  Sum_probs=194.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ...+|++.+.||+|+||.||+|... +++.||+|......         ...|+.++++++||||+++++++......++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999765 57789999754332         2358899999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |+||+. ++|.+++....  ..+++..++.|+.||+.||+|||   +.+|+||||||+|||++.++.++|+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999995 58888876533  36899999999999999999999   7899999999999999999999999999997543


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCc-cccccccCC--CCcccchhhhhc------C
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR-DLLSSLSSS--SDPKIMLIDVLD------Q  370 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~-~~~~~~~~~--~~~~~~~~~~~~------~  370 (436)
                      .. .......||..|+|||++.+..++.++|||||||++|||+++..|+ +........  ......+.+.+.      .
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            22 2223456899999999999999999999999999999999865553 211000000  000000000000      0


Q ss_pred             CCC-------------------CCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          371 RLP-------------------PPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       371 ~l~-------------------~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .++                   .+....    .......+.+++.+||+.||.+|||+.|+++|+|++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            000                   000000    0001122456899999999999999999999999864

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-39  Score=305.91  Aligned_cols=266  Identities=23%  Similarity=0.254  Sum_probs=198.7

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ++++|.+.+.||+|+||.||+|.. .+++.||+|.+........  ...+.+|+.+++.++|+||+++.+++..++..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            457899999999999999999965 4788999999865432221  2456789999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |+||+. +++.+++....  ..+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999996 67776665432  25788889999999999999999   7899999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC----------CCCcc-------
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS----------SSDPK-------  361 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~----------~~~~~-------  361 (436)
                      ..........+++.|+|||.+.+. .++.++||||||+++|||+||+.||+.......          .....       
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            333333334578899999998764 578899999999999999999999863321000          00000       


Q ss_pred             --cchhhhhcCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          362 --IMLIDVLDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       362 --~~~~~~~~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        ...........+.....  ........+.+++.+|++.||.+|||+.|++.|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              00000000000000000  000012346689999999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5e-39  Score=302.65  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |...+.||+|++|.||++.. .+++.+++|++.......   .+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            44457899999999999975 478899999986543322   35688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++++|.+++...    .+++.++..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+........
T Consensus        98 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          98 LEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            9999999998762    5889999999999999999999   88999999999999999999999999998876544333


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      ......|+..|+|||...+..++.++||||||+++|||++|+.||.....       ...... +....++.... ....
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~-~~~~  241 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKR-IRDNLPPKLKN-LHKV  241 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHH-HHhcCCCCCcc-cccC
Confidence            33345688999999999888899999999999999999999999853111       011111 11111111100 1112


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...+.+++.+||+.+|++||++.+++++.|+....+
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            234778999999999999999999999999977554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-39  Score=296.45  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=193.3

Q ss_pred             ceeeecCceEEEEEEcC--C--CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQLP--N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      +.||+|+||.||+|...  +  +..+|+|.+......  ...+.+.+|+.+++.++|+|++++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            36999999999999643  2  368999999876543  22467889999999999999999999876 45679999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      ++|+|.+++....   .+++..+..++.|++.||+|||   ..+++||||||+||+++.++.++|+|||+++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999997654   6899999999999999999999   789999999999999999999999999999876443322


Q ss_pred             cc---ccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          305 RT---LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       305 ~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      ..   ...++..|+|||...+..++.++||||||+++|||++ |+.||.....       . .....+......+...  
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~--  221 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------A-EVIAMLESGERLPRPE--  221 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------H-HHHHHHHcCCcCCCCC--
Confidence            11   1223467999999998899999999999999999998 9999863221       0 1111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       .....+.+++.+||+.+|++||++.++++.+..
T Consensus       222 -~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         222 -ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             112346789999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.4e-39  Score=299.10  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||.|++|.||++... +++.+|+|.+...........+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999765 5899999999765544333457899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA  309 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  309 (436)
                      .+++....   .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99997653   5889999999999999999999   7899999999999999999999999999998765432 223346


Q ss_pred             cccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHH
Q 013793          310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST  389 (436)
Q Consensus       310 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  389 (436)
                      ++..|+|||.+.+..++.++|+||+|+++|||++|+.||.....     +.....................   ...+.+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  225 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNYI---DKAAKD  225 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCccc---CHHHHH
Confidence            78899999999888899999999999999999999999863211     1111122222111111111111   234778


Q ss_pred             HHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          390 ISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       390 l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                      ++.+||+.+|++||+     +.|+++++|+..
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            999999999999999     999999999863

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.9e-39  Score=302.82  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=198.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHH-HhhccCCCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ++|++.+.||+|+||.||++... +|+.||+|.+........  ...+..|++. ++..+|||++++++++...+..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            46888999999999999999765 699999999876543222  1345556654 5666899999999999999999999


Q ss_pred             EeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      |||++ |+|.+++... .....+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99997 6887777542 22346899999999999999999999   55 8999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccccccccc----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .... ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.....      .............+ 
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-  226 (283)
T cd06617         155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVEEPSP-  226 (283)
T ss_pred             cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHhcCCC-
Confidence            3321 2233467889999998865    4568899999999999999999999852110      00111111111111 


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .....  .....+.+++.+||..+|++||++.++++++|+....
T Consensus       227 ~~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         227 QLPAE--KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CCCcc--ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            11100  1122367899999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=307.28  Aligned_cols=262  Identities=24%  Similarity=0.294  Sum_probs=212.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|..-++||+|+||.||-++. .+|+.||.|++..+............+|-.+|.+++.+.||.+-.+|++++..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35577788999999999999954 47999999999887766665567788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +..|.||+|.-+|.+.+. ..+++..++.++.+|+.||++||   ..+||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999987654 47999999999999999999999   88999999999999999999999999999988754


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....+||.||||||++....|+...|.||+||+||||+.|+.||.....        ....+.++++.........
T Consensus       340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHHHhcchhhcc
Confidence            43 34455899999999999999999999999999999999999999973211        1122222222211111111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      ..-...+.++....|+.||++|.     .+++|.+|++|+.
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            11222356777889999999997     4557777776643

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.5e-40  Score=302.88  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=206.7

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||.|+||.||++... +++.||+|.+...........+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999765 689999999976544333345788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999765   36889999999999999999999   7899999999999999999999999999998664332


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc-CCCCCCCChhHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVDQKVI  381 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~  381 (436)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......     .......... .....+.     
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~-----  223 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETADVLYPA-----  223 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccccccCcc-----
Confidence             233456888999999998888999999999999999999999998732210     0111111111 1111111     


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCH--HHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTM--QYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~--~ev~~~l~~  414 (436)
                      .....+.+++.+||+.||.+||++  +|+++++|+
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            112346789999999999999999  999988875

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.3e-39  Score=307.38  Aligned_cols=259  Identities=23%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC--------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|.+.+.||+|+||.||++...        ....+|+|.+.......  ....+.+|++++.++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK--DLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH--HHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            467888999999999999999642        34578999987543322  246788999999999 6999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      ..+..++||||+++|+|.+++.....             ...+++.++.+++.|++.||.|||   +.+++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence            99999999999999999999965321             235899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      ++++++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....    
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----  241 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----  241 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC----
Confidence            9999999999999999866432211  111224467999999988889999999999999999999 888875221    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                         . ....+.+..........   .....+.+++.+||+.+|++|||+.|+++.++...
T Consensus       242 ---~-~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         242 ---V-EELFKLLREGHRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ---H-HHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence               0 11111111111111110   11223668999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.4e-39  Score=296.96  Aligned_cols=252  Identities=26%  Similarity=0.452  Sum_probs=200.8

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||.||++...++..+|+|.+......    ...+.+|+++++.++|+|++++.+.+.. ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH----HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            3578889999999999999998878888999988765332    3678889999999999999999999887 7789999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++..++.++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999997643 336889999999999999999999   789999999999999999999999999999765432


Q ss_pred             CCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... .....++..|+|||++....++.++|+||||+++|+++| |+.||.....        ......+......+... 
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  226 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYRMPRPE-  226 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCCCCCcc-
Confidence            211 122335677999999998889999999999999999999 8999863211        11111112221111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                        .....+.+++.+|++.+|++||++.++.+.+.
T Consensus       227 --~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         227 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             --cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence              11233678999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.2e-39  Score=302.11  Aligned_cols=259  Identities=28%  Similarity=0.406  Sum_probs=210.6

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++.|+..+.||+|++|.||+|... ++..+++|++.....    ....+.+|++.+..++|+|++++++.+......++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            4567888899999999999999776 688999999976544    23678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |+||+++++|.+++....  ..+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999999998654  36899999999999999999999   7899999999999999999999999999987654


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++|+.||.....       ............+....  
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--  238 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRALFLITTKGIPPLKN--  238 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCcc--
Confidence            433333344578899999999888899999999999999999999999863211       11111111111111111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .......+.+++.+|++.+|.+||++.+++++.|+.+.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            11122346789999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4e-39  Score=303.15  Aligned_cols=265  Identities=25%  Similarity=0.315  Sum_probs=202.6

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|++|.||+|.. .+|+.||+|++....... .....+.+|+.++++++|||++++++++......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            478889999999999999976 478999999997654322 223678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+ +++|.+++....  ..+++.+++.++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999987543  36899999999999999999999   7899999999999999999999999999998765432


Q ss_pred             C-CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCC---ccc-chhh
Q 013793          303 S-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSD---PKI-MLID  366 (436)
Q Consensus       303 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~---~~~-~~~~  366 (436)
                      . ......++..|+|||.+.+. .++.++||||+|+++|||+||+.||.......          ....   +.. ....
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            1 12334688899999988654 46899999999999999999987775321100          0000   000 0000


Q ss_pred             hhcCCCCCCCCh----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          367 VLDQRLPPPVDQ----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       367 ~~~~~l~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ......+.....    ........+.+++.+|++.+|++|||++++++|+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000000000000    0001124577899999999999999999999999973

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=297.68  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=200.0

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc--cCCCceeeeeEEeeCC----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRSIVKLYGFCLHKK----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----  215 (436)
                      ..+..+.+.||+|.||.||+|.+ -|+.||||++...+.      +++.+|.++.+.+  +|+||+.+++.-..+.    
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            45677889999999999999999 567899999987653      6788899988775  9999999998765443    


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeecCCCCeEEe
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      +.+||.+|.++|||+++|...    .++....++++..+|.||++||.+     ..+.|.|||||+.|||+..++...|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            589999999999999999864    689999999999999999999964     47889999999999999999999999


Q ss_pred             ecccccccCCCCCC----ccccccccccccccccccCc----c--CcchhhHHHHHHHHHHHhC----------CCCccc
Q 013793          291 DFGTARRLHADSSN----RTLLAGTYGYIAPELAYTMV----M--TEKCDVYSFGVVTLEVLMG----------KHPRDL  350 (436)
Q Consensus       291 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~s~G~il~elltg----------~~p~~~  350 (436)
                      |+|+|-........    ....+||.+|||||++....    +  -..+||||||.|+||+.-+          +.||..
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999876554322    34467999999999987542    1  1368999999999999753          245432


Q ss_pred             cccccCCCCcccchhhhhcCCCCCCCChh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          351 LSSLSSSSDPKIMLIDVLDQRLPPPVDQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .-..+  ...+.+..-+..+++.+..+..  ..+.+..+.+++..||..+|.-|.|+--+.+.+-...
T Consensus       439 ~Vp~D--Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVPSD--PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCC--CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            21111  1111122222233333332221  2345666789999999999999999988877664433

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.8e-39  Score=302.13  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=199.0

Q ss_pred             eeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||+|+||+||++.. .+|+.||+|.+.............+.+|+++++.++|||++++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999964 47899999998765433333345677899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA  309 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  309 (436)
                      .+++..... ..+++.++..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||.+..... ........
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence            999876543 36899999999999999999999   78999999999999999999999999999876543 22223345


Q ss_pred             cccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHH
Q 013793          310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST  389 (436)
Q Consensus       310 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  389 (436)
                      ++..|+|||...+..++.++||||||+++|+|++|+.||.......   .............  .....   .....+.+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~--~~~~~---~~~~~~~~  227 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLEMA--VEYPD---KFSPEAKD  227 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc---cHHHHHhcccccc--ccCCc---cCCHHHHH
Confidence            7889999999988889999999999999999999999986322100   0000000111111  01110   01223668


Q ss_pred             HHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          390 ISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       390 l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      ++.+||+.||++||     ++.++++|+|+.+
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            99999999999999     8889999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-38  Score=297.87  Aligned_cols=257  Identities=24%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             cccccceeeecCceEEEEEEcCC--CCEEEEEEecCcch-------hhHHHHHHHHHHHHHHhh-ccCCCceeeeeEEee
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPN--GKVFALKKLHTSET-------EELAFIKSFRNEAQVLSQ-VLHRSIVKLYGFCLH  213 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  213 (436)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+.....       ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999997654  78899998854321       112234567788888875 699999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          214 KKCMFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887542 223468999999999999999999993  368999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      |.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....       ............
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~~  230 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEAVY  230 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhccC
Confidence            9998764433 33445688999999999988899999999999999999999999863211       111111112211


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .+....   .....+.+++.+||+.||++||++.|+..++.
T Consensus       231 ~~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EPLPEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcCCcc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111110   11234678999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.7e-39  Score=298.35  Aligned_cols=251  Identities=31%  Similarity=0.508  Sum_probs=197.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CC---CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.+......  .....+..|+.+++.++||||+++.+++......+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            35778899999999999999764 23   36999998765322  22478999999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999987643  36899999999999999999999   789999999999999999999999999998765


Q ss_pred             CCCCCCc---cccc--cccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC--
Q 013793          299 HADSSNR---TLLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--  370 (436)
Q Consensus       299 ~~~~~~~---~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~--  370 (436)
                      .......   ....  .+..|+|||.+.+..++.++||||||+++|||++ |..||.....       . .....+..  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-------~-~~~~~i~~~~  228 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------Q-DVINAIEQDY  228 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-------H-HHHHHHHcCC
Confidence            4322211   1111  2457999999998899999999999999999986 9999863211       0 11111111  


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..+.+..     ....+.+++.+||+.+|++||++.++++.+.
T Consensus       229 ~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         229 RLPPPMD-----CPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             cCCCccc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111     1233678999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-39  Score=299.46  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=190.6

Q ss_pred             ceeeecCceEEEEEEcC-CCC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      +.||+|+||.||+|... ++.  .+++|.+......  .....+.+|++++.++ +||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            35899999999999765 343  4688888753322  1236788999999999 8999999999999999999999999


Q ss_pred             cCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          225 ERGSLFCILHNDD-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       225 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                      ++|+|.+++....             ....+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECC
Confidence            9999999987542             1235889999999999999999999   78999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      ||++....... .......+..|+|||+.....++.++||||||+++|||++ |+.||.....       .. ....+..
T Consensus       156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~-~~~~~~~  226 (270)
T cd05047         156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LYEKLPQ  226 (270)
T ss_pred             CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HH-HHHHHhC
Confidence            99986322111 1112234567999999988889999999999999999997 9999853211       01 1111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ........   .....+.+++.+||+.+|.+|||+.++++.+.
T Consensus       227 ~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         227 GYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             CCCCCCCC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            11111110   11223678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.9e-39  Score=302.53  Aligned_cols=261  Identities=23%  Similarity=0.373  Sum_probs=199.1

Q ss_pred             cccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KC  216 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  216 (436)
                      .|++.+.||+|+||.||++..     .++..||+|.+.......  ....+.+|+++++.++|||++++.+++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH--HHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            467788999999999999963     357889999987654322  236789999999999999999999998875  56


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||+++++|.+++....  ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999999986543  25899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc-ccC---CCCcccc---hhh
Q 013793          297 RLHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-LSS---SSDPKIM---LID  366 (436)
Q Consensus       297 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-~~~---~~~~~~~---~~~  366 (436)
                      .+......   .....++..|+|||.+.+..++.++||||||+++|||+|++.|...... ...   .......   ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76433221   1234567789999999888899999999999999999998776431110 000   0000000   011


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+......+...   .....+.+++.+||+.+|++|||+.++++.+..
T Consensus       238 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHcCccCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            111111111111   122347789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.8e-39  Score=301.86  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=201.5

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||.|++|.||+|... +|+.||||.+.......  ....+.+|++++++++|+|++++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            5788999999999999999765 68899999987654321  12566789999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++ +|.+++........+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++.......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 88888876554457899999999999999999999   7899999999999999999999999999997654433


Q ss_pred             CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc-------CCCCc-ccchh-----hhh
Q 013793          303 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSSDP-KIMLI-----DVL  368 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------~~~~~-~~~~~-----~~~  368 (436)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......       ....+ .....     ...
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            323334578899999987654 57889999999999999999999986322100       00000 00000     000


Q ss_pred             cCCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 DQRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ~~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+......    .......+.+++.+|++.||.+||++.|+++++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            01111100000    00112346789999999999999999999999886

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=315.22  Aligned_cols=257  Identities=28%  Similarity=0.369  Sum_probs=207.6

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |...+.||.|+||.||-|+. .+.+.||||++........+...++.+|+..|.+++|||++.+-|+|......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            33456699999999999965 57889999999766555545558899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      |-| +-.+++.-..  .++.+.++..|..+.++||+|||   +.+.||||||+.|||+++.|.+||+|||.|....+.  
T Consensus       108 ClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  108 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             Hhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            965 7777776543  36888999999999999999999   899999999999999999999999999999876543  


Q ss_pred             Cccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          304 NRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                        ..++|||.|||||++.   .+.|+-|+||||+|++..|+.-+++|+--++.+       ..+..+....-|.-....|
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNesPtLqs~eW  250 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPTLQSNEW  250 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcCCCCCCCchh
Confidence              3478999999999875   468999999999999999999999996432211       1122222222111111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                         ...+.+++..||+.-|.+|||..+++.|.+..|+.|..
T Consensus       251 ---S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  251 ---SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             ---HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence               23366788999999999999999999999998886643

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.3e-39  Score=298.84  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=184.7

Q ss_pred             eeeecCceEEEEEEcCC---CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          150 CIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .||+|+||+||+|...+   ...+|+|.+......  .....+.+|++.++.++|+||+++++.+......++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999996543   456888887654332  2236788899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          227 GSLFCILHNDDE--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       227 g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      |+|.+++.....  ....++...+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999976532  223567888999999999999999   789999999999999999999999999998654332211


Q ss_pred             --ccccccccccccccccc-------cCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh---cCC
Q 013793          305 --RTLLAGTYGYIAPELAY-------TMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL---DQR  371 (436)
Q Consensus       305 --~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  371 (436)
                        .....++..|+|||+..       ...++.++||||||+++|||++ |..||.....       ........   ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~  229 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------EQVLKQVVREQDIK  229 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhhccCcc
Confidence              12234567899999864       3456889999999999999999 7788753211       00111111   111


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      ++.+..  .......+.+++..|+ .||++|||+.+|++.+
T Consensus       230 ~~~~~~--~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         230 LPKPQL--DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCCcc--cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111110  0111222455777888 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8e-39  Score=300.28  Aligned_cols=251  Identities=21%  Similarity=0.244  Sum_probs=191.0

Q ss_pred             eeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHH---hhccCCCceeeeeEEeeCCEEEEEEeecc
Q 013793          150 CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      .||+|+||.||++.. .+++.+|+|.+.............+.+|..++   ...+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999976 46899999998765332221123334444433   33479999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR  305 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  305 (436)
                      +|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++......  ..
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence            999999987543   6899999999999999999999   789999999999999999999999999998755322  22


Q ss_pred             ccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHH
Q 013793          306 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI  384 (436)
Q Consensus       306 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  384 (436)
                      ....|+..|+|||...+ ..++.++||||+||++|||++|+.||.....    ... ...... ..........   ...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~-~~~~~~-~~~~~~~~~~---~~~  223 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDK-HEIDRM-TLTVNVELPD---SFS  223 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC----cCH-HHHHHH-hhcCCcCCcc---ccC
Confidence            23468999999998864 5689999999999999999999999863211    000 001111 0111111111   112


Q ss_pred             HHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCC
Q 013793          385 LLASTISFACLQSNPKSRP-----TMQYVSQGFLITRK  417 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~  417 (436)
                      ..+.+++.+||+.||++||     +++++++|+|+..-
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            3467889999999999999     69999999999774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-38  Score=294.99  Aligned_cols=239  Identities=22%  Similarity=0.322  Sum_probs=185.8

Q ss_pred             ceeeecCceEEEEEEcCC-------------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          149 YCIGTGGYGSVYKAQLPN-------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      +.||+|+||.||+|...+             ...+++|.+......   ....+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD---ISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358999999999997532             235889987665332   2367888999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC-------eE
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-------AF  288 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~k  288 (436)
                      ..++||||+++|+|..++....  ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.       ++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999998887543  25899999999999999999999   889999999999999987654       89


Q ss_pred             EeecccccccCCCCCCccccccccccccccccc-cCccCcchhhHHHHHHHHHHH-hCCCCccccccccCCCCcccchhh
Q 013793          289 VADFGTARRLHADSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      ++|||++......    ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+.....        .....
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~  220 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEKER  220 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHHHH
Confidence            9999998755322    2345788899999886 467899999999999999998 58888652110        00111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      ...........     ....+.+++.+||+.||++||++.++++.+
T Consensus       221 ~~~~~~~~~~~-----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         221 FYEGQCMLVTP-----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHhcCccCCCC-----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            11111111010     112367899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.4e-39  Score=303.11  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=200.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  219 (436)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+....... .....+.+|++++.+++||||+++.+++...  ...++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            57888999999999999999765 68899999997554321 2224567899999999999999999999877  88999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |+||+++ +|.+++.....  .+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9999975 89888875432  6899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcc--------
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPK--------  361 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~--------  361 (436)
                      ..........+++.|+|||.+.+. .++.++|+||||+++|||++|+.||........         .....        
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            443333345578899999988765 468999999999999999999999863221000         00000        


Q ss_pred             -----cch----hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          362 -----IML----IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       362 -----~~~----~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                           ...    ...+...++..      .....+.+++.+||+.+|++|||+.|++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPAL------SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhcccccc------CCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                 000    00000111110      012336689999999999999999999999885

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=297.99  Aligned_cols=236  Identities=24%  Similarity=0.363  Sum_probs=184.4

Q ss_pred             eeeecCceEEEEEEcCC-------------------------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc
Q 013793          150 CIGTGGYGSVYKAQLPN-------------------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  204 (436)
                      .||+|+||.||+|.+..                         ...|++|.+......   ....+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD---IALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH---HHHHHHHHHHHHhcCCCCCe
Confidence            59999999999996421                         135889988654332   23678889999999999999


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      ++++++|.+....++||||+++|+|..++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||++++.
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence            999999999999999999999999999986532  36889999999999999999999   7899999999999999764


Q ss_pred             C-------CeEEeecccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHH-hCCCCcccccccc
Q 013793          285 L-------EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLS  355 (436)
Q Consensus       285 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~  355 (436)
                      +       .++++|||.+......    ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....  
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP--  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence            3       3799999988644222    22346788999998865 56899999999999999995 79998863211  


Q ss_pred             CCCCcccchhhhhcC--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          356 SSSDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       356 ~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                            .........  ..+.+..       ..+.+++.+||+.+|++|||+.++++.+
T Consensus       228 ------~~~~~~~~~~~~~~~~~~-------~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 ------SEKERFYEKKHRLPEPSC-------KELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ------HHHHHHHHhccCCCCCCC-------hHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                  001111121  1222111       2367899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=288.69  Aligned_cols=277  Identities=22%  Similarity=0.328  Sum_probs=216.2

Q ss_pred             cHHHHHHHhhcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEE
Q 013793          134 FYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFC  211 (436)
Q Consensus       134 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  211 (436)
                      .++|+.+.|+     +.||+|+++.|-.+ ...+|..||||++.+...-   ....+.+|++++.+. .|+||++++++|
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            3678888774     56999999999998 5789999999999776432   237888999999999 599999999999


Q ss_pred             eeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eE
Q 013793          212 LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AF  288 (436)
Q Consensus       212 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~k  288 (436)
                      ++...+|||||.|.||.|..++++..   .+++.++..++.+|+.||.|||   ..||.|||+||+|||..+...   +|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence            99999999999999999999998765   7999999999999999999999   899999999999999976544   79


Q ss_pred             EeecccccccCCCCC-------Cccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccC
Q 013793          289 VADFGTARRLHADSS-------NRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS  356 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  356 (436)
                      |+||.+...+.....       ...+.+|+..|||||+..     ...|+.++|.||+|||||-|++|..||...-.-.=
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            999999865432221       123467899999999653     23688999999999999999999999964322110


Q ss_pred             CCCc-------ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 013793          357 SSDP-------KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHA  424 (436)
Q Consensus       357 ~~~~-------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~  424 (436)
                      ..+.       ...+.+-+...-..-.+.++........+++...+..|+.+|.++.++++|+|+.+-.+.+.-|
T Consensus       300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence            0111       1112222222222222344555566678899999999999999999999999998876544333

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=302.78  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |++.+.||.|++|.||+|.. .+|+.||+|++....... .....+.+|+++++.++|||++++++++.+.+..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            56788999999999999965 479999999987553221 1225677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      ++ ++|.+++..... ..+++..++.++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||++........
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            95 689998875432 36899999999999999999999   78999999999999999999999999999976543333


Q ss_pred             CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCccc--------chh
Q 013793          304 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKI--------MLI  365 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~--------~~~  365 (436)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........         ......        ...
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            23334568899999987664 578999999999999999999999863221000         000000        000


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....................+.+++.+|++.||++|||+.|+++++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0000000000000000111346789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-38  Score=293.11  Aligned_cols=255  Identities=29%  Similarity=0.437  Sum_probs=207.7

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFLI  220 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  220 (436)
                      +|...+.||+|++|.||+|... +++.+++|++...... ....+.+.+|++++++++|+||+++++.+...  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4677889999999999999765 7899999998766542 22347889999999999999999999999988  899999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||+++++|.+++....   .+++.++..++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999997654   7899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          301 DSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       301 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...  ......++..|+|||...+...+.++||||||+++++|++|+.||....      ....................
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIPE  227 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCCc
Confidence            432  1334568889999999998889999999999999999999999986432      01111111111111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .....+.+++.+|++.+|++||++.|+++++|+
T Consensus       228 ---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         228 ---HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ---ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence               112347789999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-38  Score=296.24  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=188.2

Q ss_pred             ceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CCEEEEEEee
Q 013793          149 YCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKCMFLIYEY  223 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  223 (436)
                      +.||+|+||.||+|...    +...+|+|.+......  ...+.+.+|+.+++.++|||++++++++.. ++..++|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH--HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            35899999999999653    3457999998643322  224678889999999999999999998764 5568899999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999997543  24678888999999999999999   78999999999999999999999999999976533211


Q ss_pred             ----CccccccccccccccccccCccCcchhhHHHHHHHHHHHhC-CCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          304 ----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       304 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                          ......++..|+|||...+..++.++||||||+++|||++| ..||....       ............ ......
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~  225 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGR-RLLQPE  225 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCC-CCCCCC
Confidence                11223456789999999888999999999999999999995 45554211       101111111111 111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .....+.+++.+||+.+|++||++.|+++.+..
T Consensus       226 ---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         226 ---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             ---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence               011236789999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2e-38  Score=296.78  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++|++...||+|+||.||+|..+      +.+.+++|.+......  .....+.+|++++++++|+||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            57888999999999999999753      3567999988664432  234678999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          217 MFLIYEYMERGSLFCILHNDDEA------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      .++||||+++|+|.+++......      ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999999765422      25899999999999999999999   7899999999999999999999999


Q ss_pred             ecccccccCCCCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh
Q 013793          291 DFGTARRLHADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       291 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      |||++........ ......++..|+|||.+.+...+.++||||||+++|+|++ |..||.....       ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~  232 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ  232 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH
Confidence            9999875432211 1223346778999999988888999999999999999998 7888752211       11111111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ......+...   .....+.+++.+||+.+|++||++.|+++.++
T Consensus       233 ~~~~~~~~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGKLELPVPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCcCCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111111111   11224778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=291.95  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=196.2

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCC
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGS  228 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  228 (436)
                      +.||+|++|.||++...+++.||+|.+......  .....+.+|++++++++|+||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            368999999999998777999999998765543  223678999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc--c
Q 013793          229 LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR--T  306 (436)
Q Consensus       229 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~  306 (436)
                      |.+++....  ..+++..++.++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||++..........  .
T Consensus        79 l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            999997543  25789999999999999999999   7899999999999999999999999999997654221111  1


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL  385 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  385 (436)
                      ...++..|+|||.+.+..++.++||||||+++|||+| |..||.....        ......+..........   ....
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~  222 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAPQ---LCPE  222 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCCc---cCCH
Confidence            1233567999999988889999999999999999999 8888753211        11111121111111111   1123


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          386 LASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .+.+++.+|++.+|++|||+.|+++.+.
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            4778999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.7e-38  Score=302.22  Aligned_cols=257  Identities=27%  Similarity=0.367  Sum_probs=202.3

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |+..+.||+|+||.||++.. .++..+|+|.+.............+.+|+++++.++|||++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66788899999999999975 47889999998754333333346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++ +|.+.+....  ..+++.++..++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||++......  
T Consensus       107 ~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            975 7777765432  36899999999999999999999   789999999999999999999999999998754322  


Q ss_pred             Cccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          304 NRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                        ....++..|+|||.+.   ...++.++||||||+++|||++|+.||....       .............+.....  
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~--  247 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTLQSN--  247 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccCCCCCCc--
Confidence              2345788999999874   4568899999999999999999999975321       1111112222211111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                       .....+.+++.+||+.+|.+||++.++++++|+....+..
T Consensus       248 -~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         248 -EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             -cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence             1122367899999999999999999999999987665533

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-38  Score=307.35  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             hcccccceeeecCceEEEEEEcC--------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      .+|++.+.||+|+||.||++...        .+..||+|.+......  ...+.+.+|++++.++ +||||++++++|..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            46888999999999999999642        1236899988754322  2246788999999999 89999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDD-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  280 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nil  280 (436)
                      .+..++++||+++|+|.+++....             ....+++.+++.++.|++.||+|||   +.+++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence            999999999999999999987532             1235889999999999999999999   889999999999999


Q ss_pred             ecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCC
Q 013793          281 LNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSS  357 (436)
Q Consensus       281 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~  357 (436)
                      +++++.++|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....     
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----  241 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----  241 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence            999999999999999865432211  112234567999999999999999999999999999998 888875321     


Q ss_pred             CCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                        ... ....+..........   .....+.+++.+||+.+|++||++.|+++.+....
T Consensus       242 --~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         242 --VEE-LFKLLKEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             --HHH-HHHHHHcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence              111 111111111111111   11223668999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-38  Score=291.93  Aligned_cols=252  Identities=32%  Similarity=0.469  Sum_probs=204.8

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|+..+.||+|++|.||++... +++.+++|++.....   ...+.+.+|++.++.++|+|++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4777889999999999999765 788999999987654   224788899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++....  ..+++..+..++.+++.||+|||   ..+++||||+|+||++++++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999987653  36899999999999999999999   7899999999999999999999999999998765433


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      . .....++..|+|||.+.+...+.++||||||+++|+|++|+.||.....       ......... ........ ...
T Consensus       153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~-~~~  222 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT-NGPPGLRN-PEK  222 (253)
T ss_pred             c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh-cCCCCcCc-ccc
Confidence            2 3345688899999999888899999999999999999999999863211       000111111 11111110 111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ....+.+++.+||+.||++|||+.|+++++|
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            1234678999999999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.6e-39  Score=297.85  Aligned_cols=250  Identities=27%  Similarity=0.401  Sum_probs=202.7

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||.|+||.||++... +|+.+++|.+.............+.+|++++.+++|||++++++.+......++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999776 5999999999766544344457889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC------
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS------  303 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------  303 (436)
                      .+++....   .+++..+..++.|+++||+|||   +.+++||||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997654   6899999999999999999999   78999999999999999999999999999876543321      


Q ss_pred             --CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          304 --NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       304 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                        ......++..|+|||.......+.++||||||+++||+++|+.||....       ...............+...   
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---  224 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIFQNILNGKIEWPEDV---  224 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCcCCCccc---
Confidence              2233457889999999988889999999999999999999999986321       1111222222222211111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCH---HHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPTM---QYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~---~ev~~~l~~~~  416 (436)
                      .....+.+++.+||+.+|++|||+   .++++++|+..
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            012346789999999999999999   99999998853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-39  Score=302.83  Aligned_cols=261  Identities=26%  Similarity=0.292  Sum_probs=197.5

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+......  .....+.+|+.++.++. |+||+++++++...+..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            455567899999999999965 46899999998765433  22367889999999996 999999999999999999999


Q ss_pred             eeccCCChhhhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          222 EYMERGSLFCIL---HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       222 e~~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      ||++. ++.++.   ... ....+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.++|+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99864 554432   221 12468999999999999999999994  358999999999999999999999999999765


Q ss_pred             CCCCCCccccccccccccccccccC---ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .... ......|+..|+|||.+.+.   .++.++||||||+++|||++|+.||.....      ......+......+..
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~  231 (288)
T cd06616         159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVVKGDPPIL  231 (288)
T ss_pred             ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhcCCCCCcC
Confidence            4322 22334578899999998766   689999999999999999999999863210      0001111111111100


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ...........+.+++.+||+.+|++|||+.+|++++|+...
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            000001123347789999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=298.21  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=199.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .+|++.+.||+|+||.||+|... +|.    .+|+|.+......  .....+.+|+..++.++|||++++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            56788899999999999999754 333    5899988765432  223678899999999999999999999987 788


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|+||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||.++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999976432  5899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCCcc--ccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC-CCC
Q 013793          298 LHADSSNRT--LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP  373 (436)
Q Consensus       298 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~  373 (436)
                      .........  ...++..|+|||.+....++.++||||||+++||+++ |+.||+...       .......+... ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~  231 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-------AVEIPDLLEKGERLP  231 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHhCCCCCC
Confidence            653322111  1223567999999988889999999999999999998 999986321       11111111111 111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .+..     ....+.+++.+||..+|.+||++.++++.+...
T Consensus       232 ~~~~-----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         232 QPPI-----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CCCC-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111     112366888999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-38  Score=302.98  Aligned_cols=272  Identities=27%  Similarity=0.332  Sum_probs=202.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  218 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+....... .....+.+|+.++.+++|+|++++++++...  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            46789999999999999999976 468999999987543221 1113456799999999999999999998765  5689


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+.+ +|.+++....  ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++...
T Consensus        85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999975 7888876532  36899999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcccc--hh-
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKIM--LI-  365 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~--~~-  365 (436)
                      ...........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........         ......+  .. 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            544333333446788999998865 4578999999999999999999999863221100         0000000  00 


Q ss_pred             -hh-hcCCCCC-CCC---hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          366 -DV-LDQRLPP-PVD---QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       366 -~~-~~~~l~~-~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                       .. -...+.. ...   .........+.+++.+|++.||++|||+.|+++|+|+.+..-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence             00 0000000 000   0000113346689999999999999999999999999866443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=303.94  Aligned_cols=267  Identities=25%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             cccccceeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMF  218 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  218 (436)
                      .|++.+.||+|++|.||+|...   +++.||+|.+.............+.+|++++..++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999764   4789999999874321122235677899999999999999999999988  7899


Q ss_pred             EEEeeccCCChhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----CCCeEEeec
Q 013793          219 LIYEYMERGSLFCILHNDD--EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADF  292 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df  292 (436)
                      +||||+++ ++.+++....  ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 6666654322  1236889999999999999999999   789999999999999999    899999999


Q ss_pred             ccccccCCCCC---CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc--ccchh-
Q 013793          293 GTARRLHADSS---NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIMLI-  365 (436)
Q Consensus       293 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--~~~~~-  365 (436)
                      |+++.......   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.....-.....+  ..... 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322   12234578899999987664 5789999999999999999999998633211100000  00000 


Q ss_pred             --hhh-----------------------cCCCCCCCCh--hHH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          366 --DVL-----------------------DQRLPPPVDQ--KVI----QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       366 --~~~-----------------------~~~l~~~~~~--~~~----~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        +.+                       ......+...  ...    .....+.+++.+|++.||++|||+.|+++++||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence              000                       0000000000  000    122347789999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-38  Score=300.55  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=202.5

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      ..||+|+||.||++.. .+++.||+|++......   ....+.+|+.+++.++|+|++++++++...+..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh---HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            5699999999999966 47899999998654332   2367889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccc
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      +|.+++...    .+++.....++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++............
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            999987543    5789999999999999999999   789999999999999999999999999998766443333344


Q ss_pred             cccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLA  387 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  387 (436)
                      ..+++.|+|||...+..++.++||||||+++|||++|+.||.....        ......+....+..... .......+
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~~l  246 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPKLKN-LHKVSPSL  246 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhhCCcccCC-cccCCHHH
Confidence            5688999999999888889999999999999999999999853111        01111111111111100 01112236


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          388 STISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       388 ~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .+++.+||+.+|.+||++.+++++.|+....+
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            67889999999999999999999999988765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-38  Score=293.14  Aligned_cols=237  Identities=27%  Similarity=0.431  Sum_probs=187.0

Q ss_pred             ceeeecCceEEEEEEcCCCC-----------EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          149 YCIGTGGYGSVYKAQLPNGK-----------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      +.||+|+||.||+|...+..           .+++|.+......    ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            35899999999999775432           5788877655432    3778899999999999999999999988 778


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-------CeEEe
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-------EAFVA  290 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~  290 (436)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++       .++|+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999999976432  6889999999999999999999   88999999999999999888       79999


Q ss_pred             ecccccccCCCCCCccccccccccccccccccC--ccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhh
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      |||++.....    .....++..|+|||++.+.  .++.++||||||+++|||++ |..|+.....     ........ 
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~~~~~~~-  220 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SEKERFYQ-  220 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hhHHHHHh-
Confidence            9999986543    2233466789999998876  78999999999999999999 5777653211     00000000 


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .....+.+..       ..+.+++.+||..+|++|||+.++++.+
T Consensus       221 ~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 DQHRLPMPDC-------AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             cCCCCCCCCc-------hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1111111111       3467899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.6e-39  Score=302.08  Aligned_cols=268  Identities=22%  Similarity=0.265  Sum_probs=198.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCE----
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKC----  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----  216 (436)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....... .....+.+|+.++..++ ||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            46888999999999999999754 78999999886543221 12256788999999995 6999999999987665    


Q ss_pred             -EEEEEeeccCCChhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeec
Q 013793          217 -MFLIYEYMERGSLFCILHNDDE--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADF  292 (436)
Q Consensus       217 -~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df  292 (436)
                       .++||||+++ +|.+++.....  ...+++..++.++.||+.||+|||   +.+|+||||+|+||+++. ++.++|+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999986 78888765432  246899999999999999999999   789999999999999998 889999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCC-------CCc-ccc
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS-------SDP-KIM  363 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~-~~~  363 (436)
                      |++..+...........+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........       ..+ ...
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999865433333333456889999998765 45789999999999999999999998532211000       000 000


Q ss_pred             hhhh---hc----CCCCCC-CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          364 LIDV---LD----QRLPPP-VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       364 ~~~~---~~----~~l~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ....   .+    ....+. ...........+.+++.+||+.||.+||++.|++.|+|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            0000   00    000000 0000011223467899999999999999999999999873

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=300.53  Aligned_cols=261  Identities=20%  Similarity=0.328  Sum_probs=216.3

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .-|.+.+.||+|.|+.|-+|++ -+|..||||++.....++.. ...+.+|++.|+-++|||||+++++.......|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3466677899999999999965 48999999999887766543 367888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |.-.+|+|.+|+-+...  .+.+..+.+++.||+.|+.|+|   ...+|||||||+||.+ ..-|-+||.|||++-.+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999977653  5889999999999999999999   7889999999999766 5568999999999987754


Q ss_pred             CCCCccccccccccccccccccCccC-cchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      . ...+..+|+..|-|||.+.+..|+ +++||||+|||||.|++|+.||+..++       ...+.-++|-...-     
T Consensus       172 G-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------SETLTmImDCKYtv-----  238 (864)
T KOG4717|consen  172 G-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------SETLTMIMDCKYTV-----  238 (864)
T ss_pred             c-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------hhhhhhhhcccccC-----
Confidence            4 345667899999999999998875 689999999999999999999984432       11233334433221     


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK  422 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~  422 (436)
                      +......+.+|+..||..||++|-+.++|+.+.|.+.-.+...
T Consensus       239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence            1223445889999999999999999999999999987655433

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-38  Score=298.54  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=202.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CC
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KK  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  215 (436)
                      +.|++.+.||+|+||.||++...     ++..+|||.+......  .....+.+|++.++.++|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            45677889999999999999753     4688999999866543  234789999999999999999999999887  55


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            78999999999999999976532  5899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCC----C---Ccccchh
Q 013793          296 RRLHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS----S---DPKIMLI  365 (436)
Q Consensus       296 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~----~---~~~~~~~  365 (436)
                      .........   .....++..|+|||...+..++.++||||||+++|||+||+.|+.........    .   .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876533221   11223456799999998889999999999999999999999987532110000    0   0000111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +.+......+...   .....+.+++.+||+.+|++|||+.||++.+..
T Consensus       237 ~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         237 ELLKEGERLPRPP---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHHcCCcCCCCc---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            2222211111111   112347789999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-38  Score=300.31  Aligned_cols=255  Identities=24%  Similarity=0.393  Sum_probs=197.0

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++|+..+.||+|+||.||+|... +|.    .+|+|.+.......  ....+.+|+.+++.++||||++++++|... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK--ANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            356778889999999999999653 444    57899887654322  235688999999999999999999998764 4


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++++||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence            679999999999999987543  25889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ....+.+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~  229 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLLEKGER  229 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCC
Confidence            76433221  122345678999999998899999999999999999997 8899853210        111122211111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .+...   .....+.+++.+||..+|++||++.++++.+...
T Consensus       230 ~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 LPQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111   0122366889999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.3e-38  Score=291.89  Aligned_cols=246  Identities=24%  Similarity=0.425  Sum_probs=195.6

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||.||++.. +++.||+|.+.....     ...+.+|+.++..++|||++++++++... ..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            4688899999999999999975 678899999865432     25788999999999999999999998765 4789999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++.... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++...... 
T Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            999999999997653 235889999999999999999999   789999999999999999999999999998754321 


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                        ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.....       . ................   
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~---  220 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------K-EVKECVEKGYRMEPPE---  220 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------H-HHHHHHhCCCCCCCCC---
Confidence              112234568999999988899999999999999999997 9999863211       0 1111121111111111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .....+.+++.+||+.+|++||++.++++.+.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            11234668999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.2e-38  Score=299.51  Aligned_cols=269  Identities=23%  Similarity=0.278  Sum_probs=199.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|++|+||+|... +++.||+|.+....... ...+.+.+|++++++++|||++++++++......++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            46888999999999999999765 78999999986543221 12356788999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~  300 (436)
                      ||++ ++|.+++.... ...+++..+..++.||+.||+|||   +.+++|+||+|+||+++. ++.+||+|||++.....
T Consensus        81 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9996 47877775443 224678888899999999999999   789999999999999985 56789999999976543


Q ss_pred             CCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCccc-----chh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKI-----MLI  365 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~-----~~~  365 (436)
                      .........+++.|+|||.+.+. .++.++||||+|+++|+|+||+.||........         ......     ...
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            33323334578899999988664 578999999999999999999999863211000         000000     000


Q ss_pred             hhh--cCCCCCCCC-hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          366 DVL--DQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       366 ~~~--~~~l~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +..  ......... .........+.+++.+|++.+|++||++.+++++.|+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            000  000000000 0000112236789999999999999999999999998654

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-38  Score=300.18  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             hhcccccceeeecCceEEEEEEcCC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|++|.||+|...+ ++.||||.+........  ...+..|++++.+. .||||+++++++.+....++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH--HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            3568889999999999999998764 89999999976543221  25566677777666 49999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      +|||+++ ++.+++....  ..+++..+..++.+++.||+|||+  ..+|+||||+|+||++++++.++|+|||++..+.
T Consensus        92 v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          92 CMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            9999854 6776665432  268999999999999999999994  2589999999999999999999999999997654


Q ss_pred             CCCCCccccccccccccccccccCc----cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .... .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....      ........+....+..
T Consensus       167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~  239 (296)
T cd06618         167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEPPSL  239 (296)
T ss_pred             CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCCCCC
Confidence            3222 22345788999999987554    78899999999999999999999863110      0111122222221111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ...  ......+.+++.+||+.||++||++.++++++|+....+.
T Consensus       240 ~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         240 PPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             CCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence            000  0112346789999999999999999999999998775543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.3e-38  Score=291.01  Aligned_cols=256  Identities=28%  Similarity=0.424  Sum_probs=207.5

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|++|.||++... +++.+|+|++....... ...+.+.+|+++++.++|+|++++.+.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh-HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4778899999999999999764 68999999997654322 224678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          223 YMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |+++++|.+++.... ....+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987642 1347999999999999999999999   789999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      ........|++.|+|||...+..++.++||||+|+++++|++|+.||+...       ............... ...   
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~---  225 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKGQYPP-IPS---  225 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcCCCCC-CCC---
Confidence            323334568889999999988889999999999999999999999986321       111111222221111 111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....+.+++.+||..+|++|||+.++++++|+
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            112236788999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.9e-38  Score=289.92  Aligned_cols=251  Identities=28%  Similarity=0.451  Sum_probs=198.2

Q ss_pred             ccccceeeecCceEEEEEEcCC-----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      +++.+.||+|+||.||++...+     +..||+|.+.......  ..+.+..|++.+..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3467889999999999997653     4889999997665432  24788999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      +|||+++++|.+++...... .+++.++..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999999764321 2899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCCcc-ccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          300 ADSSNRT-LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       300 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ....... ...+++.|+|||...+..++.++||||+|++++||++ |+.||....       .............. ...
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~-~~~  226 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-------NEEVLEYLKKGYRL-PKP  226 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCCC-CCC
Confidence            4322211 2336789999999988889999999999999999998 788875311       11111111111111 111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .   .....+.+++.+|+..||++|||+.|+++.+
T Consensus       227 ~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 E---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1   1223467899999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=292.06  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=193.3

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHH-hhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|++|.||+|.. .+++.||+|.+.............+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4589999999999965 46899999998765433222234445555544 445899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      ++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||+++....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999997543   6889999999999999999999   78999999999999999999999999999875432    22


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILL  386 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  386 (436)
                      ...++..|+|||.+.+..++.++||||||+++|||+||..||....       ...............+... .......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~  223 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILSRRINWPEEV-KEFCSPE  223 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcccCCCCcc-cccCCHH
Confidence            3457889999999988888999999999999999999999986321       1111111111111111000 0011234


Q ss_pred             HHHHHhhccCCCCCCCCC---HHHHHHHHhhcCC
Q 013793          387 ASTISFACLQSNPKSRPT---MQYVSQGFLITRK  417 (436)
Q Consensus       387 ~~~l~~~cl~~dP~~RPt---~~ev~~~l~~~~~  417 (436)
                      +.+++.+||+.+|++||+   +.|++.|+|+...
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            678999999999999995   5788889988553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.5e-38  Score=292.18  Aligned_cols=253  Identities=27%  Similarity=0.391  Sum_probs=197.4

Q ss_pred             hcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|.+.+.||+|+||.||+|...+    ...||+|.........  ..+.+.+|+.+++.++|||++++++++.. +..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            457888999999999999997543    2468999887654322  23678899999999999999999998875 4578


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....  ..+++..++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999997643  25899999999999999999999   789999999999999999999999999999866


Q ss_pred             CCCCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhc-CCCCCC
Q 013793          299 HADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPP  375 (436)
Q Consensus       299 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~l~~~  375 (436)
                      ...... .....++..|+|||.+....++.++||||||+++||+++ |+.||......       ........ ...+.+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~  230 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGRIENGERLPMP  230 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCcCCCC
Confidence            443221 122234568999999988889999999999999999996 99998632210       00111111 111111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .     .....+.+++.+|+..+|++|||+.++++.+...
T Consensus       231 ~-----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         231 P-----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             C-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1     1122467899999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-38  Score=295.37  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=192.6

Q ss_pred             eeeecCceEEEEEEcCC-------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          150 CIGTGGYGSVYKAQLPN-------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .||+|+||.||+|...+       +..+|+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            58999999999997542       357999988654322  123678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-----CeEEeecc
Q 013793          223 YMERGSLFCILHNDD----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-----EAFVADFG  293 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg  293 (436)
                      |+++++|.+++....    ....+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999997532    2235889999999999999999999   78999999999999999887     89999999


Q ss_pred             cccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC
Q 013793          294 TARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       294 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      +++........  .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.....        ......+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~  228 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVTA  228 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHhc
Confidence            99765332211  122345678999999999999999999999999999998 9999863211        011111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ........   .....+.+++.+||+.+|++||++.+|++.+.
T Consensus       229 ~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 GGRLQKPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CCccCCcc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11111111   11234678999999999999999999998763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.8e-38  Score=298.91  Aligned_cols=257  Identities=27%  Similarity=0.357  Sum_probs=200.5

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |...+.||+|+||+||+|.. .+++.|++|.+.............+.+|+++++.++|||++++.+++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567799999999999975 47889999998755433333346788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +. |++.+++....  ..+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 57777775432  36899999999999999999999   78999999999999999999999999999864322   


Q ss_pred             Cccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          304 NRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                       .....|+..|+|||++.   ...++.++||||||+++|||++|+.|+.....       ............+.....  
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~--  243 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNDSPTLQSN--  243 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCcc--
Confidence             22356888999999874   45688899999999999999999999753211       011111111111111110  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                       .....+.+++.+||+.+|.+||++.++++++|+....+..
T Consensus       244 -~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~  283 (313)
T cd06633         244 -EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPAR  283 (313)
T ss_pred             -ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhH
Confidence             0112366899999999999999999999999998766533

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=288.74  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=206.1

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|++|.||++... +++.|++|.+....... .....+.+|++++.+++|+|++++++++.+.+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4778899999999999999654 68899999998765432 234789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999987653   6899999999999999999999   8899999999999999999999999999998775544


Q ss_pred             CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHH
Q 013793          303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQ  382 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  382 (436)
                      .......++..|+|||...+...+.++||||+|+++|+|++|+.||......       ........... .....   .
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~---~  222 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQDDH-PPLPE---G  222 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhccCC-CCCCC---C
Confidence            4334456889999999998888899999999999999999999998632210       00111111111 11111   1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+.+++.+||..+|++|||+.+++.+.|+
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            12236689999999999999999999998774

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-38  Score=297.79  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=206.3

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  220 (436)
                      ++|.+.+.||+|++|.||++... +++.||+|++.............+.+|.+++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999664 79999999987643333333467889999999998 99999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999997654   6999999999999999999999   78999999999999999999999999999886643


Q ss_pred             CCC--------------------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc
Q 013793          301 DSS--------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       301 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~  360 (436)
                      ...                    ......++..|+|||...+..++.++||||||++++++++|+.||.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------  227 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------  227 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence            321                    11234578899999999888899999999999999999999999873321       


Q ss_pred             ccchhhhhcCC--CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHHHhh
Q 013793          361 KIMLIDVLDQR--LPPPVDQKVIQDILLASTISFACLQSNPKSRPTM----QYVSQGFLI  414 (436)
Q Consensus       361 ~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~----~ev~~~l~~  414 (436)
                      ...........  ++...       ...+.+++.+||+.+|++||++    +++++|+|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         228 YLTFQKILKLEYSFPPNF-------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHHhcCCCCCCcc-------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            11112222111  11111       2236789999999999999999    999999885

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.4e-38  Score=292.22  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             HHHHHHHhhccccccee--eecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeE
Q 013793          135 YEDLIEATEDFHIKYCI--GTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGF  210 (436)
Q Consensus       135 ~~~l~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  210 (436)
                      ..+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+........        |......+ +|||++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEE
Confidence            34555566778887776  9999999999965 4788999999875432211        22222222 69999999999


Q ss_pred             EeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEE
Q 013793          211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFV  289 (436)
Q Consensus       211 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl  289 (436)
                      +...+..++||||+++++|.+++....   .+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence            999999999999999999999997654   7899999999999999999999   78999999999999999998 9999


Q ss_pred             eecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      +|||++......    ....++..|+|||.+.+..++.++||||||+++|||++|+.||......  ..... .......
T Consensus       152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~~~  224 (267)
T PHA03390        152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLE-SLLKRQQ  224 (267)
T ss_pred             ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHH-HHHHhhc
Confidence            999998765432    2245788999999999888999999999999999999999998622110  00000 0111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhhc
Q 013793          370 QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT-MQYVSQGFLIT  415 (436)
Q Consensus       370 ~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~ev~~~l~~~  415 (436)
                      .....     .......+.+++.+||+.+|.+||+ ++|+++|.|+.
T Consensus       225 ~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        225 KKLPF-----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             ccCCc-----ccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            11111     1122334778999999999999996 69999999984

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.7e-38  Score=292.78  Aligned_cols=250  Identities=20%  Similarity=0.292  Sum_probs=182.9

Q ss_pred             eeeecCceEEEEEEcCCC---CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          150 CIGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .||+|+||.||++...++   ..+++|.+.......  ..+.+.+|+..++.++||||+++++.|......++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK--EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH--HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            599999999999965433   356677766543222  247889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC--C
Q 013793          227 GSLFCILHNDDE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--S  303 (436)
Q Consensus       227 g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~  303 (436)
                      |+|.++++.... ....++.....++.|++.||+|||   +.+++||||||+|||++.++.++|+|||++.......  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999976432 234677778899999999999999   7899999999999999999999999999986432211  1


Q ss_pred             Ccccccccccccccccccc-------CccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCC-cccchhhhhcCCCCC
Q 013793          304 NRTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD-PKIMLIDVLDQRLPP  374 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~l~~  374 (436)
                      ......++..|+|||+...       ..++.++||||||+++|||++ |..||........... .........++.+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            1233467889999998743       245789999999999999997 5667752211000000 000000111111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      ..       ...+.+++..|| .+|++||++++|++.+
T Consensus       237 ~~-------~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         237 PY-------SERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             CC-------cHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            11       123556778899 6799999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=304.63  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=198.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      +++|++.+.||+|+||.||+|.. .+|+.||+|.+......  .....+.+|+.++++++|+||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            46899999999999999999964 57899999998643222  2236677899999999999999999987654     3


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++|+||+++ +|..++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence            57999999975 787777543    5899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCC---cccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc
Q 013793          296 RRLHADSSN---RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI  362 (436)
Q Consensus       296 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~  362 (436)
                      .........   .....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......         ..... .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~-~  232 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ-E  232 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH-H
Confidence            765432221   123467899999998654 568899999999999999999999985321100         00000 0


Q ss_pred             chhhhhcC-------CCC--CCCC--hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          363 MLIDVLDQ-------RLP--PPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       363 ~~~~~~~~-------~l~--~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ........       ..+  ....  .........+.+++.+||+.+|++|||+.|+++++|+..-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00000000       000  0000  00011133477899999999999999999999999986553

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-38  Score=293.37  Aligned_cols=237  Identities=22%  Similarity=0.410  Sum_probs=186.1

Q ss_pred             ceeeecCceEEEEEEcCC--------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          149 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      +.||+|+||.||+|....        ...+|+|.+.....   ...+.+.+|+.+++.++|||++++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            359999999999996532        23488888754432   2236788899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC--------eEEeec
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--------AFVADF  292 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df  292 (436)
                      |||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999999976542  5889999999999999999999   889999999999999987765        589999


Q ss_pred             ccccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCC-CCccccccccCCCCcccchhhhhcC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGK-HPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      |.+.....    .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.....        .........
T Consensus       153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~  220 (258)
T cd05078         153 GISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYED  220 (258)
T ss_pred             ccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHHHHHc
Confidence            98865432    2234578899999998764 5789999999999999999995 55442111        011111111


Q ss_pred             --CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       371 --~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                        .++....       ..+.+++.+||+.||++|||++++++.+
T Consensus       221 ~~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         221 RHQLPAPKW-------TELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             cccCCCCCc-------HHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              2222221       2367899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=293.46  Aligned_cols=263  Identities=25%  Similarity=0.295  Sum_probs=197.2

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc---cCCCceeeeeEEeeCCE----
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRSIVKLYGFCLHKKC----  216 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----  216 (436)
                      |++.+.||+|+||.||+|... +++.||+|.+....... .....+.+|++++.++   +|+|++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567889999999999999876 58999999997543322 1124566677776666   59999999999998776    


Q ss_pred             -EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          217 -MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       217 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                       .+++|||+++ +|.+++..... ..+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence             9999999975 89888875432 25899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcccc---
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKIM---  363 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~---  363 (436)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||........         .......   
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            87643322 2234578899999999988999999999999999999999999863221000         0000000   


Q ss_pred             ---hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          364 ---LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       364 ---~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .......................+.+++.+||+.||++||++.|++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence               000000011111111111223456789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.3e-38  Score=303.36  Aligned_cols=265  Identities=23%  Similarity=0.293  Sum_probs=199.2

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  214 (436)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++++..++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            457899999999999999999965 478999999986543222 1235677899999999999999999988643     


Q ss_pred             -CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          215 -KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       215 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                       ...++||||+.+ +|.+.+..     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence             347999999964 78877753     2788899999999999999999   7899999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc----
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP----  360 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~----  360 (436)
                      +++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......         .....    
T Consensus       164 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         164 LARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             cceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9987543222 233457889999999999999999999999999999999999985322100         00000    


Q ss_pred             --ccchhhhhcCCC----------------CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          361 --KIMLIDVLDQRL----------------PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       361 --~~~~~~~~~~~l----------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                        ..........+.                +.............+.+++.+||+.||++|||+.|+++++|+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence              000000000000                00000000112334678999999999999999999999998863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=289.44  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=199.4

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcc--hhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--TEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  217 (436)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+....  .........+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999965 468999999875431  11223346888999999999999999999998764  468


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|+||+++++|.+++....   .+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999987543   5788999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADS---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||....       ......+.......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQPTKP  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHHHHcCCCCC
Confidence            53211   11233458899999999998889999999999999999999999986321       111122222221111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ....   .....+.+++.+|++ +|..||+..+++.|++
T Consensus       229 ~~p~---~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         229 MLPD---GVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             CCCc---ccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence            1111   112336788899999 5799999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2e-38  Score=305.38  Aligned_cols=271  Identities=24%  Similarity=0.313  Sum_probs=203.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~  216 (436)
                      .++|++.+.||+|++|.||+|.. .+|+.||+|++....... ...+.+.+|+.++..++||||+++.+++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            46899999999999999999965 469999999987643221 123667789999999999999999988763    346


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++|+||+. |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999996 58988887543   5899999999999999999999   7899999999999999999999999999997


Q ss_pred             ccCCCCCC----cccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc--
Q 013793          297 RLHADSSN----RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP--  360 (436)
Q Consensus       297 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~--  360 (436)
                      ........    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......         .....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65432211    123468889999998765 468899999999999999999999986322100         00000  


Q ss_pred             -----ccchhhhh---cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          361 -----KIMLIDVL---DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       361 -----~~~~~~~~---~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                           .....+..   ......+...........+.+++.+||+.+|++||++.++++++|+..-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                 00000000   0000000000001123447889999999999999999999999999655443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=282.89  Aligned_cols=267  Identities=25%  Similarity=0.332  Sum_probs=213.1

Q ss_pred             Hhhccccc-ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee----
Q 013793          141 ATEDFHIK-YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH----  213 (436)
Q Consensus       141 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  213 (436)
                      .+++|.+. ++||-|-.|.|-.+.. .+|+.+|+|++...        ...++|++.--.. .|||||+++++|.+    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            46677665 4799999999999854 47899999998765        3456788875555 69999999998875    


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEe
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVA  290 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~  290 (436)
                      ....++|||.|+||.|...+..++. ..+++.++-.|+.||+.|+.|||   +.+|.||||||+|+|...   +-.+||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence            4578899999999999999987753 46999999999999999999999   889999999999999965   4568999


Q ss_pred             ecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      |||+|+.... .....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........   ...+...+...
T Consensus       207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~g  282 (400)
T KOG0604|consen  207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTG  282 (400)
T ss_pred             ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhcc
Confidence            9999987543 3344556789999999999999999999999999999999999999964332211   12222333332


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHA  424 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~  424 (436)
                      ....+. ..+........++++.+|..+|.+|.|+.+++.|+|.......+..+
T Consensus       283 qy~FP~-pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp  335 (400)
T KOG0604|consen  283 QYEFPE-PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP  335 (400)
T ss_pred             CccCCC-hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence            222222 23556666788999999999999999999999999998876655444

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-37  Score=292.52  Aligned_cols=249  Identities=22%  Similarity=0.254  Sum_probs=191.4

Q ss_pred             eeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHH---HHHhhccCCCceeeeeEEeeCCEEEEEEeecc
Q 013793          150 CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA---QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      .||+|+||.||++.. .+++.||+|.+.............+..|.   ..++...||+++++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999965 46889999998764332111112233343   34444579999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR  305 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  305 (436)
                      +|+|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......  .
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            999999886543   6999999999999999999999   7899999999999999999999999999987653322  2


Q ss_pred             cccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh--cCCCCCCCChhHHH
Q 013793          306 TLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDQKVIQ  382 (436)
Q Consensus       306 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~  382 (436)
                      ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......    ..........  ...++...      
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~------  222 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLTMAVELPDSF------  222 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc----chHHHHHHhhccCCCCCCcC------
Confidence            234689999999998754 6899999999999999999999998632110    0000000011  11111111      


Q ss_pred             HHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCC
Q 013793          383 DILLASTISFACLQSNPKSRP-----TMQYVSQGFLITRK  417 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~  417 (436)
                       ...+.+++.+|+..+|.+||     ++.++++++|+...
T Consensus       223 -s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         223 -SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             -CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence             23467889999999999999     99999999999665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-38  Score=304.78  Aligned_cols=268  Identities=22%  Similarity=0.262  Sum_probs=200.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      .++|.+.+.||+|+||+||++.. .+++.||||.+........ ....+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45788999999999999999965 4789999999875422211 135667899999999999999999988654     3


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++|+||+. ++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999996 68888886543   6899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccc----------cCCCCc----
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSDP----  360 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------~~~~~~----  360 (436)
                      +.............++..|+|||.+.. ..++.++||||||+++|+|++|+.||......          ......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            876443233334567889999998765 46889999999999999999999998532110          000000    


Q ss_pred             --ccchhhhhcC---CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          361 --KIMLIDVLDQ---RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       361 --~~~~~~~~~~---~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                        ..........   ................+.+++.+||+.+|++|||+.|+++|+|+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence              0000000000   00000000001123346789999999999999999999999998664

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-39  Score=302.84  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ...|++.+.||+||.+.||++...+.+.||+|++.....+. .....|.+|++.|.++ .|.+||++++|-..++..|+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~-qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN-QTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH-HHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            35688899999999999999999888999999886654433 3358899999999999 589999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||-+ .+|..+|...... ...| .++.+..||+.|+.+.|   ..||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus       439 mE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            99864 4999999876532 2334 78899999999999999   789999999999999876 5899999999998866


Q ss_pred             CCCC--ccccccccccccccccccC-----------ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          301 DSSN--RTLLAGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       301 ~~~~--~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      +...  ....+||+.||+||.+...           ++++++||||+|||||+|+.|+.||......      ...+..+
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aKl~aI  585 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAKLHAI  585 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHHHHhh
Confidence            5443  3557899999999987532           3678999999999999999999999743211      1112333


Q ss_pred             hcCCC--CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          368 LDQRL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       368 ~~~~l--~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .++.-  ..+.-...    ..+.+++..||+.||.+||+..++++|++..-
T Consensus       586 ~~P~~~Iefp~~~~~----~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPEN----DELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cCCCccccccCCCCc----hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            33321  11111111    11678999999999999999999999998854

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.4e-38  Score=297.65  Aligned_cols=267  Identities=24%  Similarity=0.329  Sum_probs=195.8

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----  215 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  215 (436)
                      ..++|++.+.||+|+||.||+|... +++.||||.+........ ....+.+|++++++++||||++++++|...+    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3457999999999999999999654 789999998865432211 1245568999999999999999999987654    


Q ss_pred             ----EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          216 ----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       216 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                          ..++||||+.+ +|.+.+....  ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence                45999999975 7887776532  35899999999999999999999   78999999999999999999999999


Q ss_pred             cccccccCCCCCC----ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CC
Q 013793          292 FGTARRLHADSSN----RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SS  357 (436)
Q Consensus       292 fg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~  357 (436)
                      ||++.........    .....++..|+|||.+.+. .++.++||||||+++|||+||+.||.......         ..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999866432221    1234577889999987664 47889999999999999999999985322100         00


Q ss_pred             CC----cccchhhhhc-CCCCCCCChhHH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          358 SD----PKIMLIDVLD-QRLPPPVDQKVI------QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       358 ~~----~~~~~~~~~~-~~l~~~~~~~~~------~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..    +.....+..+ ...+........      .....+.+++.+||+.||++|||+.|+++|+|+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            00    0000000000 000000000000      012235689999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-38  Score=303.30  Aligned_cols=268  Identities=24%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----EE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----CM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  217 (436)
                      +|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+++++.++|+||+++.+++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788899999999999999765 5899999998765421 122367889999999999999999999998775     78


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++ +|.+++....   .+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.++|+|||.+..
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            999999984 8888887544   7899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCC---CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc----
Q 013793          298 LHADS---SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP----  360 (436)
Q Consensus       298 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~----  360 (436)
                      .....   .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......         ....+    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65443   123334578899999999887 78999999999999999999999986322100         00000    


Q ss_pred             ---ccchhhhhc---CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          361 ---KIMLIDVLD---QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       361 ---~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                         .....+.+.   .................+.+++.+||+.+|++||++.++++++|+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence               000000000   00000000000011234678999999999999999999999999976544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.2e-38  Score=290.53  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=204.4

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|++.+.||+|++|.||++.. .+++.+|+|.+....... .....+.+|+++++.++|+||+++.+++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            477889999999999999954 478899999987654332 223677889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          223 YMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |+++++|.+++.... ....+++..++.++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999986532 1246899999999999999999999   889999999999999999999999999999876544


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                        ......++..|+|||...+..++.++|+||+|+++|||++|+.||.....       ............+ +...   
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~---  223 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYKVQRGKYP-PIPP---  223 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCC-CCch---
Confidence              22334578899999999988899999999999999999999999863211       1111111112221 1111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .....+.+++.+|++.+|++||++.++++++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~  255 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASPA  255 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence            22334778999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-38  Score=294.50  Aligned_cols=263  Identities=27%  Similarity=0.369  Sum_probs=198.7

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFLIY  221 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  221 (436)
                      |++.+.||+|++|.||+|... +++.+|+|.+..... .......+.+|+++++.++|+|++++++++...  +..++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567889999999999999765 588999999987641 122236688899999999999999999999988  8899999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ +|.+++....  ..+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99985 8888886542  36899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CC-Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc--chhhh-
Q 013793          302 SS-NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI--MLIDV-  367 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~--~~~~~-  367 (436)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+......         .......  ..... 
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            21 1233456788999997765 457899999999999999999999986322100         0000000  00000 


Q ss_pred             -h-cCCCCCCCCh---hHH-H-HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          368 -L-DQRLPPPVDQ---KVI-Q-DILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       368 -~-~~~l~~~~~~---~~~-~-~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       . ..........   ... . ....+.+++.+||+.+|++||++.++++++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence             0 0000000000   000 0 13457789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=310.14  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=205.9

Q ss_pred             cccccceeeecCceEEEEEEcCCC-CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      -|+++..||.|+||.||+|..++. -..|.|++.....   +.+..+.-|+++|..++||+||++++.|...+..++..|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            456677799999999999977654 4456677665543   335889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      ||.||-....+-.-+  ..|.+.++.-++.+++.||.|||   +..|||||||+.|||++-+|.++|+|||.+-......
T Consensus       110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            999999988776543  37999999999999999999999   8999999999999999999999999999886554443


Q ss_pred             CCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          303 SNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .....+.|||+|||||+..     ..+|+.++||||||+.|.||..+.+|-..++.+       ..+..+.... ++...
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------RVllKiaKSe-PPTLl  256 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSE-PPTLL  256 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------HHHHHHhhcC-CCccc
Confidence            4456688999999999753     567999999999999999999999995432211       1122222211 12111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       .+......+.+++.+||..||..||++.++++|+|+...+
T Consensus       257 -qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  257 -QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             -CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence             1233344577899999999999999999999999997543

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-37  Score=295.61  Aligned_cols=257  Identities=26%  Similarity=0.372  Sum_probs=200.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|+..+.||+|+||.||+|... ++..+|+|.+.............+.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999754 68899999986533222233467888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+. |++.+.+....  ..+++.++..++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 57877765432  25889999999999999999999   789999999999999999999999999998765432


Q ss_pred             CCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          302 SSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                          ....++..|+|||.+.   ...++.++|||||||++|||++|+.|+....       .............+.....
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPALQSG  237 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-------HHHHHHHHhhcCCCCcCcc
Confidence                2345788999999874   3567889999999999999999999975321       1111111111111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                         .....+.+++.+||+.+|++||++.++++++|+....+
T Consensus       238 ---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         238 ---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ---cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence               12233678999999999999999999999999877644

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.5e-38  Score=293.90  Aligned_cols=258  Identities=22%  Similarity=0.273  Sum_probs=193.6

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeC--CEEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHK--KCMFLI  220 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  220 (436)
                      |++.+.||+|+||.||+|.. .+++.||+|.++........  ....+|+..+.++. |+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            56788899999999999965 47899999998764322211  33457888888885 99999999999987  889999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      +||++ |++.+.+....  ..+++.+++.++.|++.||+|||   +.+++||||+|+||+++. +.++|+|||+++....
T Consensus        79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99997 47877776532  36899999999999999999999   789999999999999999 9999999999987643


Q ss_pred             CCCCccccccccccccccccc-cCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccchhhhh--
Q 013793          301 DSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLIDVL--  368 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~--  368 (436)
                      ... .....++..|+|||... +..++.++|||||||++|||++|+.||...+...         ..... .. ....  
T Consensus       152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~  228 (282)
T cd07831         152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA-EV-LKKFRK  228 (282)
T ss_pred             CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH-HH-HHhhcc
Confidence            322 23345788999999764 4567889999999999999999999986322110         00000 00 0000  


Q ss_pred             ----cCCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 ----DQRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ----~~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                          ....+......    .......+.+++.+||+.+|++||++.++++++|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                00000000000    01123457889999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.4e-37  Score=296.89  Aligned_cols=265  Identities=18%  Similarity=0.200  Sum_probs=194.7

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      .+.+|.|+++.||++.. +++.||+|++....... ...+.+.+|+++++.++|+||+++++++...+..+++|||+++|
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34455556666666554 78999999997653222 23478999999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC----
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS----  303 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  303 (436)
                      +|.+++..... ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||.+..+.....    
T Consensus        85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999976432 35888999999999999999999   78999999999999999999999999998875532211    


Q ss_pred             ---CccccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCcccccccc-------CCC----Cccc-----
Q 013793          304 ---NRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------SSS----DPKI-----  362 (436)
Q Consensus       304 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------~~~----~~~~-----  362 (436)
                         ......++..|+|||.+.+.  .++.++||||||+++|||++|+.||.......       ...    ....     
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence               11223467789999998763  57899999999999999999999986321100       000    0000     


Q ss_pred             -chhh----hhcCCCCC-CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          363 -MLID----VLDQRLPP-PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       363 -~~~~----~~~~~l~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       ....    ..+..... ............+.+++.+||+.||++|||+.++++++|+..-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence             0000    00000000 00000111223467899999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=292.28  Aligned_cols=263  Identities=25%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |++.+.||+|++|.||++... +++.+++|.+....... .....+.+|++++++++|+|++++++++..+...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            566788999999999999764 78999999987654332 2236788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +++ ++.+++....  ..+++..+..++.+++.||.|||   +.+|+|+||+|+||++++++.++|+|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            975 8888776543  36899999999999999999999   78999999999999999999999999999987755432


Q ss_pred             CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcc--cchhh---hh
Q 013793          304 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPK--IMLID---VL  368 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~--~~~~~---~~  368 (436)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...+....         .....  ....+   ..
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            23334578899999998776 789999999999999999999999853221100         00000  00000   00


Q ss_pred             cCCCC----CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 DQRLP----PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ~~~l~----~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....+    .............+.+++.+||+.||.+||++.+++.++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            00000    00001111234457899999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-38  Score=302.11  Aligned_cols=270  Identities=25%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  214 (436)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+++++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            47899999999999999999975 478999999987543221 1235678899999999999999999998754      


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++|+||+.. +|..+..     ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            346899999974 6766552     25889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc----
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP----  360 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~----  360 (436)
                      ++.....   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......         ....+    
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8764322   233457889999998876 468899999999999999999999986321100         00000    


Q ss_pred             ---ccchhhhhc--CCCC-CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 013793          361 ---KIMLIDVLD--QRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHA  424 (436)
Q Consensus       361 ---~~~~~~~~~--~~l~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~  424 (436)
                         .........  +..+ .............+.+++.+||+.||++||++.++++|.|+..-.+....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~  310 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET  310 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence               000000000  0000 000000001123467899999999999999999999999998776544333

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=328.48  Aligned_cols=262  Identities=27%  Similarity=0.355  Sum_probs=211.3

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      .++.-..++|.+.++||+|+||.|..++++ ++++||+|++.....-.......|..|-.+|..-+.+-|+++.-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            345556789999999999999999999775 6899999999885554444457899999999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      .+.|+|||||+||+|..++.+.+   ++++..++.++..|+-||.-+|   +.|+|||||||.|||+|..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999998776   6899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccccccccccc----c-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh
Q 013793          295 ARRLHADSSN-RTLLAGTYGYIAPELAY----T-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       295 a~~~~~~~~~-~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      +-.+..++.. ....+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||...+-.       .....++
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KIm  294 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKIM  294 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHHh
Confidence            9888766553 45567999999999875    2 57899999999999999999999999632211       1122222


Q ss_pred             cC--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHHhh
Q 013793          369 DQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPT---MQYVSQGFLI  414 (436)
Q Consensus       369 ~~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~ev~~~l~~  414 (436)
                      +.  .+.-|...   .......+|+.+.+. +|+.|..   ++++..|+||
T Consensus       295 ~hk~~l~FP~~~---~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  295 NHKESLSFPDET---DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             chhhhcCCCccc---ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence            22  22222111   123335566665554 7888887   8888777654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=305.48  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=208.9

Q ss_pred             HHHHhhcccccceeeecCceEEEEEEcCC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          138 LIEATEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       138 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++--..+....++||-|-||.||.|.++. ...||||.++.....    ..+|..|..+|+.++|||+|+++|+|.....
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            33334456677899999999999998874 567999999887654    4889999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      +|||+|||.+|+|.+||+..... .++....+.++.||+.|++||.   ...+|||||.++|+|+.++..+|++|||+++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999999987543 5677778899999999999999   7899999999999999999999999999999


Q ss_pred             ccCCCCCCcccccc---ccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCC-
Q 013793          297 RLHADSSNRTLLAG---TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR-  371 (436)
Q Consensus       297 ~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  371 (436)
                      ++..+...  ..+|   ...|.|||-+.-..++.|+|||+|||+||||.| |-.||....        .....+++... 
T Consensus       414 lMtgDTYT--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY~LLEkgy  483 (1157)
T KOG4278|consen  414 LMTGDTYT--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYGLLEKGY  483 (1157)
T ss_pred             hhcCCcee--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHHHHHhccc
Confidence            98655432  2223   457999999999999999999999999999997 888875321        11233444333 


Q ss_pred             -CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          372 -LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       372 -l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       +..+.     .+...+.+|++.||+.+|.+||++.|+-+.+.-
T Consensus       484 RM~~Pe-----GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  484 RMDGPE-----GCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             cccCCC-----CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence             33322     233457789999999999999999999887753

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-37  Score=297.50  Aligned_cols=264  Identities=21%  Similarity=0.291  Sum_probs=197.2

Q ss_pred             ceeeec--CceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeecc
Q 013793          149 YCIGTG--GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       149 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      ..||+|  +||+||++.. .+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  9999999976 479999999987654332 234788899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR  305 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  305 (436)
                      +++|.+++..... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999999876432 35889999999999999999999   7899999999999999999999999998654332211110


Q ss_pred             -------cccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccc-------cCCCC-cc--c----
Q 013793          306 -------TLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------SSSSD-PK--I----  362 (436)
Q Consensus       306 -------~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------~~~~~-~~--~----  362 (436)
                             ....++..|+|||++.+.  .++.++|||||||++|||++|+.||......       ..... +.  .    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   112345679999998764  4789999999999999999999998632110       00000 00  0    


Q ss_pred             ---------------chh---------hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          363 ---------------MLI---------DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       363 ---------------~~~---------~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                                     ...         ......+..+   ........+.+|+.+||+.||++|||+.|+++++|+...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP---SSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccch---hhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                           000         0000000000   0112334578899999999999999999999999997665


Q ss_pred             CC
Q 013793          419 PL  420 (436)
Q Consensus       419 ~~  420 (436)
                      ..
T Consensus       316 ~~  317 (328)
T cd08226         316 EQ  317 (328)
T ss_pred             Hh
Confidence            43

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-37  Score=290.39  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=194.3

Q ss_pred             ccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      |.+.+.||+|+||.||+|...    +++.||||.+........ ..+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            566788999999999999643    468899999976543322 2467889999999999999999999886542     


Q ss_pred             -EEEEEEeeccCCChhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          216 -CMFLIYEYMERGSLFCILHNDD---EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       216 -~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                       ..++++||+++|+|.+++....   ....+++...+.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence             2478999999999988875321   2235788999999999999999999   78999999999999999999999999


Q ss_pred             cccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh
Q 013793          292 FGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       292 fg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      ||+++........  .....+++.|++||......++.++||||||+++|||++ |+.||.....       ........
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~  229 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLI  229 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHH
Confidence            9999866432211  122345678999999988889999999999999999999 8888752211       00011111


Q ss_pred             cC-CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 DQ-RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ~~-~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .. .+..+.     .....+.+++.+||+.+|++||++.++++.+..
T Consensus       230 ~~~~~~~~~-----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         230 KGNRLKQPP-----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             cCCcCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            11 111111     112347789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=307.00  Aligned_cols=254  Identities=25%  Similarity=0.437  Sum_probs=206.6

Q ss_pred             cccceeeecCceEEEEEEcC--CCC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          146 HIKYCIGTGGYGSVYKAQLP--NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ...++||+|.||.|++|.+.  +|+  .||||.+.......  ...+|.+|+.+|.+++|+|+++|+|...+ ....+|+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34677999999999999664  555  48999998876553  45899999999999999999999999988 6788999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |.++.|+|.+.|++ .....|-......++.|||.||+||.   .+++|||||..+|+|+-....+||+|||+.+.+..+
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999998 44457888888999999999999999   889999999999999999999999999999988765


Q ss_pred             CCCccc---cccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhc--CCCCCC
Q 013793          302 SSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPP  375 (436)
Q Consensus       302 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~  375 (436)
                      ......   ..-...|.|||.+...+++.++|||+|||.||||+| |..||-....        ..+.+.+|  .+++.+
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERLPRP  337 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccCCCC
Confidence            543321   123567999999999999999999999999999997 7788753221        12223333  334433


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ..     +...+.+++..||..+|.+|||+..+.+.+...+..+
T Consensus       338 k~-----csedIY~imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  338 KY-----CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             CC-----ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence            32     2344778999999999999999999987766555443

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=284.28  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=212.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      -++|+..++||+|+||.|.+++- .+|+.||+|+++....-......--..|-++|+..+||.+..+-..|...+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999964 47999999999887655544456667899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||..||.|.-+|...+   .+++...+.+-..|+.||.|||   +.+||.||||.+|.|+|.+|++||+|||+++.-..
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999999997654   7888999999999999999999   88999999999999999999999999999987666


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh--cCCCCCCCCh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQRLPPPVDQ  378 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~  378 (436)
                      .......++|||.|+|||++....|+.++|.|.+|||+|||++|+.||..       .+.+....-++  +-+++.....
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-------~dh~kLFeLIl~ed~kFPr~ls~  393 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-------KDHEKLFELILMEDLKFPRTLSP  393 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-------cchhHHHHHHHhhhccCCccCCH
Confidence            66667789999999999999999999999999999999999999999852       11111111122  2233333322


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhc
Q 013793          379 KVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLIT  415 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~  415 (436)
                             ....|+...|..||.+|.     .+.||.+|.+|.
T Consensus       394 -------eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~  428 (516)
T KOG0690|consen  394 -------EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA  428 (516)
T ss_pred             -------HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence                   245677789999999997     688888887664

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=286.49  Aligned_cols=246  Identities=28%  Similarity=0.381  Sum_probs=201.7

Q ss_pred             eeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||+|+||.||++... +++.+|+|.+.............+..|+++++.++|+|++++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 5899999998776544333457888999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA  309 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  309 (436)
                      .+++....   .+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99997654   6899999999999999999999   78999999999999999999999999999987654333334456


Q ss_pred             cccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHH
Q 013793          310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLAST  389 (436)
Q Consensus       310 gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  389 (436)
                      ++..|+|||...+...+.++|+||||+++||+++|+.||....       ............+..+...     ...+.+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-----~~~l~~  222 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-------RKEIYEKILKDPLRFPEFL-----SPEARD  222 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHhcCCCCCCCCC-----CHHHHH
Confidence            8889999999988888999999999999999999999986321       1111222222222211111     223668


Q ss_pred             HHhhccCCCCCCCCCH---HHHHHHHhh
Q 013793          390 ISFACLQSNPKSRPTM---QYVSQGFLI  414 (436)
Q Consensus       390 l~~~cl~~dP~~RPt~---~ev~~~l~~  414 (436)
                      ++.+||..||++||++   .++.+++||
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999999999   899999886

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-39  Score=308.11  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=202.6

Q ss_pred             ccceeeecCceEEEEEEcC-CCCEEEEEEecCcc-hhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC--EEEEEEe
Q 013793          147 IKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-TEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK--CMFLIYE  222 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  222 (436)
                      ...+||+|+|-+||+|... +|-.||=-.++..+ .........|..|+++|+.|+||||++++.++.+..  ...+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4567999999999999654 56666532222111 112233578999999999999999999999998754  4889999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecccccccCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHAD  301 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~  301 (436)
                      .|..|+|..|+.+.+   .++.....+|++||++||.|||.+ .++|+|||||-.||+|+.+ |.+||+|+|+|+.....
T Consensus       124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999998776   678889999999999999999987 8999999999999999864 89999999999987543


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .  .....|||.|||||+.. ..|++.+||||||+.++||+|+..||..      ...+......+.....|.....   
T Consensus       200 ~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE------C~n~AQIYKKV~SGiKP~sl~k---  267 (632)
T KOG0584|consen  200 H--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE------CTNPAQIYKKVTSGIKPAALSK---  267 (632)
T ss_pred             c--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh------hCCHHHHHHHHHcCCCHHHhhc---
Confidence            3  33478999999999887 7899999999999999999999999862      2223333334433333322211   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      -....+.+++.+|+.. .++|||+.|++.+.+|.....
T Consensus       268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            1133477899999999 999999999999999987644

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=299.83  Aligned_cols=273  Identities=23%  Similarity=0.273  Sum_probs=203.9

Q ss_pred             HHHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       135 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      .+++...+++|.+.+.||+|+||.||++.. .+++.||+|++....... ...+.+.+|++++.+++||||+++.+++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            456777889999999999999999999964 578999999997643222 123567789999999999999999998864


Q ss_pred             C------CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCe
Q 013793          214 K------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       214 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  287 (436)
                      .      ...+++++++ +++|.+++...    .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence            3      3467888876 78998887643    5899999999999999999999   7899999999999999999999


Q ss_pred             EEeecccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC--------CC
Q 013793          288 FVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SS  358 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~  358 (436)
                      +|+|||++.....   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........        ..
T Consensus       160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999876432   2233467889999998766 4688899999999999999999999853211000        00


Q ss_pred             Ccccch--------h---hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          359 DPKIML--------I---DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       359 ~~~~~~--------~---~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ......        .   ..+..................+.+++.+|++.||.+||++.++++++|+..-..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence            000000        0   000000000000000011234678999999999999999999999999975443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=314.75  Aligned_cols=273  Identities=19%  Similarity=0.213  Sum_probs=190.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcC--CCCEEEEEE--------------ecCcchhhHHHHHHHHHHHHHHhhccCCCc
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP--NGKVFALKK--------------LHTSETEELAFIKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  204 (436)
                      ..++|++.+.||+|+||+||++...  ++...+.|.              +.............+.+|++++.+++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998543  222222221              111111111223568899999999999999


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDE--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  282 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~  282 (436)
                      +++++++...+..++|+|++. ++|.+++.....  .......++..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999985 467666643221  122345677889999999999999   88999999999999999


Q ss_pred             CCCCeEEeecccccccCCCCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCC-ccccccc------
Q 013793          283 SKLEAFVADFGTARRLHADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSL------  354 (436)
Q Consensus       283 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p-~~~~~~~------  354 (436)
                      .++.+||+|||+++.+..... ......||..|+|||++.+..++.++|||||||++|||++|..+ +......      
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987654322 22345699999999999999999999999999999999998754 3211000      


Q ss_pred             ------cCC----CCcccchhhhhcCC-CCCC--CChhHH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          355 ------SSS----SDPKIMLIDVLDQR-LPPP--VDQKVI---QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       355 ------~~~----~~~~~~~~~~~~~~-l~~~--~~~~~~---~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                            ...    .+......+.+... +...  ......   .....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence                  000    00000000000000 0000  000000   001224567889999999999999999999998664

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-38  Score=301.51  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=213.4

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ....|.+...||+|.|+.|..|.+ .++..||||.+......... ...+.+|+++|..++|||||+++.+.......++
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            356788899999999999999965 47999999999887665443 3558899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+.+|.+.+++...+   .+....+..++.|+.+|++|||   +..|+|||||++|+||+.++++||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999998876   5666889999999999999999   8899999999999999999999999999999886


Q ss_pred             CCCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--CCCCCC
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPV  376 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~  376 (436)
                      . .......+|++.|.|||++.+.++ ++++|+||+|+++|-|+.|..||+...-..       ....++..  +++...
T Consensus       207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------Lr~rvl~gk~rIp~~m  278 (596)
T KOG0586|consen  207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------LRPRVLRGKYRIPFYM  278 (596)
T ss_pred             c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------ccchheeeeeccccee
Confidence            3 334566789999999999998875 689999999999999999999998322111       11122222  223222


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..       .+.+++++++..+|.+|++++++..+.|.....
T Consensus       279 s~-------dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  279 SC-------DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             ec-------hhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            22       256788999999999999999999999865443

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7e-38  Score=290.67  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=197.2

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchh--hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      +|.+.+.||+|+||.||++... .+..+++|.++.....  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999654 3445566665432211  111124566789999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          221 YEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      +||+++++|.+++... .....+++..++.++.|++.||.|||   +.+++|+||+|+||++++ +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 22347899999999999999999999   789999999999999986 569999999998765


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..........|++.|+|||...+..++.++|+||||+++|+|++|+.||....       .............+ .... 
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~-  227 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPTP-SLPE-  227 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCCCC-CCcc-
Confidence            44333344568889999999988888999999999999999999999986211       11111111111111 1111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        .....+.+++.+||+.+|++||++.|+++++|+
T Consensus       228 --~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         228 --TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             --hhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence              122346789999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.8e-37  Score=297.84  Aligned_cols=278  Identities=22%  Similarity=0.293  Sum_probs=206.7

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-C
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-K  214 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  214 (436)
                      ++...+++|++.+.||+|+||.||++.. .+++.||+|++....... ...+.+..|++++..++|||++++.+++.. .
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            3455788999999999999999999964 489999999886432211 123667789999999999999999998876 5


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++|+||+ +++|.+++...    .+++.....++.|+++||+|||   +.+|+||||+|+||++++++.++|+|||.
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccc
Confidence            5789999998 56888888643    5788888999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC--------CCCcccch-
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIML-  364 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~~~~~-  364 (436)
                      +......   .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||........        ...+.... 
T Consensus       155 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         155 ARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8754322   223457889999998766 5689999999999999999999999853211000        00000000 


Q ss_pred             -------hhhh---cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcccccc
Q 013793          365 -------IDVL---DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAI  426 (436)
Q Consensus       365 -------~~~~---~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~  426 (436)
                             .+..   ....+.+...........+.+++.+|++.+|++||++.+++.+.|+.+.......+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~  303 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA  303 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc
Confidence                   0000   0000000000000112347789999999999999999999999999777665555443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-37  Score=300.46  Aligned_cols=268  Identities=29%  Similarity=0.361  Sum_probs=199.2

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC--CE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK--KC  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~  216 (436)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++........ ....+.+|+.++.++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4567888999999999999999765 688999999865322211 125677899999999 999999999998653  46


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||++ ++|..++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            899999997 5898888653    5789999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC-----Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcc
Q 013793          297 RLHADSS-----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK  361 (436)
Q Consensus       297 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~  361 (436)
                      .......     ......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||.......         ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6643321     1223458889999998765 467889999999999999999999985322110         000000


Q ss_pred             -------cchhhhhcC---CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          362 -------IMLIDVLDQ---RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       362 -------~~~~~~~~~---~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                             ......++.   .-..............+.+++.+||+.||++|||+.+++++.|+..-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                   000000000   00000000000112346789999999999999999999999987554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-37  Score=294.23  Aligned_cols=267  Identities=29%  Similarity=0.379  Sum_probs=198.1

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC---
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK---  215 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  215 (436)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.++...... .....+.+|+++++.++|||++++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            35678999999999999999999765 68899999987543221 11256778999999999999999999987655   


Q ss_pred             -------EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeE
Q 013793          216 -------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  288 (436)
Q Consensus       216 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  288 (436)
                             ..++|+||+++ ++...+...  ...+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEE
Confidence                   78999999986 676666543  236899999999999999999999   78999999999999999999999


Q ss_pred             EeecccccccCCCCC-CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CC
Q 013793          289 VADFGTARRLHADSS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SS  357 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~  357 (436)
                      |+|||++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.......         ..
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999987644332 12223467789999987653 57889999999999999999999986322110         00


Q ss_pred             CCcccchhhh--------hcCC--CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          358 SDPKIMLIDV--------LDQR--LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       358 ~~~~~~~~~~--------~~~~--l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..+. .....        .+..  ...............+.+++.+||+.||++||++.++++++|+
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPA-VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChh-hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0000 00000        0000  0000000000112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.6e-37  Score=299.22  Aligned_cols=270  Identities=23%  Similarity=0.248  Sum_probs=199.0

Q ss_pred             hccc-ccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHH-----------HHHHHHHHHHHHhhccCCCceeeee
Q 013793          143 EDFH-IKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELA-----------FIKSFRNEAQVLSQVLHRSIVKLYG  209 (436)
Q Consensus       143 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  209 (436)
                      ++|. +.+.||+|+||+||+|... +++.||||.+.........           ....+.+|++++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3567999999999999754 7899999998654322100           0124678999999999999999999


Q ss_pred             EEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       210 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                      ++...+..++||||++ |+|.+++....   .+++.....++.|++.||+|||   +.+++||||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58988886543   6889999999999999999999   789999999999999999999999


Q ss_pred             eecccccccCC--------------CCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          290 ADFGTARRLHA--------------DSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       290 ~Dfg~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                      +|||++.....              .........++..|+|||.+.+. .++.++||||||+++|||+||+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999976541              11112223467889999998764 4689999999999999999999998632211


Q ss_pred             c---------CCCCcccchhhh-------hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          355 S---------SSSDPKIMLIDV-------LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       355 ~---------~~~~~~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .         .......+....       .....+.............+.+++.+||+.+|++||++.|++.++|+....
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            0         000000000000       000000000000001123467899999999999999999999999998664


Q ss_pred             C
Q 013793          419 P  419 (436)
Q Consensus       419 ~  419 (436)
                      .
T Consensus       321 ~  321 (335)
T PTZ00024        321 L  321 (335)
T ss_pred             C
Confidence            4

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-37  Score=292.33  Aligned_cols=261  Identities=26%  Similarity=0.375  Sum_probs=201.7

Q ss_pred             cccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchhh-HHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      +|++.+.||+|+||.||++..    .+|+.||+|.+....... ....+.+.+|+.++..+ +|+||+++.+.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999965    478999999987543211 12235678899999999 589999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|+||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999997643   6888999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSS-NRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ...... ......|+..|+|||...+.  .++.++||||||+++|+|++|+.||......   ...............+ 
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-  230 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPP-  230 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccCCC-
Confidence            543221 12234588899999998753  4678999999999999999999998632110   0000111111111111 


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITRKT  418 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~~  418 (436)
                       ...   .....+.+++.+||+.||++||     ++.+++.++|+.+-.
T Consensus       231 -~~~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         231 -YPQ---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             -CCc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence             111   1122366899999999999997     899999999886654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=292.07  Aligned_cols=262  Identities=23%  Similarity=0.325  Sum_probs=197.7

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEEe
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      |++.+.||+|++|+||+|... +++.|++|++........  .....+|+..+.+++ |+|++++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567889999999999999775 578999999876533211  134456899999998 9999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+ +|+|.+++.... ...+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||.++......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 889998887653 236899999999999999999999   7899999999999999999999999999998664322


Q ss_pred             CCccccccccccccccccc-cCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc-----chhhh
Q 013793          303 SNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI-----MLIDV  367 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~-----~~~~~  367 (436)
                      . .....++..|+|||.+. ...++.++|+||||++++||++|+.||.......         .......     .....
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 P-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             C-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            2 23345788999999875 4467899999999999999999999985322100         0000000     00000


Q ss_pred             hcCCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          368 LDQRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       368 ~~~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+...+......    .......+.+++.+||+.+|++|||+.|++.++|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111111000000    00112447789999999999999999999999885

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=297.98  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=200.5

Q ss_pred             ccccceeeecCceEEEEEEcCC---CC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPN---GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ....++||.|-||.||+|.+.+   |+  .||||.-+.....+.  .+.|..|..+|++++|||||+++|+|.+. ..||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            3456789999999999996533   33  488888877554433  48899999999999999999999999875 4799


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |||.++-|.|..+|..+..  .++......++.||..||+|||   +..+|||||..+|||+.....+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999987653  6888899999999999999999   8899999999999999999999999999999886


Q ss_pred             CCCCCccc-cccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          300 ADSSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       300 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .+...... ..-...|||||.+.-.+++.+||||.|||.+||+++ |..||.....      .+....-.-..+++.+..
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------sDVI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------SDVIGHIENGERLPCPPN  616 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------cceEEEecCCCCCCCCCC
Confidence            65543322 223568999999999999999999999999999995 9999974321      111111112234443332


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                           +...+..|+.+||..+|.+||++.++...+.
T Consensus       617 -----CPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  617 -----CPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             -----CChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence                 2334667889999999999999999877654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=292.24  Aligned_cols=263  Identities=25%  Similarity=0.313  Sum_probs=201.0

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |+..+.||+|++|.||+|... +++.+|+|.+...... ....+.+..|+++++.++|+|++++.+++.+.+..++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            456778999999999999765 5899999999875421 12236677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      ++ ++|.+++....  ..+++..+..++.+++.||+|||   +.+|+||||+|+||++++++.++|+|||.++.......
T Consensus        80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            98 58999997653  36899999999999999999999   78999999999999999999999999999987654433


Q ss_pred             CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcccc--hhhh--hc
Q 013793          304 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKIM--LIDV--LD  369 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~--~~~~--~~  369 (436)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........         ...+..+  ....  .+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            33334567789999998776 789999999999999999999999853221100         0000000  0000  00


Q ss_pred             CCCCC----CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          370 QRLPP----PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       370 ~~l~~----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ...+.    ............+.+++.+||..||++||++.+++.++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            00100    0000000113347889999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-37  Score=296.30  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=194.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      .++|++.+.||+|++|.||+|... +++.+|+|++........ ....+.+|+++++.++||||+++++++....     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            578999999999999999999754 689999999865432211 1145678999999999999999998875433     


Q ss_pred             ---EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          216 ---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       216 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                         ..++|+||+.+ ++...+....  ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.++|+||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcC
Confidence               46999999975 6766665432  36899999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCCC-----------ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc-----
Q 013793          293 GTARRLHADSSN-----------RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-----  355 (436)
Q Consensus       293 g~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-----  355 (436)
                      |++.........           .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......     
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211           1223467889999987654 57899999999999999999999986322110     


Q ss_pred             ----CCCCcccc-----hhh----hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          356 ----SSSDPKIM-----LID----VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       356 ----~~~~~~~~-----~~~----~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                          ....+..+     ...    ......+.............+.+++.+|++.||++|||+.|++.++|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                00000000     000    000001110000001112346789999999999999999999999986

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=273.60  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=198.4

Q ss_pred             cccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEee
Q 013793          146 HIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      +....||.|+.|+|++++.. +|...|||.+......++  .+.+...+.++..- ++|+||+.+|||..+...++-||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee--~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH--HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            33556999999999999665 689999999987755432  36777777776665 489999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      |.. -++.++....  .++++.-.-++...+..||.||.+  ..+|+|||+||+|||+|+.|++|+||||++..+... .
T Consensus       173 Ms~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-k  246 (391)
T KOG0983|consen  173 MST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-K  246 (391)
T ss_pred             HHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc-c
Confidence            854 4455554332  257777778999999999999997  669999999999999999999999999999877543 3


Q ss_pred             CccccccccccccccccccC---ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          304 NRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      ..+..+|-+.|||||.+.-.   +|+.++||||||+.++||.||+.||..-.      .+-..+..+++.. ++.... .
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdFe~ltkvln~e-PP~L~~-~  318 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDFEVLTKVLNEE-PPLLPG-H  318 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccHHHHHHHHhcC-CCCCCc-c
Confidence            44556788999999998744   68999999999999999999999987311      1112233333322 222211 1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ..-...+.+++..||..|+.+||...++++|++..+..+
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            112233678889999999999999999999998766543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.3e-38  Score=320.05  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=197.9

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC----
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK----  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  214 (436)
                      +-..+|+..+.||+||||.||+++.+ ||+.||||++..... . .....+.+|+..+++++|||||+++..+.+.    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s-~-~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS-D-KLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchH-H-HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            34567888899999999999999876 999999999988762 2 2246788999999999999999986432110    


Q ss_pred             --------------------------------------------------------------------------------
Q 013793          215 --------------------------------------------------------------------------------  214 (436)
Q Consensus       215 --------------------------------------------------------------------------------  214 (436)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 013793          215 -----------------------------------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA  259 (436)
Q Consensus       215 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~  259 (436)
                                                         -..||-||||+...+.++++.+....  .-...++++++|++||+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence                                               01456688888877777776553211  35678899999999999


Q ss_pred             HHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC------------------CCCCCccccccccccccccccc
Q 013793          260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH------------------ADSSNRTLLAGTYGYIAPELAY  321 (436)
Q Consensus       260 ~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~  321 (436)
                      |+|   +.|||||||||.||++|++..+||+|||+|+...                  .+....+..+||.-|+|||++.
T Consensus       712 YIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999   8899999999999999999999999999998721                  1112345678999999999987


Q ss_pred             cC---ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCC
Q 013793          322 TM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSN  398 (436)
Q Consensus       322 ~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~d  398 (436)
                      +.   .|+.|+|+||+|||++||+.   ||..      ..+....+..+.+..++.+.+ -.......-.+++.++++.|
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T------sMERa~iL~~LR~g~iP~~~~-f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGT------SMERASILTNLRKGSIPEPAD-FFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCc------hHHHHHHHHhcccCCCCCCcc-cccccchHHHHHHHHHhcCC
Confidence            65   49999999999999999994   4542      233333445555555555411 12233333467899999999


Q ss_pred             CCCCCCHHHHHHHHhhc
Q 013793          399 PKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       399 P~~RPt~~ev~~~l~~~  415 (436)
                      |.+|||+.|+++.-++-
T Consensus       859 P~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  859 PSKRPTATELLNSELLP  875 (1351)
T ss_pred             CccCCCHHHHhhccCCC
Confidence            99999999999987774

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.6e-37  Score=317.16  Aligned_cols=148  Identities=28%  Similarity=0.460  Sum_probs=133.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||+||+|... +++.||||++.............+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999765 78999999997654433344577889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      ||+++++|.+++....   .+++..++.|+.||+.||+|||   ..+|+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997543   5888999999999999999999   7799999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.4e-37  Score=289.77  Aligned_cols=259  Identities=26%  Similarity=0.365  Sum_probs=198.2

Q ss_pred             cccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchh-hHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      +|++.+.||+|++|.||++..    .+++.||||.+...... .....+.+.+|+.++.++ +||||+++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999864    36788999998754322 122346688999999999 599999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....   .+++..+..++.|+++||.|||   +.+++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999987543   6889999999999999999999   78999999999999999999999999999876


Q ss_pred             cCCCCCC-ccccccccccccccccccCc--cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSSN-RTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ....... .....|+..|+|||...+..  .+.++||||||+++|||++|+.||......   ...............+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILKSKPPF  231 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHccCCCC
Confidence            5433221 22345888999999987665  788999999999999999999998532110   00011111111211111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHH---HHHHHhhcC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQY---VSQGFLITR  416 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~e---v~~~l~~~~  416 (436)
                      +..     ....+.+++.+||+.||++|||+.+   +++++|+..
T Consensus       232 ~~~-----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         232 PKT-----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             Ccc-----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence            111     1123668899999999999999654   467776644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=297.73  Aligned_cols=269  Identities=23%  Similarity=0.285  Sum_probs=202.2

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE--
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC--  216 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--  216 (436)
                      ...++|++.+.||+|++|.||+|... +++.||+|++....... .....+.+|+.+++.++|||++++.+++...+.  
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            34678999999999999999999765 68899999987543222 223567789999999999999999988776554  


Q ss_pred             ----EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          217 ----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       217 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                          .++|+||+ +++|.+++..    ..+++..+..++.|++.||+|||   +.+|+||||+|+||++++++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccc
Confidence                89999998 5699988864    26899999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC--------CCCcccc
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKIM  363 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~~~~  363 (436)
                      |++......   .....++..|+|||...+ ..++.++||||||+++|||+||+.||........        ....+..
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            999865432   233457889999998765 3678999999999999999999999853211000        0000000


Q ss_pred             --------hhhhhc---CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          364 --------LIDVLD---QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       364 --------~~~~~~---~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                              ....+.   .................+.+++.+||+.||++|||+.++++|+|+..-...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                    000000   000000000000113457789999999999999999999999999765443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-37  Score=294.58  Aligned_cols=266  Identities=25%  Similarity=0.331  Sum_probs=200.0

Q ss_pred             HHhhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC---
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK---  215 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  215 (436)
                      ...++|++.+.||+|+||.||++. ..++..||||++...... ......+.+|++++++++||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            356789999999999999999996 457899999998654322 222356789999999999999999999887643   


Q ss_pred             ---EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          216 ---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       216 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                         ..++||||+ +++|.+++...    .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence               468999999 77898887642    5899999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC-------CCCcccch
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------SSDPKIML  364 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~  364 (436)
                      |++......   .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||........       ........
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999765332   223457889999998876 4588999999999999999999999863211000       00000000


Q ss_pred             hhhhc--------CCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          365 IDVLD--------QRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       365 ~~~~~--------~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ...+.        ..++......    .......+.+++.+|++.||++|||+.++++++|+..-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            00000        0000000000    00112236789999999999999999999999999764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=328.60  Aligned_cols=263  Identities=28%  Similarity=0.408  Sum_probs=209.2

Q ss_pred             HhhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      .+-++.....||.|.||.||.|. ..+|...|+|.+...... ....+.+.+|+.++..++|||+|+++|+-...+..+|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            45566777899999999999995 567999999998765544 3345788999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      .||||++|+|.+.+...+   ..++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999997654   4667777788999999999999   8899999999999999999999999999998876


Q ss_pred             CCCCC----ccccccccccccccccccCc---cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          300 ADSSN----RTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       300 ~~~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      .....    .....||+.|||||.+.+..   ...+.||||+|||++||+||+.||.....      +......+-....
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVAAGHK 1459 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHhccCC
Confidence            54322    23467999999999987653   45789999999999999999999973321      1111112211111


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                       +..+..   ....-.+++..|+..||++|-++.|++++-+-......
T Consensus      1460 -Pq~P~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1460 -PQIPER---LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             -CCCchh---hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence             122221   22335689999999999999999999998876555443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=307.18  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=201.6

Q ss_pred             cccceeeecCceEEEEEEc-CCCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          146 HIKYCIGTGGYGSVYKAQL-PNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ...++||+|+||+||+|.+ +.|+    +||+|++......+.  ..++..|+-+|.+++|||+++++|+|.... ..||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            3467899999999999954 5554    689999877655432  378999999999999999999999998776 8899


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ++|||.|+|.++++..+  ..+.....+.|..|||+||.|||   .++++||||.++|||+..-..+||.|||+++.+..
T Consensus       776 tq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999998754  36788999999999999999999   88999999999999999999999999999999877


Q ss_pred             CCCCccccc--cccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhc--CCCCCC
Q 013793          301 DSSNRTLLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD--QRLPPP  375 (436)
Q Consensus       301 ~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~  375 (436)
                      +........  -.+.|||-|.+....++.++|||||||.+||++| |..|++....        ..+.+.+.  .+++-+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLsqP  922 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLSQP  922 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCCCC
Confidence            665443332  3457999999999999999999999999999997 9999874321        11222222  223322


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .     .....+..++.+||..|+..||++++....+...
T Consensus       923 p-----iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  923 P-----ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             C-----CccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            1     1233356678899999999999999998877543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-36  Score=294.35  Aligned_cols=262  Identities=22%  Similarity=0.263  Sum_probs=193.8

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-------
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-------  214 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  214 (436)
                      .+|.+.+.||.|+||.||+|.. .+|+.||+|.+......   ..+.+.+|+++++.++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            5788899999999999999965 47899999998765432   236788899999999999999999776543       


Q ss_pred             -------CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCC
Q 013793          215 -------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLE  286 (436)
Q Consensus       215 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~  286 (436)
                             ...++|+||++ ++|.+++...    .+++..++.++.|++.||.|||   +.+|+||||||+||+++. ++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~  153 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence                   35789999997 5888887542    5889999999999999999999   789999999999999974 567


Q ss_pred             eEEeecccccccCCCCC---Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC------
Q 013793          287 AFVADFGTARRLHADSS---NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS------  356 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~------  356 (436)
                      ++++|||.++.......   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........      
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            89999999976532211   1122357889999997654 5678899999999999999999999963221000      


Q ss_pred             -CC--Cc---cc---chhhhhc-CCCCCCCChh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          357 -SS--DP---KI---MLIDVLD-QRLPPPVDQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       357 -~~--~~---~~---~~~~~~~-~~l~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                       ..  ..   ..   ....... ..........  .......+.+++.+|++.||++|||+.|++++.|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence             00  00   00   0000000 0000000000  001123467899999999999999999999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.5e-36  Score=290.55  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=193.9

Q ss_pred             cccccceeeecCceEEEEEEcC-C--CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC----C
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK----K  215 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~  215 (436)
                      +|++.+.||+|+||.||++... .  +..||+|.+....... ...+.+.+|++++.++ .||||+++++.+...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4778899999999999999764 3  7889999987532221 1235677899999999 599999999875432    4


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++++||+. ++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5688888886 58988886543   6899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC----Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC--------CCCccc
Q 013793          296 RRLHADSS----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS--------SSDPKI  362 (436)
Q Consensus       296 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~~~  362 (436)
                      +.......    ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........        ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            86543221    1223468899999998765 4689999999999999999999999863221000        000000


Q ss_pred             chhhh-----------hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          363 MLIDV-----------LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       363 ~~~~~-----------~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .....           ...................+.+++.+|++.||++|||+.|++.++|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence            00000           000000000000001123477899999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-36  Score=284.46  Aligned_cols=257  Identities=19%  Similarity=0.222  Sum_probs=181.1

Q ss_pred             hcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHH--------HHHHHHHHHHHhhccCCCceeeeeE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAF--------IKSFRNEAQVLSQVLHRSIVKLYGF  210 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~  210 (436)
                      ++|.+.+.||+|+||+||+|...+    +..+|+|............        ......+...+..+.|+|++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999997654    4566676543322111000        0112233445667789999999987


Q ss_pred             EeeCC----EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC
Q 013793          211 CLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  286 (436)
Q Consensus       211 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  286 (436)
                      +....    ..++++|++.. ++.+.+....   ..++..+..++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            66543    34677777643 5655554332   3577888999999999999999   789999999999999999999


Q ss_pred             eEEeecccccccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCC
Q 013793          287 AFVADFGTARRLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD  359 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~  359 (436)
                      ++|+|||+++.+.....       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999987643221       12234699999999999999999999999999999999999999974321100000


Q ss_pred             c--ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          360 P--KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       360 ~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .  ......+.......+.      ....+.+++..|+..+|++||++.++.+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKIKN------ANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHhhhhhhccCC------CCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0  0001111111111111      123367899999999999999999998865

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.7e-37  Score=272.01  Aligned_cols=274  Identities=24%  Similarity=0.292  Sum_probs=202.9

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC---C--CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP---N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-  213 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-  213 (436)
                      +....|+....||+|+||.||+|..+   +  .+.+|+|+++...... ....+..+|+.+++.++|||++.+..++.+ 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            44567889999999999999999433   2  2369999998764321 123567789999999999999999999887 


Q ss_pred             CCEEEEEEeeccCCChhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CCe
Q 013793          214 KKCMFLIYEYMERGSLFCILHND--DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----LEA  287 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~  287 (436)
                      +...++++||.+. +|...++..  .....++...+.+|+.||+.|+.|||   ++=|+||||||.|||+..+    |.+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCee
Confidence            7889999999988 788777643  23457888999999999999999999   7789999999999999887    899


Q ss_pred             EEeecccccccCCCCCC---ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc--
Q 013793          288 FVADFGTARRLHADSSN---RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK--  361 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--  361 (436)
                      ||+|+|+++.+...-..   ....+-|.+|+|||.+.+. .||.+.|||+.|||+.||+|-++-|.....-.....+.  
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            99999999987654332   2345679999999998876 69999999999999999999887664211100000000  


Q ss_pred             ---cchhhhh------------------------cCCCCCCC-ChhHHH----HHHHHHHHHhhccCCCCCCCCCHHHHH
Q 013793          362 ---IMLIDVL------------------------DQRLPPPV-DQKVIQ----DILLASTISFACLQSNPKSRPTMQYVS  409 (436)
Q Consensus       362 ---~~~~~~~------------------------~~~l~~~~-~~~~~~----~~~~~~~l~~~cl~~dP~~RPt~~ev~  409 (436)
                         ..+.+++                        ........ -..+..    ......+|+.++|..||.+|.|+.+.+
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence               0000000                        00000000 000000    011156789999999999999999999


Q ss_pred             HHHhhcCCC
Q 013793          410 QGFLITRKT  418 (436)
Q Consensus       410 ~~l~~~~~~  418 (436)
                      ++..|+..+
T Consensus       336 eh~yF~~d~  344 (438)
T KOG0666|consen  336 EHPYFTEDP  344 (438)
T ss_pred             cccccccCC
Confidence            999998773

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-37  Score=298.11  Aligned_cols=201  Identities=29%  Similarity=0.445  Sum_probs=175.8

Q ss_pred             cccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC------EEE
Q 013793          146 HIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK------CMF  218 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  218 (436)
                      ...+.||+|+||.||+|+ ..+|+.||||.++......  ..+...+|++++++++|+|||++++.-.+..      ...
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            445679999999999998 4589999999998754222  2377889999999999999999998776544      578


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCC--CeEEeeccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKL--EAFVADFGT  294 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~  294 (436)
                      +|||||.+|||...+.+......|++.+.+.+..+++.||.|||   .++|+||||||.||++-  ++|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999888889999999999999999999999   88999999999999983  333  368999999


Q ss_pred             ccccCCCCCCccccccccccccccccc-cCccCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                      |+.+.++. .....+||..|++||+.. .+.++..+|.|||||++|+.+||..||.+..
T Consensus       171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99886554 667789999999999998 4889999999999999999999999997544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=293.33  Aligned_cols=246  Identities=24%  Similarity=0.304  Sum_probs=199.1

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      .++.|.+...+|.|+|+.|-.+.. ++++..+||++....       .+-.+|+.++... .|||++++.+.+.+..+.+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            367888899999999999999854 578889999997763       2334577676666 7999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCCeEEeecccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAFVADFGTARR  297 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~  297 (436)
                      +|||.+.++-+.+.+....   ... .++..|+.+|+.|+.|||   ..|++||||||+|||+ ++.++++|+|||.++.
T Consensus       393 ~v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            9999999998888876553   223 778889999999999999   8999999999999999 6899999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ...+   ....+-|..|.|||+.....+++++|+||||++||+|++|+.||...        +..  .++......+...
T Consensus       466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~--------P~~--~ei~~~i~~~~~s  532 (612)
T KOG0603|consen  466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH--------PAG--IEIHTRIQMPKFS  532 (612)
T ss_pred             Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC--------Cch--HHHHHhhcCCccc
Confidence            7544   33446688999999999999999999999999999999999998621        111  1222222222221


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                         ........+|+.+||+.||.+||+|.++..|.|+..
T Consensus       533 ---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  533 ---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             ---cccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence               122334678999999999999999999999999933

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.3e-36  Score=272.68  Aligned_cols=228  Identities=23%  Similarity=0.243  Sum_probs=181.2

Q ss_pred             cCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCChhhh
Q 013793          154 GGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCI  232 (436)
Q Consensus       154 G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  232 (436)
                      |.+|.||++.. .+++.||+|.+.....        +.+|...+....|||++++++++...+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            89999999965 4789999999876432        22344455556799999999999999999999999999999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcccccccc
Q 013793          233 LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY  312 (436)
Q Consensus       233 l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  312 (436)
                      +....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......   .....++.
T Consensus        76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~  146 (237)
T cd05576          76 ISKFL---NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN  146 (237)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence            87543   5899999999999999999999   789999999999999999999999999987655332   12234567


Q ss_pred             ccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHh
Q 013793          313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISF  392 (436)
Q Consensus       313 ~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~  392 (436)
                      .|+|||...+..++.++||||+|+++|||++|+.|++.....         ........++...       ...+.+++.
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~~~~~~~~~-------~~~~~~li~  210 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHTTLNIPEWV-------SEEARSLLQ  210 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccccccCCcccC-------CHHHHHHHH
Confidence            899999998888999999999999999999999886521100         0000011112111       223668999


Q ss_pred             hccCCCCCCCCCH-----HHHHHHHhh
Q 013793          393 ACLQSNPKSRPTM-----QYVSQGFLI  414 (436)
Q Consensus       393 ~cl~~dP~~RPt~-----~ev~~~l~~  414 (436)
                      +|++.||++||++     +++++|+|+
T Consensus       211 ~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         211 QLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHccCCHHHhcCCCccchHHHHcCCCC
Confidence            9999999999996     888888875

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=303.96  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=203.6

Q ss_pred             HhhcccccceeeecCceEEEEEEcC----C----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP----N----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFC  211 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  211 (436)
                      ..++..+.+.||+|.||.|++|...    .    ...||||.++......  ..+.+..|+++|..+ +|+||+.++|+|
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~--~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSS--EKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcH--HHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3444556679999999999999642    1    4579999998776552  358899999999999 699999999999


Q ss_pred             eeCCEEEEEEeeccCCChhhhhccCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 013793          212 LHKKCMFLIYEYMERGSLFCILHNDD-----------EA--VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  278 (436)
Q Consensus       212 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~N  278 (436)
                      ..++..++|+||+..|+|.++++..+           ..  ..++..+.+.++.|||.|++||+   +.+++||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence            99999999999999999999998765           01  23889999999999999999999   8899999999999


Q ss_pred             eeecCCCCeEEeecccccccCCCCCCc-ccccc--ccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccc
Q 013793          279 ILLNSKLEAFVADFGTARRLHADSSNR-TLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSL  354 (436)
Q Consensus       279 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~  354 (436)
                      ||+.++..+||+|||+++......... ....|  ...|||||.+....++.++||||||++||||+| |..|+..    
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~----  524 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG----  524 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC----
Confidence            999999999999999999654443332 22222  346999999999999999999999999999997 7888752    


Q ss_pred             cCCCCcccchhhhhcC--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          355 SSSSDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       355 ~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ........+.+..  ++..|..     +...+.+++..||+.+|++||++.++.+.+..
T Consensus       525 ---~~~~~~l~~~l~~G~r~~~P~~-----c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  525 ---IPPTEELLEFLKEGNRMEQPEH-----CSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             ---CCcHHHHHHHHhcCCCCCCCCC-----CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence               1101112223332  2222222     23336688999999999999999999988755

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=293.80  Aligned_cols=266  Identities=26%  Similarity=0.416  Sum_probs=220.3

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      +.+...++-|++.+.||.|.+|.||+++. ++++..|+|++......+    .+...|.+++... .|||++.++|++..
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            33444567889999999999999999954 588999999998776543    5667788999888 69999999999875


Q ss_pred             -----CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeE
Q 013793          214 -----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  288 (436)
Q Consensus       214 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  288 (436)
                           ++++|||||||.+||..+++.+.. ...+.|..+..|++.++.|+.+||   ...++|||+|-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence                 468999999999999999998776 568999999999999999999999   88999999999999999999999


Q ss_pred             EeecccccccCCCCCCccccccccccccccccccC-----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccc
Q 013793          289 VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  363 (436)
                      ++|||.+..+........+..||+.|||||++...     .|+.++|+||+|++..||--|.+|+-.+..         +
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------m  234 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------M  234 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------h
Confidence            99999998877665666678899999999987643     477899999999999999999999752211         1


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..-...++-|++....+......+.+++..||..|-++||++.+.++|++.++.+
T Consensus       235 raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  235 RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            1122223334444444555556688899999999999999999999999988443

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=285.06  Aligned_cols=253  Identities=24%  Similarity=0.292  Sum_probs=205.5

Q ss_pred             cceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          148 KYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .+.||.|-||+||-|.+ ++|+.||||++.+....... ..++++|+.+|++++||.||.+--.|+..+..++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            57899999999999954 68999999999876655433 27899999999999999999999999999999999999966


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeecccccccCCCCC
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARRLHADSS  303 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~  303 (436)
                      .-|+.+|...  ..++++.....++.||+.||.|||   ..+|+|+||||+|||+.+.   -.+||||||.|+.+... +
T Consensus       648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s  721 (888)
T KOG4236|consen  648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S  721 (888)
T ss_pred             hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence            5455555432  237888888899999999999999   7899999999999999654   46999999999987643 4


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      .....+||+.|+|||++..+.|...-|+||.|||+|--++|..||....        + .-.++-...+..+. ..+.+.
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--------d-IndQIQNAaFMyPp-~PW~ei  791 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--------D-INDQIQNAAFMYPP-NPWSEI  791 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--------c-hhHHhhccccccCC-Cchhhc
Confidence            4566789999999999999999999999999999999999999986211        1 11112222222111 124445


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ....++|+...|+..-.+|-|.+..+.|+|.+..
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            5557889999999999999999999999998654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=243.36  Aligned_cols=267  Identities=22%  Similarity=0.278  Sum_probs=200.5

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +|...++||+|++|+|++|+. .+++.||+|++.....++.- -.+..+|+-+++.++|+|||++++.........+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            355567899999999999965 46889999999766543321 2567789999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      ||.. +|..+.....  ..++...+++++.|+++||.|+|   +..+.|||+||.|.|++.+|+.|++|||+++.+.-.-
T Consensus        82 ~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9965 7877776543  26888999999999999999999   8899999999999999999999999999999876544


Q ss_pred             CCccccccccccccccccccCc-cCcchhhHHHHHHHHHHHh-CCCCcccccc---------ccCCCCcccc--hhhhhc
Q 013793          303 SNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLM-GKHPRDLLSS---------LSSSSDPKIM--LIDVLD  369 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~ellt-g~~p~~~~~~---------~~~~~~~~~~--~~~~~~  369 (436)
                      .-...-.-|.+|.+|.++.+.+ |+...|+||-|||+.|+.. |++.|.....         .-+...++.+  ....-|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            3344456789999999998875 7899999999999999996 4444432110         0011111111  111112


Q ss_pred             CCCCCCC--ChhHHHHHHH----HHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          370 QRLPPPV--DQKVIQDILL----ASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       370 ~~l~~~~--~~~~~~~~~~----~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ....+..  ...+.+....    -.+++.+.+.-+|.+|.++++.++++.|...
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            2111111  1122222222    3567888888999999999999999988654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=274.81  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=209.6

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+|....+||+|+||.|.+|..+ +.+.||||+++....-+....+--+.|-++|.-- +-|.++++...+...+..++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888999999999999999654 5678999999876443332234445666777666 578999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+.||+|-.+++..+   .+.+..+..++..||-||-|||   +.||+.||||..||++|.+|++||+|||+++.-..
T Consensus       429 MEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999999888765   6778889999999999999999   89999999999999999999999999999987666


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      +.....+++||+.|+|||.+.-..|+..+|.|||||+||||+.|+.||+       ..+++...+.+.+.....+.+-  
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-------GeDE~elF~aI~ehnvsyPKsl--  573 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-------GEDEDELFQAIMEHNVSYPKSL--  573 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHHHccCcCcccc--
Confidence            6667778999999999999999999999999999999999999999998       3455566777777776654432  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTM-----QYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~-----~ev~~~l~~~  415 (436)
                         ..+...+....+...|.+|...     ++|-.|++++
T Consensus       574 ---SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR  610 (683)
T KOG0696|consen  574 ---SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFR  610 (683)
T ss_pred             ---cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence               1224456667788999999743     4555555443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=272.68  Aligned_cols=266  Identities=21%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             hhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CC----ceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RS----IVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~  214 (436)
                      +++|.+...+|+|+||.|-.+. ...+..||||+++.....    .+...-|++++.++.+  |+    +|++.+++.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            7789999999999999999994 445789999999876543    3566779999999942  33    78888999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----------
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----------  283 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-----------  283 (436)
                      ++.++|+|.+ |-|+.+++..+. ..+++...++.|+.|++++++|||   +.+++|-||||+|||+.+           
T Consensus       164 ghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence            9999999988 559999998764 347899999999999999999999   899999999999999831           


Q ss_pred             ---------CCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          284 ---------KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       284 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                               +..++++|||.|+.-..   .....+.|..|.|||++.+-.++.++||||+||||.|+.||...|..-...
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     34589999999986433   335677899999999999999999999999999999999999887632210


Q ss_pred             c--------CCCCcccchhhh-----h-cCCCC-----------------CCCC---hhHHHHHHHHHHHHhhccCCCCC
Q 013793          355 S--------SSSDPKIMLIDV-----L-DQRLP-----------------PPVD---QKVIQDILLASTISFACLQSNPK  400 (436)
Q Consensus       355 ~--------~~~~~~~~~~~~-----~-~~~l~-----------------~~~~---~~~~~~~~~~~~l~~~cl~~dP~  400 (436)
                      +        -...+..++...     + ..++.                 .+..   .....+...+.+|+.+||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            0        000010000000     0 00000                 0000   01123445589999999999999


Q ss_pred             CCCCHHHHHHHHhhcCCCC
Q 013793          401 SRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       401 ~RPt~~ev~~~l~~~~~~~  419 (436)
                      +|+|+.|+++|+||.+..+
T Consensus       396 ~RiTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLTP  414 (415)
T ss_pred             ccccHHHHhcCHHhhcCCC
Confidence            9999999999999987654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=287.66  Aligned_cols=270  Identities=15%  Similarity=0.203  Sum_probs=185.3

Q ss_pred             HhhcccccceeeecCceEEEEEEc-----------------CCCCEEEEEEecCcchhhHH-----------HHHHHHHH
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-----------------PNGKVFALKKLHTSETEELA-----------FIKSFRNE  192 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~-----------~~~~~~~e  192 (436)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 24568999998754322110           01223346


Q ss_pred             HHHHhhccCCCc-----eeeeeEEee--------CCEEEEEEeeccCCChhhhhccCCC---------------------
Q 013793          193 AQVLSQVLHRSI-----VKLYGFCLH--------KKCMFLIYEYMERGSLFCILHNDDE---------------------  238 (436)
Q Consensus       193 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  238 (436)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677787754        3568999999999999999874311                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC-ccccccccccccc
Q 013793          239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN-RTLLAGTYGYIAP  317 (436)
Q Consensus       239 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~gt~~y~aP  317 (436)
                      ...++|..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......... .....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            123577889999999999999999   789999999999999999999999999999765432221 1122357899999


Q ss_pred             cccccCcc----------------------CcchhhHHHHHHHHHHHhCCC-CccccccccCCCCc-ccchhh---hhcC
Q 013793          318 ELAYTMVM----------------------TEKCDVYSFGVVTLEVLMGKH-PRDLLSSLSSSSDP-KIMLID---VLDQ  370 (436)
Q Consensus       318 E~~~~~~~----------------------~~~~Dv~s~G~il~elltg~~-p~~~~~~~~~~~~~-~~~~~~---~~~~  370 (436)
                      |.+.....                      ..+.||||+||++|||++|.. |+.....+...... ......   ....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      124799999999999999975 65422111110000 000000   0011


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHHHhhcC
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNP---KSRPTMQYVSQGFLITR  416 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPt~~ev~~~l~~~~  416 (436)
                      ......   .........+++.+|+..+|   .+|+|+.|+++|+|+..
T Consensus       460 ~~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            111110   11122336678889998766   68999999999999964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.7e-35  Score=295.86  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=175.3

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-C----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeE-----
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-N----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF-----  210 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-----  210 (436)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......+     ...++  .+....+.++..++..     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            5678999999999999999999765 4    6899999986543221     11111  1112222222222111     


Q ss_pred             -EeeCCEEEEEEeeccCCChhhhhccCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 013793          211 -CLHKKCMFLIYEYMERGSLFCILHNDDEA-----------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  272 (436)
Q Consensus       211 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  272 (436)
                       +......++|+||+++++|.+++......                 .......+..++.|++.||+|||   +.+|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeC
Confidence             24566799999999999999998754210                 01122345679999999999999   7899999


Q ss_pred             CCCCCceeecC-CCCeEEeecccccccCCCCC-CccccccccccccccccccC----------------------ccCcc
Q 013793          273 DISSNNILLNS-KLEAFVADFGTARRLHADSS-NRTLLAGTYGYIAPELAYTM----------------------VMTEK  328 (436)
Q Consensus       273 dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  328 (436)
                      ||||+|||++. ++.+||+|||+++.+..... ......+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 57899999999986543222 23345789999999965322                      23456


Q ss_pred             hhhHHHHHHHHHHHhCCCCccccc-----cccCCCCcccchhhhhcCCCCCCCChh---HHHHHHHHHHHHhhccCCCCC
Q 013793          329 CDVYSFGVVTLEVLMGKHPRDLLS-----SLSSSSDPKIMLIDVLDQRLPPPVDQK---VIQDILLASTISFACLQSNPK  400 (436)
Q Consensus       329 ~Dv~s~G~il~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~l~~~cl~~dP~  400 (436)
                      +|||||||++|||+++..|++...     .+.........................   .........+|+.+||+.||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            799999999999999877654210     000000000000011111110000000   000011234799999999999


Q ss_pred             CCCCHHHHHHHHhhcCCCC
Q 013793          401 SRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       401 ~RPt~~ev~~~l~~~~~~~  419 (436)
                      +|||+.|+++|+|+.+...
T Consensus       440 kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        440 QRISAKAALAHPYFDREGL  458 (566)
T ss_pred             cCCCHHHHhCCcCcCCCCc
Confidence            9999999999999987654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=275.28  Aligned_cols=264  Identities=26%  Similarity=0.372  Sum_probs=203.1

Q ss_pred             hcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhh----HHHHHHHHHHHHHHhhccCCCceeeeeEEe-eCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRSIVKLYGFCL-HKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~  216 (436)
                      ++|-..++||+|||+.||+| .+...+-||||+-+......    ..+.+-..+|.++-+.++||.||++++|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            55667789999999999999 45567889999765443322    234456788999999999999999999987 4567


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEeecc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFG  293 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg  293 (436)
                      ++-|+|||+|.+|.-+|....   .+++.++++|+.||+.||.||... .++|||-||||.|||+-.   .|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            899999999999999998765   789999999999999999999966 889999999999999954   4889999999


Q ss_pred             cccccCCCCCC-------ccccccccccccccccccC----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCccc
Q 013793          294 TARRLHADSSN-------RTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI  362 (436)
Q Consensus       294 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~  362 (436)
                      +++.+..+...       ....+||.+|++||++.-+    +++.|+||||+|||+|..+.|+.||.....-..... ..
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq-eN  697 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ-EN  697 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-hh
Confidence            99998665433       2346799999999987643    578999999999999999999999963221100000 00


Q ss_pred             chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .+.....-.+++..     ........++++||+..-++|....++..++.+..
T Consensus       698 TIlkAtEVqFP~KP-----vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  698 TILKATEVQFPPKP-----VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             chhcceeccCCCCC-----ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            11111111122111     11223567999999999999999999998887654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.1e-34  Score=261.46  Aligned_cols=243  Identities=29%  Similarity=0.417  Sum_probs=195.6

Q ss_pred             CceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCChhhhh
Q 013793          155 GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL  233 (436)
Q Consensus       155 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  233 (436)
                      +||.||+|... +++.+|+|++........  .+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999776 589999999987654332  378899999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccccccc
Q 013793          234 HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG  313 (436)
Q Consensus       234 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  313 (436)
                      ....   .+++..+..++.+++++++|||   ..+++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus        79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRG---RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             Hhcc---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            7654   3889999999999999999999   7899999999999999999999999999998765432 2334567889


Q ss_pred             cccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhh
Q 013793          314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA  393 (436)
Q Consensus       314 y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~  393 (436)
                      |++||...+..++.++||||||+++++|++|..||...      ... ....+.+.......... .......+.+++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~------~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~  223 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD------DQL-LELFKKIGKPKPPFPPP-EWKISPEAKDLIRK  223 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CcH-HHHHHHHhccCCCCccc-cccCCHHHHHHHHH
Confidence            99999998888899999999999999999999998631      111 11122222111111100 00022346789999


Q ss_pred             ccCCCCCCCCCHHHHHHHHhh
Q 013793          394 CLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       394 cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      |+..+|++||++.++++++|+
T Consensus       224 ~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      224 LLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HccCCchhccCHHHHhhCCCC
Confidence            999999999999999998874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=261.21  Aligned_cols=262  Identities=22%  Similarity=0.359  Sum_probs=213.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..+|....+||+|+|+.|..++++ +.+.||+|+++..-..+.+.+.....|-.+..+. +||.+|-+..+|......++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367889999999999999999765 6789999999877665555567778888888877 79999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |.||++||+|--++...+   .++++.++.+...|.-||.|||   +.||+.||||..|||+|..|++|+.|||+++.--
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999987777654   7999999999999999999999   8999999999999999999999999999998766


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc-CCCCcccchhhhhcCCCCCCCCh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-SSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      .+.....+++||+.|.|||.+.+..|...+|.|++||+++||+.|+.||+....-. ....++..++-++...+.-+.+-
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl  482 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL  482 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence            66666778999999999999999999999999999999999999999999765211 11223344455555544433322


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHHHhh
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPT------MQYVSQGFLI  414 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt------~~ev~~~l~~  414 (436)
                           .+....++..-++.||.+|..      ++++..|.+|
T Consensus       483 -----svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff  519 (593)
T KOG0695|consen  483 -----SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF  519 (593)
T ss_pred             -----ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence                 222445667789999999863      4555555443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-36  Score=259.69  Aligned_cols=268  Identities=23%  Similarity=0.330  Sum_probs=197.0

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--------
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--------  214 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  214 (436)
                      .|+...++|+|.||.||+|+.+ +|+.||+|+.-...... .+-....+|+++|..++|+|++.+++.|...        
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4555678999999999999665 57788988764422111 1123456799999999999999999988653        


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ..+++||++|+. +|.-++....  ..++..++.+++.++..||.|+|   ...|+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999987 7888886542  46889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCCC----ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccc-------------ccC
Q 013793          295 ARRLHADSSN----RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-------------LSS  356 (436)
Q Consensus       295 a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~-------------~~~  356 (436)
                      ++.+......    .+..+-|.+|++||.+.+. .++++.|||.-|||+.||.||.+-+.....             ...
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9877543321    2344569999999988764 799999999999999999999877653211             111


Q ss_pred             CCCcccchhhhhcCC----CCCCCChhHHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          357 SSDPKIMLIDVLDQR----LPPPVDQKVIQD------ILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~----l~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ...+...........    ++........+.      .....+|+..++..||.+||++++++.|.||...+
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            111111111111110    111000001111      11356788999999999999999999999987664

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=261.27  Aligned_cols=256  Identities=26%  Similarity=0.337  Sum_probs=192.0

Q ss_pred             ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      ..||.|.||+|+|-.+ +.|+..|||++.......+  .+++..|.+...+- +.||||+++|.+...+..|+-||.|.-
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            4599999999999955 5899999999988765332  47788888765554 789999999999999999999999954


Q ss_pred             CChhhhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC
Q 013793          227 GSLFCIL---HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       227 g~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                       ||..+.   +.. ....+++.-.-.|..-.+.||.||-.  ...|+|||+||+|||+|..|.+||||||.+..+.. +-
T Consensus       148 -SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-Si  222 (361)
T KOG1006|consen  148 -SLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SI  222 (361)
T ss_pred             -hHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH-HH
Confidence             554332   222 12367777777888889999999997  67899999999999999999999999999976642 22


Q ss_pred             CccccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC-ChhH
Q 013793          304 NRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV-DQKV  380 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~  380 (436)
                      ..+.-+|-..|||||.+...  .++.+|||||+|++|||+.||+.|++.....      -..+..+.....+.-. +...
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------feql~~Vv~gdpp~l~~~~~~  296 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------FEQLCQVVIGDPPILLFDKEC  296 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------HHHHHHHHcCCCCeecCcccc
Confidence            33445678889999998743  4899999999999999999999998632210      0011122222211111 1111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ......+..++..|+..|-..||...++..+.+.+.-
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            2233446778889999999999999999998876543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=276.58  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=208.6

Q ss_pred             hcccccceeeecCceEEEEEEcCCCC-EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+++....||-|+||.|=++...+.+ .+|+|.++....-+....+-+..|-.+|...+.|.||+++-.|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34455677999999999999775544 48899887766555555567888999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |-|-||.+...++.++   .++...+..++..+.+|++|||   ..+||+|||||+|.++|.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999998766   7888999999999999999999   899999999999999999999999999999998776


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC----CCCCCCC
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ----RLPPPVD  377 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~~  377 (436)
                      .... +++||+.|.|||.+..+..+.++|.||+|+++|||+||++||...+       +......++..    .+|... 
T Consensus       574 ~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-------pmktYn~ILkGid~i~~Pr~I-  644 (732)
T KOG0614|consen  574 RKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-------PMKTYNLILKGIDKIEFPRRI-  644 (732)
T ss_pred             Ccee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-------hHHHHHHHHhhhhhhhccccc-
Confidence            6554 4789999999999999999999999999999999999999997432       21111111111    111111 


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhc
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLIT  415 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~  415 (436)
                            .....+|+.+.+..+|.+|..     +.||-+|-||.
T Consensus       645 ------~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  645 ------TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             ------chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence                  122557888899999999986     88999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-33  Score=269.09  Aligned_cols=202  Identities=24%  Similarity=0.401  Sum_probs=175.8

Q ss_pred             hcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .-|..++.||-|+||.|.+++ ..+...||+|.+.+.+.-......-++.|-.+|...+.+-||+|+..|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            446677889999999999994 4567789999998876655555677889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC-
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA-  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~-  300 (436)
                      ||++||++-.+|-..+   -+.+..++.++..+++|+++.|   ..|+|||||||.|||||.+|++||.|||+++-+.- 
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999987654   6888999999999999999999   88999999999999999999999999999875410 


Q ss_pred             --------CCC----------------C-----------------ccccccccccccccccccCccCcchhhHHHHHHHH
Q 013793          301 --------DSS----------------N-----------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL  339 (436)
Q Consensus       301 --------~~~----------------~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~  339 (436)
                              .+.                .                 ....+||+.|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    000                0                 01246999999999999999999999999999999


Q ss_pred             HHHhCCCCccc
Q 013793          340 EVLMGKHPRDL  350 (436)
Q Consensus       340 elltg~~p~~~  350 (436)
                      ||+.|+.||-.
T Consensus       863 em~~g~~pf~~  873 (1034)
T KOG0608|consen  863 EMLVGQPPFLA  873 (1034)
T ss_pred             HHhhCCCCccC
Confidence            99999999963

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=283.04  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=190.9

Q ss_pred             cccceeeecCceE-EEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEee
Q 013793          146 HIKYCIGTGGYGS-VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       146 ~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      ...+++|.|+.|+ ||+|.. +|+.||||++-....      .-..+|+..|+.- .|||||++++.-.+....||..|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            3346789998876 689988 678999999866542      4567899999888 699999999998899999999999


Q ss_pred             ccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---C--CCeEEeecccccc
Q 013793          224 MERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---K--LEAFVADFGTARR  297 (436)
Q Consensus       224 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~  297 (436)
                      |.. +|.+++... .......-...+.+..|++.||++||   +.+||||||||.||||+.   +  ..++|+|||+++.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            965 999999874 11111122456788999999999999   899999999999999976   3  5689999999999


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhC-CCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      +..+...   .....||-||+|||++....-+.++||||+|||+|..++| ++||...-      ..   ...++.....
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~------~R---~~NIl~~~~~  731 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL------ER---QANILTGNYT  731 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH------Hh---hhhhhcCccc
Confidence            8765443   3456799999999999998888899999999999999986 99986211      11   1111111110


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      -..-.....+  ...+|+.+|++++|..||++.+|+.|+.|...
T Consensus       732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            0000000001  47789999999999999999999999977544

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-33  Score=254.40  Aligned_cols=261  Identities=20%  Similarity=0.312  Sum_probs=206.0

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeee
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG  209 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  209 (436)
                      .++....++++...++.+|+||.||+|.+.      +.+.|-||.++....+  -....+..|.-.+..+.|||+.++.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCccceeE
Confidence            455556677888889999999999999543      3345667776655432  22467888988999999999999999


Q ss_pred             EEeeC-CEEEEEEeeccCCChhhhhc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          210 FCLHK-KCMFLIYEYMERGSLFCILH-----NDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       210 ~~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      .+.+. ...++.|.++.-|+|..++.     +....+.++-.+...++.|++.|++|||   +.+++|.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence            98765 46789999999999999998     4444567888889999999999999999   899999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCCc--cccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCc
Q 013793          284 KLEAFVADFGTARRLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  360 (436)
                      ...+||+|=.+++.+.+.+...  ..-.....||+||.+....++.++|||||||+||||+| |+.|+...       ++
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-------DP  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-------DP  504 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-------CH
Confidence            9999999999999876554432  12234668999999999999999999999999999997 89998632       23


Q ss_pred             ccchhhhhc-CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          361 KIMLIDVLD-QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       361 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..+..-+.| .++..+..     +..++..++.-||..+|++||+++|++.-+.
T Consensus       505 fEm~~ylkdGyRlaQP~N-----CPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  505 FEMEHYLKDGYRLAQPFN-----CPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             HHHHHHHhccceecCCCC-----CcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            222222222 23333332     2334778888999999999999999998764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-31  Score=250.08  Aligned_cols=132  Identities=24%  Similarity=0.463  Sum_probs=112.5

Q ss_pred             hhcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-----C---CCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----H---RSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~  212 (436)
                      ..+|.+.++||.|.|++||++ ...+.+.||+|+.+.....    .+....|+++|++++     |   ..||+|++.|.
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            467889999999999999999 5567889999998876543    466778999999984     2   35999999997


Q ss_pred             e----CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 013793          213 H----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  281 (436)
Q Consensus       213 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill  281 (436)
                      .    +.+.++|+|++ |-+|..++..... ..++...+.+|+.||+.||.|||.+|  ||||-||||+|||+
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            5    45899999998 6688888876543 36899999999999999999999966  99999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=7.1e-33  Score=235.75  Aligned_cols=262  Identities=19%  Similarity=0.271  Sum_probs=200.3

Q ss_pred             HhhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCC--E
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKK--C  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  216 (436)
                      ..++|++.+++|+|.++.|+.|. ..+.+.++||++++...      +.+.+|+.+|..++ ||||+++++...+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            45789999999999999999995 56788999999988753      77889999999996 999999999998754  5


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTA  295 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a  295 (436)
                      ..+|+||+.+.+...+..      .++..++..++.+++.||.|+|   +.||+|||+||.|+++|.. -+.+|+|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchH
Confidence            789999999987766553      5777889999999999999999   8999999999999999975 56999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccc----c-------cC-------
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS----L-------SS-------  356 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~----~-------~~-------  356 (436)
                      .++.+.... ...+.+..|.-||.+-. ..++..-|+|||||++..|+..+.||-.-.+    +       ..       
T Consensus       181 EFYHp~~eY-nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  181 EFYHPGKEY-NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hhcCCCcee-eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            988765443 33456778999998865 4688899999999999999999999842110    0       00       


Q ss_pred             ---CCCcccchhhhhcCCCCCCCC-----hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          357 ---SSDPKIMLIDVLDQRLPPPVD-----QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       357 ---~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                         ...-+....++++.....+..     ....-...++++++.+.|..|.++|||++|.+.|++|....
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence               000000111111111111000     00001124477899999999999999999999999986543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3e-32  Score=228.58  Aligned_cols=198  Identities=26%  Similarity=0.374  Sum_probs=162.8

Q ss_pred             cccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEee
Q 013793          146 HIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      .....||+|++|.|-+.++ ++|...|+|.+...-....  .+....|+.+..+. .+|.+|+++|........++.||.
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~--q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE--QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH--HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3355699999999998865 5899999999987654332  36777788876555 799999999999999999999999


Q ss_pred             ccCCChhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          224 MERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       224 ~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |.- ||..+-.+ -.....+++...-+|+..+.+||.|||+  ...++|||+||+|||++.+|++|+||||.+-.+.. +
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-S  202 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD-S  202 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh-h
Confidence            965 77665432 1233468888889999999999999997  56899999999999999999999999999987643 2


Q ss_pred             CCcccccccccccccccccc----CccCcchhhHHHHHHHHHHHhCCCCcc
Q 013793          303 SNRTLLAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRD  349 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~  349 (436)
                      -..+...|-..|||||.+..    ..|+.|+||||+|+.+.||.+++.||+
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            23344567788999998764    368999999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.9e-30  Score=231.60  Aligned_cols=212  Identities=33%  Similarity=0.566  Sum_probs=184.5

Q ss_pred             eeecCceEEEEEEcCC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      ||+|.+|.||++...+ ++.+++|++.......  ....+.+|++.++.++|++++++++++......++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999997754 8999999998775432  236788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeecccccccCCCCCCcccc
Q 013793          230 FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLL  308 (436)
Q Consensus       230 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~  308 (436)
                      .+++....  ..+++..+..++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99987642  35889999999999999999999   779999999999999999 8999999999998765433223335


Q ss_pred             ccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHH
Q 013793          309 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLA  387 (436)
Q Consensus       309 ~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  387 (436)
                      .+...|++||..... ..+.+.|+|++|+++++|                                           ..+
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~  190 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL  190 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence            578899999998887 888999999999999998                                           236


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          388 STISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       388 ~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .+++.+|++.+|++||++.++++++
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhCC
Confidence            6788999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-33  Score=243.91  Aligned_cols=261  Identities=26%  Similarity=0.297  Sum_probs=193.7

Q ss_pred             cccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----EEEE
Q 013793          146 HIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----CMFL  219 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  219 (436)
                      +..+.||-|+||.||.+..+ +|+.||.|++......- ...+.+.+|+.+|..++|.|++..++...-..     +.|+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L-~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL-ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH-HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44677999999999999765 89999999997765432 23478899999999999999999988766433     5678


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ++|.|.. +|..++-...   .++...+.-+..||++||.|||   +.+|.||||||.|.|++.+...||||||+++.-.
T Consensus       135 ~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            8888854 7777776543   6888888889999999999999   8999999999999999999999999999998754


Q ss_pred             CCCC-CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccc---------ccCCCCc-------c
Q 013793          300 ADSS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSS---------LSSSSDP-------K  361 (436)
Q Consensus       300 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~---------~~~~~~~-------~  361 (436)
                      .+.. ..+.-+-|..|.|||.+.+. .|+.+.||||.|||+.|++.++..|...+.         +-+....       +
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            4332 33444568899999998875 699999999999999999998877753221         1011000       1


Q ss_pred             cchhhhhcCCCCCCCCh------hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          362 IMLIDVLDQRLPPPVDQ------KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       362 ~~~~~~~~~~l~~~~~~------~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....+++.....+...      ......-....+...++..||++|.+..+.++++..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            11222333322211110      000111124457778999999999999999988754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=237.82  Aligned_cols=259  Identities=26%  Similarity=0.318  Sum_probs=192.0

Q ss_pred             cccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC------E
Q 013793          144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK------C  216 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  216 (436)
                      +|.-...+|.|.- .|..+. .-.+++||+|++......... .+...+|..++..+.|+|+++++.++.-..      .
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~-akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH-AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc-chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            4444566888887 555553 336889999988665333222 266778999999999999999999987543      5


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++|||+|.. +|...++-     .++-.....|..|+++|+.|||   +.+|+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence            7999999965 88777762     5777888999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccc---cc------cCCCC--------
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS---SL------SSSSD--------  359 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~---~~------~~~~~--------  359 (436)
                      .-..+ ...+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|....   ++      .+..+        
T Consensus       167 ~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  167 TEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             ccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            65433 34566778999999999999989999999999999999999997764211   00      00000        


Q ss_pred             ----------ccc---chhhhh-cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          360 ----------PKI---MLIDVL-DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       360 ----------~~~---~~~~~~-~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                                +..   ...+.+ |..++..... .......+.+++.+||..||++|.+++++++|+.++
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~-~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEG-SKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccC-CccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                      000   000111 1111111111 111223367899999999999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=8.5e-31  Score=246.41  Aligned_cols=264  Identities=21%  Similarity=0.225  Sum_probs=206.9

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC------CCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH------RSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~  213 (436)
                      ...+|.+....|+|-|++|.+|... -|..||||++.......    +.-..|+++|.+|..      -++++++-.|..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            4567999999999999999999654 57899999998876553    556689999999952      478999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeec
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADF  292 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df  292 (436)
                      .+++|||||-+. -+|.+.|...+....|....+..++.|+.-||..|-   ..+|+|.||||.|||+++. ..+|||||
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccC
Confidence            999999999874 499999999888888999999999999999999999   7899999999999999976 45799999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc---------c---------
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS---------L---------  354 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~---------~---------  354 (436)
                      |.|.....+  ..+.+.-+..|.|||++.|..|+...|+||+||.|||+.||+..|.....         +         
T Consensus       582 GSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  582 GSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            999776433  23444456789999999999999999999999999999999987642110         0         


Q ss_pred             c------CCCCcc--------------------------cchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCC
Q 013793          355 S------SSSDPK--------------------------IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSR  402 (436)
Q Consensus       355 ~------~~~~~~--------------------------~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R  402 (436)
                      .      ...+.+                          ..+...+...  .............+.+|+..|+..||++|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~--q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV--QRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc--CCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            0      000000                          0000000000  01222234455567889999999999999


Q ss_pred             CCHHHHHHHHhhcC
Q 013793          403 PTMQYVSQGFLITR  416 (436)
Q Consensus       403 Pt~~ev~~~l~~~~  416 (436)
                      .|..|+++|++++.
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=258.10  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=209.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|+....+|.|++|.|||++.. +++..|+|+++......   .+-..+|+-+++..+|||||.++|.+......++.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            467888999999999999999654 78999999998765543   36677899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||||.+|+|++.-+..+   ++++.++..+.+...+||+|||   +.+-+|||||-.|||+++.+.+|++|||.+-.+..
T Consensus        91 MEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999999988766   7899999999999999999999   88999999999999999999999999999877655


Q ss_pred             CCCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .-.....+.||+.|||||+..   .+.|..++|||+.|+...|+---+.|.-....       .....-.-.....++..
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS~~qpp~l  237 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKSGFQPPTL  237 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhccCCCCCcc
Confidence            444556688999999999764   45688999999999999998777766321110       00011111112222222


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+.......+.+++..|+..+|++||+++-.++|++....
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            2233344457889999999999999999999998876544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.5e-29  Score=225.74  Aligned_cols=198  Identities=34%  Similarity=0.528  Sum_probs=171.7

Q ss_pred             ccccceeeecCceEEEEEEcCC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |.+.+.||+|++|+||++...+ ++.+|+|.+......  ...+.+.+|++.+.+++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            4567889999999999997764 889999999876543  1247888999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC-
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-  302 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  302 (436)
                      +++++|.+++.....  .+++.....++.+++.++.+||   ..+++|+|++|+||+++.++.++|+|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999999976542  1789999999999999999999   7799999999999999999999999999998765432 


Q ss_pred             CCcccccccccccccccc-ccCccCcchhhHHHHHHHHHHHhCCCCcc
Q 013793          303 SNRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGKHPRD  349 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~  349 (436)
                      .......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            122334577889999998 66678889999999999999999999986

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=247.01  Aligned_cols=201  Identities=23%  Similarity=0.356  Sum_probs=172.7

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHH-----HHHHHHHHHhhcc---CCCceeeeeEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIK-----SFRNEAQVLSQVL---HRSIVKLYGFC  211 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~-----~~~~e~~~l~~l~---h~niv~l~~~~  211 (436)
                      ...+|...+.+|.|+||.|+.|.++ +...|+||.+.+.+.-...+.+     .+-.|+.+|+.++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3456888999999999999999765 5678999998776554333322     2457999999997   99999999999


Q ss_pred             eeCCEEEEEEeec-cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          212 LHKKCMFLIYEYM-ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       212 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      ++.+.++|++|-. ++-+|.+++....   .+++.++.-|++|++-|+++||   +++|+|||||-+||.++.+|-+||+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEe
Confidence            9999999999975 5669999998655   7999999999999999999999   8999999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCcc
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRD  349 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~  349 (436)
                      |||.+......  ....++||.+|.|||++.+.+| ....|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999765433  3456789999999999998876 567999999999999999998874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=6.7e-30  Score=235.91  Aligned_cols=268  Identities=25%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEE
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFC  211 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  211 (436)
                      ++....+.|...++||.|+|++||++.+.    ..+.||+|.+......     ..+.+|+++|..+ .+.||+++.+++
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhh
Confidence            34455678899999999999999999543    4678999999877654     5688999999999 589999999999


Q ss_pred             eeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEe
Q 013793          212 LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVA  290 (436)
Q Consensus       212 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~  290 (436)
                      ..++...+|+||++.....++..      .++..++..++..+..||+++|   ..|||||||||+|+|.+. .+.-.|.
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEE
Confidence            99999999999999998888886      4678899999999999999999   899999999999999986 4667899


Q ss_pred             ecccccccCCCC---------------------------------C-----------CccccccccccccccccccC-cc
Q 013793          291 DFGTARRLHADS---------------------------------S-----------NRTLLAGTYGYIAPELAYTM-VM  325 (436)
Q Consensus       291 Dfg~a~~~~~~~---------------------------------~-----------~~~~~~gt~~y~aPE~~~~~-~~  325 (436)
                      |||+|.......                                 .           .....+||+||.|||++... .-
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            999997221000                                 0           00124699999999998765 56


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCcccccc----------------------ccCC---CCccc--chh------hhhc-CC
Q 013793          326 TEKCDVYSFGVVTLEVLMGKHPRDLLSS----------------------LSSS---SDPKI--MLI------DVLD-QR  371 (436)
Q Consensus       326 ~~~~Dv~s~G~il~elltg~~p~~~~~~----------------------~~~~---~~~~~--~~~------~~~~-~~  371 (436)
                      ++++||||.|||++-+++++.||-....                      +.+.   .....  ...      +-++ ..
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            8899999999999999999999831110                      0000   00000  000      0000 00


Q ss_pred             CCC-----CCChhHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          372 LPP-----PVDQKVIQ-DILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       372 l~~-----~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      +..     .......+ ....+.+++.+|+..||.+|.|+++.++|++|....
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            000     00001111 122478999999999999999999999999997443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=219.83  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=184.5

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeee-EEeeCCEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYG-FCLHKKCM  217 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~  217 (436)
                      ..+.|.+.+.+|+|.||.+-+++++ +.+.+++|-++.....    .++|.+|...--.+ .|.||+.-++ .|+..+..
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            4567889999999999999999765 5678999999887654    37888888876666 5899998775 56677788


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCCeEEeecccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLEAFVADFGTA  295 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a  295 (436)
                      .+++||+|.|+|.+-+...    .+.+.-..+++.|+++|+.|||   +..+||||||.+||||-  +...+||||||+.
T Consensus        98 vF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccc
Confidence            8999999999998887654    4788889999999999999999   88999999999999993  3357999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-----ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      +..+..   ....--+..|.+||.....     ...+.+|||.||++++.++||+.||+....    .++..+.......
T Consensus       171 ~k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~----~d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  171 RKVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI----MDKPYWEWEQWLK  243 (378)
T ss_pred             cccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc----cCchHHHHHHHhc
Confidence            765322   1222345578999976543     457789999999999999999999973222    1121222222222


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVS  409 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~  409 (436)
                      +..+..+.....-...+..+..+-+.++|++|-...++.
T Consensus       244 rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  244 RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            222222222222233356677888999999995544443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.4e-29  Score=269.64  Aligned_cols=201  Identities=20%  Similarity=0.276  Sum_probs=145.0

Q ss_pred             hccC-CCceeeeeEE-------eeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 013793          198 QVLH-RSIVKLYGFC-------LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  269 (436)
Q Consensus       198 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  269 (436)
                      .++| +||++++++|       .....++.++||+ +++|.+++....  ..+++.+++.++.||++||+|||   +.+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            3445 5788888877       2234577888987 559999997532  36899999999999999999999   8899


Q ss_pred             EecCCCCCceeecC-------------------CCCeEEeecccccccCCCC----------------CCcccccccccc
Q 013793          270 IHRDISSNNILLNS-------------------KLEAFVADFGTARRLHADS----------------SNRTLLAGTYGY  314 (436)
Q Consensus       270 vH~dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y  314 (436)
                      +||||||+|||++.                   ++.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456677777765421100                001113578899


Q ss_pred             ccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhc
Q 013793          315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFAC  394 (436)
Q Consensus       315 ~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~c  394 (436)
                      +|||++.+..++.++|||||||+||||++|..|+.....         .........+++..    .........++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHRVLPPQI----LLNWPKEASFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHhhcChhh----hhcCHHHHHHHHHh
Confidence            999999999999999999999999999999888652110         01111111111111    11122345677899


Q ss_pred             cCCCCCCCCCHHHHHHHHhhcCC
Q 013793          395 LQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       395 l~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      |+++|.+||+|.|+++|+|+...
T Consensus       249 L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        249 LHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CCCChhhCcChHHHhhchhhhhh
Confidence            99999999999999999999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.9e-27  Score=207.25  Aligned_cols=167  Identities=20%  Similarity=0.135  Sum_probs=125.6

Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      |+|.++++..+  ..+++.+++.|+.|++.||+|||   +.+      ||+|||++.++.+++  ||++.......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence            68899997543  36999999999999999999999   444      999999999999999  99998654322    


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC---C-CChhHHH
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP---P-VDQKVIQ  382 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~---~-~~~~~~~  382 (436)
                       ..|++.|+|||++.+..++.++|||||||++|||+||+.||......      ..............   . .......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPRDRSNLESVS  136 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCccccccHHHHH
Confidence             25789999999999999999999999999999999999998632211      11111111111110   0 0011111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          383 DILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       383 ~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ....+.+++.+||+.+|.+||++.|++++++....
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            11247899999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=6.5e-25  Score=209.35  Aligned_cols=168  Identities=17%  Similarity=0.120  Sum_probs=129.8

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC--CCCEEEEEEecCcch--hhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      ...++|.+.+.||+|+||+||+|...  +++.+|||++.....  ........+.+|++++.+++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34678999999999999999999664  578889998763311  112224678999999999999999864332   24


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCCeEEeeccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI-SSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~  294 (436)
                      ..++||||++|++|... ...      .   ...++.++++||+|||   +.||+|||| ||+|||++.++.++|+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            57999999999999632 111      1   1467889999999999   889999999 99999999999999999999


Q ss_pred             ccccCCCCCC--------ccccccccccccccccccC
Q 013793          295 ARRLHADSSN--------RTLLAGTYGYIAPELAYTM  323 (436)
Q Consensus       295 a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~  323 (436)
                      ++.+......        .+...+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9977543311        1345678889999988654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.6e-26  Score=199.66  Aligned_cols=247  Identities=19%  Similarity=0.340  Sum_probs=187.0

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      ..+|.+...|..|+|+++... +++|++...... ......|..|.-.|+.+.||||++++|.|..+....++..|||.|
T Consensus       195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhccCCCcccccccccCcc-hhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            445888999999999996544 566777654332 223478999999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccc
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL  307 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  307 (436)
                      +|+..+|+.. ....+..++.+++.++|+|++|||+- .+-|.---|.+..|++|++.+++|+- +-+++.    .+...
T Consensus       273 slynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs----fqe~g  345 (448)
T KOG0195|consen  273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS----FQEVG  345 (448)
T ss_pred             HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee----eeccc
Confidence            9999999764 33577789999999999999999964 34444557899999999999988742 222211    11122


Q ss_pred             cccccccccccccccCcc---CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHH
Q 013793          308 LAGTYGYIAPELAYTMVM---TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI  384 (436)
Q Consensus       308 ~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  384 (436)
                      ..-.+.|++||.+...+.   -+++|+|||++++||+.|+..||...+.+.-..   ....+-++..+++.....     
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---kialeglrv~ippgis~h-----  417 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---KIALEGLRVHIPPGISRH-----  417 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---hhhhccccccCCCCccHH-----
Confidence            345788999999887654   357999999999999999999997544332211   223455566666655432     


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          385 LLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       385 ~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                        +.+|+.-|++.||.+||.++.|+-.+.
T Consensus       418 --m~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  418 --MNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             --HHHHHHHHhcCCCCcCCCcceehhhHH
Confidence              446777799999999999999876654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.8e-25  Score=226.80  Aligned_cols=262  Identities=20%  Similarity=0.270  Sum_probs=192.6

Q ss_pred             cccceeeecCceEEEEEEc-CCCCEEEEEEecC---cchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          146 HIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHT---SETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ...+.+|.|.+|.|+.... ...+.++.|....   .......+...+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3567899999997777743 3344444443331   11222222334778888899999999998888887777666669


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ +|..++....   .++..++..++.|+..|+.|+|   ..||.|||+|++|++++.++.+||+|||.+......
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999987653   5788899999999999999999   899999999999999999999999999999876544


Q ss_pred             CCC----ccccccccccccccccccCccCc-chhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          302 SSN----RTLLAGTYGYIAPELAYTMVMTE-KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       302 ~~~----~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...    .....|+..|+|||.+.+..|++ ..||||.|+++..|++|+.||............   .............
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NNYSDQRNIFEGP  550 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hccccccccccCh
Confidence            332    34567999999999999998875 589999999999999999999754322111000   0000000111111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .............++.+++++||.+|.|+++|++..|++.-
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            11122223335678899999999999999999999999654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=9.2e-23  Score=194.53  Aligned_cols=262  Identities=29%  Similarity=0.396  Sum_probs=199.3

Q ss_pred             ccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCC-CceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-SIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |...+.||.|+||.||++...  ..+++|.+.............+.+|...+..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999876  78899999876554433457899999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeecccccccCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARRLHADS  302 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  302 (436)
                      +.++++.+++........+.......++.+++.++.|+|   ..+++|||+||+||+++... .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765421125788999999999999999999   78899999999999999988 79999999998654433


Q ss_pred             C------Ccccccccccccccccccc---CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC-
Q 013793          303 S------NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-  372 (436)
Q Consensus       303 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l-  372 (436)
                      .      ......|+..|+|||...+   ...+...|+||+|++++++++|..|+......    .......+.+.... 
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            2      2355679999999999987   57889999999999999999999996532210    00011111111111 


Q ss_pred             ---CCCCChhH-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          373 ---PPPVDQKV-IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       373 ---~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         ........ ......+.+++..|+..+|..|.++.+.....+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~  279 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA  279 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence               11111100 11123466788899999999999999988764433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-23  Score=198.40  Aligned_cols=257  Identities=21%  Similarity=0.247  Sum_probs=187.5

Q ss_pred             cccccceeeecCceEEEEEEcCCC--CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC----CCceeeeeEE-eeCCE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH----RSIVKLYGFC-LHKKC  216 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~  216 (436)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|..........   ..+..|..++..+..    +++..+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999976553  4788888766432211   256678888888762    6888888888 47778


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----CCeEEee
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-----LEAFVAD  291 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~D  291 (436)
                      .++||+.+ |.+|.++..... ...++....+.|+.|++.+|.++|   +.|++||||||.|+.+...     ..+.+.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            89999977 779999886555 457999999999999999999999   8999999999999999865     4689999


Q ss_pred             ccccc--ccCCCCC--------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc
Q 013793          292 FGTAR--RLHADSS--------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK  361 (436)
Q Consensus       292 fg~a~--~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  361 (436)
                      ||+++  .+.....        ......||..|.++..+.+...+++.|+||++.++.|++.|..||........    .
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~  246 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----K  246 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----H
Confidence            99998  4322211        12345699999999999999999999999999999999999999863321100    0


Q ss_pred             cchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       362 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .....................   .+.++...+-..+..++|....+...+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  247 SKFEKDPRKLLTDRFGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHHHHHhhhhccccccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            011111111111100000111   233444455558999999999998876443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=7.3e-23  Score=181.82  Aligned_cols=191  Identities=14%  Similarity=0.185  Sum_probs=145.3

Q ss_pred             eeeecCCCcccHHHHHH--HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHH------HHHHHHH
Q 013793          124 FSIWNYDGRIFYEDLIE--ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS------FRNEAQV  195 (436)
Q Consensus       124 ~~~~~~~~~~~~~~l~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~------~~~e~~~  195 (436)
                      +.++..+....|.++..  ..++|...+++|.|+||.||.+.. ++..+|+|.+.............      +.+|+..
T Consensus        10 ~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~   88 (232)
T PRK10359         10 YTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQ   88 (232)
T ss_pred             eEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHH
Confidence            44555555555666554  468899999999999999999766 57789999998765444333333      6789999


Q ss_pred             HhhccCCCceeeeeEEeeC--------CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 013793          196 LSQVLHRSIVKLYGFCLHK--------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP  267 (436)
Q Consensus       196 l~~l~h~niv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  267 (436)
                      +.++.|++|..+..++...        +..++||||++|.+|.++..       ++.    ....+++.++..+|   ..
T Consensus        89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~  154 (232)
T PRK10359         89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QH  154 (232)
T ss_pred             HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---Hc
Confidence            9999999999998886643        35789999999999987732       222    24569999999999   88


Q ss_pred             CeEecCCCCCceeecCCCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHH
Q 013793          268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL  342 (436)
Q Consensus       268 ~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ell  342 (436)
                      |++|||++|+||++++++ ++|+|||..+....+... .           .+.....+..++|+||||+.+.-..
T Consensus       155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-D-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-H-----------HHHHHhHhcccccccceeEeehHHH
Confidence            999999999999999988 999999988755322111 1           1233445667999999999887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=6.7e-23  Score=176.36  Aligned_cols=255  Identities=18%  Similarity=0.271  Sum_probs=189.7

Q ss_pred             hhcccccceeeecCceEEEEE-EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC-CCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l  219 (436)
                      ...|.+.+.||.|+||.+|.| ...+|..||||.-......     .++..|..+...+++ ..|..+..+..+...-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            457999999999999999999 5679999999987665433     567788899999965 788888889999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~  296 (436)
                      |||.. |.+|+++..-...  .++..+++-++-|++.-++|+|   ..+++||||||+|+|..-+   ..+.++|||+|+
T Consensus        89 VMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence            99988 7799998876543  6888999999999999999999   7899999999999998643   568899999999


Q ss_pred             ccCCCCCC-------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          297 RLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       297 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      .+.+....       .....||..|.+-..+.+..-+.+.|+-|+|.+|...--|..||+....-..    ......+..
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk----~QKyEkI~E  238 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK----KQKYEKISE  238 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH----HHHHHHHHH
Confidence            87543321       2446799999999888888889999999999999999999999975432111    111222223


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 013793          370 QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQG  411 (436)
Q Consensus       370 ~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~  411 (436)
                      ..+..+...-...-..++.-.+.-|-..--++-|...-+-+.
T Consensus       239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            333222211111111123334445666666666766555443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.1e-22  Score=178.52  Aligned_cols=143  Identities=20%  Similarity=0.223  Sum_probs=109.3

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHH-----------------------HHHHHHHHHHHHhhccCCCc
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-----------------------FIKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni  204 (436)
                      ...||+|++|.||+|..++|+.||||+++........                       .......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4579999999999998889999999999765321100                       01223459999999988876


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      .....+...  ..++||||++++++.......   ..+++.+...++.|++.+|.|+|+  +.+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-C
Confidence            443333222  238999999998776543222   268889999999999999999943  67999999999999998 4


Q ss_pred             CCeEEeeccccccc
Q 013793          285 LEAFVADFGTARRL  298 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~  298 (436)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-21  Score=176.36  Aligned_cols=198  Identities=22%  Similarity=0.321  Sum_probs=170.6

Q ss_pred             hcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  220 (436)
                      -.|.+.++||+|.||.++.|. +-+++.||||.-......     .++..|.+..+.+ ..++|...+-+..++.+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            368899999999999999994 568999999977655432     6788899998888 469999998888888889999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----CCeEEeecccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-----LEAFVADFGTA  295 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a  295 (436)
                      +|.+ |-||+++..-++.  .++...+.-+|.|+..-++|+|   +..+|.|||||+|+||...     ..+.++|||+|
T Consensus       103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9988 7799998876553  6899999999999999999999   8899999999999999753     34889999999


Q ss_pred             cccCCCCCC-------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccc
Q 013793          296 RRLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLL  351 (436)
Q Consensus       296 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~  351 (436)
                      +.+.+....       .....||..||+-..+.+.+-+.+-|.-|+|-++...+-|..||..+
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            988554322       23467999999999999999999999999999999999999999754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-23  Score=211.98  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=179.9

Q ss_pred             cccccceeeecCceEEEEEEcCCCCEEEEEEecCcc-hhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++...+.||.+.|=+|.+|+...|. |+||++-... .-.-...++...|++ ...++|||.+++.-+-......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777888999999999999998888 7899885543 222211233333444 555689999999888777777888889


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc--CC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL--HA  300 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~--~~  300 (436)
                      |..+ +|++.+..+.   -+...+.+.|+.|++.||.-+|   ..||+|||||.+|||++.-.-+.|+||..-+..  ..
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8866 8999997654   5777888899999999999999   899999999999999999989999999876533  22


Q ss_pred             CCC-Ccccc----ccccccccccccccC-----------ccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccc
Q 013793          301 DSS-NRTLL----AGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       301 ~~~-~~~~~----~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  363 (436)
                      ++. ....+    ..-..|+|||.+...           ..+++-||||+||++.||++ |++||+..+-+.........
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            221 11111    223479999977541           15778999999999999997 68888743322211111111


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQG  411 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~  411 (436)
                      ....+.. +..          ..+.+++..|++.||++|.++++.++.
T Consensus       255 ~e~~Le~-Ied----------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEK-IED----------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHh-CcC----------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111111 111          125678899999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2e-21  Score=171.16  Aligned_cols=143  Identities=22%  Similarity=0.293  Sum_probs=111.5

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhh-----------------------HHHHHHHHHHHHHHhhccCCCc
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-----------------------LAFIKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~h~ni  204 (436)
                      ...||+|++|.||+|...+|+.||||+++......                       ......+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999988799999999987652110                       0001234678999999999987


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhh-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCI-LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      .....+....  .++||||++++++... +..    ..++..+...++.+++.++.++|+  ..||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence            5544443332  4899999998865433 332    257788899999999999999993  28999999999999999 


Q ss_pred             CCCeEEeecccccccC
Q 013793          284 KLEAFVADFGTARRLH  299 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~  299 (436)
                      ++.++|+|||+++...
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=4.3e-22  Score=193.35  Aligned_cols=214  Identities=28%  Similarity=0.467  Sum_probs=160.9

Q ss_pred             HhhccCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 013793          196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  275 (436)
Q Consensus       196 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  275 (436)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+...  ...++|.-...++++++.||+|+|+  ++...||.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            35678999999999999999999999999999999999873  3479999999999999999999995  4444999999


Q ss_pred             CCceeecCCCCeEEeecccccccCC--CCCCccccccccccccccccccC-------ccCcchhhHHHHHHHHHHHhCCC
Q 013793          276 SNNILLNSKLEAFVADFGTARRLHA--DSSNRTLLAGTYGYIAPELAYTM-------VMTEKCDVYSFGVVTLEVLMGKH  346 (436)
Q Consensus       276 ~~Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~il~elltg~~  346 (436)
                      ++|+++|..+.+|++|||+......  ............-|.|||.+...       ..+.++||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999999999999999987642  11112222345579999988764       14678999999999999999999


Q ss_pred             CccccccccCCCCcccchhhhhc-C--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          347 PRDLLSSLSSSSDPKIMLIDVLD-Q--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       347 p~~~~~~~~~~~~~~~~~~~~~~-~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ||+.......   ++.....+.+ .  .+.+...... +....+..++..||..+|.+||++++|-..+.-...
T Consensus       157 ~~~~~~~~~~---~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVED---PDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCC---hHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9974322111   1112222222 1  1222222111 222347789999999999999999999877755444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.3e-20  Score=163.89  Aligned_cols=186  Identities=14%  Similarity=0.092  Sum_probs=140.1

Q ss_pred             cccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhH-HHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEEee
Q 013793          146 HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL-AFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      .+...|++|+||+||.+.. ++..++.+.+........ .....+.+|+++|.++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999998766 677888887776654221 11235789999999995 5889999886    346899999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCCeEEeecccccccCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI-SSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      +.|.+|......          ....++.+++++|.++|   ..||+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654321          12357789999999999   889999999 7999999999999999999998654433


Q ss_pred             CC-------------ccccccccccccccccccC-ccC-cchhhHHHHHHHHHHHhCCCCcc
Q 013793          303 SN-------------RTLLAGTYGYIAPELAYTM-VMT-EKCDVYSFGVVTLEVLMGKHPRD  349 (436)
Q Consensus       303 ~~-------------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~G~il~elltg~~p~~  349 (436)
                      ..             ......++.|++|+...-. ..+ ...+.++-|.-+|.++||+.+..
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            21             0012257778888754322 223 56788999999999999998854

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=1e-20  Score=173.18  Aligned_cols=236  Identities=20%  Similarity=0.262  Sum_probs=148.9

Q ss_pred             cccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC----------CCceeeeeEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH----------RSIVKLYGFCL  212 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~  212 (436)
                      .+...+.||.|+++.||.+... +++.+|+|+............+++.+|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455778999999999999765 689999999876554444445777777765555322          12222222221


Q ss_pred             ---------eCC--------EEEEEEeeccCCChhhhhcc---C-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 013793          213 ---------HKK--------CMFLIYEYMERGSLFCILHN---D-DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH  271 (436)
Q Consensus       213 ---------~~~--------~~~lv~e~~~~g~L~~~l~~---~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  271 (436)
                               ...        ..+++|+-+ .++|.+++..   . .....+....++.+..|+.+.+++||   ..|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     111        235677777 4588777542   1 11223445666788899999999999   889999


Q ss_pred             cCCCCCceeecCCCCeEEeecccccccCCCCCCcccccccccccccccccc--------CccCcchhhHHHHHHHHHHHh
Q 013793          272 RDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT--------MVMTEKCDVYSFGVVTLEVLM  343 (436)
Q Consensus       272 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~il~ellt  343 (436)
                      +||+|+|++++.+|.+.|+||+.....+...   .....+..|.+||....        ..++.+.|.|++|+++|.|.+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999999876543211   11334578999997644        257889999999999999999


Q ss_pred             CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCC
Q 013793          344 GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSR  402 (436)
Q Consensus       344 g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R  402 (436)
                      |+.||+.........   .    .+..  ..       .....+..|+..+|+.||.+|
T Consensus       246 ~~lPf~~~~~~~~~~---~----~f~~--C~-------~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE---W----DFSR--CR-------DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG---G----GGTT--SS----------HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc---c----cchh--cC-------CcCHHHHHHHHHHccCCcccC
Confidence            999998432211110   0    0110  00       122336789999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.6e-22  Score=193.97  Aligned_cols=226  Identities=26%  Similarity=0.356  Sum_probs=178.1

Q ss_pred             eeecCceEEEEEE----cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEEeecc
Q 013793          151 IGTGGYGSVYKAQ----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       151 lg~G~~g~Vy~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      +|+|.||.|+.++    ...|..+|+|+++......... .....|..++..++ ||.+|++...+..+...+++.+|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            7999999999873    3457788999887654332221 24456778888886 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR  305 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  305 (436)
                      +|.|...+....   .++......+...++-+++++|   ..+|+|||+|++||+++.+|.+++.|||+++..-..... 
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999998887654   5677777888889999999999   899999999999999999999999999999876443322 


Q ss_pred             cccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHH
Q 013793          306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDIL  385 (436)
Q Consensus       306 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  385 (436)
                         +||..|||||...  .....+|.||||++++||+||..||..           .....++...+..+.     ....
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~~p~-----~l~~  212 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELEMPR-----ELSA  212 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccCCch-----hhhH
Confidence               7999999999998  456789999999999999999999863           112233332332221     2233


Q ss_pred             HHHHHHhhccCCCCCCCCCH
Q 013793          386 LASTISFACLQSNPKSRPTM  405 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RPt~  405 (436)
                      .+..++..++..+|..|.-.
T Consensus       213 ~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  213 EARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHhhCHHHHhcc
Confidence            45677888889999998865

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=4.6e-20  Score=191.28  Aligned_cols=199  Identities=25%  Similarity=0.300  Sum_probs=159.2

Q ss_pred             HHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      .-.+.|.+...+|+|+||+||+|...+|+.||+|+-+.....+.....+++..+. ...  -+.|..+...+.-.+.-++
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHHccCCccee
Confidence            3456788899999999999999988889999999988876654333333333333 111  2344455555556677889


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-------CCCeEEeec
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KLEAFVADF  292 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~Df  292 (436)
                      |+||.+.|+|.+++...   ..++|...+.++.|+++.+..||   ..+||||||||+|++|..       ..-++|+||
T Consensus       772 v~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            99999999999999844   37999999999999999999999   889999999999999942       345899999


Q ss_pred             ccccccCC--CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCC
Q 013793          293 GTARRLHA--DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  347 (436)
Q Consensus       293 g~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  347 (436)
                      |-+-.+..  +.......++|-++--+|+..++.++...|.|.++.+++-|+.|+.-
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99875532  33344556788999999999999999999999999999999999854

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=4.9e-19  Score=156.91  Aligned_cols=135  Identities=18%  Similarity=0.192  Sum_probs=105.1

Q ss_pred             ccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-----cCCCceeeeeEEeeCC---E-E
Q 013793          147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-----LHRSIVKLYGFCLHKK---C-M  217 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~  217 (436)
                      -...||+|+||.||.  ++.....+||++.......   .+.+.+|+.++..+     .||||++++|++.++.   . .
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~---~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGG---DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccch---HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            356799999999996  5443444799887643322   36789999999999     5799999999999874   3 4


Q ss_pred             EEEEee--ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceeecC----CCCeEEe
Q 013793          218 FLIYEY--MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL-AYLHHDCSPSIIHRDISSNNILLNS----KLEAFVA  290 (436)
Q Consensus       218 ~lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~  290 (436)
                      .+|+||  +++|+|.+++...    .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +..++|+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            478999  6689999999653    34444  35678888777 9999   889999999999999974    3479999


Q ss_pred             ecccc
Q 013793          291 DFGTA  295 (436)
Q Consensus       291 Dfg~a  295 (436)
                      ||+-+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-19  Score=165.52  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=167.3

Q ss_pred             hhcccccceeeecCceEEEEEEcCC-C-----------------------------------CEEEEEEecCcch--hhH
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN-G-----------------------------------KVFALKKLHTSET--EEL  183 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----------------------------------~~vavK~l~~~~~--~~~  183 (436)
                      .++|++.+.||+|....||.+++++ |                                   -+.|+|.+..-+.  ...
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~  235 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA  235 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence            4568899999999999999986543 0                                   0246676643322  222


Q ss_pred             HHHHHHHHHHH--------------HHhh--------ccCCCceeeeeEEee---------------------------C
Q 013793          184 AFIKSFRNEAQ--------------VLSQ--------VLHRSIVKLYGFCLH---------------------------K  214 (436)
Q Consensus       184 ~~~~~~~~e~~--------------~l~~--------l~h~niv~l~~~~~~---------------------------~  214 (436)
                      ...+.+.+|..              ..+.        -+|||||++.++|.+                           +
T Consensus       236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~  315 (598)
T KOG4158|consen  236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP  315 (598)
T ss_pred             HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence            33344433321              1111        369999999987764                           2


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--cCCCC--eEEe
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL--NSKLE--AFVA  290 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill--~~~~~--~kl~  290 (436)
                      ...|+||...+. +|..++-.+    ..+...+.-|+.|+++|+.|||   .+||.|||+|++|||+  |+|..  ..|+
T Consensus       316 ~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVva  387 (598)
T KOG4158|consen  316 KTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVA  387 (598)
T ss_pred             ceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEc
Confidence            247888887765 888888654    3566777889999999999999   8899999999999998  45544  5689


Q ss_pred             ecccccccCC------CCCCccccccccccccccccccCc------cCcchhhHHHHHHHHHHHhCCCCccccccccCCC
Q 013793          291 DFGTARRLHA------DSSNRTLLAGTYGYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS  358 (436)
Q Consensus       291 Dfg~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  358 (436)
                      |||.+-.-..      -.+......|...-||||+.....      .-.|+|.|+.|.+.||+++...||.......-..
T Consensus       388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~  467 (598)
T KOG4158|consen  388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT  467 (598)
T ss_pred             ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence            9998743211      011223456788899999886542      1358999999999999999999986422111000


Q ss_pred             CcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 013793          359 DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ  410 (436)
Q Consensus       359 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~  410 (436)
                         ...++.--+.++...       ...+.+++...++.||++|++..-...
T Consensus       468 ---r~Yqe~qLPalp~~v-------pp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  468 ---RTYQESQLPALPSRV-------PPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             ---hhhhhhhCCCCcccC-------ChHHHHHHHHHhcCCccccCCccHHHh
Confidence               111222222222222       223667888999999999999765543

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=1e-18  Score=158.66  Aligned_cols=145  Identities=21%  Similarity=0.220  Sum_probs=111.8

Q ss_pred             hcccccceeeecCceEEEEEE--cCCCCEEEEEEecCcchhh---------------------HHHHHHHHHHHHHHhhc
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEE---------------------LAFIKSFRNEAQVLSQV  199 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~~---------------------~~~~~~~~~e~~~l~~l  199 (436)
                      .-|.+.+.||+|++|.||+|.  ..+|+.||+|.+.......                     ......+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347788999999999999998  5789999999987543110                     00113467899999999


Q ss_pred             cCCC--ceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 013793          200 LHRS--IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS-IIHRDISS  276 (436)
Q Consensus       200 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlk~  276 (436)
                      .+.+  +.+++++    ...++||||+++++|........   .+...+...++.|++.++++||   ..+ ++||||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            7533  3344443    23489999999988876653222   3555667899999999999999   788 99999999


Q ss_pred             CceeecCCCCeEEeeccccccc
Q 013793          277 NNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       277 ~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.5e-18  Score=154.14  Aligned_cols=147  Identities=19%  Similarity=0.229  Sum_probs=112.7

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhH-------------------HHHHHHHHHHHHHh
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL-------------------AFIKSFRNEAQVLS  197 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-------------------~~~~~~~~e~~~l~  197 (436)
                      ++......|.+.+.||+|+||.||++..++|+.||||++........                   ........|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444444778899999999999999888999999998765321100                   01123677889999


Q ss_pred             hccCCC--ceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 013793          198 QVLHRS--IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  275 (436)
Q Consensus       198 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  275 (436)
                      .+.|++  +...++.    ...++||||+++++|......         .....++.+++.++.++|   ..+++||||+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCC
Confidence            998774  4444432    345899999999998765431         235578899999999999   7899999999


Q ss_pred             CCceeecCCCCeEEeecccccccC
Q 013793          276 SNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       276 ~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |+||++++++.++|+|||.+....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999996553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=2e-18  Score=154.91  Aligned_cols=137  Identities=20%  Similarity=0.326  Sum_probs=114.6

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchh-----hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      +.||+|++|.||+|.. +|..+++|+.......     .......+.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 6778899986643221     111224678899999999999998888887777888999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|++|.+++....      + .+..++.+++.+|.++|   ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986432      2 78899999999999999   88999999999999999 78899999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=9.7e-20  Score=173.90  Aligned_cols=179  Identities=25%  Similarity=0.374  Sum_probs=140.7

Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++.|++|...+|.+|+.........++...+.++.|++.|+.|      .+.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999877777788999999999999999999      47899999999999999999999999999


Q ss_pred             cccCCCC------CCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh
Q 013793          296 RRLHADS------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       296 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      .......      ...+...||..||+||.+.+..|+.|+||||+|++|+|++. =..+++.          .....++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence            8775544      12345679999999999999999999999999999999997 3333321          11233334


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +..+++....+...    -..|+.+++.+.|.+||++.++..+.|.
T Consensus       474 ~g~ip~~~~~d~p~----e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  474 DGIIPPEFLQDYPE----EYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cCCCChHHhhcCcH----HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            44444322221111    2367789999999999987777766653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=5.2e-18  Score=150.79  Aligned_cols=133  Identities=20%  Similarity=0.354  Sum_probs=108.2

Q ss_pred             eeeecCceEEEEEEcCCCCEEEEEEecCcch-----hhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      .||+|+||.||+|.. +|..+++|.......     ........+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 678899998654321     11122356788999999999887766666666667779999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      +|++|.+.+....   .       .++.+++.+|.+||   +.+++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH---H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875432   0       78999999999999   88999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=4.7e-18  Score=173.27  Aligned_cols=143  Identities=19%  Similarity=0.282  Sum_probs=113.9

Q ss_pred             HHhhcccccceeeecCceEEEEEEcCCCCEEEEEEe-cCc-c---hhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKL-HTS-E---TEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l-~~~-~---~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      .....|...+.||+|+||+||+|.+.+... ++|+. ... .   .........+.+|++++..++|++++....++...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~-v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDA-VIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCccc-eeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            334555678899999999999998755443 34432 211 1   11112235688999999999999999888888877


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++||||+++++|.+++.           ....++.+++++|.+||   +.+++||||||+||++ +++.++|+|||+
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            78899999999999988874           35679999999999999   8899999999999999 577899999999


Q ss_pred             cccc
Q 013793          295 ARRL  298 (436)
Q Consensus       295 a~~~  298 (436)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            9753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=7.1e-17  Score=141.98  Aligned_cols=139  Identities=20%  Similarity=0.234  Sum_probs=99.8

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHH---------------------HHHHHHHHHhhccCCC--c
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------------------SFRNEAQVLSQVLHRS--I  204 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~---------------------~~~~e~~~l~~l~h~n--i  204 (436)
                      .+.||+|+||+||+|...+++.||||++............                     ....|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998888999999998764322111111                     1135666666665443  3


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhh-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeec
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCI-LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLN  282 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~dlk~~Nill~  282 (436)
                      .+.++.    ...++||||++++.+... +....    .. .+...++.+++.++.++|   . .+|+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence            444433    235899999999654321 21111    11 567889999999999999   6 8999999999999999


Q ss_pred             CCCCeEEeecccccccC
Q 013793          283 SKLEAFVADFGTARRLH  299 (436)
Q Consensus       283 ~~~~~kl~Dfg~a~~~~  299 (436)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=6.1e-18  Score=172.68  Aligned_cols=209  Identities=27%  Similarity=0.361  Sum_probs=141.0

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|+.++.+..|++|.||.++++ ..+.+|+| +++...       -+++   ++.....|.+|               
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc---cccccCCccee---------------
Confidence            467888999999999999999876 46678884 333221       1111   33333444444               


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                            |+-...+...+   +++..        ++.+++|||   +.+|+|||+||+|.+|+.-|++|+.|||+.+..-.
T Consensus       136 ------gDc~tllk~~g---~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ------GDCATLLKNIG---PLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ------chhhhhcccCC---CCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                  34444444332   23322        278899999   89999999999999999999999999999875421


Q ss_pred             CC---------------CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchh
Q 013793          301 DS---------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       301 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  365 (436)
                      ..               ......+||+.|+|||++....|...+|+|++|+|+||.+-|+.||...       .++..+.
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-------tpeelfg  268 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFG  268 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-------CHHHHHh
Confidence            11               0123357999999999999999999999999999999999999998632       1111122


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCH
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTM  405 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~  405 (436)
                      .++...+.-+..  ......++.+++.+.|+.+|.+|--.
T Consensus       269 ~visd~i~wpE~--dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  269 QVISDDIEWPEE--DEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             hhhhhhcccccc--CcCCCHHHHHHHHHHHHhChHhhccc
Confidence            222111111110  11112235678888999999999643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=3.7e-16  Score=131.92  Aligned_cols=134  Identities=19%  Similarity=0.185  Sum_probs=113.7

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeeeEEeeCCEEEEEEeecc
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      .+.||+|.++.||++...+ ..+++|.......     ...+.+|...+..++|  .++++++++....+..++++||++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            5679999999999998755 7889999876543     2568889999999976  589999998888888999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++.+..+          +......++.+++++++++|.....+++|||++|+||++++++.++++|||.+..
T Consensus        77 g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8877543          4567778899999999999954446899999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.6e-15  Score=138.12  Aligned_cols=139  Identities=19%  Similarity=0.268  Sum_probs=106.1

Q ss_pred             cceee-ecCceEEEEEEcCCCCEEEEEEecCcch----------hhHHHHHHHHHHHHHHhhccCCCc--eeeeeEEeeC
Q 013793          148 KYCIG-TGGYGSVYKAQLPNGKVFALKKLHTSET----------EELAFIKSFRNEAQVLSQVLHRSI--VKLYGFCLHK  214 (436)
Q Consensus       148 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  214 (436)
                      ...|| .|+.|+||.+... +..++||.+.....          ........+.+|++++..++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999874 67789998854221          001123567889999999998875  6677765443


Q ss_pred             C----EEEEEEeeccC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          215 K----CMFLIYEYMER-GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       215 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                      .    ..++|+||++| .+|.+++...    .++..    .+.+++.++.+||   ..||+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6898888642    34433    3678999999999   899999999999999999999999


Q ss_pred             eeccccccc
Q 013793          290 ADFGTARRL  298 (436)
Q Consensus       290 ~Dfg~a~~~  298 (436)
                      +|||.++..
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=2.5e-17  Score=167.65  Aligned_cols=262  Identities=21%  Similarity=0.253  Sum_probs=192.9

Q ss_pred             hcccccceeeecCceEEEEEEcCC--CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  219 (436)
                      ..|.+.+.||+|.|+.|-......  ...+|+|.+..... ..........|..+-..+. |+|++++++.....+..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~-~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK-SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC-ccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            356667779999999998886533  34566666655431 1122345556777777776 9999999999999999999


Q ss_pred             EEeeccCCChhhhh-ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeecccccc
Q 013793          220 IYEYMERGSLFCIL-HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARR  297 (436)
Q Consensus       220 v~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~  297 (436)
                      +.+|..++++.+.+ +...  ...+....-.++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999999888 4322  135556777899999999999995  56899999999999999999 999999999998


Q ss_pred             cCC-CCCC--cccccc-ccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          298 LHA-DSSN--RTLLAG-TYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       298 ~~~-~~~~--~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      +.. .+..  .....| ++.|.|||...+. ......|+||.|+++.-+++|..|++....-.      .....+.....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------~~~~~~~~~~~  248 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------GRYSSWKSNKG  248 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc------ccceeeccccc
Confidence            765 3322  233457 9999999999884 55678999999999999999999987433211      11111111110


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .. ....+........++..+++..+|..|.+.+++....|...
T Consensus       249 ~~-~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  249 RF-TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cc-ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            00 00001111222556778899999999999999999999988

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=2.3e-14  Score=141.59  Aligned_cols=145  Identities=23%  Similarity=0.269  Sum_probs=102.0

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHH-------------------------------H------HHHHH
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-------------------------------F------IKSFR  190 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~-------------------------------~------~~~~~  190 (436)
                      .+.||.|++|.||+|++++|+.||||+.++.......                               .      .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998765322110                               0      01244


Q ss_pred             HHHHHHhhcc----CCCceeeeeEEe-eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 013793          191 NEAQVLSQVL----HRSIVKLYGFCL-HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH-ALAYLHHD  264 (436)
Q Consensus       191 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~  264 (436)
                      +|...+.+++    |.+-+.+-..+. .....++||||++|++|.+.......  ..   .+..++..++. .+..+|  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH--
Confidence            5555555552    333333333332 23457999999999999887653211  12   24456666666 467788  


Q ss_pred             CCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       265 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                       ..|++|+|++|.||++++++.++++|||++..+..
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             78999999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=2e-14  Score=129.75  Aligned_cols=208  Identities=23%  Similarity=0.350  Sum_probs=143.7

Q ss_pred             HHHhhccCCCceeeeeEEeeCC-----EEEEEEeeccCCChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 013793          194 QVLSQVLHRSIVKLYGFCLHKK-----CMFLIYEYMERGSLFCILHNDDE-AVELDWAKRVNIVKAMAHALAYLHHDCSP  267 (436)
Q Consensus       194 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  267 (436)
                      .-+-++.|.|||++..|+.+..     ...++.|||..|++..+|++... ...+....-.+++.||..||.|||. |++
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            3455667999999998887643     47899999999999999986433 3356667777999999999999996 589


Q ss_pred             CeEecCCCCCceeecCCCCeEEeecccccccCC----CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh
Q 013793          268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHA----DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM  343 (436)
Q Consensus       268 ~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt  343 (436)
                      +|+|+++..+-|++..++-+|++----......    .......-.+.++|.|||+-.....+.++|||+||+..+||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999999888742111110000    0001112346789999999888888899999999999999988


Q ss_pred             CCCCc-cccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          344 GKHPR-DLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       344 g~~p~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      |..-- ...+    ....+......+ ..+....          -..++.+|++..|..||+|++.+.|+.....
T Consensus       278 lEiq~tnseS----~~~~ee~ia~~i-~~len~l----------qr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  278 LEIQSTNSES----KVEVEENIANVI-IGLENGL----------QRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             heeccCCCcc----eeehhhhhhhhe-eeccCcc----------ccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            76431 1100    111111111110 0011111          1245678999999999999999998865544

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=2.9e-13  Score=135.42  Aligned_cols=149  Identities=17%  Similarity=0.203  Sum_probs=95.3

Q ss_pred             hhcccccceeeecCceEEEEEEcCC-CCEEEEEEecCcchhh-------------------------------HHHHHH-
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEE-------------------------------LAFIKS-  188 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~-------------------------------~~~~~~-  188 (436)
                      -.+|+. +.||.|++|.||+|++++ |+.||||+.++.-...                               .+..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999887 9999999998652111                               011122 


Q ss_pred             -----HHHHHHHHhhcc----CCCceeeeeEEee-CCEEEEEEeeccCCChhhhh--ccCCCCCCCCHHHHHHHHHHHHH
Q 013793          189 -----FRNEAQVLSQVL----HRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCIL--HNDDEAVELDWAKRVNIVKAMAH  256 (436)
Q Consensus       189 -----~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~l~~~~~~~i~~~ia~  256 (436)
                           +.+|...+.+++    +.+.+.+-..+.+ ....++||||++|+.+.+.-  ...+    .+   +..++...++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d---~~~la~~~v~  270 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TD---MKLLAERGVE  270 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CC---HHHHHHHHHH
Confidence                 334444444442    3344444444433 44578999999999997642  2211    11   1122222221


Q ss_pred             HHHHHHhcCCCCeEecCCCCCceeecCCC----CeEEeecccccccCC
Q 013793          257 ALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFGTARRLHA  300 (436)
Q Consensus       257 ~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~  300 (436)
                      .  |+++-...|++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       271 ~--~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 V--FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H--HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            1  12222256999999999999999988    899999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=9.9e-13  Score=113.57  Aligned_cols=131  Identities=21%  Similarity=0.210  Sum_probs=94.9

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCce-eeeeEEeeCCEEEEEEeeccC
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV-KLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .+.++.|.++.||++... +..+++|........    ...+..|++++..+.+.+++ +++.+.  ....++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            356889999999999875 778999987655321    13457888999888665554 344433  2335799999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      .++...-           .....++.+++++|+.||...  ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Ccccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            8875430           112345678999999999421  12359999999999999 66899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=1.3e-11  Score=122.05  Aligned_cols=234  Identities=13%  Similarity=0.125  Sum_probs=150.2

Q ss_pred             EcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCC
Q 013793          163 QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVEL  242 (436)
Q Consensus       163 ~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l  242 (436)
                      +..++.+|.|........   .......+-++.|+.+|||||++++..+...+..|||+|.+.  -|..++..      +
T Consensus        33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l  101 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L  101 (690)
T ss_pred             eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence            445788888888776554   123556778889999999999999999999999999999874  45555543      2


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcccccccccccccccccc
Q 013793          243 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT  322 (436)
Q Consensus       243 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  322 (436)
                      +.....-.+.||+.||.|||+  ..+++|++|.-..|+++..|+.||++|.++..............---.|..|+.+..
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence            345556678999999999997  558999999999999999999999999988654332211111222234666665433


Q ss_pred             CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCC
Q 013793          323 MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSR  402 (436)
Q Consensus       323 ~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R  402 (436)
                      ..  -..|.|-||++++|++.|..+-  ..+......-.........+.+....    ..... ..+++..|....+-.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng~~~~--~~~~~~~~~ipk~~~~~~~k~~~~~~----~~r~n-~~~~~~~~~~~~gff~  250 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNGSLLT--KTDLSNTGKIPKALIELYCKKLGATE----LKRPN-KLRFILECRLLGGFFR  250 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCcccCc--chhhhccCccchhHHHHHHHHhcccc----ccccc-hhhHHHHHHhcccccc
Confidence            32  3469999999999999993321  11111000000011111111111000    00011 3355666777777777


Q ss_pred             CCHHHHHHHHhhcCCC
Q 013793          403 PTMQYVSQGFLITRKT  418 (436)
Q Consensus       403 Pt~~ev~~~l~~~~~~  418 (436)
                      =..-+++..++..+-+
T Consensus       251 n~fvd~~~fLeel~lk  266 (690)
T KOG1243|consen  251 NDFVDTLLFLEELRLK  266 (690)
T ss_pred             chHHHHHHHHHhcccC
Confidence            7777777766655443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1e-12  Score=128.37  Aligned_cols=251  Identities=25%  Similarity=0.272  Sum_probs=177.2

Q ss_pred             cccccceeee--cCceEEEEEEc---CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          144 DFHIKYCIGT--GGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       144 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      .|.+...+|.  |.+|.+|.+..   .++..+|+|+-+........ ...=.+|+.....+ .|+|.++....+...+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcc
Confidence            3455677999  99999999966   46888999984433221110 12334566666666 499999988888889999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeec
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADF  292 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df  292 (436)
                      ++-+|++. .+|.++.+....  .++....+.+..+..+    ||.++|   +.+++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence            99999885 688887775432  3566677777777777    999999   8999999999999999999 88999999


Q ss_pred             ccccccCCCCCCccc-----cccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccc--ccccCCCCcccchh
Q 013793          293 GTARRLHADSSNRTL-----LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLL--SSLSSSSDPKIMLI  365 (436)
Q Consensus       293 g~a~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~--~~~~~~~~~~~~~~  365 (436)
                      |+...+.........     ..|..-|++||...+. ++..+|+|++|.++++..++-.+...-  ..+.          
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~----------  336 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS----------  336 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcc----------
Confidence            999988765432222     2577789999986544 678899999999999999987664311  0000          


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +.-...++.+....   ....+......+++.+|-.|++.+.+..+....
T Consensus       337 ~~r~~~ip~e~~~~---~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEG---GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             ccccccCchhhhcC---cchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            00000011111111   111123366789999999999999998765544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=5.3e-11  Score=103.78  Aligned_cols=139  Identities=19%  Similarity=0.209  Sum_probs=98.7

Q ss_pred             ceeeecCceEEEEEEcCC-------CCEEEEEEecCcchh-------------------hHHHHHHH----HHHHHHHhh
Q 013793          149 YCIGTGGYGSVYKAQLPN-------GKVFALKKLHTSETE-------------------ELAFIKSF----RNEAQVLSQ  198 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~-------------------~~~~~~~~----~~e~~~l~~  198 (436)
                      ..||.|.-+.||.|...+       +..+|||+.+.....                   .....+.+    .+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997553       478999986432100                   00011233    389999999


Q ss_pred             ccC--CCceeeeeEEeeCCEEEEEEeeccCCChhh-hhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 013793          199 VLH--RSIVKLYGFCLHKKCMFLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYL-HHDCSPSIIHRDI  274 (436)
Q Consensus       199 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dl  274 (436)
                      +..  -++..++++    ...++||||+.++.+.. .+...    .++..+...+..+++.+|..| |   ..+++||||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            954  456666654    45689999998754422 22221    344456677889999999999 6   779999999


Q ss_pred             CCCceeecCCCCeEEeecccccccC
Q 013793          275 SSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       275 k~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ++.||++++ +.+.|+|||.+....
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCC
Confidence            999999974 679999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.28  E-value=4.7e-12  Score=130.88  Aligned_cols=73  Identities=38%  Similarity=0.550  Sum_probs=39.2

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccc-cccCccccCCCCCCCCCcccCCCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQL-SSMSRVRLSPNKGLCGNFITLPSCDA   75 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l-~~l~~~~~~~n~~lcg~~~~~~~c~~   75 (436)
                      ++|+.|||++|+|+|.+|.++++|++|+.|+|++|+|+|.+|..++.+ .++..+++.+|+++||.+ ....|..
T Consensus       466 ~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~~  539 (623)
T PLN03150        466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGP  539 (623)
T ss_pred             CCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCcc
Confidence            345555555555555555555555555555555555555555544332 234455666677788754 3456754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.28  E-value=8e-13  Score=135.81  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=167.3

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..+.+.+.+-+.+|.++.+..+.-. .|...+.|.......-.....+....+-.++-..++|-++....-+.-.....|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456667777888999998877422 343333333322111100001222223333333455666655555555667899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |++|..+++|...++..+   ..+..-....+..+..+++|||   ...+.|+|++|.|.+...++..+++|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999998765   4555566677788899999999   7779999999999999999999999998443221


Q ss_pred             CC----------C---------------------CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCc
Q 013793          300 AD----------S---------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR  348 (436)
Q Consensus       300 ~~----------~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  348 (436)
                      .-          .                     .......||+.|.+||...+......+|.|++|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00          0                     0012245899999999999999999999999999999999999998


Q ss_pred             cccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 013793          349 DLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ  406 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~  406 (436)
                      ..       ..+...+..+....++.+..  .........+++...+..+|.+|-.|.
T Consensus      1036 na-------~tpq~~f~ni~~~~~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NA-------ETPQQIFENILNRDIPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CC-------cchhhhhhccccCCCCCCCC--ccccChhhhhhhhhhhccCchhccCcc
Confidence            62       22223333333333332221  122233355677788889999998876

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=6.5e-11  Score=99.77  Aligned_cols=133  Identities=20%  Similarity=0.309  Sum_probs=102.2

Q ss_pred             eeeecCceEEEEEEcCCCCEEEEEEecCc-----chhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          150 CIGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      .+++|+-+.+|.+.+.+.. +++|.=.++     ..+..-....-.+|..++.+++--.|....=+..+.....|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999775433 555543222     2222222345678999999998767766666777788889999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      +|-.|.+.+...          ...++..+-.-+.-||   ..||+||||.++||.++.+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999998888654          2457777888889999   89999999999999998875 99999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=3.9e-12  Score=124.43  Aligned_cols=252  Identities=21%  Similarity=0.203  Sum_probs=176.2

Q ss_pred             HhhcccccceeeecCceEEEEEEc--CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      -+.+|..+..||.|.|+.|+....  .++..|++|.+..........+.. ..|+-+...+ .|.+++.....+......
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccccc
Confidence            356788889999999999999843  578899999887664433322222 3355555555 588888887777777777


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeeccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTAR  296 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~  296 (436)
                      ++--||++++++.....-   ...++...++++..+++.++.++|   +..++|+|+||+||++..+ +.-+++|||.++
T Consensus       342 ~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            799999999988766622   235777889999999999999999   8999999999999999886 788899999987


Q ss_pred             ccCCCCCCccccccccccc--cccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYI--APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .+....   ......-++.  +++......+..+.|++|||.-+.|.++|..--+...          ....+.....+.
T Consensus       416 ~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~~p~  482 (524)
T KOG0601|consen  416 RLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGDTPN  482 (524)
T ss_pred             ccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeecccccC
Confidence            532111   1122233344  5555566678889999999999999999975432110          111111121221


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .... .    ..+..+...+..+++..||.+.+...+..+.+.
T Consensus       483 ~~~~-~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  483 LPGL-K----LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             CCch-H----HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            1111 1    224456667899999999999998887766543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=6.7e-11  Score=106.72  Aligned_cols=143  Identities=21%  Similarity=0.251  Sum_probs=110.7

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeeeEEeeCC---EEEEEEee
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYGFCLHKK---CMFLIYEY  223 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~  223 (436)
                      +.|+.|.++.+|++...+|+.+++|.........  ....+..|.+++..+++  .++.+++.+.....   ..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~--~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP--SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCc--ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            4589999999999988777899999986643210  12567889999999975  34567777776643   56899999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC--------------------------------------  265 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------  265 (436)
                      ++|.++.+.+..    ..++..+...++.+++++|..||+..                                      
T Consensus        82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999988776532    14677788888889999999998421                                      


Q ss_pred             ---------------CCCeEecCCCCCceeecC--CCCeEEeecccccc
Q 013793          266 ---------------SPSIIHRDISSNNILLNS--KLEAFVADFGTARR  297 (436)
Q Consensus       266 ---------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~  297 (436)
                                     ...++|||+++.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           245799999999999998  66688999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=2.3e-10  Score=96.03  Aligned_cols=146  Identities=18%  Similarity=0.229  Sum_probs=106.4

Q ss_pred             ccceeeecCceEEEEEEcCCCCEEEEEEecCc-----chhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ....+-+|+-+.|+++.+ .|+...||.=..+     ..+..-..+...+|.+.+.+++--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456789999999999988 5676667643322     2222222356778999999997666666566666777778999


Q ss_pred             eeccC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eEEeecccccc
Q 013793          222 EYMER-GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARR  297 (436)
Q Consensus       222 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~  297 (436)
                      ||++| .++.+++........ ........+..|-+.+.-||   ..+|+||||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 466777765432222 22223678899999999999   899999999999999976543   57999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.20  E-value=1.1e-09  Score=102.80  Aligned_cols=255  Identities=16%  Similarity=0.186  Sum_probs=159.3

Q ss_pred             ccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEE------ee-CCEEE
Q 013793          147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFC------LH-KKCMF  218 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~-~~~~~  218 (436)
                      ....||+|+-+.+|..---.+  .+.|+++.......      .+.++.|... .||-+-.-+.+=      -+ +....
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchhhc--hhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            356799999999997632122  24577766543221      1233444444 566543312111      11 22367


Q ss_pred             EEEeeccCCCh-hhhhc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          219 LIYEYMERGSL-FCILH---NDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       219 lv~e~~~~g~L-~~~l~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      +.|..+++..- ..++.   .........|.-.++.++.+|.+.+.||   ..|.+-||+.++|+|+++++.+.|.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence            78887776422 11221   2233446889999999999999999999   88999999999999999999999988654


Q ss_pred             ccccCCCCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhC-CCCccccccccCCCCccc------
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKI------  362 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~------  362 (436)
                      -.. ..++......+|...|.+||...     +-.-+...|-|.+|+++++++.| ++||...........+..      
T Consensus       164 fqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         164 FQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            432 23333344567899999999765     33456789999999999999986 999975433221111110      


Q ss_pred             c---hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHh
Q 013793          363 M---LIDVLDQRLPPPVDQKVIQDILLASTISFACLQS--NPKSRPTMQYVSQGFL  413 (436)
Q Consensus       363 ~---~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPt~~ev~~~l~  413 (436)
                      .   ..+.-....+++...........+..+..+|+..  ++.-|||++-.+..+-
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~  298 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD  298 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence            0   0011112223333322333333355667778765  3678999998877653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.8e-09  Score=93.90  Aligned_cols=129  Identities=23%  Similarity=0.360  Sum_probs=84.3

Q ss_pred             EEEEEEcCCCCEEEEEEecCcc-----------------------hhhHHHHHHHHHHHHHHhhccCC--CceeeeeEEe
Q 013793          158 SVYKAQLPNGKVFALKKLHTSE-----------------------TEELAFIKSFRNEAQVLSQVLHR--SIVKLYGFCL  212 (436)
Q Consensus       158 ~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  212 (436)
                      .||.|..++|..+|||......                       ...........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998999999999864321                       01111234567899999999765  455565442 


Q ss_pred             eCCEEEEEEeecc--CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          213 HKKCMFLIYEYME--RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY-LHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       213 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                         ...|||||++  |..+..+.. ..    ++..+...++.+++..+.. +|   ..||+||||.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-VD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-CG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh-cc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence               2469999998  544443332 21    2234556777888886665 46   7899999999999999988 9999


Q ss_pred             eecccccccC
Q 013793          290 ADFGTARRLH  299 (436)
Q Consensus       290 ~Dfg~a~~~~  299 (436)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.06  E-value=5.4e-09  Score=100.71  Aligned_cols=170  Identities=17%  Similarity=0.299  Sum_probs=129.5

Q ss_pred             CceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCEEEEEEeeccC-CC
Q 013793          155 GYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKCMFLIYEYMER-GS  228 (436)
Q Consensus       155 ~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~  228 (436)
                      -..+.||+. ..||..|+.|+++..+....   ..-..-+++++++.|+|+|++.+++..    ....++||+|.|+ ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            446789984 45899999999965543322   223346788999999999999988873    3468999999986 56


Q ss_pred             hhhhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          229 LFCILHNDD------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       229 L~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      |.++-....            .....++...|.++.|++.||.++|   +.|+..+-|.+.+|+++.+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEeccccee
Confidence            766543221            2235778899999999999999999   8899999999999999999999999999887


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  347 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  347 (436)
                      .+..+...              .+.   --.+-|.=.||.+++.|.||..-
T Consensus       442 vl~~d~~~--------------~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  442 VLQEDPTE--------------PLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eecCCCCc--------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            76544310              011   12466888999999999999643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=6.1e-09  Score=95.98  Aligned_cols=144  Identities=19%  Similarity=0.130  Sum_probs=102.6

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhH--------HHHHHHHHHHHHHhhccCCC--ceeeeeEEee-----
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL--------AFIKSFRNEAQVLSQVLHRS--IVKLYGFCLH-----  213 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~--------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  213 (436)
                      +.+-......|++..+ +|+.|.||..........        .....+.+|...+.++...+  .+.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455455555777766 678899998755442210        00114778999998885444  3445666643     


Q ss_pred             CCEEEEEEeeccCC-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-------CC
Q 013793          214 KKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KL  285 (436)
Q Consensus       214 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-------~~  285 (436)
                      ....++|+|++++. +|.+++.... ....+...+..++.+++..+.-||   ..||+|||++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999986 8888875321 123456677899999999999999   899999999999999975       46


Q ss_pred             CeEEeecccccc
Q 013793          286 EAFVADFGTARR  297 (436)
Q Consensus       286 ~~kl~Dfg~a~~  297 (436)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998854

>PLN03150 hypothetical protein; Provisional

Probab=98.94  E-value=1.1e-09  Score=113.43  Aligned_cols=63  Identities=33%  Similarity=0.560  Sum_probs=59.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGL   63 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~l   63 (436)
                      |++|+.|+|++|+|+|.+|.++++|++|+.|||++|+|+|.+|..+++|++|+.|++++|...
T Consensus       441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~  503 (623)
T PLN03150        441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS  503 (623)
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence            478999999999999999999999999999999999999999999999999999999998743

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=2.9e-10  Score=113.04  Aligned_cols=157  Identities=21%  Similarity=0.242  Sum_probs=104.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC---------ccccccccccccccccc
Q 013793          251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---------RTLLAGTYGYIAPELAY  321 (436)
Q Consensus       251 ~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~  321 (436)
                      +.+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+.+.........         .........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455699999997  889999999999999999999999999987544331110         01122456799999999


Q ss_pred             cCccCcchhhHHHHHHHHHHH-hCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCC
Q 013793          322 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPK  400 (436)
Q Consensus       322 ~~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~  400 (436)
                      +...+.++|+||+|+++|.+. .|+.-++..+....... .....+.-.........       .++.+=+.+++..++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~~~~~~~~~s~~~p-------~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNLLNAGAFGYSNNLP-------SELRESLKKLLNGDSA  254 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhcccccccccccccCc-------HHHHHHHHHHhcCCcc
Confidence            988999999999999999999 45544432211110000 00000100111111111       1234445678999999


Q ss_pred             CCCCHHHHHHHHhhcCC
Q 013793          401 SRPTMQYVSQGFLITRK  417 (436)
Q Consensus       401 ~RPt~~ev~~~l~~~~~  417 (436)
                      -||++.++...+++...
T Consensus       255 ~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  255 VRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             cCcchhhhhcccccCCc
Confidence            99999999888877554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=5e-08  Score=87.40  Aligned_cols=139  Identities=23%  Similarity=0.267  Sum_probs=97.1

Q ss_pred             ccccceeeecCceEEEEEEcCCCCEEEEEEecCcchh-----------------h--HHHHHHHHHHHHHHhhccCC--C
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-----------------E--LAFIKSFRNEAQVLSQVLHR--S  203 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~--~~~~~~~~~e~~~l~~l~h~--n  203 (436)
                      ..+.+.||-|.-+.||.|..++|.++|||.=+....+                 +  .-......+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3457889999999999999999999999953222110                 0  01124567899999998654  5


Q ss_pred             ceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       204 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      +.+.+++-    ...+||||++|--|...-        ++....-.++..|++-+.-.-   ..||+|||+++-||++++
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence            66666543    457999999986664322        122333344445555454444   568999999999999999


Q ss_pred             CCCeEEeeccccccc
Q 013793          284 KLEAFVADFGTARRL  298 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~  298 (436)
                      +|.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999766543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.82  E-value=2e-09  Score=75.66  Aligned_cols=60  Identities=35%  Similarity=0.464  Sum_probs=54.0

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+|+..-|..|.++++|++|++++|+++...|..|..+++|+.+++++|.
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            579999999999995444688999999999999999997777789999999999999985

...

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.72  E-value=9.4e-08  Score=95.44  Aligned_cols=144  Identities=22%  Similarity=0.251  Sum_probs=94.5

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhH-------------------------------HHH------HHHHH
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL-------------------------------AFI------KSFRN  191 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-------------------------------~~~------~~~~~  191 (436)
                      +.|+.++-|.||+|++++|+.||||+.++.-....                               +..      -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57899999999999999999999999876432211                               001      12334


Q ss_pred             HHHHHhhcc----CCCceeeeeEEee-CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcC
Q 013793          192 EAQVLSQVL----HRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA-YLHHDC  265 (436)
Q Consensus       192 e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~  265 (436)
                      |...+.+++    ...-+++-..|.+ .....|+|||++|-.+.+...-...  .++   +..++..++++.- -+-   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f~~q~~---  282 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAFLRQLL---  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHHHHHHH---
Confidence            444444442    2223333344443 4567899999999988887432211  233   3334443333322 111   


Q ss_pred             CCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       266 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ..|++|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            34899999999999999999999999999887654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.67  E-value=2.1e-07  Score=82.85  Aligned_cols=106  Identities=23%  Similarity=0.327  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHhhccCC--CceeeeeEEeeCC----EEEEEEeeccCC-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 013793          187 KSFRNEAQVLSQVLHR--SIVKLYGFCLHKK----CMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALA  259 (436)
Q Consensus       187 ~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~  259 (436)
                      ....+|...+..+...  .+.+.+++.....    ..++|+|++++. +|.+++....   ..+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence            4566788887777533  3456677766532    458999999984 7988887633   2555678899999999999


Q ss_pred             HHHhcCCCCeEecCCCCCceeecCCC---CeEEeeccccccc
Q 013793          260 YLHHDCSPSIIHRDISSNNILLNSKL---EAFVADFGTARRL  298 (436)
Q Consensus       260 ~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~  298 (436)
                      -||   ..||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   89999999999999999887   7899999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=4.2e-07  Score=79.63  Aligned_cols=141  Identities=18%  Similarity=0.114  Sum_probs=102.3

Q ss_pred             eeecCceEEEEEEcCCCCEEEEEEecCcchhh---HHHHHHHHHHHHHHhhccCC--CceeeeeEEe-eC----CEEEEE
Q 013793          151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVLHR--SIVKLYGFCL-HK----KCMFLI  220 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv  220 (436)
                      -|+||-+.|++..+.+ +.+-+|+-...-...   ......|.+|+..+.++...  .+.+++ ++. ..    -...||
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4678999999987744 478899765221111   01237889999999999543  244545 333 21    236799


Q ss_pred             EeeccC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC--eEEeecccccc
Q 013793          221 YEYMER-GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~  297 (436)
                      +|-+++ -+|.+++.... ..+.+...+..++.+++..+.-||   ..|+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 48888876532 225677778899999999999999   899999999999999986666  89999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=6.2e-07  Score=80.94  Aligned_cols=133  Identities=18%  Similarity=0.269  Sum_probs=85.7

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      ..||+|..+.||+.   .+..+++|........     ....+|.+++..+..-.  +.+.++++...+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~-----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK-----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH-----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            45899999999984   2456788888764422     45678999999886443  46678888777788899999999


Q ss_pred             CC-hhhhhccCCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHHh-cC
Q 013793          227 GS-LFCILHNDDEAVELDWAKRVNIVKAMAHAL---------------------------------------AYLHH-DC  265 (436)
Q Consensus       227 g~-L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L---------------------------------------~~LH~-~~  265 (436)
                      .. +...+..       +......++..+++.+                                       .+|.. ..
T Consensus        79 ~~~~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        79 KRSFSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             ccchhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            63 2111110       0011111111111111                                       12221 11


Q ss_pred             CCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          266 SPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       266 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ...++|||+.|.||++++++ +.++||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34578999999999999988 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.62  E-value=1.8e-06  Score=76.00  Aligned_cols=155  Identities=19%  Similarity=0.221  Sum_probs=98.8

Q ss_pred             eecCCCcccHHHHHH--HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHH------HHHHHHHh
Q 013793          126 IWNYDGRIFYEDLIE--ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSF------RNEAQVLS  197 (436)
Q Consensus       126 ~~~~~~~~~~~~l~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~------~~e~~~l~  197 (436)
                      ++..+....+.++.+  ...+|...+++-......|.+... +|..+++|...............|      .+.+..+.
T Consensus        12 vy~~e~~~~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~   90 (229)
T PF06176_consen   12 VYYKENDEKYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTD   90 (229)
T ss_pred             EEEecCchHHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHH
Confidence            333333345555554  456777778888777777777766 568899998876543332222222      23344344


Q ss_pred             hccC---CCceeeeeEEee-----CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 013793          198 QVLH---RSIVKLYGFCLH-----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  269 (436)
Q Consensus       198 ~l~h---~niv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  269 (436)
                      +++.   -....++.+...     ....+++|||++|..|.++..       ++.    .++..+++++.-+|   ..|+
T Consensus        91 ~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~  156 (229)
T PF06176_consen   91 KIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGF  156 (229)
T ss_pred             HHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCC
Confidence            4432   222222222222     235678999999988765542       222    24566778899999   8899


Q ss_pred             EecCCCCCceeecCCCCeEEeeccccc
Q 013793          270 IHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       270 vH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .|||.+|+|+++++++ +++.||+..+
T Consensus       157 ~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  157 YHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             ccCCCCcCcEEEECCc-EEEEECcccc
Confidence            9999999999999654 9999998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.59  E-value=3.1e-08  Score=64.05  Aligned_cols=37  Identities=54%  Similarity=0.739  Sum_probs=33.5

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS   39 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~   39 (436)
                      ++|++|+|++|+|+ .||+++++|++|+.|+|++|+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            58999999999999 89999999999999999999998

...

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=2.4e-06  Score=75.97  Aligned_cols=157  Identities=21%  Similarity=0.230  Sum_probs=104.5

Q ss_pred             cccHHHHHHHhhcccccce---eeecCceEEEEEEcCCCCEEEEEEecCcchhhHH---------------------HHH
Q 013793          132 RIFYEDLIEATEDFHIKYC---IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA---------------------FIK  187 (436)
Q Consensus       132 ~~~~~~l~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~---------------------~~~  187 (436)
                      ..+++.+....+...+...   |++|.-+.||+|...++..+|||++......-..                     ...
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            3455667777777766665   5567778899998888999999998654222110                     012


Q ss_pred             HHHHHHHHHhhcc--CCCceeeeeEEeeCCEEEEEEeeccCC-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 013793          188 SFRNEAQVLSQVL--HRSIVKLYGFCLHKKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD  264 (436)
Q Consensus       188 ~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  264 (436)
                      ...+|+.-|.++.  +=.+.+.+++..    -.|||||+... .-.-.|...    ++...+...+..++++.+.-|-. 
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~-  184 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYK-  184 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHH-
Confidence            2345666666663  223334444332    36999998654 222223222    22333577788888888888873 


Q ss_pred             CCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       265 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                       ..++||+||+.-|||+. ++.+.|+|+|.|....
T Consensus       185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             47999999999999999 7899999999987654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=98.57  E-value=7.7e-08  Score=105.92  Aligned_cols=62  Identities=39%  Similarity=0.589  Sum_probs=59.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG   62 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~   62 (436)
                      +++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+..+++|+.+++++|..
T Consensus       498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  559 (968)
T PLN00113        498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL  559 (968)
T ss_pred             hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcc
Confidence            46899999999999999999999999999999999999999999999999999999998873

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.9e-06  Score=85.95  Aligned_cols=143  Identities=19%  Similarity=0.200  Sum_probs=90.4

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhH----------------------------HHHH------HHHHHHH
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL----------------------------AFIK------SFRNEAQ  194 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------~~~~------~~~~e~~  194 (436)
                      +.||.-+.|.||+|++++|+.||||+-++.-....                            +..+      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            57999999999999999999999999776422210                            0011      2333333


Q ss_pred             HHh----hccCCC---ceeeeeEEee-CCEEEEEEeeccCCChhhh--hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 013793          195 VLS----QVLHRS---IVKLYGFCLH-KKCMFLIYEYMERGSLFCI--LHNDDEAVELDWAKRVNIVKAMAHALAYLHHD  264 (436)
Q Consensus       195 ~l~----~l~h~n---iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  264 (436)
                      -..    .+.|-+   =|.+-.++.+ .....|+||||+|..+.+.  +.+.    .++....   +..+.++..  ++.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i---~~~l~~~~~--~qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDI---LNKLVEAYL--EQI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHH---HHHHHHHHH--HHH
Confidence            222    233444   1222233333 3467899999999877655  3332    3444433   333333322  222


Q ss_pred             CCCCeEecCCCCCceeecC----CCCeEEeecccccccCC
Q 013793          265 CSPSIIHRDISSNNILLNS----KLEAFVADFGTARRLHA  300 (436)
Q Consensus       265 ~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~~~~~  300 (436)
                      ...|++|+|=+|.||+++.    ++.+.+-|||+...+..
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2458999999999999984    67899999999876643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.41  E-value=4.8e-06  Score=75.45  Aligned_cols=142  Identities=22%  Similarity=0.272  Sum_probs=83.7

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCC--CceeeeeEEee---CCEEEEEEee
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR--SIVKLYGFCLH---KKCMFLIYEY  223 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~  223 (436)
                      +.++.|..+.||+....+ ..+++|..... .    ....+.+|..++..+...  .+.+++.++..   ....+++|++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~----~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-D----AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-H----HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-C----CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            568999999999999877 68999997665 1    126677888888888533  35566664433   3357899999


Q ss_pred             ccCCChhh----------------h---hccC-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHH
Q 013793          224 MERGSLFC----------------I---LHND-DEAVELDWAKR---------VNI------------VKAMAH-ALAYL  261 (436)
Q Consensus       224 ~~~g~L~~----------------~---l~~~-~~~~~l~~~~~---------~~i------------~~~ia~-~L~~L  261 (436)
                      +++..+..                .   ++.. .......+...         ...            ...+.+ .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99988877                0   1111 01111111110         000            111222 23333


Q ss_pred             Hh----cCCCCeEecCCCCCceeec-CCCCeEEeeccccc
Q 013793          262 HH----DCSPSIIHRDISSNNILLN-SKLEAFVADFGTAR  296 (436)
Q Consensus       262 H~----~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~  296 (436)
                      +.    .....++|||+.|+||+++ +++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            32    1356799999999999999 55666799998774

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.30  E-value=3.9e-06  Score=73.27  Aligned_cols=105  Identities=24%  Similarity=0.307  Sum_probs=83.5

Q ss_pred             HHHHHHHhhccC-CCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 013793          190 RNEAQVLSQVLH-RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS  268 (436)
Q Consensus       190 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  268 (436)
                      .+|..++..+.+ +++++++|+|-    .++|.||.+.+++...-..-..-..-+|..|.+|+.++++.+.++++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888876 69999999994    3689999998766432111011124689999999999999999999765556


Q ss_pred             eEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          269 IIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       269 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +.-.|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=2.5e-07  Score=91.62  Aligned_cols=182  Identities=20%  Similarity=0.182  Sum_probs=131.8

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC-ceeeeeEEeeCCEEEEEEeeccC
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-IVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      -+-+++|++++++|.+-...+....+.+...        ....-++++|.+++||| .++.++-+......+++++++.+
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3457889999999886544444445555443        34456889999999999 77777777778889999999988


Q ss_pred             C-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCc
Q 013793          227 G-SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR  305 (436)
Q Consensus       227 g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  305 (436)
                      + +-..-..  .....+...+...+.+.-+++++++|   +..=+|+|    ||+..+ +..+..||+....+.... ..
T Consensus       319 ~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~  387 (829)
T KOG0576|consen  319 GRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP  387 (829)
T ss_pred             CccccccCC--hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence            7 2211111  11123444555566777888999999   44457888    777666 678999999987765443 34


Q ss_pred             cccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCc
Q 013793          306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR  348 (436)
Q Consensus       306 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  348 (436)
                      ....+++.++|||......+..+.|+|+.|+--.++--|-.|-
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            4567999999999999999999999999998777777777663

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.27  E-value=1.5e-05  Score=73.07  Aligned_cols=139  Identities=15%  Similarity=0.161  Sum_probs=84.4

Q ss_pred             eeecCc-eEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEEeeccCCC
Q 013793          151 IGTGGY-GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGS  228 (436)
Q Consensus       151 lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  228 (436)
                      |-.|.+ ..||+....+ ..+++|......      ...+.+|++++..+. +--+.+++++....+..++|||+++|.+
T Consensus         6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            334444 7899997654 778889886653      134567888888873 4445667777776667899999999987


Q ss_pred             hhhhh-------------------ccCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh---
Q 013793          229 LFCIL-------------------HNDDE-AVELD--WAKRVNIVK--------------------AMAHALAYLHH---  263 (436)
Q Consensus       229 L~~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~~LH~---  263 (436)
                      +....                   |.... ..++.  .........                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            76432                   11110 00111  000010000                    01111222211   


Q ss_pred             -cCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          264 -DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       264 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                       .....++|||+.|.||+++++....|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             114568999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.23  E-value=2e-05  Score=84.87  Aligned_cols=80  Identities=25%  Similarity=0.399  Sum_probs=57.7

Q ss_pred             cceeeecCceEEEEEEcCCC---CEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCc--eeeeeEEeeC---CEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSI--VKLYGFCLHK---KCMF  218 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~  218 (436)
                      ...++.|.+..+|+....++   ..+++|+.........  ...+.+|++++..+. |.++  .+++.+|.+.   +..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            45688999999999876654   4678887655432111  146778999999995 6664  7778888764   4578


Q ss_pred             EEEeeccCCCh
Q 013793          219 LIYEYMERGSL  229 (436)
Q Consensus       219 lv~e~~~~g~L  229 (436)
                      +||||++|..+
T Consensus       121 lVME~v~G~~~  131 (822)
T PLN02876        121 YIMEYLEGRIF  131 (822)
T ss_pred             EEEEecCCccc
Confidence            99999998654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.17  E-value=4.1e-07  Score=75.50  Aligned_cols=58  Identities=31%  Similarity=0.523  Sum_probs=41.7

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++.+.|-||+|+++ .+|+.++.|.+|+.|++++|+++ .+|.++..+++|+.+++.-|.
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnr   90 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNR   90 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhh
Confidence            45566777777777 67777777777777777777777 677777777777777766553

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.14  E-value=2.5e-05  Score=82.87  Aligned_cols=207  Identities=15%  Similarity=0.147  Sum_probs=139.8

Q ss_pred             HHHHHHHHHhhccCCCceeeeeEEeeCCEEE----EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013793          188 SFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF----LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH  263 (436)
Q Consensus       188 ~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  263 (436)
                      ....|.+.+....|+|++.+++|..+.....    +..|+++.-++...+....   ..+....+.+..++.+||+|+| 
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h-  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLH-  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHH-
Confidence            3445677788889999999999987755433    3456777778877776554   6788888899999999999999 


Q ss_pred             cCCCCeEecCCCCC---ceeecCCCCeEEe--ecccccccCCCCCCccccccccccccccccccCcc--CcchhhHHHHH
Q 013793          264 DCSPSIIHRDISSN---NILLNSKLEAFVA--DFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM--TEKCDVYSFGV  336 (436)
Q Consensus       264 ~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~s~G~  336 (436)
                        +....|.-+..+   +.-.+.++...++  ||+..+.+...... ....-+..|.|||.......  ....|+|++|.
T Consensus       304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              444444444433   3344555666666  88888766443322 22234556778887766544  44579999999


Q ss_pred             HHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          337 VTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       337 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ....+..|..+-....          .....++.....           ...+...+|+..++++|++..+++.+++...
T Consensus       381 l~~~~~~~~~i~~~~~----------~~~~~l~~~~~~-----------~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSA----------VPVSLLDVLSTS-----------ELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             HHhhhhhcCccccccc----------chhhhhccccch-----------hhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            9999999876632110          011111111100           2445667899999999999999999998776


Q ss_pred             CCCCcc
Q 013793          417 KTPLVK  422 (436)
Q Consensus       417 ~~~~~~  422 (436)
                      +.....
T Consensus       440 ~~~~~~  445 (1351)
T KOG1035|consen  440 PTDNES  445 (1351)
T ss_pred             cccccc
Confidence            655333

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.14  E-value=2.8e-05  Score=67.73  Aligned_cols=128  Identities=23%  Similarity=0.457  Sum_probs=91.6

Q ss_pred             hcccccceeeecCc-eEEEEEEcCCCCEEEEEEecC---cch---------hhH------HHHHHHHHHHHHHhhcc---
Q 013793          143 EDFHIKYCIGTGGY-GSVYKAQLPNGKVFALKKLHT---SET---------EEL------AFIKSFRNEAQVLSQVL---  200 (436)
Q Consensus       143 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~l~~---~~~---------~~~------~~~~~~~~e~~~l~~l~---  200 (436)
                      .+++..+.||.|.- |.||+++. +|+.||+|.+..   ...         ...      .+...|..|+++.++++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56778899999999 99999998 677999999321   100         000      23456889999988885   


Q ss_pred             CCCc--eeeeeEEeeC------------------CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 013793          201 HRSI--VKLYGFCLHK------------------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY  260 (436)
Q Consensus       201 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~  260 (436)
                      +.++  |+.+||..-.                  ....||.||++...            .+    ..+-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence            3455  8999988432                  12468888876532            12    22334566777888


Q ss_pred             HHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       261 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      +|   ..||+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            99   889999999999984     4579999865

>PRK10593 hypothetical protein; Provisional

Probab=98.11  E-value=7.8e-05  Score=70.33  Aligned_cols=76  Identities=20%  Similarity=0.184  Sum_probs=56.3

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC---CCceeeeeEEee---CCEEEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH---RSIVKLYGFCLH---KKCMFLIY  221 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~  221 (436)
                      .+.||.|..+.||+....+++ +++|..+....     ...+..|.+.++.+.-   -.+.+++++|..   .+..++||
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARSFST-----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEeccccc-----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            557999999999999876664 56676443211     1577889999988843   357788888764   36689999


Q ss_pred             eeccCCCh
Q 013793          222 EYMERGSL  229 (436)
Q Consensus       222 e~~~~g~L  229 (436)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=2.7e-05  Score=65.68  Aligned_cols=128  Identities=19%  Similarity=0.255  Sum_probs=86.5

Q ss_pred             ccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCcee-eeeEEeeCCEEEEEEeecc
Q 013793          147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK-LYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~  225 (436)
                      ..+.|++|++|.||++.+.++ .+|+|+-.....     ...+..|.++|..+.--++-+ ++.|-.    ..+.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeeccCc-eEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence            356799999999999998654 778887665543     267889999999987666544 333322    235599999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceeecCCCCeEEeecccccc
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS-SNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      |-.|.+.-...      +    .+-...+++.---|.   ..||-|+.|. |...++-.+..+.|+||..|+.
T Consensus        96 G~~L~~~~~~~------~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG------D----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc------c----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            98876555321      1    122334445433444   6789999887 4444444455999999999874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.07  E-value=9.8e-05  Score=64.82  Aligned_cols=131  Identities=22%  Similarity=0.325  Sum_probs=89.0

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhh-------------HHHHHHHHHHHHHHhhcc------CCCceeee
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-------------LAFIKSFRNEAQVLSQVL------HRSIVKLY  208 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------~~~~~~~~~e~~~l~~l~------h~niv~l~  208 (436)
                      ...||+|+.-.||  .+++....+||+........             ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4569999999998  45666677899987766000             011255666666655555      78899999


Q ss_pred             eEEeeCCEEEEEEeeccC--C----ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 013793          209 GFCLHKKCMFLIYEYMER--G----SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  282 (436)
Q Consensus       209 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~  282 (436)
                      |+..++....+|+|.+.+  |    +|.+++...    .++. ...+.+.++   ..||-   ...|+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEE
Confidence            999999999999998753  2    566666433    3444 333444444   44555   56799999999999996


Q ss_pred             CCC----CeEEee
Q 013793          283 SKL----EAFVAD  291 (436)
Q Consensus       283 ~~~----~~kl~D  291 (436)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            432    355665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=4.4e-05  Score=69.52  Aligned_cols=73  Identities=12%  Similarity=0.223  Sum_probs=45.2

Q ss_pred             ceeeecCce-EEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCC---CceeeeeEEeeC---CEEEEEE
Q 013793          149 YCIGTGGYG-SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR---SIVKLYGFCLHK---KCMFLIY  221 (436)
Q Consensus       149 ~~lg~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~  221 (436)
                      +.++.|+.. .||+.    +..+++|..+....     ...+.+|.+.+..+...   .+.+.++.....   ...+++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~-----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGY-----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccch-----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            457777766 48876    23567787554321     25678899998887532   233444433332   2347899


Q ss_pred             eeccCCChh
Q 013793          222 EYMERGSLF  230 (436)
Q Consensus       222 e~~~~g~L~  230 (436)
                      ++++|.++.
T Consensus        74 ~~i~G~~l~   82 (235)
T cd05155          74 RWLEGETAT   82 (235)
T ss_pred             EeecCCCCC
Confidence            999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.05  E-value=5.7e-07  Score=74.67  Aligned_cols=59  Identities=32%  Similarity=0.550  Sum_probs=55.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |.+|+.|++++|+++ .+|.+++.|+.|+.|+++.|+|. .+|..|+.++.|..+++.-|.
T Consensus        55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynn  113 (264)
T KOG0617|consen   55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNN  113 (264)
T ss_pred             hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccc
Confidence            468999999999999 99999999999999999999998 899999999999999998775

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.99  E-value=8.6e-05  Score=67.53  Aligned_cols=141  Identities=18%  Similarity=0.196  Sum_probs=81.4

Q ss_pred             ceeeecCceEEEEEEcCC--CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc-eeeeeEEeeCCEEEEEEeecc
Q 013793          149 YCIGTGGYGSVYKAQLPN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI-VKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  225 (436)
                      +.|..|-...+|+....+  ++.|++|........    .....+|+.++..+...++ .++++.+.    ..++|||++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~   75 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP   75 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence            457778888999998764  678899976543211    1233468888888854334 34444332    248999999


Q ss_pred             CCChhhh-----------------hccCCCC--------CCCC-HHHHHHHHH----------------------HHHHH
Q 013793          226 RGSLFCI-----------------LHNDDEA--------VELD-WAKRVNIVK----------------------AMAHA  257 (436)
Q Consensus       226 ~g~L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~  257 (436)
                      |.++...                 +|.....        ...+ |.....+..                      .+...
T Consensus        76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  155 (235)
T cd05157          76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE  155 (235)
T ss_pred             CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence            8766321                 1111111        0111 222112111                      11111


Q ss_pred             HHHH----Hh-cCCCCeEecCCCCCceeecC-CCCeEEeecccccc
Q 013793          258 LAYL----HH-DCSPSIIHRDISSNNILLNS-KLEAFVADFGTARR  297 (436)
Q Consensus       258 L~~L----H~-~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~  297 (436)
                      +..|    .. .....++|+|+.+.||++++ +..+.++||..|..
T Consensus       156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1111    11 01357899999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=97.92  E-value=5.1e-06  Score=58.17  Aligned_cols=38  Identities=42%  Similarity=0.651  Sum_probs=35.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeecccccc
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKL   38 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l   38 (436)
                      +++|++|+|++|++++.-|..|..|++|++|++++|+|
T Consensus        24 l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen   24 LPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             GTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            47899999999999977778999999999999999986

...

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.89  E-value=0.00015  Score=68.48  Aligned_cols=142  Identities=18%  Similarity=0.176  Sum_probs=85.2

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ceeeeeE------EeeCCEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLYGF------CLHKKCMFL  219 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~l  219 (436)
                      .+.+..|....+|+....++ .+++|+......      .....|++++..+.+.+  +.+++..      ....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKVSA------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCCCh------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            44577787889999876544 688898765211      45566777777774332  4444331      123456789


Q ss_pred             EEeeccCCChhh----h----------hccC----CC----CCCCCHHHHH----------HHHHHHHHHHHHHHh----
Q 013793          220 IYEYMERGSLFC----I----------LHND----DE----AVELDWAKRV----------NIVKAMAHALAYLHH----  263 (436)
Q Consensus       220 v~e~~~~g~L~~----~----------l~~~----~~----~~~l~~~~~~----------~i~~~ia~~L~~LH~----  263 (436)
                      |++|++|..+..    .          +|..    ..    .....|....          .....+..++.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999999876532    0          1110    00    0112232211          011123344455442    


Q ss_pred             cCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       264 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      ....+++|||+.|.||+++++..+.|.||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            124579999999999999998777899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.84  E-value=0.00012  Score=67.47  Aligned_cols=138  Identities=14%  Similarity=0.125  Sum_probs=78.1

Q ss_pred             eeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc-eeeeeEEeeCCEEEEEEeeccCCCh
Q 013793          151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI-VKLYGFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       151 lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      +..|-...+|+... +++.+++|........-   .-...+|.++++.+....+ .++++.+.    -++|+||++|..+
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            45677889999874 56788888765432110   0134678888888854333 33444332    3689999998765


Q ss_pred             hhh-----------------hccCCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeEecCCCC
Q 013793          230 FCI-----------------LHNDDE-AVELDWAKR-VNIVKA---------MAHALAYLHHD-----CSPSIIHRDISS  276 (436)
Q Consensus       230 ~~~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~~L~~LH~~-----~~~~ivH~dlk~  276 (436)
                      ...                 +|.... ..+++.... ..+..+         +...+..+-..     ....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            421                 122111 112222211 111111         11112222111     134689999999


Q ss_pred             CceeecCCCCeEEeecccccc
Q 013793          277 NNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       277 ~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      .||++++++ +.++||+.+..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999877 78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.78  E-value=0.00076  Score=64.03  Aligned_cols=156  Identities=17%  Similarity=0.155  Sum_probs=89.5

Q ss_pred             HHHHHHHhhcccc-----cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ceee
Q 013793          135 YEDLIEATEDFHI-----KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKL  207 (436)
Q Consensus       135 ~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l  207 (436)
                      .++|....+.|.+     .+.++.|....+|+....+| .+++|..+.....     .....|.+++..+....  +.++
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~-----~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA-----EELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCCH-----HHHHHHHHHHHHHHHCCCCCCcc
Confidence            3555555556654     34567777789999876555 5788887653221     33445666666664222  3344


Q ss_pred             eeEE------eeCCEEEEEEeeccCCChhhh--------------hccCCCC---------CCCCHHHHH----------
Q 013793          208 YGFC------LHKKCMFLIYEYMERGSLFCI--------------LHNDDEA---------VELDWAKRV----------  248 (436)
Q Consensus       208 ~~~~------~~~~~~~lv~e~~~~g~L~~~--------------l~~~~~~---------~~l~~~~~~----------  248 (436)
                      +...      ...+..++++||++|..+...              +|.....         ..-.|....          
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            3321      124567899999998654211              1211000         001121110          


Q ss_pred             --HHHHHHHHHHHHHHh----cCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          249 --NIVKAMAHALAYLHH----DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       249 --~i~~~ia~~L~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                        .....+.+.++++..    ....+++|+|+.+.||++++++...|+||+.+.
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              011223344555542    235789999999999999998777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.76  E-value=0.0011  Score=63.38  Aligned_cols=157  Identities=15%  Similarity=0.159  Sum_probs=84.8

Q ss_pred             ccHHHHHHHhhcccc-----cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ce
Q 013793          133 IFYEDLIEATEDFHI-----KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IV  205 (436)
Q Consensus       133 ~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  205 (436)
                      ++.+++....+.|.+     .+.++.|....+|+....+| .+++|+......      ..+..|...+..+...+  +.
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~------~~l~~~~~~l~~L~~~glpvP   79 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA------EDLPFFLGLMQHLAARGVPVP   79 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh------HHhHHHHHHHHHHHHCCCCCC
Confidence            344555555556654     24466677788999987666 688998762211      23334455555553212  33


Q ss_pred             eeee------EEeeCCEEEEEEeeccCCChhh-----h---------hccCCC--------CCCCCH-HHHHHH------
Q 013793          206 KLYG------FCLHKKCMFLIYEYMERGSLFC-----I---------LHNDDE--------AVELDW-AKRVNI------  250 (436)
Q Consensus       206 ~l~~------~~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~~~--------~~~l~~-~~~~~i------  250 (436)
                      +.+.      +....+..++++||++|..+..     .         +|....        ...+.| .+...-      
T Consensus        80 ~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  159 (319)
T PRK05231         80 APVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLA  159 (319)
T ss_pred             cceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccC
Confidence            3332      1223556789999999875421     1         111100        011212 111111      


Q ss_pred             ------H-HHHHHHHHHHHh----cCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          251 ------V-KAMAHALAYLHH----DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       251 ------~-~~ia~~L~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                            . ..+...++.+..    ....+++|+|+.|.||+++++...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        160 DEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                  1 111112222221    124589999999999999977556799999875

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.74  E-value=1.3e-05  Score=68.77  Aligned_cols=58  Identities=36%  Similarity=0.528  Sum_probs=23.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccc-cccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE-QLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~l~~l~~~~~~~n~   61 (436)
                      |++|+.||||+|+++ .|+ .+..|+.|+.|+|++|+++ .++..+. .+++|..|++++|.
T Consensus        41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~   99 (175)
T PF14580_consen   41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNK   99 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS-
T ss_pred             hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCc
Confidence            356788888888887 565 5777888888888888887 4554342 47778888887775

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=97.73  E-value=1.5e-05  Score=74.96  Aligned_cols=58  Identities=33%  Similarity=0.536  Sum_probs=49.5

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |.+|.+|||..|++. ++|+++--|.+|++||||+|.++ .+|.+++++ .|.++.+.||+
T Consensus       251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             cccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCc
Confidence            457788999999998 89999988899999999999998 477778888 88888888886

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.68  E-value=0.00041  Score=65.72  Aligned_cols=140  Identities=24%  Similarity=0.296  Sum_probs=82.8

Q ss_pred             ceeeecCceEEEEEEcCC-------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc-eeeeeEEeeCCEEEEE
Q 013793          149 YCIGTGGYGSVYKAQLPN-------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI-VKLYGFCLHKKCMFLI  220 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  220 (436)
                      +.+..|-...+|+....+       ++.+++|........    .....+|.+++..+....+ .++++++. +   .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            345667777999997765       578999997654321    1345678888888854333 34555543 2   368


Q ss_pred             EeeccCCChhhh-----------------hccCCCCC------CCC--HHHHHH--------------------------
Q 013793          221 YEYMERGSLFCI-----------------LHNDDEAV------ELD--WAKRVN--------------------------  249 (436)
Q Consensus       221 ~e~~~~g~L~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------  249 (436)
                      +||++|..+...                 +|......      ..+  |.....                          
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            999998776431                 11111110      011  111111                          


Q ss_pred             HHHHHHHHHHHHHh------cCCCCeEecCCCCCceeecCC----CCeEEeeccccc
Q 013793          250 IVKAMAHALAYLHH------DCSPSIIHRDISSNNILLNSK----LEAFVADFGTAR  296 (436)
Q Consensus       250 i~~~ia~~L~~LH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~  296 (436)
                      +...+...+.++-.      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            01122222333431      135678999999999999985    789999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.61  E-value=3.9e-05  Score=65.81  Aligned_cols=59  Identities=36%  Similarity=0.420  Sum_probs=29.7

Q ss_pred             CCCCCEEECcCCcccccCChhc-cCCCCCCeeeccccccCCCCC--CccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGEL-TDLSRLDYLNLSWNKLSGPVP--FSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~-~~l~~L~~l~ls~N~l~g~~p--~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|+++ .++..+ ..|++|+.|+|++|++.. +-  ..+..+++|+.+++.+||
T Consensus        63 L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   63 LPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             -TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-G
T ss_pred             hhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCc
Confidence            578999999999999 787666 469999999999999974 22  235668889999999887

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.0012  Score=64.35  Aligned_cols=79  Identities=19%  Similarity=0.204  Sum_probs=52.6

Q ss_pred             cceeeecCceEEEEEEcCCC-CEEEEEEecCcchh--h--HHHHHHHHHHHHHHhhcc---CCCceeeeeEEeeCCEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETE--E--LAFIKSFRNEAQVLSQVL---HRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~--~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  219 (436)
                      .+.||-|.+..||++...+| +.++||.-......  +  .........|.+.|..+.   ..++.+++.+.  .+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            35689999999999998877 48999985422110  0  011245666778777763   24566666663  355789


Q ss_pred             EEeeccCCC
Q 013793          220 IYEYMERGS  228 (436)
Q Consensus       220 v~e~~~~g~  228 (436)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.53  E-value=3.2e-05  Score=76.66  Aligned_cols=56  Identities=38%  Similarity=0.530  Sum_probs=29.5

Q ss_pred             CCEEECcCCcccccCChhc-cCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            4 LTWLDISNNKIEGSIPGEL-TDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         4 l~~l~ls~n~l~g~ip~~~-~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +.+|+||+|++. +||.++ .+|+-|-+||||+|+|. .+|+.+..|..|+.|.+++|+
T Consensus       128 ~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP  184 (1255)
T KOG0444|consen  128 SIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP  184 (1255)
T ss_pred             cEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence            334444444444 344322 34445555555555554 344445556667777787776

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=97.52  E-value=3e-05  Score=41.81  Aligned_cols=22  Identities=45%  Similarity=0.868  Sum_probs=15.1

Q ss_pred             CCCEEECcCCcccccCChhccCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDL   25 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l   25 (436)
                      +|++||||+|+|+ .||++|++|
T Consensus         1 ~L~~Ldls~n~l~-~ip~~~~~l   22 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSSFSNL   22 (22)
T ss_dssp             TESEEEETSSEES-EEGTTTTT-
T ss_pred             CccEEECCCCcCE-eCChhhcCC
Confidence            4677777777777 777766553

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.49  E-value=4.6e-05  Score=49.16  Aligned_cols=35  Identities=29%  Similarity=0.425  Sum_probs=30.7

Q ss_pred             CCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793           26 SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus        26 ~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|++++|+++ .+|..+.+|++|+.+++++|+
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~   35 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNP   35 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSC
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCC
Confidence            57999999999999 788889999999999999996

...

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.45  E-value=1.2e-05  Score=64.39  Aligned_cols=57  Identities=26%  Similarity=0.344  Sum_probs=41.3

Q ss_pred             CCCEEECcCCcccccCChhccCC-CCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDL-SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l-~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .|+..+||+|.|. .+|..|... +.++.|||++|.++ .+|..+..++.|+.++++.|+
T Consensus        54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~  111 (177)
T KOG4579|consen   54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNP  111 (177)
T ss_pred             eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCc
Confidence            3566677777777 677766644 46777777777777 677777777777777777776

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.44  E-value=3.1e-05  Score=76.72  Aligned_cols=59  Identities=34%  Similarity=0.496  Sum_probs=49.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCc-cccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-NEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~l~~~~~~~n~   61 (436)
                      |..|+.||||+|+|. ++|..+.+-+++-+||||+|++. .||.+ +.+|..|-+|++++|.
T Consensus       102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr  161 (1255)
T KOG0444|consen  102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR  161 (1255)
T ss_pred             cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence            457888999999998 89988888889999999999998 67765 4567788888888885

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=97.42  E-value=6.6e-05  Score=70.73  Aligned_cols=59  Identities=36%  Similarity=0.631  Sum_probs=43.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCC-----------------------Cc-cccccccCccc
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-----------------------FS-NEQLSSMSRVR   56 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p-----------------------~~-~~~l~~l~~~~   56 (436)
                      +++|+.|+|+||-|. .+|.+++.+..|+.||+|+|+|. .+|                       .+ +.++.+|..++
T Consensus       434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLD  511 (565)
T KOG0472|consen  434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLD  511 (565)
T ss_pred             hhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceec
Confidence            467888888888888 88888888888888888888875 344                       22 44566677777


Q ss_pred             cCCCC
Q 013793           57 LSPNK   61 (436)
Q Consensus        57 ~~~n~   61 (436)
                      +.+|.
T Consensus       512 L~nNd  516 (565)
T KOG0472|consen  512 LQNND  516 (565)
T ss_pred             cCCCc
Confidence            76664

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.41  E-value=0.0028  Score=59.66  Aligned_cols=139  Identities=19%  Similarity=0.311  Sum_probs=85.5

Q ss_pred             ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeeeEEeeCC--EEEEEEeec
Q 013793          149 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYGFCLHKK--CMFLIYEYM  224 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~  224 (436)
                      +.+..|..-.+|..... ++.++++ ..... ..........+|+++++.+.-  --+...++.|.++.  ..+.||+|.
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~-~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRG-DPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCcc-ccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            33433444444554443 7888888 43211 111123566678888887743  23445567777665  679999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHH-HHHHHHHHHHHhc---------------------------------------
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIV-KAMAHALAYLHHD---------------------------------------  264 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~~LH~~---------------------------------------  264 (436)
                      +|....+.+....    .  .  ..++ ..+++.|+-||+.                                       
T Consensus       108 eGe~~~~~~~~~~----~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPES----L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCccc----c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            9864443332211    1  1  1122 3556666666641                                       


Q ss_pred             ----------------CCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          265 ----------------CSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       265 ----------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                                      ....++|||+.+.|++++.+..+=|.||+++..-
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                            1356899999999999999988999999999754

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.40  E-value=8e-05  Score=69.99  Aligned_cols=64  Identities=33%  Similarity=0.350  Sum_probs=45.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCC------------------------CCCCeeeccccccCCCCCCccccccccCccc
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDL------------------------SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVR   56 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l------------------------~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~   56 (436)
                      |++|++|+||+|++++.=+.+|..+                        ++|+.|+|.+|+++-.-|-+|..+.+|..++
T Consensus       273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~  352 (498)
T KOG4237|consen  273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN  352 (498)
T ss_pred             cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence            5789999999999998888777664                        4555566666666655555566666666666


Q ss_pred             cCCCCCCC
Q 013793           57 LSPNKGLC   64 (436)
Q Consensus        57 ~~~n~~lc   64 (436)
                      +-+|+..|
T Consensus       353 l~~Np~~C  360 (498)
T KOG4237|consen  353 LLSNPFNC  360 (498)
T ss_pred             hccCcccC
Confidence            66666555

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.38  E-value=3.6e-05  Score=75.70  Aligned_cols=61  Identities=28%  Similarity=0.251  Sum_probs=48.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |+.|+.||||+|.++..-++++..+++|+.||||+|+++---|.+|..|..|+.|++++|.
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns  352 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS  352 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence            5678889999999988888889899999999999999985555566667777777777664

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.36  E-value=0.0028  Score=59.06  Aligned_cols=31  Identities=19%  Similarity=0.418  Sum_probs=25.8

Q ss_pred             CCeEecCCCCCceeecCCCC-eEEeecccccc
Q 013793          267 PSIIHRDISSNNILLNSKLE-AFVADFGTARR  297 (436)
Q Consensus       267 ~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~  297 (436)
                      ..++|||+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 45999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.33  E-value=0.0048  Score=58.35  Aligned_cols=143  Identities=22%  Similarity=0.301  Sum_probs=97.3

Q ss_pred             ccceeeecCceEEEEEEcCCCCEEEEEEecCcc-----------------------hhhHHHHHHHHHHHHHHhhccCCC
Q 013793          147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-----------------------TEELAFIKSFRNEAQVLSQVLHRS  203 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~h~n  203 (436)
                      +..+|..|.-+.||.+.-.+|..+|||+++..-                       ....-..-....|++-|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            445788999999999999999999999875320                       000001122346777777776555


Q ss_pred             ceeeeeEEeeCCEEEEEEeeccCCCh-hhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 013793          204 IVKLYGFCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  282 (436)
Q Consensus       204 iv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~  282 (436)
                      |...--....  ...|||+|+..... ...|..    ..++...+..+-.+++.-+.-|-+.|  ++||.||.--|+|+-
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            4322111111  24699999864322 222322    25777788888889999999888855  899999999999986


Q ss_pred             CCCCeEEeeccccccc
Q 013793          283 SKLEAFVADFGTARRL  298 (436)
Q Consensus       283 ~~~~~kl~Dfg~a~~~  298 (436)
                      + |.+.|+|-+.+...
T Consensus       300 d-G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 D-GKLYIIDVSQSVEH  314 (520)
T ss_pred             C-CEEEEEEccccccC
Confidence            5 57899998877544

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.28  E-value=0.002  Score=60.10  Aligned_cols=73  Identities=21%  Similarity=0.312  Sum_probs=47.2

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc---CCCceeeeeEEeeCCEEEEEEeec
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      .+.++-|....+|+.. .+++.+.||.-.....      ..|..|.+-|+.+.   .-.+.+++++....+..++|+||+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESGR------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGC------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChhhH------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            4568889999999988 5778899998773321      56777888777773   345778888887777779999999


Q ss_pred             cCC
Q 013793          225 ERG  227 (436)
Q Consensus       225 ~~g  227 (436)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	436
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-41
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-29
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-29
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-28
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-28
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-28
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-28
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-28
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-28
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-27
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-27
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-27
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-27
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-27
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-27
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-27
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-27
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-27
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-27
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-27
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-26
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-26
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-24
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-24
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-24
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-24
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-22
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-20
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-15
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-15
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-14
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-06
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-04
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-04
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 101/289 (34%), Positives = 152/289 (52%), Gaps = 17/289 (5%)
Query: 132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 191
           R    +L  A+++F  K  +G GG+G VYK +L +G + A+K+L    T+       F+ 
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL--QFQT 76
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNI 250
           E +++S  +HR++++L GFC+      L+Y YM  GS+  C+    +    LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL-HADSSNRTLLA 309
               A  LAYLH  C P IIHRD+ + NILL+ + EA V DFG A+ + + D      + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLID--- 366
           G  G+IAPE   T   +EK DV+ +GV+ LE++ G+   D         D  +ML+D   
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD---LARLANDDDVMLLDWVK 253
Query: 367 --VLDQRLPPPVD---QKVIQDILLASTISFA--CLQSNPKSRPTMQYV 408
             + +++L   VD   Q   +D  +   I  A  C QS+P  RP M  V
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 101/289 (34%), Positives = 152/289 (52%), Gaps = 17/289 (5%)
Query: 132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 191
           R    +L  A+++F  K  +G GG+G VYK +L +G + A+K+L     +       F+ 
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL--QFQT 84
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNI 250
           E +++S  +HR++++L GFC+      L+Y YM  GS+  C+    +    LDW KR  I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL-HADSSNRTLLA 309
               A  LAYLH  C P IIHRD+ + NILL+ + EA V DFG A+ + + D      + 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLID--- 366
           GT G+IAPE   T   +EK DV+ +GV+ LE++ G+   D         D  +ML+D   
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD---LARLANDDDVMLLDWVK 261
Query: 367 --VLDQRLPPPVD---QKVIQDILLASTISFA--CLQSNPKSRPTMQYV 408
             + +++L   VD   Q   +D  +   I  A  C QS+P  RP M  V
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/239 (38%), Positives = 127/239 (53%), Gaps = 14/239 (5%)
Query: 115 ARATNSIDVFSIWNY-----DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKV 169
           ++ATNSI+     +Y       R+   DL EAT +F  K+ IG G +G VYK  L +G  
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 170 FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL 229
            ALK+  T E+ +         E + LS   H  +V L GFC  +  M LIY+YME G+L
Sbjct: 66  VALKR-RTPESSQGIEEFE--TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 230 FCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF 288
              L+  D   + + W +R+ I    A  L YLH   + +IIHRD+ S NILL+      
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 289 VADFGTARR-LHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
           + DFG +++    D ++   ++ GT GYI PE      +TEK DVYSFGVV  EVL  +
Sbjct: 180 ITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/239 (37%), Positives = 125/239 (52%), Gaps = 14/239 (5%)
Query: 115 ARATNSIDVFSIWNY-----DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKV 169
           ++ATNSI+     +Y       R+   DL EAT +F  K+ IG G +G VYK  L +G  
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 170 FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL 229
            ALK+  T E+ +         E + LS   H  +V L GFC  +  M LIY+YME G+L
Sbjct: 66  VALKR-RTPESSQGIEEFE--TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 230 FCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF 288
              L+  D   + + W +R+ I    A  L YLH   + +IIHRD+ S NILL+      
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 289 VADFGTARRLH--ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
           + DFG +++      +    ++ GT GYI PE      +TEK DVYSFGVV  EVL  +
Sbjct: 180 ITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY  RG ++  L    +  + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY  RG ++  L    +  + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEM 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 148
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 203
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+  N K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 139
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 194
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 121
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 127
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 123
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +   HA SS RT L+GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEM 178
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 126
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 119
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 123
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 127
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 124
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +A+FG +  +HA SS RT L GT  Y+ PE+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 179
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 114/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +A+FG +  +HA SS RT L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 124
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 179
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 148
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 203
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 180
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 112/208 (53%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 127
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE 
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEX 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                  EK D++S GV+  E L+GK P
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 123
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 178
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           A EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++LYG+      ++LI EY   G+++  L    +  + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 180
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  EK D++S GV+  E L+GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 9/206 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I++LYG+      ++LI EY   G+++  L    +    D  +    +  +A+AL+Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSRFDEQRTATYITELANALSYC 128
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  EK D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 110/206 (53%), Gaps = 9/206 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I++LYG+      ++LI EY   G+++  L    +    D  +    +  +A+AL+Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSRFDEQRTATYITELANALSYC 128
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  EK D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 21/267 (7%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  ++  +G G +G V KA+    K  A+K++  SE+E  AFI   R     LS+V H 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQ----LSRVNHP 62
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLYG CL+  C  L+ EY E GSL+ +LH  +       A  ++     +  +AYLH
Sbjct: 63  NIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
                ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++APE+  
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFE 177
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVI 381
               +EKCDV+S+G++  EV+  + P D          P   ++  +     PP+ + + 
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 382 QDILLASTISFACLQSNPKSRPTMQYV 408
           + I    ++   C   +P  RP+M+ +
Sbjct: 232 KPI---ESLMTRCWSKDPSQRPSMEEI 255

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 134/272 (49%), Gaps = 23/272 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V+++  H ++V+L
Sbjct: 39  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 95
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            GF      + L+Y YM  GSL   L   D    L W  R  I +  A+ + +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTAR--RLHADSSNRTLLAGTYGYIAPELAYTMVM 325
             IHRDI S NILL+    A ++DFG AR     A +   + + GT  Y+APE A    +
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEI 211
Query: 326 TEKCDVYSFGVVTLEVLMG-------KHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQ 378
           T K D+YSFGVV LE++ G       + P+          D +  + D +D+++    D 
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADS 270
Query: 379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             ++ +    +++  CL      RP ++ V Q
Sbjct: 271 TSVEAMY---SVASQCLHEKKNKRPDIKKVQQ 299

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 21/267 (7%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  ++  +G G +G V KA+    K  A+K++  SE+E  AFI   R     LS+V H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQ----LSRVNHP 61
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLYG CL+  C  L+ EY E GSL+ +LH  +       A  ++     +  +AYLH
Sbjct: 62  NIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
                ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFE 176
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVI 381
               +EKCDV+S+G++  EV+  + P D          P   ++  +     PP+ + + 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 382 QDILLASTISFACLQSNPKSRPTMQYV 408
           + I    ++   C   +P  RP+M+ +
Sbjct: 231 KPI---ESLMTRCWSKDPSQRPSMEEI 254

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 133/272 (48%), Gaps = 23/272 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V+++  H ++V+L
Sbjct: 39  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 95
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            GF      + L+Y YM  GSL   L   D    L W  R  I +  A+ + +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTAR--RLHADSSNRTLLAGTYGYIAPELAYTMVM 325
             IHRDI S NILL+    A ++DFG AR     A +     + GT  Y+APE A    +
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEI 211
Query: 326 TEKCDVYSFGVVTLEVLMG-------KHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQ 378
           T K D+YSFGVV LE++ G       + P+          D +  + D +D+++    D 
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADS 270
Query: 379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             ++ +    +++  CL      RP ++ V Q
Sbjct: 271 TSVEAMY---SVASQCLHEKKNKRPDIKKVQQ 299

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 132/272 (48%), Gaps = 23/272 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V+++  H ++V+L
Sbjct: 33  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 89
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            GF      + L+Y YM  GSL   L   D    L W  R  I +  A+ + +LH +   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTAR--RLHADSSNRTLLAGTYGYIAPELAYTMVM 325
             IHRDI S NILL+    A ++DFG AR     A       + GT  Y+APE A    +
Sbjct: 149 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEI 205
Query: 326 TEKCDVYSFGVVTLEVLMG-------KHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQ 378
           T K D+YSFGVV LE++ G       + P+          D +  + D +D+++    D 
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADS 264
Query: 379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             ++ +    +++  CL      RP ++ V Q
Sbjct: 265 TSVEAMY---SVASQCLHEKKNKRPDIKKVQQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 114/219 (52%), Gaps = 3/219 (1%)
Query: 129 YDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS 188
           + G +  +D+     D +IK  IG G +G+V++A+  +G   A+K L   +      +  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNE 80
Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
           F  E  ++ ++ H +IV   G       + ++ EY+ RGSL+ +LH      +LD  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           ++   +A  + YLH+  +P I+HRD+ S N+L++ K    V DFG +R   +        
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA 199
Query: 309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           AGT  ++APE+       EK DVYSFGV+  E+   + P
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 115/219 (52%), Gaps = 3/219 (1%)
Query: 129 YDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS 188
           + G +  +D+     D +IK  IG G +G+V++A+  +G   A+K L   +      +  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNE 80
Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
           F  E  ++ ++ H +IV   G       + ++ EY+ RGSL+ +LH      +LD  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           ++   +A  + YLH+  +P I+HR++ S N+L++ K    V DFG +R   +   +    
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           AGT  ++APE+       EK DVYSFGV+  E+   + P
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 152 GTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V ++  H ++V+L 
Sbjct: 31  GEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVXAKCQHENLVELL 87
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           GF      + L+Y Y   GSL   L   D    L W  R  I +  A+ + +LH +    
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH-- 145
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTAR--RLHADSSNRTLLAGTYGYIAPELAYTMVMT 326
            IHRDI S NILL+    A ++DFG AR     A     + + GT  Y APE A    +T
Sbjct: 146 -IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEIT 203
Query: 327 EKCDVYSFGVVTLEVLMG-------KHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQK 379
            K D+YSFGVV LE++ G       + P+          D +  + D +D++        
Sbjct: 204 PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTS 263
Query: 380 VIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           V     +AS     CL      RP ++ V Q
Sbjct: 264 VEAXYSVASQ----CLHEKKNKRPDIKKVQQ 290

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +G G +G+VY A+    K + ALK L  S+ E+       R E ++ S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I+++Y +   +K ++L+ E+  RG L+  L         D  +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 131
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                EK D++  GV+  E L+G  P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +G G +G+VY A+    K + ALK L  S+ E+       R E ++ S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I+++Y +   +K ++L+ E+  RG L+  L         D  +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 130
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                EK D++  GV+  E L+G  P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +G G +G+VY A+      + ALK L  S+ E+       R E ++ + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I++LY +   ++ ++LI EY  RG L+  L    ++   D  +   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H      +IHRDI   N+LL  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 140 H---GKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  EK D++  GV+  E+L+G  P
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 14/212 (6%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +  ++  IG GG+G VY+A     +V      H  + +    I++ R EA++ + + H +
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           I+ L G CL +  + L+ E+   G L  +L       ++     VN    +A  + YLH 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHD 123
Query: 264 DCSPSIIHRDISSNNILLNSKLEAF--------VADFGTARRLHADSSNRTLLAGTYGYI 315
           +    IIHRD+ S+NIL+  K+E          + DFG AR  H   + +   AG Y ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWM 181
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           APE+    + ++  DV+S+GV+  E+L G+ P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 146/301 (48%), Gaps = 48/301 (15%)
Query: 131 GRIFYEDLIEATEDFHIKY--CIGTGGYGSVYKAQLPNGK-VFALKKL----HTSETEEL 183
           G  F +  +    D  I+Y   IG GG+G V+K +L   K V A+K L       ETE +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 184 AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
              + F+ E  ++S + H +IVKLYG   +   M  + E++  G L+  L   D+A  + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIK 120
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTARR- 297
           W+ ++ ++  +A  + Y+ +  +P I+HRD+ S NI L S  E     A VADFGT+++ 
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS 179
Query: 298 LHADSSNRTLLAGTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXX 355
           +H+ S     L G + ++APE   A     TEK D YSF ++   +L G+ P D      
Sbjct: 180 VHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG- 234
Query: 356 XXXDPKIMLIDVLDQR-----LP---PPVDQKVIQDILLASTISFACLQSNPKSRPTMQY 407
                KI  I+++ +      +P   PP  + VI+           C   +PK RP   Y
Sbjct: 235 -----KIKFINMIREEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSY 279
Query: 408 V 408
           +
Sbjct: 280 I 280

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 134/289 (46%), Gaps = 39/289 (13%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSETE 181
           +ED  EA  +F          I+  IG G +G V     +LP  +    A+K L +  TE
Sbjct: 16  FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 75
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F +EA ++ Q  H +++ L G       + +I E+ME GSL   L  +D    
Sbjct: 76  KQR--RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +A  + YL      + +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 134 V--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 302 SSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXX 355
           +S+ T  +   G I     APE       T   DV+S+G+V  EV+  G+ P        
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP------YW 242
Query: 356 XXXDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRP 403
              +  ++     D RLPPP+D    +  ++L       C Q +   RP
Sbjct: 243 DMTNQDVINAIEQDYRLPPPMDCPSALHQLML------DCWQKDRNHRP 285

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 48/301 (15%)
Query: 131 GRIFYEDLIEATEDFHIKY--CIGTGGYGSVYKAQLPNGK-VFALKKL----HTSETEEL 183
           G  F +  +    D  I+Y   IG GG+G V+K +L   K V A+K L       ETE +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 184 AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
              + F+ E  ++S + H +IVKLYG   +   M  + E++  G L+  L   D+A  + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIK 120
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTARR- 297
           W+ ++ ++  +A  + Y+ +  +P I+HRD+ S NI L S  E     A VADFG +++ 
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 298 LHADSSNRTLLAGTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXX 355
           +H+ S     L G + ++APE   A     TEK D YSF ++   +L G+ P D      
Sbjct: 180 VHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG- 234
Query: 356 XXXDPKIMLIDVLDQR-----LP---PPVDQKVIQDILLASTISFACLQSNPKSRPTMQY 407
                KI  I+++ +      +P   PP  + VI+           C   +PK RP   Y
Sbjct: 235 -----KIKFINMIREEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSY 279
Query: 408 V 408
           +
Sbjct: 280 I 280

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 144/301 (47%), Gaps = 48/301 (15%)
Query: 131 GRIFYEDLIEATEDFHIKY--CIGTGGYGSVYKAQLPNGK-VFALKKL----HTSETEEL 183
           G  F +  +    D  I+Y   IG GG+G V+K +L   K V A+K L       ETE +
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 184 AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
              + F+ E  ++S + H +IVKLYG   +   M  + E++  G L+  L   D+A  + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIK 120
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTARR- 297
           W+ ++ ++  +A  + Y+ +  +P I+HRD+ S NI L S  E     A VADF  +++ 
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS 179
Query: 298 LHADSSNRTLLAGTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXX 355
           +H+ S     L G + ++APE   A     TEK D YSF ++   +L G+ P D      
Sbjct: 180 VHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG- 234
Query: 356 XXXDPKIMLIDVLDQR-----LP---PPVDQKVIQDILLASTISFACLQSNPKSRPTMQY 407
                KI  I+++ +      +P   PP  + VI+           C   +PK RP   Y
Sbjct: 235 -----KIKFINMIREEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSY 279
Query: 408 V 408
           +
Sbjct: 280 I 280

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 28/272 (10%)
Query: 147 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           I+  IG G +G V + +L  P  K    A+K L    TE     + F +EA ++ Q  H 
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHP 75
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +I++L G   +   + ++ E+ME G+L   L  +D    +   + V +++ +A  + YL 
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL- 132
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAP 317
                S +HRD+++ NIL+NS L   V+DFG +R L  +SS+ T  +   G     + AP
Sbjct: 133 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E       T   D +S+G+V  EV+  G+ P           +  ++     D RLPPP 
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP------YWDMSNQDVINAIEQDYRLPPPP 244
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           D       L+       C Q +  +RP    V
Sbjct: 245 DCPTSLHQLM-----LDCWQKDRNARPRFPQV 271

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 151 IGTGGYGSVYKAQLP--NGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           IG G +G VYK  L   +GK     A+K L    TE+      F  EA ++ Q  H +I+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNII 109
Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           +L G     K M +I EYME G+L   L   D   E    + V +++ +A  + YL    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL---A 164
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPELAYT 322
           + + +HRD+++ NIL+NS L   V+DFG +R L  D       +G      + APE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 323 MVMTEKCDVYSFGVVTLEVLM-GKHP 347
              T   DV+SFG+V  EV+  G+ P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 126/272 (46%), Gaps = 28/272 (10%)
Query: 147 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           I+  IG G +G V + +L  P  K    A+K L    TE     + F +EA ++ Q  H 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHP 77
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +I++L G   +   + ++ E+ME G+L   L  +D    +   + V +++ +A  + YL 
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL- 134
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----AP 317
                S +HRD+++ NIL+NS L   V+DFG +R L  +SS+ T  +   G I     AP
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E       T   D +S+G+V  EV+  G+ P           +  ++     D RLPPP 
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP------YWDMSNQDVINAIEQDYRLPPPP 246
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           D       L+       C Q +  +RP    V
Sbjct: 247 DCPTSLHQLM-----LDCWQKDRNARPRFPQV 273

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 30/268 (11%)
Query: 147 IKYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           I+  IG G +G V     +LP  +    A+K L +  TE+    + F +EA ++ Q  H 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 68
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +++ L G       + +I E+ME GSL   L  +D    +   + V +++ +A  + YL 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 125
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----AP 317
                + +HR +++ NIL+NS L   V+DFG +R L  D+S+ T  +   G I     AP
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E       T   DV+S+G+V  EV+  G+ P           +  ++     D RLPPP+
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP------YWDMTNQDVINAIEQDYRLPPPM 237
Query: 377 D-QKVIQDILLASTISFACLQSNPKSRP 403
           D    +  ++L       C Q +   RP
Sbjct: 238 DCPSALHQLML------DCWQKDRNHRP 259

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG AR L  D        G    
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 265
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 266 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETE 181
           YED  +   +F          I   +G G +G V   + +LP+ K    A+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F  EA ++ Q  H +I++L G     K + ++ EYME GSL   L   D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXX 357
                   G      + +PE       T   DV+S+G+V  EV+  G+ P          
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-- 258
Query: 358 XDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                 +I  +D+  RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 259 ------VIKAVDEGYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETE 181
           YED  +   +F          I   +G G +G V   + +LP+ K    A+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F  EA ++ Q  H +I++L G     K + ++ EYME GSL   L   D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXX 357
                   G      + +PE       T   DV+S+G+V  EV+  G+ P          
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-- 258
Query: 358 XDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                 +I  +D+  RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 259 ------VIKAVDEGYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETE 181
           YED  +   +F          I   +G G +G V   + +LP+ K    A+K L    TE
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F  EA ++ Q  H +I++L G     K + ++ EYME GSL   L   D    
Sbjct: 86  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 144 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXX 357
                   G      + +PE       T   DV+S+G+V  EV+  G+ P          
Sbjct: 199 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-- 256
Query: 358 XDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                 +I  +D+  RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 257 ------VIKAVDEGYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 298

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 66
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 67  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 124
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 125 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 181
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 230
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 231 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 403
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 404 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 435

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 403
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 404 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 435

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKIRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 134/279 (48%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+++ NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 322
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 323 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 380
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 486
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 487 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 518

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 403
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 404 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 435

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 64
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 122
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 123 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 179
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 228
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 229 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 260

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 62
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 63  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 121 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 177
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 226
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 227 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 258

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G    
Sbjct: 157 ASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 265
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 266 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE 128
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAAL 185
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 234
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 235 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 266

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+          A+K L           +SF  EAQ++ ++ H  +V+LY  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP----ESFLEEAQIMKKLKHDKLVQLYA- 71
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            + ++ ++++ EYM +GSL   L  D E   L     V++   +A  +AY+      + I
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 127
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ S NIL+ + L   +ADFG AR +   + + R        + APE A     T K 
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 330 DVYSFGVVTLE-VLMGKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLPPPVDQKVIQD 383
           DV+SFG++  E V  G+ P            P +   +VL+Q     R+P P D  +   
Sbjct: 188 DVWSFGILLTELVTKGRVPY-----------PGMNNREVLEQVERGYRMPCPQDCPISLH 236
Query: 384 ILLASTISFACLQSNPKSRPTMQYVSQGFL 413
            L+       C + +P+ RPT +Y+ Q FL
Sbjct: 237 ELM-----IHCWKKDPEERPTFEYL-QSFL 260

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 30  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 86
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 144
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G    
Sbjct: 145 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 253
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 254 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 288

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 124/275 (45%), Gaps = 30/275 (10%)
Query: 144 DFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q 
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 74
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + 
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMK 132
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIA 316
           YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G      + +
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ--RLP 373
           PE       T   DV+S+G+V  EV+  G+ P                +I  +D+  RLP
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYRLP 241
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           PP+D       L+       C Q +  +RP  + +
Sbjct: 242 PPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 271

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +   + + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G    
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 265
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 266 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE 128
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 185
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 234
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 235 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 266

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG  R L  D        G    
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 265
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 266 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G    
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 265
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 266 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G   K      G+V  +K+L   + E     ++F  E +V+  + H +++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIG 74
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                K +  I EY++ G+L  I+ + D   +  W++RV+  K +A  +AYLH   S +I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRL--------------HADSSNRTLLAGTYGYI 315
           IHRD++S+N L+       VADFG AR +                D   R  + G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVL 342
           APE+       EK DV+SFG+V  E++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ----EAQVMKKLRHE 240
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 241 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG  R +  +  + R        + APE A 
Sbjct: 299 R---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAAL 355
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 404
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 405 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 436

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 63
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ + ++ EYM +GSL   L  +     L   + V++   +A  +AY+ 
Sbjct: 64  KLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 121
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +   + + R        + APE A 
Sbjct: 122 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 178
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 227
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C +  P+ RPT +Y+ Q FL
Sbjct: 228 PECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 259

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +G L   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDE---AVELDWAKRVNIVKAMAHAL 258
             I++++G     + +F+I +Y+E G LF +L         V   +A  V +      AL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL------AL 119
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            YLH   S  II+RD+   NILL+      + DFG A+ +         L GT  YIAPE
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLCGTPDYIAPE 173
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +  T    +  D +SFG++  E+L G  P
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 39/288 (13%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETE 181
           +ED  +A  +F          I+  IG G +G V   +L  P  +    A+K L    T+
Sbjct: 12  FEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F +EA ++ Q  H +I+ L G     K + +I EYME GSL   L  +D    
Sbjct: 72  KQR--RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +   + YL      S +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 130 V--IQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXX 357
                   G      + APE       T   DV+S+G+V  EV+  G+ P          
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 242
Query: 358 XDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRP 403
                 +I  +++  RLPPP+D  +    L+       C Q     RP
Sbjct: 243 ------VIKAIEEGYRLPPPMDCPIALHQLM-----LDCWQKERSDRP 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 39/293 (13%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETE 181
           YED  +   +F          I   +G G +G V   + +LP+ K    A+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F  EA ++ Q  H +I++L G     K + ++ E ME GSL   L   D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXX 357
                   G      + +PE       T   DV+S+G+V  EV+  G+ P          
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-- 258
Query: 358 XDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                 +I  +D+  RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 259 ------VIKAVDEGYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY   + ++ ++++ EYM +G L   L  +     L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ-----RLP-P 374
               T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCP 237
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL 413
           P   + + D++        C + +P+ RPT +Y+ Q FL
Sbjct: 238 PECPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 6/211 (2%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  EDF +   +G G +  VY+A+ +  G   A+K +      +   ++  +NE ++  Q
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + H SI++LY +      ++L+ E    G +   L N  +    + A+  + +  +   +
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGM 125
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            YLH   S  I+HRD++ +N+LL   +   +ADFG A +L         L GT  YI+PE
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           +A       + DV+S G +   +L+G+ P D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 125
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 182
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 130
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 187
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 18  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 73
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 74  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 127
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 184
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 130
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 187
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 30/275 (10%)
Query: 144 DFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q 
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 74
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I++L G     K + ++ E ME GSL   L   D    +   + V +++ +A  + 
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMK 132
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIA 316
           YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G      + +
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ--RLP 373
           PE       T   DV+S+G+V  EV+  G+ P                +I  +D+  RLP
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYRLP 241
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           PP+D       L+       C Q +  +RP  + +
Sbjct: 242 PPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 271

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 125
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 182
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 43  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 98
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 99  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 152
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 209
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 99
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 153
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 210
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 31/280 (11%)
Query: 139 IEATEDFHIKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQ 194
           ++AT +  I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++ Q  H +I++L G     K + ++ E ME GSL   L   D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D        G    
Sbjct: 157 ASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + +PE       T   DV+S+G+V  EV+  G+ P                +I  +D+
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDE 265
Query: 371 --RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLPPP+D       L+       C Q +  +RP  + +
Sbjct: 266 GYRLPPPMDCPAALYQLM-----LDCWQKDRNNRPKFEQI 300

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 99
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 153
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 210
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 36  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 91
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 92  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 145
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 202
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 145 FHIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
             I+  IG G +G V   +L  P  +    A+K L    T++    + F +EA ++ Q  
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFD 67
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +I+ L G     K + +I EYME GSL   L  +D    +   + V +++ +   + Y
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 125
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAP 317
           L      S +HRD+++ NIL+NS L   V+DFG +R L  D        G      + AP
Sbjct: 126 LS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ--RLPP 374
           E       T   DV+S+G+V  EV+  G+ P                +I  +++  RLPP
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIEEGYRLPP 234
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRP 403
           P+D  +    L+       C Q     RP
Sbjct: 235 PMDCPIALHQLM-----LDCWQKERSDRP 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +  E F +   +G G YGSVYKA     G++ A+K++   E++    IK    E  ++ Q
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-ESDLQEIIK----EISIMQQ 80
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
                +VK YG       ++++ EY   GS+  I+   ++ +  D  +   I+++    L
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGL 138
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            YLH       IHRDI + NILLN++  A +ADFG A +L    + R  + GT  ++APE
Sbjct: 139 EYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE 195
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +   +      D++S G+  +E+  GK P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 145 FHIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
             I+  IG G +G V   +L  P  +    A+K L    T++    + F +EA ++ Q  
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFD 73
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +I+ L G     K + +I EYME GSL   L  +D    +   + V +++ +   + Y
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 131
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAP 317
           L      S +HRD+++ NIL+NS L   V+DFG +R L  D        G      + AP
Sbjct: 132 LS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ--RLPP 374
           E       T   DV+S+G+V  EV+  G+ P                +I  +++  RLPP
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIEEGYRLPP 240
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRP 403
           P+D  +    L+       C Q     RP
Sbjct: 241 PMDCPIALHQLM-----LDCWQKERSDRP 264

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +    + + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 72  YSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 125
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           IHRD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQD 182
Query: 328 K------CDVYSFGVVTLEVLMGKHP 347
           K       DVY+FG+V  E++ G+ P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 131 GRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFI 186
           GR F  + IEA+   HI+  IG+G  G V   +L  P  +    A+K L    TE     
Sbjct: 39  GRSFTRE-IEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-- 94
Query: 187 KSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK 246
           + F +EA ++ Q  H +I++L G     +   ++ EYME GSL   L   D    +   +
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQ 152
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V +++ +   + YL        +HRD+++ N+L++S L   V+DFG +R L  D     
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 307 LLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              G      + APE       +   DV+SFGVV  EVL  G+ P
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 113/203 (55%), Gaps = 16/203 (7%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 20  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 75
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 76  YST-KPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSI 129
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPE---LAYTMV 324
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++APE   +  +  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + DVY+FG+V  E++ G+ P
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLP 212

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 113/203 (55%), Gaps = 16/203 (7%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +   K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 88  YST-KPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSI 141
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPE---LAYTMV 324
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++APE   +  +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + DVY+FG+V  E++ G+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 131 GRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFI 186
           GR F  + IEA+   HI+  IG+G  G V   +L  P  +    A+K L    TE     
Sbjct: 39  GRSFTRE-IEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-- 94
Query: 187 KSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK 246
           + F +EA ++ Q  H +I++L G     +   ++ EYME GSL   L   D    +   +
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQ 152
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V +++ +   + YL        +HRD+++ N+L++S L   V+DFG +R L  D     
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 307 LLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              G      + APE       +   DV+SFGVV  EVL  G+ P
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 129/269 (47%), Gaps = 22/269 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+ A        A+K +          +++F  EA V+  + H 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHD 70
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +VKL+   + K+ +++I E+M +GSL   L +D E  +    K ++    +A  +A++ 
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + IHRD+ + NIL+++ L   +ADFG AR +  +  + R        + APE   
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKV 380
               T K DV+SFG++ +E++  G+ P           +P+++       R+P P  +  
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRP--ENC 237
Query: 381 IQDILLASTISFACLQSNPKSRPTMQYVS 409
            +++     I   C ++ P+ RPT +Y+ 
Sbjct: 238 PEELY---NIMMRCWKNRPEERPTFEYIQ 263

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 135 YEDLIEATEDFH---------IKYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSETE 181
           YED  +A  +F          I+  IG G +G V   + +LP  +    A+K L    TE
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F  EA ++ Q  H +I+ L G     K + ++ EYME GSL   L  +D    
Sbjct: 65  KQR--RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ ++  + YL        +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 123 V--IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                   G      + APE       T   DV+S+G+V  EV+  G+ P
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 118/223 (52%), Gaps = 17/223 (7%)
Query: 130 DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSF 189
           D   ++E  IEA+E   +   IG+G +G+VYK +  +G V A+K L   +     F ++F
Sbjct: 26  DSSYYWE--IEASE-VMLSTRIGSGSFGTVYKGKW-HGDV-AVKILKVVDPTPEQF-QAF 79
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           RNE  VL +  H +I+   G+ + K  + ++ ++ E  SL+  LH  +   ++   + ++
Sbjct: 80  RNEVAVLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLID 136
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTL 307
           I +  A  + YLH   + +IIHRD+ SNNI L+  L   + DFG  T +   + S     
Sbjct: 137 IARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ 193
Query: 308 LAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHP 347
             G+  ++APE+         + + DVYS+G+V  E++ G+ P
Sbjct: 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 7/205 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ + Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 202 RSIVKLYGFCLHKK--CMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVNIVKAMAHAL 258
            +IV+ Y   + +    ++++ EY E G L  ++     E   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 259 AYLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
              H   D   +++HRD+   N+ L+ K    + DFG AR L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEV 341
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 129/268 (48%), Gaps = 22/268 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+ A        A+K +          +++F  EA V+  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHD 243
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +VKL+   + K+ +++I E+M +GSL   L +D E  +    K ++    +A  +A++ 
Sbjct: 244 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAY 321
                + IHRD+ + NIL+++ L   +ADFG AR +  +  + R        + APE   
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKV 380
               T K DV+SFG++ +E++  G+ P           +P+++       R+P P  +  
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRP--ENC 410
Query: 381 IQDILLASTISFACLQSNPKSRPTMQYV 408
            +++     I   C ++ P+ RPT +Y+
Sbjct: 411 PEELY---NIMMRCWKNRPEERPTFEYI 435

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 21/267 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH   S   
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 125
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+   E  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 185
Query: 330 DVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P              + ++ ++ +  PP ++    + +     
Sbjct: 186 DIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKNNPPTLEGNYSKPL---KE 234
Query: 390 ISFACLQSNPKSRPTMQYVSQGFLITR 416
              ACL   P  RPT + + +   I R
Sbjct: 235 FVEACLNKEPSFRPTAKELLKHKFILR 261

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 7/205 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ + Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 202 RSIVKLYGFCLHKK--CMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVNIVKAMAHAL 258
            +IV+ Y   + +    ++++ EY E G L  ++     E   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 259 AYLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
              H   D   +++HRD+   N+ L+ K    + DFG AR L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEV 341
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 113/203 (55%), Gaps = 16/203 (7%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H +I+   G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           +    + + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH   + SI
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSI 141
Query: 270 IHRDISSNNILLNSKLEAFVADFG--TARRLHADSSNRTLLAGTYGYIAPE---LAYTMV 324
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++APE   +  +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + DVY+FG+V  E++ G+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 21/267 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH   S   
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 145
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+   E  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 205
Query: 330 DVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P             K++ +  + +  PP ++    + +     
Sbjct: 206 DIWSLGITAIELARGEPPHSELHPM------KVLFL--IPKNNPPTLEGNYSKPL---KE 254
Query: 390 ISFACLQSNPKSRPTMQYVSQGFLITR 416
              ACL   P  RPT + + +   I R
Sbjct: 255 FVEACLNKEPSFRPTAKELLKHKFILR 281

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 21/267 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH   S   
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 125
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+   E  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 330 DVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P              + ++ ++ +  PP ++    + +     
Sbjct: 186 DIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKNNPPTLEGNYSKPL---KE 234
Query: 390 ISFACLQSNPKSRPTMQYVSQGFLITR 416
              ACL   P  RPT + + +   I R
Sbjct: 235 FVEACLNKEPSFRPTAKELLKHKFILR 261

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 21/267 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH   S   
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 140
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+   E  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 330 DVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P             K++ +  + +  PP ++    + +     
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPM------KVLFL--IPKNNPPTLEGNYSKPL---KE 249
Query: 390 ISFACLQSNPKSRPTMQYVSQGFLITR 416
              ACL   P  RPT + + +   I R
Sbjct: 250 FVEACLNKEPSFRPTAKELLKHKFILR 276

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
            D  +K  +G G +G V+ A+  N    K   L  +   +   LA  K F+ EA++L+ +
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV-----------ELDWAK 246
            H  IVK YG C     + +++EYM+ G L  F   H  D  +           EL  ++
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR- 305
            ++I   +A  + YL    S   +HRD+++ N L+ + L   + DFG +R +++    R 
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 306 ---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              T+L     ++ PE       T + DV+SFGV+  E+   GK P
Sbjct: 192 GGHTMLP--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 117/262 (44%), Gaps = 31/262 (11%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+K       +V A+K +   E E+    +  + E  VLSQ     + K YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSSYVTKYYG 88
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    +++I EY+  GS   +L     A   D  +   ++K +   L YLH   S   
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKK 141
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI + N+LL+ + +  +ADFG A +L      R    GT  ++APE+        K 
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 201
Query: 330 DVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAST 389
           D++S G+  +E+  G+ P           D   M +  L  +  PP    ++ D     T
Sbjct: 202 DIWSLGITAIELAKGEPPN---------SDMHPMRVLFLIPKNNPPT---LVGDF----T 245
Query: 390 ISF-----ACLQSNPKSRPTMQ 406
            SF     ACL  +P  RPT +
Sbjct: 246 KSFKEFIDACLNKDPSFRPTAK 267

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+     N    A+K L          +++F  EA ++  + H  +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
              ++ +++I EYM +GSL   L + DE  ++   K ++    +A  +AY+      + I
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ + N+L++  L   +ADFG AR +  +  + R        + APE       T K 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 330 DVYSFGVVTLEVLM-GKHP 347
           DV+SFG++  E++  GK P
Sbjct: 193 DVWSFGILLYEIVTYGKIP 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 7/205 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ + Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 202 RSIVKLYGFCLHKK--CMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVNIVKAMAHAL 258
            +IV+ Y   + +    ++++ EY E G L  ++     E   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 259 AYLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
              H   D   +++HRD+   N+ L+ K    + DFG AR L+ D        GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEV 341
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 151 IGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAF------IKSFR----NEAQVLSQV 199
           +G+G YG V   +  NG    A+K +  S+ ++  +      I+ F     NE  +L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +I+KL+     KK  +L+ E+ E G LF  + N  +  E D A   NI+K +   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGIC 160
Query: 260 YLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           YLH     +I+HRDI   NILL   NS L   + DFG +     D   R  L   Y YIA
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY-YIA 216
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE+       EKCDV+S GV+   +L G  P
Sbjct: 217 PEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 37/277 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFI---------KSFRNEAQVLSQVLH 201
           IG G +G VYK  + N         HT E   +  I         +  + E  VLSQ   
Sbjct: 27  IGKGSFGEVYKG-IDN---------HTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 76
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             I + +G  L    +++I EY+  GS   +L    +   L+      I++ +   L YL
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYL 132
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S   IHRDI + N+LL+ + +  +ADFG A +L      R    GT  ++APE+  
Sbjct: 133 H---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK 189
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVI 381
                 K D++S G+  +E+  G+ P           D   M +  L  +  PP  +   
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPPNS---------DLHPMRVLFLIPKNSPPTLEG-- 238
Query: 382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT 418
           Q          ACL  +P+ RPT + + +   ITR T
Sbjct: 239 QHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 275

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E +H    IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLY     KK + L++E++++  L  +L   +  +E   AK  + +  + + +AY H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH 117
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
           +   +   D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E +H    IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLY     KK + L++E++++  L  +L   +  +E   AK  + +  + + +AY H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH 117
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
           +   +   D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 38/228 (16%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V KA+   + + +A+KK+  +E E+L+ I S   E  +L+ + H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVMLLASLNHQ 62
Query: 203 SIVKLYGFCLHKK-------------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
            +V+ Y   L ++              +F+  EY E G+L+ ++H+++   + D   R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-- 120
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH---------- 299
           + + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H          
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 300 ----ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 342
                 S N T   GT  Y+A E L  T    EK D+YS G++  E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   IG G +  V   ++   G+V+A+K ++  +  +   +  FR E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK--RVNIVKAM--AHA 257
           R I +L+     +  ++L+ EY   G L  +L    E +  + A+     IV A+   H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIA 316
           L Y         +HRDI  +NILL+      +ADFG+  +L AD + R+L+A GT  Y++
Sbjct: 181 LGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 317 PELAYTMVMTE-------KCDVYSFGVVTLEVLMGKHP 347
           PE+   +           +CD ++ GV   E+  G+ P
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 19  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 134
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESL 189
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 237
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 238 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 109/207 (52%), Gaps = 17/207 (8%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVL 200
           D ++K  IG G  G V  A+  + G+  A+K   L   +  EL F     NE  ++    
Sbjct: 48  DSYVK--IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQ 100
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H ++V++Y   L  + ++++ E+++ G+L  I+      V L+  +   + +A+  ALAY
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAY 156
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   +  +IHRDI S++ILL       ++DFG   ++  D   R  L GT  ++APE+ 
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI 213
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              +   + D++S G++ +E++ G+ P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 127/270 (47%), Gaps = 34/270 (12%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+ A        A+K +          +++F  EA V+  + H 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHD 237
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +VKL+   + K+ +++I E+M +GSL   L +D E  +    K ++    +A  +A++ 
Sbjct: 238 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPELA 320
                + IHRD+ + NIL+++ L   +ADFG AR           +   +   + APE  
Sbjct: 296 QR---NYIHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAI 341
Query: 321 YTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQK 379
                T K DV+SFG++ +E++  G+ P           +P+++       R+P P  + 
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRP--EN 393
Query: 380 VIQDILLASTISFACLQSNPKSRPTMQYVS 409
             +++     I   C ++ P+ RPT +Y+ 
Sbjct: 394 CPEELY---NIMMRCWKNRPEERPTFEYIQ 420

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 135 YEDLIEATEDF---------HIKYCIGTGGYGSV--YKAQLPNGK--VFALKKLHTSETE 181
           YED   A   F          I+  IG G +G V   + +LP  +    A+K L    TE
Sbjct: 26  YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 182 ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE 241
           +    + F  EA ++ Q  H ++V L G     K + ++ E+ME G+L   L   D    
Sbjct: 86  KQR--RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +   + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R +  D
Sbjct: 144 V--IQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 302 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                   G      + APE       T   DV+S+G+V  EV+  G+ P
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 15  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 129
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 130 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESL 185
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 186 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 233
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 234 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 12  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE- 126
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESL 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVL---MGKHPRDXXXXXXXXXDP-KIMLIDVLDQRL--P 373
           AY    + K DV++FGV+  E+    M  +P           DP ++  +   D R+  P
Sbjct: 183 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYP---------GIDPSQVYELLEKDYRMERP 232
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
               +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 EGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 264

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E +H    IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLY     KK + L++E++++  L  +L   +  +E   AK  + +  + + +AY H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH 117
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
           +   +   D++S G +  E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G  G V+          A+K L        AF+     E
Sbjct: 3   WWEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 58
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 59  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  A+ + R      
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 227
Query: 371 RL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    +++ Q + L       C +  P+ RPT  Y+
Sbjct: 228 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 15  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 130
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 131 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAPAGAKFPIKWTAPESL 185
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 186 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 233
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 234 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 14  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 128
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 184
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 232
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 19  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 133
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 189
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 237
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 238 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 19  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 134
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 189
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 237
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 238 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 19  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 133
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 134 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 189
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 237
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 238 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 14  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 128
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 184
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 232
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 147 IKYCIGTGGYGSVYKAQLPN-----GKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           +K  +G G +G V+ A+  N      K+  A+K L  +        K F  EA++L+ + 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 73
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV--------ELDWAKRVNI 250
           H  IVK YG C+    + +++EYM+ G L  F   H  D  +        EL  ++ ++I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----T 306
            + +A  + YL    S   +HRD+++ N L+   L   + DFG +R +++    R    T
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
           +L     ++ PE       T + DV+S GVV  E+   GK P
Sbjct: 191 MLP--IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 18  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 132
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 188
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 189 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 236
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 237 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 16  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 130
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 131 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAPAGAKFPIKWTAPESL 186
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 187 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 234
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 235 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 268

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 16  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 130
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 131 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 186
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 187 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 234
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 235 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 268

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 27  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 83
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 141
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 142 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 197
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 198 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 245
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 246 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 279

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 16  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE- 130
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 131 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 186
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 187 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 234
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 235 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 268

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   IG G +G V   +L N  KVFA+K L+  E  + A    FR E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK----RVNIVKAMAHA 257
           + I  L+        ++L+ +Y   G L  +L   ++ +  + A+     + I     H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIA 316
           L Y         +HRDI  +NIL++      +ADFG+  +L  D + ++ +A GT  YI+
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 317 PELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHP 347
           PE+   M   +     +CD +S GV   E+L G+ P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 5   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 60
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 61  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 118
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 119 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 176 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 229
Query: 371 RLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P +  +++ Q + L       C +  P+ RPT  Y+
Sbjct: 230 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 262

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E + I   +G GG  +VY A+  + N KV A+K +     E+   +K F  E    SQ+ 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H++IV +        C +L+ EY+E  +L   + +    + +D A  +N    +   + +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTA--INFTNQILDGIKH 126
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGYIAPEL 319
            H      I+HRDI   NIL++S     + DFG A+ L   S  +T  + GT  Y +PE 
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           A      E  D+YS G+V  E+L+G+ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 4   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 59
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 60  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 117
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 118 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 175 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 228
Query: 371 RLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P +  +++ Q + L       C +  P+ RPT  Y+
Sbjct: 229 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 261

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 58
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 59  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 227
Query: 371 RLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P +  +++ Q + L       C +  P+ RPT  Y+
Sbjct: 228 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 260

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 12  WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 68  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 125
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +   + + R      
Sbjct: 126 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 183 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 236
Query: 371 RL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    +++ Q + L       C +  P+ RPT  Y+
Sbjct: 237 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 269

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 58
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 59  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +   + + R      
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 227
Query: 371 RL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    +++ Q + L       C +  P+ RPT  Y+
Sbjct: 228 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 11  WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 66
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 67  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 124
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +   + + R      
Sbjct: 125 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 182 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 235
Query: 371 RL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    +++ Q + L       C +  P+ RPT  Y+
Sbjct: 236 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 268

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 8   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 63
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 64  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 121
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 122 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 179 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 232
Query: 371 RLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P +  +++ Q + L       C +  P+ RPT  Y+
Sbjct: 233 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 265

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 58
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 59  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 227
Query: 371 RLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P +  +++ Q + L       C +  P+ RPT  Y+
Sbjct: 228 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 260

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 12  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE- 126
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 127 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF--TAHAGAKFPIKWTAPESL 182
Query: 320 AYTMVMTEKCDVYSFGVVTLEVL---MGKHPRDXXXXXXXXXDP-KIMLIDVLDQRL--P 373
           AY    + K DV++FGV+  E+    M  +P           DP ++  +   D R+  P
Sbjct: 183 AYNK-FSIKSDVWAFGVLLWEIATYGMSPYP---------GIDPSQVYELLEKDYRMERP 232
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
               +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 EGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 9   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 64
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 65  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 122
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 123 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 233
Query: 371 RLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P +  +++ Q + L       C +  P+ RPT  Y+
Sbjct: 234 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 266

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 19  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEK 134
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 135 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 189
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 190 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 237
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 238 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 41/281 (14%)
Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   ++    + K VFA K +  S       +K  + E   +   +HRS     +
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 101
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      +F++ E   R SL   LH   +A+    A+    ++ +     YLH +
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHRN 158
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  LE  + DFG A ++  D   + +L GT  YIAPE+     
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP---PVDQKVI 381
            + + DV+S G +   +L+GK P +             + I   +  +P    PV   +I
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKNEYSIPKHINPVAASLI 270
Query: 382 QDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR 416
           Q +          LQ++P +RPT+      ++ + G++  R
Sbjct: 271 QKM----------LQTDPTARPTINELLNDEFFTSGYIPAR 301

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 14  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE- 128
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 184
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 232
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 201 HRSIVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLAGTY 312
           AL + H +    IIHRD+   NIL+++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQTAAVIGTA 183
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 41/281 (14%)
Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   ++    + K VFA K +  S       +K  + E   +   +HRS     +
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      +F++ E   R SL   LH   +A+    A+    ++ +     YLH +
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN 134
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  LE  + DFG A ++  D   + +L GT  YIAPE+     
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP---PVDQKVI 381
            + + DV+S G +   +L+GK P +             + I   +  +P    PV   +I
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKNEYSIPKHINPVAASLI 246
Query: 382 QDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR 416
           Q +          LQ++P +RPT+      ++ + G++  R
Sbjct: 247 QKM----------LQTDPTARPTINELLNDEFFTSGYIPAR 277

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 41/281 (14%)
Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   ++    + K VFA K +  S       +K  + E   +   +HRS     +
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      +F++ E   R SL   LH   +A+    A+    ++ +     YLH +
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHRN 160
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  LE  + DFG A ++  D   + +L GT  YIAPE+     
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP---PVDQKVI 381
            + + DV+S G +   +L+GK P +             + I   +  +P    PV   +I
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNEYSIPKHINPVAASLI 272
Query: 382 QDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR 416
           Q +          LQ++P +RPT+      ++ + G++  R
Sbjct: 273 QKM----------LQTDPTARPTINELLNDEFFTSGYIPAR 303

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 14  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE- 128
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 184
Query: 320 AYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 232
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 127/289 (43%), Gaps = 56/289 (19%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 14  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L            LD+ +  N  +  A  L Y+  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNL------------LDYLRECNRQEVSAVVLLYMAT 118
Query: 264 DCSPSI--------IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---Y 312
             S ++        IHRD+++ N L+       VADFG +R +  D+   T  AG     
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPI 176
Query: 313 GYIAPE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVL-- 368
            + APE LAY    + K DV++FGV+  E+   G  P            P I L  V   
Sbjct: 177 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYEL 224
Query: 369 ---DQRL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
              D R+  P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 225 LEKDYRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 14  DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE- 128
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPE-L 319
               + IHRD+++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 184
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 185 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 232
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 233 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 9   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 64
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 65  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 122
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +   + + R      
Sbjct: 123 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 233
Query: 371 RL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    +++ Q + L       C +  P+ RPT  Y+
Sbjct: 234 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 266

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H ++V++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 93
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ LH   + 
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQ 146
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL   +    
Sbjct: 147 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 328 KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP 374
           + D++S G++ +E++ G+ P           +P +  + ++   LPP
Sbjct: 207 EVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 245

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 134 FYEDLIEA-TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++ED  E   E   +   +G G +G V+          A+K L        AF+     E
Sbjct: 13  WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----E 68
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           A ++ Q+ H+ +V+LY   + ++ +++I EYME GSL   L      ++L   K +++  
Sbjct: 69  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 126
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGT 311
            +A  +A++      + IHRD+ + NIL++  L   +ADFG AR +  +  + R      
Sbjct: 127 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             + APE       T K DV+SFG++  E++  G+ P           +P+++       
Sbjct: 184 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGY 237
Query: 371 RL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    +++ Q + L       C +  P+ RPT  Y+
Sbjct: 238 RMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYL 270

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H ++V++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 91
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ LH   + 
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQ 144
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL   +    
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 328 KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP 374
           + D++S G++ +E++ G+ P           +P +  + ++   LPP
Sbjct: 205 EVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 243

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 52/287 (18%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G +G VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 12  DITMKHKLGGGQFGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L            LD+ +  N  +  A  L Y+  
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNL------------LDYLRECNRQEVSAVVLLYMAT 116
Query: 264 DCSPSI--------IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---Y 312
             S ++        IHRD+++ N L+       VADFG +R +  D+   T  AG     
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPI 174
Query: 313 GYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL---MGKHPRDXXXXXXXXXDP-KIMLIDV 367
            + APE LAY    + K DV++FGV+  E+    M  +P           DP ++  +  
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP---------GIDPSQVYELLE 224
Query: 368 LDQRL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            D R+  P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 225 KDYRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 264

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   ++    + K VFA K +  S       +K  + E   +   +HRS     +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 79
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      +F++ E   R SL   LH   +A+    A+    ++ +     YLH +
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHRN 136
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  LE  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG 193
Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP---PVDQKVI 381
            + + DV+S G +   +L+GK P +             + I   +  +P    PV   +I
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKNEYSIPKHINPVAASLI 248
Query: 382 QDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR 416
           Q +          LQ++P +RPT+      ++ + G++  R
Sbjct: 249 QKM----------LQTDPTARPTINELLNDEFFTSGYIPAR 279

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   ++    + K VFA K +  S       +K  + E   +   +HRS     +
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 83
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      +F++ E   R SL   LH   +A+    A+    ++ +     YLH +
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHRN 140
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  LE  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG 197
Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP---PVDQKVI 381
            + + DV+S G +   +L+GK P +             + I   +  +P    PV   +I
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKNEYSIPKHINPVAASLI 252
Query: 382 QDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR 416
           Q +          LQ++P +RPT+      ++ + G++  R
Sbjct: 253 QKM----------LQTDPTARPTINELLNDEFFTSGYIPAR 283

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H ++V++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ LH   + 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQ 135
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL   +    
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 328 KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP 374
           + D++S G++ +E++ G+ P           +P +  + ++   LPP
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H ++V++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 86
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ LH   + 
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQ 139
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL   +    
Sbjct: 140 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 328 KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP 374
           + D++S G++ +E++ G+ P           +P +  + ++   LPP
Sbjct: 200 EVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 238

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           D  +K+ +G G +G V+ A+  N        + A+K L   E  E A  + F+ EA++L+
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLT 98
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV----------ELDWA 245
            + H+ IV+ +G C   + + +++EYM  G L  F   H  D  +           L   
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--- 302
           + + +   +A  + YL        +HRD+++ N L+   L   + DFG +R +++     
Sbjct: 159 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 303 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              RT+L     ++ PE       T + DV+SFGVV  E+   GK P
Sbjct: 216 VGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H ++V++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 213
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ LH   + 
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQ 266
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL   +    
Sbjct: 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 328 KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP 374
           + D++S G++ +E++ G+ P           +P +  + ++   LPP
Sbjct: 327 EVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 365

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 151 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   ++    + K VFA K +  S       +K  + E   +   +HRS     +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 79
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      +F++ E   R SL   LH   +A+    A+    ++ +     YLH +
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHRN 136
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  LE  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG 193
Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP---PVDQKVI 381
            + + DV+S G +   +L+GK P +             + I   +  +P    PV   +I
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKNEYSIPKHINPVAASLI 248
Query: 382 QDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR 416
           Q +          LQ++P +RPT+      ++ + G++  R
Sbjct: 249 QKM----------LQTDPTARPTINELLNDEFFTSGYIPAR 279

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+     N    A+K L          +++F  EA ++  + H  +V+LY  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
              ++ +++I E+M +GSL   L + DE  ++   K ++    +A  +AY+      + I
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ + N+L++  L   +ADFG AR +  +  + R        + APE       T K 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 330 DVYSFGVVTLEVLM-GKHP 347
           +V+SFG++  E++  GK P
Sbjct: 192 NVWSFGILLYEIVTYGKIP 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           D  +K+ +G G +G V+ A+  N        + A+K L   E  E A  + F+ EA++L+
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLT 75
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV----------ELDWA 245
            + H+ IV+ +G C   + + +++EYM  G L  F   H  D  +           L   
Sbjct: 76  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--- 302
           + + +   +A  + YL        +HRD+++ N L+   L   + DFG +R +++     
Sbjct: 136 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 192
Query: 303 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              RT+L     ++ PE       T + DV+SFGVV  E+   GK P
Sbjct: 193 VGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H ++V++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 136
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  A+  AL+ LH   + 
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQ 189
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL       ++DFG   ++  +   R  L GT  ++APEL   +    
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 328 KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPP 374
           + D++S G++ +E++ G+ P           +P +  + ++   LPP
Sbjct: 250 EVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPP 288

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           D  +K+ +G G +G V+ A+  N        + A+K L   E  E A  + F+ EA++L+
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLT 69
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAV----------ELDWA 245
            + H+ IV+ +G C   + + +++EYM  G L  F   H  D  +           L   
Sbjct: 70  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--- 302
           + + +   +A  + YL        +HRD+++ N L+   L   + DFG +R +++     
Sbjct: 130 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 186
Query: 303 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              RT+L     ++ PE       T + DV+SFGVV  E+   GK P
Sbjct: 187 VGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 62
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 119
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L  + +N     GT  Y++P
Sbjct: 120 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE--FVGTRSYMSP 175
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRL--PPP 375
           E       + + D++S G+  +E+ +G++PR           P + + ++LD  +  PPP
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR-----------PPMAIFELLDYIVNEPPP 224
Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR 416
                +  +     ++  CL  NP  R  ++ +     I R
Sbjct: 225 KLPSAVFSLEFQDFVN-KCLIKNPAERADLKQLMVHAFIKR 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 201 HRSIVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLAGTY 312
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 201 HRSIVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLAGTY 312
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 123/262 (46%), Gaps = 26/262 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+          A+K L        AF+     EA ++ Q+ H+ +V+LY  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 70
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            + ++ +++I EYME GSL   L      ++L   K +++   +A  +A++      + I
Sbjct: 71  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 126
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+ + NIL++  L   +ADFG AR +  +  + R        + APE       T K 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 330 DVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVD--QKVIQDILL 386
           DV+SFG++  E++  G+ P           +P+++       R+  P +  +++ Q + L
Sbjct: 187 DVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 240
Query: 387 ASTISFACLQSNPKSRPTMQYV 408
                  C +  P+ RPT  Y+
Sbjct: 241 -------CWKERPEDRPTFDYL 255

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 251
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 252 TIMYSCWHEKADERPTFK 269

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +D+ ++  IG+G    V  A   P  +  A+K+++  + +    +     E Q +SQ  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHH 72
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-----DDEAVELDWAKRVNIVKAMAH 256
            +IV  Y   + K  ++L+ + +  GS+  I+ +     + ++  LD +    I++ +  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD-----SSNRTLLAGT 311
            L YLH +     IHRD+ + NILL       +ADFG +  L        +  R    GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 312 YGYIAPELAYTMVMTE-KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             ++APE+   +   + K D++SFG+  +E+  G  P            P + ++ +  Q
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY--------PPMKVLMLTLQ 241
Query: 371 RLPPPVDQKVI-QDILLASTISFA-----CLQSNPKSRPT 404
             PP ++  V  +++L     SF      CLQ +P+ RPT
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 26/260 (10%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G+G +G V   +       A+K +      E  F +    EAQ + ++ H  +VK YG 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHPKLVKFYGV 71
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  +  ++++ EY+  G L   L +  + +E   ++ + +   +   +A+L    S   I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YGYIAPELAYTMVMTE 327
           HRD+++ N L++  L   V+DFG  R +  D    ++  GT     + APE+ +    + 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKYSS 184
Query: 328 KCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILL 386
           K DV++FG++  EV  +GK P D         + +++L      RL  P    +  D + 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYD------LYTNSEVVLKVSQGHRLYRP---HLASDTIY 235
Query: 387 ASTISFACLQSNPKSRPTMQ 406
              I ++C    P+ RPT Q
Sbjct: 236 --QIMYSCWHELPEKRPTFQ 253

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +D+ ++  IG+G    V  A   P  +  A+K+++  + +    +     E Q +SQ  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHH 67
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-----DDEAVELDWAKRVNIVKAMAH 256
            +IV  Y   + K  ++L+ + +  GS+  I+ +     + ++  LD +    I++ +  
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD-----SSNRTLLAGT 311
            L YLH +     IHRD+ + NILL       +ADFG +  L        +  R    GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 312 YGYIAPELAYTMVMTE-KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             ++APE+   +   + K D++SFG+  +E+  G  P            P + ++ +  Q
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY--------PPMKVLMLTLQ 236
Query: 371 RLPPPVDQKVI-QDILLASTISFA-----CLQSNPKSRPT 404
             PP ++  V  +++L     SF      CLQ +P+ RPT
Sbjct: 237 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 260 DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 316
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E++    + +   ++ A+ YL  
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 375
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY---GYIAPE-L 319
               + IHR++++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 376 K---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 430
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 431 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 478
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 479 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 512

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 221 DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL  
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEK 336
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY---GYIAPE-L 319
               + IHR++++ N L+       VADFG +R +  D+   T  AG      + APE L
Sbjct: 337 K---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 391
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVL-----DQRL- 372
           AY    + K DV++FGV+  E+   G  P            P I L  V      D R+ 
Sbjct: 392 AYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRME 439
Query: 373 -PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            P    +KV +       +  AC Q NP  RP+   + Q F
Sbjct: 440 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 473

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 38/228 (16%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V KA+   + + +A+KK+  +E E+L+ I S   E  +L+ + H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVMLLASLNHQ 62
Query: 203 SIVKLYGFCLHKK-------------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
            +V+ Y   L ++              +F+  EY E  +L+ ++H+++   + D   R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR-- 120
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH---------- 299
           + + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H          
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 300 ----ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 342
                 S N T   GT  Y+A E L  T    EK D+YS G++  E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + +IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 85
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    ++++ EY+  GSL  ++        +D  +   + +    AL +LH   S  +
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        K 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 330 DVYSFGVVTLEVLMGKHP 347
           D++S G++ +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 139 IEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           ++  E + I   +G G +G VYKA+    G + A K + T   EEL   + +  E ++L+
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILA 63
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV-KAMAH 256
              H  IVKL G   H   ++++ E+   G++  I+   D  +      ++ +V + M  
Sbjct: 64  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLE 120
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL +LH   S  IIHRD+ + N+L+  + +  +ADFG + +       R    GT  ++A
Sbjct: 121 ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 317 PELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHP 347
           PE+     M +     K D++S G+  +E+   + P
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + +IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    ++++ EY+  GSL  ++        +D  +   + +    AL +LH   S  +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 330 DVYSFGVVTLEVLMGKHP 347
           D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 71
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 126
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 235
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 236 TIMYSCWHEKADERPTFK 253

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + +IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    ++++ EY+  GSL  ++        +D  +   + +    AL +LH   S  +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 330 DVYSFGVVTLEVLMGKHP 347
           D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 236
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 237 TIMYSCWHEKADERPTFK 254

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 251
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 252 TIMYSCWHEKADERPTFK 269

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 78
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 133
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 242
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 243 TIMYSCWHEKADERPTFK 260

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 122
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 231
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 232 TIMYSCWHEKADERPTFK 249

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 139 IEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           ++  E + I   +G G +G VYKA+    G + A K + T   EEL   + +  E ++L+
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILA 71
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV-KAMAH 256
              H  IVKL G   H   ++++ E+   G++  I+   D  +      ++ +V + M  
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLE 128
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL +LH   S  IIHRD+ + N+L+  + +  +ADFG + +       R    GT  ++A
Sbjct: 129 ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 317 PELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHP 347
           PE+     M +     K D++S G+  +E+   + P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + +IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    ++++ EY+  GSL  ++        +D  +   + +    AL +LH   S  +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 330 DVYSFGVVTLEVLMGKHP 347
           D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG G  G V  A +   GK  A+KK  L   +  EL F     NE  ++    H ++V +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHDNVVDM 107
Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
           Y   L    ++++ E++E G+L  I+ +      ++  +   +  ++  AL+YLH+    
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ--- 160
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRDI S++ILL S     ++DFG   ++  +   R  L GT  ++APE+   +    
Sbjct: 161 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 328 KCDVYSFGVVTLEVLMGKHP 347
           + D++S G++ +E++ G+ P
Sbjct: 221 EVDIWSLGIMVIEMIDGEPP 240

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 73
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 128
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K 
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 330 DVYSFGVVTLEVLM-GKHP 347
           DV+SFGV+  EV   GK P
Sbjct: 189 DVWSFGVLMWEVFSEGKIP 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 68
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 123
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 330 DVYSFGVVTLEVLM-GKHPRD 349
           DV+SFGV+  EV   GK P +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYE 204

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 201 HRSIVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLAGTY 312
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 123/262 (46%), Gaps = 26/262 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G +G V+          A+K L        AF+     EA ++ Q+ H+ +V+LY  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 71
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
            + ++ +++I EYME GSL   L      ++L   K +++   +A  +A++      + I
Sbjct: 72  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 127
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HR++ + NIL++  L   +ADFG AR +  +  + R        + APE       T K 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 330 DVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVD--QKVIQDILL 386
           DV+SFG++  E++  G+ P           +P+++       R+  P +  +++ Q + L
Sbjct: 188 DVWSFGILLTEIVTHGRIP------YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 241
Query: 387 ASTISFACLQSNPKSRPTMQYV 408
                  C +  P+ RPT  Y+
Sbjct: 242 -------CWKERPEDRPTFDYL 256

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 112/258 (43%), Gaps = 22/258 (8%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+N +    V+DFG +R +  D    +  +     +  PE+      + K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLAS 388
           D+++FGV+  E+  +GK P +              +   L    P    +KV        
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY------- 236
Query: 389 TISFACLQSNPKSRPTMQ 406
           TI ++C       RPT +
Sbjct: 237 TIMYSCWHEKADERPTFK 254

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 125
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 330 DVYSFGVVTLEVLM-GKHPRD 349
           DV+SFGV+  EV   GK P +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYE 206

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   IG G +G V   ++ N  +++A+K L+  E  + A    FR E  VL     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  D A+    +  M  A+  +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 191
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIAPELA 320
           H       +HRDI  +N+LL+      +ADFG+  +++ D + ++ +A GT  YI+PE+ 
Sbjct: 192 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 321 YTM-----VMTEKCDVYSFGVVTLEVLMGKHP 347
             M         +CD +S GV   E+L G+ P
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGV 90
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 145
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K 
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 330 DVYSFGVVTLEVLM-GKHPRD 349
           DV+SFGV+  EV   GK P +
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYE 226

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 201 HRSIVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLAGTY 312
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTS----ETEELAFIKSFRNEAQ 194
           E F +   +G GGYG V++ +       GK+FA+K L  +      ++ A  K+ RN   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 195 VLSQVLHRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           +L +V H  IV L Y F    K ++LI EY+  G LF  L  +   +E D A     +  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-DTA--CFYLAE 129
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           ++ AL +LH      II+RD+   NI+LN +    + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+APE+          D +S G +  ++L G  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTS----ETEELAFIKSFRNEAQ 194
           E F +   +G GGYG V++ +       GK+FA+K L  +      ++ A  K+ RN   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 195 VLSQVLHRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           +L +V H  IV L Y F    K ++LI EY+  G LF  L  +   +E D A     +  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-DTA--CFYLAE 129
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           ++ AL +LH      II+RD+   NI+LN +    + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+APE+          D +S G +  ++L G  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++++ L+E  +       +G G YG VYKA+   G++ ALK++     +E     + R E
Sbjct: 14  LYFQGLMEKYQKLE---KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-E 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
             +L ++ H +IV L      ++C+ L++E+ME+  L  +L  D+    L  ++    + 
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLY 126
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
            +   +A+ H      I+HRD+   N+L+NS     +ADFG AR       + T    T 
Sbjct: 127 QLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 313 GYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            Y AP+ L  +   +   D++S G +  E++ GK
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   IG G +G V   ++ N  +++A+K L+  E  + A    FR E  VL     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  D A+    +  M  A+  +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 207
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGYIAPELA 320
           H       +HRDI  +N+LL+      +ADFG+  +++ D + ++ +A GT  YI+PE+ 
Sbjct: 208 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 321 YTM-----VMTEKCDVYSFGVVTLEVLMGKHP 347
             M         +CD +S GV   E+L G+ P
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 11/214 (5%)
Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           ++++ L+E  +       +G G YG VYKA+   G++ ALK++     +E     + R E
Sbjct: 14  LYFQGLMEKYQKLE---KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-E 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
             +L ++ H +IV L      ++C+ L++E+ME+  L  +L  +   ++ D   ++ + +
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQ 127
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
            +   +A+ H      I+HRD+   N+L+NS     +ADFG AR       + T    T 
Sbjct: 128 LL-RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 313 GYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            Y AP+ L  +   +   D++S G +  E++ GK
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 38/228 (16%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V KA+   + + +A+KK+  +E E+L+ I S   E  +L+ + H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVXLLASLNHQ 62
Query: 203 SIVKLYGFCLHKK-------------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
            +V+ Y   L ++              +F+  EY E  +L+ ++H+++   + D   R  
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR-- 120
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH---------- 299
           + + +  AL+Y+H   S  IIHR++   NI ++      + DFG A+ +H          
Sbjct: 121 LFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 300 ----ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 342
                 S N T   GT  Y+A E L  T    EK D YS G++  E +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + +IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 85
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
             L    ++++ EY+  GSL  ++        +D  +   + +    AL +LH   S  +
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           IHR+I S+NILL       + DFG   ++  + S R+ + GT  ++APE+        K 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 330 DVYSFGVVTLEVLMGKHP 347
           D++S G++ +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 201 HRSIVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLLAGTY 312
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 145 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 200
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 154 GGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS--QVLHRSIVKLYGFC 211
           G +G V+KAQL N  V A+K     + +      S++NE +V S   + H +I++  G  
Sbjct: 35  GRFGCVWKAQLLNEYV-AVKIFPIQDKQ------SWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 212 LHKKC----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-- 265
                    ++LI  + E+GSL   L    +A  + W +  +I + MA  LAYLH D   
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 266 -----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPE 318
                 P+I HRDI S N+LL + L A +ADFG A +  A  S  +     GT  Y+APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 319 LAYTMVMTE-----KCDVYSFGVVTLEV 341
           +    +  +     + D+Y+ G+V  E+
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+S     +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      ++++ E   R SL   LH   +AV    A+    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 161
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  ++  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + D++S G +   +L+GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           CL +  + L++E+ME G L   L         +    + +   +   +AYL      S+I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEE---ASVI 125
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 330 DVYSFGVVTLEVLM-GKHPRD 349
           DV+SFGV+  EV   GK P +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYE 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 71
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
           CL +  + L+ E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 126
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKC 329
           HRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 330 DVYSFGVVTLEVLM-GKHP 347
           DV+SFGV+  EV   GK P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+S     +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      ++++ E   R SL   LH   +AV    A+    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 161
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  ++  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + D++S G +   +L+GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 150 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H +I+KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K   +L+ E    G LF  + +     E+D A+   I++ +   + Y+H +    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 146
Query: 269 IIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           I+HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAPE+ +    
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAPEVLHG-TY 204
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            EKCDV+S GV+   +L G  P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H +I+KLY 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           F   K   +L+ E    G LF  + +     E+D A+   I++ +   + Y+H +    I
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KI 153
Query: 270 IHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMT 326
           +HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAPE+ +     
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAPEVLHG-TYD 211
Query: 327 EKCDVYSFGVVTLEVLMGKHP 347
           EKCDV+S GV+   +L G  P
Sbjct: 212 EKCDVWSTGVILYILLSGCPP 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+S     +
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 88
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      ++++ E   R SL   LH   +AV    A+    ++     + YLH++
Sbjct: 89  VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  ++  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 146 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + D++S G +   +L+GK P
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPP 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 28/226 (12%)
Query: 141 ATEDFHIKY----CIGTGGYGSVYK-AQLPNGKVFALK-------KLHTSETEELAFIKS 188
           A ++F+ KY     IG G    V +      G  FA+K       +L   + EE+   ++
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR--EA 145
Query: 189 FRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
            R E  +L QV  H  I+ L         MFL+++ M +G LF  L    E V L   + 
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKET 202
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
            +I++++  A+++LH +   +I+HRD+   NILL+  ++  ++DFG +  L      R  
Sbjct: 203 RSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE- 258
Query: 308 LAGTYGYIAPE-LAYTMVMT-----EKCDVYSFGVVTLEVLMGKHP 347
           L GT GY+APE L  +M  T     ++ D+++ GV+   +L G  P
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 150 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H +I+KLY
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K   +L+ E    G LF  + +     E+D A+   I++ +   + Y+H +    
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 169
Query: 269 IIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           I+HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAPE+ +    
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAPEVLHG-TY 227
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            EKCDV+S GV+   +L G  P
Sbjct: 228 DEKCDVWSTGVILYILLSGCPP 249

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED  +   IG G +G V+  +L  +  + A+K    +   +L     F  EA++L Q  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSH 171
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IV+L G C  K+ ++++ E ++ G     L    E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYL 229
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPE 318
              C    IHRD+++ N L+  K    ++DFG +R   AD   +++  L      + APE
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPE 285
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  + + DV+SFG++  E   +G  P
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 150 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H +I+KLY
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K   +L+ E    G LF  + +     E+D A+   I++ +   + Y+H +    
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 170
Query: 269 IIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           I+HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAPE+ +    
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAPEVLHG-TY 228
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            EKCDV+S GV+   +L G  P
Sbjct: 229 DEKCDVWSTGVILYILLSGCPP 250

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 7   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 63
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 121
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 122 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 179 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 12  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 68
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 126
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 127 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 64
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 95
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 153
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 154 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 67
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 125
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 64
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-----I 204
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+S     +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V  +GF      ++++ E   R SL   LH   +AV    A+    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 161
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
               +IHRD+   N+ LN  ++  + DFG A ++  D   +  L GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
            + + D++S G +   +L+GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED  +   IG G +G V+  +L  +  + A+K    +   +L     F  EA++L Q  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSH 171
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IV+L G C  K+ ++++ E ++ G     L    E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYL 229
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPE 318
              C    IHRD+++ N L+  K    ++DFG +R   AD   +++  L      + APE
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPE 285
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  + + DV+SFG++  E   +G  P
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 6   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 62
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 120
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 121 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 178 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 13  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 69
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 127
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 128 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 185 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V K Q  P+G + A K +H      L    + RN+     QVLH
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 69
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L  + + +  +   +V+I  A+   
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSI--AVLRG 126
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           LAYL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y+AP
Sbjct: 127 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMAP 182
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 14  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 70
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 128
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 129 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 186 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 15  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 71
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 129
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 130 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 187 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 82
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 82
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 40/296 (13%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 193
           +++ TE   +K  +G+G +G+VYK   +P G+   +    K+    T   A ++ F +EA
Sbjct: 34  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 91
Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVN 249
            +++ + H  +V+L G CL    + L+ + M  G L   +H   + +     L+W   V 
Sbjct: 92  LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQ 148
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           I K M     YL       ++HRD+++ N+L+ S     + DFG AR L  D        
Sbjct: 149 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 201
Query: 310 GTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLID 366
           G     ++A E  +    T + DV+S+GV   E++  G  P D          P   + D
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPD 253
Query: 367 VLD--QRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
           +L+  +RLP PP+      D+ +   +   C   +  SRP  + ++  F    + P
Sbjct: 254 LLEKGERLPQPPI---CTIDVYM---VMVKCWMIDADSRPKFKELAAEFSRMARDP 303

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 40/296 (13%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 193
           +++ TE   +K  +G+G +G+VYK   +P G+   +    K+    T   A ++ F +EA
Sbjct: 11  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 68
Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVN 249
            +++ + H  +V+L G CL    + L+ + M  G L   +H   + +     L+W   V 
Sbjct: 69  LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQ 125
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           I K M     YL       ++HRD+++ N+L+ S     + DFG AR L  D        
Sbjct: 126 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 178
Query: 310 GTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLID 366
           G     ++A E  +    T + DV+S+GV   E++  G  P D          P   + D
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPD 230
Query: 367 VLD--QRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
           +L+  +RLP PP+      D+ +   +   C   +  SRP  + ++  F    + P
Sbjct: 231 LLEKGERLPQPPI---CTIDVYM---VMVKCWMIDADSRPKFKELAAEFSRMARDP 280

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 32/275 (11%)
Query: 151 IGTGGYG-SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G ++      +G+ + +K+++ S        +S R E  VL+ + H +IV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRE 90
Query: 210 FCLHKKCMFLIYEYMERGSLF-------CILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
                  ++++ +Y E G LF        +L  +D+   LDW   V I  A+ H      
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWF--VQICLALKHV----- 141
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
           HD    I+HRDI S NI L       + DFG AR L++         GT  Y++PE+   
Sbjct: 142 HD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQ 382
                K D+++ G V  E+   KH  +           K +++ ++     PPV      
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSF-PPVSLHYSY 251
Query: 383 DILLASTISFACLQSNPKSRPTMQYV-SQGFLITR 416
           D  L S +S    + NP+ RP++  +  +GF+  R
Sbjct: 252 D--LRSLVS-QLFKRNPRDRPSVNSILEKGFIAKR 283

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 22/281 (7%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 116
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIM--LIDVLDQRLPPP 375
           E       + + D++S G+  +E+ +G++P            P  +  L+D +    PP 
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPK 232
Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR 416
           +   V    L        CL  NP  R  ++ +     I R
Sbjct: 233 LPSGVFS--LEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 150 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H +I KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K   +L+ E    G LF  + +     E+D A+   I++ +   + Y H +    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKN---K 146
Query: 269 IIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           I+HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAPE+ +    
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAY-YIAPEVLHG-TY 204
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            EKCDV+S GV+   +L G  P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 13/217 (5%)
Query: 137 DLIEATEDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQV 195
           DL    ED+ +   IG G +G V   +  +  KV+A+K L   E  + +    F  E  +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           ++      +V+L+      + ++++ EYM  G L  ++ N D  V   WA+       + 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARF--YTAEVV 178
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGY 314
            AL  +H   S   IHRD+  +N+LL+      +ADFGT  +++ +   R   A GT  Y
Sbjct: 179 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 315 IAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 347
           I+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 122/289 (42%), Gaps = 56/289 (19%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           D  +K+ +G G YG VY       K ++L     +  E+   ++ F  EA V+ ++ H +
Sbjct: 33  DITMKHKLGGGQYGEVYVGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 89
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +V+L G C  +   +++ EYM  G+L            LD+ +  N  +  A  L Y+  
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNL------------LDYLRECNREEVTAVVLLYMAT 137
Query: 264 DCSPSI--------IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---Y 312
             S ++        IHRD+++ N L+       VADFG +R +  D+   T  AG     
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPI 195
Query: 313 GYIAPE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPKIMLIDVLD- 369
            + APE LAY    + K DV++FGV+  E+   G  P            P I L  V D 
Sbjct: 196 KWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYDL 243
Query: 370 ------QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
                    P     KV +       +  AC + +P  RP+     Q F
Sbjct: 244 LEKGYRMEQPEGCPPKVYE-------LMRACWKWSPADRPSFAETHQAF 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 13/217 (5%)
Query: 137 DLIEATEDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQV 195
           DL    ED+ +   IG G +G V   +  +  KV+A+K L   E  + +    F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           ++      +V+L+      + ++++ EYM  G L  ++ N D  V   WA+       + 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARF--YTAEVV 183
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGY 314
            AL  +H   S   IHRD+  +N+LL+      +ADFGT  +++ +   R   A GT  Y
Sbjct: 184 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 315 IAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 347
           I+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 67
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQ 125
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 13/217 (5%)
Query: 137 DLIEATEDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQV 195
           DL    ED+ +   IG G +G V   +  +  KV+A+K L   E  + +    F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           ++      +V+L+      + ++++ EYM  G L  ++ N D  V   WA+       + 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TAEVV 183
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-GTYGY 314
            AL  +H   S   IHRD+  +N+LL+      +ADFGT  +++ +   R   A GT  Y
Sbjct: 184 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 315 IAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 347
           I+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 11  EERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 67
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI E++  GSL   L    E +  D  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQ 125
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 64
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHRD+++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 121
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 178
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 179 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 234
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 24/279 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 78
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 135
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 136 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 191
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVD 377
           E       + + D++S G+  +E+ +G++P           +    L+D +    PP + 
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFE----LLDYIVNEPPPKLP 247
Query: 378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR 416
             V    L        CL  NP  R  ++ +     I R
Sbjct: 248 SGVFS--LEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 202
           F +   +G G YG VYK + +  G++ A+K +  +  EE    +  + E  +L +  H R
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 203 SIVKLYGFCLHKK------CMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMA 255
           +I   YG  + K        ++L+ E+   GS+  ++ N     ++ +W     I + + 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 139
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             L++LH      +IHRDI   N+LL    E  + DFG + +L      R    GT  ++
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 316 APELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHP 347
           APE+             K D++S G+  +E+  G  P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 10/208 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF +   +G G +G V+ A+     + FA+K L          ++    E +VLS    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 202 RSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
              +  + FC    K+ +F + EY+  G L   +++     + D ++       +   L 
Sbjct: 78  HPFLT-HMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH   S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAPE+
Sbjct: 134 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEI 190
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                     D +SFGV+  E+L+G+ P
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 38/223 (17%)
Query: 151 IGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKS-FRNEAQVLSQVLHRSIVK 206
           IG G +G V++A+ P     + F +  +   + E  A +++ F+ EA ++++  + +IVK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 207 LYGFCLHKKCMFLIYEYMERGSL-----------FCILHNDDEAVE----------LDWA 245
           L G C   K M L++EYM  G L            C L + D +            L  A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH------ 299
           +++ I + +A  +AYL        +HRD+++ N L+   +   +ADFG +R ++      
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           AD ++    A    ++ PE  +    T + DV+++GVV  E+ 
Sbjct: 232 ADGND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 151 IGTGGYGSVY--KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G YG V   K +L  G   A+K +  S     +   +  +E  VL Q+ H +I+KLY
Sbjct: 29  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K+  +L+ E    G LF  +    +  E+D A    I+K +     YLH     +
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLHKH---N 141
Query: 269 IIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           I+HRD+   N+LL SK       + DFG +         +  L   Y YIAPE+      
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAPEVLRKK-Y 199
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            EKCDV+S GV+   +L G  P
Sbjct: 200 DEKCDVWSCGVILYILLCGYPP 221

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 142 TEDFHIKYCIGTGGYGSV----YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
            ED+ +   IG G +G V    +KA   + KV+A+K L   E  + +    F  E  +++
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKA---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 +V+L+      K ++++ EYM  G L  ++ N D  V   WAK       +  A
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY--TAEVVLA 186
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL------HADSSNRTLLAGT 311
           L  +H   S  +IHRD+  +N+LL+      +ADFGT  ++      H D++      GT
Sbjct: 187 LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-----VGT 238
Query: 312 YGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 347
             YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 10/208 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF +   +G G +G V+ A+     + FA+K L          ++    E +VLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 202 RSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
              +  + FC    K+ +F + EY+  G L   +++     + D ++       +   L 
Sbjct: 77  HPFLT-HMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH   S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAPE+
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEI 189
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                     D +SFGV+  E+L+G+ P
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V K +  + G++ A+KK   S+ +++    + R E ++L Q+ H ++V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAV---ELDWAKRVNIVKAMAHALAYLHHDCS 266
            C  KK  +L++E+++   L      DD  +    LD+      +  + + + + H   S
Sbjct: 92  VCKKKKRWYLVFEFVDHTIL------DDLELFPNGLDYQVVQKYLFQIINGIGFCH---S 142
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMT 326
            +IIHRDI   NIL++      + DFG AR L A          T  Y APEL    V  
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 327 EKC-DVYSFGVVTLEVLMGK 345
            K  DV++ G +  E+ MG+
Sbjct: 203 GKAVDVWAIGCLVTEMFMGE 222

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 116
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 116
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 86
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 143
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 144 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 199
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVF----ALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           DFH    IG G +G V  A+    +VF     L+K    + +E   I S RN   +L  V
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNV 96
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHAL 258
            H  +V L+        ++ + +Y+  G LF  L  +   +E     R     A +A AL
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASAL 152
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            YLH   S +I++RD+   NILL+S+    + DFG  +     +S  +   GT  Y+APE
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           + +        D +  G V  E+L G  P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+K+   +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++
Sbjct: 9   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 65
Query: 196 LSQVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  + H +IVK  G C    ++ + LI EY+  GSL   L    E +  D  K +     
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 123
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   + YL    +   IHR++++ NIL+ ++    + DFG  + L  D     +      
Sbjct: 124 ICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 314 ---YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE       +   DV+SFGVV  E+ 
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 116
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 202 RS----IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 IV  YG       + +  E+M+ GSL  +L       E    K V+I  A+   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKG 116
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++P
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E       + + D++S G+  +E+ +G++P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 151 IGTGGYGSVY--KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G YG V   K +L  G   A+K +  S     +   +  +E  VL Q+ H +I+KLY
Sbjct: 12  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
            F   K+  +L+ E    G LF  +    +  E+D A    I+K +     YLH     +
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLH---KHN 124
Query: 269 IIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           I+HRD+   N+LL SK       + DFG +         +  L   Y YIAPE+      
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAPEVLRKK-Y 182
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            EKCDV+S GV+   +L G  P
Sbjct: 183 DEKCDVWSCGVILYILLCGYPP 204

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-- 200
            D  +  C+G G YG V++       V    K+ +S  E     KS+  E ++ + V+  
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAV--KIFSSRDE-----KSWFRETELYNTVMLR 60
Query: 201 HRSIVKLYGFCLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +I+      +  +     ++LI  Y E GSL+  L    +   LD    + IV ++A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIAS 116
Query: 257 ALAYLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-- 309
            LA+LH +       P+I HRD+ S NIL+    +  +AD G A  +H+ S+N+  +   
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNN 175
Query: 310 ---GTYGYIAPELAYTMVMTE------KCDVYSFGVVTLEV 341
              GT  Y+APE+    +  +      + D+++FG+V  EV
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 143 EDF-HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF  I   +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV-KAMAHALAY 260
            +IVKL     ++  ++++ E+   G++  ++   +  +      ++ +V K    AL Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH +    IIHRD+ + NIL     +  +ADFG + +       R    GT  ++APE+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVV 207
Query: 321 YTMVMTE-----KCDVYSFGVVTLEV 341
                 +     K DV+S G+  +E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  + + + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GT G   V K +L   KV A+K L+  +   L  +   R E Q L    H  I+KLY  
Sbjct: 26  VGTFGKVKVGKHELTGHKV-AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
                 +F++ EY+  G LF  +  +     LD  +   + + +   + Y H      ++
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 329
           HRD+   N+LL++ + A +ADFG +  + +D        G+  Y APE ++  +    + 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSCGSPNYAAPEVISGRLYAGPEV 197
Query: 330 DVYSFGVVTLEVLMGKHPRD 349
           D++S GV+   +L G  P D
Sbjct: 198 DIWSSGVILYALLCGTLPFD 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 21/233 (9%)
Query: 123 VFSIWNYDGRIFYEDLIEATED-----FHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLH 176
           VF IW    + +Y   +E   D     + I   +GTG +G V++  +   G  FA K + 
Sbjct: 136 VFDIW----KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191
Query: 177 TSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND 236
           T    +    ++ R E Q +S + H ++V L+        M +IYE+M  G LF  + ++
Sbjct: 192 TPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 248
Query: 237 DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL--EAFVADFGT 294
              +  D A  V  ++ +   L ++H +   + +H D+   NI+  +K   E  + DFG 
Sbjct: 249 HNKMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              L    S + +  GT  + APE+A    +    D++S GV++  +L G  P
Sbjct: 304 TAHLDPKQSVK-VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRSIVKL 207
           C+G G YG V++       V    K+ +S  E     KS+  E ++ + V+  H +I+  
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAV--KIFSSRDE-----KSWFRETELYNTVMLRHENILGF 67
Query: 208 YGFCLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
               +  +     ++LI  Y E GSL+  L    +   LD    + IV ++A  LA+LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 264 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-----GTYG 313
           +       P+I HRD+ S NIL+    +  +AD G A  +H+ S+N+  +      GT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 182
Query: 314 YIAPELAYTMVMTE------KCDVYSFGVVTLEV 341
           Y+APE+    +  +      + D+++FG+V  EV
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 21/195 (10%)
Query: 167 GKVFALKKLHTSETEELAFIKSFRN-------------EAQVLSQVLHRSIVKL-YGFCL 212
           GKVF +KK+  S+  +L  +K  +              E  +L +V H  IVKL Y F  
Sbjct: 38  GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97
Query: 213 HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 272
             K ++LI +++  G LF  L  +    E D       +  +A AL +LH   S  II+R
Sbjct: 98  EGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELALALDHLH---SLGIIYR 150
Query: 273 DISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVY 332
           D+   NILL+ +    + DFG ++             GT  Y+APE+      T+  D +
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 333 SFGVVTLEVLMGKHP 347
           SFGV+  E+L G  P
Sbjct: 211 SFGVLMFEMLTGTLP 225

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SFR 190
           ED+ +   +G G YG V   QL   +V          TEE   +K            + +
Sbjct: 7   EDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENIK 53
Query: 191 NEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI 250
            E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R   
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--F 110
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--L 308
              +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  +
Sbjct: 111 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 309 AGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 143 EDF-HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF  I   +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV-KAMAHALAY 260
            +IVKL     ++  ++++ E+   G++  ++   +  +      ++ +V K    AL Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH +    IIHRD+ + NIL     +  +ADFG + +       R    GT  ++APE+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 207
Query: 321 YTMVMTE-----KCDVYSFGVVTLEV 341
                 +     K DV+S G+  +E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 4   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 50
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 51  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 107
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 108 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 52
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 109
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 110 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 143 EDF-HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF  I   +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV-KAMAHALAY 260
            +IVKL     ++  ++++ E+   G++  ++   +  +      ++ +V K    AL Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH +    IIHRD+ + NIL     +  +ADFG + +       R    GT  ++APE+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVV 207
Query: 321 YTMVMTE-----KCDVYSFGVVTLEV 341
                 +     K DV+S G+  +E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRSIVKL 207
           C+G G YG V++       V    K+ +S  E     KS+  E ++ + V+  H +I+  
Sbjct: 44  CVGKGRYGEVWRGSWQGENVAV--KIFSSRDE-----KSWFRETELYNTVMLRHENILGF 96
Query: 208 YGFCLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
               +  +     ++LI  Y E GSL+  L    +   LD    + IV ++A  LA+LH 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 264 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-----GTYG 313
           +       P+I HRD+ S NIL+    +  +AD G A  +H+ S+N+  +      GT  
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 211
Query: 314 YIAPELAYTMVMTE------KCDVYSFGVVTLEV 341
           Y+APE+    +  +      + D+++FG+V  EV
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SFR 190
           ED+ +   +G G YG V   QL   +V          TEE   +K            + +
Sbjct: 6   EDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENIK 52
Query: 191 NEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI 250
            E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R   
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--F 109
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--L 308
              +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  +
Sbjct: 110 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 309 AGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)
Query: 123 VFSIWNYDGRIFYEDLIEATED-----FHIKYCIGTGGYGSVYK-AQLPNGKVFALKKL- 175
           VF IW    + +Y   +E   D     + I   +GTG +G V++  +   G  FA K + 
Sbjct: 30  VFDIW----KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 85
Query: 176 --HTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL 233
             H S+ E      + R E Q +S + H ++V L+        M +IYE+M  G LF  +
Sbjct: 86  TPHESDKE------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 139
Query: 234 HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL--EAFVAD 291
            ++   +  D A  V  ++ +   L ++H +   + +H D+   NI+  +K   E  + D
Sbjct: 140 ADEHNKMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID 194
Query: 292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           FG    L    S + +  GT  + APE+A    +    D++S GV++  +L G  P
Sbjct: 195 FGLTAHLDPKQSVK-VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 23/196 (11%)
Query: 167 GKVFALKKLHTSETEELAFIKSFRN-------------EAQVLSQVLHRSIVKL-YGFCL 212
           GKVF +KK+  S+  +L  +K  +              E  +L +V H  IVKL Y F  
Sbjct: 38  GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97
Query: 213 HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHDCSPSIIH 271
             K ++LI +++  G LF  L  +    E D    V    A +A AL +LH   S  II+
Sbjct: 98  EGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDHLH---SLGIIY 149
Query: 272 RDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 331
           RD+   NILL+ +    + DFG ++             GT  Y+APE+      T+  D 
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209
Query: 332 YSFGVVTLEVLMGKHP 347
           +SFGV+  E+L G  P
Sbjct: 210 WSFGVLMFEMLTGTLP 225

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 23/196 (11%)
Query: 167 GKVFALKKLHTSETEELAFIKSFRN-------------EAQVLSQVLHRSIVKL-YGFCL 212
           GKVF +KK+  S+  +L  +K  +              E  +L +V H  IVKL Y F  
Sbjct: 39  GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 98
Query: 213 HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAYLHHDCSPSIIH 271
             K ++LI +++  G LF  L  +    E D    V    A +A AL +LH   S  II+
Sbjct: 99  EGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDHLH---SLGIIY 150
Query: 272 RDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 331
           RD+   NILL+ +    + DFG ++             GT  Y+APE+      T+  D 
Sbjct: 151 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 210
Query: 332 YSFGVVTLEVLMGKHP 347
           +SFGV+  E+L G  P
Sbjct: 211 WSFGVLMFEMLTGTLP 226

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + H   VKLY      + ++    Y + G   C+L    +    D          +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNG---CLLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYIA 316
            YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PEL      ++  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLS 197
           E+F +   +GTG YG V+  +       GK++A+K L  +   ++    +  R E QVL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 198 QVLHRS-IVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI-VKAM 254
            +     +V L Y F    K + LI +Y+  G LF  L   +   E      V I V  +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEI 168
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYG 313
             AL +LH      II+RDI   NILL+S     + DFG ++   AD + R     GT  
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 314 YIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+AP++         +  D +S GV+  E+L G  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCILHNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L               F   HN +E  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEE--QLSSKD 151
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 93
Query: 199 VLHRSIVKLYGFCLHK-KCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKA 253
           + H   VKLY FC    + ++    Y + G L   +      D+       A+ V+    
Sbjct: 94  LDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS---- 148
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGT 311
              AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT
Sbjct: 149 ---ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 148
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS----NRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 167
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 204 IVKLYGFCLHKK-CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 168
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 199
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV----------- 248
            H +IV L G C H   + +I EY   G L   L      +E D A  +           
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIV 222
Query: 309 AGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIM 363
            G       ++APE  +  V T + DV+S+G++  E+  +G +P                
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK---- 278
Query: 364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 279 LVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 317

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 199
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV----------- 248
            H +IV L G C H   + +I EY   G L   L      +E D A  +           
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIV 222
Query: 309 AGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIM 363
            G       ++APE  +  V T + DV+S+G++  E+  +G +P                
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK---- 278
Query: 364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 279 LVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 317

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 204 IVKLYGFCLHKK-CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 146
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 119/298 (39%), Gaps = 27/298 (9%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 10  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 70  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 126
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 127 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 238
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDIS 430
           P P D    QDI     +   C    P+ RPT   +    L  + T +    A+QD  
Sbjct: 239 PRPED--CPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM---RALQDFE 288

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 149
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 141
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 44/281 (15%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 199
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 99
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEA-------VELDWAKRVNIVK 252
            H +IV L G C H   + +I EY   G L   L    EA         L+    ++   
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT- 311
            +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G  
Sbjct: 160 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNA 214
Query: 312 ---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDV 367
                ++APE  +  V T + DV+S+G++  E+  +G +P                L+  
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK----LVKD 270
Query: 368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 271 GYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 305

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 147
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 148
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 154 GGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           G +G V+KAQL N     K+F L+   + ++E   F         +L  +      +  G
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFI----AAEKRG 81
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC---- 265
             L  + ++LI  + ++GSL   L  +     + W +  ++ + M+  L+YLH D     
Sbjct: 82  SNLEVE-LWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 266 ----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYIAPEL 319
                PSI HRD  S N+LL S L A +ADFG A R        +     GT  Y+APE+
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 320 AYTMVMTE-----KCDVYSFGVVTLEVL 342
               +  +     + D+Y+ G+V  E++
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 39/230 (16%)
Query: 150 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
            +G G +G V KA   + K        A+K L   E    + ++   +E  VL QV H  
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----------------------HNDDEAV 240
           ++KLYG C     + LI EY + GSL   L                       H D+ A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            +     ++    ++  + YL      S++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 148 TM--GDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 301 DSSNRTLLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           + S      G     ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 149
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           F I   IG G +G V   Q  +  K++A+K ++  +  E   +++   E Q++  + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCIL----HNDDEAVELDWAKRVNIVKAMAHALA 259
           +V L+     ++ MF++ + +  G L   L    H  +E V+L        +  +  AL 
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVMALD 129
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YL +     IIHRD+  +NILL+      + DF  A  L  ++   T +AGT  Y+APE+
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEM 185
Query: 320 -------AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                   Y+  +    D +S GV   E+L G+ P
Sbjct: 186 FSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL- 144
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 76  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 132
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 133 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 244
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P P D    QDI     +   C    P+ RPT
Sbjct: 245 PRPED--CPQDIY---NVMVQCWAHKPEDRPT 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHA 257
              VKLY      + ++    Y + G L   +      D+       A+ V+       A
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 122
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYI 315
           L YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y+
Sbjct: 123 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 58/288 (20%)
Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 199
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEA-------VELDWAKRVNIVK 252
            H +IV L G C H   + +I EY   G L   L    EA         L+    ++   
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT- 311
            +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G  
Sbjct: 168 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNA 222
Query: 312 ---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIM---- 363
                ++APE  +  V T + DV+S+G++  E+  +G +P            P I+    
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVNSK 271
Query: 364 ---LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
              L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 272 FYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 313

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 66  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 122
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 179
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 234
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P P D    QDI     +   C    P+ RPT
Sbjct: 235 PRPED--CPQDIY---NVMVQCWAHKPEDRPT 261

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GT G   + + QL   KV A+K L+  +   L  +   + E Q L    H  I+KLY  
Sbjct: 21  VGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
                  F++ EY+  G LF  +       E++ A+R  + + +  A+ Y H      ++
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---VV 133
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 329
           HRD+   N+LL++ + A +ADFG +  +      RT   G+  Y APE ++  +    + 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYAGPEV 192
Query: 330 DVYSFGVVTLEVLMGKHPRD 349
           D++S GV+   +L G  P D
Sbjct: 193 DIWSCGVILYALLCGTLPFD 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 65
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 120
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 121 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHA 257
              VKLY      + ++    Y + G L   +      D+       A+ V+       A
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 120
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYI 315
           L YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y+
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHA 257
              VKLY      + ++    Y + G L   +      D+       A+ V+       A
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 119
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYI 315
           L YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y+
Sbjct: 120 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 10  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 70  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 126
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 127 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 238
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P P D    QDI     +   C    P+ RPT
Sbjct: 239 PRPED--CPQDIY---NVMVQCWAHKPEDRPT 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 76  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 132
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 133 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 244
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P P D    QDI     +   C    P+ RPT
Sbjct: 245 PRPED--CPQDIY---NVMVQCWAHKPEDRPT 271

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 66  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 122
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 234
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P P D    QDI     +   C    P+ RPT
Sbjct: 235 PRPED--CPQDIY---NVMVQCWAHKPEDRPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 24/272 (8%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVL 196
             +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
             + HR++++LYG  L    M ++ E    GSL   L        L    R  +   +A 
Sbjct: 66  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 122
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT---YG 313
            + YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       + 
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLDQRL 372
           + APE   T   +   D + FGV   E+   G+ P              +  ID   +RL
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERL 234
Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P P D    QDI     +   C    P+ RPT
Sbjct: 235 PRPED--CPQDIY---NVMVQCWAHKPEDRPT 261

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 91
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 146
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 147 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 89
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 144
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 145 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHA 257
              VKLY      + ++    Y + G L   +      D+       A+ V+       A
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 126
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYI 315
           L YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y+
Sbjct: 127 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S++ H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKLNHQ 94
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S++ H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKLNHQ 108
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 145 FHIKYCIGTGGYGSVY---KAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           F +   +G G +G V+   K   P+ G ++A+K L  +  +    +++ + E  +L+ V 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 201 HRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           H  +VKL Y F    K ++LI +++  G LF  L  +    E D       +  +A  L 
Sbjct: 89  HPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELALGLD 144
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE+
Sbjct: 145 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                 +   D +S+GV+  E+L G  P
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 208
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 85
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 146 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 202
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 149
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +GT G   + + QL   KV A+K L+  +   L  +   + E Q L    H  I+KLY  
Sbjct: 21  VGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
                  F++ EY+  G LF  +       E++ A+R  + + +  A+ Y H      ++
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---VV 133
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 329
           HRD+   N+LL++ + A +ADFG +  + +D        G+  Y APE ++  +    + 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSCGSPNYAAPEVISGRLYAGPEV 192
Query: 330 DVYSFGVVTLEVLMGKHPRD 349
           D++S GV+   +L G  P D
Sbjct: 193 DIWSCGVILYALLCGTLPFD 212

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 150
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 89
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 144
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 145 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 147
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 93
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 108
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 154
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 78
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L             +C   + +   +L     V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 149
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS----SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 93
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHA 257
              VKLY      + ++    Y + G L   +      D+       A+ V+       A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 141
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYI 315
           L YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 93/223 (41%), Gaps = 34/223 (15%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 189
            ED+ +   +G G  G V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAAGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
           + E  +   + H ++VK YG        +L  EY   G LF  +  D    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-- 307
               +   + YLH      I HRDI   N+LL+ +    ++DFG A     ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 308 LAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           + GT  Y+APE L       E  DV+S G+V   +L G+ P D
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L             +C   + +   +L     V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H ++V+L G 
Sbjct: 20  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 73
Query: 211 CLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
            + +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           +HRD+++ N+L++    A V+DFG  +   +      L      + APE       + K 
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREAAFSTKS 186
Query: 330 DVYSFGVVTLEV 341
           DV+SFG++  E+
Sbjct: 187 DVWSFGILLWEI 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 150 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
            +G G +G V KA   + K        A+K L   E    + ++   +E  VL QV H  
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----------------------HNDDEAV 240
           ++KLYG C     + LI EY + GSL   L                       H D+ A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            +     ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 148 TM--GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 301 DSSNRTLLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           + S      G     ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 82
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L   L               HN +E  +L    
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 140
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 241

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 94
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 110
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 171 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 227
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 86
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L   L               HN +E  +L    
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 144
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 245

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 100
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L   L               HN +E  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 151
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L   L               HN +E  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE--QLSSKD 151
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++++ +K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF  +   +   E D +   + ++ +  ++AY
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 120
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+      ++  D+++ GV+   +L+G  P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 39/230 (16%)
Query: 150 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
            +G G +G V KA   + K        A+K L   E    + ++   +E  VL QV H  
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----------------------HNDDEAV 240
           ++KLYG C     + LI EY + GSL   L                       H D+ A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            +     ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 148 TM--GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 301 DSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           + S   R+       ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++++ +K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 86
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF  +   +   E D +   + ++ +  ++AY
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 143
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 199
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+      ++  D+++ GV+   +L+G  P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 85
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L   L               HN +E  +L    
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 143
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM----EALIISKFNHQ 108
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++++ +K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 62
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF  +   +   E D +   + ++ +  ++AY
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 119
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 120 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 175
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+      ++  D+++ GV+   +L+G  P
Sbjct: 176 EVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRSIVKL 207
           C+G G YG V++  L +G+  A+K + +S  E+     S+  E ++ + VL  H +I+  
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQ-----SWFRETEIYNTVLLRHDNILGF 67
Query: 208 YGFCLHKKC----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
               +  +     ++LI  Y E GSL+  L    + +E   A R+ +  + A  LA+LH 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQR--QTLEPHLALRLAV--SAACGLAHLHV 123
Query: 264 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA-----GTYG 313
           +       P+I HRD  S N+L+ S L+  +AD G A  +H+  S+   +      GT  
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKR 182
Query: 314 YIAPELAYTMVMTE------KCDVYSFGVVTLEV 341
           Y+APE+    + T+        D+++FG+V  E+
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++++ +K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF  +   +   E D +   + ++ +  ++AY
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 120
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+      ++  D+++ GV+   +L+G  P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 134
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDWAK 246
           ++I+ L G C     +++I EY  +G+L   L               HN +E  +L    
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 192
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     + 
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 307 LLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 143 EDFHIKYCIGTGGYGS-VYKAQLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF     +G G + + V   +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAM 254
           + H   VKLY      + ++    Y + G L   +      D+       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTY 312
             AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 120
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND----DEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 49/295 (16%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQVLH 201
           DF     IG+GG+G V+KA+   +GK + +K++ + +E  E         E + L+++ H
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE--------REVKALAKLDH 63
Query: 202 RSIVKLYGFCL-----------------HKKCMFLIYEYMERGSLFCILHNDDEAVELDW 244
            +IV  Y  C                    KC+F+  E+ ++G+L   +       +LD 
Sbjct: 64  VNIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDK 121
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
              + + + +   + Y+H   S  +I+RD+  +NI L    +  + DFG    L  D   
Sbjct: 122 VLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GK 177
Query: 305 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIML 364
           R    GT  Y++PE   +    ++ D+Y+ G++  E+L   H  D               
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSK------FF 228
Query: 365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
            D+ D  +    D+K         T+    L   P+ RP    + +   + +K+P
Sbjct: 229 TDLRDGIISDIFDKK-------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 146 HIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           H    IG G +G VY   L   +GK         +   ++  +  F  E  ++    H +
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 204 IVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++ L G CL  +    ++  YM+ G L   + N+     +     +     +A  + +L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL- 150
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL---HADS-SNRTLLAGTYGYIAPE 318
              S   +HRD+++ N +L+ K    VADFG AR +     DS  N+T       ++A E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
              T   T K DV+SFGV+  E++    P
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           T+++ +   +G G +  V +  ++P G+ +A K ++T +       K    EA++   + 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF      ++ V  ++    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
           ++H     I+HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+       +  D+++ GV+   +L+G  P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHA 257
              VKLY      + ++    Y + G L   +      D+       A+ V+       A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 141
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYI 315
           L YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S  +      GT  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +PEL       +  D+++ G +  +++ G  P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLS 197
           AT  +     IG G YG+VYKA+ P+ G   ALK +     EE   I + R  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 198 QVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
              H ++V+L   C   +      + L++E++++     +       +  +  K  ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLMR 119
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
                L +LH +C   I+HRD+   NIL+ S     +ADFG A R+++       +  T 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQMALAPVVVTL 175
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            Y APE+          D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 138/306 (45%), Gaps = 49/306 (16%)
Query: 116 RATNSIDVFSIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKK 174
           R  +S    SI N +  +  +DL    E       +G G YG V K + +P+G++ A+K+
Sbjct: 31  RDLDSKACISIGNQNFEVKADDLEPIME-------LGRGAYGVVEKMRHVPSGQIMAVKR 83
Query: 175 LHTSETEELAFIKSFRNEAQVLS-QVLHRSI-----VKLYGFCLHKKCMFLIYEYMERG- 227
           +        A + S   +  ++   +  R++     V  YG    +  +++  E M+   
Sbjct: 84  IR-------ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSL 136
Query: 228 -SLFCILHNDDEAVELDWAKR--VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
              +  + +  + +  D   +  V+IVKA+ H  + L      S+IHRD+  +N+L+N+ 
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL------SVIHRDVKPSNVLINAL 190
Query: 285 LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE----KCDVYSFGVVTLE 340
            +  + DFG +  L  DS  +T+ AG   Y+APE     +  +    K D++S G+  +E
Sbjct: 191 GQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249
Query: 341 VLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA--CLQSN 398
           + + + P D          P   L  V+++  P     ++  D   A  + F   CL+ N
Sbjct: 250 LAILRFPYDSWGT------PFQQLKQVVEEPSP-----QLPADKFSAEFVDFTSQCLKKN 298
Query: 399 PKSRPT 404
            K RPT
Sbjct: 299 SKERPT 304

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           T+++ +   +G G +  V +  ++P G+ +A K ++T +       K    EA++   + 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF      ++ V  ++    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
           ++H     I+HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+       +  D+++ GV+   +L+G  P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 210 FCLHKKCMFLIYEY-MERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
             L +   +L+ EY +   S    +H    + VE+       +       LAYLH   S 
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 134
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           ++IHRD+ + NILL+      + DFG+A  +    +      GT  ++APE+   M   +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILAMDEGQ 190
Query: 328 ---KCDVYSFGVVTLEVLMGKHP 347
              K DV+S G+  +E+   K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 25/297 (8%)
Query: 143 EDFHIKY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ED+ + +  +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALA 259
            R IV L      K  + L+   M  G +   ++N D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQK 379
                     D ++ GV   E++  + P           + K +   VL+Q +  P    
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP---- 413
Query: 380 VIQDILLASTISF--ACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISEL 434
              D    ++  F  A LQ +P+ R        GF       L  H   +DIS  +L
Sbjct: 414 ---DKFSPASKDFCEALLQKDPEKR-------LGFRDGSCDGLRTHPLFRDISWRQL 460

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 25/297 (8%)
Query: 143 EDFHIKY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ED+ + +  +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALA 259
            R IV L      K  + L+   M  G +   ++N D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQK 379
                     D ++ GV   E++  + P           + K +   VL+Q +  P    
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP---- 413
Query: 380 VIQDILLASTISF--ACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISEL 434
              D    ++  F  A LQ +P+ R        GF       L  H   +DIS  +L
Sbjct: 414 ---DKFSPASKDFCEALLQKDPEKR-------LGFRDGSCDGLRTHPLFRDISWRQL 460

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 54/289 (18%)
Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 199
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL---------------HNDDEAVELDW 244
            H +IV L G C H   + +I EY   G L   L               HN +E  +L  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE--QLSS 165
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
              ++    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+ 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN- 221
Query: 305 RTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXD 359
             ++ G       ++APE  +  V T + DV+S+G++  E+  +G +P            
Sbjct: 222 -YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 280
Query: 360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
               L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 281 ----LVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 319

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ H + ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 210 FCLHKKCMFLIYEY-MERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
             L +   +L+ EY +   S    +H    + VE+       +       LAYLH   S 
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 173
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           ++IHRD+ + NILL+      + DFG+A  +    +      GT  ++APE+   M   +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILAMDEGQ 229
Query: 328 ---KCDVYSFGVVTLEVLMGKHP 347
              K DV+S G+  +E+   K P
Sbjct: 230 YDGKVDVWSLGITCIELAERKPP 252

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 25/297 (8%)
Query: 143 EDFHIKY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ED+ + +  +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALA 259
            R IV L      K  + L+   M  G +   ++N D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQK 379
                     D ++ GV   E++  + P           + K +   VL+Q +  P    
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP---- 413
Query: 380 VIQDILLASTISF--ACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISEL 434
              D    ++  F  A LQ +P+ R        GF       L  H   +DIS  +L
Sbjct: 414 ---DKFSPASKDFCEALLQKDPEKR-------LGFRDGSCDGLRTHPLFRDISWRQL 460

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 25/297 (8%)
Query: 143 EDFHIKY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ED+ + +  +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALA 259
            R IV L      K  + L+   M  G +   ++N D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++APEL
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQK 379
                     D ++ GV   E++  + P           + K +   VL+Q +  P    
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP---- 413
Query: 380 VIQDILLASTISF--ACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISEL 434
              D    ++  F  A LQ +P+ R        GF       L  H   +DIS  +L
Sbjct: 414 ---DKFSPASKDFCEALLQKDPEKR-------LGFRDGSCDGLRTHPLFRDISWRQL 460

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLS 197
           AT  +     IG G YG+VYKA+ P+ G   ALK +     EE   I + R  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 198 QVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
              H ++V+L   C   +      + L++E++++     +       +  +  K  ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLMR 119
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
                L +LH +C   I+HRD+   NIL+ S     +ADFG A R+++       +  T 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQMALDPVVVTL 175
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            Y APE+          D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H ++V+L G 
Sbjct: 14  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 67
Query: 211 CLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
            + +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           +HRD+++ N+L++    A V+DFG  +   +      L      + APE       + K 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKS 180
Query: 330 DVYSFGVVTLEV 341
           DV+SFG++  E+
Sbjct: 181 DVWSFGILLWEI 192

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 148 KYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +  +G G YG VY  + L N    A+K++   ++    + +    E  +   + H++IV+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQ 69
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
             G       + +  E +  GSL  +L +    ++ +        K +   L YLH +  
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 267 PSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPEL--AYTM 323
             I+HRDI  +N+L+N+      ++DFGT++RL   +       GT  Y+APE+      
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 324 VMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQD 383
              +  D++S G   +E+  GK P           +P+  +  V   ++ P + + +  +
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPP------FYELGEPQAAMFKVGMFKVHPEIPESMSAE 240
Query: 384 ILLASTISFACLQSNPKSR 402
              A      C + +P  R
Sbjct: 241 ---AKAFILKCFEPDPDKR 256

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H ++V+L G 
Sbjct: 29  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 82
Query: 211 CLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
            + +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           +HRD+++ N+L++    A V+DFG  +   +      L      + APE       + K 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKS 195
Query: 330 DVYSFGVVTLEV 341
           DV+SFG++  E+
Sbjct: 196 DVWSFGILLWEI 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 151 IGTGGYGSVY----KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G YG V     K       +  ++K   S +     ++    E  VL  + H +I+K
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE----EVAVLKLLDHPNIMK 100
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           LY F   K+  +L+ E  + G LF  I+H     ++ +      I+K +   + YLH   
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLH--- 153
Query: 266 SPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             +I+HRD+   N+LL SK +     + DFG +         +  L   Y YIAPE+   
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY-YIAPEVLRK 212
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
               EKCDV+S GV+   +L G  P
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPP 236

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQ 198
           F  K  +GTG +  V  A+    GK+FA+K      L   E+       S  NE  VL +
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES-------SIENEIAVLRK 76
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + H +IV L         ++L+ + +  G LF  +       E D +    +++ +  A+
Sbjct: 77  IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAV 133
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEA---FVADFGTARRLHADSSNRTLLAGTYGYI 315
            YLH      I+HRD+   N+L  S+ E     ++DFG ++ +       +   GT GY+
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYV 189
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           APE+      ++  D +S GV+   +L G  P
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 134
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++     R          
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 111
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG AR ++     R          
Sbjct: 172 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 228
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLS 197
           AT  +     IG G YG+VYKA+ P+ G   ALK +     EE   I + R  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 198 QVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
              H ++V+L   C   +      + L++E++++     +       +  +  K  ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLMR 119
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
                L +LH +C   I+HRD+   NIL+ S     +ADFG A R+++       +  T 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQMALFPVVVTL 175
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            Y APE+          D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 125/308 (40%), Gaps = 62/308 (20%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQVLH 201
           DF     IG+GG+G V+KA+   +GK + ++++ + +E  E         E + L+++ H
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE--------REVKALAKLDH 64
Query: 202 RSIVKLYGFCL------------------------------HKKCMFLIYEYMERGSLFC 231
            +IV  Y  C                                 KC+F+  E+ ++G+L  
Sbjct: 65  VNIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQ 123
Query: 232 ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD 291
            +       +LD    + + + +   + Y+H   S  +IHRD+  +NI L    +  + D
Sbjct: 124 WIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXX 351
           FG    L  D   RT   GT  Y++PE   +    ++ D+Y+ G++  E+L   H  D  
Sbjct: 180 FGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTA 235
Query: 352 XXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQG 411
                         D+ D  +    D+K         T+    L   P+ RP    + + 
Sbjct: 236 FETSK------FFTDLRDGIISDIFDKK-------EKTLLQKLLSKKPEDRPNTSEILRT 282
Query: 412 FLITRKTP 419
             + +K+P
Sbjct: 283 LTVWKKSP 290

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 31/285 (10%)
Query: 136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALK---KLHTSETEELAFIKSFRNE 192
           ED++   + F +   +G G +GSV +AQL       +K   K+  ++    + I+ F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCM------FLIYEYMERGSLFCIL---HNDDEAVELD 243
           A  + +  H  + KL G  L  +         +I  +M+ G L   L      +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
               V  +  +A  + YL    S + IHRD+++ N +L   +   VADFG +R++++   
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 304 NRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDP 360
            R   A      ++A E     + T   DV++FGV   E++  G+ P           + 
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP------YAGIENA 246
Query: 361 KIMLIDVLDQRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +I    +   RL  PP   + + D++      + C  ++PK RP+
Sbjct: 247 EIYNYLIGGNRLKQPPECMEEVYDLM------YQCWSADPKQRPS 285

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG VY  + L N    A+K++   ++    + +    E  +   + H++IV+  G
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                  + +  E +  GSL  +L +    ++ +        K +   L YLH +    I
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 270 IHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPEL--AYTMVMT 326
           +HRDI  +N+L+N+      ++DFGT++RL   +       GT  Y+APE+         
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 327 EKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILL 386
           +  D++S G   +E+  GK P           +P+  +  V   ++ P + + +  +   
Sbjct: 204 KAADIWSLGCTIIEMATGKPP------FYELGEPQAAMFKVGMFKVHPEIPESMSAE--- 254
Query: 387 ASTISFACLQSNPKSR 402
           A      C + +P  R
Sbjct: 255 AKAFILKCFEPDPDKR 270

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H ++V+L G 
Sbjct: 201 IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 254
Query: 211 CLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
            + +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 329
           +HRD+++ N+L++    A V+DFG  +   +      L      + APE       + K 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKS 367
Query: 330 DVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVL 368
           DV+SFG++  E+   G+ P            P+I L DV+
Sbjct: 368 DVWSFGILLWEIYSFGRVPY-----------PRIPLKDVV 396

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI---VKAMAHALA 259
           +IVKL+     +K ++L+ EY   G +F      D  V   W K        + +  A+ 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVF------DYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y H      I+HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL
Sbjct: 121 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPEL 176
Query: 320 AYTMVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                    + DV+S GV+   ++ G  P D
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 151 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 202
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 94
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHAL 258
           +IV+  G  L     F++ E M  G L   L        +   L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARRLHADSSNRTLLAG--TYG 313
            YL  +     IHRDI++ N LL       VA   DFG A+ ++  S  R          
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           ++ PE     + T K D +SFGV+  E+ 
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TEE   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEE--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+KY   +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+
Sbjct: 8   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 64
Query: 196 LSQVLHRSIVKLYG--FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  +    IVK  G  +   ++ + L+ EY+  G L   L        LD ++ +     
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 122
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLLAG 310
           +   + YL    S   +HRD+++ NIL+ S+    +ADFG A+ L  D      R     
Sbjct: 123 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 126
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPE 182
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILM 207

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 57/294 (19%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 199
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 92
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------------------- 240
            H +IV L G C H   + +I EY   G L   L    EA+                   
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 241 -ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
             L+    ++    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR + 
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 300 ADSSNRTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXX 354
            DS+   ++ G       ++APE  +  V T + DV+S+G++  E+  +G +P       
Sbjct: 210 NDSN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 267
Query: 355 XXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                    L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 268 SKFYK----LVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 311

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+KY   +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+
Sbjct: 9   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 65
Query: 196 LSQVLHRSIVKLYG--FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  +    IVK  G  +   ++ + L+ EY+  G L   L        LD ++ +     
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 123
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLLAG 310
           +   + YL    S   +HRD+++ NIL+ S+    +ADFG A+ L  D      R     
Sbjct: 124 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 181 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+KY   +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+
Sbjct: 5   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 61
Query: 196 LSQVLHRSIVKLYG--FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  +    IVK  G  +   +  + L+ EY+  G L   L        LD ++ +     
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 119
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLLAG 310
           +   + YL    S   +HRD+++ NIL+ S+    +ADFG A+ L  D      R     
Sbjct: 120 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 68
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWC--V 125
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 126 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 71
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 128
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 129 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 143 EDFHIKYC--IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           E+ H+KY   +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 77
Query: 196 LSQVLHRSIVKLYG--FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  +    IVK  G  +   ++ + L+ EY+  G L   L        LD ++ +     
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 135
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLLAG 310
           +   + YL    S   +HRD+++ NIL+ S+    +ADFG A+ L  D      R     
Sbjct: 136 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G +G V++  +   G+VF  K ++T    +   +K   NE  +++Q+ H  ++ L+ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHD 115
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               K  M LI E++  G LF  +  +D   ++  A+ +N ++     L ++H     SI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SI 170
Query: 270 IHRDISSNNILLNSKLEAFVA--DFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           +H DI   NI+  +K  + V   DFG A +L+ D   +   A T  + APE+     +  
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPVGF 229
Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D+++ GV+   +L G  P
Sbjct: 230 YTDMWAIGVLGYVLLSGLSP 249

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ ++  IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL+  +   +ADFG +      +   T   G+  Y APEL   
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-FCGSPPYAAPELFQG 187
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 71
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 72  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 128
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 129 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWC--V 124
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 71
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++LI EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCH 128
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +          T   G+  Y APEL   
Sbjct: 129 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-FCGSPPYAAPELFQG 184
Query: 323 MVM-TEKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 68
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 125
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 126 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK--AQTHGKWPVKWYAPECINYY 189
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKE 65
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGL 123
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 124 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 319 -LAYTMVMTEKCDVYSFGVVTLEVL 342
            L      +   D++S G +  E++
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 145
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 203
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 21  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 77
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 78  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 134
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 135 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           T+++ +   IG G +  V +  +L  G  +A K ++T +       K    EA++   + 
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L+     +   +L+++ +  G LF      ++ V  ++    +    +   L  
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILEA 115
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
           + H     ++HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+       +  D+++ GV+   +L+G  P
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 205
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 205
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 489
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 547
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 17  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 73
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 74  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 130
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 131 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 184 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E ++I   +G G +G V K +     + +A+K ++ +  +        R E ++L ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I+KL+         +++ E    G LF  +       E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 262 HHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           H     +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAPE
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPE 193
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +       EKCDV+S GV+   +L G  P
Sbjct: 194 VLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           F  K  +G+G +G V+  +  +  +  + K    +  ++  ++    E +VL  + H +I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNI 82
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           +K++        M+++ E  E G L   I+        L       ++K M +ALAY H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH- 141
Query: 264 DCSPSIIHRDISSNNILL-----NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
             S  ++H+D+   NIL      +S ++  + DFG A    +D  + T  AGT  Y+APE
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIK--IIDFGLAELFKSDE-HSTNAAGTALYMAPE 196
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMG 344
           + +   +T KCD++S GVV   +L G
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKE 65
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGL 123
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 124 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 319 -LAYTMVMTEKCDVYSFGVVTLEVL 342
            L      +   D++S G +  E++
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 36  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 92
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 149
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 150 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 189
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 29/249 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGK----VFALKKLHTSETEELAFIKSFRNE 192
           +++ TE   +K  +G+G +G+VYK   +P+G+      A+K L  + + +    K   +E
Sbjct: 13  ILKETELRKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDE 69
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVNIV 251
           A V++ V    + +L G CL      L+ + M  G   C+L H  +    L     +N  
Sbjct: 70  AYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYG---CLLDHVRENRGRLGSQDLLNWC 125
Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             +A  ++YL       ++HRD+++ N+L+ S     + DFG AR L  D +      G 
Sbjct: 126 MQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 182
Query: 312 Y--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVL 368
               ++A E       T + DV+S+GV   E++  G  P D          P   + D+L
Sbjct: 183 VPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--------PAREIPDLL 234
Query: 369 D--QRLPPP 375
           +  +RLP P
Sbjct: 235 EKGERLPQP 243

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 5   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 61
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 118
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 119 QIAKGMN----YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 137
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 195
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 8   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 64
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W  ++
Sbjct: 65  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
                 A  + YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 124 ------AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 490
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 548
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 127
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 185
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EYM  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    VADFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 126
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 182
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILM 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EYM  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    VADFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C  +  M L+ E  E G L   L  +    + +    + +V  ++  + YL      +
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 125
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG-----YIAPELAYTM 323
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 183
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
             + K DV+SFGV+  E    G+ P
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 62
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R +      
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 237
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+LL   +   C Q NPK RP+
Sbjct: 238 VMEGGLLDKPDNCP-------DMLL--ELMRMCWQYNPKMRPS 271

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 151 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
           +G G +GSV +   ++   ++    K+    TE+ A  +    EAQ++ Q+ +  IV+L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G C   + + L+ E    G L   L    E + +  +    ++  ++  + YL      +
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 130
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL-AGTY--GYIAPELAYTMVM 325
            +HRD+++ N+LL ++  A ++DFG ++ L AD S  T   AG +   + APE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 326 TEKCDVYSFGVVTLEVL-MGKHP 347
           + + DV+S+GV   E L  G+ P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 151 IGTGGYGSVY-KAQLPNGKVFALKKLHTSETEELAFI-KSFRNEAQVLSQVLHRSIVKLY 208
           +G+G +  V+   Q   GK+FALK +  S     AF   S  NE  VL ++ H +IV L 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                    +L+ + +  G LF  +       E D +    +++ +  A+ YLH +    
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHEN---G 126
Query: 269 IIHRDISSNNILL-----NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
           I+HRD+   N+L      NSK+   + DFG ++     +   +   GT GY+APE+    
Sbjct: 127 IVHRDLKPENLLYLTPEENSKI--MITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 324 VMTEKCDVYSFGVVTLEVLMGKHP 347
             ++  D +S GV+T  +L G  P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 126
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 182
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILM 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 67  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILM 204

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQG 186
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 98  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 154
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 155 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 210
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEILM 235

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQG 186
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 72  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 128
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 129 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 184
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEILM 209

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E ++I   +G G +G V K +     + +A+K ++ +  +        R E ++L ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I+KL+         +++ E    G LF  +       E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 262 HHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           H     +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAPE
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPE 193
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +       EKCDV+S GV+   +L G  P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 75  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 187
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILM 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 151 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G   +G VYK  L    P  +  A+      +  E    + FR+EA + +++ H ++V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 207 LYGFCLHKKCMFLIYEYMERGSL--FCILH---------NDDEAVE--LDWAKRVNIVKA 253
           L G     + + +I+ Y   G L  F ++          +DD  V+  L+    V++V  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 254 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           +A  + YL  HH     ++H+D+++ N+L+  KL   ++D G  R ++A +    LL  +
Sbjct: 154 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADYYKLLGNS 207
Query: 312 Y---GYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
                ++APE       +   D++S+GVV  EV 
Sbjct: 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 73  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 129
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 130 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 185
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEILM 210

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E ++I   +G G +G V K +     + +A+K ++ +  +        R E ++L ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I+KL+         +++ E    G LF  +       E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 262 HHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           H     +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAPE
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPE 193
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +       EKCDV+S GV+   +L G  P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 51/282 (18%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           DF    C+G GG+G V++A+    KV    +A+K++      ELA  K  R E + L+++
Sbjct: 6   DFEPIQCLGRGGFGVVFEAK---NKVDDCNYAIKRIRLP-NRELAREKVMR-EVKALAKL 60
Query: 200 LHRSIVKLYGFCLHKKC------------MFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
            H  IV+ +   L K              +++  +   + +L   ++      E + +  
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
           ++I   +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D   +T+
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 308 LA------------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXX 355
           L             GT  Y++PE  +    + K D++S G++  E+L   +P        
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERV 234
Query: 356 XXXDPKIMLIDVLDQRLPPPVDQK------VIQDILLASTIS 391
                   L DV + + PP   QK      ++QD+L  S + 
Sbjct: 235 RT------LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPME 270

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 65
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMV 202

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 151 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G   +G VYK  L    P  +  A+      +  E    + FR+EA + +++ H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 207 LYGFCLHKKCMFLIYEYMERGSL--FCILH---------NDDEAVE--LDWAKRVNIVKA 253
           L G     + + +I+ Y   G L  F ++          +DD  V+  L+    V++V  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 254 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           +A  + YL  HH     ++H+D+++ N+L+  KL   ++D G  R ++A +    LL  +
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADYYKLLGNS 190
Query: 312 Y---GYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
                ++APE       +   D++S+GVV  EV 
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMV 198

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 145 FHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           F ++  +G G    VY+  Q    K +ALK L  +  +++      R E  VL ++ H +
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV-----RTEIGVLLRLSHPN 109
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           I+KL         + L+ E +  G LF  +       E D A   + VK +  A+AYLH 
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DAVKQILEAVAYLHE 166
Query: 264 DCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           +    I+HRD+   N+L  +        +ADFG ++ +      +T+  GT GY APE+ 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CGTPGYCAPEIL 222
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                  + D++S G++T  +L G  P
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE 
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V    +   G+ +A+K L          +     E++VL    H 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  AL Y
Sbjct: 71  FLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEY 125
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+ 
Sbjct: 126 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 182
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 450 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 562
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V+K +    G++ A+KK   SE + +    + R E ++L Q+ H ++V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR---VNIVKAMA----HALAYLH 262
               K+ + L++EY +      +LH      ELD  +R    ++VK++      A+ + H
Sbjct: 70  VFRRKRRLHLVFEYCDH----TVLH------ELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 263 -HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
            H+C    IHRD+   NIL+       + DFG AR L   S        T  Y +PEL  
Sbjct: 120 KHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 322 TMVM-TEKCDVYSFGVVTLEVLMG 344
                    DV++ G V  E+L G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
             E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++LI EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCH 131
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +              G   Y APEL   
Sbjct: 132 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQG 187
Query: 323 MVM-TEKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 136 EDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEA 193
           + L  A + +     IG G YG V+KA+ L NG  F ALK++     EE   + + R  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 194 QV--LSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAK 246
            +  L    H ++V+L+  C   +      + L++E++++     +    +  V  +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
             +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG A R+++     T
Sbjct: 124 --DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT 177
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            +  T  Y APE+          D++S G +  E+   K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           +G G YG V+K+     G+V A+KK+  +        ++FR E  +L+++  H +IV L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 209 GFCL--HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
                 + + ++L+++YME      I  N  E V   +     +V  +   + YLH   S
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-----VVYQLIKVIKYLH---S 127
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTAR---------------------RLHADSSNR 305
             ++HRD+  +NILLN++    VADFG +R                         D    
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 306 TLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
           T    T  Y APE L  +   T+  D++S G +  E+L GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQV 199
           DF     +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62
Query: 200 LHRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHA 257
            H  +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  A
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+          D +  GVV  E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 146
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 136 EDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEA 193
           + L  A + +     IG G YG V+KA+ L NG  F ALK++     EE   + + R  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 194 QV--LSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAK 246
            +  L    H ++V+L+  C   +      + L++E++++     +    +  V  +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
             +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG A R+++     T
Sbjct: 124 --DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT 177
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            +  T  Y APE+          D++S G +  E+   K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V    +   G+ +A+K L          +     E++VL    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  AL Y
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEY 120
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+ 
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 136 EDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEA 193
           + L  A + +     IG G YG V+KA+ L NG  F ALK++     EE   + + R  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 194 QV--LSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAK 246
            +  L    H ++V+L+  C   +      + L++E++++     +    +  V  +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
             +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG A R+++     T
Sbjct: 124 --DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT 177
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            +  T  Y APE+          D++S G +  E+   K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A++ +  ++    +  K FR E +++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQG 186
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRS---- 203
           IG G YGSV K    P+G++ A+K++ ++  E        + + Q+L    V+ RS    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--------KEQKQLLMDLDVVMRSSDCP 81
Query: 204 -IVKLYGFCLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
            IV+ YG    +     CM L+    ++   +     DD   E    K   I  A   AL
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK---ITLATVKAL 138
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            +L  +    IIHRDI  +NILL+      + DFG + +L  DS  +T  AG   Y+APE
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 195
Query: 319 L----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                A       + DV+S G+   E+  G+ P
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 126
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L+++     + DFG +R +  DS+      G     ++APE
Sbjct: 127 LE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 182
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILM 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V    +   G+ +A+K L          +     E++VL    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  AL Y
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEY 120
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+ 
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V    +   G+ +A+K L          +     E++VL    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  AL Y
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEY 120
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+ 
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V    +   G+ +A+K L          +     E++VL    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  AL Y
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEY 120
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+ 
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 8/209 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
             ++F     +G G +G V  A++   G ++A+K L      +   ++    E ++LS  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 200 L-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             H  + +L+        +F + E++  G L   + +  ++   D A+       +  AL
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            +LH      II+RD+  +N+LL+ +    +ADFG  +    +        GT  YIAPE
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +   M+     D ++ GV+  E+L G  P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQ 194
           +++ TE   IK  +G+G +G+VYK   +P G+   +    +   E       K   +EA 
Sbjct: 45  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRVNI 250
           V++ V +  + +L G CL    + LI + M  G L  +   H D+   +  L+W   V I
Sbjct: 104 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQI 160
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
            K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+        G
Sbjct: 161 AKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 311 TY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
                ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K+F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF     +G G +G V    +   G+ +A+K L          +     E++VL    H 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E    +R     A +  AL Y
Sbjct: 69  FLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEY 123
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+ 
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 180
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 39/292 (13%)
Query: 133 IFYEDLIE-ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EE 182
           +F  D  E A E   +   +G G +G VY+          P  +V A+K ++ + +  E 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRER 63
Query: 183 LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVEL 242
           + F+    NEA V+ +     +V+L G     +   +I E M RG L   L +    +E 
Sbjct: 64  IEFL----NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 119
Query: 243 D-------WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 295
           +        +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 176
Query: 296 RRLHADSSNRTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXX 352
           R ++     R    G     +++PE     V T   DV+SFGVV  E+  + + P     
Sbjct: 177 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 236
Query: 353 XXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
                    +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 237 NEQVLR--FVMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 277

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKL- 207
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 208 ---YGFCLHKKCMF--LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
              Y     K  ++  L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 71
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R +      
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 246
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 247 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 280

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 10/210 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 200
           +DF +   IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALA 259
           H  +V L+     +  +F + EY+  G L   +    +  E    +      A ++ AL 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALN 124
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAPE+
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI 181
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                     D ++ GV+  E++ G+ P D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 87
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K+F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 64
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N  +       + DFG  R ++     
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 239
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+LL   +   C Q NPK RP+
Sbjct: 240 VMEGGLLDKPDNCP-------DMLL--ELMRMCWQYNPKMRPS 273

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 92
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 10/210 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 200
           +DF +   IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALA 259
           H  +V L+     +  +F + EY+  G L   +    +  E    +      A ++ AL 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALN 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAPE+
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI 177
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                     D ++ GV+  E++ G+ P D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 70
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 245
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 246 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 279

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 142 TEDFHIKYCIGTGGYGSVYK------AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           T+D+ +   +G G +  V +       Q    K+   KKL   + ++L        EA++
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL------EREARI 83
Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
              + H +IV+L+     +   +L+++ +  G LF      ++ V  ++    +    + 
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIH 137
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTY 312
             L  ++H     I+HRD+   N+LL SK +     +ADFG A  +  +       AGT 
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTP 197
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           GY++PE+       +  D+++ GV+   +L+G  P
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 89
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 64
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 239
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 240 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 273

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 71
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 246
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 247 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 280

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 140 EATED-FHIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           E  ED + +   +G+G +  V K  Q   GK +A   +KK   S +      +    E  
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L ++ H +I+ L+    +K  + LI E +  G LF  L  + E++  D A     +K +
Sbjct: 68  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA--TQFLKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILL------NSKLEAFVADFGTARRLHADSSNRTLL 308
              + YLH   S  I H D+   NI+L      N +++  + DFG A ++ A +  + + 
Sbjct: 125 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEFKNIF 179
Query: 309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            GT  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 77
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 341
           R    G     +++PE     V T   DV+SFGVV  E+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHT-------SETEELAFIKSFRNEAQVLSQVLHRS 203
           +G G +GSV +       V+ ++K           +  E A  +    EAQ++ Q+ +  
Sbjct: 344 LGCGNFGSVRQG------VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IV+L G C   + + L+ E    G L   L    E + +  +    ++  ++  + YL  
Sbjct: 398 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEE 454
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL-AGTY--GYIAPELA 320
               + +HR++++ N+LL ++  A ++DFG ++ L AD S  T   AG +   + APE  
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 321 YTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                + + DV+S+GV   E L  G+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K+F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI-VKAMAHALAYL 261
            F      KK    + L+ +Y+   +++ +  +   A +      V + +  +  +LAY+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           H   S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL 
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELI 194
Query: 321 YTMV-MTEKCDVYSFGVVTLEVLMGK 345
           +     T   DV+S G V  E+L+G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    VADFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 70
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 245
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 246 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 279

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 77
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------NDDEAVELDW 244
           EA V+ +     +V+L G     +   +I E M RG L   L        N+        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 341
           R    G     +++PE     V T   DV+SFGVV  E+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G + +VYKA+  N  ++ A+KK+   H SE ++    ++   E ++L ++ H +I+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD-GINRTALREIKLLQELSHPNIIG 76
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L     HK  + L++++ME   L  I+ ++   +     K   ++      L YLH    
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW- 132
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMT 326
             I+HRD+  NN+LL+      +ADFG A+   + +        T  Y APEL +   M 
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 327 E-KCDVYSFGVVTLEVLM 343
               D+++ G +  E+L+
Sbjct: 191 GVGVDMWAVGCILAELLL 208

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  Q   GK +A   +KK   S +      +    E  +L ++ H +I+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L  + E++  D A     +K +   + YLH   S
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA--TQFLKQILDGVHYLH---S 126
Query: 267 PSIIHRDISSNNILL------NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
             I H D+   NI+L      N +++  + DFG A ++ A +  + +  GT  ++APE+ 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIV 183
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
               +  + D++S GV+T  +L G  P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  + +G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 99
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD-------W 244
           EA V+ +     +V+L G     +   +I E M RG L   L +    +E +        
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 274
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 275 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 308

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 10/210 (4%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 200
           +DF +   IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALA 259
           H  +V L+     +  +F + EY+  G L   +    +  E    +      A ++ AL 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALN 135
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAPE+
Sbjct: 136 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI 192
Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                     D ++ GV+  E++ G+ P D
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 80
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 141 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 196
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 197 GATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +       +      G   Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQG 186
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 143 EDFHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           E   +  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G  + +  +++I E    G L   L        LD A  +     ++ ALAY
Sbjct: 450 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY--GYIAPE 318
           L    S   +HRDI++ N+L+++     + DFG +R +  DS+      G     ++APE
Sbjct: 507 LE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 562
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM 343
                  T   DV+ FGV   E+LM
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 38/283 (13%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRN 191
           A E   +   +G G +G VY+          P  +V A+K ++ + +  E + F+    N
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 67
Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------NDDEAVELDW 244
           EA V+ +     +V+L G     +   +I E M RG L   L        N+        
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
           +K + +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 305 RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDXXXXXXXXXDPK 361
           R    G     +++PE     V T   DV+SFGVV  E+  + + P              
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--F 242
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           +M   +LD+    P       D+L    +   C Q NPK RP+
Sbjct: 243 VMEGGLLDKPDNCP-------DMLF--ELMRMCWQYNPKMRPS 276

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 98
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 159 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 214
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  + +G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 87
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 148 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 203
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 192
           +++ TE   IK  + +G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVE--LDWAKRV 248
           A V++ V +  + +L G CL      LI + M  G L  +   H D+   +  L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+       
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 309 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRD 349
            G     ++A E     + T + DV+S+GV   E++  G  P D
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 92
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 153 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 208
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 83
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 144 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 199
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 207
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 207
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YGSV  A    +G+  A+KKL      E+   +++R E  +L  + H +++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAV---ELDWAKRVNIVKAMAHALAYLHHDCS 266
                  +   Y++     +   +  D + +   E    K   +V  M   L Y+H   S
Sbjct: 109 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---S 162
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVM 325
             ++HRD+   N+ +N   E  + DFG AR  HAD +  T    T  Y APE+  + M  
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HAD-AEMTGYVVTRWYRAPEVILSWMHY 219
Query: 326 TEKCDVYSFGVVTLEVLMGK 345
            +  D++S G +  E+L GK
Sbjct: 220 NQTVDIWSVGCIMAEMLTGK 239

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 84
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 145 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 200
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 201 GATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           D   +  IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 83
Query: 201 HR-SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-------------DDEAVELDWAK 246
           H  +I+ L G C H+  ++L  EY   G+L   L               +  A  L   +
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            ++    +A  + YL        IHRD+++ NIL+     A +ADFG +R        +T
Sbjct: 144 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-YVKKT 199
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           +      ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           D   +  IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 73
Query: 201 HR-SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-------------DDEAVELDWAK 246
           H  +I+ L G C H+  ++L  EY   G+L   L               +  A  L   +
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            ++    +A  + YL        IHRD+++ NIL+     A +ADFG +R        +T
Sbjct: 134 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-YVKKT 189
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           +      ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 63
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 121
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 122 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 21/225 (9%)
Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKS 188
           ++++ ++E  + + +   +G+G +  V K  Q   GK +A   +KK     +      + 
Sbjct: 18  LYFQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE 75
Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
              E  +L ++ H +I+ L+    +K  + LI E +  G LF  L  + E++  D A   
Sbjct: 76  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA--T 132
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL------NSKLEAFVADFGTARRLHADS 302
             +K +   + YLH   S  I H D+   NI+L      N +++  + DFG A ++ A +
Sbjct: 133 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGN 187
Query: 303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             + +  GT  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 188 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 229
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I  Y  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 107
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 168 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 223
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE L 
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++++     +  +    + L   K  + +  +   LA
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 120 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 51/258 (19%)
Query: 138 LIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEEL--AFIKSFRNEAQ 194
           L+E  + +H+K  IG G YG V  A +     + A+K ++ ++  ++    ++  + E +
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-------------CIL-------- 233
           ++ ++ H +I +LY     ++ + L+ E    G L              C +        
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 234 ---HNDDEAVE---------LDWAKR----VNIVKAMAHALAYLHHDCSPSIIHRDISSN 277
                ++EA+          LD+ +R     NI++ +  AL YLH+     I HRDI   
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197
Query: 278 NILL--NSKLEAFVADFGTARRLH----ADSSNRTLLAGTYGYIAPELAYTMVMT--EKC 329
           N L   N   E  + DFG ++  +     +    T  AGT  ++APE+  T   +   KC
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 330 DVYSFGVVTLEVLMGKHP 347
           D +S GV+   +LMG  P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 229
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A++ +  ++    +  K FR E +++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++ +   +ADFG +       +      G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQG 186
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 115
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 176 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 231
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFAL---KKLHTSETEELAFIKSFRNEAQVLSQ 198
           +DF +   IG G Y  V   +L    +++A+   KK   ++ E++ ++++   E  V  Q
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQ 108
Query: 199 VL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAH 256
              H  +V L+     +  +F + EY+  G L   +    +  E    +      A ++ 
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISL 164
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIA
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           PE+          D ++ GV+  E++ G+ P D
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE L 
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V AL K+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V AL K+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 118 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 42/271 (15%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRSI---- 204
           +G G YG V K + +P+G++ A+K++        A + S   +  ++   +  R++    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR-------ATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 205 -VKLYGFCLHKKCMFLIYEYMERG--SLFCILHNDDEAVELDWAKR--VNIVKAMAHALA 259
            V  YG    +  +++  E M+      +  + +  + +  D   +  V+IVKA+ H  +
Sbjct: 68  TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
            L      S+IHRD+  +N+L+N+  +  + DFG +  L  D   + + AG   Y+APE 
Sbjct: 128 KL------SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPER 180
Query: 320 AYTMVMTE----KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPP 375
               +  +    K D++S G+  +E+ + + P D          P   L  V+++  P  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSP-- 232
Query: 376 VDQKVIQDILLASTISFA--CLQSNPKSRPT 404
              ++  D   A  + F   CL+ N K RPT
Sbjct: 233 ---QLPADKFSAEFVDFTSQCLKKNSKERPT 260

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAF---IKSFRNEA--Q 194
           AT  +     IG G YG+VYKA+ P+ G   ALK +             I + R  A  +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 195 VLSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
            L    H ++V+L   C   +      + L++E++++     +       +  +  K  +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--D 124
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG A R+++     T + 
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQMALTPVV 180
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            T  Y APE+          D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 117
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 178 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 233
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H +IV+L 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 158
Query: 209 GFCL---HKK---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            F      KK    + L+ +Y+         H       L        +  +  +LAY+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
              S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APEL +
Sbjct: 219 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 274
Query: 322 TMV-MTEKCDVYSFGVVTLEVLMGK 345
                T   DV+S G V  E+L+G+
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 151 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 201
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------------NDDEAVELDWAKRV 248
           ++I+ L G C     +++I  Y  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL 308
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 309 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 62
Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K  + +  +   LA+ 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
           H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE L 
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                +   D++S G +  E++
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++       +  +    + L   K  + +  +   LA
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+ R    
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRH-EN 97
Query: 207 LYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           + GF             ++L+ +Y E GSLF  L+     VE      + +  + A  LA
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLA 153
Query: 260 YLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL------L 308
           +LH +       P+I HRD+ S NIL+       +AD G A R   DS+  T+       
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHR 211
Query: 309 AGTYGYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV 341
            GT  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++       +  +    + L   K  + +  +   LA
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 121 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YG+V  A     G   A+KKL+     EL   +++R E ++L  + H +++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 210 FCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVN-IVKAMAHALAYLH 262
                + +      +L+  +M  G+    L   ++  E     R+  +V  M   L Y+H
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE----DRIQFLVYQMLKGLRYIH 145
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
              +  IIHRD+   N+ +N   E  + DFG AR+  ADS     +  T  Y APE+   
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMXGXVV-TRWYRAPEVILN 199
Query: 323 -MVMTEKCDVYSFGVVTLEVLMGK 345
            M  T+  D++S G +  E++ GK
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 147
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEYLAPEIILSKGYNKA 204
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 205 VDWWALGVLIYEMAAGYPP 223

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  LAGT  Y+APE+  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEYLAPEIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++       +  +    + L   K  + +  +   LA
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
            H +IVKL      +  ++L++E++       +  +    + L   K  + +  +   LA
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           + H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE 
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 319 LAYTMVMTEKCDVYSFGVVTLEVL 342
           L      +   D++S G +  E++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+ R    
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRH-EN 84
Query: 207 LYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           + GF             ++L+ +Y E GSLF  L+     VE      + +  + A  LA
Sbjct: 85  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLA 140
Query: 260 YLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL------L 308
           +LH +       P+I HRD+ S NIL+       +AD G A R   DS+  T+       
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHR 198
Query: 309 AGTYGYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV 341
            GT  Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE------------ 192
           + +K  +GTGG+G            + L+ +H    E++A IK  R E            
Sbjct: 17  WEMKERLGTGGFG------------YVLRWIHQDTGEQVA-IKQCRQELSPKNRERWCLE 63
Query: 193 AQVLSQVLHRSIVKLYGF--CLHK----KCMFLIYEYMERGSLFCILHNDDEAVELDWAK 246
            Q++ ++ H ++V        L K        L  EY E G L   L+  +    L    
Sbjct: 64  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 123
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARRLHADSS 303
              ++  ++ AL YLH +    IIHRD+   NI+L     +L   + D G A+ L     
Sbjct: 124 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             T   GT  Y+APEL      T   D +SFG +  E + G  P
Sbjct: 181 C-TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+ R    
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRH-EN 58
Query: 207 LYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           + GF             ++L+ +Y E GSLF  L+     VE      + +  + A  LA
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLA 114
Query: 260 YLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL------L 308
           +LH +       P+I HRD+ S NIL+       +AD G A R   DS+  T+       
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHR 172
Query: 309 AGTYGYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DXXXXXXX 356
            GT  Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H           
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 357 XXDPKI--MLIDVLDQRLPP--PVDQKVIQDILLASTISFACLQSNPKSRPT 404
             DP +  M   V +Q+L P  P   +  + + + + I   C  +N  +R T
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE------------ 192
           + +K  +GTGG+G            + L+ +H    E++A IK  R E            
Sbjct: 16  WEMKERLGTGGFG------------YVLRWIHQDTGEQVA-IKQCRQELSPKNRERWCLE 62
Query: 193 AQVLSQVLHRSIVKLYGF--CLHK----KCMFLIYEYMERGSLFCILHNDDEAVELDWAK 246
            Q++ ++ H ++V        L K        L  EY E G L   L+  +    L    
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARRLHADSS 303
              ++  ++ AL YLH +    IIHRD+   NI+L     +L   + D G A+ L     
Sbjct: 123 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             T   GT  Y+APEL      T   D +SFG +  E + G  P
Sbjct: 180 C-TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G V+K  +   G   A K + T   ++   +K   NE  V++Q+ H ++++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYD 153
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               K  + L+ EY++ G LF  +   DE+  L     +  +K +   + ++H      I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICEGIRHMHQ---MYI 208
Query: 270 IHRDISSNNIL-LNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
           +H D+   NIL +N   +   + DFG ARR       +    GT  ++APE+     ++ 
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSF 267
Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D++S GV+   +L G  P
Sbjct: 268 PTDMWSVGVIAYMLLSGLSP 287

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ +   IG G +  V  A+ +  GK  A+K +  ++    +  K FR E ++   + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKL+     +K ++L+ EY   G +F  L       E +   +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+ + N+LL++     +ADFG +       +      G   Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQG 186
Query: 323 MVMT-EKCDVYSFGVVTLEVLMGKHPRD 349
                 + DV+S GV+   ++ G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 35  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 94
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 149
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 150 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 208
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 209 LGVIMYILLCGYPP 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 37  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 96
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 151
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 152 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 210
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 211 LGVIMYILLCGYPP 224

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G Y +VYK       V+   K    ++EE     + R E  ++ ++ H +IV+LY  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHENIVRLYDV 71
Query: 211 CLHKKCMFLIYEYMERGSLFCI----LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
              +  + L++E+M+      +    + N    +EL+  K       +   LA+ H +  
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQGLAFCHEN-- 127
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVM 325
             I+HRD+   N+L+N + +  + DFG AR      +  +    T  Y AP+ L  +   
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 326 TEKCDVYSFGVVTLEVLMGK 345
           +   D++S G +  E++ GK
Sbjct: 187 STSIDIWSCGCILAEMITGK 206

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 45  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 104
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 159
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 160 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 218
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 219 LGVIMYILLCGYPP 232

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 36  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 95
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 150
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 151 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 209
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 210 LGVIMYILLCGYPP 223

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YGSV  A    +G+  A+KKL      E+   +++R E  +L  + H +++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAV---ELDWAKRVNIVKAMAHALAYLHHDCS 266
                  +   Y++     +   +  D + +   +    K   +V  M   L Y+H   S
Sbjct: 91  VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---S 144
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVM 325
             ++HRD+   N+ +N   E  + DFG AR  HAD +  T    T  Y APE+  + M  
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HAD-AEMTGYVVTRWYRAPEVILSWMHY 201
Query: 326 TEKCDVYSFGVVTLEVLMGK 345
            +  D++S G +  E+L GK
Sbjct: 202 NQTVDIWSVGCIMAEMLTGK 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+ R    
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRH-EN 59
Query: 207 LYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           + GF             ++L+ +Y E GSLF  L+     VE      + +  + A  LA
Sbjct: 60  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLA 115
Query: 260 YLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL------L 308
           +LH +       P+I HRD+ S NIL+       +AD G A R   DS+  T+       
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHR 173
Query: 309 AGTYGYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DXXXXXXX 356
            GT  Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H           
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 233
Query: 357 XXDPKI--MLIDVLDQRLPP--PVDQKVIQDILLASTISFACLQSNPKSRPT 404
             DP +  M   V +Q+L P  P   +  + + + + I   C  +N  +R T
Sbjct: 234 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 285

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+ R    
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRH-EN 64
Query: 207 LYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           + GF             ++L+ +Y E GSLF  L+     VE      + +  + A  LA
Sbjct: 65  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLA 120
Query: 260 YLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL------L 308
           +LH +       P+I HRD+ S NIL+       +AD G A R   DS+  T+       
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHR 178
Query: 309 AGTYGYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DXXXXXXX 356
            GT  Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H           
Sbjct: 179 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 238
Query: 357 XXDPKI--MLIDVLDQRLPP--PVDQKVIQDILLASTISFACLQSNPKSRPT 404
             DP +  M   V +Q+L P  P   +  + + + + I   C  +N  +R T
Sbjct: 239 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 290

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 75  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 189
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 248
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 249 LGVIMYILLCGYPP 262

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 147 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+ R    
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRH-EN 61
Query: 207 LYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           + GF             ++L+ +Y E GSLF  L+     VE      + +  + A  LA
Sbjct: 62  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLA 117
Query: 260 YLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL------L 308
           +LH +       P+I HRD+ S NIL+       +AD G A R   DS+  T+       
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHR 175
Query: 309 AGTYGYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DXXXXXXX 356
            GT  Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H           
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 235
Query: 357 XXDPKI--MLIDVLDQRLPP--PVDQKVIQDILLASTISFACLQSNPKSRPT 404
             DP +  M   V +Q+L P  P   +  + + + + I   C  +N  +R T
Sbjct: 236 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 287

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 30  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 89
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 144
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 145 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 203
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 204 LGVIMYILLCGYPP 217

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 31  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 29  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 88
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 143
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 202
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/266 (22%), Positives = 108/266 (40%), Gaps = 11/266 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F I+  IG G +  VY+A  L +G   ALKK+   +  +         E  +L Q+ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +++K Y   +    + ++ E  + G L  ++ +  +   L       + K      + L 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPERTVWKYFVQLCSALE 150
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
           H  S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++PE  + 
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQ 382
                K D++S G +  E+   + P             KI   D       PP+      
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY------PPLPSDHYS 264
Query: 383 DILLASTISFACLQSNPKSRPTMQYV 408
           + L    +   C+  +P+ RP + YV
Sbjct: 265 EEL--RQLVNMCINPDPEKRPDVTYV 288

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           D   +  IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 80
Query: 201 HR-SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-------------DDEAVELDWAK 246
           H  +I+ L G C H+  ++L  EY   G+L   L               +  A  L   +
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            ++    +A  + YL        IHR++++ NIL+     A +ADFG +R        +T
Sbjct: 141 LLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRGQEV-YVKKT 196
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           +      ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 81  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 140
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 195
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 196 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 254
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 255 LGVIMYILLCGYPP 268

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 31  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQ---LPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+       +V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HRD+++ N ++       + DFG  R ++  +  R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 257
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V   + +       C Q NPK RPT
Sbjct: 258 PERVTDLMRM-------CWQFNPKMRPT 278

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 43/223 (19%)
Query: 151 IGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           IG G YG+VYK  L       KVF+         E+  +         +   ++    V 
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80
Query: 207 LYGFCLHKKCMFLIYEYMERGSL--FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
             G    +    L+ EY   GSL  +  LH  D      W     +  ++   LAYLH +
Sbjct: 81  ADG----RMEYLLVMEYYPNGSLXKYLSLHTSD------WVSSCRLAHSVTRGLAYLHTE 130
Query: 265 C------SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL---------- 308
                   P+I HRD++S N+L+ +     ++DFG + RL   + NR +           
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL---TGNRLVRPGEEDNAAIS 187
Query: 309 -AGTYGYIAPELAYTMV-------MTEKCDVYSFGVVTLEVLM 343
             GT  Y+APE+    V         ++ D+Y+ G++  E+ M
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 28/231 (12%)
Query: 130 DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE--------T 180
           D  + +ED+ E  E       IG G +  V +      G+ FA+K +  ++        T
Sbjct: 17  DDDVLFEDVYELCE------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 181 EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL-FCILHNDDEA 239
           E+L      + EA +   + H  IV+L         +++++E+M+   L F I+   D  
Sbjct: 71  EDL------KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 240 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTAR 296
                A   + ++ +  AL Y H +   +IIHRD+   N+LL SK  +    + DFG A 
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAI 181
Query: 297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +L           GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 107/268 (39%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQ---LPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+       +V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HRD+++ N ++       + DFG  R +      R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 257
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V       + +   C Q NPK RPT
Sbjct: 258 PERV-------TDLMRMCWQFNPKMRPT 278

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
            IG G +G V++A+L      A+KK+           K F+N E Q++  V H ++V L 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVDLK 98
Query: 209 GFCL----HKKCMF--LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK----AMAHAL 258
            F       K  +F  L+ EY+       +        +L     + ++K     +  +L
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAP 317
           AY+H   S  I HRDI   N+LL+       + DFG+A+ L A   N + +   Y Y AP
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAP 210
Query: 318 ELAYTMV-MTEKCDVYSFGVVTLEVLMGK 345
           EL +     T   D++S G V  E++ G+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 102
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 103 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 156
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 213
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 214 VDWWALGVLIYEMAAGYPP 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 44/218 (20%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G YG V+  +    KV A+K   T  TEE ++ +    E ++   VL R    + GF
Sbjct: 45  IGKGRYGEVWMGKWRGEKV-AVKVFFT--TEEASWFR----ETEIYQTVLMRH-ENILGF 96
Query: 211 CLHK-------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
                        ++LI +Y E GSL+  L    ++  LD    + +  +    L +LH 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 264 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL----LAGTYGY 314
           +       P+I HRD+ S NIL+       +AD G A +  +D++   +      GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 315 IAPEL-----------AYTMVMTEKCDVYSFGVVTLEV 341
           + PE+           +Y M      D+YSFG++  EV
Sbjct: 213 MPPEVLDESLNRNHFQSYIMA-----DMYSFGLILWEV 245

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 107/268 (39%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQ---LPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+       +V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HRD+++ N ++       + DFG  R +      R    G     ++AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 254
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V       + +   C Q NPK RPT
Sbjct: 255 PERV-------TDLMRMCWQFNPKMRPT 275

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 94
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 148
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 205
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 206 VDWWALGVLIYEMAAGYPP 224

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 154
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 211
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +  V +  ++  G+ +A K ++T +       K    EA++   + H +IV+L+ 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPNIVRLHD 88
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               +   +LI++ +  G LF      ++ V  ++    +    +   L  + H     +
Sbjct: 89  SISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 270 IHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMT 326
           +HRD+   N+LL SKL+     +ADFG A  +  +       AGT GY++PE+       
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 327 EKCDVYSFGVVTLEVLMGKHP 347
           +  D+++ GV+   +L+G  P
Sbjct: 203 KPVDLWACGVILYILLVGYPP 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKS---FRNEAQVLSQVLHRSIVK 206
           +G G +G VY+    +  K  A  ++      E A ++    F NEA V+       +V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HRD+++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 257
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V       + +   C Q NPK RPT
Sbjct: 258 PERV-------TDLMRMCWQFNPKMRPT 278

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 125/290 (43%), Gaps = 41/290 (14%)
Query: 141 ATEDFHIK-------YCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS--ETEELAFIKSFR 190
           A E+F +K         +G G YG V K + +P+G++ A+K++  +    E+   +    
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD 84
Query: 191 NEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG--SLFCILHNDDEAVELDWAKR- 247
              + +        V  YG    +  +++  E  +      +  + +  + +  D   + 
Sbjct: 85  ISXRTVDCPF---TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKI 141
Query: 248 -VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V+IVKA+ H  + L      S+IHRD+  +N+L+N+  +    DFG +  L  D   + 
Sbjct: 142 AVSIVKALEHLHSKL------SVIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKD 194
Query: 307 LLAGTYGYIAPELAYTMVMTE----KCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKI 362
           + AG   Y APE     +  +    K D++S G+  +E+ + + P D          P  
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGT------PFQ 248
Query: 363 MLIDVLDQRLPPPVDQKVIQDILLASTISFA--CLQSNPKSRPTMQYVSQ 410
            L  V+++  P     ++  D   A  + F   CL+ N K RPT   + Q
Sbjct: 249 QLKQVVEEPSP-----QLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 75  NGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I K++  A+ YLH   S +I HRD+  
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREAS--EIXKSIGEAIQYLH---SINIAHRDVKP 189
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD +S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWS 248
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 249 LGVIXYILLCGYPP 262

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 179
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 236
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPP 258

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+APE+  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+APE+  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLXGTPEYLAPEIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 154
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 211
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 38/273 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALK------KLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           +G G +GSV +  L      +LK      KL  S   E   I+ F +EA  +    H ++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---IEEFLSEAACMKDFSHPNV 98
Query: 205 VKLYGFCLHKKCM-----FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           ++L G C+           +I  +M+ G L   L                ++K M     
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT--LLAGTYGYIAP 317
            + +  + + +HRD+++ N +L   +   VADFG ++++++    R   +      +IA 
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDXXXXXXXXXDPKIMLIDVLD-----QR 371
           E     V T K DV++FGV   E+   G  P            P +   ++ D      R
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-----------PGVQNHEMYDYLLHGHR 267
Query: 372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           L  P D   + ++     I ++C +++P  RPT
Sbjct: 268 LKQPED--CLDELY---EIMYSCWRTDPLDRPT 295

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQ---LPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+       +V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HRD+++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 256
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V       + +   C Q NPK RPT
Sbjct: 257 PERV-------TDLMRMCWQFNPKMRPT 277

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+APE+  +  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSKG 215
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+APE+  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+APE+  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMVMTE 327
           +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+APE+  +    +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSKGYNK 217
Query: 328 KCDVYSFGVVTLEVLMGKHP 347
             D ++ GV+  E+  G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 215
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 29  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 88
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 143
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYG--YIAPELAYTMVMTEKCDV 331
            N+L  SK    +    DFG A+     +S+ +L    Y   Y+APE+       + CD+
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDM 200
Query: 332 YSFGVVTLEVLMGKHP 347
           +S GV+   +L G  P
Sbjct: 201 WSLGVIMYILLCGYPP 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 179
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT---LCGTPEYLAPEIILSKGY 236
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPP 258

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 25/199 (12%)
Query: 145 FHIKYCIGTGGYGSVYKA--QLPNGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQVLH 201
           + +K CI  GG G +Y A  +  NG+   LK L H+ + E  A   + R   Q L++V+H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER---QFLAEVVH 138
Query: 202 RSIVKLYGFCLHKK-----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
            SIV+++ F  H         +++ EY+   SL        +  +L  A+ +  +  +  
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILP 193
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL+YLH   S  +++ D+   NI+L  +    + D G   R+++       L GT G+ A
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFG----YLYGTPGFQA 245
Query: 317 PELAYTMVMTEKCDVYSFG 335
           PE+  T   T   D+Y+ G
Sbjct: 246 PEIVRTG-PTVATDIYTVG 263

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS---------ETEELAFIKSFRNE 192
           +++ I   IG G YG V  A+    G+  A+KK+  +            EL  +K F+++
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
             +  + + R  V    F    K ++++ + ME   L  I+H+  + + L+  +    + 
Sbjct: 115 NIIAIKDILRPTVPYGEF----KSVYVVLDLME-SDLHQIIHSS-QPLTLEHVR--YFLY 166
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLL 308
            +   L Y+H   S  +IHRD+  +N+L+N   E  + DFG AR L    +      T  
Sbjct: 167 QLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 309 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKH 346
             T  Y APEL  ++   T+  D++S G +  E+L  + 
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IVKL+     +   FL+ E +  G LF  +       E + +    I++ +  A+++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLVSAVSH 121
Query: 261 LHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           +H      ++HRD+   N+L    N  LE  + DFG AR    D+        T  Y AP
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           EL       E CD++S GV+   +L G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 179
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 236
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPP 258

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 151 IGTGGYGSVYKAQLPNGKV------FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           IG G + +VYK       V         +KL  SE +       F+ EA+ L  + H +I
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ------RFKEEAEXLKGLQHPNI 87
Query: 205 VKLY----GFCLHKKCMFLIYEYMERGSLFCILHN---DDEAVELDWAKRVNIVKAMAHA 257
           V+ Y         KKC+ L+ E    G+L   L         V   W +++         
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKG 141
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIA 316
           L +LH   +P IIHRD+  +NI +     +  + D G A    A  +   +  GT  + A
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFXA 198
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE  Y     E  DVY+FG   LE    ++P
Sbjct: 199 PE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 140 EATEDFH-IKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           +  EDF+ I   +G+G +  V K  +   G  +A   +KK  +  +      +    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L QVLH +++ L+    ++  + LI E +  G LF  L   +   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRLHADSSNRTLLAG 310
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 140 EATEDFH-IKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           +  EDF+ I   +G+G +  V K  +   G  +A   +KK  +  +      +    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L QVLH +++ L+    ++  + LI E +  G LF  L   +    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRLHADSSNRTLLAG 310
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N++++ +    V DFG A+R+      RT  L GT  Y+APE+  +  
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIIISKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H++IV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                K + L++E+ ++       + D    +LD     + +  +   L + H   S ++
Sbjct: 69  VLHSDKKLTLVFEFCDQD---LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY-TMVMTEK 328
           +HRD+   N+L+N   E  +ADFG AR         +    T  Y  P++ +   + +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D++S G +  E+     P
Sbjct: 183 IDMWSAGCIFAELANAARP 201

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 142 TEDFHIKYCIGTGGYGSVYK-AQLPNGKVFA-----LKKLHTSETEELAFIKSFRNEAQV 195
           TE++ +   +G G +  V +  ++  G+ +A      KKL   + ++L        EA++
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------EREARI 63
Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
              + H +IV+L+     +   +LI++ +  G LF      ++ V  ++    +    + 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQ 117
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTY 312
             L  + H     ++HR++   N+LL SKL+     +ADFG A  +  +       AGT 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           GY++PE+       +  D+++ GV+   +L+G  P
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 8/208 (3%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF+    +G G +G V  A     + ++A+K L      +   ++    E +VL+ +   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 203 SIVKLYGFCLHK-KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +     C      ++ + EY+  G L   +++  +  +    + V     ++  L +L
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H      II+RD+  +N++L+S+    +ADFG  +    D        GT  YIAPE+  
Sbjct: 137 H---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIA 193
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
                +  D +++GV+  E+L G+ P D
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK--------KLHTSETEELAFIKSFRNEA 193
           E++  K  +G G    V +    P  K +A+K             E +EL   ++   E 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR--EATLKEV 74
Query: 194 QVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
            +L +V  H +I++L          FL+++ M++G LF  L    E V L   +   I++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
           A+   +  LH     +I+HRD+   NILL+  +   + DFG + +L      R+ + GT 
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-VCGTP 187
Query: 313 GYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHP 347
            Y+APE+    +        ++ D++S GV+   +L G  P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 50/260 (19%)
Query: 130 DGRIFYEDLIEATEDFHIKY---------CIGTGGYGSVYKAQLPNGKVFALKKLHTS-- 178
           D   FY D  E   D   ++          +G+G +G V      N   + + K   S  
Sbjct: 23  DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM-----NATAYGISKTGVSIQ 77
Query: 179 -------ETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMERGSLF 230
                  E  + +  ++  +E ++++Q+  H +IV L G C     ++LI+EY   G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 231 CILHNDDEA-----VELDWAKRVN---------------IVKAMAHALAYLHHDCSPSII 270
             L +  E      +E +  KR+                    +A  + +L      S +
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 194
Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEK 328
           HRD+++ N+L+       + DFG AR + +DS+   R        ++APE  +  + T K
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 329 CDVYSFGVVTLEVL-MGKHP 347
            DV+S+G++  E+  +G +P
Sbjct: 255 SDVWSYGILLWEIFSLGVNP 274

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 210 FCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
               K  + L+   M  G L F I H          A+ V     +   L  LH +    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRE---R 306
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           I++RD+   NILL+      ++D G A  +    + +  + GT GY+APE+      T  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 365
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ G +  E++ G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 210 FCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
               K  + L+   M  G L F I H          A+ V     +   L  LH +    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRE---R 306
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           I++RD+   NILL+      ++D G A  +    + +  + GT GY+APE+      T  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 365
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ G +  E++ G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS---------ETEELAFIKSFRNE 192
           +++ I   IG G YG V  A+    G+  A+KK+  +            EL  +K F+++
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
             +  + + R  V    F    K ++++ + ME   L  I+H+  + + L+  +    + 
Sbjct: 114 NIIAIKDILRPTVPYGEF----KSVYVVLDLME-SDLHQIIHSS-QPLTLEHVR--YFLY 165
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR----TLL 308
            +   L Y+H   S  +IHRD+  +N+L+N   E  + DFG AR L    +      T  
Sbjct: 166 QLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 309 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKH 346
             T  Y APEL  ++   T+  D++S G +  E+L  + 
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 140 EATEDFH-IKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           +  EDF+ I   +G+G +  V K  +   G  +A   +KK  +  +      +    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L QVLH +++ L+    ++  + LI E +  G LF  L   +   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRLHADSSNRTLLAG 310
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 140 EATEDFH-IKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           +  EDF+ I   +G+G +  V K  +   G  +A   +KK  +  +      +    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L QVLH +++ L+    ++  + LI E +  G LF  L   +    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRLHADSSNRTLLAG 310
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK--------KLHTSETEELAFIKSFRNEA 193
           E++  K  +G G    V +    P  K +A+K             E +EL   ++   E 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR--EATLKEV 61
Query: 194 QVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
            +L +V  H +I++L          FL+++ M++G LF  L    E V L   +   I++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 118
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
           A+   +  LH     +I+HRD+   NILL+  +   + DFG + +L      R  + GT 
Sbjct: 119 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTP 174
Query: 313 GYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHP 347
            Y+APE+    +        ++ D++S GV+   +L G  P
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 10/199 (5%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                   ++++ EY+  G +F  L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 328
           +I+RD+   N+L++ +    V DFG A+R+   +     L GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGYNKA 218
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D ++ GV+  ++  G  P
Sbjct: 219 VDWWALGVLIYQMAAGYPP 237

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 140 EATEDFH-IKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           +  EDF+ I   +G+G +  V K  +   G  +A   +KK  +  +      +    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L QVLH +++ L+    ++  + LI E +  G LF  L   +    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRLHADSSNRTLLAG 310
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQ---LPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+       +V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HRD+++ N ++       + DFG  R +      R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 257
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V       + +   C Q NP  RPT
Sbjct: 258 PERV-------TDLMRMCWQFNPNMRPT 278

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           + DF +K  +G G YG V  A   P G++ A+KK+   +    A +++ R E ++L    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR-EIKILKHFK 67
Query: 201 HRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           H +I+ ++             +++I E M+       LH       L        +    
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTL 122
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH---ADSSNRT------ 306
            A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR +    AD+S  T      
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 307 -LLAGTYGYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 345
                T  Y APE+  T     +  DV+S G +  E+ + +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 35/232 (15%)
Query: 135 YEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEA 193
           +ED+ + T +      +G G Y  V  A  L NGK +A+K +        + +  FR E 
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV--FR-EV 61
Query: 194 QVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           + L Q   +++I++L  F       +L++E ++ GS+   +       E + ++   +V+
Sbjct: 62  ETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR---VVR 118
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KLEAFVADFGTARRLHADSS-- 303
            +A AL +LH   +  I HRD+   NIL  S       K+  F  D G+  +L+   +  
Sbjct: 119 DVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDF--DLGSGMKLNNSCTPI 173
Query: 304 ---NRTLLAGTYGYIAPELA--YTMVMT---EKCDVYSFGVVTLEVLMGKHP 347
                T   G+  Y+APE+   +T   T   ++CD++S GVV   +L G  P
Sbjct: 174 TTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           + DF +K  +G G YG V  A   P G++ A+KK+   +    A +++ R E ++L    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR-EIKILKHFK 67
Query: 201 HRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           H +I+ ++             +++I E M+       LH       L        +    
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTL 122
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG----- 310
            A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR +   +++ +   G     
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 311 -----TYGYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 345
                T  Y APE+  T     +  DV+S G +  E+ + +
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 151 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G G +G V    Y  +  N G+  A+K L          I   + E ++L  + H +IV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 86
Query: 206 KLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           K  G C       + LI E++  GSL   L  +   + L   +++     +   + YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG- 143
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG---YIAPELA 320
             S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+         + APE  
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                    DV+SFGV   E+L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 95  DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    GT  Y+ PE    M 
Sbjct: 147 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---IIDPNHEIEF 261
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 262 PDIPEKDLQDVLK------CCLKRDPKQR 284

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           + DF +K  +G G YG V  A   P G++ A+KK+   +    A +++ R E ++L    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR-EIKILKHFK 67
Query: 201 HRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           H +I+ ++             +++I E M+       LH       L        +    
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTL 122
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG----- 310
            A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR +   +++ +   G     
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 311 -----TYGYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 345
                T  Y APE+  T     +  DV+S G +  E+ + +
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++   V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N+L++ +    VADFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 140 EATEDFH-IKYCIGTGGYGSVYKA-QLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQ 194
           +  EDF+ I   +G+G +  V K  +   G  +A   +KK  +  +      +    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +L QVLH +I+ L+    ++  + LI E +  G LF  L   +   E    +  + +K +
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRLHADSSNRTLLAG 310
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 151 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G G +G V    Y  +  N G+  A+K L          I   + E ++L  + H +IV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 74
Query: 206 KLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           K  G C       + LI E++  GSL   L  +   + L   +++     +   + YL  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG- 131
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG---YIAPELA 320
             S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+         + APE  
Sbjct: 132 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 321 YTMVMTEKCDVYSFGVVTLEVL 342
                    DV+SFGV   E+L
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK--------KLHTSETEELAFIKSFRNEA 193
           E++  K  +G G    V +    P  K +A+K             E +EL   ++   E 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR--EATLKEV 74
Query: 194 QVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
            +L +V  H +I++L          FL+++ M++G LF  L    E V L   +   I++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
           A+   +  LH     +I+HRD+   NILL+  +   + DFG + +L      R  + GT 
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTP 187
Query: 313 GYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHP 347
            Y+APE+    +        ++ D++S GV+   +L G  P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 79  DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 130
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    GT  Y+ PE    M 
Sbjct: 131 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEIEF 245
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 246 PDIPEKDLQDVLK------CCLKRDPKQR 268

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEA 193
           A ED  +   +G G +G VY+    N K       V   KK  T + +E      F +EA
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-----KFMSEA 76
Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            ++  + H  IVKL G  + ++  ++I E    G L   L  +  ++++     V     
Sbjct: 77  VIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 133
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGTY 312
           +  A+AYL    S + +HRDI+  NIL+ S     + DFG +R +   D    ++     
Sbjct: 134 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 190
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            +++PE       T   DV+ F V   E+L  GK P
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY   G +F  L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM 325
           S  +I+RD+   N++++ +    V DFG A+R+   +     L GT  Y+APE+  +   
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIILSKGY 216
Query: 326 TEKCDVYSFGVVTLEVLMGKHP 347
            +  D ++ GV+  E+  G  P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPP 238

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 145 FHIKYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +  +  +GTG +  V  A+      L   K  A K L   E        S  NE  VL +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG-------SMENEIAVLHK 72
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + H +IV L         ++LI + +  G LF  +       E D ++   ++  +  A+
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAV 129
Query: 259 AYLHHDCSPSIIHRDISSNNIL---LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
            YLH      I+HRD+   N+L   L+   +  ++DFG ++ +    S  +   GT GY+
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYV 185
Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           APE+      ++  D +S GV+   +L G  P
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    GT  Y+ PE    M 
Sbjct: 175 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEIEF 289
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 290 PDIPEKDLQDVLK------CCLKRDPKQR 312

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEA 193
           A ED  +   +G G +G VY+    N K       V   KK  T + +E      F +EA
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-----KFMSEA 60
Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            ++  + H  IVKL G  + ++  ++I E    G L   L  +  ++++     V     
Sbjct: 61  VIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 117
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGTY 312
           +  A+AYL    S + +HRDI+  NIL+ S     + DFG +R +   D    ++     
Sbjct: 118 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 174
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            +++PE       T   DV+ F V   E+L  GK P
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 41/290 (14%)
Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           IF ++     E   I   IG G +G VY  +        L  +     ++L   K+F+ E
Sbjct: 23  IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQL---KAFKRE 79
Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
                Q  H ++V   G C+    + +I    +  +L+ ++   D  + LD  K   I +
Sbjct: 80  VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQ 137
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG---TARRLHADSSNRTLLA 309
            +   + YLH   +  I+H+D+ S N+  ++  +  + DFG    +  L A      L  
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 310 --GTYGYIAPELAYTMV---------MTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXX 358
             G   ++APE+   +           ++  DV++ G +  E+   + P           
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------FKT 245
Query: 359 DPKIMLIDVLDQRLPPPVDQ----KVIQDILLASTISFACLQSNPKSRPT 404
            P   +I  +   + P + Q    K I DILL       C     + RPT
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEISDILL------FCWAFEQEERPT 289

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +  +  +GTG +  V  A+     K+ A+K +     E      S  NE  VL ++ H +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE--GKEGSMENEIAVLHKIKHPN 77
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           IV L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 264 DCSPSIIHRDISSNNIL---LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
                I+HRD+   N+L   L+   +  ++DFG ++ +    S  +   GT GY+APE+ 
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL 190
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                ++  D +S GV+   +L G  P
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 75  DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 126
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    GT  Y+ PE    M 
Sbjct: 127 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEIEF 241
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 242 PDIPEKDLQDVLK------CCLKRDPKQR 264

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG+  V   + L +G  +ALK++   E ++    +  + EA +     H +I++L  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHPNILRLVA 93
Query: 210 FCLHKKCM----FLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           +CL ++      +L+  + +RG+L+  +    D+   L   + + ++  +   L  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARR--LHADSSNRTLLAG-------TYGYI 315
            +    HRD+   NILL  + +  + D G+  +  +H + S + L          T  Y 
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 316 APELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRD 349
           APEL       V+ E+ DV+S G V   ++ G+ P D
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 147 IKYCIGTGGYGSV-----YKAQLPNGKVFALKKL------HTSETEELAFIKSFRNEAQV 195
           I+  +G G +G V     YK Q      F  ++L      H     E++++K  R     
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR----- 67
Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
                H  I+KLY        + ++ EY   G LF  +       E D  +R    + + 
Sbjct: 68  -----HPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE-DEGRR--FFQQII 118
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
            A+ Y H      I+HRD+   N+LL+  L   +ADFG +  +  D +      G+  Y 
Sbjct: 119 CAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGSPNYA 174
Query: 316 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
           APE +   +    + DV+S G+V   +L+G+ P D
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 76  DYEITDQYIYMV---MECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    GT  Y+ PE    M 
Sbjct: 128 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEIEF 242
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 243 PDIPEKDLQDVLK------CCLKRDPKQR 265

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEA 193
           A ED  +   +G G +G VY+    N K       V   KK  T + +E      F +EA
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-----KFMSEA 64
Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            ++  + H  IVKL G  + ++  ++I E    G L   L  +  ++++     V     
Sbjct: 65  VIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 121
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-ADSSNRTLLAGTY 312
           +  A+AYL    S + +HRDI+  NIL+ S     + DFG +R +   D    ++     
Sbjct: 122 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
            +++PE       T   DV+ F V   E+L  GK P
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 15/140 (10%)
Query: 214 KKCMFLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 272
           K+C+ +I E ME G LF  I    D+A     A    I++ +  A+ +LH   S +I HR
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREA--AEIMRDIGTAIQFLH---SHNIAHR 133
Query: 273 DISSNNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYG--YIAPELAYTMVMTE 327
           D+   N+L  SK +  V    DFG A+    +++   L    Y   Y+APE+       +
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDK 189
Query: 328 KCDVYSFGVVTLEVLMGKHP 347
            CD++S GV+   +L G  P
Sbjct: 190 SCDMWSLGVIMYILLCGFPP 209

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 15/140 (10%)
Query: 214 KKCMFLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 272
           K+C+ +I E ME G LF  I    D+A     A    I++ +  A+ +LH   S +I HR
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREA--AEIMRDIGTAIQFLH---SHNIAHR 152
Query: 273 DISSNNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYG--YIAPELAYTMVMTE 327
           D+   N+L  SK +  V    DFG A+    +++   L    Y   Y+APE+       +
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDK 208
Query: 328 KCDVYSFGVVTLEVLMGKHP 347
            CD++S GV+   +L G  P
Sbjct: 209 SCDMWSLGVIMYILLCGFPP 228

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT  Y+AP +  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPAIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ I   +G G +G V  A     G+  ALK ++     +         E   L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            I+KLY     K  + ++ EY     LF  +   D+  E + A+R    + +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQE-ARR--FFQQIISAVEYCH 120
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 I+HRD+   N+LL+  L   +ADFG +  +  D +      G+  Y APE ++ 
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISG 176
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            +    + DV+S GV+   +L  + P D
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ I   +G G +G V  A     G+  ALK ++     +         E   L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            I+KLY     K  + ++ EY     LF  +   D+  E + A+R    + +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQE-ARR--FFQQIISAVEYCH 124
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 I+HRD+   N+LL+  L   +ADFG +  +  D +      G+  Y APE ++ 
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISG 180
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            +    + DV+S GV+   +L  + P D
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 47  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 105
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 106 ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 156
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 157 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 215
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 216 FICLSGYPP 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           +  +  +GTG +  V  A+    +     K    E  E     S  NE  VL ++ H +I
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE-GKEGSMENEIAVLHKIKHPNI 78
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH-- 133
Query: 265 CSPSIIHRDISSNNIL---LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
               I+HRD+   N+L   L+   +  ++DFG ++ +    S  +   GT GY+APE+  
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLA 191
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
               ++  D +S GV+   +L G  P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 100 ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 150
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 210 FICLSGYPP 218

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    GT  Y+ PE    M 
Sbjct: 175 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEIEF 289
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 290 PDIPEKDLQDVLK------CCLKRDPKQR 312

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 10/207 (4%)
Query: 144 DFHIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F     +G G +G V    +   G+ +A+K L          +     E +VL    H 
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E     R     A +  AL Y
Sbjct: 212 FLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDY 266
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+ 
Sbjct: 267 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 40  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 98
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 99  ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 149
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 150 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 209 FICLSGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           +  +  +GTG +  V  A+    +     K    E  E     S  NE  VL ++ H +I
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE-GKEGSMENEIAVLHKIKHPNI 78
Query: 205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
           V L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH-- 133
Query: 265 CSPSIIHRDISSNNIL---LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
               I+HRD+   N+L   L+   +  ++DFG ++ +    S  +   GT GY+APE+  
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLA 191
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
               ++  D +S GV+   +L G  P
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 100 ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 150
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 210 FICLSGYPP 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 10/207 (4%)
Query: 144 DFHIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F     +G G +G V    +   G+ +A+K L          +     E +VL    H 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E     R     A +  AL Y
Sbjct: 209 FLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDY 263
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+ 
Sbjct: 264 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 131
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 190
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 100 ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 150
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 210 FICLSGYPP 218

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ I   +G G +G V  A     G+  ALK ++     +         E   L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            I+KLY     K  + ++ EY     LF  +   D+  E + A+R    + +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQE-ARR--FFQQIISAVEYCH 129
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 I+HRD+   N+LL+  L   +ADFG +  +  D +      G+  Y APE ++ 
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISG 185
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            +    + DV+S GV+   +L  + P D
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 131
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 190
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR-NEAQVLSQVLHRSIVKLY 208
           +G G +G V++ +    G   A+KK+          ++ FR  E    + +    IV LY
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G       + +  E +E GSL  ++    E   L   + +  +      L YLH   S  
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH---SRR 205
Query: 269 IIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTY-----GYIAPELAYT 322
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+   
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
                K DV+S   + L +L G HP
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 144 DFHIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F     +G G +G V    +   G+ +A+K L          +     E +VL    H 
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +  L Y F  H +  F++ EY   G LF   H   E V  +   R    + ++ AL YL
Sbjct: 71  FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 126
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+  
Sbjct: 127 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
                   D +  GVV  E++ G+ P
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H++IV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                K + L++E+ ++       + D    +LD     + +  +   L + H   S ++
Sbjct: 69  VLHSDKKLTLVFEFCDQD---LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY-TMVMTEK 328
           +HRD+   N+L+N   E  +A+FG AR         +    T  Y  P++ +   + +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D++S G +  E+     P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 30/272 (11%)
Query: 146 HIKYCIGTGGYGSVYKA----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           H    IG G +G VY      Q  N    A+K L  S   E+  +++F  E  ++  + H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 202 RSIVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
            +++ L G  L  + +  ++  YM  G L   + +      +     ++    +A  + Y
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEY 139
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR----RLHADSSNRTLLAGTYGYIA 316
           L        +HRD+++ N +L+      VADFG AR    R +              + A
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQ--RLPP 374
            E   T   T K DV+SFGV+  E+L    P           DP   L   L Q  RLP 
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAP------PYRHIDP-FDLTHFLAQGRRLPQ 249
Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           P   +   D L    +   C +++P  RPT +
Sbjct: 250 P---EYCPDSLY--QVMQQCWEADPAVRPTFR 276

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++ I   +G G +G V  A     G+  ALK ++     +         E   L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            I+KLY     K  + ++ EY     LF  +   D+  E + A+R    + +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQE-ARR--FFQQIISAVEYCH 130
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
                 I+HRD+   N+LL+  L   +ADFG +  +  D +      G+  Y APE ++ 
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISG 186
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            +    + DV+S GV+   +L  + P D
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 10/207 (4%)
Query: 144 DFHIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F     +G G +G V    +   G+ +A+K L          +     E +VL    H 
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
            +  L Y F  H +  F++ EY   G LF  L  +    E     R     A +  AL Y
Sbjct: 70  FLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDY 124
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+ 
Sbjct: 125 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                    D +  GVV  E++ G+ P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 144 DFHIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +F     +G G +G V    +   G+ +A+K L          +     E +VL    H 
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 203 SIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +  L Y F  H +  F++ EY   G LF   H   E V  +   R    + ++ AL YL
Sbjct: 69  FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 124
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+  
Sbjct: 125 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
                   D +  GVV  E++ G+ P
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 105/237 (44%), Gaps = 36/237 (15%)
Query: 128 NYDGRIFYEDLIEATE----DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL 183
           NY   I+    ++  +    D+ I   +  G +  +   +  N K +ALKK   S  E+ 
Sbjct: 12  NYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-KFYALKKYEKSLLEKK 70
Query: 184 A-FIKS-------------FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL 229
             F KS             F+NE Q+++ + +   +   G   +   +++IYEYME  S 
Sbjct: 71  RDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS- 129
Query: 230 FCILHNDDEAVELDWAKRV--------NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 281
             IL  D+    LD              I+K++ ++ +Y+H++   +I HRD+  +NIL+
Sbjct: 130 --ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILM 185
Query: 282 NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL--AYTMVMTEKCDVYSFGV 336
           +      ++DFG +  +       +   GTY ++ PE     +     K D++S G+
Sbjct: 186 DKNGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQ---LPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+       +V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HR++++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 257
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V       + +   C Q NP  RPT
Sbjct: 258 PERV-------TDLMRMCWQFNPNMRPT 278

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 28/268 (10%)
Query: 151 IGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKS---FRNEAQVLSQVLHRSIVK 206
           +G G +G VY+    +  K  A  ++      E A ++    F NEA V+       +V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK-------RVNIVKAMAHALA 259
           L G     +   ++ E M  G L   L +     E +  +        + +   +A  +A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAP 317
           YL+   +   +HR++++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQRLPPPV 376
           E     V T   D++SFGVV  E+  + + P              +M    LDQ  P   
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ--PDNC 258
Query: 377 DQKVIQDILLASTISFACLQSNPKSRPT 404
            ++V   + +       C Q NP  RPT
Sbjct: 259 PERVTDLMRM-------CWQFNPNMRPT 279

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 73
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 187
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 150 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD---WAKRVNIVKAMAHALAYLHHDC 265
                   ++++ EY+  G +F  L       E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAYTMV 324
           S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT   +APE+  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEALAPEIILSKG 214
Query: 325 MTEKCDVYSFGVVTLEVLMGKHP 347
             +  D ++ GV+  E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 73
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAP 187
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           ++ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 224
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 225 ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 275
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 335 FICLSGYPP 343

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNG---KVFALKKLHTSETEELAFIK 187
           RIF E     TE   +K  +G+G +G+V+K   +P G   K+    K+   ++   +F +
Sbjct: 26  RIFKE-----TELRKLK-VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-Q 78
Query: 188 SFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LD 243
           +  +    +  + H  IV+L G C     + L+ +Y+  GSL   +     A+     L+
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 137
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
           W   V I K M     YL       ++HR++++ N+LL S  +  VADFG A  L  D  
Sbjct: 138 WG--VQIAKGMY----YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-- 186
Query: 304 NRTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           ++ LL         ++A E  +    T + DV+S+GV   E++  G  P
Sbjct: 187 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 151 IGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E    +    +K + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYYLH---S 132
Query: 267 PSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
             I H D+   NI+L      K    + DFG A ++   +  + +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
             +  + D++S GV+T  +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNG---KVFALKKLHTSETEELAFIK 187
           RIF E     TE   +K  +G+G +G+V+K   +P G   K+    K+   ++   +F +
Sbjct: 8   RIFKE-----TELRKLK-VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-Q 60
Query: 188 SFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LD 243
           +  +    +  + H  IV+L G C     + L+ +Y+  GSL   +     A+     L+
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
           W   V I K M     YL       ++HR++++ N+LL S  +  VADFG A  L  D  
Sbjct: 120 WG--VQIAKGMY----YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-- 168
Query: 304 NRTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
           ++ LL         ++A E  +    T + DV+S+GV   E++  G  P
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G  G V  A     G   A+KKL      +    +++R E  +L  V H++I+ L  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 88
Query: 210 FCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
               +K +      +L+ E M+  +L  ++H     +ELD  +   ++  M   + +LH 
Sbjct: 89  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 141
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  IIHRD+  +NI++ S     + DFG AR    +      +   Y Y APE+   M
Sbjct: 142 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY-YRAPEVILGM 198
Query: 324 VMTEKCDVYSFGVVTLEVLMG 344
              E  D++S G +  E++ G
Sbjct: 199 GYKENVDIWSVGCIMGELVKG 219

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
           ++ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 180 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 238
Query: 228 SLFCILHNDDEAVELDWAKRVNI---VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 284
            LF      D+ V     K          M  A+ YLH +    IIHRD+   N+LL+S+
Sbjct: 239 ELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 289
Query: 285 LEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            E     + DFG ++ L   S  RT L GT  Y+APE+     T       D +S GV+ 
Sbjct: 290 EEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 348
Query: 339 LEVLMGKHP 347
              L G  P
Sbjct: 349 FICLSGYPP 357

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     IG+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 82
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAP 196
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 95  DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D     +    GT  Y+ PE    M 
Sbjct: 147 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---IIDPNHEIEF 261
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 262 PDIPEKDLQDVLK------CCLKRDPKQR 284

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 97
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVA-TRWYRAP 211
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR-NEAQVLSQVLHRSIVKLY 208
           +G G +G V++ +    G   A+KK+          ++ FR  E    + +    IV LY
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G       + +  E +E GSL  ++    E   L   + +  +      L YLH   S  
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH---SRR 186
Query: 269 IIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTY-----GYIAPELAYT 322
           I+H D+ ++N+LL+S    A + DFG A  L  D   + LL G Y      ++APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
                K DV+S   + L +L G HP
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLXGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 73
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 187
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 97
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAP 211
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 8/206 (3%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF+    +G G +G V  ++     +++A+K L      +   ++    E +VL+     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 203 SIVKLYGFCLHK-KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +     C      ++ + EY+  G L   +++  +         V     +A  L +L
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
               S  II+RD+  +N++L+S+    +ADFG  +    D        GT  YIAPE+  
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP 347
                +  D ++FGV+  E+L G+ P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 96
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAP 210
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 87
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 148 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 201
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLVGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S GV+  E++ G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G YGSV   Y A+L   +  A+KKL       +   +++R E ++L  + H +++ L
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 208 YGFCLHKKCMFLIYE-YMERGSLFCILHN-------DDEAVELDWAKRVNIVKAMAHALA 259
                    +    E Y+    +   L+N        DE V+        +V  +   L 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-------LVYQLLRGLK 137
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y+H   S  IIHRD+  +N+ +N   E  + DFG AR+  AD      +A T  Y APE+
Sbjct: 138 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADEEMTGYVA-TRWYRAPEI 191
Query: 320 AYT-MVMTEKCDVYSFGVVTLEVLMGK 345
               M   +  D++S G +  E+L GK
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLVGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S GV+  E++ G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGXVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 82
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAP 196
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H ++V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 210 FCLHK-----KC---MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            C  K     +C   ++L++++ E   L  +L N      L   KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
           H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 73
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 187
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 74
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 188
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 79
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 193
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 74
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 188
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
           ++ + EY+  G L   +++  +         V     +A  L +L    S  II+RD+  
Sbjct: 417 LYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKL 470
Query: 277 NNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 336
           +N++L+S+    +ADFG  +    D        GT  YIAPE+       +  D ++FGV
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 337 VTLEVLMGKHP 347
           +  E+L G+ P
Sbjct: 531 LLYEMLAGQAP 541

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YGSV  A     G   A+KKL +   + +   K    E ++L  + H +++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 210 FCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                + +    + Y+    +   L+N  +  +L       ++  +   L Y+H   S  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 151
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTE 327
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   +
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 328 KCDVYSFGVVTLEVLMGK 345
             D++S G +  E+L G+
Sbjct: 209 TVDIWSVGCIMAELLTGR 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H ++V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 210 FCLHK-----KC---MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            C  K     +C   ++L++++ E   L  +L N      L   KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
           H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H ++V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 210 FCLHK-----KC---MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            C  K     +C   ++L++++ E   L  +L N      L   KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
           H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 37/269 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLY 208
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   S  I++LY
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 209 GFCLHKKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
            + +  + ++++   ME G+  L   L    +   +D  +R +  K M  A+  +H    
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMV 324
             I+H D+   N L+   +   + DFG A ++  D+++  +    G   Y+ PE    M 
Sbjct: 175 -GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 325 MTEK-----------CDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPKIMLIDVLDQRLP 373
            + +            DV+S G +   +  GK P                +ID   +   
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHEIEF 289
Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSR 402
           P + +K +QD+L        CL+ +PK R
Sbjct: 290 PDIPEKDLQDVLK------CCLKRDPKQR 312

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 82
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 196
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 75
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 136 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 189
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 76
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 137 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 190
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 96
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAP 210
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 82
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 196
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H ++V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 210 FCLHK-----KC---MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            C  K     +C   ++L++++ E   L  +L N      L   KRV  ++ + + L Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 140
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 296
           H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 141 HRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 84
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 198
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAP 202
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKH 89
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 203
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 97
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 211
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G YGSV   Y A+L   +  A+KKL       +   +++R E ++L  + H +++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 208 YGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
                    +    E Y+    +   L+N  ++  L       +V  +   L Y+H   S
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---S 149
Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVM 325
             IIHRD+  +N+ +N   E  + DFG AR+  AD      +A T  Y APE+    M  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQ--ADEEMTGYVA-TRWYRAPEIMLNWMHY 206
Query: 326 TEKCDVYSFGVVTLEVLMGK 345
            +  D++S G +  E+L GK
Sbjct: 207 NQTVDIWSVGCIMAELLQGK 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAY-TMVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 89
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 203
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 79
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 193
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 89
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 203
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 100
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 214
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 79
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 193
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 83
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 197
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 88
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAP 202
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 100
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVA-TRWYRAP 214
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G YGSV   Y A+L   +  A+KKL       +   +++R E ++L  + H +++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 208 YGFCLHKKCMFLIYE-YMERGSLFCILHN-------DDEAVELDWAKRVNIVKAMAHALA 259
                    +    E Y+    +   L+N        DE V+        +V  +   L 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-------LVYQLLRGLK 145
Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           Y+H   S  IIHRD+  +N+ +N   E  + DFG AR+  AD      +A T  Y APE+
Sbjct: 146 YIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQ--ADEEMTGYVA-TRWYRAPEI 199
Query: 320 AYT-MVMTEKCDVYSFGVVTLEVLMGK 345
               M   +  D++S G +  E+L GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIML 243
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY-- 260
           S+V   G C    CM   +   ++ S    L N     +L +    + V + A    Y  
Sbjct: 244 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 299
Query: 261 -----LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA--GTYG 313
                L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 314 YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLXGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 37  LGRGAFGQVIEAD-----AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHAL 258
             ++V L G C      + +I E+ + G+L   L +  +E V             + H +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 259 AY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLA 309
            Y       +    S   IHRD+++ NILL+ K    + DFG AR +  D     +    
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
               ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G Y +VYK +      + ALK++   E EE A   + R E  +L  + H +IV L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               +K + L++EY+++  L   L +    + +   K    +  +   LAY H      +
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL--FLFQLLRGLAYCHRQ---KV 121
Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEK 328
           +HRD+   N+L+N + E  +ADFG AR     +        T  Y  P+ L  +   + +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 329 CDVYSFGVVTLEVLMGK 345
            D++  G +  E+  G+
Sbjct: 182 IDMWGVGCIFYEMATGR 198

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLXGIKHL 135
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 191
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIML 242
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY-- 260
           S+V   G C    CM   +   ++ S    L N     +L +    + V + A    Y  
Sbjct: 243 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 298
Query: 261 -----LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA--GTYG 313
                L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+G
Sbjct: 299 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 354
Query: 314 YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIML 243
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY-- 260
           S+V   G C    CM   +   ++ S    L N     +L +    + V + A    Y  
Sbjct: 244 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 299
Query: 261 -----LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA--GTYG 313
                L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 314 YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 79
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDE-MTGYVATRWYRAP 193
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 144 DFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           DF +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIML 243
Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY-- 260
           S+V   G C    CM   +   ++ S    L N     +L +    + V + A    Y  
Sbjct: 244 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 299
Query: 261 -----LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA--GTYG 313
                L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 314 YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 34/178 (19%)
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-----NSKLEAFVADFGTARRLHADS 302
           + +++     LA+LH   S +I+HRD+  +NIL+     + K++A ++DFG  ++L    
Sbjct: 121 ITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 303 ---SNRTLLAGTYGYIAPELAYTMVMTEKC--------DVYSFGVVTLEVLM-GKHPRDX 350
              S R+ + GT G+IAPE+     ++E C        D++S G V   V+  G HP   
Sbjct: 178 HSFSRRSGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--- 229
Query: 351 XXXXXXXXDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                      I+L       L P   + VI   L+   I+      +P+ RP+ ++V
Sbjct: 230 -FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAM-----DPQKRPSAKHV 281

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
             ++V L G C      + +I E+ + G+L   L +      + +         + H + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIX 148
Query: 260 Y-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAG 310
           Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +     
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 83
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDE-MTGYVATRWYRAP 197
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G YGSV  A     G   A+KKL +   + +   K    E ++L  + H +++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 210 FCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
                + +    + Y+    +   L+N  +  +L       ++  +   L Y+H   S  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 151
Query: 269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTE 327
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   +
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 328 KCDVYSFGVVTLEVLMGK 345
             D++S G +  E+L G+
Sbjct: 209 TVDIWSVGCIMAELLTGR 226

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-SIVKLY 208
           +G G +G V++ +    G   A+KK+          ++ FR E  V    L    IV LY
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G       + +  E +E GSL  ++       E    + +  +      L YLH   +  
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH---TRR 170
Query: 269 IIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTY-----GYIAPELAYT 322
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+   
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
                K D++S   + L +L G HP
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
             ++V L G C      + +I E+ + G+L   L +      + +         + H + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIC 148
Query: 260 Y-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAG 310
           Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +     
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
              ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 130 DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKS 188
           D  + +ED+ E  E       IG G +  V +      G+ FA+K +  ++      + +
Sbjct: 17  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 189 --FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWA 245
              + EA +   + H  IV+L         +++++E+M+   L F I+   D       A
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADS 302
              + ++ +  AL Y H +   +IIHRD+  + +LL SK  +    +  FG A +L    
Sbjct: 131 VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                  GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 72  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 126
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 185
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     + 
Sbjct: 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 37  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPE-DLYKDFLTLE 150
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     + 
Sbjct: 151 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 148
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     + 
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 148
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     + 
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-SIVKLY 208
           +G G +G V++ +    G   A+KK+          ++ FR E  V    L    IV LY
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G       + +  E +E GSL  ++       E    + +  +      L YLH   +  
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH---TRR 186
Query: 269 IIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTY-----GYIAPELAYT 322
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
                K D++S   + L +L G HP
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 130 DGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKS 188
           D  + +ED+ E  E       IG G +  V +      G+ FA+K +  ++      + +
Sbjct: 19  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 72
Query: 189 --FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL-FCILHNDDEAVELDWA 245
              + EA +   + H  IV+L         +++++E+M+   L F I+   D       A
Sbjct: 73  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 132
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADS 302
              + ++ +  AL Y H +   +IIHRD+  + +LL SK  +    +  FG A +L    
Sbjct: 133 VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189
Query: 303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                  GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + D+G AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 84
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR     +   T    T  Y AP
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAP 198
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 37/239 (15%)
Query: 128 NYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFI 186
           ++ GR  +ED+ +  ED      +G G +  V     L   + +A+K +     ++   I
Sbjct: 5   SFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIE----KQPGHI 53
Query: 187 KS--FRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
           +S  FR E ++L Q   HR++++L  F   +   +L++E M  GS+   +H      EL+
Sbjct: 54  RSRVFR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-----SKLEAFVADFGTARRL 298
            +    +V+ +A AL +LH+     I HRD+   NIL       S ++    D G+  +L
Sbjct: 113 ASV---VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
Query: 299 HADS---SNRTLL--AGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 347
           + D    S   LL   G+  Y+APE+         +  ++CD++S GV+   +L G  P
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE-------ELAFIKSFRNEAQVL 196
             ++  +  GG+  VY+AQ + +G+ +ALK+L ++E E       E+ F+K       ++
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
                 SI K        +  FL+   + +G L   L   +    L     + I      
Sbjct: 90  QFCSAASIGKEESDT--GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL-----HADSSNRTLLA-- 309
           A+ ++H    P IIHRD+   N+LL+++    + DFG+A  +     ++ S+ R  L   
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 310 -----GTYGYIAPE---LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                 T  Y  PE   L     + EK D+++ G +   +   +HP
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 84
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR     +   T    T  Y AP
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAP 198
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 84
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR     +   T    T  Y AP
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAP 198
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-SIVKLY 208
           +G G +G V++ +    G   A+KK+          ++ FR E  V    L    IV LY
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G       + +  E +E GSL  ++       E    + +  +      L YLH   +  
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH---TRR 184
Query: 269 IIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTY-----GYIAPELAYT 322
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+   
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 323 MVMTEKCDVYSFGVVTLEVLMGKHP 347
                K D++S   + L +L G HP
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  ++ +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG  R  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G  G V  A     G   A+KKL      +    +++R E  +L  V H++I+ L  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 90
Query: 210 FCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
               +K +      +L+ E M+  +L  ++H     +ELD  +   ++  M   + +LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 143
Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
             S  IIHRD+  +NI++ S     + DFG AR    +      +   Y Y APE+   M
Sbjct: 144 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGM 200
Query: 324 VMTEKCDVYSFGVVTLEVLMG 344
                 D++S G +  E++ G
Sbjct: 201 GYAANVDIWSVGCIMGELVKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLVGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 26  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 139
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     + 
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 142 TEDFHIKYCIGTGGYGS----VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           ++ + +K  IG G Y      V+KA      V  + K     +EE+  +  +        
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ------ 79
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
              H +I+ L       K ++L+ E M  G L   +       E + +    ++  +   
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKT 133
Query: 258 LAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARRLHADSSNRTLLAGTYG 313
           + YLH   S  ++HRD+  +NIL    +   E   + DFG A++L A++        T  
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           ++APE+       E CD++S G++   +L G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 143
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 199
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 26  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 139
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D     + 
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 143
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 199
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 136
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 192
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 141
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 142 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 197
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 148
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR +  D     + 
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 135
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 191
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 37/239 (15%)
Query: 128 NYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFI 186
           ++ GR  +ED+ +  ED      +G G +  V     L   + +A+K +     ++   I
Sbjct: 5   SFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIE----KQPGHI 53
Query: 187 KS--FRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
           +S  FR E ++L Q   HR++++L  F   +   +L++E M  GS+   +H      EL+
Sbjct: 54  RSRVFR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADF--GTARRL 298
            +    +V+ +A AL +LH+     I HRD+   NIL    N      + DF  G+  +L
Sbjct: 113 ASV---VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKL 166
Query: 299 HADS---SNRTLL--AGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 347
           + D    S   LL   G+  Y+APE+         +  ++CD++S GV+   +L G  P
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 136
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 192
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 180
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 236
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 145 FHIKYC-----IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQ 194
           FH +Y      +G G +G  S+Y     N   G++ A+K L      +      ++ E  
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEID 85
Query: 195 VLSQVLHRSIVKLYGFC--LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           +L  + H  I+K  G C       + L+ EY+  GSL   L        +  A+ +   +
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQ 141
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL---HADSSNRTLLA 309
            +   +AYLH   +   IHRD+++ N+LL++     + DFG A+ +   H     R    
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGD 198
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
               + APE           DV+SFGV   E+L
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 142 TEDFHIKYCIGTGGYGS----VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           ++ + +K  IG G Y      V+KA      V  + K     +EE+  +  +        
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ------ 79
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
              H +I+ L       K ++L+ E M  G L   +       E + +    ++  +   
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKT 133
Query: 258 LAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARRLHADSSNRTLLAGTYG 313
           + YLH   S  ++HRD+  +NIL    +   E   + DFG A++L A++        T  
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           ++APE+       E CD++S G++   +L G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 145 FHIKYC-----IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQ 194
           FH +Y      +G G +G  S+Y     N   G++ A+K L      +      ++ E  
Sbjct: 11  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQ--HRSGWKQEID 68
Query: 195 VLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           +L  + H  I+K  G C  +  K + L+ EY+  GSL   L        +  A+ +   +
Sbjct: 69  ILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQ 124
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL---HADSSNRTLLA 309
            +   +AYLH   S   IHR++++ N+LL++     + DFG A+ +   H     R    
Sbjct: 125 QICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
               + APE           DV+SFGV   E+L
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +L+ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 180
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 236
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG VYKA      +  A+K++     EE     + R E  +L ++ HR+I++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-SPS 268
              H   + LI+EY E      +  N D +        + ++K+  + L    + C S  
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVS--------MRVIKSFLYQLINGVNFCHSRR 152
Query: 269 IIHRDISSNNILLN----SKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYT 322
            +HRD+   N+LL+    S+     + DFG AR         T    T  Y  PE L  +
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212
Query: 323 MVMTEKCDVYSFGVVTLEVLM 343
              +   D++S   +  E+LM
Sbjct: 213 RHYSTSVDIWSIACIWAEMLM 233

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 143
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 199
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 134 FYEDLIEATEDFHIKYCIGTGGYG----SVYKAQLPNGKVFALKKLHTSETEELAFIKSF 189
            + + I+ T+ + +K  IG G Y      ++KA      V  + K     TEE+  +  +
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRY 72
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
                      H +I+ L       K ++++ E M+ G L   +       E + +    
Sbjct: 73  GQ---------HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA--- 120
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARRLHADSSNR 305
           ++  +   + YLH   +  ++HRD+  +NIL    +   E+  + DFG A++L A++   
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                T  ++APE+         CD++S GV+   +L G  P
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 30/221 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 36  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK---AMAH 256
             ++V L G C      + +I E+ + G+L   L +      + +    ++ K    + H
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKTPEDLYKDFLTLEH 149
Query: 257 ALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTL 307
            + Y       +    S   IHRD+++ NILL+ K    + DFG AR +  D     +  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                 ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPEVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+  +L  ++      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 26  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 139
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR +  D     + 
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  +  + +G   A+KKL       +   +++R E ++L  
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKH 106
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L         +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 167 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTD-DEMTGYVATRWYRAP 220
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M      D++S G +  E+L G+
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 201
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 26  LGRGAFGQVIEAD-----AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 202 R-SIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVK---AMA 255
             ++V L G C      + +I E+ + G+L   L +  +E V    A   ++ K    + 
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE-DLYKDFLTLE 139
Query: 256 HALAY-------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRT 306
           H + Y       +    S   IHRD+++ NILL+ K    + DFG AR +  D     + 
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 347
                  ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 144
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+  
Sbjct: 145 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRY-YRAPEVIL 200
Query: 322 TMVMTEKCDVYSFGVVTLEVLMG 344
            M   E  D++S G +  E++ G
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  +  FG AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 54/292 (18%)
Query: 151 IGTGGYGSVYKA------QLPNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQVL 200
           +G G +G V +A      +       A+K L    H +E E L       +E +VLS + 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM------SELKVLSYLG 107
Query: 201 -HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV---------------ELDW 244
            H +IV L G C       +I EY   G L   L    ++                 LD 
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
              ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+ 
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN- 223
Query: 305 RTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXD 359
             ++ G       ++APE  +  V T + DV+S+G+   E+  +G  P           D
Sbjct: 224 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 277
Query: 360 PKIM-LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            K   +I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 278 SKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 323

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 54/292 (18%)
Query: 151 IGTGGYGSVYKA------QLPNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQVL 200
           +G G +G V +A      +       A+K L    H +E E L       +E +VLS + 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM------SELKVLSYLG 84
Query: 201 -HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV---------------ELDW 244
            H +IV L G C       +I EY   G L   L    ++                 LD 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
              ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+ 
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN- 200
Query: 305 RTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXD 359
             ++ G       ++APE  +  V T + DV+S+G+   E+  +G  P           D
Sbjct: 201 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 254
Query: 360 PKIM-LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            K   +I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 300

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 145 FHIKYC-----IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQ 194
           FH +Y      +G G +G  S+Y     N   G++ A+K L      +L     ++ E +
Sbjct: 5   FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIE 62
Query: 195 VLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           +L  + H  IVK  G C  +  K + L+ EY+  GSL   L      V L  A+ +   +
Sbjct: 63  ILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGL--AQLLLFAQ 118
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL---HADSSNRTLLA 309
            +   +AYLH   +   IHR +++ N+LL++     + DFG A+ +   H     R    
Sbjct: 119 QICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 175
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
               + APE           DV+SFGV   E+L
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 145 FHIKYC-----IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQ 194
           FH +Y      +G G +G  S+Y     N   G++ A+K L      +L     ++ E +
Sbjct: 6   FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIE 63
Query: 195 VLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           +L  + H  IVK  G C  +  K + L+ EY+  GSL   L      V L  A+ +   +
Sbjct: 64  ILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGL--AQLLLFAQ 119
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL---HADSSNRTLLA 309
            +   +AYLH   +   IHR +++ N+LL++     + DFG A+ +   H     R    
Sbjct: 120 QICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 176
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
               + APE           DV+SFGV   E+L
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + DF  AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + D G AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 54/292 (18%)
Query: 151 IGTGGYGSVYKA------QLPNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQVL 200
           +G G +G V +A      +       A+K L    H +E E L       +E +VLS + 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM------SELKVLSYLG 100
Query: 201 -HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV---------------ELDW 244
            H +IV L G C       +I EY   G L   L    ++                 LD 
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
              ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+ 
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN- 216
Query: 305 RTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXD 359
             ++ G       ++APE  +  V T + DV+S+G+   E+  +G  P           D
Sbjct: 217 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 270
Query: 360 PKIM-LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            K   +I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 271 SKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 316

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 145 FHIKYC-----IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQ 194
           FH +Y      +G G +G  S+Y     N   G++ A+K L      +      ++ E  
Sbjct: 11  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQ--HRSGWKQEID 68
Query: 195 VLSQVLHRSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           +L  + H  I+K  G C  +  K + L+ EY+  GSL   L        +  A+ +   +
Sbjct: 69  ILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQ 124
Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL---HADSSNRTLLA 309
            +   +AYLH   +   IHR++++ N+LL++     + DFG A+ +   H     R    
Sbjct: 125 QICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 310 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
               + APE           DV+SFGV   E+L
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + D G AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 52/291 (17%)
Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVL- 200
           +G G +G V +A       + L K   + T  +  +K         +  +E +VLS +  
Sbjct: 54  LGAGAFGKVVEAT-----AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV---------------ELDWA 245
           H +IV L G C       +I EY   G L   L    ++                 LD  
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR 305
             ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+  
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-- 223
Query: 306 TLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDP 360
            ++ G       ++APE  +  V T + DV+S+G+   E+  +G  P           D 
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDS 278
Query: 361 KIM-LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           K   +I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 279 KFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 323

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 54/292 (18%)
Query: 151 IGTGGYGSVYKA------QLPNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQVL 200
           +G G +G V +A      +       A+K L    H +E E L       +E +VLS + 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM------SELKVLSYLG 102
Query: 201 -HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV---------------ELDW 244
            H +IV L G C       +I EY   G L   L    ++                 LD 
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
              ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+ 
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN- 218
Query: 305 RTLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXD 359
             ++ G       ++APE  +  V T + DV+S+G+   E+  +G  P           D
Sbjct: 219 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 272
Query: 360 PKIM-LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            K   +I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 273 SKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 318

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL       +   +++R E ++L  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 199 VLHRSIVKLYGFCLHKKCMFLIYE-YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           + H +++ L       + +    + Y+    +   L+N  +  +L       ++  +   
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L Y+H   S  IIHRD+  +N+ +N   E  + D G AR  H D    T    T  Y AP
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDE-MTGYVATRWYRAP 191
Query: 318 ELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           E+    M   +  D++S G +  E+L G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 34/285 (11%)
Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKK-LHTSETEELA--FIKSFRNEAQVLS 197
            TE+ + +       +  +   +L  GK   +++ +  S  +E A  F+K  R      +
Sbjct: 14  GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA 73
Query: 198 QVLHR-SIVKLYGFC-----LHK-----KCMFLIYEYMERGSLF--CILHNDDEAVELDW 244
           ++LH  ++++L   C     LH+       + LI EY   G +F  C+    +   E D 
Sbjct: 74  EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND- 132
Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAFVADFGTARRLHAD 301
              + ++K +   + YLH +   +I+H D+   NILL+S     +  + DFG +R++   
Sbjct: 133 --VIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDPK 361
              R ++ GT  Y+APE+     +T   D+++ G++   +L    P           +  
Sbjct: 188 CELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246
Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
            + +D  ++     V Q       LA+    + L  NP+ RPT +
Sbjct: 247 QVNVDYSEETF-SSVSQ-------LATDFIQSLLVKNPEKRPTAE 283

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 97  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 149
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 150 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 95  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 147
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 148 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 86  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 138
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 139 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 109 IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KCQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 87  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 139
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL---AGTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL---AGTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 87  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 139
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 25/171 (14%)
Query: 190 RNEAQVLSQVLHRSIVKLYG--FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
           + E Q+L ++ H+++++L    +   K+ M+++ EY       C +    ++V     KR
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----CVCGMQEMLDSVP---EKR 105
Query: 248 VNIVKAMAH------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH-- 299
             + +A  +       L YLH   S  I+H+DI   N+LL +     ++  G A  LH  
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 300 -ADSSNRTLLAGTYGYIAPELAYTMVMTE--KCDVYSFGVVTLEVLMGKHP 347
            AD + RT   G+  +  PE+A  +      K D++S GV    +  G +P
Sbjct: 163 AADDTCRT-SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G+G  G V+K +    G V A+K++  S  +E    +   +   VL       IV+ +G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV--NIVKAMAHALAYLHHDCSP 267
             +    +F+  E M  G+    L    + ++    +R+   +  A+  AL YL      
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLK---KRMQGPIPERILGKMTVAIVKALYYLKE--KH 144
Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTE 327
            +IHRD+  +NILL+ + +  + DFG + RL  D   +   AG   Y+APE       T+
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 328 -----KCDVYSFGVVTLEVLMGKHP 347
                + DV+S G+  +E+  G+ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 136
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 192
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 23/222 (10%)
Query: 134 FYEDLIEATEDFHIKYCIGTGGYG----SVYKAQLPNGKVFALKKLHTSETEELAFIKSF 189
            + + I+ T+ + +K  IG G Y      ++KA      V  + K     TEE+  +  +
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRY 72
Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
                      H +I+ L       K ++++ E  + G L   +       E + +    
Sbjct: 73  GQ---------HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASA--- 120
Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARRLHADSSNR 305
           ++  +   + YLH   +  ++HRD+  +NIL    +   E+  + DFG A++L A++   
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                T  ++APE+         CD++S GV+    L G  P
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 147
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+  
Sbjct: 148 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVIL 203
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 63/125 (50%), Gaps = 28/125 (22%)
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGT 294
           +++++ +A  +A+LH   S  IIHRD+   NIL+++              L   ++DFG 
Sbjct: 118 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 295 ARRLHA-DSSNRTLL---AGTYGYIAPE-------LAYTMVMTEKCDVYSFGVVTLEVL- 342
            ++L +  SS RT L   +GT G+ APE       L     +T   D++S G V   +L 
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 343 MGKHP 347
            GKHP
Sbjct: 235 KGKHP 239

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A++K+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L    H +I+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTM 323
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 216 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 275
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
           V T + DV+SFGV+  E+  +G  P
Sbjct: 276 VYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTM 323
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 218 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 277
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
           V T + DV+SFGV+  E+  +G  P
Sbjct: 278 VYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTM 323
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 209 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 268
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
           V T + DV+SFGV+  E+  +G  P
Sbjct: 269 VYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 151 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H++I+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 208 YGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
                 +K +      +++ E M+      I       +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHL 142
Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+  
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVIL 198
Query: 322 TMVMTEKCDVYSFGVVTLEVLMGK 345
            M   E  D++S G +  E++  K
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTM 323
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 324 VMTEKCDVYSFGVVTLEVL-MGKHP 347
           V T + DV+SFGV+  E+  +G  P
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L    H +I+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++++ + ME   L+ +L    +   L        +  +   L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 105/250 (42%), Gaps = 51/250 (20%)
Query: 134 FYEDLIEATEDFHIKYCIGTGGYGSVY--KAQLPNG--KVFALKKL-HTSETEELAFIKS 188
            YE + + +  F I+  IG G + SVY   AQL  G  +  ALK L  TS    +A    
Sbjct: 12  LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIA---- 67
Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI-YEYMERGSLFCILHNDDEAVELDWAKR 247
              E Q L+    +  V    +C  K    +I   Y+E  S   IL++      L + + 
Sbjct: 68  --AELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQEV 119
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHAD----- 301
              +  +  AL  +H      I+HRD+  +N L N +L+ + + DFG A+  H       
Sbjct: 120 REYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176
Query: 302 ------------SSNRTLL-----------AGTYGYIAPE-LAYTMVMTEKCDVYSFGVV 337
                       S N+  +           AGT G+ APE L      T   D++S GV+
Sbjct: 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236
Query: 338 TLEVLMGKHP 347
            L +L G++P
Sbjct: 237 FLSLLSGRYP 246

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 24/121 (19%)
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGT 294
           +++++ +A  +A+LH   S  IIHRD+   NIL+++              L   ++DFG 
Sbjct: 136 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 295 ARRLHADS----SNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVL-MGKH 346
            ++L +       N    +GT G+ APEL   +    +T   D++S G V   +L  GKH
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 347 P 347
           P
Sbjct: 253 P 253

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 24/121 (19%)
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGT 294
           +++++ +A  +A+LH   S  IIHRD+   NIL+++              L   ++DFG 
Sbjct: 136 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 295 ARRLHADS----SNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVL-MGKH 346
            ++L +       N    +GT G+ APEL   +    +T   D++S G V   +L  GKH
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 347 P 347
           P
Sbjct: 253 P 253

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V+K +   +G+++A+K+        ++  +  ++ A+ L++V     V    
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-------SMSPFRGPKDRARKLAEVGSHEKVGQ-- 115
Query: 210 FCLHKKCMFLIYEYMERGSLFCIL---------HNDDEAVELDWAKRVNIVKAMAHALAY 260
              H  C+ L   + E G L+            H +     L  A+    ++    ALA+
Sbjct: 116 ---HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  ++H D+   NI L  +    + DFG    L    +   +  G   Y+APEL 
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-VQEGDPRYMAPELL 228
Query: 321 YTMVMTEKCDVYSFGVVTLEV 341
                T   DV+S G+  LEV
Sbjct: 229 QGSYGT-AADVFSLGLTILEV 248

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H +I+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 210 FCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     K ++L+   M    L+ +L    +   L        +  +   L Y+H  
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMG-ADLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPELAY 321
            S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
            +   T+  D++S G +  E+L  +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE--------ELAFIKSFRNEAQVL 196
           + ++  I +G YG+V       G   A+K++  + ++        +    K    E ++L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 197 SQVLHRSIVKLYGFCLH-----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
           +   H +I+ L    +H        ++L+ E M R  L  ++H+    +        +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ-----HIQ 137
Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             M H L  LH      ++HRD+   NILL    +  + DF  AR   AD +N+T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTH 196
Query: 312 YGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 345
             Y APEL       T+  D++S G V  E+   K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE--------ELAFIKSFRNEAQVL 196
           + ++  I +G YG+V       G   A+K++  + ++        +    K    E ++L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 197 SQVLHRSIVKLYGFCLH-----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
           +   H +I+ L    +H        ++L+ E M R  L  ++H+    +        +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ-----HIQ 137
Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             M H L  LH      ++HRD+   NILL    +  + DF  AR   AD +N+T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTH 196
Query: 312 YGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 345
             Y APEL       T+  D++S G V  E+   K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-------EAQ 194
            ED      +G G +  ++K      +V    +LH +E       K+ RN        A 
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGV--RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++S++ H+ +V  YG C+      L+ E+++ GSL   L  +   + + W  ++ + K +
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILL 281
           A A+ +L  +   ++IH ++ + NILL
Sbjct: 123 AAAMHFLEEN---TLIHGNVCAKNILL 146

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 39/194 (20%)
Query: 166 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RSIVKLY-GFCLHKKCM 217
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      +KC+
Sbjct: 31  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 218 FLIYEYMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 276
            ++ E ++ G LF  I    D+A     A    I+K++  A+ YLH   S +I HRD+  
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 277 NNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 333
            N+L  SK    +    DFG A+    +  +++                      CD++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS----------------------CDMWS 183
Query: 334 FGVVTLEVLMGKHP 347
            GV+   +L G  P
Sbjct: 184 LGVIMYILLCGYPP 197

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 46/239 (19%)
Query: 139 IEATEDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           ++  +++ IK+ IG G YG VY A   N  K  A+KK++    E+L   K    E  +L+
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILN 82
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           ++    I++L+   + +       + ++   L+ +L   D  ++  +   + + +     
Sbjct: 83  RLKSDYIIRLHDLIIPE-------DLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKT 135
Query: 258 LAY--------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS------ 303
           + Y        +H      IIHRD+   N LLN      + DFG AR +++D        
Sbjct: 136 ILYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVND 192
Query: 304 -------------NRTLLAG------TYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVL 342
                        N+ L         T  Y APEL       T   D++S G +  E+L
Sbjct: 193 LEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-------EAQ 194
            ED      +G G +  ++K      +V    +LH +E       K+ RN        A 
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGV--RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           ++S++ H+ +V  YG C       L+ E+++ GSL   L  +   + + W  ++ + K +
Sbjct: 65  MMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 255 AHALAYLHHDCSPSIIHRDISSNNILL 281
           A A+ +L  +   ++IH ++ + NILL
Sbjct: 123 AWAMHFLEEN---TLIHGNVCAKNILL 146

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/75 (42%), Positives = 44/75 (58%), Gaps = 9/75 (12%)
Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP-- 59
           KNL  LD+ NN+I G++P  LT L  L  LN+S+N L G +P    Q  ++ R  +S   
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP----QGGNLQRFDVSAYA 299
Query: 60  -NKGLCGNFITLPSC 73
            NK LCG+   LP+C
Sbjct: 300 NNKCLCGS--PLPAC 312

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 139 IEATEDFHIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           +   +++ IK+ IG G YG VY A   N  K  A+KK++    E+L   K    E  +L+
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILN 80
Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           ++    I++LY   +         + ++   L+ +L   D  ++  +   + + +     
Sbjct: 81  RLKSDYIIRLYDLIIPD-------DLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 258 LAY--------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS------ 303
           + Y        +H      IIHRD+   N LLN      V DFG AR ++++        
Sbjct: 134 ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 304 ----------NRTLLAG------TYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVL 342
                     N+ L         T  Y APEL       T+  D++S G +  E+L
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 15/107 (14%)
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
           ++I   +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D   +T+
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 308 LA------------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
           L             GT  Y++PE  +    + K D++S G++  E+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 151 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V  A     K   A+KK+  S  E   + +    E Q+L +  H +++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 210 FCLHK-----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                     + ++++ + ME   L+ +L    ++ +L        +  +   L Y+H  
Sbjct: 109 ILRASTLEAMRDVYIVQDLME-TDLYKLL----KSQQLSNDHICYFLYQILRGLKYIH-- 161
Query: 265 CSPSIIHRDISSNNILLNSKLEAFVADFGTAR---RLHADSSNRTLLAGTYGYIAPELAY 321
            S +++HRD+  +N+L+N+  +  + DFG AR     H  +   T    T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 322 -TMVMTEKCDVYSFGVVTLEVLM------GKH 346
            +   T+  D++S G +  E+L       GKH
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 28/125 (22%)
Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGT 294
           +++++ +A  +A+LH   S  IIHRD+   NIL+++              L   ++DFG 
Sbjct: 118 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 295 ARRLHADS----SNRTLLAGTYGYIAPE-------LAYTMVMTEKCDVYSFGVVTLEVL- 342
            ++L +       N    +GT G+ APE       L     +T   D++S G V   +L 
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 343 MGKHP 347
            GKHP
Sbjct: 235 KGKHP 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 96/239 (40%), Gaps = 56/239 (23%)
Query: 145 FHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + I++ IGTG YG V +A      +V A+KK+     E+L   K    E  +L+++ H  
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK--RVNIVKAMAH----- 256
           +VK+    + K     + ++ E   L+ +L    E  + D+ K  R  +     H     
Sbjct: 114 VVKVLDIVIPKD----VEKFDE---LYVVL----EIADSDFKKLFRTPVYLTELHIKTLL 162
Query: 257 -----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL------------- 298
                 + Y+H   S  I+HRD+   N L+N      V DFG AR +             
Sbjct: 163 YNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 299 ------------HADSSNRTLLAG--TYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVL 342
                       H  +  R L     T  Y APEL       TE  DV+S G +  E+L
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 16/153 (10%)
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA--DSSNRTLLAGT 311
           +A  + +L    S   IHRD+++ NILL+      + DFG AR ++   D   +      
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDXXXXXXXXXDPKIMLIDVLDQ 370
             ++APE  +  + + K DV+S+GV+  E+  +G  P           D    L + +  
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP---YPGVQMDEDFCSRLREGMRM 321
Query: 371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRP 403
           R P     ++ Q       I   C   +PK RP
Sbjct: 322 RAPEYSTPEIYQ-------IMLDCWHRDPKERP 347

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 13/215 (6%)
Query: 140 EATEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRN-----EA 193
           E ++ +     +G+G +G V+ A      K   +K +   +  E  +I+  +      E 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            +LS+V H +I+K+     ++    L+ E  + GS   +    D    LD      I + 
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +  A+ YL       IIHRDI   NI++       + DFG+A  L       T   GT  
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIE 194
Query: 314 YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y APE L        + +++S GV    ++  ++P
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 104/215 (48%), Gaps = 31/215 (14%)
Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY- 208
           +G GG G V+ A   +  K  A+KK+  ++ +    +K    E +++ ++ H +IVK++ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS---VKHALREIKIIRRLDHDNIVKVFE 75
Query: 209 -------------GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
                        G       ++++ EYME   L  +L   ++   L+   R+ + + + 
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLFMYQLL- 130
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHADSSNRTLLAG---T 311
             L Y+H   S +++HRD+   N+ +N++ L   + DFG AR +    S++  L+    T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 312 YGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
             Y +P L  +    T+  D+++ G +  E+L GK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 186 IKSFRNEAQVLSQVLHRSIVKLYGFC--LHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
           I+    E  +L ++ H ++VKL       ++  +++++E + +G +  +     + +  D
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSED 137
Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
            A+     + +   + YLH+     IIHRDI  +N+L+       +ADFG +       +
Sbjct: 138 QARFY--FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 304 NRTLLAGTYGYIAPE-LAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDXXXXXXXXXDP 360
             +   GT  ++APE L+ T  +   +  DV++ GV     + G+ P           D 
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP---------FMDE 243
Query: 361 KIMLI--DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSR 402
           +IM +   +  Q L  P    + +D+     +    L  NP+SR
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDL---KDLITRMLDKNPESR 284

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 25/115 (21%)
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNIL-LNSKLEAF------------------V 289
           ++   + HAL +LH +    + H D+   NIL +NS+ E                    V
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 344
           ADFG+A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 184 ADFGSAT---FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 25/115 (21%)
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNIL-LNSKLEAF------------------V 289
           ++   + HAL +LH +    + H D+   NIL +NS+ E                    V
Sbjct: 136 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 344
           ADFG+A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 193 ADFGSAT---FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H  S ++ HRDI  +N+L+N       + DFG+A++L     N   +   Y Y APEL +
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-YRAPELIF 204
Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGK 345
                T   D++S G +  E+++G+
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLA 309
           +  +  A+ ++H   S  I HRDI   N+L+NSK     + DFG+A++L     +   + 
Sbjct: 147 IYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXIC 203
Query: 310 GTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 345
             + Y APEL       T   D++S G V  E+++GK
Sbjct: 204 SRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 25/115 (21%)
Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNIL-LNSKLEAF------------------V 289
           ++   + HAL +LH +    + H D+   NIL +NS+ E                    V
Sbjct: 159 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 344
           ADFG+A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 216 ADFGSAT---FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---- 200
           + I   IG G +G V KA     + +   K+  ++       K+F N+AQ+  ++L    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-------KAFLNQAQIEVRLLELMN 108
Query: 201 -HRSIVKLYGFCLHKKCMF-----LIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKA 253
            H + +K Y   L +  MF     L++E +   +L+ +L N +   V L+  ++    + 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQ 165
Query: 254 MAHALAYLHHDCSP--SIIHRDISSNNILL-NSKLEAF-VADFGTA----RRLHADSSNR 305
           M  AL +L    +P  SIIH D+   NILL N K  A  + DFG++    +R++    +R
Sbjct: 166 MCTALLFL---ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSR 222
Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
                   Y +PE+   M      D++S G + +E+  G+
Sbjct: 223 F-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---- 200
           + I   IG G +G V KA     + +   K+  ++       K+F N+AQ+  ++L    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-------KAFLNQAQIEVRLLELMN 108
Query: 201 -HRSIVKLYGFCLHKKCMF-----LIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKA 253
            H + +K Y   L +  MF     L++E +   +L+ +L N +   V L+  ++    + 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQ 165
Query: 254 MAHALAYLHHDCSP--SIIHRDISSNNILL-NSKLEAF-VADFGTA----RRLHADSSNR 305
           M  AL +L    +P  SIIH D+   NILL N K  A  + DFG++    +R++    +R
Sbjct: 166 MCTALLFL---ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSR 222
Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
                   Y +PE+   M      D++S G + +E+  G+
Sbjct: 223 F-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---- 200
           + I   IG G +G V KA     + +   K+  ++       K+F N+AQ+  ++L    
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-------KAFLNQAQIEVRLLELMN 89
Query: 201 -HRSIVKLYGFCLHKKCMF-----LIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKA 253
            H + +K Y   L +  MF     L++E +   +L+ +L N +   V L+  ++    + 
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQ 146
Query: 254 MAHALAYLHHDCSP--SIIHRDISSNNILL-NSKLEAF-VADFGTA----RRLHADSSNR 305
           M  AL +L    +P  SIIH D+   NILL N K  A  + DFG++    +R++    +R
Sbjct: 147 MCTALLFL---ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSR 203
Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
                   Y +PE+   M      D++S G + +E+  G+
Sbjct: 204 F-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 236

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 145 FHIKYCIGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
           + +   +G+GG+GSVY        LP   +  ++K   S+  EL        E  +L +V
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVA-IKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 200 LH--RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV--NIVKAMA 255
                 +++L  +        LI E ME          +  A++ + A+     +++A+ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 256 HALAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
           H      H+C   ++HRDI   NIL++ ++ E  + DFG+   L    +  T   GT  Y
Sbjct: 129 HC-----HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVY 179
Query: 315 IAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             PE + Y         V+S G++  +++ G  P
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 25/100 (25%)
Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M  L  L++ +N I GSIP E+ DL  L+ L+LS NKL G +P +   L+ ++ + LS N
Sbjct: 652 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 711
Query: 61  K-----------------------GLCGNFITLPSCDATK 77
                                   GLCG    LP CD + 
Sbjct: 712 NLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRCDPSN 749

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 25/100 (25%)
Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M  L  L++ +N I GSIP E+ DL  L+ L+LS NKL G +P +   L+ ++ + LS N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 61  K-----------------------GLCGNFITLPSCDATK 77
                                   GLCG    LP CD + 
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRCDPSN 752

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	436
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-90
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-79
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-73
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-68
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-51
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-36
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-35
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-27
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-26
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-19
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-19
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-12
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-12
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-10
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-08
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-04
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-05
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  274 bits (704), Expect = 7e-90
 Identities = 103/295 (34%), Positives = 154/295 (52%), Gaps = 26/295 (8%)

Query: 131 GRIF-YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSF 189
            + F   +L  A+++F  K  +G GG+G VYK +L +G + A+K+L   E         F
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQF 74

Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE-LDWAKRV 248
           + E +++S  +HR++++L GFC+      L+Y YM  GS+   L    E+   LDW KR 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN-RTL 307
            I    A  LAYLH  C P IIHRD+ + NILL+ + EA V DFG A+ +    ++  T 
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID- 366
           + GT G+IAPE   T   +EK DV+ +GV+ LE++ G+   DL      ++D  +ML+D 
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDDVMLLDW 251

Query: 367 ------------VLDQRLPPPVDQK-VIQDILLASTISFACLQSNPKSRPTMQYV 408
                       ++D  L      + V Q I +A      C QS+P  RP M  V
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL----LCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  245 bits (629), Expect = 9e-79
 Identities = 97/317 (30%), Positives = 138/317 (43%), Gaps = 23/317 (7%)

Query: 104 VKRKYKKPKVKARATNSIDVFSIWNYDGRIF-YEDLIEATEDFHIKYCIGTGGYGSVYKA 162
           +  KY K         S     +  ++       DL EAT +F  K+ IG G +G VYK 
Sbjct: 1   MGSKYSKATNSINDALSSS--YLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58

Query: 163 QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE 222
            L +G   ALK+     ++    I+ F  E + LS   H  +V L GFC  +  M LIY+
Sbjct: 59  VLRDGAKVALKRRTPESSQG---IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115

Query: 223 YMERGSLFCILHNDDEAVE-LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 281
           YME G+L   L+  D     + W +R+ I    A  L YLH      IIHRD+ S NILL
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILL 172

Query: 282 NSKLEAFVADFGTARRLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 339
           +      + DFG +++          T++ GT GYI PE      +TEK DVYSFGVV  
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 340 EVLMGKHPRDLLSSLSSSS--------DPKIMLIDVLDQRLPPPVDQKVIQDILLASTIS 391
           EVL  +            +             L  ++D  L   +  +    +      +
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE---SLRKFGDTA 289

Query: 392 FACLQSNPKSRPTMQYV 408
             CL  + + RP+M  V
Sbjct: 290 VKCLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  231 bits (592), Expect = 2e-73
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 44/303 (14%)

Query: 132 RIF-YEDLIEATEDFHIKYC------IGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-L 183
             F + +L   T +F  +        +G GG+G VYK  + N    A+KKL         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 184 AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELD 243
              + F  E +V+++  H ++V+L GF      + L+Y YM  GSL   L   D    L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS- 302
           W  R  I +  A+ + +LH +     IHRDI S NILL+    A ++DFG AR     + 
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 303 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD 359
              ++R  + GT  Y+APE A    +T K D+YSFGVV LE++ G    D          
Sbjct: 189 TVMTSR--IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-------EHR 238

Query: 360 PKIMLID--------------VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTM 405
              +L+D               +D+++    +      +    +++  CL      RP +
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM----NDADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 406 QYV 408
           + V
Sbjct: 295 KKV 297

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  219 bits (559), Expect = 2e-68
 Identities = 80/306 (26%), Positives = 129/306 (42%), Gaps = 44/306 (14%)

Query: 135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ 194
            E+L   +    +      G +G V+KAQL N  V A+K     +       +S++NE +
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDK------QSWQNEYE 68

Query: 195 V--LSQVLHRSIVKLYGFCLH----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
           V  L  + H +I++  G           ++LI  + E+GSL   L  +     + W +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELC 124

Query: 249 NIVKAMAHALAYLHHD-------CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           +I + MA  LAYLH D         P+I HRDI S N+LL + L A +ADFG A +  A 
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 302 SS--NRTLLAGTYGYIAPELA-----YTMVMTEKCDVYSFGVVTLEVLMGKHPRD----- 349
            S  +     GT  Y+APE+      +      + D+Y+ G+V  E+       D     
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 350 --LLSSLSSSSDPKI--MLIDVLDQRLPPPVDQKVIQDI---LLASTISFACLQSNPKSR 402
             L         P +  M   V+ ++  P +     +     +L  TI   C   + ++R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE-ECWDHDAEAR 303

Query: 403 PTMQYV 408
            +   V
Sbjct: 304 LSAGCV 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (530), Expect = 3e-64
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 23/270 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  ++  +G G +G V KA+    K  A+K++ +         K+F  E + LS+V H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 61

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLYG CL+  C+  + EY E GSL+ +LH  +       A  ++     +  +AYLH
Sbjct: 62  NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
                ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFE 176

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
               +EKCDV+S+G++  EV+  + P  ++         P   ++  +     PP+ + +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEI-------GGPAFRIMWAVHNGTRPPLIKNL 229

Query: 381 IQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            +   + S ++  C   +P  RP+M+ + +
Sbjct: 230 PKP--IESLMT-RCWSKDPSQRPSMEEIVK 256

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  206 bits (527), Expect = 9e-64
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 31/275 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            D +IK  IG G +G+V++A+  +G   A+K L   +      +  F  E  ++ ++ H 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHP 94

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IV   G       + ++ EY+ RGSL+ +LH      +LD  +R+++   +A  + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL--- 319
           +  +P I+HR++ S N+L++ K    V DFG +R   +   +    AGT  ++APE+   
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 320 -AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD- 377
                   EK DVYSFGV+  E+   + P   L+         +  +    +RL  P + 
Sbjct: 214 EPS----NEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFKCKRLEIPRNL 264

Query: 378 ----QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                 +I+           C  + P  RP+   +
Sbjct: 265 NPQVAAIIEG----------CWTNEPWKRPSFATI 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (515), Expect = 3e-62
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 46/289 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH----TSETEELAFIKSFRNEAQVLS 197
            +   +  IG GG+G V+K + + +  V A+K L       ETE +   + F+ E  ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
            + H +IVKLYG   +   M  + E++  G L+  L +  +A  + W+ ++ ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF-----VADFGTARRLHADSSNRTLLAGTY 312
           + Y+ +  +P I+HRD+ S NI L S  E       VADFG +++     S      G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190

Query: 313 GYIAPEL------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 366
            ++APE       +Y    TEK D YSF ++   +L G+ P D  S         I +I 
Sbjct: 191 QWMAPETIGAEEESY----TEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FINMIR 243

Query: 367 VLDQRLPPPVD-----QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
               R   P D     + VI+           C   +PK RP   Y+ +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIEL----------CWSGDPKKRPHFSYIVK 282

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (507), Expect = 3e-61
 Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 26/275 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-FIKSFRNEAQVLSQVLH 201
            +  ++  IG GG+G VY+A    G   A+K       E+++  I++ R EA++ + + H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I+ L G CL +  + L+ E+   G L  +L        +     VN    +A  + YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAF--------VADFGTARRLHADSSNRTLLAGTYG 313
           H +    IIHRD+ S+NIL+  K+E          + DFG AR  H   + +   AG Y 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYA 179

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 373
           ++APE+    + ++  DV+S+GV+  E+L G+ P   +  L+       +   V   +L 
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAMNKLA 232

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            P+     +     + +   C   +P SRP+   +
Sbjct: 233 LPIPSTCPEPF---AKLMEDCWNPDPHSRPSFTNI 264

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  189 bits (482), Expect = 9e-57
 Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 55/317 (17%)

Query: 135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ 194
             +     ++  +   IG G YG+VYK  L + +  A+K    +        ++F NE  
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKN 57

Query: 195 V--LSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
           +  +  + H +I +                 L+ EY   GSL   L         DW   
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSS 113

Query: 248 VNIVKAMAHALAYLHHD------CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
             +  ++   LAYLH +        P+I HRD++S N+L+ +     ++DFG + RL  +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 302 SSNR--------TLLAGTYGYIAPELAYTMV-------MTEKCDVYSFGVVTLEVLMGKH 346
              R            GT  Y+APE+    V         ++ D+Y+ G++  E+ M   
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 347 PRDLLSSLSS---------SSDPKI--MLIDVLDQRLPPPVDQKVIQDIL----LASTIS 391
                 S+            + P    M + V  ++  P   +   ++ L    L  TI 
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 392 FACLQSNPKSRPTMQYV 408
             C   + ++R T Q  
Sbjct: 294 -DCWDQDAEARLTAQXA 309

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  187 bits (477), Expect = 1e-56
 Identities = 50/276 (18%), Positives = 100/276 (36%), Gaps = 34/276 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +  +    +     G ++K +   G    +K L   +       + F  E   L    H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHP 67

Query: 203 SIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           +++ + G C         LI  +M  GSL+ +LH +     +D ++ V     MA  +A+
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAF 126

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL- 319
           LH    P I    ++S +++++  + A ++           S           ++APE  
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180

Query: 320 --AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
                       D++SF V+  E++  + P   LS++        M + +   R   P  
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVALEGLRPTIPPG 235

Query: 378 -----QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                 K+++           C+  +P  RP    +
Sbjct: 236 ISPHVSKLMKI----------CMNEDPAKRPKFDMI 261

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  185 bits (472), Expect = 2e-55
 Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 36/283 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            D      +G G +G   K      G+V  +K+L   + E     ++F  E +V+  + H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEH 66

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +++K  G     K +  I EY++ G+L  I+ + D   +  W++RV+  K +A  +AYL
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYL 124

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL--------------HADSSNRTL 307
           H   S +IIHRD++S+N L+       VADFG AR +                D   R  
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV 367
           + G   ++APE+       EK DV+SFG+V  E++   +        +        L   
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----MDFGLNVR 237

Query: 368 LDQRLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                  P +              I+  C   +P+ RP+   +
Sbjct: 238 GFLDRYCPPNCPPSFFP-------ITVRCCDLDPEKRPSFVKL 273

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  183 bits (466), Expect = 9e-55
 Identities = 70/299 (23%), Positives = 118/299 (39%), Gaps = 44/299 (14%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQV 199
             D  +  C+G G YG V++     G+  A+K   + +       KS+  E ++     +
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVML 59

Query: 200 LHRSIVKLYGFCLHKKC----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
            H +I+      +  +     ++LI  Y E GSL+  L        LD    + IV ++A
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIA 115

Query: 256 HALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS----NRT 306
             LA+LH +       P+I HRD+ S NIL+    +  +AD G A      ++       
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 307 LLAGTYGYIAPEL------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----- 355
              GT  Y+APE+             ++ D+++FG+V  EV        ++         
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235

Query: 356 -SSSDPKI--MLIDVLDQRLPPPVDQKVIQDI---LLASTISFACLQSNPKSRPTMQYV 408
              +DP    M   V   +  P +  +   D     LA  +   C   NP +R T   +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK-ECWYQNPSARLTALRI 293

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (463), Expect = 4e-54
 Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 37/282 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   I   IG G +G VY  +  +G+V A++ +      E   +K+F+ E     Q  H 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNE-DQLKAFKREVMAYRQTRHE 89

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           ++V   G C+    + +I    +  +L+ ++ +      LD  K   I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLH 147

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-----TLLAGTYGYIAP 317
              +  I+H+D+ S N+  ++  +  + DFG         + R      +  G   ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 318 EL---------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL 368
           E+            +  ++  DV++ G +  E+   + P     + +      I+     
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMGT 257

Query: 369 DQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYV 408
             +         K I DILL       C     + RPT   +
Sbjct: 258 GMKPNLSQIGMGKEISDILL------FCWAFEQEERPTFTKL 293

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (455), Expect = 3e-53
 Identities = 69/274 (25%), Positives = 133/274 (48%), Gaps = 26/274 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
               +   IG+G +G+VYK +  +G V A+K L+ +       +++F+NE  VL +  H 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 80

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +I+   G+      + ++ ++ E  SL+  LH  +   + +  K ++I +  A  + YLH
Sbjct: 81  NILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH 137

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR--RLHADSSNRTLLAGTYGYIAPEL- 319
              + SIIHRD+ SNNI L+      + DFG A      + S     L+G+  ++APE+ 
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 320 --AYTMVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIMLIDVLDQRLPPPV 376
               +   + + DVY+FG+V  E++ G+ P  ++        + +  +I+++ +    P 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIEMVGRGSLSPD 246

Query: 377 DQKVIQDI--LLASTISFACLQSNPKSRPTMQYV 408
             KV  +    +   ++  CL+     RP+   +
Sbjct: 247 LSKVRSNCPKRMKRLMA-ECLKKKRDERPSFPRI 279

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (458), Expect = 3e-53
 Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 44/298 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVL 200
           +   +   IG G YG V+  +   G+  A+K   T+E        S+  E ++     + 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE------EASWFRETEIYQTVLMR 89

Query: 201 HRSIVKLYGFCLHKKC----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +I+      +        ++LI +Y E GSL+  L +      LD    + +  +   
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVS 145

Query: 257 ALAYLH-----HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL--- 308
            L +LH         P+I HRD+ S NIL+       +AD G A +  +D++   +    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 309 -AGTYGYIAPE-LAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDLLSSLS------ 355
             GT  Y+ PE L  ++           D+YSFG++  EV        ++          
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 356 SSSDPKI--MLIDVLDQRLPPPVDQKVIQDIL---LASTISFACLQSNPKSRPTMQYV 408
             SDP    M   V  ++L P    +   D     +   ++  C   NP SR T   V
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT-ECWAHNPASRLTALRV 322

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (449), Expect = 7e-52
 Identities = 67/298 (22%), Positives = 121/298 (40%), Gaps = 44/298 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVL 200
               ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++     + 
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR 94

Query: 201 HRSIVKLYGFCLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +I+               ++L+ +Y E GSLF  L+       +     + +  + A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTAS 150

Query: 257 ALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL--- 308
            LA+LH +       P+I HRD+ S NIL+       +AD G A R  + +    +    
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 309 -AGTYGYIAPE-LAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDLLS------SLS 355
             GT  Y+APE L  ++ M      ++ D+Y+ G+V  E+        +           
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 356 SSSDPKI--MLIDVLDQRLPPPVDQKVIQDIL---LASTISFACLQSNPKSRPTMQYV 408
             SDP +  M   V +Q+L P +  +         +A  +   C  +N  +R T   +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYANGAARLTALRI 327

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (379), Expect = 1e-41
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 33/271 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E +     IG G +G     +   +G+ + +K+++ S        +  R E  VL+ + H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKH 82

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND-----DEAVELDWAKRVNIVKAMAH 256
            +IV+          ++++ +Y E G LF  ++        E   LDW  +      +  
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICL 136

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL ++H      I+HRDI S NI L       + DFG AR L++         GT  Y++
Sbjct: 137 ALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDLLSSLSSSSDPKIMLIDVLDQRLP 373
           PE+        K D+++ G V  E+   KH      + + +      KI+          
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL-----KII------SGSF 242

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           PPV      D  L S +S    + NP+ RP+
Sbjct: 243 PPVSLHYSYD--LRSLVS-QLFKRNPRDRPS 270

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (372), Expect = 3e-41
 Identities = 63/264 (23%), Positives = 108/264 (40%), Gaps = 29/264 (10%)

Query: 150 CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            IG G + +VYK          A  +L   +  + +  + F+ EA++L  + H +IV+ Y
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 209 GFCL----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD 264
                    KKC+ L+ E M  G+L   L               +  + +   L +LH  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLH-T 147

Query: 265 CSPSIIHRDISSNNILLNSKL-EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM 323
            +P IIHRD+  +NI +        + D G A      +S    + GT  ++APE+ Y  
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM-YEE 204

Query: 324 VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ---KV 380
              E  DVY+FG+  LE+   ++P     + +      I    V     P   D+     
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRR-VTSGVKPASFDKVAIPE 258

Query: 381 IQDILLASTISFACLQSNPKSRPT 404
           +++I+        C++ N   R +
Sbjct: 259 VKEIIE------GCIRQNKDERYS 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  144 bits (365), Expect = 4e-40
 Identities = 62/289 (21%), Positives = 113/289 (39%), Gaps = 43/289 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            DF    C+G GG+G V++A+   +   +A+K++     E     +    E + L+++ H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62

Query: 202 RSIVKLYGFCLHKKCM------------FLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
             IV+ +   L K               ++  +   + +L   ++      E + +  ++
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS------- 302
           I   +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D        
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 303 -----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS 357
                +  T   GT  Y++PE  +    + K D++S G++  E         LL   S+ 
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE---------LLYPFSTQ 230

Query: 358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
            +    L DV + + PP   QK          +    L  +P  RP   
Sbjct: 231 MERVRTLTDVRNLKFPPLFTQKYPC---EYVMVQ-DMLSPSPMERPEAI 275

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (363), Expect = 6e-40
 Identities = 59/287 (20%), Positives = 114/287 (39%), Gaps = 57/287 (19%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            DF     IG+GG+G V+KA+   +GK + +K++  +        +    E + L+++ H
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63

Query: 202 RSIVKLYGF----------------CLHKKCMFLIYEYMERGSLFCILHND-----DEAV 240
            +IV   G                     KC+F+  E+ ++G+L   +        D+ +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            L+  ++      +   + Y+H   S  +I+RD+  +NI L    +  + DFG    L  
Sbjct: 124 ALELFEQ------ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSD 359
           D        GT  Y++PE   +    ++ D+Y+ G++  E+L +     +          
Sbjct: 175 DGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------- 226

Query: 360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
                 D+ D  +    D+K        + +    L   P+ RP   
Sbjct: 227 ---FFTDLRDGIISDIFDKK------EKTLLQ-KLLSKKPEDRPNTS 263

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (363), Expect = 1e-39
 Identities = 58/279 (20%), Positives = 113/279 (40%), Gaps = 31/279 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            +F I+  IG G +  VY+A  L +G   ALKK+   +  +         E  +L Q+ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND-------DEAVELDWAKRVNIVKAM 254
            +++K Y   +    + ++ E  + G L  ++ +         E     +  +      +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
             AL ++H   S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y
Sbjct: 146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           ++PE  +      K D++S G +  E+   + P           +   +   +     PP
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLYSLCKKIEQCDYPP 257

Query: 375 -PVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            P D   + ++ ++        C+  +P+ RP + YV  
Sbjct: 258 LPSDHYSEELRQLVN------MCINPDPEKRPDVTYVYD 290

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (367), Expect = 1e-39
 Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 42/282 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ED  +   IG G +G V+  +L   N  V A+K    +   +L     F  EA++L Q  
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLV-AVKSCRETLPPDL--KAKFLQEARILKQYS 170

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV+L G C  K+ ++++ E ++ G     L  +   + +     + +V   A  + Y
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEY 228

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI----- 315
           L    S   IHRD+++ N L+  K    ++DFG +R            +G    +     
Sbjct: 229 LE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWT 282

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---- 370
           APE       + + DV+SFG++  E    G  P            P +      +     
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPY-----------PNLSNQQTREFVEKG 331

Query: 371 -RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            RLP P      +  ++        C    P  RP+   + Q
Sbjct: 332 GRLPCPELCPDAVFRLME------QCWAYEPGQRPSFSTIYQ 367

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  142 bits (361), Expect = 1e-39
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 41/270 (15%)

Query: 150 CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY 208
            +G G YG VY    L N    A+K++   ++      +    E  +   + H++IV+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYL 85

Query: 209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS 268
           G       + +  E +  GSL  +L +    ++ +        K +   L YLH      
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142

Query: 269 IIHRDISSNNILLNS-----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL---- 319
           I+HRDI  +N+L+N+     K+    +DFGT++RL   +       GT  Y+APE+    
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKI----SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198

Query: 320 --AYTMVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIMLIDVLDQRLPPPV 376
              Y        D++S G   +E+  GK P  +L    ++     +  + +      P  
Sbjct: 199 PRGYGK----AADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVGMFKV--HPE- 246

Query: 377 DQKVIQDILLASTISF--ACLQSNPKSRPT 404
               I + + A   +F   C + +P  R  
Sbjct: 247 ----IPESMSAEAKAFILKCFEPDPDKRAC 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  141 bits (358), Expect = 7e-39
 Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 41/283 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
             + I   IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 86

Query: 203 S--IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           S  I++LY + +  + ++++ E      L   L    ++++    K     K M  A+  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKS--YWKNMLEAVHT 142

Query: 261 LHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARRLHADSSN--RTLLAGTYGYI 315
           +H      I+H D+   N L+     KL     DFG A ++  D+++  +    GT  Y+
Sbjct: 143 IH---QHGIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 316 APEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML 364
            PE                 ++ K DV+S G +   +  GK P   +     +   K+  
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHA 251

Query: 365 IDVLDQRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           I   +  +  P + +K +QD+L        CL+ +PK R ++ 
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIP 288

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (357), Expect = 2e-38
 Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 41/283 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
             + I   IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 67

Query: 203 S--IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           S  I++LY + +  + ++++ E      L   L    ++++    K     K M  A+  
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKS--YWKNMLEAVHT 123

Query: 261 LHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARRLHADSSN--RTLLAGTYGYI 315
           +H      I+H D+   N L+     KL     DFG A ++  D+++  +    GT  Y+
Sbjct: 124 IH---QHGIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 316 APEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML 364
            PE                 ++ K DV+S G +   +  GK P   +     +   K+  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHA 232

Query: 365 IDVLDQRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           I   +  +  P + +K +QD+L        CL+ +PK R ++ 
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIP 269

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (351), Expect = 3e-38
 Identities = 68/279 (24%), Positives = 109/279 (39%), Gaps = 36/279 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ + Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64

Query: 202 RSIVKLYG-FCLHKKCMFLIY-EYMERGSLFCILHND-------DEAVELDWAKRVNIVK 252
            +IV+ Y            I  EY E G L  ++          DE   L    +     
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ----- 119

Query: 253 AMAHALAYLH--HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
            +  AL   H   D   +++HRD+   N+ L+ K    + DFG AR L+ D+S      G
Sbjct: 120 -LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDLLSSLSSSSDPKIMLIDV 367
           T  Y++PE    M   EK D++S G +  E+     P                   L   
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGK 227

Query: 368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           + +     +  +   +  L   I+   L      RP+++
Sbjct: 228 IREGKFRRIPYRYSDE--LNEIIT-RMLNLKDYHRPSVE 263

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  138 bits (350), Expect = 7e-38
 Identities = 69/294 (23%), Positives = 125/294 (42%), Gaps = 48/294 (16%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
             DF     +G G +G V KA+   + + +A+KK+  +E +    + +  +E  +L+ + 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLN 60

Query: 201 HRSIVKLYGF-------------CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
           H+ +V+ Y                  K  +F+  EY E G+L+ ++H+++   + D   R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD------ 301
             + + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H        
Sbjct: 121 --LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 302 --------SSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS 352
                   S N T   GT  Y+A E L  T    EK D+YS G++  E++          
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235

Query: 353 SLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           ++      K+  + +     PP  D   ++       I    +  +P  RP  +
Sbjct: 236 NILK----KLRSVSI---EFPPDFDDNKMKV--EKKIIR-LLIDHDPNKRPGAR 279

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (351), Expect = 3e-37
 Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 41/283 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
             + I   IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 114

Query: 203 S--IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           S  I++LY + +  + ++++ E      L   L    ++++    K     K M  A+  
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKS--YWKNMLEAVHT 170

Query: 261 LHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARRLHADSSNRTL--LAGTYGYI 315
           +H      I+H D+   N L+     KL     DFG A ++  D+++       G   Y+
Sbjct: 171 IH---QHGIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 316 APEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML 364
            PE                 ++ K DV+S G +   +  GK P   +     +   K+  
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHA 279

Query: 365 IDVLDQRLP-PPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           I   +  +  P + +K +QD+L        CL+ +PK R ++ 
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIP 316

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  136 bits (345), Expect = 4e-37
 Identities = 58/285 (20%), Positives = 117/285 (41%), Gaps = 35/285 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + +     +G GG+  V   + L +G  +ALK++   E ++       + EA +     H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA---QREADMHRLFNH 85

Query: 202 RSIVKLYGFCL----HKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMAH 256
            +I++L  +CL     K   +L+  + +RG+L+  I    D+   L   + + ++  +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA------- 309
            L  +H   +    HRD+   NILL  + +  + D G+  +                   
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 310 --GTYGYIAPEL----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 363
              T  Y APEL    ++ ++  E+ DV+S G V   ++ G+ P D++     S      
Sbjct: 203 QRCTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------ 255

Query: 364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           +   +  +L  P   +      L   ++ + +  +P  RP +  +
Sbjct: 256 VALAVQNQLSIPQSPRHSSA--LWQLLN-SMMTVDPHQRPHIPLL 297

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (347), Expect = 5e-37
 Identities = 31/292 (10%), Positives = 69/292 (23%), Gaps = 49/292 (16%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +  G    V+    +   + FALK          + ++         +++L  S  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 210 FCLHKKCM--------------------------FLIYEYMERGSLFCILHNDDEAVE-- 241
                                              L+        L  +    D      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 242 --LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
                     +   +    A L    S  ++H   + +N+ +       + D     +  
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK-- 243

Query: 300 ADSSNRTLLAGTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS 357
              +     +    Y   E   A T   T   + +  G+    V     P  L++     
Sbjct: 244 -VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 358 SDPKIMLIDVLDQRLPPPVDQKV---IQDILLASTISFACLQSNPKSRPTMQ 406
           S  +  L       L       +   ++ ++         L  + + R    
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPL 348

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  139 bits (351), Expect = 6e-37
 Identities = 59/282 (20%), Positives = 117/282 (41%), Gaps = 42/282 (14%)

Query: 144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HR 202
            F  K  +G G  G++    + + +  A+K++                E Q+L +   H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL------PECFSFADREVQLLRESDEHP 78

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++++ +     ++  ++  E     +L   +   D   + L+    + +++     LA+L
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134

Query: 262 HHDCSPSIIHRDISSNNILL-----NSKLEAFVADFGTARRLHADSSNRTLL---AGTYG 313
           H   S +I+HRD+  +NIL+     + K++A ++DFG  ++L     + +      GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 314 YIAPEL---AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLD 369
           +IAPE+         T   D++S G V   V+  G HP          S  +   I +  
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-------KSLQRQANILLGA 244

Query: 370 QRLPPPVDQKVIQDI---LLASTISFACLQSNPKSRPTMQYV 408
             L     +K    I   L+        +  +P+ RP+ ++V
Sbjct: 245 CSLDCLHPEKHEDVIARELIEK-----MIAMDPQKRPSAKHV 281

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  135 bits (341), Expect = 7e-37
 Identities = 83/270 (30%), Positives = 133/270 (49%), Gaps = 31/270 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   +G G +G+VY A+   +  + ALK L  ++ E+       R E ++ S + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHAL 258
            +I++LYG+      ++LI EY   G+++  L      DE            +  +A+AL
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TAT--YITELANAL 122

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           +Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPE 177

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPPPV 376
           +    +  EK D++S GV+  E L+GK P +       ++  +     I  ++   P  V
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFV 230

Query: 377 DQKVIQDILLASTISFACLQSNPKSRPTMQ 406
            +   +D++         L+ NP  RP ++
Sbjct: 231 TEGA-RDLIS------RLLKHNPSQRPMLR 253

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  136 bits (343), Expect = 2e-36
 Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 44/296 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF     +G G  G V+K    P+G V A K +H               E QVL +   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNS 90

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             IV  YG       + +  E+M+ GSL  +L       E    K   +  A+   L YL
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 147

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
                  I+HRD+  +NIL+NS+ E  + DFG + +L  DS   +   GT  Y++PE   
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYMSPERLQ 203

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP-------------------------------RDL 350
               + + D++S G+  +E+ +G++P                                  
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 351 LSSLSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           L+     S P + + ++LD     PPP     +  +     ++  CL  NP  R  
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERAD 318

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (340), Expect = 3e-36
 Identities = 69/283 (24%), Positives = 107/283 (37%), Gaps = 52/283 (18%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSETEELAFIKSFRNEAQVL 196
           E       +  +G G +G V++ +    G   A+KK  L     EEL             
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV----------AC 104

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKA 253
           + +    IV LYG       + +  E +E GSL  ++       E   L        +  
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL------YYLGQ 158

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHADSSNRTL----- 307
               L YLH   +  I+H D+ ++N+LL+S    A + DFG A  L  D   ++L     
Sbjct: 159 ALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 308 LAGTYGYIAPELAYTMVM----TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM 363
           + GT  ++APE    +VM      K D++S   + L +L G HP            P  +
Sbjct: 216 IPGTETHMAPE----VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-----PLCL 266

Query: 364 LIDVLDQRLPPPVDQKVIQDILLASTISF--ACLQSNPKSRPT 404
            I       PPP+ +  I       T       L+  P  R +
Sbjct: 267 KI----ASEPPPIRE--IPPSCAPLTAQAIQEGLRKEPVHRAS 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  134 bits (339), Expect = 4e-36
 Identities = 74/282 (26%), Positives = 110/282 (39%), Gaps = 44/282 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVL 200
           ED      IG G YGSV K    P+G++ A+K++ ++  E+    K    +  V +    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSD 79

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN------IVKAM 254
              IV+ YG    +   ++  E M   S           V       +       I  A 
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKY----VYSVLDDVIPEEILGKITLAT 134

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
             AL +L  +    IIHRDI  +NILL+      + DFG + +L  DS  +T  AG   Y
Sbjct: 135 VKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPY 191

Query: 315 IAPE--------LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 366
           +APE          Y      + DV+S G+   E+  G+ P    +S          + D
Sbjct: 192 MAPERIDPSASRQGY----DVRSDVWSLGITLYELATGRFPYPKWNS----------VFD 237

Query: 367 VLDQ--RLPPPVDQKVIQDILLASTISF--ACLQSNPKSRPT 404
            L Q  +  PP      +     S I+F   CL  +   RP 
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  133 bits (336), Expect = 9e-36
 Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 45/280 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVL 200
            D      +G+G  G V+K +    G V A+K++  S  +E    K    +  V+     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHD 82

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
              IV+ +G  +    +F+  E M   +            E    K   +  A+  AL Y
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK---MTVAIVKALYY 139

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           L       +IHRD+  +NILL+ + +  + DFG + RL  D   +   AG   Y+APE  
Sbjct: 140 LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERI 196

Query: 321 YTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLP 373
                T+     + DV+S G+  +E+  G+ P     +            +VL +  +  
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----------DFEVLTKVLQEE 246

Query: 374 PPVDQKVIQDILLASTISF---------ACLQSNPKSRPT 404
           PP         LL   + F          CL  + + RP 
Sbjct: 247 PP---------LLPGHMGFSGDFQSFVKDCLTKDHRKRPK 277

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  132 bits (334), Expect = 1e-35
 Identities = 80/268 (29%), Positives = 115/268 (42%), Gaps = 29/268 (10%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            E F     IG G +G V+K       KV A+K +   E E+   I+  + E  VLSQ  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCD 78

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
              + K YG  L    +++I EY+  GS   +L        LD  +   I++ +   L Y
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDY 134

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S   IHRDI + N+LL+   E  +ADFG A +L      R    GT  ++APE+ 
Sbjct: 135 LH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--KIMLIDVLDQRLPPPVDQ 378
                  K D++S G+  +E+  G+ P        S   P   + LI     +  PP   
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPH-------SELHPMKVLFLI----PKNNPP--- 237

Query: 379 KVIQDILLASTISF--ACLQSNPKSRPT 404
             ++         F  ACL   P  RPT
Sbjct: 238 -TLEGNYSKPLKEFVEACLNKEPSFRPT 264

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  131 bits (332), Expect = 3e-35
 Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 51/290 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK--KLHTSETEELAFIKSFRNEAQVLSQV 199
           +D+ ++  IG+G    V  A   P  +  A+K   L   +T     +     E Q +SQ 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQC 70

Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----HNDDEAVELDWAKRVNIVKAM 254
            H +IV  Y   + K  ++L+ + +  GS+  I+       + ++  LD +    I++ +
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG-----TARRLHADSSNRTLLA 309
              L YLH       IHRD+ + NILL       +ADFG             +  R    
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 310 GTYGYIAPELAYTMVMTE------KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--K 361
           GT  ++APE     VM +      K D++SFG+  +E+  G  P            P   
Sbjct: 188 GTPCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAPY-------HKYPPMKV 235

Query: 362 IMLIDVLDQRLPPPVDQKVIQDILLASTIS--F-----ACLQSNPKSRPT 404
           +ML      +  PP  +  +QD  +       F      CLQ +P+ RPT
Sbjct: 236 LMLT----LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  130 bits (328), Expect = 5e-35
 Identities = 71/292 (24%), Positives = 116/292 (39%), Gaps = 46/292 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            +      IG+G +G V+        KV A+K +      E  FI+    EA+V+ ++ H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSH 62

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +V+LYG CL +  + L+ E+ME G L   L              + +   +   +AYL
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYL 120

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYI--- 315
                  +IHRD+++ N L+       V+DFG  R +  D   SS  T        +   
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKWA 172

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---- 370
           +PE+      + K DV+SFGV+  EV   GK P                  +V++     
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-----------ENRSNSEVVEDISTG 221

Query: 371 -RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL 420
            RL  P      +  I+        C +  P+ RP    + +      ++ L
Sbjct: 222 FRLYKPRLASTHVYQIMN------HCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  130 bits (329), Expect = 6e-35
 Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 48/282 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVL 200
           +D      +G G YG V K + +P+G++ A+K++  +   +    K    +  + +  V 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVD 64

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN------IVKAM 254
               V  YG    +  +++  E M+  SL            +D  + +       I  ++
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ-----VIDKGQTIPEDILGKIAVSI 118

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
             AL +LH   S  +IHRD+  +N+L+N+  +  + DFG +  L  D   + + AG   Y
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPY 175

Query: 315 IAPE--------LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 366
           +APE          Y++    K D++S G+  +E+ + + P        S   P      
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP------YDSWGTP----FQ 221

Query: 367 VLDQ--RLPPPVDQKVIQDILLASTISF--ACLQSNPKSRPT 404
            L Q    P P   ++  D   A  + F   CL+ N K RPT
Sbjct: 222 QLKQVVEEPSP---QLPADKFSAEFVDFTSQCLKKNSKERPT 260

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  134 bits (339), Expect = 7e-35
 Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 40/282 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            D  +K+ +G G YG VY+      +  V A+K L     E   F+K    EA V+ ++ 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFLK----EAAVMKEIK 274

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H ++V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 333

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAP 317
           L      + IHR++++ N L+       VADFG +R +  D   +           + AP
Sbjct: 334 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAP 388

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----R 371
           E       + K DV++FGV+  E+   G  P            P I L  V +      R
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYR 437

Query: 372 LPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           +  P    + + +++       AC Q NP  RP+   + Q F
Sbjct: 438 MERPEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF 473

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  132 bits (332), Expect = 7e-35
 Identities = 36/227 (15%), Positives = 72/227 (31%), Gaps = 27/227 (11%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           ++  ++ + +G G +  VY+A         N + F LK    +   E           + 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMER 120

Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKA 253
           L   +    +K Y   L +    L+ E    G+L   ++      E  +     ++    
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-----------VADFGTARRLHADS 302
           M + +  +H      IIH DI  +N +L +                + D G +  +    
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 303 SNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                     T G+   E+        + D +        +L G + 
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  129 bits (326), Expect = 2e-34
 Identities = 60/271 (22%), Positives = 95/271 (35%), Gaps = 38/271 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 200
           + F     +G G YG V+K +   +G+++A+K+  +              E     +V  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQ 115

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND----DEAVELDWAKRVNIVKAMAH 256
           H   V+L         ++L  E     SL            EA    + +          
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRD------TLL 168

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           ALA+LH   S  ++H D+   NI L  +    + DFG    L    +      G   Y+A
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMA 224

Query: 317 PEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 373
           PEL   +Y        DV+S G+  LEV                   ++         LP
Sbjct: 225 PELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGW-----QQLR-----QGYLP 270

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P     +  +  L S +    L+ +PK R T
Sbjct: 271 PEFTAGLSSE--LRSVLV-MMLEPDPKLRAT 298

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  128 bits (325), Expect = 2e-34
 Identities = 65/266 (24%), Positives = 120/266 (45%), Gaps = 24/266 (9%)

Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            + +     IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENK 75

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           + +IV      L    ++++ EY+  GSL  ++        +D  +   + +    AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEF 131

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+ 
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
                  K D++S G++ +E++ G+ P    + L +     + LI         P  Q  
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLI----ATNGTPELQN- 238

Query: 381 IQDILLASTISF--ACLQSNPKSRPT 404
             + L A    F   CL+ + + R +
Sbjct: 239 -PEKLSAIFRDFLNRCLEMDVEKRGS 263

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  129 bits (327), Expect = 3e-34
 Identities = 68/286 (23%), Positives = 109/286 (38%), Gaps = 59/286 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF---ALKKLH--TSETEELAFIKSFRNEAQV 195
            +F     +G+G +G+VYK        KV    A+K+L   TS       +     EA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYV 70

Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
           ++ V +  + +L G CL    + LI + M  G L   +    + +     L+W   V I 
Sbjct: 71  MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIA 127

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG- 310
           K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+        G 
Sbjct: 128 KGMN----YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

Query: 311 -----TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML 364
                     A E     + T + DV+S+GV   E++  G  P              I  
Sbjct: 181 VPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----------DGIPA 225

Query: 365 IDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
            ++        RLP P      +  I+        C   +  SRP 
Sbjct: 226 SEISSILEKGERLPQPPICTIDVYMIMR------KCWMIDADSRPK 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  127 bits (322), Expect = 3e-34
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 38/276 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E+  +   +G+G +G V   +       A+K +      E  F +    EAQ + ++ H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHP 63

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +VK YG C  +  ++++ EY+  G L   L +  +   L+ ++ + +   +   +A+L 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE 121

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI---APEL 319
              S   IHRD+++ N L++  L   V+DFG  R +  D    +   GT   +   APE+
Sbjct: 122 ---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAPEV 176

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP 373
            +    + K DV++FG++  EV   GK P                  +V+ +     RL 
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPY-----------DLYTNSEVVLKVSQGHRLY 225

Query: 374 PPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            P      I  I+       +C    P+ RPT Q +
Sbjct: 226 RPHLASDTIYQIMY------SCWHELPEKRPTFQQL 255

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (323), Expect = 4e-34
 Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 44/279 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +D      +GTG +G V   +       A+K +      E  FI+    EA+V+  + H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHE 79

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LYG C  ++ +F+I EYM  G L   L            + + + K +  A+ YL 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYI---A 316
              S   +HRD+++ N L+N +    V+DFG +R +  D   SS  +        +    
Sbjct: 138 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSP 189

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ----- 370
           PE+      + K D+++FGV+  E+   GK P             +    +  +      
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-----------ERFTNSETAEHIAQGL 238

Query: 371 RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           RL  P    + +  I+       +C       RPT + +
Sbjct: 239 RLYRPHLASEKVYTIMY------SCWHEKADERPTFKIL 271

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  128 bits (324), Expect = 4e-34
 Identities = 63/266 (23%), Positives = 122/266 (45%), Gaps = 24/266 (9%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
                    IG G  G V  A+   +G+  A+K +   + +    +    NE  ++    
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQ 100

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H ++V++Y   L  + ++++ E+++ G+L  I+      V L+  +   + +A+  ALAY
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAY 156

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   +  +IHRDI S++ILL       ++DFG   ++  D   R  L GT  ++APE+ 
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
              +   + D++S G++ +E++ G+ P    S + +     +  +    +  PPP  +  
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRL----RDSPPPKLKN- 263

Query: 381 IQDILLASTISF--ACLQSNPKSRPT 404
               +      F    L  +P+ R T
Sbjct: 264 -SHKVSPVLRDFLERMLVRDPQERAT 288

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (322), Expect = 7e-34
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 27/271 (9%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            E + I   +G G +G VYKA+    G + A K + T   EEL        E ++L+   
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCD 74

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  IVKL G   H   ++++ E+   G++  I+   D  +     +   + + M  AL +
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNF 132

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  IIHRD+ + N+L+  + +  +ADFG + +       R    GT  ++APE+ 
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 321 YTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
               M +     K D++S G+  +E+   + P   L+ +       ++ I     +  PP
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKI----AKSDPP 240

Query: 376 VDQKVIQDILLASTISF--ACLQSNPKSRPT 404
                           F    L  NP++RP+
Sbjct: 241 TLLT--PSKWSVEFRDFLKIALDKNPETRPS 269

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (320), Expect = 8e-34
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 42/279 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            D  +K+ +G G YG VY+       +  A+K L     E   F+K    EA V+ ++ H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 68

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            ++V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL 127

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----A 316
                 + IHRD+++ N L+       VADFG +R +  D    T  A           A
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 180

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ----- 370
           PE       + K DV++FGV+  E+   G  P            P I L  V +      
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDY 229

Query: 371 RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           R+  P    + + +++       AC Q NP  RP+   +
Sbjct: 230 RMERPEGCPEKVYELMR------ACWQWNPSDRPSFAEI 262

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  130 bits (328), Expect = 1e-33
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 40/281 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E   ++  +G G +G V+        +V A+K L        AF++    EAQV+ ++ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRH 238

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +V+LY     ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV 296

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPE 318
                 + +HRD+ + NIL+   L   VADFG AR +  +   +           + APE
Sbjct: 297 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPE 351

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RL 372
            A     T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRM 400

Query: 373 PPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           P P +  + + D++        C +  P+ RPT +Y+    
Sbjct: 401 PCPPECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 435

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  127 bits (320), Expect = 1e-33
 Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 24/266 (9%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            E F +   +G G YGSVYKA     G++ A+K++          ++    E  ++ Q  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCD 82

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
              +VK YG       ++++ EY   GS+  I+   ++ +  D      I+++    L Y
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEY 140

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH       IHRDI + NILLN++  A +ADFG A +L    + R  + GT  ++APE+ 
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
             +      D++S G+  +E+  GK P   +  + +     I +I       PPP  +K 
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMI----PTNPPPTFRK- 247

Query: 381 IQDILLASTISF--ACLQSNPKSRPT 404
             ++   +   F   CL  +P+ R T
Sbjct: 248 -PELWSDNFTDFVKQCLVKSPEQRAT 272

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  131 bits (330), Expect = 2e-33
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 40/281 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E   ++  +G G +G V+        +V A+K L        AF++    EAQV+ ++ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRH 321

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +V+LY     ++ ++++ EYM +GSL   L  +     L   + V++   +A  +AY+
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV 379

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYIAPE 318
                 + +HRD+ + NIL+   L   VADFG AR +  +   +           + APE
Sbjct: 380 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPE 434

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RL 372
            A     T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRM 483

Query: 373 PPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           P P +  + + D++        C +  P+ RPT +Y+    
Sbjct: 484 PCPPECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 518

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  125 bits (317), Expect = 3e-33
 Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 15/209 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +G G +G+VY A+   N  + ALK L  S+ E+       R E ++ S + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHAL 258
            +I+++Y +   +K ++L+ E+  RG L+  L      DE      +     ++ +A AL
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR----SAT--FMEELADAL 127

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            Y H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ PE
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPE 182

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +       EK D++  GV+  E L+G  P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (315), Expect = 5e-33
 Identities = 63/269 (23%), Positives = 108/269 (40%), Gaps = 43/269 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG  +VY A+        A+K +     E+   +K F  E    SQ+ H++IV +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                 C +L+ EY+E  +L   +        L     +N    +   + + H      I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM---RI 132

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGYIAPELAYTMVMTEK 328
           +HRDI   NIL++S     + DFG A+ L   S  +T  + GT  Y +PE A      E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 329 CDVYSFGVVTLEVLMG--------------KHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
            D+YS G+V  E+L+G              KH +D + ++++     I          P 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI----------PQ 242

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRP 403
            +   +++             + +  +R 
Sbjct: 243 SLSNVILR-----------ATEKDKANRY 260

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (316), Expect = 5e-33
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 8/199 (4%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G GG G VY+A+     ++ ALK +  + + +  F    + EA+   ++    +V ++ 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
           F      +++    +    L  +L      +    A  V IV+ +  AL   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRA--VAIVRQIGSALDAAHAA---GA 155

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGYIAPELAYTMVMTEK 328
            HRD+   NIL+++   A++ DFG A     +   +     GT  Y+APE       T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 329 CDVYSFGVVTLEVLMGKHP 347
            D+Y+   V  E L G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (323), Expect = 6e-33
 Identities = 66/278 (23%), Positives = 122/278 (43%), Gaps = 38/278 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  +   IG G +G V        KV A+K +    T + AF+     EA V++Q+ H 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLA----EASVMTQLRHS 246

Query: 203 SIVKLYGFCLHKK-CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++V+L G  + +K  ++++ EYM +GSL   L +   +  L     +     +  A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL 305

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
                 + +HRD+++ N+L++    A V+DFG  +   +      L      + APE   
Sbjct: 306 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR 359

Query: 322 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPP 375
               + K DV+SFG++  E+   G+ P            P+I L DV+ +     ++  P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVVPRVEKGYKMDAP 408

Query: 376 VD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
                 + D++        C   +  +RPT   + +  
Sbjct: 409 DGCPPAVYDVMK------NCWHLDAATRPTFLQLREQL 440

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (314), Expect = 7e-33
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 46/281 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +D  +   +G G +G V + +   P+GK    A+K L      +   +  F  E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIVKAM 254
           + HR++++LYG  L    M ++ E    GSL   L              +A  V + + M
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGM 134

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT--- 311
                YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       
Sbjct: 135 G----YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
           + + APE   T   +   D + FGV   E+   G+ P              +    +L +
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-----------IGLNGSQILHK 236

Query: 371 ------RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
                 RLP P D  + I ++++       C    P+ RPT
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMV------QCWAHKPEDRPT 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  128 bits (323), Expect = 7e-33
 Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 38/276 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+ A        A+K +        AF+     EA V+  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +VKL+     K+ +++I E+M +GSL   L +D+ + +    K ++    +A  +A++ 
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE 301

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI---APEL 319
                + IHRD+ + NIL+++ L   +ADFG AR +  +    T   G    I   APE 
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEA 356

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLP 373
                 T K DV+SFG++ +E++  G+ P            P +   +V+       R+P
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPY-----------PGMSNPEVIRALERGYRMP 405

Query: 374 PPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            P +  + + +I++       C ++ P+ RPT +Y+
Sbjct: 406 RPENCPEELYNIMM------RCWKNRPEERPTFEYI 435

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  124 bits (313), Expect = 8e-33
 Identities = 63/275 (22%), Positives = 118/275 (42%), Gaps = 48/275 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  +   IG G +G V        KV A+K +    T +     +F  EA V++Q+ H 
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHS 74

Query: 203 SIVKLYGFCLHKK-CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++V+L G  + +K  ++++ EYM +GSL   L +   +  L     +     +  A+ YL
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL 133

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----A 316
                 + +HRD+++ N+L++    A V+DFG  +   +            G +     A
Sbjct: 134 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWTA 182

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ----- 370
           PE       + K DV+SFG++  E+   G+ P            P+I L DV+ +     
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVVPRVEKGY 231

Query: 371 RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           ++  P      + +++        C   +   RP+
Sbjct: 232 KMDAPDGCPPAVYEVMK------NCWHLDAAMRPS 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  126 bits (318), Expect = 8e-33
 Identities = 78/280 (27%), Positives = 124/280 (44%), Gaps = 38/280 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQ 198
            +  I   +G G +G V   +L  P+ K    A+K L    TE+    + F  EA ++ Q
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             H +I++L G     K + ++ EYME GSL   L   D   +    + V +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI--- 315
            YL        +HRD+++ NIL+NS L   V+DFG  R L  D        G    I   
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ---- 370
           +PE       T   DV+S+G+V  EV+  G+ P             ++   DV+      
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-----------WEMSNQDVIKAVDEG 266

Query: 371 -RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            RLPPP+D    +  ++L       C Q +  +RP  + +
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRPKFEQI 300

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  124 bits (313), Expect = 9e-33
 Identities = 67/270 (24%), Positives = 122/270 (45%), Gaps = 28/270 (10%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF +   +G G +  VY+A+ +  G   A+K +      +   ++  +NE ++  Q+ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            SI++LY +      ++L+ E    G +   L N  +    + A+    +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYL 128

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  I+HRD++ +N+LL   +   +ADFG A +L         L GT  YI+PE+A 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPPPVD-- 377
                 + DV+S G +   +L+G+ P D       +   K  L  + + D  +P  +   
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD-------TDTVKNTLNKVVLADYEMPSFLSIE 238

Query: 378 -QKVIQDILLASTISFACLQSNPKSRPTMQ 406
            + +I  +          L+ NP  R ++ 
Sbjct: 239 AKDLIHQL----------LRRNPADRLSLS 258

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (327), Expect = 1e-32
 Identities = 61/269 (22%), Positives = 107/269 (39%), Gaps = 47/269 (17%)

Query: 145 FHIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           + +K CI  GG G +Y A  +  NG+   LK L  S   E         E Q L++V+H 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE--AQAMAMAERQFLAEVVHP 139

Query: 203 SIVKLYGFCLH-----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           SIV+++ F  H         +++ EY+   SL        +  +L  A+ +  +  +  A
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPA 194

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
           L+YLH   S  +++ D+   NI+L     K    + D G   R+++       L GT G+
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEEQLK----LIDLGAVSRINSFGY----LYGTPGF 243

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
            APE+  T   T   D+Y+ G     + +    R+             +  D    +   
Sbjct: 244 QAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN-------GRYVDGLPEDDPVLKTYD 295

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRP 403
              + + +            +  +P+ R 
Sbjct: 296 SYGRLLRR-----------AIDPDPRQRF 313

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (315), Expect = 1e-32
 Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 42/282 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL---PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQ 198
              HI+  IG+G  G V   +L       V  A+K L    TE     + F +EA ++ Q
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             H +I++L G     +   ++ EYME GSL   L   D   +    + V +++ +   +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGM 164

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI--- 315
            YL        +HRD+++ N+L++S L   V+DFG +R L  D         T G I   
Sbjct: 165 RYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIPIR 219

Query: 316 --APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-- 370
             APE       +   DV+SFGVV  EVL  G+ P              +   DV+    
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY-----------WNMTNRDVISSVE 268

Query: 371 ---RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
              RLP P+     +  ++L       C   +   RP    +
Sbjct: 269 EGYRLPAPMGCPHALHQLML------DCWHKDRAQRPRFSQI 304

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (320), Expect = 1e-32
 Identities = 60/307 (19%), Positives = 121/307 (39%), Gaps = 51/307 (16%)

Query: 136 EDLIEATEDFHIKYC----IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 191
            ++    +           +G G  G+V       G+  A+K++       + F      
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALM 57

Query: 192 EAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL----HNDDEAVELDWAK 246
           E ++L++   H ++++ Y      + +++  E     +L  ++     +D+         
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-------------VADFG 293
            +++++ +A  +A+LH   S  IIHRD+   NIL+++                  ++DFG
Sbjct: 117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 294 TARRLHADSSNRTL----LAGTYGYIAPEL-------AYTMVMTEKCDVYSFGVVTLEVL 342
             ++L +  S+        +GT G+ APEL            +T   D++S G V   +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 343 -MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKS 401
             GKHP         S +  I+        +    D+ +I +   A+ +    +  +P  
Sbjct: 234 SKGKHPFG----DKYSRESNIIRGIFSLDEMKCLHDRSLIAE---ATDLISQMIDHDPLK 286

Query: 402 RPTMQYV 408
           RPT   V
Sbjct: 287 RPTAMKV 293

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  125 bits (315), Expect = 1e-32
 Identities = 82/281 (29%), Positives = 123/281 (43%), Gaps = 39/281 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLS 197
                +  IG G +G VYK  L   +GK     A+K L    TE+      F  EA ++ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           Q  H +I++L G     K M +I EYME G+L   L   D   E    + V +++ +A  
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 159

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-- 315
           + YL    + + +HRD+++ NIL+NS L   V+DFG +R L  D       +G    I  
Sbjct: 160 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216

Query: 316 -APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ--- 370
            APE       T   DV+SFG+V  EV+  G+ P             ++   +V+     
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-----------WELSNHEVMKAIND 265

Query: 371 --RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
             RLP P+D    I  +++       C Q     RP    +
Sbjct: 266 GFRLPTPMDCPSAIYQLMM------QCWQQERARRPKFADI 300

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (310), Expect = 2e-32
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 44/275 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   +   +G G +G V+          A+K L        AF+     EA ++ Q+ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQ 68

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY     ++ +++I EYME GSL   L       +L   K +++   +A  +A++ 
Sbjct: 69  RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIE 126

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLAGTYGYI---A 316
                + IHRD+ + NIL++  L   +ADFG AR +  +   +            I   A
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWTA 178

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ----- 370
           PE       T K DV+SFG++  E++  G+ P            P +   +V+       
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-----------PGMTNPEVIQNLERGY 227

Query: 371 RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           R+  P +  + +  ++        C +  P+ RPT
Sbjct: 228 RMVRPDNCPEELYQLMR------LCWKERPEDRPT 256

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  123 bits (310), Expect = 2e-32
 Identities = 61/273 (22%), Positives = 114/273 (41%), Gaps = 42/273 (15%)

Query: 147 IKYCIGTGGYGSVYKAQL--PNGKVF-ALKKLH--TSETEELAFIKSFRNEAQVLSQVLH 201
               +G G +GSV +        ++  A+K L   T + +    ++    EAQ++ Q+ +
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDN 69

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             IV+L G C   + + L+ E    G L   L    E  E+  +    ++  ++  + YL
Sbjct: 70  PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL 126

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI---APE 318
                 + +HRD+++ N+LL ++  A ++DFG ++ L AD S  T  +     +   APE
Sbjct: 127 ---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 319 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RL 372
                  + + DV+S+GV   E L  G+ P             K+   +V+       R+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPY-----------KKMKGPEVMAFIEQGKRM 232

Query: 373 PPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
             P +    +  ++        C     + RP 
Sbjct: 233 ECPPECPPELYALMS------DCWIYKWEDRPD 259

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  123 bits (311), Expect = 3e-32
 Identities = 61/296 (20%), Positives = 110/296 (37%), Gaps = 45/296 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
                   +G G +G V   +        G+  A+K L          I   + E ++L 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILR 78

Query: 198 QVLHRSIVKLYGFCLHKKC--MFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
            + H +IVK  G C       + LI E++  GSL   L  +   +     L +A ++   
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI--- 135

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
                 + YL    S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T     
Sbjct: 136 ---CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKD 187

Query: 312 YGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD---PKI 362
                    APE           DV+SFGV   E+L         ++           ++
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 363 MLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
            +  +++      RLP P +    +  ++        C +  P +R + Q + +GF
Sbjct: 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMR------KCWEFQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  123 bits (310), Expect = 5e-32
 Identities = 70/310 (22%), Positives = 114/310 (36%), Gaps = 48/310 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
                   +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILK 79

Query: 198 QVLHRSIVKLYGFCLHKKC--MFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
            +    IVK  G         + L+ EY+  G L   L      ++    L ++    I 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQIC 137

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           K M     YL    S   +HRD+++ NIL+ S+    +ADFG A+ L  D          
Sbjct: 138 KGME----YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VRE 188

Query: 312 YGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP---RDLLSSLSSSSDPKI 362
            G       APE     + + + DV+SFGVV  E+                +        
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 363 MLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF--LI 414
            L  +L+      RLP P      + +++        C   +P+ RP+   +      L 
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFSALGPQLDMLW 302

Query: 415 TRKTPLVKHA 424
           +       HA
Sbjct: 303 SGSRGCETHA 312

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  124 bits (312), Expect = 7e-32
 Identities = 48/316 (15%), Positives = 115/316 (36%), Gaps = 65/316 (20%)

Query: 142 TEDFHIKYCIGTG--GYGSVYKAQ-LPNGKVFALKK--LHTSETEELAFIKSFRNEAQVL 196
              + +   IG G     +V  A+  P G+   +++  L     E + F+   + E  V 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL---QGELHVS 80

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
               H +IV      +    ++++  +M  GS   ++        ++      I++ +  
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLK 139

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLL-------A 309
           AL Y+HH      +HR + +++IL++   + +++   +   + +    + ++        
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 310 GTYGYIAPELAYTMVMTE-------KCDVYSFGVVTLEVLMGK------HPRDLLSSLSS 356
               +++PE     V+ +       K D+YS G+   E+  G           +L    +
Sbjct: 197 KVLPWLSPE-----VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA----------------------- 393
            + P ++    +          + + +  L+ +++ +                       
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 394 -----CLQSNPKSRPT 404
                CLQ NP +RP+
Sbjct: 312 HFVEQCLQRNPDARPS 327

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  122 bits (308), Expect = 9e-32
 Identities = 68/285 (23%), Positives = 111/285 (38%), Gaps = 57/285 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF---ALKKLH--TSETEELAFIKSFRNEAQV 195
            +F     +G+G +G+VYK        KV    A+K+L   TS       +     EA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYV 70

Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
           ++ V +  + +L G CL    + LI + M  G L   +    + +     L+W   V I 
Sbjct: 71  MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIA 127

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           K M     YL       ++HRD+++ N+L+ +     + DFG A+ L A+          
Sbjct: 128 KGMN----YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AE 177

Query: 312 YGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 365
            G +     A E     + T + DV+S+GV   E++  G  P              I   
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----------DGIPAS 226

Query: 366 DVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           ++        RLP P      +  I++       C   +  SRP 
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMV------KCWMIDADSRPK 265

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 1e-31
 Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 33/272 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             +     +G GG+   ++       +VFA K +  S   +    +    E  +   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-----NDDEAVELDWAKRVNIVKAMAH 256
           + +V  +GF      +F++ E   R SL  +        + EA       R   ++ +  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
              YLH      +IHRD+   N+ LN  LE  + DFG A ++  D   + +L GT  YIA
Sbjct: 127 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPP 374
           PE+      + + DV+S G +   +L+GK P +       +S  K     I   +  +P 
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKETYLRIKKNEYSIPK 236

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
            ++       L+        LQ++P +RPT+ 
Sbjct: 237 HINPVAAS--LIQK-----MLQTDPTARPTIN 261

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (307), Expect = 1e-31
 Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 33/272 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             +     +G GG+   ++       +VFA K +  S   +    +    E  +   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-----NDDEAVELDWAKRVNIVKAMAH 256
           + +V  +GF      +F++ E   R SL  +        + EA       R   ++ +  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
              YLH      +IHRD+   N+ LN  LE  + DFG A ++  D   + +L GT  YIA
Sbjct: 153 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML--IDVLDQRLPP 374
           PE+      + + DV+S G +   +L+GK P +       +S  K     I   +  +P 
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKETYLRIKKNEYSIPK 262

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
            ++       L+        LQ++P +RPT+ 
Sbjct: 263 HINPVAAS--LIQK-----MLQTDPTARPTIN 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  120 bits (304), Expect = 2e-31
 Identities = 53/286 (18%), Positives = 101/286 (35%), Gaps = 45/286 (15%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           T +FH    IG+G +GSV+K     +G ++A+K+            ++   E    + + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLG 68

Query: 201 -HRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMAHAL 258
            H  +V+ +        M +  EY   GSL   I  N         A+  +++  +   L
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFV-------------------ADFGTARRLH 299
            Y+H   S S++H DI  +NI ++                           D G   R+ 
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184

Query: 300 ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS 358
              S+  +  G   ++A E L        K D+++  +  +     +             
Sbjct: 185 ---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH--- 238

Query: 359 DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPT 404
             +I       Q   P + Q + Q+      +    +  +P+ RP+
Sbjct: 239 --EIR------QGRLPRIPQVLSQE--FTELLK-VMIHPDPERRPS 273

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (314), Expect = 2e-31
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 22/221 (9%)

Query: 138 LIEATEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           +  +T  F  +Y      G G +G V        G+  A+K +   + ++    +S   E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
            Q+L Q+ H +I+KLY F   K   +L+ E    G LF  + +     E+D A+   I++
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIR 133

Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLA 309
            +   + Y+H      I+HRD+   N+LL SK +     + DFG +    A    +    
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KI 189

Query: 310 GTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           GT  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 190 GTAYYIAPEVLHGTY----DEKCDVWSTGVILYILLSGCPP 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  120 bits (302), Expect = 3e-31
 Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 42/269 (15%)

Query: 151 IGTGGYGSVYKAQLPNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G +G+V K      KV    A+K L  +E  + A       EA V+ Q+ +  IV++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            G C   +   L+ E  E G L   L  +     +     + +V  ++  + YL      
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ES 136

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI-----APELAYT 322
           + +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G       APE    
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINY 194

Query: 323 MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPV 376
              + K DV+SFGV+  E    G+ P              +   +V        R+  P 
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPY-----------RGMKGSEVTAMLEKGERMGCPA 243

Query: 377 D-QKVIQDILLASTISFACLQSNPKSRPT 404
              + + D++        C   + ++RP 
Sbjct: 244 GCPREMYDLMN------LCWTYDVENRPG 266

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  120 bits (304), Expect = 3e-31
 Identities = 63/285 (22%), Positives = 106/285 (37%), Gaps = 57/285 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL----PNGKVF-ALK--KLHTSETEELAFIKSFRNEAQV 195
            +      +G+G +G+V+K        + K+   +K  +  +      A           
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD----HMLA 68

Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
           +  + H  IV+L G C     + L+ +Y+  GSL   +     A+     L+W   V I 
Sbjct: 69  IGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIA 125

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           K M     YL       ++HR++++ N+LL S  +  VADFG A  L  D         +
Sbjct: 126 KGMY----YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYS 175

Query: 312 YGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 365
                    A E  +    T + DV+S+GV   E++  G  P              + L 
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY-----------AGLRLA 224

Query: 366 DVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           +V D      RL  P      +  +++       C   +   RPT
Sbjct: 225 EVPDLLEKGERLAQPQICTIDVYMVMV------KCWMIDENIRPT 263

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  124 bits (312), Expect = 6e-31
 Identities = 62/275 (22%), Positives = 116/275 (42%), Gaps = 42/275 (15%)

Query: 151 IGTGGYGSVYKAQL--PNGKVF-ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRSIV 205
           +G G +GSV +        ++  A+K L   T + +    ++    EAQ++ Q+ +  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPYIV 399

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
           +L G C   + + L+ E    G L   L    E  E+  +    ++  ++  + YL    
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL---E 453

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI---APELAYT 322
             + +HR++++ N+LL ++  A ++DFG ++ L AD S  T  +     +   APE    
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 323 MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-----RLPPPV 376
              + + DV+S+GV   E L  G+ P             K+   +V+       R+  P 
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY-----------KKMKGPEVMAFIEQGKRMECPP 562

Query: 377 D-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           +    +  ++        C     + RP    V Q
Sbjct: 563 ECPPELYALMS------DCWIYKWEDRPDFLTVEQ 591

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (304), Expect = 6e-31
 Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 34/272 (12%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            + F     IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H + ++  G  L +   +L+ EY   GS   +L    + ++        +       LAY
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S ++IHRD+ + NILL+      + DFG+A  +    +      GT  ++APE+ 
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVI 222

Query: 321 YTMVMTE---KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
             M   +   K DV+S G+  +E+   K P   ++++S+     +  I     +   P  
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHI----AQNESPAL 273

Query: 378 Q-----KVIQDILLASTISFACLQSNPKSRPT 404
           Q     +  ++ +       +CLQ  P+ RPT
Sbjct: 274 QSGHWSEYFRNFVD------SCLQKIPQDRPT 299

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (301), Expect = 9e-31
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 41/283 (14%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
              F +   +G G YG VYK + +  G++ A+K +  +  E     +  + E  +L +  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYS 78

Query: 201 -HRSIVKLYGFCLHKKC------MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            HR+I   YG  + K        ++L+ E+   GS+  ++ N      L       I + 
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICRE 137

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   L++LH      +IHRDI   N+LL    E  + DFG + +L      R    GT  
Sbjct: 138 ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 314 YIAPELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL 368
           ++APE+       +     K D++S G+  +E+  G  P   +  + +     + LI   
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLI--- 246

Query: 369 DQRLPPPVDQ-----KVIQDILLASTISFACLQSNPKSRPTMQ 406
             R P P  +     K  Q  +       +CL  N   RP  +
Sbjct: 247 -PRNPAPRLKSKKWSKKFQSFIE------SCLVKNHSQRPATE 282

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  118 bits (298), Expect = 1e-30
 Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 69/297 (23%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFA-----------LKKLHTSETEELAFIKSFRN 191
           ED      +G G +  ++K        +            L K H + +E       F  
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES------FFE 61

Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
            A ++S++ H+ +V  YG C+      L+ E+++ GSL   L  +   + + W  ++ + 
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVA 119

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF--------VADFGTARRLHADSS 303
           K +A A+ +L      ++IH ++ + NILL  + +          ++D G +  +     
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175

Query: 304 NRTLLAGTYGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS 356
                             PE +     +    D +SFG    E+   G  P   LS+L S
Sbjct: 176 --------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDS 224

Query: 357 SSDPKIMLIDVLDQ-----RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                      L       +LP P   ++   I         C+   P  RP+ + +
Sbjct: 225 Q--------RKLQFYEDRHQLPAPKAAELANLIN-------NCMDYEPDHRPSFRAI 266

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (298), Expect = 1e-30
 Identities = 73/297 (24%), Positives = 118/297 (39%), Gaps = 47/297 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
                   +G G +GSV   +        G+V A+KKL  S  E L   + F  E ++L 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILK 66

Query: 198 QVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
            + H +IVK  G C    ++ + LI EY+  GSL   L    E ++    L +     I 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQIC 124

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           K M     YL    +   IHRD+++ NIL+ ++    + DFG  + L  D          
Sbjct: 125 KGME----YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VKE 175

Query: 312 YGYI-----APELAYTMVMTEKCDVYSFGVV-----TLEVLMGKHPRDLLSSLSSSSDPK 361
            G       APE       +   DV+SFGVV     T        P + +  + +    +
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 362 IMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           +++  +++      RLP P      I  I+        C  +N   RP+ + ++   
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 286

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (298), Expect = 2e-30
 Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 50/275 (18%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY- 208
           +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + H +IV +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 209 -GF--CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
            G          +++ EY++  +L  I+H       +   + + ++     AL + H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT---LLAGTYGYIAPELAYT 322
              IIHRD+   NI++++     V DFG AR +    ++ T    + GT  Y++PE A  
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 323 MVMTEKCDVYSFGVVTLEVLMG--------------KHPRDLLSSLSSSSDPKIMLIDVL 368
             +  + DVYS G V  EVL G              +H R+     S+            
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-----------R 242

Query: 369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRP 403
            + L   +D  V++            L  NP++R 
Sbjct: 243 HEGLSADLDAVVLK-----------ALAKNPENRY 266

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  121 bits (305), Expect = 2e-30
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 23/221 (10%)

Query: 138 LIEATEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNE 192
           +          Y      G+G YG V            A+K +  +     +       E
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEE 86

Query: 193 AQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
             VL  + H +I+KLY F   K+  +L+ E  + G LF  + +  +  E+D A    I+K
Sbjct: 87  VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIK 143

Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLA 309
            +   + YLH     +I+HRD+   N+LL SK +     + DFG +     +        
Sbjct: 144 QVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL 199

Query: 310 GTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           GT  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 200 GTAYYIAPEVLRKKY----DEKCDVWSIGVILFILLAGYPP 236

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  117 bits (295), Expect = 4e-30
 Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 53/296 (17%)

Query: 136 EDLIEATEDFHIKY---------CIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEE 182
            +L++A +   I            IG G +G VY   L   +GK    A+K L+      
Sbjct: 9   PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 183 LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHNDDEAVE 241
              +  F  E  ++    H +++ L G CL  +    ++  YM+ G L   + N+     
Sbjct: 69  E--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--N 124

Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
                 +     +A  + YL    S   +HRD+++ N +L+ K    VADFG AR ++  
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

Query: 302 SSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-------GKHPRD 349
                    T   +     A E   T   T K DV+SFGV+  E++          +  D
Sbjct: 182 EYYSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

Query: 350 LLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           +   L               +RL  P      + +++L       C     + RP+
Sbjct: 241 ITVYLLQ------------GRRLLQPEYCPDPLYEVML------KCWHPKAEMRPS 278

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  116 bits (294), Expect = 4e-30
 Identities = 72/280 (25%), Positives = 112/280 (40%), Gaps = 49/280 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVL 196
           E   +  CIG G +G V++     P       A+K     TS++    F++    EA  +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ----EALTM 70

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
            Q  H  IVKL G    +  +++I E    G L   L        LD A  +     ++ 
Sbjct: 71  RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLST 127

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI- 315
           ALAYL    S   +HRDI++ N+L++S     + DFG +R +   +  +     + G + 
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLP 180

Query: 316 ----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
               APE       T   DV+ FGV   E+LM G  P              +   DV+ +
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----------QGVKNNDVIGR 229

Query: 371 -----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
                RLP P +    +  ++        C   +P  RP 
Sbjct: 230 IENGERLPMPPNCPPTLYSLMT------KCWAYDPSRRPR 263

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  117 bits (296), Expect = 5e-30
 Identities = 73/297 (24%), Positives = 116/297 (39%), Gaps = 47/297 (15%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
                   +G G +GSV   +        G+V A+KKL  S  E L   + F  E ++L 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILK 97

Query: 198 QVLHRSIVKLYGFCLHKKC--MFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIV 251
            + H +IVK  G C       + LI EY+  GSL   L    E ++    L +     I 
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQIC 155

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
           K M     YL    +   IHRD+++ NIL+ ++    + DFG  + L  D          
Sbjct: 156 KGME----YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VKE 206

Query: 312 YGYI-----APELAYTMVMTEKCDVYSFGVV-----TLEVLMGKHPRDLLSSLSSSSDPK 361
            G       APE       +   DV+SFGVV     T        P + +  + +    +
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266

Query: 362 IMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           +++  +++      RLP P      I  I+        C  +N   RP+ + ++   
Sbjct: 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 317

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (293), Expect = 6e-30
 Identities = 68/289 (23%), Positives = 114/289 (39%), Gaps = 59/289 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVL 196
           ED  +   +G G +G VY+       G+    A+K      +   +  F+     EA ++
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS----EAVIM 67

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE----LDWAKRVNIVK 252
             + H  IVKL G    ++  ++I E    G L   L  +  +++    + ++ ++    
Sbjct: 68  KNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI---- 122

Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD---SSNRTLLA 309
               A+AYL    S + +HRDI+  NIL+ S     + DFG +R +  +    ++ T L 
Sbjct: 123 --CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177

Query: 310 GTYGYI---APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI 365
                I   +PE       T   DV+ F V   E+L  GK P   L +            
Sbjct: 178 -----IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----------- 221

Query: 366 DVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           DV+       RLP P     V+  ++        C   +P  RP    +
Sbjct: 222 DVIGVLEKGDRLPKPDLCPPVLYTLMT------RCWDYDPSDRPRFTEL 264

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  117 bits (296), Expect = 9e-30
 Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 53/296 (17%)

Query: 136 EDLIEATEDF---------HIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEE 182
            +L++A +           H    IG G +G VY   L   +GK    A+K L+      
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132

Query: 183 LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHNDDEAVE 241
              +  F  E  ++    H +++ L G CL  +    ++  YM+ G L   + N+     
Sbjct: 133 E--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--N 188

Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
                 +     +A  + +L    S   +HRD+++ N +L+ K    VADFG AR ++  
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

Query: 302 SSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-------GKHPRD 349
             +      T   +     A E   T   T K DV+SFGV+  E++          +  D
Sbjct: 246 EFDSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

Query: 350 LLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           +   L               +RL  P      + +++L       C     + RP+
Sbjct: 305 ITVYLLQ------------GRRLLQPEYCPDPLYEVML------KCWHPKAEMRPS 342

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (293), Expect = 1e-29
 Identities = 53/296 (17%), Positives = 110/296 (37%), Gaps = 38/296 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             + +   +G G   +V++ +    G +FA+K  +         +     E +VL ++ H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66

Query: 202 RSIVKLYGF--CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           ++IVKL+        +   LI E+   GSL+ +L     A  L  ++ + +++ +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLAGTYGYI 315
           +L       I+HR+I   NI+     +      + DFG AR L  D    +L  GT  Y+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182

Query: 316 APELAYTMVM--------TEKCDVYSFGVVTLEVLMGKHP----------RDLLSSLSSS 357
            P++    V+            D++S GV       G  P          ++++  + + 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISF-------ACLQSNPKSRPTMQ 406
                +      +  P      +     L+  +           L+++ +      
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  118 bits (298), Expect = 2e-29
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)

Query: 139 IEATEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEA 193
           +     F  +Y I    G G +G V K       + +A+K ++ +  +      +   E 
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREV 72

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           ++L ++ H +I+KL+         +++ E    G LF  +       E D A+   I+K 
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQ 129

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAG 310
           +   + Y+H     +I+HRD+   NILL SK +     + DFG +     ++  +    G
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIG 185

Query: 311 TYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 186 TAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (290), Expect = 2e-29
 Identities = 61/294 (20%), Positives = 106/294 (36%), Gaps = 43/294 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
                   +G G +G V            G++ A+K L      +      ++ E  +L 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILR 88

Query: 198 QVLHRSIVKLYGFCLHKKC--MFLIYEYMERGSLFCILHNDDEAVE--LDWAKRVNIVKA 253
            + H  I+K  G C       + L+ EY+  GSL   L      +   L +A    I + 
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEG 146

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           MA    YLH   +   IHRD+++ N+LL++     + DFG A+ +              G
Sbjct: 147 MA----YLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDG 197

Query: 314 YI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSD---PKIML 364
                  APE           DV+SFGV   E+L      +   +           ++ +
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257

Query: 365 IDVLD-----QRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
           + + +     +RLP P      +  ++        C ++    RPT + +    
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVYHLMK------NCWETEASFRPTFENLIPIL 305

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  116 bits (292), Expect = 3e-29
 Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 22/210 (10%)

Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--ETEELAFIKSFRNEAQVLSQ 198
            + + +   IG G +  V +      G+ FA+K +  +   +      +  + EA +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV-------NIV 251
           + H  IV+L         +++++E+M+   L        E V+   A  V       + +
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYM 136

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLL 308
           + +  AL Y H     +IIHRD+  + +LL SK  +    +  FG A +L          
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
            GT  ++APE+       +  DV+  GV+ 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  116 bits (292), Expect = 3e-29
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)

Query: 144 DFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
                  +G G +G V+K  +   G   A K + T   ++    +  +NE  V++Q+ H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++++LY     K  + L+ EY++ G LF  I+       ELD       +K +   + ++
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI---LFMKQICEGIRHM 203

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARRLHADSSNRTLLAGTYGYIAPE- 318
           H      I+H D+   NIL  ++    +   DFG ARR       +    GT  ++APE 
Sbjct: 204 H---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEV 259

Query: 319 LAYTMVMTEKCDVYSFGVVT 338
           + Y  V +   D++S GV+ 
Sbjct: 260 VNYDFV-SFPTDMWSVGVIA 278

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (289), Expect = 1e-28
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 21/220 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             + +   +G G   +V++ +    G +FA+K  +         +     E +VL ++ H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66

Query: 202 RSIVKLYGF--CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
           ++IVKL+        +   LI E+   GSL+ +L     A  L  ++ + +++ +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLAGTYGYI 315
           +L       I+HR+I   NI+     +      + DFG AR L  D    +L  GT  Y+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182

Query: 316 APELAYTMVM--------TEKCDVYSFGVVTLEVLMGKHP 347
            P++    V+            D++S GV       G  P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  113 bits (285), Expect = 1e-28
 Identities = 63/286 (22%), Positives = 108/286 (37%), Gaps = 50/286 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-----KVFALKKLH--TSETEELAFIKSFRNEAQV 195
              H    IG G +G VY  +  +      +  A+K L   T   +  AF++    E  +
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLR----EGLL 75

Query: 196 LSQVLHRSIVKLYGFCLHKKCM-FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           +  + H +++ L G  L  + +  ++  YM  G L   + +            ++    +
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQV 133

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
           A  + YL        +HRD+++ N +L+      VADFG AR +             +  
Sbjct: 134 ARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV-QQHRHAR 189

Query: 315 I-----APELAYTMVMTEKCDVYSFGVVTLEVLM-------GKHPRDLLSSLSSSSDPKI 362
           +     A E   T   T K DV+SFGV+  E+L           P DL   L+       
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------ 243

Query: 363 MLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQY 407
                  +RLP P      +  ++        C +++P  RPT + 
Sbjct: 244 ------GRRLPQPEYCPDSLYQVMQ------QCWEADPAVRPTFRV 277

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (289), Expect = 1e-28
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
               +  Y I    G+G +G V++  +   G+VF  K ++T    +     + +NE  ++
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIM 102

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMA 255
           +Q+ H  ++ L+     K  M LI E++  G LF  I   D +  E +     N ++   
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI---NYMRQAC 159

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARRLHADSSNRTLLAGTYG 313
             L ++H     SI+H DI   NI+  +K  + V   DFG A +L+ D   +     T  
Sbjct: 160 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAE 215

Query: 314 YIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           + APE +    V     D+++ GV+   +L G  P
Sbjct: 216 FAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSP 249

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  116 bits (293), Expect = 1e-28
 Identities = 68/231 (29%), Positives = 97/231 (41%), Gaps = 32/231 (13%)

Query: 138 LIEATEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTS----------ETEE 182
           + +        Y      G+G YG V    +       A+K +  S              
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 183 LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVEL 242
             F +   NE  +L  + H +I+KL+     KK  +L+ E+ E G LF  + N  +  E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 243 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLH 299
           D A    I+K +   + YLH     +I+HRDI   NILL +K       + DFG +    
Sbjct: 147 DAAN---IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 300 ADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            D   R    GT  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 201 KDYKLRD-RLGTAYYIAPEVLKKKY----NEKCDVWSCGVIMYILLCGYPP 246

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  117 bits (294), Expect = 1e-28
 Identities = 58/249 (23%), Positives = 104/249 (41%), Gaps = 21/249 (8%)

Query: 109 KKPKVKARATNSIDVFSIWNYDGRIFYEDLIEA-TEDFHIKYCI----GTGGYGSVYKA- 162
           +   V+ + T S +  +      + +Y   +E   +     Y I    GTG +G V++  
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177

Query: 163 QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE 222
           +   G  FA K + T    +    ++ R E Q +S + H ++V L+        M +IYE
Sbjct: 178 ERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234

Query: 223 YMERGSLFC-ILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 281
           +M  G LF  +    ++  E +       ++ +   L ++H     + +H D+   NI+ 
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAV---EYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 288

Query: 282 NSKLEAFV--ADFGTARRLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 338
            +K    +   DFG    L    S +    GT  + APE      V     D++S GV++
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPV-GYYTDMWSVGVLS 346

Query: 339 LEVLMGKHP 347
             +L G  P
Sbjct: 347 YILLSGLSP 355

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (289), Expect = 1e-28
 Identities = 44/295 (14%), Positives = 90/295 (30%), Gaps = 60/295 (20%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ----------- 198
           +G     +  +A     G+ F +   + +E      IK  + E   L             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 199 -----------VLHRSIVKLYGFCLHKKCM-----FLIYEYMER--GSLFCILHNDDEAV 240
                      V      K+    L ++ M     F +Y  M+    +   +L +     
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 241 E-LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
           + L    R+ +   +   LA LH      ++H  +   +I+L+ +   F+  F    R  
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 260

Query: 300 ADSSNRTLLAGTYG---YIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLL 351
             +S  + +   +      A  +         +MT   D ++ G+    +     P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 352 SSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           ++L          I    + +P PV     + +L         L+   + R    
Sbjct: 321 AALGG-----SEWIFRSCKNIPQPV-----RALLE------GFLRYPKEDRLLPL 359

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (290), Expect = 1e-28
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 30/225 (13%)

Query: 133 IFYEDLIEATEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEE 182
           +  +D     +    +Y +    G+G  G V  A +    K  A++     K       E
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180

Query: 183 LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE- 241
                +   E ++L ++ H  I+K+  F    +  +++ E ME G LF      D+ V  
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGN 233

Query: 242 --LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTAR 296
             L  A        M  A+ YLH      IIHRD+   N+LL+S+ E     + DFG ++
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290

Query: 297 RLHADSSNRTLLAGTYGYIAPE-LAYTMVM--TEKCDVYSFGVVT 338
            L   S  RT L GT  Y+APE L            D +S GV+ 
Sbjct: 291 ILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (283), Expect = 1e-28
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
              F  +Y I    G G +G V K       + +A+K ++ +  +      +   E ++L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELDWAKRVNI 250
            ++ H +I+KL+         +++ E    G LF      DE +      E D A+   I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAAR---I 126

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTL 307
           +K +   + Y+H     +I+HRD+   NILL SK +     + DFG +     ++  +  
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD- 182

Query: 308 LAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
             GT  YIAPE+    Y     EKCDV+S GV+ 
Sbjct: 183 RIGTAYYIAPEVLRGTY----DEKCDVWSAGVIL 212

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  117 bits (294), Expect = 2e-28
 Identities = 66/286 (23%), Positives = 107/286 (37%), Gaps = 30/286 (10%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            + +K  +GTGG+G V +      G+  A+K+     + +    + +  E Q++ ++ H 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHP 72

Query: 203 SIVKLY------GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           ++V                   L  EY E G L   L+  +    L       ++  ++ 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYG 313
           AL YLH      IIHRD+   NI+L    +     + D G A+ L         + GT  
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQ 188

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-------HPRDLLSSLSSSSDPKIMLID 366
           Y+APEL      T   D +SFG +  E + G         P      +   S+  I++ D
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 367 VLDQR------LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
            L         LP P     I    L   +    L  + + R T  
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM-LMWHQRQRGTDP 293

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  116 bits (292), Expect = 3e-28
 Identities = 72/280 (25%), Positives = 112/280 (40%), Gaps = 49/280 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVL 196
           E   +  CIG G +G V++     P       A+K     TS++    F++    EA  +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ----EALTM 445

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
            Q  H  IVKL G    +  +++I E    G L   L        LD A  +     ++ 
Sbjct: 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLST 502

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI- 315
           ALAYL    S   +HRDI++ N+L++S     + DFG +R +   +  +     + G + 
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLP 555

Query: 316 ----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
               APE       T   DV+ FGV   E+LM G  P              +   DV+ +
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----------QGVKNNDVIGR 604

Query: 371 -----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
                RLP P +    +  ++        C   +P  RP 
Sbjct: 605 IENGERLPMPPNCPPTLYSLMT------KCWAYDPSRRPR 638

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  112 bits (282), Expect = 5e-28
 Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 58/287 (20%)

Query: 151 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 201
           +G G +G VY+ Q+          +V A+K L    SE +EL F+     EA ++S+  H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLM----EALIISKFNH 92

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL----HNDDEAVELDWAKRVNIVKAMAHA 257
           ++IV+  G  L     F++ E M  G L   L        +   L     +++ + +A  
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGY 314
             YL        IHRDI++ N LL       V    DFG AR ++  S  R    G    
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAM 206

Query: 315 I-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDV 367
           +      PE      + T K D +SFGV+  E+  +G  P            P     +V
Sbjct: 207 LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY-----------PSKSNQEV 254

Query: 368 LDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
           L+      R+ PP +    +  I+        C Q  P+ RP    +
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAII 295

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  111 bits (279), Expect = 6e-28
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 40/217 (18%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRN 191
           +  F   Y +    G G +  V +      G  FA K     KL   + ++L        
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------ER 54

Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDW---AKRV 248
           EA++  ++ H +IV+L+     +   +L+++ +  G LF      ++ V  ++   A   
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADAS 108

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNR 305
           + ++ +  ++AY H   S  I+HR++   N+LL SK +     +ADFG A  ++   +  
Sbjct: 109 HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165

Query: 306 TLLAGTYGYIAPEL----AYTMVMTEKCDVYSFGVVT 338
              AGT GY++PE+     Y    ++  D+++ GV+ 
Sbjct: 166 G-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVIL 197

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (283), Expect = 6e-28
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 21/210 (10%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 193
            +     Y I    G+G +  V K  +   G  +A K   K  +  +      +    E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            +L QVLH +I+ L+    ++  + LI E +  G LF  L   +   E +     + +K 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQ 123

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLA 309
           +   + YLH   +  I H D+   NI+L  K        + DFG A  +      +  + 
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IF 179

Query: 310 GTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 338
           GT  ++APE + Y  +   + D++S GV+T
Sbjct: 180 GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 208

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (280), Expect = 8e-28
 Identities = 59/290 (20%), Positives = 113/290 (38%), Gaps = 42/290 (14%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HR 202
             ++  +  GG+  VY+AQ + +G+ +ALK+L ++E E+    ++   E   + ++  H 
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHP 86

Query: 203 SIVKLYGFCL-------HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           +IV+               +  FL+   + +G L   L   +    L     + I     
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA------ 309
            A+ ++H    P IIHRD+   N+LL+++    + DFG+A  +                 
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 310 ------GTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP 360
                  T  Y  PE+        + EK D+++ G +   +   +HP +  + L      
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260

Query: 361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                 +++ +   P            S I    LQ NP+ R ++  V  
Sbjct: 261 ------IVNGKYSIPPHDTQYTV--FHSLIRA-MLQVNPEERLSIAEVVH 301

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  112 bits (282), Expect = 8e-28
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 40/223 (17%)

Query: 136 EDLIEATEDFHIKY----CIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAF 185
           E ++ A+  F   Y     +G G +  V +      G  FA K     KL   + ++L  
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-- 75

Query: 186 IKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDW- 244
                 EA++  ++ H +IV+L+     +   +L+++ +  G LF      ++ V  ++ 
Sbjct: 76  ----EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFY 125

Query: 245 --AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLH 299
             A   + ++ +  ++AY H   S  I+HR++   N+LL SK +     +ADFG A  ++
Sbjct: 126 SEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 300 ADSSNRTLLAGTYGYIAPEL----AYTMVMTEKCDVYSFGVVT 338
              +     AGT GY++PE+     Y    ++  D+++ GV+ 
Sbjct: 183 DSEAWHG-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVIL 220

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (285), Expect = 9e-28
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 39/217 (17%)

Query: 142 TEDFHIKYC----IGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRN 191
              F  +Y     +G G +  V +  ++  G+ +A       KL   + ++L        
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------ER 59

Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDW---AKRV 248
           EA++   + H +IV+L+     +   +LI++ +  G LF      ++ V  ++   A   
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADAS 113

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNR 305
           + ++ +  A+ + H      ++HR++   N+LL SKL+     +ADFG A  +  +    
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 306 TLLAGTYGYIAPEL----AYTMVMTEKCDVYSFGVVT 338
              AGT GY++PE+     Y     +  D+++ GV+ 
Sbjct: 171 FGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVIL 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  110 bits (277), Expect = 1e-27
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 22/209 (10%)

Query: 142 TEDFHIKYC----IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
                  +     +G+G +G V+   +  +G    +K ++   ++    ++    E +VL
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVL 74

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMA 255
             + H +I+K++        M+++ E  E G L   I+        L       ++K M 
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTY 312
           +ALAY H   S  ++H+D+   NIL           + DFG A    +D  +    AGT 
Sbjct: 135 NALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-AAGTA 190

Query: 313 GYIAPEL---AYTMVMTEKCDVYSFGVVT 338
            Y+APE+         T KCD++S GVV 
Sbjct: 191 LYMAPEVFKRDV----TFKCDIWSAGVVM 215

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  112 bits (281), Expect = 1e-27
 Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 58/283 (20%)

Query: 151 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 201
           +G G +G VY+ Q+          +V A+K L    SE +EL F+     EA ++S+  H
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFL----MEALIISKFNH 133

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL----HNDDEAVELDWAKRVNIVKAMAHA 257
           ++IV+  G  L     F++ E M  G L   L        +   L     +++ + +A  
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFV---ADFGTARRLHADSSNRTLLAGTYGY 314
             YL        IHRDI++ N LL       V    DFG AR ++     R    G    
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAM 247

Query: 315 I-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDV 367
           +      PE      + T K D +SFGV+  E+  +G  P            P     +V
Sbjct: 248 LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY-----------PSKSNQEV 295

Query: 368 LDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           L+      R+ PP +    +  I+        C Q  P+ RP 
Sbjct: 296 LEFVTSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPN 332

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  110 bits (278), Expect = 2e-27
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 21/210 (10%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 193
            +     Y I    G+G +  V K  +   G  +A K   K  +  +      +    E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            +L QVLH +++ L+    ++  + LI E +  G LF  L   +   E +     + +K 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQ 123

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLA 309
           +   + YLH   +  I H D+   NI+L  K        + DFG A  +      +  + 
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IF 179

Query: 310 GTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 338
           GT  ++APE + Y  +   + D++S GV+T
Sbjct: 180 GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 208

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  110 bits (277), Expect = 2e-27
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 56/290 (19%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-------PNGKVFALKKL--HTSETEELAFIKSFRNEA 193
           E   +   +G G +G VY+          P  +V A+K +    S  E + F+     EA
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLN----EA 79

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-------HNDDEAVELDWAK 246
            V+ +     +V+L G     +   +I E M RG L   L        N+        +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            + +   +A  +AYL+   +   +HRD+++ N ++       + DFG  R ++     R 
Sbjct: 140 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 195

Query: 307 LLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 360
              G  G +     +PE     V T   DV+SFGVV  E+    + P             
Sbjct: 196 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----------Q 242

Query: 361 KIMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
            +    VL        L  P +   ++ +++        C Q NPK RP+
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPS 286

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (279), Expect = 2e-27
 Identities = 42/299 (14%), Positives = 93/299 (31%), Gaps = 67/299 (22%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQ--------------- 194
           +G     +  +A     G+ F +   + +E      IK  + E                 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 195 ----------VLSQVLHRSIVKLYGFCLHKKCM--FLIYEYME--RGSLFCILHNDDEAV 240
                     ++     + ++++         +  F +Y  M+    +   +L +     
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 241 E-LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
           + L    R+ +   +   LA LH      ++H  +   +I+L+ +   F+  F    R  
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 300 ADSSNRTLLAGTYGYIAPEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPR 348
                R + + + G+  PEL               +MT   D ++ G+V   +     P 
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 349 DLLSSLSSSSDPKIM-LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
                ++  +       I    + +P PV     + +L         L+   + R    
Sbjct: 313 -----ITKDAALGGSEWIFRSCKNIPQPV-----RALLE------GFLRYPKEDRLLPL 355

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (274), Expect = 2e-27
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 37/214 (17%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
             D +  Y +    G G +G V  A Q       A KK+     E+   +  F+ E +++
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIM 60

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELDWAKRVNI 250
             + H +I++LY        ++L+ E    G LF      +  V      E D A+   I
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF------ERVVHKRVFRESDAAR---I 111

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTL 307
           +K +  A+AY H     ++ HRD+   N L  +        + DFG A R       RT 
Sbjct: 112 MKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT- 167

Query: 308 LAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVT 338
             GT  Y++P++    Y      +CD +S GV+ 
Sbjct: 168 KVGTPYYVSPQVLEGLY----GPECDEWSAGVMM 197

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  110 bits (276), Expect = 3e-27
 Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 55/290 (18%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEAQV 195
           + F +   +G G +GSV +AQL           V  LK    + ++   F++    EA  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR----EAAC 78

Query: 196 LSQVLHRSIVKLYGFCL------HKKCMFLIYEYMERGSLFCILHN---DDEAVELDWAK 246
           + +  H  + KL G  L            +I  +M+ G L   L      +    L    
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT 306
            V  +  +A  + YL    S + IHRD+++ N +L   +   VADFG +R++++    R 
Sbjct: 139 LVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR- 194

Query: 307 LLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP 360
              G    +     A E     + T   DV++FGV   E++  G+ P             
Sbjct: 195 --QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-----------A 241

Query: 361 KIMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
            I   ++ +      RL  P +  + + D++        C  ++PK RP+
Sbjct: 242 GIENAEIYNYLIGGNRLKQPPECMEEVYDLMY------QCWSADPKQRPS 285

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (276), Expect = 3e-27
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 195
            +++ +   +G+G  G V  A +    K  A+K     K       E     +   E ++
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE---LDWAKRVNIVK 252
           L ++ H  I+K+  F    +  +++ E ME G LF      D+ V    L  A       
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFY 121

Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLA 309
            M  A+ YLH      IIHRD+   N+LL+S+ E     + DFG ++ L   S  RT L 
Sbjct: 122 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LC 177

Query: 310 GTYGYIAPE-LAYTMVM--TEKCDVYSFGVVT 338
           GT  Y+APE L            D +S GV+ 
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  110 bits (277), Expect = 3e-27
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
            +     + +    G G    VY+  Q    K +ALK L  +  ++       R E  VL
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVL 102

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELDWAKRVNI 250
            ++ H +I+KL         + L+ E +  G LF      D  V      E D A     
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAAD---A 153

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTL 307
           VK +  A+AYLH      I+HRD+   N+L  +        +ADFG ++ +      +T 
Sbjct: 154 VKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT- 209

Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
           + GT GY APE+        + D++S G++T
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 5e-27
 Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 193
            E+    Y      G+G +  V K  +   G  +A K   K  T  +      +    E 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            +L ++ H +++ L+    +K  + LI E +  G LF  L   +   E +       +K 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---EFLKQ 122

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLA 309
           + + + YLH   S  I H D+   NI+L  +        + DFG A ++   +  +  + 
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IF 178

Query: 310 GTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 338
           GT  ++APE + Y  +   + D++S GV+T
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 207

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  108 bits (272), Expect = 5e-27
 Identities = 60/301 (19%), Positives = 108/301 (35%), Gaps = 64/301 (21%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEA 193
                   +G   +G VYK  L           V A+K L           F      EA
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRH----EA 63

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDEAV 240
            + +++ H ++V L G     + + +I+ Y   G L                  +     
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            L+    V++V  +A  + YL    S  ++H+D+++ N+L+  KL   ++D G  R ++A
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180

Query: 301 DSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------R 348
               +         +     APE       +   D++S+GVV  EV   G  P      +
Sbjct: 181 ADYYK---LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

Query: 349 DLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQY 407
           D++  + +             Q LP P D    +  +++       C    P  RP  + 
Sbjct: 238 DVVEMIRN------------RQVLPCPDDCPAWVYALMI------ECWNEFPSRRPRFKD 279

Query: 408 V 408
           +
Sbjct: 280 I 280

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (274), Expect = 7e-27
 Identities = 47/230 (20%), Positives = 93/230 (40%), Gaps = 34/230 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS-------------- 188
            D+ I   +  G +  +   +  + K +ALKK   S  E+                    
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-----NDDEAVELD 243
           F+NE Q+++ + +   +   G   +   +++IYEYME  S+          + +    + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
                 I+K++ ++ +Y+H+    +I HRD+  +NIL++      ++DFG +   +    
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDK 205

Query: 304 NRTLLAGTYGYIAPELAYTMVMTE------KCDVYSFGVVTLEVLMGKHP 347
                 GTY ++ PE        E      K D++S G+    +     P
Sbjct: 206 KIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  108 bits (273), Expect = 7e-27
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 143 EDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           ++ + KY I    G G +G V++  +  + K +  K +    T+        + E  +L+
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILN 56

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKAMAH 256
              HR+I+ L+      + + +I+E++    +F  I  +  E  E +     + V  +  
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---SYVHQVCE 113

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARRLHADSSNRTLLAGTYGY 314
           AL +LH   S +I H DI   NI+  ++  + +   +FG AR+L    + R  L     Y
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEY 169

Query: 315 IAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            APE   + +V +   D++S G +   +L G +P
Sbjct: 170 YAPEVHQHDVV-STATDMWSLGTLVYVLLSGINP 202

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (271), Expect = 7e-27
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 17/197 (8%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
           +G+G +  V K  Q   GK +A K   K   S +      +    E  +L ++ H +I+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           L+    +K  + LI E +  G LF  L   +   E +       +K +   + YLH   S
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---QFLKQILDGVHYLH---S 126

Query: 267 PSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
             I H D+   NI+L  K        + DFG A ++ A +  +  + GT  ++APE + Y
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPEFVAPEIVNY 185

Query: 322 TMVMTEKCDVYSFGVVT 338
             +   + D++S GV+T
Sbjct: 186 EPL-GLEADMWSIGVIT 201

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  110 bits (276), Expect = 9e-27
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 26/220 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   IG G +  V   ++   G+V+A+K ++  +  +   +  FR E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 202 RSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALA 259
           R I +L+ F    +  ++L+ EY   G L  +L    E +  + A+      A +  A+ 
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR---FYLAEIVMAID 176

Query: 260 YLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLA-GTYGY 314
            +H       +HRDI  +NILL+     +L    ADFG+  +L AD + R+L+A GT  Y
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRCGHIRL----ADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 315 IAPELAYTMVMTEK-------CDVYSFGVVTLEVLMGKHP 347
           ++PE+   +            CD ++ GV   E+  G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  110 bits (277), Expect = 1e-26
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 22/217 (10%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   IG G +G V   +L    KVFA+K L+  E  + A    FR E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
           + I  L+        ++L+ +Y   G L  +L   ++ +  + A+      A M  A+  
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR---FYLAEMVIAIDS 190

Query: 261 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTLLA-GTYGYI 315
           +H       +HRDI  +NIL++     +L    ADFG+  +L  D + ++ +A GT  YI
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMNGHIRL----ADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 316 APELAYTMVMTEK-----CDVYSFGVVTLEVLMGKHP 347
           +PE+   M   +      CD +S GV   E+L G+ P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (271), Expect = 1e-26
 Identities = 47/273 (17%), Positives = 95/273 (34%), Gaps = 28/273 (10%)

Query: 146 HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIV 205
            I             K Q    +++   +         + + +   + + +     ++ V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 206 KLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
                   K  +++  +   + +L   ++      + +    ++I   +A A+ +LH   
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--- 181

Query: 266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS------------NRTLLAGTYG 313
           S  ++HRD+  +NI         V DFG    +  D                T   GT  
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 373
           Y++PE  +    + K D++S G++  E         LL S S+  +   ++ DV + + P
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFE---------LLYSFSTQMERVRIITDVRNLKFP 292

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
               QK  Q       +    L  +P  RP   
Sbjct: 293 LLFTQKYPQ---EHMMVQ-DMLSPSPTERPEAT 321

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  107 bits (270), Expect = 1e-26
 Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 54/289 (18%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEAQV 195
               +   +G G +GSV +  L           V  +K  ++S+ E   F+     EA  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS----EAAC 89

Query: 196 LSQVLHRSIVKLYGFCL-----HKKCMFLIYEYMERGSLFCILHN---DDEAVELDWAKR 247
           +    H ++++L G C+           +I  +M+ G L   L     +     +     
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
           +  +  +A  + YL    + + +HRD+++ N +L   +   VADFG ++++++    R  
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-- 204

Query: 308 LAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPK 361
             G    +     A E     V T K DV++FGV   E+   G  P            P 
Sbjct: 205 -QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-----------PG 252

Query: 362 IMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
           +   ++ D      RL  P D    + +I+       +C +++P  RPT
Sbjct: 253 VQNHEMYDYLLHGHRLKQPEDCLDELYEIMY------SCWRTDPLDRPT 295

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  107 bits (270), Expect = 2e-26
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 138 LIEATEDFHIKYCI-----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFI 186
             ++ E+F+  Y +     G G +  V +      G+ +A K     +       E+   
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI--- 75

Query: 187 KSFRNEAQVLSQVLHR-SIVKLYGFCLHKKCMFLIYEYMERGSLF--CILHNDDEAVELD 243
               +E  VL        ++ L+    +   + LI EY   G +F  C+    +   E D
Sbjct: 76  ---LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132

Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHA 300
                 ++K +   + YLH     +I+H D+   NILL+S        + DFG +R++  
Sbjct: 133 VI---RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

Query: 301 DSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 338
               R ++ GT  Y+APE L Y  + T   D+++ G++ 
Sbjct: 187 ACELREIM-GTPEYLAPEILNYDPI-TTATDMWNIGIIA 223

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (270), Expect = 2e-26
 Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 62/291 (21%)

Query: 151 IGTGGYGSVYKAQLPNG-------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +G G +G V+ A+  N         V A+K L  +        + F+ EA++L+ + H+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAELLTMLQHQH 104

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSL------------FCILHNDDEAVELDWAKRVNIV 251
           IV+ +G C   + + +++EYM  G L                  D     L   + + + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             +A  + YL        +HRD+++ N L+   L   + DFG +R +++    R    G 
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGG 218

Query: 312 YGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDLLSSLSSSS 358
              +      PE + Y    T + DV+SFGVV  E+   GK P       + +  ++   
Sbjct: 219 RTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-- 275

Query: 359 DPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                      + L  P      +  I+        C Q  P+ R +++ V
Sbjct: 276 ----------GRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDV 310

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  107 bits (270), Expect = 2e-26
 Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 65/295 (22%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF---ALKKL--HTSETEELAFIKSFRNEAQVLS 197
            D   +  IG G +G V KA++    +    A+K++  + S+ +   F      E +VL 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----ELEVLC 80

Query: 198 QVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDEAVELD 243
           ++  H +I+ L G C H+  ++L  EY   G+L                   +  A  L 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
             + ++    +A  + YL        IHRD+++ NIL+     A +ADFG +R       
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------G 191

Query: 304 NRTLLAGTYGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDL 350
               +  T G +     A E L Y+ V T   DV+S+GV+  E++ +G  P       +L
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250

Query: 351 LSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
              L                RL  P++    + D++        C +  P  RP+
Sbjct: 251 YEKLPQ------------GYRLEKPLNCDDEVYDLMR------QCWREKPYERPS 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (270), Expect = 3e-26
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 36/221 (16%)

Query: 141 ATEDFHIKY----CIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFR 190
           A ++F+ KY     IG G    V +      G  FA+K         S  +     ++ R
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 191 NEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELD 243
            E  +L QV  H  I+ L         MFL+++ M +G LF      D         E +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF------DYLTEKVALSEKE 201

Query: 244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS 303
                 I++++  A+++LH   + +I+HRD+   NILL+  ++  ++DFG +  L     
Sbjct: 202 TRS---IMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK 255

Query: 304 NRTLLAGTYGYIAPE-LAYTMVMTEK-----CDVYSFGVVT 338
            R  L GT GY+APE L  +M  T        D+++ GV+ 
Sbjct: 256 LRE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (267), Expect = 4e-26
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 25/208 (12%)

Query: 142 TEDFHIKYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           T +    +      G+G +  V+   Q   GK+FALK +  S         S  NE  VL
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVL 60

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDW---AKRVNIVKA 253
            ++ H +IV L          +L+ + +  G LF      D  +E           +++ 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQ 114

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAG 310
           +  A+ YLH      I+HRD+   N+L  +  E     + DFG ++     +   +   G
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACG 169

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVT 338
           T GY+APE+      ++  D +S GV+T
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  105 bits (265), Expect = 7e-26
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 59/290 (20%)

Query: 151 IGTGGYGSVYKAQLPNGKVF------ALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRS 203
           +G G +G V+ A+  N          A+K L   +      F +    EA++L+ + H  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR----EAELLTNLQHEH 78

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDEAVELDWAKRVNI 250
           IVK YG C     + +++EYM+ G L                        EL  ++ ++I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
              +A  + YL    S   +HRD+++ N L+ + L   + DFG +R +++    R    G
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VG 192

Query: 311 TYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIML 364
            +  +      PE       T + DV+SFGV+  E+   GK P             ++  
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-----------FQLSN 241

Query: 365 IDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
            +V++       L  P    K + D++L       C Q  P+ R  ++ +
Sbjct: 242 TEVIECITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEI 285

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  107 bits (268), Expect = 1e-25
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 15/212 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ +   IG G +G V   +     KV+A+K L   E  + +    F  E  +++    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALAY 260
             +V+L+      + ++++ EYM  G L  ++ N D  V   WA+      A +  AL  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWAR---FYTAEVVLALDA 183

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGYIAPEL 319
           +H   S   IHRD+  +N+LL+      +ADFGT  +++ +   R     GT  YI+PE+
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 320 ----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                       +CD +S GV   E+L+G  P
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  104 bits (261), Expect = 2e-25
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 140 EATEDFHIKY----CIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIK-S 188
            +T  F+  Y     +G G    V +    P  K +A+K        +   EE+  ++ +
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 189 FRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE---LDW 244
              E  +L +V  H +I++L          FL+++ M++G LF      D   E   L  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF------DYLTEKVTLSE 123

Query: 245 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN 304
            +   I++A+   +  LH     +I+HRD+   NILL+  +   + DFG + +L      
Sbjct: 124 KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180

Query: 305 RTLLAGTYGYIAPE-LAYTMVM-----TEKCDVYSFGVVT 338
           R  + GT  Y+APE +  +M        ++ D++S GV+ 
Sbjct: 181 RE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  104 bits (261), Expect = 4e-25
 Identities = 63/304 (20%), Positives = 119/304 (39%), Gaps = 63/304 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNE 192
           +   +   +G G +G V  A+               A+K L    +E +    +     E
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 90

Query: 193 AQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDE 238
            +++  +  H++I+ L G C     +++I EY  +G+L             +    N   
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL 298
             ++ +   V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 299 HADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLS 352
           +     +     T G +     APE  +  V T + DV+SFGV+  E+  +G  P     
Sbjct: 208 NNIDYYK---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY---- 260

Query: 353 SLSSSSDPKIMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQ 406
                  P I + ++        R+  P +    +  ++        C  + P  RPT +
Sbjct: 261 -------PGIPVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFK 307

Query: 407 YVSQ 410
            + +
Sbjct: 308 QLVE 311

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (260), Expect = 6e-25
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 39/213 (18%)

Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           T+ + +K  IG G Y    +         FA+K +  S+       +    E ++L +  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYG 73

Query: 201 -HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELDWAKRVNIVKA 253
            H +I+ L       K ++++ E M+ G L       D+ +      E + +    ++  
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELL------DKILRQKFFSEREASA---VLFT 124

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLA 309
           +   + YLH   +  ++HRD+  +NIL   +        + DFG A++L A++       
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 310 GTYGYIAPEL----AYTMVMTEKCDVYSFGVVT 338
            T  ++APE+     Y       CD++S GV+ 
Sbjct: 182 YTANFVAPEVLERQGY----DAACDIWSLGVLL 210

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (259), Expect = 6e-25
 Identities = 59/257 (22%), Positives = 102/257 (39%), Gaps = 57/257 (22%)

Query: 142 TEDFHIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 195
            + +H+K  IG G YG V  A +     + A+K     K+     ++   ++  + E ++
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKTEVRL 81

Query: 196 LSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLF------------------------- 230
           + ++ H +I +LY     ++ + L+ E    G L                          
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 231 CILHNDDEAVELDWAKRV------------NIVKAMAHALAYLHHDCSPSIIHRDISSNN 278
           C   N++         R             NI++ +  AL YLH   +  I HRDI   N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPEN 198

Query: 279 ILLNSKLEAFV--ADFGTARRLHADSSNR----TLLAGTYGYIAPELAYTMVM--TEKCD 330
            L ++     +   DFG ++  +  ++      T  AGT  ++APE+  T       KCD
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 331 VYSFGVVTLEVLMGKHP 347
            +S GV+   +LMG  P
Sbjct: 259 AWSAGVLLHLLLMGAVP 275

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  104 bits (261), Expect = 6e-25
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + F I   IG G +G V   Q     K++A+K ++  +  E   +++   E Q++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 202 RSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKA-MAH 256
             +V L Y F   +  MF++ + +  G L   L  +    E         V +    +  
Sbjct: 75  PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEE-------TVKLFICELVM 126

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL YL    +  IIHRD+  +NILL+      + DF  A  L  ++   T +AGT  Y+A
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182

Query: 317 PELAYTMVMTEKCDVY-------SFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD 369
           PE    M  + K   Y       S GV   E+L G+ P      + SS+  K ++     
Sbjct: 183 PE----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH----IRSSTSSKEIVHTFET 234

Query: 370 QRLP-PPVDQKVIQDILLASTISFACLQSNPKSR 402
             +  P    + +  +L         L+ NP  R
Sbjct: 235 TVVTYPSAWSQEMVSLLK------KLLEPNPDQR 262

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  103 bits (260), Expect = 9e-25
 Identities = 63/304 (20%), Positives = 119/304 (39%), Gaps = 63/304 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNE 192
           +   +   +G G +G V  A+               A+K L    +E +    I     E
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----E 124

Query: 193 AQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDE 238
            +++  +  H++I+ L G C     +++I EY  +G+L             +    + + 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL 298
             +L     V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

Query: 299 HADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLS 352
           H     +     T G +     APE  +  + T + DV+SFGV+  E+  +G  P     
Sbjct: 242 HHIDYYK---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---- 294

Query: 353 SLSSSSDPKIMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQ 406
                  P + + ++        R+  P +    +  ++        C  + P  RPT +
Sbjct: 295 -------PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFK 341

Query: 407 YVSQ 410
            + +
Sbjct: 342 QLVE 345

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  102 bits (256), Expect = 2e-24
 Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 36/215 (16%)

Query: 142 TEDFHIKY-------CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEA 193
              F+  Y        +G G +    K     + + FA+K +              + E 
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEI 56

Query: 194 QVLSQV-LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELDWAK 246
             L     H +IVKL+     +   FL+ E +  G LF      +         E + + 
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF------ERIKKKKHFSETEASY 110

Query: 247 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSS 303
              I++ +  A++++H      ++HRD+   N+L   + +     + DFG AR    D+ 
Sbjct: 111 ---IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164

Query: 304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
                  T  Y APEL       E CD++S GV+ 
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  102 bits (257), Expect = 2e-24
 Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 63/302 (20%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNE 192
           +   +   +G G +G V  A+               A+K L    +E +    +     E
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 136

Query: 193 AQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCILHNDDE 238
            +++  +  H++I+ L G C     +++I EY  +G+L             +    N   
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL 298
             ++ +   V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 299 HADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLS 352
           +     +     T G +     APE  +  V T + DV+SFGV+  E+  +G  P     
Sbjct: 254 NNIDYYK---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY---- 306

Query: 353 SLSSSSDPKIMLIDVLDQ-----RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQ 406
                  P I + ++        R+  P +    +  ++        C  + P  RPT +
Sbjct: 307 -------PGIPVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFK 353

Query: 407 YV 408
            +
Sbjct: 354 QL 355

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (254), Expect = 2e-24
 Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 43/225 (19%)

Query: 142 TEDFHIKY-----CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
           +  F   Y      +G G +  V     L   + +A+K +                E ++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEM 63

Query: 196 LSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAV------ELDWAKRV 248
           L Q   HR++++L  F   +   +L++E M  GS+                 EL+ +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL------SHIHKRRHFNELEASV-- 115

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNR 305
            +V+ +A AL +LH   +  I HRD+   NIL     +     + DF     +  +    
Sbjct: 116 -VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 306 TL-------LAGTYGYIAPELAYTMVMT-----EKCDVYSFGVVT 338
            +         G+  Y+APE+            ++CD++S GV+ 
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (255), Expect = 3e-24
 Identities = 72/295 (24%), Positives = 115/295 (38%), Gaps = 64/295 (21%)

Query: 151 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL- 200
           +G G +G V +A            KV A+K L       E+ A +     E +++S +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMS----ELKIMSHLGQ 108

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR-----------VN 249
           H +IV L G C H   + +I EY   G L   L      +E D A             ++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
               +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+      
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---V 222

Query: 310 GTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-------RDLLSSLSS 356
                +     APE  +  V T + DV+S+G++  E+  +G +P             +  
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282

Query: 357 SSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                         ++  P    K I  I+       AC    P  RPT Q +  
Sbjct: 283 G------------YQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQICS 319

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  101 bits (254), Expect = 3e-24
 Identities = 71/301 (23%), Positives = 114/301 (37%), Gaps = 56/301 (18%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQ 194
                   +G G +G V +A              A+K L      TE  A +     E +
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS----ELK 78

Query: 195 VLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCILHNDDE 238
           VLS +  H +IV L G C       +I EY   G L                     +D+
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL 298
            + LD    ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 299 HADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLS 352
             DS+           +     APE  +  V T + DV+S+G+   E+  +G  P     
Sbjct: 196 KNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YP 249

Query: 353 SLSSSSDPKIMLIDVLDQ--RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVS 409
            +   S        ++ +  R+  P      + DI+        C  ++P  RPT + + 
Sbjct: 250 GMPVDSK----FYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIV 299

Query: 410 Q 410
           Q
Sbjct: 300 Q 300

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  101 bits (253), Expect = 4e-24
 Identities = 68/311 (21%), Positives = 121/311 (38%), Gaps = 72/311 (23%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEA 193
           ++  +   +G G +G V KA   +         V A+K L  + S +E    +     E 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLLS----EF 77

Query: 194 QVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSL---------------------FCI 232
            VL QV H  ++KLYG C     + LI EY + GSL                        
Sbjct: 78  NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137

Query: 233 LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF 292
             +  +   L     ++    ++  + YL       ++HRD+++ NIL+    +  ++DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDF 194

Query: 293 GTARRLHADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM---- 343
           G +R ++ + S       + G I     A E  +  + T + DV+SFGV+  E++     
Sbjct: 195 GLSRDVYEEDSYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251

Query: 344 ---GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNP 399
              G  P  L + L +              R+  P +  + +  ++L       C +  P
Sbjct: 252 PYPGIPPERLFNLLKTG------------HRMERPDNCSEEMYRLML------QCWKQEP 293

Query: 400 KSRPTMQYVSQ 410
             RP    +S+
Sbjct: 294 DKRPVFADISK 304

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (252), Expect = 5e-24
 Identities = 65/306 (21%), Positives = 110/306 (35%), Gaps = 67/306 (21%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEA 193
           +   +   +G G +G V +A             V A+K L    + +E  A +     E 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMS----EL 81

Query: 194 QVLSQVL-HRSIVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCILHNDDE 238
           ++L  +  H ++V L G C      + +I E+ + G+L             + +   D  
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141

Query: 239 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL 298
              L     +     +A  + +L    S   IHRD+++ NILL+ K    + DFG AR +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

Query: 299 HADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP----- 347
           + D             +     APE  +  V T + DV+SFGV+  E+  +G  P     
Sbjct: 199 YKDPDYV---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

Query: 348 --RDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
              +    L                R+  P      +   +L       C    P  RPT
Sbjct: 256 IDEEFCRRLKEG------------TRMRAPDYTTPEMYQTML------DCWHGEPSQRPT 297

Query: 405 MQYVSQ 410
              + +
Sbjct: 298 FSELVE 303

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 21/214 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A+     + +A+K L      +   +     E  V+S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MA 255
              VKLY      + ++    Y + G L   +               +          + 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIV 140

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN-RTL-LAGTYG 313
            AL YLH      IIHRD+   NILLN  +   + DFGTA+ L  +S   R     GT  
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 61/303 (20%), Positives = 114/303 (37%), Gaps = 71/303 (23%)

Query: 151 IGTGGYGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-H 201
           +G+G +G V  A              A+K L      +E  A +     E ++++Q+  H
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGSH 108

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM------- 254
            +IV L G C     ++LI+EY   G L   L +  E    D  +  N  +         
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 255 -------------AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
                        A  + +L      S +HRD+++ N+L+       + DFG AR + +D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 302 SSNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-------R 348
           S+           +     APE  +  + T K DV+S+G++  E+  +G +P        
Sbjct: 226 SNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

Query: 349 DLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQY 407
           +    + +              ++  P    + I  I+       +C   + + RP+   
Sbjct: 283 NFYKLIQNG------------FKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFPN 324

Query: 408 VSQ 410
           ++ 
Sbjct: 325 LTS 327

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 7e-23
 Identities = 66/305 (21%), Positives = 113/305 (37%), Gaps = 72/305 (23%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQ 194
            +      IG G +G V++A+ P    +      A+K L    S   +  F +    EA 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR----EAA 102

Query: 195 VLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-----HNDDEAVELDWAKRVN 249
           ++++  + +IVKL G C   K M L++EYM  G L   L     H        D + R  
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 250 IVKAMAHAL----------------AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG 293
           +       L                AYL        +HRD+++ N L+   +   +ADFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 294 TARRLHADSSNRTLLAGTYGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKH 346
            +R +++    +   A     I      PE + Y    T + DV+++GVV  E+   G  
Sbjct: 220 LSRNIYSADYYK---ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQ 275

Query: 347 P------RDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNP 399
           P       +++  +                 L  P +    + +++        C    P
Sbjct: 276 PYYGMAHEEVIYYVRDG------------NILACPENCPLELYNLMR------LCWSKLP 317

Query: 400 KSRPT 404
             RP+
Sbjct: 318 ADRPS 322

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 26/199 (13%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           +G G  G V +       + FALK L              R E ++  +      IV++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 121

Query: 209 GFC----LHKKCMFLIYEYMERGSLF-CILHNDDEA-VELDWAKRVNIVKAMAHALAYLH 262
                    +KC+ ++ E ++ G LF  I    D+A  E + +    I+K++  A+ YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH 178

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
              S +I HRD+   N+L  SK       + DFG A+   + +S  T    T  Y+APE+
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEV 234

Query: 320 AYTMVMTEKCDVYSFGVVT 338
                  + CD++S GV+ 
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 32/213 (15%)

Query: 142 TEDFHIKY-----CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 195
                  Y      +G G  G V +      G+  ALK L+ S           R E   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDH 74

Query: 196 LSQVL-HRSIVKLYGFC----LHKKCMFLIYEYMERGSLFC-ILHNDDEA-VELDWAKRV 248
             Q      IV +          K+C+ +I E ME G LF  I    D+A  E + A+  
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE-- 132

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNR 305
            I++ +  A+ +LH   S +I HRD+   N+L  SK +     + DFG A+      +  
Sbjct: 133 -IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL 186

Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
                T  Y+APE+       + CD++S GV+ 
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V K +    G++ A+KK   S+ +++    + R E ++L Q+ H ++V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
            C  KK  +L++E+++  ++   L  +     LD+      +  + + + + H   S +I
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH---SHNI 145

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL-----AYTMV 324
           IHRDI   NIL++      + DFG AR L A          T  Y APEL      Y   
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205

Query: 325 MTEKCDVYSFGVVTLEVLMGK 345
           +    DV++ G +  E+ MG+
Sbjct: 206 V----DVWAIGCLVTEMFMGE 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 8/170 (4%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG V+K +    G++ A+KK   SE + +    + R E ++L Q+ H ++V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               K+ + L++EY +  ++   L  D     +      +I      A+ + H     + 
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH---KHNC 123

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           IHRD+   NIL+       + DFG AR L   S        T  Y +PEL
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 14/210 (6%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             F     +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 202 RSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAV--ELDWAKRVNIVKA-MAHA 257
           R +V L  +    K  + L+   M  G L   +++  +A   E     R     A +   
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAEICCG 298

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
           L  LH      I++RD+   NILL+      ++D G A  +    + +    GT GY+AP
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAP 354

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           E+      T   D ++ G +  E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 16/200 (8%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H +IVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
              KK + L++E++++  L  +L   +  +E   AK  + +  + + +AY H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---VL 122

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL-----AYTMVM 325
           HRD+   N+L+N + E  +ADFG AR         T    T  Y AP++      Y    
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY---- 178

Query: 326 TEKCDVYSFGVVTLEVLMGK 345
           +   D++S G +  E++ G 
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           +G G YG VYKA+   G++ ALK++     +E     + R E  +L ++ H +IV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87

Query: 211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 270
              ++C+ L++E+ME+  L  +L  D+    L  ++    +  +   +A+ H      I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---IL 141

Query: 271 HRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL-----AYTMVM 325
           HRD+   N+L+NS     +ADFG AR       + T    T  Y AP++      Y    
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY---- 197

Query: 326 TEKCDVYSFGVVTLEVLMGK 345
           +   D++S G +  E++ GK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.3 bits (229), Expect = 3e-20
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 17/212 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-- 199
            DF +   IG GG+G VY  +    GK++A+K L     +         NE  +LS V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 200 -LHRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAH 256
                IV +  +  H    +  I + M  G L   L       E      +    A +  
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIIL 303

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
            L ++H   +  +++RD+   NILL+      ++D G A        +     GT+GY+A
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMA 358

Query: 317 PE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE L   +      D +S G +  ++L G  P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + F     +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MA 255
             +VKL         ++++ EY+  G +F  L             R +   A      + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGY 314
               YLH   S  +I+RD+   N+L++ +    V DFG A+R+      RT  L GT   
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEA 204

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.7 bits (221), Expect = 5e-20
 Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 8/170 (4%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H++IV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
                K + L++E+ ++  L      D    +LD     + +  +   L + H      +
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +HRD+   N+L+N   E  +A+FG AR         +    T  Y  P++
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.0 bits (226), Expect = 6e-20
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 7/208 (3%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + F     +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 202 RSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAHALA 259
           R IV L  +    K  + L+   M  G +   ++N DE        R     A +   L 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++APEL
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
                     D ++ GV   E++  + P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.8 bits (221), Expect = 8e-20
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 9/178 (5%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E +     +G G Y +VYK +      + ALK++   E EE A   + R E  +L  + H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKH 59

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IV L+     +K + L++EY+++  L   L  DD    ++       +  +   LAY 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           H      ++HRD+   N+L+N + E  +ADFG AR     +        T  Y  P++
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 46/205 (22%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG VYKA      +  A+K++     EE     + R E  +L ++ HR+I++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
              H   + LI+EY E   L   +   D+  ++      + +  + + + + H   S   
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCH---SRRC 153

Query: 270 IHRDISSNNILLNSKLEAF-----VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
           +HRD+   N+LL+    +      + DFG AR               +G   P   +T  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--------------AFG--IPIRQFTHE 197

Query: 325 MTEKCDVYSFGVVTL-----EVLMG 344
                      ++TL     E+L+G
Sbjct: 198 -----------IITLWYRPPEILLG 211

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 44/216 (20%)

Query: 139 IEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 197
           + ++  F     +G G Y +VYK      G   ALK++   ++EE     + R E  ++ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIR-EISLMK 58

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH- 256
           ++ H +IV+LY     +  + L++E+M+   L   +              +N+VK     
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMD-SRTVGNTPRGLELNLVKYFQWQ 116

Query: 257 ---ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
               LA+ H +    I+HRD+   N+L+N + +  + DFG              LA  +G
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFG--------------LARAFG 159

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMG 344
              P   ++   +E        VVTL     +VLMG
Sbjct: 160 --IPVNTFS---SE--------VVTLWYRAPDVLMG 182

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 27/259 (10%), Positives = 71/259 (27%), Gaps = 49/259 (18%)

Query: 150 CIGTGGYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK 206
             G       ++A    L   +  AL  +          ++   +    LS++    + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS 266
           +      +    ++ E++  GSL  +               +  ++++A A    H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148

Query: 267 PSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMT 326
             +       + + ++   +  +A   T    +                           
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD------------------------ 183

Query: 327 EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP--VDQKVIQDI 384
              D+   G     +L+ + P       S  +            +   P  +D+ +   I
Sbjct: 184 ---DIRGIGASLYALLVNRWPLPEAGVRSGLA----PAERDTAGQPIEPADIDRDIPFQI 236

Query: 385 LLASTISFACLQSNPKSRP 403
              S ++   +Q +   R 
Sbjct: 237 ---SAVAARSVQGDGGIRS 252

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 50/219 (22%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             +     IG G +G V+KA+    G+  ALKK+     +E   I + R E ++L  + H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKH 75

Query: 202 RSIVKLYG--------FCLHKKCMFLIYEYME---RGSLFCILHNDDEAVELDWAKRVNI 250
            ++V L          +   K  ++L++++ E    G L       +  V+   ++   +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL------SNVLVKFTLSEIKRV 129

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
           ++ + + L Y+H +    I+HRD+ + N+L+       +ADFG AR              
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR-------------- 172

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMG 344
                    A+++    + + Y+  VVTL     E+L+G
Sbjct: 173 ---------AFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 30/73 (41%), Positives = 39/73 (53%), Gaps = 3/73 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            KNL  LD+ NN+I G++P  LT L  L  LN+S+N L G +P     L        + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

Query: 61  KGLCGNFITLPSC 73
           K LCG    LP+C
Sbjct: 302 KCLCG--SPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 18/61 (29%), Positives = 33/61 (54%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L +L I++  + G+IP  L+ +  L  L+ S+N LSG +P S   L ++  +    N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159

Query: 61  K 61
           +
Sbjct: 160 R 160

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRV-RLSP 59
           +K L  LD S N + G++P  ++ L  L  +    N++SG +P S    S +     +S 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 60  NK 61
           N+
Sbjct: 184 NR 185

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 17/62 (27%), Positives = 31/62 (50%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISN-NKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           +  L +L I   N + G IP  +  L++L YL ++   +SG +P    Q+ ++  +  S 
Sbjct: 75  LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134

Query: 60  NK 61
           N 
Sbjct: 135 NA 136

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 12/59 (20%), Positives = 26/59 (44%), Gaps = 1/59 (1%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           NL ++D+S N +EG              ++L+ N L+  +        +++ + L  N+
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 1/60 (1%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           K  T + IS N++ G IP    +L+ L +++LS N L G          +  ++ L+ N 
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 3/64 (4%)

Query: 1   MKNLTWLDISNNKIEGS--IPGELTDLSRLDYLNLS-WNKLSGPVPFSNEQLSSMSRVRL 57
              +  LD+S   +     IP  L +L  L++L +   N L GP+P +  +L+ +  + +
Sbjct: 49  TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108

Query: 58  SPNK 61
           +   
Sbjct: 109 THTN 112

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 41.0 bits (97), Expect = 5e-04
 Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 5/69 (7%)

Query: 7  LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE--QLSSMSRVRLSPNKGLC 64
           D  N    G +    T   R++ L+LS   L  P P  +    L  ++ + +     L 
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 65 GNFITLPSC 73
          G    +P  
Sbjct: 91 G---PIPPA 96

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 6e-19
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 51/207 (24%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAF---IKSFRNEAQVLSQVLHRSIVK 206
           +G G + +VYKA+     ++ A+KK+      E        + R E ++L ++ H +I+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIG 76

Query: 207 LYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH----ALAYLH 262
           L     HK  + L++++ME   L  I+   D ++ L      + +KA        L YLH
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PSHIKAYMLMTLQGLEYLH 129

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT 322
                 I+HRD+  NN+LL+      +ADFG A+              ++G  +P  AYT
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAK--------------SFG--SPNRAYT 170

Query: 323 MVMTEKCDVYSFGVVTL-----EVLMG 344
               +        VVT      E+L G
Sbjct: 171 ---HQ--------VVTRWYRAPELLFG 186

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 16/211 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
            +F     +G G +G V   +    G+ +A   LKK      +E+A   +   E +VL  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQN 204

Query: 199 VLHRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAH 256
             H  +  L  +       +  + EY   G LF  L  +    E     R     A +  
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVS 259

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL YLH + +  +++RD+   N++L+      + DFG  +    D +      GT  Y+A
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE+          D +  GVV  E++ G+ P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 47/191 (24%), Positives = 85/191 (44%), Gaps = 27/191 (14%)

Query: 147 IKYCIGTGGYGSVYKAQ---LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
               +G G YG VYKA+     + K +ALK++     E      S   E  +L ++ H +
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSACREIALLRELKHPN 79

Query: 204 IVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN--IVKAMAH--- 256
           ++ L    L    + ++L+++Y E   L+ I+     +       ++   +VK++ +   
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 257 -ALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARRLHADSSNRTLLAG- 310
             + YLH +    ++HRD+   NIL+  +        +AD G AR  ++       L   
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 311 --TYGYIAPEL 319
             T+ Y APEL
Sbjct: 196 VVTFWYRAPEL 206

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 36/212 (16%)

Query: 151 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +G VY+A+L  +G++ A+KK+   +  +       R E Q++ ++ H +IV+L  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------R-ELQIMRKLDHCNIVRLRY 114

Query: 210 F------CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA----MAHALA 259
           F         +  + L+ +Y+         H       L     V  VK     +  +LA
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSLA 170

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYIAPE 318
           Y+H   S  I HRDI   N+LL+       + DFG+A++L     N + +   Y Y APE
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPE 226

Query: 319 L-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
           L      YT  +    DV+S G V  E+L+G+
Sbjct: 227 LIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 24/213 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MA 255
             I++++G     + +F+I +Y+E G LF +L           ++R     A      + 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAEVC 116

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGY 314
            AL YLH   S  II+RD+   NILL+      + DFG A+ +     + T  L GT  Y
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDY 169

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           IAPE+  T    +  D +SFG++  E+L G  P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 44/273 (16%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H +IVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 269
               +K ++LI EY   G +F  L       E   A+     + +  A+ Y H      I
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS--KFRQIVSAVQYCHQKR---I 135

Query: 270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL----AYTMVM 325
           +HRD+ + N+LL++ +   +ADFG +              G   Y APEL     Y    
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYD--- 191

Query: 326 TEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI 384
             + DV+S GV+ L  L+ G  P D         + K +   VL  +   P         
Sbjct: 192 GPEVDVWSLGVI-LYTLVSGSLPFD-------GQNLKELRERVLRGKYRIP--------- 234

Query: 385 LLASTISFAC-------LQSNPKSRPTMQYVSQ 410
                +S  C       L  NP  R T++ + +
Sbjct: 235 ---FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 47/199 (23%)

Query: 151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLY 208
           +G G  G V +       + FALK L              R E ++  +      IV++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 77

Query: 209 GFC----LHKKCMFLIYEYMERGSLF-CILHNDDEA-VELDWAKRVNIVKAMAHALAYLH 262
                    +KC+ ++ E ++ G LF  I    D+A  E + +    I+K++  A+ YLH
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH 134

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
              S +I HRD+   N+L  SK       + DFG A+               Y       
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---------TTGEKYD------ 176

Query: 320 AYTMVMTEKCDVYSFGVVT 338
                  + CD++S GV+ 
Sbjct: 177 -------KSCDMWSLGVIM 188

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 63/274 (22%), Positives = 102/274 (37%), Gaps = 53/274 (19%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRS--I 204
           +G+GG+GSVY    + +    A+K   K   S+  EL        E  +L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 205 VKLYGFCLHKKCMFLIYEYME-RGSLF--CILH---NDDEAVELDWAKRVNIVKAMAHAL 258
           ++L  +        LI E  E    LF          ++ A       R +    +  A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-------R-SFFWQVLEAV 162

Query: 259 AYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
            + H   +  ++HRDI   NIL++  + E  + DFG+   L  D+       GT  Y  P
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTD-FDGTRVYSPP 217

Query: 318 EL----AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRL 372
           E      Y         V+S G++ L  ++ G  P +         D +I+   V     
Sbjct: 218 EWIRYHRYH---GRSAAVWSLGIL-LYDMVCGDIPFE--------HDEEIIRGQV---FF 262

Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
              V  +     L+       CL   P  RPT +
Sbjct: 263 RQRVSSECQH--LIRW-----CLALRPSDRPTFE 289

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 55/276 (19%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQV----LHR 202
           +G GG+G+V+    L +    A+K   +        L+   +   E  +L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGS-LF--CILH---NDDEAVELDWAKRVNIVKAMAH 256
            +++L  +   ++   L+ E       LF          +  +       R      +  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-CFFGQVVA 150

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
           A+ + H   S  ++HRDI   NIL++ +   A + DFG+   LH D        GT  Y 
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTRVYS 205

Query: 316 APEL----AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
            PE      Y         V+S G++ L  ++ G  P +         D +I+  ++   
Sbjct: 206 PPEWISRHQYH---ALPATVWSLGIL-LYDMVCGDIPFE--------RDQEILEAEL--- 250

Query: 371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
             P  V        L+       CL   P SRP+++
Sbjct: 251 HFPAHVSPDCCA--LIRR-----CLAPKPSSRPSLE 279

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 67/219 (30%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAF---IKSFRNEA---QVLSQVLHRS 203
           IG G YG+VYKA+   +G   ALK +             I + R E    + L    H +
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75

Query: 204 IVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI----VKAM 254
           +V+L   C   +      + L++E++++          D    LD A    +    +K +
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ----------DLRTYLDKAPPPGLPAETIKDL 125

Query: 255 AH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
                  L +LH +C   I+HRD+   NIL+ S     +ADFG AR              
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-------------- 168

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMG 344
            Y     ++A T V           VVTL     EVL+ 
Sbjct: 169 IYS---YQMALTPV-----------VVTLWYRAPEVLLQ 193

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 65/218 (29%)

Query: 151 IGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRSIV 205
           IG G YG V+KA+     G+  ALK++     EE   + + R E  VL       H ++V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77

Query: 206 KLY-----GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI----VKAMAH 256
           +L+          +  + L++E++++          D    LD      +    +K M  
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ----------DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 257 ----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTY 312
                L +LH      ++HRD+   NIL+ S  +  +ADFG AR               Y
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--------------IY 170

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMGK 345
                ++A T V           VVTL     EVL+  
Sbjct: 171 S---FQMALTSV-----------VVTLWYRAPEVLLQS 194

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 45/216 (20%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF 210
           IG G +G V++A+L      A+KK+   +  +       R E Q++  V H ++V L  F
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------R-ELQIMRIVKHPNVVDLKAF 100

Query: 211 ------CLHKKCMFLIYEYMERGSLF-CILHNDDEAVELDWAKRVNIVKA----MAHALA 259
                    +  + L+ EY+   +++    H       +     + ++K     +  +LA
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLA 155

Query: 260 YLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
           Y+H   S  I HRDI   N+LL+      KL     DFG+A+ L A   N + +   Y Y
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKL----IDFGSAKILIAGEPNVSYICSRY-Y 207

Query: 315 IAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
            APEL      YT  +    D++S G V  E++ G+
Sbjct: 208 RAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 17/211 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
            DF     +G G +G V   +    G+ +A   L+K      +E+A   +   E++VL  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQN 61

Query: 199 VLHRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MAH 256
             H  +  L  +       +  + EY   G LF  L  +    E    +R     A +  
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVS 116

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           AL YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+A
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           PE+          D +  GVV  E++ G+ P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 52/237 (21%), Positives = 91/237 (38%), Gaps = 58/237 (24%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKK--LHTSETE-ELAFIKSFRNEAQV 195
           +  + F ++   G G +G+V   +    G   A+KK          EL  ++        
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-------D 72

Query: 196 LSQVLHRSIVKLYGFCLHKK-------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
           L+ + H +IV+L  +             + ++ EY+        LH            R 
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR-----CCRNYYRR 122

Query: 249 NIVKAMAH----------ALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFG 293
            +                ++  LH   S ++ HRDI  +N+L+N      KL     DFG
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL----CDFG 177

Query: 294 TARRLHADSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
           +A++L     N   +   Y Y APEL      YT  +    D++S G +  E+++G+
Sbjct: 178 SAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 47/227 (20%)

Query: 143 EDFHIKYCIGTGGYGSVY----KAQLPNGKVFALKKL-----------HTSETEELAFIK 187
             F +   +G G +G V+     +     +++A+K L            T          
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT---------- 73

Query: 188 SFRNEAQVLSQVLHRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAK 246
             + E  +L +V H  IVKL Y F    K ++LI +++  G LF  L  +    E    +
Sbjct: 74  --KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE----E 126

Query: 247 RVNIVKA-MAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTAR-RLHA 300
            V    A +A AL +LH   S  II+RD+   NILL+     KL     DFG ++  +  
Sbjct: 127 DVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKL----TDFGLSKESIDH 179

Query: 301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           +    +   GT  Y+APE+      T+  D +SFGV+  E+L G  P
Sbjct: 180 EKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGK----VFALKKLH----TSETEELAFIKSFRNEAQ 194
           E F +   +G GGYG V++ +   G     +FA+K L         ++ A  K+   E  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERN 73

Query: 195 VLSQVLHRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           +L +V H  IV L Y F    K ++LI EY+  G LF  L  +   +E           A
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME----DTACFYLA 128

Query: 254 -MAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARR-LHADSSNRTL 307
            ++ AL +LH      II+RD+   NI+LN     KL     DFG  +  +H  +   T 
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKL----TDFGLCKESIHDGTVTHTF 181

Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             GT  Y+APE+          D +S G +  ++L G  P
Sbjct: 182 C-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 47/271 (17%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRSI 204
           +G+G +G V+ A      K   +K     K+      E   +     E  +LS+V H +I
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 205 VKLYGFCLHKKCMFLIYEYMERGS-LF-CILHND--DEAVELDWAKRVNIVKAMAHALAY 260
           +K+     ++    L+ E    G  LF  I  +   DE +    A    I + +  A+ Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL----ASY--IFRQLVSAVGY 145

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL- 319
           L       IIHRDI   NI++       + DFG+A  L       T   GT  Y APE+ 
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVL 201

Query: 320 ---AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
               Y      + +++S GV  L  L+  ++P   L         + +   +     P  
Sbjct: 202 MGNPYR---GPELEMWSLGVT-LYTLVFEENPFCELE--------ETVEAAI---HPPYL 246

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           V ++++   L++       LQ  P+ R T++
Sbjct: 247 VSKELMS--LVSG-----LLQPVPERRTTLE 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 28/204 (13%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G V   +    G   A+K L+  +   L  +   + E Q L    H  I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MAHALAYLHH 263
                   F++ EY+  G LF      D   +     RV  ++A      +  A+ Y H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELF------DYICK---HGRVEEMEARRLFQQILSAVDYCH- 128

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL---- 319
                ++HRD+   N+LL++ + A +ADFG +  +      RT   G+  Y APE+    
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 185

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM 343
            Y      + D++S GV+ L  L+
Sbjct: 186 LYA---GPEVDIWSCGVI-LYALL 205

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 69/226 (30%), Positives = 98/226 (43%), Gaps = 39/226 (17%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP----NGKVFA---LKKLHTSETEELAFIKSFRNEAQV 195
           E+F +   +GTG YG V+  +       GK++A   LKK    +  +    +  R E QV
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT--TEHTRTERQV 111

Query: 196 LSQVLHRS-IVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           L  +     +V L Y F    K + LI +Y+  G LF  L   +   E      V I   
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVG 166

Query: 254 -MAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSNRTL- 307
            +  AL +LH      II+RDI   NILL+S     L     DFG ++   AD + R   
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVL----TDFGLSKEFVADETERAYD 219

Query: 308 LAGTYGYIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGKHP 347
             GT  Y+AP+    +V           D +S GV+  E+L G  P
Sbjct: 220 FCGTIEYMAPD----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 29/271 (10%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +DF +   IG G Y  V   +L    +++A   +KK   ++ E++ ++++   E  V  Q
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQ 65

Query: 199 VL-HRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
              H  +V L+  C   +  +F + EY+  G L   +    +  E    +      A ++
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEIS 120

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR-RLHADSSNRTLLAGTYGY 314
            AL YLH      II+RD+  +N+LL+S+    + D+G  +  L    +  T   GT  Y
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 176

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--RDLLSSLSSSSDPKIMLIDVLDQRL 372
           IAPE+          D ++ GV+  E++ G+ P      S     +    +   +L++++
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 373 P-PPVDQKVIQDILLASTISFACLQSNPKSR 402
             P         +L       + L  +PK R
Sbjct: 237 RIPRSLSVKAASVLK------SFLNKDPKER 261

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 20/216 (9%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +    +     IG G YG V  A    N    A+KK+   E +     ++ R E ++L +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKILLR 81

Query: 199 VLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
             H +I+ +              ++++ + ME       L+   +   L        +  
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQHLSNDHICYFLYQ 136

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--- 310
           +   L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR    D  +   L     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 311 TYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           T  Y APE+       T+  D++S G +  E+L  +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 24/215 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
           EDF +   +G G +G V+ A+     + FA   LKK      +++        E +VLS 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV---EKRVLSL 73

Query: 199 VL-HRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
              H  +  +   F   +  +F + EY+  G L   + +  +        R     A + 
Sbjct: 74  AWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEII 128

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARR-LHADSSNRTLLAGTY 312
             L +LH   S  I++RD+  +NILL+   +  +  ADFG  +  +  D+   T   GT 
Sbjct: 129 LGLQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNT-FCGTP 182

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
            YIAPE+          D +SFGV+  E+L+G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 23/227 (10%)

Query: 134 FYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-- 191
              +L      + ++  I +G YG+V       G   A+K++  + ++    +    +  
Sbjct: 13  LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG-RTVNILSDSF 71

Query: 192 -------EAQVLSQVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEA 239
                  E ++L+   H +I+ L    +H +      ++L+ E M    L  ++H+    
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV 130

Query: 240 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH 299
           +     +    +  +   L  LH      ++HRD+   NILL    +  + DF  AR   
Sbjct: 131 ISPQHIQ--YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 300 ADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           AD +N+T       Y APEL       T+  D++S G V  E+   K
Sbjct: 186 AD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 4/73 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             NL W+ +SNN++ G IP  +  L  L  L LS N  SG +P       S+  + L+ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548

Query: 61  KGLCGNFITLPSC 73
               G    +P+ 
Sbjct: 549 L-FNGT---IPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 25/77 (32%), Positives = 35/77 (45%), Gaps = 9/77 (11%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  LDIS NK+ G     ++  + L  LN+S N+  GP+P     L S+  + L+ N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAEN 279

Query: 61  K-------GLCGNFITL 70
           K        L G   TL
Sbjct: 280 KFTGEIPDFLSGACDTL 296

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 33/96 (34%), Positives = 45/96 (46%), Gaps = 25/96 (26%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS-- 58
           M  L  L++ +N I GSIP E+ DL  L+ L+LS NKL G +P +   L+ ++ + LS  
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714

Query: 59  ------P---------------NKGLCGNFITLPSC 73
                 P               N GLCG    LP C
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGY--PLPRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 21/61 (34%), Positives = 33/61 (54%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             ++ +LD+S N + G IP E+  +  L  LNL  N +SG +P     L  ++ + LS N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690

Query: 61  K 61
           K
Sbjct: 691 K 691

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 1/67 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L +  N +EG IP EL  +  L+ L L +N L+G +P      ++++ + LS N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500

Query: 61  KGLCGNF 67
           + L G  
Sbjct: 501 R-LTGEI 506

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN-EQLSSMSRVRLSP 59
              LT LD+S N   G++P      S L+ L LS N  SG +P     ++  +  + LS 
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352

Query: 60  NK 61
           N+
Sbjct: 353 NE 354

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 19/61 (31%), Positives = 38/61 (62%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +K L  L +  N + G IP  L++ + L++++LS N+L+G +P    +L +++ ++LS N
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524

Query: 61  K 61
            
Sbjct: 525 S 525

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 23/61 (37%), Positives = 32/61 (52%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L + NN   G IP  L++ S L  L+LS+N LSG +P S   LS +  ++L  N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452

Query: 61  K 61
            
Sbjct: 453 M 453

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 4/73 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L +S N + G+IP  L  LS+L  L L  N L G +P     + ++  + L  N
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476

Query: 61  KGLCGNFITLPSC 73
             L G    +PS 
Sbjct: 477 D-LTG---EIPSG 485

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.5 bits (163), Expect = 8e-12
 Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 3/64 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLS-RLDYLNLSWNKLSGPVP--FSNEQLSSMSRVRL 57
           M+ L  LD+S N+  G +P  LT+LS  L  L+LS N  SGP+         +++  + L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401

Query: 58  SPNK 61
             N 
Sbjct: 402 QNNG 405

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             NL +LD+S+N     IP  L D S L +L++S NKLSG    +    + +  + +S N
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257

Query: 61  K 61
           +
Sbjct: 258 Q 258

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTD---LSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRL 57
           + +L  LD+S N I G+             L +L +S NK+SG V  S     ++  + +
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSR--CVNLEFLDV 207

Query: 58  SPNK 61
           S N 
Sbjct: 208 SSNN 211

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 61.8 bits (151), Expect = 2e-10
 Identities = 22/63 (34%), Positives = 33/63 (52%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSGPVPFSNEQLS-SMSRVRLS 58
              L  L +S+N   G +P + L  +  L  L+LS+N+ SG +P S   LS S+  + LS
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376

Query: 59  PNK 61
            N 
Sbjct: 377 SNN 379

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 19/59 (32%), Positives = 34/59 (57%), Gaps = 1/59 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-NEQLSSMSRVRLS 58
           ++NL  L +SNN   G+IP EL D   L +L+L+ N  +G +P +  +Q   ++   ++
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 57.6 bits (140), Expect = 4e-09
 Identities = 20/63 (31%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE--QLSSMSRVRLS 58
           +  L  L +SN+ I GS+       + L  L+LS N LSGPV         S +  + +S
Sbjct: 76  LTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVS 134

Query: 59  PNK 61
            N 
Sbjct: 135 SNT 137

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 3/64 (4%)

Query: 1   MKNLTWLDISNNKIEGSIP--GELTDLSRLDYLNLSWNKLSGPVPFSNE-QLSSMSRVRL 57
             +LT LD+S N + G +     L   S L +LN+S N L  P   S   +L+S+  + L
Sbjct: 99  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158

Query: 58  SPNK 61
           S N 
Sbjct: 159 SANS 162

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 56.8 bits (138), Expect = 8e-09
 Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 4/65 (6%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVR--- 56
              L +L++S+N ++          L+ L+ L+LS N +SG              ++   
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184

Query: 57  LSPNK 61
           +S NK
Sbjct: 185 ISGNK 189

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 11/61 (18%), Positives = 25/61 (40%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +      +I++    G       +   + +L++S+N LSG +P     +  +  + L  N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666

Query: 61  K 61
            
Sbjct: 667 D 667

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 12/60 (20%), Positives = 24/60 (40%), Gaps = 4/60 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            ++L WLD++ N   G+IP  +   S      ++ N ++G      +          + N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGN 592

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 10/55 (18%), Positives = 21/55 (38%)

Query: 7   LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
              +  + +G    +L  LS  +  N++     G    + +   SM  + +S N 
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNM 643

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 44.1 bits (105), Expect = 8e-05
 Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 6/62 (9%)

Query: 3   NLTWLDISNNKIE---GSIPGELTDLSRLDYLNLSWNKLSGPVP-FSNEQLSSMSRVRLS 58
            +T +D+S+  +     ++   L  L+ L+ L LS + ++G V  F     +S++ + LS
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC--SASLTSLDLS 108

Query: 59  PN 60
            N
Sbjct: 109 RN 110

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 43.7 bits (104), Expect = 1e-04
 Identities = 8/58 (13%), Positives = 19/58 (32%), Gaps = 2/58 (3%)

Query: 6   WLDISNNKIEGSIPGELTDLSRLDYLNLSWN--KLSGPVPFSNEQLSSMSRVRLSPNK 61
              I+ N I G     + +       + + N  +  G       +LS+ +   ++   
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 37/275 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +DF +   IG G Y  V   +L    +++A   +KK   ++ E++ ++++   E  V  Q
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQ 108

Query: 199 VL-HRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
              H  +V L+  C   +  +F + EY+  G L   +    +  E    +      A ++
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEIS 163

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTAR-RLHADSSNRTLLAG 310
            AL YLH      II+RD+  +N+LL+S    KL     D+G  +  L    +  T   G
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKL----TDYGMCKEGLRPGDTTST-FCG 215

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--RDLLSSLSSSSDPKIMLIDVL 368
           T  YIAPE+          D ++ GV+  E++ G+ P      S     +    +   +L
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275

Query: 369 DQRLPPPVD-QKVIQDILLASTISFACLQSNPKSR 402
           ++++  P         +L       + L  +PK R
Sbjct: 276 EKQIRIPRSLSVKAASVLK------SFLNKDPKER 304

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
           ++F     +G G +G V  A++   G ++A   LKK    + +++    +   E ++LS 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT---EKRILSL 79

Query: 199 VL-HRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
              H  + +L   F    + +F + E++  G L   +       E     R     A + 
Sbjct: 80  ARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEII 134

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR-RLHADSSNRTLLAGTYGY 314
            AL +LH      II+RD+  +N+LL+ +    +ADFG  +  +    +  T   GT  Y
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDY 190

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           IAPE+   M+     D ++ GV+  E+L G  P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 20/213 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
            DF+    +G G +G V  ++     +++A   LKK    + +++        E +VL+ 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV---EKRVLAL 397

Query: 199 VL-HRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
                 + +L+  C      ++ + EY+  G L   +       E           A +A
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIA 452

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR-LHADSSNRTLLAGTYGY 314
             L +L    S  II+RD+  +N++L+S+    +ADFG  +  +    + +T   GT  Y
Sbjct: 453 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDY 508

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           IAPE+       +  D ++FGV+  E+L G+ P
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 20/214 (9%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 197
              + +     IG+G  G V  A      +  A+KKL    + +  A  +++R E  ++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-KRAYR-ELVLMK 79

Query: 198 QVLHRSIVKLYGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
            V H++I+ L      +K +      +++ E M+  +L  ++  +     LD  +   ++
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLL 133

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             M   + +LH   S  IIHRD+  +NI++ S     + DFG AR     S   T    T
Sbjct: 134 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVT 189

Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
             Y APE+   M   E  D++S G +  E++ G 
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 46/231 (19%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALK-----------------------KLHTSETEELAFI 186
           IG G YG V  A    +   +A+K                              +    I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 187 KSFRNEAQVLSQVLHRSIVKLYG--FCLHKKCMFLIYEYMERGSLFCILHND----DEAV 240
           +    E  +L ++ H ++VKL       ++  +++++E + +G +  +        D+A 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
                      + +   + YLH      IIHRDI  +N+L+       +ADFG +     
Sbjct: 141 --------FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 301 DSSNRTLLAGTYGYIAPELAYTMVMT---EKCDVYSFGVVTLEVLM-GKHP 347
             +  +   GT  ++APE           +  DV++ G VTL   + G+ P
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTLYCFVFGQCP 239

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
            DFH    IG G +G V  A+       +A   L+K    + +E   I S RN   VL +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN---VLLK 94

Query: 199 VL-HRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
            + H  +V L + F    K ++ + +Y+  G LF  L  +   +E     R     A +A
Sbjct: 95  NVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIA 149

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARR-LHADSSNRTLLAG 310
            AL YLH   S +I++RD+   NILL+S     L     DFG  +  +  +S+  T   G
Sbjct: 150 SALGYLH---SLNIVYRDLKPENILLDSQGHIVL----TDFGLCKENIEHNSTTST-FCG 201

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  Y+APE+ +        D +  G V  E+L G  P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 198
            DF+    +G G +G V  ++     +++A   LKK    + +++        E +VL+ 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV---EKRVLAL 76

Query: 199 VL-HRSIVKL-YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA-MA 255
                 + +L   F    + ++ + EY+  G L   +       E           A +A
Sbjct: 77  PGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIA 131

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARR-LHADSSNRTLLAG 310
             L +L    S  II+RD+  +N++L+S    K+    ADFG  +  +    + +T   G
Sbjct: 132 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKI----ADFGMCKENIWDGVTTKT-FCG 183

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           T  YIAPE+       +  D ++FGV+  E+L G+ P
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 53/239 (22%), Positives = 95/239 (39%), Gaps = 57/239 (23%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN------- 191
           +    +     +G GG G V+ A      K  A+KK+               +       
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHA 55

Query: 192 --EAQVLSQVLHRSIVKLY--------------GFCLHKKCMFLIYEYMERGSLFCILHN 235
             E +++ ++ H +IVK++              G       ++++ EYME       L N
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLAN 110

Query: 236 DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGT 294
             E   L        +  +   L Y+H   S +++HRD+   N+ +N++ L   + DFG 
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167

Query: 295 ARRLHADSSNRTLLAG---TYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 345
           AR +    S++  L+    T  Y +P L      YT  +    D+++ G +  E+L GK
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G V   +    G   A+K L+  +   L  +   R E Q L    H  I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MAHALAYLHH 263
                  +F++ EY+  G LF      D   +     R++  ++      +   + Y H 
Sbjct: 84  VISTPSDIFMVMEYVSGGELF------DYICK---NGRLDEKESRRLFQQILSGVDYCH- 133

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL---- 319
                ++HRD+   N+LL++ + A +ADFG +  +      RT   G+  Y APE+    
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 190

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM 343
            Y      + D++S GV+ L  L+
Sbjct: 191 LYA---GPEVDIWSSGVI-LYALL 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 9e-14
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
             + DF +K  +G G YG V  A   P G++ A+KK+   +    A +++ R E ++L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR-EIKILKH 65

Query: 199 VLHRSIVKLY-----GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
             H +I+ ++         +   +++I E M+       LH       L        +  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLHRVISTQMLSDDHIQYFIYQ 120

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
              A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR +   +++ +   G   
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 314 ----------YIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
                     Y APE+  T    +   DV+S G +  E+ + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 197
           E    +     +G+G YG+V  A     G   A+KKL+   ++E  A  +++R E ++L 
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYR-ELRLLK 79

Query: 198 QVLHRSIVKLYGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
            + H +++ L       + +      +L+  +M        L    +  +L   +   +V
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEKLGEDRIQFLV 134

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR+     S  T    T
Sbjct: 135 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVT 188

Query: 312 YGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
             Y APE+    M  T+  D++S G +  E++ GK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 33/207 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V  A      +  A+K +      +    ++ + E  +   + H ++VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYG 72

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MAHALAYLHH 263
                   +L  EY   G LF      D          +    A      +   + YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELF------DRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPEL- 319
                I HRDI   N+LL+ +    ++DFG A  +   ++   LL    GT  Y+APEL 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 320 ---AYTMVMTEKCDVYSFGVVTLEVLM 343
               +     E  DV+S G+V L  ++
Sbjct: 180 KRREFH---AEPVDVWSCGIV-LTAML 202

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 70/245 (28%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRSIVKLY 208
           +GTG +G V +   + +GK FALKK+             ++N E  ++  + H +I+KL 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVLDHVNIIKLV 66

Query: 209 GF---CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR----VNIV---------K 252
            +      ++                    ++    +         +N++         K
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 253 AMAH----------------------ALAYLHHDCSPSIIHRDISSNNILLNS-----KL 285
            +                        A+ ++H   S  I HRDI   N+L+NS     KL
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLE 340
                DFG+A++L     +   +   + Y APEL      YT  +    D++S G V  E
Sbjct: 184 ----CDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGCVFGE 234

Query: 341 VLMGK 345
           +++GK
Sbjct: 235 LILGK 239

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 20/214 (9%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 197
              + +     IG+G  G V  A      +  A+KKL    + +  A  +++R E  ++ 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYR-ELVLMK 116

Query: 198 QVLHRSIVKLY------GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
            V H++I+ L             + ++L+ E M+       L    +  ELD  +   ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQM-ELDHERMSYLL 170

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             M   + +LH   S  IIHRD+  +NI++ S     + DFG AR     S   T    T
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVT 226

Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
             Y APE+   M   E  D++S G +  E++  K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKS-FRNEAQVLSQVLHRSIVKLY 208
           +G G YG V +          A+K L   +   +   ++  + E Q+L ++ H+++++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 209 GFCLH--KKCMFLIYEYMERGS--LFCILHNDDEAVELDWAKRVNIVKA------MAHAL 258
               +  K+ M+++ EY   G   +       D   E    KR  + +A      +   L
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML------DSVPE----KRFPVCQAHGYFCQLIDGL 122

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--LAGTYGYIA 316
            YLH   S  I+H+DI   N+LL +     ++  G A  LH  +++ T     G+  +  
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 317 PELAYTMVMTE--KCDVYSFGVVTLEVLM-GKHPRD 349
           PE+A  +      K D++S GV  L  +  G +P +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVT-LYNITTGLYPFE 214

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 22/215 (10%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 197
           E  E +     +G+G YGSV  A     G   A+KKL    ++   A  +++R E ++L 
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYR-ELRLLK 83

Query: 198 QVLHRSIVKLYGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
            + H +++ L       + +      +L+   M        L+N  +  +L       ++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLI 138

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             +   L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR     +   T    T
Sbjct: 139 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVAT 192

Query: 312 YGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
             Y APE+    M   +  D++S G +  E+L G+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 197
           E  + +     +G+G YGSV  A    +G+  A+KKL    ++E  A  +++R E  +L 
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA-KRAYR-ELLLLK 78

Query: 198 QVLHRSIVKLYGFCLHKKCM------FLIYEYMERGSLFCILHN------DDEAVELDWA 245
            + H +++ L         +      +L+  +M+       L         +E ++    
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEKIQY--- 130

Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR 305
               +V  M   L Y+H   S  ++HRD+   N+ +N   E  + DFG AR      +  
Sbjct: 131 ----LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEM 180

Query: 306 TLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 345
           T    T  Y APE+  + M   +  D++S G +  E+L GK
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 33/207 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G YG V  A      +  A+K +      +    ++ + E  +   + H ++VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYG 72

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MAHALAYLHH 263
                   +L  EY   G LF      D          +    A      +   + YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELF------DRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGYIAPEL- 319
                I HRDI   N+LL+ +    ++DFG A  +   ++   LL    GT  Y+APEL 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 320 ---AYTMVMTEKCDVYSFGVVTLEVLM 343
               +     E  DV+S G+V L  ++
Sbjct: 180 KRREFH---AEPVDVWSCGIV-LTAML 202

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 46/234 (19%), Positives = 83/234 (35%), Gaps = 51/234 (21%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIK-SFRNEAQVLS 197
           +  + + I++ IGTG YG V +A      +V A+KK+     E+L   K   R E  +L+
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILR-EIAILN 107

Query: 198 QVLHRSIVKLY-----GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           ++ H  +VK+              ++++ E  +                        + +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKK--------------LFR 148

Query: 253 A-----MAH----------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR 297
                   H           + Y+H   S  I+HRD+   N L+N      V DFG AR 
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205

Query: 298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMGKH 346
           +    +  + L  +       L             +  VVT      E+++ + 
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 29/204 (14%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           +G G +G V  A      +  ALK +     ++         E   L  + H  I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA------MAHALAYLHH 263
                  + ++ EY   G LF      D  VE    KR+   +       +  A+ Y H 
Sbjct: 77  VITTPTDIVMVIEYAG-GELF------DYIVE---KKRMTEDEGRRFFQQIICAIEYCH- 125

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL---- 319
                I+HRD+   N+LL+  L   +ADFG +  +   +  +T   G+  Y APE+    
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGK 182

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLM 343
            Y      + DV+S G+V L V++
Sbjct: 183 LYA---GPEVDVWSCGIV-LYVML 202

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 41/223 (18%), Positives = 87/223 (39%), Gaps = 40/223 (17%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE----ELAFIKSFRNEAQ 194
              +D+ +   +G G Y  V++A  + N +   +K L   + +    E+  +++ R    
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG--- 89

Query: 195 VLSQVLHRSIVKLYGFCLH---KKCMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNI 250
                   +I+ L    +     +   L++E++       +     D  +          
Sbjct: 90  ------GPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------Y 135

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARRLHADSSNRTLLA 309
           +  +  AL Y H   S  I+HRD+  +N++++ +  +  + D+G A   H        +A
Sbjct: 136 MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192

Query: 310 GTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
             Y +  PEL      Y   +    D++S G +   ++  K P
Sbjct: 193 SRY-FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 37/212 (17%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETE------ELAFIKSF 189
                + +   +G G YG V+K+     G+V A+KK+     + T+      E+  +   
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 190 RNEAQVLSQVLHRSIVKLYGFCL--HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR 247
                      H +IV L       + + ++L+++YME       LH    A  L+   +
Sbjct: 66  SG---------HENIVNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHK 111

Query: 248 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
             +V  +   + YLH   S  ++HRD+  +NILLN++    VADFG +R           
Sbjct: 112 QYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 308 LAGTYGYIAPELAYTM-VMTEKCDVYSFGVVT 338
           +  +             ++T+    Y   V T
Sbjct: 169 IPLSINENTENFDDDQPILTD----Y---VAT 193

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 46/223 (20%), Positives = 76/223 (34%), Gaps = 55/223 (24%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 197
              +++ IK+ IG G YG VY A      K  A+KK++   E       +  R E  +L+
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC-KRILR-EITILN 80

Query: 198 QVLHRSIVKLYGFCLHKKC-----MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVK 252
           ++    I++LY   +         ++++ E  +       L                + K
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKK--------------LFK 121

Query: 253 AMAH---------------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR 297
                                 ++H      IIHRD+   N LLN      V DFG AR 
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178

Query: 298 LH--ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 338
           ++   D++    L                +T     +   VVT
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTS----H---VVT 214

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 28/159 (17%)

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
           A  + +L    S   IHRD+++ NILL+ K    + DFG AR ++ D             
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDAR 256

Query: 315 I-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVL 368
           +     APE  +  V T + DV+SFGV+  E+  +G  P      +    +        L
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEE----FCRRL 309

Query: 369 DQ--RLPPPVD-QKVIQDILLASTISFACLQSNPKSRPT 404
            +  R+  P      +   +L       C    P  RPT
Sbjct: 310 KEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRPT 342

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 27/150 (18%), Positives = 51/150 (34%), Gaps = 20/150 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           +   +   +G G +G V +A           +  A+K L    T      ++  +E ++L
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79

Query: 197 SQVL-HRSIVKLYGFCLHKKC-MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
             +  H ++V L G C      + +I E+ + G+L   L +          KR   V   
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----------KRNEFVPYK 129

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSK 284
                +         I  D+      + S 
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSS 159

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 35/211 (16%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG+G +G     +     ++ A+K +      +    ++ + E      + H +IV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83

Query: 210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA------HALAYLHH 263
             L    + +I EY   G L+      +       A R +  +A          ++Y H 
Sbjct: 84  VILTPTHLAIIMEYASGGELY------ERICN---AGRFSEDEARFFFQQLLSGVSYCH- 133

Query: 264 DCSPSIIHRDISSNNILLNSKLEAF--VADFGTARRLHADSSNRTLLAGTYGYIAPEL-- 319
             S  I HRD+   N LL+        + DFG ++     S  ++ + GT  YIAPE+  
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 190

Query: 320 --AYTMVMTEKCDVYSFGVVTLEVLM-GKHP 347
              Y     +  DV+S GV  L V++ G +P
Sbjct: 191 RQEYD---GKIADVWSCGVT-LYVMLVGAYP 217

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.3 bits (145), Expect = 3e-10
 Identities = 34/248 (13%), Positives = 74/248 (29%), Gaps = 54/248 (21%)

Query: 141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLH-----TSETEELAFIKSFRNEAQV 195
            TE       IG G +G V++    +  V A+K +                +    E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 196 LSQVL---------HRSIVKLYGFCLHK----KCMFLIYEYM--ERGS------------ 228
             ++              + L      +      +   +++    +GS            
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 229 LFCILHNDDEAVEL--------DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL 280
           LF +L  +   ++L          A   +I+  +  +LA      S    HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 281 LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVT 338
           L       +             + ++    + G     + YT+  +  +   V+    + 
Sbjct: 195 LKKTSLKKLHYTL---------NGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245

Query: 339 LEVLMGKH 346
            ++  G  
Sbjct: 246 EDLFTGDG 253

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 43/219 (19%), Positives = 84/219 (38%), Gaps = 35/219 (15%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALK------KLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           +G G + +V+ A+ + N    A+K          +  +E+  ++   +        +  +
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 204 -IVKLYGFCLHKKC----MFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVNIVKAMAHA 257
            I+KL     HK      + +++E +   +L  ++   +   + L + K+  I K +   
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLLLG 143

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF------VADFGTARRLHADSSNRTLLAGT 311
           L Y+H  C   IIH DI   N+L+             +AD G A        + T    T
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQT 198

Query: 312 YGYIAPE----LAYTMVMTEKCDVYSFGVVTLEVLMGKH 346
             Y +PE      +        D++S   +  E++ G  
Sbjct: 199 REYRSPEVLLGAPWGC----GADIWSTACLIFELITGDF 233

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 4/76 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLSP 59
              L  L+++ N+I            +++ L+ + NKL   P  F  + +S MS +  S 
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411

Query: 60  NK---GLCGNFITLPS 72
           N+       NF  L  
Sbjct: 412 NEIGSVDGKNFDPLDP 427

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           MK L  L+   N++EG +P       +L  LNL++N+++            +  +  + N
Sbjct: 329 MKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387

Query: 61  K 61
           K
Sbjct: 388 K 388

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 14/78 (17%), Positives = 31/78 (39%), Gaps = 10/78 (12%)

Query: 1   MKNLTWLDISNNKI-EGSIPGELTDLSRLDYLNLSWNKLSGPVP-FSNEQLSSMSRVRLS 58
            + +  + I  N +    +   L  + +L  L   +N+L G +P F +     ++ + L+
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS--EIKLASLNLA 361

Query: 59  PNK------GLCGNFITL 70
            N+        CG    +
Sbjct: 362 YNQITEIPANFCGFTEQV 379

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 7/68 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-------PVPFSNEQLSSMS 53
             N++ +++SNN+I        +  S L  +NL  N L+            + +    ++
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491

Query: 54  RVRLSPNK 61
            + L  NK
Sbjct: 492 SIDLRFNK 499

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 13/68 (19%), Positives = 25/68 (36%), Gaps = 7/68 (10%)

Query: 1   MKNLTWLDISNNKIEG-------SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMS 53
           +  ++ +D S N+I          +         +  +NLS N++S          S +S
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460

Query: 54  RVRLSPNK 61
            + L  N 
Sbjct: 461 SINLMGNM 468

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 10/71 (14%), Positives = 20/71 (28%), Gaps = 5/71 (7%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN----EQLSSMSRVRLS 58
            +T L +      G +P  +  L+ L+ L L  +                  S  + +  
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 59  PNKGLCGNFIT 69
                   F+ 
Sbjct: 142 RM-HYQKTFVD 151

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 8/69 (11%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKL--------SGPVPFSNEQLSSM 52
           +K+LT +++ N      +P  L  L  +  +N++ N+                      +
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307

Query: 53  SRVRLSPNK 61
             + +  N 
Sbjct: 308 QIIYIGYNN 316

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 14/81 (17%), Positives = 28/81 (34%), Gaps = 13/81 (16%)

Query: 1   MKNLTWLDISNNKIEG-------SIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSM 52
              L+ +++  N +                +   L  ++L +NKL+     F    L  +
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYL 515

Query: 53  SRVRLSPNKGLCGNFITLPSC 73
             + LS N     +F   P+ 
Sbjct: 516 VGIDLSYN-----SFSKFPTQ 531

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 11/78 (14%), Positives = 27/78 (34%), Gaps = 12/78 (15%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRL------DYLNLSWNKLSGPVPFSNEQLSSMSR 54
           +  L  +D+S N      P +  + S L      +  +   N+     P       S+++
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570

Query: 55  VRLSPNKGLCGNFITLPS 72
           +++  N     +   +  
Sbjct: 571 LQIGSN-----DIRKVNE 583

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 5/58 (8%), Positives = 16/58 (27%), Gaps = 1/58 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
               T +   +N I   +   +  L++L    +  +           +  +    +  
Sbjct: 182 TLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 12/78 (15%), Positives = 23/78 (29%), Gaps = 9/78 (11%)

Query: 1   MKNLTWLDISN------NKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSR 54
              L    I N      N+     P  +T    L  L +  N +   V        ++S 
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISV 591

Query: 55  VRLSPNKGLCGNFITLPS 72
           + +  N  +  +   +  
Sbjct: 592 LDIKDNPNISIDLSYVCP 609

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 10/61 (16%), Positives = 19/61 (31%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             +LT L I +N I   +  ++     +  L++  N                    L  +
Sbjct: 565 CPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

Query: 61  K 61
           K
Sbjct: 622 K 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 10/89 (11%), Positives = 26/89 (29%), Gaps = 19/89 (21%)

Query: 1   MKNLTWLDISNNKIEG-------------------SIPGELTDLSRLDYLNLSWNKLSGP 41
           +  L    + N+                       +   +  +L  L  + +        
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 42  VPFSNEQLSSMSRVRLSPNKGLCGNFITL 70
           +P   + L  M  + ++ N+G+ G  +  
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKD 293

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 5/71 (7%), Positives = 18/71 (25%), Gaps = 6/71 (8%)

Query: 1   MKNLTWLDISNNKIEG----SIPGELTDLSRLDYLNLSWNKLSGPVP--FSNEQLSSMSR 54
           +  L  L + ++  +       P  ++     +                   E  S + +
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163

Query: 55  VRLSPNKGLCG 65
             ++ +     
Sbjct: 164 DCINSDPQQKS 174

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 7/39 (17%), Positives = 13/39 (33%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
             N++ LDI +N         +          L ++K  
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 20/61 (32%), Positives = 31/61 (50%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           ++NLT+LD+S  ++E   P     LS L  LN+S N       F  + L+S+  +  S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 61  K 61
            
Sbjct: 529 H 529

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 15/61 (24%), Positives = 24/61 (39%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  LD+S  +I+    G    LS L  L L+ N +      +   LSS+ ++     
Sbjct: 51  FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110

Query: 61  K 61
            
Sbjct: 111 N 111

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 13/61 (21%), Positives = 26/61 (42%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L+ L ++ N I+    G  + LS L  L      L+    F    L ++  + ++ N
Sbjct: 75  LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134

Query: 61  K 61
            
Sbjct: 135 L 135

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 3/66 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP--FSNEQLSSMSRVRLS 58
           + +L  L++S+N            L+ L  L+ S N +         +   SS++ + L+
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH-FPSSLAFLNLT 551

Query: 59  PNKGLC 64
            N   C
Sbjct: 552 QNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 19/70 (27%), Positives = 36/70 (51%), Gaps = 3/70 (4%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           +K L  L++++N I+   +P   ++L+ L++L+LS NK+          L  M  + LS 
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 60  NKGLCGNFIT 69
           +  L  N + 
Sbjct: 183 D--LSLNPMN 190

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 13/59 (22%), Positives = 24/59 (40%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          +   LD+S N +             L  L+LS  ++      + + LS +S + L+ N 
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 7/70 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKL-SGPVPFSNEQLSSMSRVRLSP 59
           + +L  L      +       +  L  L  LN++ N + S  +P     L+++  + LS 
Sbjct: 99  LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS- 157

Query: 60  NKGLCGNFIT 69
                 N I 
Sbjct: 158 -----SNKIQ 162

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 12/43 (27%), Positives = 20/43 (46%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP 43
           ++NL +LDIS+     +  G    LS L+ L ++ N       
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 17/62 (27%), Positives = 31/62 (50%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSI-PGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           + +L  L ++ N  + +  P   T+L  L +L+LS  +L    P +   LSS+  + +S 
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503

Query: 60  NK 61
           N 
Sbjct: 504 NN 505

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 13/63 (20%), Positives = 28/63 (44%), Gaps = 3/63 (4%)

Query: 1   MKNLTWLDISNNKI--EGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           + +L +LD+S N +  +G         + L YL+LS+N +   +  +   L  +  +   
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ 404

Query: 59  PNK 61
            + 
Sbjct: 405 HSN 407

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 11/75 (14%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDY----LNLSWNKLSGPVPFSNEQLSSMSRVR 56
           + NL  LD+S+NKI+     +L  L ++      L+LS N ++   P +      +   +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA---FKEIRLHK 204

Query: 57  LSPNKGLCGNFITLP 71
           L+    L  NF +L 
Sbjct: 205 LT----LRNNFDSLN 215

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 12/62 (19%), Positives = 25/62 (40%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           ++ L  LD  ++ ++          L  L YL++S              LSS+  ++++ 
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454

Query: 60  NK 61
           N 
Sbjct: 455 NS 456

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 2/62 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN-EQLSSMSRVRLSP 59
             +L +LD+S N +   +      L +L++L+   + L     FS    L ++  + +S 
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430

Query: 60  NK 61
             
Sbjct: 431 TH 432

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 6/73 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + N++   + +  IE       +      +L L   K      F   +L S+ R+  + N
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSN 335

Query: 61  KGL-CGNFITLPS 72
           KG    + + LPS
Sbjct: 336 KGGNAFSEVDLPS 348

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 23/76 (30%), Positives = 37/76 (48%), Gaps = 6/76 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           +K+L  L  ++NK   +      DL  L++L+LS N LS  G    S+   +S+  + LS
Sbjct: 324 LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 59  PNK--GLCGNFITLPS 72
            N    +  NF+ L  
Sbjct: 382 FNGVITMSSNFLGLEQ 397

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 10/67 (14%), Positives = 19/67 (28%), Gaps = 8/67 (11%)

Query: 1   MKNLTWLDISNNKIE------GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSR 54
           ++ L  L I   ++         I      L+ +   +L    +     FS         
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQH 308

Query: 55  VRLSPNK 61
           + L   K
Sbjct: 309 LELVNCK 315

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 16/71 (22%), Positives = 26/71 (36%), Gaps = 2/71 (2%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN-EQLSSMSRVRLSPNK 61
               LD+S N +    PG   ++ RL  L L  N  S  V  +  + L+ +   RL   +
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 62  GLCGNFITLPS 72
                 +    
Sbjct: 237 FRNEGNLEKFD 247

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            N+  LD+S N +      +L   ++L+ LNLS N L   +   +  LS++  + L+ N
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLES--LSTLRTLDLNNN 90

Query: 61 K 61
           
Sbjct: 91 Y 91

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 2/66 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  LD+S+NK+   +  E    + + +++L  NKL   +  +     ++    L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247

Query: 61  KGLCGN 66
              CG 
Sbjct: 248 GFHCGT 253

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 12/62 (19%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLSP 59
            +    + ++NNKI      +    SR+ YL+L  N++             ++  + L  
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 60  NK 61
           N 
Sbjct: 179 NF 180

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 9/61 (14%), Positives = 22/61 (36%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
                  ++++ ++ ++         +  L+LS N LS          + +  + LS N
Sbjct: 9  GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 61 K 61
           
Sbjct: 69 V 69

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 8/61 (13%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  LD++NN ++     EL     ++ L+ + N +S     S  +      + L+ N
Sbjct: 79  LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANN 130

Query: 61  K 61
           K
Sbjct: 131 K 131

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 3/62 (4%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              + +LD+  N+I+  +          L++LNL +N +   V       + +  + LS 
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSS 200

Query: 60  NK 61
           NK
Sbjct: 201 NK 202

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 11/39 (28%), Positives = 19/39 (48%), Gaps = 2/39 (5%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
             L  L++S+N +      +L  LS L  L+L+ N + 
Sbjct: 57 FTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 17/61 (27%), Positives = 25/61 (40%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              LT LD+  N I    P     L  L  LNL  N+LS     +    ++++ + L  N
Sbjct: 48  YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107

Query: 61  K 61
            
Sbjct: 108 S 108

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 19/61 (31%), Positives = 27/61 (44%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             NLT L + +N I+            L  L+LS N LS     +  QL ++  + LS N
Sbjct: 96  CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

Query: 61  K 61
           K
Sbjct: 156 K 156

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 15/58 (25%), Positives = 25/58 (43%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           NLT LD+S N +          L +L+Y  L +N +      S   L ++  + L  +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 20/63 (31%), Positives = 29/63 (46%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRLS 58
            KNL  LD+S+N +  +  G    L  L  L LS NK+             SS+ ++ LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 59  PNK 61
            N+
Sbjct: 180 SNQ 182

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 12/61 (19%), Positives = 23/61 (37%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L++ +N  +        DL  L  ++L  N L+           S+  + L  N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594

Query: 61  K 61
            
Sbjct: 595 L 595

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 10/65 (15%), Positives = 22/65 (33%), Gaps = 1/65 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-NEQLSSMSRVRLSP 59
           +  L  +D+  N +         +   L  LNL  N ++            +++ + +  
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 60  NKGLC 64
           N   C
Sbjct: 619 NPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 15/62 (24%), Positives = 30/62 (48%), Gaps = 3/62 (4%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRLSP 59
           +L  L++S+N+I+   PG    + RL  L L+  +L   +          +S+  + LS 
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231

Query: 60  NK 61
           ++
Sbjct: 232 SQ 233

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 10/61 (16%), Positives = 23/61 (37%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L++ +N++           + L  L+L  N +         +  ++  + LS N
Sbjct: 72  LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131

Query: 61  K 61
            
Sbjct: 132 G 132

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPG-ELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           + +L  LD+  N+I   + G E   L  +  + LS+NK       S   + S+ R+ L  
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 60  NK 61
             
Sbjct: 464 VA 465

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 15/65 (23%), Positives = 25/65 (38%), Gaps = 6/65 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG----PVPFSNEQLSSMSRVR 56
           ++N+  + +S NK           +  L  L L    L      P PF    L +++ + 
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP--LRNLTILD 486

Query: 57  LSPNK 61
           LS N 
Sbjct: 487 LSNNN 491

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 14/60 (23%), Positives = 31/60 (51%)

Query: 2  KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           N+T L++++N++        T  S+L  L++ +N +S   P   ++L  +  + L  N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 4/65 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG----PVPFSNEQLSSMSRVR 56
           +K L  L++ +N I G      T L  L YL+LS +  S        F +   S +  + 
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387

Query: 57  LSPNK 61
           L+ NK
Sbjct: 388 LTKNK 392

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDL--SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           ++NL  L +SNNKI+     EL     S L  L LS N++    P     +  +  + L+
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 59  PNK 61
             +
Sbjct: 204 NVQ 206

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 21/69 (30%), Positives = 32/69 (46%), Gaps = 8/69 (11%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--------GPVPFSNEQLSSM 52
           ++NLT LD+SNN I       L  L +L+ L+L  N L+        G   +  + LS +
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538

Query: 53  SRVRLSPNK 61
             + L  N 
Sbjct: 539 HILNLESNG 547

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 14/66 (21%), Positives = 32/66 (48%), Gaps = 5/66 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTD---LSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRV 55
           +  L  L ++N ++  S+  +L      + +  L+LS ++LS      F   + ++++ +
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253

Query: 56  RLSPNK 61
            LS N 
Sbjct: 254 DLSYNN 259

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 15/62 (24%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN-EQLSSMSRVRLSP 59
              L  L+++ NKI        + L  L+ L+L  N++   +       L ++  + LS 
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 60  NK 61
           NK
Sbjct: 440 NK 441

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 14/63 (22%), Positives = 24/63 (38%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEG--SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           + +L  L +    ++   S P     L  L  L+LS N ++       E L  +  + L 
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512

Query: 59  PNK 61
            N 
Sbjct: 513 HNN 515

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 15/80 (18%), Positives = 29/80 (36%), Gaps = 6/80 (7%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           ++ T   IS   +          L  L++LN+  N + G        L ++  + LS   
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS--- 361

Query: 62  GLCGNFITLPSCDATKPATL 81
               +F +L +       +L
Sbjct: 362 ---NSFTSLRTLTNETFVSL 378

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 15/70 (21%), Positives = 24/70 (34%), Gaps = 9/70 (12%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNL---------SWNKLSGPVPFSNEQLSS 51
           +  L +  +  N I+      L  L  + YLNL         S   L     FS + L  
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330

Query: 52  MSRVRLSPNK 61
           +  + +  N 
Sbjct: 331 LEHLNMEDND 340

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 14/63 (22%), Positives = 26/63 (41%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDL--SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
             ++  L +SN+++  +       L  + L  L+LS+N L+     S   L  +    L 
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280

Query: 59  PNK 61
            N 
Sbjct: 281 YNN 283

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 8/69 (11%)

Query: 1   MKNLTWLDISNNKIE--------GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSM 52
           ++ L  LD+ +N +         G     L  LS L  LNL  N          + L  +
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562

Query: 53  SRVRLSPNK 61
             + L  N 
Sbjct: 563 KIIDLGLNN 571

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 46/221 (20%), Positives = 82/221 (37%), Gaps = 43/221 (19%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR- 202
           + +   IG G +G V KA      +  ALK +           K F  +A    ++L   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--------EKRFHRQAAEEIRILEHL 150

Query: 203 ---------SIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVNIVK 252
                    +++ +      +  + + +E +   +L+ ++  N  +   L   ++     
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAH 207

Query: 253 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF--VADFGTARRLHADSSNRTLLAG 310
           ++   L  LH      IIH D+   NILL  +  +   V DFG++   H           
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--------- 255

Query: 311 TYGYI------APELAYTMVMTEKCDVYSFGVVTLEVLMGK 345
            Y YI      APE+          D++S G +  E+L G 
Sbjct: 256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            N+  LD+S N +      +L   ++L+ LNLS N L   +   +  LS++  + L+ N
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLES--LSTLRTLDLNNN 90

Query: 61 K 61
           
Sbjct: 91 Y 91

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 13/61 (21%), Positives = 26/61 (42%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  LD+S+NK+   +  E    + + +++L  NKL   +  +     ++    L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247

Query: 61  K 61
            
Sbjct: 248 G 248

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 15/67 (22%), Positives = 25/67 (37%), Gaps = 2/67 (2%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS-GPVPFSNEQLSSMSRVRLSP 59
              +TW+ + NNK+   I   L     L++ +L  N    G +     +   +  V    
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 60  NKGLCGN 66
            K L G 
Sbjct: 272 VKKLTGQ 278

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 12/62 (19%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLSP 59
            +    + ++NNKI      +    SR+ YL+L  N++             ++  + L  
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 60  NK 61
           N 
Sbjct: 179 NF 180

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 9/61 (14%), Positives = 22/61 (36%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
                  ++++ ++ ++         +  L+LS N LS          + +  + LS N
Sbjct: 9  GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 61 K 61
           
Sbjct: 69 V 69

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 15/61 (24%), Positives = 30/61 (49%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L++  N I   + G++   ++L  L+LS NKL+  +    +  + ++ + L  N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNN 224

Query: 61  K 61
           K
Sbjct: 225 K 225

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 3/62 (4%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              + +LD+  N+I+  +          L++LNL +N +   V       + +  + LS 
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSS 200

Query: 60  NK 61
           NK
Sbjct: 201 NK 202

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 11/39 (28%), Positives = 19/39 (48%), Gaps = 2/39 (5%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
             L  L++S+N +      +L  LS L  L+L+ N + 
Sbjct: 57 FTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 8/61 (13%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  LD++NN ++     EL     ++ L+ + N +S     S  +      + L+ N
Sbjct: 79  LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANN 130

Query: 61  K 61
           K
Sbjct: 131 K 131

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 13/64 (20%), Positives = 25/64 (39%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L++S+N +          L  L  L+ S+N++            S++   L+ N
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555

Query: 61  KGLC 64
              C
Sbjct: 556 SVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 22/61 (36%), Positives = 30/61 (49%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             NLT+LD+S  ++E    G    L RL  LN+S N L         QL S+S +  S N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531

Query: 61  K 61
           +
Sbjct: 532 R 532

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 18/72 (25%), Positives = 29/72 (40%), Gaps = 11/72 (15%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG---PVPFSNEQLSSMSRVRL 57
           + +L  L     K+       +  L  L  LN++ N +     P  FSN  L+++  V L
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN--LTNLVHVDL 160

Query: 58  SPNKGLCGNFIT 69
           S       N+I 
Sbjct: 161 S------YNYIQ 166

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 17/69 (24%), Positives = 33/69 (47%), Gaps = 6/69 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L+ L ++ N I+   PG  + L+ L+ L     KL+    F   QL ++ ++ ++  
Sbjct: 79  LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA-- 136

Query: 61  KGLCGNFIT 69
                NFI 
Sbjct: 137 ----HNFIH 141

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 17/71 (23%), Positives = 25/71 (35%), Gaps = 10/71 (14%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP--FSNEQLSSMSRVRLS 58
              L WLD+S  +IE         L  L  L L+ N +    P  FS   L+S+  +   
Sbjct: 55  FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG--LTSLENLVAV 112

Query: 59  PNKGLCGNFIT 69
                    + 
Sbjct: 113 ------ETKLA 117

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           ++ L +LDIS    +    G    L+ L+ L ++ N          F+N   ++++ + L
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN--TTNLTFLDL 480

Query: 58  SPNK 61
           S  +
Sbjct: 481 SKCQ 484

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 16/70 (22%), Positives = 34/70 (48%), Gaps = 3/70 (4%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           +  L  L++++N I    +P   ++L+ L +++LS+N +        + L    +V LS 
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186

Query: 60  NKGLCGNFIT 69
           +  +  N I 
Sbjct: 187 D--MSLNPID 194

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 12/59 (20%), Positives = 27/59 (45%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          +   +D+S N ++       ++ S L +L+LS  ++      +   L  +S + L+ N 
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 6/76 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           +  L  L ++ NK   SI  +   L  L YL+LS N LS  G   +S+   +S+  + LS
Sbjct: 327 LPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384

Query: 59  PNK--GLCGNFITLPS 72
            N    +  NF+ L  
Sbjct: 385 FNGAIIMSANFMGLEE 400

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 11/62 (17%), Positives = 28/62 (45%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           ++ L  LD  ++ ++          L +L YL++S+             L+S++ ++++ 
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457

Query: 60  NK 61
           N 
Sbjct: 458 NS 459

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 2/62 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN-EQLSSMSRVRLSP 59
             +L  LD+S N     +      L  L +L+   + L     FS    L  +  + +S 
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433

Query: 60  NK 61
             
Sbjct: 434 TN 435

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 11/62 (17%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           + +L  L ++ N  + +       + + L +L+LS  +L        + L  +  + +S 
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506

Query: 60  NK 61
           N 
Sbjct: 507 NN 508

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDL--SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           + +L++LD+S N +  S     +DL  + L +L+LS+N        +   L  +  +   
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQ 407

Query: 59  PNK 61
            + 
Sbjct: 408 HST 410

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 13/73 (17%), Positives = 30/73 (41%), Gaps = 6/73 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + N++ + ++   I      ++    +   L++   +L     F    L  +  + L+ N
Sbjct: 284 LANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMN 338

Query: 61  KG-LCGNFITLPS 72
           KG +    + LPS
Sbjct: 339 KGSISFKKVALPS 351

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 5/65 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLD----YLNLSWNKLSGPVPFSNEQLSSMSRVR 56
           + NL  +D+S N I+     +L  L         L++S N +   +     Q   +  + 
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELT 210

Query: 57  LSPNK 61
           L  N 
Sbjct: 211 LRGNF 215

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 2/75 (2%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP-FSNEQLSSMSRVRLSPN 60
           +    LD+S N I+  I  +     +L  L L  N  S  +     + L+ +   RL   
Sbjct: 181 QVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239

Query: 61  KGLCGNFITLPSCDA 75
           +      + +     
Sbjct: 240 EFKDERNLEIFEPSI 254

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 18/81 (22%), Positives = 27/81 (33%), Gaps = 11/81 (13%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
                 L I   +++   P    DL  L  L L+ NK S         L S+S + LS  
Sbjct: 306 HFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGSISFKKVA--LPSLSYLDLS-- 358

Query: 61  KGLCGNFITLPSCDATKPATL 81
                N ++   C +      
Sbjct: 359 ----RNALSFSGCCSYSDLGT 375

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 4/70 (5%), Positives = 18/70 (25%), Gaps = 2/70 (2%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG 62
            +    ++          +   L+ +  ++L+   +                + +   + 
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQL 319

Query: 63  LCGNFITLPS 72
                + LP 
Sbjct: 320 KQFPTLDLPF 329

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 56.4 bits (137), Expect = 6e-09
 Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L ++NN++       +  L+ L  L LS N ++   P ++  LS M     +  
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS--LSKMDSADFANQ 343

Query: 61  K 61
            
Sbjct: 344 V 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 50.6 bits (122), Expect = 5e-07
 Identities = 12/61 (19%), Positives = 32/61 (52%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  +  L++  N     +   L++++ L+YL ++ +K+    P +N  L+ +  + L+ N
Sbjct: 131 LTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIAN--LTDLYSLSLNYN 187

Query: 61  K 61
           +
Sbjct: 188 Q 188

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M  L  L I NNKI    P  L +LS+L +L +  N++S      +  L+ +  + +  N
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKD--LTKLKMLNVGSN 275

Query: 61  K 61
           +
Sbjct: 276 Q 276

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 15/61 (24%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL +L+++ N+I    P  L++L +L  L +  NK++      N  L+++  + L+ +
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQN--LTNLRELYLNED 120

Query: 61  K 61
            
Sbjct: 121 N 121

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 15/61 (24%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L ++ N+IE   P  L  L+ L Y     N+++   P +N  ++ ++ +++  N
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVAN--MTRLNSLKIGNN 231

Query: 61  K 61
           K
Sbjct: 232 K 232

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LTWL+I  N+I   I   + DL++L  LN+  N++S     +N  LS ++ + L+ N
Sbjct: 242 LSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISDISVLNN--LSQLNSLFLNNN 297

Query: 61  K 61
           +
Sbjct: 298 Q 298

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 19/61 (31%), Positives = 37/61 (60%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          ++++T L ++  K+  SI G +  L+ L+YLNL+ N+++   P SN  L  ++ + +  N
Sbjct: 43 LESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISPLSN--LVKLTNLYIGTN 98

Query: 61 K 61
          K
Sbjct: 99 K 99

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 14/61 (22%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L +     N+I    P  + +++RL+ L +  NK++   P +N  LS ++ + +  N
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLAN--LSQLTWLEIGTN 253

Query: 61  K 61
           +
Sbjct: 254 Q 254

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.9 bits (115), Expect = 3e-06
 Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L++ +N+I   I   L +LS+L+ L L+ N+L          L++++ + LS N
Sbjct: 264 LTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321

Query: 61  K 61
            
Sbjct: 322 H 322

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.5 bits (114), Expect = 4e-06
 Identities = 14/61 (22%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M  L +L ++ +K++   P  + +L+ L  L+L++N++    P ++  L+S+       N
Sbjct: 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLAS--LTSLHYFTAYVN 209

Query: 61  K 61
           +
Sbjct: 210 Q 210

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.4 bits (111), Expect = 9e-06
 Identities = 20/72 (27%), Positives = 33/72 (45%), Gaps = 9/72 (12%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LT L I  NKI  +    L +L+ L  L L+ + +S   P +N  L+ M  + L  N
Sbjct: 87  LVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLAN--LTKMYSLNLGAN 142

Query: 61  KGLCGNFITLPS 72
                + ++  S
Sbjct: 143 -----HNLSDLS 149

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.1 bits (100), Expect = 2e-04
 Identities = 12/39 (30%), Positives = 19/39 (48%), Gaps = 2/39 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
           + NLT L +S N I    P  L  LS++D  + +   + 
Sbjct: 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 42.1 bits (100), Expect = 2e-04
 Identities = 6/61 (9%), Positives = 22/61 (36%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          +       +    +   +     +L  +  L ++  K++         L+++  + L+ N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEY--LTNLEYLNLNGN 76

Query: 61 K 61
          +
Sbjct: 77 Q 77

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 13/70 (18%), Positives = 25/70 (35%), Gaps = 9/70 (12%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE---------QLSS 51
           +K+LT +++ N      +P  L DL  L  LN++ N+         +             
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549

Query: 52  MSRVRLSPNK 61
           +    +  N 
Sbjct: 550 IQIFYMGYNN 559

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 20/63 (31%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGEL-TDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLS 58
              LT L +  N+IE  IP +      +++ L  S NKL   P  F+ + +  M  V  S
Sbjct: 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652

Query: 59  PNK 61
            NK
Sbjct: 653 YNK 655

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 7/60 (11%), Positives = 21/60 (35%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              +T L ++    +G +P  +  L+ L  L+   +  +       ++  +        +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 12/68 (17%), Positives = 26/68 (38%), Gaps = 7/68 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS-------GPVPFSNEQLSSMS 53
             N + + +S N+I+          S +  + LS N ++        P   + +    ++
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 54  RVRLSPNK 61
            + L  NK
Sbjct: 732 TIDLRFNK 739

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 16/81 (19%), Positives = 31/81 (38%), Gaps = 13/81 (16%)

Query: 1   MKNLTWLDISNNKIE-------GSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSM 52
              ++ + +SNN +            G   +   L  ++L +NKL+     F    L  +
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYL 755

Query: 53  SRVRLSPNKGLCGNFITLPSC 73
           S + +S N      F + P+ 
Sbjct: 756 SNMDVSYN-----CFSSFPTQ 771

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 12/67 (17%), Positives = 27/67 (40%), Gaps = 7/67 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNL------SWNKLSGPVPFSNEQLSSMSR 54
           +  L+ +D+S N    S P +  + S+L    +        N++    P       S+ +
Sbjct: 752 LPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810

Query: 55  VRLSPNK 61
           +++  N 
Sbjct: 811 LQIGSND 817

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 10/71 (14%), Positives = 25/71 (35%), Gaps = 10/71 (14%)

Query: 1   MKNLTWLDISNNKIEG---------SIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLS 50
           +  L  L+I+ N+             +  +     ++    + +N L   P   S +++ 
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573

Query: 51  SMSRVRLSPNK 61
            +  +    NK
Sbjct: 574 KLGLLDCVHNK 584

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 13/74 (17%), Positives = 28/74 (37%), Gaps = 6/74 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKL-SGPVP-FSNEQLSSMSRVRLS 58
             +L  L I +N I   +  +L    +L  L+++ N   S  V        + M  +   
Sbjct: 805 CPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861

Query: 59  PNKGLCG-NFITLP 71
             + + G + + + 
Sbjct: 862 KTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 10/62 (16%), Positives = 22/62 (35%), Gaps = 3/62 (4%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              +    +  N +E       L  + +L  L+   NK+     F       ++ ++L  
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGT--NVKLTDLKLDY 604

Query: 60  NK 61
           N+
Sbjct: 605 NQ 606

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 13/66 (19%), Positives = 23/66 (34%), Gaps = 5/66 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLS-----RLDYLNLSWNKLSGPVPFSNEQLSSMSRV 55
           +  +  +D S NKI          +          + LS+N++           S +S +
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI 702

Query: 56  RLSPNK 61
            LS N 
Sbjct: 703 ILSNNL 708

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 10/78 (12%), Positives = 23/78 (29%), Gaps = 9/78 (11%)

Query: 1   MKNLTWLDI------SNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSR 54
              L    I        N+I    P  +T    L  L +  N +        +    +  
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQLYI 831

Query: 55  VRLSPNKGLCGNFITLPS 72
           + ++ N  +  +  ++  
Sbjct: 832 LDIADNPNISIDVTSVCP 849

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 8/68 (11%)

Query: 1   MKNLTWLDISNNKIEGSIP--GELTDLSRLDYLNLSWNKLSG-----PVPFSNEQLSSMS 53
              +  L  S+NK++  IP       +  +  ++ S+NK+            + +  + S
Sbjct: 618 TDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676

Query: 54  RVRLSPNK 61
            V LS N+
Sbjct: 677 TVTLSYNE 684

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 8/80 (10%), Positives = 22/80 (27%), Gaps = 19/80 (23%)

Query: 1   MKNLTWLDISNNKIEG-------------------SIPGELTDLSRLDYLNLSWNKLSGP 41
           +  L  +  +N+                       +     ++L  L  + L        
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506

Query: 42  VPFSNEQLSSMSRVRLSPNK 61
           +P     L  +  + ++ N+
Sbjct: 507 LPDFLYDLPELQSLNIACNR 526

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 7/58 (12%), Positives = 21/58 (36%), Gaps = 1/58 (1%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             T +    N+I   I   +  L++L  +  + +  +      + + ++    +   N
Sbjct: 426 KDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 51/226 (22%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKS---FRNEAQVLSQVL 200
           + I   IG G +G V KA      +  A+K            IK+   F N+AQ+  ++L
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----------IIKNKKAFLNQAQIEVRLL 104

Query: 201 HR----------SIVKLYGFCLHKKCMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRVN 249
                        IV L    + +  + L++E +   +L+ +L + +   V L+  ++  
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK-- 161

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILL--NSKLEAFVADFGTARRLHADSSNRTL 307
             + M  AL +L      SIIH D+   NILL    +    + DFG++ +L         
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---- 216

Query: 308 LAGTY----GYIAPE----LAYTMVMTEKCDVYSFGVVTLEVLMGK 345
               Y     Y +PE    + Y +      D++S G + +E+  G+
Sbjct: 217 ---QYIQSRFYRSPEVLLGMPYDL----AIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 59/309 (19%), Positives = 105/309 (33%), Gaps = 94/309 (30%)

Query: 143 EDFHIKYCI----GTGGYGSVYKAQ-LPNGKVFALK--KLHTSETEELAFIKSFRNEAQV 195
           + F+ +Y +    G G + +V+ +  +   K  A+K  K     TE         +E ++
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA------LDEIRL 86

Query: 196 LSQVL--------HRSIVKLYG-FCL------HKKCMFLIYEYMERGSLFCILH-NDDEA 239
           L  V            +V+L   F +      H  CM  ++E +    L   +  ++ + 
Sbjct: 87  LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CM--VFEVL-GHHLLKWIIKSNYQG 142

Query: 240 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN----------------- 282
           + L   K+  I++ +   L YLH  C   IIH DI   NILL+                 
Sbjct: 143 LPLPCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 283 --------------------------------SKLEAFVADFGTARRLHADSSNRTLLAG 310
                                            KL+  +AD G A  +H    + T    
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQ 255

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI--MLIDVL 368
           T  Y + E+          D++S   +  E+  G +  +  S    + D     ++I++L
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315

Query: 369 DQRLPPPVD 377
                 P  
Sbjct: 316 G---KVPRK 321

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 3/64 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVR---L 57
           +  L  L++S++ ++ S       L  L +LNL  N            L ++ R+    L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 58  SPNK 61
           S   
Sbjct: 484 SFCD 487

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 12/69 (17%), Positives = 17/69 (24%), Gaps = 6/69 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            K L  L      I       L +   L+ L L  N +S            +  +     
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ-- 161

Query: 61  KGLCGNFIT 69
                N I 
Sbjct: 162 ----NNAIH 166

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 17/69 (24%), Positives = 31/69 (44%), Gaps = 7/69 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L +S   +        T L  +++++LS N+L+     S E LS +  + L+  
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS---SSIEALSHLKGIYLN-- 529

Query: 61  KGLCGNFIT 69
             L  N I+
Sbjct: 530 --LASNHIS 536

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 14/69 (20%), Positives = 25/69 (36%), Gaps = 6/69 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NLT+LD++  +I            RLD L L+ N L      +     ++  +     
Sbjct: 56  LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI-- 113

Query: 61  KGLCGNFIT 69
                  I+
Sbjct: 114 ----QTGIS 118

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG---PVPFSNEQLSSMSRVRL 57
           + +L  L++S N+          +  +L+ L+L++ +L       PF N  L  +  + L
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN--LHLLKVLNL 432

Query: 58  SPNK 61
           S + 
Sbjct: 433 SHSL 436

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 16/61 (26%), Positives = 24/61 (39%), Gaps = 1/61 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  LD++   +   +P  L  LS L  L LS NK       S     S++ + +  N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335

Query: 61  K 61
            
Sbjct: 336 T 336

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +K +  +D+S+N++  S    L+ L  + YLNL+ N +S  +P     LS    + L  N
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557

Query: 61  K 61
            
Sbjct: 558 P 558

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           +  L  L +S NK E       ++   L +L++  N     +      N  L ++  + L
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN--LENLRELDL 357

Query: 58  SPNK 61
           S + 
Sbjct: 358 SHDD 361

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 9/59 (15%), Positives = 23/59 (38%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          +   L+ S N +        + L  L +L+L+  ++      + +    +  + L+ N 
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 9/61 (14%), Positives = 18/61 (29%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L ++ N +       L+    L +L      +S           ++  + L  N
Sbjct: 80  QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139

Query: 61  K 61
            
Sbjct: 140 H 140

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 14/69 (20%), Positives = 23/69 (33%), Gaps = 4/69 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            K L  L + +N I      +     +L  L+   N +          L   + + L+  
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN-- 185

Query: 61  KGLCGNFIT 69
             L GN I 
Sbjct: 186 --LNGNDIA 192

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 18/63 (28%), Positives = 34/63 (53%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGS--IPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           ++NL  LD+S++ IE S     +L +LS L  LNLS+N+       + ++   +  + L+
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408

Query: 59  PNK 61
             +
Sbjct: 409 FTR 411

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 19/66 (28%), Positives = 28/66 (42%), Gaps = 7/66 (10%)

Query: 1   MKNLTWLDISNNKIEGSI---PGELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRV 55
           +  L  L++  N            L  L RL+ L LS+  LS      F++  L  M+ V
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS--LKMMNHV 505

Query: 56  RLSPNK 61
            LS N+
Sbjct: 506 DLSHNR 511

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 3/64 (4%)

Query: 1   MKNLTWLDISNNKIEGSI-PGELTDLSRLDYLNLSWNKL--SGPVPFSNEQLSSMSRVRL 57
             +LT L I  N     +  G L +L  L  L+LS + +  S         LS +  + L
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383

Query: 58  SPNK 61
           S N+
Sbjct: 384 SYNE 387

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 13/60 (21%), Positives = 25/60 (41%), Gaps = 3/60 (5%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLSPNK 61
           ++  +++  +             S L  L+L+   LS  P       LS++ ++ LS NK
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG--LSTLKKLVLSANK 312

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              L  LD++  +++         +L  L  LNLS + L        + L ++  + L  
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458

Query: 60  NK 61
           N 
Sbjct: 459 NH 460

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 16/61 (26%), Positives = 37/61 (60%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NLT ++ SNN++    P  L +L++L  + ++ N+++   P +N  L++++ + L  N
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN--LTNLTGLTLFNN 122

Query: 61  K 61
           +
Sbjct: 123 Q 123

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 17/61 (27%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNLT+L +  N I    P  ++ L++L  L    NK+S     +N  L++++ +    N
Sbjct: 308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLAN--LTNINWLSAGHN 363

Query: 61  K 61
           +
Sbjct: 364 Q 364

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 50.3 bits (121), Expect = 6e-07
 Identities = 14/61 (22%), Positives = 31/61 (50%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L   NNK+       L +L+ +++L+   N++S   P +N  L+ ++++ L+  
Sbjct: 330 LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN--LTRITQLGLNDQ 385

Query: 61  K 61
            
Sbjct: 386 A 386

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LT L+++ N++E   P  +++L  L YL L +N +S   P S+  L+ + R+    N
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSS--LTKLQRLFFYNN 341

Query: 61  K 61
           K
Sbjct: 342 K 342

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 18/61 (29%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  + ++NN+I    P  L +L+ L  L L  N+++   P  N  L++++R+ LS N
Sbjct: 89  LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKN--LTNLNRLELSSN 144

Query: 61  K 61
            
Sbjct: 145 T 145

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 17/61 (27%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L ++ N+++    G L  L+ L  L+L+ N++S   P S   L+ ++ ++L  N
Sbjct: 220 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSG--LTKLTELKLGAN 275

Query: 61  K 61
           +
Sbjct: 276 Q 276

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 18/61 (29%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L  +NN+I    P  L  L+ LD L+L+ N+L      ++  L++++ + L+ N
Sbjct: 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLAS--LTNLTDLDLANN 253

Query: 61  K 61
           +
Sbjct: 254 Q 254

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 20/61 (32%), Positives = 37/61 (60%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NLT LD++NN+I    P  L+ L++L  L L  N++S   P +   L++++ + L+ N
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG--LTALTNLELNEN 297

Query: 61  K 61
           +
Sbjct: 298 Q 298

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LT L +  N+I    P  L  L+ L  L L+ N+L    P SN  L +++ + L  N
Sbjct: 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISN--LKNLTYLTLYFN 319

Query: 61  K 61
            
Sbjct: 320 N 320

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 19/58 (32%), Positives = 30/58 (51%), Gaps = 4/58 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           + NLT L + NN+I    P  L +L+ L+ L LS N +S     S   L+S+ ++   
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG--LTSLQQLSFG 164

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 18/61 (29%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  LDIS+NK+  S    L  L+ L+ L  + N++S   P     L+++  + L+ N
Sbjct: 176 LTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGN 231

Query: 61  K 61
           +
Sbjct: 232 Q 232

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 2/69 (2%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + N+ WL   +N+I    P  L +L+R+  L L+    +         +S  + V+    
Sbjct: 352 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409

Query: 61  KGLCGNFIT 69
             +    I+
Sbjct: 410 ALIAPATIS 418

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  +T L      I+ SI G +  L+ L  +N S N+L+   P  N  L+ +  + ++ N
Sbjct: 45  LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITPLKN--LTKLVDILMNNN 100

Query: 61  K 61
           +
Sbjct: 101 Q 101

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 7/61 (11%), Positives = 22/61 (36%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          +       +    +  ++    TDL ++  L      +          L++++++  S N
Sbjct: 23 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEY--LNNLTQINFSNN 78

Query: 61 K 61
          +
Sbjct: 79 Q 79

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 13/61 (21%), Positives = 29/61 (47%), Gaps = 5/61 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L   N   +      L +L+ L+ L++S NK+S     +   L+++  +  + N
Sbjct: 155 LTSLQQLSFGNQVTDLK---PLANLTTLERLDISSNKVSDISVLAK--LTNLESLIATNN 209

Query: 61  K 61
           +
Sbjct: 210 Q 210

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  LD+S+N +   +        RL+ L L  N +   +  S     ++  + LS N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHN 355

Query: 61  KGLCGNFITLPS 72
              C +   L  
Sbjct: 356 DWDCNSLRALFR 367

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M+ L  L ISNN++  ++      +  L  L+LS N L   V  +  Q   +  + L  N
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 334

Query: 61  K 61
            
Sbjct: 335 S 335

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 14/62 (22%), Positives = 28/62 (45%), Gaps = 3/62 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLSP 59
              L  +D+S N++E  +      + RL+ L +S N+L    +      + ++  + LS 
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQP--IPTLKVLDLSH 310

Query: 60  NK 61
           N 
Sbjct: 311 NH 312

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 8/62 (12%), Positives = 26/62 (41%), Gaps = 2/62 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           + N   +   N+ +   +P   L    +++ LNL+  ++     ++     ++ ++ +  
Sbjct: 50  LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 60  NK 61
           N 
Sbjct: 109 NA 110

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGEL-TDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRL 57
           +  LT L +  N +  S+P  +  +  +L  L++S N L       F     +S+  ++L
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA--TTSLQNLQL 178

Query: 58  SPNK 61
           S N+
Sbjct: 179 SSNR 182

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 19/62 (30%), Positives = 28/62 (45%), Gaps = 5/62 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              LT L +SNN +E  I  +     + L  L LS N+L+  V  S   + S+    +S 
Sbjct: 146 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSY 201

Query: 60  NK 61
           N 
Sbjct: 202 NL 203

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 11/64 (17%), Positives = 26/64 (40%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRL 57
            + +  L++++ +IE  I          +  L + +N +    P  F N  +  ++ + L
Sbjct: 74  FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN--VPLLTVLVL 130

Query: 58  SPNK 61
             N 
Sbjct: 131 ERND 134

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 13/60 (21%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
             LT L + +N +       L +   L  ++LS+N+L   +     ++  + R+ +S N+
Sbjct: 232 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  LD+S+N +   +        RL+ L L  N +   +  S     ++  + LS N
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHN 349

Query: 61  KGLCGNFITLPS 72
              C +   L  
Sbjct: 350 DWDCNSLRALFR 361

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           M+ L  L ISNN++  ++      +  L  L+LS N L   V  +  Q   +  + L  N
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 328

Query: 61  K 61
            
Sbjct: 329 S 329

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 14/62 (22%), Positives = 28/62 (45%), Gaps = 3/62 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRLSP 59
              L  +D+S N++E  +      + RL+ L +S N+L    +      + ++  + LS 
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQP--IPTLKVLDLSH 304

Query: 60  NK 61
           N 
Sbjct: 305 NH 306

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 7/61 (11%), Positives = 24/61 (39%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + N   +   N+ +       L    +++ LNL+  ++     ++     ++ ++ +  N
Sbjct: 44  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103

Query: 61  K 61
            
Sbjct: 104 A 104

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 19/62 (30%), Positives = 28/62 (45%), Gaps = 5/62 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              LT L +SNN +E  I  +     + L  L LS N+L+  V  S   + S+    +S 
Sbjct: 140 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSY 195

Query: 60  NK 61
           N 
Sbjct: 196 NL 197

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGEL-TDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRL 57
           +  LT L +  N +  S+P  +  +  +L  L++S N L       F     +S+  ++L
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA--TTSLQNLQL 172

Query: 58  SPNK 61
           S N+
Sbjct: 173 SSNR 176

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 11/64 (17%), Positives = 26/64 (40%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRL 57
            + +  L++++ +IE  I          +  L + +N +    P  F N  +  ++ + L
Sbjct: 68  FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN--VPLLTVLVL 124

Query: 58  SPNK 61
             N 
Sbjct: 125 ERND 128

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 16/59 (27%), Positives = 23/59 (38%), Gaps = 5/59 (8%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
            +  LD S+N I   + G +     L  L L  N L+      N     +  V LS N+
Sbjct: 206 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDTAWLLN--YPGLVEVDLSYNE 259

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 13/50 (26%), Positives = 22/50 (44%), Gaps = 1/50 (2%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSM 52
            L  L +  N++   +P  L  LS    +NL  N LS     +  +++S 
Sbjct: 262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 13/70 (18%), Positives = 25/70 (35%), Gaps = 13/70 (18%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG 62
            L  L++S N++  S+P     L  L   +     L           S + ++ +  N+ 
Sbjct: 82  ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQ- 132

Query: 63  LCGNFITLPS 72
                 +LP 
Sbjct: 133 ----LTSLPV 138

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 5/61 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L +S N++  S+P   + L  L    +  N+L+  +P S   LSS + V L  N
Sbjct: 240 PSELKELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLTR-LPESLIHLSSETTVNLEGN 294

Query: 61  K 61
            
Sbjct: 295 P 295

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 5/60 (8%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
            ++T L I +N +  S+P    +L     L +S N+L+  +P     L  +S        
Sbjct: 61  AHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLTS-LPVLPPGLLELSIFSNPLTH 115

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 48.0 bits (115), Expect = 1e-06
 Identities = 13/63 (20%), Positives = 25/63 (39%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L I    +       L+ L+ L  L++S +     +      L  ++ + LS N
Sbjct: 87  LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

Query: 61  KGL 63
             +
Sbjct: 147 GAI 149

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             N+  L I+N       P  ++ LS L+ L +    ++     +   L+S++ + +S +
Sbjct: 65  AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122

Query: 61  K 61
            
Sbjct: 123 A 123

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 12/61 (19%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          M +LT++ ++N  +   + G +     +  L ++    +   P S   LS++ R+R+   
Sbjct: 43 MNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNPISG--LSNLERLRIMGK 98

Query: 61 K 61
           
Sbjct: 99 D 99

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 7/40 (17%), Positives = 15/40 (37%), Gaps = 2/40 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG 40
           +  L  L+I  + +       + D  +L+ L      + G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 9/61 (14%), Positives = 22/61 (36%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  +  +D+S N     I   L  L  L  LN+ ++ +       +     ++++     
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIED--FPKLNQLYAFSQ 191

Query: 61  K 61
            
Sbjct: 192 T 192

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           ++NL +LDIS+     +  G    LS L+ L ++ N          F+   L +++ + L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE--LRNLTFLDL 477

Query: 58  SPNK 61
           S  +
Sbjct: 478 SQCQ 481

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 4/76 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L+ L ++ N I+    G  + LS L  L      L+    F    L ++  + ++ N
Sbjct: 75  LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134

Query: 61  K----GLCGNFITLPS 72
                 L   F  L +
Sbjct: 135 LIQSFKLPEYFSNLTN 150

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 17/64 (26%), Positives = 34/64 (53%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSI-PGELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRL 57
           + +L  L ++ N  + +  P   T+L  L +L+LS  +L    P  F++  LSS+  + +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS--LSSLQVLNM 501

Query: 58  SPNK 61
           + N+
Sbjct: 502 ASNQ 505

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 19/61 (31%), Positives = 34/61 (55%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           ++NLT+LD+S  ++E   P     LS L  LN++ N+L        ++L+S+ ++ L  N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

Query: 61  K 61
            
Sbjct: 529 P 529

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 15/61 (24%), Positives = 24/61 (39%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  LD+S  +I+    G    LS L  L L+ N +      +   LSS+ ++     
Sbjct: 51  FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110

Query: 61  K 61
            
Sbjct: 111 N 111

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIE--GSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRL 57
           + +L +LD+S N +   G         + L YL+LS+N +      F    L  +  +  
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG--LEQLEHLDF 403

Query: 58  SPNK 61
             + 
Sbjct: 404 QHSN 407

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 13/59 (22%), Positives = 24/59 (40%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          +   LD+S N +             L  L+LS  ++      + + LS +S + L+ N 
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 12/62 (19%), Positives = 28/62 (45%), Gaps = 6/62 (9%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG---PVPFSNEQLSSMSRVRLSP 59
           +L +LD+S N +  ++      L +L++L+   + L        F +  L ++  + +S 
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS--LRNLIYLDISH 430

Query: 60  NK 61
             
Sbjct: 431 TH 432

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 19/70 (27%), Positives = 35/70 (50%), Gaps = 3/70 (4%)

Query: 1   MKNLTWLDISNNKI-EGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           +K L  L++++N I    +P   ++L+ L++L+LS NK+          L  M  + LS 
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 60  NKGLCGNFIT 69
           +  L  N + 
Sbjct: 183 D--LSLNPMN 190

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 21/76 (27%), Positives = 35/76 (46%), Gaps = 15/76 (19%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDY----LNLSWNKLSG--PVPFSNEQLSSMSR 54
           + NL  LD+S+NKI+     +L  L ++      L+LS N ++   P  F   +L  ++ 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT- 206

Query: 55  VRLSPNKGLCGNFITL 70
                   L  NF +L
Sbjct: 207 --------LRNNFDSL 214

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 16/61 (26%), Positives = 26/61 (42%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNLT LDIS N     +P       ++ +LNLS   +            ++  + +S N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNN 441

Query: 61  K 61
            
Sbjct: 442 N 442

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 10/61 (16%), Positives = 24/61 (39%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L+I    +       L  +  + +L L  ++ +  +    + LSS+  + L   
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206

Query: 61  K 61
            
Sbjct: 207 N 207

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 16/59 (27%), Positives = 27/59 (45%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           +  LD+S NKI     G+L   + L  L L  ++++     +   L S+  + LS N 
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 15/61 (24%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L IS NK++ ++P        L  + +S N+L        ++L+S+ ++ L  N
Sbjct: 450 LPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

Query: 61  K 61
            
Sbjct: 508 P 508

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 3/64 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE---QLSSMSRVRL 57
           ++ +  + + N+K+          L  L++L+LS N +      ++       S+  + L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368

Query: 58  SPNK 61
           S N 
Sbjct: 369 SQNH 372

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 21/78 (26%), Positives = 32/78 (41%), Gaps = 8/78 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRLS 58
             NL  L + +++I          L  L++L+LS N LS      F    LSS+  + L 
Sbjct: 49  CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP--LSSLKYLNLM 106

Query: 59  PNK----GLCGNFITLPS 72
            N     G+   F  L +
Sbjct: 107 GNPYQTLGVTSLFPNLTN 124

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 11/76 (14%), Positives = 25/76 (32%), Gaps = 6/76 (7%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK- 61
            +  L I    +   +    + L ++  + +  +K+       ++ L S+  + LS N  
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

Query: 62  -----GLCGNFITLPS 72
                         PS
Sbjct: 347 VEEYLKNSACKGAWPS 362

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.9 bits (96), Expect = 8e-04
 Identities = 12/62 (19%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           + NL  L I N +    I   +   L+ L+ L +    L      S + +  +  + L  
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 60  NK 61
           ++
Sbjct: 182 SE 183

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 19/74 (25%), Positives = 30/74 (40%), Gaps = 7/74 (9%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK- 61
            L  L IS+N+I+            L+YL+LS NKL   +        ++  + LS N  
Sbjct: 46  KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCHP--TVNLKHLDLSFNAF 102

Query: 62  ---GLCGNFITLPS 72
               +C  F  +  
Sbjct: 103 DALPICKEFGNMSQ 116

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 7/61 (11%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRLSP 59
            +  LD+ +NKI+ SIP ++  L  L  LN++ N+L   VP   F    L+S+ ++ L  
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDR--LTSLQKIWLHT 477

Query: 60  N 60
           N
Sbjct: 478 N 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 16/60 (26%), Positives = 27/60 (45%)

Query: 2  KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          +  T L+IS N I      ++  LS+L  L +S N++        +    +  + LS NK
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 3/62 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTD-LSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           MK+L  LDIS N +              L  LN+S N L+  +         +  + L  
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430

Query: 60  NK 61
           NK
Sbjct: 431 NK 432

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 15/63 (23%), Positives = 28/63 (44%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           +     LD SNN +  ++      L+ L+ L L  N+L     +     Q+ S+ ++ +S
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382

Query: 59  PNK 61
            N 
Sbjct: 383 QNS 385

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 12/63 (19%), Positives = 26/63 (41%), Gaps = 2/63 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  + I    +   +P  +   + L+ L L+ N L   +P S   L+ +  + +   
Sbjct: 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRAC 160

Query: 61  KGL 63
             L
Sbjct: 161 PEL 163

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 15/72 (20%), Positives = 26/72 (36%), Gaps = 6/72 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L +    I  S+P  + +L  L  L +  + LS  +  +   L  +  + L   
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239

Query: 61  KGLCGNFITLPS 72
             L       P 
Sbjct: 240 TAL----RNYPP 247

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 17/72 (23%), Positives = 31/72 (43%), Gaps = 5/72 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           ++NL  L I N+ +  ++   +  L +L+ L+L         P      + + R+ L   
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD- 262

Query: 61  KGLCGNFITLPS 72
              C N +TLP 
Sbjct: 263 ---CSNLLTLPL 271

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 12/72 (16%), Positives = 28/72 (38%), Gaps = 7/72 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
                 L++ +  +    P +   LS L ++ +    L   +P + +Q + +  + L+ N
Sbjct: 80  QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137

Query: 61  KGLCGNFITLPS 72
                    LP+
Sbjct: 138 P-----LRALPA 144

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 11/61 (18%), Positives = 28/61 (45%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISN-NKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
              L  L + + + +  ++P ++  L++L+ L+L        +P    QL +   + + P
Sbjct: 252 RAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 60  N 60
           +
Sbjct: 311 H 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 12/64 (18%), Positives = 23/64 (35%), Gaps = 2/64 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSW-NKLSGPVPFSNEQLSSMSRVRLSP 59
           +  L  LD+       + P      + L  L L   + L   +P    +L+ + ++ L  
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRG 286

Query: 60  NKGL 63
              L
Sbjct: 287 CVNL 290

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 17/61 (27%), Positives = 27/61 (44%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +K+L  L+++ NKI          L  L  LNLS+N L      +   L  ++ + L  N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348

Query: 61  K 61
            
Sbjct: 349 H 349

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 24/80 (30%), Positives = 35/80 (43%), Gaps = 10/80 (12%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG----PVPFSNEQLSSMSRVR 56
           + NL  LD+ ++KI    P     L  L  L L +  LS        F N  L +++R+ 
Sbjct: 72  LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN--LKALTRLD 129

Query: 57  LSPNK----GLCGNFITLPS 72
           LS N+     L  +F  L S
Sbjct: 130 LSKNQIRSLYLHPSFGKLNS 149

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 8/90 (8%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVP--FSNEQLSSMSRVRL 57
           +K LT LD+S N+I    +      L+ L  ++ S N++           Q  ++S   L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181

Query: 58  SPNKGLCGNFITLPSCDATKPATLFVEIFL 87
           + N     +  +  S D  K    F  + L
Sbjct: 182 AAN-----SLYSRVSVDWGKCMNPFRNMVL 206

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 5/64 (7%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
          +     L +S N I          L +L  L L        +    F N  L ++  + L
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRN--LPNLRILDL 80

Query: 58 SPNK 61
            +K
Sbjct: 81 GSSK 84

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSI-PGELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRL 57
           ++ L  L++ +     +I      +L  L  L+L  +K+    P  F    L  +  +RL
Sbjct: 47  LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQG--LFHLFELRL 104

Query: 58  SPNK 61
               
Sbjct: 105 YFCG 108

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 12/61 (19%), Positives = 26/61 (42%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L++S N +          L ++ Y++L  N ++     + + L  +  + L  N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372

Query: 61  K 61
            
Sbjct: 373 A 373

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 13/61 (21%), Positives = 31/61 (50%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L +++N +    PG  + L+ L  L+L+ N+L+          +++  + +S N
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRN 536

Query: 61  K 61
           +
Sbjct: 537 Q 537

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 14/59 (23%), Positives = 27/59 (45%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           ++  LD+S+  +          L  L  LNL++NK++     +   L ++  + LS N 
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 5/61 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  + ++D+  N I          L +L  L+L  N L+     +   + S+  + LS N
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN 391

Query: 61  K 61
           K
Sbjct: 392 K 392

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 7/67 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG------PVPFSNEQLSSMSR 54
             +L  L ++NNK+   +PG L D   +  + L  N +S         P  N + +S S 
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297

Query: 55  VRLSPNK 61
           V L  N 
Sbjct: 298 VSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNL  L + NNKI    PG    L +L+ L LS N+L        +   ++  +R+  N
Sbjct: 75  LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE---LPEKMPKTLQELRVHEN 131

Query: 61  K 61
           +
Sbjct: 132 E 132

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 8/65 (12%)

Query: 2   KNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKL-SGPVP---FSNEQLSSMSRVR 56
           K L  L +  N+I   +       L+++  + L  N L S  +    F    +  +S +R
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG--MKKLSYIR 177

Query: 57  LSPNK 61
           ++   
Sbjct: 178 IADTN 182

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 19/61 (31%), Positives = 25/61 (40%), Gaps = 1/61 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L +S N I     G L +   L  L+L+ NKL   VP        +  V L  N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNN 273

Query: 61  K 61
            
Sbjct: 274 N 274

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 4/62 (6%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLSP 59
            +   LD+ NNKI     G+  +L  L  L L  NK+S   P  F+   L  + R+ LS 
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP--LVKLERLYLSK 109

Query: 60  NK 61
           N+
Sbjct: 110 NQ 111

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 2/60 (3%)

Query: 3   NLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           +LT L +  NKI   +    L  L+ L  L LS+N +S     S      +  + L+ NK
Sbjct: 193 SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 14/72 (19%), Positives = 25/72 (34%), Gaps = 14/72 (19%)

Query: 1   MKNLTWLDISNNKIEGSIP-------GELTDLSRLDYLNLSWNKLSG----PVPFSNEQL 49
            K +  + + NN I  +I        G  T  +    ++L  N +      P  F    +
Sbjct: 262 HKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC--V 318

Query: 50  SSMSRVRLSPNK 61
              + V+L   K
Sbjct: 319 YVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 7/63 (11%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           MK L+++ I++  I  +IP  L     L  L+L  NK++           L++++++ LS
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKG--LNNLAKLGLS 224

Query: 59  PNK 61
            N 
Sbjct: 225 FNS 227

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 18/61 (29%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +K L  L + +N I   I G L  L +L+ L L  NK++     S   L+ +  + L  N
Sbjct: 108 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDN 163

Query: 61  K 61
           +
Sbjct: 164 Q 164

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.6 bits (102), Expect = 9e-05
 Identities = 20/61 (32%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNL WL +  NKI+  +   L DL +L  L+L  N +S      +  L  +  + L  N
Sbjct: 86  LKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLVH--LPQLESLYLGNN 141

Query: 61  K 61
           K
Sbjct: 142 K 142

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L + NNKI   I   L+ L++LD L+L  N++S  VP +   L+ +  + LS N
Sbjct: 130 LPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAG--LTKLQNLYLSKN 185

Query: 61  K 61
            
Sbjct: 186 H 186

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 15/61 (24%), Positives = 27/61 (44%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L + +N+I   I   L  L++L  L LS N +S     +   L ++  + L   
Sbjct: 152 LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALAG--LKNLDVLELFSQ 207

Query: 61  K 61
           +
Sbjct: 208 E 208

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + N+T L ++ NK+   I   LT+L  L +L L  NK+       +  L  +  + L  N
Sbjct: 64  LPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLKD--LKKLKSLSLEHN 119

Query: 61  K 61
            
Sbjct: 120 G 120

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 40.5 bits (94), Expect = 8e-04
 Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          + ++  +  +N+ I+ S+ G +  L  +  L L+ NKL+   P +N  L ++  + L  N
Sbjct: 42 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKPLTN--LKNLGWLFLDEN 97

Query: 61 K 61
          K
Sbjct: 98 K 98

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 40.5 bits (94), Expect = 9e-04
 Identities = 13/61 (21%), Positives = 20/61 (32%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L +S N I   +   L  L  LD L L   +           L   + V+ +  
Sbjct: 174 LTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231

Query: 61  K 61
            
Sbjct: 232 S 232

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 4/74 (5%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLSPN 60
           + T L++ +NK++    G    L++L  L+LS N LS  G    S+   +S+  + LS N
Sbjct: 29  SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 61  K--GLCGNFITLPS 72
               +  NF+ L  
Sbjct: 89  GVITMSSNFLGLEQ 102

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSI-PGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRL 57
           + +L  L ++ N  + +  P   T+L  L +L+LS  +L    P  F++  LSS+  + +
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS--LSSLQVLNM 206

Query: 58  SPNK 61
           S N 
Sbjct: 207 SHNN 210

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRL 57
           ++NLT+LD+S  ++E  +       LS L  LN+S N        P+    L+S+  +  
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC--LNSLQVLDY 230

Query: 58  SPNK 61
           S N 
Sbjct: 231 SLNH 234

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           ++NL +LDIS+     +  G    LS L+ L ++ N          F+   L +++ + L
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE--LRNLTFLDL 182

Query: 58  SPNK 61
           S  +
Sbjct: 183 SQCQ 186

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 12/63 (19%), Positives = 28/63 (44%), Gaps = 6/63 (9%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG---PVPFSNEQLSSMSRVRLS 58
            +L +LD+S N +  ++      L +L++L+   + L        F +  L ++  + +S
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS--LRNLIYLDIS 134

Query: 59  PNK 61
              
Sbjct: 135 HTH 137

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 5/64 (7%)

Query: 1   MKNLTWLDISNNKIE--GSIPGELTDLSRLDYLNLSWNKLSG-PVPFSNEQLSSMSRVRL 57
           +  LT L +S+N +   G         + L YL+LS+N +      F    L  +  +  
Sbjct: 51  LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG--LEQLEHLDF 108

Query: 58  SPNK 61
             + 
Sbjct: 109 QHSN 112

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 42/193 (21%), Positives = 71/193 (36%), Gaps = 35/193 (18%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALK-----KLHTSET----EELAFIKSFRNEAQVLSQVLH 201
           IG GG+G +Y A + + +          K+  S+      EL F +      Q+   +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 202 RS-----IVKLYGFCLHKKCM----FLIYEYMERGSLFCILHNDDEAVELDWAKRV-NIV 251
           R      + K +G  LH K      F+I +      L  I   + +       K V  + 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSR---KTVLQLS 158

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTARR-------LHADS 302
             +   L Y+H       +H DI ++N+LLN K     ++ D+G A R           +
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 303 SNRTLLAGTYGYI 315
             +    GT  + 
Sbjct: 216 DPKRCHDGTIEFT 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 37/190 (19%), Positives = 67/190 (35%), Gaps = 37/190 (19%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + +   IG G +G +++   L N +  A+K                R+E +    +   +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCT 66

Query: 204 -IVKLYGFCLHKKCMFLIYEYMERGSL-----FCILHNDDEAVELDWAKRVNIVKAMAHA 257
            I  +Y F        L+ + +   SL      C      + V           K M   
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTV-------AMAAKQMLAR 118

Query: 258 LAYLHHDCSPSIIHRDISSNNILL------NSKLEAFVADFGTARR-------LHADSSN 304
           +  +H     S+++RDI  +N L+      N+ +  +V DFG  +         H     
Sbjct: 119 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 305 RTLLAGTYGY 314
           +  L+GT  Y
Sbjct: 175 KKNLSGTARY 184

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.5 bits (107), Expect = 2e-05
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  +T LD+S+N++  ++P  L  L  L+ L  S N L      +N  L  +  + L  N
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVAN--LPRLQELLLCNN 518

Query: 61  K 61
           +
Sbjct: 519 R 519

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 41.7 bits (97), Expect = 4e-04
 Identities = 13/39 (33%), Positives = 22/39 (56%), Gaps = 2/39 (5%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
           ++ L  L  S+N +E ++ G + +L RL  L L  N+L 
Sbjct: 485 LRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 20/61 (32%), Positives = 26/61 (42%), Gaps = 1/61 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L + +N+I     G L+ L  L  L+L  NKLS  VP     L  +  V L  N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTN 274

Query: 61  K 61
            
Sbjct: 275 N 275

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 7/67 (10%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSN----EQLSSMSR 54
           +  L  L + NNK+   +P  L DL  L  + L  N ++  G   F       + +  + 
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298

Query: 55  VRLSPNK 61
           + L  N 
Sbjct: 299 ISLFNNP 305

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 3/61 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +++L  L + NNKI        + L +L  L +S N L           SS+  +R+  N
Sbjct: 77  LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE---IPPNLPSSLVELRIHDN 133

Query: 61  K 61
           +
Sbjct: 134 R 134

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 6/63 (9%)

Query: 2   KNLTWLDISNNKIEGSIPGE-LTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           + L  L + +NKI+ +I  E L   S+L  L L  N++        S   L ++  + L 
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF--LPTLRELHLD 249

Query: 59  PNK 61
            NK
Sbjct: 250 NNK 252

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 13/69 (18%), Positives = 25/69 (36%), Gaps = 7/69 (10%)

Query: 2   KNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            +L  L I +N+I   +P G  + L  ++ + +  N L     F       +    L   
Sbjct: 123 SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLR-- 178

Query: 61  KGLCGNFIT 69
             +    +T
Sbjct: 179 --ISEAKLT 185

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 18/62 (29%), Positives = 26/62 (41%), Gaps = 4/62 (6%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLSP 59
            + T LD+ NN I      +   L  L  L L  NK+S      FS   L  + ++ +S 
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP--LRKLQKLYISK 111

Query: 60  NK 61
           N 
Sbjct: 112 NH 113

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 37/187 (19%), Positives = 69/187 (36%), Gaps = 33/187 (17%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           F +   IG+G +G +Y    +   +  A+K  +               E+++   +   +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGT 63

Query: 204 -IVKLYGFCLHKKCMFLIYEYMERGSL-----FCILHNDDEAVELDWAKRVNIVKAMAHA 257
            I  +  F +      L+ + +   SL     FC      + V       + +   M + 
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTV-------LMLADQMINR 115

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEA---FVADFGTARR-------LHADSSNRTL 307
           + ++H   S S +HRDI  +N L+     A   ++ DFG A++        H        
Sbjct: 116 VEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 308 LAGTYGY 314
           L GT  Y
Sbjct: 173 LTGTARY 179

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 12/61 (19%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  +T L++S N ++ ++   +  L  +  L+L+  +++   P +   LS++  + L  N
Sbjct: 84  LTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLAG--LSNLQVLYLDLN 139

Query: 61  K 61
           +
Sbjct: 140 Q 140

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 18/61 (29%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L +  N+I  +I   L  L+ L YL++   ++S   P +N  LS ++ ++   N
Sbjct: 128 LSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPLAN--LSKLTTLKADDN 183

Query: 61  K 61
           K
Sbjct: 184 K 184

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          +  +T L      +  +I G +  L+ L  L L  N+++   P  N  L+ ++ + LS N
Sbjct: 40 LDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAPLKN--LTKITELELSGN 95

Query: 61 K 61
           
Sbjct: 96 P 96

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL +L I N ++   +   L +LS+L  L    NK+S   P ++  L ++  V L  N
Sbjct: 150 LTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLAS--LPNLIEVHLKNN 205

Query: 61  K 61
           +
Sbjct: 206 Q 206

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 15/61 (24%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L++ +N+I   +   L +L+++  L LS N L      +   L S+  + L+  
Sbjct: 62  LNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAG--LQSIKTLDLTST 117

Query: 61  K 61
           +
Sbjct: 118 Q 118

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 13/61 (21%), Positives = 31/61 (50%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           ++++  LD+++ +I    P  L  LS L  L L  N+++   P +   L+++  + +   
Sbjct: 106 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLAG--LTNLQYLSIGNA 161

Query: 61  K 61
           +
Sbjct: 162 Q 162

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LT L   +NKI   I   L  L  L  ++L  N++S   P +N   S++  V L+  
Sbjct: 172 LSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLAN--TSNLFIVTLTNQ 227

Query: 61  K 61
            
Sbjct: 228 T 228

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 2/56 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVR 56
           + NL  + + NN+I   +   L + S L  + L+   ++    F N  L   + V+
Sbjct: 194 LPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 30/163 (18%), Positives = 60/163 (36%), Gaps = 26/163 (15%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + +   IG+G +G +Y    +  G+  A+K                  E+++   +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGV 65

Query: 204 -IVKLYGFCLHKKCMFLIYEYMERGSL-----FCILHNDDEAVELDWAKRVNIVKAMAHA 257
            I  +           ++ E +   SL     FC      + V       + +   M   
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTV-------LLLADQMISR 117

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEA---FVADFGTARR 297
           + Y+H   S + IHRD+  +N L+    +    ++ DFG A++
Sbjct: 118 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 11/60 (18%), Positives = 24/60 (40%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  + +   ++    P     L+ L  LN+S N+L+         + ++  + L  N
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 4/63 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           +  L +L++S N I       L +L RL  + L   +L+   P  F    L+ +  + +S
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG--LNYLRVLNVS 304

Query: 59  PNK 61
            N+
Sbjct: 305 GNQ 307

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 14/84 (16%), Positives = 28/84 (33%), Gaps = 11/84 (13%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRL 57
           + +L  L +    +  SIP   L+ L  L  L L    ++      F    L  +  + +
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR--LYRLKVLEI 207

Query: 58  SPNKGLCGNFITLPSCDATKPATL 81
           S        ++   + +      L
Sbjct: 208 SHW-----PYLDTMTPNCLYGLNL 226

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
             +L  L+++ N +    PG   +L  L  L L  N+L   +P   F+   LS+++++ +
Sbjct: 55  FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTG--LSNLTKLDI 111

Query: 58  SPNK 61
           S NK
Sbjct: 112 SENK 115

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 21/63 (33%), Positives = 28/63 (44%), Gaps = 4/63 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           + NLT LDIS NKI   +     DL  L  L +  N L       FS   L+S+ ++ L 
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG--LNSLEQLTLE 160

Query: 59  PNK 61
              
Sbjct: 161 KCN 163

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 6/62 (9%)

Query: 3   NLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLSP 59
           NLT L I++  +  ++P   +  L  L +LNLS+N +S           L  +  ++L  
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE--LLRLQEIQLVG 281

Query: 60  NK 61
            +
Sbjct: 282 GQ 283

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 4/61 (6%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLSPN 60
              LD+  N+I+     E      L+ L L+ N +S   P  F+N  L ++  + L  N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN--LFNLRTLGLRSN 90

Query: 61 K 61
          +
Sbjct: 91 R 91

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL +L+++   +   IP  LT L +LD L+LS N LS   P S + L  + ++ +  +
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 61  K 61
           +
Sbjct: 242 Q 242

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 13/60 (21%), Positives = 25/60 (41%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L +  ++I+        +L  L  +NL+ N L+         L  + R+ L  N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           +++L  L +S N I     G    L+ L+ L L  N+L+  +P   F    LS +  + L
Sbjct: 87  LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVY--LSKLKELWL 143

Query: 58  SPNK 61
             N 
Sbjct: 144 RNNP 147

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 4/63 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           +  L  LD+S N +    PG    L  L  L +  +++       F N  L S+  + L+
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN--LQSLVEINLA 263

Query: 59  PNK 61
            N 
Sbjct: 264 HNN 266

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 13/59 (22%), Positives = 26/59 (44%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           N   L++  N+I+         L  L+ L LS N +      +   L++++ + L  N+
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 6/63 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           + NL +L++    I+  +P  LT L  L+ L +S N      P  F    LSS+ ++ + 
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHG--LSSLKKLWVM 250

Query: 59  PNK 61
            ++
Sbjct: 251 NSQ 253

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 14/60 (23%), Positives = 24/60 (40%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + +L  L + N+++          L+ L  LNL+ N LS         L  +  + L  N
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 4/63 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRLS 58
           +  L  L++S N      PG    LS L  L +  +++S      F    L+S+  + L+
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG--LASLVELNLA 274

Query: 59  PNK 61
            N 
Sbjct: 275 HNN 277

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 17/64 (26%), Positives = 26/64 (40%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           + +L  L +  N I     G    L+ L+ L L  N L+  +P   F    LS +  + L
Sbjct: 98  LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEY--LSKLRELWL 154

Query: 58  SPNK 61
             N 
Sbjct: 155 RNNP 158

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 13/59 (22%), Positives = 24/59 (40%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           N  +L++  N I+         L  L+ L L  N +      +   L+S++ + L  N 
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 32/167 (19%), Positives = 59/167 (35%), Gaps = 32/167 (19%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           F +   IG G +G +   + L   +  A+K                  E +   Q+    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGD 65

Query: 204 -IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR-------VNIVKAMA 255
            I ++Y F    K   ++ E +   SL        E +  D   R       + I   + 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGP-SL--------EDL-FDLCDRTFSLKTVLMIAIQLI 115

Query: 256 HALAYLHHDCSPSIIHRDISSNNILL-----NSKLEAFVADFGTARR 297
             + Y+H   S ++I+RD+   N L+      ++    + DF  A+ 
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 6/65 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRL----DYLNLSWNKLSGPVPFSNEQLSSMSRVR 56
            ++L  LD+S N +E S+P              +     N+++  +P +   L     + 
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTII 236

Query: 57  LSPNK 61
           L  N 
Sbjct: 237 LEDNP 241

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 11/52 (21%), Positives = 19/52 (36%), Gaps = 1/52 (1%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMS 53
           +   +     N+I   IP  +  L     + L  N LS  +  S  Q ++  
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 18/71 (25%), Positives = 30/71 (42%), Gaps = 13/71 (18%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
             +T L+I+ N +  S+P     L  LD      N+LS  +P   E  +S+  + +  N+
Sbjct: 80  PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST-LP---ELPASLKHLDVDNNQ 131

Query: 62  GLCGNFITLPS 72
                   LP 
Sbjct: 132 -----LTMLPE 137

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 18/61 (29%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +K L  L + +N I   I G L  L +L+ L L  NK++     S   L+ +  + L  N
Sbjct: 111 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDN 166

Query: 61  K 61
           +
Sbjct: 167 Q 167

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L + NNKI   I   L+ L++LD L+L  N++S  VP +   L+ +  + LS N
Sbjct: 133 LPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAG--LTKLQNLYLSKN 188

Query: 61  K 61
            
Sbjct: 189 H 189

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNL WL +  NK++  +   L DL +L  L+L  N +S      +  L  +  + L  N
Sbjct: 89  LKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLVH--LPQLESLYLGNN 144

Query: 61  K 61
           K
Sbjct: 145 K 145

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 15/61 (24%), Positives = 27/61 (44%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L + +N+I   I   L  L++L  L LS N +S     +   L ++  + L   
Sbjct: 155 LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALAG--LKNLDVLELFSQ 210

Query: 61  K 61
           +
Sbjct: 211 E 211

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + N+T L ++ NK+   I   L +L  L +L L  NK+       +  L  +  + L  N
Sbjct: 67  LPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSSLKD--LKKLKSLSLEHN 122

Query: 61  K 61
            
Sbjct: 123 G 123

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 47/251 (18%), Positives = 81/251 (32%), Gaps = 81/251 (32%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKS---FRNEAQVLSQVL 200
           F +   +G G +G V   Q + N K +A+K            +++   +   A++ + +L
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-----------VVRNIKKYTRSAKIEADIL 85

Query: 201 HR---------SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR---- 247
            +         +IVK +G  ++   M LI+E +   SL+            +   R    
Sbjct: 86  KKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLY------------EIITRNNYN 132

Query: 248 ---VNIVKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
              +  +K        AL YL    S  + H D+   NILL+                  
Sbjct: 133 GFHIEDIKLYCIEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189

Query: 301 DSSNRTLLAGT----------------YGYI------APE----LAYTMVMTEKCDVYSF 334
                   +                     I      APE    L + +      D++SF
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV----SSDMWSF 245

Query: 335 GVVTLEVLMGK 345
           G V  E+  G 
Sbjct: 246 GCVLAELYTGS 256

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 8/65 (12%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVR 56
           + NL  L +S+N +   I       +  L YL+LS N L   +    FS+  L ++  + 
Sbjct: 63  LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSD--LQALEVLL 118

Query: 57  LSPNK 61
           L  N 
Sbjct: 119 LYNNH 123

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 17/65 (26%), Positives = 34/65 (52%), Gaps = 8/65 (12%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVR 56
           + NL +LD+S+N +  ++     +DL  L+ L L  N +   V    F +  ++ + ++ 
Sbjct: 87  VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFED--MAQLQKLY 142

Query: 57  LSPNK 61
           LS N+
Sbjct: 143 LSQNQ 147

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 7/66 (10%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP---FSN-EQLSSMSRV 55
           ++ L  L + NN I   +      D+++L  L LS N++S   P     +  +L  +  +
Sbjct: 111 LQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLL 168

Query: 56  RLSPNK 61
            LS NK
Sbjct: 169 DLSSNK 174

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 28/168 (16%)

Query: 151 IGTGGYGSVYKAQ---------LPNGKVFALK--KLHTSETEELAFIKSFRNEAQV---- 195
                 G +Y+A           P  + F+LK          E  F +      QV    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 196 -LSQVLHRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCIL-HNDDEAVELDWAKRV-NIV 251
            L      +I    GF +H  K  FL+   + R SL   L  +    +     + V  + 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSE---RSVLQVA 165

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA--FVADFGTARR 297
             +  AL +LH       +H ++++ NI ++ + ++   +A +G A R
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 6/61 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              LT+LD S+NK+   I   +T L++L Y + S N L+         LS ++ +     
Sbjct: 211 NIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQT 264

Query: 61  K 61
            
Sbjct: 265 D 265

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 14/61 (22%), Positives = 28/61 (45%), Gaps = 5/61 (8%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          +  LT LD  N+ I   + G +  L+ L  L  + N ++  +  S    ++++ +    N
Sbjct: 41 LATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT-LDLSQ--NTNLTYLACDSN 95

Query: 61 K 61
          K
Sbjct: 96 K 96

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 17/61 (27%), Positives = 31/61 (50%), Gaps = 6/61 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             NLT+L   +NK+  ++   +T L++L YLN   NKL+  +  S      ++ +  + N
Sbjct: 84  NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQ--NPLLTYLNCARN 137

Query: 61  K 61
            
Sbjct: 138 T 138

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 15/60 (25%), Positives = 26/60 (43%), Gaps = 6/60 (10%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           K L  L+   N I   +   L    +L +L+ S NKL+  +  +   L+ ++    S N 
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-IDVTP--LTQLTYFDCSVNP 244

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 15/61 (24%), Positives = 29/61 (47%), Gaps = 6/61 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LT L  ++N I  ++   L+  + L YL    NKL+  +  +   L+ ++ +    N
Sbjct: 63  LTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN-LDVTP--LTKLTYLNCDTN 116

Query: 61  K 61
           K
Sbjct: 117 K 117

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 10/74 (13%), Positives = 22/74 (29%), Gaps = 3/74 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L   N  I+      +  +  L+    +  +    +P      +S++       
Sbjct: 338 NTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTIT-MPKETLTNNSLTIAVSPDL 394

Query: 61  KGLCGNFITLPSCD 74
               GN + +   D
Sbjct: 395 LDQFGNPMNIEPGD 408

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSG--PVPFSNEQLSSMSRVRL 57
           +  L  L +    ++  +  G    L+ L YL L  N L       F +  L +++ + L
Sbjct: 104 LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRD--LGNLTHLFL 160

Query: 58  SPNK 61
             N+
Sbjct: 161 HGNR 164

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 6/64 (9%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP--FSNEQLSSMSRVRL 57
           +  L +L + +N ++ ++P     DL  L +L L  N++S      F    L S+ R+ L
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG--LHSLDRLLL 184

Query: 58  SPNK 61
             N+
Sbjct: 185 HQNR 188

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 4/63 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS--GPVPFSNEQLSSMSRVRLS 58
           + NLT L +  N+I          L  LD L L  N+++   P  F +  L  +  + L 
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD--LGRLMTLYLF 209

Query: 59  PNK 61
            N 
Sbjct: 210 ANN 212

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 11/61 (18%), Positives = 21/61 (34%), Gaps = 6/61 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  +D+ NN ++  +P     L  +       N+L       N  L  ++ +    N
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLEELPELQN--LPFLTAIYADNN 205

Query: 61  K 61
            
Sbjct: 206 S 206

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 11/61 (18%), Positives = 20/61 (32%), Gaps = 6/61 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  LT +   NN ++  +P     L  +       N L       N  L  ++ +    N
Sbjct: 194 LPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILEELPELQN--LPFLTTIYADNN 247

Query: 61  K 61
            
Sbjct: 248 L 248

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 10/40 (25%), Positives = 14/40 (35%), Gaps = 1/40 (2%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG 40
             +L  L  S N +   +P     L  L   N +   LS 
Sbjct: 90  PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD 128

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 9/61 (14%), Positives = 22/61 (36%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            +NL  L +  N +    P        ++ L ++  ++  P  F++E    +       +
Sbjct: 395 PQNLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450

Query: 61  K 61
            
Sbjct: 451 H 451

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 6/61 (9%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             +L ++   NN++E  +P EL +L  L  +    N L   +P   +   S+  +    N
Sbjct: 172 PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LP---DLPLSLESIVAGNN 225

Query: 61  K 61
            
Sbjct: 226 I 226

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 16/60 (26%), Positives = 30/60 (50%), Gaps = 6/60 (10%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
             L +L +SNN++E  +P EL + S L  +++  N L   +P   +   S+  +    N+
Sbjct: 131 PLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LP---DLPPSLEFIAAGNNQ 184

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 7/61 (11%)

Query: 3   NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRLSP 59
            +  LD+ NN+I  SIP ++T L  L  LN++ N+L   VP   F    L+S+  + L  
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDR--LTSLQYIWLHD 506

Query: 60  N 60
           N
Sbjct: 507 N 507

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 10/64 (15%), Positives = 19/64 (29%), Gaps = 4/64 (6%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE----QLSSMSRVRL 57
             L  L I+          ++     L  L+LS N   G     +     +  ++  + L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 58  SPNK 61
               
Sbjct: 209 RNAG 212

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 15/61 (24%), Positives = 29/61 (47%), Gaps = 5/61 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
              L  L++S   ++  +P  L   ++L  L+LS+N+L    P   ++L  +  + L  N
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSP-DELPQVGNLSLKGN 306

Query: 61  K 61
            
Sbjct: 307 P 307

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 15/68 (22%), Positives = 21/68 (30%), Gaps = 7/68 (10%)

Query: 1   MKNLTWLDISNNKIEGSI-------PGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMS 53
              L+ LD+S+N   G         P +   L  L   N      SG           + 
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231

Query: 54  RVRLSPNK 61
            + LS N 
Sbjct: 232 GLDLSHNS 239

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 10/40 (25%), Positives = 19/40 (47%), Gaps = 2/40 (5%)

Query: 2   KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGP 41
             L+ LD+S N+++   P    +L ++  L+L  N     
Sbjct: 274 AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + L +L   N  +  SI   L  L++L  L LS N++SG +    E+  +++ + LS N
Sbjct: 41 FEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98

Query: 61 K 61
          K
Sbjct: 99 K 99

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.7 bits (93), Expect = 4e-04
 Identities = 12/39 (30%), Positives = 21/39 (53%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
           +  L  L++S+N++ G +         L +LNLS NK+ 
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 60/449 (13%), Positives = 115/449 (25%), Gaps = 166/449 (36%)

Query: 6   WLDISNNKIEGSIPGELTDL-SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLC 64
           WL++ N     ++   L  L  ++D    S +  S  +      + +  R RL  +K   
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYE 244

Query: 65  GNFITL-------------PSC------------DA------------------TKPATL 81
              + L              SC            D                   T     
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304

Query: 82  FVEIF----------LP---LAIVPSVI-VFACLLVVK-------RKYKKPKVKARATNS 120
              +           LP   L   P  + + A  +          +     K+     +S
Sbjct: 305 --SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362

Query: 121 IDV------------FSIWNYDGRI------------FYEDLIEATEDFHIKYCIGTGGY 156
           ++V             S++     I               D++      H    +     
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV----- 417

Query: 157 GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLY----GFCL 212
                 + P     ++  ++      L       NE       LHRSIV  Y     F  
Sbjct: 418 -----EKQPKESTISIPSIY------LELKVKLENEYA-----LHRSIVDHYNIPKTFDS 461

Query: 213 HKK---------CMFLIY-----EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
                          + +     E+ ER +LF ++  D       + ++    K      
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----FRFLEQ----K------ 506

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARRLHADSSNRTLLAGTYGYIAP 317
             + HD +    +   S  N L   K  + ++ D         +      L        P
Sbjct: 507 --IRHDSTA--WNASGSILNTLQQLKFYKPYICD---------NDPKYERLVNAILDFLP 553

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKH 346
           ++   ++ ++  D+          LM + 
Sbjct: 554 KIEENLICSKYTDLLRIA------LMAED 576

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 1/64 (1%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L I  + +    P       RL  LNLS+N L   + +   Q  S+  + LS N
Sbjct: 55  LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113

Query: 61  KGLC 64
              C
Sbjct: 114 PLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 40.9 bits (95), Expect = 6e-04
 Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 1  MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSP 59
           +NLT L I N +    +   +L  L  L  L +  + L    P +      +SR+ LS 
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89

Query: 60 NK 61
          N 
Sbjct: 90 NA 91

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 8/62 (12%)

Query: 3   NLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRLS 58
            L  LD+S N I  ++       L  L  L L  N+L   VP   F    L+S+ ++ L 
Sbjct: 348 KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDR--LTSLQKIWLH 403

Query: 59  PN 60
            N
Sbjct: 404 TN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 8/64 (12%)

Query: 3   NLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKL-SGPVP---FSNEQLSSMSRVRL 57
           +L  L +  N+    +  G    L+ L+ L L+   L    +    F    L+S+  + L
Sbjct: 80  SLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP--LTSLEMLVL 136

Query: 58  SPNK 61
             N 
Sbjct: 137 RDNN 140

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 7/64 (10%)

Query: 3   NLTWLDISNNKIEGSI--PGELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRL 57
           NL  L ++   ++G++        L+ L+ L L  N +    P   F N  +     + L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN--MRRFHVLDL 161

Query: 58  SPNK 61
           + NK
Sbjct: 162 TFNK 165

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 9/40 (22%), Positives = 16/40 (40%), Gaps = 1/40 (2%)

Query: 1  MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLS 39
          +++L +L +        I       LS L  L L +N+  
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNL  L I NNK++ SI   L  LS+L+ L+L  N+++     +   L  ++ + L+  
Sbjct: 127 LKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLTR--LKKVNWIDLTGQ 182

Query: 61  K 61
           K
Sbjct: 183 K 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 14/49 (28%), Positives = 26/49 (53%), Gaps = 2/49 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQL 49
             NL  L +S+N+I   +   L DL++L+ L+++ N+L       +  L
Sbjct: 62  FTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACL 108

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 13/61 (21%), Positives = 31/61 (50%), Gaps = 4/61 (6%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
          +  +   +  N+ I+ S+ G +   + L  L+LS N++S   P  +  L+ +  + ++ N
Sbjct: 40 LSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISDLSPLKD--LTKLEELSVNRN 95

Query: 61 K 61
          +
Sbjct: 96 R 96

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 12/61 (19%), Positives = 27/61 (44%), Gaps = 5/61 (8%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L ++ N+++ ++ G +     L  L L  N+L       +  L ++  + +  N
Sbjct: 84  LTKLEELSVNRNRLK-NLNG-IPSAC-LSRLFLDNNELRDTDSLIH--LKNLEILSIRNN 138

Query: 61  K 61
           K
Sbjct: 139 K 139

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 2/59 (3%)

Query: 3   NLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +L  L ++ NKI   +      DL  L+ L+L  NKL      +   L ++  + L+ N
Sbjct: 105 SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             NL +L + N  +  S+   L  L +L  L LS N++ G +    E+L +++ + LS N
Sbjct: 48  FVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105

Query: 61  K 61
           K
Sbjct: 106 K 106

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 39.3 bits (92), Expect = 6e-04
 Identities = 15/39 (38%), Positives = 21/39 (53%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
           +  L  L++S N+I G +      L  L +LNLS NKL 
Sbjct: 70  LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 16/62 (25%), Positives = 28/62 (45%), Gaps = 8/62 (12%)

Query: 3   NLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVRLS 58
           +L  L + +N+I   +       LS +  L+L  N+++  V    F    L S+S + L 
Sbjct: 106 SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT--LHSLSTLNLL 161

Query: 59  PN 60
            N
Sbjct: 162 AN 163

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 37/171 (21%), Positives = 62/171 (36%), Gaps = 37/171 (21%)

Query: 151 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE------ELAFIKSFRNEAQVLSQVLHRS 203
           IG+GG+G +Y A      +  A   +     E      EL F +    +  +   +  + 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 204 -----IVKLYGFCLH----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKR------V 248
                I   YG  L     +   F++   MER      L  D + +             +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMV---MER------LGIDLQKI-SGQNGTFKKSTVL 154

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTARR 297
            +   M   L Y+H       +H DI + N+LL  K     ++AD+G + R
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 17/59 (28%), Positives = 23/59 (38%), Gaps = 3/59 (5%)

Query: 3   NLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            L  L ++NN +   +P G L  L  LD L L  N L   +P        +    L  N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 13/39 (33%), Positives = 25/39 (64%), Gaps = 1/39 (2%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS 39
           +  L  LD+S+N+++ S+P     L  L  L++S+N+L+
Sbjct: 76  LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 8/65 (12%)

Query: 1   MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVP---FSNEQLSSMSRVR 56
             NL  L +++N I  +I     + L  L++L+LS+N LS  +    F    LSS++ + 
Sbjct: 75  CVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKP--LSSLTFLN 130

Query: 57  LSPNK 61
           L  N 
Sbjct: 131 LLGNP 135

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 12/72 (16%), Positives = 27/72 (37%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L+I  + ++   P  L  +  + +L L   +    +    +  SS+  + L   
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232

Query: 61  KGLCGNFITLPS 72
                +F  L +
Sbjct: 233 DLDTFHFSELST 244

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	436
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.0
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.94
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	98.92
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.9
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.85
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.81
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.78
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	98.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.69
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.65
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.65
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.64
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.62
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.6
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.58
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.57
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.56
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.54
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.53
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.53
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.51
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.49
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.48
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.47
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.47
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.46
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.42
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.4
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.39
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.38
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.37
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.37
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.36
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.36
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.35
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.35
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.34
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.3
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.3
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.3
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.27
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.26
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.25
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.24
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.2
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.2
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.14
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.1
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.1
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.1
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.1
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.06
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.03
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.02
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.02
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.02
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.01
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	97.99
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	97.99
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	97.98
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	97.98
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	97.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	97.97
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	97.96
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	97.96
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	97.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	97.94
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	97.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	97.91
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	97.9
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	97.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	97.88
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	97.84
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	97.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	97.8
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.78
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	97.73
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.73
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	97.72
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	97.7
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.7
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.7
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	97.67
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	97.67
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	97.63
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.62
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	97.62
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	97.61
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	97.6
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.58
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	97.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.56
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	97.53
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.53
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.52
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.47
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.35
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.33
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.32
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.3
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.28
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.14
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.02
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	96.97
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.95
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.83
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.74
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.71
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.64
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	96.59
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.53
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.29
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.27
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.2
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.08
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.08
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	95.85
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	95.6
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	95.43
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	94.93
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.65
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	94.01
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.28
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	92.21
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	91.45
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.75
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	89.32
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	88.02
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	85.22
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	85.0
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	82.88

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-58  Score=434.28  Aligned_cols=270  Identities=22%  Similarity=0.343  Sum_probs=224.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999965 579999999997654333333477899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++||+|.+++...+   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999997654   6999999999999999999999   789999999999999999999999999999987543


Q ss_pred             CC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..  .....+||+.|+|||++.+..++.++||||+||++|||+||+.||...       ........+.......+..  
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-------~~~~~~~~i~~~~~~~p~~--  256 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-------NEGLIFAKIIKLEYDFPEK--  256 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCCTT--
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCcc--
Confidence            32  344578999999999999999999999999999999999999999632       1122233333333222111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccccccchhhhhhC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN  436 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~~~~~~~~~~~  436 (436)
                      .   ...+.+|+.+||+.||++|||++|++.+.|..      .||.++++.|+.+++
T Consensus       257 ~---s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~------~Hp~F~~idw~~l~~  304 (311)
T 4aw0_A          257 F---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLK------AHPFFESVTWENLHQ  304 (311)
T ss_dssp             C---CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHH------TSGGGTTCCCTTGGG
T ss_pred             c---CHHHHHHHHHHccCCHhHCcChHHHcCCHHHH------CCCCcCCCCHHHhcC
Confidence            1   12367899999999999999999987777663      367778888887763

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-58  Score=438.34  Aligned_cols=260  Identities=23%  Similarity=0.375  Sum_probs=211.1

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++........ ..+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            6899999999999999999965 5799999999976544332 3478999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |||+||+|.+++...+ ...+++.+++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999997543 235789999999999999999999   789999999999999999999999999999876443


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .......+||+.|+|||++.+..++.++|||||||++|||+||+.||...+       .......+.....++.. ... 
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~~~-~~~-  249 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIISGSFPPVS-LHY-  249 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCC-TTS-
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCCC-ccC-
Confidence            333345679999999999999999999999999999999999999997321       12223334433332211 111 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                        ...+.+|+.+||+.||++|||+.|+++|+|+.+..
T Consensus       250 --s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          250 --SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             --CHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence              22367899999999999999999999999997653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.2e-58  Score=434.87  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=215.6

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|++.+.||+|+||+||+|.. .+|+.||||++.......   .+.+.+|+++|+.++|||||++++++.+.+..+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5688999999999999999976 479999999997543322   256789999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |||++|+|.+++...    .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999999753    5999999999999999999999   789999999999999999999999999999987665


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+... .++.... ..
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~-~~~~~~~-~~  294 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDN-LPPRLKN-LH  294 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHS-SCCCCSC-GG
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcC-CCCCCCc-cc
Confidence            555667889999999999999999999999999999999999999996321       11112222222 1111110 11


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....+.+|+.+||+.||++|||+.|+++|+|+++..+
T Consensus       295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            12234678999999999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-57  Score=426.58  Aligned_cols=259  Identities=24%  Similarity=0.426  Sum_probs=201.8

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      +++.+.+.||+|+||+||+|.+.+  .||||+++...... ...+.|.+|++++++++|||||+++|+|.+ +..+||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            567888999999999999998754  58999997654332 235789999999999999999999999865 46899999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      ||++|+|.++++...  ..++|.+++.|+.|||.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999999997643  36999999999999999999999   7899999999999999999999999999998764322


Q ss_pred             C--Ccccccccccccccccccc---CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC-CCCC
Q 013793          303 S--NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-PPPV  376 (436)
Q Consensus       303 ~--~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~  376 (436)
                      .  ......||+.|||||++.+   ..++.++|||||||++|||+||+.||.....       .......+.... .+..
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-------RDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHTTCCCCCS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCCc
Confidence            2  2345679999999999864   4689999999999999999999999963221       111122221111 1111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..........+.+|+.+||+.||++||||.||+++++..+.
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11011122346789999999999999999999999986654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3e-57  Score=426.97  Aligned_cols=256  Identities=22%  Similarity=0.354  Sum_probs=206.9

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      +++++.+.||+|+||+||+|.+.      +++.||||+++......  ..++|.+|+.++++++|||||+++|+|.+.+.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~--~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH--HHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            35667889999999999999763      56789999997654322  23789999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          217 MFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                      .++|||||++|+|.++|.....             ...++|.+++.|+.|||+||+|||   +.+|+||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECC
Confidence            9999999999999999975421             246999999999999999999999   789999999999999999


Q ss_pred             CCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCc
Q 013793          284 KLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDP  360 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~  360 (436)
                      ++.+||+|||+++.......  ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...+       .
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-------~  253 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------N  253 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-------H
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------H
Confidence            99999999999987643322  2344679999999999999999999999999999999998 899986322       1


Q ss_pred             ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ......+...... +.+..   ....+.+|+.+||+.||++||||.||+++|..
T Consensus       254 ~~~~~~i~~~~~~-~~p~~---~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          254 QDVVEMIRNRQVL-PCPDD---CPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHHHHHTTCCC-CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHcCCCC-CCccc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            1112222222211 11111   12336789999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-57  Score=419.93  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             cccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCEEEEE
Q 013793          146 HIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKCMFLI  220 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  220 (436)
                      ++.++||+|+||+||+|.. .+++.||+|++........ ..+.|.+|++++++++|||||++++++.+    .+..++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            5677899999999999965 4789999999976543332 34789999999999999999999999875    3468999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecC-CCCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNS-KLEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~  297 (436)
                      ||||++|+|.+++....   .+++..+..++.||+.||+|||   +.+  |+||||||+|||++. ++.+||+|||+|+.
T Consensus       108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999999999997643   7999999999999999999999   555  999999999999985 78999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..  .......+||+.|||||++.+ .++.++|||||||++|||+||+.||....      ........+.....+...+
T Consensus       182 ~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~------~~~~~~~~i~~~~~~~~~~  252 (290)
T 3fpq_A          182 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGG
T ss_pred             CC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------cHHHHHHHHHcCCCCCCCC
Confidence            43  233455789999999998865 69999999999999999999999996221      1111111222221111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..   ....+.+|+.+||+.||++|||+.|+++|+|++.+
T Consensus       253 ~~---~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          253 KV---AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             cc---CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            11   11236789999999999999999999999999764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-57  Score=425.45  Aligned_cols=255  Identities=26%  Similarity=0.438  Sum_probs=207.4

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++.....   ..++|.+|++++++++|||||+++|+|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH---HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            57888999999999999999763      4788999999865433   24789999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC
Q 013793          217 MFLIYEYMERGSLFCILHNDD----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  286 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  286 (436)
                      .++|||||++|+|.++++..+          ....++|.+++.|+.|||+||+|||   +++|+||||||+|||+++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCc
Confidence            999999999999999997642          2347999999999999999999999   789999999999999999999


Q ss_pred             eEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccc
Q 013793          287 AFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  363 (436)
                      +||+|||+|+........  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+       ....
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-------~~~~  239 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEV  239 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHH
Confidence            999999999876443322  223468999999999999999999999999999999999 899987322       1112


Q ss_pred             hhhhhcCC-CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          364 LIDVLDQR-LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       364 ~~~~~~~~-l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ...+.... ++.+..     ....+.+|+.+||+.||++|||++||++.+...
T Consensus       240 ~~~i~~~~~~~~p~~-----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          240 IECITQGRVLQRPRT-----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHHHHHTCCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCcc-----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            22222222 221111     122367899999999999999999998877543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.8e-57  Score=428.06  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=203.2

Q ss_pred             hcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.....   ..+.|.+|++++++++|||||+++|+|.+.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            56778899999999999999764      4788999999865433   24789999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          217 MFLIYEYMERGSLFCILHNDDE------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      .+||||||++|+|.++++....            ..+++|.+++.|+.|||+||+|||   +.+|+||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCC
Confidence            9999999999999999976432            246999999999999999999999   7899999999999999999


Q ss_pred             CCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcc
Q 013793          285 LEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPK  361 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~  361 (436)
                      +.+||+|||+++.......  ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....       .
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~  267 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------T  267 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------H
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999987644332  2234679999999999999999999999999999999999 8999863221       1


Q ss_pred             cchhhhhcC-CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          362 IMLIDVLDQ-RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       362 ~~~~~~~~~-~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .....+... +++.+..     ....+.+|+.+||+.||++||||.||+++|.....
T Consensus       268 ~~~~~i~~g~~~~~p~~-----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          268 EAIDCITQGRELERPRA-----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHHTCCCCCCTT-----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCccc-----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            112222221 2222111     12236789999999999999999999999876443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-56  Score=413.77  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.............+.+|+++++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999975 479999999998665444444567999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+ +|+|.+++...+   .+++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999987654   6999999999999999999999   789999999999999999999999999999876433


Q ss_pred             CCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      . ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||...+       .......+.......+..  .
T Consensus       166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~~~~~p~~--~  235 (275)
T 3hyh_A          166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNGVYTLPKF--L  235 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTT--S
T ss_pred             C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCCC--C
Confidence            2 3345689999999999998876 589999999999999999999996321       112222333332222111  1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                         ...+.+|+.+||+.||++|||++|+++|+|++...
T Consensus       236 ---s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~  270 (275)
T 3hyh_A          236 ---SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL  270 (275)
T ss_dssp             ---CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence               12367899999999999999999999999997653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-56  Score=434.78  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=215.3

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|++.+.||+|+||+||+|.. .+|+.||||++.......   .+.+.+|+++|+.++|||||++++++.+.+..+|||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            5699999999999999999975 479999999997654332   256889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |||+||+|.+++...    .+++.++..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999999753    5999999999999999999999   789999999999999999999999999999987666


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||....       .......+... .++.... ..
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~-~~~~~~~-~~  371 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDN-LPPRLKN-LH  371 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHS-CCCCCSC-TT
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcC-CCCCCcc-cc
Confidence            555667889999999999999999999999999999999999999996321       11111222221 1111100 00


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....+.+|+.+||+.||++|||+.|+++|+|+++..+
T Consensus       372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            11223678999999999999999999999999987644

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.6e-57  Score=420.91  Aligned_cols=255  Identities=25%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             hcccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|++.+.||+|+||+||+|+.    .+++.||||+++........ ...+.+|++++++++|||||++++++.+.+..+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            6799999999999999999965    25789999999764322111 145778999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +|||||+||+|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999998654   6999999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ..........+||+.|+|||++.+..++.++||||+||++|||+||+.||...       ........+.......+.. 
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~~~p~~-  248 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-------DRKETMTMILKAKLGMPQF-  248 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT-
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-------CHHHHHHHHHcCCCCCCCc-
Confidence            55444555678999999999999999999999999999999999999999632       1122233333333332211 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                          ....+.+|+.+||+.||++|||     ++|+++|+|++.
T Consensus       249 ----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          249 ----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             ----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             ----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence                1123678999999999999998     689999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-54  Score=409.56  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=201.5

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----EEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----CMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  218 (436)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++.......    ..+..|+..+.+++|||||+++|+|.+.+    ..+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4677889999999999999988 68999999997654321    23345666677889999999999998754    679


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      ||||||++|+|.++++..    .++|..+.+++.|++.||+|||+.     +.++|+||||||+|||+|.++.+||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999999764    589999999999999999999953     13499999999999999999999999999


Q ss_pred             cccccCCCCCC----ccccccccccccccccccC------ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCC----
Q 013793          294 TARRLHADSSN----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD----  359 (436)
Q Consensus       294 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~----  359 (436)
                      +++........    .....||+.|+|||++.+.      .++.++|||||||++|||+||+.|+...........    
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876543322    2235799999999998754      478899999999999999999988753322111100    


Q ss_pred             c----ccchhhhhcCCCCCCCChh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          360 P----KIMLIDVLDQRLPPPVDQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       360 ~----~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .    ......+....+.+..+..  ..+....+.+|+.+||+.||++||||.||++.|....
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            0    1111222333333333221  2234455778999999999999999999999986543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.2e-55  Score=413.07  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=202.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|++.+.||+|+||+||+|.. .+|+.||||+++....        ..+|+.+++.++|||||++++++.+.+..+||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35688889999999999999975 5799999999976532        23699999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeecccccccC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARRLH  299 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~  299 (436)
                      ||||+||+|.+++...+   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+.+.
T Consensus       129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999997654   6999999999999999999999   88999999999999999987 69999999999775


Q ss_pred             CCCCC-----ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          300 ADSSN-----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       300 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .+...     ....+||+.|||||++.+..++.++|||||||++|||+||+.||....       .......+.....+.
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~  275 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-------RGPLCLKIASEPPPI  275 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-------CSCCHHHHHHSCCGG
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHHcCCCCc
Confidence            43321     223579999999999999999999999999999999999999996321       112223333222110


Q ss_pred             -CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          375 -PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       375 -~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       ....   .....+.+++.+||+.||++|||+.|+++++..
T Consensus       276 ~~~~~---~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          276 REIPP---SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             GGSCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhcCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             0111   112236789999999999999999999887643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-54  Score=407.41  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC------
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK------  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  215 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++......  ..+.+.+|++++++++|||||++++++.+.+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            5699999999999999999975 579999999997654332  2467899999999999999999999987644      


Q ss_pred             ------EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          216 ------CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       216 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                            ..++|||||++|+|.+++.........++..++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence                  36899999999999999987765556777889999999999999999   789999999999999999999999


Q ss_pred             eecccccccCCCCCC------------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCC
Q 013793          290 ADFGTARRLHADSSN------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS  357 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  357 (436)
                      +|||+|+.+......            .+..+||+.|||||++.+..++.++|||||||++|||++   ||.....    
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            999999877543221            233579999999999999999999999999999999996   6642110    


Q ss_pred             CCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                        .............+    ...........+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       233 --~~~~~~~~~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          233 --RVRTLTDVRNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             --HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             --HHHHHHHHhcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence              01111222222222    1122333345679999999999999999999999999653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9e-55  Score=417.16  Aligned_cols=260  Identities=24%  Similarity=0.351  Sum_probs=209.1

Q ss_pred             HHHHhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC-CCceeeeeE
Q 013793          138 LIEATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RSIVKLYGF  210 (436)
Q Consensus       138 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~  210 (436)
                      ++-..++|++.+.||+|+||+||+|.+.      .++.||||.+........  .+.|.+|++++.+++| ||||+++|+
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~--~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH--HHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3334578999999999999999999753      246899999987654432  4789999999999965 899999999


Q ss_pred             EeeC-CEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 013793          211 CLHK-KCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  276 (436)
Q Consensus       211 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~  276 (436)
                      |.+. +..++|||||++|+|.++|+....             ...++|.+++.++.|||+||+|||   +.+|+||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            9764 568999999999999999975421             245899999999999999999999   78999999999


Q ss_pred             CceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccccc
Q 013793          277 NNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS  353 (436)
Q Consensus       277 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  353 (436)
                      +|||+++++.+||+|||+|+.+..+...  .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... 
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~-  292 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-  292 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC-
Confidence            9999999999999999999977544332  234578999999999999999999999999999999998 999986321 


Q ss_pred             ccCCCCcccchhhhhcC--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          354 LSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       354 ~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                            ........+..  +++.+..     ....+.+++.+||+.||++|||+.||+++|..
T Consensus       293 ------~~~~~~~~i~~g~~~~~p~~-----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          293 ------IDEEFCRRLKEGTRMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             ------CSHHHHHHHHHTCCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHHHHHHHHHcCCCCCCCcc-----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence                  11112222221  2222111     12236788999999999999999999999853

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=402.05  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=205.4

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------C
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------K  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  215 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....... ...+.+.+|+++|+.++|||||++++++...      +
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999965 579999999997654332 2246788999999999999999999987643      5


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++|||||+ |+|.+++...+   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67999997654   7999999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCC----CCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcc
Q 013793          296 RRLHAD----SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK  361 (436)
Q Consensus       296 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~  361 (436)
                      +.+...    .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+...         ......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            876432    2223457899999999998775 56999999999999999999999996322100         000000


Q ss_pred             -------cchhhhhcCCCCCCCChhHH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          362 -------IMLIDVLDQRLPPPVDQKVI----QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       362 -------~~~~~~~~~~l~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                             ........ .++........    .....+.+|+.+||+.||++|||+.|+++|+|+++.
T Consensus       286 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          286 VIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             Hhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                   00000000 01110000000    112346789999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-50  Score=390.64  Aligned_cols=263  Identities=25%  Similarity=0.273  Sum_probs=201.0

Q ss_pred             HHhhcccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      ...+.|++.+.||+|+||+||+|..    .+++.||||++......     ..+.+|++++..+ +|||||++++++.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-----HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-----HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3567899999999999999999964    25788999998765432     5677899999998 699999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFG  293 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg  293 (436)
                      +..++||||+++|+|.+++.      .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999984      4899999999999999999999   7899999999999999877 799999999


Q ss_pred             cccccCCCCC----------------------------CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhC
Q 013793          294 TARRLHADSS----------------------------NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMG  344 (436)
Q Consensus       294 ~a~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg  344 (436)
                      +|+.......                            .....+||+.|+|||++.+. .++.++||||+||++|||+||
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9986533211                            12335799999999998876 589999999999999999999


Q ss_pred             CCCccccccc----------------------------cCCCCcccchhhhh------cCCCCCCC---------ChhHH
Q 013793          345 KHPRDLLSSL----------------------------SSSSDPKIMLIDVL------DQRLPPPV---------DQKVI  381 (436)
Q Consensus       345 ~~p~~~~~~~----------------------------~~~~~~~~~~~~~~------~~~l~~~~---------~~~~~  381 (436)
                      +.||......                            .....+........      +...+...         ...+.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            9998522110                            00000000000000      00000000         00000


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .....+.+|+.+||+.||++|||++|+++|+|++.
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            11223678999999999999999999999999964

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.6e-50  Score=406.99  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=213.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++.......   .+.+.+|+++|+.++|||||++++++.+.+..++|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999965 579999999997765432   36788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--LEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~  298 (436)
                      ||||+||+|.+++....  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+++.+
T Consensus       233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999986532  36899999999999999999999   7899999999999999854  89999999999987


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      .... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+.. 
T Consensus       308 ~~~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~-  378 (573)
T 3uto_A          308 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDWNMDDS-  378 (573)
T ss_dssp             CTTS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCCSG-
T ss_pred             cCCC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHhCCCCCCcc-
Confidence            5433 3345679999999999999999999999999999999999999996321       111222222222211110 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ........+.+|+.+||+.||.+|||+.|+++|+|++...
T Consensus       379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            0111123367899999999999999999999999998653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.4e-50  Score=406.51  Aligned_cols=258  Identities=22%  Similarity=0.271  Sum_probs=207.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++........   ........++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36899999999999999999965 4799999999975432211   1122333456677788999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||++||+|.+++...+   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999998654   6999999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      +....  ....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....    .+...............+.
T Consensus       342 ~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i~~~i~~~~~~~p~  415 (689)
T 3v5w_A          342 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMAVELPD  415 (689)
T ss_dssp             CSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHHHHHHHHCCCCCCT
T ss_pred             cCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhcCCCCCCCc
Confidence            65432  345689999999999864 5799999999999999999999999963211    1111112222233222211


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                      .  .   ...+.+|+.+||+.||.+|++     ++||++|+||..
T Consensus       416 ~--~---S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          416 S--F---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             T--S---CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             c--C---CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            1  1   123678999999999999998     799999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.9e-48  Score=362.68  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=215.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.. .+++.||||++.......   .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            46799999999999999999975 579999999987554333   25688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++...    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999999754    5899999999999999999999   78999999999999999999999999999987766


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC-CCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL-PPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~  379 (436)
                      .........||+.|+|||.+.+..++.++||||||+++|||+||+.||.....       ............ ...... 
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~-  240 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPELQNPE-  240 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHCSCCCSCGG-
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCCcc-
Confidence            55555667899999999999999999999999999999999999999863211       111111111111 111111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                        .....+.+++.+||+.||++|||+.|+++|+|+....+..
T Consensus       241 --~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  280 (297)
T 3fxz_A          241 --KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS  280 (297)
T ss_dssp             --GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             --ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence              1122367899999999999999999999999998776643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.7e-48  Score=368.19  Aligned_cols=283  Identities=34%  Similarity=0.565  Sum_probs=227.0

Q ss_pred             cccHHHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEE
Q 013793          132 RIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFC  211 (436)
Q Consensus       132 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  211 (436)
                      .+++.++..+.++|++.+.||+|+||+||+|...+++.||||++........  ...+.+|+++++.++||||+++++++
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEE
Confidence            5678899999999999999999999999999988899999999976543221  13688999999999999999999999


Q ss_pred             eeCCEEEEEEeeccCCChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          212 LHKKCMFLIYEYMERGSLFCILHNDDE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       212 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      ...+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            999999999999999999999987542 3459999999999999999999995444599999999999999999999999


Q ss_pred             ecccccccCCCCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCC----------CC
Q 013793          291 DFGTARRLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS----------SD  359 (436)
Q Consensus       291 Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~----------~~  359 (436)
                      |||+++........ .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+........          ..
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99999876543332 33456999999999999999999999999999999999999999632211100          00


Q ss_pred             cccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       360 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .........+..+.....   ......+.+++.+||+.||.+|||+.||+++++......
T Consensus       257 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYK---DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCC---HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             hchhhhhhcChhhccccC---HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            111122222333332222   334556889999999999999999999999998755443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3e-47  Score=363.40  Aligned_cols=269  Identities=24%  Similarity=0.342  Sum_probs=220.2

Q ss_pred             CcccHHHHHHHhhc----------ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc
Q 013793          131 GRIFYEDLIEATED----------FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV  199 (436)
Q Consensus       131 ~~~~~~~l~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l  199 (436)
                      +.++++++..+++.          |+..+.||+|+||.||+|... +|+.||||++.......   .+.+.+|+.+++.+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l   99 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDY   99 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhC
Confidence            45778888888765          777789999999999999765 79999999997654332   26788999999999


Q ss_pred             cCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       200 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      +||||+++++++...+..++||||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||
T Consensus       100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI  172 (321)
T 2c30_A          100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI  172 (321)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence            9999999999999999999999999999999998643    5899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD  359 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~  359 (436)
                      +++.++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------  246 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------  246 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence            99999999999999998776554444556799999999999999999999999999999999999999863211      


Q ss_pred             cccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       360 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       ......+.....+....  .......+.+++.+||+.||++|||+.|+++++|+.+..
T Consensus       247 -~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          247 -VQAMKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -HHHHHHHHHSSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -HHHHHHHhcCCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence             11111222211111000  111122367899999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-47  Score=364.25  Aligned_cols=256  Identities=23%  Similarity=0.366  Sum_probs=212.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            46799999999999999999976 689999999997654332 2346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++...+   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999997654   6899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCccC-cchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......||+.|+|||.+.+..++ .++||||+||++|||+||+.||+...       .......+.......+..  
T Consensus       167 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~--  236 (328)
T 3fe3_A          167 GG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERVLRGKYRIPFY--  236 (328)
T ss_dssp             SC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--
T ss_pred             CC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCC--
Confidence            32 34556799999999999888765 79999999999999999999996321       111222233332222211  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                         ....+.+++.+||+.||.+|||+.|+++|+|+...
T Consensus       237 ---~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          237 ---MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             ---SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             ---CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence               11236689999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-47  Score=364.65  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=212.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|+++............+.+|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999764 7999999999764332222246788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999997543   6899999999999999999999   78999999999999999999999999999987544


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..   
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~---  227 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRT---  227 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC---
Confidence            4444556789999999999999999999999999999999999999986311       111222222222221111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                        ....+.+++.+||+.||++||     ++.|+++|+|+..
T Consensus       228 --~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          228 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             --SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             --CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence              112367899999999999999     9999999999854

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-47  Score=360.85  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=213.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||+||+|... +++.||+|.+......    ...+.+|++++..++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            468999999999999999999764 6889999999765432    25688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KLEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~  298 (436)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999997542  36899999999999999999999   789999999999999987  789999999999876


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....       .......+.......+. .
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~-~  225 (321)
T 1tki_A          155 KPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFDE-E  225 (321)
T ss_dssp             CTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCH-H
T ss_pred             CCCC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHcCCCCCCh-h
Confidence            5432 3344679999999999999889999999999999999999999986321       11222233333322111 1


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ........+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            11112334778999999999999999999999999987644

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=368.42  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=209.6

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|++.+.||+|+||+||+|+.. +|+.||||++.............+.+|.+++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999754 6899999999765433333346788899999988 7999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999997654   6999999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||...       ........+.......+.. 
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p~~-  246 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-------NEDDLFEAILNDEVVYPTW-  246 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT-
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCCC-
Confidence            44444455678999999999999999999999999999999999999999632       1222233333333322221 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~------~ev~~~l~~~~  416 (436)
                          ....+.+++.+||+.||++||++      .|+++|+|+..
T Consensus       247 ----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          247 ----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             ----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             ----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence                11236689999999999999999      99999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-47  Score=359.47  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=202.3

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..++|++.+.||+|+||+||+|.. +|+.||||++....... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            457899999999999999999987 68889999997665432 2347789999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      |||+++|+|.+++........+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999987654445999999999999999999999   778  999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh--cC--CCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQ--RLPP  374 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~--~l~~  374 (436)
                      ...........||+.|+|||.+.+..++.++||||||+++|||+||+.||.....       ........  ..  .++.
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~  262 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRLEIPR  262 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHHSCCCCCCCT
T ss_pred             cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCCCc
Confidence            5443334556799999999999999999999999999999999999999863211       11111111  11  1121


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..+       ..+.+++.+||+.||++|||+.++++.+.....
T Consensus       263 ~~~-------~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          263 NLN-------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             TSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             cCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            121       236789999999999999999999998765433

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=373.20  Aligned_cols=262  Identities=20%  Similarity=0.263  Sum_probs=213.6

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||+||+|.. .+|+.+|+|++........ ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH-HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            467899999999999999999964 5789999999987654332 24678999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+.+....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++   .++.+||+|||+++
T Consensus        88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999987654   6899999999999999999999   78999999999999998   46789999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      .............||+.|+|||.+.+..++.++||||+||++|+|++|+.||....       .......+.......+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~  234 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-------QHRLYQQIKAGAYDFPS  234 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCT
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCCCCCc
Confidence            77655554556789999999999999999999999999999999999999986321       11122222222221111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .. +......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       235 ~~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          235 PE-WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TT-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             cc-cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            00 01112336789999999999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-46  Score=355.23  Aligned_cols=267  Identities=22%  Similarity=0.308  Sum_probs=207.0

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||+|...+|+.||+|++....... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc-hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            46899999999999999999998889999999997653322 22367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ +|.+++....  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 7888776543  35899999999999999999999   789999999999999999999999999999877554


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC----------
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ----------  370 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  370 (436)
                      ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......    ........+..          
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHHHHHHCCCCTTTSGGGT
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHCCCChHHhhhhh
Confidence            444555678999999999876 568999999999999999999999996322110    00000000000          


Q ss_pred             --------CCCCCCChhH----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          371 --------RLPPPVDQKV----IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       371 --------~l~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                              ..........    ......+.+|+.+||+.||++|||+.|+++|+|++.-.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                    0000000000    001123678999999999999999999999999976544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9e-47  Score=368.59  Aligned_cols=264  Identities=22%  Similarity=0.367  Sum_probs=212.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++............+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999765 6889999999866544333345678899999887 89999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++|+|..++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999997643   6999999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCC--CCcccchhhhhcCCCCCCCC
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS--SDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .........+....+..+..
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            4444456678999999999999999999999999999999999999999643211110  11111222333333322211


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHHhhcC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR  416 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~ev~~~l~~~~  416 (436)
                           ....+.+|+.+||+.||.+||++      .|+++|+||..
T Consensus       285 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          285 -----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             -----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             -----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence                 11236789999999999999984      89999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.9e-47  Score=359.79  Aligned_cols=274  Identities=34%  Similarity=0.512  Sum_probs=219.9

Q ss_pred             cHHHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          134 FYEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       134 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      .+.++..++++|++.+.||+|+||+||+|...+++.||||++.......   .+.+.+|+++++.++||||+++++++..
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH---HHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH---HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3445556788999999999999999999998889999999987664332   3678899999999999999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                      .+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999976532 336999999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc--------cc
Q 013793          293 GTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP--------KI  362 (436)
Q Consensus       293 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--------~~  362 (436)
                      |+++.......  ......||+.|+|||.+.+..++.++||||||+++|||+||+.||............        ..
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99986543222  223456899999999999999999999999999999999999998632211100000        00


Q ss_pred             chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .....+++.+.....   ......+.+++.+||+.||++|||+.|++++++...
T Consensus       264 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          264 QLEQIVDPNLADKIR---PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             CCCSSSSSSCTTCSC---HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cHHHhcChhhccccC---HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            011122222222222   234555788999999999999999999999997543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-46  Score=358.99  Aligned_cols=257  Identities=21%  Similarity=0.355  Sum_probs=207.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      .++|++.+.||+|+||.||+|... +|+.||||++.......  ..+.+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            467999999999999999999775 89999999997554332  2377899999999999999999999986543     


Q ss_pred             ----------------------------------------------------EEEEEEeeccCCChhhhhccCCCCCCCC
Q 013793          216 ----------------------------------------------------CMFLIYEYMERGSLFCILHNDDEAVELD  243 (436)
Q Consensus       216 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~  243 (436)
                                                                          ..++||||+++|+|.+++.........+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                3799999999999999999877666778


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC------------Cccccccc
Q 013793          244 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS------------NRTLLAGT  311 (436)
Q Consensus       244 ~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~gt  311 (436)
                      +..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......            ......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            8889999999999999999   78999999999999999999999999999987754421            22335699


Q ss_pred             cccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHH
Q 013793          312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTIS  391 (436)
Q Consensus       312 ~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~  391 (436)
                      +.|+|||.+.+..++.++||||||+++|||++|..|+....         ...........    ..........+.+++
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~~~----~~~~~~~~~~~~~li  306 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNLKF----PLLFTQKYPQEHMMV  306 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTTCC----CHHHHHHCHHHHHHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhccCC----CcccccCChhHHHHH
Confidence            99999999999999999999999999999999988754211         01111111111    122223334467899


Q ss_pred             hhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          392 FACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       392 ~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .+||+.||++|||+.|+++|+|+..
T Consensus       307 ~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HHHccCCCCcCCCHHHHhhchhhhc
Confidence            9999999999999999999999853

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=354.76  Aligned_cols=258  Identities=22%  Similarity=0.300  Sum_probs=202.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhh-----------------------HHHHHHHHHHHHHHh
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE-----------------------LAFIKSFRNEAQVLS  197 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~-----------------------~~~~~~~~~e~~~l~  197 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.......                       ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            36799999999999999999975 478999999997653211                       112356889999999


Q ss_pred             hccCCCceeeeeEEee--CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 013793          198 QVLHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  275 (436)
Q Consensus       198 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  275 (436)
                      +++||||+++++++.+  ....++||||+++++|.+++..    ..+++.+++.++.|++.||+|||   +.+|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence            9999999999999987  5689999999999999887643    36999999999999999999999   7899999999


Q ss_pred             CCceeecCCCCeEEeecccccccCCCCCCccccccccccccccccccCc---cCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          276 SNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       276 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                      |+|||++.++.+||+|||+++.............||+.|+|||.+.+..   .+.++||||||+++|||++|+.||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999999987755444445567999999999987764   4789999999999999999999986321


Q ss_pred             cccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          353 SLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .       ......+.......+....   ....+.+++.+||+.||++|||+.|+++|+|+++
T Consensus       245 ~-------~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          245 I-------MCLHSKIKSQALEFPDQPD---IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             H-------HHHHHHHHHCCCCCCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             H-------HHHHHHHhcccCCCCCccc---cCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            1       1111122222222111111   1123678999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-46  Score=358.19  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +++.||||++.......  ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999765 88999999997654332  126688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            99999999999997654   6899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CC--CCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DS--SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..  .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....      ..................
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~  231 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNPW  231 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT------TSHHHHHHHTTCTTSTTG
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHhcccccCCcc
Confidence            22  12334679999999999987765 7899999999999999999999963211      111112222222111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .   .....+.+++.+||+.||++|||+.|+++++|+....
T Consensus       232 ~---~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          232 K---KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             G---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             c---cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            1   1122356899999999999999999999999997653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.6e-47  Score=361.15  Aligned_cols=263  Identities=21%  Similarity=0.292  Sum_probs=191.1

Q ss_pred             ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          149 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      +.||+|+||+||+|... +++.||||++.....      ..+.+|+.++..+. ||||+++++++.+....++||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH------HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhhh------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            78999999999999764 789999999975432      56678999999996 99999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---CeEEeecccccccCCCCC
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAFVADFGTARRLHADSS  303 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~  303 (436)
                      |+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||+++.......
T Consensus        91 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           91 GELFERIKKKK---HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            99999998654   6999999999999999999999   78999999999999998765   799999999987655544


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+.......+ ...+...
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~  243 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-GEAWKNV  243 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-SHHHHTS
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-cccccCC
Confidence            455567899999999999999999999999999999999999999743221111111111222222222211 1112223


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHA  424 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~  424 (436)
                      ...+.+++.+||+.||++|||+.|+++|+|+....+....+
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~  284 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP  284 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSC
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCC
Confidence            34477899999999999999999999999998776554443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-46  Score=359.71  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=208.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||+||+|.. .+++.||||++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5789999999999999999975 688999999987543322222357889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+ +|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 688988887543   6999999999999999999999   779999999999999999999999999999876443


Q ss_pred             CCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--CCCCCCCh
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQ  378 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~  378 (436)
                      . ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+.....       .....+...  .++...+ 
T Consensus       162 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~~p~~~s-  232 (336)
T 3h4j_B          162 N-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------NLFKKVNSCVYVMPDFLS-  232 (336)
T ss_dssp             B-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------TCBCCCCSSCCCCCTTSC-
T ss_pred             c-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCCCCCcccCC-
Confidence            2 2344679999999999988776 78999999999999999999999732211       001111111  1111111 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                            ..+.+++.+||+.||.+|||+.|+++|+|+....+
T Consensus       233 ------~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          233 ------PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             ------HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             ------HHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence                  23668999999999999999999999999986544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.3e-46  Score=362.26  Aligned_cols=261  Identities=24%  Similarity=0.306  Sum_probs=211.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .+.|++.+.||+|+||+||+|... +|+.||+|.+........   ...+.+.+|+.++..++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999764 799999999976543210   0126788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----CeEEeecc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFG  293 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  293 (436)
                      ++||||+++|+|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997543   6999999999999999999999   78999999999999998877    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      +++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....       .......+......
T Consensus       165 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~  236 (361)
T 2yab_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITAVSYD  236 (361)
T ss_dssp             SCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCC
T ss_pred             CceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCC
Confidence            998765432 2345679999999999999999999999999999999999999986321       11112222222221


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+. ..+......+.+++.+||..||++|||+.|+++|+|+...
T Consensus       237 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          237 FDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             CCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CCc-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            110 1011122346789999999999999999999999999743

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-46  Score=360.25  Aligned_cols=264  Identities=23%  Similarity=0.367  Sum_probs=213.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357899999999999999999765 6899999999866544444457788999999988 89999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999997643   6899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCC--CCcccchhhhhcCCCCCCCC
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS--SDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..........||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  .........+.......+..
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            4444455678999999999999999999999999999999999999999643211110  01111122223332222111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHHhhcC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTM------QYVSQGFLITR  416 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~ev~~~l~~~~  416 (436)
                           ....+.+++.+||+.||.+||++      .|+++|+|+..
T Consensus       242 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          242 -----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             -----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             -----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence                 11236789999999999999995      89999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=349.46  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=209.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||+||+|.. .+++.||+|++......   ..+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            46788999999999999999976 47899999998665432   247899999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999998643  36899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCCCc--------------cccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          301 DSSNR--------------TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       301 ~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      .....              ....||+.|+|||.+.+..++.++||||||+++|||++|..|+.......  .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~--~~~~~~~~~  238 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT--MDFGLNVRG  238 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC--TTSSBCHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH--HHHhhhhhc
Confidence            32211              14569999999999999999999999999999999999999976322111  111112222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ..+...+...+.       .+.+++.+||+.||++|||+.++++.+...+
T Consensus       239 ~~~~~~~~~~~~-------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          239 FLDRYCPPNCPP-------SFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HHHHTCCTTCCT-------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCCCCCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            333333322222       2667899999999999999999999886544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4e-46  Score=361.29  Aligned_cols=261  Identities=23%  Similarity=0.329  Sum_probs=212.2

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            457899999999999999999965 478999999997654332 224678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.+   +.+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999987543   6899999999999999999999   7899999999999999865   459999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.......+.
T Consensus       180 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~  251 (362)
T 2bdw_A          180 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPS  251 (362)
T ss_dssp             CCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCT
T ss_pred             EecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCc
Confidence            76533 23345679999999999999899999999999999999999999986321       11112222222222111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .. +......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       252 ~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          252 PE-WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             TG-GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             cc-ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            10 11122346789999999999999999999999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=354.04  Aligned_cols=254  Identities=27%  Similarity=0.371  Sum_probs=211.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||++... +|+.||+|++...........+.+.+|..+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999764 7999999999765332222246778899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999998654   6899999999999999999999   88999999999999999999999999999987543


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..   
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~---  225 (318)
T 1fot_A          159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNAELRFPPF---  225 (318)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCC---
Confidence            2   234679999999999999999999999999999999999999986321       112223333333222111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                        ....+.+++.+||+.||++||     +++|+++|+|+..
T Consensus       226 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             --SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             --CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence              112367899999999999999     9999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.6e-47  Score=362.68  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=211.5

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      ...++|.+.+.||+|+||.||+|... +|+.||+|+++............+..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34678999999999999999999765 6899999999765322222235677899999887 899999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999997643   6899999999999999999999   78999999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ............||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~  240 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELFHSIRMDNPFYPRW  240 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCCCCCCcc
Confidence            5444444556789999999999999999999999999999999999999986321       111222222222211111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHHhhcC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQ-YVSQGFLITR  416 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-ev~~~l~~~~  416 (436)
                           ....+.+++.+||+.||++||++. |+++|+|+..
T Consensus       241 -----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          241 -----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             -----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             -----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence                 112367899999999999999998 9999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.5e-46  Score=351.55  Aligned_cols=263  Identities=25%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+...........+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35799999999999999999975 47899999998665444444567899999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997654   6899999999999999999999   78999999999999999999999999999987644


Q ss_pred             CCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....       .......+....+......
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~  236 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKHIQDSVPNVTTDV  236 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHHHSSCCCCHHHHS
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhhccCCCcchhc
Confidence            322 22345699999999999999999999999999999999999999963221       1111111222111100000


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRP-TMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RP-t~~ev~~~l~~~~~  417 (436)
                      .......+.+++.+||+.||.+|| +++++.+.+.....
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            001112367899999999999999 78888877765443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=355.66  Aligned_cols=262  Identities=24%  Similarity=0.316  Sum_probs=211.0

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+........   ...+.+.+|+.++..++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999764 789999999976432210   0136788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----CeEEeecc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFG  293 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  293 (436)
                      ++||||+++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999997543   6899999999999999999999   78999999999999999887    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      +++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....       .......+......
T Consensus       164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~  235 (326)
T 2y0a_A          164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNYE  235 (326)
T ss_dssp             TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHTCCC
T ss_pred             CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHHhcCCC
Confidence            998765332 2344579999999999999999999999999999999999999986321       11111111111111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .+ ..........+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       236 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          236 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             CC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            10 000111123467899999999999999999999999997654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-46  Score=359.88  Aligned_cols=258  Identities=21%  Similarity=0.318  Sum_probs=212.9

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.............+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999765 5889999999765432222346778899999988 8999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999997643   6899999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...........||+.|+|||.+.+..++.++|||||||++|||++|+.||...       ........+.......+.. 
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p~~-  243 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYPKS-  243 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT-
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhCCCCCCCC-
Confidence            44444455678999999999999999999999999999999999999998632       1122233333333322211 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                          ....+.+++.+||+.||++||     +++|+++|+|+..
T Consensus       244 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          244 ----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             ----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             ----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence                112367899999999999999     4699999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-46  Score=362.12  Aligned_cols=264  Identities=20%  Similarity=0.267  Sum_probs=211.2

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH--HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++........  ...+.+.+|+.++..++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999965 4789999999864322110  01367889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eEEeeccc
Q 013793          219 LIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGT  294 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~  294 (436)
                      +||||+++|+|.+.+.... ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775432 2235899999999999999999999   789999999999999987655   99999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ++.............||+.|+|||.+.+..++.++|||||||++|||++|+.||....        ......+.......
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~~  251 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYKM  251 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCCC
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCCC
Confidence            9877654444455679999999999999999999999999999999999999986311        11122222222211


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .. .........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       252 ~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          252 NP-RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             Cc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            10 0011122346789999999999999999999999999753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=352.07  Aligned_cols=254  Identities=22%  Similarity=0.253  Sum_probs=199.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||+||+|... +|+.||||++.......... .....|+..+.++ +||||++++++|.+.+..++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            367999999999999999999765 79999999987654333322 4445556555555 89999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+ +++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 678988887643  36999999999999999999999   7799999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... ......||++|+|||++.+ .++.++||||||+++|||++|..|+.....          ...+.....+...   
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~~---  273 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEF---  273 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHHH---
T ss_pred             cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCccc---
Confidence            332 2344569999999998876 789999999999999999999776542111          1111111111100   


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .......+.+++.+||+.||++|||+.|+++++|++++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p  311 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP  311 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence            11112347789999999999999999999999999764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=346.45  Aligned_cols=259  Identities=26%  Similarity=0.440  Sum_probs=189.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+...........+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999975 57999999999755433222346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999997643  36899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--CCCCCCCh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQ  378 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~  378 (436)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||......       .........  ..+...  
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~--  235 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-------NTLNKVVLADYEMPSFL--  235 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSCCCCCTTS--
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-------HHHHHHhhcccCCcccc--
Confidence            433334467899999999999989999999999999999999999998742211       011111111  111111  


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                           ...+.+++.+||+.||++|||+.++++|+|+.+...
T Consensus       236 -----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          236 -----SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             -----CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             -----CHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence                 123668999999999999999999999999977643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.3e-46  Score=348.61  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=204.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|... +++.||||++....... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            47899999999999999999764 78999999997654322 22367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++ ++.+.+....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99986 5555554322  26899999999999999999999   789999999999999999999999999999877655


Q ss_pred             CCCccccccccccccccccccCc-cCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCCccc--chhhhh
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSDPKI--MLIDVL  368 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~~~~--~~~~~~  368 (436)
                      ........||+.|+|||.+.+.. ++.++||||||+++|||+||..|+.......          .......  ......
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            44455567899999999988765 7999999999999999999988853211000          0000000  000000


Q ss_pred             cCCC----C--CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          369 DQRL----P--PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       369 ~~~l----~--~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +...    +  .............+.+++.+||+.||++|||+.|+++|+|+..-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            0000    0  00000000112236689999999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.9e-47  Score=374.58  Aligned_cols=266  Identities=25%  Similarity=0.326  Sum_probs=213.3

Q ss_pred             HHHHHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       135 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      +.++....++|++.++||+|+||+||+|... +++.||+|++.............+.+|..++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445556789999999999999999999765 578999999976433222222448899999999999999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      .+..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999998632  36999999999999999999999   7899999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          294 TARRLHADSSN-RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       294 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      +++........ .....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+       .......+
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-------~~~~~~~i  293 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKI  293 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-------hhHHHHhh
Confidence            99876544332 23467999999999987     5678999999999999999999999996321       11112222


Q ss_pred             hc----CCCCCCCChhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHhhcC
Q 013793          368 LD----QRLPPPVDQKVIQDILLASTISFACLQSNPKS--RPTMQYVSQGFLITR  416 (436)
Q Consensus       368 ~~----~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~ev~~~l~~~~  416 (436)
                      +.    ..++.....    ....+.+|+.+||..+|++  ||+++|+++|+|+..
T Consensus       294 ~~~~~~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          294 MNHKERFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HTHHHHCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             hhccccccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            21    122221100    1123668899999988888  999999999999964

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=357.60  Aligned_cols=259  Identities=26%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||+||+|... +++.||||++.....     .+.+.+|++++.+++||||+++++++...+..++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            3567999999999999999999765 688999999976532     2567889999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999997653   6899999999999999999999   789999999999999975   8899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC--C
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP--P  374 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~--~  374 (436)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....      ........+......  .
T Consensus       200 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~i~~~~~~~~~  272 (349)
T 2w4o_A          200 IVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER------GDQFMFRRILNCEYYFIS  272 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT------CHHHHHHHHHTTCCCCCT
T ss_pred             ccCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc------ccHHHHHHHHhCCCccCC
Confidence            654322 2334578999999999999999999999999999999999999986321      111112222222221  1


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      +...   .....+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       273 ~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          273 PWWD---EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             TTTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             chhh---hCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            1111   112236789999999999999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.9e-46  Score=354.10  Aligned_cols=257  Identities=26%  Similarity=0.348  Sum_probs=201.0

Q ss_pred             hhcccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchhh-HHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++|++.+.||+|+||.||++..    .+++.||+|++....... ......+.+|++++..++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999976    478999999998653221 1223567889999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999997543   6889999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||....       .......+.......+.
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~p~  242 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-------RKKTIDKILKCKLNLPP  242 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCT
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCC
Confidence            65444444455679999999999999999999999999999999999999986321       11122233332222111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      .     ....+.+++.+||+.||++||     ++.|+++|+|+..
T Consensus       243 ~-----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          243 Y-----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             T-----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             C-----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            1     112367899999999999999     8999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.8e-46  Score=372.72  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=203.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.............+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999965 57899999999765332333346778899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999997643   6899999999999999999999   5 799999999999999999999999999998655


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.......+..  
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--  371 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRT--  371 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCCCCcc--
Confidence            44444556789999999999999999999999999999999999999986321       111222222222221111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~  417 (436)
                         ....+.+++.+||+.||.+||     ++.|+++|+|+...
T Consensus       372 ---~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          372 ---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ---CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence               112367899999999999999     99999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-46  Score=351.16  Aligned_cols=267  Identities=25%  Similarity=0.338  Sum_probs=203.0

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|...+|+.||+|++........ ....+.+|+++++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc-cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            57889999999999999999888899999999976543221 12567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9986 8988887543  36899999999999999999999   7899999999999999999999999999998765443


Q ss_pred             CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CC---CCcccchhhhh
Q 013793          303 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SS---SDPKIMLIDVL  368 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~---~~~~~~~~~~~  368 (436)
                      .......||+.|+|||.+.+. .++.++||||||+++|||+||+.||.......          ..   ..+........
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            334455789999999998764 58999999999999999999999986422100          00   00000000000


Q ss_pred             cCCCCC----CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          369 DQRLPP----PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       369 ~~~l~~----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ++....    +...........+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            111100    000000011223668999999999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-45  Score=368.00  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=213.4

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999765 79999999997654332223467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999997543   6999999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      . ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+...       .......+.+.....+...  
T Consensus       170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~--  239 (476)
T 2y94_A          170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------VPTLFKKICDGIFYTPQYL--  239 (476)
T ss_dssp             C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------SHHHHHHHHTTCCCCCTTC--
T ss_pred             c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCCcCCCccC--
Confidence            2 3345679999999999988765 789999999999999999999996321       1112223333332222111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                         ...+.+++.+||+.||++|||+.|+++|+|+....+
T Consensus       240 ---s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          240 ---NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             ---CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             ---CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence               123678999999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-45  Score=356.87  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=207.2

Q ss_pred             hhcccccceeeecCceEEEEEEc--------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|.+.+.||+|+||+||+|..        .++..||||+++.....  ...+.+.+|++++..+ +||||++++++|.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            46789999999999999999964        24567999999866433  2347899999999999 8999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      ..+..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||   +.+|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence            99999999999999999999976532             235899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      |++.++.+||+|||+++.......  ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....    
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----  310 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  310 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC----
Confidence            999999999999999987654332  2233457889999999999999999999999999999999 999986321    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ... ....+...........   ....+.+++.+||+.||++|||+.|+++++..
T Consensus       311 ---~~~-~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          311 ---VEE-LFKLLKEGHRMDKPAN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             ---GGG-HHHHHHTTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHH-HHHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               111 1122222111111111   12236789999999999999999999998854

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.7e-46  Score=356.67  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=211.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||++... +|+.||+|++.............+.+|++++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367899999999999999999764 7999999999765433222346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999997643   6899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+..   
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~---  260 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVRFPSH---  260 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC---
Confidence            2   234579999999999999999999999999999999999999986321       112222333333222111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                        ....+.+++.+||+.||.+||+     ++|+++|+|+..
T Consensus       261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence              1123678999999999999998     999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-45  Score=351.40  Aligned_cols=262  Identities=25%  Similarity=0.342  Sum_probs=204.5

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----EE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----CM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  217 (436)
                      .++|++.+.||+|+||+||+|... ++.||||++......    ......|+.++.+++||||+++++++....    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            468999999999999999999875 789999999765432    245566889999999999999999998744    47


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCceeecCCCCe
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP----------SIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~ivH~dlk~~Nill~~~~~~  287 (436)
                      ++||||+++|+|.+++...    .+++..++.++.|++.||+|||   +.          +|+||||||+|||++.++.+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            9999999999999999764    4899999999999999999999   66          99999999999999999999


Q ss_pred             EEeecccccccCCCCCC--cccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCC--
Q 013793          288 FVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS--  358 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--  358 (436)
                      ||+|||+++........  .....||+.|+|||.+.+     ..++.++|||||||++|||+||+.||..........  
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999999876543322  333579999999999886     456778999999999999999999986432111000  


Q ss_pred             -------CcccchhhhhcCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          359 -------DPKIMLIDVLDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       359 -------~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                             ...............+....  ........+.+++.+||+.||++|||+.||++.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   00001111112222222111  1122344578999999999999999999999998654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.9e-45  Score=344.68  Aligned_cols=275  Identities=30%  Similarity=0.480  Sum_probs=220.4

Q ss_pred             cccHHHHHHHhhccccc------ceeeecCceEEEEEEcCCCCEEEEEEecCcch-hhHHHHHHHHHHHHHHhhccCCCc
Q 013793          132 RIFYEDLIEATEDFHIK------YCIGTGGYGSVYKAQLPNGKVFALKKLHTSET-EELAFIKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       132 ~~~~~~l~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni  204 (436)
                      .+++.++..++++|...      +.||+|+||+||+|.. +++.||||++..... ......+.+.+|+.++..++||||
T Consensus        14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            56789999999999877      8999999999999987 688999999875421 112224778999999999999999


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      +++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~  169 (307)
T 2nru_A           93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEA  169 (307)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred             EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCC
Confidence            9999999999999999999999999999976554557999999999999999999999   7899999999999999999


Q ss_pred             CCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCC----
Q 013793          285 LEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS----  358 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~----  358 (436)
                      +.++|+|||+++........  .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||+.........    
T Consensus       170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (307)
T 2nru_A          170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE  248 (307)
T ss_dssp             CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred             CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence            99999999999876443222  233568999999998765 58899999999999999999999997432211000    


Q ss_pred             ---CcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          359 ---DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       359 ---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         .......+.++..+...    .......+.+++.+||+.||.+|||+.++++++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          249 EIEDEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHTTSCCHHHHSCSSCSCC----CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             Hhhhhhhhhhhhcccccccc----chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence               00011222233333221    223345577899999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=358.09  Aligned_cols=259  Identities=25%  Similarity=0.351  Sum_probs=209.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||++... +++.||+|++.............+.+|++++..++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999654 6899999999765433323346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999998654   6999999999999999999999   78999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccccccccc---CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      . .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....    .................+..
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~p~~  242 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIVHTFETTVVTYPSA  242 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHHHHHHHCCCCCCTT
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhhcccCCCCc
Confidence            3 33455679999999999874   4589999999999999999999999963211    11111111111222211111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhhcC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPT-MQYVSQGFLITR  416 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~ev~~~l~~~~  416 (436)
                        .   ...+.+++.+||+.||.+||+ ++++.+|+|+..
T Consensus       243 --~---s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          243 --W---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             --S---CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             --C---CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence              1   123678999999999999998 999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=356.62  Aligned_cols=258  Identities=23%  Similarity=0.301  Sum_probs=210.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|.+.......   ...+.+|++++..++||||+++++++.+....++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            467999999999999999999654 78999999997664332   25788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KLEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~  298 (436)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus       127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999997543  36899999999999999999999   789999999999999974  477999999999876


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC--CCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL--PPPV  376 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~  376 (436)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ......+.....  +...
T Consensus       202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~  273 (387)
T 1kob_A          202 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDA  273 (387)
T ss_dssp             CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSST
T ss_pred             CCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccc
Confidence            5432 23345799999999999999999999999999999999999999863221       111112221111  1111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..   .....+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       274 ~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          274 FS---SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             TT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             cc---cCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            11   1122367899999999999999999999999997653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=368.12  Aligned_cols=266  Identities=23%  Similarity=0.310  Sum_probs=211.5

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      ++.....++|++.+.||+|+||+||+++.. +|+.||||++.............+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344445789999999999999999999764 7999999999764333222235578999999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      +..++||||+++|+|.+++...+  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999997542  26899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccccccccccc-------cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          295 ARRLHADSSN-RTLLAGTYGYIAPELAY-------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       295 a~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      ++........ .....||+.|+|||++.       +..++.++|||||||++|||++|+.||...+       .......
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~  281 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-------TAETYGK  281 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-------HHHHHHH
Confidence            9876544332 23457999999999987       3578999999999999999999999996321       1111222


Q ss_pred             hhcC--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHHHhhcC
Q 013793          367 VLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSR---PTMQYVSQGFLITR  416 (436)
Q Consensus       367 ~~~~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Pt~~ev~~~l~~~~  416 (436)
                      +...  .+..+..  .......+.+++.+||. +|.+|   |+++|+++|+||..
T Consensus       282 i~~~~~~~~~p~~--~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          282 IVHYKEHLSLPLV--DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             HHTHHHHCCCC------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             HHhcccCcCCCcc--ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            2211  1111100  00112236789999999 99998   69999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-46  Score=368.06  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=211.4

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      .++....++|++.+.||+|+||+||+|... +++.||+|++.............+.+|..++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344445789999999999999999999765 6899999999754322211124577899999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      +..++||||+++|+|.+++...    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999999754    5899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCC-CccccccccccccccccccCc----cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          295 ARRLHADSS-NRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       295 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      ++....... ......||+.|+|||++.+..    ++.++|||||||++|||+||+.||...+       .......++.
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~  287 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMN  287 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHT
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-------hhhHHHHHHh
Confidence            987654332 233567999999999987665    8899999999999999999999996321       1112222222


Q ss_pred             ----CCCCCCCChhHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHhhcC
Q 013793          370 ----QRLPPPVDQKVIQDILLASTISFACLQSNPKS--RPTMQYVSQGFLITR  416 (436)
Q Consensus       370 ----~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~ev~~~l~~~~  416 (436)
                          ...+....     ....+.+|+.+||+.+|.+  ||+++||++|+|+..
T Consensus       288 ~~~~~~~p~~~~-----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          288 HKNSLTFPDDND-----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHCCCCTTCC-----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ccccccCCCccc-----ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence                11221111     1123668899999999998  999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.1e-45  Score=343.09  Aligned_cols=266  Identities=22%  Similarity=0.327  Sum_probs=213.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++.+++||||+++++++...+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999965 468999999997654332 2247788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~  297 (436)
                      |||+++++|.+.+....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999998887543   6899999999999999999999   789999999999999987655   99999999987


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....       .......+.......+..
T Consensus       158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~  229 (284)
T 3kk8_A          158 VNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPSP  229 (284)
T ss_dssp             CCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTT
T ss_pred             cccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-------hhHHHHHHHhccccCCch
Confidence            64332 2344679999999999999999999999999999999999999986321       111112222222111110


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccc
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKH  423 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~  423 (436)
                      . .......+.+++.+||+.||++|||+.|+++|+|+.........
T Consensus       230 ~-~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          230 E-WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             T-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             h-hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence            0 00112236789999999999999999999999999887664443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-45  Score=355.29  Aligned_cols=259  Identities=26%  Similarity=0.369  Sum_probs=209.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|+..+.||+|+||+||+|.. .+++.||||++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45688999999999999999975 68999999999765444444457889999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||++ |+|.+++....  ..+++.++..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 57888775432  36899999999999999999999   77999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      .    ....||+.|+|||.+.   ...++.++|||||||++|||+||+.||.....       ......+.....+....
T Consensus       207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~  275 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQS  275 (348)
T ss_dssp             B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCCC
T ss_pred             C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCC
Confidence            2    3357899999999884   56789999999999999999999999863211       11111222222111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ...   ...+.+++.+||+.||++|||+.++++++|+.+..+.
T Consensus       276 ~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          276 GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             CCC---CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            111   1236689999999999999999999999999877553

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-45  Score=343.64  Aligned_cols=257  Identities=31%  Similarity=0.474  Sum_probs=209.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +++.||+|++.............+.+|+++++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            568999999999999999999654 6789999999765444333346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999997643   6899999999999999999999   88999999999999999999999999999865432


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCCh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQ  378 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~  378 (436)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....       .......+....  .+.... 
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~-  231 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFTFPDFVT-  231 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCTTSC-
T ss_pred             c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-------HHHHHHHHHhCCCCCCCcCC-
Confidence            2  2344578999999999999999999999999999999999999986321       111111222211  222121 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                            ..+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       232 ------~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          232 ------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             ------HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             ------HHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence                  235689999999999999999999999999776443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.6e-45  Score=349.35  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=194.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|++.......  ....+.+|++++++++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            467899999999999999999764 68999999997554221  125678899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDD---EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      |||++ |+|.+++....   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99998 59998886432   2235899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc-----
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI-----  362 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~-----  362 (436)
                      ............||+.|+|||.+.+. .++.++|||||||++|||+||+.||.......         .......     
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            75444444556789999999998764 68999999999999999999999986322100         0000000     


Q ss_pred             ---------------chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          363 ---------------MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       363 ---------------~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                                     ...+.+.+......       ...+.+++.+||+.||++|||+.|+++|+|+..-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPL-------DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCC-------CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhcccccccccchhHHHhhcccccccC-------CHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                           00000000011111       12477899999999999999999999999997643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=345.33  Aligned_cols=271  Identities=25%  Similarity=0.305  Sum_probs=204.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....... ...+.+.+|++++.+++||||+++++++...+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            57899999999999999999765 68999999987654332 23467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999999887543   6899999999999999999999   789999999999999999999999999999877544


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcccc----hhhh
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPKIM----LIDV  367 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~~~----~~~~  367 (436)
                      ........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||........         ...+...    ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            444455678999999999876 5789999999999999999999999863221000         0000000    0000


Q ss_pred             -hcCCCCCCCCh-----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          368 -LDQRLPPPVDQ-----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       368 -~~~~l~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                       .....+.+...     ........+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence             00011110000     000112236789999999999999999999999999876443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=354.44  Aligned_cols=259  Identities=22%  Similarity=0.363  Sum_probs=203.8

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||++...+++.||||++....... ...+.+.+|++++..++|  |||+++++++...+..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            35689999999999999999998899999999997654332 234788999999999976  999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||| +.+|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 56889999998654   6899999999999999999999   78999999999999997 5789999999998765


Q ss_pred             CCCCC--cccccccccccccccccc-----------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          300 ADSSN--RTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       300 ~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      .....  .....||+.|+|||++.+           ..++.++|||||||++|||++|+.||....      ........
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~  232 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHA  232 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHH
Confidence            43322  234579999999999865           678999999999999999999999986311      11112223


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..+...........   ...+.+++.+||+.||.+|||+.|+++|+|+....
T Consensus       233 ~~~~~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          233 IIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             HHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HhcCCcccCCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            33322221111111   12366899999999999999999999999997654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.1e-45  Score=339.38  Aligned_cols=256  Identities=26%  Similarity=0.422  Sum_probs=209.3

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||.||+|...++..||+|++.......    +.+.+|++++.+++||||+++++++.+.+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            46789999999999999999999888899999998765432    56889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999997643  25899999999999999999999   789999999999999999999999999999876443


Q ss_pred             CCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCC-CCCCCCh
Q 013793          302 SSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR-LPPPVDQ  378 (436)
Q Consensus       302 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~  378 (436)
                      ... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+....       ........... ...+.. 
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-  229 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHRLYRPHL-  229 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCCCTT-
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHHHHcCCCCCCCCc-
Confidence            221 223446778999999999899999999999999999999 9999863221       11111111111 111111 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       .   ...+.+++.+||+.||++|||+.|+++++...++.
T Consensus       230 -~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          230 -A---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -S---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -C---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence             1   12367899999999999999999999999876653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=349.12  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||+||+|...    .+..||||++.......  ..+.+.+|++++..++||||+++++++.+.+..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            357888999999999999999764    34569999998654332  247889999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999997543  36899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .......   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....       .. ....+.....
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~-~~~~~~~~~~  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RD-VISSVEEGYR  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HH-HHHHHHTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HH-HHHHHHcCCC
Confidence            6543322   222346778999999999999999999999999999999 9999863211       11 1111111111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+....   ....+.+++.+||+.||++|||+.|+++.+.....
T Consensus       273 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          273 LPAPMG---CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCC---cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111111   12236789999999999999999999999875443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-45  Score=356.45  Aligned_cols=259  Identities=20%  Similarity=0.296  Sum_probs=199.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||++... +++.||||++.......    +.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            467999999999999999999765 78999999997654432    5678999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC--eEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~  298 (436)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++..
T Consensus        95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999999997543   6999999999999999999999   789999999999999987765  999999999754


Q ss_pred             CCCCCCccccccccccccccccccCccCcc-hhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ... .......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||......   .................+..
T Consensus       169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  244 (361)
T 3uc3_A          169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSVKYSIPDD  244 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTTCCCCCTT
T ss_pred             ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcCCCCCCCc
Confidence            322 22334569999999999988877655 89999999999999999999632211   00011122222222221111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..   ....+.+|+.+||+.||++|||+.|+++|+|+.+.
T Consensus       245 ~~---~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          245 IR---ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             SC---CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CC---CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            11   11236689999999999999999999999999665

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-45  Score=356.21  Aligned_cols=265  Identities=17%  Similarity=0.281  Sum_probs=208.8

Q ss_pred             hhcccccceeeec--CceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          142 TEDFHIKYCIGTG--GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      .++|++.+.||+|  +||+||+|... +|+.||||++....... ...+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            4679999999999  99999999765 79999999997654332 33577889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++..... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.+...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999976532 35899999999999999999999   789999999999999999999999999998654


Q ss_pred             CCCC-------CCcccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          299 HADS-------SNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       299 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      ....       .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||......       ......+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~  251 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKLN  251 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-------THHHHC--
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHhc
Confidence            2211       11223468999999999987  57999999999999999999999999632211       00000000


Q ss_pred             CCCC-----------------------------------C------CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 013793          370 QRLP-----------------------------------P------PVDQKVIQDILLASTISFACLQSNPKSRPTMQYV  408 (436)
Q Consensus       370 ~~l~-----------------------------------~------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev  408 (436)
                      ...+                                   .      +...........+.+|+.+||+.||++|||+.|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            0000                                   0      0000001112347789999999999999999999


Q ss_pred             HHHHhhcCCC
Q 013793          409 SQGFLITRKT  418 (436)
Q Consensus       409 ~~~l~~~~~~  418 (436)
                      ++|+|+....
T Consensus       332 l~hp~f~~~~  341 (389)
T 3gni_B          332 LNHSFFKQIK  341 (389)
T ss_dssp             TTSGGGGGC-
T ss_pred             hcCHHHHHHh
Confidence            9999998654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-45  Score=344.55  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=198.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhh--ccCCCceeeeeEEeeC----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRSIVKLYGFCLHK----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~  215 (436)
                      .++|++.+.||+|+||+||+|.. +++.||||++.....      ..+..|.+++..  ++||||+++++++...    .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            46899999999999999999987 689999999976532      445566666666  7999999999987653    4


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCCeEEe
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      ..++||||+++|+|.++++..    .+++..++.++.|++.||+|||...     +.+|+||||||+|||++.++.+||+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            689999999999999999643    6999999999999999999999422     5799999999999999999999999


Q ss_pred             ecccccccCCCCCC----ccccccccccccccccccC------ccCcchhhHHHHHHHHHHHhC----------CCCccc
Q 013793          291 DFGTARRLHADSSN----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMG----------KHPRDL  350 (436)
Q Consensus       291 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg----------~~p~~~  350 (436)
                      |||+++........    .....||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999866443322    2234799999999998876      566899999999999999999          666642


Q ss_pred             cccccCCCCcccchhhhh-cCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          351 LSSLSSSSDPKIMLIDVL-DQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....   ........... .....+....  ........+.+++.+||+.||++|||+.||++.+..
T Consensus       236 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPN---DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCS---SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCC---CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            1110   00001111111 1111111111  122344557899999999999999999999998864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.3e-45  Score=343.37  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=214.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||.||++... +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467889999999999999999765 6889999998765433333457888999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999887543   6899999999999999999999   78999999999999999999999999999987755


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ..............+..   
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~---  237 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEYSIPKH---  237 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCTT---
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhccCCCccc---
Confidence            44444556799999999999998999999999999999999999999863211       11111222222111111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                        ....+.+++.+||+.||++|||+.|+++++|+....
T Consensus       238 --~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          238 --INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             --cCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence              112366889999999999999999999999998664

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-45  Score=341.28  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=208.1

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||+|...+++.||+|++.......    +.+.+|++++.+++||||+++++++.+.+..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            36788999999999999999998889999999998765432    56889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            9999999999997643  36899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....       .......+... ........
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~~  231 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTG-FRLYKPRL  231 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTT-CCCCCCTT
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHhcC-ccCCCCCc
Confidence            21 1233456788999999999999999999999999999999 999986321       11111122111 11111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .   ...+.+++.+||+.||++|||+.|+++++....
T Consensus       232 ~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          232 A---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            1   123678999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-45  Score=357.65  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=203.0

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHH-HhhccCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.............+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999765 688999999976654333334566677776 577899999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999997643   6889999999999999999999   7899999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..........||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......++...+..+... 
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~-  262 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNKPLQLKPNI-  262 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-------HHHHHHHHHHSCCCCCSSS-
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcccCCCCCC-
Confidence            44444556789999999999999999999999999999999999999986321       1122333333332211111 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHHHhhcC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTM----QYVSQGFLITR  416 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~----~ev~~~l~~~~  416 (436)
                          ...+.+++.+||+.||.+||++    .++.+|+|+..
T Consensus       263 ----~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          263 ----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             ----CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence                1236689999999999999987    68999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=346.70  Aligned_cols=267  Identities=20%  Similarity=0.286  Sum_probs=210.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC--EEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK--CMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  219 (436)
                      ++|.+.+.||+|+||+||+|... +++.||||++........  .+.+.+|++++++++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            57889999999999999999765 589999999976543222  366789999999999999999999998765  7899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCCeEEeecccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTA  295 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a  295 (436)
                      ||||+++|+|.+++........+++.+++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999987655455999999999999999999999   7899999999999999    78888999999999


Q ss_pred             cccCCCCCCccccccccccccccccc--------cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAY--------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      +....... .....||+.|+|||.+.        +..++.++|||||||++|||+||+.||........   .......+
T Consensus       164 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~  239 (319)
T 4euu_A          164 RELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKI  239 (319)
T ss_dssp             EECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---CHHHHHHH
T ss_pred             eecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHH
Confidence            87654332 34456999999999876        56789999999999999999999999963221100   00001111


Q ss_pred             hc---------------------CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          368 LD---------------------QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       368 ~~---------------------~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      +.                     ..++... .........+.+++.+||+.||++|||++|+++++.......
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~  311 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG  311 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTC-SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred             hcCCCcccchhhhcccCCccccCccCCccc-ccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence            11                     1111111 111233445778999999999999999999999998766544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-45  Score=355.54  Aligned_cols=258  Identities=22%  Similarity=0.314  Sum_probs=206.6

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|++.+.||+|+||.||++... +++.||||++.....       ...+|++++.++ +||||+++++++.+.+..+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4678999999999999999999764 789999999976543       234688888888 7999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----CCeEEeeccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGT  294 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~  294 (436)
                      +||||+++|+|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||+.++    +.+||+|||+
T Consensus        93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999997654   6899999999999999999999   7899999999999998543    3499999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ++.............||+.|+|||.+.+..++.++|||||||++|||++|+.||....    ..........+.......
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP----DDTPEEILARIGSGKFSL  242 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSCHHHHHHHHHHCCCCC
T ss_pred             cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCCHHHHHHHHccCCccc
Confidence            9877655444556679999999999988889999999999999999999999996311    011111122222222221


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      +.. .+......+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       243 ~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          243 SGG-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CST-TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             Ccc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            110 00111223678999999999999999999999999964

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-44  Score=337.42  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=211.2

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||.||+|... +++.||||++.......  ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            3568999999999999999999765 78999999997554322  23678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||.+....
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999999997543   6899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCC--CCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          300 ADS--SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       300 ~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...  .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||+....      .................
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~  230 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNP  230 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT------TSHHHHHHHTTCTTSTT
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHhhhcccccCc
Confidence            322  12334568999999999987765 7899999999999999999999963211      11111122211111111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ..   .....+.+++.+||+.||++|||+.|+++++|+.....
T Consensus       231 ~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          231 WK---KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             hh---hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            11   11223668999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=355.94  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=201.7

Q ss_pred             ccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeecc
Q 013793          147 IKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       147 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      ..+.||+|+||.||+|.. .+|+.||+|++.......   .+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            356899999999999965 579999999998765432   3678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--cCCCCeEEeecccccccCCCCC
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL--NSKLEAFVADFGTARRLHADSS  303 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~  303 (436)
                      +|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++...... 
T Consensus       170 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          170 GGELFDRIIDES--YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             TCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            999999886542  36899999999999999999999   7899999999999999  567889999999998765433 


Q ss_pred             CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHH
Q 013793          304 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQD  383 (436)
Q Consensus       304 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  383 (436)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....       .......+.......+.. .....
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~-~~~~~  315 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-------DAETLNNILACRWDLEDE-EFQDI  315 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCSCSG-GGTTS
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccCCCChh-hhccC
Confidence            2334569999999999999999999999999999999999999986321       111222333222211110 01111


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          384 ILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       384 ~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ...+.+++.+||+.||.+|||+.|+++|+|+...
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            2346789999999999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-45  Score=354.22  Aligned_cols=271  Identities=25%  Similarity=0.313  Sum_probs=209.9

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh--hHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      ++....++|++.+.||+|+||+||+|.. .+++.||+|++......  .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3456788999999999999999999965 57889999998754321  11224788999999999999999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDD-------------------------------------EAVELDWAKRVNIVKAMAH  256 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~  256 (436)
                      .+..++||||+++|+|.+++....                                     ....+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999985210                                     0112456778899999999


Q ss_pred             HHHHHHhcCCCCeEecCCCCCceeecCCC--CeEEeecccccccCCCCC----Ccccccccccccccccccc--CccCcc
Q 013793          257 ALAYLHHDCSPSIIHRDISSNNILLNSKL--EAFVADFGTARRLHADSS----NRTLLAGTYGYIAPELAYT--MVMTEK  328 (436)
Q Consensus       257 ~L~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~  328 (436)
                      ||+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999   77999999999999998776  899999999986543221    2344569999999999875  678999


Q ss_pred             hhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 013793          329 CDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYV  408 (436)
Q Consensus       329 ~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev  408 (436)
                      +||||||+++|||++|+.||....       ...............+... .......+.+++.+||+.||.+|||+.|+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVN-------DADTISQVLNKKLCFENPN-YNVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCTTSGG-GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcccccCCcc-cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            999999999999999999986322       1122233333333221111 11112346789999999999999999999


Q ss_pred             HHHHhhcCCC
Q 013793          409 SQGFLITRKT  418 (436)
Q Consensus       409 ~~~l~~~~~~  418 (436)
                      ++|+|+..-.
T Consensus       329 l~hp~~~~~~  338 (345)
T 3hko_A          329 LQHPWISQFS  338 (345)
T ss_dssp             HHSHHHHTTS
T ss_pred             hcChhhccCh
Confidence            9999997653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.5e-45  Score=342.12  Aligned_cols=264  Identities=28%  Similarity=0.436  Sum_probs=215.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +++.||+|++.............+.+|++++..++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999765 6789999998765433222236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999997643   6899999999999999999999   88999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCCh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQ  378 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~  378 (436)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....       ......+....  ++...+ 
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~-  236 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHRRIVNVDLKFPPFLS-  236 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCTTSC-
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHHHHhccccCCCCcCC-
Confidence            2  23345689999999999999999999999999999999999999863211       11112222222  222221 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccccc
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQ  427 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~~  427 (436)
                            ..+.+++.+||+.||.+|||+.|+++|+|+.........+..+
T Consensus       237 ------~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~~  279 (284)
T 2vgo_A          237 ------DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ  279 (284)
T ss_dssp             ------HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC-
T ss_pred             ------HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCccc
Confidence                  2366899999999999999999999999998776555544443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-44  Score=351.45  Aligned_cols=267  Identities=25%  Similarity=0.369  Sum_probs=213.4

Q ss_pred             HHHHHHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcc-----hhhHHHHHHHHHHHHHHhhc-cCCCceee
Q 013793          135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-----TEELAFIKSFRNEAQVLSQV-LHRSIVKL  207 (436)
Q Consensus       135 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~niv~l  207 (436)
                      +.......++|++.+.||+|+||.||+|... +|+.||||++....     .......+.+.+|+.++.++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556788999999999999999999775 79999999987543     12223346788999999999 79999999


Q ss_pred             eeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCe
Q 013793          208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       208 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  287 (436)
                      ++++......++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999997543   6899999999999999999999   7799999999999999999999


Q ss_pred             EEeecccccccCCCCCCcccccccccccccccccc------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc
Q 013793          288 FVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK  361 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~  361 (436)
                      +|+|||++..+.... ......||+.|+|||++.+      ..++.++|||||||++|||+||+.||....       ..
T Consensus       240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-------~~  311 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-------QI  311 (365)
T ss_dssp             EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HH
T ss_pred             EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-------HH
Confidence            999999998765433 2344679999999998863      358889999999999999999999986321       11


Q ss_pred             cchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          362 IMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       362 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .....+......... ..+......+.+++.+||+.||++|||+.|+++|+|+.+
T Consensus       312 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          312 LMLRMIMEGQYQFSS-PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHHTCCCCCH-HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHhCCCCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            111122222221111 001111233678999999999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.8e-45  Score=356.17  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=204.8

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc--CCCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+|++.+.||+|+||+||++...+++.||||++....... .....+.+|++++.+++  ||||+++++++...+..++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH-HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4599999999999999999998889999999997654322 23478899999999996  59999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      || +.+++|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 57889999998654   6899999999999999999999   88999999999999996 57899999999987654


Q ss_pred             CCC--Ccccccccccccccccccc-----------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          301 DSS--NRTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       301 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      ...  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||....      ........+
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~  280 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAI  280 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHH
Confidence            332  1234579999999999865           368899999999999999999999986321      111122333


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ++...........   ...+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       281 ~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          281 IDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             hCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            3333221111111   12366899999999999999999999999997653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.3e-45  Score=359.31  Aligned_cols=263  Identities=24%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             HHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh-----hHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      ...++|.+.+.||+|+||+||+|.. .+++.||||++......     .......+.+|++++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4567899999999999999999965 57899999999764321     1112235789999999999999999999975 


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEe
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVA  290 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~  290 (436)
                      .+..++||||+++|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence            455899999999999999987654   6999999999999999999999   7799999999999999754   459999


Q ss_pred             ecccccccCCCCCCcccccccccccccccccc---CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      |||+++..... .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||....       ......+.
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-------TQVSLKDQ  356 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS-------SSCCHHHH
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc-------chHHHHHH
Confidence            99999876433 22345679999999999863   567889999999999999999999986321       11112222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +..................+.+++.+||+.||++|||+.|+++|+|++..
T Consensus       357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            22211111111111223347789999999999999999999999999643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-45  Score=356.11  Aligned_cols=264  Identities=23%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeee
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLY  208 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~  208 (436)
                      .++....++|++.+.||+|+||.||+|.+      .+++.||||++.......  ..+.+.+|++++.++ +||||++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH--HHHHHHHHHHHHHhhcCCcceeeee
Confidence            34445678899999999999999999962      356899999998654332  246789999999999 789999999


Q ss_pred             eEEeeCC-EEEEEEeeccCCChhhhhccCCC-------------------------------------------------
Q 013793          209 GFCLHKK-CMFLIYEYMERGSLFCILHNDDE-------------------------------------------------  238 (436)
Q Consensus       209 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------  238 (436)
                      +++.+.+ ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9998765 48999999999999999976532                                                 


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC-
Q 013793          239 --------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS-  303 (436)
Q Consensus       239 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  303 (436)
                                    ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                          112899999999999999999999   78999999999999999999999999999987644332 


Q ss_pred             -CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          304 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       304 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                       ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....       ........+...........  
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~--  320 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDEEFCRRLKEGTRMRAPDY--  320 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-------CSHHHHHHHHHTCCCCCCTT--
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc-------hhHHHHHHHHcCCCCCCCCC--
Confidence             2334568899999999999999999999999999999998 999986321       11111111111111111111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       ....+.+++.+||+.||++|||+.|+++++..
T Consensus       321 -~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          321 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             11236788999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.8e-45  Score=348.81  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=214.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||.||++... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467899999999999999999765 6889999998765433333457888999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999987543   6899999999999999999999   78999999999999999999999999999987754


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--CCCCCCh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--LPPPVDQ  378 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~  378 (436)
                      .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ......+....  ++...+ 
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~-  265 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEYSIPKHIN-  265 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCTTSC-
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhcCCCCCCccCC-
Confidence            44444556799999999999999999999999999999999999999863211       11111122222  222121 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                            ..+.+++.+||+.||++|||+.|+++++|+....
T Consensus       266 ------~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          266 ------PVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             ------HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ------HHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence                  2366789999999999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-44  Score=353.95  Aligned_cols=259  Identities=24%  Similarity=0.344  Sum_probs=197.4

Q ss_pred             hhccccc-ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee----C
Q 013793          142 TEDFHIK-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH----K  214 (436)
Q Consensus       142 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~  214 (436)
                      .++|.+. +.||+|+||+||++... +++.||||++...        ..+.+|++++.++ +||||+++++++..    .
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            3566665 68999999999999654 7899999999643        3456788877544 89999999999876    5


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEee
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVAD  291 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  291 (436)
                      ...++||||+++|+|.+++.... ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEe
Confidence            67899999999999999998653 236999999999999999999999   789999999999999998   78999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      ||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ......+....
T Consensus       208 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~i~~~~  283 (400)
T 1nxk_A          208 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ  283 (400)
T ss_dssp             CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---CSHHHHHHHTC
T ss_pred             cccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---HHHHHHHHcCc
Confidence            99998654322 234567899999999999999999999999999999999999999643221110   11112222222


Q ss_pred             C--CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          372 L--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       372 l--~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .  +.+...   .....+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       284 ~~~~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          284 YEFPNPEWS---EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             CCCCTTTTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             ccCCCcccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence            1  111111   11223678999999999999999999999999986544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=350.42  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=209.2

Q ss_pred             HHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH-----HHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL-----AFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      ...++|++.+.||+|+||+||+|.. .+++.||||++........     .....+.+|++++.+++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3467899999999999999999964 5789999999976532110     012456789999999999999999999999


Q ss_pred             CCEEEEEEeeccCC-ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          214 KKCMFLIYEYMERG-SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       214 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                      .+..++||||+.+| +|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 9999997654   6999999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      |+++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....             .....
T Consensus       175 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~~  240 (335)
T 3dls_A          175 GSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TVEAA  240 (335)
T ss_dssp             TTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GTTTC
T ss_pred             ccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HHhhc
Confidence            9998765433 2344679999999999988876 8899999999999999999999863221             11111


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ...+..     ....+.+++.+||+.||++|||+.|+++++|+....
T Consensus       241 ~~~~~~-----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          241 IHPPYL-----VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cCCCcc-----cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            111111     112367899999999999999999999999997653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.1e-45  Score=355.58  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=194.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||.||+|...    ++..||||.++......  ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            357899999999999999999764    57789999998654322  247899999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.++++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999997643  36899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .......   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ......+.....
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~~~  268 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEGYR  268 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTTEE
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            6543221   122235678999999999999999999999999999998 9999863211        111122222111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .+...   .....+.+++.+||+.||++||++.+|++.+...
T Consensus       269 ~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          269 LPPPM---DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             CCCCT---TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCc---cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            11111   1122367899999999999999999999987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-44  Score=349.99  Aligned_cols=265  Identities=25%  Similarity=0.321  Sum_probs=206.1

Q ss_pred             HHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-----CCCceeeeeEEe
Q 013793          139 IEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----HRSIVKLYGFCL  212 (436)
Q Consensus       139 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~  212 (436)
                      ....++|.+.+.||+|+||+||+|.. .+++.||||++......    ...+..|++++..+.     ||||+++++++.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH----HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh----hhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            33467899999999999999999976 57899999999754322    356778999999986     999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---------
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---------  283 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---------  283 (436)
                      ..+..++||||+ +++|.+++..... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.         
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccc
Confidence            999999999999 9999999986542 35899999999999999999999   789999999999999975         


Q ss_pred             ----------------CCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCC
Q 013793          284 ----------------KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  347 (436)
Q Consensus       284 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  347 (436)
                                      ++.+||+|||+++.....   .....||+.|+|||.+.+..++.++|||||||++|||+||+.|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence                            789999999999865432   2345789999999999999999999999999999999999999


Q ss_pred             cccccccc--------CCCCcccchh-------------hhhcCCCCCCCCh-hHH------------HHHHHHHHHHhh
Q 013793          348 RDLLSSLS--------SSSDPKIMLI-------------DVLDQRLPPPVDQ-KVI------------QDILLASTISFA  393 (436)
Q Consensus       348 ~~~~~~~~--------~~~~~~~~~~-------------~~~~~~l~~~~~~-~~~------------~~~~~~~~l~~~  393 (436)
                      |.......        ....+.....             .......+..... ...            .....+.+|+.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            96322100        0000000000             0000001110000 000            001346689999


Q ss_pred             ccCCCCCCCCCHHHHHHHHhhc
Q 013793          394 CLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       394 cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ||+.||++|||+.|+++|+|++
T Consensus       339 ~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-44  Score=345.92  Aligned_cols=262  Identities=23%  Similarity=0.308  Sum_probs=210.9

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+........   ...+.+.+|+.++.+++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3567999999999999999999764 789999999976432210   013678899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----CeEEeec
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADF  292 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df  292 (436)
                      .++||||+++++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++    .++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999997643   6899999999999999999999   78999999999999999887    7999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      |+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....       .......+.....
T Consensus       164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~  235 (321)
T 2a2a_A          164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITSVSY  235 (321)
T ss_dssp             TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCC
T ss_pred             ccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhccc
Confidence            9998765432 2344569999999999999999999999999999999999999986321       1111112221111


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..+ ..........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       236 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          236 DFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             ccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            110 00001112336789999999999999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.3e-45  Score=339.35  Aligned_cols=259  Identities=22%  Similarity=0.329  Sum_probs=210.3

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|.+.+.||+|+||+||+|... ++..+|+|++.......   .+.+.+|++++.+++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            3567999999999999999999765 57899999987654332   3678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~  296 (436)
                      ||||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||++   +.++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999887643   6899999999999999999999   7899999999999999   788999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||....       .......+.......+.
T Consensus       158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~  228 (277)
T 3f3z_A          158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-------DSEVMLKIREGTFTFPE  228 (277)
T ss_dssp             ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCH
T ss_pred             eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCc
Confidence            765433 23445799999999988654 8999999999999999999999986321       11122222222222111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       .........+.+++.+||+.||++|||+.|+++|+|++...
T Consensus       229 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          229 -KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             -HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             -hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence             10111223467899999999999999999999999997653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-44  Score=366.15  Aligned_cols=263  Identities=25%  Similarity=0.319  Sum_probs=214.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++.............+.+|++++..++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999764 79999999997654333223467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          222 EYMERGSLFCILHNDDE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      ||+++|+|.+++..... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999876432 346999999999999999999999   78999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....   ..........+.......+..   
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~~~~~p~~---  415 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQAVTYPDK---  415 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHCCCCCCTT---
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhcccCCCcc---
Confidence            54444556899999999999999999999999999999999999999963211   011111222333332222111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                        ....+.+++.+||+.||++||+     +.++++|+|+..
T Consensus       416 --~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          416 --FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             --cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence              1123668999999999999996     489999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-45  Score=350.31  Aligned_cols=262  Identities=22%  Similarity=0.354  Sum_probs=207.8

Q ss_pred             HhhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  213 (436)
                      ..++|++.+.||+|+||.||+|..      .++..||||.+......  ...+.+.+|+.++.++ +||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            457899999999999999999975      24668999999765322  2236789999999999 89999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEA--------------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD  273 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  273 (436)
                      .+..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||   +.+|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            99999999999999999999765421                    34899999999999999999999   78999999


Q ss_pred             CCCCceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccc
Q 013793          274 ISSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDL  350 (436)
Q Consensus       274 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~  350 (436)
                      |||+||+++.++.+||+|||++.........  .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999999876543322  233457889999999999999999999999999999998 9999863


Q ss_pred             cccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          351 LSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..       ........+...........   ....+.+++.+||+.||.+|||+.|++++++..-.
T Consensus       278 ~~-------~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          278 IP-------VDANFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CC-------CSHHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CC-------cHHHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            21       11122222222222111111   12236789999999999999999999999976544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.9e-46  Score=351.32  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----E
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----C  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  216 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.............+.+|++++.+++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999975 678999999998765554455678999999999999999999999987654    3


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||+++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            499999999999999997644   6899999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC---CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....       ..............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPI  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCC
Confidence            7644322   1233568999999999999999999999999999999999999986321       11111122222211


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ++. .........+.+++.+||+.||++||++.+++++.|+..
T Consensus       238 ~~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PPS-ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHH-HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Ccc-cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            100 000011223678999999999999999999999888754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.1e-44  Score=337.50  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=201.6

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKCMF  218 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  218 (436)
                      .|.+.+.||+|+||+||+|.. .++..||+|.+....... ...+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            477788999999999999965 578899999997654332 234788999999999999999999999875    45689


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeec-CCCCeEEeecccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLN-SKLEAFVADFGTA  295 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a  295 (436)
                      +||||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+  |+||||||+||+++ .++.+||+|||++
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999997643   6899999999999999999999   667  99999999999998 7899999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .....  .......||+.|+|||.+. ..++.++||||||+++|+|++|+.||.....      .............+..
T Consensus       180 ~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          180 TLKRA--SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPAS  250 (290)
T ss_dssp             GGCCT--TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGG
T ss_pred             ccccc--cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCCccc
Confidence            75432  2234456999999999876 4589999999999999999999999863211      1111111111111111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ...   .....+.+++.+||+.||++|||+.|+++|+|++..
T Consensus       251 ~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          251 FDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GGG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             cCC---CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            111   111236789999999999999999999999999764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.8e-45  Score=356.56  Aligned_cols=256  Identities=24%  Similarity=0.383  Sum_probs=205.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||.||+|... +++.||||.++.....  .....+.+|++++++++||||+++++++...+..++|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            467889999999999999999875 7899999999765332  2236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999997542  35899999999999999999999   78999999999999999999999999999986433


Q ss_pred             CCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ....  .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....        ....+.+......+..
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  337 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPCP  337 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCCC
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            2111  112235678999999998999999999999999999998 9999863221        1111222221111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ..   ....+.+++.+||+.||++|||+.++++.+...
T Consensus       338 ~~---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          338 EL---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11   112366899999999999999999999988654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-44  Score=339.11  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=204.1

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||++...++..||+|++.......    +.+.+|++++.+++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            46789999999999999999999888899999998765442    56889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999997632  36899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....       ...... +...........
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~~  245 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEH-IAQGLRLYRPHL  245 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHH-HHTTCCCCCCTT
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHH-HhcccCCCCCCc
Confidence            11 1223446788999999998899999999999999999998 9999863221       111111 111111111110


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .   ...+.+++.+||+.||++|||+.|++++++.
T Consensus       246 ~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          246 A---SEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1   1236689999999999999999999999865

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=338.66  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             ccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEee
Q 013793          145 FHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEY  223 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  223 (436)
                      |.....||+|+||.||+|.. .+++.||||.+......   ..+.+.+|+.++..++||||+++++++...+..++||||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            44456899999999999975 57889999999765432   236788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeecccccccCCCC
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARRLHADS  302 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~  302 (436)
                      +++++|.+++........+++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.++|+|||+++......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999999987655556788999999999999999999   789999999999999987 8999999999998765443


Q ss_pred             CCccccccccccccccccccCc--cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh----hcCCCCCCC
Q 013793          303 SNRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV----LDQRLPPPV  376 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~l~~~~  376 (436)
                      .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||......      .......    ....++...
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~  251 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMFKVHPEIPESM  251 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHHCCCCCCCTTS
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhccccccccccccC
Confidence            3344567899999999987653  789999999999999999999998632110      0001111    111222222


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      +       ..+.+++.+||+.||++|||+.|+++++|+.....
T Consensus       252 ~-------~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          252 S-------AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             C-------HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             C-------HHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            1       23668899999999999999999999999976654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-44  Score=367.18  Aligned_cols=260  Identities=23%  Similarity=0.286  Sum_probs=212.1

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.............+.+|++++..++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999764 7999999999765433222236688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999997654 235899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--CCCCCCCh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--RLPPPVDQ  378 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~  378 (436)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..........+...  .++...  
T Consensus       339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~---~~~~~~i~~~i~~~~~~~p~~~--  412 (576)
T 2acx_A          339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK---KIKREEVERLVKEVPEEYSERF--  412 (576)
T ss_dssp             TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS---CCCHHHHHHHHHHCCCCCCTTS--
T ss_pred             Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc---chhHHHHHHHhhcccccCCccC--
Confidence            32 23445799999999999999999999999999999999999999973211   00011111111111  122112  


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                           ...+.+|+.+||+.||.+||     ++.|+++|+|+..
T Consensus       413 -----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          413 -----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             -----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             -----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence                 12367899999999999999     8999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=350.97  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=207.6

Q ss_pred             hhcccccceeeecCceEEEEEEc--------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|.+.+.||+|+||+||+|..        ..+..||||++.......  ....+.+|++++..+ +||||+++++++.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH--HHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            46789999999999999999974        234679999998764332  347889999999999 9999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      ..+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||   +.+|+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence            99999999999999999999976532             235999999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      |++.++.+||+|||+++.......  ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....    
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----  298 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----  298 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence            999999999999999987654322  2333457889999999999999999999999999999999 999986321    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         .. ...+.+...........   ....+.+++.+||+.||++|||+.|+++++...
T Consensus       299 ---~~-~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          299 ---VE-ELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             ---HH-HHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HH-HHHHHHHcCCCCCCCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               11 11122222111111111   112367899999999999999999999998644

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=353.34  Aligned_cols=261  Identities=25%  Similarity=0.339  Sum_probs=206.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++|++.+.||+|+||+||+|...      +++.||||++........  ...+.+|+.++++++||||+++++++....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH--HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh--HHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            467889999999999999999743      467899999976543322  367889999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---CeE
Q 013793          216 CMFLIYEYMERGSLFCILHNDD----EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAF  288 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k  288 (436)
                      ..++||||+++|+|.+++....    ....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999997643    2246899999999999999999999   78999999999999999554   599


Q ss_pred             EeecccccccCCCC--CCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchh
Q 013793          289 VADFGTARRLHADS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       289 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  365 (436)
                      |+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....       ......
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-------~~~~~~  297 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLE  297 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHH
Confidence            99999997653221  22234567899999999999999999999999999999998 999986321       111111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .+.... .......   ....+.+++.+||+.||++|||+.+|+++++.....
T Consensus       298 ~i~~~~-~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          298 FVTSGG-RMDPPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHTTC-CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHcCC-CCCCCcc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            111111 1111111   112367899999999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=347.46  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=209.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      ..++|++.+.||+|+||.||+|...      +++.||||.++......  ..+.+.+|++++.+++||||+++++++.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            4678999999999999999999764      35889999998654332  347899999999999999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDE---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD  273 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~d  273 (436)
                      +..++||||+++|+|.+++.....                     ...+++.+++.++.|++.||+|||   +.+|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            999999999999999999976421                     146999999999999999999999   78999999


Q ss_pred             CCCCceeecCCCCeEEeecccccccCCCC--CCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccc
Q 013793          274 ISSNNILLNSKLEAFVADFGTARRLHADS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDL  350 (436)
Q Consensus       274 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~  350 (436)
                      |||+||+++.++.+||+|||+++......  .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999998654322  12234567899999999999899999999999999999999 9999863


Q ss_pred             cccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          351 LSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..       .......+....... ....   ....+.+++.+||+.||++|||+.++++++.....
T Consensus       280 ~~-------~~~~~~~~~~~~~~~-~~~~---~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          280 MA-------HEEVIYYVRDGNILA-CPEN---CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             SC-------HHHHHHHHHTTCCCC-CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CC-------hHHHHHHHhCCCcCC-CCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            21       111122222222211 1111   11236789999999999999999999999976554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-44  Score=344.08  Aligned_cols=267  Identities=21%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             hccccc-ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          143 EDFHIK-YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       143 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      +.|.+. +.||+|+||+||+|.. .+++.||||++.......   ...+.+|++++.++ +||||+++++++.+.+..++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            567774 7899999999999975 478999999997654322   26788999999985 79999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999997643   6899999999999999999999   779999999999999998776   9999999997


Q ss_pred             ccCCCCC-------Ccccccccccccccccccc-----CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc----
Q 013793          297 RLHADSS-------NRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP----  360 (436)
Q Consensus       297 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~----  360 (436)
                      .......       ......||+.|+|||.+.+     ..++.++||||||+++|||++|+.||............    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6542211       1223458999999999875     56889999999999999999999999743211100000    


Q ss_pred             ----ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          361 ----KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       361 ----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                          ......+.......+. .........+.+++.+||+.||++|||+.|+++|+|+....+
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             hhHHHHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence                0011122222221111 001112234778999999999999999999999999986544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-44  Score=336.13  Aligned_cols=259  Identities=22%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+.............+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357899999999999999999765 7999999999765433222346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999997643   6899999999999999999999   77999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||+...       .......+.......+..  
T Consensus       164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~--  233 (276)
T 2h6d_A          164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLFKKIRGGVFYIPEY--  233 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT--
T ss_pred             Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhcCcccCchh--
Confidence            32 2234568999999999987765 689999999999999999999986321       111111222221111111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                         ....+.+++.+||+.||++|||+.|+++|+|++...+
T Consensus       234 ---~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          234 ---LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             ---cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence               0123668999999999999999999999999977643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-44  Score=335.48  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=191.8

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhh-HHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... ++.||||++....... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999874 8899999987653322 22246788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--------CCCeEEeec
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--------KLEAFVADF  292 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Df  292 (436)
                      |||+++++|.+++...    .+++..++.++.|++.||+|||+....+|+||||||+||+++.        ++.++|+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999999643    6899999999999999999999432123999999999999986        678999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      |+++......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ............
T Consensus       161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~  231 (271)
T 3dtc_A          161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVAMNKL  231 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHTSCC
T ss_pred             Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhhcCCC
Confidence            9998654332  2345689999999999999999999999999999999999999863221       111122222222


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ..+.....   ...+.+++.+||+.||++|||+.|+++++.
T Consensus       232 ~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          232 ALPIPSTC---PEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCccc---CHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence            21111111   123678999999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.6e-45  Score=348.40  Aligned_cols=269  Identities=21%  Similarity=0.285  Sum_probs=198.3

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||+||+|.. .+++.||||++....... .....+.+|++++++++||||+++++++.+.+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            457899999999999999999964 578999999997654332 223667899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-----CCCCeEEeeccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-----SKLEAFVADFGT  294 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfg~  294 (436)
                      ||||+++ +|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999985 9999997654   6899999999999999999999   78999999999999994     455699999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCC---c
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSD---P  360 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~---~  360 (436)
                      ++.............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......          ....   +
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            98775444444556789999999998875 48999999999999999999999986322100          0000   0


Q ss_pred             ccchhhhhcCCCCCCCChhHHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          361 KIMLIDVLDQRLPPPVDQKVIQ-----DILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       361 ~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ............+.........     ....+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            0000000000000000000000     12346789999999999999999999999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-44  Score=339.40  Aligned_cols=258  Identities=30%  Similarity=0.451  Sum_probs=211.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|++.......  ..+.+.+|+.++..++||||+++++++......++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            45688999999999999999965 578999999997654322  237788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        99 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           99 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            9999999999999643    6899999999999999999999   78999999999999999999999999999987655


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........|++.|+|||.+.+..++.++||||||+++|||++|+.||.....       ......+..... .......
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  243 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP-PTLEGNY  243 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC-CCCCSSC
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCCC-CCCcccc
Confidence            44444556799999999999999999999999999999999999999863211       111111111111 1111101


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                         ...+.+++.+||+.||++|||+.|+++++|+.+...
T Consensus       244 ---~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          244 ---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             ---CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             ---CHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence               123678999999999999999999999999976543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.4e-44  Score=340.83  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=207.4

Q ss_pred             hhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++|.+.+.||+|+||.||+|..      .+++.||||++......  ...+.+.+|+++++.++||||+++++++...+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            56789999999999999999964      34588999999865432  23478899999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 013793          216 CMFLIYEYMERGSLFCILHNDDE---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  274 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl  274 (436)
                      ..++||||+++|+|.+++.....                     ...+++.+++.++.|++.||+|||   +.+|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence            99999999999999999986532                     134899999999999999999999   789999999


Q ss_pred             CCCceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccc
Q 013793          275 SSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLL  351 (436)
Q Consensus       275 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~  351 (436)
                      ||+||+++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876443322  233457789999999999999999999999999999999 99998632


Q ss_pred             ccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          352 SSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .       .. .....+...........   ....+.+++.+||+.||++|||+.|+++++..
T Consensus       257 ~-------~~-~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          257 P-------PE-RLFNLLKTGHRMERPDN---CSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             C-------GG-GHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-------HH-HHHHHhhcCCcCCCCcc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1       11 12222222211111111   12236789999999999999999999998854

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-44  Score=337.59  Aligned_cols=253  Identities=19%  Similarity=0.311  Sum_probs=203.0

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|++.+.||+|+||+||+|... +++.||+|++......... ...+.+|+..+..+ +||||+++++++.+.+..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            4578999999999999999999765 7999999999865433222 36788899999999 9999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--------------
Q 013793          219 LIYEYMERGSLFCILHNDDE-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--------------  283 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~--------------  283 (436)
                      +||||+++|+|.+++..... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.              
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999975421 136899999999999999999999   789999999999999984              


Q ss_pred             -----CCCeEEeecccccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCC
Q 013793          284 -----KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS  357 (436)
Q Consensus       284 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~  357 (436)
                           ...++|+|||.+.......    ...||+.|+|||.+.+. .++.++||||||+++|||++|+.|+....     
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence                 4479999999998764332    24589999999998776 66789999999999999999998754211     


Q ss_pred             CCcccchhhhhcCCC---CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          358 SDPKIMLIDVLDQRL---PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l---~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                           ....+.....   +...+       ..+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       236 -----~~~~~~~~~~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          236 -----QWHEIRQGRLPRIPQVLS-------QEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             -----HHHHHHTTCCCCCSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             -----HHHHHHcCCCCCCCcccC-------HHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence                 1112222222   22121       2367899999999999999999999999997653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-44  Score=337.06  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=206.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||+||++... +++.||+|.+........   ...+.+.+|+.++.+++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999765 789999999876432211   0136788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----CeEEeecc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFG  293 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  293 (436)
                      ++||||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++    .++|+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999997543   6899999999999999999999   78999999999999998877    79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....       ......+......
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~  229 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNYD  229 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCC
T ss_pred             cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhcccC
Confidence            998764332 23345689999999999999999999999999999999999999863211       1111111111111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+ ..........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       230 ~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          230 FD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             CC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             Cc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            10 00011112346789999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=350.29  Aligned_cols=268  Identities=19%  Similarity=0.231  Sum_probs=198.0

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|.+.+.||+|+||+||+|... +++.||+|++........  ...+.+|+++++.++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            57899999999999999999765 789999999976543211  124557999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++ |+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             ECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9998 48888887653  25899999999999999999999   789999999999999999999999999999876544


Q ss_pred             CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccc-----hhh
Q 013793          302 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM-----LID  366 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~-----~~~  366 (436)
                      ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......         .......+     ...
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            444455678999999999876 568999999999999999999999996422100         00000000     000


Q ss_pred             hhcCCCCCCCCh----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          367 VLDQRLPPPVDQ----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       367 ~~~~~l~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ......+.....    ........+.+|+.+||+.||++|||+.|+++|+|+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            000000000000    0001122367899999999999999999999999997653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=340.45  Aligned_cols=272  Identities=24%  Similarity=0.297  Sum_probs=199.4

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhh--HHHHHHHHHHHHHHhhc---cCCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE--LAFIKSFRNEAQVLSQV---LHRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~  214 (436)
                      ..++|++.+.||+|+||+||+|.. .+++.||||++.......  ......+.+|++++..+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            367899999999999999999975 578999999986432110  00013455677766666   499999999999875


Q ss_pred             C-----EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          215 K-----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       215 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                      .     ..++||||+. |+|.+++..... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            5     5899999997 599999986542 24999999999999999999999   789999999999999999999999


Q ss_pred             eecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc
Q 013793          290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP  360 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~  360 (436)
                      +|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......         .....
T Consensus       162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999998764332 3345678999999999999999999999999999999999999986322100         00000


Q ss_pred             cc------chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          361 KI------MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       361 ~~------~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ..      ..........+.+...........+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            00      00000000000000000001123367899999999999999999999999997653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-44  Score=374.73  Aligned_cols=258  Identities=21%  Similarity=0.319  Sum_probs=215.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|++.+.||+|+||.||+|... +++.||||++.............+..|.+++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3578999999999999999999754 6889999999764332222346678899999988 7999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999998654   6999999999999999999999   789999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ...........||+.|+|||++.+..++.++||||||+++|||++|+.||...       ........++......+.. 
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~-  564 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYPKS-  564 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHSSCCCCCTT-
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhCCCCCCcc-
Confidence            54444556678999999999999999999999999999999999999999632       2222334444444332221 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTM-----QYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~ev~~~l~~~~  416 (436)
                          ....+.+|+.+||+.||++||++     +||++|+||..
T Consensus       565 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          565 ----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             ----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             ----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence                12236789999999999999997     99999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-44  Score=339.04  Aligned_cols=259  Identities=25%  Similarity=0.344  Sum_probs=200.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|.+.+.||+|+||+||++.. .++..+|+|++........  .+.+.+|++++++++||||+++++++.+....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            46799999999999999999965 4789999999876543211  36788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeeccccc
Q 013793          221 YEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTAR  296 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~  296 (436)
                      |||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999999886431 1236899999999999999999999   7899999999999999   456789999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.....       ................
T Consensus       176 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          176 LFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEVQQKATYKEPNYAV  246 (285)
T ss_dssp             C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCC
T ss_pred             ecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHHHhhhccCCccccc
Confidence            664332 234456899999999875 5689999999999999999999999863211       0111111111111000


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ..  ......+.+++.+||+.||++|||+.|+++++|+++
T Consensus       247 ~~--~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          247 EC--RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cc--CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            00  001123668999999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.2e-45  Score=366.37  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=211.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +|+.||||++.............+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999765 8999999998654322112236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~  297 (436)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999987654   6899999999999999999999   7899999999999999   5678999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..... ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||....       .......+.......+..
T Consensus       179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~  249 (484)
T 3nyv_A          179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-------EYDILKKVEKGKYTFELP  249 (484)
T ss_dssp             BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCSG
T ss_pred             ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCCc
Confidence            65433 3344579999999999876 68999999999999999999999996321       111222222222222111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      . +......+.+++.+||+.||++|||+.|+++|+|++...
T Consensus       250 ~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          250 Q-WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             G-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             c-cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            1 112223467899999999999999999999999997653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.4e-44  Score=357.77  Aligned_cols=264  Identities=23%  Similarity=0.266  Sum_probs=199.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  214 (436)
                      .++|++.+.||+|+||+||+|.. .+++.||||++....... ...+.+.+|+.+++.++||||+++++++...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            46899999999999999999964 578999999997653322 2347788999999999999999999999654      


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++||||++++ |.+.+..     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            4679999999875 6555542     4889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc-----
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP-----  360 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~-----  360 (436)
                      ++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......         ....+     
T Consensus       211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9876433 23345679999999999999999999999999999999999999996422100         00000     


Q ss_pred             -ccchhhhhcC---------------CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          361 -KIMLIDVLDQ---------------RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       361 -~~~~~~~~~~---------------~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                       ..........               .+.+............+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence             0000001110               0011111111222445789999999999999999999999999974

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.3e-44  Score=340.77  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=208.0

Q ss_pred             hhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||+||+|..      .+++.||||.+.......  ..+.+.+|+.++.++ +||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH--HHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            46789999999999999999974      357889999998664432  237889999999999 999999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDE---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      +..++||||+++|+|.+++.....               ...+++.+++.++.|++.||+|||   +.+|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence            999999999999999999976532               125899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      +++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....    
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----  252 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP----  252 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc----
Confidence            9999999999999999876544332  223457789999999999999999999999999999999 999986321    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ........+...........   ....+.+++.+||+.||.+|||+.|+++++..
T Consensus       253 ---~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          253 ---VDSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             ---SSHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---chhHHHHHhccCCCCCCccc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence               11112222222211111111   11236789999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5e-45  Score=340.79  Aligned_cols=263  Identities=26%  Similarity=0.404  Sum_probs=207.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  218 (436)
                      .++|++.+.||+|+||.||++... +++.||+|.+....... ...+.+.+|++++++++||||+++++++..  ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            468999999999999999999764 78999999997654332 234788999999999999999999998854  56899


Q ss_pred             EEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceeecCCCCeEEeec
Q 013793          219 LIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPS-----IIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999997532 2235899999999999999999999   555     999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      |+++.............|++.|+|||.+.+..++.++||||||+++|||+||+.||....       .......+.....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~  233 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREGKF  233 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCC
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-------HHHHHHHHhhccc
Confidence            999876543332334568999999999999899999999999999999999999986321       1111112222221


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      +. ....   ....+.+++.+||+.||++|||+.|+++++|+.++.+
T Consensus       234 ~~-~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          234 RR-IPYR---YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             CC-CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             cc-CCcc---cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            11 1111   1123678999999999999999999999999977643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.7e-44  Score=353.88  Aligned_cols=268  Identities=24%  Similarity=0.280  Sum_probs=201.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+++++.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            46899999999999999999965 46889999999765332 22347889999999999999999999999876     5


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||++ |+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            7899999987 59999997643   6999999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC----------------------Ccccccccccccccccc-ccCccCcchhhHHHHHHHHHHHhCCCCccccc
Q 013793          296 RRLHADSS----------------------NRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLS  352 (436)
Q Consensus       296 ~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~  352 (436)
                      +.......                      ......||+.|+|||++ ....++.++||||+||++|||++|..|+....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            87644321                      12456799999999986 56679999999999999999999766654211


Q ss_pred             cccCCCCcc--------------------------------------------cchhhhhc---CCCCCCCChhHHHHHH
Q 013793          353 SLSSSSDPK--------------------------------------------IMLIDVLD---QRLPPPVDQKVIQDIL  385 (436)
Q Consensus       353 ~~~~~~~~~--------------------------------------------~~~~~~~~---~~l~~~~~~~~~~~~~  385 (436)
                      .......+.                                            ......+.   ...+............
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence            000000000                                            00000000   0000000000001123


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          386 LASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       386 ~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            46789999999999999999999999999764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.7e-45  Score=342.84  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=201.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  214 (436)
                      .++|++.+.||+|+||+||+|.+     .+++.||||++......   ..+.+.+|++++.+++||||+++++++...  
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46789999999999999999973     36889999999865433   246789999999999999999999998654  


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            45899999999999999997653  25899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCC---CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc-----ccCCCCccc---c
Q 013793          295 ARRLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-----LSSSSDPKI---M  363 (436)
Q Consensus       295 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-----~~~~~~~~~---~  363 (436)
                      ++.......   ......++..|+|||.+.+..++.++||||||+++|||+||..|+.....     .........   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987644322   12334577789999999999999999999999999999999999753211     000000000   1


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ..+.+......+....   ....+.+++.+||+.||++|||+.|+++.+...
T Consensus       241 ~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhccCcCCCCcC---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111111111111111   122367899999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.6e-44  Score=344.03  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=197.1

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCE----EEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++|++.+.||+|+||+||+|... +++.    ||+|.+......  ...+.+.+|+.++++++||||++++++|.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            357899999999999999999753 4443    588887654322  22367899999999999999999999998765 


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++|+||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCccee
Confidence            789999999999999997643  36899999999999999999999   7799999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+...        .......+.....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~~~~~~~~  237 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISSILEKGER  237 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGHHHHHHTTCC
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--------HHHHHHHHHcCCC
Confidence            76543332  233456889999999999999999999999999999999 999986321        1112222222221


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .+....   ....+.+++.+||+.||++|||+.|+++++...
T Consensus       238 ~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          238 LPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             CCCCTT---BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111   122367899999999999999999999988543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.4e-45  Score=353.51  Aligned_cols=264  Identities=11%  Similarity=0.036  Sum_probs=189.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc--cCCCceeee-------eEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRSIVKLY-------GFC  211 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~  211 (436)
                      ..+|.+.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34688899999999999999975 47899999999887654444457788886555555  699988755       444


Q ss_pred             eeC-----------------CEEEEEEeeccCCChhhhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 013793          212 LHK-----------------KCMFLIYEYMERGSLFCILHNDDEAVELDWAKR------VNIVKAMAHALAYLHHDCSPS  268 (436)
Q Consensus       212 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~  268 (436)
                      ...                 ...++||||++ |+|.+++.....  .+++..+      ..++.||+.||+|||   +.+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            332                 34799999999 899999986422  3455556      788899999999999   789


Q ss_pred             eEecCCCCCceeecCCCCeEEeecccccccCCCCCCcccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCC
Q 013793          269 IIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKH  346 (436)
Q Consensus       269 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~  346 (436)
                      |+||||||+|||++.++.+||+|||+++....   ......+|+.|+|||.+.+  ..++.++|||||||++|||+||+.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999986532   1224456799999999987  679999999999999999999999


Q ss_pred             CccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          347 PRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       347 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ||..........................+...   .....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT---PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSS---CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhcc---CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            99743221111100000011111111111100   112236789999999999999999999999998653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-44  Score=340.09  Aligned_cols=259  Identities=24%  Similarity=0.351  Sum_probs=208.9

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|.+.+.||+|+||+||++... +|+.||+|.+.......   ...+.+|++++..++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            3568999999999999999999764 79999999998654322   2568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~  296 (436)
                      ||||+++++|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+||++   ++++.++|+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999987543   6899999999999999999999   7899999999999999   788999999999997


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC--C
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP--P  374 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~--~  374 (436)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....       .......+......  .
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~  228 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-------ESKLFEKIKEGYYEFES  228 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHCCCCCCT
T ss_pred             ecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCc
Confidence            54322  2334568999999999999999999999999999999999999986321       11111122222111  1


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      +...   .....+.+++.+||+.||++|||+.|+++|+|+....+.
T Consensus       229 ~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          229 PFWD---DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             TTTT---TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             cccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence            1111   112236789999999999999999999999999876554

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=348.00  Aligned_cols=274  Identities=22%  Similarity=0.276  Sum_probs=202.3

Q ss_pred             HHHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH--HHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          139 IEATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       139 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      ....++|++.+.||+|+||.||+|... +|+.||||++........  .....+.+|++++..++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999875 689999999976433221  11246789999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+++ +|.+++....  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 8888886543  36889999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccc--
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIM--  363 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~--  363 (436)
                      +.............||+.|+|||.+.+. .++.++|||||||++|||++|..||.......         .......+  
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            8775554445556799999999998764 58999999999999999999999986322100         00000000  


Q ss_pred             ---hhhhhcCCCCCCCC--hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          364 ---LIDVLDQRLPPPVD--QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       364 ---~~~~~~~~l~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                         ..+.......+...  .........+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence               00000000000000  00011123477899999999999999999999999997653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=340.43  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=198.0

Q ss_pred             HHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc--cCCCceeeeeEEeeC---
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRSIVKLYGFCLHK---  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~---  214 (436)
                      ...++|++.+.||+|+||.||+|... ++.||||++.....      ..+..|.+++...  +||||+++++++...   
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            35678999999999999999999875 89999999865432      3344555555554  899999999999887   


Q ss_pred             -CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeEecCCCCCceeecCCC
Q 013793          215 -KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP--------SIIHRDISSNNILLNSKL  285 (436)
Q Consensus       215 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~--------~ivH~dlk~~Nill~~~~  285 (436)
                       ...++||||+++|+|.+++...    .+++..++.++.|++.||+|||   +.        +|+||||||+|||++.++
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence             7899999999999999999754    5899999999999999999999   66        999999999999999999


Q ss_pred             CeEEeecccccccCCCCCC----ccccccccccccccccccCccCcc------hhhHHHHHHHHHHHhCCCCcccccccc
Q 013793          286 EAFVADFGTARRLHADSSN----RTLLAGTYGYIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGKHPRDLLSSLS  355 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~il~elltg~~p~~~~~~~~  355 (436)
                      .+||+|||+++........    .....||+.|+|||.+.+...+.+      +|||||||++|||+||..|+.......
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            9999999999776443322    124579999999999987766554      999999999999999954442211100


Q ss_pred             C-------CCCcccchhhhh-cCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          356 S-------SSDPKIMLIDVL-DQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       356 ~-------~~~~~~~~~~~~-~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .       ............ .....+....  ........+.+++.+||+.||++|||+.||++++....
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            0       000001111111 1222222211  11234455789999999999999999999999986543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.1e-45  Score=347.73  Aligned_cols=269  Identities=24%  Similarity=0.331  Sum_probs=203.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            467999999999999999999765 68999999986654332 2346788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999998876543   6899999999999999999999   78999999999999999999999999999987655


Q ss_pred             CCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcc--------c
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPK--------I  362 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~--------~  362 (436)
                      .........||+.|+|||.+.+. .++.++||||||+++|||++|+.||........         ...+.        .
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            44444556789999999998875 789999999999999999999999863221000         00000        0


Q ss_pred             chhhhhcCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          363 MLIDVLDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .......+.+......  ........+.+++.+||+.||++|||+.|+++|+|++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            0000000000000000  000112347789999999999999999999999999654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=338.51  Aligned_cols=253  Identities=29%  Similarity=0.486  Sum_probs=195.8

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|... ++.||||.+.....     .+.+.+|++++++++||||+++++++.+  ..++|||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-----RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTH-----HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhH-----HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            57888999999999999999874 78899999975432     3678899999999999999999998874  4789999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC-eEEeecccccccCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-AFVADFGTARRLHAD  301 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~  301 (436)
                      |+++|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999987665556889999999999999999999533389999999999999998886 799999999765322


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                         .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+....      ..............++....  
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~--  228 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVHNGTRPPLIKN--  228 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHHTTCCCCCBTT--
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHhcCCCCCcccc--
Confidence               2334689999999999999999999999999999999999999863211      11001111111111111111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                       ....+.+++.+||+.||++|||+.++++.+...
T Consensus       229 -~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          229 -LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence             112366899999999999999999999987643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.1e-44  Score=331.61  Aligned_cols=254  Identities=19%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  219 (436)
                      .++|++.+.||+|+||+||+|... ++.||||++........ ..+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHH-HHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            357889999999999999999884 88999999987643322 246799999999999999999999999887  77899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCCeEEeecccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ||||+++|+|.+++.... ...+++.+++.++.|++.||+|||   +.+  |+||||||+||+++.++.++|+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999999999999998653 235899999999999999999999   677  99999999999999999999999988754


Q ss_pred             cCCCCCCccccccccccccccccccCccCc---chhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTE---KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ...     ....||+.|+|||.+.+...+.   ++||||||+++|||+||+.||.....       .............+
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~  230 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRP  230 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCCCC
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCCCC
Confidence            322     2346899999999998765544   89999999999999999999863211       11112222222221


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ......   ...+.+++.+||+.||++|||+.|+++.+....
T Consensus       231 ~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 TIPPGI---SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111111   123678999999999999999999999986543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-44  Score=358.14  Aligned_cols=268  Identities=24%  Similarity=0.287  Sum_probs=188.9

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      .++|++.+.||+|+||+||+|... +++.||||++....... ...+.+.+|++++..++||||+++++++...     .
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL-IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH-HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            468999999999999999999654 78999999997643322 2347889999999999999999999999543     5


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+. |+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccc
Confidence            6899999985 68999887543   6999999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC---------------------------Ccccccccccccccccc-ccCccCcchhhHHHHHHHHHHHhC---
Q 013793          296 RRLHADSS---------------------------NRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMG---  344 (436)
Q Consensus       296 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg---  344 (436)
                      +.......                           ......||++|+|||++ .+..++.++|||||||++|||+||   
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            87643211                           12345689999999976 566799999999999999999994   


Q ss_pred             --------CCCccccccccCCCCcc-------------c---chhhhh-----------------------cCCCCCCCC
Q 013793          345 --------KHPRDLLSSLSSSSDPK-------------I---MLIDVL-----------------------DQRLPPPVD  377 (436)
Q Consensus       345 --------~~p~~~~~~~~~~~~~~-------------~---~~~~~~-----------------------~~~l~~~~~  377 (436)
                              +.+|.....+.......             .   .+.+.+                       .........
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                    44443211100000000             0   000000                       000000000


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .........+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            0001112346789999999999999999999999999765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-44  Score=353.31  Aligned_cols=267  Identities=25%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCC--E
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKK--C  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  216 (436)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++....... .....+.+|+.++..+. ||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            467899999999999999999965 579999999996543222 22367788999999997 999999999997544  6


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||++ |+|..++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 5899888753    5899999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCC---------------------CCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          297 RLHAD---------------------SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       297 ~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                      .....                     ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                     111234579999999999876 67899999999999999999999999632210


Q ss_pred             c---------CCCCcc-------cchh---hhhc------CCCCCCCChhHH----------HHHHHHHHHHhhccCCCC
Q 013793          355 S---------SSSDPK-------IMLI---DVLD------QRLPPPVDQKVI----------QDILLASTISFACLQSNP  399 (436)
Q Consensus       355 ~---------~~~~~~-------~~~~---~~~~------~~l~~~~~~~~~----------~~~~~~~~l~~~cl~~dP  399 (436)
                      .         ......       ....   +.+.      ..........+.          .....+.+|+.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            0         000000       0000   0000      000000000000          012246789999999999


Q ss_pred             CCCCCHHHHHHHHhhcC
Q 013793          400 KSRPTMQYVSQGFLITR  416 (436)
Q Consensus       400 ~~RPt~~ev~~~l~~~~  416 (436)
                      ++|||+.|+++|+|+..
T Consensus       318 ~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          318 NKRISANDALKHPFVSI  334 (388)
T ss_dssp             GGSCCHHHHTTSTTTTT
T ss_pred             ccCCCHHHHhCCHHHHH
Confidence            99999999999999854

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-44  Score=361.67  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=208.9

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||+||+|... +++.||||++........ ....+.+|++++++++||||+++++++.+....++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            3568999999999999999999764 789999999864322111 13678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+.+....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999887543   6899999999999999999999   78999999999999995   45679999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||....       .......+.........
T Consensus       173 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~  243 (486)
T 3mwu_A          173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFDL  243 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCSCS
T ss_pred             ECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCC
Confidence            764432 2344579999999999875 58999999999999999999999986321       11122222222222111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .. +......+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       244 ~~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          244 PQ-WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             GG-GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             cc-cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            11 1112234678999999999999999999999999987544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-44  Score=343.99  Aligned_cols=270  Identities=20%  Similarity=0.298  Sum_probs=211.2

Q ss_pred             cccHHHHHHHhhccccc-ceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeee
Q 013793          132 RIFYEDLIEATEDFHIK-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLY  208 (436)
Q Consensus       132 ~~~~~~l~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~  208 (436)
                      .+.++......+.|.+. +.||+|+||+||+|... +++.||+|++........ ....+.+|+.++..+ +||||++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEE
Confidence            34455556667788887 89999999999999665 799999999976543221 136788999999999 569999999


Q ss_pred             eEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CC
Q 013793          209 GFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KL  285 (436)
Q Consensus       209 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~  285 (436)
                      +++...+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999986542 236899999999999999999999   789999999999999998   78


Q ss_pred             CeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchh
Q 013793          286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  365 (436)
                      .+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       .....
T Consensus       172 ~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~  243 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-------QETYL  243 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             cEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHH
Confidence            99999999998764332 23345799999999999999999999999999999999999999863211       11111


Q ss_pred             hhhcCC--CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          366 DVLDQR--LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       366 ~~~~~~--l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+....  .+.....   .....+.+++.+||+.||++|||+.|+++|+|++.-
T Consensus       244 ~i~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          244 NISQVNVDYSEETFS---SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHTCCCCCTTTTT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHhcccccCchhhc---ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            111111  1111111   112236789999999999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.7e-44  Score=359.01  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=207.3

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..++|++.+.||+|+||.||+|...++..||||+++.....    .+.+.+|++++++++||||+++++++. .+..++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            45788999999999999999999988899999999875433    367899999999999999999999986 5678999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999997542 225889999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhc-CCCCCCCC
Q 013793          301 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPPVD  377 (436)
Q Consensus       301 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~  377 (436)
                      ... ......++..|+|||.+....++.++||||||+++|||+| |+.||....       .......+.. .+++.+..
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~~~~  409 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPEN  409 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHHTCCCCCCTT
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCCC
Confidence            211 1223346788999999998999999999999999999999 999986321       1111111111 12221111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                           ....+.+++.+||+.||++|||+.+|++.+.....
T Consensus       410 -----~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          410 -----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                 12236789999999999999999999999876544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-44  Score=362.34  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.+. ++..||||.++.....    .+.+.+|++++++++||||++++++|...+..++|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            567888999999999999999776 4889999999865433    36789999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++..... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       295 ~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999999976432 36899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          301 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       301 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||....       . ....+.+..........
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~~  442 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------L-SQVYELLEKDYRMERPE  442 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-------G-GGHHHHHHTTCCCCCCT
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-------H-HHHHHHHHcCCCCCCCC
Confidence            322 1223346788999999999999999999999999999999 999986321       1 11222222222211111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .   ....+.+|+.+||+.||++|||+.++++.+...-
T Consensus       443 ~---~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          443 G---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             C---CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1   1223678999999999999999999999987543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-44  Score=345.87  Aligned_cols=256  Identities=18%  Similarity=0.236  Sum_probs=203.7

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||+||+|.. .+++.||||++......     ..+.+|++++..+ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            36789999999999999999975 68899999998765432     4678899999999 99999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC-----eEEeeccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGT  294 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~  294 (436)
                      ||||+ +++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+
T Consensus        83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            99999 999999998642  36999999999999999999999   789999999999999998887     99999999


Q ss_pred             ccccCCCCCC-------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          295 ARRLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       295 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      ++........       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....    .........+
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~~~i  232 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKI  232 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHHHHH
Confidence            9876443221       2356799999999999999999999999999999999999999973210    0000111111


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .......+... .......+.+++..||+.||.+||++.++.+.+.
T Consensus       233 ~~~~~~~~~~~-~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          233 GDTKRATPIEV-LCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHSCHHH-HTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HhhhccCCHHH-HhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            11111111100 0000115778999999999999999999998774

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.8e-45  Score=356.67  Aligned_cols=251  Identities=16%  Similarity=0.146  Sum_probs=194.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHH---HHHhhccCCCceeee-------eE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA---QVLSQVLHRSIVKLY-------GF  210 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  210 (436)
                      .++|.+.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|+   +.++.++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788999999999999999986 57999999999754332222347888999   556666899999998       66


Q ss_pred             EeeCC-----------------EEEEEEeeccCCChhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 013793          211 CLHKK-----------------CMFLIYEYMERGSLFCILHNDDE----AVELDWAKRVNIVKAMAHALAYLHHDCSPSI  269 (436)
Q Consensus       211 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  269 (436)
                      +...+                 ..++||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55543                 278999999 6899999975321    123456888899999999999999   7899


Q ss_pred             EecCCCCCceeecCCCCeEEeecccccccCCCCCCccccccccccccccccccC-----------ccCcchhhHHHHHHH
Q 013793          270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVT  338 (436)
Q Consensus       270 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il  338 (436)
                      +||||||+|||++.++.+||+|||+++....   ......| +.|+|||++.+.           .++.++|||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            9999999999999999999999999986322   2344567 999999999887           899999999999999


Q ss_pred             HHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          339 LEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       339 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      |||+||+.||......       ........ .. ...+       ..+.+++.+||+.||++|||+.|+++++|+..
T Consensus       304 ~elltg~~Pf~~~~~~-------~~~~~~~~-~~-~~~~-------~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAAL-------GGSEWIFR-SC-KNIP-------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC-------------CCSGGGGS-SC-CCCC-------HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccc-------cchhhhhh-hc-cCCC-------HHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999998632211       11111111 11 1111       23668999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-43  Score=354.20  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=202.4

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-EEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-CMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... |+.||||.++....     .+.+.+|++++++++||||+++++++.... ..++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            467889999999999999999875 77999999987642     267899999999999999999999987765 78999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            99999999999998653 224789999999999999999999   78999999999999999999999999999985432


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .   .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       ...... +......+....
T Consensus       342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~-i~~~~~~~~p~~  410 (450)
T 1k9a_A          342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPR-VEKGYKMDAPDG  410 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-------TTHHHH-HHTTCCCCCCTT
T ss_pred             c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-HHcCCCCCCCCc
Confidence            2   122357889999999999999999999999999999998 9999863211       111111 111111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                         ....+.+++.+||+.||++|||+.++++.+....
T Consensus       411 ---~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          411 ---CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               1223678999999999999999999999886543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.6e-44  Score=340.98  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=185.7

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCC----CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ..++|++.+.||+|+||+||+|.....    ..||||++........ ..+.+.+|++++++++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH-HHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH-HHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            356899999999999999999976543    2799999976543322 24788999999999999999999999988765


Q ss_pred             E------EEEEeeccCCChhhhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCe
Q 013793          217 M------FLIYEYMERGSLFCILHNDD---EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       217 ~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  287 (436)
                      .      ++||||+++|+|.+++....   ....+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence            5      99999999999999986432   2235899999999999999999999   7899999999999999999999


Q ss_pred             EEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccch
Q 013793          288 FVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  364 (436)
                      ||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....       .....
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~~~~~  249 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAEIY  249 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-------hHHHH
Confidence            99999999876443221  223456789999999999999999999999999999999 999986321       11112


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .......... ....   ....+.+++.+||+.||++|||+.++++.+
T Consensus       250 ~~~~~~~~~~-~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  293 (323)
T 3qup_A          250 NYLIGGNRLK-QPPE---CMEEVYDLMYQCWSADPKQRPSFTCLRMEL  293 (323)
T ss_dssp             HHHHTTCCCC-CCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhcCCCCC-CCCc---cCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            2222221111 1111   112367899999999999999966655544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.9e-44  Score=361.31  Aligned_cols=263  Identities=27%  Similarity=0.346  Sum_probs=208.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH----------HHHHHHHHHHHHHhhccCCCceeeee
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL----------AFIKSFRNEAQVLSQVLHRSIVKLYG  209 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~  209 (436)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++........          ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999764 688999999976542211          12367889999999999999999999


Q ss_pred             EEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---C
Q 013793          210 FCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---E  286 (436)
Q Consensus       210 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~  286 (436)
                      ++.+....++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999887643   6999999999999999999999   78999999999999998775   6


Q ss_pred             eEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          287 AFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      +||+|||+++...... ......||+.|+|||.+. ..++.++||||+||++|+|++|+.||....       .......
T Consensus       188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~  258 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-------DQDIIKK  258 (504)
T ss_dssp             EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH
T ss_pred             EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH
Confidence            9999999998765432 334467999999999886 468999999999999999999999996321       1112222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      +.......+. ..+......+.+++.+||+.||.+|||+.|+++|+|++....
T Consensus       259 i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          259 VEKGKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHCCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             HHcCCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            2222222111 111112234778999999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.6e-44  Score=333.05  Aligned_cols=253  Identities=25%  Similarity=0.440  Sum_probs=206.7

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee------
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH------  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  213 (436)
                      ...+|++.+.||+|+||.||+|... +++.||+|.+....       ..+.+|++++.+++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            4567999999999999999999765 79999999997654       345689999999999999999998864      


Q ss_pred             ----------CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 013793          214 ----------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  283 (436)
Q Consensus       214 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~  283 (436)
                                ....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence                      445899999999999999997542 236899999999999999999999   789999999999999999


Q ss_pred             CCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccc
Q 013793          284 KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       284 ~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  363 (436)
                      ++.++|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.....         .
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------~  227 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---------F  227 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---------H
T ss_pred             CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---------H
Confidence            9999999999998765433 23345689999999999999999999999999999999999998752111         1


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                      ........++...+.       .+.+++.+||+.||++|||+.|++++++.....+..
T Consensus       228 ~~~~~~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          228 FTDLRDGIISDIFDK-------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHHHHTTCCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             HHHhhcccccccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            112222223222221       256789999999999999999999999988776544

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5e-44  Score=337.13  Aligned_cols=259  Identities=17%  Similarity=0.211  Sum_probs=205.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     ..+.+|++++..+ +|+|++++++++......++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            35789999999999999999974 68999999998755432     4677899999999 79999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC-----eEEeeccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGT  294 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~  294 (436)
                      ||||+ +++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+
T Consensus        84 v~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            99999 999999998653  25899999999999999999999   889999999999999987776     99999999


Q ss_pred             ccccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          295 ARRLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       295 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      ++.......       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....    .........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~~~  233 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERI  233 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc----cccHHHHHHH
Confidence            987654322       12445699999999999999999999999999999999999999974211    0111111111


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .......+...........+.+++.+||+.||++|||+.+|++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            111110100000001123467899999999999999999999988654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=340.10  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=203.2

Q ss_pred             HHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee--
Q 013793          138 LIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH--  213 (436)
Q Consensus       138 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--  213 (436)
                      +....++|++.+.||+|+||.||+|.. .+++.||||++.......    ..+.+|+.++.++ +||||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            334578899999999999999999976 578999999997654332    6788999999999 89999999999987  


Q ss_pred             ----CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEE
Q 013793          214 ----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       214 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  289 (436)
                          .+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence                467899999999999999997643 236899999999999999999999   789999999999999999999999


Q ss_pred             eecccccccCCCCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccch
Q 013793          290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~  364 (436)
                      +|||++..............|++.|+|||.+.     +..++.++||||||+++|||+||+.||.....       ....
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~  243 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRAL  243 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHH
Confidence            99999987654333344557899999999987     56789999999999999999999999863221       1111


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ........+.......   ...+.+++.+||+.||.+|||+.++++|+|+.....
T Consensus       244 ~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          244 FLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             HHHHHSCCCCCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             HHhhcCccccCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            1111111111111101   123678999999999999999999999999986643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.2e-44  Score=345.27  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-C-----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-N-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      ...++|.+.+.||+|+||+||+|... +     ...||+|.+.......  ..+.+.+|+.++..+ +||||+++++++.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34578999999999999999999754 2     3479999998764332  247789999999999 8999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDD-----------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  281 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill  281 (436)
                      ..+..++||||+++|+|.+++....           ....+++..++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence            9999999999999999999987532           1235899999999999999999999   7899999999999999


Q ss_pred             cCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCC
Q 013793          282 NSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSS  358 (436)
Q Consensus       282 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~  358 (436)
                      +.++.+||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....      
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------  271 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL------  271 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC------
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc------
Confidence            99999999999999866443322  233457889999999999999999999999999999998 999986321      


Q ss_pred             CcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          359 DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       359 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       .....................   ...+.+++.+||+.||.+|||+.|+++++..
T Consensus       272 -~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          272 -VNSKFYKLVKDGYQMAQPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -SSHHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -hhHHHHHHHhcCCCCCCCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence             111122222221111111101   1236789999999999999999999998864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=338.77  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+.....     ...+.+|++++..++||||+++++++...+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            4567999999999999999999765 689999999976543     2578899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++++|.+++....  ..+++..++.++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus       102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999999986322  36899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..........|++.|+|||.+.+..++.++||||||+++|||++|+.||......       .......... ...... 
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~-  247 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTNP-PPTFRK-  247 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCCCSS-
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC-CcccCC-
Confidence            5444444567899999999999999999999999999999999999998632210       0011111111 100000 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      .......+.+++.+||+.||.+|||+.++++++|+......
T Consensus       248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            00112236789999999999999999999999999877543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-43  Score=331.91  Aligned_cols=254  Identities=25%  Similarity=0.357  Sum_probs=192.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||.||+|....    +..||+|.+......  ...+.+.+|+.++++++||||+++++++. .+..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            4678999999999999999997642    457999998765433  23477899999999999999999999985 4568


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence            89999999999999997643  36899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          298 LHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       298 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....       .......+...... +
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-------~~~~~~~i~~~~~~-~  237 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERL-P  237 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCCC-C
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-------HHHHHHHHHcCCCC-C
Confidence            6443221 223456789999999998899999999999999999997 999986321       11111122211111 1


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ....   ....+.+++.+||+.||++|||+.|+++++..
T Consensus       238 ~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          238 MPPN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111   11236689999999999999999999998864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.3e-44  Score=340.53  Aligned_cols=261  Identities=25%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh-----hHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||.+......     .......+.+|++++.+++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            356899999999999999999965 46889999999764321     111234588999999999999999999998766


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eEEee
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVAD  291 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  291 (436)
                      . .++||||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999987543   6899999999999999999999   789999999999999987654   99999


Q ss_pred             cccccccCCCCCCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      ||+++..... .......||+.|+|||.+.   ...++.++||||||+++|||++|+.||.....      .......+.
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~  233 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT------QVSLKDQIT  233 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC------SSCHHHHHH
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------HHHHHHHHH
Confidence            9999876432 1223456899999999874   46789999999999999999999999863211      111111111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ...... ...........+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          234 SGKYNF-IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hCcccc-CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            111111 11111112234678999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.5e-44  Score=352.99  Aligned_cols=269  Identities=19%  Similarity=0.237  Sum_probs=202.2

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc------cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV------LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~  214 (436)
                      ..+|++.+.||+|+||+||+|.. .+++.||||++......    ...+.+|++++..+      +|+||+++++++...
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch----HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            45799999999999999999965 46899999999765432    25667788887777      467999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC--eEEeec
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADF  292 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Df  292 (436)
                      ...++||||+. ++|.+++..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.  +||+||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            99999999996 689998876542 35899999999999999999999   779999999999999999987  999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcc--
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK--  361 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~--  361 (436)
                      |+++.....   .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......         ......  
T Consensus       247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            999764322   334578999999999999999999999999999999999999986322100         000000  


Q ss_pred             ---cchhhhhcC---------------------------CC-CCCCChhHHHH-----HHHHHHHHhhccCCCCCCCCCH
Q 013793          362 ---IMLIDVLDQ---------------------------RL-PPPVDQKVIQD-----ILLASTISFACLQSNPKSRPTM  405 (436)
Q Consensus       362 ---~~~~~~~~~---------------------------~l-~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~  405 (436)
                         ......++.                           .. .++....+...     ...+.+|+.+||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence               000000000                           00 00001111111     2346789999999999999999


Q ss_pred             HHHHHHHhhcCCCCCcc
Q 013793          406 QYVSQGFLITRKTPLVK  422 (436)
Q Consensus       406 ~ev~~~l~~~~~~~~~~  422 (436)
                      .|+++|+|+++..+...
T Consensus       404 ~e~L~Hpw~~~~~~~~~  420 (429)
T 3kvw_A          404 GQALRHPWLRRRLPKPP  420 (429)
T ss_dssp             HHHHTSTTTC-------
T ss_pred             HHHhCChhhccCCCCCC
Confidence            99999999988755443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.5e-44  Score=330.92  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=207.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||.||++...+++.||+|.+.......    +.+.+|++++..++||||+++++++.+.+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            35788999999999999999998889999999998765432    57889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            9999999999997653  36899999999999999999999   789999999999999999999999999999865332


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....       .......+... ........
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~i~~~-~~~~~~~~  229 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTG-FRLYKPRL  229 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTT-CCCCCCTT
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-------HHHHHHHHhcC-CcCCCCcc
Confidence            11 1223456788999999998899999999999999999999 899986321       11111111111 11111110


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                         ....+.+++.+||+.||++|||+.++++++....
T Consensus       230 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          230 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               1123668999999999999999999999987543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-44  Score=347.74  Aligned_cols=264  Identities=26%  Similarity=0.353  Sum_probs=207.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +++.||+|++......  ...+.+.+|+.++..++||||+++++++...+..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            467999999999999999999765 7899999999876432  2347789999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++..+..++.+++.||+|||+  ..+|+||||||+||+++.++.++|+|||++.....
T Consensus       110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999997654   68999999999999999999993  13899999999999999999999999999975532


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc-------------------------
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------------------------  355 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------------------  355 (436)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......                         
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            2  1234578999999999999999999999999999999999999986322100                         


Q ss_pred             ------CCCCccc----chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          356 ------SSSDPKI----MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       356 ------~~~~~~~----~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                            .......    ..........+.....   .....+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG---VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTT---TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcc---cccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                  0000000    0001111111110000   012236789999999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.2e-44  Score=334.89  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=192.7

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||+|...+  .+|+|++....... ...+.+.+|++++++++||||+++++++ .....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4678999999999999999998643  59999997654332 2347889999999999999999999965 455689999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999996543  36899999999999999999999   789999999999999999999999999999765432


Q ss_pred             C--CCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          302 S--SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       302 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      .  .......||+.|+|||.+.   +..++.++||||||+++|||++|+.||.....      .................
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC------HHHHHHHHHHTSCCCCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch------HHHHHHHhcccccCcch
Confidence            2  2223456899999999886   56788999999999999999999999863211      11111111111221111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ..........+.+++.+||+.||++|||+.|+++.+...
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            100011123467899999999999999999999998654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.1e-43  Score=332.97  Aligned_cols=261  Identities=22%  Similarity=0.308  Sum_probs=209.5

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcc------hhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE------TEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLH  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  213 (436)
                      .++|++.+.||+|+||.||+|... +|+.||||++....      .......+.+.+|++++.++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            578999999999999999999764 78999999997543      111233467889999999995 9999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      .+..++||||+++++|.+++....   .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999997643   6899999999999999999999   7899999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccc------cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAY------TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      ++....... ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||....       .......+
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~  241 (298)
T 1phk_A          170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRMI  241 (298)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHH
T ss_pred             chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-------HHHHHHHH
Confidence            998765432 234456899999999875      4568899999999999999999999986321       11111222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .......+... .......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       242 ~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          242 MSGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             HHTCCCCCTTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             hcCCcccCccc-ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            22222111110 11122336789999999999999999999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-43  Score=334.62  Aligned_cols=265  Identities=20%  Similarity=0.286  Sum_probs=198.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.............+.+|+.++..++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999975 57999999999864433334457889999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          221 YEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986421 2236899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..........|++.|+|||.+.+..++.++||||||+++|||++|+.||....     .........+.....+......
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  262 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIEQCDYPPLPSDH  262 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHHHHHHTTCSCCCCTTT
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHHHHHhhcccCCCCcccc
Confidence            44433445578999999999999999999999999999999999999985311     0000111111111221111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                         ....+.+++.+||+.||++|||+.+|++.+....+
T Consensus       263 ---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          263 ---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence               11236789999999999999999999998865543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.3e-43  Score=329.85  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=200.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHH----HHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAF----IKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++..........    .+.+.+|++++.+++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            36788999999999999999976 578999999996544322111    167889999999999999999999997766 


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCC-----eEE
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLE-----AFV  289 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl  289 (436)
                       ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             69999999999999887543  36899999999999999999999   777  999999999999988776     999


Q ss_pred             eecccccccCCCCCCccccccccccccccccc--cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          290 ADFGTARRLHADSSNRTLLAGTYGYIAPELAY--TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      +|||+++....   ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||.....     .........
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~  242 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-----GKIKFINMI  242 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-----CHHHHHHHH
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-----cHHHHHHHH
Confidence            99999975432   234467999999999984  45678999999999999999999999863211     111111122


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .............   ...+.+++.+||+.||++|||+.|+++.+.
T Consensus       243 ~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          243 REEGLRPTIPEDC---PPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             HHSCCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccCCCCCCCccc---CHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            2222222221111   223678999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.6e-44  Score=360.05  Aligned_cols=259  Identities=25%  Similarity=0.322  Sum_probs=203.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||+||+|... ++..||+|++........ ....+.+|+.+++.++||||+++++++.+....++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3567999999999999999999764 789999999976532211 13678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++..   +.+||+|||+++
T Consensus       114 v~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999999887543   6899999999999999999999   7899999999999999764   559999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||....       .......+.......+.
T Consensus       188 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~  258 (494)
T 3lij_A          188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-------DQEILRKVEKGKYTFDS  258 (494)
T ss_dssp             ECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCS
T ss_pred             ECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCc
Confidence            765432 234467999999999876 568999999999999999999999986321       11112222222222111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      . .+......+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus       259 ~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          259 P-EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             G-GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             h-hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            1 01112233678999999999999999999999999865

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-43  Score=339.15  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=204.7

Q ss_pred             hhcccccceeeecCceEEEEEEc--------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|.+.+.||+|+||+||+|..        .++..||||++......  .....+.+|++++..+ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            47899999999999999999975        35678999999865433  2247789999999999 8999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      ..+..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||   +.+|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence            99999999999999999999986532             234899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      +++.++.+||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....    
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----  264 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  264 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence            999999999999999987654332  1233457789999999998899999999999999999999 999986321    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         .......+.... .......   ....+.+++.+||+.||.+|||+.|+++++...
T Consensus       265 ---~~~~~~~~~~~~-~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          265 ---VEELFKLLKEGH-RMDKPAN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             ---HHHHHHHHHHTC-CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCC-CCCCCcc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               111111111111 1111111   112367899999999999999999999988643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-43  Score=341.98  Aligned_cols=264  Identities=23%  Similarity=0.258  Sum_probs=196.7

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh-HHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            46799999999999999999965 478999999997643322 23467889999999999999999999998665     


Q ss_pred             -EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          216 -CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       216 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                       ..++||||+++ +|.+.+..     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence             78999999975 78887752     4889999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc-----
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP-----  360 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~-----  360 (436)
                      ++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......         ....+     
T Consensus       174 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          174 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            98654322 2344578999999999999999999999999999999999999996432100         00000     


Q ss_pred             ----------------ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          361 ----------------KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       361 ----------------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                                      .............+............+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                            00000000000011111112223455789999999999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.4e-44  Score=355.99  Aligned_cols=256  Identities=26%  Similarity=0.420  Sum_probs=201.0

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..++|++.+.||+|+||.||+|.+.++..||||.++.....    .+.+.+|++++++++||||+++++++.+ +..++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            35678899999999999999999988888999999875433    2678899999999999999999999876 668999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999997432 235899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          301 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       301 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       ...... +......+...
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~-i~~~~~~~~~~  404 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQ-VERGYRMPCPP  404 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHH-HHTTCCCCCCT
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-HHcCCCCCCCC
Confidence            322 1223456789999999999999999999999999999999 9999863211       111111 11111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .   ....+.+++.+||+.||++|||+.++++.+....
T Consensus       405 ~---~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          405 E---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             C---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1   1223678999999999999999999999886543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-43  Score=329.56  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             hcccccc-eeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|.+.+ .||+|+||.||+|...   ++..||||++......  ...+.+.+|++++..++||||+++++++ ..+..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            4566666 8999999999999753   6788999999875432  2347889999999999999999999999 556689


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999997543  36899999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ......   .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....       ... ....+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~-~~~~i~~~~~~  232 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPE-VMAFIEQGKRM  232 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------THH-HHHHHHTTCCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-------HHH-HHHHHhcCCcC
Confidence            543322   223346889999999998899999999999999999998 999986321       111 11111111111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .....   ....+.+++.+||+.||++||++.+++++++..
T Consensus       233 ~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          233 ECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             CCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC---cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111   122367899999999999999999999998643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.2e-44  Score=342.28  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCE----EEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      ++|++.+.||+|+||+||+|... +++.    ||+|.+.......  ....+.+|+.++..++||||+++++++. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            57888999999999999999754 4443    7888875443211  1245678999999999999999999986 4568


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            89999999999999997642  36899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCC--C
Q 013793          298 LHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR--L  372 (436)
Q Consensus       298 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--l  372 (436)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       . ...+.+...  .
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~~~~  236 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-------A-EVPDLLEKGERL  236 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-------T-HHHHHHHTTCBC
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-------H-HHHHHHHcCCCC
Confidence            754332  2244567889999999999999999999999999999999 9999863211       1 111111111  1


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ..+..     ....+.+++.+||+.||.+|||+.|+++++...
T Consensus       237 ~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          237 AQPQI-----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             CCCTT-----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             CCCCc-----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11110     011256788999999999999999999998543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-44  Score=345.37  Aligned_cols=265  Identities=23%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+++++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            46789999999999999999975 57999999999654332 223477889999999999999999999998753     


Q ss_pred             -EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          216 -CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       216 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                       ..++||||+ +++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence             469999999 88999998753    5899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcc---
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK---  361 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~---  361 (436)
                      ++.....   .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......         ......   
T Consensus       175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9875432   344678999999999877 679999999999999999999999996322100         000000   


Q ss_pred             ----cchhhh---hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          362 ----IMLIDV---LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       362 ----~~~~~~---~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                          ......   +..................+.+|+.+||+.||++|||+.|+++|+|+..-.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                000000   000000000000001123367899999999999999999999999997653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.9e-44  Score=336.26  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||+||+|... ++..||+|.+......    .+.+.+|++++++++||||+++++++.+.+..++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            4578999999999999999999765 5889999999865543    3678899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++++|.+++..... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999976432 36899999999999999999999   7799999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          300 ADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       300 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....       . ....+.+.........
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-------~-~~~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------L-SQVYELLEKDYRMERP  234 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------G-GGHHHHHHTTCCCCCC
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------H-HHHHHHHhccCCCCCC
Confidence            43322 233456788999999999999999999999999999999 999986321       1 1122222222211111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ...   ...+.+++.+||+.||++|||+.|+++.+..
T Consensus       235 ~~~---~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          235 EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC---CHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            111   1236789999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.7e-44  Score=335.38  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=192.4

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++........ ....+.++...++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH-HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            46899999999999999999975 5789999999976543322 224455566668888999999999999999999999


Q ss_pred             EeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      |||+++ +|.+++... .....+++..++.++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999985 887776541 12236999999999999999999999   65 9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccc----ccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELA----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .... ......||+.|+|||.+    .+..++.++||||||+++|||+||+.||+...      ..............+.
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~  233 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------TPFQQLKQVVEEPSPQ  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------CHHHHHHHHHHSCCCC
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------chHHHHHHHhccCCCC
Confidence            4432 23334689999999995    56678999999999999999999999986311      1111122222222221


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .....   ....+.+++.+||+.||++|||+.|+++|+|++..
T Consensus       234 ~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          234 LPADK---FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CCTTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccc---CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            11111   11236789999999999999999999999999754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.3e-44  Score=343.84  Aligned_cols=271  Identities=22%  Similarity=0.285  Sum_probs=203.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-------  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  213 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++........ ....+.+|++++..++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-chHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            36799999999999999999976 5799999999865533221 12567789999999999999999999987       


Q ss_pred             -CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          214 -KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       214 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                       .+..++||||+++ +|.+.+....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence             4468999999986 7777766543  25899999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCC----CCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccc-------------
Q 013793          293 GTARRLHADS----SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-------------  354 (436)
Q Consensus       293 g~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-------------  354 (436)
                      |+++......    .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||......             
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9998764322    12344568999999998876 45899999999999999999999998642210             


Q ss_pred             cCCCCcccchhhhhcCC-CCCCCChhHHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          355 SSSSDPKIMLIDVLDQR-LPPPVDQKVIQD------ILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       355 ~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....+.....+..... ............      ...+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            00000000000000000 000000001111      233678999999999999999999999999976544

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-44  Score=345.10  Aligned_cols=264  Identities=21%  Similarity=0.328  Sum_probs=208.5

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHH--------------HHHHHHHHHHHHhhccCCCceee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA--------------FIKSFRNEAQVLSQVLHRSIVKL  207 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~l  207 (436)
                      .++|.+.+.||+|+||.||+|.. +++.||||.+.........              ....+.+|++++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999988 9999999998754322110              11678899999999999999999


Q ss_pred             eeEEeeCCEEEEEEeeccCCChhhh------hccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCcee
Q 013793          208 YGFCLHKKCMFLIYEYMERGSLFCI------LHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNIL  280 (436)
Q Consensus       208 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~dlk~~Nil  280 (436)
                      ++++.+.+..++||||+++|+|.++      +... ....+++..++.++.|++.||+|||   + .+|+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            9999999999999999999999998      5442 1347999999999999999999999   5 89999999999999


Q ss_pred             ecCCCCeEEeecccccccCCCCCCccccccccccccccccccC-ccCc-chhhHHHHHHHHHHHhCCCCccccccccCCC
Q 013793          281 LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTE-KCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS  358 (436)
Q Consensus       281 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  358 (436)
                      ++.++.++|+|||.+......  ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......    
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999999876433  33446789999999999877 6666 999999999999999999998632210    


Q ss_pred             CcccchhhhhcCCCCCCC--------------ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          359 DPKIMLIDVLDQRLPPPV--------------DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       359 ~~~~~~~~~~~~~l~~~~--------------~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                        ......+.......+.              ..........+.+++.+||+.||.+|||+.|+++|+|+....
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence              1111111111111110              000011123467899999999999999999999999997653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.6e-43  Score=337.32  Aligned_cols=260  Identities=18%  Similarity=0.222  Sum_probs=202.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEee--CCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLH--KKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~  217 (436)
                      .++|++.+.||+|+||+||+|.. .+++.||||++.....      +.+.+|++++.+++ ||||+++++++..  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            46799999999999999999964 6789999999986542      56889999999997 9999999999988  6678


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeeccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTAR  296 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~  296 (436)
                      ++||||+++++|.+++.      .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++
T Consensus       109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            99999999999999885      4888999999999999999999   78999999999999999776 89999999998


Q ss_pred             ccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccc--------------------c
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL--------------------S  355 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--------------------~  355 (436)
                      ....... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......                    .
T Consensus       180 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          180 FYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             ECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             EcCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            7654332 344578999999999877 67899999999999999999999998421100                    0


Q ss_pred             -CCCCcccchhhhhcCCCCCCC-----ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          356 -SSSDPKIMLIDVLDQRLPPPV-----DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       356 -~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                       ..........+..........     ..........+.+|+.+||+.||++|||+.|+++|+|++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence             000000000000000000000     00000012346789999999999999999999999999754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=331.77  Aligned_cols=261  Identities=21%  Similarity=0.278  Sum_probs=203.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhh-HHHHHHHHHHHHHHhhccCCCceeeeeEEe--eCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRSIVKLYGFCL--HKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  217 (436)
                      .++|.+.+.||+|+||.||++... +++.||+|++....... ......+.+|++++..++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999764 78999999997653221 122467899999999999999999999984  45678


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||++++ |.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 777766543 236899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCC--CccccccccccccccccccCc--cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSS--NRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ......  ......||+.|+|||.+.+..  .+.++||||||+++|||++|+.||....       .......+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~  231 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFENIGKGSYA  231 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHHhcCCCC
Confidence            643222  223456899999999987643  4789999999999999999999986321       11111122222221


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .+..     ....+.+++.+||+.||++|||+.|+++|+|+....+
T Consensus       232 ~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          232 IPGD-----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             CCSS-----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CCCc-----cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            1111     1123668999999999999999999999999987644

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-43  Score=335.44  Aligned_cols=262  Identities=22%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.++.+++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999764 788999999987655544455789999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999997643   6899999999999999999999   7899999999999999999999999999997664


Q ss_pred             CCCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          300 ADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       300 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      .... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....        ......+....+.+.. 
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~-  256 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIPRPST-  256 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCCCGGG-
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCCCccc-
Confidence            3321 22345689999999999999999999999999999999999999863221        0111112111111000 


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhcCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRP-TMQYVSQGFLITRK  417 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RP-t~~ev~~~l~~~~~  417 (436)
                      ........+.+++.+||+.||++|| +++++++.+...-.
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            0000112366789999999999999 99999998875443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-43  Score=336.08  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=207.9

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeee
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYG  209 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~  209 (436)
                      ......++|++.+.||+|+||+||+|..      .+++.||||++.......  ..+.+.+|++++.++ +||||+++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH--HHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            3334567899999999999999999963      357899999998764432  236789999999999 7999999999


Q ss_pred             EEeeCC-EEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 013793          210 FCLHKK-CMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  275 (436)
Q Consensus       210 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk  275 (436)
                      ++...+ ..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||   +.+|+|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCc
Confidence            988754 58999999999999999986542             123889999999999999999999   7899999999


Q ss_pred             CCceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccc
Q 013793          276 SNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLS  352 (436)
Q Consensus       276 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~  352 (436)
                      |+||+++.++.+||+|||+++........  .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999999999876443322  233457889999999999999999999999999999998 999986321


Q ss_pred             cccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          353 SLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                             ........+...........   ....+.+++.+||+.||.+|||+.|+++++...
T Consensus       256 -------~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          256 -------IDEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             -------CSHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------hhHHHHHHhccCccCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   11111111111111111110   112367889999999999999999999998653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-43  Score=338.81  Aligned_cols=263  Identities=24%  Similarity=0.328  Sum_probs=209.2

Q ss_pred             HHHhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEe
Q 013793          139 IEATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCL  212 (436)
Q Consensus       139 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  212 (436)
                      ....++|++.+.||+|+||.||+|...      +++.||+|.+.......  ....+.+|+++++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH--HHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            345678999999999999999999654      46789999998654332  2367889999999999999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDD-------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      +.+..++||||+++|+|.+++....       ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999987532       1235789999999999999999999   78999999999999999999


Q ss_pred             CeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCccc
Q 013793          286 EAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKI  362 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~  362 (436)
                      .+||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....       ...
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~  248 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQ  248 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-------HHH
Confidence            9999999999865433221  223456889999999999999999999999999999999 889986321       111


Q ss_pred             chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ....+..........    .....+.+++.+||+.||++|||+.|+++++.....
T Consensus       249 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            112222222211111    111236789999999999999999999999976544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-43  Score=333.31  Aligned_cols=260  Identities=17%  Similarity=0.276  Sum_probs=202.7

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEE-eeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFC-LHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     ..+.+|++++..++|++++..+.++ ......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            46899999999999999999975 68999999998765432     4678899999999988877766655 56778899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~  296 (436)
                      ||||+ +++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            99999 999999997433  26899999999999999999999   7899999999999999   588999999999998


Q ss_pred             ccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          297 RLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       297 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      .......       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......    ........+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~  232 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISE  232 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch----hhhhhhhhhcc
Confidence            7654332       123457999999999999999999999999999999999999999743211    11111111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          370 QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       370 ~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .....+...........+.+++.+||+.||++|||+.++++.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence            11111100000011123678999999999999999999999886543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.5e-44  Score=346.34  Aligned_cols=261  Identities=16%  Similarity=0.237  Sum_probs=198.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCC------CCEEEEEEecCcchhhHHHH--------HHHHHHHHHHhhccCCCceee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFI--------KSFRNEAQVLSQVLHRSIVKL  207 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~--------~~~~~e~~~l~~l~h~niv~l  207 (436)
                      .++|.+.+.||+|+||+||+|.+.+      ++.||||++...........        ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999997754      47899999876643221111        123456667788899999999


Q ss_pred             eeEEeeC----CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-
Q 013793          208 YGFCLHK----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-  282 (436)
Q Consensus       208 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~-  282 (436)
                      ++++...    ...++||||+ +++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            9999875    4589999999 999999997642  36999999999999999999999   77999999999999999 


Q ss_pred             -CCCCeEEeecccccccCCCCCC-------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          283 -SKLEAFVADFGTARRLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       283 -~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                       .++.+||+|||+++.+......       .....||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999876433221       13345999999999999999999999999999999999999999732110


Q ss_pred             cCCCC-----cccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          355 SSSSD-----PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       355 ~~~~~-----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....     ........++..++...      ....+.+++..||+.||++||++.++++.+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAAN------APGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTC------CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhccccc------CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            00000     00001111222211111      02236788999999999999999999988753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5e-43  Score=339.77  Aligned_cols=276  Identities=21%  Similarity=0.271  Sum_probs=204.2

Q ss_pred             HHHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcch--------hhHHHHHHHHHHHHHHhhccCCCcee
Q 013793          135 YEDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET--------EELAFIKSFRNEAQVLSQVLHRSIVK  206 (436)
Q Consensus       135 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~~~e~~~l~~l~h~niv~  206 (436)
                      ..++....++|.+.+.||+|+||.||+|...+|+.||||++.....        ......+.+.+|++++.+++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            5677888999999999999999999999988899999999865322        12223478899999999999999999


Q ss_pred             eeeEEee-----CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 013793          207 LYGFCLH-----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  281 (436)
Q Consensus       207 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill  281 (436)
                      +++++..     ....++||||++ |+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            9999854     346899999998 58888877543  36899999999999999999999   7899999999999999


Q ss_pred             cCCCCeEEeecccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc-----
Q 013793          282 NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-----  355 (436)
Q Consensus       282 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-----  355 (436)
                      +.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......     
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             CTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999997543322 2344578999999998877 678999999999999999999999996322100     


Q ss_pred             ----CCCCc-------ccchhhhhcCCCCCCCChhH----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          356 ----SSSDP-------KIMLIDVLDQRLPPPVDQKV----IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       356 ----~~~~~-------~~~~~~~~~~~l~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                          .....       .....+..............    ......+.+++.+||+.||++|||+.|+++|+|+..-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                00000       00000111111110000000    0112336789999999999999999999999999765

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3e-43  Score=328.79  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||+|...++..||+|.+......    .+.+.+|++++..++||||+++++++.. +..++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            4678999999999999999999888889999999765433    2678899999999999999999999874 4589999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++.... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++......
T Consensus        87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999999997532 225899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       ......+ ...........
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~~~  234 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNL-ERGYRMVRPDN  234 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHH-HTTCCCCCCTT
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHH-hcccCCCCccc
Confidence            22 1233456788999999998899999999999999999999 9999863211       1111111 11111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         ....+.+++.+||+.||++|||+.++++.+..
T Consensus       235 ---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          235 ---CPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---ccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence               11236789999999999999999999987753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=346.00  Aligned_cols=265  Identities=20%  Similarity=0.291  Sum_probs=208.2

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC--EEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK--CMFL  219 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  219 (436)
                      ++|.+.+.||+|+||+||+|... +|+.||||++........  .+.+.+|++++++++||||+++++++....  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            57889999999999999999765 589999999976543221  366788999999999999999999998765  7899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCCeEEeecccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTA  295 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a  295 (436)
                      ||||+++|+|.+++........+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999987654445999999999999999999999   7899999999999999    77888999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc--------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYT--------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      +...... ......||+.|+|||.+.+        ..++.++|||||||++|||+||+.||.......   ........+
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~~  239 (396)
T 4eut_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKI  239 (396)
T ss_dssp             EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT---TCHHHHHHH
T ss_pred             eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc---chHHHHHHH
Confidence            8764432 2334569999999998865        567889999999999999999999996422110   001111111


Q ss_pred             hcC---------------------CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          368 LDQ---------------------RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       368 ~~~---------------------~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      +..                     .++... .........+.+++.+||+.||++||++.|+++.+...-.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTC-SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCccc-ccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            111                     111111 1112344457789999999999999999999998865444

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.3e-44  Score=337.18  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.......   .+.+.+|++++..++||||+++++++...+..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            567999999999999999999765 68999999987654322   36788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999887532  25899999999999999999999   78999999999999999999999999998754322


Q ss_pred             CCCCcccccccccccccccc-----ccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          301 DSSNRTLLAGTYGYIAPELA-----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .........|++.|+|||.+     .+..++.++||||||+++|||++|+.||.....       ............+..
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~  242 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSDPPTL  242 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCC
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhccCCccc
Confidence            11122335689999999988     356789999999999999999999999863221       111112221111111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...  ......+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       243 ~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          243 LTP--SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             SSG--GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             CCc--cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            100  111223678999999999999999999999999976543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-43  Score=333.60  Aligned_cols=262  Identities=22%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             hcccccceeeecCceEEEEEE-----cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--C
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQ-----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--K  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  215 (436)
                      +.|++.+.||+|+||.||+|.     ..+++.||+|++.......  ....+.+|++++..++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            458889999999999999998     3478999999997654322  236788999999999999999999999876  6


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence            6899999999999999996543  25899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC---CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc----cCCCCccc---chh
Q 013793          296 RRLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----SSSSDPKI---MLI  365 (436)
Q Consensus       296 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----~~~~~~~~---~~~  365 (436)
                      ........   ......||..|+|||.+.+..++.++||||||+++|||+||+.|+......    ........   ...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87754432   123456888899999999999999999999999999999999986422100    00000000   111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..+......+....   ....+.+++.+||+.||.+|||+.|+++.+..
T Consensus       254 ~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          254 NTLKEGKRLPCPPN---CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHTTCCCCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCC---CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11111111111111   11236789999999999999999999998853

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=350.54  Aligned_cols=262  Identities=26%  Similarity=0.385  Sum_probs=205.0

Q ss_pred             hhcccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchh-hHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  215 (436)
                      .++|++.+.||+|+||+||++..    .+++.||||+++..... .......+.+|++++..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999976    47899999998753210 000124567899999999 6999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+++|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999997643   6899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC-CccccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCC
Q 013793          296 RRLHADSS-NRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL  372 (436)
Q Consensus       296 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l  372 (436)
                      +....... ......||+.|+|||.+.+.  .++.++|||||||++|||+||+.||......   ...............
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEP  283 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc---chHHHHHHHHhccCC
Confidence            86543222 22345799999999998863  5789999999999999999999998632110   000111112222221


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcCC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITRK  417 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~~  417 (436)
                      +.+..     ....+.+++.+||+.||.+||     ++.|+++++|+...
T Consensus       284 ~~~~~-----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          284 PYPQE-----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CCCTT-----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCCcc-----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            11111     112366899999999999999     99999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.3e-43  Score=336.26  Aligned_cols=263  Identities=24%  Similarity=0.362  Sum_probs=206.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEe--eC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCL--HK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~  214 (436)
                      .++|++.+.||+|+||.||+|.+     .+++.||||++.......   .+.+.+|++++.+++||||+++++++.  +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH---HHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            36789999999999999999983     468899999998765332   367899999999999999999999887  45


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++||||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccc
Confidence            67899999999999999997633  25899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCC---CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc-----c--CCCCcccch
Q 013793          295 ARRLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL-----S--SSSDPKIML  364 (436)
Q Consensus       295 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-----~--~~~~~~~~~  364 (436)
                      ++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     .  .........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            987654332   123345788899999999999999999999999999999999998632210     0  000000111


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .+.+......+....   ....+.+++.+||+.||++|||+.|+++++...
T Consensus       254 ~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          254 LELLEEGQRLPAPPA---CPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             HHHhhcccCCCCCCc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            122222222111111   122367899999999999999999999888643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.6e-43  Score=333.89  Aligned_cols=261  Identities=22%  Similarity=0.356  Sum_probs=202.8

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc--CCCceeeeeEEeeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~  218 (436)
                      ..++|++.+.||+|+||.||++...+++.||||++....... .....+.+|++++.+++  ||||+++++++...+..+
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            356799999999999999999998889999999997654332 23478899999999997  599999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||| +.+++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||++++ +.+||+|||+++..
T Consensus       105 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9999 66889999998654   6899999999999999999999   789999999999999975 89999999999876


Q ss_pred             CCCCCC--cccccccccccccccccc-----------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchh
Q 013793          299 HADSSN--RTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       299 ~~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  365 (436)
                      ......  .....|++.|+|||.+.+           ..++.++||||||+++|||++|+.||....      .......
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~  250 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLH  250 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------HHHHHHH
Confidence            443221  234568999999999875           468889999999999999999999986321      1111122


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...+...........   ...+.+++.+||+.||++|||+.|+++++|+.....
T Consensus       251 ~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          251 AIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             HHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             HHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            233322221111111   123668899999999999999999999999987643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7e-44  Score=336.81  Aligned_cols=265  Identities=25%  Similarity=0.382  Sum_probs=187.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +++.||||.+.......  ..+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch--hHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            568999999999999999999764 78999999987653322  236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          221 YEYMERGSLFCILHND-----DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      |||+++++|.+++...     .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999998641     12346899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCC-----Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          296 RRLHADSS-----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       296 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      ........     ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||......       ........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~  241 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------KVLMLTLQ  241 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------GHHHHHHT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-------hHHHHHhc
Confidence            76643221     1234568999999999876 56899999999999999999999998642211       00111111


Q ss_pred             CCCCCCCChh-----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          370 QRLPPPVDQK-----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       370 ~~l~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ...+......     .......+.+++.+||+.||.+|||+.|+++|+|+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            1100000000     000112366899999999999999999999999997653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.2e-43  Score=333.65  Aligned_cols=259  Identities=22%  Similarity=0.328  Sum_probs=203.6

Q ss_pred             ccccceeeecCceEEEEEEcC-----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC--CEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK--KCM  217 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  217 (436)
                      |++.+.||+|+||+||++.+.     +++.||||++.......  ....+.+|++++++++||||+++++++.+.  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH--HHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            488999999999999988542     68899999998764322  247789999999999999999999999884  678


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++...    .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999999764    4899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc----cCCCCc---ccchhhh
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----SSSSDP---KIMLIDV  367 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----~~~~~~---~~~~~~~  367 (436)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||+||+.||......    ......   .....+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            7544321   23345788899999999999999999999999999999999998632110    000000   0011222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          368 LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       368 ~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +......+....   ....+.+++.+||+.||++|||+.|+++.+...
T Consensus       264 ~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          264 LERGERLPRPDK---CPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcccCCCCCcc---ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            222222111111   122367899999999999999999999988643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=338.50  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=191.9

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHH--HHHHhhccCCCceeeeeEEee-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE--AQVLSQVLHRSIVKLYGFCLH-----K  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~l~~~~~~-----~  214 (436)
                      .++|++.+.||+|+||+||+|.. +++.||||++.....      ..+..|  +..+..++||||+++++.+..     .
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            46789999999999999999977 689999999975543      233334  444556899999999986543     3


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCceeecCCC
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP---------SIIHRDISSNNILLNSKL  285 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~ivH~dlk~~Nill~~~~  285 (436)
                      ...++||||+++|+|.+++...    ..++..+..++.|++.||+|||   +.         +|+||||||+|||++.++
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             ceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence            3678999999999999999765    3589999999999999999999   66         999999999999999999


Q ss_pred             CeEEeecccccccCCCC--------CCcccccccccccccccccc-------CccCcchhhHHHHHHHHHHHhCCCCccc
Q 013793          286 EAFVADFGTARRLHADS--------SNRTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLMGKHPRDL  350 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~elltg~~p~~~  350 (436)
                      .+||+|||+++.+....        .......||+.|+|||.+.+       ..++.++|||||||++|||+||+.|+..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            99999999998764322        11234569999999999887       4667899999999999999999887643


Q ss_pred             cccccCCCC---------cc-cchhh-h----hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          351 LSSLSSSSD---------PK-IMLID-V----LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       351 ~~~~~~~~~---------~~-~~~~~-~----~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .........         +. ..... .    ..+.++..... .......+.+++.+||+.||++|||+.|+++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            221110000         00 00000 0    11111111111 11233457889999999999999999999887643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9e-43  Score=331.12  Aligned_cols=260  Identities=22%  Similarity=0.364  Sum_probs=194.6

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      ...++|.+.+.||+|+||.||+|...    ++..||+|.+....... ...+.+.+|+.++.+++||||+++++++.+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            34678899999999999999999653    34589999997654332 22477899999999999999999999998765


Q ss_pred             E-----EEEEEeeccCCChhhhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCe
Q 013793          216 C-----MFLIYEYMERGSLFCILHND---DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       216 ~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  287 (436)
                      .     .++||||+++|+|.+++...   .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence            3     49999999999999998532   22346999999999999999999999   8899999999999999999999


Q ss_pred             EEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccch
Q 013793          288 FVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  364 (436)
                      ||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....       .....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~  259 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-------NHEMY  259 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GGGHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHH
Confidence            9999999987643322  1233457889999999999999999999999999999999 888886321       11111


Q ss_pred             hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          365 IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       365 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ......... .....   ....+.+++.+||+.||++|||+.++++++..
T Consensus       260 ~~~~~~~~~-~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          260 DYLLHGHRL-KQPED---CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             HHHHTTCCC-CCBTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHcCCCC-CCCcc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            222221111 11111   11236789999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.8e-43  Score=340.25  Aligned_cols=275  Identities=20%  Similarity=0.220  Sum_probs=193.0

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK  214 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  214 (436)
                      +......++|++.+.||+|+||+||+|.. .+|+.||||++.......    ..+.++++.+..++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            45667789999999999999999999976 478999999986543322    3456778888999999999999999764


Q ss_pred             CE-------EEEEEeeccCCChhhhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CC
Q 013793          215 KC-------MFLIYEYMERGSLFCILH-NDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KL  285 (436)
Q Consensus       215 ~~-------~~lv~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~  285 (436)
                      +.       .++||||++++ |...+. .......+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred             ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence            43       78999999875 433332 122334689999999999999999999942 579999999999999997 89


Q ss_pred             CeEEeecccccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccC-------C
Q 013793          286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-------S  357 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-------~  357 (436)
                      .+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||........       .
T Consensus       170 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999999998765433 23345689999999998665 489999999999999999999999963221000       0


Q ss_pred             CCcccchhhhhcCCCC-------CCCC-h-----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          358 SDPKIMLIDVLDQRLP-------PPVD-Q-----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~-------~~~~-~-----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..+.......+.+...       .... .     ........+.+|+.+||+.||.+|||+.|+++|+|+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence            0000000000000000       0000 0     000023347789999999999999999999999999765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.5e-43  Score=331.00  Aligned_cols=251  Identities=21%  Similarity=0.368  Sum_probs=200.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CC-------CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NG-------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  213 (436)
                      .++|.+.+.||+|+||+||+|... ++       ..||+|.+.......   .+.+.+|++++++++||||+++++++..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG---HHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH---HHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            367889999999999999999654 23       479999997654332   3678899999999999999999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC-------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-------  286 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-------  286 (436)
                      .+..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.       
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence            999999999999999999998653  24899999999999999999999   789999999999999998887       


Q ss_pred             -eEEeecccccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCC-ccccccccCCCCcccc
Q 013793          287 -AFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSSSSDPKIM  363 (436)
Q Consensus       287 -~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p-~~~~~~~~~~~~~~~~  363 (436)
                       +||+|||++.....    .....|++.|+|||.+.+ ..++.++||||||+++|||++|..| +....       . ..
T Consensus       159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~-~~  226 (289)
T 4fvq_A          159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------S-QR  226 (289)
T ss_dssp             EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------H-HH
T ss_pred             eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-------h-HH
Confidence             99999999865432    233458889999999987 6789999999999999999996554 33111       1 11


Q ss_pred             hhhhh--cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          364 LIDVL--DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       364 ~~~~~--~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .....  ...++...+.       .+.+++.+||+.||++|||+.|+++++...-.+.
T Consensus       227 ~~~~~~~~~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          227 KLQFYEDRHQLPAPKAA-------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHHHHHTTCCCCCCSSC-------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             HHHHhhccCCCCCCCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            11111  1122222221       2567899999999999999999999998765543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-42  Score=335.73  Aligned_cols=269  Identities=21%  Similarity=0.310  Sum_probs=203.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      .++|.+.+.||+|+||.||+|... +|+.||||++......  .....+.+|++++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            468999999999999999999764 7899999999754432  2236788999999999999999999988764     6


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+. |+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            7899999997 5899988753    5899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCC----------cccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------
Q 013793          296 RRLHADSSN----------RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------  355 (436)
Q Consensus       296 ~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------  355 (436)
                      +........          .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......         
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            876432211          123468999999998764 678999999999999999999999986432100         


Q ss_pred             CCCC--------cccchhhhhcCCC--CC-CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          356 SSSD--------PKIMLIDVLDQRL--PP-PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       356 ~~~~--------~~~~~~~~~~~~l--~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ....        ......+......  +. ............+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence            0000        0000001111000  00 0000000112336789999999999999999999999999875443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.6e-43  Score=339.25  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  ...+.+.+|++++.+++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            46799999999999999999965 47889999999764432  2347788999999999999999999999765     3


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+++ +|.+++...    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence            68999999984 899988653    5899999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCC---cccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC---------CCCcc-
Q 013793          296 RRLHADSSN---RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS---------SSDPK-  361 (436)
Q Consensus       296 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---------~~~~~-  361 (436)
                      +........   .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........         ..... 
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            876533221   234579999999998654 4589999999999999999999999963221100         00000 


Q ss_pred             ------cchhhhhcCCCCCCCChhH----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          362 ------IMLIDVLDQRLPPPVDQKV----IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       362 ------~~~~~~~~~~l~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                            ........ .++.......    ......+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       256 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          256 LNCIINLKARNYLL-SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHTCCCHHHHHHHH-TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHhhhhhHHHHHH-hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                  00000000 0000000000    0112336789999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.3e-43  Score=331.10  Aligned_cols=260  Identities=17%  Similarity=0.283  Sum_probs=199.0

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEE-eeCCEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFC-LHKKCMF  218 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~  218 (436)
                      ..++|++.+.||+|+||+||+|.. .+++.||||++......     ..+.+|++++..++|++++..++++ ......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            457899999999999999999975 67899999987654432     4577899999999988877777665 5677889


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeecccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTA  295 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a  295 (436)
                      +||||+ +++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            999999 999999997543  25899999999999999999999   7899999999999999   78899999999999


Q ss_pred             cccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh
Q 013793          296 RRLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       296 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      +.......       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~  231 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERIS  231 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----SSSHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh----hhhhhhhhh
Confidence            87654322       1234578999999999999999999999999999999999999997432111    111111111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ......+...........+.+++.+||+.||++|||+.++++.+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            11111110000000122477899999999999999999999987543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-43  Score=347.26  Aligned_cols=264  Identities=23%  Similarity=0.269  Sum_probs=197.5

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC------E
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK------C  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  216 (436)
                      .+|.+.+.||+|+||+||+|....+..+|+|++.....       ...+|+++++.++||||+++++++...+      .
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            46889999999999999999987777799998865432       2236999999999999999999996543      3


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCCeEEeecccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTA  295 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a  295 (436)
                      .++||||++++.+............+++..++.++.|+++||+|||   +.+|+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            7899999988655444332222347899999999999999999999   78999999999999999 7999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc---
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI---  362 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~---  362 (436)
                      +....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......         .......   
T Consensus       190 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          190 KILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             EECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            87644332 3445789999999998765 58999999999999999999999996422100         0000000   


Q ss_pred             chhhhhcCCCCCCCChhHH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          363 MLIDVLDQRLPPPVDQKVI-----QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       363 ~~~~~~~~~l~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .........++........     .....+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            0000001111110000000     012347789999999999999999999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.7e-43  Score=343.27  Aligned_cols=265  Identities=23%  Similarity=0.289  Sum_probs=187.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  214 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+++++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            46899999999999999999964 578999999997643222 2346788999999999999999999998754      


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      ...++|+||+ +++|.+++...    .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999999 68999888652    6999999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc----
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP----  360 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~----  360 (436)
                      ++.....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......         .....    
T Consensus       179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432   334578999999999877 678999999999999999999999996322100         00000    


Q ss_pred             ---ccchhhhhcC--CCCCC-CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          361 ---KIMLIDVLDQ--RLPPP-VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       361 ---~~~~~~~~~~--~l~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                         .......+..  ..+.. ...........+.+|+.+||+.||++|||+.|+++|+|+..-.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence               0000000000  00000 0000001123467899999999999999999999999997643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.5e-43  Score=325.80  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=199.0

Q ss_pred             hhcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|.+.+.||+|+||+||+|...+    +..||+|.+.......  ..+.+.+|+++++.++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH--HHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch--HHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            5689999999999999999997532    3469999998764322  247889999999999999999999998754 46


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            89999999999999997543  35899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC-CCCC
Q 013793          298 LHADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPP  374 (436)
Q Consensus       298 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~  374 (436)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....       .......... ..+.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-------~~~~~~~~~~~~~~~  235 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-------KDVIGVLEKGDRLPK  235 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-------GGHHHHHHHTCCCCC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-------HHHHHHHhcCCCCCC
Confidence            644322 1233457889999999998899999999999999999998 9999863211       1111111111 1111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +..     ....+.+++.+||+.||++|||+.|+++++..
T Consensus       236 ~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          236 PDL-----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             CTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC-----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence            111     11236789999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-43  Score=334.65  Aligned_cols=254  Identities=31%  Similarity=0.437  Sum_probs=197.2

Q ss_pred             hcccccceeeecCceEEEEEEcCC-----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      ++|.+.+.||+|+||+||+|....     +..||||.+.......  ....+.+|++++..++||||+++++++...+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            467778999999999999996542     2469999998654332  236788999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999997643  36899999999999999999999   77999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC-CC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RL  372 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l  372 (436)
                      .......   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....       ......+... +.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~  269 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL  269 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCcC
Confidence            6543221   122346788999999999999999999999999999999 9999863211       1111112111 11


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +.+..     ....+.+++.+||+.||++||++.++++++...
T Consensus       270 ~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          270 PTPMD-----CPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             CCCTT-----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCccc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111     122367899999999999999999999988643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=333.60  Aligned_cols=263  Identities=20%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~  216 (436)
                      .++|++.+.||+|+||.||++.. .+++.||||++......   ..+.+.+|++++..++||||+++++++..    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH---HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            46799999999999999999976 68999999998664432   24678899999999999999999999973    347


Q ss_pred             EEEEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          217 MFLIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      .++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            899999999999999987521 2346899999999999999999999   779999999999999999999999999998


Q ss_pred             cccCCCCCC---------ccccccccccccccccccCc---cCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccc
Q 013793          296 RRLHADSSN---------RTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       296 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~  363 (436)
                      .........         .....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||+......     . .
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~  255 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-----D-S  255 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----S-C
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----c-h
Confidence            765321111         12235799999999987553   7899999999999999999999986321110     0 0


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...........+....   ....+.+++.+||+.||.+|||+.++++++....+..
T Consensus       256 ~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          256 VALAVQNQLSIPQSPR---HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HHHHHHCC--CCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             hhHHhhccCCCCcccc---CCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            1111111111111111   1123678999999999999999999999998776544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=339.43  Aligned_cols=266  Identities=19%  Similarity=0.204  Sum_probs=197.8

Q ss_pred             hhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHH--------HHHHHHHHHHHhhccCCCceeeee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAF--------IKSFRNEAQVLSQVLHRSIVKLYG  209 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~  209 (436)
                      .++|.+.+.||+|+||+||+|...    ++..+|+|++..........        ...+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357899999999999999999775    57889999987654321111        124667888999999999999999


Q ss_pred             EEee----CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          210 FCLH----KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       210 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      ++..    ....++||||+ +++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCC
Confidence            9988    77899999999 999999998654   7999999999999999999999   77999999999999999887


Q ss_pred             --CeEEeecccccccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC
Q 013793          286 --EAFVADFGTARRLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS  356 (436)
Q Consensus       286 --~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  356 (436)
                        .+||+|||+++.+.....       ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.....   
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---  265 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK---  265 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence              999999999987643221       12345799999999999999999999999999999999999999952110   


Q ss_pred             CCCcccchhhhhcCCCCCCCChh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ...............++......  .......+.+++.+||+.||++|||+.+|++.+.....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            00000000111111111100000  00112247789999999999999999999999976543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.4e-43  Score=335.40  Aligned_cols=262  Identities=26%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             hhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++|++.+.||+|+||.||+|..      .+++.||||.+.......  ....+.+|+.++.+++||||+++++++....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh--hHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            46899999999999999999974      357789999997554332  2367889999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeE
Q 013793          216 CMFLIYEYMERGSLFCILHNDDE----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAF  288 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~k  288 (436)
                      ..++||||+++|+|.+++.....    ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   +..++
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999986532    235899999999999999999999   789999999999999984   45699


Q ss_pred             EeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchh
Q 013793          289 VADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  365 (436)
                      |+|||++........  ......|++.|+|||.+.+..++.++||||||+++|||+| |+.||....       ......
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~  256 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLE  256 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-------HHHHHH
Confidence            999999976533221  2233567889999999998999999999999999999998 999986321       111111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .+....... ....   ....+.+++.+||+.||.+|||+.++++++|.....+
T Consensus       257 ~~~~~~~~~-~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          257 FVTSGGRMD-PPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHTTCCCC-CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHhcCCCCC-CCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            111111111 1111   1123678999999999999999999999998765543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=326.15  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             cccccceeeecCceEEEEEEcC-C---CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE-E
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP-N---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM-F  218 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~  218 (436)
                      .|...+.||+|+||+||+|... +   +..+|+|.+.......  ..+.+.+|+++++.++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHH--HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            4556789999999999999643 2   2379999997654332  347889999999999999999999999876655 9


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+.+|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999999997643  36899999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCC----CCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ....    .......+++.|+|||.+.+..++.++||||||+++|||+||..|+...      ... ......+......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~------~~~-~~~~~~~~~~~~~  247 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH------IDP-FDLTHFLAQGRRL  247 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCG-GGHHHHHHTTCCC
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc------CCH-HHHHHHhhcCCCC
Confidence            4321    1223456788999999999999999999999999999999966664311      111 1122222221111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +.....   ...+.+++.+||+.||.+|||+.++++.+...
T Consensus       248 ~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          248 PQPEYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccc---hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111111   12367899999999999999999999988653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=346.99  Aligned_cols=269  Identities=23%  Similarity=0.316  Sum_probs=187.6

Q ss_pred             hhcccc-cceeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CC
Q 013793          142 TEDFHI-KYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KK  215 (436)
Q Consensus       142 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  215 (436)
                      .+.|++ .++||+|+||+||+|...   +++.||||++......     ..+.+|+++++.++||||+++++++..  ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            344665 457999999999999865   5789999999865433     467789999999999999999999954  67


Q ss_pred             EEEEEEeeccCCChhhhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCC
Q 013793          216 CMFLIYEYMERGSLFCILHND------DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKL  285 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~  285 (436)
                      ..++||||+++ +|.+++...      .....+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence            89999999975 777776532      12235899999999999999999999   7899999999999999    7789


Q ss_pred             CeEEeecccccccCCCC---CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc-
Q 013793          286 EAFVADFGTARRLHADS---SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP-  360 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-  360 (436)
                      .+||+|||+++......   .......||+.|+|||++.+. .++.++|||||||++|||+||+.||............ 
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            99999999998764322   123346789999999998874 5899999999999999999999999632211000000 


Q ss_pred             -ccchhhh---hcCC-------------------------CCCCCChhHH-----HHHHHHHHHHhhccCCCCCCCCCHH
Q 013793          361 -KIMLIDV---LDQR-------------------------LPPPVDQKVI-----QDILLASTISFACLQSNPKSRPTMQ  406 (436)
Q Consensus       361 -~~~~~~~---~~~~-------------------------l~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~  406 (436)
                       ......+   +...                         ..........     .....+.+|+.+||+.||.+|||+.
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence             0000000   0000                         0000000000     0022367899999999999999999


Q ss_pred             HHHHHHhhcCCCC
Q 013793          407 YVSQGFLITRKTP  419 (436)
Q Consensus       407 ev~~~l~~~~~~~  419 (436)
                      |+++|+|+.....
T Consensus       330 e~L~hp~f~~~~~  342 (405)
T 3rgf_A          330 QAMQDPYFLEDPL  342 (405)
T ss_dssp             HHHTSGGGTSSSC
T ss_pred             HHhcChhhccCCC
Confidence            9999999987643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-42  Score=334.76  Aligned_cols=266  Identities=24%  Similarity=0.373  Sum_probs=206.3

Q ss_pred             HHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhh--ccCCCceeeeeEEeeCC-
Q 013793          139 IEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRSIVKLYGFCLHKK-  215 (436)
Q Consensus       139 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~-  215 (436)
                      ....++|.+.+.||+|+||+||+|.. +++.||||++.....      ..+.+|.+++..  ++||||+++++++.... 
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            44567899999999999999999987 589999999975432      566778888887  78999999999998876 


Q ss_pred             ---EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCCe
Q 013793          216 ---CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIIHRDISSNNILLNSKLEA  287 (436)
Q Consensus       216 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~  287 (436)
                         ..++||||+++|+|.+++...    .+++.+++.++.|++.||+|||...     +.+|+||||||+||+++.++.+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             ccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence               789999999999999999754    5899999999999999999999321     4689999999999999999999


Q ss_pred             EEeecccccccCCCCCC----ccccccccccccccccccC------ccCcchhhHHHHHHHHHHHhC----------CCC
Q 013793          288 FVADFGTARRLHADSSN----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMG----------KHP  347 (436)
Q Consensus       288 kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg----------~~p  347 (436)
                      ||+|||++.........    .....||+.|+|||.+.+.      .++.++||||||+++|||+||          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999876543321    2345699999999998765      344789999999999999999          566


Q ss_pred             ccccccccCCCCcccchhhhhcCCCCCCCChh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          348 RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      |......  ..........+......+.....  .......+.+++.+||+.||++|||+.||++++.....
T Consensus       267 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          267 YYDLVPS--DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTSCS--SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCcC--cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            6422110  00001111122222232222211  12344557889999999999999999999999876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-43  Score=340.94  Aligned_cols=254  Identities=25%  Similarity=0.382  Sum_probs=190.4

Q ss_pred             cccccceeeecCceEEEEEEcC--CC--CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CCEEE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLP--NG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKCMF  218 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  218 (436)
                      .|++.+.||+|+||+||+|...  ++  ..||||.+.......  ..+.+.+|+.++++++||||++++++|.. .+..+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH--HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            4667789999999999999753  32  368999987543322  24789999999999999999999998765 45789


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....  ..+++.+++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999997643  35889999999999999999999   789999999999999999999999999999866


Q ss_pred             CCCCC----CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCC-C
Q 013793          299 HADSS----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR-L  372 (436)
Q Consensus       299 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-l  372 (436)
                      .....    ......+++.|+|||.+.+..++.++||||||+++|||+| |..||.....       ........... .
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-------~~~~~~~~~~~~~  315 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLLQGRRL  315 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-------SCHHHHHHTTCCC
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-------HHHHHHHHcCCCC
Confidence            43221    1233457789999999999999999999999999999999 6777653211       11111122111 1


Q ss_pred             CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       373 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ..+..     ....+.+++.+||+.||++|||+.|+++++....
T Consensus       316 ~~p~~-----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          316 LQPEY-----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111     1123678999999999999999999999986543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=334.83  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      .++|++.+.||+|+||+||+|... +++    .||+|.+.......  ..+.+.+|+.++..++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            367899999999999999999753 444    35788776543222  1367889999999999999999999998765 


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++|+||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            789999999999999997653  26899999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      ........  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....        .......+.....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~  237 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISSILEKGER  237 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGHHHHHHTTCC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHcCCC
Confidence            76443322  233456788999999999999999999999999999999 999986321        1112222222221


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+....   ....+.+++.+||+.||.+|||+.|+++.+.....
T Consensus       238 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 LPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            111111   11236789999999999999999999998865443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.1e-43  Score=327.66  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=198.7

Q ss_pred             hhcccccc-eeeecCceEEEEEEc---CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKY-CIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|.+.+ .||+|+||+||+|..   .+++.||||++....... ...+.+.+|++++..++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C-HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            45778887 999999999999943   356889999997654322 2347899999999999999999999999 56678


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999998654   6899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .......   .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....       . .....+.....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~-~~~~~~~~~~~  238 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------S-EVTAMLEKGER  238 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------H-HHHHHHHTTCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------H-HHHHHHHcCCC
Confidence            6543322   122346788999999998889999999999999999999 9999863211       1 11111211111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ......   ....+.+++.+||+.||++||++.++++.+.
T Consensus       239 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          239 MGCPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             CCCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111   1223678999999999999999999998875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.5e-43  Score=344.79  Aligned_cols=262  Identities=20%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc--------CCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--------HRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~  212 (436)
                      .++|++.+.||+|+||+||+|.. .+++.||||++.....    ..+.+.+|++++..++        |+||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            36799999999999999999964 5788999999976532    2367889999999986        788999999988


Q ss_pred             ----eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCC--
Q 013793          213 ----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKL--  285 (436)
Q Consensus       213 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~--  285 (436)
                          .....++||||+ +++|.+.+.... ...+++..++.++.||+.||+|||   +. +|+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence                456799999999 556666655432 236899999999999999999999   66 999999999999999775  


Q ss_pred             -----------------------------------------------CeEEeecccccccCCCCCCcccccccccccccc
Q 013793          286 -----------------------------------------------EAFVADFGTARRLHADSSNRTLLAGTYGYIAPE  318 (436)
Q Consensus       286 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE  318 (436)
                                                                     .+||+|||+++.....   .....||+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence                                                           7999999999876433   23456899999999


Q ss_pred             ccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc--cchhhhhcC-----------------------CCC
Q 013793          319 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK--IMLIDVLDQ-----------------------RLP  373 (436)
Q Consensus       319 ~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~-----------------------~l~  373 (436)
                      ++.+..++.++|||||||++|||+||+.||.............  ....+....                       .+.
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999996432110000000  000000000                       000


Q ss_pred             C--CCC---------hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          374 P--PVD---------QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       374 ~--~~~---------~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      .  +..         .........+.+|+.+||+.||++|||+.|+++|+|+.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence            0  000         00123344578999999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.7e-43  Score=334.61  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=178.9

Q ss_pred             hhcccccc-eeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CC
Q 013793          142 TEDFHIKY-CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KK  215 (436)
Q Consensus       142 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~  215 (436)
                      .++|.+.+ .||+|+||+||+|... +++.||||++.....       ...+....+..++||||+++++++..    ..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            56788854 6999999999999765 799999999976432       11222334566799999999999976    45


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEeec
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADF  292 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df  292 (436)
                      ..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence            68999999999999999986532 36999999999999999999999   779999999999999976   455999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh--cC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL--DQ  370 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~  370 (436)
                      |+++.....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........   .......  ..
T Consensus       176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~  250 (336)
T 3fhr_A          176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY  250 (336)
T ss_dssp             TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc
Confidence            999865432  2234568999999999998899999999999999999999999986432111000   0000011  11


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ..+.+...   .....+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       251 ~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          251 GFPNPEWS---EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             CCCTTTST---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             ccCchhhc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            11111111   11223678999999999999999999999999987544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-43  Score=340.64  Aligned_cols=264  Identities=23%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             HHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC----
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK----  214 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  214 (436)
                      ...++|++.+.||+|+||+||+|.. .+|+.||||++.....       ...+|+++++.++||||+++++++...    
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            4567899999999999999999965 6899999999876532       234699999999999999999998543    


Q ss_pred             ----------------------------------CEEEEEEeeccCCChhhhhccC-CCCCCCCHHHHHHHHHHHHHHHH
Q 013793          215 ----------------------------------KCMFLIYEYMERGSLFCILHND-DEAVELDWAKRVNIVKAMAHALA  259 (436)
Q Consensus       215 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~  259 (436)
                                                        ...++||||+++ +|.+.+... .....+++..+..++.|++.||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              348899999985 777766531 12236999999999999999999


Q ss_pred             HHHhcCCCCeEecCCCCCceeec-CCCCeEEeecccccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHH
Q 013793          260 YLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVV  337 (436)
Q Consensus       260 ~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~i  337 (436)
                      |||   +.+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||+
T Consensus       156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            999   88999999999999998 68899999999998764433 23445689999999988765 58999999999999


Q ss_pred             HHHHHhCCCCcccccccc---------CCCCcccchhhh----hcCCCCCCCChhHH-----HHHHHHHHHHhhccCCCC
Q 013793          338 TLEVLMGKHPRDLLSSLS---------SSSDPKIMLIDV----LDQRLPPPVDQKVI-----QDILLASTISFACLQSNP  399 (436)
Q Consensus       338 l~elltg~~p~~~~~~~~---------~~~~~~~~~~~~----~~~~l~~~~~~~~~-----~~~~~~~~l~~~cl~~dP  399 (436)
                      +|||++|+.||.......         ...... .....    ....++......+.     .....+.+|+.+||+.||
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKE-QMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH-HHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-HHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            999999999996422110         000000 00000    00000000000000     012236789999999999


Q ss_pred             CCCCCHHHHHHHHhhcC
Q 013793          400 KSRPTMQYVSQGFLITR  416 (436)
Q Consensus       400 ~~RPt~~ev~~~l~~~~  416 (436)
                      ++|||+.|+++|+|+..
T Consensus       311 ~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             GGSCCHHHHHTSGGGHH
T ss_pred             hhCCCHHHHhcCHHHHH
Confidence            99999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.4e-42  Score=325.81  Aligned_cols=256  Identities=23%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             hhcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CCE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKC  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  216 (436)
                      ..+|++.+.||+|+||+||+|...+    ...+|+|.+.......  ..+.+.+|++++++++||||+++++++.. .+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHH--HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHH--HHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3467888999999999999997542    2368999988654332  24778999999999999999999998654 567


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence            899999999999999997543  36899999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC----CccccccccccccccccccCccCcchhhHHHHHHHHHHHhC-CCCccccccccCCCCcccchhhhhcCC
Q 013793          297 RLHADSS----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       297 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      .......    ......+|+.|+|||.+.+..++.++||||||+++|||++| ..||....       ............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~~~~~~~~~~~  249 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGR  249 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-------TTTHHHHHHTTC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-------HHHHHHHHhcCC
Confidence            6643221    12334578899999999999999999999999999999995 55554211       111111111111


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ... ....   ....+.+++.+||+.||++|||+.|+++.+...
T Consensus       250 ~~~-~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          250 RLL-QPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             CCC-CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-CCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111 0010   112367899999999999999999999988653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=332.66  Aligned_cols=255  Identities=22%  Similarity=0.312  Sum_probs=186.2

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEe-------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCL-------  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------  212 (436)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++......   ....+.+|+.++.++. ||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH---HHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            35789999999999999999975 47899999998655432   2367889999999996 999999999994       


Q ss_pred             -eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeecCCCCeEE
Q 013793          213 -HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLEAFV  289 (436)
Q Consensus       213 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl  289 (436)
                       .....++||||+. |+|.+++........+++.+++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence             3446899999996 699988875333447999999999999999999999   677  999999999999999999999


Q ss_pred             eecccccccCCCCCC------------cccccccccccccccc---ccCccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          290 ADFGTARRLHADSSN------------RTLLAGTYGYIAPELA---YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       290 ~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                      +|||+++........            .....||+.|+|||.+   .+..++.++||||||+++|||+||+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221            1134589999999998   5667899999999999999999999998632211


Q ss_pred             cCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          355 SSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       355 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .       ................       .+.+++.+||+.||++|||+.|++++++....
T Consensus       260 ~-------~~~~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 R-------IVNGKYSIPPHDTQYT-------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -------------CCCCTTCCSSG-------GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-------hhcCcccCCcccccch-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0       0111111111111111       25678999999999999999999999976543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.1e-43  Score=328.71  Aligned_cols=261  Identities=24%  Similarity=0.330  Sum_probs=207.2

Q ss_pred             HHhhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          140 EATEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       140 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ...++|++.+.||+|+||.||+|... +++.||+|++........ ....+.+|++++++++||||+++++++...+..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            34678999999999999999999765 789999999865432211 1367889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CCeEEeecccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTA  295 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a  295 (436)
                      +|+||+++++|.+++....   .+++.+++.++.|++.||+|||   +.+++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999999887543   6899999999999999999999   7899999999999999764   46999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ....... ......|++.|+|||.+.+. ++.++||||||+++|+|++|+.||....       .......+........
T Consensus       172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~  242 (287)
T 2wei_A          172 TCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFD  242 (287)
T ss_dssp             GTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCC
T ss_pred             eeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCC
Confidence            8764332 22334589999999988754 8999999999999999999999986321       1111222222222111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ... .......+.+++.+||+.||++|||+.|+++++|+...
T Consensus       243 ~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          243 LPQ-WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             SGG-GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             chh-hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            110 01112236789999999999999999999999998653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-42  Score=332.40  Aligned_cols=263  Identities=20%  Similarity=0.304  Sum_probs=204.1

Q ss_pred             hhcccccceeeecCceEEEEEEc--CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC------ceeeeeEEee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS------IVKLYGFCLH  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  213 (436)
                      .++|++.+.||+|+||+||+|..  .+++.||||++.....    ..+.+.+|++++..++|++      ++++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            35799999999999999999975  4788999999976532    2367888999999887664      9999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS----------  283 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~----------  283 (436)
                      .+..++||||+ +++|.+++..... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999 8899999976542 36899999999999999999999   789999999999999987          


Q ss_pred             ---------CCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          284 ---------KLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       284 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                               ++.+||+|||+++.....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                     668999999999865332   23457899999999999999999999999999999999999998632210


Q ss_pred             cC--------CCCcccchhhh----------------------h---cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCC
Q 013793          355 SS--------SSDPKIMLIDV----------------------L---DQRLPPPVDQKVIQDILLASTISFACLQSNPKS  401 (436)
Q Consensus       355 ~~--------~~~~~~~~~~~----------------------~---~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~  401 (436)
                      ..        ...+.......                      .   ...+.. ...........+.+++.+||+.||.+
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG-GCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhh-hcccchhhHHHHHHHHHHHhCcCccc
Confidence            00        00000000000                      0   000000 00001122345779999999999999


Q ss_pred             CCCHHHHHHHHhhcCC
Q 013793          402 RPTMQYVSQGFLITRK  417 (436)
Q Consensus       402 RPt~~ev~~~l~~~~~  417 (436)
                      |||+.|+++|+|+..-
T Consensus       320 Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          320 RITLREALKHPFFDLL  335 (339)
T ss_dssp             SCCHHHHTTSGGGGGG
T ss_pred             ccCHHHHhcCHHHHHH
Confidence            9999999999999653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.5e-43  Score=330.21  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=195.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC--CCC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||+||+|.+.  +++  .||||+++..........+.+.+|++++.+++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467899999999999999999742  333  68999987654333334578899999999999999999999998765 8


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++|+||+++|+|.+++....  ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999997542  35899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....       .......+......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGER  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-------HHHHHHHHHccCCC
Confidence            6543322   223457888999999998889999999999999999999 999986321       11112222222111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .+....   ....+.+++.+||+.||++|||+.++++++....+.
T Consensus       244 ~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          244 LPRPED---CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCCCcC---cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            111111   122367899999999999999999999998765543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.8e-43  Score=345.32  Aligned_cols=262  Identities=24%  Similarity=0.324  Sum_probs=194.6

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------C
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------K  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  215 (436)
                      .+|++.+.||+|+||.||+|... +|+.||||++.....       ...+|+++++.++||||+++++++...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            46888999999999999999764 699999999876432       234699999999999999999998642      2


Q ss_pred             EEEEEEeeccCCChhhhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CCeEEeecc
Q 013793          216 CMFLIYEYMERGSLFCILHN-DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFG  293 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg  293 (436)
                      ..++||||+++ ++.+.+.. ......+++..++.++.||++||+|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence            36799999986 55555432 112346999999999999999999999   8899999999999999965 568999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCccccccccCC-------CCcccchh
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSS-------SDPKIMLI  365 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-------~~~~~~~~  365 (436)
                      +++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.........       ..+.....
T Consensus       203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9987644332 3345789999999998765 7899999999999999999999999642210000       00000000


Q ss_pred             hhhcC-----CCCCCCChhHH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          366 DVLDQ-----RLPPPVDQKVI-----QDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       366 ~~~~~-----~l~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ....+     .++......+.     .....+.+|+.+||+.||.+|||+.|+++|+|+..
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence            00000     11100000000     01234778999999999999999999999999964

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.9e-43  Score=330.19  Aligned_cols=256  Identities=26%  Similarity=0.465  Sum_probs=196.4

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee------
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH------  213 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  213 (436)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+....    ...+.+.+|++++++++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            357899999999999999999975 479999999996532    224778899999999999999999998865      


Q ss_pred             -------CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC
Q 013793          214 -------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  286 (436)
Q Consensus       214 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  286 (436)
                             ....++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCC
Confidence                   456899999999999999997543  35788999999999999999999   779999999999999999999


Q ss_pred             eEEeecccccccCCCC--------------CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccc
Q 013793          287 AFVADFGTARRLHADS--------------SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLL  351 (436)
Q Consensus       287 ~kl~Dfg~a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~  351 (436)
                      ++|+|||++.......              .......|++.|+|||.+.+. .++.++||||||+++|||++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            9999999998654221              112345689999999998764 78999999999999999998   44311


Q ss_pred             ccccCCCCcccchhhhhc--CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          352 SSLSSSSDPKIMLIDVLD--QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..      .......+..  ..++.....   .....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       232 ~~------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          232 ME------RVNILKKLRSVSIEFPPDFDD---NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HH------HHHHHHHHHSTTCCCCTTCCT---TTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hh------HHHHHHhccccccccCccccc---cchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            00      0001111111  112222211   112236689999999999999999999999999654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-42  Score=332.14  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=200.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCE--EEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKV--FALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||.||+|... ++..  +|+|.+......  ...+.+.+|++++.++ +||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            367899999999999999999764 5554  499998754322  2236788999999999 899999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          218 FLIYEYMERGSLFCILHNDD-------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      ++||||+++|+|.+++....             ....+++.+++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCC
Confidence            99999999999999997653             2346899999999999999999999   7899999999999999999


Q ss_pred             CCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccc
Q 013793          285 LEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIM  363 (436)
Q Consensus       285 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  363 (436)
                      +.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....       .. 
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~-  249 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-  249 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HH-
Confidence            99999999999754322 12233457889999999998889999999999999999998 9999863211       11 


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..+.+...........   ....+.+++.+||+.||++|||+.|+++++..
T Consensus       250 ~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          250 LYEKLPQGYRLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HHHHGGGTCCCCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111111111111111   11236789999999999999999999998864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=331.16  Aligned_cols=266  Identities=22%  Similarity=0.260  Sum_probs=195.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEe--------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCL--------  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------  212 (436)
                      .++|.+.+.||+|+||.||+|... +++.||+|++......   ..+.+.+|++++++++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH---HHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            367889999999999999999765 5899999999765432   2477889999999999999999999873        


Q ss_pred             ------eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCC
Q 013793          213 ------HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKL  285 (436)
Q Consensus       213 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~  285 (436)
                            +....++||||++ |+|.+++...    .+++..++.++.|++.||+|||   +.+|+||||||+||+++ +++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence                  4467899999998 5999998643    5899999999999999999999   78999999999999997 567


Q ss_pred             CeEEeecccccccCCCCC---Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccC-----
Q 013793          286 EAFVADFGTARRLHADSS---NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS-----  356 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-----  356 (436)
                      .+||+|||+++.......   ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........     
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999987643221   2233457899999998765 6789999999999999999999999964321100     


Q ss_pred             ---CCCcccchhhhh-------cCCCCCCC-C--hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          357 ---SSDPKIMLIDVL-------DQRLPPPV-D--QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       357 ---~~~~~~~~~~~~-------~~~l~~~~-~--~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                         .........+..       ......+. .  .........+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence               000000000000       00000000 0  00001123477899999999999999999999999997543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=337.62  Aligned_cols=247  Identities=16%  Similarity=0.204  Sum_probs=195.6

Q ss_pred             HhhcccccceeeecCceEEEEEE------cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc---CCCceeeeeEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRSIVKLYGFC  211 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~  211 (436)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||++.....      ..+..|.+++..++   |+|++++++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            35679999999999999999993      45788999999987643      45666777777775   99999999999


Q ss_pred             eeCCEEEEEEeeccCCChhhhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC------
Q 013793          212 LHKKCMFLIYEYMERGSLFCILHNDD--EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS------  283 (436)
Q Consensus       212 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~------  283 (436)
                      ...+..++||||+++|+|.+++....  ....+++..++.|+.|++.||+|||   +.+|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcc
Confidence            99999999999999999999997421  2346999999999999999999999   889999999999999998      


Q ss_pred             -----CCCeEEeecccccccCC--CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccC
Q 013793          284 -----KLEAFVADFGTARRLHA--DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSS  356 (436)
Q Consensus       284 -----~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~  356 (436)
                           ++.+||+|||+++.+..  .........||++|+|||++.+..++.++|||||||++|||+||+.||......  
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--  291 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--  291 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence                 89999999999976532  222334567999999999999999999999999999999999999998632210  


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHH
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSR-PTMQYVSQGF  412 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Pt~~ev~~~l  412 (436)
                          ...    ....+.....      ...+.+++..|++.+|.+| |+++++.+.+
T Consensus       292 ----~~~----~~~~~~~~~~------~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          292 ----ECK----PEGLFRRLPH------LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             ----EEE----ECSCCTTCSS------HHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             ----cee----echhccccCc------HHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence                000    1111111111      1224578889999999998 5666665544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=357.52  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=205.1

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++.....    .+.+.+|++++++++||||+++++++.+ +..++|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            35678889999999999999999988888999999875533    2678899999999999999999999876 668999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999997532 225899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          301 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       301 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      ... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....       .. ..+.+......+...
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~-~~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------RE-VLDQVERGYRMPCPP  487 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HH-HHHHHHTTCCCCCCT
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcCCCCCCCC
Confidence            211 1223346788999999999999999999999999999999 9999863211       11 111111111111111


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .   ....+.+|+.+||+.||++|||+.++++.+...-
T Consensus       488 ~---~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          488 E---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1   1223678999999999999999999999987543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.2e-42  Score=337.78  Aligned_cols=266  Identities=22%  Similarity=0.325  Sum_probs=203.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CC-----CceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HR-----SIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||+||+|... +++.||||++.....    ....+..|++++..++ |+     +++++.+++...
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            578999999999999999999754 788999999986532    2366778888888885 45     499999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCCeEEeec
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLEAFVADF  292 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Df  292 (436)
                      +..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||.. ..+|+||||||+|||++  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 599999976532 3589999999999999999999942 46899999999999994  4788999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc---
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP---  360 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~---  360 (436)
                      |+++.....   .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......         .....   
T Consensus       206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL  282 (382)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999876432   234578999999999999999999999999999999999999997322100         00000   


Q ss_pred             --ccchhhhhcC----------------CCCCCC----------------------ChhHHHHHHHHHHHHhhccCCCCC
Q 013793          361 --KIMLIDVLDQ----------------RLPPPV----------------------DQKVIQDILLASTISFACLQSNPK  400 (436)
Q Consensus       361 --~~~~~~~~~~----------------~l~~~~----------------------~~~~~~~~~~~~~l~~~cl~~dP~  400 (436)
                        .......+..                ...++.                      ......+...+.+|+.+||+.||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence              0000000000                000000                      000112234578999999999999


Q ss_pred             CCCCHHHHHHHHhhcCC
Q 013793          401 SRPTMQYVSQGFLITRK  417 (436)
Q Consensus       401 ~RPt~~ev~~~l~~~~~  417 (436)
                      +|||+.|+++|+|++..
T Consensus       363 ~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          363 TRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TSCCHHHHTTSGGGCC-
T ss_pred             hCCCHHHHhcCcccccC
Confidence            99999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-42  Score=338.42  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=199.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE---
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM---  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  217 (436)
                      .++|.+.+.||+|+||+||+|.. .+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...+..   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch-hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            46789999999999999999965 478999999997654332 2347888999999999999999999999877654   


Q ss_pred             ---EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          218 ---FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       218 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                         ++||||+. ++|.+++..     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 588887742     4899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCC-----
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSD-----  359 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~-----  359 (436)
                      ++.....   .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......         ....     
T Consensus       191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            9865332   334568999999999887 688999999999999999999999996322100         0000     


Q ss_pred             --cccchhhhhcCCCCCCCC---hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          360 --PKIMLIDVLDQRLPPPVD---QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       360 --~~~~~~~~~~~~l~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                        ...............+..   .........+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence              000000000000000000   0000112347789999999999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-42  Score=332.19  Aligned_cols=271  Identities=24%  Similarity=0.322  Sum_probs=202.7

Q ss_pred             HhhcccccceeeecCceEEEEEEc--CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc---cCCCceeeeeEEe---
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRSIVKLYGFCL---  212 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---  212 (436)
                      +.++|++.+.||+|+||.||+|..  .+|+.||+|++........ ....+.+|+.++..+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            457899999999999999999976  4688999999865432210 013455677776666   8999999999987   


Q ss_pred             --eCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          213 --HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       213 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                        .....++||||++ |+|.+++..... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999998 699999876542 25899999999999999999999   7899999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcc
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPK  361 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~  361 (436)
                      |||+++...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......         ......
T Consensus       163 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            999998654322 2334568999999999999999999999999999999999999986322100         000000


Q ss_pred             cc------hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          362 IM------LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       362 ~~------~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .+      ...........+...........+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            00      0000000000000000001122366899999999999999999999999997654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-42  Score=324.70  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=195.5

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-CEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-KCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv  220 (436)
                      .++|++.+.||+|+||+||++.. +|+.||||.+.....     .+.+.+|++++.+++||||+++++++.+. +..++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            46799999999999999999987 488999999986542     26788999999999999999999997654 478999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999999997542 123789999999999999999999   78999999999999999999999999999976533


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      .   .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....       .. ....+...........
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~~  238 (278)
T 1byg_A          170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KD-VVPRVEKGYKMDAPDG  238 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-------GG-HHHHHTTTCCCCCCTT
T ss_pred             c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcCCCCCCccc
Confidence            2   223457889999999999999999999999999999998 9999863211       11 1111111111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                         ....+.+++.+||+.||++|||+.|+++.+...+
T Consensus       239 ---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          239 ---CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence               1223678999999999999999999999886543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=330.73  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=204.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-----CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  215 (436)
                      .++|++.+.||+|+||.||++..     .+++.||||++.......   .+.+.+|++++.+++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH---HHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH---HHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            45688999999999999999973     468899999998754332   367899999999999999999999987654 


Q ss_pred             -EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          216 -CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       216 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                       ..++||||+++++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence             6799999999999999997653  25899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccc-----ccCCCCccc---c
Q 013793          295 ARRLHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS-----LSSSSDPKI---M  363 (436)
Q Consensus       295 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-----~~~~~~~~~---~  363 (436)
                      ++........   .....++..|+|||.+.+..++.++||||||+++|||+||+.|+.....     .........   .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9876544321   2234577789999999988999999999999999999999998763210     000000000   1


Q ss_pred             hhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          364 LIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       364 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ..+.+......+....   ....+.+++.+||+.||++|||+.|+++.+...
T Consensus       272 ~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1122222111111111   122367899999999999999999999988654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=356.89  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=194.4

Q ss_pred             cccccc-eeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEE
Q 013793          144 DFHIKY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       144 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++......  ..+.+.+|++++++++|||||+++++|.. +..++
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            344444 7999999999999653   56679999998653221  23788999999999999999999999976 56899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      ||||+++|+|.+++....  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999997543  36999999999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          300 ADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       300 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      .....   .....+++.|+|||++.+..++.++|||||||++|||+| |+.||.....       .. ..+.+.......
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~-~~~~i~~~~~~~  559 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PE-VMAFIEQGKRME  559 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-------HH-HHHHHHTTCCCC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-------HH-HHHHHHcCCCCC
Confidence            43321   122345689999999999999999999999999999998 9999863211       11 112222111111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ....   ....+.+++.+||+.||++||++.+|++.+.
T Consensus       560 ~p~~---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          560 CPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             CCTT---CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1111   1223678999999999999999999987764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-42  Score=332.62  Aligned_cols=260  Identities=25%  Similarity=0.305  Sum_probs=181.7

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHH-HHhhccCCCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++........  ...+..|+. +++.++||||+++++++...+..++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH--HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH--HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            36788899999999999999976 4789999999976543322  245555555 7777899999999999999999999


Q ss_pred             EEeeccCCChhhhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHND--DEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      ||||+++ +|.+++...  .....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999986 777776531  11236899999999999999999999   66 99999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccccccc----ccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC--
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELA----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ--  370 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  370 (436)
                      ...... ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........      ........  
T Consensus       175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~  247 (327)
T 3aln_A          175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVKGDP  247 (327)
T ss_dssp             C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred             eccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhcCCC
Confidence            764332 22334689999999998    456789999999999999999999999864221100      01111111  


Q ss_pred             -CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          371 -RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       371 -~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                       .++.....   .....+.+++.+||+.||++|||+.|+++++|+...
T Consensus       248 ~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          248 PQLSNSEER---EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCCCCSSC---CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCcccc---cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence             11111100   011236789999999999999999999999998643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-42  Score=343.46  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=189.8

Q ss_pred             cccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEEe
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      .|...+.||+|+||+||.+...+|+.||||++.....      +.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3455688999999999877667899999999875432      4567899999887 89999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-------------C
Q 013793          223 YMERGSLFCILHNDDEAV----ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-------------L  285 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~-------------~  285 (436)
                      |+. |+|.+++.......    ..++..++.++.||+.||+|||   +.+|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence            996 69999998654211    1234456789999999999999   7899999999999999754             4


Q ss_pred             CeEEeecccccccCCCCCC----cccccccccccccccccc-------CccCcchhhHHHHHHHHHHHh-CCCCcccccc
Q 013793          286 EAFVADFGTARRLHADSSN----RTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSS  353 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~  353 (436)
                      .+||+|||+++........    .....||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.... 
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-  244 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-  244 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT-
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch-
Confidence            8999999999877543321    234579999999999875       578999999999999999999 999986211 


Q ss_pred             ccCCCCcccchhhhhcCCCC--CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          354 LSSSSDPKIMLIDVLDQRLP--PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                           ..   ...++.....  .............+.+++.+||+.||++|||+.||++|+|+..
T Consensus       245 -----~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          245 -----SR---ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -----TH---HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -----hh---HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                 00   1111111111  1000011223345778999999999999999999999999853

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8e-42  Score=332.46  Aligned_cols=265  Identities=18%  Similarity=0.245  Sum_probs=202.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-----------CCCceeeee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----------HRSIVKLYG  209 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~  209 (436)
                      .++|.+.+.||+|+||+||+|.. .+++.||||++......    ...+.+|++++.+++           ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            35799999999999999999975 57899999999865332    366788999988886           899999999


Q ss_pred             EEeeCC----EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeec--
Q 013793          210 FCLHKK----CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLN--  282 (436)
Q Consensus       210 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~--  282 (436)
                      ++...+    ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||   +. +|+||||||+|||++  
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEecc
Confidence            998654    789999999 8899999976432 35899999999999999999999   66 999999999999994  


Q ss_pred             ----CCCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCC
Q 013793          283 ----SKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS  358 (436)
Q Consensus       283 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~  358 (436)
                          ..+.+||+|||+++.....   .....||+.|+|||.+.+..++.++||||||+++|||+||+.||..........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence                4457999999999876432   234568999999999999999999999999999999999999997432110000


Q ss_pred             Ccccchhhhh---cC-----------------------CCCC-CCC----------hhHHHHHHHHHHHHhhccCCCCCC
Q 013793          359 DPKIMLIDVL---DQ-----------------------RLPP-PVD----------QKVIQDILLASTISFACLQSNPKS  401 (436)
Q Consensus       359 ~~~~~~~~~~---~~-----------------------~l~~-~~~----------~~~~~~~~~~~~l~~~cl~~dP~~  401 (436)
                       .......+.   ..                       .+.. ...          .........+.+|+.+||+.||++
T Consensus       246 -~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          246 -DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             -HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             -hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence             000000000   00                       0000 000          001233445779999999999999


Q ss_pred             CCCHHHHHHHHhhcCCCC
Q 013793          402 RPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       402 RPt~~ev~~~l~~~~~~~  419 (436)
                      |||+.|+++|+|+.....
T Consensus       325 Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          325 RADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             CBCHHHHHTCGGGTTCTT
T ss_pred             cCCHHHHhhChhhhcccC
Confidence            999999999999987644

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=332.25  Aligned_cols=263  Identities=24%  Similarity=0.288  Sum_probs=199.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC----  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  216 (436)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.++..++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            35788899999999999999975 47899999999765432 2234778899999999999999999999987654    


Q ss_pred             --EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          217 --MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       217 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                        .++||||++ ++|.+++..     .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence              499999998 588887743     4899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCC-----
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSD-----  359 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~-----  359 (436)
                      ++.....   .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......         ....     
T Consensus       173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865332   234568999999999877 678999999999999999999999997422100         0000     


Q ss_pred             --cccchhhhhc---CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          360 --PKIMLIDVLD---QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       360 --~~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                        ........+.   .................+.+++.+||+.||++|||+.|+++|+|+..-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence              0000000000   000000000001112346789999999999999999999999999754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.4e-42  Score=357.39  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=193.8

Q ss_pred             ceeeecCceEEEEEEc---CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeecc
Q 013793          149 YCIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~---~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      +.||+|+||.||+|.+   .+++.||||+++...... ...+.+.+|++++.+++|||||+++++|.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999954   356789999997654322 223789999999999999999999999965 45889999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCC--
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS--  303 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  303 (436)
                      +|+|.+++....   .+++.+++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus       453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999997654   6899999999999999999999   78999999999999999999999999999987654332  


Q ss_pred             -CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          304 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       304 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                       ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....       . ...+.+...........  
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~-~~~~~i~~~~~~~~p~~--  596 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------S-EVTAMLEKGERMGCPAG--  596 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------H-HHHHHHHTTCCCCCCTT--
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHHcCCCCCCCCC--
Confidence             1233446788999999999999999999999999999998 9999863221       1 11222222111111111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                       ....+.+++.+||+.||++||++.+|++.+..
T Consensus       597 -~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          597 -CPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             -CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             12236789999999999999999999988753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=341.98  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=191.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..+|.+.+.||+|+||+||.....+++.||||++.....      ..+.+|++++..+ +|||||++++++.+....++|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            346888899999999997766666899999999976543      2345799999999 799999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCCeEEeecccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFGTA  295 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a  295 (436)
                      |||++ |+|.+++.....  .+.+.+++.++.||+.||+|||   +.+|+||||||+|||++.     ...+||+|||++
T Consensus        97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            99997 599999976542  3455567899999999999999   789999999999999943     346789999999


Q ss_pred             cccCCCC---CCccccccccccccccccc---cCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhh
Q 013793          296 RRLHADS---SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       296 ~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      +......   .......||++|+|||.+.   ...++.++|||||||++|||+| |+.||....       . . .....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-------~-~-~~~~~  241 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-------Q-R-QANIL  241 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-------T-H-HHHHH
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-------H-H-HHHHH
Confidence            8765432   1234467999999999987   4567889999999999999999 999985211       0 0 11111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ..................+.+++.+||+.||.+|||+.||++|+|+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            111110000001122334678999999999999999999999999854

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-41  Score=328.64  Aligned_cols=266  Identities=21%  Similarity=0.283  Sum_probs=202.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CC-CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC------ceeeeeEEee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS------IVKLYGFCLH  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  213 (436)
                      .++|++.+.||+|+||+||+|... ++ +.||+|++.....    ....+.+|++++..++|++      ++.+.+++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            468999999999999999999754 44 6899999976432    2367788999999998766      8999999999


Q ss_pred             CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee------------
Q 013793          214 KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL------------  281 (436)
Q Consensus       214 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill------------  281 (436)
                      .+..++||||+ ++++.+++.... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||+            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccc
Confidence            99999999999 667777766543 236899999999999999999999   8899999999999999            


Q ss_pred             -------cCCCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc
Q 013793          282 -------NSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL  354 (436)
Q Consensus       282 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~  354 (436)
                             +.++.+||+|||+++.....   .....||+.|+|||.+.+..++.++||||||+++|||+||+.||......
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   67889999999999865332   23457999999999999999999999999999999999999999632210


Q ss_pred             cC--------CCCcccchhhhh------cC--CCCCCC----------------ChhHHHHHHHHHHHHhhccCCCCCCC
Q 013793          355 SS--------SSDPKIMLIDVL------DQ--RLPPPV----------------DQKVIQDILLASTISFACLQSNPKSR  402 (436)
Q Consensus       355 ~~--------~~~~~~~~~~~~------~~--~l~~~~----------------~~~~~~~~~~~~~l~~~cl~~dP~~R  402 (436)
                      ..        ...+........      ..  ......                ..........+.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            00        000000000000      00  000000                00001123357789999999999999


Q ss_pred             CCHHHHHHHHhhcCCCC
Q 013793          403 PTMQYVSQGFLITRKTP  419 (436)
Q Consensus       403 Pt~~ev~~~l~~~~~~~  419 (436)
                      ||+.|+++|+|+....+
T Consensus       326 pt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CCHHHHTTSGGGGGCCH
T ss_pred             cCHHHHhcChhhcCCCh
Confidence            99999999999986543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5e-42  Score=343.33  Aligned_cols=258  Identities=18%  Similarity=0.283  Sum_probs=200.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC-CCceeeeeEEeeCCEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l  219 (436)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     ..+.+|++++..++| +++..+..++...+..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            36799999999999999999975 67999999988765432     457789999999976 556666667778889999


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~  296 (436)
                      ||||+ +++|.+++....  ..+++.+++.|+.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++
T Consensus        81 vme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            99999 999999997543  26999999999999999999999   7899999999999999   688999999999998


Q ss_pred             ccCCCCCC-------ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc
Q 013793          297 RLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD  369 (436)
Q Consensus       297 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  369 (436)
                      .+......       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......    ........+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~  230 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISE  230 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch----hHHHHHHHHhh
Confidence            76543321       22567999999999999999999999999999999999999999742210    00011111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          370 QRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       370 ~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .................+.+++..||+.||++||++.+|++.+..
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          231 KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            111110000000112347789999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=335.27  Aligned_cols=255  Identities=18%  Similarity=0.236  Sum_probs=198.5

Q ss_pred             hcccccceeeecCceEEEEEEcCC---------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCcee-------
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPN---------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVK-------  206 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------  206 (436)
                      ++|.+.+.||+|+||.||+|....         ++.||+|.+...        ..+.+|++++.+++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            679999999999999999997653         789999998754        35678999999999999987       


Q ss_pred             --------eeeEEee-CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 013793          207 --------LYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  277 (436)
Q Consensus       207 --------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~  277 (436)
                              +++++.. ....++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||   +.+|+||||||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~  188 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE  188 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence                    6777776 77899999999 999999998652 237999999999999999999999   779999999999


Q ss_pred             ceeecCCC--CeEEeecccccccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCc
Q 013793          278 NILLNSKL--EAFVADFGTARRLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR  348 (436)
Q Consensus       278 Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  348 (436)
                      |||++.++  .+||+|||+++.+.....       ......||+.|+|||.+.+..++.++||||||+++|||+||+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  899999999987643221       123357999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCcccchhhh---hcCCCCCCCCh--hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          349 DLLSSLSSSSDPKIMLIDV---LDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~---~~~~l~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .....     .. ......   ...........  ........+.+++.+||+.||++|||+.++++.+....
T Consensus       269 ~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          269 TNCLP-----NT-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GGGTT-----CH-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCc-----CH-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            74321     00 001110   01111000000  00001123678999999999999999999999886543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=326.96  Aligned_cols=253  Identities=21%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             HHHhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhc----cCCCceeeeeE
Q 013793          139 IEATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQV----LHRSIVKLYGF  210 (436)
Q Consensus       139 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l----~h~niv~l~~~  210 (436)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++........   .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999976 4789999999976543221   1123456799999998    89999999999


Q ss_pred             EeeCCEEEEEEee-ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCCeE
Q 013793          211 CLHKKCMFLIYEY-MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEAF  288 (436)
Q Consensus       211 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k  288 (436)
                      +...+..++|+|| +++++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++ .++.++
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 89999999997643   6899999999999999999999   77999999999999999 889999


Q ss_pred             EeecccccccCCCCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhh
Q 013793          289 VADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV  367 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  367 (436)
                      |+|||+++.....  ......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....             +.
T Consensus       181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~  245 (312)
T 2iwi_A          181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------EI  245 (312)
T ss_dssp             ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HH
T ss_pred             EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------HH
Confidence            9999999876433  2344568999999999887766 458999999999999999999986321             11


Q ss_pred             hcCC--CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          368 LDQR--LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       368 ~~~~--l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ....  ++...+       ..+.+++.+||+.||++|||+.|+++++|+.....
T Consensus       246 ~~~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          246 LEAELHFPAHVS-------PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHTCCCCCTTSC-------HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             hhhccCCcccCC-------HHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            1111  111121       23668999999999999999999999999987644

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-42  Score=330.27  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=203.9

Q ss_pred             HhhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhcc--CCCceeeeeEEeeC
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVL--HRSIVKLYGFCLHK  214 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~  214 (436)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++........   .....+.+|++++.+++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            356799999999999999999964 5789999999976432110   01145667999999996  59999999999999


Q ss_pred             CEEEEEEeeccC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCCeEEeec
Q 013793          215 KCMFLIYEYMER-GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADF  292 (436)
Q Consensus       215 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df  292 (436)
                      +..++|+|++.+ ++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999976 89999987643   6899999999999999999999   78999999999999999 7899999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          293 GTARRLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       293 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      |+++.....  ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||.....             .....
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~  259 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ  259 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhccc
Confidence            999876432  2334568999999999887765 7889999999999999999999863221             11111


Q ss_pred             --CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          372 --LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       372 --l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                        .+...+       ..+.+++.+||+.||++|||+.|+++++|+....
T Consensus       260 ~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 VFFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCCSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccccccCC-------HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              111111       2366899999999999999999999999997664

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.5e-42  Score=324.88  Aligned_cols=259  Identities=24%  Similarity=0.316  Sum_probs=184.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||.||+|... +|+.||||++........ ..+.+.++..++..++||||+++++++...+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            467889999999999999999764 789999999976644322 224455555678888999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeecCCCCeEEeecccccccC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARRLH  299 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  299 (436)
                      |||+ ++.+..+....  ...+++..++.++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 45555554432  236899999999999999999999   53 99999999999999999999999999997664


Q ss_pred             CCCCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          300 ADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ... ......|++.|+|||.+.     ...++.++||||||+++|||++|+.||....      ..............+.
T Consensus       177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------TDFEVLTKVLQEEPPL  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHHSCCCC
T ss_pred             CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------ccHHHHHHHhccCCCC
Confidence            332 233456899999999984     4568899999999999999999999986311      1111122222221110


Q ss_pred             -CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          375 -PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       375 -~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                       +...   .....+.+++.+||+.||.+|||+.|+++|+|+.+.
T Consensus       250 ~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          250 LPGHM---GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCSSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCccC---CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence             1000   011236688999999999999999999999998653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=327.12  Aligned_cols=259  Identities=20%  Similarity=0.340  Sum_probs=196.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ..++|++.+.||+|+||.||+|...+  .+|+|.+........ ..+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            35678999999999999999998754  489999875432211 124577899999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++ ++.++|+|||+++....
T Consensus       108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            99999999999997643  36899999999999999999999   78999999999999998 67999999999876532


Q ss_pred             C-----CCCcccccccccccccccccc---------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhh
Q 013793          301 D-----SSNRTLLAGTYGYIAPELAYT---------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID  366 (436)
Q Consensus       301 ~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  366 (436)
                      .     ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||....       .......
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~  254 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEAIIWQ  254 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-------HHHHHHH
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH
Confidence            1     112233468999999998864         357889999999999999999999986321       1111111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          367 VLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       367 ~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ......+......   ....+.+++.+||+.||++|||+.++++.+......
T Consensus       255 ~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          255 MGTGMKPNLSQIG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHTTCCCCCCCSS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             hccCCCCCCCcCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1111111110000   011266889999999999999999999999766554

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.9e-41  Score=347.64  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             HhhcccccceeeecCceEEEEEEcC----CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE
Q 013793          141 ATEDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC  216 (436)
Q Consensus       141 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  216 (436)
                      ..++|++.+.||+|+||+||+|...    .+..||||.+.......  ..+.+.+|+.++++++||||+++++++.+ +.
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~  464 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIVKLIGVITE-NP  464 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence            3567888999999999999999764    24679999987654332  34778999999999999999999999854 56


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            899999999999999997543  35899999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCC-CC
Q 013793          297 RLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQR-LP  373 (436)
Q Consensus       297 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-l~  373 (436)
                      ........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....       ......+.... .+
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~~  612 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERLP  612 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHHTCCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCCCC
Confidence            76443221 223456789999999998899999999999999999997 9999863211       11111121111 11


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+..     ....+.+++.+||+.||++|||+.|+++.+..
T Consensus       613 ~~~~-----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          613 MPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcc-----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111     11236789999999999999999999998854

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-41  Score=348.55  Aligned_cols=268  Identities=24%  Similarity=0.274  Sum_probs=203.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee------C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH------K  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~  214 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......  ...+.+.+|++++.+++||||+++++++..      .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            46899999999999999999976 47899999998765332  224778999999999999999999998765      6


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC---eEEee
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVAD  291 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  291 (436)
                      +..++||||+++|+|.+++........+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.   ++|+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            678999999999999999987665557999999999999999999999   789999999999999997765   89999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc---cCC----CCcccch
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL---SSS----SDPKIML  364 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~---~~~----~~~~~~~  364 (436)
                      ||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......   ...    .......
T Consensus       168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99998765433 234467999999999999999999999999999999999999998632110   000    0000000


Q ss_pred             hhhh------cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          365 IDVL------DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       365 ~~~~------~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      .+..      ...++.+.. ........+.+++.+||+.||++|||+.|+++++|+..
T Consensus       247 ~~~l~g~~~~~~~lp~p~~-l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNH-LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCC-CCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhccccccccccCCchh-hchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            0000      111111110 01112334778999999999999999999988888654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.3e-40  Score=311.49  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=186.0

Q ss_pred             hhccccc-ceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHH-hhccCCCceeeeeEEee----C
Q 013793          142 TEDFHIK-YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHRSIVKLYGFCLH----K  214 (436)
Q Consensus       142 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~  214 (436)
                      .++|.+. +.||+|+||.||++.. .+++.||+|++...        ..+.+|++++ ...+||||+++++++..    .
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            3567776 7899999999999965 57899999999653        3456788887 55589999999999987    6


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEee
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVAD  291 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  291 (436)
                      ...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.++|+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence            778999999999999999986532 36899999999999999999999   789999999999999998   78899999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      ||++....                      +..++.++||||||+++|||+||+.||...........   .........
T Consensus       164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~  218 (299)
T 3m2w_A          164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQ  218 (299)
T ss_dssp             CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTC
T ss_pred             cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhcc
Confidence            99986532                      23467899999999999999999999964322110000   000000111


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccc
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKH  423 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~  423 (436)
                      ...+ ..........+.+++.+||+.||++|||+.|+++|+|+.........
T Consensus       219 ~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~  269 (299)
T 3m2w_A          219 YEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  269 (299)
T ss_dssp             CSSC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred             ccCC-chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence            1100 00001122347789999999999999999999999999876544333

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-39  Score=340.71  Aligned_cols=238  Identities=27%  Similarity=0.382  Sum_probs=191.3

Q ss_pred             hhcccccceeeecCceEEEEEEcC--CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCE---
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKC---  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  216 (436)
                      .++|++.+.||+|+||+||+|...  +|+.||||++......  .....+.+|++++.+++||||+++++++...+.   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            368999999999999999999764  6899999998764332  224678899999999999999999999987655   


Q ss_pred             --EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          217 --MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       217 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                        .++||||+++++|.+++..     .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence              7999999999999887753     5899999999999999999999   7899999999999999986 899999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ++.....    ....||++|+|||++.+.. +.++|||||||++|||++|..|+.....                ..++.
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------~~~~~  286 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------------DGLPE  286 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC----------------SSCCT
T ss_pred             chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc----------------ccccc
Confidence            9876433    3456999999999987654 8899999999999999999888752110                00111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                        ..........+.+++.+||+.||++||+..+.+.+.+
T Consensus       287 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          287 --DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             --TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             --cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence              1111222344778999999999999997766665544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-40  Score=324.67  Aligned_cols=251  Identities=16%  Similarity=0.149  Sum_probs=185.6

Q ss_pred             hhcccccceeeecCceEEEEEE-cCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC-CCcee---------eeeE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RSIVK---------LYGF  210 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~---------l~~~  210 (436)
                      +.+|...+.||+|+||+||+|. ..+|+.||||++...........+.+.+|+.++..++| +|...         ....
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3457788999999999999997 55799999999985544433335778999999999977 32211         1111


Q ss_pred             ------------Eee-----CCEEEEEEeeccCCChhhhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 013793          211 ------------CLH-----KKCMFLIYEYMERGSLFCILHN----DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  269 (436)
Q Consensus       211 ------------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  269 (436)
                                  +..     ....+++|+++ +++|.+++..    ......+++..++.++.|+++||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                        111     12346666655 6799988841    112346888999999999999999999   7899


Q ss_pred             EecCCCCCceeecCCCCeEEeecccccccCCCCCCcccccccccccccccc----------ccCccCcchhhHHHHHHHH
Q 013793          270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA----------YTMVMTEKCDVYSFGVVTL  339 (436)
Q Consensus       270 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~il~  339 (436)
                      +||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++|
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            99999999999999999999999999865432   334567 999999998          5567889999999999999


Q ss_pred             HHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          340 EVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       340 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ||+||+.||......       ......+...  ...+       ..+.+++.+||+.||++||++.|+++++|+..
T Consensus       309 elltg~~Pf~~~~~~-------~~~~~~~~~~--~~~~-------~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          309 WIWCADLPNTDDAAL-------GGSEWIFRSC--KNIP-------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHHSSCCCCTTGGG-------SCSGGGGSSC--CCCC-------HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHCCCCCCCcchh-------hhHHHHHhhc--ccCC-------HHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999999643211       1111111111  1111       23678999999999999999999999988754

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.6e-39  Score=300.96  Aligned_cols=234  Identities=10%  Similarity=0.040  Sum_probs=182.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|+..+.+++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999765 58999999998765544444578899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++++|.+++...     ....++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+++|        
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            999999999999542     355678899999999999999   7899999999999999999999998543        


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                                  |++|       ++.++||||||+++|||+||+.||.........    .............. .....
T Consensus       175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~  230 (286)
T 3uqc_A          175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL----APAERDTAGQPIEP-ADIDR  230 (286)
T ss_dssp             ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS----EECCBCTTSCBCCH-HHHCT
T ss_pred             ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh----HHHHHHhccCCCCh-hhccc
Confidence                        3332       688999999999999999999999743221100    00001111111100 00000


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .....+.+++.+||+.||++| |+.|+++.+.....
T Consensus       231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          231 DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            112236789999999999999 99999999876443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.6e-39  Score=309.52  Aligned_cols=250  Identities=16%  Similarity=0.130  Sum_probs=189.0

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchh-----hHHHHHHHHHHHHHHhhcc---------CCCceee
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVL---------HRSIVKL  207 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~niv~l  207 (436)
                      .++|++.+.||+|+||+||+|.. +|+.||||++......     .....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999987 7899999999765321     1111256778888888886         7777776


Q ss_pred             eeEEe-----------------e-------------CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 013793          208 YGFCL-----------------H-------------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA  257 (436)
Q Consensus       208 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~  257 (436)
                      .+.+.                 +             .+..++||||+++|++.+.+..    ..+++.+++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            66543                 2             6789999999999987777643    258999999999999999


Q ss_pred             HHHHHhcCCCCeEecCCCCCceeecCCC--------------------CeEEeecccccccCCCCCCccccccccccccc
Q 013793          258 LAYLHHDCSPSIIHRDISSNNILLNSKL--------------------EAFVADFGTARRLHADSSNRTLLAGTYGYIAP  317 (436)
Q Consensus       258 L~~LH~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP  317 (436)
                      |+|||+  +.+|+||||||+|||++.++                    .+||+|||+++.....     ...||+.|+||
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP  246 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence            999993  35899999999999999887                    8999999999876432     34799999999


Q ss_pred             cccccCccCcchhhHHHHHH-HHHHHhCCCCccccccccCCCCcccchhhhhcC-CCC-CCCChhHHHHHHHHHHHHhhc
Q 013793          318 ELAYTMVMTEKCDVYSFGVV-TLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLP-PPVDQKVIQDILLASTISFAC  394 (436)
Q Consensus       318 E~~~~~~~~~~~Dv~s~G~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~-~~~~~~~~~~~~~~~~l~~~c  394 (436)
                      |.+.+.. +.++||||+|++ .+++++|..||....+..      ......... ... .............+.+|+.+|
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~  319 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH------YLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM  319 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH------HHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh------HHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence            9998776 899999998777 788889999985321100      001111111 111 111122334455688999999


Q ss_pred             cCCCCCCCCCHHHHH-HHHhhc
Q 013793          395 LQSNPKSRPTMQYVS-QGFLIT  415 (436)
Q Consensus       395 l~~dP~~RPt~~ev~-~~l~~~  415 (436)
                      |+.|     |+.|++ +|+|++
T Consensus       320 L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          320 LNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GGSS-----SHHHHHHHCGGGC
T ss_pred             hccC-----CHHHHHhcCCCcC
Confidence            9976     999999 999984

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.2e-33  Score=284.24  Aligned_cols=188  Identities=18%  Similarity=0.114  Sum_probs=133.9

Q ss_pred             eeecCceEEEEE-EcCCCCEEEEEEecCcc-------hhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEEEEE
Q 013793          151 IGTGGYGSVYKA-QLPNGKVFALKKLHTSE-------TEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       151 lg~G~~g~Vy~~-~~~~~~~vavK~l~~~~-------~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .+.|+.|.+..+ +.-.|+.+|||.+....       .......++|.+|+++|+++ .|+||+++++++++.+..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455666665554 23358889999996541       12223357799999999999 7999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++|++|.+++...+   +++..   +|+.||+.||+|+|   +.||+||||||+|||+++++.+||+|||+|+....+
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999998654   45543   58999999999999   889999999999999999999999999999987666


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCc
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR  348 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~  348 (436)
                      .......+||++|+|||++.+. +..++|+||+|++++++.++..++
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            5556667899999999998764 567899999999988887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.5e-28  Score=249.26  Aligned_cols=186  Identities=15%  Similarity=0.170  Sum_probs=147.4

Q ss_pred             cccceeeecCceEEEEEEcCCCCEEEEEEecCcch-----hhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          146 HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ...+.||+|+||+||++.. .++.+++|+......     ......+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 577889998654332     1122245689999999999999999777777777888999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++++|.+++..           +..++.|+++||+|||   +.+|+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999975           4589999999999999   789999999999999999  999999999997644


Q ss_pred             CCCC-------cccccccccccccccccc--CccCcchhhHHHHHHHHHHHhCCCCc
Q 013793          301 DSSN-------RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPR  348 (436)
Q Consensus       301 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~  348 (436)
                      ....       .....||+.|+|||++..  ..|+..+|+||..+-.++.+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211       134679999999999987  56788899999999999988887765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=9.8e-25  Score=203.31  Aligned_cols=167  Identities=16%  Similarity=0.169  Sum_probs=128.3

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhH---------------HHHHHHHHHHHHHhhcc
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL---------------AFIKSFRNEAQVLSQVL  200 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------~~~~~~~~e~~~l~~l~  200 (436)
                      ..+......|.+.+.||+|+||.||+|...+|+.||+|.++.......               .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344455666778899999999999999888899999999975432110               12367889999999998


Q ss_pred             CCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 013793          201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  280 (436)
Q Consensus       201 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nil  280 (436)
                        | +++.+++.. +..++||||+++|+|.+ +..         .+...++.|++.||.|||   +.+|+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence              5 666665543 45699999999999988 421         224579999999999999   789999999999999


Q ss_pred             ecCCCCeEEeecccccccCCCCCCcccccccccccccccccc----------CccCcchhhHH
Q 013793          281 LNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYT----------MVMTEKCDVYS  333 (436)
Q Consensus       281 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~s  333 (436)
                      ++ ++.++|+|||+++..             ..|.|||++..          .++...+|+|.
T Consensus       226 l~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVEV-------------GEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EE-TTEEEECCCTTCEET-------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EE-CCcEEEEECCCCeEC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99 999999999999642             34788987643          34455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=3.4e-20  Score=170.48  Aligned_cols=141  Identities=20%  Similarity=0.248  Sum_probs=107.3

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCE--EEEEEecCcchh---------------------hHHHHHHHHHHHHHHhhc
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKV--FALKKLHTSETE---------------------ELAFIKSFRNEAQVLSQV  199 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~---------------------~~~~~~~~~~e~~~l~~l  199 (436)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||+++.....                     .......+.+|++.+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            366788999999999999987 68888  999987553211                     011124678999999999


Q ss_pred             cCCCc--eeeeeEEeeCCEEEEEEeeccC-C----ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 013793          200 LHRSI--VKLYGFCLHKKCMFLIYEYMER-G----SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  272 (436)
Q Consensus       200 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  272 (436)
                      +|+++  ..+++.    ...++||||+.+ |    +|.+....      .++.++..++.|++.||.|||.  ..+|+||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence            88864  333332    346899999953 4    55554422      2345678899999999999995  4699999


Q ss_pred             CCCCCceeecCCCCeEEeeccccccc
Q 013793          273 DISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       273 dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.6e-17  Score=158.88  Aligned_cols=141  Identities=11%  Similarity=0.135  Sum_probs=102.3

Q ss_pred             cccccceeeecCceEEEEEEcCCCCEEEEEEecCcchh---------------hHHH----HHHHHHHHHHHhhccCCCc
Q 013793          144 DFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE---------------ELAF----IKSFRNEAQVLSQVLHRSI  204 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------~~~~----~~~~~~e~~~l~~l~h~ni  204 (436)
                      -|.+.+.||+|++|.||+|..++|+.||||+++.....               ....    .....+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38899999999999999999999999999987542110               0000    1122456777777755544


Q ss_pred             eeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 013793          205 VKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  284 (436)
Q Consensus       205 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~  284 (436)
                      ....-+....  .+|||||++|+.|..+...         .....++.|++.+|.+||   ..|||||||||.|||++++
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence            3222222222  3699999999888765432         234568899999999999   7799999999999999887


Q ss_pred             CC----------eEEeeccccccc
Q 013793          285 LE----------AFVADFGTARRL  298 (436)
Q Consensus       285 ~~----------~kl~Dfg~a~~~  298 (436)
                      +.          +.|+||+.+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            63          889999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=1.4e-12  Score=119.61  Aligned_cols=148  Identities=14%  Similarity=0.090  Sum_probs=115.1

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCC
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKK  215 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  215 (436)
                      .+....+.|.+...++.|+.+.||++... ++.+++|.........   ...+.+|++++..+. +..+.++++++...+
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            44555677888888898999999999864 6889999987532111   145778999999884 677888999999999


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD-------------------------------  264 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------  264 (436)
                      ..++||||++|.+|.+.+..        ......++.+++++|+.||..                               
T Consensus        84 ~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             ceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            99999999999998776421        122347889999999999961                               


Q ss_pred             -------------------------CCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          265 -------------------------CSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       265 -------------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                                               ....++|||++|.||+++++..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     01458999999999999876666799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=7.7e-12  Score=114.32  Aligned_cols=138  Identities=16%  Similarity=0.115  Sum_probs=101.3

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv  220 (436)
                      .++.+....+.|..+.||++...+|+.+++|.......      ..+..|+++++.+.+.+  +.+++++....+..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            34444333345666999999887888899999766421      45678899998886544  45688888887889999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-----------------------------------  265 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------  265 (436)
                      |||++|.++.  ...      .+   ...++.++++.|+.||...                                   
T Consensus        94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999998884  211      11   2357788888888888521                                   


Q ss_pred             --------------------CCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          266 --------------------SPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       266 --------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                                          ...++|||++|.||+++++..+.|+|||.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                11299999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=1.1e-10  Score=112.20  Aligned_cols=142  Identities=18%  Similarity=0.272  Sum_probs=106.5

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEec--CcchhhHHHHHHHHHHHHHHhhcc--CCCceeeeeEEeeC---CEEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVL--HRSIVKLYGFCLHK---KCMFLI  220 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv  220 (436)
                      .+.++.|.++.||+....+ ..+++|+..  ......  ....+.+|+++++.+.  +..+.++++++.+.   +..++|
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4568999999999998755 678888876  332111  1256778999999996  45578889888776   457899


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-----------------------------------  265 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------  265 (436)
                      |||++|..+.+..     ...++..++..++.++++.|+.||...                                   
T Consensus       120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999998775421     124678888999999999999999620                                   


Q ss_pred             --------------------CCCeEecCCCCCceeecCCCC--eEEeecccccc
Q 013793          266 --------------------SPSIIHRDISSNNILLNSKLE--AFVADFGTARR  297 (436)
Q Consensus       266 --------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~  297 (436)
                                          ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                257999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=1.2e-10  Score=109.08  Aligned_cols=185  Identities=22%  Similarity=0.214  Sum_probs=122.0

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCC--ceeeeeEEeeCC---EEEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRS--IVKLYGFCLHKK---CMFLIY  221 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~  221 (436)
                      .+.++.|.+..||+..    ..+++|.....     .....+.+|.+++..+. +..  +.+++......+   ..++||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4568999999999864    45888986543     11367889999998883 333  344454443333   357899


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD-------------------------------------  264 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------  264 (436)
                      |+++|.++.+...     ..++..++..++.++++.++.||..                                     
T Consensus        96 ~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           96 TKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             ECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             cccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            9999988865332     1467778888888999988888851                                     


Q ss_pred             ------------------CCCCeEecCCCCCceeecC--CCCeEEeecccccccCCCCCCccccc------c--------
Q 013793          265 ------------------CSPSIIHRDISSNNILLNS--KLEAFVADFGTARRLHADSSNRTLLA------G--------  310 (436)
Q Consensus       265 ------------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~------g--------  310 (436)
                                        ....++|||++|.||++++  +..+.|+||+.+....+.. ......      +        
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHH
Confidence                              0145899999999999998  4567899999987542210 000000      0        


Q ss_pred             -cccccc-ccccccCccCcchhhHHHHHHHHHHHhCCCCcc
Q 013793          311 -TYGYIA-PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD  349 (436)
Q Consensus       311 -t~~y~a-PE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  349 (436)
                       ..+... |+...  ......+.|++|.++|++.+|+.++-
T Consensus       250 ~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             001111 22111  11223689999999999999998763

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.00  E-value=1.7e-10  Score=122.13  Aligned_cols=73  Identities=40%  Similarity=0.693  Sum_probs=41.7

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccc-----------------------cccCccccC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQL-----------------------SSMSRVRLS   58 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l-----------------------~~l~~~~~~   58 (436)
                      ++|+.||||+|+|+|.||.+|++|++|+.||||+|+|+|.+|..+..+                       .++....+.
T Consensus       656 ~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~  735 (768)
T 3rgz_A          656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL  735 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGC
T ss_pred             ccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhc
Confidence            445555555555555555555555555555555555555555544444                       444555666


Q ss_pred             CCCCCCCCcccCCCCCCC
Q 013793           59 PNKGLCGNFITLPSCDAT   76 (436)
Q Consensus        59 ~n~~lcg~~~~~~~c~~~   76 (436)
                      +|+++||.+.  +.|...
T Consensus       736 gN~~Lcg~~l--~~C~~~  751 (768)
T 3rgz_A          736 NNPGLCGYPL--PRCDPS  751 (768)
T ss_dssp             SCTEEESTTS--CCCCSC
T ss_pred             CCchhcCCCC--cCCCCC
Confidence            7788898764  367644

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.94  E-value=2.7e-10  Score=113.98  Aligned_cols=29  Identities=21%  Similarity=0.020  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          187 KSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       187 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      ++|..|++.+++++|+|+|+++|||....
T Consensus       324 ~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          324 ETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             -CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            78999999999999999999999998653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=98.92  E-value=5.6e-10  Score=105.09  Aligned_cols=70  Identities=41%  Similarity=0.691  Sum_probs=64.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCCCcccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSC   73 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg~~~~~~~c   73 (436)
                      +++|++|+|++|+++|.+|..++++++|+.|+|++|+|+|.+|.. +.+++|+.+++.+|+.+||.+.  +.|
T Consensus       243 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p~--~~C  312 (313)
T 1ogq_A          243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL--PAC  312 (313)
T ss_dssp             CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTTS--SCC
T ss_pred             cCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCCCC--CCC
Confidence            468999999999999999999999999999999999999999985 8899999999999999999754  356

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.85  E-value=3.3e-09  Score=90.34  Aligned_cols=60  Identities=23%  Similarity=0.311  Sum_probs=38.6

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++|+.+++++|.
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            356667777777766556666666666666666666665444445666666666666664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.81  E-value=3e-09  Score=92.50  Aligned_cols=61  Identities=21%  Similarity=0.274  Sum_probs=48.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++.+|..|+++++|++|+|++|+|++..|..+..+++|+.+++++|.
T Consensus        53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  113 (192)
T 1w8a_A           53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence            4678888888888887778888888888888888888887777767778888888887775

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.78  E-value=7.3e-09  Score=88.56  Aligned_cols=60  Identities=25%  Similarity=0.317  Sum_probs=45.6

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..+++|+.|++++|.
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            467888888888887777788888888888888888886444445777888888887775

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=98.76  E-value=4e-09  Score=111.55  Aligned_cols=62  Identities=34%  Similarity=0.486  Sum_probs=59.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG   62 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~   62 (436)
                      +++|+.||||+|+|+|.||.++++|++|+.||||+|+|+|.+|.+++++++|+.|++++|..
T Consensus       631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l  692 (768)
T 3rgz_A          631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL  692 (768)
T ss_dssp             SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence            46899999999999999999999999999999999999999999999999999999999973

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.75  E-value=7.3e-09  Score=92.16  Aligned_cols=61  Identities=21%  Similarity=0.159  Sum_probs=44.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        80 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (220)
T 2v70_A           80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ  140 (220)
T ss_dssp             CTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSC
T ss_pred             CCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCc
Confidence            3567777777777776666667777777777777777777667777777777777777764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.71  E-value=1.2e-08  Score=88.88  Aligned_cols=61  Identities=31%  Similarity=0.409  Sum_probs=49.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|+|++..|..|.+|++|+.|+|++|++++..|..+..+++|+.|++++|.
T Consensus        53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            4678888888888887767778888888888888888887777778888888888888776

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.69  E-value=1.2e-08  Score=88.61  Aligned_cols=59  Identities=27%  Similarity=0.297  Sum_probs=41.0

Q ss_pred             CCCEEECcCCcccccCCh-hccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPG-ELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|+|++|+|++..|. .++++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~   89 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence            567777777777744443 36777777777777777777667777777777777777665

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=2.1e-07  Score=85.32  Aligned_cols=135  Identities=20%  Similarity=0.180  Sum_probs=98.2

Q ss_pred             eeeecCce-EEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEEEEeeccC
Q 013793          150 CIGTGGYG-SVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       150 ~lg~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .+..|..| .||+.... ++..+++|+-....      ...+..|...|+.+. +-.+.++++++.+.+..++|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            34556555 68988765 56678999866442      256778999888884 33467788999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-----------------------------------------  265 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------------  265 (436)
                      .++.+.....       ......+..+++..|+-||...                                         
T Consensus       105 ~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          105 KTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             ccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            8877655321       1234456677777777777410                                         


Q ss_pred             --------------CCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          266 --------------SPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       266 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                                    ...++|||+.+.||++++++.+-|+||+.+..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          12379999999999999887777999998753

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.65  E-value=2.3e-08  Score=88.84  Aligned_cols=61  Identities=25%  Similarity=0.207  Sum_probs=43.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        79 l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  139 (220)
T 2v9t_B           79 LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK  139 (220)
T ss_dssp             CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCc
Confidence            4567777777777774333345777777777777777777667777777777777777765

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.65  E-value=2.6e-08  Score=85.03  Aligned_cols=65  Identities=26%  Similarity=0.298  Sum_probs=53.5

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      +++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.+++++|+..|.
T Consensus        56 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           56 LVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            46899999999999964445578999999999999999965555588899999999999987664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.64  E-value=2.9e-08  Score=94.55  Aligned_cols=60  Identities=28%  Similarity=0.231  Sum_probs=49.6

Q ss_pred             CCCCEEECcC-CcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISN-NKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~-n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|..|++|+.|+|++|.
T Consensus        31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~   91 (347)
T 2ifg_A           31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (347)
T ss_dssp             SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence            5688888886 88887666788888888888888888888777778888888888888875

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.63  E-value=3.3e-08  Score=84.08  Aligned_cols=65  Identities=28%  Similarity=0.347  Sum_probs=56.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      +++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.+++++|+..|.
T Consensus        53 l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           53 LTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             cccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            57899999999999966666779999999999999999976666788999999999999987774

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.62  E-value=3.5e-08  Score=85.83  Aligned_cols=59  Identities=25%  Similarity=0.367  Sum_probs=51.6

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+|+ .+|..|.++++|+.|+|++|++++..|..|..+++|+.|++++|.
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            47889999999998 888899999999999999999998777778888999999998886

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.60  E-value=5.8e-08  Score=83.01  Aligned_cols=61  Identities=28%  Similarity=0.358  Sum_probs=50.8

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..|..++++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  111 (177)
T 2o6r_A           51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQ  111 (177)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCc
Confidence            4688999999999986555667899999999999999997666667888899999998885

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.58  E-value=3.2e-08  Score=94.31  Aligned_cols=64  Identities=28%  Similarity=0.287  Sum_probs=55.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      |++|+.|||++|+|+|..|..|++|++|+.|||++|+|++..|..+..++ |+.|++.+|+..|.
T Consensus        55 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             ccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            57899999999999999999999999999999999999965544455554 99999999997774

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.57  E-value=6.7e-08  Score=86.42  Aligned_cols=60  Identities=27%  Similarity=0.394  Sum_probs=47.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|..+..+++|+.+++++|.
T Consensus        87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  146 (229)
T 3e6j_A           87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ  146 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred             CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence            467888888888888655556788888888888888888 678777788888888887775

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.56  E-value=5.8e-08  Score=86.25  Aligned_cols=62  Identities=24%  Similarity=0.258  Sum_probs=54.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG   62 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~   62 (436)
                      +++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..+..+++|+.|++++|..
T Consensus        56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  117 (220)
T 2v70_A           56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI  117 (220)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCC
T ss_pred             CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcC
Confidence            46899999999999977777899999999999999999987777788899999999988863

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=98.55  E-value=3.4e-08  Score=92.76  Aligned_cols=61  Identities=28%  Similarity=0.515  Sum_probs=45.8

Q ss_pred             CCCCCEEECcC-CcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISN-NKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~-n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++ |+++|.+|..|++|++|++|+|++|+++|.+|..+..+++|+.+++++|.
T Consensus        75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~  136 (313)
T 1ogq_A           75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence            45677777774 77777777777777777777777777777777777777777777777764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=5.7e-07  Score=84.10  Aligned_cols=137  Identities=17%  Similarity=0.116  Sum_probs=93.8

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCC---CceeeeeEEe-eCCEEEEEEee
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR---SIVKLYGFCL-HKKCMFLIYEY  223 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~  223 (436)
                      .+.++.|....||+.    |..+++|.-...     .....+.+|.+++..+.+.   .+.+.+.++. ..+..++||||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            356888998999988    566888885322     1236788999999999652   3556666664 34557899999


Q ss_pred             ccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 013793          224 MERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD---------------------------------------  264 (436)
Q Consensus       224 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------  264 (436)
                      ++|..+.+..-.     .++..++..++.++++.|+.||..                                       
T Consensus        95 i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           95 VQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             cCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            999887653211     234444555555555555555531                                       


Q ss_pred             ------------------CCCCeEecCCCCCceeecC---CCC-eEEeeccccccc
Q 013793          265 ------------------CSPSIIHRDISSNNILLNS---KLE-AFVADFGTARRL  298 (436)
Q Consensus       265 ------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~a~~~  298 (436)
                                        ....++|||+++.||++++   ++. +.|+||+.+...
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              2345799999999999987   455 479999988653

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.54  E-value=7e-08  Score=99.31  Aligned_cols=60  Identities=33%  Similarity=0.453  Sum_probs=39.5

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++||||+|+|++.+|..|++|++|+.|+|++|+|++..|..+..+++|+.|++++|.
T Consensus       494 ~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  553 (635)
T 4g8a_A          494 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  553 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred             cccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence            466666666666666666666666666666666666666555556666666666666664

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.53  E-value=9.1e-08  Score=90.48  Aligned_cols=59  Identities=20%  Similarity=0.224  Sum_probs=36.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+++ .+|+.++++++|++|+|++|++.|.+|..++.+++|+.+++++|.
T Consensus       206 ~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~  264 (328)
T 4fcg_A          206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS  264 (328)
T ss_dssp             TTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCT
T ss_pred             CCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCC
Confidence            45666666666666 355566666666666666666666666666666666666666554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.53  E-value=9.7e-08  Score=86.57  Aligned_cols=61  Identities=23%  Similarity=0.338  Sum_probs=41.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       106 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A          106 LTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            3567777777777775444456777777777777777775555456677777777777664

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.51  E-value=2.6e-08  Score=82.56  Aligned_cols=59  Identities=29%  Similarity=0.425  Sum_probs=45.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|++++.  ..++++++|++|+|++|++++.+|..+..+++|+.+++++|.
T Consensus        41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~   99 (149)
T 2je0_A           41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK   99 (149)
T ss_dssp             CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSC
T ss_pred             cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCc
Confidence            45778888888888754  677788888888888888887777766667788888887775

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.49  E-value=1.5e-07  Score=86.38  Aligned_cols=60  Identities=28%  Similarity=0.466  Sum_probs=38.2

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+|++..|..++.+++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       133 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            466666777666665555556666666666666666665555555666666666666654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.48  E-value=1.7e-07  Score=82.31  Aligned_cols=61  Identities=26%  Similarity=0.404  Sum_probs=46.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..|..++++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (208)
T 2o6s_A           75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ  135 (208)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc
Confidence            4678888888888885555567788888888888888886555556777888888887775

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.47  E-value=8.2e-08  Score=87.32  Aligned_cols=63  Identities=25%  Similarity=0.404  Sum_probs=54.2

Q ss_pred             CCCCCEEECcCCcccc--cCChhccCCCCCCeeeccccccCCCCCCcccccc--ccCccccCCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEG--SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLS--SMSRVRLSPNKGLCGN   66 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g--~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~--~l~~~~~~~n~~lcg~   66 (436)
                      +++|++|+||+|+|++  .+|..++.+++|+.|+||+|+|++.  ..+..+.  +|+.|++.+|+ +|+.
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np-l~~~  235 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS-LCDT  235 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST-TGGG
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc-Cccc
Confidence            5789999999999998  7888999999999999999999975  3355555  89999999998 6654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.47  E-value=1.8e-07  Score=79.93  Aligned_cols=60  Identities=25%  Similarity=0.326  Sum_probs=52.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|++++..|..++++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            579999999999997666678999999999999999997666667889999999999886

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.46  E-value=1.6e-07  Score=83.35  Aligned_cols=59  Identities=27%  Similarity=0.365  Sum_probs=32.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|.
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            45555555555554444455555555555555555555555555555555555555553

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.42  E-value=2.3e-07  Score=82.93  Aligned_cols=61  Identities=23%  Similarity=0.265  Sum_probs=51.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.|++++|.
T Consensus        63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  123 (229)
T 3e6j_A           63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNK  123 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCc
Confidence            4689999999999985444567899999999999999997666667889999999998886

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.40  E-value=1.6e-07  Score=79.45  Aligned_cols=58  Identities=31%  Similarity=0.450  Sum_probs=40.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|.+++.  ..++.+++|++|+|++|++++.+|..+..+++|+.+++++|.
T Consensus        49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  106 (168)
T 2ell_A           49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK  106 (168)
T ss_dssp             GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSS
T ss_pred             CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCc
Confidence            5677777777777743  567777777777777777776666666667777777777664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.39  E-value=9.9e-08  Score=83.11  Aligned_cols=60  Identities=22%  Similarity=0.278  Sum_probs=33.1

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++..|..++.|++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A           88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            455555555555555555555555555555555555555455555555555555555553

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.38  E-value=2.1e-07  Score=94.57  Aligned_cols=58  Identities=29%  Similarity=0.428  Sum_probs=50.5

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|+.|+|++|+|+ .||..+++|++|+.|+|++|+|++ +| .++.+++|+.|++++|.
T Consensus       462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~  519 (567)
T 1dce_A          462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR  519 (567)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCC
Confidence            468899999999998 889999999999999999999986 77 68888899999998885

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.38  E-value=2e-07  Score=96.36  Aligned_cols=65  Identities=17%  Similarity=0.242  Sum_probs=60.2

Q ss_pred             CCCCCEEECcCCccccc-----------------CChhcc--CCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGS-----------------IPGELT--DLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~-----------------ip~~~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|+|+|.                 +|++++  +|++|++|+|++|+++|.+|..++++++|+.+++++|.
T Consensus       205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~  284 (636)
T 4eco_A          205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR  284 (636)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred             ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence            57899999999999997                 999999  99999999999999999999999999999999999987


Q ss_pred             CCCC
Q 013793           62 GLCG   65 (436)
Q Consensus        62 ~lcg   65 (436)
                      .+.|
T Consensus       285 ~l~~  288 (636)
T 4eco_A          285 GISG  288 (636)
T ss_dssp             TSCH
T ss_pred             CCcc
Confidence            4444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.37  E-value=2.8e-07  Score=87.13  Aligned_cols=66  Identities=17%  Similarity=0.130  Sum_probs=60.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGN   66 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg~   66 (436)
                      +++|++|+|++|++.|.+|..++++++|+.|+|++|++.+.+|..+..+++|+.+++++|+.+...
T Consensus       228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i  293 (328)
T 4fcg_A          228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL  293 (328)
T ss_dssp             CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC
T ss_pred             CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc
Confidence            578999999999999999999999999999999999999999999999999999999998755433

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.37  E-value=1.6e-07  Score=77.71  Aligned_cols=59  Identities=19%  Similarity=0.316  Sum_probs=53.9

Q ss_pred             CCCCEEECcCCccc-ccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCC
Q 013793            2 KNLTWLDISNNKIE-GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG   62 (436)
Q Consensus         2 ~~l~~l~ls~n~l~-g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~   62 (436)
                      ++|+.|+|++|+++ |.+|..+..+++|++|+|++|++++.  ..+..+++|+.+++++|..
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i   76 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRV   76 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCC
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcc
Confidence            57999999999999 99999999999999999999999976  6688999999999998863

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.36  E-value=1.8e-07  Score=86.36  Aligned_cols=61  Identities=26%  Similarity=0.311  Sum_probs=41.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       152 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  212 (285)
T 1ozn_A          152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN  212 (285)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence            3567777777777775444456777777777777777776666666666777777776664

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.36  E-value=4.4e-07  Score=79.60  Aligned_cols=61  Identities=30%  Similarity=0.407  Sum_probs=53.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  111 (208)
T 2o6s_A           51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQ  111 (208)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCc
Confidence            4789999999999996656667999999999999999997666667899999999999885

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.35  E-value=4.9e-07  Score=82.83  Aligned_cols=61  Identities=23%  Similarity=0.359  Sum_probs=40.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|++..+..|+.+++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       132 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (270)
T 2o6q_A          132 LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ  192 (270)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCc
Confidence            3567777777777774444456777777777777777775555556666677777776664

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.35  E-value=4.3e-07  Score=82.24  Aligned_cols=60  Identities=20%  Similarity=0.333  Sum_probs=45.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|++++|.
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~   94 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ   94 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence            357778888888877777777778888888888888877666667777777777777765

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.34  E-value=3.2e-07  Score=93.25  Aligned_cols=56  Identities=21%  Similarity=0.307  Sum_probs=48.6

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .|+.|+|++|+|++ +|. +++|++|+.|+|++|+|+ .+|..++.+++|+.|++++|.
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~  497 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA  497 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCC
Confidence            57889999999985 786 889999999999999998 788888889999999998886

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.34  E-value=4.9e-07  Score=89.27  Aligned_cols=60  Identities=23%  Similarity=0.302  Sum_probs=38.6

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++..|..++++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  382 (455)
T 3v47_A          323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQ  382 (455)
T ss_dssp             TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCc
Confidence            456666666666665556666666666666666666666556666666666666666654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.34  E-value=3.3e-07  Score=94.27  Aligned_cols=65  Identities=22%  Similarity=0.228  Sum_probs=55.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccc-cccCccccCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQL-SSMSRVRLSPNKGLCG   65 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l-~~l~~~~~~~n~~lcg   65 (436)
                      |++|++|+||+|+|++..|..|++|++|++|||++|+|++..|..+..+ ++|+.+++++|+..|.
T Consensus       517 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          517 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            4688899999999988778888888999999999999988888888877 6788889988888773

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=1.3e-06  Score=83.31  Aligned_cols=81  Identities=10%  Similarity=0.005  Sum_probs=55.3

Q ss_pred             ccee-eecCceEEEEEEcC-------CCCEEEEEEecCcc---hhhHHHHHHHHHHHHHHhhcc-C--CCceeeeeEEee
Q 013793          148 KYCI-GTGGYGSVYKAQLP-------NGKVFALKKLHTSE---TEELAFIKSFRNEAQVLSQVL-H--RSIVKLYGFCLH  213 (436)
Q Consensus       148 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~  213 (436)
                      .+.| +.|....+|+....       ++..+++|......   ...   ...+.+|..++..+. +  -.+.++++++.+
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3457 78888999998664       26788999865432   000   034567888888774 2  346778887766


Q ss_pred             C---CEEEEEEeeccCCChhh
Q 013793          214 K---KCMFLIYEYMERGSLFC  231 (436)
Q Consensus       214 ~---~~~~lv~e~~~~g~L~~  231 (436)
                      .   +..++||||++|..+.+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCCB
T ss_pred             CCccCCceEEEEecCCCChhh
Confidence            5   35689999999877654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.32  E-value=3.1e-07  Score=78.35  Aligned_cols=58  Identities=21%  Similarity=0.250  Sum_probs=44.6

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|||++|+|++.  +.++.+++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~   99 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   99 (176)
T ss_dssp             TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCc
Confidence            3788888888888854  578888888888888888885333334778888888888876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.30  E-value=3.3e-07  Score=97.34  Aligned_cols=65  Identities=17%  Similarity=0.188  Sum_probs=59.9

Q ss_pred             CCCCCEEECcCCcccc-----------------cCChhcc--CCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEG-----------------SIPGELT--DLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g-----------------~ip~~~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|+.|+|++|+|+|                 .||++++  +|++|++|+|++|+++|.+|..++++++|+.|++++|.
T Consensus       447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~  526 (876)
T 4ecn_A          447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR  526 (876)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred             CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence            5789999999999998                 4999988  99999999999999999999999999999999999997


Q ss_pred             CCCC
Q 013793           62 GLCG   65 (436)
Q Consensus        62 ~lcg   65 (436)
                      .+.|
T Consensus       527 ~lsg  530 (876)
T 4ecn_A          527 GISA  530 (876)
T ss_dssp             TSCH
T ss_pred             Cccc
Confidence            4554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.30  E-value=4.5e-07  Score=94.96  Aligned_cols=59  Identities=27%  Similarity=0.379  Sum_probs=44.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|.|+ .||.+|++|++|++|+|++|+|+ .+|.+++.|++|+.|++++|.
T Consensus       246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  304 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM  304 (727)
T ss_dssp             CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred             CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence            456777777777777 77777777777777777777777 677777777777777777774

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.30  E-value=7.4e-07  Score=82.62  Aligned_cols=61  Identities=25%  Similarity=0.278  Sum_probs=45.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.+++++|.
T Consensus       123 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence            4678888888888886555667788888888888888885444445667778888777775

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.28  E-value=5.6e-07  Score=88.63  Aligned_cols=60  Identities=23%  Similarity=0.296  Sum_probs=39.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|||++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.|++++|.
T Consensus       207 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  266 (440)
T 3zyj_A          207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN  266 (440)
T ss_dssp             SSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSC
T ss_pred             cccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCC
Confidence            567777777777776666666666666666666666666556566666666666666654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.28  E-value=6.5e-07  Score=83.49  Aligned_cols=62  Identities=32%  Similarity=0.429  Sum_probs=52.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG   62 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~   62 (436)
                      +++|++|+|++|++++..|..++++++|+.|+|++|++++..+..+..+++|+.+++++|..
T Consensus       174 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  235 (306)
T 2z66_A          174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI  235 (306)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred             CcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence            46888999999999887788888999999999999999876666778888888888888863

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.27  E-value=6.7e-07  Score=88.39  Aligned_cols=61  Identities=25%  Similarity=0.264  Sum_probs=43.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       217 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  277 (452)
T 3zyi_A          217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN  277 (452)
T ss_dssp             CTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             cccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCc
Confidence            3567777777777777777777777777777777777776666666677777777776664

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.27  E-value=7.7e-07  Score=90.45  Aligned_cols=59  Identities=27%  Similarity=0.434  Sum_probs=30.6

Q ss_pred             CCCCEEECcCCccc-ccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            2 KNLTWLDISNNKIE-GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         2 ~~l~~l~ls~n~l~-g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      ++|++|+|++|+++ |.+|..++.+++|+.|+|++|++++..|..+..+++|+.+++++|
T Consensus       445 ~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            34555555555554 445555555555555555555555444544555555555555544

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.26  E-value=4.7e-07  Score=94.87  Aligned_cols=58  Identities=28%  Similarity=0.452  Sum_probs=35.2

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|||++|+|+ .||.+|++|++|++|+|++|.|+ .||..++.|++|+.|++++|.
T Consensus       270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~  327 (727)
T 4b8c_D          270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP  327 (727)
T ss_dssp             TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred             CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence            45666666666666 55666666666666666666664 556556666666666666554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.25  E-value=9.8e-07  Score=80.93  Aligned_cols=61  Identities=28%  Similarity=0.401  Sum_probs=51.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..++++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus       108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~  168 (272)
T 3rfs_A          108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ  168 (272)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCC
Confidence            4688999999999997777778889999999999999987666667888899999998885

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.24  E-value=7.4e-07  Score=75.29  Aligned_cols=58  Identities=24%  Similarity=0.323  Sum_probs=54.1

Q ss_pred             CCCCEEECcCCccc-ccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIE-GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~-g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+++ |.+|..+..+++|++|+|++|++++.  ..+..+++|+.+++++|.
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~   82 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENR   82 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCC
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCc
Confidence            67999999999998 99999999999999999999999975  668999999999999886

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.24  E-value=7.3e-07  Score=77.55  Aligned_cols=60  Identities=22%  Similarity=0.365  Sum_probs=54.5

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|++++..|..++++++|+.|+|++|++.+.+| .+..+++|+.+++++|.
T Consensus       111 l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBC
T ss_pred             CCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCC
Confidence            5789999999999999999999999999999999999555787 58999999999999886

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.22  E-value=1.1e-06  Score=88.97  Aligned_cols=63  Identities=25%  Similarity=0.324  Sum_probs=52.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      +++|++|||++|+|+ .||. .+.+++|++|+|++|+|++.+|..+..+++|+.+++++|+..|.
T Consensus       450 l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          450 LPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            467888888888888 7886 57788899999999999988887788888899999998887664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.21  E-value=5.8e-07  Score=84.45  Aligned_cols=62  Identities=24%  Similarity=0.313  Sum_probs=39.5

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      ++|++|+|++|+++ .+|+.+..+++|+.|+|++|+++ .+|..+..+++|+.+++++|+..|+
T Consensus       191 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             TTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             ccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence            45666666666666 35555666666666666666666 4566666666666666666665543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.21  E-value=8.5e-07  Score=84.94  Aligned_cols=59  Identities=27%  Similarity=0.278  Sum_probs=27.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      ++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..|..+..+++|+.|++++|
T Consensus        64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  122 (361)
T 2xot_A           64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN  122 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCC
Confidence            34444444444444433344444444444444444444333333444444444444444

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.21  E-value=1.3e-06  Score=81.00  Aligned_cols=60  Identities=27%  Similarity=0.331  Sum_probs=51.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..|..+..+++|+.|++++|.
T Consensus        76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~  135 (290)
T 1p9a_G           76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (290)
T ss_dssp             CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence            467889999999998 788888888999999999999987666778888888888888885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.21  E-value=8.3e-06  Score=77.09  Aligned_cols=139  Identities=19%  Similarity=0.313  Sum_probs=79.2

Q ss_pred             eeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeee------EEeeCCEEEEEE
Q 013793          150 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYG------FCLHKKCMFLIY  221 (436)
Q Consensus       150 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~  221 (436)
                      .|+.|..+.||+....+| .+++|+.....       ..+..|.+++..+..  -.+.+++.      +....+..+++|
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            455577899999987665 48999987632       222334444444421  12333332      123466789999


Q ss_pred             eeccCCChh--------------hhhccCCC----C-------CCCCHHHHH----------------------------
Q 013793          222 EYMERGSLF--------------CILHNDDE----A-------VELDWAKRV----------------------------  248 (436)
Q Consensus       222 e~~~~g~L~--------------~~l~~~~~----~-------~~l~~~~~~----------------------------  248 (436)
                      ||++|..+.              ..+|....    .       ..-.|....                            
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986542              11121100    0       011232211                            


Q ss_pred             ---HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          249 ---NIVKAMAHALAYLHH----------DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       249 ---~i~~~ia~~L~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                         .+...+..++++|+.          .....++|||+++.||+++.++.+.|+||+.+.
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence               111223445666652          125789999999999999888889999999774

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.20  E-value=9.5e-07  Score=84.61  Aligned_cols=61  Identities=26%  Similarity=0.297  Sum_probs=55.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|+.|||++|+|++..|..|.+|++|+.|+|++|++++..|..+..+++|+.|++++|.
T Consensus        87 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  147 (361)
T 2xot_A           87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ  147 (361)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCc
Confidence            4789999999999997777789999999999999999998888889999999999999886

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.20  E-value=7.9e-07  Score=83.31  Aligned_cols=60  Identities=18%  Similarity=0.231  Sum_probs=50.4

Q ss_pred             CCCCCEEECcCCcccccCChhc--cCCCCCCeeeccccccCCCCCCccccc-----cccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGEL--TDLSRLDYLNLSWNKLSGPVPFSNEQL-----SSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~--~~l~~L~~l~ls~N~l~g~~p~~~~~l-----~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+++|.+|..+  +.+++|++|+|++|++++. |..++.+     ++|+.+++++|.
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~  160 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAH  160 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCS
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCC
Confidence            4678899999999998888876  8889999999999999876 7777776     788888888876

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.18  E-value=1.2e-06  Score=87.18  Aligned_cols=60  Identities=25%  Similarity=0.301  Sum_probs=33.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  307 (477)
T 2id5_A          248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ  307 (477)
T ss_dssp             TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred             cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence            455666666666655555555555555555555555555555555555555555555553

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.17  E-value=1.4e-06  Score=81.13  Aligned_cols=61  Identities=28%  Similarity=0.431  Sum_probs=55.4

Q ss_pred             CCCCCEEECcCCcccc-cCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g-~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|.+++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence            4689999999999987 689999999999999999999998888889999999999999886

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.15  E-value=1.3e-06  Score=86.29  Aligned_cols=61  Identities=28%  Similarity=0.231  Sum_probs=45.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  358 (455)
T 3v47_A          298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH  358 (455)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCc
Confidence            3567777777777777777777777777777777777776666667777777777777764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.14  E-value=7.1e-07  Score=83.63  Aligned_cols=59  Identities=19%  Similarity=0.157  Sum_probs=34.5

Q ss_pred             CCCCEEECcCCcccccCChhccCC-----CCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDL-----SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l-----~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..++.+++|+.+++++|.
T Consensus       121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  184 (312)
T 1wwl_A          121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP  184 (312)
T ss_dssp             CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT
T ss_pred             CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC
Confidence            4556666666666644 5555555     566666666666665555555566666666665554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.14  E-value=2.4e-06  Score=78.81  Aligned_cols=61  Identities=26%  Similarity=0.297  Sum_probs=48.8

Q ss_pred             CCCCCEEECcCCc-ccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNK-IEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~-l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|. +++..|..+..+++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  140 (285)
T 1ozn_A           79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA  140 (285)
T ss_dssp             CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCc
Confidence            4678888888887 765557788888888888888888887777777888888888888775

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.14  E-value=9.8e-07  Score=75.22  Aligned_cols=56  Identities=20%  Similarity=0.170  Sum_probs=39.1

Q ss_pred             CCCCEEECcCCcccccCChhccCCC-CCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLS-RLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~-~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .+|++|+|++|+++ .+|. +..+. +|++|+|++|++++.  ..+..+++|+.+++++|.
T Consensus        19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~   75 (176)
T 1a9n_A           19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNR   75 (176)
T ss_dssp             TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSC
T ss_pred             CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCc
Confidence            46777788888777 5654 44444 778888888877753  457777777777777775

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.13  E-value=2.1e-06  Score=88.60  Aligned_cols=57  Identities=23%  Similarity=0.336  Sum_probs=41.1

Q ss_pred             CCCEEECcCCcccccCChhcc--CCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELT--DLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|+|++|+|+ .||..+.  .+++|+.|+|++|++++ +|..+..+++|+.+++++|.
T Consensus       489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~  547 (636)
T 4eco_A          489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR  547 (636)
T ss_dssp             GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB
T ss_pred             CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc
Confidence            6777777777777 6777776  77777777777777776 77777777777777776544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.13  E-value=9.5e-07  Score=90.62  Aligned_cols=60  Identities=20%  Similarity=0.244  Sum_probs=43.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|++++.+|..|+++++|+.|+|++|++++..|..+..+++| .+++++|.
T Consensus       475 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~  534 (606)
T 3t6q_A          475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH  534 (606)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred             CCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc
Confidence            3567777777777777777777777777777777777777777767777666 66666664

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.13  E-value=2.1e-06  Score=91.68  Aligned_cols=59  Identities=27%  Similarity=0.426  Sum_probs=35.1

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      ++|+.||||+|+|++..|..+.  ++|+.|||++|+|+|.+|..   +.+|..+++++|+..|.
T Consensus       504 ~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~---~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          504 TALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICE  562 (844)
T ss_dssp             CSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC---CSSCCEEEEEEECCCCS
T ss_pred             hhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH---hCCcCEEEecCCCcccc
Confidence            4455555555555543333333  45555555555555555543   34677889999998884

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.12  E-value=3.4e-06  Score=86.50  Aligned_cols=61  Identities=28%  Similarity=0.318  Sum_probs=44.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|||++|++++..|..|++|++|++|+|++|++++..|..++++++|+.+++++|.
T Consensus        55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~  115 (606)
T 3vq2_A           55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK  115 (606)
T ss_dssp             CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSC
T ss_pred             CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCc
Confidence            3567777777777776667777777777777777777776667777777777777777664

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.12  E-value=2.8e-06  Score=77.74  Aligned_cols=61  Identities=28%  Similarity=0.449  Sum_probs=53.1

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|+.+++++|.
T Consensus       108 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A          108 LVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence            4689999999999997777788999999999999999997655568889999999998885

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.12  E-value=1.4e-06  Score=89.39  Aligned_cols=60  Identities=18%  Similarity=0.257  Sum_probs=34.1

Q ss_pred             CCCCEEECcCCcccc-cCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g-~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++ .+|..++++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  508 (606)
T 3vq2_A          448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN  508 (606)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence            455556666665555 255555555555555555555555555555555555555555553

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.11  E-value=1.9e-06  Score=79.03  Aligned_cols=59  Identities=22%  Similarity=0.167  Sum_probs=46.3

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            57888888888886666678888888888888888886666677778888888887775

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.10  E-value=2.8e-06  Score=80.10  Aligned_cols=60  Identities=30%  Similarity=0.310  Sum_probs=37.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  251 (330)
T 1xku_A          192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  251 (330)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence            356666666666666556666666666666666666665555556666666666666654

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.10  E-value=3e-06  Score=77.72  Aligned_cols=61  Identities=25%  Similarity=0.231  Sum_probs=52.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..++++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~  111 (276)
T 2z62_A           51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN  111 (276)
T ss_dssp             CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCC
Confidence            4688999999999987777788899999999999999987777778888888888888775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.10  E-value=4e-05  Score=71.45  Aligned_cols=138  Identities=21%  Similarity=0.234  Sum_probs=92.1

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc---CCCceeeeeEEeeCCEEEEEEeec
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      .+.|+.|....+|+... ++..+++|......      ...+..|.+.|+.+.   ...+.++++++...+..++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            45689999999999986 56788899876432      256788988888884   356788888888888899999999


Q ss_pred             cCCChhh-----------hhccCCC--C-----------------CCCCHHHHH---HHHH----------------HHH
Q 013793          225 ERGSLFC-----------ILHNDDE--A-----------------VELDWAKRV---NIVK----------------AMA  255 (436)
Q Consensus       225 ~~g~L~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~ia  255 (436)
                      ++..+..           .+|....  .                 -.-+|....   ++..                .+.
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9986521           1232211  0                 012454321   1111                111


Q ss_pred             HH-HHHHH-hcCCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          256 HA-LAYLH-HDCSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       256 ~~-L~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      .. ...|. ....+.++|||+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 12332 12257899999999999999887 8888974

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.10  E-value=2.6e-06  Score=84.16  Aligned_cols=59  Identities=22%  Similarity=0.249  Sum_probs=39.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|+|++|++++..|..|++|++|+.|+|++|++++..|..+..+++|+.|++++|.
T Consensus        76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            56677777777776666667777777777777777766555666666666666666664

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.09  E-value=2.2e-06  Score=80.11  Aligned_cols=57  Identities=28%  Similarity=0.364  Sum_probs=29.2

Q ss_pred             CCCCEEECcCCcccccCChhccCC---CCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDL---SRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l---~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++||||+|+|++.+|+.++.+   ++|++|+|++|+|+ .+|..+.  ++|+.+++++|.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~  283 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNR  283 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCc
Confidence            445555555555555445555444   35555555555555 4454432  455555555553

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.08  E-value=2.2e-06  Score=84.38  Aligned_cols=57  Identities=33%  Similarity=0.459  Sum_probs=28.7

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      ++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++..|..+..+++|+.|++++|
T Consensus       185 ~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  241 (440)
T 3zyj_A          185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS  241 (440)
T ss_dssp             SSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             cccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCC
Confidence            34555555555555 444 2445555555555555555444444555555555555444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.07  E-value=1.7e-06  Score=87.60  Aligned_cols=60  Identities=28%  Similarity=0.226  Sum_probs=31.8

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++..|..|++|++|++|+|++|++++..|..++.+++|+.+++++|.
T Consensus        50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~  109 (549)
T 2z81_A           50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP  109 (549)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred             CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence            445555555555555444555555555555555555554444445555555555555553

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.07  E-value=2.3e-06  Score=87.78  Aligned_cols=60  Identities=22%  Similarity=0.149  Sum_probs=34.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|||++|++++..|..|++|++|++|+|++|++++..|..++.+++|+.+++++|.
T Consensus        57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  116 (606)
T 3t6q_A           57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG  116 (606)
T ss_dssp             TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSC
T ss_pred             ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccC
Confidence            455566666666655555556666666666666666655555555555555555555553

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.06  E-value=2.2e-06  Score=80.89  Aligned_cols=59  Identities=27%  Similarity=0.257  Sum_probs=31.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|+|++|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.+++++|.
T Consensus       194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  252 (332)
T 2ft3_A          194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK  252 (332)
T ss_dssp             SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSC
T ss_pred             CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCc
Confidence            45555555555554444555555555555555555555444445555555555555543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.06  E-value=3.9e-06  Score=85.30  Aligned_cols=61  Identities=36%  Similarity=0.517  Sum_probs=40.3

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCc-cccccccCccccCCCCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-NEQLSSMSRVRLSPNKGLC   64 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~l~~~~~~~n~~lc   64 (436)
                      ++|++|||++|+|+ .||..+.++++|+.|+|++|+|+ .+|.. +..+++|+.+++++|+..|
T Consensus       450 ~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred             CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCC
Confidence            35666666666666 66666666777777777777776 45554 6666667777777776555

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.06  E-value=3.4e-06  Score=89.59  Aligned_cols=57  Identities=23%  Similarity=0.355  Sum_probs=42.8

Q ss_pred             CCCEEECcCCcccccCChhcc--CCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELT--DLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~--~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|+|++|+|+ .||..+.  .+++|+.|+|++|+|++ +|.++..+++|+.|++++|+
T Consensus       729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~  787 (876)
T 4ecn_A          729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR  787 (876)
T ss_dssp             GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB
T ss_pred             CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC
Confidence            6777777777777 6777776  77777777777777776 67777777777777777655

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.06  E-value=2.1e-06  Score=81.83  Aligned_cols=59  Identities=29%  Similarity=0.232  Sum_probs=35.6

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|+|++|++++..+..++++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  111 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY  111 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence            56666666666664444456666666666666666665555556666666666666554

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.05  E-value=2e-05  Score=76.28  Aligned_cols=78  Identities=13%  Similarity=0.094  Sum_probs=48.4

Q ss_pred             cceeeecCceEEEEEEcC-CCCEEEEEEecCcch-hhH---HHHHHHHHHHHHHhhccC--CCc-eeeeeEEeeCCEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSET-EEL---AFIKSFRNEAQVLSQVLH--RSI-VKLYGFCLHKKCMFL  219 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~---~~~~~~~~e~~~l~~l~h--~ni-v~l~~~~~~~~~~~l  219 (436)
                      .+.+|.|.++.||++... +++.++||....... ...   .....+..|.+++..+..  +.. .+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            456899999999999764 568899998754321 000   001345678888887742  333 345543  3445689


Q ss_pred             EEeeccCC
Q 013793          220 IYEYMERG  227 (436)
Q Consensus       220 v~e~~~~g  227 (436)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.04  E-value=4.2e-06  Score=78.88  Aligned_cols=60  Identities=33%  Similarity=0.394  Sum_probs=55.1

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  111 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ  111 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence            478999999999997777789999999999999999998889999999999999999886

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.03  E-value=4e-06  Score=85.88  Aligned_cols=61  Identities=13%  Similarity=0.202  Sum_probs=46.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..++.+++|+.|++++|.
T Consensus        74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  134 (597)
T 3oja_B           74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND  134 (597)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCC
Confidence            4577888888888887777778888888888888888887666667777778888777774

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.02  E-value=1.4e-06  Score=86.92  Aligned_cols=60  Identities=20%  Similarity=0.135  Sum_probs=47.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccc-cccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNE-QLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+|+|..|..++++++|+.|+|++|+++|.+|..+. .+++|+.|++++|.
T Consensus       120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            5677888888888877777888888888888888888887777765 67888888887775

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.02  E-value=3.2e-06  Score=90.24  Aligned_cols=61  Identities=31%  Similarity=0.339  Sum_probs=39.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCc--cccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS--NEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~--~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|++++..|..|++|++|++|+|++|++++.+|..  +.++++|+.|++++|.
T Consensus        72 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~  134 (844)
T 3j0a_A           72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ  134 (844)
T ss_dssp             CTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCC
T ss_pred             CCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCc
Confidence            356666677766666666666666666666666666666655544  5666666666666654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.02  E-value=5.1e-06  Score=83.48  Aligned_cols=60  Identities=35%  Similarity=0.546  Sum_probs=35.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCc-cccccccCccccCCCCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-NEQLSSMSRVRLSPNKGLC   64 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~l~~~~~~~n~~lc   64 (436)
                      +|++|||++|+++ .||..+..+++|+.|+|++|+|+ .+|.. +..+++|+.+++++|+..|
T Consensus       422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcc
Confidence            5566666666666 56665556666666666666666 35544 5556666666666665444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.01  E-value=4.8e-06  Score=82.71  Aligned_cols=59  Identities=24%  Similarity=0.322  Sum_probs=37.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|||++|++++..|..|.++++|++|+|++|++++..|..+.++++|+.|++++|.
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            56666666666665556666666666666666666666556666666666666666553

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.00  E-value=5.5e-06  Score=80.03  Aligned_cols=61  Identities=13%  Similarity=0.202  Sum_probs=48.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..++.+++|+.+++++|.
T Consensus        68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  128 (390)
T 3o6n_A           68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND  128 (390)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCc
Confidence            4678888888888886666788888888888888888887777777888888888887775

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=97.99  E-value=8.7e-06  Score=83.38  Aligned_cols=61  Identities=20%  Similarity=0.145  Sum_probs=51.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|.|++..|..|++|++|++|+|++|+|++..|..++.+++|+.|++++|.
T Consensus        98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~  158 (597)
T 3oja_B           98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN  158 (597)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc
Confidence            4689999999999998778888999999999999999995444446888999999998885

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=97.99  E-value=3.4e-06  Score=79.99  Aligned_cols=59  Identities=29%  Similarity=0.367  Sum_probs=44.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|..+..+++|+.+++++|+
T Consensus       264 l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~  322 (347)
T 4fmz_A          264 LTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH  322 (347)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred             CCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence            4577888888888874 43 57778888888888888877777777777788888887776

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=97.98  E-value=2.7e-06  Score=88.53  Aligned_cols=58  Identities=24%  Similarity=0.336  Sum_probs=34.4

Q ss_pred             CCCCEEECcCCcccccCCh-hccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            2 KNLTWLDISNNKIEGSIPG-ELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      ++|++|+|++|+|+ .||. .|.+|++|+.|+|++|++++..|..+..+++|+.+++++|
T Consensus       536 ~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N  594 (680)
T 1ziw_A          536 SHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN  594 (680)
T ss_dssp             TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence            56667777777766 4554 4666666666666666666433333455555555555544

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=97.98  E-value=5.9e-06  Score=83.87  Aligned_cols=60  Identities=27%  Similarity=0.385  Sum_probs=33.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccC-CCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS-GPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~-g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|.+++.+|..+..+++|+.|+|++|+++ |.+|..+..+++|+.+++++|.
T Consensus       421 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~  481 (570)
T 2z63_A          421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  481 (570)
T ss_dssp             TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCc
Confidence            45555555555555555555555555555555555554 3455555555555555555553

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=97.97  E-value=4.2e-06  Score=85.05  Aligned_cols=60  Identities=22%  Similarity=0.146  Sum_probs=48.0

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|||++|++++..|.+|+++++|++|+|++|++++..|..+..+++|+.|++++|.
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  111 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR  111 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCc
Confidence            467888888888886666788888888888888888887777778888888888888775

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=97.97  E-value=4.3e-06  Score=78.93  Aligned_cols=60  Identities=27%  Similarity=0.274  Sum_probs=53.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  113 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH  113 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence            478999999999997778889999999999999999998888889999999999998886

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=97.96  E-value=8.3e-07  Score=77.25  Aligned_cols=58  Identities=22%  Similarity=0.304  Sum_probs=34.9

Q ss_pred             CCCCEEECcCCcccccCCh------hccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPG------ELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~------~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .+|+.++|+.|.|+|.+|.      .++++++|++|+|++|++++ +| .+..+++|+.+++++|.
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~   81 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNL   81 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEE
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCC
Confidence            3455566666666666665      56666666666666666664 55 45556666666665553

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=97.96  E-value=2.7e-06  Score=85.49  Aligned_cols=59  Identities=27%  Similarity=0.220  Sum_probs=35.3

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|||++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.+++++|.
T Consensus        22 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B           22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             TCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             cccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            45666666666665555566666666666666666665555556666666666665553

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=97.96  E-value=4e-06  Score=78.38  Aligned_cols=60  Identities=15%  Similarity=0.123  Sum_probs=47.8

Q ss_pred             CCCCEEECcCCcccccCChhc--cCCCCCCeeeccccccCCCCC----CccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGEL--TDLSRLDYLNLSWNKLSGPVP----FSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~--~~l~~L~~l~ls~N~l~g~~p----~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+++|.+|..+  +++++|+.|+|++|++++..|    ..+..+++|+.+++++|.
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~  156 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAH  156 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCS
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCC
Confidence            468889999999988888888  888888888888888887666    234457788888887775

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.94  E-value=4.4e-05  Score=70.42  Aligned_cols=78  Identities=18%  Similarity=0.170  Sum_probs=55.0

Q ss_pred             ccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCC---CceeeeeEEeeCCEEEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR---SIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~  221 (436)
                      ....+.+|.|..+.||+.+..||+.|++|+-.......   ...+..|.+.|+.+.-.   .+.+++++.    ..++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            34466799999999999999999999999876543221   14577899888888421   234444432    237899


Q ss_pred             eeccCCCh
Q 013793          222 EYMERGSL  229 (436)
Q Consensus       222 e~~~~g~L  229 (436)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=97.94  E-value=2.1e-06  Score=80.52  Aligned_cols=58  Identities=31%  Similarity=0.388  Sum_probs=53.0

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|||++|++++..|..|+++++|++|+|++|++++..|  +..+++|+.+++++|.
T Consensus        34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~   91 (317)
T 3o53_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY   91 (317)
T ss_dssp             GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred             CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence            589999999999998778899999999999999999997665  8899999999999885

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=97.92  E-value=9.8e-06  Score=78.24  Aligned_cols=60  Identities=22%  Similarity=0.250  Sum_probs=52.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCc-cccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFS-NEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..++++++|++|+|++|+++ .+|.. +..+++|+.+++++|.
T Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~  152 (390)
T 3o6n_A           92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN  152 (390)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCc
Confidence            468999999999999887888999999999999999999 56654 5889999999999886

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=97.91  E-value=5.4e-06  Score=74.23  Aligned_cols=61  Identities=11%  Similarity=0.142  Sum_probs=45.7

Q ss_pred             CCCCCEEECcCCc-ccccCChhccCCCCCCeeeccc-cccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNK-IEGSIPGELTDLSRLDYLNLSW-NKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~-l~g~ip~~~~~l~~L~~l~ls~-N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+ +++..|..|.++++|++|+|++ |++++..|..+..+++|+.+++++|.
T Consensus        54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~  116 (239)
T 2xwt_C           54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG  116 (239)
T ss_dssp             CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEEC
T ss_pred             CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCC
Confidence            4678888888886 7754455788888888888887 88886555667778888888887775

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=97.90  E-value=7.3e-06  Score=78.04  Aligned_cols=61  Identities=30%  Similarity=0.281  Sum_probs=53.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|+.+++++|.
T Consensus        75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  135 (353)
T 2z80_A           75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP  135 (353)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCC
T ss_pred             CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCC
Confidence            4789999999999998888899999999999999999996444448889999999999886

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=97.90  E-value=1e-05  Score=84.08  Aligned_cols=60  Identities=17%  Similarity=0.104  Sum_probs=33.9

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++..|..|++|++|++|+|++|++++..|..++.+++|+.+++++|.
T Consensus        73 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  132 (680)
T 1ziw_A           73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG  132 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSC
T ss_pred             cCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCc
Confidence            456666666666663222346666666666666666655444555556666666655553

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=97.88  E-value=4.2e-06  Score=74.96  Aligned_cols=60  Identities=12%  Similarity=0.160  Sum_probs=52.0

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccc-cCCCCCCccccccccCccccCC-CC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNK-LSGPVPFSNEQLSSMSRVRLSP-NK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~-l~g~~p~~~~~l~~l~~~~~~~-n~   61 (436)
                      ++|++|+|++|++++..|..|+++++|++|+|++|+ +++..|..+..+++|+.+++++ |.
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~   92 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN   92 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETT
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCC
Confidence            479999999999997666689999999999999997 8865555788999999999987 64

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=97.84  E-value=1.1e-05  Score=73.57  Aligned_cols=57  Identities=19%  Similarity=0.345  Sum_probs=48.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+++ .+| .+..+++|+.|+|++|++++ +|. +..+++|+.+++++|.
T Consensus        40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~   96 (263)
T 1xeu_A           40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNR   96 (263)
T ss_dssp             HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSC
T ss_pred             cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCc
Confidence            368899999999998 688 78899999999999999986 444 8889999999998886

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=97.83  E-value=8.3e-06  Score=74.32  Aligned_cols=56  Identities=27%  Similarity=0.327  Sum_probs=43.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++ +| .++.+++|+.|+|++|++++ +| .+..+++|+.+++++|.
T Consensus       106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~  161 (263)
T 1xeu_A          106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNE  161 (263)
T ss_dssp             SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSC
T ss_pred             CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCc
Confidence            468888888888884 44 58888888888888888885 44 47778888888888775

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=97.80  E-value=1.7e-05  Score=73.40  Aligned_cols=57  Identities=28%  Similarity=0.404  Sum_probs=41.4

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++ + +.+..+++|+.|+|++|++++.  ..+..+++|+.|++++|.
T Consensus       111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~  167 (291)
T 1h6t_A          111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQ  167 (291)
T ss_dssp             CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred             CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCc
Confidence            4677888888888874 4 3677778888888888887753  346777777777777774

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.78  E-value=3.5e-06  Score=79.51  Aligned_cols=57  Identities=11%  Similarity=0.038  Sum_probs=30.3

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCC-CCCccccccccCccccCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGP-VPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~-~p~~~~~l~~l~~~~~~~n   60 (436)
                      +|+.|+|++|.+++.+|. +..+++|+.|+|++|++++. +|..+..+++|+.+++++|
T Consensus        71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~  128 (336)
T 2ast_B           71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL  128 (336)
T ss_dssp             TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCc
Confidence            455555555555544433 44555555555555555544 4444555555555555554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=97.73  E-value=3e-06  Score=73.61  Aligned_cols=58  Identities=24%  Similarity=0.356  Sum_probs=53.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+..+++|+.+++++|.
T Consensus        47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~  104 (198)
T 1ds9_A           47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQ  104 (198)
T ss_dssp             TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEE
T ss_pred             CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCc
Confidence            4789999999999996 88 9999999999999999999 789878888999999999885

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=97.73  E-value=2.3e-05  Score=80.08  Aligned_cols=55  Identities=29%  Similarity=0.384  Sum_probs=27.2

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      ++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++.  ..+..|++|+.|++++|
T Consensus       109 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N  163 (605)
T 1m9s_A          109 KKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN  163 (605)
T ss_dssp             TTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSS
T ss_pred             CCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCC
Confidence            445555555555553 22 355555555555555555532  23444455555555444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.73  E-value=0.00016  Score=67.70  Aligned_cols=158  Identities=12%  Similarity=0.094  Sum_probs=89.0

Q ss_pred             ccHHHHHHHhhccccc-----ceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ce
Q 013793          133 IFYEDLIEATEDFHIK-----YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IV  205 (436)
Q Consensus       133 ~~~~~l~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  205 (436)
                      ++.+++......|.+.     +.|+.|....+|+....+| .+++|........     ..+..|..++..+...+  +.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~-----~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH-----HHHHHHHHHHHHHHHCCCCCC
Confidence            4456666666667652     3466688889999987666 5789988763111     34456777777664222  23


Q ss_pred             eeeeE------EeeCCEEEEEEeeccCCChhh--------------hhccC----CCC--CC---CCHHHHHH-------
Q 013793          206 KLYGF------CLHKKCMFLIYEYMERGSLFC--------------ILHND----DEA--VE---LDWAKRVN-------  249 (436)
Q Consensus       206 ~l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~--~~---l~~~~~~~-------  249 (436)
                      +++..      ....+..+++++|++|..+..              .+|..    ...  ..   ..|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33321      123456789999999865421              01211    000  00   12322110       


Q ss_pred             -----HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          250 -----IVKAMAHALAYLHHD----CSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       250 -----i~~~ia~~L~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                           +...+...+++++..    ...+++|+|+.+.||+++++..+.|+||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 011244455555532    13578999999999999987666899998774

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=97.72  E-value=2.4e-05  Score=72.35  Aligned_cols=54  Identities=24%  Similarity=0.295  Sum_probs=24.1

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      +|+.|++++|.++ .+| .+..+++|+.|+|++|++++..|  +..+++|+.+++++|
T Consensus        47 ~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n  100 (291)
T 1h6t_A           47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN  100 (291)
T ss_dssp             TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             cccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence            3444444444444 233 24444444444444444443222  444444444444444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00018  Score=70.22  Aligned_cols=78  Identities=13%  Similarity=0.055  Sum_probs=48.9

Q ss_pred             CCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcccccc--ccccccccccccC---ccCcchhhHHHHHHHHH
Q 013793          266 SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG--TYGYIAPELAYTM---VMTEKCDVYSFGVVTLE  340 (436)
Q Consensus       266 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~s~G~il~e  340 (436)
                      ...++|||+++.||+++.++ +.++||+.+....+.. .......  ...|.+|+.....   ......++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999999876 9999999887532110 0000000  1245666554311   12234556678888888


Q ss_pred             HHhCC
Q 013793          341 VLMGK  345 (436)
Q Consensus       341 lltg~  345 (436)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=97.70  E-value=2.1e-06  Score=84.87  Aligned_cols=59  Identities=14%  Similarity=0.144  Sum_probs=31.3

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCcccccccc-------------CccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSM-------------SRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l-------------~~~~~~~n~   61 (436)
                      ++|+.|++++|+| |.||+++++|++|++|++++|+++|.+|.+++++.++             +.+++++|.
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence            5799999999999 8999999999999999999999999999999887764             677777664

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.70  E-value=2.9e-05  Score=79.53  Aligned_cols=55  Identities=35%  Similarity=0.318  Sum_probs=31.1

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|+ .+|..+.++++|+.+++++|+
T Consensus       241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~  295 (622)
T 3g06_A          241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP  295 (622)
T ss_dssp             TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred             CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence            34555555555555 4444   3455666666666665 556556666666666666654

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.70  E-value=4.6e-05  Score=61.20  Aligned_cols=59  Identities=22%  Similarity=0.285  Sum_probs=49.0

Q ss_pred             CEEECcCCccc-ccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            5 TWLDISNNKIE-GSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         5 ~~l~ls~n~l~-g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      ..+|.++|+|+ ..||..+.  ++|+.|+|++|+|+..-+..|..+++|+.+++.+|+..|.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence            47899999997 57887654  3799999999999954445577899999999999999884

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=97.67  E-value=2.3e-05  Score=80.14  Aligned_cols=57  Identities=35%  Similarity=0.444  Sum_probs=42.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|+.|+|++|+|++.  +.++.|++|+.|+|++|+|++..|  +..+++|+.|++++|.
T Consensus       130 l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          130 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             CTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             CCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence            46788888888888753  577788888888888888876555  7777777777777774

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=97.67  E-value=3.3e-05  Score=72.05  Aligned_cols=57  Identities=28%  Similarity=0.418  Sum_probs=38.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++ +|. ++.+++|+.|+|++|++++ +|. +..+++|+.+++++|.
T Consensus       128 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          128 LSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNK  184 (308)
T ss_dssp             CTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCc
Confidence            4567777777777774 343 7777777777777777775 333 6666777777776664

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=97.63  E-value=3.7e-05  Score=71.69  Aligned_cols=57  Identities=19%  Similarity=0.353  Sum_probs=49.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++ +|. +..+++|+.|+|++|++++. |. +..+++|+.+++++|.
T Consensus       106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~  162 (308)
T 1h6u_A          106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQ  162 (308)
T ss_dssp             CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCc
Confidence            4789999999999995 664 99999999999999999964 43 8889999999999885

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.62  E-value=0.0011  Score=62.13  Aligned_cols=158  Identities=16%  Similarity=0.214  Sum_probs=89.5

Q ss_pred             ccHHHHHHHhhcccc-----cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC--ce
Q 013793          133 IFYEDLIEATEDFHI-----KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS--IV  205 (436)
Q Consensus       133 ~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  205 (436)
                      ++.+++....+.|.+     ...++ |....||+....+|+.+++|.........    ..+..|..++..+....  ++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~----~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH----HHHHHHHHHHHHHHHcCCeec
Confidence            344555555555543     23466 88889999987778889999987442211    44556777777774222  34


Q ss_pred             eeeeE-----EeeCCEEEEEEeeccCCChhh-----h---------hcc----CC--CCCCCCHHHH----HHH------
Q 013793          206 KLYGF-----CLHKKCMFLIYEYMERGSLFC-----I---------LHN----DD--EAVELDWAKR----VNI------  250 (436)
Q Consensus       206 ~l~~~-----~~~~~~~~lv~e~~~~g~L~~-----~---------l~~----~~--~~~~l~~~~~----~~i------  250 (436)
                      +++..     ....+..+++|||++|..+..     .         +|.    ..  ....+++...    ..+      
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44432     123456688999998854421     0         111    00  0112222211    001      


Q ss_pred             ---------HHHHHHHHHHHHhc----CCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          251 ---------VKAMAHALAYLHHD----CSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       251 ---------~~~ia~~L~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                               ...+...++.+...    ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     11111223333211    245689999999999999 4 889999988754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=97.62  E-value=4.4e-05  Score=77.32  Aligned_cols=33  Identities=30%  Similarity=0.593  Sum_probs=13.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLS   39 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~   39 (436)
                      +|++|+|++|+|++ ||. +++  +|+.|+|++|+|+
T Consensus       101 ~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~  133 (571)
T 3cvr_A          101 SLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLT  133 (571)
T ss_dssp             TCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCS
T ss_pred             CCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCC
Confidence            34444444444443 443 332  4444444444444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=97.61  E-value=3.7e-05  Score=75.86  Aligned_cols=51  Identities=31%  Similarity=0.432  Sum_probs=29.0

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|+|++|+++| +|..   +++|+.|+|++|+++ .+|.   .+++|+.+++++|.
T Consensus       318 ~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~  368 (454)
T 1jl5_A          318 SLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNP  368 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSC
T ss_pred             cCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCC
Confidence            56666666666664 5543   355666666666665 3554   34555556665554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=97.60  E-value=2.4e-05  Score=74.05  Aligned_cols=58  Identities=33%  Similarity=0.579  Sum_probs=47.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKG   62 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~   62 (436)
                      +++|++|+|++|++++ + +.+..+++|+.|+|++|++++ +| .+..+++|+.+++++|..
T Consensus       242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l  299 (347)
T 4fmz_A          242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQL  299 (347)
T ss_dssp             CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCC
T ss_pred             CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcC
Confidence            4688999999999985 4 468889999999999999986 44 478888999999988863

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.58  E-value=0.00028  Score=65.36  Aligned_cols=71  Identities=13%  Similarity=0.086  Sum_probs=43.8

Q ss_pred             cceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc-eeeeeEEeeCCEEEEEEeec-c
Q 013793          148 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI-VKLYGFCLHKKCMFLIYEYM-E  225 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~  225 (436)
                      .+.|+.|....+|+.     ..+++|+.......    .....+|..++..+...++ .++++++  .+.-++++||+ +
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            567889999999999     55788887653211    0123457777777743333 4555543  33347899999 5


Q ss_pred             CCCh
Q 013793          226 RGSL  229 (436)
Q Consensus       226 ~g~L  229 (436)
                      +.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            5444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=97.57  E-value=7.7e-05  Score=73.63  Aligned_cols=54  Identities=28%  Similarity=0.363  Sum_probs=36.1

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++|++++ +  .++.+++|+.|+|++|++++ +|  ++.+++|+.+++++|.
T Consensus       191 ~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~  244 (457)
T 3bz5_A          191 KLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP  244 (457)
T ss_dssp             TTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred             CCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence            566777777777774 3  26667777777777777775 55  5666667777776664

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.56  E-value=0.00033  Score=68.39  Aligned_cols=73  Identities=22%  Similarity=0.279  Sum_probs=48.9

Q ss_pred             cceeeecCceEEEEEEcCC--------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc-eeeeeEEeeCCEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI-VKLYGFCLHKKCMF  218 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~  218 (436)
                      .+.|+.|....+|++..++        ++.+++|+.......     ..+..|..++..+...++ .++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~-----~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcH-----HHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            3457888889999998753        578999988542210     234468888888853333 566665542    3


Q ss_pred             EEEeeccCCCh
Q 013793          219 LIYEYMERGSL  229 (436)
Q Consensus       219 lv~e~~~~g~L  229 (436)
                      +|+||++|.++
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=97.53  E-value=7.7e-05  Score=73.66  Aligned_cols=54  Identities=28%  Similarity=0.364  Sum_probs=32.4

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|+|+| +|  ++.+++|++|+|++|++++ +|  ++.+++|+.+++++|.
T Consensus        64 ~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~  117 (457)
T 3bz5_A           64 TGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNK  117 (457)
T ss_dssp             TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSC
T ss_pred             CCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCc
Confidence            456666666666664 44  6666666666666666665 33  5556666666665553

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.53  E-value=1.2e-05  Score=77.50  Aligned_cols=61  Identities=16%  Similarity=0.212  Sum_probs=46.0

Q ss_pred             CCCCCEEECcCCccc--c---cCChhccCCCCCCeeeccccccC----CCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIE--G---SIPGELTDLSRLDYLNLSWNKLS----GPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~--g---~ip~~~~~l~~L~~l~ls~N~l~----g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+++  |   .+|..+..+++|+.|+|++|+++    +.+|..+..+++|+.|++++|.
T Consensus       186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~  255 (386)
T 2ca6_A          186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL  255 (386)
T ss_dssp             CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred             CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCC
Confidence            357888888888877  3   45557778888888888888886    5677777777888888887775

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.52  E-value=2.1e-05  Score=75.74  Aligned_cols=61  Identities=18%  Similarity=0.203  Sum_probs=45.4

Q ss_pred             CCCCCEEECcCCcccccCC----hhccCCCCCCeeecccc---ccCCCCCCcc-------ccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIP----GELTDLSRLDYLNLSWN---KLSGPVPFSN-------EQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip----~~~~~l~~L~~l~ls~N---~l~g~~p~~~-------~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++..|    ..+.++++|++|+|++|   +++|.+|..+       ..+++|+.+++++|.
T Consensus        31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~  105 (386)
T 2ca6_A           31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  105 (386)
T ss_dssp             CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence            3678888888888887644    34667888888888884   5666677654       567888888888775

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=97.51  E-value=5.3e-05  Score=76.71  Aligned_cols=52  Identities=27%  Similarity=0.335  Sum_probs=28.8

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCcccccccc-------CccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSM-------SRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l-------~~~~~~~n~   61 (436)
                      ++|+.|+|++|+|++ ||. |+  ++|+.|+|++|+|+ .+|. +..  +|       +.+++++|.
T Consensus       160 ~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~  218 (571)
T 3cvr_A          160 TSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENR  218 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSC
T ss_pred             CCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCc
Confidence            456666666666664 665 44  56666666666666 4555 333  44       555555554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.00037  Score=65.52  Aligned_cols=141  Identities=17%  Similarity=0.171  Sum_probs=73.0

Q ss_pred             eeeecCceE-EEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeeeEEeeCCEEEEEEeeccC
Q 013793          150 CIGTGGYGS-VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYGFCLHKKCMFLIYEYMER  226 (436)
Q Consensus       150 ~lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  226 (436)
                      .|+.|.... +|+....+|..+++|.......      ..+..|+.++..+..  -.+.+++.+....+  +++||++.+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~   96 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD   96 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence            455554444 6677765577788887654321      123345666666632  23455666644443  689999977


Q ss_pred             CChhhhhccC---------------------CC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH-
Q 013793          227 GSLFCILHND---------------------DE--AVELDWAKRV-------N-------------IVKAMAHALAYLH-  262 (436)
Q Consensus       227 g~L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~ia~~L~~LH-  262 (436)
                      ..+.+++...                     ..  ...++.....       .             ....+...+..+. 
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            6664433211                     00  0111111000       0             0011112222221 


Q ss_pred             --hcCCCCeEecCCCCCceeecCC----CCeEEeeccccccc
Q 013793          263 --HDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARRL  298 (436)
Q Consensus       263 --~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~  298 (436)
                        ......++|||+.+.||+++.+    ..+.|+||+.+..-
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              1125689999999999999875    67899999988653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.48  E-value=3.2e-05  Score=72.85  Aligned_cols=59  Identities=20%  Similarity=0.157  Sum_probs=34.3

Q ss_pred             CCCEEECcCC--ccc-ccCChhccCCCCCCeeeccccc-cCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNN--KIE-GSIPGELTDLSRLDYLNLSWNK-LSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n--~l~-g~ip~~~~~l~~L~~l~ls~N~-l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|+|++|  .++ +.+|..+.++++|+.|+|++|. +++..+..+..+++|+.+++++|.
T Consensus       196 ~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~  258 (336)
T 2ast_B          196 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY  258 (336)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred             CCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence            5566666666  343 4555555566666666666665 555555555566666666666554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.48  E-value=0.00037  Score=66.70  Aligned_cols=141  Identities=18%  Similarity=0.249  Sum_probs=81.6

Q ss_pred             ceeeecCceEEEEEEcCC--------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEE
Q 013793          149 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  219 (436)
                      +.+..|-...+|+...++        ++.+++|+..... ..   ...+.+|.++++.+. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            456668888899998753        5789999863321 11   245568988888884 3333556666543    29


Q ss_pred             EEeeccCCChhhh-----------------hccCCC--CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 013793          220 IYEYMERGSLFCI-----------------LHNDDE--AVELD--WAKRVNIVKAMAH-------------------ALA  259 (436)
Q Consensus       220 v~e~~~~g~L~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia~-------------------~L~  259 (436)
                      |+||++|..|..-                 +|....  .....  |.+..++..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998655311                 122110  11122  3444444443321                   223


Q ss_pred             HHH----h-cCCCCeEecCCCCCceeecCC----CCeEEeecccccc
Q 013793          260 YLH----H-DCSPSIIHRDISSNNILLNSK----LEAFVADFGTARR  297 (436)
Q Consensus       260 ~LH----~-~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~  297 (436)
                      .|.    . .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    1 123468999999999999876    6899999988753

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.47  E-value=7.6e-05  Score=73.84  Aligned_cols=57  Identities=26%  Similarity=0.442  Sum_probs=42.8

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|||++|++++ +|+ +++|++|++|+|++|++++..|  +..+++|+.+++++|.
T Consensus        67 l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~  123 (466)
T 1o6v_A           67 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQ  123 (466)
T ss_dssp             CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             hcCCCEEECCCCccCC-chh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCC
Confidence            4678888888888884 444 7888888888888888876444  7778888888887764

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.47  E-value=7.8e-05  Score=73.76  Aligned_cols=57  Identities=30%  Similarity=0.395  Sum_probs=35.0

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..|  +..+++|+.+++++|.
T Consensus       264 l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~  320 (466)
T 1o6v_A          264 LTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN  320 (466)
T ss_dssp             CTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSC
T ss_pred             CCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCc
Confidence            3566677777777664 333 6666666666666666665333  5566666666666654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.35  E-value=3.8e-05  Score=73.37  Aligned_cols=60  Identities=25%  Similarity=0.202  Sum_probs=47.7

Q ss_pred             CCCCEEECcCCcccccCC----hhccCCC-CCCeeeccccccCCCCCCccccc-----cccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIP----GELTDLS-RLDYLNLSWNKLSGPVPFSNEQL-----SSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip----~~~~~l~-~L~~l~ls~N~l~g~~p~~~~~l-----~~l~~~~~~~n~   61 (436)
                      ++|++|||++|++++.-+    ..+.+++ +|+.|+|++|++++..+..+..+     ++|+.+++++|.
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~   91 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNF   91 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCc
Confidence            358888999888886555    6777888 88888888888887777666664     788888888876

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.33  E-value=5.5e-05  Score=72.23  Aligned_cols=55  Identities=16%  Similarity=0.098  Sum_probs=30.9

Q ss_pred             EECcCCcccccCChhccCCCCCCeeeccccccCCCCC----Ccccccc-ccCccccCCCC
Q 013793            7 LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP----FSNEQLS-SMSRVRLSPNK   61 (436)
Q Consensus         7 l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p----~~~~~l~-~l~~~~~~~n~   61 (436)
                      ++|++|+++|.+|..+...++|+.|||++|++++..+    ..+..++ +|+.+++++|.
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~   62 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS   62 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCC
Confidence            4566666666666555555556666666666654433    3344455 56666665553

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.32  E-value=9.1e-05  Score=70.34  Aligned_cols=52  Identities=15%  Similarity=0.207  Sum_probs=40.5

Q ss_pred             CCCCEEECcCCcccccCCh-hccCCCCCCeeeccccccCCCCCC-ccccccccCc
Q 013793            2 KNLTWLDISNNKIEGSIPG-ELTDLSRLDYLNLSWNKLSGPVPF-SNEQLSSMSR   54 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~l~~   54 (436)
                      ++|++|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.+|. .|.+++++..
T Consensus        30 ~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~   83 (350)
T 4ay9_X           30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE   83 (350)
T ss_dssp             TTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE
T ss_pred             CCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh
Confidence            47889999999998 5654 688999999999999998777775 3556666554

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.30  E-value=8.4e-05  Score=70.58  Aligned_cols=61  Identities=20%  Similarity=0.193  Sum_probs=53.1

Q ss_pred             CCCCCEEECcCCcccccCCh-hccCCCCCCe-eeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPG-ELTDLSRLDY-LNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~-l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++||||+|++.+.||. .|.+|++|.. +++++|++++..|..+..+++|+.+++++|.
T Consensus        53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~  115 (350)
T 4ay9_X           53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG  115 (350)
T ss_dssp             CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred             CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccc
Confidence            57899999999999888886 6789998875 6778899997778889999999999999886

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.28  E-value=0.00012  Score=66.32  Aligned_cols=55  Identities=25%  Similarity=0.347  Sum_probs=44.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCC--CCCeeeccccccCCCCCCc-------cccccccCcccc
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLS--RLDYLNLSWNKLSGPVPFS-------NEQLSSMSRVRL   57 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~--~L~~l~ls~N~l~g~~p~~-------~~~l~~l~~~~~   57 (436)
                      +++|+.||||+|+|++.  .++..+.  +|+.|+|++|.+++.+|..       +..+++|..|+-
T Consensus       195 l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg  258 (267)
T 3rw6_A          195 APNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG  258 (267)
T ss_dssp             STTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred             CCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence            57899999999999964  4566666  9999999999999988842       456777777654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.14  E-value=0.00071  Score=64.59  Aligned_cols=73  Identities=14%  Similarity=0.038  Sum_probs=43.4

Q ss_pred             ceeeecCceEEEEEEcCC---------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC-ceeeeeEEeeCCEEE
Q 013793          149 YCIGTGGYGSVYKAQLPN---------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-IVKLYGFCLHKKCMF  218 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~  218 (436)
                      ..++.|....+|+....+         ++.+++|+.......-    .....|.+++..+...+ ..++++..  .  -+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~----~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL----YNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT----SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce----ecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            457778888999997654         2688888875532110    12356777787775333 34566543  2  26


Q ss_pred             EEEeeccCCCh
Q 013793          219 LIYEYMERGSL  229 (436)
Q Consensus       219 lv~e~~~~g~L  229 (436)
                      +||||++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999997544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.11  E-value=0.002  Score=63.22  Aligned_cols=74  Identities=18%  Similarity=0.160  Sum_probs=46.9

Q ss_pred             cceeeecCceEEEEEEcCC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc-eeeeeEEeeCCEEEEEEeecc
Q 013793          148 KYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI-VKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  225 (436)
                      .+.|+.|-...+|+....+ +..+++|+.......-    -...+|..++..+...++ .++++.+.  +  .+|+||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            3457888889999998765 5788899875432110    112468888888865444 45666663  2  35999999


Q ss_pred             CCCh
Q 013793          226 RGSL  229 (436)
Q Consensus       226 ~g~L  229 (436)
                      |..|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7554

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.02  E-value=7.2e-05  Score=73.68  Aligned_cols=60  Identities=18%  Similarity=0.030  Sum_probs=42.4

Q ss_pred             CCCCEEECcCCccccc----CChhccCCCCCCeeeccccccCCCCCCcccc-----ccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGS----IPGELTDLSRLDYLNLSWNKLSGPVPFSNEQ-----LSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~-----l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|.+++.    +|..+..+++|+.|+|++|++++..+..+..     .++|+.+++++|.
T Consensus       313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            4788888888888765    6677777788888888888877654443332     4577777777774

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=96.97  E-value=0.0006  Score=69.79  Aligned_cols=50  Identities=26%  Similarity=0.380  Sum_probs=23.8

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      +|+.|+|++|+|+ .||.   .+++|++|+|++|+|+ .+|.   .+++|+.|++++|
T Consensus        62 ~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N  111 (622)
T 3g06_A           62 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSN  111 (622)
T ss_dssp             TCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSC
T ss_pred             CCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCC
Confidence            4555555555555 4444   3445555555555554 2443   2334444444433

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.95  E-value=0.004  Score=58.64  Aligned_cols=32  Identities=19%  Similarity=0.391  Sum_probs=28.2

Q ss_pred             CCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          266 SPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       266 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45789999999999999888899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.83  E-value=0.0078  Score=52.10  Aligned_cols=103  Identities=19%  Similarity=0.098  Sum_probs=66.7

Q ss_pred             CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCCcc
Q 013793          227 GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT  306 (436)
Q Consensus       227 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  306 (436)
                      -+|.+.|...+  .++++.+++.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence            37888887654  3799999999999999998876211011  1223457889999999988764 1110          


Q ss_pred             ccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCC
Q 013793          307 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  347 (436)
Q Consensus       307 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p  347 (436)
                        .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1122466888763 3557889999999999999854444

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.79  E-value=0.00018  Score=68.89  Aligned_cols=60  Identities=17%  Similarity=0.194  Sum_probs=40.0

Q ss_pred             CCCCEEECcCCcccc----cCChhccCCCCCCeeeccccccCCC----CCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEG----SIPGELTDLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|.|+.    .++..+..+++|++|||++|+++..    ++..+...++|+.|++++|.
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~  222 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNG  222 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSC
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCC
Confidence            467888888888754    3555566777788888888877642    23344555667777777664

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.71  E-value=0.0012  Score=52.86  Aligned_cols=37  Identities=27%  Similarity=0.346  Sum_probs=32.4

Q ss_pred             CCCCEEECcCCcccccCC-hhccCCCCCCeeeccccccC
Q 013793            2 KNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLS   39 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip-~~~~~l~~L~~l~ls~N~l~   39 (436)
                      .+|+.|||++|+|+ .|| ..|..+++|+.|+|++|.+.
T Consensus        31 ~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           31 VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            37999999999999 555 46789999999999999885

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.64  E-value=0.00019  Score=73.11  Aligned_cols=60  Identities=12%  Similarity=0.124  Sum_probs=38.5

Q ss_pred             CCCCEEECcCCcccc-cCChhccCCCCCCeeeccccccCCC-CCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSGP-VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g-~ip~~~~~l~~L~~l~ls~N~l~g~-~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++ .+|..+..+++|++|+|++|+|++. ++.....+++|+.+++++|.
T Consensus       463 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          463 PNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             TTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             ccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            467777777777765 4555556677777777777776544 33333456677777777665

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=96.59  E-value=0.00029  Score=69.22  Aligned_cols=60  Identities=17%  Similarity=0.130  Sum_probs=32.5

Q ss_pred             CCCCEEECcCCcccc----cCChhccCCCCCCeeeccccccCCCCCCccc-ccc----ccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEG----SIPGELTDLSRLDYLNLSWNKLSGPVPFSNE-QLS----SMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~l~----~l~~~~~~~n~   61 (436)
                      ++|++|+|++|++++    .+|..+..+++|++|+|++|+++...+..+. .++    +|+.+++++|.
T Consensus        28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~   96 (461)
T 1z7x_W           28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC   96 (461)
T ss_dssp             TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSC
T ss_pred             CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCC
Confidence            456666666666653    3455566666666666666666543222221 122    45666665554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.53  E-value=0.00035  Score=66.92  Aligned_cols=60  Identities=18%  Similarity=0.121  Sum_probs=45.9

Q ss_pred             CCCCEEECcCCcccccCChhcc-----CCCCCCeeeccccccCC----CCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELT-----DLSRLDYLNLSWNKLSG----PVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~-----~l~~L~~l~ls~N~l~g----~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|||++|+|+..-...++     ..++|+.|+|++|+++.    .++..+..+++|+.|++++|.
T Consensus       126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~  194 (372)
T 3un9_A          126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTG  194 (372)
T ss_dssp             HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSS
T ss_pred             HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCC
Confidence            4688999999999765555553     46889999999999874    244445667889999999886

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.29  E-value=0.0083  Score=58.17  Aligned_cols=140  Identities=13%  Similarity=0.108  Sum_probs=82.1

Q ss_pred             ceeeecCceEEEEEEcCC--------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCC-ceeeeeEEeeCCEEEE
Q 013793          149 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS-IVKLYGFCLHKKCMFL  219 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l  219 (436)
                      +.+..|-...+|+....+        ++.+++|+.......    .-...+|..+++.+...+ ..++++.+  .+  ++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~  147 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--PE--GR  147 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence            456678888999997753        578999986543211    112346778877774323 34555533  22  68


Q ss_pred             EEeeccCCChhh--h---------------hccC-------C---CCCCCCHHHHHHHHHHH------------------
Q 013793          220 IYEYMERGSLFC--I---------------LHND-------D---EAVELDWAKRVNIVKAM------------------  254 (436)
Q Consensus       220 v~e~~~~g~L~~--~---------------l~~~-------~---~~~~l~~~~~~~i~~~i------------------  254 (436)
                      |+||++|..|..  +               +|..       .   ...+.-|.+..++..++                  
T Consensus       148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  227 (424)
T 3mes_A          148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK  227 (424)
T ss_dssp             EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred             EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence            999999866421  1               1110       0   11111244443333222                  


Q ss_pred             -HHHHHHHHh---------------------cCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          255 -AHALAYLHH---------------------DCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       255 -a~~L~~LH~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                       ...+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence             222333321                     11346899999999999 8888999999998864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.27  E-value=0.00044  Score=65.79  Aligned_cols=38  Identities=13%  Similarity=0.091  Sum_probs=20.1

Q ss_pred             CCCCCCeeeccccccCCCCCCccc---cccccCccccCCCC
Q 013793           24 DLSRLDYLNLSWNKLSGPVPFSNE---QLSSMSRVRLSPNK   61 (436)
Q Consensus        24 ~l~~L~~l~ls~N~l~g~~p~~~~---~l~~l~~~~~~~n~   61 (436)
                      .+++|++|+|++|.+++..+..+.   .+++|+.|+++.|.
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~  290 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV  290 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence            356666666666666533222221   34566666665543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.20  E-value=0.00088  Score=57.21  Aligned_cols=60  Identities=10%  Similarity=0.127  Sum_probs=34.5

Q ss_pred             CCCCEEECcCC-cccc----cCChhccCCCCCCeeeccccccCCC----CCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNN-KIEG----SIPGELTDLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n-~l~g----~ip~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++| .++.    .+...+...++|++|+|++|+++..    +...+...++|+.|++++|.
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~  104 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF  104 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence            45777777777 6642    2444555667777777777776531    12223334556666666664

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.08  E-value=0.00078  Score=68.48  Aligned_cols=60  Identities=10%  Similarity=0.129  Sum_probs=35.3

Q ss_pred             CCCCCEEECcCCccccc----CChhccCCCCCCeeeccccccCC----CCCCccccccccCccccCCC
Q 013793            1 MKNLTWLDISNNKIEGS----IPGELTDLSRLDYLNLSWNKLSG----PVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~l~ls~N~l~g----~~p~~~~~l~~l~~~~~~~n   60 (436)
                      +++|++|+|++|.+++.    ++..+.++++|+.|+|++|.+++    .++..+.++++|+.+++.+|
T Consensus       163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~  230 (592)
T 3ogk_B          163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF  230 (592)
T ss_dssp             CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSC
T ss_pred             CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCc
Confidence            35677777777776655    44445566666666666666652    22333344566666666554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.08  E-value=0.00068  Score=68.92  Aligned_cols=59  Identities=12%  Similarity=0.160  Sum_probs=25.8

Q ss_pred             CCCCEEECcCCcccccCChhccC-CCCCCeeeccccccCCCCCCcc-ccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTD-LSRLDYLNLSWNKLSGPVPFSN-EQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~-l~~L~~l~ls~N~l~g~~p~~~-~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|+
T Consensus       432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~  492 (594)
T 2p1m_B          432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP  492 (594)
T ss_dssp             TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred             CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence            3455555544 444444444443 4445555555554443322222 234444444444443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=95.85  E-value=0.0014  Score=55.85  Aligned_cols=60  Identities=17%  Similarity=0.199  Sum_probs=45.9

Q ss_pred             CCCCEEECcCCcccc----cCChhccCCCCCCeeeccccccCCC----CCCccccccccCcccc--CCCC
Q 013793            2 KNLTWLDISNNKIEG----SIPGELTDLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRL--SPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~--~~n~   61 (436)
                      ++|++|||++|+|+.    .+...+...+.|+.|+|++|+++..    +...+...++|+.|++  ++|.
T Consensus        65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~  134 (185)
T 1io0_A           65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQP  134 (185)
T ss_dssp             CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSC
T ss_pred             CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCC
Confidence            579999999999864    3455666778999999999999753    3445666678999999  5564

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=95.60  E-value=0.0058  Score=57.15  Aligned_cols=60  Identities=22%  Similarity=0.278  Sum_probs=46.5

Q ss_pred             CCCCCEEECcCCccc------c-------------cCC-hhccC--------CCCCCeeeccccccCCCCCCcccccccc
Q 013793            1 MKNLTWLDISNNKIE------G-------------SIP-GELTD--------LSRLDYLNLSWNKLSGPVPFSNEQLSSM   52 (436)
Q Consensus         1 l~~l~~l~ls~n~l~------g-------------~ip-~~~~~--------l~~L~~l~ls~N~l~g~~p~~~~~l~~l   52 (436)
                      +++|++||||+|+++      |             .|| ..|.+        |++|+.|+|++ +++..-+.+|..|++|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L  126 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL  126 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence            578999999999998      1             223 35566        99999999999 8884334568889999


Q ss_pred             CccccCCCC
Q 013793           53 SRVRLSPNK   61 (436)
Q Consensus        53 ~~~~~~~n~   61 (436)
                      +.+.+.+|.
T Consensus       127 ~~l~l~~n~  135 (329)
T 3sb4_A          127 KICQIRKKT  135 (329)
T ss_dssp             CEEEBCCSS
T ss_pred             ceEEcCCCC
Confidence            999998875

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=95.43  E-value=0.011  Score=55.16  Aligned_cols=58  Identities=24%  Similarity=0.240  Sum_probs=47.2

Q ss_pred             CCCCCEEECcCCcccccCC-hhccCCCCCCeeeccccccCCCCCCccccccccC-ccccCCC
Q 013793            1 MKNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMS-RVRLSPN   60 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip-~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~-~~~~~~n   60 (436)
                      +++|+.|+|++|+++ .|| ..|.+|++|+.|+|++| ++..-+.+|..+.+|+ .+.+.++
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~~  284 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPAS  284 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECTT
T ss_pred             cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEccc
Confidence            468999999999999 555 47999999999999998 7743345688888898 8888663

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=94.93  E-value=0.0026  Score=64.59  Aligned_cols=59  Identities=15%  Similarity=0.070  Sum_probs=30.6

Q ss_pred             CCCCEEECc--C----Ccccc-----cCChhccCCCCCCeeeccccccCCCCCCcccc-ccccCccccCCCC
Q 013793            2 KNLTWLDIS--N----NKIEG-----SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQ-LSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls--~----n~l~g-----~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~-l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|+  +    |++++     .++..+..+++|+.|+|++ ++++..+..++. +++|+.+++++|.
T Consensus       397 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~  467 (594)
T 2p1m_B          397 PNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG  467 (594)
T ss_dssp             TTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred             CCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC
Confidence            456666666  3    44441     2222345566666666655 444433333333 5566666665554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.65  E-value=0.13  Score=49.29  Aligned_cols=30  Identities=30%  Similarity=0.432  Sum_probs=25.0

Q ss_pred             CeEecCCCCCceee------cCCCCeEEeecccccc
Q 013793          268 SIIHRDISSNNILL------NSKLEAFVADFGTARR  297 (436)
Q Consensus       268 ~ivH~dlk~~Nill------~~~~~~kl~Dfg~a~~  297 (436)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567799999998864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=94.01  E-value=0.012  Score=55.74  Aligned_cols=61  Identities=16%  Similarity=0.286  Sum_probs=49.9

Q ss_pred             CCCCCEEECcCCcccccCChhcc---CCCCCCeeeccccccCCC----CCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELT---DLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~---~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|.+++..+..+.   .+++|+.||||.|++++.    ++..+..+++|+.|+++.|.
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~  318 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY  318 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence            46899999999999876665554   588999999999999863    55555678899999998774

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.28  E-value=0.49  Score=40.76  Aligned_cols=116  Identities=4%  Similarity=0.012  Sum_probs=80.2

Q ss_pred             cCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       200 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      .||+.++. .+-.+.+...+.|+.-+.+  .++-.    -..++...+++++.+|+....+++     .-+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFDN----IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGGG----GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCccc--CCHHH----HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceE
Confidence            57888866 5556666666666654322  22221    125778999999999998886666     347889999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcc
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD  349 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~  349 (436)
                      +++.++.+++.-.|+-..+.+.                      ..+...=.-.+=+++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P~----------------------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDPL----------------------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSCC----------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCCCCC----------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999888875433221                      11222223457889999999999986

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=92.21  E-value=0.019  Score=48.16  Aligned_cols=61  Identities=13%  Similarity=0.101  Sum_probs=40.7

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccc-cCCCCCCccccc----cccCccccCCCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNK-LSGPVPFSNEQL----SSMSRVRLSPNKGL   63 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~-l~g~~p~~~~~l----~~l~~~~~~~n~~l   63 (436)
                      +|+.||||++.++..==..+..|++|+.|+|+++. ++..==..+..+    ++|+.|++++++.+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~I  127 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNV  127 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcC
Confidence            57899999998865433457889999999999984 553111112332    36888888776533

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=91.45  E-value=0.021  Score=47.89  Aligned_cols=64  Identities=11%  Similarity=0.121  Sum_probs=45.2

Q ss_pred             CCCCCEEECcCCc-ccccCChhccCC----CCCCeeeccccc-cCCCCCCccccccccCccccCCCCCCC
Q 013793            1 MKNLTWLDISNNK-IEGSIPGELTDL----SRLDYLNLSWNK-LSGPVPFSNEQLSSMSRVRLSPNKGLC   64 (436)
Q Consensus         1 l~~l~~l~ls~n~-l~g~ip~~~~~l----~~L~~l~ls~N~-l~g~~p~~~~~l~~l~~~~~~~n~~lc   64 (436)
                      +++|++|+|+++. ++..==..++.+    ++|+.||||++. +|..==..+..+++|+.|++++.+.+.
T Consensus        84 ~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It  153 (176)
T 3e4g_A           84 LQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVK  153 (176)
T ss_dssp             CSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred             CCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence            5789999999996 664333345554    479999999974 663211235678899999998766444

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.38  E-value=0.35  Score=29.94  Aligned_cols=6  Identities=17%  Similarity=0.534  Sum_probs=2.3

Q ss_pred             Hhhhcc
Q 013793          103 VVKRKY  108 (436)
Q Consensus       103 ~~~~~~  108 (436)
                      +++|++
T Consensus        34 ~~RRr~   39 (44)
T 2ks1_B           34 FMRRRH   39 (44)
T ss_dssp             HHHTTT
T ss_pred             HhhhhH
Confidence            333333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.75  E-value=1.2  Score=38.56  Aligned_cols=115  Identities=12%  Similarity=0.139  Sum_probs=78.7

Q ss_pred             cCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCc
Q 013793          200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA-YLHHDCSPSIIHRDISSNN  278 (436)
Q Consensus       200 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~dlk~~N  278 (436)
                      .||++  -...-.+.+...+.|+.-+++.=..-+.      .++..++++++.+++.... +++     .-+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            57777  4444466777777777654443333332      5778899999888887666 555     45788999999


Q ss_pred             eeecCCCCeEEeecccccccCCCCCCccccccccccccccccccCccCcchhh-HHHHHHHHHHHhCCCCccc
Q 013793          279 ILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV-YSFGVVTLEVLMGKHPRDL  350 (436)
Q Consensus       279 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-~s~G~il~elltg~~p~~~  350 (436)
                      +++|.++.+++.-.|+-..+.                 |.-     .+ ..|. -.+=+++..++.++..|+.
T Consensus       115 L~f~~~~~p~i~hRGi~~~lp-----------------P~e-----~~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLP-----------------PDE-----WD-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBS-----------------SCS-----CC-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEEeCCCcEEEEEcCCcccCC-----------------CCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999998888654332                 211     11 2233 3577888999999988863

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=89.32  E-value=0.098  Score=44.69  Aligned_cols=37  Identities=16%  Similarity=0.281  Sum_probs=20.5

Q ss_pred             CCCEEECcCC-cccc----cCChhccCCCCCCeeeccccccC
Q 013793            3 NLTWLDISNN-KIEG----SIPGELTDLSRLDYLNLSWNKLS   39 (436)
Q Consensus         3 ~l~~l~ls~n-~l~g----~ip~~~~~l~~L~~l~ls~N~l~   39 (436)
                      +|++|+|++| ++..    .|-..+..-+.|+.|+|++|+++
T Consensus        42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig   83 (197)
T 1pgv_A           42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   83 (197)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence            5666666664 5431    13334445566666666666665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=88.02  E-value=0.41  Score=45.85  Aligned_cols=56  Identities=16%  Similarity=0.118  Sum_probs=36.3

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      +|+.++|.+ +++-.-+..|.+|++|+.++|++|+++ .||.......+|+.+.+.++
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~  213 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT  213 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc
Confidence            577777775 666333457777888888888888777 45554333566666666543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=85.22  E-value=0.63  Score=44.53  Aligned_cols=56  Identities=9%  Similarity=0.128  Sum_probs=33.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCC----CCC-CccccccccCccccCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSG----PVP-FSNEQLSSMSRVRLSP   59 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g----~~p-~~~~~l~~l~~~~~~~   59 (436)
                      +|+.++| .|+++-.-+..|.+|++|+.+++.+|.++.    .|+ ..|..|++|+.+.+.+
T Consensus       249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~  309 (401)
T 4fdw_A          249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE  309 (401)
T ss_dssp             CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT
T ss_pred             CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC
Confidence            5677777 444653334567777777777777776641    122 3455666666666654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=85.00  E-value=0.14  Score=43.72  Aligned_cols=60  Identities=17%  Similarity=0.176  Sum_probs=39.7

Q ss_pred             CCCCEEECcCCcccc----cCChhccCCCCCCeeeccccccCCC----CCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEG----SIPGELTDLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g----~ip~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +.|+.|+|++|++..    .|-..+..-+.|+.|+|++|+++..    |-..+..=+.|+.|++++|.
T Consensus        70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A           70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence            478999999999862    2334455668899999999998732    11112223457788887553

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=82.88  E-value=2  Score=26.40  Aligned_cols=10  Identities=30%  Similarity=0.564  Sum_probs=4.1

Q ss_pred             HHHhhhccCC
Q 013793          101 LLVVKRKYKK  110 (436)
Q Consensus       101 ~~~~~~~~~~  110 (436)
                      +++++||+.+
T Consensus        32 ~~~~RRR~~~   41 (44)
T 2jwa_A           32 GILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHCSC
T ss_pred             Hhheehhhhh
Confidence            3344444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	436
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-51
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-51
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-63
 Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 20/273 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
               +   IG+G +G+VYK +       A+K L+ +       +++F+NE  VL +  H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 64

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +I+   G+      + ++ ++ E  SL+  LH  +   + +  K ++I +  A  + YLH
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH 121

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--LAGTYGYIAPELA 320
                SIIHRD+ SNNI L+  L   + DFG A      S +     L+G+  ++APE+ 
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 321 YTM---VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
                   + + DVY+FG+V  E++ G+ P       S+ ++   ++  V    L P + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLS 232

Query: 378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           +           +   CL+     RP    +  
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 6e-62
 Identities = 65/272 (23%), Positives = 119/272 (43%), Gaps = 22/272 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ + Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 62

Query: 202 RSIVKLYGFCLHK--KCMFLIYEYMERGSLFCILHNDDEAVE-LDWAKRVNIVKAMAHAL 258
            +IV+ Y   + +    ++++ EY E G L  ++    +  + LD    + ++  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 259 AYLH--HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
              H   D   +++HRD+   N+ L+ K    + DFG AR L+ D+S      GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 376
           PE    M   EK D++S G +  E+     P         +   K +   + + +     
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFRRIP 235

Query: 377 DQ--KVIQDILLASTISFACLQSNPKSRPTMQ 406
            +    + +I+         L      RP+++
Sbjct: 236 YRYSDELNEIIT------RMLNLKDYHRPSVE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 3e-61
 Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 24/271 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   +   +G G +G V+          A+K L            +F  EA ++ Q+ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY     +  +++I EYME GSL   L      ++L   K +++   +A  +A++ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN-RTLLAGTYGYIAPELAY 321
                  IHRD+ + NIL++  L   +ADFG AR +  +    R        + APE   
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP--VDQK 379
               T K DV+SFG++  E++               ++P+++       R+  P    ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 380 VIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           + Q + L       C +  P+ RPT  Y+  
Sbjct: 239 LYQLMRL-------CWKERPEDRPTFDYLRS 262

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-61
 Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 21/265 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF I   +G G +G+VY A+   +  + ALK L  ++ E+       R E ++ S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +I++LYG+      ++LI EY   G+++  L       + D  +    +  +A+AL+Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  +IHRDI   N+LL S  E  +ADFG +   HA SS RT L GT  Y+ PE+  
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI 381
             +  EK D++S GV+  E L+GK P +     +++       I  ++   P  V +   
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE-----ANTYQETYKRISRVEFTFPDFVTEGA- 231

Query: 382 QDILLASTISFACLQSNPKSRPTMQ 406
           +D++         L+ NP  RP ++
Sbjct: 232 RDLIS------RLLKHNPSQRPMLR 250

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 5e-61
 Identities = 72/300 (24%), Positives = 118/300 (39%), Gaps = 44/300 (14%)

Query: 141 ATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
             +DF     +G G  G V+K    P+G V A K +H               E QVL + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHEC 61

Query: 200 LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALA 259
               IV  YG       + +  E+M+ GSL  +L        +       +  A+   L 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118

Query: 260 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           YL       I+HRD+  +NIL+NS+ E  + DFG + +L    +N     GT  Y++PE 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPER 174

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------------------------R 348
                 + + D++S G+  +E+ +G++P                                
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 349 DLLSSLSSSSDPKIMLIDVLDQRL--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
             LSS    S P + + ++LD  +  PPP     +  +     ++  CL  NP  R  ++
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERADLK 293

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-57
 Identities = 62/268 (23%), Positives = 113/268 (42%), Gaps = 22/268 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           +D      +GTG +G V   +       A+K +      E      F  EA+V+  + H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LYG C  ++ +F+I EYM  G L   L            + + + K +  A+ YL 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAY 321
                  +HRD+++ N L+N +    V+DFG +R +  D    ++       +  PE+  
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 322 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
               + K D+++FGV+  E+  +GK P +  ++            + + Q L        
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHLA 226

Query: 381 IQDILLASTISFACLQSNPKSRPTMQYV 408
            + +    TI ++C       RPT + +
Sbjct: 227 SEKVY---TIMYSCWHEKADERPTFKIL 251

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (477), Expect = 6e-57
 Identities = 75/316 (23%), Positives = 135/316 (42%), Gaps = 35/316 (11%)

Query: 131 GRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSF 189
             +F++D  +  + F     IG G +G+VY A+ + N +V A+KK+  S  +     +  
Sbjct: 5   AELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 190 RNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVN 249
             E + L ++ H + ++  G  L +   +L+ EY    +   +  +      L   +   
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAA 119

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA 309
           +       LAYLH   S ++IHRD+ + NILL+      + DFG+A  +   +S      
Sbjct: 120 VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FV 172

Query: 310 GTYGYIAPELAYTMVM---TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLID 366
           GT  ++APE+   M       K DV+S G+  +E+   K P         + +    L  
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYH 225

Query: 367 VLDQRLPPPVDQKV---IQDILLASTISFACLQSNPKSRPTMQYVSQ-GFLITRKTPLVK 422
           +     P           ++ +       +CLQ  P+ RPT + + +  F++  + P V 
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVD------SCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279

Query: 423 HAAIQDI--SISELRN 436
              IQ    ++ EL N
Sbjct: 280 MDLIQRTKDAVRELDN 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-56
 Identities = 63/269 (23%), Positives = 114/269 (42%), Gaps = 20/269 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E   ++  +G G +G V+          A+K L           ++F  EAQV+ ++ H 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LY     +  ++++ EYM +GSL   L  +         + V++   +A  +AY+ 
Sbjct: 73  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE 130

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD-SSNRTLLAGTYGYIAPELAY 321
                  +HRD+ + NIL+   L   VADFG AR +  +  + R        + APE A 
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI 381
               T K DV+SFG++  E+                      ++D +++    P   +  
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPY-------PGMVNREVLDQVERGYRMPCPPECP 240

Query: 382 QDILLASTISFACLQSNPKSRPTMQYVSQ 410
           + +     +   C +  P+ RPT +Y+  
Sbjct: 241 ESLH---DLMCQCWRKEPEERPTFEYLQA 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 9e-56
 Identities = 67/271 (24%), Positives = 108/271 (39%), Gaps = 27/271 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           ED+ +   +G G YG V  A      +  A+K +      +    ++ + E  +   + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            ++VK YG        +L  EY   G LF  +  D   + +           +   + YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYL 119

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--LAGTYGYIAPEL 319
           H      I HRDI   N+LL+ +    ++DFG A     ++  R L  + GT  Y+APEL
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 320 AYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ 378
                   E  DV+S G+V   +L G+ P D        SD      D  +++      +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWK 230

Query: 379 KV---IQDILLASTISFACLQSNPKSRPTMQ 406
           K+      +L         L  NP +R T+ 
Sbjct: 231 KIDSAPLALLH------KILVENPSARITIP 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-55
 Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 24/271 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            +      IG+G +G V+     N    A+K +      E    + F  EA+V+ ++ H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +V+LYG CL +  + L++E+ME G L   L              + +   +      + 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MA 115

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL-LAGTYGYIAPELAY 321
           +     +IHRD+++ N L+       V+DFG  R +  D    +        + +PE+  
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP--VDQK 379
               + K DV+SFGV+  EV              + S+ +++       RL  P      
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFRLYKPRLASTH 230

Query: 380 VIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           V Q +         C +  P+ RP    + +
Sbjct: 231 VYQIMNH-------CWKERPEDRPAFSRLLR 254

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 1e-55
 Identities = 57/269 (21%), Positives = 110/269 (40%), Gaps = 24/269 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           ++  +   IG G +G V       G   A+K +    T +     +F  EA V++Q+ H 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60

Query: 203 SIVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++V+L G  +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
                 + +HRD+++ N+L++    A V+DFG  +     SS +        + APE   
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI 381
               + K DV+SFG++  E+                  P   ++  +++           
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMDAPDGCP 226

Query: 382 QDILLASTISFACLQSNPKSRPTMQYVSQ 410
             +     +   C   +   RP+   + +
Sbjct: 227 PAVY---EVMKNCWHLDAAMRPSFLQLRE 252

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (466), Expect = 2e-55
 Identities = 83/310 (26%), Positives = 135/310 (43%), Gaps = 48/310 (15%)

Query: 121 IDVFSIWNYDGRIFYEDLIEATEDFH---------IKYCIGTGGYGSVYKAQLP----NG 167
           ID F+         +ED  EA  +F          I+  IG G +G V    L       
Sbjct: 4   IDPFT---------FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE 54

Query: 168 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERG 227
              A+K L +  TE+    + F +EA ++ Q  H +++ L G       + +I E+ME G
Sbjct: 55  IFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112

Query: 228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 287
           SL   L  +D   +    + V +++ +A  + YL        +HRD+++ NIL+NS L  
Sbjct: 113 SLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVC 167

Query: 288 FVADFGTARRLHADSSNRTLLA-----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 342
            V+DFG +R L  D+S+ T  +         + APE       T   DV+S+G+V  EV+
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227

Query: 343 M-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ-KVIQDILLASTISFACLQSNPK 400
             G+ P          ++  ++     D RLPPP+D    +  ++L       C Q +  
Sbjct: 228 SYGERP------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML------DCWQKDRN 275

Query: 401 SRPTMQYVSQ 410
            RP    +  
Sbjct: 276 HRPKFGQIVN 285

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 3e-55
 Identities = 61/298 (20%), Positives = 110/298 (36%), Gaps = 29/298 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           EDF     +G G + +V  A+ L   + +A+K L      +   +     E  V+S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
              VKLY      + ++    Y + G L   +         D          +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--LAGTYGYIAPEL 319
           H      IIHRD+   NILLN  +   + DFGTA+ L  +S         GT  Y++PEL
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-Q 378
                  +  D+++ G +  +++ G  P         + +  ++   ++      P    
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYDFPEKFF 234

Query: 379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN 436
              +D++         L  +   R   + +     +        H   + ++   L  
Sbjct: 235 PKARDLVE------KLLVLDATKRLGCEEMEGYGPL------KAHPFFESVTWENLHQ 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-55
 Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 26/281 (9%)

Query: 135 YEDL---IEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR 190
           YE +   +   + + I   +G G +G VYKAQ      + A K + T   EE   ++ + 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYM 57

Query: 191 NEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNI 250
            E  +L+   H +IVKL     ++  ++++ E+   G++  ++   +    L  ++   +
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115

Query: 251 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAG 310
            K    AL YLH      IIHRD+ + NIL     +  +ADFG + +       R    G
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172

Query: 311 TYGYIAPELAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI 365
           T  ++APE+             K DV+S G+  +E+   + P   L+ +      KI   
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKS 230

Query: 366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           +      P        +D L        CL+ N  +R T  
Sbjct: 231 EPPTLAQPSRWSSN-FKDFLK------KCLEKNVDARWTTS 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 6e-55
 Identities = 64/262 (24%), Positives = 108/262 (41%), Gaps = 23/262 (8%)

Query: 151 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYG 209
           IG G + +VYK          A  +L   +  + +  + F+ EA++L  + H +IV+ Y 
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 210 FCL----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC 265
                   KKC+ L+ E M  G+L   L        +      +  + +   L +LH   
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 266 SPSIIHRDISSNNILLNSKL-EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMV 324
            P IIHRD+  +NI +        + D G A    A  +    + GT  ++APE+ Y   
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPEFMAPEM-YEEK 188

Query: 325 MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDI 384
             E  DVY+FG+  LE+   ++P       S   +   +   V     P   D+  I + 
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKVAIPE- 241

Query: 385 LLASTISFACLQSNPKSRPTMQ 406
                I   C++ N   R +++
Sbjct: 242 --VKEIIEGCIRQNKDERYSIK 261

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 7e-55
 Identities = 59/269 (21%), Positives = 119/269 (44%), Gaps = 26/269 (9%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            + +     IG G  G+VY A  +  G+  A+++++  +  +    +   NE  V+ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENK 75

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           + +IV      L    ++++ EY+  GSL  ++         D  +   + +    AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEF 131

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           LH   S  +IHRDI S+NILL       + DFG   ++  + S R+ + GT  ++APE+ 
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
                  K D++S G++ +E++ G+ P        + +  + + +   +        +K+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPEKL 242

Query: 381 ---IQDILLASTISFACLQSNPKSRPTMQ 406
               +D L        CL  + + R + +
Sbjct: 243 SAIFRDFLN------RCLDMDVEKRGSAK 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-54
 Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 29/284 (10%)

Query: 136 EDLIEATEDFHI-KYCIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRN 191
           + L    ++  I    +G G +GSV +            A+K L     +     +    
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 58

Query: 192 EAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
           EAQ++ Q+ +  IV+L G C   + + L+ E    G L   L    E  E+  +    ++
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLL 308
             ++  + YL      + +HRD+++ N+LL ++  A ++DFG ++ L AD S    R+  
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 309 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDV 367
                + APE       + + DV+S+GV   E L  G+ P            P++M    
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------KMKGPEVMAFIE 226

Query: 368 LDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             +R+  P +    +  ++        C     + RP    V Q
Sbjct: 227 QGKRMECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQ 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (459), Expect = 1e-54
 Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 25/288 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            D  +K+ +G G YG VY+          A+K L     E    ++ F  EA V+ ++ H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKH 72

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            ++V+L G C  +   ++I E+M  G+L   L   +   E+     + +   ++ A+ YL
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL 131

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-TLLAGTYGYIAPELA 320
                 + IHRD+++ N L+       VADFG +R +  D+            + APE  
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
                + K DV++FGV+  E+            LS        + ++L++       +  
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGC 241

Query: 381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQD 428
            + +     +  AC Q NP  RP+   + Q F       + + ++I D
Sbjct: 242 PEKVY---ELMRACWQWNPSDRPSFAEIHQAF-----ETMFQESSISD 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-54
 Identities = 64/292 (21%), Positives = 109/292 (37%), Gaps = 38/292 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
                   +G G +G V +A              A+K L  S        ++  +E +VL
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 197 SQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN---------------DDEAV 240
           S +  H +IV L G C       +I EY   G L   L                 +D+ +
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
            LD    ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 301 DSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS 358
           DS+   +        ++APE  +  V T + DV+S+G+   E+                 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGM 251

Query: 359 DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                   ++ +       +    ++     I   C  ++P  RPT + + Q
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQ 300

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 4e-53
 Identities = 62/268 (23%), Positives = 113/268 (42%), Gaps = 28/268 (10%)

Query: 151 IGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL 207
           +G+G +G+V K         K  A+K L     +  A       EA V+ Q+ +  IV++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRM 73

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
            G C  +  M L+ E  E G L   L  +     +     + +V  ++  + YL      
Sbjct: 74  IGICEAESWM-LVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLLAGTYGYIAPELAYTMV 324
           + +HRD+++ N+LL ++  A ++DFG ++ L AD +    +T       + APE      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 325 MTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQ 382
            + K DV+SFGV+  E    G+ P             ++  +    +R+  P    + + 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP------YRGMKGSEVTAMLEKGERMGCPAGCPREMY 240

Query: 383 DILLASTISFACLQSNPKSRPTMQYVSQ 410
           D++        C   + ++RP    V  
Sbjct: 241 DLMN------LCWTYDVENRPGFAAVEL 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (450), Expect = 4e-53
 Identities = 61/299 (20%), Positives = 118/299 (39%), Gaps = 48/299 (16%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVL 196
            +      IG G +G V++A+ P         + A+K L    + +      F+ EA ++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 70

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVE--------------- 241
           ++  + +IVKL G C   K M L++EYM  G L   L +                     
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 242 ------LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 295
                 L  A+++ I + +A  +AYL        +HRD+++ N L+   +   +ADFG +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 296 RRLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS 353
           R +++    +     A    ++ PE  +    T + DV+++GVV  E+            
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---- 243

Query: 354 LSSSSDPKIMLIDVLDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                  + ++  V D  +    +     + +++        C    P  RP+   + +
Sbjct: 244 --YGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRPSFCSIHR 294

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-53
 Identities = 55/297 (18%), Positives = 110/297 (37%), Gaps = 43/297 (14%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           E+      +G+G +G V  A              A+K L           ++  +E +++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 94

Query: 197 SQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-------------------- 235
           +Q+  H +IV L G C     ++LI+EY   G L   L +                    
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 236 DDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 295
           +++   L +   +     +A  + +L      S +HRD+++ N+L+       + DFG A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 296 RRLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSS 353
           R + +DS+            ++APE  +  + T K DV+S+G++  E+            
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------ 265

Query: 354 LSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                        ++             ++I     I  +C   + + RP+   ++ 
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSRKRPSFPNLTS 319

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 6e-52
 Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 38/297 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
               ++  IG G +G V++ +   G+  A+K   + E            E      + H 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR----EAEIYQTVMLRHE 57

Query: 203 SIVKLYGFC----LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           +I+               ++L+ +Y E GSLF  L+       +     + +  + A  L
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGL 113

Query: 259 AYLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN----RTLLA 309
           A+LH +       P+I HRD+ S NIL+       +AD G A R  + +           
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 310 GTYGYIAPELAYTMVM------TEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------- 355
           GT  Y+APE+    +        ++ D+Y+ G+V  E+        +             
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 356 SSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA--CLQSNPKSRPTMQYVSQ 410
           S    + M   V +Q+L P +  +      L         C  +N  +R T   + +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (443), Expect = 2e-51
 Identities = 69/311 (22%), Positives = 129/311 (41%), Gaps = 33/311 (10%)

Query: 123 VFSIWNYD----GRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT 177
           VF IW         I ++ +++    + I   +GTG +G V++      G  FA K + T
Sbjct: 5   VFDIWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61

Query: 178 SETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDD 237
               +    ++ R E Q +S + H ++V L+        M +IYE+M  G LF  +   D
Sbjct: 62  PHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--D 116

Query: 238 EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTA 295
           E  ++   + V  ++ +   L ++H +     +H D+   NI+  +K    +   DFG  
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173

Query: 296 RRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS 355
             L    S +    GT  + APE+A    +    D++S GV++  +L G  P        
Sbjct: 174 AHLDPKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-----G 227

Query: 356 SSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ------YVS 409
            + D  +  +   D  +       + +D      I    L ++P +R T+       +++
Sbjct: 228 ENDDETLRNVKSCDWNMDDSAFSGISED--GKDFIR-KLLLADPNTRMTIHQALEHPWLT 284

Query: 410 QGFLITRKTPL 420
            G    R + +
Sbjct: 285 PGNAPGRDSQI 295

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 65/296 (21%), Positives = 119/296 (40%), Gaps = 31/296 (10%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 200
           EDF +   +G G +G V+ A+     + FA+K L          ++    E +VLS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H  +  ++     K+ +F + EY+  G L   + +  +    D ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELA 320
           L    S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAPE+ 
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV 380
                    D +SFGV+  E+L+G+ P           + ++     +D    P   +K 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPRWLEKE 229

Query: 381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN 436
            +D+L+            P+ R  +           +  + +H   ++I+  EL  
Sbjct: 230 AKDLLV------KLFVREPEKRLGV-----------RGDIRQHPLFREINWEELER 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 58/275 (21%), Positives = 100/275 (36%), Gaps = 22/275 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           +D  +   +G G +G V + +           A+K L      +   +  F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
           + HR++++LYG       M ++ E    GSL   L        L    R      +A  +
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN---RTLLAGTYGYI 315
            YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +   +      + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
           APE   T   +   D + FGV   E+                 +   +L  +  +    P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE------PWIGLNGSQILHKIDKEGERLP 235

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
             +   QDI     +   C    P+ RPT   +  
Sbjct: 236 RPEDCPQDIY---NVMVQCWAHKPEDRPTFVALRD 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (441), Expect = 4e-51
 Identities = 61/270 (22%), Positives = 113/270 (41%), Gaps = 26/270 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + + I   +G+G +G V++      G+VF  K ++T    +     + +NE  +++Q+ H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             ++ L+     K  M LI E++  G LF  +  +D    +  A+ +N ++     L ++
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHM 143

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARRLHADSSNRTLLAGTYGYIAPEL 319
           H     SI+H DI   NI+  +K  + V   DFG A +L+ D   +     T  + APE+
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEI 199

Query: 320 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK 379
                +    D+++ GV+   +L G  P              +  +   D          
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSS 254

Query: 380 V---IQDILLASTISFACLQSNPKSRPTMQ 406
           V    +D +         LQ  P+ R T+ 
Sbjct: 255 VSPEAKDFIK------NLLQKEPRKRLTVH 278

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-51
 Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 35/286 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQV 199
            D   +  IG G +G V KA++         A+K++    +++    + F  E +VL ++
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67

Query: 200 L-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-------------DDEAVELDWA 245
             H +I+ L G C H+  ++L  EY   G+L   L               +  A  L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 246 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR 305
           + ++    +A  + YL        IHRD+++ NIL+     A +ADFG + R       +
Sbjct: 128 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKK 183

Query: 306 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLI 365
           T+      ++A E     V T   DV+S+GV+  E++               +  ++   
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238

Query: 366 DVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
                RL  P++    + D++        C +  P  RP+   +  
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILV 278

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 3e-50
 Identities = 66/276 (23%), Positives = 106/276 (38%), Gaps = 25/276 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNG-----KVFALKKLHTSETEELAFIKSFRNEAQVLS 197
                +  IG G +G VYK  L           A+K L    TE+      F  EA ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMG 64

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
           Q  H +I++L G     K M +I EYME G+        ++  E    + V +++ +A  
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLA---GTYGY 314
           +    +  + + +HRD+++ NIL+NS L   V+DFG +R L  D       +       +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 315 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
            APE       T   DV+SFG+V  EV+                     ++  ++     
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------WELSNHEVMKAINDGFRL 232

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           P        I     +   C Q     RP    +  
Sbjct: 233 PTPMDCPSAIY---QLMMQCWQQERARRPKFADIVS 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-50
 Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 31/302 (10%)

Query: 121 IDVFSIWNYDGRIFYEDLIEATEDFHIKY--CIGTGGYGSVYKAQLPNGK----VFALKK 174
           ID+ ++ N +     + ++       + +   IG G +G VY   L +        A+K 
Sbjct: 4   IDLSAL-NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62

Query: 175 LHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKCMFLIYEYMERGSLFCIL 233
           L+         +  F  E  ++    H +++ L G CL  +    ++  YM+ G L   +
Sbjct: 63  LNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 234 HNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG 293
            N+     +       +  A       +    S   +HRD+++ N +L+ K    VADFG
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175

Query: 294 TARRLHADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 349
            AR ++        N+T       ++A E   T   T K DV+SFGV+  E++    P  
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235

Query: 350 LLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKVIQDILLASTISFACLQSNPKSRPTMQYV 408
                   +   I +  +  +RL  P      + +++L       C     + RP+   +
Sbjct: 236 -----PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSEL 284

Query: 409 SQ 410
             
Sbjct: 285 VS 286

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (425), Expect = 1e-49
 Identities = 67/271 (24%), Positives = 120/271 (44%), Gaps = 22/271 (8%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           ++ + +   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 201 HRSIVKLYGFCLHK----KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           H +IV +Y     +       +++ EY++  +L  I+H +     +   + + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL---LAGTYG 313
           AL +        IIHRD+   NI++++     V DFG AR +    ++ T    + GT  
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 373
           Y++PE A    +  + DVYS G V  EVL G+ P       +  S   +    V +  +P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIP 233

Query: 374 PPVDQKVIQDILLASTISFACLQSNPKSRPT 404
           P    + +   L A  +    L  NP++R  
Sbjct: 234 PSARHEGLSADLDA--VVLKALAKNPENRYQ 262

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-49
 Identities = 63/293 (21%), Positives = 124/293 (42%), Gaps = 21/293 (7%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E + I   +G G +G V++     + K +  K +    T++       + E  +L+ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNI 57

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             HR+I+ L+      + + +I+E++    +F  ++    A EL+  + V+ V  +  AL
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEAL 115

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARRLHADSSNRTLLAGTYGYIA 316
            +LH   S +I H DI   NI+  ++  + +   +FG AR+L    + R  L     Y A
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYA 171

Query: 317 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 376
           PE+    V++   D++S G +   +L G +P         +   + ++ ++++       
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL-------AETNQQIIENIMNAEYTFDE 224

Query: 377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDI 429
           +      I     +    L    KSR T     Q   + +K   V    I+ +
Sbjct: 225 EAFKEISIEAMDFVD-RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 2e-48
 Identities = 66/275 (24%), Positives = 110/275 (40%), Gaps = 27/275 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E   +  CIG G +G V++    +        A+K      ++     + F  EA  + Q
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
             H  IVKL G    +  +++I E    G L   L     +  LD A  +     ++ AL
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 121

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR-TLLAGTYGYIAP 317
           AYL    S   +HRDI++ N+L++S     + DFG +R +   +  + +       ++AP
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV 376
           E       T   DV+ FGV   E+LM G  P           +  ++      +RLP P 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ------GVKNNDVIGRIENGERLPMPP 232

Query: 377 D-QKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
           +    +  ++        C   +P  RP    +  
Sbjct: 233 NCPPTLYSLMT------KCWAYDPSRRPRFTELKA 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  166 bits (420), Expect = 2e-48
 Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 31/296 (10%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           +DF I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             I++++G     + +F+I +Y+E G LF +L                     A     L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLAL 117

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
            +  S  II+RD+   NILL+      + DFG A+ +         L GT  YIAPE+  
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDQKV 380
           T    +  D +SFG++  E+L G  P          S+       +L+  L  PP   + 
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFPPFFNED 227

Query: 381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELRN 436
           ++D+L         +  +   R                 +  H   +++   +L +
Sbjct: 228 VKDLLS------RLITRDLSQRLGNLQNGT-------EDVKNHPWFKEVVWEKLLS 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (412), Expect = 2e-47
 Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 27/272 (9%)

Query: 142 TEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
            + +  +  +GTG +  V  A+     K+ A+K +     E      S  NE  VL ++ 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK 65

Query: 201 HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAY 260
           H +IV L         ++LI + +  G LF  +                ++  +  A+ Y
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKY 122

Query: 261 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARRLHADSSNRTLLAGTYGYIAP 317
           LH      I+HRD+   N+L  S  E     ++DFG ++     S   T   GT GY+AP
Sbjct: 123 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 178

Query: 318 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
           E+      ++  D +S GV+   +L G  P         +       I   +     P  
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYW 233

Query: 378 QKV---IQDILLASTISFACLQSNPKSRPTMQ 406
             +    +D +         ++ +P+ R T +
Sbjct: 234 DDISDSAKDFIR------HLMEKDPEKRFTCE 259

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-46
 Identities = 56/285 (19%), Positives = 112/285 (39%), Gaps = 31/285 (10%)

Query: 133 IFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKS 188
           +F ++ ++  + +     +G+G +  V K +    G  +A K +    T  +      + 
Sbjct: 2   VFRQENVD--DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 189 FRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
              E  +L ++ H +++ L+    +K  + LI E +  G LF  L   +   E + A   
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEF 118

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARRLHADSSN 304
                +   L  +++  S  I H D+   NI+L      K    + DFG A ++   +  
Sbjct: 119 -----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172

Query: 305 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIML 364
              + GT  ++APE+     +  + D++S GV+T  +L G  P         +    +  
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLAN 227

Query: 365 IDVLDQRLPPPVDQKV---IQDILLASTISFACLQSNPKSRPTMQ 406
           +  ++               +D +         L  +PK R T+Q
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQ 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-46
 Identities = 64/285 (22%), Positives = 118/285 (41%), Gaps = 27/285 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVF----ALKKLHTSETEELAFIKSFRNEAQVLS 197
            +F     +G+G +G+VYK   +P G+      A+K+L  + + +    K   +EA V++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 66

Query: 198 QVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
            V +  + +L G CL    + LI + M  G L   +    +   +     +N    +A  
Sbjct: 67  SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 123

Query: 258 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL--LAGTYGYI 315
           + YL       ++HRD+++ N+L+ +     + DFG A+ L A+              ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP 374
           A E     + T + DV+S+GV   E++  G  P D          P   +  +L++    
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--------GIPASEISSILEKGERL 232

Query: 375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP 419
           P       D+     I   C   +  SRP  + +   F    + P
Sbjct: 233 PQPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (403), Expect = 2e-46
 Identities = 61/281 (21%), Positives = 115/281 (40%), Gaps = 35/281 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELA------FIKSFRNEAQV 195
           E++  K  +G G    V +    P  K +A+K +  +     +        ++   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 196 LSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAM 254
           L +V  H +I++L          FL+++ M++G LF  L      V L   +   I++A+
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 119

Query: 255 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGY 314
              +  LH     +I+HRD+   NILL+  +   + DFG + +L      R  + GT  Y
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 175

Query: 315 IAPELAYTMVM------TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL 368
           +APE+    +        ++ D++S GV+   +L G  P              + +I   
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSG 230

Query: 369 DQRLPPPVDQKV---IQDILLASTISFACLQSNPKSRPTMQ 406
           + +   P        ++D++         L   P+ R T +
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAE 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 3e-46
 Identities = 61/283 (21%), Positives = 108/283 (38%), Gaps = 34/283 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           E   +   +G G +G VY+               A+K ++ + +        F NEA V+
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILH-------NDDEAVELDWAKRVN 249
            +     +V+L G     +   +I E M RG L   L        N+        +K + 
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 250 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNR--TL 307
           +   +A  +AYL    +   +HRD+++ N ++       + DFG  R ++     R    
Sbjct: 138 MAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 308 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDV 367
                 +++PE     V T   DV+SFGVV  E+                   + +L  V
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQVLRFV 248

Query: 368 LDQRLPPPVDQ--KVIQDILLASTISFACLQSNPKSRPTMQYV 408
           ++  L    D    ++ +++        C Q NPK RP+   +
Sbjct: 249 MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEI 285

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-46
 Identities = 60/292 (20%), Positives = 112/292 (38%), Gaps = 39/292 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQ 194
           +   +   +G G +G V  A+               A+K L +  TE+   +    +E +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70

Query: 195 VLSQVL-HRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHN-------------DDEAV 240
           ++  +  H++I+ L G C     +++I EY  +G+L   L                +   
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA 300
           +L     V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H 
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 301 DSSNRTLLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSS 358
               +          ++APE  +  + T + DV+SFGV+  E+                 
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-------PG 240

Query: 359 DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
            P   L  +L +            ++     +   C  + P  RPT + + +
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFKQLVE 289

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (402), Expect = 3e-45
 Identities = 57/269 (21%), Positives = 96/269 (35%), Gaps = 22/269 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQ 198
            DF +   IG GG+G VY  +    GK++A+K L        +      + R    ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHAL 258
                IV +         +  I + M  G L   L       E D          +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGL 120

Query: 259 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE 318
            ++H   +  +++RD+   NILL+      ++D G A        + +   GT+GY+APE
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPE 175

Query: 319 -LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD 377
            L   +      D +S G +  ++L G  P                 ID +   +   + 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELP 229

Query: 378 QKVIQDILLASTISFACLQSNPKSRPTMQ 406
                +  L S +    LQ +   R    
Sbjct: 230 DSFSPE--LRSLLE-GLLQRDVNRRLGCL 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (386), Expect = 7e-44
 Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 25/282 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
           E +H    IG G YG VYKAQ   G+ FALKK+   + +E     +   E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 203 SIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
           +IVKLY     KK + L++E++++     +   +     +           +   L  + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF------LLQLLNGIA 114

Query: 263 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LAY 321
           +     ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDVL 368
           +   +   D++S G +  E++ G                  +L + +S + P +  +   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 369 DQRLP--PPVDQKVIQDILLASTISF--ACLQSNPKSRPTMQ 406
           D       P+  +     L  S I      L+ +P  R T +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-44
 Identities = 60/276 (21%), Positives = 103/276 (37%), Gaps = 26/276 (9%)

Query: 151 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRSIVKL 207
           +G G + +VYKA+  N  ++ A+KK+      E      ++   E ++L ++ H +I+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 208 YGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSP 267
                HK  + L++++ME      I  N                  M   L  L +    
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY------MLMTLQGLEYLHQH 119

Query: 268 SIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVM-T 326
            I+HRD+  NN+LL+      +ADFG A+   + +   T    T  Y APEL +   M  
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 327 EKCDVYSFGVVTLEVLMGKHP--------------RDLLSSLSSSSDPKIMLIDVLDQRL 372
              D+++ G +  E+L+                    L +           L D +  + 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 373 PPPVDQKVIQDILLASTISF--ACLQSNPKSRPTMQ 406
            P +    I        +         NP +R T  
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-43
 Identities = 55/265 (20%), Positives = 97/265 (36%), Gaps = 21/265 (7%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
            DF     +G G +G V   +    G+ +A+K L          +     E++VL    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +  L         +  + EY   G LF  L  +    E             A  ++ L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGAEIVSAL 118

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
            +  S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+  
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD-QKV 380
                   D +  GVV  E++ G+ P         + D + +   +L + +  P      
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPE 231

Query: 381 IQDILLASTISFACLQSNPKSRPTM 405
            + +L         L+ +PK R   
Sbjct: 232 AKSLLA------GLLKKDPKQRLGG 250

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 1e-42
 Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 25/283 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           E+F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNH 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
            +IVKL      +  ++L++E++ +     +  +    + L   K       +   L  L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPE-LA 320
               S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 321 YTMVMTEKCDVYSFGVVTLEVLMGKHP-------------RDLLSSLSSSSDPKIMLIDV 367
                +   D++S G +  E++  +                  L +      P +  +  
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 368 LDQRLPPPVDQKVIQDILLASTISF----ACLQSNPKSRPTMQ 406
                P    Q   + +              L  +P  R + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 1e-42
 Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 37/291 (12%)

Query: 143 EDFHIKYCIGTGGYGSVYKA------QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           +   +   +G G +G V +A      +    +  A+K L    T      ++  +E ++L
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70

Query: 197 SQVLHRS-IVKLYGFCLHK-KCMFLIYEYMERGSLFCILHN-------------DDEAVE 241
             + H   +V L G C      + +I E+ + G+L   L +             D     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           L     +     +A  + +L    S   IHRD+++ NILL+ K    + DFG AR ++ D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 302 SSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSD 359
                +        ++APE  +  V T + DV+SFGV+  E+            +    +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEE 245

Query: 360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQ 410
               L +    R P     ++ Q +L        C    P  RPT   + +
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLD-------CWHGEPSQRPTFSELVE 289

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-42
 Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 27/274 (9%)

Query: 143 EDFHI-KYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 200
           +D+ +    +G G  G V +       + FALK L              R E ++  +  
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRAS 62

Query: 201 -HRSIVKLYGFC----LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
               IV++          +KC+ ++ E ++ G LF  + +  +       +   I+K++ 
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIG 121

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARRLHADSSNRTLLAGTY 312
            A+ YLH   S +I HRD+   N+L  SK       + DFG A+   + +S  T    T 
Sbjct: 122 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTP 177

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 372
            Y+APE+       + CD++S GV+   +L G  P      L+ S   K   I +     
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQYEF 236

Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
           P P   +V ++  +   I    L++ P  R T+ 
Sbjct: 237 PNPEWSEVSEE--VKMLIR-NLLKTEPTQRMTIT 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 9e-42
 Identities = 57/271 (21%), Positives = 101/271 (37%), Gaps = 33/271 (12%)

Query: 144 DFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQV 199
            + +   +G+GG+GSVY    + +    A+K +     S+  EL        E  +L +V
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 200 --LHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHA 257
                 +++L  +        LI E  E          +  A  L      +    +  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 122

Query: 258 LAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARRLHADSSNRTLLAGTYGYIA 316
           + +     +  ++HRDI   NIL++ ++ E  + DFG+   L    +  T   GT  Y  
Sbjct: 123 VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 177

Query: 317 PE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP 375
           PE + Y         V+S G++  +++ G  P +         +  I       QR+   
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------HDEEIIRGQVFFRQRVSSE 230

Query: 376 VDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
                 Q ++        CL   P  RPT +
Sbjct: 231 C-----QHLIR------WCLALRPSDRPTFE 250

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 1e-41
 Identities = 43/280 (15%), Positives = 95/280 (33%), Gaps = 27/280 (9%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + +   IG+G +G +Y    +  G+  A+K                  E+++   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63

Query: 204 IVKLYGFCLH-KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            +    +C        ++ E +             +         + +   M   + Y+H
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH 120

Query: 263 HDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARRLHADSSN-------RTLLAGTY 312
              S + IHRD+  +N L+         ++ DFG A++     ++          L GT 
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 313 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRL 372
            Y +      +  + + D+ S G V +   +G  P   L     ++  +     + ++++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL----KAATKRQKYERISEKKM 233

Query: 373 PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
             P++          +T    C       +P   Y+ Q F
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 9e-41
 Identities = 59/288 (20%), Positives = 110/288 (38%), Gaps = 35/288 (12%)

Query: 144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 202
            +     IG G +G VY+A+L  +G++ A+KK+   +       +    E Q++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73

Query: 203 SIVKLYGFCLH------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
           +IV+L  F         +  + L+ +Y+         H       L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARRLHADSSNRTLLAGTYGYI 315
           +LAY+H   S  I HRDI   N+LL+       + DFG+A++L     N + +   Y   
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP----------RDLLSSLSSSSDPKIMLI 365
              +      T   DV+S G V  E+L+G+             +++  L + +  +I  +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 366 DVLDQRLPPPVDQKVIQDILLASTISFA-------CLQSNPKSRPTMQ 406
           +        P  +      +                L+  P +R T  
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-40
 Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 29/293 (9%)

Query: 138 LIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 196
           + +    +     IG G YG V  A    N    A+KK+   E +   + +    E ++L
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKIL 60

Query: 197 SQVLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
            +  H +I+ +           +   Y+    +   L+   +   L        +  +  
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL---LAGTYG 313
            L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR    D  +         T  
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 314 YIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHP-------------RDLLSSLSSSSD 359
           Y APE+       T+  D++S G +  E+L  +                 +L S S    
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 360 PKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA------CLQSNPKSRPTMQ 406
             I+ +   +  L  P   KV  + L  +  S A       L  NP  R  ++
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 57/262 (21%), Positives = 98/262 (37%), Gaps = 22/262 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + F     +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
             +VKL         ++++ EY+  G +F  L                    +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
           H   S  +I+RD+   N+L++ +    V DFG A+R+         L GT   +APE+  
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIIL 211

Query: 322 TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI 381
           +    +  D ++ GV+  E+  G  P       +         I     R P      + 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 382 QDILLASTISFACLQSNPKSRP 403
             +          LQ +   R 
Sbjct: 267 DLLR-------NLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 1e-39
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 36/306 (11%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLS 197
           E+F +   +GTG YG V+  +       GK++A+K L  +   ++    +  R E QVL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 198 QVLHRS-IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAH 256
            +     +V L+     +  + LI +Y+  G LF  L   +   E +          +  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137

Query: 257 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRT-LLAGTYGYI 315
            +  L H     II+RDI   NILL+S     + DFG ++   AD + R     GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 316 APELAYTMVM--TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP 373
           AP++         +  D +S GV+  E+L G  P                 I     +  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-----VDGEKNSQAEISRRILKSE 252

Query: 374 PPVDQKV---IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDIS 430
           PP  Q++    +D++         L  +PK R                 + +H   Q I+
Sbjct: 253 PPYPQEMSALAKDLIQ------RLLMKDPKKRLGCGPRD-------ADEIKEHLFFQKIN 299

Query: 431 ISELRN 436
             +L  
Sbjct: 300 WDDLAA 305

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-39
 Identities = 56/290 (19%), Positives = 108/290 (37%), Gaps = 30/290 (10%)

Query: 141 ATEDFHIKYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFR--NEAQVL 196
           A + +     IG G YG V+KA+     G+  ALK++     EE   + + R     + L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 197 SQVLHRSIVKLYGFCL-----HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIV 251
               H ++V+L+  C       +  + L++E++++     +    +    +      +++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 122

Query: 252 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGT 311
             +   L +LH      ++HRD+   NIL+ S  +  +ADFG AR      +  ++   T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVT 178

Query: 312 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------RDLLSSLSSSS 358
             Y APE+          D++S G +  E+   K                D++       
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 359 DPKIMLIDVLDQRLPPPVDQKVIQDILLASTISF--ACLQSNPKSRPTMQ 406
            P+ + +             +     +          CL  NP  R +  
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 53/284 (18%), Positives = 113/284 (39%), Gaps = 27/284 (9%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + +     IG G YG+V+KA+     ++ ALK++   + +E     S   E  +L ++ H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60

Query: 202 RSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYL 261
           ++IV+L+      K + L++E+ ++         + +               +   L  L
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK------SFLFQLLKGL 114

Query: 262 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAY 321
               S +++HRD+   N+L+N   E  +A+FG AR         +    T  Y  P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 322 -TMVMTEKCDVYSFGVVTLEVLMGKHP-----------RDLLSSLSSSSDPKIMLIDVLD 369
              + +   D++S G +  E+     P           + +   L + ++ +   +  L 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 370 QRLPPPVDQKVIQDILLASTISFA-------CLQSNPKSRPTMQ 406
              P P+       + +   ++          L+ NP  R + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 45/282 (15%), Positives = 89/282 (31%), Gaps = 29/282 (10%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + +   IG G +G +++   L N +  A+K                R+E +    +   +
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCT 61

Query: 204 -IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLH 262
            I  +Y F        L+ + +       +     +             K M   +  +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIH 118

Query: 263 HDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTARRLHADSSN-------RTLLAG 310
                S+++RDI  +N L+           +V DFG  +      +        +  L+G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 311 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ 370
           T  Y++         + + D+ + G V +  L G  P   L   ++++  K   I    Q
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--AATNKQKYERIGEKKQ 233

Query: 371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF 412
             P         +                 + P   Y+   F
Sbjct: 234 STPLRELCAGFPEEF--YKYMHYARNLAFDATPDYDYLQGLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 60/298 (20%), Positives = 107/298 (35%), Gaps = 41/298 (13%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
             +     IG G +G V+KA+    G+  ALKK+     +E  F  +   E ++L  + H
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKH 68

Query: 202 RSIVKLYGFCL--------HKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
            ++V L   C          K  ++L++++ E      + +   +   L   KRV     
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV----- 122

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSS----NRTLLA 309
           M   L  L++     I+HRD+ + N+L+       +ADFG AR      +      T   
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 310 GTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------RDLLSSLS 355
            T  Y  PE L          D++  G +  E+                     L  S++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 356 SSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA-------CLQSNPKSRPTMQ 406
               P +   ++ ++       ++ ++D L A              L  +P  R    
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 62/304 (20%), Positives = 113/304 (37%), Gaps = 42/304 (13%)

Query: 134 FY-EDLIEATEDFHIKY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIK 187
           FY +++ +   +    Y     +G+G YG+V  A     G   A+KKL+     EL F K
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAK 62

Query: 188 SFRNEAQVLSQVLHRSIVKLYGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVE 241
               E ++L  + H +++ L       + +      +L+  +M       + H      +
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----K 117

Query: 242 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD 301
           L   +   +V  M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR   AD
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QAD 172

Query: 302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------- 347
           S     +   +      +   M  T+  D++S G +  E++ GK                
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 348 RDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFA-----CLQSNPKSR 402
           +   +  +               +  P +++K    IL  ++          L  + + R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292

Query: 403 PTMQ 406
            T  
Sbjct: 293 VTAG 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 3e-33
 Identities = 50/313 (15%), Positives = 107/313 (34%), Gaps = 49/313 (15%)

Query: 125 SIWNYDGRIFYEDLIEATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEEL 183
             W+Y+    +       +D+ +   +G G Y  V++A  + N +   +K L   + ++ 
Sbjct: 20  EYWDYES---HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK- 75

Query: 184 AFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH--KKCMFLIYEYMERGSLFCILHNDDEAV 240
                 + E ++L  +    +I+ L         +   L++E++       +        
Sbjct: 76  -----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----- 125

Query: 241 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARRLH 299
            L        +  +  AL Y H      I+HRD+  +N++++ +  +  + D+G A   H
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP------------ 347
                   +A  Y      L    +     D++S G +   ++  K P            
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 348 -----------RDLLSSLSSSSDPKIMLIDVLDQRLP-PPVDQKVIQDILLASTISF--A 393
                       D +   +   DP+   I     R           Q ++    + F   
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 394 CLQSNPKSRPTMQ 406
            L+ + +SR T +
Sbjct: 302 LLRYDHQSRLTAR 314

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-32
 Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 18/212 (8%)

Query: 143 EDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 201
           + +     IG+G  G V  A      +  A+KKL      +    K    E  ++  V H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75

Query: 202 RSIVKLYGFCLHKKCM------FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMA 255
           ++I+ L      +K +      +L+ E M+      I          D  +   ++  M 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQML 129

Query: 256 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYGYI 315
             + +LH      IIHRD+  +NI++ S     + DFG A R    S   T    T  Y 
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYR 185

Query: 316 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 347
           APE+   M   E  D++S G +  E++  K  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/292 (21%), Positives = 103/292 (35%), Gaps = 35/292 (11%)

Query: 140 EATEDFHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 198
           E  E +     +G+G YGSV  A     G   A+KKL     + +   K    E ++L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 73

Query: 199 VLHRSIVKLYGFC-----LHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKA 253
           + H +++ L         L +     +  ++    L  I+       +L       ++  
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQ 129

Query: 254 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTLLAGTYG 313
           +   L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +A  + 
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWY 184

Query: 314 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP------RDLLSSL------------- 354
                +   M   +  D++S G +  E+L G+         D L  +             
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 355 SSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQ 406
             SS+     I  L Q          I    LA  +    L  +   R T  
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 1e-25
 Identities = 51/303 (16%), Positives = 109/303 (35%), Gaps = 38/303 (12%)

Query: 145 FHIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRS 203
           + +   +G G + +V+ A+ + N    A+K +   +     + ++  +E ++L +V    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDAD 70

Query: 204 IVKLYGFCLH---------------KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRV 248
             K      +                  + +++E +    L  I   +   + L + K+ 
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ- 129

Query: 249 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK------LEAFVADFGTARRLHADS 302
            I K +   L Y+H  C   IIH DI   N+L+         ++  +AD G A       
Sbjct: 130 -ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 303 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKI 362
           +N      T  Y +PE+          D++S   +  E++ G    +     S + D   
Sbjct: 187 TNSI---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

Query: 363 MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVK 422
           +   +      P    +  +      T +F   +   ++   +++     ++T K    K
Sbjct: 244 IAQIIELLGELPSYLLRNGK-----YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298

Query: 423 HAA 425
             A
Sbjct: 299 DEA 301

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 2e-20
 Identities = 27/164 (16%), Positives = 56/164 (34%), Gaps = 17/164 (10%)

Query: 151 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFI-------KSFRNEAQVLSQVLHRS 203
           +G G   +V+           +K      T               F   A   ++   R+
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 204 IVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH 263
           + KL G  + K   +      E  ++   L +  E   +       ++  +   +A  +H
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 264 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSNRTL 307
                I+H D+S  N+L+ S+   ++ DF  +  +  +     L
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 73.2 bits (178), Expect = 5e-15
 Identities = 30/73 (41%), Positives = 39/73 (53%), Gaps = 3/73 (4%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
            KNL  LD+ NN+I G++P  LT L  L  LN+S+N L G +P     L        + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANN 301

Query: 61  KGLCGNFITLPSC 73
           K LCG    LP+C
Sbjct: 302 KCLCG--SPLPAC 312

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.4 bits (132), Expect = 6e-09
 Identities = 14/60 (23%), Positives = 32/60 (53%), Gaps = 4/60 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +  L  L  +NNK+       L +L+ +++L+   N++S   P +N  L+ ++++ L+  
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN--LTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 6e-07
 Identities = 17/61 (27%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNLT+L +  N I    P  ++ L++L  L  + NK+S     +N  L++++ +    N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLAN--LTNINWLSAGHN 361

Query: 61  K 61
           +
Sbjct: 362 Q 362

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 14/46 (30%), Positives = 22/46 (47%), Gaps = 2/46 (4%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN 46
          +  +T L      I+ SI G +  L+ L  +N S N+L+   P  N
Sbjct: 43 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITPLKN 86

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 17/61 (27%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           + NL  L ++ N+++    G L  L+ L  L+L+ N++S   P S   L+ ++ ++L  N
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSG--LTKLTELKLGAN 273

Query: 61  K 61
           +
Sbjct: 274 Q 274

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 48.5 bits (114), Expect = 6e-07
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 2  KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
           +   LD+ NNKI     G+  +L  L  L L  NK+S   P +   L  + R+ LS N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 39.6 bits (91), Expect = 5e-04
 Identities = 21/73 (28%), Positives = 28/73 (38%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
           +KNL  L + NNKI    PG    L +L+ L LS N+L        + L  +        
Sbjct: 54  LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113

Query: 61  KGLCGNFITLPSC 73
           K     F  L   
Sbjct: 114 KVRKSVFNGLNQM 126

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 1e-05
 Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 4/58 (6%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           +  LT L   +NKI    P  L  L  L  ++L  N++S   P +N   S++  V L+
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLAN--TSNLFIVTLT 225

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 5e-05
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 8/61 (13%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN 60
             +L  L++SNNK+   +P       RL+ L  S+N L+  VP   E   ++ ++ +  N
Sbjct: 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VP---ELPQNLKQLHVEYN 334

Query: 61  K 61
            
Sbjct: 335 P 335

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 13/60 (21%), Positives = 24/60 (40%), Gaps = 8/60 (13%)

Query: 2  KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK 61
          +    L+++N  +  S+P     L  L     S N L+  +P   E   S+  + +  N 
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELP---ELPQSLKSLLVDNNN 89

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 11/36 (30%), Positives = 16/36 (44%)

Query: 2  KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNK 37
          K+ T L +S N +       L   +RL  LNL   +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 5e-04
 Identities = 9/36 (25%), Positives = 15/36 (41%), Gaps = 1/36 (2%)

Query: 3  NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKL 38
              LD+   KI   I      L + D ++ S N++
Sbjct: 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 9e-04
 Identities = 9/37 (24%), Positives = 13/37 (35%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNK 37
                 LDIS  +I       L +L +L   +    K
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 10/46 (21%), Positives = 22/46 (47%), Gaps = 2/46 (4%)

Query: 1  MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSN 46
          + ++  +  +N+ I+      +  L  +  L L+ NKL+   P +N
Sbjct: 45 LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLAN 88

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 11/44 (25%), Positives = 17/44 (38%), Gaps = 5/44 (11%)

Query: 1   MKNLTWLDISNNKIEGSIPGELTD-----LSRLDYLNLSWNKLS 39
              L  L +  N+IE      L       +  L +L L+ N+ S
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.001
 Identities = 12/41 (29%), Positives = 18/41 (43%), Gaps = 1/41 (2%)

Query: 1   MKNLTWLDISNNKIEG-SIPGELTDLSRLDYLNLSWNKLSG 40
           +  L  L + NN+++  +    L    RL  LNL  N L  
Sbjct: 64  LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.5 bits (81), Expect = 0.003
 Identities = 9/37 (24%), Positives = 19/37 (51%), Gaps = 2/37 (5%)

Query: 7  LDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVP 43
          L +++  +  ++   L  L  + +L+LS N+L    P
Sbjct: 3  LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP 37

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 8/44 (18%), Positives = 15/44 (34%), Gaps = 4/44 (9%)

Query: 1  MKNLTWLDISNNKIEG----SIPGELTDLSRLDYLNLSWNKLSG 40
          ++    + + +  +       I   L     L  LNL  N+L  
Sbjct: 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 69

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.6 bits (81), Expect = 0.004
 Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 3/74 (4%)

Query: 1   MKNLTWLDISNNKIEG--SIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLS 58
           +  L  L++SNN++     +   +     L  LNLS N+L         +   +  + L 
Sbjct: 64  IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD 123

Query: 59  PNKGLCGNFITLPS 72
            N  L   F    +
Sbjct: 124 GNS-LSDTFRDQST 136

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	436
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.27
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.64
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.63
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.6
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	98.55
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.48
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.43
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.38
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.31
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.23
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.2
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.17
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.02
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	97.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	97.82
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.81
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.8
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.77
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	97.72
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.69
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.68
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.62
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.56
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.46
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.46
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.43
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.34
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.32
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.25
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.12
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.07
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.83
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.75
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.6
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	96.22
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.86
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.25
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	94.15
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	93.96
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.23
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	91.66
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	84.01

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=413.55  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=210.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......+  ..+.+.+|++++++++|||||++++++.+.+..++|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            36799999999999999999976 579999999997654332  236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++.+++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999997544   7999999999999999999999   78999999999999999999999999999987644


Q ss_pred             CCC--CccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          301 DSS--NRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       301 ~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ...  ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....      ...................
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~~~~~~~~~~~~~~  229 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTYLNPW  229 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS------TTSHHHHHHHTTCTTSTTG
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCCCCCcc
Confidence            322  2345679999999999988776 678999999999999999999996321      1111112222222111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .   .....+.+|+.+||+.||++|||++|+++|+|++++.
T Consensus       230 ~---~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         230 K---KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             G---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             c---cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            1   1122366899999999999999999999999997653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=411.39  Aligned_cols=255  Identities=31%  Similarity=0.466  Sum_probs=213.3

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|... +++.||+|++...........+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999764 78999999997654433333477889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999997644   6999999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+       .......+.......+..    
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~----  226 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFTFPDF----  226 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCCCTT----
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCcc----
Confidence              2345679999999999999999999999999999999999999996321       111222223332221111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                       ....+.+|+.+||+.||++|||++|+++|+|++..
T Consensus       227 -~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         227 -VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             -SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence             11236689999999999999999999999999653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-56  Score=412.40  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=215.9

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.......   .+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4699999999999999999975 579999999997654332   267889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++...    .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            999999999988653    5899999999999999999999   789999999999999999999999999999987665


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC-CCCCCCChhH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDQKV  380 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~  380 (436)
                      ........||+.|+|||.+.+..++.++||||+||++|||+||+.||.....       .......... ........  
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~--  240 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPELQNPE--  240 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHCSCCCSSGG--
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCCCCCCCCcc--
Confidence            5556667899999999999999999999999999999999999999963211       1111122211 11111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLV  421 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~  421 (436)
                       .....+.+|+.+||+.||++|||+.|+++|+|++...+..
T Consensus       241 -~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~  280 (293)
T d1yhwa1         241 -KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS  280 (293)
T ss_dssp             -GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             -cCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCC
Confidence             1123367899999999999999999999999997665543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=413.85  Aligned_cols=269  Identities=22%  Similarity=0.334  Sum_probs=218.9

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6799999999999999999976 579999999997654333233467899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++...+   .+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999987654   6999999999999999999999   789999999999999999999999999999877543


Q ss_pred             CC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          302 SS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       302 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+       .......+.......+..  
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--  232 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EYLIFQKIIKLEYDFPEK--  232 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHTTCCCCCTT--
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-------HHHHHHHHHcCCCCCCcc--
Confidence            32  2344679999999999999999999999999999999999999996321       112222333332221111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCCccccccccchhhhhh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPLVKHAAIQDISISELR  435 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~~~~~~~~~~~~~~~~  435 (436)
                         ....+.+|+.+||+.||++|||++|++++.|..      .||.++++.|+.++
T Consensus       233 ---~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~------~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         233 ---FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK------AHPFFESVTWENLH  279 (288)
T ss_dssp             ---CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH------TSGGGTTCCCTTGG
T ss_pred             ---CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH------cCCccCCCCHHHhh
Confidence               112367899999999999999999988777764      35777888887765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=409.02  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=198.6

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee--CCEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH--KKCMF  218 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  218 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......+. ..+.+.+|++++++++|||||++++++.+  .+..+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH-HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH-HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            36899999999999999999965 5799999999977654332 34778999999999999999999999865  45689


Q ss_pred             EEEeeccCCChhhhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          219 LIYEYMERGSLFCILHNDD-EAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999986432 2346999999999999999999999532  245999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      +.+..+........||+.|+|||++.+..++.++|||||||++|||+||+.||...+       .......+.....+. 
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-------~~~~~~~i~~~~~~~-  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREGKFRR-  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCC-
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCC-
Confidence            987655555556789999999999999999999999999999999999999996321       111222233332221 


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .....   ...+.+|+.+||+.||++|||+.|+++|+|.
T Consensus       234 ~~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 IPYRY---SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCccc---CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            11111   1236789999999999999999999999984

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-55  Score=412.10  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=212.9

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4589999999999999999965 578999999998765544455678999999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |||++|+|..++....   .+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987765543   6999999999999999999999   78999999999999999999999999999986543 


Q ss_pred             CCCcccccccccccccccccc---CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          302 SSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                         .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||....       .......+.....+.....
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~  237 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPALQSG  237 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCCSCT
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCCCC
Confidence               234579999999999864   468999999999999999999999986321       1112223333332222211


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ..   ...+.+|+.+||+.||++|||++|+++|+|+.+..+.
T Consensus       238 ~~---s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         238 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             CC---CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence            11   1236789999999999999999999999999876543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=410.76  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=211.1

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      +.|++.+.||+|+||+||+|.. .+++.||||++.......   .+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            4688999999999999999975 578999999997654332   367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999876532  26999999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccc-----cCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          302 SSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ........||+.|+|||++.     +..++.++|||||||++|||+||+.||....       .......+.....+...
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~  236 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-------PMRVLLKIAKSEPPTLA  236 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------GGGHHHHHHHSCCCCCS
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCC
Confidence            22334567999999999874     4568999999999999999999999996321       12222333332221111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      .  .......+.+|+.+||+.||++|||+.|+++|+|++....
T Consensus       237 ~--~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~  277 (288)
T d2jfla1         237 Q--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN  277 (288)
T ss_dssp             S--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred             c--cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0  1112234678999999999999999999999999975533

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-55  Score=403.59  Aligned_cols=259  Identities=26%  Similarity=0.429  Sum_probs=200.3

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||+|++.+  .||||+++....... ..+.|.+|++++++++|||||++++++.+ +..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            3678899999999999999998753  599999976543322 24789999999999999999999998865 4579999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....  ..+++.+++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            9999999999997543  26999999999999999999999   789999999999999999999999999999876543


Q ss_pred             CC--Ccccccccccccccccccc---CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhc-CCCCCC
Q 013793          302 SS--NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLD-QRLPPP  375 (436)
Q Consensus       302 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~l~~~  375 (436)
                      ..  ......||+.|+|||++.+   ..++.++|||||||++|||+||+.||....       ........+. ....+.
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~p~  230 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIFMVGRGYLSPD  230 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHHTSCCCC
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcCCCCCc
Confidence            22  2345679999999999864   358999999999999999999999986321       1111111221 111111


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ...........+.+|+.+||+.||++|||++||+++++..+
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11101111234678999999999999999999999987643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-55  Score=400.44  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=197.1

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++......    +++.+|++++++++|||||+++|+|...+..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            5788899999999999999999899999999998655432    678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|.+++....  ..+++..++.++.|+|.||+|||   +.+|+||||||+|||+|+++.+||+|||+++......
T Consensus        81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            999999999987643  36899999999999999999999   7899999999999999999999999999998765433


Q ss_pred             CC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHhC-CCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          303 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       303 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. .....||+.|+|||.+.+..++.++|||||||++|||+|+ +.|+...       ........+.. ......+.. 
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~-~~~~~~p~~-  226 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDIST-GFRLYKPRL-  226 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHHHH-TCCCCCCTT-
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHh-cCCCCCccc-
Confidence            22 2345689999999999999999999999999999999995 4444311       11111112211 111111111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                        ....+.+++.+||+.||++||||+||+++|...
T Consensus       227 --~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              112367899999999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=397.68  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             ccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee----CCEEEE
Q 013793          145 FHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH----KKCMFL  219 (436)
Q Consensus       145 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  219 (436)
                      |++.+.||+|+||+||+|... +++.||+|++....... ...+.+.+|++++++++|||||++++++.+    ....++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            356678999999999999754 78899999997654332 224679999999999999999999999875    356899


Q ss_pred             EEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeec-CCCCeEEeeccccc
Q 013793          220 IYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLN-SKLEAFVADFGTAR  296 (436)
Q Consensus       220 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~  296 (436)
                      ||||+++|+|.+++....   .+++.+++.++.||+.||+|||   +.+  |+||||||+|||++ +++.+||+|||+++
T Consensus        90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999997653   6899999999999999999999   556  99999999999996 57899999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCC
Q 013793          297 RLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPV  376 (436)
Q Consensus       297 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  376 (436)
                      ....  .......||+.|+|||++.+ .++.++|||||||++|||+||+.||....      ........+.....+...
T Consensus       164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASF  234 (270)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGG
T ss_pred             eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc------cHHHHHHHHHcCCCCccc
Confidence            6432  23345679999999998865 59999999999999999999999986211      111111122221111111


Q ss_pred             ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          377 DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       377 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +..   ....+.+|+.+||+.||++|||+.|+++|+|++
T Consensus       235 ~~~---~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         235 DKV---AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             Ccc---CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            111   122367899999999999999999999999984

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-54  Score=403.04  Aligned_cols=263  Identities=30%  Similarity=0.473  Sum_probs=199.6

Q ss_pred             cccHHHHHHHhh---------cccccceeeecCceEEEEEEcC-CC---CEEEEEEecCcchhhHHHHHHHHHHHHHHhh
Q 013793          132 RIFYEDLIEATE---------DFHIKYCIGTGGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQ  198 (436)
Q Consensus       132 ~~~~~~l~~~~~---------~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~  198 (436)
                      .++|+|+.+++.         +|++.+.||+|+||+||+|.+. ++   ..||||.+.......  ..+.|.+|++++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~   83 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQ   83 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH--HHHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH--HHHHHHHHHHHHHh
Confidence            345566666554         4556789999999999999764 33   368999987654432  24689999999999


Q ss_pred             ccCCCceeeeeEEeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 013793          199 VLHRSIVKLYGFCLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  278 (436)
Q Consensus       199 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~N  278 (436)
                      ++|||||+++|+|.+.+..++|||||++|+|.+++....  ..++|.+++.++.|||+||+|||   +.+|+||||||+|
T Consensus        84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~N  158 (299)
T d1jpaa_          84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARN  158 (299)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccce
Confidence            999999999999999999999999999999999887643  36899999999999999999999   7899999999999


Q ss_pred             eeecCCCCeEEeecccccccCCCCCC-----ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccc
Q 013793          279 ILLNSKLEAFVADFGTARRLHADSSN-----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLS  352 (436)
Q Consensus       279 ill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~  352 (436)
                      ||++.++.+||+|||+++........     .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999876543322     122457899999999999999999999999999999998 899986321


Q ss_pred             cccCCCCcccchhhhhcC--CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          353 SLSSSSDPKIMLIDVLDQ--RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .       .. ....+..  +++.+..     ....+.+|+.+||+.||++||||.||++.+..
T Consensus       239 ~-------~~-~~~~i~~~~~~~~~~~-----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         239 N-------QD-VINAIEQDYRLPPPMD-----CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             H-------HH-HHHHHHTTCCCCCCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             H-------HH-HHHHHHcCCCCCCCcc-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1       11 1122222  2222211     12236789999999999999999999998853

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=398.97  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=202.9

Q ss_pred             hhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      .++|++.+.||+|+||+||+|.+++++.||||+++......    +.|.+|++++++++|||||+++|++.+ +..++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            46788999999999999999999888999999997655432    678999999999999999999998865 4578999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++.... ...++|.++++|+.||++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.....
T Consensus        87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999876543 235999999999999999999999   789999999999999999999999999999987543


Q ss_pred             CC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          302 SS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       302 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .. ......||+.|+|||.+.+..++.++|||||||++|||+||..|+...      ......... +........+...
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~------~~~~~~~~~-i~~~~~~~~p~~~  235 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------MTNPEVIQN-LERGYRMVRPDNC  235 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT------CCHHHHHHH-HHTTCCCCCCTTC
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC------CCHHHHHHH-HHhcCCCCCcccC
Confidence            32 234456899999999999999999999999999999999976654311      111111112 2221111111111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                         ...+.+|+.+||+.||++||||+||++.|
T Consensus       236 ---~~~l~~li~~cl~~~P~~Rpt~~ei~~~L  264 (272)
T d1qpca_         236 ---PEELYQLMRLCWKERPEDRPTFDYLRSVL  264 (272)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence               12367899999999999999999999865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-54  Score=405.39  Aligned_cols=259  Identities=23%  Similarity=0.316  Sum_probs=196.7

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .+.|++.+.||+|+||+||+|... +|+.||||++........  ...+.+|++++++++|||||++++++.+.+..++|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            466999999999999999999764 789999999976544322  35688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~  297 (436)
                      |||++||+|.+++...+   .+++.++..++.||+.||+|||   +.+|+||||||+|||++   +++.+||+|||+++.
T Consensus        86 mE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999997654   6999999999999999999999   78999999999999994   578999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC--CC
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP--PP  375 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~--~~  375 (436)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....       .......+......  .+
T Consensus       160 ~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~  231 (307)
T d1a06a_         160 EDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-------DAKLFEQILKAEYEFDSP  231 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHTTCCCCCTT
T ss_pred             ccCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHhccCCCCCCc
Confidence            64332 2344679999999999999999999999999999999999999996321       11112222222221  11


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ...   .....+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       232 ~~~---~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  272 (307)
T d1a06a_         232 YWD---DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA  272 (307)
T ss_dssp             TTT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred             ccc---CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence            111   11223678999999999999999999999999976543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=411.43  Aligned_cols=265  Identities=26%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|+++......  ....+.+|+.++++++|||||+++++|.+.+..++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46899999999999999999975 578999999997653332  236788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.+.+   .+++..+..++.|++.||+|||+  ..+|+||||||+|||+++++.+||+|||+|+....
T Consensus        83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999997654   69999999999999999999994  24899999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCC-----------
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSD-----------  359 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~-----------  359 (436)
                      .  ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......          ....           
T Consensus       158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            2  2234689999999999999999999999999999999999999996322100          0000           


Q ss_pred             ----------cccch---hhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          360 ----------PKIML---IDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       360 ----------~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                                +....   ........++.....  .....+.+|+.+||+.||++|||++|+++|+|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBT--TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                      00000   000000011111000  011246789999999999999999999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=390.18  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=209.5

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|++++++.||||+++......    ++|.+|+.++++++||||++++|+|.+.+..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            5789999999999999999999889999999998765442    678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|..++....  ..+++..+++++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999999976543  36899999999999999999999   7899999999999999999999999999998765443


Q ss_pred             C-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcC-CCCCCCChh
Q 013793          303 S-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVDQK  379 (436)
Q Consensus       303 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~  379 (436)
                      . ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+....       ......+... +++.+..  
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~~p~~--  225 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRLYRPHL--  225 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCCCCCTT--
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCCCCCccc--
Confidence            3 2334668999999999999999999999999999999998 8999873221       1112222221 1222111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                         ....+.+|+.+||+.||++|||++|+++++.
T Consensus       226 ---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         226 ---ASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence               1234778999999999999999999999984

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-53  Score=405.62  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=213.4

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.......   .+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45899999999999999999975 579999999997765432   36788999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KLEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~  298 (436)
                      ||||++|+|.+++....  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++.+
T Consensus       102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            99999999999986432  36999999999999999999999   789999999999999964  678999999999877


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      .... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+       .......+.......+...
T Consensus       177 ~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         177 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             CTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCSCCGG
T ss_pred             cccc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccc
Confidence            5433 3345679999999999999999999999999999999999999996321       1122223322222211110


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                       .......+.+|+.+||+.||++|||+.|+++|+|++...
T Consensus       249 -~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         249 -FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             -GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             -ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence             111123367899999999999999999999999997653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-54  Score=399.50  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=209.0

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|.+. +++.||||+++.....    .+++.+|++++++++|||||+++|+|.+.+..++|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            467888999999999999999765 6889999999765443    26789999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        92 ~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          92 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999997643 247899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCC-ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          301 DSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       301 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      +... .....|++.|+|||++.+..++.++|||||||++|||++|..|+...      . ......+.+......+....
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~------~-~~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------I-DLSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT------C-CHHHHHHHHHTTCCCCCCTT
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc------c-hHHHHHHHHhcCCCCCCCcc
Confidence            4332 23345889999999999999999999999999999999987775421      1 11112233333322222221


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .   ...+.+|+.+||+.||++|||+.||++.+..
T Consensus       241 ~---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~  272 (287)
T d1opja_         241 C---PEKVYELMRACWQWNPSDRPSFAEIHQAFET  272 (287)
T ss_dssp             C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1   2236789999999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=402.98  Aligned_cols=256  Identities=22%  Similarity=0.299  Sum_probs=215.8

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999975 589999999997654333333477889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999998654   6899999999999999999999   789999999999999999999999999999977655


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+       .......+....+..+..    
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~----  227 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRT----  227 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT----
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-------HHHHHHHHhcCCCCCCcc----
Confidence            555566789999999999999999999999999999999999999986321       112222333333222211    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                       ....+.+|+.+||+.||.+||+     ++|+++|+|+..
T Consensus       228 -~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             -SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             -CCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence             1123678999999999999994     999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-52  Score=401.47  Aligned_cols=258  Identities=23%  Similarity=0.304  Sum_probs=212.3

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++......   ...+.+|++++++++|||||++++++.+.+..++||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999975 579999999998765432   367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCCeEEeecccccccC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLEAFVADFGTARRLH  299 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~  299 (436)
                      ||+++|+|.+++....  ..+++.+++.|+.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            9999999998876543  36999999999999999999999   78999999999999998  57899999999998875


Q ss_pred             CCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChh
Q 013793          300 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQK  379 (436)
Q Consensus       300 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  379 (436)
                      ... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....       .......+.......+... 
T Consensus       181 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~-  251 (352)
T d1koba_         181 PDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCDWEFDEDA-  251 (352)
T ss_dssp             TTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCCCCCCSST-
T ss_pred             CCC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccc-
Confidence            443 3345679999999999999999999999999999999999999996321       1112222222222111100 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          380 VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       380 ~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .......+.+|+.+||+.||.+|||+.|+++|+|++..
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            01112236789999999999999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=390.65  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             hcccccce-eeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYC-IGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||+++......  ..+.|.+|++++++++|||||+++|+|.. +..+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH--HHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            45666774 999999999999653   45579999997654332  34789999999999999999999999865 4578


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999986543  36999999999999999999999   789999999999999999999999999999877


Q ss_pred             CCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....       ......+.... ..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~~~i~~~~-~~  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGK-RM  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTTC-CC
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC-CC
Confidence            544322   234568999999999999999999999999999999998 9999873211       11112222211 11


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      +.+..   ....+.+|+.+||+.||++|||+.+|++.+
T Consensus       232 ~~p~~---~~~~l~~li~~cl~~~p~~RPs~~~i~~~L  266 (285)
T d1u59a_         232 ECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRM  266 (285)
T ss_dssp             CCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            11111   112367899999999999999999997655

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=395.05  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=211.5

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhH---HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .+.|++.+.||+|+||+||+|.. .+|+.||||++........   ...+.+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35799999999999999999976 5799999999865432211   1236789999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----CeEEeecc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFG  293 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  293 (436)
                      ++|||||++|+|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999997654   6999999999999999999999   78999999999999998776    49999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          294 TARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       294 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      +++...... ......||+.|+|||.+.+..++.++||||+||++|||+||+.||....       .......+......
T Consensus       163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~  234 (293)
T d1jksa_         163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNYE  234 (293)
T ss_dssp             TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHTTCCC
T ss_pred             hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcCCC
Confidence            998765433 3345678999999999999999999999999999999999999996321       11112222222221


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+. .........+.+|+.+||+.||++|||++|+++|+|++..
T Consensus       235 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         235 FED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             CCH-HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCc-hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            110 1011122346789999999999999999999999999754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=401.14  Aligned_cols=257  Identities=23%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             hhcccccceeeecCceEEEEEEcCC------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||+||+|....      ...||||.+.......  ....+.+|+.++.++ +|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH--HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3678999999999999999997542      2369999987654332  236788999999998 899999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDE--------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  274 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl  274 (436)
                      +..++||||+++|+|.++++....                    ...+++.+++.++.||+.||+|||   +.+|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence            999999999999999999976432                    235899999999999999999999   789999999


Q ss_pred             CCCceeecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCcccc
Q 013793          275 SSNNILLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLL  351 (436)
Q Consensus       275 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~  351 (436)
                      ||+|||++.++.+||+|||+|+........  .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332  234568999999999999999999999999999999998 89998632


Q ss_pred             ccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          352 SSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      .       .......++......+.+...   ...+.+|+.+||+.||++|||++||+++|-
T Consensus       271 ~-------~~~~~~~~~~~~~~~~~p~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 P-------VDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             C-------CSHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C-------HHHHHHHHHhcCCCCCCCCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1       112233333333222222111   223678999999999999999999999984

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=390.07  Aligned_cols=255  Identities=27%  Similarity=0.376  Sum_probs=198.1

Q ss_pred             hcccccceeeecCceEEEEEEcCCC-----CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNG-----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      +.|+..++||+|+||+||+|.+.+.     ..||||+++.......  ...|.+|++++++++|||||+++|++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH--HHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            4678899999999999999976532     4799999976554332  36789999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+.+|++.+++....  ..++|.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence            99999999999999886543  36999999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      +......   .....||+.|+|||++.+..++.++|||||||++|||+||..|+...      .... .....+......
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~------~~~~-~~~~~i~~~~~~  232 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE------LSNH-EVMKAINDGFRL  232 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------CCHH-HHHHHHHTTCCC
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc------CCHH-HHHHHHhccCCC
Confidence            6543221   23356899999999999999999999999999999999976665311      1111 122222222222


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +....   ....+.+|+.+||+.||++||||.||++.+..
T Consensus       233 ~~~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         233 PTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             CCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCchh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence            22221   12336789999999999999999999998854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-52  Score=394.95  Aligned_cols=253  Identities=27%  Similarity=0.377  Sum_probs=212.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..........+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999976 579999999997654333333477889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||++||+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999988655   6888999999999999999999   889999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                         .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+       .......+.......+...   
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~~---  224 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNAELRFPPFF---  224 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHCCCCCCTTS---
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-------HHHHHHHHHcCCCCCCCCC---
Confidence               334679999999999999999999999999999999999999996321       1122233333332221111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                        ...+.+++.+||+.||.+||     |++|+++|+|++.
T Consensus       225 --s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         225 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             --CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             --CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence              12366899999999999996     9999999999865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-52  Score=386.17  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=211.4

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchh------hHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeC
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE------ELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHK  214 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  214 (436)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......      .....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999975 57999999998754321      1223457889999999997 99999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                      +..++||||+++|+|.+++....   .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997644   7999999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccccccccccc------CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      ++...... ......||+.|+|||.+.+      ..++.++||||+||++|||+||+.||....       .......+.
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-------~~~~~~~i~  228 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRMIM  228 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHH
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-------HHHHHHHHH
Confidence            98875543 3345679999999998753      346889999999999999999999996321       111222333


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ......+... .......+.+|+.+||+.||++|||+.||++|+|+++
T Consensus       229 ~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         229 SGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HTCCCCCTTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             hCCCCCCCcc-cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            3322211110 1112234778999999999999999999999999965

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=387.35  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=193.2

Q ss_pred             ceeeecCceEEEEEEcC---CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeecc
Q 013793          149 YCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYME  225 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  225 (436)
                      +.||+|+||+||+|.+.   .++.||||+++...... ...+.+.+|++++++++|||||+++|+|.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C-HHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH-HHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            46999999999999754   35689999997654332 234789999999999999999999999865 45789999999


Q ss_pred             CCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC-
Q 013793          226 RGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN-  304 (436)
Q Consensus       226 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  304 (436)
                      +|+|.+++....   .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999998654   6999999999999999999999   789999999999999999999999999999876544332 


Q ss_pred             --ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          305 --RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       305 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                        .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....       .. .....+......+.+..  
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-------~~-~~~~~i~~~~~~~~p~~--  234 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GS-EVTAMLEKGERMGCPAG--  234 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HH-HHHHHHHTTCCCCCCTT--
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-------HH-HHHHHHHcCCCCCCCcc--
Confidence              233568999999999999999999999999999999998 899986321       11 12222222111111111  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                       ....+.+|+.+||+.||++|||+++|++.+
T Consensus       235 -~~~~~~~li~~cl~~dp~~RPs~~~i~~~L  264 (277)
T d1xbba_         235 -CPREMYDLMNLCWTYDVENRPGFAAVELRL  264 (277)
T ss_dssp             -CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             -cCHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence             122367899999999999999999997654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=388.36  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=200.1

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++......    +.|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            6799999999999999999999888899999997665432    678999999999999999999999865 55789999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+++|+|..++.... ...++|.+++.++.||+.||+|||   +.+|+||||||+|||+|+++.+||+|||+++......
T Consensus        92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             ecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999998887542 235999999999999999999999   7899999999999999999999999999998764333


Q ss_pred             C-CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          303 S-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       303 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                      . ......||+.|+|||++.++.++.++|||||||++|||+||..|+...      . ........+......+..... 
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~------~-~~~~~~~~i~~~~~~~~~~~~-  239 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG------M-VNREVLDQVERGYRMPCPPEC-  239 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT------C-CHHHHHHHHHTTCCCCCCTTS-
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC------C-CHHHHHHHHHhcCCCCCCccc-
Confidence            2 234466899999999999999999999999999999999977665421      1 111112222222222222211 


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH--hhcCC
Q 013793          382 QDILLASTISFACLQSNPKSRPTMQYVSQGF--LITRK  417 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l--~~~~~  417 (436)
                        ...+.+++.+||+.||++||||++|++.+  |+...
T Consensus       240 --~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         240 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence              22367899999999999999999999855  45443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=392.51  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=213.4

Q ss_pred             hhcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      .++|++.+.||+|+||+||+|... +|+.||||+++......    ..+.+|+++|+.++|||||++++++.+.+..++|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            467999999999999999999764 78999999998765432    5678999999999999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC--CCeEEeeccccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--LEAFVADFGTARRL  298 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~  298 (436)
                      ||||+||+|.+++...+  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999997543  36899999999999999999999   7899999999999999854  57999999999876


Q ss_pred             CCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCCh
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQ  378 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  378 (436)
                      .... ......+|+.|+|||...+..++.++||||+||++|||++|+.||....       .......+.......+. .
T Consensus       155 ~~~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~-~  225 (321)
T d1tkia_         155 KPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFDE-E  225 (321)
T ss_dssp             CTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCH-H
T ss_pred             ccCC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCh-h
Confidence            4332 2344678999999999999999999999999999999999999996321       11222333333322211 1


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          379 KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       379 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                      ........+.+|+.+||+.||++|||+.|+++|+|+++..+
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  266 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence            01112234678999999999999999999999999976543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=394.81  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=210.8

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHh-hccCCCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  220 (436)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..........+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999764 79999999997543322222355667777665 67999999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCC
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHA  300 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  300 (436)
                      |||+++|+|.+++....   .+++.+++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999998654   6899999999999999999999   78999999999999999999999999999987766


Q ss_pred             CCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          301 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       301 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                      .........||+.|+|||++.+..++.++||||+||++|||+||+.||...+       .......+.......+..   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~p~~---  225 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELFHSIRMDNPFYPRW---  225 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCcc---
Confidence            5555666789999999999999999999999999999999999999996321       111222222222221111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHHhhcC
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQ-YVSQGFLITR  416 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~-ev~~~l~~~~  416 (436)
                        ....+.+|+.+||+.||++|||+. |+++|+|+..
T Consensus       226 --~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         226 --LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             --CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence              112367899999999999999995 8999999854

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-51  Score=395.06  Aligned_cols=257  Identities=22%  Similarity=0.265  Sum_probs=203.8

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHH---HHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSF---RNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++.............+   ..++.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5799999999999999999975 4799999999875433222112233   34567777888999999999999999999


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|+|.+++....   .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999997654   6889999999999999999999   789999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCC
Q 013793          299 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVD  377 (436)
Q Consensus       299 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  377 (436)
                      ....  .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.....    .................+  
T Consensus       158 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~--  229 (364)
T d1omwa3         158 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMAVELP--  229 (364)
T ss_dssp             SSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHHHHSSSCCCCCC--
T ss_pred             CCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccCCCCCC--
Confidence            5432  344679999999999865 5689999999999999999999999963211    000001111111111111  


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHhhcC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPT-----MQYVSQGFLITR  416 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~ev~~~l~~~~  416 (436)
                      ...   ...+.+|+.+||+.||++|||     ++|+++|+|+..
T Consensus       230 ~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         230 DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             SSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             CCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            111   123678999999999999999     799999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-51  Score=394.31  Aligned_cols=253  Identities=22%  Similarity=0.301  Sum_probs=212.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|+++++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999976 579999999997544333333467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+.+|+|..++....   .+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999997654   6999999999999999999999   789999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCCCCCChhHH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVI  381 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  381 (436)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||...       ........+.......+..    
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~----  260 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKIVSGKVRFPSH----  260 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT----
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-------CHHHHHHHHhcCCCCCCcc----
Confidence               33467999999999999999999999999999999999999999632       1122233333333322211    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          382 QDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       382 ~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                       ....+.+++.+||+.||.+|+     |++|+++|+||..
T Consensus       261 -~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         261 -FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             -CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             -CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence             112367899999999999994     9999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=388.51  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=206.2

Q ss_pred             hhcccccc-eeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEee----C
Q 013793          142 TEDFHIKY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLH----K  214 (436)
Q Consensus       142 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~  214 (436)
                      .++|.+.. .||+|+||+||+|.. .+++.||||+++..        ..+.+|++++.++ +|||||++++++.+    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            46788765 699999999999965 67999999999653        4566799887665 89999999999875    4


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCCeEEee
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVAD  291 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  291 (436)
                      ...++|||||+||+|.+++.... ...+++.+++.|+.||+.||+|||   +.+|+||||||+|||+++   ++.+||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence            56899999999999999997643 236999999999999999999999   789999999999999986   46799999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR  371 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  371 (436)
                      ||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.....   ......+....
T Consensus       158 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~  233 (335)
T d2ozaa1         158 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ  233 (335)
T ss_dssp             CTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS
T ss_pred             cceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCC
Confidence            99998765433 334567999999999999999999999999999999999999999743211100   00011111111


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTPL  420 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~~  420 (436)
                      ...+.. ........+.+|+.+||+.||++|||+.|+++|+|+.+....
T Consensus       234 ~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  281 (335)
T d2ozaa1         234 YEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  281 (335)
T ss_dssp             SSCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred             CCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence            111111 122233457889999999999999999999999999766543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-51  Score=387.41  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=210.0

Q ss_pred             HHHHHhhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeE
Q 013793          137 DLIEATEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGF  210 (436)
Q Consensus       137 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  210 (436)
                      +++-..++|++.+.||+|+||+||+|+..      +++.||||+++......  ..+.+.+|++++++++||||++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChH--HHHHHHHHHHHHHhcCCCCcccceee
Confidence            34445678999999999999999999753      46789999997654432  34789999999999999999999999


Q ss_pred             EeeCCEEEEEEeeccCCChhhhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 013793          211 CLHKKCMFLIYEYMERGSLFCILHNDD---------------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  269 (436)
Q Consensus       211 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  269 (436)
                      |...+..++||||+++|+|.+++....                     ....+++..++.|+.|++.||+|||   +.+|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence            999999999999999999999986432                     1235899999999999999999999   7899


Q ss_pred             EecCCCCCceeecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCC-C
Q 013793          270 IHRDISSNNILLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-H  346 (436)
Q Consensus       270 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~  346 (436)
                      +||||||+|||+|.++.+||+|||+++.......  ......|++.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999987644332  223456889999999999999999999999999999999996 5


Q ss_pred             CccccccccCCCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          347 PRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       347 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      ||...       ........+.+...++ .+...   ...+.+|+.+||+.||++||||.||++.+...
T Consensus       242 p~~~~-------~~~e~~~~v~~~~~~~-~p~~~---~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         242 PYYGM-------AHEEVIYYVRDGNILA-CPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTTS-------CHHHHHHHHHTTCCCC-CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCC-------CHHHHHHHHHcCCCCC-CCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            66521       1122223333333221 11111   12367899999999999999999999988653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=385.83  Aligned_cols=265  Identities=23%  Similarity=0.278  Sum_probs=201.0

Q ss_pred             cceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhH--HHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEeec
Q 013793          148 KYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYEYM  224 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  224 (436)
                      .++||+|+||+||+|... +|+.||||+++.......  ...+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999764 799999999976543221  12356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCCCC
Q 013793          225 ERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADSSN  304 (436)
Q Consensus       225 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  304 (436)
                      .++++..+.....   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            9988877765433   6889999999999999999999   789999999999999999999999999999887665555


Q ss_pred             ccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc----------CCCC---ccc-chhh-hh
Q 013793          305 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS----------SSSD---PKI-MLID-VL  368 (436)
Q Consensus       305 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~----------~~~~---~~~-~~~~-~~  368 (436)
                      .....||+.|+|||.+.+. .++.++||||+||++|||+||+.||.......          ....   ... .... ..
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            5567899999999988654 57999999999999999999999986322110          0000   000 0000 00


Q ss_pred             cCCCCCCC-ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          369 DQRLPPPV-DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       369 ~~~l~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      ....+... ..........+.+|+.+||+.||++|||++|+++|+|++..+
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            00000000 000001123477899999999999999999999999997653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=378.67  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=194.7

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  221 (436)
                      ++|++.+.||+|+||.||+|.+ .|+.||||+++....     .+.+.+|++++++++||||++++|+|.+ .+..++||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            5688899999999999999998 478899999976543     2678999999999999999999999965 45689999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+++|+|.+++.... ...++|..+++|+.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus        81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999997542 225899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCCccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCCCChhH
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPPVDQKV  380 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  380 (436)
                         .....+++.|+|||++.+..++.++||||||+++|||+| |+.||....       ... ....+.....++.....
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-------~~~-~~~~i~~~~~~~~~~~~  225 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKD-VVPRVEKGYKMDAPDGC  225 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-------GGG-HHHHHTTTCCCCCCTTC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-------HHH-HHHHHHcCCCCCCCccC
Confidence               233467899999999999999999999999999999998 677775221       111 12222221111222111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          381 IQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       381 ~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                         ...+.+|+.+||+.||++||||.|+++++...
T Consensus       226 ---~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         226 ---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               12367899999999999999999999998643

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=380.34  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=195.0

Q ss_pred             hcccccceeeecCceEEEEEEcC--CC--CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP--NG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++...........+.|.+|++++++++|||||+++|+|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            57899999999999999999653  33  36899998766544444457899999999999999999999999764 678


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRL  298 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  298 (436)
                      +||||+++|++.+++....  ..+++..++.++.|+|.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999998877543  36999999999999999999999   789999999999999999999999999999987


Q ss_pred             CCCCCC---ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          299 HADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       299 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      ......   .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+       .......+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~~~~~i~~~~~~~  234 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGERL  234 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHHHHHHHHhCCCCC
Confidence            544332   233457889999999999999999999999999999998 899986321       112223333332222


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      +.....   ...+.+|+.+||+.||++|||+.||.+.+..
T Consensus       235 ~~~~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 PRPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            222111   1236789999999999999999999987754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=379.33  Aligned_cols=270  Identities=22%  Similarity=0.286  Sum_probs=205.2

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            5899999999999999999975 67999999999754322 122367889999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      ||+.++.+.......  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.|+.....
T Consensus        81 e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            999765444333332  236999999999999999999999   789999999999999999999999999999887665


Q ss_pred             CCCccccccccccccccccccCc-cCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc--chhhh--
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI--MLIDV--  367 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~--~~~~~--  367 (436)
                      ........||+.|+|||...... ++.++||||+||++|||++|+.||...+...         .......  .....  
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            55556678999999999877655 5889999999999999999999996432100         0000000  00000  


Q ss_pred             hcCCCCCCCChhH----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCC
Q 013793          368 LDQRLPPPVDQKV----IQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKT  418 (436)
Q Consensus       368 ~~~~l~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~  418 (436)
                      .....+.......    ......+.+|+.+||+.||++|||++|+++|+|++.-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            0000110000000    01123467899999999999999999999999997643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=375.15  Aligned_cols=254  Identities=25%  Similarity=0.362  Sum_probs=193.5

Q ss_pred             hhcccccceeeecCceEEEEEEcCC----CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      .++|++.+.||+|+||+||+|.+..    +..||||.++......  ..+.+.+|++++++++|||||+++|++.+ +..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence            3678999999999999999997642    3568999987654332  34789999999999999999999999964 568


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++||||+++|+|.+++....  ..+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence            99999999999999876543  36899999999999999999999   78999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCCC
Q 013793          298 LHADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPPP  375 (436)
Q Consensus       298 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  375 (436)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....       .......+...... +
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-------~~~~~~~i~~~~~~-~  229 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERL-P  229 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCCC-C
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCC-C
Confidence            654332 2344568999999999999999999999999999999998 898986322       11122222222111 1


Q ss_pred             CChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          376 VDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       376 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      .+...   ...+.+|+.+||+.||++|||+.||++++..
T Consensus       230 ~~~~~---~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         230 MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11111   2236789999999999999999999998854

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.5e-51  Score=378.02  Aligned_cols=259  Identities=25%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----E
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----C  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  216 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++............+.+|+++++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999965 589999999998765544455578999999999999999999999988643    4


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||++||+|.+++...+   .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++..+++|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999887654   6999999999999999999999   7899999999999999999999999999987


Q ss_pred             ccCCCCC---CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||....       ........+.....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPI  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-------HHHHHHHHHhcCCC
Confidence            6543322   2344679999999999999999999999999999999999999996321       11112222222111


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhh
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRP-TMQYVSQGFLI  414 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~ev~~~l~~  414 (436)
                      ++.. ........+.+++.+||+.||++|| |++++.+.+..
T Consensus       233 ~~~~-~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         233 PPSA-RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CGGG-TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCch-hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            1100 0001122367899999999999999 88888876643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=383.30  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=197.7

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCC----EEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCM  217 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  217 (436)
                      ++|++.+.||+|+||+||+|.+. +|+    .||+|+++......  ..+.+.+|++++++++|||||+++|+|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C--THHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            46999999999999999999754 444    58999887543322  237899999999999999999999999875 46


Q ss_pred             EEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          218 FLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       218 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      ++++||+.+|+|.+++....  ..+++..++.++.|||.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence            78889999999999887643  36899999999999999999999   78999999999999999999999999999998


Q ss_pred             cCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccCCCCcccchhhhhcCCCCC
Q 013793          298 LHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSSSSDPKIMLIDVLDQRLPP  374 (436)
Q Consensus       298 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  374 (436)
                      .......  .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||+...       .. .....+......
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-------~~-~~~~~i~~~~~~  232 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------AS-EISSILEKGERL  232 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------GG-GHHHHHHHTCCC
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-------HH-HHHHHHHcCCCC
Confidence            7554332  233468999999999999999999999999999999998 788886321       11 122222221111


Q ss_pred             CCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          375 PVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       375 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                      +.+..   ....+.+|+.+||+.||++|||+.||+++++..
T Consensus       233 ~~p~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 PQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcc---cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            11111   122367899999999999999999999987543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=380.43  Aligned_cols=258  Identities=23%  Similarity=0.331  Sum_probs=194.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||.||+|...      +++.||||+++.......  .+.+.+|...+.++ +|+||+.+++++.+.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~--~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH--HHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            367999999999999999999642      356899999976543322  36778888888887 689999999998765


Q ss_pred             -CEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 013793          215 -KCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  280 (436)
Q Consensus       215 -~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nil  280 (436)
                       ...++||||+++|+|.++++....             ...+++.+++.++.||++||+|||   +.+|+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence             468999999999999999975421             235899999999999999999999   789999999999999


Q ss_pred             ecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCC-CCccccccccCC
Q 013793          281 LNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDLLSSLSSS  357 (436)
Q Consensus       281 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~  357 (436)
                      +++++.+||+|||+|+.......  ......||+.|+|||.+.+..++.++|||||||++|||+||. .||....     
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-----  241 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----  241 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-----
Confidence            99999999999999987644333  234467999999999999999999999999999999999975 5665211     


Q ss_pred             CCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          358 SDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       358 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        ........+......+.....   ...+.+++.+||+.||++|||+.||++++..
T Consensus       242 --~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         242 --IDEEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             --CSHHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHHHhcCCCCCCCccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              111122222221111111111   1236789999999999999999999999853

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.1e-51  Score=379.35  Aligned_cols=267  Identities=25%  Similarity=0.340  Sum_probs=204.6

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEEe
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIYE  222 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  222 (436)
                      ++|++.+.||+|+||+||+|..++|+.||||++......+ ...+.+.+|+.++++++|||||++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            5799999999999999999999999999999997654332 223678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      |+.++.+..+.....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.+.......
T Consensus        81 ~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            999887777765443   7999999999999999999999   7899999999999999999999999999998876554


Q ss_pred             CCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc-------------CCCCcccchhhhh
Q 013793          303 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS-------------SSSDPKIMLIDVL  368 (436)
Q Consensus       303 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-------------~~~~~~~~~~~~~  368 (436)
                      .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+...             .............
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            445556789999999998754 57999999999999999999999996332100             0000000000000


Q ss_pred             cCCC----CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          369 DQRL----PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       369 ~~~l----~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ....    ..+...........+.+|+.+||+.||++|||++|+++|+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            0000    00000000011123678999999999999999999999999863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-50  Score=375.87  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             cceeeecCceEEEEEEcCCC----CEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-CCEEEEEEe
Q 013793          148 KYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-KKCMFLIYE  222 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  222 (436)
                      .++||+|+||+||+|.+.++    ..||||+++.....  ...+.|.+|++++++++|||||+++|++.+ ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            56899999999999976532    25899999754332  234789999999999999999999999876 468999999


Q ss_pred             eccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCCC
Q 013793          223 YMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHADS  302 (436)
Q Consensus       223 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  302 (436)
                      ||++|+|.+++....  ..+++..++.++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999999987653  35788899999999999999999   7899999999999999999999999999998765433


Q ss_pred             CC----ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC-CCCCCCC
Q 013793          303 SN----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ-RLPPPVD  377 (436)
Q Consensus       303 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~  377 (436)
                      ..    .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.....      .......+... +...+..
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~------~~~~~~~i~~g~~~~~p~~  258 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRRLLQPEY  258 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCCCCTT
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC------HHHHHHHHHcCCCCCCccc
Confidence            22    2335689999999999999999999999999999999998888753211      11112222221 1111111


Q ss_pred             hhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          378 QKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       378 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                           ....+.+|+.+||+.||++||||.||++++.....
T Consensus       259 -----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         259 -----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 11236789999999999999999999999865543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=375.06  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=200.1

Q ss_pred             hcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----EEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----CMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  218 (436)
                      ++|.+.+.||+|+||.||+|++ +|+.||||++.......    .....|+..+..++|||||+++++|.+.+    ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            5677889999999999999987 68899999997553221    22334555666789999999999998754    689


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeecCCCCeEEeecc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFG  293 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  293 (436)
                      +|||||++|+|.++++..    .++|.++++++.|+|.||+|+|+.     ..++|+||||||+|||+++++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999999864    589999999999999999999952     13699999999999999999999999999


Q ss_pred             cccccCCCCC----CccccccccccccccccccC------ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCc---
Q 013793          294 TARRLHADSS----NRTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDP---  360 (436)
Q Consensus       294 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~---  360 (436)
                      +++.......    ......||+.|+|||++.+.      .++.++|||||||++|||+||..|+............   
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            9987754332    22346799999999998754      3678999999999999999999887533221111100   


Q ss_pred             -----ccchhhhhcCCCCCCCChh--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhc
Q 013793          361 -----KIMLIDVLDQRLPPPVDQK--VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLIT  415 (436)
Q Consensus       361 -----~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~  415 (436)
                           ........+..+.+.....  .......+.+|+.+||+.||++|||+.||+++|...
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                 1111122233333222221  223445577899999999999999999999988643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=378.41  Aligned_cols=254  Identities=25%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCC--EEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeCCEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHKKCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  218 (436)
                      ++|++.+.||+|+||+||+|.+. +|.  .||||++.......  ..+.+.+|+++++++ +|||||+++|+|.+.+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH--HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            67889999999999999999765 344  47888876543322  236799999999999 7999999999999999999


Q ss_pred             EEEeeccCCChhhhhccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 013793          219 LIYEYMERGSLFCILHND-------------DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  285 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  285 (436)
                      +||||+++|+|.++++..             .....+++.+++.++.|||.||.|||   +.+|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence            999999999999999754             23457999999999999999999999   78999999999999999999


Q ss_pred             CeEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCC-CccccccccCCCCcccch
Q 013793          286 EAFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH-PRDLLSSLSSSSDPKIML  364 (436)
Q Consensus       286 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~-p~~~~~~~~~~~~~~~~~  364 (436)
                      .+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||...       ......
T Consensus       165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-------~~~~~~  236 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAELY  236 (309)
T ss_dssp             CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHH
T ss_pred             ceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-------CHHHHH
Confidence            999999999986543322 234568999999999999999999999999999999999765 55421       111112


Q ss_pred             hhhhcC-CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          365 IDVLDQ-RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       365 ~~~~~~-~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                      ..+... +++.+..     ....+.+|+.+||+.||++||||.||+++|..
T Consensus       237 ~~i~~~~~~~~~~~-----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         237 EKLPQGYRLEKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             HHGGGTCCCCCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            222221 1211111     12236789999999999999999999998743

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-50  Score=376.37  Aligned_cols=258  Identities=24%  Similarity=0.344  Sum_probs=208.3

Q ss_pred             hhcccccceeeecCceEEEEEEc------CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEeeC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCLHK  214 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  214 (436)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++.......  ...+.+|+.++.++ +|||||+++|+|.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH--HHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            46888999999999999999964      3567899999987654332  36789999999999 699999999999999


Q ss_pred             CEEEEEEeeccCCChhhhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          215 KCMFLIYEYMERGSLFCILHNDD---------------EAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      +..++||||+++|+|.++++...               ....+++.+++.++.||++||+|||   +.+++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence            99999999999999999987543               2236899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCC-ccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-RDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p-~~~~~~~~~  356 (436)
                      +++.++.++++|||.++........  .....||+.|+|||.+.+..++.++|||||||++|||+|+..| +...     
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-----  251 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-----  251 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-----
Confidence            9999999999999999877544332  2346789999999999999999999999999999999995444 4321     


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                        .......+.+............   ...+.+|+.+||+.||++||||.||++.+..
T Consensus       252 --~~~~~~~~~i~~~~~~~~~~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         252 --PVDSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             --CSSHHHHHHHHHTCCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CHHHHHHHHHhcCCCCCCcccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              1112233343333332222211   2236789999999999999999999998853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=374.18  Aligned_cols=247  Identities=21%  Similarity=0.331  Sum_probs=201.0

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhh---HHHHHHHHHHHHHHhhcc--CCCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVL--HRSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  216 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.......   ......+.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999975 579999999986532211   001134668999999996  8999999999999999


Q ss_pred             EEEEEeeccC-CChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCCeEEeeccc
Q 013793          217 MFLIYEYMER-GSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGT  294 (436)
Q Consensus       217 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~  294 (436)
                      .++||||+.+ +++.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 67778876543   6999999999999999999999   789999999999999985 47999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCcc-CcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCC--
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQR--  371 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  371 (436)
                      ++.....  ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....             +....  
T Consensus       158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~~~  222 (273)
T d1xwsa_         158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQVF  222 (273)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCCC
T ss_pred             ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------HhhcccC
Confidence            9865432  3345679999999999987765 6779999999999999999999963221             11111  


Q ss_pred             CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          372 LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       372 l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ++...+       ..+.+|+.+||+.||++|||++|+++|+|++..
T Consensus       223 ~~~~~s-------~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         223 FRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCCCC-------HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            122222       236789999999999999999999999999654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=372.71  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=202.6

Q ss_pred             hhcccccceeeecCceEEEEEEcC--------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc-cCCCceeeeeEEe
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRSIVKLYGFCL  212 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  212 (436)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++......  ....+.+|...+.++ +|||||+++++|.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH--HHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            367889999999999999999642        23479999997765433  247788999999888 8999999999999


Q ss_pred             eCCEEEEEEeeccCCChhhhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 013793          213 HKKCMFLIYEYMERGSLFCILHNDDE-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  279 (436)
Q Consensus       213 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Ni  279 (436)
                      +.+..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||   +.+|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence            99999999999999999999975431             246899999999999999999999   78999999999999


Q ss_pred             eecCCCCeEEeecccccccCCCCC--CccccccccccccccccccCccCcchhhHHHHHHHHHHHh-CCCCccccccccC
Q 013793          280 LLNSKLEAFVADFGTARRLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDLLSSLSS  356 (436)
Q Consensus       280 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~  356 (436)
                      |++.++.+||+|||+++.......  ......|++.|+|||.+.++.++.++||||||+++|||+| |+.||....    
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----  242 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----  242 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----
Confidence            999999999999999987654332  2344568999999999999999999999999999999998 688875221    


Q ss_pred             CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 013793          357 SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLI  414 (436)
Q Consensus       357 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~  414 (436)
                         .. ...+.+......+.....   ...+.+|+.+||+.||++|||+.||++.|..
T Consensus       243 ---~~-~~~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         243 ---VE-ELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             ---HH-HHHHHHHTTCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HH-HHHHHHHcCCCCCCCccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence               11 122222222222222111   1236789999999999999999999998843

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=371.61  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=209.2

Q ss_pred             hhcccccceeeecCceEEEEEEcC------CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  215 (436)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++......  ....+.+|++++++++|||||+++|+|...+
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH--HHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            478899999999999999999653      35789999997654332  2367899999999999999999999999999


Q ss_pred             EEEEEEeeccCCChhhhhccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeE
Q 013793          216 CMFLIYEYMERGSLFCILHND-------DEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  288 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  288 (436)
                      ..++||||+++|+|.+++...       .....+++..+.+++.|+|+||+|||   +.+|+||||||+|||+|+++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence            999999999999999988642       22345799999999999999999999   78999999999999999999999


Q ss_pred             EeecccccccCCCCCC--ccccccccccccccccccCccCcchhhHHHHHHHHHHHhCC-CCccccccccCCCCcccchh
Q 013793          289 VADFGTARRLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDLLSSLSSSSDPKIMLI  365 (436)
Q Consensus       289 l~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~  365 (436)
                      |+|||+++........  .....||+.|+|||.+.+..++.++||||||+++|||+||. .||...       .......
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~  246 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLR  246 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHH
Confidence            9999999876443332  23346899999999999999999999999999999999985 566421       1122233


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          366 DVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       366 ~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      .+.+...++....    ....+.+++.+||+.||++||||.||++++.....
T Consensus       247 ~i~~~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCCCCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            3333332211111    11237789999999999999999999999866544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=371.90  Aligned_cols=269  Identities=23%  Similarity=0.311  Sum_probs=198.9

Q ss_pred             hhcccccceeeecCceEEEEEEc-CC-CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhc---cCCCceeeeeEEee---
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRSIVKLYGFCLH---  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---  213 (436)
                      .++|++.+.||+|+||+||+|.. .+ ++.||||+++....... ....+.+|+.+++.+   +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999975 44 66799999865432211 013455677776665   79999999999864   


Q ss_pred             --CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEee
Q 013793          214 --KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  291 (436)
Q Consensus       214 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  291 (436)
                        ....+++|||++++++.......  ...+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence              34689999999998776554433  236899999999999999999999   78999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCc--
Q 013793          292 FGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDP--  360 (436)
Q Consensus       292 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~--  360 (436)
                      ||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...+...         .....  
T Consensus       160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            9999865332 23445679999999999999999999999999999999999999996432100         00000  


Q ss_pred             ----ccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          361 ----KIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       361 ----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                          ..............+...........+.+|+.+||+.||++|||+.|+++|+|++.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                000000000000000000000112236689999999999999999999999999654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=365.51  Aligned_cols=269  Identities=21%  Similarity=0.259  Sum_probs=199.3

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee-------
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH-------  213 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  213 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......+ .....+.+|+++|++++|||++++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            47899999999999999999975 589999999986543322 123678899999999999999999998865       


Q ss_pred             -CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeec
Q 013793          214 -KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  292 (436)
Q Consensus       214 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  292 (436)
                       ....++||||+.++.+........   .++...++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeec
Confidence             345799999999887766654433   6888999999999999999999   789999999999999999999999999


Q ss_pred             ccccccCCCCC----CccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCC
Q 013793          293 GTARRLHADSS----NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSS  358 (436)
Q Consensus       293 g~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~  358 (436)
                      |+++.......    ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||+......         ...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987653222    22335699999999998765 68999999999999999999999996322100         000


Q ss_pred             Cc-------ccchhhhhcCCCCCCCChh----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          359 DP-------KIMLIDVLDQRLPPPVDQK----VIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       359 ~~-------~~~~~~~~~~~l~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                      ..       ...................    .......+.+|+.+||+.||++|||++|+++|+||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00       0000000000000000000    01112235689999999999999999999999999854

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-47  Score=355.76  Aligned_cols=267  Identities=20%  Similarity=0.273  Sum_probs=208.9

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCCEEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKKCMFLIY  221 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  221 (436)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++...... .....+.+|+.+++.++||||+++++++......++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            5799999999999999999975 588999999996554322 23478899999999999999999999999999999999


Q ss_pred             eeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccccccCCC
Q 013793          222 EYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARRLHAD  301 (436)
Q Consensus       222 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  301 (436)
                      |++.++++..++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++.....
T Consensus        81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999999988887554   6889999999999999999999   789999999999999999999999999999987665


Q ss_pred             CCCccccccccccccccccccCc-cCcchhhHHHHHHHHHHHhCCCCccccccc----------cCCCCcc--cchhhhh
Q 013793          302 SSNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SSSSDPK--IMLIDVL  368 (436)
Q Consensus       302 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------~~~~~~~--~~~~~~~  368 (436)
                      ........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||......          .......  .......
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            55555667889999999887665 689999999999999999999996321110          0000000  0000000


Q ss_pred             cCC----C--CCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          369 DQR----L--PPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       369 ~~~----l--~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      +..    .  ..............+.+|+.+||+.||.+|||++|+++|+|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            000    0  00000000111123668999999999999999999999999964

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-48  Score=368.65  Aligned_cols=269  Identities=21%  Similarity=0.248  Sum_probs=200.4

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC----E
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK----C  216 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  216 (436)
                      +++|++.+.||+|+||+||+|.. .+|+.||||++......  ...+.+.+|+++|++++||||+++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            45799999999999999999964 68999999999765432  23478899999999999999999999997653    2


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .+++++|+.+|+|.+++...    .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            35556677899999999754    5899999999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC---Ccccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCccc-
Q 013793          297 RLHADSS---NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKI-  362 (436)
Q Consensus       297 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~-  362 (436)
                      .......   ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||.......         ....... 
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            7644322   2344669999999998854 467899999999999999999999986322100         0000000 


Q ss_pred             ------chhhh---hcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCCCC
Q 013793          363 ------MLIDV---LDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRKTP  419 (436)
Q Consensus       363 ------~~~~~---~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~~~  419 (436)
                            .....   .......+...........+.+|+.+||+.||++|||+.|+++|+|++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                  00000   0000000000000011123678999999999999999999999999875543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=369.55  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=197.1

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeCC-----
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHKK-----  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  215 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++...... ...+.+.+|+++|++++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            46799999999999999999975 579999999997654332 33478899999999999999999999998654     


Q ss_pred             -EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccc
Q 013793          216 -CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  294 (436)
Q Consensus       216 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  294 (436)
                       ..++||||+ +.+|..+.+..    .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence             579999999 55777776543    5999999999999999999999   78999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCC------
Q 013793          295 ARRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSS------  358 (436)
Q Consensus       295 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~------  358 (436)
                      ++.....   .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......         ...      
T Consensus       168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            9876432   3456799999999988764 57899999999999999999999986432100         000      


Q ss_pred             --Cccc--chhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          359 --DPKI--MLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       359 --~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                        ....  ........................+.+|+.+||..||++|||+.|+++|+|++.-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence              0000  0000000000000000000111236689999999999999999999999999764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=369.75  Aligned_cols=261  Identities=24%  Similarity=0.299  Sum_probs=196.1

Q ss_pred             cccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC------CE
Q 013793          144 DFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK------KC  216 (436)
Q Consensus       144 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  216 (436)
                      +|+..++||+|+||+||+|+. .+|+.||||++.....       ...+|++++++++||||+++++++...      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            578889999999999999976 4799999999976542       234799999999999999999998653      24


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeecccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTA  295 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a  295 (436)
                      .++||||++++.+..+.+.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence            7899999988755544433333447999999999999999999999   89999999999999999775 8999999999


Q ss_pred             cccCCCCCCcccccccccccccccccc-CccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCCcccchh
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSDPKIMLI  365 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~~~~~~~  365 (436)
                      +...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......         ..... ....
T Consensus       171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~-~~~~  248 (350)
T d1q5ka_         171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR-EQIR  248 (350)
T ss_dssp             EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH-HHHH
T ss_pred             hhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH-Hhhh
Confidence            8765433 2344679999999998765 578999999999999999999999996322100         00000 0000


Q ss_pred             hh----hcCCCCCCCCh-----hHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          366 DV----LDQRLPPPVDQ-----KVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       366 ~~----~~~~l~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ..    .+..++.....     ........+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            00    00000000000     00001223678999999999999999999999999865

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-46  Score=355.59  Aligned_cols=255  Identities=18%  Similarity=0.229  Sum_probs=199.3

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeC--CEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHK--KCMF  218 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~  218 (436)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....      +.+.+|+++|..++ ||||+++++++...  ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH------HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            6899999999999999999976 5799999999976542      56789999999995 99999999998753  5689


Q ss_pred             EEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-CeEEeecccccc
Q 013793          219 LIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARR  297 (436)
Q Consensus       219 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~  297 (436)
                      +||||+++++|..+..      .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999999987642      5899999999999999999999   88999999999999998655 689999999987


Q ss_pred             cCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------------------
Q 013793          298 LHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------------------  355 (436)
Q Consensus       298 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------------------  355 (436)
                      ..... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......                     
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            65433 33456789999999998765 47999999999999999999999985321100                     


Q ss_pred             CCCCcccchhhhhcCC--------CCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          356 SSSDPKIMLIDVLDQR--------LPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       356 ~~~~~~~~~~~~~~~~--------l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                      ................        .....   .......+.+|+.+||+.||++|||++|+++|+||+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSEN---QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTT---GGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccccCcccchhcccccccchhhcccccc---cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            0000000000000000        00000   0111223678999999999999999999999999965

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=364.73  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             hcccccceeeecCceEEEEEEc----CCCCEEEEEEecCcchh-hHHHHHHHHHHHHHHhhccC-CCceeeeeEEeeCCE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLH-RSIVKLYGFCLHKKC  216 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  216 (436)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++..... .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999964    25889999998654221 01112567889999999977 899999999999999


Q ss_pred             EEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          217 MFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       217 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                      .++||||+.+|+|.+++....   .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999997655   5778899999999999999999   7899999999999999999999999999998


Q ss_pred             ccCCCCC-CccccccccccccccccccC--ccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcCCCC
Q 013793          297 RLHADSS-NRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQRLP  373 (436)
Q Consensus       297 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  373 (436)
                      .+..... ......|++.|+|||.+.+.  .++.++||||+||+||||+||+.||...+..   ...............+
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~---~~~~~i~~~~~~~~~~  254 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPP  254 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcccCCCC
Confidence            7643322 23456799999999998754  4788999999999999999999999743211   0001111122222222


Q ss_pred             CCCChhHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhhcC
Q 013793          374 PPVDQKVIQDILLASTISFACLQSNPKSRP-----TMQYVSQGFLITR  416 (436)
Q Consensus       374 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~ev~~~l~~~~  416 (436)
                      .+.     .....+.+|+.+||++||++||     |++|+++|+|++.
T Consensus       255 ~~~-----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         255 YPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CCT-----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             Ccc-----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            111     1123367899999999999999     5899999999865

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=357.90  Aligned_cols=263  Identities=23%  Similarity=0.253  Sum_probs=195.5

Q ss_pred             hcccccceeeecCceEEEEEEcC-CCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEee------CC
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLH------KK  215 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  215 (436)
                      ++|++.++||+|+||+||+|... +|+.||||++....... .....+.+|+.++++++|||||++++++..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            57999999999999999999764 79999999997654332 234678899999999999999999999964      36


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..++||||+.++.+. .+.     ..+++.+++.++.|++.||+|||   +.||+||||||+|||++.++.++++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhh
Confidence            789999999776554 443     25899999999999999999999   789999999999999999999999999998


Q ss_pred             cccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccc----------cC---------
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSL----------SS---------  356 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------~~---------  356 (436)
                      +...... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...+..          ..         
T Consensus       167 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         167 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hcccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            8654332 334567899999999999999999999999999999999999998532110          00         


Q ss_pred             -----------CCCcccchhhhhcCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcC
Q 013793          357 -----------SSDPKIMLIDVLDQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITR  416 (436)
Q Consensus       357 -----------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~  416 (436)
                                 ..............................+.+|+.+||+.||++|||++|+++|+|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                       000000001111111111222223334556789999999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=358.86  Aligned_cols=265  Identities=22%  Similarity=0.256  Sum_probs=199.2

Q ss_pred             hhcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceeeeeEEeeC-----C
Q 013793          142 TEDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKLYGFCLHK-----K  215 (436)
Q Consensus       142 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  215 (436)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++........ ..+.+.+|++++++++|||+|++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH-HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            56799999999999999999974 5899999999986543322 246788999999999999999999998643     3


Q ss_pred             EEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEeecccc
Q 013793          216 CMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  295 (436)
Q Consensus       216 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  295 (436)
                      ..+++++|+.+|+|.+++...    .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence            456778888999999999643    5999999999999999999999   789999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-ccCcchhhHHHHHHHHHHHhCCCCcccccccc---------CCCC------
Q 013793          296 RRLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLS---------SSSD------  359 (436)
Q Consensus       296 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---------~~~~------  359 (436)
                      .....   ......|++.|+|||...+. .++.++||||+||++|+|++|+.||...+...         ....      
T Consensus       169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            76432   23446789999999987665 56899999999999999999999986322100         0000      


Q ss_pred             -cccchhhhhcC--CCCCCC-ChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhcCC
Q 013793          360 -PKIMLIDVLDQ--RLPPPV-DQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFLITRK  417 (436)
Q Consensus       360 -~~~~~~~~~~~--~l~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~~~~~  417 (436)
                       ...........  ..+... ..........+.+|+.+||+.||++|||+.|+++|+|++.-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence             00000000000  000000 00000112336789999999999999999999999999854

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-46  Score=347.25  Aligned_cols=255  Identities=17%  Similarity=0.269  Sum_probs=189.7

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCceee-eeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSIVKL-YGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv  220 (436)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++......     ..+..|+++++.++|+|++.. .++..+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999965 57899999998765432     457789999999987765555 5555778889999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCCeEEeecccccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARR  297 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~  297 (436)
                      |||+. +++...+....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++   .+..++|+|||+|+.
T Consensus        82 me~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          82 MELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99995 56666554432  36899999999999999999999   78999999999999875   456799999999997


Q ss_pred             cCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhhcC
Q 013793          298 LHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVLDQ  370 (436)
Q Consensus       298 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  370 (436)
                      +.....       ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..........    ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~----~~~~~~~~  231 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----KYERISEK  231 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHH
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH----HHHHhhcc
Confidence            754322       1234579999999999999999999999999999999999999997432211111    11111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 013793          371 RLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGF  412 (436)
Q Consensus       371 ~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l  412 (436)
                      .+..+...........+.+++..||+.+|++||++.++.+.+
T Consensus       232 ~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l  273 (299)
T d1ckia_         232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  273 (299)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred             cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            111100000001112367899999999999999998765433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-45  Score=342.04  Aligned_cols=256  Identities=18%  Similarity=0.216  Sum_probs=198.0

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC-CCceeeeeEEeeCCEEEEE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RSIVKLYGFCLHKKCMFLI  220 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv  220 (436)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......     ..+.+|++.+..+.| +|++.+++++......++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            5799999999999999999975 47899999998654332     456788899999965 8999999999999999999


Q ss_pred             EeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCCeEEeecccc
Q 013793          221 YEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFGTA  295 (436)
Q Consensus       221 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a  295 (436)
                      |||+ +++|.+++....  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+|
T Consensus        80 me~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence            9999 689999887644  26899999999999999999999   899999999999999974     578999999999


Q ss_pred             cccCCCCC-------CccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcccchhhhh
Q 013793          296 RRLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPKIMLIDVL  368 (436)
Q Consensus       296 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  368 (436)
                      +.......       ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......    ........+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~~~~~~~i~  229 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIG  229 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch----hHHHHHHHHH
Confidence            87643221       123457999999999999999999999999999999999999999632210    0000111111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 013793          369 DQRLPPPVDQKVIQDILLASTISFACLQSNPKSRPTMQYVSQGFL  413 (436)
Q Consensus       369 ~~~l~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ev~~~l~  413 (436)
                      ......+...........+.+++..|++.+|++||+++.+.+.+.
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            111000000000001123677888999999999999888877554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-41  Score=326.55  Aligned_cols=266  Identities=19%  Similarity=0.213  Sum_probs=194.1

Q ss_pred             hcccccceeeecCceEEEEEEc-CCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-----------CCCceeeeeE
Q 013793          143 EDFHIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----------HRSIVKLYGF  210 (436)
Q Consensus       143 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~  210 (436)
                      .+|++.+.||+|+||+||+|+. .+|+.||||+++.....    .+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            3599999999999999999975 58999999999865432    256678888887775           5789999988


Q ss_pred             Eee--CCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCC--
Q 013793          211 CLH--KKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--  286 (436)
Q Consensus       211 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--  286 (436)
                      +..  ....+++++++..+..............+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.  
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence            765  35667777777665544433333344578899999999999999999995  479999999999999987653  


Q ss_pred             ----eEEeecccccccCCCCCCccccccccccccccccccCccCcchhhHHHHHHHHHHHhCCCCccccccccCCCCcc-
Q 013793          287 ----AFVADFGTARRLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDLLSSLSSSSDPK-  361 (436)
Q Consensus       287 ----~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~-  361 (436)
                          ++++|||.+......   .....||+.|+|||.+....++.++||||+||+++||++|+.||............. 
T Consensus       167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence                899999999865432   234679999999999999999999999999999999999999986432110000000 


Q ss_pred             -------------cch------hhhhc-----CCCCCCC-----------ChhHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 013793          362 -------------IML------IDVLD-----QRLPPPV-----------DQKVIQDILLASTISFACLQSNPKSRPTMQ  406 (436)
Q Consensus       362 -------------~~~------~~~~~-----~~l~~~~-----------~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~  406 (436)
                                   ...      ....+     ..+....           ..........+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence                         000      00000     0000000           000123344578999999999999999999


Q ss_pred             HHHHHHhhcCC
Q 013793          407 YVSQGFLITRK  417 (436)
Q Consensus       407 ev~~~l~~~~~  417 (436)
                      |+++|+|++..
T Consensus       324 e~L~Hp~f~~~  334 (362)
T d1q8ya_         324 GLVNHPWLKDT  334 (362)
T ss_dssp             HHHTCGGGTTC
T ss_pred             HHhcCcccCCC
Confidence            99999999844

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.6e-25  Score=191.54  Aligned_cols=167  Identities=16%  Similarity=0.223  Sum_probs=122.2

Q ss_pred             cccceeeecCceEEEEEEcCCCCEEEEEEecCcchh---------------hHHHHHHHHHHHHHHhhccCCCceeeeeE
Q 013793          146 HIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE---------------ELAFIKSFRNEAQVLSQVLHRSIVKLYGF  210 (436)
Q Consensus       146 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~niv~l~~~  210 (436)
                      .+.+.||+|+||+||+|...+|+.||||+++.....               .........+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457889999999999999889999999987642111               11122445678899999999999888765


Q ss_pred             EeeCCEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCCeEEe
Q 013793          211 CLHKKCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  290 (436)
Q Consensus       211 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  290 (436)
                      ..    .+++|||++++.+..          ++......++.|++++++|||   ..+|+||||||+|||++++ .++|+
T Consensus        83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            32    379999998865432          344556789999999999999   7899999999999999975 48999


Q ss_pred             ecccccccCCCCCCcccccccccccccc-----ccccCccCcchhhHHHHHHH
Q 013793          291 DFGTARRLHADSSNRTLLAGTYGYIAPE-----LAYTMVMTEKCDVYSFGVVT  338 (436)
Q Consensus       291 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Dv~s~G~il  338 (436)
                      |||+|.....+...        .|....     .+..+.++.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999765432211        111110     01246678899999976443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.27  E-value=1e-12  Score=121.64  Aligned_cols=71  Identities=42%  Similarity=0.687  Sum_probs=65.8

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCCCcccCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCGNFITLPSCD   74 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg~~~~~~~c~   74 (436)
                      +++|+.|||++|+|+|.||++|++|++|++|||++|+|+|.+|. +++|++|+.+++.+|+.+||.|  +|+|.
T Consensus       243 ~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~p--lp~c~  313 (313)
T d1ogqa_         243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP--LPACT  313 (313)
T ss_dssp             CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTT--SSCCC
T ss_pred             ccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCC--CCCCC
Confidence            46899999999999999999999999999999999999999996 7899999999999999999975  56774

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.66  E-value=9.5e-09  Score=80.55  Aligned_cols=58  Identities=29%  Similarity=0.395  Sum_probs=45.8

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++||||+|+|+ .+|+.++.+++|+.|++++|++++ +|. +..+++|+.+++++|.
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNR   76 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSC
T ss_pred             CCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCCc
Confidence            457888888888887 678788888888888888888874 553 7788888888888775

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=9.5e-08  Score=84.92  Aligned_cols=149  Identities=14%  Similarity=0.106  Sum_probs=102.6

Q ss_pred             HHHHHHhhcccccceeeecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeC
Q 013793          136 EDLIEATEDFHIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHK  214 (436)
Q Consensus       136 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  214 (436)
                      .++....+.|...+..+-++.+.||+... +++.+++|+........   ...+.+|...+..+. +--+.+++.++...
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            56777777887666544445578999875 55667888876543222   134567888777764 33366778888888


Q ss_pred             CEEEEEEeeccCCChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 013793          215 KCMFLIYEYMERGSLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHHDC-----------------------------  265 (436)
Q Consensus       215 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------  265 (436)
                      +..++||++++|..+.+.....        .....++.++++.++.||+..                             
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            9999999999998876544221        112335666667777777411                             


Q ss_pred             ---------------------------CCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          266 ---------------------------SPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       266 ---------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                                                 ...++|+|+.|.||+++++..+-|.||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                       1237999999999999987767799998775

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.64  E-value=1e-08  Score=87.08  Aligned_cols=61  Identities=21%  Similarity=0.274  Sum_probs=42.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|++++.+|..+..+++|++|+|++|++++..|..|.++++|+.|++++|.
T Consensus        53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~  113 (192)
T d1w8aa_          53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCcc
Confidence            3567777777777776666677777777777777777775555556667777777777665

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=2.2e-08  Score=81.76  Aligned_cols=63  Identities=29%  Similarity=0.333  Sum_probs=41.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLC   64 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lc   64 (436)
                      |++|+.|+|++|+|++.-|..|..+++|++|+|++|+|+ .+|.......++..+++++|+.-|
T Consensus        55 l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC  117 (156)
T ss_dssp             CCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             ccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcccC
Confidence            356777777777777555566777777777777777776 455544444456677777776555

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.60  E-value=2.1e-08  Score=89.64  Aligned_cols=64  Identities=28%  Similarity=0.265  Sum_probs=58.9

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLCG   65 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lcg   65 (436)
                      +++|+.|++++|+|++..|..|..+++|++|||++|+|+ .||.++..+++|+.+++++|+..|.
T Consensus       147 l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence            468999999999999877788999999999999999999 8999999999999999999998884

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=98.55  E-value=1.3e-08  Score=93.40  Aligned_cols=59  Identities=25%  Similarity=0.491  Sum_probs=54.1

Q ss_pred             CCCEEECcCCcccc--cCChhccCCCCCCeeeccc-cccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEG--SIPGELTDLSRLDYLNLSW-NKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g--~ip~~~~~l~~L~~l~ls~-N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++.|||++|+++|  .||+++++|++|++|||++ |+|+|.+|.++++|++|+.|++++|.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~  112 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN  112 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEEC
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccc
Confidence            58899999999988  6899999999999999986 89999999999999999999998886

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.48  E-value=5.1e-08  Score=82.54  Aligned_cols=59  Identities=29%  Similarity=0.327  Sum_probs=40.0

Q ss_pred             CCCEEECcCCcccccC-ChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSI-PGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~i-p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++++|+|++|+|++.+ +..|+++++|+.|+|++|++++..+..+..+++|+.+++++|.
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~   89 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence            5677777777776544 3455667777777777777776666666667777777777664

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.43  E-value=8.8e-08  Score=74.82  Aligned_cols=54  Identities=22%  Similarity=0.319  Sum_probs=50.0

Q ss_pred             CEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            5 TWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         5 ~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++||||+|+++ .+| .+.+|++|++|||++|+++ .+|..++.+++|+.+++++|.
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~   54 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA   54 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccc
Confidence            58999999999 777 5999999999999999998 689889999999999999986

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.38  E-value=6.5e-07  Score=78.92  Aligned_cols=129  Identities=18%  Similarity=0.163  Sum_probs=87.1

Q ss_pred             eeecCc-eEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccC--CCceeeeeEEeeCCEEEEEEeeccCC
Q 013793          151 IGTGGY-GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RSIVKLYGFCLHKKCMFLIYEYMERG  227 (436)
Q Consensus       151 lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  227 (436)
                      +..|.. +.||+....++..+++|.-.....      ..+..|.+.++.+..  -.+.+++++..+.+..++||++++|.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            444543 679999988888899998766543      345667777777643  33566788888888899999999986


Q ss_pred             ChhhhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 013793          228 SLFCILHNDDEAVELDWAKRVNIVKAMAHALAYLHH--------------------------------------------  263 (436)
Q Consensus       228 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------------------------------------------  263 (436)
                      ++.+..        ..   ....+.++++.|+-||.                                            
T Consensus        92 ~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (255)
T d1nd4a_          92 DLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  160 (255)
T ss_dssp             ETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             cccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence            653311        11   11222334444444442                                            


Q ss_pred             -------c----CCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          264 -------D----CSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       264 -------~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                             .    ....++|||+.|.||+++++..+-|+||+.+.
T Consensus       161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   0    02347999999999999987667899998774

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=1.4e-07  Score=84.99  Aligned_cols=63  Identities=29%  Similarity=0.339  Sum_probs=31.3

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGLC   64 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~lc   64 (436)
                      ++|+.|+|++|++++..|..|.++++|++||+++|++++..|..+..+++|+.+++++|+..|
T Consensus       177 ~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            344555555555554444555555555555555555554444444445555555555555444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.23  E-value=2.3e-07  Score=76.06  Aligned_cols=57  Identities=19%  Similarity=0.209  Sum_probs=42.2

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .+|++|||++|+++ .||..+..+++|+.||||+|+++ .++ .+..+++|+.+++++|.
T Consensus        18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~   74 (162)
T d1a9na_          18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNR   74 (162)
T ss_dssp             TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSC
T ss_pred             CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccc
Confidence            35777888888887 67766677788888888888877 454 36677777777777775

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.20  E-value=4.8e-07  Score=74.09  Aligned_cols=59  Identities=20%  Similarity=0.291  Sum_probs=50.8

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.||||+|+|+ .++ .+..|++|+.|+|++|+++...|..+..+++++.+++++|.
T Consensus        40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~   98 (162)
T d1a9na_          40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   98 (162)
T ss_dssp             TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccc
Confidence            468999999999999 776 58999999999999999995334345679999999999986

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.17  E-value=6.8e-07  Score=72.62  Aligned_cols=61  Identities=28%  Similarity=0.224  Sum_probs=53.0

Q ss_pred             CCCCCEEECcCC-cccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNN-KIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n-~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++| .|+..-|..|.+|++|+.|+|++|+|++.-|..|..+++|+.+++++|.
T Consensus        30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             ccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence            468999999876 4885445679999999999999999997667789999999999999997

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.02  E-value=2.5e-06  Score=77.28  Aligned_cols=59  Identities=32%  Similarity=0.312  Sum_probs=42.7

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++++.|++++|++++..|..+.++++|++|+|++|+|+ .+|.++..+++|+.+++++|.
T Consensus       195 ~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~  253 (305)
T d1xkua_         195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN  253 (305)
T ss_dssp             TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSC
T ss_pred             ccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCc
Confidence            45677777777777666667777777777777777776 567777777777777777765

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.96  E-value=2.7e-06  Score=76.27  Aligned_cols=59  Identities=27%  Similarity=0.312  Sum_probs=27.9

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|+.|+|++|+|++..|..|.++++|++|++++|++++..|..|..++++..+++++|.
T Consensus       154 ~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~  212 (284)
T d1ozna_         154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN  212 (284)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             chhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccc
Confidence            34444444444444444444444444444444444444444444444444444444443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.82  E-value=8.6e-06  Score=73.55  Aligned_cols=59  Identities=36%  Similarity=0.451  Sum_probs=53.6

Q ss_pred             CCCCEEECcCCcccccCC-hhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIP-GELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip-~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|||++|+|+ .|| .+|.+|++|++|++++|.++...|..|.++++|+.+++++|.
T Consensus        31 ~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~   90 (305)
T d1xkua_          31 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ   90 (305)
T ss_dssp             TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence            57899999999999 566 479999999999999999998778889999999999999885

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.81  E-value=1.8e-06  Score=70.54  Aligned_cols=60  Identities=23%  Similarity=0.259  Sum_probs=47.1

Q ss_pred             CCCCCEEECcCCcccc--cCChhccCCCCCCeeeccccccCCCCCC-ccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEG--SIPGELTDLSRLDYLNLSWNKLSGPVPF-SNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g--~ip~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++||||+|+|+.  .++..+..|++|+.||||+|+++ .++. ......++..+++.+|+
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Np  126 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNS  126 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTST
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCC
Confidence            5789999999999983  23456788999999999999999 4553 22334568889999987

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.80  E-value=1.4e-06  Score=73.66  Aligned_cols=58  Identities=24%  Similarity=0.363  Sum_probs=46.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|+++ .|| .+..|++|+.|+|++|+++ .+|.....+++|+.+++++|.
T Consensus        47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~  104 (198)
T d1m9la_          47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQ  104 (198)
T ss_dssp             TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEE
T ss_pred             ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccc
Confidence            568889999999998 676 5888999999999999987 577655556678888887774

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.77  E-value=9.3e-06  Score=69.16  Aligned_cols=54  Identities=22%  Similarity=0.267  Sum_probs=25.7

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPN   60 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n   60 (436)
                      +|+.|++++|.++ .++ .+..|++|+.|+|++|++++ +|. ++.+++|+.+++++|
T Consensus        47 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDEN  100 (210)
T ss_dssp             TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred             CccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-ccc-cccCccccccccccc
Confidence            4455555555554 233 24455555555555555553 221 344455555555444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.72  E-value=1.7e-05  Score=70.03  Aligned_cols=61  Identities=25%  Similarity=0.278  Sum_probs=50.8

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +.+|+.|++++|.+++..|..+..+++|+.|++++|+|++..|..+..+++|+.|++++|.
T Consensus       123 l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  183 (266)
T d1p9ag_         123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (266)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCC
Confidence            3577888888888886556667788999999999999998777778889999999999886

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=5.6e-05  Score=70.72  Aligned_cols=79  Identities=14%  Similarity=0.104  Sum_probs=46.8

Q ss_pred             cceeeecCceEEEEEEcCC-CCEEEEEEecCcchhhH----HHHHHHHHHHHHHhhcc-C--CCceeeeeEEeeCCEEEE
Q 013793          148 KYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEEL----AFIKSFRNEAQVLSQVL-H--RSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       148 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~----~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  219 (436)
                      .+.||.|....||+....+ ++.++||.-........    ........|.+.|..+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998754 67899997543211000    00123445777777663 2  334555544  4445679


Q ss_pred             EEeeccCCC
Q 013793          220 IYEYMERGS  228 (436)
Q Consensus       220 v~e~~~~g~  228 (436)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.69  E-value=1.7e-05  Score=66.75  Aligned_cols=56  Identities=25%  Similarity=0.342  Sum_probs=39.5

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .+|++|++++|.++ .++ .+..|++|++|+|++|++++..|  +..+++|+.+++++|.
T Consensus        40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            46777777777777 554 46777777777777777775333  6677777777777665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.68  E-value=1.4e-05  Score=74.30  Aligned_cols=55  Identities=24%  Similarity=0.311  Sum_probs=26.0

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +|++|++++|+++ .++ .+..|++|++|||++|++++ +|. +.++++|+.|++++|+
T Consensus        45 ~l~~L~l~~~~I~-~l~-gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          45 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             TCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred             CCCEEECCCCCCC-Ccc-ccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccc
Confidence            4455555555544 332 34445555555555555543 222 4445555555554443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.67  E-value=5.7e-05  Score=68.75  Aligned_cols=135  Identities=17%  Similarity=0.227  Sum_probs=78.1

Q ss_pred             eEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc--eeee-----eEEeeCCEEEEEEeeccCCCh
Q 013793          157 GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI--VKLY-----GFCLHKKCMFLIYEYMERGSL  229 (436)
Q Consensus       157 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L  229 (436)
                      -.||++..++|+.|++|+.+......    +++..|...+..+...++  +..+     ......+..+.++++++|..+
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            47999999999999999987654332    556678888777743222  1111     123345678889999987533


Q ss_pred             hhh--------------hc----cC--CCCCCCCHH-------------------HHHHHHHHHHHHHHHHH----hcCC
Q 013793          230 FCI--------------LH----ND--DEAVELDWA-------------------KRVNIVKAMAHALAYLH----HDCS  266 (436)
Q Consensus       230 ~~~--------------l~----~~--~~~~~l~~~-------------------~~~~i~~~ia~~L~~LH----~~~~  266 (436)
                      ...              +|    ..  .....+++.                   .+..+...+...++.+.    ....
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            110              01    00  011111111                   11112222222333332    1224


Q ss_pred             CCeEecCCCCCceeecCCCCeEEeecccccc
Q 013793          267 PSIIHRDISSNNILLNSKLEAFVADFGTARR  297 (436)
Q Consensus       267 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  297 (436)
                      .+++|+|+.+.|||++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            578999999999999754  45899998764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.62  E-value=1.9e-05  Score=66.56  Aligned_cols=59  Identities=24%  Similarity=0.358  Sum_probs=50.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNKGL   63 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~~l   63 (436)
                      |++|++|+|++|++++ +|+ +++|++|+.|++++|.+. .+|. +..+++|+.+++++|...
T Consensus        61 l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~  119 (199)
T d2omxa2          61 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQIT  119 (199)
T ss_dssp             CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCC
T ss_pred             CCCcCcCccccccccC-ccc-ccCCcccccccccccccc-cccc-cccccccccccccccccc
Confidence            5799999999999995 553 999999999999999998 4654 888999999999877643

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.56  E-value=2.6e-05  Score=72.36  Aligned_cols=57  Identities=32%  Similarity=0.460  Sum_probs=46.2

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +.+|+.|+|++|++++ +| .+..+++|++|+|++|++++ +| .+..+++|+.+++++|.
T Consensus       306 ~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~  362 (384)
T d2omza2         306 LKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ  362 (384)
T ss_dssp             CTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred             hcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence            3578889999999985 44 38888999999999999884 55 58888899999998875

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.46  E-value=4.3e-05  Score=65.62  Aligned_cols=57  Identities=30%  Similarity=0.465  Sum_probs=47.5

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|+.|++++|.+++ ++ .+++|++|+.|||++|++++ +|. +..+++|+.+++++|+
T Consensus       150 ~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~  206 (227)
T d1h6ua2         150 LTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQ  206 (227)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSC
T ss_pred             cccccccccccccccc-ch-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCc
Confidence            3579999999999884 33 48899999999999999985 554 7889999999999885

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.46  E-value=0.00038  Score=62.67  Aligned_cols=158  Identities=12%  Similarity=0.041  Sum_probs=85.4

Q ss_pred             ccHHHHHHHhhccccccee-----eecCceEEEEEEcCCCCEEEEEEecCcchhhHHHHHHHHHHHHHHhhccCCCc--e
Q 013793          133 IFYEDLIEATEDFHIKYCI-----GTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRSI--V  205 (436)
Q Consensus       133 ~~~~~l~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v  205 (436)
                      ++-+|+.....+|.+.+..     ..|---+.|+....+|+ +++|+.+.....     +.+..|++++..+...++  .
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence            4567888888889876543     35556778999877665 899998654221     344556667777643222  1


Q ss_pred             eee------eEEeeCCEEEEEEeeccCCChhhhh--------------c----cC--CCCCCCC----------------
Q 013793          206 KLY------GFCLHKKCMFLIYEYMERGSLFCIL--------------H----ND--DEAVELD----------------  243 (436)
Q Consensus       206 ~l~------~~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~--~~~~~l~----------------  243 (436)
                      ..+      .+.........++.+..+.......              +    ..  .......                
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            111      1122345566777777664332111              0    00  0000000                


Q ss_pred             --HHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCCeEEeeccccc
Q 013793          244 --WAKRVNIVKAMAHALAYLHH-DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  296 (436)
Q Consensus       244 --~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  296 (436)
                        .......+......+.-.+. ....++||+|+.+.||+++++...-|.||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence              00111112222222222221 225689999999999999998777899999874

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.43  E-value=3e-06  Score=71.68  Aligned_cols=58  Identities=28%  Similarity=0.368  Sum_probs=47.7

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|+.|+|++|+|+ .||.....+++|+.|++++|+++. ++ .+..+++|+.+++++|.
T Consensus        69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~  126 (198)
T d1m9la_          69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNK  126 (198)
T ss_dssp             HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEE
T ss_pred             CccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccch
Confidence            468999999999998 788777777889999999999984 44 37778888888888775

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.34  E-value=5.5e-05  Score=64.15  Aligned_cols=57  Identities=30%  Similarity=0.413  Sum_probs=50.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|++|+|++|++++ +| .+++|++|++|++++|++++ +| .+..+++|+.+++.+|.
T Consensus        67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~  123 (210)
T d1h6ta2          67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNG  123 (210)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSC
T ss_pred             CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccccccc
Confidence            5799999999999995 66 47899999999999999994 66 48889999999998876

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.32  E-value=0.0001  Score=67.17  Aligned_cols=53  Identities=30%  Similarity=0.400  Sum_probs=45.6

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      +++|++|+|++|+|+ .||+.   +++|+.|+|++|+|+ .+|..   +++|+.+++++|+
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~  335 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNP  335 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCc
Confidence            368999999999999 89964   678999999999998 78863   4678889999997

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.25  E-value=7.5e-05  Score=64.58  Aligned_cols=59  Identities=15%  Similarity=0.223  Sum_probs=42.6

Q ss_pred             CCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCC-ccccccccCccccCCC
Q 013793            2 KNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPF-SNEQLSSMSRVRLSPN   60 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~l~~l~~~~~~~n   60 (436)
                      ++++.|||++|+++...+..|.+|++|++|+|++|.+...+|. .+..++++..+.+..+
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            4688888888888843334678888888888888888766554 4566777777766543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.19  E-value=9.8e-05  Score=63.25  Aligned_cols=57  Identities=23%  Similarity=0.303  Sum_probs=49.3

Q ss_pred             CCCCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      |++|+.|++++|+++ .++ .+.+|++|++|+|++|++++..|  +..+++++.+++.+|.
T Consensus        40 l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~   96 (227)
T d1h6ua2          40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP   96 (227)
T ss_dssp             HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred             cCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence            358999999999999 675 69999999999999999997544  7889999999998775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.12  E-value=0.0012  Score=61.42  Aligned_cols=72  Identities=21%  Similarity=0.232  Sum_probs=47.6

Q ss_pred             ceeeecCceEEEEEEcCC--------CCEEEEEEecCcchhhHHHHHHHHHHHHHHhhcc-CCCceeeeeEEeeCCEEEE
Q 013793          149 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRSIVKLYGFCLHKKCMFL  219 (436)
Q Consensus       149 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  219 (436)
                      +.|+-|-.=.+|++..++        .+.|.+++.......     ....+|..+++.+. +.-..++++++.+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-----idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            457778888999997654        346777776533221     33457888888884 4334467776643    58


Q ss_pred             EEeeccCCCh
Q 013793          220 IYEYMERGSL  229 (436)
Q Consensus       220 v~e~~~~g~L  229 (436)
                      |+||++|..+
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.07  E-value=0.00026  Score=64.26  Aligned_cols=41  Identities=24%  Similarity=0.291  Sum_probs=29.8

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCeeeccccccCCCCCCcccc
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYLNLSWNKLSGPVPFSNEQ   48 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~   48 (436)
                      +|+.||||+|+|+ ++|+.   +++|++|+||+|+|+ .+|..+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~~   79 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQS   79 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCTT
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchhh
Confidence            5778888888887 67753   456788888888887 67765443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.83  E-value=0.00035  Score=62.00  Aligned_cols=58  Identities=19%  Similarity=0.256  Sum_probs=33.6

Q ss_pred             CCCCEEECcCC-cccccCChhccCCCCCCeeeccc-cccCCCCCCccccccccCccccCC
Q 013793            2 KNLTWLDISNN-KIEGSIPGELTDLSRLDYLNLSW-NKLSGPVPFSNEQLSSMSRVRLSP   59 (436)
Q Consensus         2 ~~l~~l~ls~n-~l~g~ip~~~~~l~~L~~l~ls~-N~l~g~~p~~~~~l~~l~~~~~~~   59 (436)
                      ++|++|||++| .+++..+..++++++|++|+|++ ++++..-...++++++|+.+++.+
T Consensus       175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~  234 (284)
T d2astb2         175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG  234 (284)
T ss_dssp             TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence            45666666654 35555566666666666666666 345544444455556666666544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.75  E-value=0.00012  Score=65.20  Aligned_cols=60  Identities=32%  Similarity=0.376  Sum_probs=51.8

Q ss_pred             CCCCEEECcCCccccc-CChhccCCCCCCeeeccccccCCCCCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGS-IPGELTDLSRLDYLNLSWNKLSGPVPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~-ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .+|++||||+|.+++. ++..+.++++|++|+|++|++++..+..++++++|+.++++++.
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~  106 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS  106 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccc
Confidence            4799999999998755 56667899999999999999998888888889999999998754

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.60  E-value=0.00033  Score=56.46  Aligned_cols=55  Identities=25%  Similarity=0.273  Sum_probs=41.8

Q ss_pred             CCCCCEEECcCCcccccCCh-hccCCCCCCeeeccccccCCCCCCc-------cccccccCccc
Q 013793            1 MKNLTWLDISNNKIEGSIPG-ELTDLSRLDYLNLSWNKLSGPVPFS-------NEQLSSMSRVR   56 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~ip~-~~~~l~~L~~l~ls~N~l~g~~p~~-------~~~l~~l~~~~   56 (436)
                      +++|+.||||+|.++ .+++ .......|+.|+|++|.+++.....       +..+++|+.|+
T Consensus        90 l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          90 APNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             STTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             CCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            578999999999999 6664 4445567999999999998765532       34567777664

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.22  E-value=0.0014  Score=56.15  Aligned_cols=57  Identities=21%  Similarity=0.135  Sum_probs=27.2

Q ss_pred             CCCEEECcCCcccccCChhccCCCCCCee-eccccccCCCCCC-ccccccccCccccCCCC
Q 013793            3 NLTWLDISNNKIEGSIPGELTDLSRLDYL-NLSWNKLSGPVPF-SNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~ip~~~~~l~~L~~l-~ls~N~l~g~~p~-~~~~l~~l~~~~~~~n~   61 (436)
                      .++.|++++|+++ .+|....+.++++.+ ++++|+++ .+|. .|..+++|+.+++++|.
T Consensus       154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~  212 (242)
T d1xwdc1         154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTR  212 (242)
T ss_dssp             SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSC
T ss_pred             cceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCc
Confidence            3445555555555 344444344443333 34445555 3433 24455555555555553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.86  E-value=0.00058  Score=64.17  Aligned_cols=60  Identities=28%  Similarity=0.191  Sum_probs=40.6

Q ss_pred             CCCCEEECcCCccccc----CChhcc-CCCCCCeeeccccccCCC----CCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGS----IPGELT-DLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~----ip~~~~-~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~~~n~   61 (436)
                      .+|++||||+|+++..    ++..+. ..+.|++|+|++|+|+..    ++..+..+++|+.|++++|+
T Consensus       340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~  408 (460)
T d1z7xw1         340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC  408 (460)
T ss_dssp             SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred             cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCc
Confidence            4688888888887642    444444 356688888888888642    34445556778888887774

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.25  E-value=0.0016  Score=60.93  Aligned_cols=38  Identities=21%  Similarity=0.225  Sum_probs=24.8

Q ss_pred             CCCCEEECcCCccc----ccCChhccCCCCCCeeeccccccC
Q 013793            2 KNLTWLDISNNKIE----GSIPGELTDLSRLDYLNLSWNKLS   39 (436)
Q Consensus         2 ~~l~~l~ls~n~l~----g~ip~~~~~l~~L~~l~ls~N~l~   39 (436)
                      ++|++|+|++|+++    ..|+..+..+++|+.|||++|+++
T Consensus        27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1          27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence            56677777777665    244555666777777777777664

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=94.15  E-value=0.0043  Score=56.11  Aligned_cols=36  Identities=22%  Similarity=0.203  Sum_probs=15.8

Q ss_pred             CCCEEECcCCccccc-----CChhccCCCCCCeeecccccc
Q 013793            3 NLTWLDISNNKIEGS-----IPGELTDLSRLDYLNLSWNKL   38 (436)
Q Consensus         3 ~l~~l~ls~n~l~g~-----ip~~~~~l~~L~~l~ls~N~l   38 (436)
                      +|+.|+|++|+++..     +...+..+++|+.|+|++|.+
T Consensus       187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i  227 (344)
T d2ca6a1         187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  227 (344)
T ss_dssp             TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             hhcccccccccccccccccchhhhhcchhhhcccccccccc
Confidence            444555555544311     222334444455555555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=93.96  E-value=0.0051  Score=55.61  Aligned_cols=61  Identities=21%  Similarity=0.187  Sum_probs=45.2

Q ss_pred             CCCCCEEECcCCccccc----CChhccCCCCCCeeeccccccCCCCCCc----ccc--ccccCccccCCCC
Q 013793            1 MKNLTWLDISNNKIEGS----IPGELTDLSRLDYLNLSWNKLSGPVPFS----NEQ--LSSMSRVRLSPNK   61 (436)
Q Consensus         1 l~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~l~ls~N~l~g~~p~~----~~~--l~~l~~~~~~~n~   61 (436)
                      +++|+.|+|++|.++..    +...+..+++|+.|+|++|++++.-...    +..  ..+++.+++++|.
T Consensus       214 ~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~  284 (344)
T d2ca6a1         214 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE  284 (344)
T ss_dssp             CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred             hhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCc
Confidence            36899999999998643    5667889999999999999997531111    212  2468888888775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.23  E-value=0.0081  Score=48.12  Aligned_cols=60  Identities=13%  Similarity=0.163  Sum_probs=35.3

Q ss_pred             CCCCEEECcCC-ccccc----CChhccCCCCCCeeeccccccCCCCC----CccccccccCccccCCCC
Q 013793            2 KNLTWLDISNN-KIEGS----IPGELTDLSRLDYLNLSWNKLSGPVP----FSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n-~l~g~----ip~~~~~l~~L~~l~ls~N~l~g~~p----~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|+++ .++..    +=..+...+.|+.|+|++|.++..-.    ..+...+.|+.+++++|.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~   83 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNF   83 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSB
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhh
Confidence            56788888764 45322    22345566778888888887752211    122334567777777664

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=91.66  E-value=0.021  Score=45.60  Aligned_cols=60  Identities=18%  Similarity=0.186  Sum_probs=41.7

Q ss_pred             CCCCEEECcCCccccc----CChhccCCCCCCeeeccccccCCC----CCCccccccccCccccCCCC
Q 013793            2 KNLTWLDISNNKIEGS----IPGELTDLSRLDYLNLSWNKLSGP----VPFSNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~n~l~g~----ip~~~~~l~~L~~l~ls~N~l~g~----~p~~~~~l~~l~~~~~~~n~   61 (436)
                      ++|++|+|++|.+...    +-..+...+.|+.|+|++|+++..    +-..+..-++|+.|++++|.
T Consensus        44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~  111 (167)
T d1pgva_          44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  111 (167)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCc
Confidence            5689999999998632    223455678899999999988742    11123445678888887764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=84.01  E-value=0.13  Score=40.52  Aligned_cols=60  Identities=13%  Similarity=0.195  Sum_probs=38.5

Q ss_pred             CCCCEEECcC-Cccccc----CChhccCCCCCCeeeccccccCCCCCC----ccccccccCccccCCCC
Q 013793            2 KNLTWLDISN-NKIEGS----IPGELTDLSRLDYLNLSWNKLSGPVPF----SNEQLSSMSRVRLSPNK   61 (436)
Q Consensus         2 ~~l~~l~ls~-n~l~g~----ip~~~~~l~~L~~l~ls~N~l~g~~p~----~~~~l~~l~~~~~~~n~   61 (436)
                      ++|+.|+|++ |.++..    +=..+..++.|+.|+|++|.++..--.    .+...++++.+++.+|.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~   85 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF   85 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccc
Confidence            6789999987 456422    233455788899999999988643111    22334567777776654